PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Serebryany, E; Yu, SH; Trauger, SA; Budnik, B; Shakhnovich, EI				Serebryany, Eugene; Yu, Shuhuai; Trauger, Sunia A.; Budnik, Bogdan; Shakhnovich, Eugene I.			Dynamic disulfide exchange in a crystallin protein in the human eye lens promotes cataract-associated aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lens; crystallin; cataract; disulfide; protein aggregation; protein misfolding; conformational intermediates; disulfide exchange; oxidoreductase; redox mechanism	GAMMA-D-CRYSTALLIN; AMYOTROPHIC-LATERAL-SCLEROSIS; ALPHA-A-CRYSTALLIN; POSTTRANSLATIONAL MODIFICATIONS; BOND FORMATION; IN-VITRO; PROTEOMIC ANALYSIS; GLOBULAR-PROTEINS; CYSTEINE RESIDUES; MASS-SPECTROMETRY	Increased light scattering in the eye lens due to aggregation of the long-lived lens proteins, crystallins, is the cause of cataract disease. Several mutations in the gene encoding human D-crystallin (HD) cause misfolding and aggregation. Cataract-associated substitutions at Trp(42) cause the protein to aggregate in vitro from a partially unfolded intermediate locked by an internal disulfide bridge, and proteomic evidence suggests a similar aggregation precursor is involved in age-onset cataract. Surprisingly, WT HD can promote aggregation of the W42Q variant while itself remaining soluble. Here, a search for a biochemical mechanism for this interaction has revealed a previously unknown oxidoreductase activity in HD. Using in vitro oxidation, mutational analysis, cysteine labeling, and MS, we have assigned this activity to a redox-active internal disulfide bond that is dynamically exchanged among HD molecules. The W42Q variant acts as a disulfide sink, reducing oxidized WT and forming a distinct internal disulfide that kinetically traps the aggregation-prone intermediate. Our findings suggest a redox hot potato competition among WT and mutant or modified polypeptides wherein variants with the lowest kinetic stability are trapped in aggregation-prone intermediate states upon accepting disulfides from more stable variants. Such reactions may occur in other long-lived proteins that function in oxidizing environments. In these cases, aggregation may be forestalled by inhibiting disulfide flow toward mutant or damaged polypeptides.	[Serebryany, Eugene; Shakhnovich, Eugene I.] Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA; [Yu, Shuhuai] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China; [Trauger, Sunia A.] Harvard Univ, Small Mol Mass Spectrometry Core Facil, Fac Arts & Sci, Cambridge, MA 02138 USA; [Budnik, Bogdan] Harvard Univ, Mass Spectrometry & Prote Resource Lab, Fac Arts & Sci, Cambridge, MA 02138 USA	Harvard University; Jiangnan University; Harvard University; Harvard University	Shakhnovich, EI (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	shakhnovich@chemistry.harvard.edu	Budnik, Bogdan/AGG-8824-2022; Budnik, Bogdan/AAH-9987-2019	Budnik, Bogdan/0000-0003-3622-2003; 	National Institutes of Health [R01GM111955, F32GM126651]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM126651, R01GM111955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grants R01GM111955 (to E. I. S.) and F32GM126651 (to E. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; Bah A, 2016, J BIOL CHEM, V291, P6696, DOI 10.1074/jbc.R115.695056; Banerjee R, 2012, J BIOL CHEM, V287, P4397, DOI 10.1074/jbc.R111.287995; Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592; Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; Basilio D, 2014, NAT STRUCT MOL BIOL, V21, P456, DOI 10.1038/nsmb.2814; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Boscia F, 2000, INVEST OPHTH VIS SCI, V41, P2461; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Chang JY, 2001, J BIOL CHEM, V276, P4845, DOI 10.1074/jbc.M005160200; Cherian-Shaw M, 1999, MOL CELL BIOCHEM, V199, P163, DOI 10.1023/A:1006906615469; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Connors LH, 2007, BIOCHEMISTRY-US, V46, P14259, DOI 10.1021/bi7013773; Cook KM, 2013, ANTIOXID REDOX SIGN, V18, P1987, DOI 10.1089/ars.2012.4807; CREIGHTON TE, 1988, BIOESSAYS, V8, P57, DOI 10.1002/bies.950080204; de Graff AMR, 2016, STRUCTURE, V24, P329, DOI 10.1016/j.str.2015.11.006; Deis LN, 2014, STRUCTURE, V22, P1467, DOI 10.1016/j.str.2014.08.014; Derewenda U, 2009, BIOCHEMISTRY-US, V48, P8664, DOI 10.1021/bi900437z; Fan XJ, 2015, MOL CELL PROTEOMICS, V14, P3211, DOI 10.1074/mcp.M115.050948; Fass D, 2018, CHEM REV, V118, P293, DOI 10.1021/acs.chemrev.7b00123; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Forman-Kay JD, 2013, STRUCTURE, V21, P1492, DOI 10.1016/j.str.2013.08.001; FRIEDBURG D, 1973, EXP EYE RES, V15, P173, DOI 10.1016/0014-4835(73)90116-4; Fuchs SM, 2011, CURR BIOL, V21, P53, DOI 10.1016/j.cub.2010.11.058; Garcia-Manyes S, 2016, J BIOL CHEM, V291, P4226, DOI 10.1074/jbc.M115.673871; GIBLIN FJ, 1995, EXP EYE RES, V60, P219, DOI 10.1016/S0014-4835(05)80105-8; Go YM, 2015, FREE RADICAL BIO MED, V84, P227, DOI 10.1016/j.freeradbiomed.2015.03.022; GOODSON RJ, 1990, BIO-TECHNOL, V8, P343, DOI 10.1038/nbt0490-343; Grad LI, 2014, PRION, V8, P33, DOI 10.4161/pri.27602; Hains PG, 2007, J PROTEOME RES, V6, P3935, DOI 10.1021/pr070138h; Hains PG, 2008, BBA-PROTEINS PROTEOM, V1784, P1959, DOI 10.1016/j.bbapap.2008.07.016; Hanson SRA, 1998, EXP EYE RES, V67, P301, DOI 10.1006/exer.1998.0530; Hoehenwarter W, 2006, AMINO ACIDS, V30, P369, DOI 10.1007/s00726-005-0283-9; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Huang F, 2003, ANGEW CHEM INT EDIT, V42, P2269, DOI 10.1002/anie.200250684; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Ji FL, 2013, J BIOL CHEM, V288, P99, DOI 10.1074/jbc.M112.416354; Jones DP, 2010, J INTERN MED, V268, P432, DOI 10.1111/j.1365-2796.2010.02268.x; Karamanos TK, 2014, MOL CELL, V55, P214, DOI 10.1016/j.molcel.2014.05.026; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; Kong FR, 2011, PROTEIN SCI, V20, P513, DOI 10.1002/pro.583; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Lampi KJ, 2014, PROG BIOPHYS MOL BIO, V115, P21, DOI 10.1016/j.pbiomolbio.2014.02.004; Lapko VN, 2003, PROTEIN SCI, V12, P1762, DOI 10.1110/ps.0305403; Lapko VN, 2002, BIOCHEMISTRY-US, V41, P14645, DOI 10.1021/bi0267700; LOU MF, 1992, EXP EYE RES, V55, P889, DOI 10.1016/0014-4835(92)90015-K; Lou MF, 2003, PROG RETIN EYE RES, V22, P657, DOI 10.1016/S1350-9462(03)00050-8; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Ma ZX, 1998, EXP EYE RES, V67, P21, DOI 10.1006/exer.1998.0482; MCDERMOTT M, 1991, BIOCHEMISTRY-US, V30, P8653, DOI 10.1021/bi00099a023; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Mills IA, 2007, PROTEIN SCI, V16, P2427, DOI 10.1110/ps.072970207; Moran SD, 2013, BIOCHEMISTRY-US, V52, P6169, DOI 10.1021/bi4008353; Moreau KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037256; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Moreau KL, 2009, J BIOL CHEM, V284, P33285, DOI 10.1074/jbc.M109.031344; Murzin AG, 2008, SCIENCE, V320, P1725, DOI 10.1126/science.1158868; Oka OBV, 2015, BIOCHEM J, V469, P279, DOI 10.1042/BJ20141423; OZAKI Y, 1987, J BIOL CHEM, V262, P15445; Quintanar L, 2016, ACS CHEM BIOL, V11, P263, DOI 10.1021/acschembio.5b00919; Ramkumar S, 2018, BBA-MOL BASIS DIS, V1864, P3595, DOI 10.1016/j.bbadis.2018.08.021; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Ronzoni R, 2016, HUM MOL GENET, V25, P642, DOI 10.1093/hmg/ddv501; Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI [10.1089/ars.2009.2513, 10.1089/ARS.2009.2513]; Schafheimer N, 2013, PHOTOCHEM PHOTOBIOL, V89, P1106, DOI 10.1111/php.12096; Serebryany E, 2016, J BIOL CHEM, V291, P19172, DOI 10.1074/jbc.M116.735977; Serebryany E, 2016, PROTEIN SCI, V25, P1115, DOI 10.1002/pro.2924; Serebryany E, 2015, J BIOL CHEM, V290, P11491, DOI 10.1074/jbc.M114.621581; Serebryany E, 2014, PROG BIOPHYS MOL BIO, V115, P32, DOI 10.1016/j.pbiomolbio.2014.05.002; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Shang F, 2004, EXP EYE RES, V78, P1, DOI 10.1016/j.exer.2003.10.003; SIEZEN RJ, 1987, P NATL ACAD SCI USA, V84, P6088, DOI 10.1073/pnas.84.17.6088; SPECTOR A, 1978, P NATL ACAD SCI USA, V75, P3244, DOI 10.1073/pnas.75.7.3244; Su S, 2011, INVEST OPHTH VIS SCI, V52, P4182, DOI 10.1167/iovs.10-7094; Sweeney MHJ, 1998, EXP EYE RES, V67, P587, DOI 10.1006/exer.1998.0549; Takemoto LJ, 1996, BIOCHEM BIOPH RES CO, V223, P216, DOI 10.1006/bbrc.1996.0873; Takemoto LJ, 1997, CURR EYE RES, V16, P719, DOI 10.1076/ceyr.16.7.719.5055; Takemoto LJ, 1997, EXP EYE RES, V64, P609, DOI 10.1006/exer.1996.0247; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Trivedi MV, 2009, CURR PROTEIN PEPT SC, V10, P614, DOI 10.2174/138920309789630534; Truscott RJW, 2016, TRENDS BIOCHEM SCI, V41, P654, DOI 10.1016/j.tibs.2016.06.004; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang BL, 2017, AGING CELL, V16, P244, DOI 10.1111/acel.12548; Wang BB, 2011, HUM MUTAT, V32, pE1939, DOI 10.1002/humu.21386; Wang Y, 2016, ELIFE, V5, DOI [10.7554/elife.17505, 10.7554/eLife.17505]; Woycechowsky KJ, 2000, CURR OPIN CHEM BIOL, V4, P533, DOI 10.1016/S1367-5931(00)00128-9; Woycechowsky KJ, 2003, BIOCHEMISTRY-US, V42, P5387, DOI 10.1021/bi026993q; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Xin FX, 2012, BIOINFORMATICS, V28, P2905, DOI 10.1093/bioinformatics/bts541; YU NT, 1985, P NATL ACAD SCI USA, V82, P7965, DOI 10.1073/pnas.82.23.7965; Zougman A, 2014, PROTEOMICS, V14, P1006, DOI 10.1002/pmic.201300553	104	31	31	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17997	18009		10.1074/jbc.RA118.004551	http://dx.doi.org/10.1074/jbc.RA118.004551			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30242128	hybrid, Green Published			2022-12-28	WOS:000450409500027
J	Chang, AN; Gao, N; Liu, ZN; Huang, J; Nairn, AC; Kamm, KE; Stull, JT				Chang, Audrey N.; Gao, Ning; Liu, Zhenan; Huang, Jian; Nairn, Angus C.; Kamm, Kristine E.; Stull, James T.			The dominant protein phosphatase PP1c isoform in smooth muscle cells, PP1c beta, is essential for smooth muscle contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein phosphorylation; smooth muscle; myosin; muscle physiology; protein phosphatase; contraction; MYPT1; PP1c	MYOSIN LIGHT-CHAIN; TARGETING SUBUNIT-1 PHOSPHORYLATION; CONSTITUTIVE PHOSPHORYLATION; KINASE ACTIVATION; CATALYTIC SUBUNIT; FORCE GENERATION; BINDING; MECHANISM; ROLES; DIPHOSPHORYLATION	Contractile force development of smooth muscle is controlled by balanced kinase and phosphatase activities toward the myosin regulatory light chain (RLC). Numerous biochemical and pharmacological studies have investigated the specificity and regulatory activity of smooth muscle myosin light-chain phosphatase (MLCP) bound to myosin filaments and comprised of the regulatory myosin phosphatase target subunit 1 (MYPT1) and catalytic protein phosphatase 1c (PP1c) subunits. Recent physiological and biochemical evidence obtained with smooth muscle tissues from a conditional MYPT1 knockout suggests that a soluble, MYPT1-unbound form of PP1c may additionally contribute to myosin RLC dephosphorylation and relaxation of smooth muscle. Using a combination of isoelectric focusing and isoform-specific immunoblotting, we found here that more than 90% of the total PP1c in mouse smooth muscles is the isoform. Moreover, conditional knockout of PP1c or PP1c in adult smooth muscles did not result in an apparent phenotype in mice up to 6 months of age and did not affect smooth muscle contractions ex vivo. In contrast, smooth muscle-specific conditional PP1c knockout decreased contractile force development in bladder, ileal, and aortic tissues and reduced mouse survival. Bladder smooth muscle tissue from WT mice was selectively permeabilized to remove soluble PP1c to measure contributions of total (-toxin treatment) and myosin-bound (Triton X-100 treatment) phosphatase activities toward phosphorylated RLC in myofilaments. Triton X-100 reduced PP1c content by 60% and the rate of RLC dephosphorylation by 2-fold. These results are consistent with the selective dephosphorylation of RLC by both MYPT1-bound and -unbound PP1c forms in smooth muscle.	[Chang, Audrey N.; Gao, Ning; Liu, Zhenan; Huang, Jian; Kamm, Kristine E.; Stull, James T.] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Chang, Audrey N.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University	Chang, AN (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.; Chang, AN (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	audreyn.chang@utsouthwestern.edu		Nairn, Angus/0000-0002-7075-0195	American Heart Association Scientist Development Grant; National Institutes of Health [DA10044, R01 HL112778, R01 HL080536]; Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080536, R01HL112778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by an American Heart Association Scientist Development Grant (to A. N. C.), National Institutes of Health Grants DA10044 (to A. C. N) and R01 HL112778 and R01 HL080536 (to J. T. S.), the Moss Heart Fund (to J. T. S.), and the Fouad A. and Val Imm Bashour Distinguished Chair in Physiology (to J. T. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Brautigan DL, 2013, FEBS J, V280, P324, DOI 10.1111/j.1742-4658.2012.08609.x; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; CASSIDY P, 1979, J BIOL CHEM, V254, P1148; Chang AN, 2016, J MOL CELL CARDIOL, V101, P35, DOI 10.1016/j.yjmcc.2016.10.004; Chang AN, 2016, P NATL ACAD SCI USA, V113, pE3824, DOI 10.1073/pnas.1600633113; Chang AN, 2015, J BIOL CHEM, V290, P10703, DOI 10.1074/jbc.M115.642165; Chen CP, 2015, J PHYSIOL-LONDON, V593, P681, DOI 10.1113/jphysiol.2014.283853; Chen MJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag1796; CHEN YH, 1994, FEBS LETT, V356, P51, DOI 10.1016/0014-5793(94)01231-8; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Cohen PTW, 2002, J CELL SCI, V115, P241; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Dippold RP, 2014, AM J PHYSIOL-REG I, V307, pR256, DOI 10.1152/ajpregu.00145.2014; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Fisher SA, 2010, PHYSIOL GENOMICS, V42A, P169, DOI 10.1152/physiolgenomics.00111.2010; FUSSLE R, 1981, J CELL BIOL, V91, P83, DOI 10.1083/jcb.91.1.83; Gao N, 2017, J PHYSIOL-LONDON, V595, P6231, DOI 10.1113/JP274715; Gao N, 2016, J PHYSIOL-LONDON, V594, P3209, DOI 10.1113/JP271703; Gao N, 2013, J BIOL CHEM, V288, P7596, DOI 10.1074/jbc.M112.427112; GARDNER JP, 1989, PFLUG ARCH EUR J PHY, V414, P484, DOI 10.1007/BF00585061; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Hartshorne DJ, 1998, ACTA PHYSIOL SCAND, V164, P483; Hatch V, 2001, J CELL BIOL, V154, P611, DOI 10.1083/jcb.200105079; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; He WQ, 2013, GASTROENTEROLOGY, V144, P1456, DOI 10.1053/j.gastro.2013.02.045; He WQ, 2011, AM J PHYSIOL-HEART C, V301, pH584, DOI 10.1152/ajpheart.01212.2010; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Hong F, 2011, ARCH BIOCHEM BIOPHYS, V510, P135, DOI 10.1016/j.abb.2011.04.018; Huang J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193769; IIZUKA K, 1994, CELL CALCIUM, V16, P431, DOI 10.1016/0143-4160(94)90073-6; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; KAMM KE, 1989, J BIOL CHEM, V264, P21223; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Khasnis M, 2014, BIOCHEMISTRY-US, V53, P2701, DOI 10.1021/bi5001728; Kitazawa T, 1999, J PHYSIOL-LONDON, V520, P139, DOI 10.1111/j.1469-7793.1999.00139.x; Kuang SQ, 2012, CIRC RES, V110, P1411, DOI 10.1161/CIRCRESAHA.111.261743; Lin PJ, 1999, J BIOL CHEM, V274, P5987, DOI 10.1074/jbc.274.9.5987; Liu RJ, 2015, J MOL CELL CARDIOL, V87, P204, DOI 10.1016/j.yjmcc.2015.08.018; Mabuchi Y, 2010, BIOCHEMISTRY-US, V49, P2903, DOI 10.1021/bi901963e; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Milewicz DM, 2017, ARTERIOSCL THROM VAS, V37, P26, DOI 10.1161/ATVBAHA.116.303229; Mizuno Y, 2008, AM J PHYSIOL-CELL PH, V295, pC358, DOI 10.1152/ajpcell.90645.2007; Moffat LD, 2011, J BIOL CHEM, V286, P36978, DOI 10.1074/jbc.M111.257949; PATO MD, 1983, EUR J BIOCHEM, V132, P283, DOI 10.1111/j.1432-1033.1983.tb07360.x; PATO MD, 1983, J BIOL CHEM, V258, P7047; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Qiao YN, 2014, J BIOL CHEM, V289, P22512, DOI 10.1074/jbc.M113.525444; Scotto-Lavino E, 2010, J BIOL CHEM, V285, P6419, DOI 10.1074/jbc.M109.074773; SHIMIZU H, 1994, J BIOL CHEM, V269, P30407; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Smith L, 2000, FEBS LETT, V480, P298, DOI 10.1016/S0014-5793(00)01931-1; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Tsai MH, 2014, J PHYSIOL-LONDON, V592, P3031, DOI 10.1113/jphysiol.2014.273011; Tsai MH, 2012, J PHYSIOL-LONDON, V590, P5107, DOI 10.1113/jphysiol.2012.235424; Verbinnen I, 2017, BIOCHEM SOC T, V45, P89, DOI 10.1042/BST20160154; Walsh MP, 2011, IUBMB LIFE, V63, P987, DOI 10.1002/iub.527; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Watanabe T, 2003, METHOD ENZYMOL, V366, P321; Wilson DP, 2005, BIOCHEM J, V392, P641, DOI 10.1042/BJ20051173; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Zhang WC, 2010, J BIOL CHEM, V285, P5522, DOI 10.1074/jbc.M109.062836; ZHANG ZJ, 1992, J BIOL CHEM, V267, P1484	66	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16677	16686		10.1074/jbc.RA118.003083	http://dx.doi.org/10.1074/jbc.RA118.003083			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30185619	Green Published, hybrid			2022-12-28	WOS:000448515100011
J	Kohno, M; Arakawa, T; Ota, H; Mori, T; Nishimoto, T; Fushinobu, S				Kohno, Masaki; Arakawa, Takatoshi; Ota, Hiromi; Mori, Tetsuya; Nishimoto, Tomoyuki; Fushinobu, Shinya			Structural features of a bacterial cyclic alpha-maltosyl-(1 -> 6)-maltose (CMM) hydrolase critical for CMM recognition and hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; crystal structure; X-ray crystallography; carbohydrate metabolism; oligosaccharide; amylase; carbohydrate degradation; cyclic oligosaccharides; cyclodextrins; neopullulanase; CMM catabolism; hydrolytic enzyme	VULGARIS R-47 ALPHA-AMYLASE-2; BACILLUS-GLOBISPORUS C-11; ARTHROBACTER-GLOBIFORMIS STRAIN; CYCLODEXTRIN-BINDING-PROTEIN; X-RAY STRUCTURE; THERMOACTINOMYCES-VULGARIS; ALPHA-AMYLASE; SUBSTRATE-BINDING; STEAROTHERMOPHILUS NEOPULLULANASE; ANGSTROM RESOLUTION	Cyclic -maltosyl-(16)-maltose (CMM, cyclo-{6)--d-Glcp-(14)--d-Glcp-(16)--d-Glcp-(14)--d-Glcp-(1})is a cyclic glucotetrasaccharide with alternating -1,4 and -1,6 linkages. CMM is composed of two maltose units and is one of the smallest cyclic glucooligosaccharides. Although CMM is resistant to usual amylases, it is efficiently hydrolyzed by CMM hydrolase (CMMase), belonging to subfamily 20 of glycoside hydrolase family 13 (GH13_20). Here, we determined the ligand-free crystal structure of CMMase from the soil-associated bacterium Arthrobacter globiformis and its structures in complex with maltose, panose, and CMM to elucidate the structural basis of substrate recognition by CMMase. The structures disclosed that although the monomer structure consists of three domains commonly adopted by GH13 and other -amylase-related enzymes, CMMase forms a unique wing-like dimer structure. The complex structure with CMM revealed four specific subsites, namely -3, -2, -1, and +1. We also observed that the bound CMM molecule adopts a low-energy conformer compared with the X-ray structure of a single CMM crystal, also determined here. Comparison of the CMMase active site with those in other enzymes of the GH13_20 family revealed that three regions forming the wall of the cleft, denoted PYF (Pro-203/Tyr-204/Phe-205), CS (Cys-163/Ser-164), and Y (Tyr-168), are present only in CMMase and are involved in CMM recognition. Combinations of multiple substitutions in these regions markedly decreased the activity toward CMM, indicating that the specificity for this cyclic tetrasaccharide is supported by the entire shape of the pocket. In summary, our work uncovers the mechanistic basis for the highly specific interactions of CMMase with its substrate CMM.	[Kohno, Masaki; Arakawa, Takatoshi; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Arakawa, Takatoshi; Fushinobu, Shinya] Univ Tokyo, Collaborat Res Inst Innovat Microbiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Kohno, Masaki; Mori, Tetsuya; Nishimoto, Tomoyuki] Hayashibara Co Ltd, R&D Div, Naka Ku, 675-1 Fujisaki, Okayama 7028006, Japan; [Ota, Hiromi] Okayama Univ, Adv Sci Res Ctr, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan	University of Tokyo; University of Tokyo; Okayama University	Fushinobu, S (corresponding author), Univ Tokyo, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Arakawa, Takatoshi/K-9739-2013; Ota, Hiromi/AAE-4359-2019; Fushinobu, Shinya/E-4987-2011	Arakawa, Takatoshi/0000-0001-6496-5440; Fushinobu, Shinya/0000-0003-1346-6435	Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED)	Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by the Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED). The authors declare that they have no conflicts of interest with the contents of this article.	Aga H, 2002, J BIOSCI BIOENG, V94, P336, DOI 10.1263/jbb.94.336; Aga H, 2002, BIOSCI BIOTECH BIOCH, V66, P1057, DOI 10.1271/bbb.66.1057; Biwer A, 2002, APPL MICROBIOL BIOT, V59, P609, DOI 10.1007/s00253-002-1057-x; Bradbrook GM, 2000, CARBOHYD RES, V329, P655, DOI 10.1016/S0008-6215(00)00212-3; Choi JH, 2009, BIOCHEM BIOPH RES CO, V378, P224, DOI 10.1016/j.bbrc.2008.11.020; COTE GL, 1994, EUR J BIOCHEM, V226, P641, DOI 10.1111/j.1432-1033.1994.tb20091.x; DOWD MK, 1994, BIOPOLYMERS, V34, P625, DOI 10.1002/bip.360340505; Dumbrepatil AB, 2010, PROTEINS, V78, P348, DOI 10.1002/prot.22548; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank M, 2007, NUCLEIC ACIDS RES, V35, pD287, DOI 10.1093/nar/gkl907; Guo JX, 2018, ACTA CRYSTALLOGR D, V74, P305, DOI 10.1107/S2059798318001754; Hashimoto Y, 2001, J BACTERIOL, V183, P5050, DOI 10.1128/JB.183.17.5050-5057.2001; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hondoh H, 2003, J MOL BIOL, V326, P177, DOI 10.1016/S0022-2836(02)01402-X; Huitema C., 2018, BIORXIV2018316588, DOI [10.1101/316588., DOI 10.1101/316588]; Ito K, 2007, BBA-PROTEINS PROTEOM, V1774, P443, DOI 10.1016/j.bbapap.2007.02.006; Janecek S, 1997, J MOL EVOL, V45, P322, DOI 10.1007/PL00006236; Jung TY, 2012, J BIOL CHEM, V287, P7979, DOI 10.1074/jbc.M111.304774; Kamasaka H, 2002, APPL ENVIRON MICROB, V68, P1658, DOI 10.1128/AEM.68.4.1658-1664.2002; Kamionka A, 2001, FEMS MICROBIOL LETT, V204, P55, DOI 10.1111/j.1574-6968.2001.tb10862.x; Kamitori S, 1999, J MOL BIOL, V287, P907, DOI 10.1006/jmbi.1999.2647; Kamitori S, 2002, J MOL BIOL, V318, P443, DOI 10.1016/S0022-2836(02)00111-0; Kim YK, 2004, CARBOHYD RES, V339, P1179, DOI 10.1016/j.carres.2004.02.008; Kondo S, 2001, J BIOCHEM, V129, P423, DOI 10.1093/oxfordjournals.jbchem.a002873; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee HS, 2002, J BIOL CHEM, V277, P21891, DOI 10.1074/jbc.M201623200; Light SH, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.202; Light SH, 2017, STRUCTURE, V25, P295, DOI 10.1016/j.str.2016.12.007; Lima HOS, 1998, APPL BIOCHEM BIOTECH, V70-2, P789, DOI 10.1007/BF02920189; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Machius M, 1998, STRUCTURE, V6, P281, DOI 10.1016/S0969-2126(98)00032-X; Mori T., 2009, Journal of Applied Glycoscience, V56, P127; Mori T., 2011, Journal of Applied Glycoscience, V58, P39, DOI 10.5458/jag.jag.JAG-2010_011; Mori T, 2008, BIOSCI BIOTECH BIOCH, V72, P1673, DOI 10.1271/bbb.70759; Mukai K, 2006, APPL ENVIRON MICROB, V72, P1065, DOI 10.1128/AEM.72.2.1065-1071.2006; Mukai K, 2005, CARBOHYD RES, V340, P1469, DOI 10.1016/j.carres.2005.03.010; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimoto T, 2002, BIOSCI BIOTECH BIOCH, V66, P1806, DOI 10.1271/bbb.66.1806; OGUMA T, 1993, BIOSCI BIOTECH BIOCH, V57, P1225, DOI 10.1271/bbb.57.1225; OGUMA T, 1994, FEBS LETT, V345, P135, DOI 10.1016/0014-5793(94)00418-8; Ohtaki A, 2004, J BIOL CHEM, V279, P31033, DOI 10.1074/jbc.M404311200; Ohtaki A, 2001, CARBOHYD RES, V334, P309, DOI 10.1016/S0008-6215(01)00190-2; Ohtaki A, 2006, CARBOHYD RES, V341, P1041, DOI 10.1016/j.carres.2006.01.029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pajatsch M, 1998, J BACTERIOL, V180, P2630, DOI 10.1128/JB.180.10.2630-2635.1998; PALOHEIMO M, 1992, APPL MICROBIOL BIOT, V36, P584; Park JT, 2013, BBA-PROTEINS PROTEOM, V1834, P380, DOI 10.1016/j.bbapap.2012.08.001; Schardinger F., 1903, NAHR U GENUSSM, V6, P865, DOI DOI 10.1007/BF02067497; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Tagami T, 2016, J BIOL CHEM, V291, P16438, DOI 10.1074/jbc.M116.727305; TAKATA H, 1992, J BIOL CHEM, V267, P18447; TONOZUKA T, 1995, BBA-PROTEIN STRUCT M, V1252, P35, DOI 10.1016/0167-4838(95)00101-Y; Uitdehaag JCM, 2001, PROTEINS, V43, P327, DOI 10.1002/prot.1044; Utsumi Y, 2009, J APPL GLYCOSCI, V56, P215, DOI [DOI 10.5458/JAG.56.215, 10.5458/jag.56.215]; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Watanabe H, 2006, CARBOHYD RES, V341, P957, DOI 10.1016/j.carres.2006.02.028; Watanabe H, 2006, BIOSCI BIOTECH BIOCH, V70, P2690, DOI 10.1271/bbb.60294; Watanabe H, 2006, BIOSCI BIOTECH BIOCH, V70, P1954, DOI 10.1271/bbb.60131; Yopi Tonozuka T., 2002, J APPL GLYCOSCI, V49, P107, DOI [10.5458/jag.49.107, DOI 10.5458/JAG.49.107]	59	4	4	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16874	16888		10.1074/jbc.RA118.004472	http://dx.doi.org/10.1074/jbc.RA118.004472			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30181215	Green Published, hybrid			2022-12-28	WOS:000448515100027
J	Shevket, SH; Gonzalez, D; Cartwright, JL; Kleanthous, C; Ferguson, SJ; Redfield, C; Mavridou, DAI				Shevket, Shevket H.; Gonzalez, Diego; Cartwright, Jared L.; Kleanthous, Colin; Ferguson, Stuart J.; Redfield, Christina; Mavridou, Despoina A. I.			The CcmC-CcmE interaction during cytochrome c maturation by System I is driven by protein-protein and not protein-heme contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome c; heme; post-translational modification (PTM); Gram-negative bacteria; nuclear magnetic resonance (NMR); CcmC; CcmE; cytochrome c maturation; protein-protein interactions; System I	BIOGENESIS SYSTEM; ESCHERICHIA-COLI; CHAPERONE CCME; APOCYTOCHROME-C; NMR-SPECTROSCOPY; LIGATION COMPLEX; BINDING SITE; TRAFFICKING; PATHWAY; BACTERIA	Cytochromes c are ubiquitous proteins, essential for life in most organisms. Their distinctive characteristic is the covalent attachment of heme to their polypeptide chain. This post-translational modification is performed by a dedicated protein system, which in many Gram-negative bacteria and plant mitochondria is a nine-protein apparatus (CcmA-I) called System I. Despite decades of study, mechanistic understanding of the protein-protein interactions in this highly complex maturation machinery is still lacking. Here, we focused on the interaction of CcmC, the protein that sources the heme cofactor, with CcmE, the pivotal component of System I responsible for the transfer of the heme to the apocytochrome. Using in silico analyses, we identified a putative interaction site between these two proteins (residues Asp(47), Gln(50), and Arg(55) on CcmC; Arg(73), Asp(101), and Glu(105) on CcmE), and we validated our findings by in vivo experiments in Escherichia coli. Moreover, employing NMR spectroscopy, we examined whether a heme-binding site on CcmE contributes to this interaction and found that CcmC and CcmE associate via protein-protein rather than protein-heme contacts. The combination of in vivo site-directed mutagenesis studies and high-resolution structural techniques enabled us to determine at the residue level the mechanism for the formation of one of the key protein complexes for cytochrome c maturation by System I.	[Mavridou, Despoina A. I.] Imperial Coll London, Dept Life Sci, MRC, Ctr Mol Bacteriol & Infect, London SW7 2DD, England; [Shevket, Shevket H.; Kleanthous, Colin; Ferguson, Stuart J.; Redfield, Christina] Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England; [Gonzalez, Diego] Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, Quartier UNIL Sorge, Lausanne, Switzerland; [Cartwright, Jared L.] Univ York, Dept Biol, Biosci Technol Facil, Wentworth Way, York YO10 5DD, N Yorkshire, England	Imperial College London; University of Oxford; University of Lausanne; University of York - UK	Mavridou, DAI (corresponding author), Imperial Coll London, Dept Life Sci, MRC, Ctr Mol Bacteriol & Infect, London SW7 2DD, England.; Ferguson, SJ; Redfield, C (corresponding author), Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England.	stuart.ferguson@bioch.ox.ac.uk; christina.redfield@bioch.ox.ac.uk; d.mavridou@imperial.ac.uk	Mavridou, Despoina/ABG-5940-2020	Mavridou, Despoina/0000-0002-7449-1151; Gonzalez, Diego/0000-0003-3414-1461; Redfield, Christina/0000-0001-7297-7708	Medical Research Council (MRC) [MR/M009505/1]; institutional MRC studentship; Swiss National Science Foundation [P2LAP3_155109, P300PA_167703]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/N006445/1]; BBSRC [BB/N006445/1] Funding Source: UKRI; MRC [MR/M009505/1] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); institutional MRC studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by Medical Research Council (MRC) Career Development Award MR/M009505/1 (to D. A. I. M.), an institutional MRC studentship (to S. H. S), Swiss National Science Foundation Postdoc Mobility Fellowships P2LAP3_155109 and P300PA_167703 (to D. G.), and Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/N006445/1 (to S. J. F). The authors declare that they have no conflicts of interest with the contents of this article.	Allen JWA, 2011, FEBS J, V278, P4198, DOI 10.1111/j.1742-4658.2011.08231.x; Allen JWA, 2002, J BIOL CHEM, V277, P33559, DOI 10.1074/jbc.M204963200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMBLER RP, 1991, BIOCHIM BIOPHYS ACTA, V1058, P42, DOI 10.1016/S0005-2728(05)80266-X; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Babbitt SE, 2015, TRENDS BIOCHEM SCI, V40, P446, DOI 10.1016/j.tibs.2015.05.006; Barker PD, 1999, STRUCTURE, V7, pR281, DOI 10.1016/S0969-2126(00)88334-3; Bartsch R. G., 1971, METHODS ENZYMOL, V23, P344, DOI [10.1016/S0076-6879(71)23110-4, DOI 10.1016/S0076-6879(71)23110-4]; BECKMAN DL, 1992, GENE DEV, V6, P268, DOI 10.1101/gad.6.2.268; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; Christensen O, 2007, FEBS J, V274, P2322, DOI 10.1111/j.1742-4658.2007.05769.x; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Daltrop O, 2002, P NATL ACAD SCI USA, V99, P9703, DOI 10.1073/pnas.152120699; de Vitry C, 2011, FEBS J, V278, P4189, DOI 10.1111/j.1742-4658.2011.08373.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Matteo A, 2007, J BIOL CHEM, V282, P27012, DOI 10.1074/jbc.M702702200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Enggist E, 2003, J BACTERIOL, V185, P175, DOI 10.1128/JB.185.1.175-183.2003; Enggist E, 2002, STRUCTURE, V10, P1551, DOI 10.1016/S0969-2126(02)00885-7; Feissner RE, 2006, MOL MICROBIOL, V61, P219, DOI 10.1111/j.1365-2958.2006.05221.x; Garcia-Rubio I, 2007, BIOPHYS J, V92, P1361, DOI 10.1529/biophysj.106.098277; Goldman BS, 1998, P NATL ACAD SCI USA, V95, P5003, DOI 10.1073/pnas.95.9.5003; GOODHEW CF, 1986, BIOCHIM BIOPHYS ACTA, V852, P288, DOI 10.1016/0005-2728(86)90234-3; Han D, 2008, PROTEINS, V70, P900, DOI 10.1002/prot.21597; Harvat EM, 2009, BIOCHEMISTRY-US, V48, P1820, DOI 10.1021/bi801609a; HUSSAIN H, 1994, MOL MICROBIOL, V12, P153, DOI 10.1111/j.1365-2958.1994.tb01004.x; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; Mavridou DAI, 2007, J MOL BIOL, V370, P643, DOI 10.1016/j.jmb.2007.04.038; Mavridou DAI, 2013, BIOCHEMISTRY-US, V52, P7262, DOI 10.1021/bi400398t; Mavridou DAI, 2013, IUBMB LIFE, V65, P209, DOI 10.1002/iub.1123; Mavridou DAI, 2012, FEBS LETT, V586, P1702, DOI 10.1016/j.febslet.2012.04.055; Mavridou DAI, 2012, J BIOL CHEM, V287, P2342, DOI 10.1074/jbc.M111.313692; Moore G. R., 1990, CYTOCHROMES C EVOLUT; Ouyang N, 2006, PROTEINS, V65, P1021, DOI 10.1002/prot.21184; Ovchinnikov S, 2014, ELIFE, V3, DOI 10.7554/eLife.02030; Page MD, 1997, MOL MICROBIOL, V24, P977, DOI 10.1046/j.1365-2958.1997.4061775.x; PEARCE DA, 1995, J BIOL CHEM, V270, P20879, DOI 10.1074/jbc.270.36.20879; RAMSEIER TM, 1991, J BIOL CHEM, V266, P7793; Rayapuram N, 2008, J BIOL CHEM, V283, P25200, DOI 10.1074/jbc.M802621200; Ren Q, 2002, J BIOL CHEM, V277, P7657, DOI 10.1074/jbc.M110979200; Richard-Fogal C, 2010, J MOL BIOL, V401, P350, DOI 10.1016/j.jmb.2010.06.041; Richard-Fogal CL, 2008, J BACTERIOL, V190, P3489, DOI 10.1128/JB.00146-08; Richard-Fogal CL, 2009, EMBO J, V28, P2349, DOI 10.1038/emboj.2009.189; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; SAMBONGI Y, 1994, FEBS LETT, V340, P65, DOI 10.1016/0014-5793(94)80174-6; Sanders C, 2008, J BIOL CHEM, V283, P29715, DOI 10.1074/jbc.M805413200; Sanders C, 2010, TRENDS MICROBIOL, V18, P266, DOI 10.1016/j.tim.2010.03.006; Schulz H, 1998, SCIENCE, V281, P1197, DOI 10.1126/science.281.5380.1197; Schulz H, 2000, MOL MICROBIOL, V37, P1379, DOI 10.1046/j.1365-2958.2000.02083.x; Shimizu H, 2001, BIOCHEMISTRY-US, V40, P13483, DOI 10.1021/bi011481h; Simon J, 2011, FEBS J, V278, P4179, DOI 10.1111/j.1742-4658.2011.08374.x; Stevens JM, 2003, J BIOL CHEM, V278, P20500, DOI 10.1074/jbc.M212925200; Stevens JM, 2011, FEBS J, V278, P4170, DOI 10.1111/j.1742-4658.2011.08376.x; Sutherland MC, 2018, J MOL BIOL, V430, P1065, DOI [10.1016/j.jmb.2018.02.021, 10.1016/j.jmb.2018.01.022]; Sutherland MC, 2016, BIOCHEMISTRY-US, V55, P3150, DOI 10.1021/acs.biochem.6b00427; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; THONYMEYER L, 1994, MOL MICROBIOL, V12, P1, DOI 10.1111/j.1365-2958.1994.tb00988.x; ThonyMeyer L, 1997, EUR J BIOCHEM, V246, P794, DOI 10.1111/j.1432-1033.1997.t01-1-00794.x; Uchida T, 2004, J BIOL CHEM, V279, P51981, DOI 10.1074/jbc.M408963200; Verissimo AF, 2017, J BIOL CHEM, V292, P13154, DOI 10.1074/jbc.M117.794586; Verissimo AF, 2014, BBA-BIOENERGETICS, V1837, P989, DOI 10.1016/j.bbabio.2014.03.003; Verissimo AF, 2011, J BIOL CHEM, V286, P40452, DOI 10.1074/jbc.M111.277764; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449	65	5	5	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16778	16790		10.1074/jbc.RA118.005024	http://dx.doi.org/10.1074/jbc.RA118.005024			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30206118	Green Published, hybrid			2022-12-28	WOS:000448515100019
J	Valach, M; Leveille-Kunst, A; Gray, MW; Burger, G				Valach, Matus; Leveille-Kunst, Alexandra; Gray, Michael W.; Burger, Gertraud			Respiratory chain Complex I of unparalleled divergence in diplonemids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electron transfer; mitochondrial respiratory chain complex; proteomics; protozoan; RNA editing; mitochondria; NADH-dehydrogenase; respirasome; supercomplex	ELECTRON-TRANSPORT CHAIN; MULTIPLE SEQUENCE ALIGNMENT; MEMBRANE-PROTEIN COMPLEXES; ARABIDOPSIS-THALIANA; SUBUNIT COMPOSITION; NATIVE ELECTROPHORESIS; TARGETING SEQUENCES; ACCESSORY SUBUNITS; TRYPANOSOMA-BRUCEI; MASS-SPECTROMETRY	Mitochondrial genes of Euglenozoa (Kinetoplastida, Diplonemea, and Euglenida) are notorious for being barely recognizable, raising the question of whether such divergent genes actually code for functional proteins. Here we demonstrate the translation and identify the function of five previously unassigned y genes encoded by mitochondrial DNA (mtDNA) of diplonemids. As is the rule in diplonemid mitochondria, y genes are fragmented, with gene pieces transcribed separately and then trans-spliced to form contiguous mRNAs. Further, y transcripts undergo massive RNA editing, including uridine insertions that generate up to 16-residue-long phenylalanine tracts, a feature otherwise absent from conserved mitochondrial proteins. By protein sequence analyses, MS, and enzymatic assays in Diplonema papillatum, we show that these y genes encode the subunits Nad2, -3, -4L, -6, and -9 of the respiratory chain Complex I (CI; NADH:ubiquinone oxidoreductase). The few conserved residues of these proteins are essentially those involved in proton pumping across the inner mitochondrial membrane and in coupling ubiquinone reduction to proton pumping (Nad2, -3, -4L, and -6) and in interactions with subunits containing electron-transporting Fe-S clusters (Nad9). Thus, in diplonemids, 10 CI subunits are mtDNA-encoded. Further, MS of D. papillatum CI allowed identification of 26 conventional and 15 putative diplonemid-specific nucleus-encoded components. Most conventional accessory subunits are well-conserved but unusually long, possibly compensating for the streamlined mtDNA-encoded components and for missing, otherwise widely distributed, conventional subunits. Finally, D. papillatum CI predominantly exists as a supercomplex I:III:IV that is exceptionally stable, making this protist an organism of choice for structural studies.	[Valach, Matus; Leveille-Kunst, Alexandra; Burger, Gertraud] Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada; [Valach, Matus; Leveille-Kunst, Alexandra; Burger, Gertraud] Univ Montreal, Robert Cedergren Ctr Bioinformat & Genom, Montreal, PQ H3T 1J4, Canada; [Gray, Michael W.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Gray, Michael W.] Dalhousie Univ, Ctr Comparat Genom & Evolutionary Bioinformat, Halifax, NS B3H 4R2, Canada	Universite de Montreal; Universite de Montreal; Dalhousie University; Dalhousie University	Valach, M; Burger, G (corresponding author), Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada.; Valach, M; Burger, G (corresponding author), Univ Montreal, Robert Cedergren Ctr Bioinformat & Genom, Montreal, PQ H3T 1J4, Canada.	matus.a.valach@gmail.com; gertraud.burger@umontreal.ca		Leveille-Kunst, Alexandra/0000-0003-2644-5334; Valach, Matus/0000-0001-8689-0080	Canadian Institute of Health Research (CIHR) Operating Grant [MOP-79309]; Gordon and Betty Moore Foundation Grant [GBMF-4983]; NSERC [RGPIN-2014-05286]	Canadian Institute of Health Research (CIHR) Operating Grant(Canadian Institutes of Health Research (CIHR)); Gordon and Betty Moore Foundation Grant; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institute of Health Research (CIHR) Operating Grant MOP-79309 (to G.B.), Gordon and Betty Moore Foundation Grant GBMF-4983 (to G.B.), and NSERC Grant RGPIN-2014-05286 (to G.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Acestor N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006908; Agip ANA, 2018, NAT STRUCT MOL BIOL, V25, P548, DOI 10.1038/s41594-018-0073-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angerer Heike, 2015, Biology-Basel, V4, P133, DOI 10.3390/biology4010133; Angerer H, 2014, P NATL ACAD SCI USA, V111, P5207, DOI 10.1073/pnas.1322438111; Angerer H, 2011, BIOCHEM J, V437, P279, DOI 10.1042/BJ20110359; Baeza-Delgado C, 2013, EUR BIOPHYS J BIOPHY, V42, P199, DOI 10.1007/s00249-012-0813-9; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Blaza JN, 2018, STRUCTURE, V26, P312, DOI 10.1016/j.str.2017.12.014; Bridges HR, 2010, MOL CELL PROTEOMICS, V9, P2318, DOI 10.1074/mcp.M110.001255; Burger G, 2003, NUCLEIC ACIDS RES, V31, P2353, DOI 10.1093/nar/gkg326; Burger G, 2016, TRENDS GENET, V32, P553, DOI 10.1016/j.tig.2016.06.005; Burger G, 2013, GENOME BIOL EVOL, V5, P418, DOI 10.1093/gbe/evt008; Cardol P, 2004, BBA-BIOENERGETICS, V1658, P212, DOI 10.1016/j.bbabio.2004.06.001; Cardol P, 2011, BBA-BIOENERGETICS, V1807, P1390, DOI 10.1016/j.bbabio.2011.06.015; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davies KM, 2018, P NATL ACAD SCI USA, V115, P3024, DOI 10.1073/pnas.1720702115; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; Di Luca A, 2017, P NATL ACAD SCI USA, V114, pE6314, DOI 10.1073/pnas.1706278114; Duarte M, 2014, J BIOENERG BIOMEMBR, V46, P299, DOI 10.1007/s10863-014-9556-x; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellens KW, 2017, NUCLEIC ACIDS RES, V45, P11495, DOI 10.1093/nar/gkx937; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Faux NG, 2005, GENOME RES, V15, P537, DOI 10.1101/gr.3096505; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Formosa LE, 2018, SEMIN CELL DEV BIOL, V76, P154, DOI 10.1016/j.semcdb.2017.08.011; Fromm S, 2016, NEW PHYTOL, V211, P194, DOI 10.1111/nph.13886; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200; Gawryluk RMR, 2012, BBA-BIOENERGETICS, V1817, P2027, DOI 10.1016/j.bbabio.2012.06.005; Gawryluk RMR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-176; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Hirst Judy, 2011, Biochem J, V437, pe1, DOI 10.1042/BJ20110918; Hosler JP, 2006, ANNU REV BIOCHEM, V75, P165, DOI 10.1146/annurev.biochem.75.062003.101730; Junge W, 2015, ANNU REV BIOCHEM, V84, P631, DOI 10.1146/annurev-biochem-060614-034124; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kannan S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-455; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kiethega GN, 2013, RNA BIOL, V10, P301, DOI 10.4161/rna.23340; Kiethega GN, 2011, MOL BIOL EVOL, V28, P2425, DOI 10.1093/molbev/msr075; Klodmann J, 2010, PLANT CELL, V22, P797, DOI 10.1105/tpc.109.073726; Kumar AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166854; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Letts JA, 2017, NAT STRUCT MOL BIOL, V24, P800, DOI 10.1038/nsmb.3460; Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774; Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lukes J, 2015, CURR BIOL, V25, pR702, DOI 10.1016/j.cub.2015.04.052; Lukes J, 2011, IUBMB LIFE, V63, P528, DOI 10.1002/iub.489; Mach J, 2013, GENOME BIOL EVOL, V5, P860, DOI 10.1093/gbe/evt056; Marande W, 2005, EUKARYOT CELL, V4, P1137, DOI 10.1128/EC.4.6.1137-1146.2005; Marande W, 2007, SCIENCE, V318, P415, DOI 10.1126/science.1148033; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Meyer EH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00106; Meyer EH, 2011, J BIOL CHEM, V286, P26081, DOI 10.1074/jbc.M110.209601; Milenkovic D, 2017, CELL METAB, V25, P765, DOI 10.1016/j.cmet.2017.03.009; Moreira S, 2016, NUCLEIC ACIDS RES, V44, P4907, DOI 10.1093/nar/gkw188; Morgner N, 2008, BBA-BIOENERGETICS, V1777, P1384, DOI 10.1016/j.bbabio.2008.08.001; Opperdoes FR, 2008, TRENDS PARASITOL, V24, P310, DOI 10.1016/j.pt.2008.03.013; Cordoba JP, 2016, J EXP BOT, V67, P1589, DOI 10.1093/jxb/erv556; Perez E, 2014, MITOCHONDRION, V19, P338, DOI 10.1016/j.mito.2014.02.001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rich PR, 2017, BIOCHEM SOC T, V45, P813, DOI 10.1042/BST20160139; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Senkler J, 2017, PLANT J, V89, P1079, DOI 10.1111/tpj.13448; Smith DGS, 2007, J MOL BIOL, V374, P837, DOI 10.1016/j.jmb.2007.09.051; Soo RM, 2017, SCIENCE, V355, P1436, DOI 10.1126/science.aal3794; Sorokina M, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-10; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754; Subrahmanian N, 2016, BBA-BIOENERGETICS, V1857, P1001, DOI 10.1016/j.bbabio.2016.01.009; Surve S, 2012, EUKARYOT CELL, V11, P183, DOI 10.1128/EC.05282-11; Suthammarak W, 2013, AGING CELL, V12, P1132, DOI 10.1111/acel.12144; Tashyreva D, 2018, PROTIST, V169, P158, DOI 10.1016/j.protis.2018.02.001; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Valach M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14286-z; Valach M, 2016, RNA BIOL, V13, P1204, DOI 10.1080/15476286.2016.1240143; Valach M, 2014, NUCLEIC ACIDS RES, V42, P2660, DOI 10.1093/nar/gkt1152; van der Sluis EO, 2015, GENOME BIOL EVOL, V7, P1235, DOI 10.1093/gbe/evv061; Verkhovskaya M, 2013, INT J BIOCHEM CELL B, V45, P491, DOI 10.1016/j.biocel.2012.08.024; White SH, 2008, ANNU REV BIOPHYS, V37, P23, DOI 10.1146/annurev.biophys.37.032807.125904; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012; Xia D, 2013, BBA-BIOENERGETICS, V1827, P1278, DOI 10.1016/j.bbabio.2012.11.008; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095	104	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16043	16056		10.1074/jbc.RA118.005326	http://dx.doi.org/10.1074/jbc.RA118.005326			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30166340	hybrid, Green Published			2022-12-28	WOS:000447256000024
J	Whitley, SK; Balasubramani, A; Zindl, CL; Sen, R; Shibata, Y; Crawford, GE; Weathington, NM; Hatton, RD; Weaver, CT				Whitley, Sarah K.; Balasubramani, Anand; Zindl, Carlene L.; Sen, Ranjan; Shibata, Yoichiro; Crawford, Gregory E.; Weathington, Nathaniel M.; Hatton, Robin D.; Weaver, Casey T.			IL-1R signaling promotes STAT3 and NF-kappa B factor recruitment to distal cis-regulatory elements that regulate Il17a/f transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin immunoprecipitation (ChiP); DNA-protein interaction; NF-kappa B (NF-KB); STAT3; interleukin 17A (IL-17 or IL-17A); interleukin 1 (IL-1)	INTERFERON-GAMMA PRODUCTION; HYPER-IGE SYNDROME; CD4(+) T-CELLS; C-REL; LYMPHOCYTE-PROLIFERATION; GENE-EXPRESSION; T(H)17 CELLS; DIFFERENTIATION; CYTOKINE; GENERATION	Interleukin (IL)-1 beta plays a critical role in IL-6-beta- and transforming growth factor beta (TGF beta)-initiated Th17 differentiation and induction of Th17-mediated autoimmunity. However, the means by which IL-1 regulates various aspects of Th17 development remain poorly understood. We recently reported that IL-1 beta enhances STAT3 phosphorylation via NF-kappa B-mediated repression of SOCS3 to facilitate Il17 transcription and Th17 differentiation, identifying an effect of IL-1 signaling on proximal events of STAT3 signaling. Here, we show that IL-1 beta promotes STAT3 binding to key cis-elements that control IL-17 expression. Additionally, we demonstrate that the IL-1-induced NF-kappa B factor RelA directly regulates the Il17a/f loci in cooperation with STAT3. Our findings reveal that IL-1 impacts both proximal signaling events and downstream interactions between transcription factors and cis-regulatory elements to promote Il17a/f transcription and Th17 differentiation.	[Whitley, Sarah K.; Balasubramani, Anand; Weaver, Casey T.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Zindl, Carlene L.; Hatton, Robin D.; Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Sen, Ranjan] NIA, Lab Cellular & Mol Biol, NIH, Baltimore, MD 21224 USA; [Shibata, Yoichiro; Crawford, Gregory E.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Weathington, Nathaniel M.] Univ Pittsburgh, Dept Med, Med Ctr, 930 Scaife Hall, Pittsburgh, PA 15213 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Whitley, SK (corresponding author), Univ Pittsburgh, Med Ctr, Dept Dermatol, 200 Lothrop St,W1028 BST, Pittsburgh, PA 15261 USA.	whitleysk@upmc.edu		Zindl, Carlene/0000-0003-4841-3552; Hatton, Robin/0000-0002-4797-9899	National Institutes of Health [R01AI035783, R01DK103744, R01DK115172]; UAB Medical Scientist Training Program - National Institutes of Health [T32 GM008361]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL126135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK115172, R01DK103744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB Medical Scientist Training Program - National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01AI035783 and R01DK103744 (to C. T. W.) and R01DK115172 (to C. T. W. and R. D. H.), and the UAB Medical Scientist Training Program (to S. K. W.), supported by National Institutes of Health Grant T32 GM008361. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balasubramani A, 2010, IMMUNITY, V33, P35, DOI 10.1016/j.immuni.2010.07.004; Basu R, 2015, NAT IMMUNOL, V16, P286, DOI 10.1038/ni.3099; Chen GB, 2010, J IMMUNOL, V185, P2350, DOI 10.4049/jimmunol.1000317; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Hwang ES, 2010, YONSEI MED J, V51, P484, DOI 10.3349/ymj.2010.51.4.484; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Lee YK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186351; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Molinero LL, 2012, P NATL ACAD SCI USA, V109, P18529, DOI 10.1073/pnas.1204557109; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Steinbrecher KA, 2008, J IMMUNOL, V180, P2588, DOI 10.4049/jimmunol.180.4.2588; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Suzuki N, 2002, TRENDS IMMUNOL, V23, P503, DOI 10.1016/S1471-4906(02)02298-6; Visekruna A, 2010, EUR J IMMUNOL, V40, P671, DOI 10.1002/eji.200940260; Wendt KS, 2009, CHROMOSOME RES, V17, P201, DOI 10.1007/s10577-008-9017-7; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	41	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15790	15800		10.1074/jbc.RA118.002721	http://dx.doi.org/10.1074/jbc.RA118.002721			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30093408	hybrid, Green Published			2022-12-28	WOS:000447256000004
J	Qiu, RD; Zhang, J; Xiang, X				Qiu, Rongde; Zhang, Jun; Xiang, Xin			p25 of the dynactin complex plays a dual role in cargo binding and dynactin regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dynein; kinesin; microtubule; molecular motor; cytoskeleton; Aspergillus; dynactin; endosome; intracellular transport; p25	ACTIN-RELATED PROTEIN; MICROTUBULE PLUS-END; DYNEIN HEAVY-CHAIN; EARLY-ENDOSOME INTERACTION; LONG-DISTANCE MOVEMENT; ASPERGILLUS-NIDULANS; CYTOPLASMIC DYNEIN; IN-VIVO; POINTED-END; ORGANELLE TRANSPORT	Cytoplasmic dynein binds its cargoes via the dynactin complex and cargo adapters, and the dynactin pointed-end protein p25 is required for dynein-dynactin binding to the early endosomal dynein adapter HookA (Hook in the fungus Aspergillus nidulans). However, it is unclear whether the HookA-dynein-dynactin interaction requires p27, another pointed-end protein forming heterodimers with p25 within vertebrate dynactin. Here, live-cell imaging and biochemical pulldown experiments revealed that although p27 is a component of the dynactin complex in A. nidulans, it is dispensable for dynein-dynactin to interact with C-HookA (cytosolic HookA lacking its early endosome-binding C terminus) and is not critical for dynein-mediated early endosome transport. Using mutagenesis, imaging, and biochemical approaches, we found that several p25 regions are required for the C-HookA-dynein-dynactin interaction, with the N terminus and loop1 being the most critical regions. Interestingly, p25 was also important for the microtubule (MT) plus-end accumulation of dynactin. This p25 function in dynactin localization also involved p25's N terminus and the loop1 critical for the C-HookA-dynein-dynactin interaction. Given that dynactin's MT plus-end localization does not require HookA and that the kinesin-1-dependent plus-end accumulation of dynactin is unnecessary for the C-HookA-dynein-dynactin interaction, our results indicate that p25 plays a dual role in cargo binding and dynactin regulation. As cargo adapters are implicated in dynein activation via binding to dynactin's pointed end to switch the conformation of p150, a major dynactin component, our results suggest p25 as a critical pointed-end protein involved in this process.	[Qiu, Rongde; Zhang, Jun; Xiang, Xin] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Xiang, X (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA.	xin.xiang@usuhs.edu		Qiu, Rongde/0000-0003-2078-9718	National Institutes of Health [RO1 GM097580, RO1 GM121850]; Uniformed Services University bridge grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097580, P01GM068087, R01GM121850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uniformed Services University bridge grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants RO1 GM097580 and RO1 GM121850 (to X. X.) and a Uniformed Services University bridge grant (to X. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abenza JF, 2010, MOL BIOL CELL, V21, P2756, DOI 10.1091/mbc.E10-02-0119; Abenza JF, 2009, TRAFFIC, V10, P57, DOI 10.1111/j.1600-0854.2008.00848.x; Bielska E, 2014, J CELL BIOL, V204, P989, DOI 10.1083/jcb.201309022; Cheong FKY, 2014, MOL BIOL CELL, V25, P2171, DOI 10.1091/mbc.E14-03-0842; Chowdhury S, 2015, NAT STRUCT MOL BIOL, V22, P345, DOI 10.1038/nsmb.2996; Cianfrocco MA, 2015, ANNU REV CELL DEV BI, V31, P83, DOI 10.1146/annurev-cellbio-100814-125438; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; Efimov VP, 2006, MOL BIOL CELL, V17, P2021, DOI 10.1091/mbc.E05-11-1084; Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101; Grotjahn DA, 2018, NAT STRUCT MOL BIOL, V25, P203, DOI 10.1038/s41594-018-0027-7; Guo XL, 2016, P NATL ACAD SCI USA, V113, pE5318, DOI 10.1073/pnas.1601844113; Han GS, 2001, CURR BIOL, V11, P719, DOI 10.1016/S0960-9822(01)00200-7; HOLZBAUR ELF, 1991, NATURE, V351, P579, DOI 10.1038/351579a0; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Konzack S, 2005, MOL BIOL CELL, V16, P497, DOI 10.1091/mbc.E04-02-0083; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; Lee IH, 2001, MOL BIOL CELL, V12, P2195, DOI 10.1091/mbc.12.7.2195; Lee IG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03412-8; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Li SH, 2005, MOL BIOL CELL, V16, P3591, DOI 10.1091/mbc.E04-12-1071; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Minke PF, 1999, MOL MICROBIOL, V32, P1065, DOI 10.1046/j.1365-2958.1999.01421.x; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Olenick MA, 2016, J BIOL CHEM, V291, P18239, DOI 10.1074/jbc.M116.738211; Parisi G, 2004, FEBS LETT, V562, P1, DOI 10.1016/S0014-5793(04)00165-6; Penalva MA, 2017, MOL BIOL CELL, V28, P947, DOI 10.1091/mbc.E16-08-0566; Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006; Qiu RD, 2013, J BIOL CHEM, V288, P2271, DOI 10.1074/jbc.M112.412403; Raaijmakers JA, 2013, J CELL BIOL, V201, P201, DOI 10.1083/jcb.201208098; Reck-Peterson SL, 2018, NAT REV MOL CELL BIO, V19, P382, DOI 10.1038/s41580-018-0004-3; Riquelme M, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00068-17; SCHAFER DA, 1994, J CELL BIOL, V126, P403, DOI 10.1083/jcb.126.2.403; Schlager MA, 2014, EMBO J, V33, P1855, DOI 10.15252/embj.201488792; Schroeder CM, 2016, J CELL BIOL, V214, P309, DOI 10.1083/jcb.201604002; Schroeder CM, 2014, ELIFE, V3, DOI 10.7554/eLife.03351; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210; Steinberg G, 2018, FUNGAL KINGDOM, P231, DOI 10.1128/microbiolspec.FUNK-0034-2016; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Urnavicius L, 2018, NATURE, V554, P202, DOI 10.1038/nature25462; Urnavicius L, 2015, SCIENCE, V347, P1441, DOI 10.1126/science.aaa4080; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Wedlich-Soldner R, 2002, EMBO J, V21, P2946, DOI 10.1093/emboj/cdf296; Wu XF, 2006, TRENDS CELL BIOL, V16, P135, DOI 10.1016/j.tcb.2006.01.004; Xiang X, 2000, CURR BIOL, V10, P603, DOI 10.1016/S0960-9822(00)00488-7; XIANG X, 1995, P NATL ACAD SCI USA, V92, P9890, DOI 10.1073/pnas.92.21.9890; Xiang X, 2015, CELL MOL LIFE SCI, V72, P3267, DOI 10.1007/s00018-015-1926-y; Xu L, 2008, MOL BIOL CELL, V19, P5059, DOI 10.1091/mbc.E08-05-0473; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; Yao XL, 2014, MOL BIOL CELL, V25, P2181, DOI 10.1091/mbc.E14-04-0873; Yao XL, 2012, TRAFFIC, V13, P375, DOI 10.1111/j.1600-0854.2011.01312.x; Yeh TY, 2013, EMBO J, V32, P1023, DOI 10.1038/emboj.2013.30; Yeh TY, 2012, MOL BIOL CELL, V23, P3827, DOI 10.1091/mbc.E12-07-0496; Zeng CJT, 2014, MOL MICROBIOL, V94, P506, DOI 10.1111/mmi.12792; Zhang J, 2003, MOL BIOL CELL, V14, P1479, DOI 10.1091/mbc.E02-08-0516; Zhang J, 2008, TRAFFIC, V9, P1073, DOI 10.1111/j.1600-0854.2008.00748.x; Zhang J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29818-4; Zhang J, 2014, J CELL BIOL, V204, P1009, DOI 10.1083/jcb.201308009; Zhang J, 2013, CYTOSKELETON, V70, P215, DOI 10.1002/cm.21102; Zhang J, 2011, J CELL BIOL, V193, P1245, DOI 10.1083/jcb.201011022; Zhang J, 2010, J CELL SCI, V123, P3596, DOI 10.1242/jcs.075259; Zheng WJ, 2017, BIOCHEMISTRY-US, V56, P313, DOI 10.1021/acs.biochem.6b01002; Zhuang L, 2007, GENETICS, V175, P1185, DOI 10.1534/genetics.106.069013	71	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15606	15619		10.1074/jbc.RA118.004000	http://dx.doi.org/10.1074/jbc.RA118.004000			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30143531	hybrid, Green Published			2022-12-28	WOS:000446549200024
J	Son, YO; Pratheeshkumar, P; Roy, RV; Hitron, JA; Wang, L; Zhang, Z; Shi, XL				Son, Young-Ok; Pratheeshkumar, Poyil; Roy, Ram Vinod; Hitron, John Andrew; Wang, Lei; Zhang, Zhuo; Shi, Xianglin			RETRACTION: Nrf2/p62 signaling in apoptosis resistance and its role in cadmium-induced carcinogenesis (Retraction of Vol 289, Pg 28660, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Son YO, 2014, J BIOL CHEM, V289, P28660, DOI 10.1074/jbc.M114.595496	1	0	0	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15455	15455		10.1074/jbc.W118.005757	http://dx.doi.org/10.1074/jbc.W118.005757			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30291176	hybrid, Green Published			2022-12-28	WOS:000446549200010
J	Boyle, KA; Van Wickle, J; Hill, RB; Marchese, A; Kalyanaraman, B; Dwinell, MB				Boyle, Kathleen A.; Van Wickle, Jonathan; Hill, R. Blake; Marchese, Adriano; Kalyanaraman, Balaraman; Dwinell, Michael B.			Mitochondria-targeted drugs stimulate mitophagy and abrogate colon cancer cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); cancer biology; cell growth; mitophagy; mitochondrial metabolism; colon cancer; KRAS proto-oncogene; cell proliferation; metformin	ACTIVATED PROTEIN-KINASE; COLORECTAL-CANCER; CARCINOMA-CELLS; IN-VIVO; S6 KINASE; AUTOPHAGY; GROWTH; PHOSPHORYLATION; ANTIOXIDANT; THERAPY	Mutations in the KRAS proto-oncogene are present in 50% of all colorectal cancers and are increasingly associated with chemotherapeutic resistance to frontline biologic drugs. Accumulating evidence indicates key roles for overactive KRAS mutations in the metabolic reprogramming from oxidative phosphorylation to aerobic glycolysis in cancer cells. Here, we sought to exploit the more negative membrane potential of cancer cell mitochondria as an untapped avenue for interfering with energy metabolism in KRAS variant-containing and KRAS WT colorectal cancer cells. Mitochondrial function, intracellular ATP levels, cellular uptake, energy sensor signaling, and functional effects on cancer cell proliferation were assayed. 3-Carboxyl proxyl nitroxide (Mito-CP) and Mito-Metformin, two mitochondria-targeted compounds, depleted intracellular ATP levels and persistently inhibited ATP-linked oxygen consumption in both KRAS WT and KRAS variant-containing colon cancer cells and had only limited effects on nontransformed intestinal epithelial cells. These anti-proliferative effects reflected the activation of AMP-activated protein kinase (AMPK) and the phosphorylation-mediated suppression of the mTOR target ribosomal protein S6 kinase B1 (RPS6KB1 or p70S6K). Moreover, Mito-CP and Mito-Metformin released Unc-51-like autophagy-activating kinase 1 (ULK1) from mTOR-mediated inhibition, affected mitochondrial morphology, and decreased mitochondrial membrane potential, all indicators of mitophagy. Pharmacological inhibition of the AMPK signaling cascade mitigated the anti-proliferative effects of Mito-CP and Mito-Metformin. This is the first demonstration that drugs selectively targeting mitochondria induce mitophagy in cancer cells. Targeting bioenergetic metabolism with mitochondria-targeted drugs to stimulate mitophagy provides an attractive approach for therapeutic intervention in KRAS WT and overactive mutant-expressing colon cancer.	[Boyle, Kathleen A.; Van Wickle, Jonathan; Dwinell, Michael B.] Med Coll Wisconsin, Dept Microbiol & Immunol, Milwaukee, WI 53226 USA; [Hill, R. Blake; Marchese, Adriano] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Dwinell, Michael B.] Med Coll Wisconsin, Dept Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Boyle, Kathleen A.; Hill, R. Blake; Marchese, Adriano; Kalyanaraman, Balaraman; Dwinell, Michael B.] Med Coll Wisconsin, MCW Canc Ctr, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Dwinell, MB (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mdwinell@mcw.edu			NCI, National Institutes of Health [U01 CA178960, R01 CA152810]; Medical College of Wisconsin Cancer Center; Advancing a Healthier Wisconsin Endowment; Bobbie Nick Voss Charitable Foundation; NATIONAL CANCER INSTITUTE [R01CA152810, U01CA178960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067180, R01GM122889] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical College of Wisconsin Cancer Center; Advancing a Healthier Wisconsin Endowment; Bobbie Nick Voss Charitable Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NCI, National Institutes of Health Grants U01 CA178960 (to M. B. D. and B. K.) and R01 CA152810 (to B. K.), the Medical College of Wisconsin Cancer Center (to M. B. D. and B. K.), the Advancing a Healthier Wisconsin Endowment (to M. B. D.), and the Bobbie Nick Voss Charitable Foundation continuing philanthropic donations (to M. B. D.). M. B. D. has ownership interests in Protein Foundry, LLC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; American Cancer Society, CANC FACTS FIG 2017; Beckham TH, 2013, J PHARMACOL EXP THER, V344, P167, DOI 10.1124/jpet.112.199216; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Burada F, 2015, WORLD J GASTRO ONCOL, V7, P271, DOI 10.4251/wjgo.v7.i11.271; Callahan J, 2006, BIOMACROMOLECULES, V7, P2347, DOI 10.1021/bm060336m; Chandran K, 2009, BIOPHYS J, V96, P1388, DOI 10.1016/j.bpj.2008.10.042; Cheng G, 2014, BRIT J CANCER, V111, P85, DOI 10.1038/bjc.2014.272; Cheng G, 2016, CANCER RES, V76, P3904, DOI 10.1158/0008-5472.CAN-15-2534; Cheng G, 2015, CANCER LETT, V365, P96, DOI 10.1016/j.canlet.2015.05.016; Cheng G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-285; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cunniff B, 2013, J CELL PHYSIOL, V228, P835, DOI 10.1002/jcp.24232; Czarny P, 2015, INT J MOL SCI, V16, P2641, DOI 10.3390/ijms16022641; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Dhanasekaran A, 2005, FREE RADICAL BIO MED, V39, P567, DOI 10.1016/j.freeradbiomed.2005.04.016; Dilip A, 2013, ANTI-CANCER DRUG, V24, P881, DOI 10.1097/CAD.0b013e32836442c6; Divakaruni AS, 2013, P NATL ACAD SCI USA, V110, P5422, DOI 10.1073/pnas.1303360110; Dong LF, 2011, FREE RADICAL BIO MED, V50, P1546, DOI 10.1016/j.freeradbiomed.2011.02.032; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Ellington AA, 2005, CARCINOGENESIS, V26, P159, DOI 10.1093/carcin/bgh297; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Higurashi T, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-118; Hosono K, 2010, MOL CARCINOGEN, V49, P662, DOI 10.1002/mc.20637; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Masui K, 2014, TRENDS ENDOCRIN MET, V25, P364, DOI 10.1016/j.tem.2014.04.002; Millard M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013131; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Modica-Napolitano JS, 2001, ADV DRUG DELIVER REV, V49, P63, DOI 10.1016/S0169-409X(01)00125-9; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Murphy MP, 1997, TRENDS BIOTECHNOL, V15, P326, DOI 10.1016/S0167-7799(97)01068-8; NADAKAVUKAREN KK, 1985, CANCER RES, V45, P6093; Neufeld TP, 2010, CURR OPIN CELL BIOL, V22, P157, DOI 10.1016/j.ceb.2009.11.005; Panda PK, 2015, SEMIN CELL DEV BIOL, V39, P43, DOI 10.1016/j.semcdb.2015.02.013; Patel BB, 2008, INT J CANCER, V122, P267, DOI 10.1002/ijc.23097; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Psahoulia FH, 2007, CARCINOGENESIS, V28, P1021, DOI 10.1093/carcin/bgl232; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Rao VA, 2010, J BIOL CHEM, V285, P34447, DOI 10.1074/jbc.M110.133579; Rodriguez-Enriquez S, 2012, BBA-BIOENERGETICS, V1817, P1597, DOI 10.1016/j.bbabio.2012.05.005; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Senft D, 2016, CURR OPIN CELL BIOL, V39, P43, DOI 10.1016/j.ceb.2016.02.001; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Smith JM, 2005, AM J PHYSIOL-GASTR L, V288, pG316, DOI 10.1152/ajpgi.00208.2004; Smith RAJ, 1999, EUR J BIOCHEM, V263, P709, DOI 10.1046/j.1432-1327.1999.00543.x; Smith RAJ, 2003, P NATL ACAD SCI USA, V100, P5407, DOI 10.1073/pnas.0931245100; Smith RAJ, 2008, ANN NY ACAD SCI, V1147, P105, DOI 10.1196/annals.1427.003; Starenki D, 2013, J CLIN ENDOCR METAB, V98, P1529, DOI 10.1210/jc.2012-3671; Stipanuk MH, 2009, NUTR REV, V67, P677, DOI 10.1111/j.1753-4887.2009.00252.x; SUMMERHAYES IC, 1982, P NATL ACAD SCI-BIOL, V79, P5292, DOI 10.1073/pnas.79.17.5292; Tchevkina E., 2012, PROTEIN PHOSPHORYLAT, P1, DOI [10.5772/2944, DOI 10.5772/2944]; Tomimoto A, 2008, CANCER SCI, V99, P2136, DOI 10.1111/j.1349-7006.2008.00933.x; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wendt MK, 2006, ONCOGENE, V25, P4986, DOI 10.1038/sj.onc.1209505; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Yin N, 2017, J BIOL CHEM, V292, P15070, DOI 10.1074/jbc.M117.779488; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang ZJ, 2011, DIABETES CARE, V34, P2323, DOI 10.2337/dc11-0512; Zhao BZ, 2016, GENES DIS, V3, P82, DOI 10.1016/j.gendis.2015.12.002; Zielonka J, 2017, CHEM REV, V117, P10043, DOI 10.1021/acs.chemrev.7b00042	76	70	70	3	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14891	14904		10.1074/jbc.RA117.001469	http://dx.doi.org/10.1074/jbc.RA117.001469			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30087121	hybrid, Green Published			2022-12-28	WOS:000446155000024
J	Kleinpeter, AB; Jureka, AS; Falahat, SM; Green, TJ; Petit, CM				Kleinpeter, Alex B.; Jureka, Alexander S.; Falahat, Sally M.; Green, Todd J.; Petit, Chad M.			Structural analyses reveal the mechanism of inhibition of influenza virus NS1 by two antiviral compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						influenza; nuclear magnetic resonance (NMR); antiviral agent; protein structure; viral protein; viral replication; influenza virus; 1918 H1N1; 2013 H7N9; CPSF30; nonstructural protein 1; NS1	A VIRUS; EFFECTOR DOMAIN; CHEMICAL-SHIFT; NONSTRUCTURAL PROTEIN-1; SEASONAL INFLUENZA; DIMER INTERFACE; CPSF30 BINDING; RESISTANCE; SURVEILLANCE; SUBSTITUTION	The influenza virus is a significant public health concern causing 250,000-500,000 deaths worldwide each year. Its ability to change quickly results in the potential for rapid generation of pandemic strains for which most individuals would have no antibody protection. This pandemic potential highlights the need for the continuous development of new drugs against influenza virus. As an essential component and well established virulence determinant, NS1 (nonstructural protein 1) of influenza virus is a highly prioritized target for the development of anti-influenza compounds. Here, we used NMR to determine that the NS1 effector domain (NS1(ED)) derived from the A/Brevig Mission/1/1918 (H1N1) strain of influenza (1918(H1N1)) binds to two previously described anti-influenza compounds A9 (JJ3297) and A22. We then used X-ray crystallography to determine the three-dimensional structure of the 1918(H1N1) NS1(ED). Further-more, we mapped the A9/A22-binding site onto our 1918(H1N1) NS1(ED) structure and determined that A9 and A22 interact with the NS1(ED) in the hydrophobic pocket known to facilitate binding to the 30-kDa subunit of the cleavage and polyadenylation specificity factor (CPSF30), suggesting that the two compounds likely attenuate influenza replication by inhibiting the NS1(ED)-CPSF30 interaction. Finally, our structure revealed that NS1(ED) could dimerize via an interface that we termed the alpha(3)-alpha(3) dimer. Taken together, the findings presented here provide strong evidence for the mechanism of action of two anti-influenza compounds that target NS1 and contribute significant structural insights into NS1 that we hope will promote and inform the development and optimization of influenza therapies based on A9/A22.	[Kleinpeter, Alex B.; Jureka, Alexander S.; Falahat, Sally M.; Petit, Chad M.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Green, Todd J.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Petit, CM (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	cpetit@uab.edu	Kleinpeter, Alex/AAO-9289-2020	Jureka, Alexander/0000-0001-6839-1835; Kleinpeter, Alex/0000-0001-5630-1345; Green, Todd/0000-0003-1158-4710	National Institutes of Health [R01 AI1346931, R01 AI116738]; NCI, National Institutes of Health [1P30 CA-13148]; National Center for Research Resources [1S10 RR022994-01A1]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116738, R01AI134693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 AI1346931 (to C. M. P.) and R01 AI116738 (to T. J. G). This work was supported in part by NCI, National Institutes of Health Grants 1P30 CA-13148 and 1P30 CA-13148, National Center for Research Resources Grant 1S10 RR022994-01A1 and by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abed Y, 2005, ANTIMICROB AGENTS CH, V49, P556, DOI 10.1128/AAC.49.2.556-559.2005; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aramini JM, 2014, STRUCTURE, V22, P515, DOI 10.1016/j.str.2014.01.010; Aramini JM, 2011, J BIOL CHEM, V286, P26050, DOI 10.1074/jbc.M111.248765; Ayllon J, 2015, CURR TOP MICROBIOL, V386, P73, DOI 10.1007/82_2014_400; Ayllon J, 2014, J VIROL, V88, P12146, DOI 10.1128/JVI.01567-14; Basu D, 2009, J VIROL, V83, P1881, DOI 10.1128/JVI.01805-08; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Dankar SK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-243; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; de St Maurice A, 2017, PEDIATR TRANSPLANT, V21, DOI 10.1111/petr.12884; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel DA, 2013, ANTIVIR RES, V99, P409, DOI 10.1016/j.antiviral.2013.06.005; Forbes N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084673; Foster MP, 1998, J BIOMOL NMR, V12, P51, DOI 10.1023/A:1008290631575; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2008, VIROLOGY, V378, P1, DOI 10.1016/j.virol.2008.05.026; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Hale BG, 2010, J VIROL, V84, P6909, DOI 10.1128/JVI.00081-10; Jablonski JJ, 2012, BIOORGAN MED CHEM, V20, P487, DOI 10.1016/j.bmc.2011.10.026; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jureka AS, 2015, STRUCTURE, V23, P2001, DOI 10.1016/j.str.2015.08.007; Kerry PS, 2011, ACTA CRYSTALLOGR F, V67, P858, DOI 10.1107/S1744309111019312; Kerry PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017946; Kile JC, 2017, MMWR-MORBID MORTAL W, V66, P928, DOI 10.15585/mmwr.mm6635a2; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krug RM, 2015, CURR OPIN VIROL, V12, P1, DOI 10.1016/j.coviro.2015.01.007; Kwon JJ, 2018, J GEN VIROL, V99, P292, DOI 10.1099/jgv.0.001029; Lackenby A, 2011, EUROSURVEILLANCE, V16, P10; Lackenby A, 2008, Euro Surveill, V13; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Nelson MI, 2009, VIROLOGY, V388, P270, DOI 10.1016/j.virol.2009.03.026; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Spesock A, 2011, J VIROL, V85, P7048, DOI 10.1128/JVI.00417-11; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Trebbien R, 2018, J CLIN VIROL, V102, P1, DOI 10.1016/j.jcv.2018.02.005; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Twu KY, 2007, J VIROL, V81, P8112, DOI 10.1128/JVI.00006-07; Twu KY, 2006, J VIROL, V80, P3957, DOI 10.1128/JVI.80.8.3957-3965.2006; Walkiewicz MP, 2011, J GEN VIROL, V92, P60, DOI 10.1099/vir.0.025015-0; WARD AC, 1994, ARCH VIROL, V138, P299, DOI 10.1007/BF01379133; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wu NC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006682; Xia SL, 2010, ARCH BIOCHEM BIOPHYS, V494, P198, DOI 10.1016/j.abb.2009.12.008; Xia SL, 2009, ACTA CRYSTALLOGR D, V65, P11, DOI 10.1107/S0907444908032186; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zhang L, 2012, ADV INFECT DIS, V2, P92, DOI DOI 10.4236/aid.2012.24015; Zost SJ, 2017, P NATL ACAD SCI USA, V114, P12578, DOI 10.1073/pnas.1712377114	65	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14659	14668		10.1074/jbc.RA118.004012	http://dx.doi.org/10.1074/jbc.RA118.004012			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30076219	Green Published, hybrid			2022-12-28	WOS:000446155000007
J	Mitamura, Y; Nunomura, S; Nanri, Y; Arima, K; Yoshihara, T; Komiya, K; Fukuda, S; Takatori, H; Nakajima, H; Furue, M; Izuhara, K				Mitamura, Yasutaka; Nunomura, Satoshi; Nanri, Yasuhiro; Arima, Kazuhiko; Yoshihara, Tomohito; Komiya, Kosaku; Fukuda, Shogo; Takatori, Hiroaki; Nakajima, Hiroshi; Furue, Masutaka; Izuhara, Kenji			Hierarchical control of interleukin 13 (IL-13) signals in lung fibroblasts by STAT6 and SOX11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allergy; cell signaling; cytokine; fibroblast; fibrosis; interleukin; STAT transcription factor; transcription	TRANSCRIPTION FACTOR SOX11; ALLERGIC INFLAMMATION; GENE-EXPRESSION; INHALED CORTICOSTEROIDS; ADULT NEUROGENESIS; PULMONARY-FIBROSIS; BRONCHIAL-ASTHMA; DOUBLE-BLIND; PERIOSTIN; CELLS	Interleukin (IL)-13 is a signature cytokine of type 2 inflammation important for the pathogenesis of various diseases, including allergic diseases. Signal transducer and activator of transcription (STAT) 6 is a critical transcriptional factor for the IL-13 signals; however, it remains unknown how expression of the IL-13-induced genes is differentiated by the transcriptional machineries. In this study, we identified IL-13-induced transcriptional factors in lung fibroblasts using DNA microarrays in which SOX11 was included. Knockdown of SOX11 down-regulated expression of periostin and CCL26, both of which are known to be downstream molecules of IL-13, whereas enforced expression of SOX11 together with IL-13 stimulation enhanced expression of periostin. Moreover, we found that in DNA microarrays combining IL-13 induction and SOX11 knockdown there exist both SOX11-dependent and -independent molecules in IL-13-inducible molecules. In the former, many inflammation-related and fibrosis-related molecules, including periostin and CCL26, are involved. These results suggest that SOX11 acts as a trans-acting transcriptional factor downstream of STAT6 and that in lung fibroblasts the IL-13 signals are hierarchically controlled by STAT6 and SOX11.	[Mitamura, Yasutaka; Nunomura, Satoshi; Nanri, Yasuhiro; Arima, Kazuhiko; Yoshihara, Tomohito; Komiya, Kosaku; Fukuda, Shogo; Izuhara, Kenji] Saga Med Sch, Dept Biomol Sci, Div Med Biochem, 5-1-1 Nabeshima, Saga 8498501, Japan; [Mitamura, Yasutaka; Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka 8128582, Japan; [Komiya, Kosaku] Oita Univ, Fac Med, Dept Resp Med & Infect Dis, Yufu 8795593, Japan; [Takatori, Hiroaki; Nakajima, Hiroshi] Chiba Univ, Grad Sch Med, Dept Allergy & Clin Immunol, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608670, Japan	Saga University; Kyushu University; Oita University; Chiba University	Izuhara, K (corresponding author), Saga Med Sch, Dept Biomol Sci, Div Med Biochem, 5-1-1 Nabeshima, Saga 8498501, Japan.	kizuhara@cc.saga-u.ac.jp	Mitamura, Yasutaka/AAT-2110-2021; Nakajima, Hiroshi/AFU-9313-2022; Mitamura, Yasutaka/X-2529-2019; Nunomura, Satoshi/Q-4249-2017; Arima, Kazuhiko/I-8962-2014	Mitamura, Yasutaka/0000-0001-6389-9285; Nakajima, Hiroshi/0000-0001-8595-9381; Nunomura, Satoshi/0000-0002-9315-4185; Arima, Kazuhiko/0000-0002-0607-8787	Japan Society for the Promotion of Science KAKENHI [JP15K15372, JP16H05343]; AstraZeneca	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AstraZeneca(AstraZeneca)	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants JP15K15372 and JP16H05343 (to K. I.) and by AstraZeneca (to K. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Arima K, 2005, J BIOL CHEM, V280, P24915, DOI 10.1074/jbc.M502571200; Bea S, 2017, CURR ONCOL REP, V19, DOI 10.1007/s11912-017-0598-1; Brightling CE, 2015, LANCET RESP MED, V3, P692, DOI 10.1016/S2213-2600(15)00197-6; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; DELPHIN S, 1995, J EXP MED, V181, P181, DOI 10.1084/jem.181.1.181; Egwuagu CE, 2002, J IMMUNOL, V168, P3181, DOI 10.4049/jimmunol.168.7.3181; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Haslinger A, 2009, EUR J NEUROSCI, V29, P2103, DOI 10.1111/j.1460-9568.2009.06768.x; Hebenstreit D, 2003, J IMMUNOL, V171, P5901, DOI 10.4049/jimmunol.171.11.5901; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Hoeck J, 2001, J IMMUNOL, V167, P3216, DOI 10.4049/jimmunol.167.6.3216; Huang XL, 2015, INFLAMM RES, V64, P151, DOI 10.1007/s00011-015-0806-0; Izuhara K, 2006, CURR MED CHEM, V13, P2291, DOI 10.2174/092986706777935140; Izuhara K, 2011, INFLAMMATION AND ALLERGY DRUG DESIGN, P175; Izuhara K, 2014, ALLERGOL INT, V63, P143, DOI 10.2332/allergolint.13-RAI-0663; Kabata H, 2015, ALLERGOL INT, V64, P227, DOI 10.1016/j.alit.2015.03.004; Kamachi Y, 2013, DEVELOPMENT, V140, P4129, DOI 10.1242/dev.091793; Kanemitsu Y, 2014, AM J RESP CRIT CARE, V190, P472, DOI 10.1164/rccm.201403-0562LE; Kanemitsu Y, 2013, J ALLERGY CLIN IMMUN, V132, P305, DOI 10.1016/j.jaci.2013.04.050; Kubo M, 2017, ALLERGOL INT, V66, P377, DOI 10.1016/j.alit.2017.04.006; Lefebvre V, 2016, CURR OSTEOPOROS REP, V14, P32, DOI 10.1007/s11914-016-0296-1; Lin L, 2011, DEV DYNAM, V240, P52, DOI 10.1002/dvdy.22489; Liu TJ, 2004, J IMMUNOL, V173, P3425, DOI 10.4049/jimmunol.173.5.3425; Maier E, 2012, EUR J IMMUNOL, V42, P2827, DOI 10.1002/eji.201242433; Masuoka M, 2012, J CLIN INVEST, V122, P2590, DOI 10.1172/JCI58978; Matsunaga MC, 2016, J DRUGS DERMATOL, V15, P925; May RD, 2015, CYTOKINE, V75, P89, DOI 10.1016/j.cyto.2015.05.018; Messner B, 1997, J IMMUNOL, V159, P3330; Miyake K, 2017, ALLERGOL INT, V66, P382, DOI 10.1016/j.alit.2017.04.007; Passalacqua G, 2017, PULM PHARMACOL THER, V45, P95, DOI 10.1016/j.pupt.2017.05.007; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Taniguchi K, 2014, J INVEST DERMATOL, V134, P1295, DOI 10.1038/jid.2013.500; Travagli J, 2004, J BIOL CHEM, V279, P35183, DOI 10.1074/jbc.M403223200; Uchida M, 2012, AM J RESP CELL MOL, V46, P677, DOI 10.1165/rcmb.2011-0115OC; Venkov C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025354; Walsh GM, 2017, EXPERT REV CLIN IMMU, V13, P143, DOI 10.1080/1744666X.2016.1216316; Wang Y, 2013, DEV DYNAM, V242, P638, DOI 10.1002/dvdy.23962; Wenzel S, 2016, LANCET, V388, P31, DOI 10.1016/S0140-6736(16)30307-5; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x	41	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14646	14658		10.1074/jbc.RA117.001364	http://dx.doi.org/10.1074/jbc.RA117.001364			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30076218	hybrid, Green Published			2022-12-28	WOS:000446155000006
J	Tran, K; Jethmalani, Y; Jaiswal, D; Green, EM				Tran, Khoa; Jethmalani, Yogita; Jaiswal, Deepika; Green, Erin M.			Set4 is a chromatin-associated protein, promotes survival during oxidative stress, and regulates stress response genes in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; chromatin regulation; gene expression; oxidative stress; stress response; yeast; gene regulation; SET domain; Set4	SACCHAROMYCES-CEREVISIAE; HISTONE DEACETYLASE; H3K4 METHYLATION; MCM PROTEINS; EXPRESSION; REPRESSOR; RECRUITS; HOMOLOG; COMPLEX; GROWTH	The Set4 protein in the yeast Saccharomyces cerevisiae contains both a PHD finger and a SET domain, a common signature of chromatin-associated proteins, and shares sequence homology with the yeast protein Set3, the fly protein UpSET, and the human protein mixed-lineage leukemia 5 (MLL5). However, the biological role for Set4 and its potential function in chromatin regulation has not been well defined. Here, we analyzed yeast cell phenotypes associated with loss of Set4 or its overexpression, which revealed that Set4 protects against oxidative stress induced by hydrogen peroxide. Gene expression analysis indicated that Set4 promotes the activation of stress response genes in the presence of oxidative insults. Using ChIP analysis and other biochemical assays, we also found that Set4 interacts with chromatin and directly localizes to stress response genes upon oxidative stress. However, recombinant Set4 did not show detectable methyltransferase activity on histones. Our findings also suggest that Set4 abundance in the cell is balanced under normal and stress conditions to promote survival. Overall, these results suggest a model in which Set4 is a stress-responsive, chromatin-associated protein that activates gene expression programs required for cellular protection against oxidative stress. This work advances our understanding of mechanisms that protect cells during oxidative stress and further defines the role of the Set3-Set4 subfamily of SET domain-containing proteins in controlling gene expression in response to adverse environmental conditions.	[Tran, Khoa; Jethmalani, Yogita; Jaiswal, Deepika; Green, Erin M.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA	University System of Maryland; University of Maryland Baltimore County	Green, EM (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA.	egreen@umbc.edu	Jaiswal, Deepika/K-6047-2019; Jethmalani, Yogita/S-9685-2019; Green, Erin/J-6098-2019	Jaiswal, Deepika/0000-0003-3504-4081; Jethmalani, Yogita/0000-0003-3422-8356; Green, Erin/0000-0003-3923-6726	National Science Foundation [DBI0722569]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM124342] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Green laboratory for additional technical support, helpful discussions, and comments on the manuscript. We also thank Leila Bahmani Kazerooni, Pushya Pradeep, and Julie Wolf from the Applied Molecular Biology program at UMBC for technical assistance; Sue Ostrand-Rosenberg, members of the Rosenberg laboratory, and Gregory Szeto for help with flow cytometry; and Tagide deCarvalho of the Keith R. Porter Imaging Facility (funded by National Science Foundation Grant DBI0722569) for assistance with microscopy. We also acknowledge Philip Farabaugh, Lasse Lindahl, Kevin Struhl, and Scott McIsaac for yeast strains and plasmids.	Ali M, 2013, P NATL ACAD SCI USA, V110, P11296, DOI 10.1073/pnas.1310156110; Aragon AD, 2008, MOL BIOL CELL, V19, P1271, DOI 10.1091/mbc.E07-07-0666; Azad GK, 2014, FEBS OPEN BIO, V4, P77, DOI 10.1016/j.fob.2014.01.002; Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Baker LA, 2013, MOL CELL BIOL, V33, P3735, DOI 10.1128/MCB.00025-13; Branco MR, 2004, J BIOL CHEM, V279, P6501, DOI 10.1074/jbc.M311818200; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Cullen Paul J, 2015, Cold Spring Harb Protoc, V2015, P172, DOI 10.1101/pdb.prot085076; Cullen PJ, 2012, GENETICS, V190, P23, DOI 10.1534/genetics.111.127456; da Rosa JL, 2011, GENETICS, V187, P9, DOI 10.1534/genetics.110.123117; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gatchalian J, 2017, J MOL BIOL, V429, P2066, DOI 10.1016/j.jmb.2016.09.020; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Green EM, 2012, NAT STRUCT MOL BIOL, V19, P361, DOI 10.1038/nsmb.2252; Hickman MJ, 2007, MOL CELL BIOL, V27, P7414, DOI 10.1128/MCB.00887-07; Jaiswal D, 2017, G3-GENES GENOM GENET, V7, P3971, DOI 10.1534/g3.117.300150; Jaiswal D, 2017, J MOL BIOL, V429, P1946, DOI 10.1016/j.jmb.2016.10.018; Jezek M, 2017, JOVE-J VIS EXP, DOI 10.3791/57080; Jezek M, 2017, EPIGENETICS-US, V12, P93, DOI 10.1080/15592294.2016.1265712; Kelley R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000488; Kemmeren P, 2014, CELL, V157, P740, DOI 10.1016/j.cell.2014.02.054; Kim T, 2012, CELL, V150, P1158, DOI 10.1016/j.cell.2012.08.016; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Lai LC, 2006, EUKARYOT CELL, V5, P1468, DOI 10.1128/EC.00107-06; Law MJ, 2015, GENETICS, V199, P435, DOI 10.1534/genetics.114.172841; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Martinez-Montanes F, 2013, EUKARYOT CELL, V12, P636, DOI 10.1128/EC.00037-13; Mas-y-Mas S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165139; McDaniel SL, 2017, CELL REP, V19, P2371, DOI 10.1016/j.celrep.2017.05.057; McElroy KA, 2017, G3-GENES GENOM GENET, V7, P625, DOI 10.1534/g3.116.037788; McIsaac RS, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1402; Moqtaderi Z, 2008, YEAST, V25, P287, DOI 10.1002/yea.1581; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Nadal-Ribelles M, 2015, NUCLEIC ACIDS RES, V43, P4937, DOI 10.1093/nar/gkv220; Nin DS, 2014, MOL CANCER THER, V13, P2572, DOI 10.1158/1535-7163.MCT-14-0019; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Rincon-Arano H, 2012, CELL, V151, P1214, DOI 10.1016/j.cell.2012.11.009; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Serratore ND, 2018, GENETICS, V208, P1037, DOI 10.1534/genetics.117.300554; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shively CA, 2013, GENETICS, V193, P1297, DOI 10.1534/genetics.112.147876; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Tasdogan A, 2016, CELL STEM CELL, V19, P752, DOI 10.1016/j.stem.2016.08.007; Tsang CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4446; Weiner A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001369	52	15	16	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14429	14443		10.1074/jbc.RA118.003078	http://dx.doi.org/10.1074/jbc.RA118.003078			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30082318	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000444671500022
J	Turner, EC; Kavanagh, DJ; Mulvaney, EP; McLean, C; Wikstrom, K; Reid, HM; Kinsella, BT				Turner, Elizebeth C.; Kavanagh, David J.; Mulvaney, Eamon P.; McLean, Caitriona; Wikstrom, Katarina; Reid, Helen M.; Kinsella, B. Therese			RETRACTION: Identification of an interaction between the TP alpha and TP beta isoforms of the human thromboxane A2 receptor with protein kinase C-related kinase (PRK) 1. Implications for prostate cancer (Retraction of Vol 286, Pg 15440, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Turner EC, 2011, J BIOL CHEM, V286, P15440, DOI 10.1074/jbc.M110.181180	1	1	1	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12286	12286		10.1074/jbc.W118.004805	http://dx.doi.org/10.1074/jbc.W118.004805			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	30076258	Green Published, hybrid			2022-12-28	WOS:000440803200028
J	Tran, KA; Dillingham, CM; Sridharan, R				Tran, Khoa A.; Dillingham, Caleb M.; Sridharan, Rupa			The role of alpha-ketoglutarate- dependent proteins in pluripotency acquisition and maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						induced pluripotent stem cell (iPS cell) (iPSC); pluripotency; histone demethylase; DNA demethylation; stem cells; epigenetics; chromatin; reprogramming; cell differentiation; alpha-KG enzymes; cell fate	EMBRYONIC STEM-CELLS; TET PROTEINS; SELF-RENEWAL; DNA METHYLATION; DEMETHYLASE JMJD3; 5-METHYLCYTOSINE OXIDATION; CARDIAC DIFFERENTIATION; NEURAL DIFFERENTIATION; HISTONE DEMETHYLASES; ENHANCER ACTIVITY	alpha-Ketoglutarate is an important metabolic intermediate that acts as a cofactor for several chromatin-modifying enzymes, including histone demethylases and the Tet family of enzymes that are involved in DNA demethylation. In this review, we focus on the function and genomic localization of these -ketoglutarate-dependent enzymes in the maintenance of pluripotency during cellular reprogramming to induced pluripotent stem cells and in disruption of pluripotency during in vitro differentiation. The enzymatic function of many of these -ketoglutarate-dependent proteins is required for pluripotency acquisition and maintenance. A better understanding of their specific function will be essential in furthering our knowledge of pluripotency.	[Tran, Khoa A.; Dillingham, Caleb M.; Sridharan, Rupa] Univ Wisconsin Madison, Wisconsin Inst Discovery, Madison, WI 53715 USA; [Sridharan, Rupa] Univ Wisconsin Madison, Dept Cell & Regenerat Biol, Madison, WI 53715 USA; [Tran, Khoa A.] Univ Wisconsin Madison, Mol & Cellular Pharmacol Program, Madison, WI 53715 USA; [Dillingham, Caleb M.] Univ Wisconsin Madison, Cellular & Mol Pathol Program, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sridharan, R (corresponding author), Univ Wisconsin Madison, Dept Cell & Regenerat Biol, Madison, WI 53715 USA.	rsridharan2@wisc.edu			Shaw Scientist Award; National Institutes of Health [RO1GM113033]; National Institute of General Medical Sciences, National Institutes of Health [T32GM081061]; Advanced Opportunity Fellowship at the University of Wisconsin-Madison; National Science Foundation Graduate Research Fellowship Program [DGE-1256259]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081061, R01GM113033] Funding Source: NIH RePORTER	Shaw Scientist Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Advanced Opportunity Fellowship at the University of Wisconsin-Madison; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Shaw Scientist Award and National Institutes of Health Grant RO1GM113033 (to R. S.). This research was also supported by the National Institute of General Medical Sciences, National Institutes of Health Award T32GM081061. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by an Advanced Opportunity Fellowship at the University of Wisconsin-Madison and by National Science Foundation Graduate Research Fellowship Program Grant DGE-1256259.	Akiyama T, 2016, DEVELOPMENT, V143, P3674, DOI 10.1242/dev.139360; Antony J, 2013, MOL CELL BIOL, V33, P974, DOI 10.1128/MCB.01014-12; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Beshiri ML, 2012, P NATL ACAD SCI USA, V109, P18499, DOI 10.1073/pnas.1216724109; Bino L, 2016, CHEM-BIOL INTERACT, V244, P204, DOI 10.1016/j.cbi.2015.12.007; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Brauchle M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060549; Brien GL, 2012, NAT STRUCT MOL BIOL, V19, P1273, DOI 10.1038/nsmb.2449; Burgold T, 2012, CELL REP, V2, P1244, DOI 10.1016/j.celrep.2012.09.013; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Chakraborty D, 2016, P NATL ACAD SCI USA, V113, pE7212, DOI 10.1073/pnas.1612626113; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Chung YG, 2015, CELL STEM CELL, V17, P758, DOI 10.1016/j.stem.2015.10.001; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Das PP, 2014, MOL CELL, V53, P32, DOI 10.1016/j.molcel.2013.11.011; Dawlaty MM, 2014, DEV CELL, V29, P102, DOI 10.1016/j.devcel.2014.03.003; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; de la Rica L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1096-8; Dey BK, 2008, MOL CELL BIOL, V28, P5312, DOI 10.1128/MCB.00128-08; Dhar SS, 2016, NUCLEIC ACIDS RES, V44, P3659, DOI 10.1093/nar/gkv1516; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Ebata KT, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0143-3; Etchegaray JP, 2015, NAT CELL BIOL, V17, P545, DOI 10.1038/ncb3147; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fidalgo M, 2016, CELL STEM CELL, V19, P355, DOI 10.1016/j.stem.2016.05.025; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Hainer SJ, 2016, ELIFE, V5, DOI 10.7554/eLife.21964; He RS, 2017, NUCLEIC ACIDS RES, V45, P6427, DOI 10.1093/nar/gkx251; Hon GC, 2014, MOL CELL, V56, P286, DOI 10.1016/j.molcel.2014.08.026; Hore TA, 2016, P NATL ACAD SCI USA, V113, P12202, DOI 10.1073/pnas.1608679113; Hu X, 2014, CELL STEM CELL, V14, P512, DOI 10.1016/j.stem.2014.01.001; Huang CY, 2010, CELL RES, V20, P154, DOI 10.1038/cr.2010.5; Huang Y, 2014, P NATL ACAD SCI USA, V111, P1361, DOI 10.1073/pnas.1322921111; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jeong CH, 2007, J BIOL CHEM, V282, P13672, DOI 10.1074/jbc.M700534200; Jiang W, 2013, CELL RES, V23, P122, DOI 10.1038/cr.2012.119; Kartikasari AER, 2013, EMBO J, V32, P1393, DOI 10.1038/emboj.2013.78; Kidder BL, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r32; Ko M, 2013, NATURE, V497, P122, DOI 10.1038/nature12052; Kong LC, 2016, NUCLEIC ACIDS RES, V44, P8682, DOI 10.1093/nar/gkw529; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Li SH, 2018, CELL REP, V23, P389, DOI 10.1016/j.celrep.2018.03.051; Liang GY, 2012, NAT CELL BIOL, V14, P457, DOI 10.1038/ncb2483; Liu WQ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.10; Liu Z, 2018, CELL, V172, P881, DOI 10.1016/j.cell.2018.01.020; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Lu FL, 2014, GENE DEV, V28, P2103, DOI 10.1101/gad.248005.114; Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Mathieu J, 2014, CELL STEM CELL, V14, P592, DOI 10.1016/j.stem.2014.02.012; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Monfort A, 2013, EMBO REP, V14, P337, DOI 10.1038/embor.2013.29; Ohtani K, 2013, CIRC RES, V113, P856, DOI 10.1161/CIRCRESAHA.113.302035; Okashita N, 2015, BIOCHEM BIOPH RES CO, V466, P138, DOI 10.1016/j.bbrc.2015.08.122; Ougland R, 2012, STEM CELLS, V30, P2672, DOI 10.1002/stem.1228; Outchkourov NS, 2013, CELL REP, V3, P1071, DOI 10.1016/j.celrep.2013.02.030; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Pedersen MT, 2016, EMBO J, V35, P1550, DOI 10.15252/embj.201593317; Pfaffeneder T, 2014, NAT CHEM BIOL, V10, P574, DOI [10.1038/NCHEMBIO.1532, 10.1038/nchembio.1532]; Prigione A, 2014, STEM CELLS, V32, P364, DOI 10.1002/stem.1552; Schmitz SU, 2011, EMBO J, V30, P4586, DOI 10.1038/emboj.2011.383; Shakya A, 2015, MOL CELL BIOL, V35, P1014, DOI 10.1128/MCB.01105-14; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Shpargel KB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004507; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Sim YJ, 2017, STEM CELL REP, V8, P1312, DOI 10.1016/j.stemcr.2017.04.001; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2013, NAT CELL BIOL, V15, P872, DOI 10.1038/ncb2768; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang Y, 2016, STEM CELLS, V34, P1527, DOI 10.1002/stem.2333; Terndrup M, 2014, MOL CELL BIOL, V34, P1031, DOI 10.1128/MCB.00864-13; Tomaz RA, 2017, DEVELOPMENT, V144, P567, DOI 10.1242/dev.142489; Torres CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060020; Tran KA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7188; Tu JJ, 2015, NUCLEIC ACIDS RES, V43, P7805, DOI 10.1093/nar/gkv653; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Verma N, 2018, NAT GENET, V50, P83, DOI 10.1038/s41588-017-0002-y; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wang JL, 2014, J BIOL CHEM, V289, P2384, DOI 10.1074/jbc.M113.535799; Wang T, 2013, NAT CELL BIOL, V15, P700, DOI 10.1038/ncb2748; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang Y, 2016, NUCLEIC ACIDS RES, V44, P6741, DOI 10.1093/nar/gkw301; Wei JW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06569-2; Weinberger L, 2016, NAT REV MOL CELL BIO, V17, P155, DOI 10.1038/nrm.2015.28; Welstead GG, 2012, P NATL ACAD SCI USA, V109, P13004, DOI 10.1073/pnas.1210787109; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu J, 2016, CELL, V166, P1371, DOI 10.1016/j.cell.2016.08.008; Wu TP, 2016, NATURE, V532, P329, DOI 10.1038/nature17640; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Xiao F, 2017, STEM CELL REP, V9, P927, DOI 10.1016/j.stemcr.2017.07.013; Xie LQ, 2011, EMBO J, V30, P1473, DOI 10.1038/emboj.2011.91; Xiong J, 2016, MOL CELL, V64, P913, DOI 10.1016/j.molcel.2016.10.013; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yamaguchi S, 2013, CELL RES, V23, P329, DOI 10.1038/cr.2013.22; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027; Zaidan NZ, 2018, STEM CELL REP, V10, P627, DOI 10.1016/j.stemcr.2017.12.016; Zhang WH, 2016, MOL CELL, V64, P1062, DOI 10.1016/j.molcel.2016.10.030; Zhao W, 2013, CELL, V152, P1037, DOI 10.1016/j.cell.2013.02.006; Zhou Z, 2017, ELIFE, V6, DOI 10.7554/eLife.30178; Zhou ZW, 2017, CELL REP, V21, P2160, DOI 10.1016/j.celrep.2017.10.091; Zhu H, 2014, STEM CELLS, V32, P2098, DOI 10.1002/stem.1724; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	122	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5408	5419		10.1074/jbc.TM118.000831	http://dx.doi.org/10.1074/jbc.TM118.000831			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30181211	Green Published, hybrid			2022-12-28	WOS:000464517500014
J	Bozelli, JC; Jennings, W; Black, S; Hou, YH; Lameire, D; Chatha, P; Kimura, T; Berno, B; Khondker, A; Rheinstadter, MC; Epand, RM				Bozelli, Jose Carlos, Jr.; Jennings, William; Black, Stephanie; Hou, Yu Heng; Lameire, Darius; Chatha, Preet; Kimura, Tomohiro; Berno, Bob; Khondker, Adree; Rheinstadter, Maikel C.; Epand, Richard M.			Membrane curvature allosterically regulates the phosphatidylinositol cycle, controlling its rate and acyl-chain composition of its lipid intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidylinositol signaling; membrane biophysics; membrane enzyme; membrane lipid; endoplasmic reticulum (ER); plasma membrane; diacylglycerol kinase (DGK; DAGK); diacylglycerol; lipid signaling; lipid trafficking; phosphatidylinositol cycle; membrane shape; regulation of enzyme by membrane curvature; PM-ER junctions; contact sites; negative Gaussian curvature; membrane trafficking; allostery; membrane protein	DIACYLGLYCEROL KINASE-EPSILON; LATERAL PRESSURE PROFILE; CELL-MEMBRANE; PROTEIN FUNCTION; ELASTIC STRESS; CONTACT SITES; CUBIC PHASES; PHOSPHOINOSITIDES; FUSION; ROLES	Signaling events at membranes are often mediated by membrane lipid composition or membrane physical properties. These membrane properties could act either by favoring the membrane binding of downstream effectors or by modulating their activity. Several proteins can sense/generate membrane physical curvature (i.e. shape). However, the modulation of the activity of enzymes by a membrane's shape has not yet been reported. Here, using a cell-free assay with purified diacylglycerol kinase E (DGKE) and liposomes, we studied the activity and acyl-chain specificity of an enzyme of the phosphatidylinositol (PI) cycle, DGKE. By systematically varying the model membrane lipid composition and physical properties, we found that DGKE has low activity and lacks acyl-chain specificity in locally flat membranes, regardless of the lipid composition. On the other hand, these enzyme properties were greatly enhanced in membrane structures with a negative Gaussian curvature. We also found that this is not a consequence of preferential binding of the enzyme to those structures, but rather is due to a curvature-mediated allosteric regulation of DGKE activity and acyl-chain specificity. Moreover, in a fine-tuned interplay between the enzyme and the membrane, DGKE favored the formation of structures with greater Gaussian curvature. DGKE does not bear a regulatory domain, and these findings reveal the importance of membrane curvature in regulating DGKE activity and acyl-chain specificity. Hence, this study highlights that a hierarchic coupling of membrane physical property and lipid composition synergistically regulates membrane signaling events. We propose that this regulatory mechanism of membrane-associated enzyme activity is likely more common than is currently appreciated.	[Bozelli, Jose Carlos, Jr.; Jennings, William; Black, Stephanie; Hou, Yu Heng; Lameire, Darius; Chatha, Preet; Kimura, Tomohiro; Epand, Richard M.] McMaster Univ, Hlth Sci Ctr, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Berno, Bob; Epand, Richard M.] McMaster Univ, Dept Chem, Hamilton, ON L8S 4L8, Canada; [Khondker, Adree; Rheinstadter, Maikel C.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4L8, Canada; [Khondker, Adree; Rheinstadter, Maikel C.] McMaster Univ, Origins Inst, Hamilton, ON L8S 4L8, Canada	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; McMaster University; McMaster University; McMaster University	Epand, RM (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada.	epand@mcmaster.ca	Kimura, Tomohiro/AEJ-1621-2022; , Richard/R-2316-2019; Rheinstadter, Maikel C/D-5322-2009	, Richard/0000-0002-9602-9558; Rheinstadter, Maikel C/0000-0002-0558-7475; Bozelli Jr, Jose Carlos/0000-0001-9533-0886; Hou, Yu Heng/0000-0001-7886-8772; Kimura, Tomohiro/0000-0002-4192-7852; Khondker, Adree/0000-0003-3246-4662	Canadian Natural Sciences and Engineering Research Council [RGPIN-2018-05585, RGPIN-2016-06450]; Canada Foundation for Innovation (CFI); CIHR; Ontario Ministry of Economic Development and Innovation; McMaster University	Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Economic Development and Innovation; McMaster University	This work was supported by Canadian Natural Sciences and Engineering Research Council grant RGPIN-2018-05585 (to R. M. E.) and RGPIN-2016-06450 (to M. C. R.). This work was also supported by the Canada Foundation for Innovation (CFI), CIHR, and the Ontario Ministry of Economic Development and Innovation (to M. C. R.) and a University Scholar Award from McMaster University (to M. C. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Almsherqi ZA, 2009, INT REV CEL MOL BIO, V274, P275, DOI 10.1016/S1937-6448(08)02006-6; Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Attard GS, 2000, P NATL ACAD SCI USA, V97, P9032, DOI 10.1073/pnas.160260697; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Besprozvannaya M, 2018, ELIFE, V7, DOI 10.7554/eLife.31019; Bohnert M, 2018, NAT REV MOL CELL BIO, V19, P483, DOI 10.1038/s41580-018-0022-1; Bone LN, 2017, MOL BIOL CELL, V28, P161, DOI 10.1091/mbc.E16-09-0668; Brown MF, 2012, BIOCHEMISTRY-US, V51, P9782, DOI 10.1021/bi301332v; Cantor RS, 1997, BIOCHEMISTRY-US, V36, P2339, DOI 10.1021/bi9627323; Cho H, 2006, MOL CELLS, V22, P97; Colotto A, 1996, BIOCHEMISTRY-US, V35, P980, DOI 10.1021/bi951991+; CULLIS PR, 1979, BIOCHIM BIOPHYS ACTA, V559, P399, DOI 10.1016/0304-4157(79)90012-1; D'Souza K, 2012, J MOL BIOL, V416, P619, DOI 10.1016/j.jmb.2012.01.008; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; Decaffmeyer M, 2008, J MOL BIOL, V383, P797, DOI 10.1016/j.jmb.2008.08.076; Demurtas D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9915; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Ding W, 2015, J PHYS CHEM B, V119, P15263, DOI 10.1021/acs.jpcb.5b06604; Doignon F, 2016, MOL CELL BIOL, V36, P765, DOI 10.1128/MCB.00843-15; DUZGUNES N, 1983, BIOCHIM BIOPHYS ACTA, V732, P289, DOI 10.1016/0005-2736(83)90214-6; Epand RM, 2007, METHOD ENZYMOL, V434, P293, DOI 10.1016/S0076-6879(07)34016-0; Fuhrmans M, 2009, J AM CHEM SOC, V131, P9166, DOI 10.1021/ja903224q; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; Graber ZT, 2017, PHYS CHEM CHEM PHYS, V19, P15285, DOI 10.1039/c7cp00718c; Haider A, 2018, DEV CELL, V45, P481, DOI 10.1016/j.devcel.2018.04.012; Hozumi Y, 2017, CELL TISSUE RES, V368, P441, DOI 10.1007/s00441-017-2579-y; Hozumi Y, 2015, CELL TISSUE RES, V362, P295, DOI 10.1007/s00441-015-2199-3; Iversen L, 2015, NAT CHEM BIOL, V11, P822, DOI 10.1038/nchembio.1941; Jarsch IK, 2016, J CELL BIOL, V214, P375, DOI 10.1083/jcb.201604003; Jennings W, 2017, BIOCHEMISTRY-US, V56, P1337, DOI 10.1021/acs.biochem.6b01193; Khondker A, 2018, ACS INFECT DIS, V4, P926, DOI 10.1021/acsinfecdis.7b00156; Kimura T, 2016, PROG LIPID RES, V62, P75, DOI 10.1016/j.plipres.2016.02.001; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kobayashi N, 2007, EUR J CELL BIOL, V86, P433, DOI 10.1016/j.ejcb.2007.05.002; Kollmitzer B, 2013, SOFT MATTER, V9, P10877, DOI 10.1039/c3sm51829a; Lees JA, 2017, SCIENCE, V355, DOI 10.1126/science.aah6171; Li MQ, 2017, BBA-BIOENERGETICS, V1858, P763, DOI 10.1016/j.bbabio.2017.06.003; Luzzati V, 1997, CURR OPIN STRUC BIOL, V7, P661, DOI 10.1016/S0959-440X(97)80075-9; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Milne SB, 2008, BIOCHEMISTRY-US, V47, P9372, DOI 10.1021/bi800492c; Mujalli A, 2018, BBA-MOL CELL BIOL L, V1863, P1121, DOI 10.1016/j.bbalip.2018.06.009; Natalini PM, 2013, EXP EYE RES, V112, P139, DOI 10.1016/j.exer.2013.04.012; NIEVA JL, 1995, FEBS LETT, V368, P143, DOI 10.1016/0014-5793(95)00631-I; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; RAND RP, 1985, BIOPHYS J, V47, P483, DOI 10.1016/S0006-3495(85)83941-2; Rappolt M, 2003, BIOPHYS J, V84, P3111, DOI 10.1016/S0006-3495(03)70036-8; Renne MF, 2018, FEBS LETT, V592, P1330, DOI 10.1002/1873-3468.12944; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Saheki Y, 2017, ANNU REV BIOCHEM, V86, P659, DOI 10.1146/annurev-biochem-061516-044932; Salditt T, 2016, SEMIN CELL DEV BIOL, V60, P65, DOI 10.1016/j.semcdb.2016.06.014; Salvador-Gallego R, 2017, CELL, V171, P1224, DOI 10.1016/j.cell.2017.11.005; Sato Y, 2016, BBA-PROTEINS PROTEOM, V1864, P1170, DOI 10.1016/j.bbapap.2016.06.012; Schlame M, 2012, NAT CHEM BIOL, V8, P862, DOI 10.1038/NCHEMBIO.1064; Shai N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03957-8; Shulga YV, 2011, J MOL BIOL, V409, P101, DOI 10.1016/j.jmb.2011.03.071; Soubias O, 2010, BIOPHYS J, V99, P817, DOI 10.1016/j.bpj.2010.04.068; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Tang W, 1996, J BIOL CHEM, V271, P10237, DOI 10.1074/jbc.271.17.10237; Tyler AII, 2015, SOFT MATTER, V11, P3279, DOI 10.1039/c5sm00311c; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Xie S., 2015, CELL LOGIST, V5, DOI [10.1080/21592799.2015.1078431, DOI 10.1080/21592799.2015.1078431]; Yao HW, 2015, P NATL ACAD SCI USA, V112, P10926, DOI 10.1073/pnas.1501430112; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	65	30	31	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17780	17791		10.1074/jbc.RA118.005293	http://dx.doi.org/10.1074/jbc.RA118.005293			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30237168	Green Published, hybrid			2022-12-28	WOS:000450409500010
J	Qi, H; Shi, XY; Yu, M; Liu, BY; Liu, MH; Song, S; Chen, SY; Zou, JH; Zhu, WG; Luo, JY				Qi, Hao; Shi, Xiaoyan; Yu, Miao; Liu, Boya; Liu, Minghui; Song, Shi; Chen, Shuaiyi; Zou, Junhua; Zhu, Wei-Guo; Luo, Jianyuan			Sirtuin 7-mediated deacetylation of WD repeat domain 77 (WDR77) suppresses cancer cell growth by reducing WDR77/PRMT5 transmethylase complex activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone methylation; cell proliferation; post-translational modification (PTM); colon cancer; epigenetics; H4R3me2; protein acetylation; SIRT7; transmethylase; WDR77	RNA-POLYMERASE-I; DISEASE; PRMT5; OVEREXPRESSION; TRANSCRIPTION; REPRESSION; EXPRESSION; STRESS; ROLES	The histone transmethylase complex comprising WD repeat domain 77 (WDR77) and protein arginine methyltransferase 5 (PRMT5) catalyzes dimethylation of H4R3 (H4R3me2) and drives cancer cell proliferation and migration, but its regulation is not fully understood. Here, we report that sirtuin 7 (SIRT7) directly deacetylates WDR77 and that this deacetylation interferes with the WDR77-PRMT5 interaction and suppresses proliferation of human colon cancer HCT116 cells. Using co-expression in HEK293T cells and co-immunoprecipitation assays, we observed that SIRT7 deacetylates WDR77 at Lys-3 and Lys-243, which reduced of WDR77's interaction with PRMT5. More importantly, this reduction suppressed the transmethylase activity of the WDR77/PRMT5 complex, resulting in a reduction of the H4R3me2 modification. Rescue of the WDR77-KO HCT116 cells with a WDR77-2KR (K3R and K243R) variant yielded cell migration and proliferation rates that were significantly lower than those of WDR77-KO HCT116 cells rescued with WT WDR77. In summary, SIRT7 is a major deacetylase for WDR77, and SIRT7-mediated deacetylation of WDR77 at Lys-3 and Lys-243 weakens the WDR77-PRMT5 interaction and activity and thereby suppresses growth of cancer cells.	[Qi, Hao; Yu, Miao; Liu, Boya; Liu, Minghui; Song, Shi; Chen, Shuaiyi; Zou, Junhua; Luo, Jianyuan] Peking Univ, Hlth Sci Ctr, Ctr Med Genet, Dept Med Genet, Beijing 100191, Peoples R China; [Shi, Xiaoyan] Henan Univ, Coll Pharm, Kaifeng 475001, Henan, Peoples R China; [Zhu, Wei-Guo] Shenzhen Univ, Dept Biochem & Mol Biol, Sch Med, Shenzhen 518060, Peoples R China	Peking University; Henan University; Shenzhen University	Luo, JY (corresponding author), Peking Univ, Hlth Sci Ctr, Ctr Med Genet, Dept Med Genet, Beijing 100191, Peoples R China.	luojianyuan@bjmu.edu.cn	Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914; Zhu, Wei-Guo/0000-0001-8385-6581	National Natural Science Foundation of China [81270427, 81471405, 81671389, 81621063]; National Research Program of China 973 Program [2013CB530801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Program of China 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 81270427, 81471405, 81671389, and 81621063 and National Research Program of China 973 Program Grant 2013CB530801 (to J. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Ashraf N, 2006, BRIT J CANCER, V95, P1056, DOI 10.1038/sj.bjc.6603384; Bao XX, 2013, J HISTOCHEM CYTOCHEM, V61, P206, DOI 10.1369/0022155413475452; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Chen H, 2017, ONCOGENE, V36, P373, DOI 10.1038/onc.2016.205; Chen SF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10734; Chen SF, 2013, MOL CELL, V52, P303, DOI 10.1016/j.molcel.2013.10.010; de Nigris F, 2002, BRIT J CANCER, V87, P1479, DOI 10.1038/sj.bjc.6600636; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Hirschey MD, 2011, CELL METAB, V14, P718, DOI 10.1016/j.cmet.2011.10.006; Ho MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057008; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; Ibrahim R, 2014, HUM PATHOL, V45, P1397, DOI 10.1016/j.humpath.2014.02.013; Kiran S, 2015, CELL SIGNAL, V27, P673, DOI 10.1016/j.cellsig.2014.11.026; Lai CC, 2013, TUMOR BIOL, V34, P1847, DOI 10.1007/s13277-013-0726-y; Malik S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09841; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Nahalkova J, 2015, MOL CELL BIOCHEM, V409, P13, DOI 10.1007/s11010-015-2507-y; Osborne B, 2016, FREE RADICAL BIO MED, V100, P164, DOI 10.1016/j.freeradbiomed.2016.04.197; Ryu D, 2014, CELL METAB, V20, P856, DOI 10.1016/j.cmet.2014.08.001; Stopa N, 2015, CELL MOL LIFE SCI, V72, P2041, DOI 10.1007/s00018-015-1847-9; Tang XL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00396-9; Taylor DM, 2008, CELL MOL LIFE SCI, V65, P4000, DOI 10.1007/s00018-008-8357-y; Yu HY, 2014, CLIN CANCER RES, V20, P3434, DOI 10.1158/1078-0432.CCR-13-2952; Zhang CH, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600395	26	14	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17769	17779		10.1074/jbc.RA118.003629	http://dx.doi.org/10.1074/jbc.RA118.003629			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30282801	hybrid, Green Published			2022-12-28	WOS:000450409500009
J	Garland-Kuntz, EE; Vago, FS; Sieng, M; Van Camp, M; Chakravarthy, S; Blaine, A; Corpstein, C; Jiang, W; Lyon, AM				Garland-Kuntz, Elisabeth E.; Vago, Frank S.; Sieng, Monita; Van Camp, Michelle; Chakravarthy, Srinivas; Blaine, Arryn; Corpstein, Clairissa; Jiang, Wen; Lyon, Angeline M.			Direct observation of conformational dynamics of the PH domain in phospholipases CE and may contribute to subfamily-specific roles in regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Phospholipase C; signal transduction; conformational change; calcium; structural biology; phosphatidylinositol lipid; signaling protein; second messenger; PKC	PLECKSTRIN HOMOLOGY DOMAIN; ANGLE SCATTERING DATA; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; BIOLOGICAL MACROMOLECULES; CRYSTAL-STRUCTURE; MEMBRANE-BINDING; TERMINAL REGION; BETA; EPSILON; ACTIVATION	Phospholipase C (PLC) enzymes produce second messengers that increase the intracellular Ca2+ concentration and activate protein kinase C (PKC). These enzymes also share a highly conserved arrangement of core domains. However, the contributions of the individual domains to regulation are poorly understood, particularly in isoforms lacking high-resolution information, such as PLCE. Here, we used small-angle X-ray scattering (SAXS), EM, and functional assays to gain insights into the molecular architecture of PLCE, revealing that its PH domain is conformationally dynamic and essential for activity. We further demonstrate that the PH domain of PLC exhibits similar dynamics in solution that are substantially different from its conformation observed in multiple previously reported crystal structures. We propose that this conformational heterogeneity contributes to subfamily-specific differences in activity and regulation by extracellular signals.	[Garland-Kuntz, Elisabeth E.; Sieng, Monita; Van Camp, Michelle; Blaine, Arryn; Corpstein, Clairissa; Lyon, Angeline M.] Purdue Univ, Dept Chem, 560 Oval Dr, W Lafayette, IN 47907 USA; [Vago, Frank S.; Jiang, Wen; Lyon, Angeline M.] Purdue Univ, Dept Biol Sci, 560 Oval Dr, W Lafayette, IN 47907 USA; [Chakravarthy, Srinivas] Argonne Natl Lab, Adv Photon Source, Sector 18ID, Biophys Collaborat Access Team,IIT, Lemont, IL 60439 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Illinois Institute of Technology; United States Department of Energy (DOE); Argonne National Laboratory	Lyon, AM (corresponding author), Purdue Univ, Dept Chem, 560 Oval Dr, W Lafayette, IN 47907 USA.; Lyon, AM (corresponding author), Purdue Univ, Dept Biol Sci, 560 Oval Dr, W Lafayette, IN 47907 USA.	lyonam@purdue.edu	jiang, wen/GYI-9662-2022	Lyon, Angeline/0000-0001-7501-0148	DOE Office of Science [DE-AC02-06CH11357]; NIGMS, National Institutes of Health (NIH) [9 P41 GM103622]; NIGMS, NIH [1S10OD018090-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL141076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018090] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. V. Smrcka (University of Michigan) for the R. norvegicus PLC epsilon cDNA and technical and editorial advice. We thank J. Tesmer (Purdue University) and M. Tantama (Purdue University) for helpful discussions. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. This project was supported by NIGMS, National Institutes of Health (NIH), Grant 9 P41 GM103622. Use of the Pilatus 3 1M detector was provided by NIGMS, NIH, Grant 1S10OD018090-01.	Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; CIFUENTES ME, 1993, J BIOL CHEM, V268, P11586; Drin G, 2006, BIOCHEMISTRY-US, V45, P5712, DOI 10.1021/bi052317n; Dusaban SS, 2013, P NATL ACAD SCI USA, V110, P3609, DOI 10.1073/pnas.1217355110; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Feng JW, 2005, BIOCHEMISTRY-US, V44, P2577, DOI 10.1021/bi0482607; Filtz TM, 2009, FASEB J, V23, P3564, DOI 10.1096/fj.09-133983; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; Ghosh Mousumi, 2003, V237, P67; Glukhova A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7250; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Grubb DR, 2015, J MOL CELL CARDIOL, V84, P95, DOI 10.1016/j.yjmcc.2015.04.016; Guo YJ, 2003, J BIOL CHEM, V278, P29995, DOI 10.1074/jbc.M301438200; Han DS, 2011, MOL PHARMACOL, V80, P434, DOI 10.1124/mol.111.073403; Harden TK, 2009, J LIPID RES, V50, pS243, DOI 10.1194/jlr.R800045-JLR200; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; Hudson BN, 2017, BIOCHEMISTRY-US, V56, P5604, DOI 10.1021/acs.biochem.7b00547; Ilkaeva O, 2002, J BIOL CHEM, V277, P4294, DOI 10.1074/jbc.M109612200; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Kadamur G, 2016, J BIOL CHEM, V291, P11394, DOI 10.1074/jbc.M116.723940; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kim CG, 1996, J BIOL CHEM, V271, P21187, DOI 10.1074/jbc.271.35.21187; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Korasick DA, 2018, PROTEIN SCI, V27, P814, DOI 10.1002/pro.3376; Lyon AM, 2014, STRUCTURE, V22, P1844, DOI 10.1016/j.str.2014.10.008; Lyon AM, 2013, MOL PHARMACOL, V84, P488, DOI 10.1124/mol.113.087403; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Lyon AM, 2011, NAT STRUCT MOL BIOL, V18, P999, DOI 10.1038/nsmb.2095; Madukwe JC, 2018, J BIOL CHEM, V293, P6387, DOI 10.1074/jbc.RA118.002354; Mezzasalma TM, 2007, J BIOMOL SCREEN, V12, P418, DOI 10.1177/1087057106297984; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; PARK DG, 1993, J BIOL CHEM, V268, P3710; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Runnels LW, 1996, BIOCHEMISTRY-US, V35, P16824, DOI 10.1021/bi961606w; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Seifert JP, 2008, J BIOL CHEM, V283, P29690, DOI 10.1074/jbc.M805038200; Seifert JP, 2006, METHOD ENZYMOL, V406, P260, DOI 10.1016/S0076-6879(06)06019-8; Seifert JP, 2004, J BIOL CHEM, V279, P47992, DOI 10.1074/jbc.M407111200; Singer AU, 2002, NAT STRUCT BIOL, V9, P32, DOI 10.1038/nsb731; Skou S, 2014, NAT PROTOC, V9, P1727, DOI 10.1038/nprot.2014.116; Smrcka AV, 2015, J CARDIOVASC PHARM, V65, P203, DOI 10.1097/FJC.0000000000000195; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Trewhella J, 2017, ACTA CRYSTALLOGR D, V73, P710, DOI 10.1107/S2059798317011597; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wing MR, 2001, J BIOL CHEM, V276, P48257, DOI 10.1074/jbc.C100574200; Zhang LH, 2013, CELL, V153, P216, DOI 10.1016/j.cell.2013.02.047; Zhang LH, 2011, J BIOL CHEM, V286, P23012, DOI 10.1074/jbc.M111.231993; Zhang W, 2001, J BIOL CHEM, V276, P2503, DOI 10.1074/jbc.M003562200	65	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17477	17490		10.1074/jbc.RA118.003656	http://dx.doi.org/10.1074/jbc.RA118.003656			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30242131	Green Published, hybrid			2022-12-28	WOS:000449799000014
J	Wang, WB; Daley, JM; Kwon, YH; Xue, XY; Krasner, DS; Miller, AS; Nguyen, KA; Williamson, EA; Shim, EY; Lee, SE; Hromas, R; Sung, P				Wang, Weibin; Daley, James M.; Kwon, Youngho; Xue, Xiaoyu; Krasner, Danielle S.; Miller, Adam S.; Nguyen, Kevin A.; Williamson, Elizabeth A.; Shim, Eun Yong; Lee, Sang Eun; Hromas, Robert; Sung, Patrick			A DNA nick at Ku-blocked double-strand break ends serves as an entry site for exonuclease 1 (Exo1) or Sgs1-Dna2 in long-range DNA end resection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA repair; homologous recombination; DNA helicase; DNA binding protein; DNA gap; DNA nick; Exo1; nuclease; Sgs1-Dna2; DNA end resection	REPAIR PATHWAY CHOICE; REPLICATION PROTEIN-A; GENE 6 EXONUCLEASE; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; BACTERIOPHAGE T7; MRE11-RAD50-XRS2; COMPLEX; RAD51; SAE2	The repair of DNA double-strand breaks (DSBs) by homologous recombination (HR) is initiated by nucleolytic resection of the DNA break ends. The current model, being based primarily on genetic analyses in Saccharomyces cerevisiae and companion biochemical reconstitution studies, posits that end resection proceeds in two distinct stages. Specifically, the initiation of resection is mediated by the nuclease activity of the Mre11-Rad50-Xrs2 (MRX) complex in conjunction with its cofactor Sae2, and long-range resection is carried out by exonuclease 1 (Exo1) or the Sgs1-Top3-Rmi1-Dna2 ensemble. Using fully reconstituted systems, we show here that DNA with ends occluded by the DNA end-joining factor Ku70-Ku80 becomes a suitable substrate for long-range 5-3 resection when a nick is introduced at a locale proximal to one of the Ku-bound DNA ends. We also show that Sgs1 can unwind duplex DNA harboring a nick, in a manner dependent on a species-specific interaction with the ssDNA-binding factor replication protein A (RPA). These biochemical systems and results will be valuable for guiding future endeavors directed at delineating the mechanistic intricacy of DNA end resection in eukaryotes.	[Wang, Weibin; Daley, James M.; Kwon, Youngho; Xue, Xiaoyu; Krasner, Danielle S.; Miller, Adam S.; Nguyen, Kevin A.; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Kwon, Youngho; Sung, Patrick] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, San Antonio, TX 78229 USA; [Williamson, Elizabeth A.; Hromas, Robert] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Shim, Eun Yong; Lee, Sang Eun] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiat Oncol, San Antonio, TX 78229 USA; [Lee, Sang Eun] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA	Yale University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Sung, P (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.; Sung, P (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, San Antonio, TX 78229 USA.	patrick.sung@yale.edu	Nguyen, Kevin/AAS-4909-2021		NCI NIH HHS [R01 CA205224, R01 CA220123] Funding Source: Medline; NIEHS NIH HHS [R01 ES007061] Funding Source: Medline; NIGMS NIH HHS [R01 GM071011, R01 GM109645] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA205224, R01CA220123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109645, R01GM071011] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adkins NL, 2013, NAT STRUCT MOL BIOL, V20, P836, DOI 10.1038/nsmb.2585; Arnoult N, 2017, NATURE, V549, P548, DOI 10.1038/nature24023; Cannan WJ, 2016, J CELL PHYSIOL, V231, P3, DOI 10.1002/jcp.25048; Cannavo E, 2013, P NATL ACAD SCI USA, V110, pE1661, DOI 10.1073/pnas.1305166110; Cejka P, 2015, J BIOL CHEM, V290, P22931, DOI 10.1074/jbc.R115.675942; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Daley JM, 2014, MOL CELL BIOL, V34, P1380, DOI 10.1128/MCB.01639-13; Daley JM, 2005, J BIOL CHEM, V280, P29030, DOI 10.1074/jbc.M505277200; Fortini BK, 2011, J BIOL CHEM, V286, P23763, DOI 10.1074/jbc.M111.243071; Fouquin A, 2017, NUCLEIC ACIDS RES, V45, P12325, DOI 10.1093/nar/gkx881; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Gnugge R, 2017, GENE DEV, V31, P2311, DOI 10.1101/gad.310771.117; Gradia SD, 2017, METHOD ENZYMOL, V592, P1, DOI 10.1016/bs.mie.2017.03.008; Hegnauer AM, 2012, EMBO J, V31, P3768, DOI 10.1038/emboj.2012.195; Her J, 2018, J BIOL CHEM, V293, P10502, DOI 10.1074/jbc.TM118.000371; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Karanam K, 2012, MOL CELL, V47, P320, DOI 10.1016/j.molcel.2012.05.052; KERR C, 1972, J BIOL CHEM, V247, P311; KERR C, 1972, J BIOL CHEM, V247, P305; Kim HS, 2017, J BIOL CHEM, V292, P2795, DOI 10.1074/jbc.M116.758235; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Krasner DS, 2015, J BIOL CHEM, V290, P18806, DOI 10.1074/jbc.M115.660191; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Miller AS, 2017, GENE DEV, V31, P503, DOI 10.1101/gad.295659.116; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Niu HY, 2009, GENE DEV, V23, P1481, DOI 10.1101/gad.1824209; Pannunzio NR, 2018, J BIOL CHEM, V293, P10512, DOI 10.1074/jbc.TM117.000374; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Reginato G, 2017, GENE DEV, V31, P2325, DOI 10.1101/gad.308254.117; Sallmyr A, 2018, J BIOL CHEM, V293, P10536, DOI 10.1074/jbc.TM117.000375; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tammaro M, 2016, NUCLEIC ACIDS RES, V44, P221, DOI 10.1093/nar/gkv969; Thorslund T, 2010, NAT STRUCT MOL BIOL, V17, P1263, DOI 10.1038/nsmb.1905; Trujillo KM, 2003, J BIOL CHEM, V278, P48957, DOI 10.1074/jbc.M309877200; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Van Komen S, 2006, METHOD ENZYMOL, V408, P445, DOI 10.1016/S0076-6879(06)08028-1; Wang WB, 2017, GENE DEV, V31, P2331, DOI 10.1101/gad.307900.117; White RR, 2016, MOL CELL, V63, P729, DOI 10.1016/j.molcel.2016.08.004; Wright WD, 2018, J BIOL CHEM, V293, P10524, DOI 10.1074/jbc.TM118.000372; Wu DL, 2008, GENETICS, V178, P1237, DOI 10.1534/genetics.107.083535; Xue XY, 2016, GENE DEV, V30, P687, DOI 10.1101/gad.276139.115; Yang G, 2018, NUCLEIC ACIDS RES, V46, P3446, DOI 10.1093/nar/gky088; Zhao WX, 2015, MOL CELL, V59, P176, DOI 10.1016/j.molcel.2015.05.032	54	15	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17061	17069		10.1074/jbc.RA118.004769	http://dx.doi.org/10.1074/jbc.RA118.004769			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30224356	Green Published, hybrid			2022-12-28	WOS:000449466500009
J	Park, JF; Yu, YP; Gong, N; Trinh, V; Luo, ZD				Park, John Francisco; Yu, Yanhui Peter; Gong, Nian; Trinh, Van Nancy; Luo, Z. David			The EGF-LIKE domain of thrombospondin-4 is a key determinant in the development of pain states due to increased excitatory synaptogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						thrombospondin; pain; synaptic plasticity; calcium channel; extracellular matrix protein; allodynia; neuropathic pain; pro-nociceptive domain; synaptogenesis; TSP4	CALCIUM-CHANNEL SUBUNIT; DORSAL-ROOT GANGLION; UP-REGULATION CONTRIBUTES; NEUROPATHIC PAIN; GABAPENTIN NEURONTIN; SYNAPSE FORMATION; HORN NEURONS; IN-VITRO; ALPHA(2)DELTA; SENSITIZATION	Up-regulation of thrombospondin-4 (TSP4) or voltage-gated calcium channel subunit (21) (Ca-v21) proteins in the spinal cord contributes to neuropathic pain development through an unidentified mechanism. We have previously shown that TSP4 interacts with Ca-v21 to promote excitatory synaptogenesis and the development of chronic pain states. However, the TSP4 determinants responsible for these changes are not known. Here, we tested the hypothesis that the Ca-v21-binding domains of TSP4 are synaptogenic and pronociceptive. We mapped the major Ca-v21-binding domains of TSP4 within the coiled-coil and epidermal growth factor (EGF)-like domains in vitro. Intrathecal injection of TSP4 fragment proteins containing the EGF-like domain (EGF-LIKE) into naive rodents was sufficient for inducing behavioral hypersensitivity similar to that produced by an equal molar dose of full-length TSP4. Gabapentin, a drug that binds to Ca-v21, blocked EGF-LIKE-induced behavioral hypersensitivity in a dose-dependent manner, supporting the notion that EGF-LIKE interacts with Ca-v21 and thereby mediates behavioral hypersensitivity. This notion was further supported by our findings that a peptide within EGF-LIKE (EGFD355-369) could block TSP4- or Ca-v21-induced behavioral hypersensitivity after intrathecal injections. Furthermore, only TSP4 proteins that contained EGF-LIKE could promote excitatory synaptogenesis between sensory and spinal cord neurons, which could be blocked by peptide EGFD355-369. Together, these findings indicate that EGF-LIKE is the molecular determinant that mediates aberrant excitatory synaptogenesis and chronic pain development. Blocking interactions between EGF-LIKE and Ca-v21 could be an alternative approach in designing target-specific pain medications.	[Park, John Francisco; Yu, Yanhui Peter; Luo, Z. David] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; [Gong, Nian; Trinh, Van Nancy; Luo, Z. David] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Gillespie Bldg,Rm 3113,837 Hlth Sci Rd, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Luo, ZD (corresponding author), Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Gillespie Bldg,Rm 3113,837 Hlth Sci Rd, Irvine, CA 92697 USA.	zluo@uci.edu			National Institutes of Health [DE021847, NS064341]; Pharmaceutical Research and Manufacturers of America Foundation [PRMAF-52427]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmaceutical Research and Manufacturers of America Foundation	This work supported in part by National Institutes of Health Grants DE021847 and NS064341 (to Z. D. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of Pre-Doctoral Fellowship in Pharmacology/Toxicology PRMAF-52427 from the Pharmaceutical Research and Manufacturers of America Foundation.	Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Albuquerque Cristovao, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5274; Albuquerque Cristovao, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5275; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Artru AA, 1999, SPINAL DRUG DELIVERY, P177; Bauer CS, 2009, J NEUROSCI, V29, P4076, DOI 10.1523/JNEUROSCI.0356-09.2009; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Burkey TH, 2004, METH MOLEC MED, P189; Chen JJ, 2018, CELL REP, V22, P2307, DOI 10.1016/j.celrep.2018.02.021; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; DELREE P, 1989, J NEUROSCI RES, V23, P198, DOI 10.1002/jnr.490230210; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gee NS, 1996, J BIOL CHEM, V271, P5768, DOI 10.1074/jbc.271.10.5768; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hendrich J, 2008, P NATL ACAD SCI USA, V105, P3628, DOI 10.1073/pnas.0708930105; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Joseph DJ, 2010, J NEUROSCI METH, V189, P197, DOI 10.1016/j.jneumeth.2010.04.002; Kim DS, 2012, J NEUROSCI, V32, P8977, DOI 10.1523/JNEUROSCI.6494-11.2012; Kim DS, 2009, PAIN, V143, P114, DOI 10.1016/j.pain.2009.02.006; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Lana B, 2016, SCI REP-UK, V6, DOI 10.1038/srep24531; Li CY, 2006, PAIN, V125, P20, DOI 10.1016/j.pain.2006.04.022; Li CY, 2004, J NEUROSCI, V24, P8494, DOI 10.1523/JNEUROSCI.2982-04.2004; Li KW, 2014, EUR J PAIN, V18, P489, DOI 10.1002/j.1532-2149.2013.00396.x; Li KW, 2014, J BIOL CHEM, V289, P7025, DOI 10.1074/jbc.M114.548990; Lin YX, 2004, J NEUROPHYSIOL, V92, P2820, DOI 10.1152/jn.00048.2004; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marais E, 2001, MOL PHARMACOL, V59, P1243, DOI 10.1124/mol.59.5.1243; Milligan ED, 2005, EUR J NEUROSCI, V21, P2136, DOI 10.1111/j.1460-9568.2005.04057.x; Narouz-Ott L, 2000, J BIOL CHEM, V275, P37110, DOI 10.1074/jbc.M007223200; Nguyen D, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-6; Ohshiro H, 2007, J NEUROSCI METH, V165, P49, DOI 10.1016/j.jneumeth.2007.05.018; Park J, 2016, J BIOL CHEM, V291, P13335, DOI 10.1074/jbc.M116.723478; RADULOVIC LL, 1995, DRUG METAB DISPOS, V23, P441; Ruthazer ES, 2006, J NEUROSCI, V26, P3594, DOI 10.1523/JNEUROSCI.0069-06.2006; Ruzza C, 2015, PEPTIDES, V69, P26, DOI 10.1016/j.peptides.2015.03.021; Seybold VS, 2004, METH MOLEC MED, P203; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Valder CR, 2003, J NEUROCHEM, V87, P560, DOI 10.1046/j.1471-4159.2003.02016.x; VARON S, 1971, BRAIN RES, V30, P83, DOI 10.1016/0006-8993(71)90007-2; VIDAL M, 1990, EMBO J, V9, P833, DOI 10.1002/j.1460-2075.1990.tb08180.x; Wang H, 2002, NEUROSCIENCE, V114, P529, DOI 10.1016/S0306-4522(02)00341-X; Wang MH, 1999, BIOCHEM J, V342, P313, DOI 10.1042/0264-6021:3420313; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Yu YP, 2018, BRIT J PHARMACOL, V175, P2348, DOI 10.1111/bph.14149; Zeng J, 2013, EUR J PAIN, V17, P1458, DOI 10.1002/j.1532-2149.2013.00326.x; Zhou C, 2015, EUR J PAIN, V19, P1267, DOI 10.1002/ejp.656; Zhou C, 2014, EUR J PAIN, V18, P649, DOI 10.1002/j.1532-2149.2013.00416.x; Zurborg S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-66	56	8	9	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16453	16463		10.1074/jbc.RA118.003591	http://dx.doi.org/10.1074/jbc.RA118.003591			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30194282	hybrid, Green Published			2022-12-28	WOS:000447833600027
J	Rodriguez-Castaneda, F; Lemnna, RB; Cuervo, I; Bengtsen, M; Moen, LM; Ledsaak, M; Eskeland, R; Gabrielsen, OS				Rodriguez-Castaneda, Fernando; Lemnna, Roza Berhanu; Cuervo, Ignacio; Bengtsen, Mads; Moen, Lisa Marie; Ledsaak, Marit; Eskeland, Ragnhild; Gabrielsen, Odd Stokke			The SUMO protease SENP1 and the chromatin remodeler CHD3 interact and jointly affect chromatin accessibility and gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						small ubiquitin-like modifier (SUMO); sumoylation; chromatin remodeling; chromatin regulation; transcription; transcription coregulator; ATAC-seq; CHD3; HAP1; SENP1; SUMO protease	FACTOR C-MYB; TRANSCRIPTION FACTORS; HUMAN GENOME; BINDING PROTEINS; E3 LIGASE; SUMOYLATION; COMPLEX; PHOSPHORYLATION; DESUMOYLATION; COACTIVATOR	The small ubiquitin-like modifier (SUMO) post-translationally modifies lysine residues of transcription factors and co-regulators and thereby contributes to an important layer of control of the activities of these transcriptional regulators. Likewise, deSUMOylation of these factors by the sentrin-specific proteases (SENPs) also plays a role in gene regulation, but whether SENPs functionally interact with other regulatory factors that control gene expression is unclear. In the present work, we focused on SENP1, specifically, on its role in activation of gene expression investigated through analysis of the SENP1 interactome, which revealed that SENP1 physically interacts with the chromatin remodeler chromodomain helicase DNA-binding protein 3 (CHD3). Using several additional methods, including GST pulldown and co-immunoprecipitation assays, we validated and mapped this interaction, and using CRISPR-Cas9-generated CHD3- and SENP1-KO cells (in the haploid HAP1 cell line), we investigated whether these two proteins are functionally linked in regulating chromatin remodeling and gene expression. Genome-wide ATAC-Seq analysis of the CHD3- and SENP1-KO cells revealed a large degree of overlap in differential chromatin openness between these two mutant cell lines. Moreover, motif analysis and comparison with ChIP-Seq profiles in K562 cells pointed to an association of CHD3 and SENP1 with CCCTC-binding factor (CTCF) and SUMOylated chromatin-associated factors. Lastly, genome-wide RNA-Seq also indicated that these two proteins co-regulate the expression of several genes. We propose that the functional link between chromatin remodeling by CHD3 and deSUMOylation by SENP1 uncovered here provides another level of control of gene expression.	[Rodriguez-Castaneda, Fernando; Lemnna, Roza Berhanu; Cuervo, Ignacio; Bengtsen, Mads; Moen, Lisa Marie; Ledsaak, Marit; Eskeland, Ragnhild; Gabrielsen, Odd Stokke] Univ Oslo, Dept Biosci, POB 1066 Blindern, N-0316 Oslo, Norway; [Eskeland, Ragnhild] Univ Oslo, Inst Clin Med, Ctr Canc Cell Reprogramming, POB 1112 Blindern, N-0317 Oslo, Norway	University of Oslo; University of Oslo	Gabrielsen, OS (corresponding author), Univ Oslo, Dept Biosci, POB 1066 Blindern, N-0316 Oslo, Norway.	o.s.gabrielsen@ibv.uio.no	Eskeland, Ragnhild/AFM-2892-2022; Lemma, Roza Berhanu/AAM-9288-2020; Eskeland, Ragnhild/GSN-9383-2022; Eskeland, Ragnhild/K-7018-2014	Lemma, Roza Berhanu/0000-0003-1069-8011; Eskeland, Ragnhild/0000-0003-2789-3171; Eskeland, Ragnhild/0000-0003-2789-3171	Norwegian Cancer Society [3485238-2013]; Research Council of Norway [240768, 231217]	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway)	This work was supported by Norwegian Cancer Society Grant 3485238-2013 (to R. E.) and Research Council of Norway Grants 240768 (to O. S. G.) and 231217 (to R. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Abugessaisa I, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw105; Allen MD, 2007, J MOL BIOL, V371, P1135, DOI 10.1016/j.jmb.2007.06.007; Alm-Kristiansen AH, 2008, ONCOGENE, V27, P4644, DOI 10.1038/onc.2008.105; Alm-Kristiansen AH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-21; Alm-Kristiansen AH, 2009, BIOCHEM BIOPH RES CO, V387, P494, DOI 10.1016/j.bbrc.2009.07.053; Bartek J, 2010, CANCER CELL, V17, P9, DOI 10.1016/j.ccr.2009.12.030; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Bengtsen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133280; Bettermann K, 2012, CANCER LETT, V316, P113, DOI 10.1016/j.canlet.2011.10.036; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Chymkowitch P, 2015, BIOESSAYS, V37, P1095, DOI 10.1002/bies.201500065; Cox E, 2017, MOL CELL PROTEOMICS, V16, P812, DOI 10.1074/mcp.M116.063719; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Dahle O, 2004, EXP CELL RES, V297, P118, DOI 10.1016/j.yexcr.2004.03.014; Dahle O, 2003, EUR J BIOCHEM, V270, P1338, DOI 10.1046/j.1432-1033.2003.03504.x; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Fuglerud BM, 2017, NUCLEIC ACIDS RES, V45, P7681, DOI 10.1093/nar/gkx364; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2003, CURR OPIN GENET DEV, V13, P108, DOI 10.1016/S0959-437X(03)00021-2; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hendriks IA, 2017, NAT STRUCT MOL BIOL, V24, P325, DOI 10.1038/nsmb.3366; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Huang CJ, 2015, DNA CELL BIOL, V34, P652, DOI 10.1089/dna.2015.2933; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Ji X, 2016, CELL STEM CELL, V18, P262, DOI 10.1016/j.stem.2015.11.007; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Ledsaak M, 2016, BBA-GENE REGUL MECH, V1859, P705, DOI 10.1016/j.bbagrm.2016.03.011; Lobanenkov VV, 2018, NUCLEUS-PHILA, V9, P33, DOI 10.1080/19491034.2017.1394536; MacPherson MJ, 2009, MOL CELL BIOL, V29, P714, DOI 10.1128/MCB.00825-08; Matre V, 2009, BIOCHEM BIOPH RES CO, V388, P150, DOI 10.1016/j.bbrc.2009.07.139; Molvaersmyr AK, 2010, NUCLEIC ACIDS RES, V38, P4970, DOI 10.1093/nar/gkq245; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Niskanen EA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0717-y; Nunez-O'Mara A, 2013, BIOL CHEM, V394, P459, DOI 10.1515/hsz-2012-0319; Ouyang J, 2009, EPIGENETICS-US, V4, P440, DOI 10.4161/epi.4.7.9807; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Saether T, 2007, J BIOL CHEM, V282, P13994, DOI 10.1074/jbc.M700755200; Sarge KD, 2011, INT REV CEL MOL BIO, V288, P167, DOI 10.1016/B978-0-12-386041-5.00004-2; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shen QT, 2017, BIOCHEM J, V474, P3455, DOI 10.1042/BCJ20170172; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Stielow B, 2008, EMBO REP, V9, P899, DOI 10.1038/embor.2008.127; Stielow B, 2008, MOL CELL, V29, P742, DOI 10.1016/j.molcel.2007.12.032; Swinstead EE, 2016, BIOESSAYS, V38, P1150, DOI 10.1002/bies.201600137; Nguyen TV, 2012, MOL CELL, V45, P210, DOI 10.1016/j.molcel.2011.12.026; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang YG, 2009, J CELL SCI, V122, P4249, DOI 10.1242/jcs.050542; Whalen S, 2016, NAT GENET, V48, P488, DOI 10.1038/ng.3539; Wiechens N, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005940; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Yamashita D, 2016, J BIOL CHEM, V291, P11619, DOI 10.1074/jbc.M115.713370; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Yu LY, 2010, J EXP MED, V207, P1183, DOI 10.1084/jem.20092215	70	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15439	15454		10.1074/jbc.RA118.002844	http://dx.doi.org/10.1074/jbc.RA118.002844			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30082317	hybrid, Green Published			2022-12-28	WOS:000446549200009
J	Kawagoe, S; Nakagawa, H; Kumeta, H; Ishimori, K; Saio, T				Kawagoe, Soichiro; Nakagawa, Hiroshi; Kumeta, Hiroyuki; Ishimori, Koichiro; Saio, Tomohide			Structural insight into proline cis/trans isomerization of unfolded proteins catalyzed by the trigger factor chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular chaperone; prolyl isomerase; molecular dynamics; protein folding; structure-function; nuclear magnetic resonance (NMR); hydrophobic interaction; peptidyl-prolyl isomerase domain; trigger factor	ESCHERICHIA-COLI; PROLYL ISOMERIZATION; ENZYMATIC CATALYSIS; SUBSTRATE-BINDING; HYDROGEN-BONDS; ISOMERASE; DYNAMICS; DOMAIN; IDENTIFICATION; SPECIFICITY	Molecular chaperones often possess functional modules that are specialized in assisting the formation of specific structural elements, such as a disulfide bridges and peptidyl-prolyl bonds in cis form, in the client protein. A ribosome-associated molecular chaperone trigger factor (TF), which has a peptidyl-prolyl cis/trans isomerase (PPIase) domain, acts as a highly efficient catalyst in the folding process limited by peptidyl-prolyl isomerization. Herein we report a study on the mechanism through which TF recognizes the proline residue in the unfolded client protein during the cis/trans isomerization process. The solution structure of TF in complex with the client protein showed that TF recognizes the proline-aromatic motif located in the hydrophobic stretch of the unfolded client protein through its conserved hydrophobic cleft, which suggests that TF preferentially accelerates the isomerization of the peptidyl-prolyl bond that is eventually folded into the core of the protein in its native fold. Molecular dynamics simulation revealed that TF exploits the backbone amide group of Ile(195) to form an intermolecular hydrogen bond with the carbonyl oxygen of the amino acid residue preceding the proline residue at the transition state, which presumably stabilizes the transition state and thus accelerates the isomerization. The importance of such intermolecular hydrogen-bond formation during the catalysis was further corroborated by the activity assay and NMR relaxation analysis.	[Kawagoe, Soichiro; Ishimori, Koichiro; Saio, Tomohide] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido 0608628, Japan; [Nakagawa, Hiroshi] Japan Atom Energy Agcy, Mat Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Kumeta, Hiroyuki] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0110021, Japan; [Ishimori, Koichiro; Saio, Tomohide] Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido 0600810, Japan; [Saio, Tomohide] Japan Sci & Technol Agcy, PRESTO, Tokyo 1020076, Japan	Hokkaido University; Japan Atomic Energy Agency; Hokkaido University; Hokkaido University; Japan Science & Technology Agency (JST)	Ishimori, K; Saio, T (corresponding author), Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido 0600810, Japan.	koichiro@sci.hokudai.ac.jp; saio@sci.hokudai.ac.jp	Ishimori, Koichiro/S-1247-2016; Ishimori, Koichiro/AAQ-4434-2021	Ishimori, Koichiro/0000-0002-5868-0462; Ishimori, Koichiro/0000-0002-5868-0462; Saio, Tomohide/0000-0003-3639-7399; Kumeta, Hiroyuki/0000-0003-3713-2122; Kawagoe, Soichiro/0000-0002-7158-4504	JSPS KAKENHI [17H05657, 17H05867, 18H05229]; PRESTO, Japan Science and Technology Agency	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by in part by JSPS KAKENHI Grants 17H05657, 17H05867, and 18H05229 and by PRESTO, Japan Science and Technology Agency. The authors declare that they have no conflicts of interest with the contents of this article.	Alag R, 2013, EUKARYOT CELL, V12, P627, DOI 10.1128/EC.00016-13; ALBERS MW, 1990, J ORG CHEM, V55, P4984, DOI 10.1021/jo00304a003; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bang N, 2000, EUR J BIOCHEM, V267, P3270, DOI 10.1046/j.1432-1327.2000.01355.x; Bieri M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-421; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Camilloni C, 2014, P NATL ACAD SCI USA, V111, P10203, DOI 10.1073/pnas.1404220111; Case D., 2015, AMBER, V14; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Hamelberg D, 2009, J AM CHEM SOC, V131, P147, DOI 10.1021/ja806146g; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hesterkamp T, 1996, FEBS LETT, V385, P67, DOI 10.1016/0014-5793(96)00351-1; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; Huang CD, 2016, NATURE, V537, P202, DOI 10.1038/nature18965; Ikura T, 2008, PROTEIN ENG DES SEL, V21, P83, DOI 10.1093/protein/gzm087; Ikura T, 2007, PROTEIN SCI, V16, P2618, DOI 10.1110/ps.073203707; Kandror O, 1997, P NATL ACAD SCI USA, V94, P4978, DOI 10.1073/pnas.94.10.4978; Kramer G, 2004, J BIOL CHEM, V279, P14165, DOI 10.1074/jbc.M313635200; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; Liu CP, 2010, INT J BIOCHEM CELL B, V42, P890, DOI 10.1016/j.biocel.2010.01.019; Low C, 2010, J MOL BIOL, V398, P375, DOI 10.1016/j.jmb.2010.03.014; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; LUZ Z, 1963, J CHEM PHYS, V39, P366, DOI 10.1063/1.1734254; Merz F, 2006, J BIOL CHEM, V281, P31963, DOI 10.1074/jbc.M605164200; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; MUCKE M, 1992, BIOCHEMISTRY-US, V31, P7848; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Quistgaard EM, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0300-3; ROSEN MK, 1990, SCIENCE, V248, P863, DOI 10.1126/science.1693013; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saio T, 2018, ELIFE, V7, DOI 10.7554/eLife.35731; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; SCHMID FX, 1993, ANNU REV BIOPH BIOM, V22, P123, DOI 10.1146/annurev.bb.22.060193.001011; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sheu SY, 2003, P NATL ACAD SCI USA, V100, P12683, DOI 10.1073/pnas.2133366100; STOLLER G, 1995, EMBO J, V14, P4939, DOI 10.1002/j.1460-2075.1995.tb00177.x; Teilum K, 2017, PROTEIN SCI, V26, P436, DOI 10.1002/pro.3105; Torshin IY, 2002, PROTEIN ENG, V15, P359, DOI 10.1093/protein/15.5.359; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P14637, DOI 10.1021/bi020574b; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017	51	12	12	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15095	15106		10.1074/jbc.RA118.003579	http://dx.doi.org/10.1074/jbc.RA118.003579			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30093407	hybrid, Green Published			2022-12-28	WOS:000445998400013
J	Pfanzagl, V; Nys, K; Bellei, M; Michlits, H; Mlynek, G; Battistuzzi, G; Djinovic-Carugo, K; Van Doorslaer, S; Furtmuller, PG; Hofbauer, S; Obinger, C				Pfanzagl, Vera; Nys, Kevin; Bellei, Marzia; Michlits, Hanna; Mlynek, Georg; Battistuzzi, Gianantonio; Djinovic-Carugo, Kristina; Van Doorslaer, Sabine; Furtmueller, Paul G.; Hofbauer, Stefan; Obinger, Christian			Roles of distal aspartate and arginine of B-class dye-decolorizing peroxidase in heterolytic hydrogen peroxide cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme; enzyme kinetics; Klebsiella pneumonia; pre-steady-state kinetics; site-directed mutagenesis; X-ray crystallography; electron paramagnetic resonance (EPR); Compound I; Compound II; heme peroxidase; oxoiron	CYTOCHROME-C PEROXIDASE; HORSERADISH-PEROXIDASE; CHLORITE DISMUTASE; MAMMALIAN PEROXIDASES; REDOX THERMODYNAMICS; STRUCTURE VALIDATION; CATALYTIC-PROPERTIES; CRYSTAL-STRUCTURE; LIGAND-BINDING; COMPOUND-I	Dye-decolorizing peroxidases (DyPs) represent the most recently classified hydrogen peroxide-dependent heme peroxidase family. Although widely distributed with more than 5000 annotated genes and hailed for their biotechnological potential, detailed biochemical characterization of their reaction mechanism remains limited. Here, we present the high-resolution crystal structures of WT B-class DyP from the pathogenic bacterium Klebsiella pneumoniae (KpDyP) (1.6 angstrom) and the variants D143A (1.3 angstrom), R232A (1.9 angstrom), and D143A/R232A (1.1 angstrom). We demonstrate the impact of elimination of the DyP-typical, distal residues Asp-143 and Arg-232 on (i) the spectral and redox properties, (ii) the kinetics of heterolytic cleavage of hydrogen peroxide, (iii) the formation of the low-spin cyanide complex, and (iv) the stability and reactivity of an oxoiron(IV)porphyrin pi-cation radical (Compound I). Structural and functional studies reveal that the distal aspartate is responsible for deprotonation of H2O2 and for the poor oxidation capacity of Compound I. Elimination of the distal arginine promotes a collapse of the distal heme cavity, including blocking of one access channel and a conformational change of the catalytic aspartate. We also provide evidence of formation of an oxoiron(IV)-type Compound II in KpDyP with absorbance maxima at 418, 527, and 553 nm. In summary, a reaction mechanism of the peroxidase cycle of B-class DyPs is proposed. Our observations challenge the idea that peroxidase activity toward conventional aromatic substrates is related to the physiological roles of B-class DyPs.	[Pfanzagl, Vera; Michlits, Hanna; Furtmueller, Paul G.; Hofbauer, Stefan; Obinger, Christian] BOKU Univ Nat Resources & Life Sci, Dept Chem, Div Biochem, A-1190 Vienna, Austria; [Nys, Kevin; Van Doorslaer, Sabine] Univ Antwerp, Dept Phys, B-2610 Antwerp, Belgium; [Bellei, Marzia] Univ Modena & Reggio Emilia, Dept Life Sci, Via Campi 103, I-41125 Modena, Italy; [Battistuzzi, Gianantonio] Univ Modena & Reggio Emilia, Dept Chem & Geol, Via Campi 103, I-41125 Modena, Italy; [Mlynek, Georg; Djinovic-Carugo, Kristina] Univ Vienna, Max F Perutz Labs, Dept Struct & Computat Biol, A-1030 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Antwerp; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Obinger, C (corresponding author), BOKU Univ Nat Resources & Life Sci, Dept Chem, Div Biochem, A-1190 Vienna, Austria.	christian.obinger@boku.ac.at	Pfanzagl, Vera/AAE-9025-2019; Van Doorslaer, Sabine/E-5050-2017; Battistuzzi, Gianantonio/L-7183-2015; Furtmüller, Paul G./Y-5819-2018; Obinger, Christian/AAV-3173-2021; Hofbauer, Stefan/I-3889-2014; Djinovic-Carugo, Kristina/AAW-1167-2021	Van Doorslaer, Sabine/0000-0002-1685-9202; Battistuzzi, Gianantonio/0000-0003-4716-5745; Furtmüller, Paul G./0000-0002-1199-2469; Hofbauer, Stefan/0000-0003-3375-7715; Djinovic-Carugo, Kristina/0000-0003-0252-2972; Michlits, Hanna/0000-0001-5537-5035; Pfanzagl, Vera/0000-0002-9361-8365; Obinger, Christian/0000-0002-7133-3430	Instruct-ERIC	Instruct-ERIC	We thank Diamond Light Source for beam time (proposal mx16011) and the staff of beamline I24 for assistance with crystal testing and data collection. We acknowledge the support and the use of resources of Instruct-ERIC.	AASA R, 1975, BIOCHIM BIOPHYS ACTA, V391, P259, DOI 10.1016/0005-2744(75)90249-1; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z; Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Baratto MC, 2015, J PHYS CHEM B, V119, P13583, DOI 10.1021/acs.jpcb.5b02961; Barr Ian, 2015, Bio Protoc, V5; Battistuzzi G, 2001, BIOCHEMISTRY-US, V40, P6422, DOI 10.1021/bi002565d; Battistuzzi G, 2006, BIOCHEMISTRY-US, V45, P12750, DOI 10.1021/bi061647k; Battistuzzi G, 2011, BIOCHEMISTRY-US, V50, P7987, DOI [10.1021/bi20084321, 10.1021/bi2008432]; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V500, P21, DOI 10.1016/j.abb.2010.03.002; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V494, P72, DOI 10.1016/j.abb.2009.11.021; Beteva A, 2006, ACTA CRYSTALLOGR D, V62, P1162, DOI 10.1107/S0907444906032859; BLUMBERG WE, 1968, J BIOL CHEM, V243, P1854; Chen C, 2015, J BIOL CHEM, V290, P23447, DOI 10.1074/jbc.M115.658807; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dailey HA, 2011, MBIO, V2, DOI 10.1128/mBio.00248-11; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Schutter A, 2015, J PHYS CHEM B, V119, P13859, DOI 10.1021/acs.jpcb.5b04141; Dunford H. B., 1999, HEME PEROXIDASES; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERMAN JE, 1993, BIOCHEMISTRY-US, V32, P9798, DOI 10.1021/bi00088a035; Fitch CA, 2015, PROTEIN SCI, V24, P752, DOI 10.1002/pro.2647; Freire DM, 2015, J INORG BIOCHEM, V151, P1, DOI 10.1016/j.jinorgbio.2015.07.006; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Hofbauer S, 2016, FEBS J, V283, P4386, DOI 10.1111/febs.13930; Hofbauer S, 2014, BIOCHEMISTRY-US, V53, P3145, DOI 10.1021/bi500401k; Jantschko W, 2002, ARCH BIOCHEM BIOPHYS, V398, P12, DOI 10.1006/abbi.2001.2674; Jones P, 2005, J INORG BIOCHEM, V99, P2292, DOI 10.1016/j.jinorgbio.2005.08.009; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim SJ, 1999, BIOTECHNOL BIOENG, V62, P114, DOI 10.1002/(SICI)1097-0290(19990105)62:1&lt;114::AID-BIT13&gt;3.0.CO;2-T; Lendzian F, 2005, BBA-BIOENERGETICS, V1707, P67, DOI 10.1016/j.bbabio.2004.02.011; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; Linde D, 2015, BIOCHEM J, V466, P253, DOI 10.1042/BJ20141211; Mendes S, 2015, ARCH BIOCHEM BIOPHYS, V574, P99, DOI 10.1016/j.abb.2015.03.009; NAKAJIMA R, 1980, J BIOL CHEM, V255, P2067; NEWMYER SL, 1995, J BIOL CHEM, V270, P19430, DOI 10.1074/jbc.270.33.19430; Nicolussi A, 2017, BIOCHEMISTRY-US, V56, P4525, DOI 10.1021/acs.biochem.7b00632; Paumann-Page M, 2017, J BIOL CHEM, V292, P4583, DOI 10.1074/jbc.M117.775213; POULOS TL, 1980, J BIOL CHEM, V255, P8199; POULOS TL, 1980, J BIOL CHEM, V255, P575; Roberts JN, 2011, BIOCHEMISTRY-US, V50, P5108, DOI 10.1021/bi200427h; RodriguezLopez JN, 1996, J BIOL CHEM, V271, P4023; Sarada BV, 2000, ANAL CHEM, V72, P1632, DOI 10.1021/ac9908748; Schaffner I, 2015, MOL MICROBIOL, V96, P1053, DOI 10.1111/mmi.12989; SCHULZ CE, 1979, FEBS LETT, V103, P102, DOI 10.1016/0014-5793(79)81259-4; Shrestha R, 2017, ACS CATAL, V7, P6352, DOI 10.1021/acscatal.7b01861; Shrestha R, 2016, ACS CATAL, V6, P8036, DOI 10.1021/acscatal.6b01952; Singh R, 2013, ACS CHEM BIOL, V8, P700, DOI 10.1021/cb300608x; Singh R, 2012, J BIOL CHEM, V287, P10623, DOI 10.1074/jbc.M111.332171; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Strittmatter E, 2015, ARCH BIOCHEM BIOPHYS, V574, P75, DOI 10.1016/j.abb.2014.12.016; Sugano Y, 2000, APPL ENVIRON MICROB, V66, P1754, DOI 10.1128/AEM.66.4.1754-1758.2000; Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200; Svistunenko DA, 2012, BIOCHIMIE, V94, P1274, DOI 10.1016/j.biochi.2012.02.021; Uchida T, 2015, BIOCHEMISTRY-US, V54, P6610, DOI 10.1021/acs.biochem.5b00952; VITELLO LB, 1993, BIOCHEMISTRY-US, V32, P9807, DOI 10.1021/bi00088a036; Vlasits J, 2010, ARCH BIOCHEM BIOPHYS, V500, P74, DOI 10.1016/j.abb.2010.04.018; Weil J. A., 2006, ELECT PARAMAGNETIC R; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yoshida T, 2015, ARCH BIOCHEM BIOPHYS, V574, P49, DOI 10.1016/j.abb.2015.01.022; Zamocky M, 2015, ARCH BIOCHEM BIOPHYS, V574, P108, DOI 10.1016/j.abb.2014.12.025; Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g; Zheng H, 2017, ACTA CRYSTALLOGR D, V73, P223, DOI 10.1107/S2059798317001061; Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172	66	27	27	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14823	14838		10.1074/jbc.RA118.004773	http://dx.doi.org/10.1074/jbc.RA118.004773			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30072383	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000446155000019
J	Poppe, J; Reichelt, J; Blankenfeldt, W				Poppe, Juliane; Reichelt, Joachim; Blankenfeldt, Wulf			Pseudomonas aeruginosa pyoverdine maturation enzyme PvdP has a noncanonical domain architecture and affords insight into a new subclass of tyrosinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						siderophore; Pseudomonas aeruginosa (P-aeruginosa); infectious disease; copper; protein structure; tyrosinase; biosynthesis; enzyme; streptavidin	CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; IDENTIFICATION; SIDEROPHORE; MECHANISM; CRYSTALLOGRAPHY; BIOSYNTHESIS; CHROMOPHORE; VALIDATION; SECRETION	Pyoverdines (PVDs) are important chromophore-containing siderophores of fluorescent pseudomonad bacteria such as the opportunistic human pathogen Pseudomonas aeruginosa in which they play an essential role in host infection. PVD biosynthesis encompasses a complex pathway comprising cytosolic nonribosomal peptide synthetases that produce a polypeptide precursor that periplasmic enzymes convert to the final product. The structures of most enzymes involved in PVD chromophore maturation have been elucidated, but the structure of the essential tyrosinase PvdP, a monooxygenase required for the penultimate step in PVD biosynthesis, is not known. Here, we closed this gap by determining the crystal structure of PvdP in an apo and tyrosine-complexed state at 2.1 and 2.7 , respectively. These structures revealed that PvdP is a homodimer, with each chain consisting of a C-terminal tyrosinase domain and an N-terminal eight-stranded beta-barrel reminiscent of streptavidin that appears to have a structural role only. We observed that ligand binding leads to the displacement of a "placeholder" tyrosine that blocks the active site in the apo structure. This exposes a large, deep binding site that seems suitable for accommodating ferribactin, a substrate of PvdP in PVD biosynthesis. The binding site consists almost exclusively of residues from the tyrosinase domain. Of note, we also found that this domain is more closely related to tyrosinases from arthropods rather than to tyrosinases from other bacteria. In conclusion, our work unravels the structural basis of PvdP's activity in PVD biosynthesis, observations that may inform structure-guided development of PvdP-specific inhibitors to manage P. aeruginosa infections.	[Poppe, Juliane; Reichelt, Joachim; Blankenfeldt, Wulf] Helmholtz Ctr Infect Res, Dept Struct & Funct Proteins, Inhoffenstr 7, D-38124 Braunschweig, Germany; [Blankenfeldt, Wulf] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, Spielmannstr 7, D-38106 Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology	Blankenfeldt, W (corresponding author), Helmholtz Ctr Infect Res, Dept Struct & Funct Proteins, Inhoffenstr 7, D-38124 Braunschweig, Germany.	wulf.blankenfeldt@helmholtz-hzi.de	Blankenfeldt, Wulf/F-8877-2010	Blankenfeldt, Wulf/0000-0001-9886-9668				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aguilera F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-96; ALBRECHTGARY AM, 1994, INORG CHEM, V33, P6391, DOI 10.1021/ic00104a059; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Budzikiewicz H, 2004, PROG CH ORG NAT PROD, V87, P81; Burkhardt A, 2016, EUR PHYS J PLUS, V131, P1, DOI 10.1140/epjp/i2016-16056-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dawson NL, 2017, NUCLEIC ACIDS RES, V45, pD289, DOI 10.1093/nar/gkw1098; Decker H, 2007, GENE, V398, P183, DOI 10.1016/j.gene.2007.02.051; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dorrestein PC, 2003, ORG LETT, V5, P2215, DOI 10.1021/ol034531e; Drake EJ, 2016, ACTA CRYSTALLOGR F, V72, P403, DOI 10.1107/S2053230X16006257; Drake EJ, 2011, ACS CHEM BIOL, V6, P1277, DOI 10.1021/cb2002973; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Goldfeder M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5505; Han HY, 2007, BBA-PROTEINS PROTEOM, V1774, P822, DOI 10.1016/j.bbapap.2007.04.011; HASSETT DJ, 1992, INFECT IMMUN, V60, P328, DOI 10.1128/IAI.60.2.328-336.1992; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanteev M, 2015, PROTEIN SCI, V24, P1360, DOI 10.1002/pro.2734; Kanteev M, 2013, J BIOL INORG CHEM, V18, P895, DOI 10.1007/s00775-013-1034-0; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kleywegt GJ, 1997, J MOL BIOL, V273, P371, DOI 10.1006/jmbi.1997.1309; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamont IL, 2003, MICROBIOL-SGM, V149, P833, DOI 10.1099/mic.0.26085-0; Le Trong I, 2011, ACTA CRYSTALLOGR D, V67, P813, DOI 10.1107/S0907444911027806; Lee SY, 2016, J ENZYM INHIB MED CH, V31, P1, DOI 10.3109/14756366.2015.1004058; Lewenza S, 2005, GENOME RES, V15, P321, DOI 10.1101/gr.3257305; Li YC, 2009, P NATL ACAD SCI USA, V106, P17002, DOI 10.1073/pnas.0906095106; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; McMorran BJ, 2001, MICROBIOL-SGM, V147, P1517, DOI 10.1099/00221287-147-6-1517; Meneely KM, 2009, BIOCHEMISTRY-US, V48, P4371, DOI 10.1021/bi900442z; Meyer JM, 2008, BIOMETALS, V21, P259, DOI 10.1007/s10534-007-9115-6; Meyer JM, 1997, MICROBIOL-UK, V143, P35, DOI 10.1099/00221287-143-1-35; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Nadal-Jimenez P, 2014, J BACTERIOL, V196, P2681, DOI 10.1128/JB.01376-13; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Ringel MT, 2018, J BIOL CHEM, V293, P2330, DOI 10.1074/jbc.RA117.000121; Ringel MT, 2016, J BIOL CHEM, V291, P23929, DOI 10.1074/jbc.M116.755611; Royer WE, 2006, STRUCTURE, V14, P1167, DOI 10.1016/j.str.2006.05.011; Satoh A, 2002, J BIOL CHEM, V277, P2830, DOI 10.1074/jbc.M109090200; Schalk IJ, 2013, ENVIRON MICROBIOL, V15, P1661, DOI 10.1111/1462-2920.12013; Sendovski M, 2011, J MOL BIOL, V405, P227, DOI 10.1016/j.jmb.2010.10.048; Turner KH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004518; Vandenende CS, 2004, J BACTERIOL, V186, P5596, DOI 10.1128/JB.186.17.5596-5602.2004; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; Voulhoux R, 2006, J BACTERIOL, V188, P3317, DOI 10.1128/JB.188.9.3317-3323.2006; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yeterian E, 2010, AMINO ACIDS, V38, P1447, DOI 10.1007/s00726-009-0358-0; Yuan ZL, 2017, BIOCHEM BIOPH RES CO, V484, P195, DOI 10.1016/j.bbrc.2016.12.181	57	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14926	14936		10.1074/jbc.RA118.002560	http://dx.doi.org/10.1074/jbc.RA118.002560			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30030378	Green Published, hybrid			2022-12-28	WOS:000446155000028
J	Shimada, A; Hatano, K; Tadehara, H; Yano, N; Shinzawa-Itoh, K; Yamashita, E; Muramoto, K; Tsukihara, T; Yoshikawa, S				Shimada, Atsuhiro; Hatano, Keita; Tadehara, Hitomi; Yano, Naomine; Shinzawa-Itoh, Kyoko; Yamashita, Eiki; Muramoto, Kazumasa; Tsukihara, Tomitake; Yoshikawa, Shinya			X-ray structural analyses of azide-bound cytochrome c oxidases reveal that the H-pathway is critically important for the proton-pumping activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; cytochrome c oxidase (complex IV); proton pump; mitochondrial membrane potential; X-ray crystallography; bioenergetics; heme; metalloenzyme; azide; copper	BOVINE HEART; PARACOCCUS-DENITRIFICANS; RESONANCE RAMAN; O-2 REDUCTION; MECHANISM; RESOLUTION; BINDING; SITES; REEVALUATION; HEME	Cytochrome c oxidase (CcO) is the terminal oxidase of cellular respiration, reducing O-2 to water and pumping protons. X-ray structural features have suggested that CcO pumps protons via a mechanism involving electrostatic repulsions between pumping protons in the hydrogen-bond network of a proton-conducting pathway (the H-pathway) and net positive charges created upon oxidation of an iron site, heme a (Fe-a(2+)), for reduction of O-2 at another iron site, heme a(3) (Fe-a3(2+)). The protons for pumping are transferred to the hydrogen-bond network from the N-side via the water channel of the H-pathway. Back-leakage of protons to the N-side is thought to be blocked by closure of the water channel. To experimentally test this, we examined X-ray structures of the azide-bound, oxidized bovine CcO and found that an azide derivative (N-3(-)-Fe-a3(3+), Cu-B(2+)-N-3(-)) induces a translational movement of the heme a(3) plane. This was accompanied by opening of the water channel, revealing that Fe-a3 and the H-pathway are tightly coupled. The channel opening in the oxidized state is likely to induce back-leakage of pumping protons, which lowers the proton level in the hydrogen-bond network during enzymatic turnover. The proton level decrease weakens the electron affinity of Fe-a, if Fe-a electrostatically interacts with protons in the hydrogen-bond network. The previously reported azide-induced redox-potential decrease in Fe-a supports existence of the electrostatic interaction. In summary, our results indicate that the H-pathway is critical for CcO's proton-pumping function.	[Shimada, Atsuhiro; Hatano, Keita; Tadehara, Hitomi; Yano, Naomine; Shinzawa-Itoh, Kyoko; Tsukihara, Tomitake; Yoshikawa, Shinya] Univ Hyogo, Grad Sch Life Sci, Picobiol Inst, 3-2-1 Koto, Akoh, Hyogo 6781297, Japan; [Muramoto, Kazumasa] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, 3-2-1 Koto, Akoh, Hyogo 6781297, Japan; [Yamashita, Eiki; Tsukihara, Tomitake] Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Tsukihara, Tomitake] Japan Sci & Technol Agcy, CREST, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan; [Shimada, Atsuhiro] Gifu Univ, Fac Appl Biol Sci, Dept Appl Life Sci, 1-1 Yanagido, Gifu 5011193, Japan	University of Hyogo; University of Hyogo; Osaka University; Japan Science & Technology Agency (JST); Gifu University	Tsukihara, T; Yoshikawa, S (corresponding author), Univ Hyogo, Grad Sch Life Sci, Picobiol Inst, 3-2-1 Koto, Akoh, Hyogo 6781297, Japan.; Muramoto, K (corresponding author), Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, 3-2-1 Koto, Akoh, Hyogo 6781297, Japan.	muramoto@sci.u-hyogo.ac.jp; tsuki@protein.osaka-u.ac.jp; yoshi@sci.u-hyogo.ac.jp	Yamashita, Eiki/V-6758-2019	Yamashita, Eiki/0000-0002-4278-0039; Shimada, Atsuhiro/0000-0002-7208-7315	Academia Sinica; National Synchrotron Radiation Research Center	Academia Sinica(Academia Sinica - Taiwan); National Synchrotron Radiation Research Center	Diffraction data were collected in the SPring-8 Facility at BL44XU under proposals 2013A6500, 2013B6500, 2014A6500, 2014B6500, 2015A6500, 2015B6500, 2016A6500, and 2016B6500 from Spring-8. MAR300HE was financially supported by Academia Sinica and National Synchrotron Radiation Research Center. We thank Rika Inaoka and Ichiro Nakadai for preliminary experiments for X-ray structural analyses of azide-bound CcO.	Aoyama H, 2009, P NATL ACAD SCI USA, V106, P2165, DOI 10.1073/pnas.0806391106; BRICOGNE G, 1974, ACTA CRYSTALLOGR A, VA 30, P395, DOI 10.1107/S0567739474010722; BRICOGNE G, 1976, ACTA CRYSTALLOGR A, V32, P832, DOI 10.1107/S0567739476001691; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Fei MJ, 2000, ACTA CRYSTALLOGR D, V56, P529, DOI 10.1107/S0907444900002213; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Hikita M, 2015, CHEM LETT, V44, P1142, DOI 10.1246/cl.150384; Hirata K, 2014, NAT METHODS, V11, P734, DOI [10.1038/NMETH.2962, 10.1038/nmeth.2962]; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Keilin D, 1939, PROC R SOC SER B-BIO, V127, P167, DOI 10.1098/rspb.1939.0016; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; LI WB, 1993, BIOCHEMISTRY-US, V32, P1833, DOI 10.1021/bi00058a018; Mochizuki M, 1999, J BIOL CHEM, V274, P33403, DOI 10.1074/jbc.274.47.33403; Muramoto K, 2010, P NATL ACAD SCI USA, V107, P7740, DOI 10.1073/pnas.0910410107; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qin L, 2009, BIOCHEMISTRY-US, V48, P5121, DOI 10.1021/bi9001387; Rich PR, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0183; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; Sakaguchi M, 2010, J BIOENERG BIOMEMBR, V42, P241, DOI 10.1007/s10863-010-9282-y; Sharma V, 2017, P NATL ACAD SCI USA, V114, pE10339, DOI 10.1073/pnas.1708628114; Shimada A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603042; Shimokata K, 2007, P NATL ACAD SCI USA, V104, P4200, DOI 10.1073/pnas.0611627104; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Vamvouka M, 1999, J PHYS CHEM B, V103, P3030, DOI 10.1021/jp984589o; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; WEVER R, 1973, BIOCHIM BIOPHYS ACTA, V325, P8, DOI 10.1016/0005-2728(73)90145-X; WEVER R, 1973, BIOCHIM BIOPHYS ACTA, V325, P1, DOI 10.1016/0005-2728(73)90144-8; WIKSTROM MKF, 1976, FEBS LETT, V65, P259, DOI 10.1016/0014-5793(76)80127-5; WILLIAMS RJP, 1995, NATURE, V376, P643, DOI 10.1038/376643a0; WILSON DF, 1972, BIOCHIM BIOPHYS ACTA, V256, P277, DOI 10.1016/0005-2728(72)90058-8; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yano N, 2016, J BIOL CHEM, V291, P23882, DOI 10.1074/jbc.M115.711770; YOSHIKAWA S, 1992, J BIOL CHEM, V267, P9757; YOSHIKAWA S, 1972, J BIOCHEM, V71, P859, DOI 10.1093/oxfordjournals.jbchem.a129835; Yoshikawa S, 2015, CHEM REV, V115, P1936, DOI 10.1021/cr500266a; Yoshikawa S, 2011, ANNU REV BIOPHYS, V40, P205, DOI 10.1146/annurev-biophys-042910-155341	39	10	10	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14868	14879		10.1074/jbc.RA118.003123	http://dx.doi.org/10.1074/jbc.RA118.003123			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30077971	Green Published, hybrid			2022-12-28	WOS:000446155000022
J	Bhowmick, DC; Jeremic, A				Bhowmick, Diti Chatterjee; Jeremic, Aleksandar			Functional proteasome complex is required for turnover of islet amyloid polypeptide in pancreatic -cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; insulin; secretion; proteasome; transcription; type 2 diabetes; FoxA2; hyperglycemia; Islet amyloid polypeptide	ENDOPLASMIC-RETICULUM STRESS; INSULIN GENE-EXPRESSION; MESSENGER-RNA STABILITY; CHROMOSOMAL LOCALIZATION; DIABETES-MELLITUS; BETA-CELLS; AMYLIN; PROTEIN; TRANSCRIPTION; SECRETION	Human islet amyloid polypeptide (hIAPP) is the principal constituent of amyloid deposits and toxic oligomers in the pancreatic islets. Together with hyperglycemia, hIAPP-derived oligomers and aggregates are important culprits in type 2 diabetes mellitus (T2DM). Here, we explored the role of the cell's main proteolytic complex, the proteasome, in hIAPP turnover in normal and stressed -cells evoked by chronic hyperglycemia. Moderate inhibition (10-35%) of proteasome activity/function in cultured human islets by the proteasome inhibitor lactacystin enhanced intracellular accumulation of hIAPP. Unexpectedly, prolonged (>1 h) and marked (>50%) impairment of proteasome activity/function had a strong inhibitory effect on hIAPP transcription and secretion from normal and stressed -cells. This negative compensatory feedback mechanism for controlling IAPP turnover was also observed in the lactacystin-treated rat insulinoma -cell line (INS 832/13), demonstrating the presence of an evolutionarily conserved mechanism for IAPP production. In line with these in situ studies, our current ex vivo data showed that proteasome activity and hIAPP expression are also down-regulated in islets isolated from T2DM subjects. Gene expression and promoter activity studies demonstrated that the functional proteasome complex is required for efficient activation of the hIAPP promoter and for full expression of IAPP's essential transcription factor, FOXA2. ChIP studies revealed that promoter occupancy of FoxA2 at the rat IAPP promoter region is an important and limiting factor for amylin expression in proteasome-impaired murine cells. This study suggests a novel regulatory pathway in -cells involving proteasome, FOXA2, and IAPP, which can be possibly targeted to regulate hIAPP levels and islet amyloidosis in T2DM.	[Bhowmick, Diti Chatterjee; Jeremic, Aleksandar] George Washington Univ, Dept Biol Sci, 800 22nd St NW, Washington, DC 20052 USA; [Bhowmick, Diti Chatterjee; Jeremic, Aleksandar] George Washington Univ, Dept Biomed Sci, Washington, DC 20052 USA	George Washington University; George Washington University	Jeremic, A (corresponding author), George Washington Univ, Dept Biol Sci, 800 22nd St NW, Washington, DC 20052 USA.	jerema@gwu.edu			NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091845] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Christopher Day and Meghana Keswani for preparation of hIAPP promoter plasmid. We thank our colleagues Rob Donaldson and Anne Chiaramello for critical reading of the manuscript and stimulating discussions on the subject. We thank NIDDK-supported Integrated Islet Distribution Program at City of Hope for making human islets available for this study.	Alarcon C, 2012, ENDOCRINOLOGY, V153, P2082, DOI 10.1210/en.2011-2019; Back SH, 2012, EXP DIABETES RES, DOI 10.1155/2012/618396; Baranello RJ, 2015, CURR ALZHEIMER RES, V12, P32, DOI 10.2174/1567205012666141218140953; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; Bhaumik SR, 2008, CRIT REV BIOCHEM MOL, V43, P419, DOI 10.1080/10409230802605914 ; Brender JR, 2015, J PHYS CHEM B, V119, P2886, DOI 10.1021/jp511758w; Broca C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092066; Brooks SA, 2010, WIRES RNA, V1, P240, DOI 10.1002/wrna.11; Bugliani M, 2013, MOL CELL ENDOCRINOL, V367, P1, DOI 10.1016/j.mce.2012.12.001; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chondrogianni N, 2014, MOL ASPECTS MED, V35, P1, DOI 10.1016/j.mam.2012.09.001; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; GERMAN MS, 1992, MOL CELL BIOL, V12, P1777, DOI 10.1128/MCB.12.4.1777; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Hwang JJ, 2008, DIABETES CARE, V31, P945, DOI 10.2337/dc07-2433; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jaisson S, 2014, DIABETOLOGIA, V57, P1517, DOI 10.1007/s00125-014-3257-1; Jing G, 2014, J BIOL CHEM, V289, P11807, DOI 10.1074/jbc.M113.525022; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kitiphongspattana K, 2005, J BIOL CHEM, V280, P15727, DOI 10.1074/jbc.M410876200; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Kwak J, 2011, BBA-GENE REGUL MECH, V1809, P88, DOI 10.1016/j.bbagrm.2010.08.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutz TA, 2006, PHYSIOL BEHAV, V89, P465, DOI 10.1016/j.physbeh.2006.04.001; Lutz TA, 2010, AM J PHYSIOL-REG I, V298, pR1475, DOI 10.1152/ajpregu.00703.2009; Marques O, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.94; Martin C, 2006, DIABETES EDUCATOR, V32, p101S, DOI 10.1177/0145721706288237; Mather KJ, 2002, DIABETES-METAB RES, V18, P118, DOI 10.1002/dmrr.263; MOSSELMAN S, 1988, FEBS LETT, V239, P227, DOI 10.1016/0014-5793(88)80922-0; Mukherjee A, 2015, TRENDS MOL MED, V21, P439, DOI 10.1016/j.molmed.2015.04.005; Mulder H, 1996, AM J PHYSIOL-ENDOC M, V271, pE1008, DOI 10.1152/ajpendo.1996.271.6.E1008; NAKAZATO M, 1990, REGUL PEPTIDES, V31, P179, DOI 10.1016/0167-0115(90)90004-G; NISHI M, 1989, MOL ENDOCRINOL, V3, P1775, DOI 10.1210/mend-3-11-1775; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Pillay K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/826706; Scherbaum WA, 1998, EXP CLIN ENDOCR DIAB, V106, P97, DOI 10.1055/s-0029-1211958; Schwarz K, 2000, J IMMUNOL, V164, P6147, DOI 10.4049/jimmunol.164.12.6147; Shepherd LMA, 2004, BBA-GENE STRUCT EXPR, V1681, P28, DOI 10.1016/j.bbaexp.2004.09.009; Singh S, 2016, BIOCHEM J, V473, P2655, DOI 10.1042/BCJ20160026; Tarcsa E, 2000, J BIOL CHEM, V275, P20295, DOI 10.1074/jbc.M001555200; Trikha S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073080; WAGONER PK, 1993, P NATL ACAD SCI USA, V90, P9145, DOI 10.1073/pnas.90.19.9145; Wang M, 1996, MOL ENDOCRINOL, V10, P243, DOI 10.1210/me.10.3.243; WELSH M, 1985, J BIOL CHEM, V260, P3590; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287	51	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14210	14223		10.1074/jbc.RA118.002414	http://dx.doi.org/10.1074/jbc.RA118.002414			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30012886	Green Published, hybrid			2022-12-28	WOS:000444671500003
J	Kampourakis, T; Ponnam, S; Sun, YB; Sevrieva, I; Irving, M				Kampourakis, Thomas; Ponnam, Saraswathi; Sun, Yin-Biao; Sevrieva, Ivanka; Irving, Malcolm			Structural and functional effects of myosin-binding protein-C phosphorylation in heart muscle are not mimicked by serine-to-aspartate substitutions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myosin; cardiac muscle; protein phosphorylation; muscle; phosphorylation; cardiac muscle regulation; myofibril; myosin-binding protein-C; phosphomimetic; polarized fluorescence muscle fiber; tris-phosphorylation	THIN-FILAMENTS; REGULATORY DOMAIN; CARDIAC-MUSCLE; ACTIVATION; CALCIUM	Myosin-binding protein-C (cMyBP-C) is a key regulator of contractility in heart muscle, and its regulatory function is controlled in turn by phosphorylation of multiple serines in its m-domain. The structural and functional effects of m-domain phosphorylation have often been inferred from those of the corresponding serine-to-aspartate (Ser-Asp) substitutions, in both in vivo and in vitro studies. Here, using a combination of in vitro binding assays and in situ structural and functional assays in ventricular trabeculae of rat heart and the expressed C1mC2 region of cMyBP-C, containing the m-domain flanked by domains C1 and C2, we tested whether these substitutions do in fact mimic the effects of phosphorylation. In situ changes in thin and thick filament structure were determined from changes in polarized fluorescence from bifunctional probes attached to troponin C or myosin regulatory light chain, respectively. We show that both the action of exogenous C1mC2 to activate contraction in the absence of calcium and the accompanying change in thin filament structure are abolished by tris-phosphorylation of the m-domain, but unaffected by the corresponding Ser-Asp substitutions. The latter produced an intermediate change in thick filament structure. Both tris-phosphorylation and Ser-Asp substitutions abolished the interaction between C1mC2 and myosin sub-fragment 2 (myosin S2) in vitro, but yielded different effects on thin filament binding. These results suggest that some previous inferences from the effects of Ser-Asp substitutions in cMyBP-C should be reconsidered and that the distinct effects of tris-phosphorylation and Ser-Asp substitutions on cMyBP-C may provide a useful basis for future studies.	[Kampourakis, Thomas] Kings Coll London, Randall Ctr Cell & Mol Biophys, London SE1 1UL, England; Kings Coll London, Sch Basic & Med Biosci, British Heart Fdn, Ctr Res Excellence, London SE1 1UL, England	University of London; King's College London; University of London; King's College London; University College London	Kampourakis, T (corresponding author), Kings Coll London, Randall Ctr Cell & Mol Biophys, London SE1 1UL, England.	thomas.kampourakis@kcl.ac.uk	; Sun, Yin-Biao/F-9988-2018	Kampourakis, Thomas/0000-0002-8269-1567; Sevrieva, Ivanka/0000-0001-8471-6484; Ponnam, Saraswathi/0000-0002-5592-3684; Sun, Yin-Biao/0000-0002-4992-8198	British Heart Foundation Basic Science Intermediate Fellowship [FS/16/3/31887]; MRC [G0601065, MR/M026655/1] Funding Source: UKRI	British Heart Foundation Basic Science Intermediate Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by British Heart Foundation Basic Science Intermediate Fellowship FS/16/3/31887 (to T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Bardswell SC, 2010, J BIOL CHEM, V285, P5674, DOI 10.1074/jbc.M109.066456; Colson BA, 2016, P NATL ACAD SCI USA, V113, P3233, DOI 10.1073/pnas.1521281113; Copeland O, 2010, J MOL CELL CARDIOL, V49, P1003, DOI 10.1016/j.yjmcc.2010.09.007; Dale RE, 1999, BIOPHYS J, V76, P1606, DOI 10.1016/S0006-3495(99)77320-0; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Harris SP, 2016, P NATL ACAD SCI USA, V113, P1558, DOI 10.1073/pnas.1518891113; Kampourakis T, 2018, J MOL CELL CARDIOL, V117, P72, DOI 10.1016/j.yjmcc.2018.02.009; Kampourakis T, 2018, J PHYSIOL-LONDON, V596, P31, DOI 10.1113/JP275050; Kampourakis T, 2016, P NATL ACAD SCI USA, V113, pE3039, DOI 10.1073/pnas.1602776113; Kampourakis T, 2014, P NATL ACAD SCI USA, V111, P18763, DOI 10.1073/pnas.1413922112; Kensler RW, 2017, P NATL ACAD SCI USA, V114, pE1355, DOI 10.1073/pnas.1614020114; Kumar M, 2015, J BIOL CHEM, V290, P29241, DOI 10.1074/jbc.M115.686790; Mun JY, 2014, P NATL ACAD SCI USA, V111, P2170, DOI 10.1073/pnas.1316001111; Pfuhl M, 2012, J MUSCLE RES CELL M, V33, P83, DOI 10.1007/s10974-012-9291-z; Previs MJ, 2016, P NATL ACAD SCI USA, V113, P3239, DOI 10.1073/pnas.1522236113; Previs MJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400205; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; Sevrieva I, 2014, J MOL CELL CARDIOL, V75, P181, DOI 10.1016/j.yjmcc.2014.07.015; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Spiess M, 1999, J STRUCT BIOL, V126, P98, DOI 10.1006/jsbi.1999.4111; Sun YB, 2009, J PHYSIOL-LONDON, V587, P155, DOI 10.1113/jphysiol.2008.164707	23	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14270	14275		10.1074/jbc.AC118.004816	http://dx.doi.org/10.1074/jbc.AC118.004816			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30082313	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000444671500008
J	Nickens, DG; Rogers, CM; Bochman, ML				Nickens, David G.; Rogers, Cody M.; Bochman, Matthew L.			The Saccharomyces cerevisiae Hrq1 and Pif1 DNA helicases synergistically modulate telomerase activity in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						telomerase; DNA helicase; Saccharomyces cerevisiae; telomere; DNA; Hrq1; Pif; RecQ; RECQL4	ROTHMUND-THOMSON SYNDROME; WERNER-SYNDROME PROTEIN; YEAST TELOMERASE; REVERSE-TRANSCRIPTASE; LENGTH; REPLICATION; MAINTENANCE; ELONGATION; PROCESSIVITY; COMPLEX	Telomere length homeostasis is vital for maintaining genomic stability and is regulated by multiple factors, including telomerase activity and DNA helicases. The Saccharomyces cerevisiae Pif1 helicase was the first discovered catalytic inhibitor of telomerase, but recent experimental evidence suggests that Hrq1, the yeast homolog of the disease-linked human RecQ-like helicase 4 (RECQL4), plays a similar role via an undefined mechanism. Using yeast extracts enriched for telomerase activity and an in vitro primer extension assay, here we determined the effects of recombinant WT and inactive Hrq1 and Pif1 on total telomerase activity and telomerase processivity. We found that titrations of these helicases alone have equal-but-opposite biphasic effects on telomerase, with Hrq1 stimulating activity at high concentrations. When the helicases were combined in reactions, however, they synergistically inhibited or stimulated telomerase activity depending on which helicase was catalytically active. These results suggest that Hrq1 and Pif1 interact and that their concerted activities ensure proper telomere length homeostasis in vivo. We propose a model in which Hrq1 and Pif1 cooperatively contribute to telomere length homeostasis in yeast.	[Nickens, David G.; Rogers, Cody M.; Bochman, Matthew L.] Indiana Univ, Mol & Cellular Biochem Dept, 212 South Hawthorne Dr,Simon Hall MSB1,Rm 405B, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Bochman, ML (corresponding author), Indiana Univ, Mol & Cellular Biochem Dept, 212 South Hawthorne Dr,Simon Hall MSB1,Rm 405B, Bloomington, IN 47405 USA.	bochman@indiana.edu	Bochman, Matthew L./I-2033-2019	Bochman, Matthew L./0000-0002-2807-0452	College of Arts and Sciences, Indiana University; Collaboration in Translational Research Pilot Grant from the Indiana Clinical and Translational Sciences Institute; American Cancer Society [RSG-16-180-01-DMC]	College of Arts and Sciences, Indiana University; Collaboration in Translational Research Pilot Grant from the Indiana Clinical and Translational Sciences Institute; American Cancer Society(American Cancer Society)	This work was supported by funds from the College of Arts and Sciences, Indiana University, a Collaboration in Translational Research Pilot Grant from the Indiana Clinical and Translational Sciences Institute, and American Cancer Society Grant RSG-16-180-01-DMC. The authors declare that they have no conflicts of interest with the contents of this article.	Armstrong CA, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160338; Azam M, 2006, NUCLEIC ACIDS RES, V34, P506, DOI 10.1093/nar/gkj452; Barefield C, 2012, NUCLEIC ACIDS RES, V40, P7358, DOI 10.1093/nar/gks407; Barranco-Medina S, 2010, BIOCHEMISTRY-US, V49, P8445, DOI 10.1021/bi100984j; Bochman ML, 2014, CELL REP, V6, P346, DOI 10.1016/j.celrep.2013.12.037; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; Bosoy D, 2004, NUCLEIC ACIDS RES, V32, P93, DOI 10.1093/nar/gkg943; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Boule JB, 2010, METHODS MOL BIOL, V587, P359, DOI 10.1007/978-1-60327-355-8_25; Chib S, 2016, J BIOL CHEM, V291, P5889, DOI 10.1074/jbc.M115.688648; Chung WH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000948; COHN M, 1995, SCIENCE, V269, P396, DOI 10.1126/science.7618104; COLLINS K, 1993, GENE DEV, V7, P1364, DOI 10.1101/gad.7.7b.1364; Collins K, 1998, P NATL ACAD SCI USA, V95, P8485, DOI 10.1073/pnas.95.15.8485; Damerla RR, 2012, CELL CYCLE, V11, P3036, DOI 10.4161/cc.21399; Dey A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020333; Dietschy T, 2007, CELL MOL LIFE SCI, V64, P796, DOI 10.1007/s00018-007-6468-5; Drosopoulos WC, 2015, J CELL BIOL, V210, P191, DOI 10.1083/jcb.201410061; Edwards DN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9331; Eitsuka T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020478; Eugster A, 2006, NAT STRUCT MOL BIOL, V13, P734, DOI 10.1038/nsmb1126; Ferrarelli LK, 2013, DNA REPAIR, V12, P518, DOI 10.1016/j.dnarep.2013.04.005; Forstemann K, 2001, MOL CELL BIOL, V21, P7277, DOI 10.1128/MCB.21.21.7277-7286.2001; Ghosh AK, 2012, J BIOL CHEM, V287, P196, DOI 10.1074/jbc.M111.295063; Greider CW, 2016, GENE DEV, V30, P1483, DOI 10.1101/gad.280578.116; Hardy J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6004; Huang PH, 2001, CURR BIOL, V11, P125, DOI 10.1016/S0960-9822(01)00021-5; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Leao R, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0422-8; Lewis KA, 2012, STRUCTURE, V20, P28, DOI 10.1016/j.str.2011.10.017; Li H, 1998, J BIOL CHEM, V273, P33436, DOI 10.1074/jbc.273.50.33436; Li JR, 2014, NUCLEIC ACIDS RES, V42, P8527, DOI 10.1093/nar/gku541; Lydeard JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000973; MacNeil DE, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090064; Makovets S, 2009, NAT CELL BIOL, V11, P1383, DOI 10.1038/ncb1985; Melek M, 1996, BIOESSAYS, V18, P301, DOI 10.1002/bies.950180408; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Niu HW, 2000, MOL CELL BIOL, V20, P6806, DOI 10.1128/MCB.20.18.6806-6815.2000; Opresko PL, 2008, MECH AGEING DEV, V129, P79, DOI 10.1016/j.mad.2007.10.007; Oulton R, 2004, MOL BIOL CELL, V15, P3244, DOI 10.1091/mbc.E04-03-0178; Pardue ML, 2005, CHROMOSOME RES, V13, P443, DOI 10.1007/s10577-005-0993-6; Peng Y, 2001, MOL CELL, V7, P1201, DOI 10.1016/S1097-2765(01)00268-4; Phillips JA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005186; Pickett HA, 2012, CELL CYCLE, V11, P1309, DOI 10.4161/cc.19632; Rogers CM, 2017, NUCLEIC ACIDS RES, V45, P5217, DOI 10.1093/nar/gkx151; Rogers CM, 2017, BIOCHEM BIOPH RES CO, V486, P1116, DOI 10.1016/j.bbrc.2017.04.003; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Srivatsan A, 2018, METHODS MOL BIOL, V1672, P43, DOI 10.1007/978-1-4939-7306-4_5; Strecker J, 2017, ELIFE, V6, DOI 10.7554/eLife.23783; Tzfati Y, 2000, SCIENCE, V288, P863, DOI 10.1126/science.288.5467.863; Vasianovich Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004679; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Wellinger RJ, 2012, GENETICS, V191, P1073, DOI 10.1534/genetics.111.137851; Zhang DH, 2006, NUCLEIC ACIDS RES, V34, P1393, DOI 10.1093/nar/gkl029; ZHAO S, 1994, GENE, V146, P215, DOI 10.1016/0378-1119(94)90295-X; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771; Zhou RB, 2014, ELIFE, V3, DOI 10.7554/eLife.02190	62	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14481	14496		10.1074/jbc.RA118.004092	http://dx.doi.org/10.1074/jbc.RA118.004092			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30068549	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000444671500026
J	Ishikawa, Y; Rubin, K; Bachinger, HP; Kalamajski, S				Ishikawa, Yoshihiro; Rubin, Kristofer; Baechinger, Hans Peter; Kalamajski, Sebastian			The endoplasmic reticulum-resident collagen chaperone Hsp47 interacts with and promotes the secretion of decorin, fibromodulin, and lumican	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); collagen; small leucine-rich proteoglycan (SLRP); protein secretion; protein-protein interaction; chaperone; decorin; fibromodulin; heat shock protein (HSP); extracellular matrix; Hsp47; lumican; small leucine-rich protein	LEUCINE-RICH PROTEOGLYCANS; HEAT-SHOCK-PROTEIN; I COLLAGEN; NULL MICE; OSTEOGENESIS IMPERFECTA; TENDON FIBROBLASTS; CORNEAL OPACITY; SKIN FRAGILITY; DEFICIENT MICE; CROSS-LINKING	The build-up of diversified and tissue-specific assemblies of extracellular matrix (ECM) proteins depends on secreted and cell surface-located molecular arrays that coordinate ECM proteins into discrete designs. The family of small leucine-rich proteins (SLRPs) associates with and dictates the structure of fibrillar collagens, which form the backbone of most ECM types. However, whether SLRPs form complexes with proteins other than collagens is unclear. Here, we demonstrate that heat shock protein 47 (Hsp47), a well-established endoplasmic reticulum-resident collagen chaperone, also binds the SLRPs decorin, lumican, and fibromodulin with affinities comparable with that in the Hsp47-type I collagen interaction. Furthermore, we show that a lack of Hsp47 inhibits the cellular secretion of decorin and lumican. Our results expand the understanding of the concerted molecular interactions that control the secretion and organization of a functional collagenous ECM.	[Ishikawa, Yoshihiro; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Ishikawa, Yoshihiro; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Rubin, Kristofer; Kalamajski, Sebastian] Uppsala Univ, Dept Med Biochem & Microbiol, S-75237 Uppsala, Sweden	Oregon Health & Science University; Uppsala University	Kalamajski, S (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, S-75237 Uppsala, Sweden.	sebastian.kalamajski@imbim.uu.se	Rubin, Kristofer/AAC-1810-2020	Rubin, Kristofer/0000-0003-2789-6276; Ishikawa, Yoshihiro/0000-0003-2013-0518; Kalamajski, Sebastian/0000-0002-6600-9302	Science for Life Laboratory (Solna, Sweden)	Science for Life Laboratory (Solna, Sweden)	In situ PLA was performed by the PLA Proteomics Facility (Uppsala, Sweden), which is supported by Science for Life Laboratory (Solna, Sweden).	Canty-Laird EG, 2012, BIOCHEM J, V441, P707, DOI 10.1042/BJ20111379; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Eyre DR, 2013, CALCIFIED TISSUE INT, V93, P338, DOI 10.1007/s00223-013-9723-9; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gomez-Navarro N, 2016, J CELL BIOL, V215, P769, DOI 10.1083/jcb.201610031; Gorur A, 2017, J CELL BIOL, V216, P1745, DOI 10.1083/jcb.201702135; HIRAYOSHI K, 1991, MOL CELL BIOL, V11, P4036, DOI 10.1128/MCB.11.8.4036; Humphries SM, 2008, J BIOL CHEM, V283, P12129, DOI 10.1074/jbc.M708198200; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Ishikawa Y, 2017, J BIOL CHEM, V292, P17216, DOI 10.1074/jbc.M117.802298; Ishikawa Y, 2016, P NATL ACAD SCI USA, V113, pE6036, DOI 10.1073/pnas.1609571113; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Jonsson M, 2003, J BIOL CHEM, V278, P21415, DOI 10.1074/jbc.M210977200; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; Kalamajski S, 2016, J BIOL CHEM, V291, P7951, DOI 10.1074/jbc.M115.693408; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Liu M, 2017, J CELL BIOL, V216, P1035, DOI 10.1083/jcb.201611088; Ma WF, 2016, P NATL ACAD SCI USA, V113, P10061, DOI 10.1073/pnas.1605916113; Macdonald JR, 2001, J BIOL CHEM, V276, P25399, DOI 10.1074/jbc.M102471200; Maeda M, 2017, J CELL BIOL, V216, P1731, DOI 10.1083/jcb.201703084; Malhotra V, 2015, ANNU REV CELL DEV BI, V31, P109, DOI 10.1146/annurev-cellbio-100913-013002; Marini JC, 2013, J CLIN ENDOCR METAB, V98, P3095, DOI 10.1210/jc.2013-1505; Matsuoka Y, 2004, MOL BIOL CELL, V15, P4467, DOI 10.1091/mbc.E04-01-0050; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; Olsson PO, 2016, MOL CANCER THER, V15, P2455, DOI 10.1158/1535-7163.MCT-16-0026; Pokidysheva E, 2013, J BIOL CHEM, V288, P24742, DOI 10.1074/jbc.M113.464156; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Schmidt K, 2013, BIOL OPEN, V2, P256, DOI 10.1242/bio.20133251; Sepulveda D, 2018, MOL CELL, V69, P238, DOI 10.1016/j.molcel.2017.12.028; SMITH T, 1995, J BIOL CHEM, V270, P18323, DOI 10.1074/jbc.270.31.18323; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Tanabe T, 2016, MOL BIOL CELL, V27, P2008, DOI 10.1091/mbc.E16-03-0180; Venditti R, 2012, SCIENCE, V337, P1668, DOI 10.1126/science.1224947; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Vranka J, 2001, MATRIX BIOL, V20, P439, DOI 10.1016/S0945-053X(01)00148-2; Wilson DG, 2011, J CELL BIOL, V194, P347, DOI 10.1083/jcb.2010071621942c; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	46	15	16	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13707	13716		10.1074/jbc.RA117.000758	http://dx.doi.org/10.1074/jbc.RA117.000758			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30002123	Green Published, hybrid			2022-12-28	WOS:000443375500029
J	Huo, H; Fryatt, AG; Farmer, LK; Schmid, R; Evans, RJ				Huo, Hong; Fryatt, Alistair G.; Farmer, Louise K.; Schmid, Ralf; Evans, Richard J.			Mapping the binding site of the P2X receptor antagonist PPADS reveals the importance of orthosteric site charge and the cysteine-rich head region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						purinergic receptor; mutagenesis; ion channel; oocyte; molecular docking; antagonist; cysteine; orthosteric site; P2XR; PPADS	AGONIST BINDING; CONFORMATIONAL-CHANGES; EXTRACELLULAR LOOP; ATP BINDING; ACTIVATION; RESIDUES; MUTANTS; INSIGHT	ATP is the native agonist for cell-surface ligand-gated P2X receptor (P2XR) cation channels. The seven mammalian subunits (P2X1-7) form homo- and heterotrimeric P2XRs having significant physiological and pathophysiological roles. Pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (PPADS) is an effective antagonist at most mammalian P2XRs. Lys-249 in the extracellular domain of P2XR has previously been shown to contribute to PPADS action. To map this antagonist site, we generated human P2X1R cysteine substitutions within a circle centered at Lys-249 (with a radius of 13 equal to the length of PPADS). We hypothesized that cysteine substitutions of residues involved in PPADS binding would (i) reduce cysteine accessibility (measured by MTSEA-biotinylation), (ii) exhibit altered PPADS affinity, and (iii) quench the fluorescence of cysteine residues modified with MTS-TAMRA. Of the 26 residues tested, these criteria were met by only four (Lys-70, Asp-170, Lys-190, and Lys-249), defining the antagonist site, validating molecular docking results, and thereby providing the first experimentally supported model of PPADS binding. This binding site overlapped with the ATP-binding site, indicating that PPADS sterically blocks agonist access. Moreover, PPADS induced a conformational change at the cysteine-rich head (CRH) region adjacent to the orthosteric ATP-binding pocket. The importance of this movement was confirmed by demonstrating that substitution introducing positive charge present in the CRH of the hP2X1R causes PPADS sensitivity at the normally insensitive rat P2X4R. This study provides a template for developing P2XR subtype selectivity based on the differences among the mammalian subunits around the orthosteric P2XR-binding site and the CRH.	[Huo, Hong; Fryatt, Alistair G.; Farmer, Louise K.; Schmid, Ralf; Evans, Richard J.] Univ Leicester, Dept Mol & Cell Biol, Leicester, Leics, England; [Schmid, Ralf] Univ Leicester, Leicester Inst Struct & Chem Biol, Leicester, Leics, England	University of Leicester; University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Mol & Cell Biol, Leicester, Leics, England.	rje6@le.ac.uk	Schmid, Ralf/ABE-1065-2020; Schmid, Ralf/E-6722-2011	Schmid, Ralf/0000-0002-0203-4023; Schmid, Ralf/0000-0002-0203-4023; Farmer, Louise/0000-0002-9462-2606	British Heart Foundation [FS/09/059/27972, PG/11/64/28772]	British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Studentship FS/09/059/27972 (to L.F.) and project Grant PG/11/64/28772. The authors declare that they have no conflicts of interest with the contents of this article.	Allsopp RC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00732-5; Allsopp RC, 2011, J BIOL CHEM, V286, P29207, DOI 10.1074/jbc.M111.260364; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Chessell IP, 1998, BRIT J PHARMACOL, V124, P1314, DOI 10.1038/sj.bjp.0701958; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; Farmer LK, 2015, J BIOL CHEM, V290, P1559, DOI 10.1074/jbc.M114.592246; Fryatt AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep32918; Fryatt AG, 2014, MOL PHARMACOL, V86, P707, DOI 10.1124/mol.114.095307; GarciaGuzman M, 1997, MOL PHARMACOL, V51, P109, DOI 10.1124/mol.51.1.109; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Karasawa A, 2016, ELIFE, V5, DOI 10.7554/eLife.22153; Kasuya G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00887-9; Kim YC, 1998, DRUG DEVELOP RES, V45, P52, DOI 10.1002/(SICI)1098-2299(199810)45:2<52::AID-DDR2>3.0.CO;2-V; LAMBRECHT G, 1992, EUR J PHARMACOL, V217, P217, DOI 10.1016/0014-2999(92)90877-7; Lorinczi E, 2012, P NATL ACAD SCI USA, V109, P11396, DOI 10.1073/pnas.1118759109; Mansoor SE, 2016, NATURE, V538, P66, DOI 10.1038/nature19367; Michel AD, 2008, BRIT J PHARMACOL, V155, P738, DOI 10.1038/bjp.2008.306; Mulryan K, 2000, NATURE, V403, P86, DOI 10.1038/47495; Ralevic V, 1998, PHARMACOL REV, V50, P413; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; Roberts JA, 2012, P NATL ACAD SCI USA, V109, P4663, DOI 10.1073/pnas.1201872109; Roberts JA, 2009, J NEUROCHEM, V109, P1042, DOI 10.1111/j.1471-4159.2009.06035.x; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]	28	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12820	12831		10.1074/jbc.RA118.003737	http://dx.doi.org/10.1074/jbc.RA118.003737			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29997254	Green Published, hybrid			2022-12-28	WOS:000442203500015
J	Gunther, LK; Yengo, CM				Gunther, Laura K.; Yengo, Christopher M.			Getting site-specific with actomyosin inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ESSENTIAL LIGHT-CHAIN; MYOSIN; CARDIOMYOPATHY; ISOFORM; DEPENDS	Actin and myosin play important roles in many devastating diseases and thus are attractive targets for small-molecule therapy. In this issue of JBC, Guhathakurta et al. have developed a high-throughput screening assay to find small molecules that interfere with the actomyosin interaction. They utilized time-resolved FRET (TR-FRET) and a unique donor-acceptor pair (filamentous actin and a peptide that binds near the myosin-binding site on actin) to find novel molecules that interfere with the actomyosin ATPase and alter the structure of actin filaments. These findings demonstrate the power and potential of high-throughput TR-FRET in monitoring molecular interactions.	[Gunther, Laura K.; Yengo, Christopher M.] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Yengo, CM (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.	cyengo@pennstatehealth.psu.edu		Yengo, Christopher/0000-0003-3987-9019; Gunther, Laura/0000-0003-4588-2572	NHLBI, National Institutes of Health [R01HL127699]; NIDCD, National Institutes of Health [F32DC016788]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC016788] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NHLBI, National Institutes of Health Grant R01HL127699 and NIDCD, National Institutes of Health Grant F32DC016788. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Guhathakurta P, 2018, J BIOL CHEM, V293, P12288, DOI 10.1074/jbc.RA118.002702; Guhathakurta P, 2015, P NATL ACAD SCI USA, V112, P4660, DOI 10.1073/pnas.1420101112; Kim DH, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0899-x; LOWEY S, 1993, NATURE, V365, P454, DOI 10.1038/365454a0; Masters TA, 2017, HANDB EXP PHARMACOL, V235, P77, DOI 10.1007/164_2016_29; Newell-Litwa KA, 2015, DIS MODEL MECH, V8, P1495, DOI 10.1242/dmm.022103; Petersen KJ, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4900727; Prochniewicz E, 2013, BIOCHEMISTRY-US, V52, P1622, DOI 10.1021/bi3014467; Spudich JA, 2016, J EXP BIOL, V219, P161, DOI 10.1242/jeb.125930	10	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12299	12300		10.1074/jbc.H118.004679	http://dx.doi.org/10.1074/jbc.H118.004679			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	30076260	Green Published, hybrid			2022-12-28	WOS:000440803200031
J	Chen, Y; Gao, J; Xie, J; Liang, J; Zheng, GL; Xie, LP; Zhang, RQ				Chen, Yan; Gao, Jing; Xie, Jun; Liang, Jian; Zheng, Guilan; Xie, Liping; Zhang, Rongqing			Transcriptional regulation of the matrix protein Shematrin-2 during shell formation in pearl oyster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biomineralization; extracellular matrix protein; biomaterials; calcium; crystal structure; Pf-C; EBP-A; Pf-C; EBP-B; shell formation; Shematrin-2; transcriptional regulation	CCAAT/ENHANCER-BINDING PROTEINS; MOUSE AMELOGENIN GENE; PINCTADA-FUCATA; PRISMATIC LAYER; C/EBP-BETA; EXTRAPALLIAL FLUID; CALCIUM-CARBONATE; KEY MACROMOLECULE; NACRE FORMATION; GLOBIN GENE	The molluscan shell is a fascinating biomineral consisting of a highly organized calcium carbonate composite. Biomineralization is elaborately controlled and involves several macromolecules, especially matrix proteins, but little is known about the regulatory mechanisms. The matrix protein Shematrin-2, expression of which peaks in the mantle tissues and in the shell components of the pearl oyster Pinctada fucata, has been suggested to be a key participant in biomineralization. Here, we expressed and purified Shematrin-2 from P. fucata and explored its function and transcriptional regulation. An in vitro functional assay revealed that Shematrin-2 binds the calcite, aragonite, and chitin components of the shell, decreases the rate of calcium carbonate deposition, and changes the morphology of the deposited crystal in the calcite crystallization system. Furthermore, we cloned the Shematrin-2 gene promoter, and analysis of its sequence revealed putative binding sites for the transcription factors CCAAT enhancer-binding proteins (Pf-C/EBPs) and nuclear factor-Y (NF-Y). Using transient co-transfection and reporter gene assays, we found that cloned and recombinantly expressed Pf-C/EBP-A and Pf-C/EBP-B greatly and dose-dependently up-regulate the promoter activity of the Shematrin-2 gene. Importantly, Pf-C/EBP-A and Pf-C/EBP-B knockdowns decreased Shematrin-2 gene expression and induced changes in the inner-surface structures in prismatic layers that were similar to those of antibody-based Shematrin-2 inhibition. Altogether, our data reveal that the transcription factors Pf-C/EBP-A and Pf-C/EBP-B up-regulate the expression of the matrix protein Shematrin-2 during shell formation in P. fucata, improving our understanding of the transcriptional regulation of molluscan shell development at the molecular level.	[Chen, Yan; Gao, Jing; Xie, Jun; Liang, Jian; Zheng, Guilan; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Sch Life Sci, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China; [Zhang, Rongqing] Tsinghua Univ, Dept Biotechnol & Biomed, Yangtze Delta Reg Inst, Jiaxing 314006, Zhejiang, Peoples R China	Tsinghua University; Tsinghua University	Xie, LP; Zhang, RQ (corresponding author), Tsinghua Univ, Sch Life Sci, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China.; Zhang, RQ (corresponding author), Tsinghua Univ, Dept Biotechnol & Biomed, Yangtze Delta Reg Inst, Jiaxing 314006, Zhejiang, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Natural Science Foundation of China [31572594]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China Grant 31572594. The authors declare that they have no conflicts of interest with the contents of this article.	Aleksic M, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-2; Arias JL, 2008, CHEM REV, V108, P4475, DOI 10.1021/cr078269p; BARBERIS A, 1987, CELL, V50, P347, DOI 10.1016/0092-8674(87)90489-2; Centrella M, 2004, GENE, V342, P13, DOI 10.1016/j.gene.2004.06.036; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; Fang D, 2012, J BIOL CHEM, V287, P15776, DOI 10.1074/jbc.M112.341594; Flausse A, 2013, J BIOMED MATER RES A, V101, P3211, DOI 10.1002/jbm.a.34629; FRITZ M, 1994, NATURE, V371, P49, DOI 10.1038/371049a0; Gao J, 2016, FEBS J, V283, P1962, DOI 10.1111/febs.13716; Gutierrez S, 2002, J BIOL CHEM, V277, P1316, DOI 10.1074/jbc.M106611200; Hsu YC, 2010, J BIOL CHEM, V285, P13885, DOI 10.1074/jbc.M109.081463; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; Inoue H, 2004, BIOCHEM BIOPH RES CO, V318, P649, DOI 10.1016/j.bbrc.2004.04.075; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; Kinoshita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021238; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; Launspach M, 2014, ACTA BIOMATER, V10, P3986, DOI 10.1016/j.actbio.2014.02.050; Li H, 2007, CELL MOL IMMUNOL, V4, P407; Liang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131868; Lin Y, 2014, ACTA BIOCH BIOPH SIN, V46, P709, DOI 10.1093/abbs/gmu054; Liu J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1524-2; Liu Y, 2009, FUTURE MICROBIOL, V4, P299, DOI 10.2217/FMB.09.4; Lowenstam H. A., 1989, ON BLOMINERALIZATION; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; MISCHOULON D, 1992, MOL CELL BIOL, V12, P2553, DOI 10.1128/MCB.12.6.2553; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Miyashita T, 2000, MAR BIOTECHNOL, V2, P409; Miyazaki Y, 2010, COMP BIOCHEM PHYS B, V155, P241, DOI 10.1016/j.cbpb.2009.11.009; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Nerlov C, 2008, CURR OPIN CELL BIOL, V20, P180, DOI 10.1016/j.ceb.2008.02.002; Nikitin V P, 2004, Ross Fiziol Zh Im I M Sechenova, V90, P455; Osada S, 1996, FEBS LETT, V390, P44, DOI 10.1016/0014-5793(96)00622-9; Osada S, 1996, J BIOL CHEM, V271, P3891; Pan C, 2014, J BIOL CHEM, V289, P2776, DOI 10.1074/jbc.M113.504027; Pulido-Salgado M, 2015, PROG NEUROBIOL, V132, P1, DOI 10.1016/j.pneurobio.2015.06.003; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Sun J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131711; SUPERTIFURGA G, 1988, EMBO J, V7, P3099, DOI 10.1002/j.1460-2075.1988.tb03176.x; Suzuki M, 2007, FEBS J, V274, P5158, DOI 10.1111/j.1742-4658.2007.06036.x; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takeuchi T, 2008, FEBS LETT, V582, P591, DOI 10.1016/j.febslet.2008.01.026; Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Wen CL, 2012, PHYTOMEDICINE, V19, P424, DOI 10.1016/j.phymed.2011.11.003; Xie J, 2016, CRYST GROWTH DES, V16, P672, DOI 10.1021/acs.cgd.5b01203; Xu GF, 2001, J AM CHEM SOC, V123, P2196, DOI 10.1021/ja002537i; Xu Y, 2006, J BIOL CHEM, V281, P16090, DOI 10.1074/jbc.M510514200; Yan ZG, 2007, BIOMACROMOLECULES, V8, P3597, DOI 10.1021/bm0701494; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Zhang C, 2006, BIOCHEM BIOPH RES CO, V344, P735, DOI 10.1016/j.bbrc.2006.03.179; Zhao M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103830; Zheng XN, 2015, SCI REP-UK, V5, DOI 10.1038/srep14408; Zhou YL, 2000, J BIOL CHEM, V275, P12273, DOI 10.1074/jbc.275.16.12273; ZORBAS H, 1992, J BIOL CHEM, V267, P8478	59	7	7	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17803	17816		10.1074/jbc.RA118.005281	http://dx.doi.org/10.1074/jbc.RA118.005281			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30282805	Green Published, hybrid			2022-12-28	WOS:000450409500012
J	Breit, A; Miek, L; Schredelseker, J; Geibel, M; Merrow, M; Gudermann, T				Breit, Andreas; Miek, Laura; Schredelseker, Johann; Geibel, Mirjam; Merrow, Martha; Gudermann, Thomas			Insulin-like growth factor-1 acts as a zeitgeber on hypothalamic circadian clock gene expression via glycogen synthase kinase-3 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circadian clock; insulin-like growth factor (IGF); growth factor; glycogen synthase kinase 3 (GSK-3); aging	REFERENCE RANGES; IGF-I; LOCOMOTOR-ACTIVITY; PROTEIN-3 IGFBP-3; BODY-TEMPERATURE; FACTOR (IGF)-I; PHASE-SHIFTS; SERUM-LEVELS; PHOSPHORYLATION; RECEPTOR	Brain and muscle ARNT-like protein-1 (BMAL-1) is an important component of the cellular circadian clock. Proteins such as epidermal (EGF) or nerve growth factor (NGF) affect the cellular clock via extracellular signal-regulated kinases-1/2 (ERK-1/2) in NIH3T3 or neuronal stem cells, but no such data are available for the insulin-like growth factor-1 (IGF-1). The hypothalamus expresses receptors for all three growth factors, acts as a central circadian pacemaker, and releases hormones in a circadian fashion. However, little is known about growth factor-induced modulation of clock gene activity in hypothalamic cells. Here, we investigated effects of IGF-1, EGF, or NGF on the Bmal-1 promoter in two hypothalamic cell lines. We found that only IGF-1 but not EGF or NGF enhanced activity of the Bmal-1 promoter. Inhibition of ERK-1/2 activity did not affect IGF-1-induced Bmal-1 promoter activation and all three growth factors similarly phosphorylated ERK-1/2, questioning a role for ERK-1/2 in controlling BMAL-1 promoter activity. Of note, only IGF-1 induced sustained phosphorylation of glycogen synthase kinase-3 (GSK-3). Moreover, the GSK-3 inhibitor lithium or siRNA-mediated GSK-3 knockdown diminished the effects of IGF-1 on the Bmal-1 promoter. When IGF-1 was used in the context of temperature cycles entraining hypothalamic clock gene expression to a 24-h rhythm, it shifted the phase of Bmal-1 promoter activity, indicating that IGF-1 functions as a zeitgeber for cellular hypothalamic circadian clocks. Our results reveal that IGF-1 regulates clock gene expression and that GSK-3 but not ERK-1/2 is required for the IGF-1-mediated regulation of the Bmal-1 promoter in hypothalamic cells.	[Breit, Andreas; Miek, Laura; Schredelseker, Johann; Gudermann, Thomas] Ludwig Maximilians Univ Munchen, Med Fac, Walther Straub Inst Pharmacol & Toxicol, D-80336 Munich, Germany; [Geibel, Mirjam; Merrow, Martha] Ludwig Maximilians Univ Munchen, Med Fac, Inst Med Psychol, Goethestr 31, D-80336 Munich, Germany	University of Munich; University of Munich	Breit, A (corresponding author), Ludwig Maximilians Univ Munchen, Med Fac, Walther Straub Inst Pharmacol & Toxicol, D-80336 Munich, Germany.; Merrow, M (corresponding author), Ludwig Maximilians Univ Munchen, Med Fac, Inst Med Psychol, Goethestr 31, D-80336 Munich, Germany.	andreas.breit@lrz.uni-muenchen.de; merrow@lmu.de						Akashi M, 2000, GENE DEV, V14, P645; Baeza-Raja B, 2013, J NEUROSCI, V33, P10221, DOI 10.1523/JNEUROSCI.2757-12.2013; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Belsham DD, 2009, FASEB J, V23, P4256, DOI 10.1096/fj.09-133454; Bereket A, 2006, HORM RES, V65, P96, DOI 10.1159/000091301; Bina KG, 1996, NEUROSCI LETT, V206, P97, DOI 10.1016/S0304-3940(96)12432-0; Brabant G, 2003, HORM RES, V60, P53, DOI 10.1159/000071871; Breit A, 2015, MOL ENDOCRINOL, V29, P445, DOI 10.1210/me.2014-1300; Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Cao C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000118; Cavadas C, 2016, NAT REV ENDOCRINOL, V12, P723, DOI 10.1038/nrendo.2016.107; Chaudhari A, 2017, MOL BIOL CELL, V28, P834, DOI 10.1091/mbc.E16-08-0624; Costa SSF, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00043; Crowder RJ, 2000, J BIOL CHEM, V275, P34266, DOI 10.1074/jbc.M006160200; Dang FB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12696; Denduluri SK, 2015, GENES DIS, V2, P13, DOI 10.1016/j.gendis.2014.10.004; Duffy JF, 2015, SLEEP MED CLIN, V10, P423, DOI 10.1016/j.jsmc.2015.08.002; Duffy JF, 2002, NEUROSCI LETT, V318, P117, DOI 10.1016/S0304-3940(01)02427-2; Dyer AH, 2016, NEUROSCIENCE, V325, P89, DOI 10.1016/j.neuroscience.2016.03.056; ELDARFINKELMAN H, 1995, J BIOL CHEM, V270, P987, DOI 10.1074/jbc.270.3.987; Elmlinger MW, 2004, CLIN CHEM LAB MED, V42, P654, DOI 10.1515/CCLM.2004.112; Fahrenkrug J, 2012, J MOL NEUROSCI, V48, P584, DOI 10.1007/s12031-012-9804-7; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Glas E, 2016, SCI REP-UK, V6, DOI 10.1038/srep32776; Haus E, 2001, CHRONOBIOL INT, V18, P709, DOI 10.1081/CBI-100106083; Heuck C, 1999, PEDIATR RES, V45, P733, DOI 10.1203/00006450-199905010-00021; HIMMLER A, 1993, J RECEPTOR RES, V13, P79, DOI 10.3109/10799899309073647; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Ikeda Y, 2018, EBIOMEDICINE, V28, P210, DOI 10.1016/j.ebiom.2018.01.012; Iwahana E, 2004, EUR J NEUROSCI, V19, P2281, DOI 10.1111/j.0953-816X.2004.03322.x; Juul A, 1997, J CLIN ENDOCR METAB, V82, P2497, DOI 10.1210/jc.82.8.2497; JUUL A, 1995, J CLIN ENDOCR METAB, V80, P2534, DOI 10.1210/jc.80.8.2534; Kalsbeek Andries, 2013, Handb Exp Pharmacol, P185, DOI 10.1007/978-3-642-25950-0_8; Kamat A, 2008, J GERONTOL A-BIOL, V63, P683, DOI 10.1093/gerona/63.7.683; Khan AS, 2002, CARDIOVASC RES, V54, P25, DOI 10.1016/S0008-6363(01)00533-8; Kinoshita C, 2012, NEUROREPORT, V23, P98, DOI 10.1097/WNR.0b013e32834e7ec2; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kramer Achim, 2003, Novartis Found Symp, V253, P250; Lauriola M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6073; Lazar MA, 2016, RES PERSPECT END INT, P63, DOI 10.1007/978-3-319-27069-2_7; Liu Y, 1998, SCIENCE, V281, P825, DOI 10.1126/science.281.5378.825; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; MATTILA AL, 1985, J CLIN ENDOCR METAB, V61, P997, DOI 10.1210/jcem-61-5-997; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Mogi A, 2018, NEUROSCIENCE, V379, P45, DOI 10.1016/j.neuroscience.2018.02.045; Morris CJ, 2012, MOL CELL ENDOCRINOL, V349, P91, DOI 10.1016/j.mce.2011.09.003; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Noguchi T, 2016, NEUROSCI LETT, V619, P49, DOI 10.1016/j.neulet.2016.02.030; Oscarsson J, 1997, CLIN ENDOCRINOL, V46, P63, DOI 10.1046/j.1365-2265.1997.d01-1740.x; Osland TM, 2011, J PSYCHOPHARMACOL, V25, P924, DOI 10.1177/0269881110379508; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Palta M, 2014, DIABETES-METAB RES, V30, P777, DOI 10.1002/dmrr.2554; Park N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138661; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Pizzio GA, 2005, EUR J NEUROSCI, V22, P665, DOI 10.1111/j.1460-9568.2005.04247.x; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Skjaerbaek C, 2000, CLIN ENDOCRINOL, V52, P25, DOI 10.1046/j.1365-2265.2000.00876.x; SONNTAG WE, 1980, ENDOCRINOLOGY, V107, P1875, DOI 10.1210/endo-107-6-1875; Spengler ML, 2009, CELL CYCLE, V8, P4138, DOI 10.4161/cc.8.24.10273; Vadigepalli R, 2006, NEUROREPORT, V17, P1437, DOI 10.1097/01.wnr.0000227989.15422.71; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; WINFREE AT, 1982, AM J PHYSIOL, V243, pR193, DOI 10.1152/ajpregu.1982.243.3.R193; Xiang S, 2012, BREAST CANCER-BASIC, V6, P137, DOI 10.4137/BCBCR.S9673; Xuefan SS, 2010, ENDOCR J, V57, P221, DOI 10.1507/endocrj.K09E-200; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zheng XZ, 2012, TRENDS NEUROSCI, V35, P574, DOI 10.1016/j.tins.2012.05.007	75	17	17	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17278	17290		10.1074/jbc.RA118.004429	http://dx.doi.org/10.1074/jbc.RA118.004429			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30217816	Green Published, hybrid			2022-12-28	WOS:000449466500026
J	Howe, C; Ho, F; Nenninger, A; Raleiras, P; Stensjo, K				Howe, Christoph; Ho, Felix; Nenninger, Anja; Raleiras, Patricia; Stensjo, Karin			Differential biochemical properties of three canonical Dps proteins from the cyanobacterium Nostoc punctiforme suggest distinct cellular functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ferritin; DNA binding protein; iron; oxidative stress; reactive oxygen species (ROS); multifunctional protein; bacterial metabolism; cyanobacteria; metal homeostasis; DNA-binding proteins from starved cells	DNA-BINDING PROTEIN; SP PCC 7120; OXIDATIVE STRESS; MYCOBACTERIUM-SMEGMATIS; FERROXIDASE CENTER; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; GENE-EXPRESSION; METAL-BINDING	DNA-binding proteins from starved cells (Dps, EC: 1.16.3.1) have a variety of different biochemical activities such as DNA-binding, iron sequestration, and H2O2 detoxification. Most bacteria commonly feature one or two Dps enzymes, whereas the cyanobacterium Nostoc punctiforme displays an unusually high number of five Dps proteins (NpDps1-5). Our previous studies have indicated physiological differences, as well as cell-specific expression, among these five proteins. Three of the five NpDps proteins, NpDps1, -2, and -3, were classified as canonical Dps proteins. To further investigate their properties and possible importance for physiological function, here we characterized and compared them in vitro. Nondenaturing PAGE, gel filtration, and dynamic light-scattering experiments disclosed that the three NpDps proteins exist as multimeric protein species in the bacterial cell. We also demonstrate Dps-mediated iron oxidation catalysis in the presence of H2O2. However, no iron oxidation with O-2 as the electron acceptor was detected under our experimental conditions. In modeled structures of NpDps1, -2, and -3, protein channels were identified that could serve as the entrance for ferrous iron into the dodecameric structures. Furthermore, we could demonstrate pH-dependent DNA-binding properties for NpDps2 and -3. This study adds critical insights into the functions and stabilities of the three canonical Dps proteins from N. punctiforme and suggests that each of the Dps proteins within this bacterium has a specific biochemical property and function.	[Howe, Christoph; Ho, Felix; Nenninger, Anja; Raleiras, Patricia; Stensjo, Karin] Uppsala Univ, Dept Chem, Angstrom Lab, Mol Biomimet, SE-75120 Uppsala, Sweden; [Nenninger, Anja] Univ Exeter, Dept Biosci, Exeter, Devon, England; [Raleiras, Patricia] Medicago AB, Danmark Berga 13, SE-75598 Uppsala, Sweden	Uppsala University; University of Exeter	Stensjo, K (corresponding author), Uppsala Univ, Dept Chem, Angstrom Lab, Mol Biomimet, SE-75120 Uppsala, Sweden.	karin.stensjo@kemi.uu.se	Stensjo, Karin/E-3801-2017; Raleiras, Patrícia/A-2375-2016	Stensjo, Karin/0000-0001-6993-8476; Raleiras, Patrícia/0000-0001-7898-7827; Ho, Felix/0000-0001-7731-3396	NordForsk; NCoE Program [82845]; Swedish Energy Agency [11674-5]; Science for Life Laboratory, Mass Spectrometry Based Proteomics Facility in Uppsala	NordForsk; NCoE Program; Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Science for Life Laboratory, Mass Spectrometry Based Proteomics Facility in Uppsala	This work was supported by NordForsk, NCoE Program "NordAqua" project 82845, Swedish Energy Agency project 11674-5, and the Science for Life Laboratory, Mass Spectrometry Based Proteomics Facility in Uppsala. The authors declare that they have no conflicts of interest with the contents of this article.	Alaleona F, 2010, FEBS J, V277, P903, DOI 10.1111/j.1742-4658.2009.07532.x; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Ardini M, 2013, BBA-GEN SUBJECTS, V1830, P3745, DOI 10.1016/j.bbagen.2013.02.003; ARTISS JD, 1981, CLIN BIOCHEM, V14, P311, DOI 10.1016/S0009-9120(81)91065-1; BELKIN S, 1987, PLANT PHYSIOL, V84, P25, DOI 10.1104/pp.84.1.25; Bellapadrona G, 2009, J BIOL CHEM, V284, P19101, DOI 10.1074/jbc.M109.014670; Calhoun LN, 2011, J APPL MICROBIOL, V110, P375, DOI 10.1111/j.1365-2672.2010.04890.x; Campbell EL, 2007, J BACTERIOL, V189, P5247, DOI 10.1128/JB.00360-07; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Castruita M, 2006, APPL ENVIRON MICROB, V72, P2918, DOI 10.1128/AEM.72.4.2918-2924.2006; Ceci P, 2005, J BIOL CHEM, V280, P34776, DOI 10.1074/jbc.M502343200; Ceci P, 2004, NUCLEIC ACIDS RES, V32, P5935, DOI 10.1093/nar/gkh915; Ceci P, 2011, J BIOL INORG CHEM, V16, P869, DOI 10.1007/s00775-011-0784-9; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Chowdhury RP, 2008, BIOCHEMISTRY-US, V47, P11110, DOI 10.1021/bi801158e; Christman HD, 2011, J BACTERIOL, V193, P6874, DOI 10.1128/JB.05999-11; Cuypers MG, 2007, J MOL BIOL, V371, P787, DOI 10.1016/j.jmb.2006.11.032; de los Rios A, 2015, BIODIVERS CONSERV, V24, P841, DOI 10.1007/s10531-015-0907-7; Durham KA, 2002, J BASIC MICROB, V42, P367, DOI 10.1002/1521-4028(200212)42:6<367::AID-JOBM367>3.0.CO;2-T; Ekman M, 2014, ENVIRON MICROBIOL, V16, P829, DOI 10.1111/1462-2920.12233; FALKNER G, 1976, PLANT PHYSIOL, V58, P717, DOI 10.1104/pp.58.6.717; Fan RL, 2009, BIOCHEMISTRY-US, V48, P5623, DOI 10.1021/bi900387t; Franceschini S, 2006, FEBS J, V273, P4913, DOI 10.1111/j.1742-4658.2006.05490.x; Fujisawa T, 2017, NUCLEIC ACIDS RES, V45, pD551, DOI 10.1093/nar/gkw1131; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; Gupta S, 2003, J BIOL CHEM, V278, P5235, DOI 10.1074/jbc.M208825200; Hahn A, 2015, ENVIRON MICROBIOL, V17, P767, DOI 10.1111/1462-2920.12516; Haikarainen T, 2010, CELL MOL LIFE SCI, V67, P341, DOI 10.1007/s00018-009-0168-2; HENNESSY DJ, 1984, CAN J CHEM, V62, P721, DOI 10.1139/v84-121; HINTERSTOISSER B, 1987, FEBS LETT, V217, P169, DOI 10.1016/0014-5793(87)80657-9; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Kauko A, 2006, J MOL BIOL, V364, P97, DOI 10.1016/j.jmb.2006.08.061; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Nguyen KH, 2012, BIOCHEMISTRY-US, V51, P6679, DOI 10.1021/bi300703x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li H, 2004, J BACTERIOL, V186, P3331, DOI 10.1128/JB.186.11.3331-3345.2004; Martinez A, 1997, J BACTERIOL, V179, P5188, DOI 10.1128/jb.179.16.5188-5194.1997; Meeks JC, 2002, ARCH MICROBIOL, V178, P395, DOI 10.1007/s00203-002-0476-5; Meeks JC, 2002, MICROBIOL MOL BIOL R, V66, P94, DOI 10.1128/MMBR.66.1.94-121.2002; Moparthi VK, 2016, BBA-BIOENERGETICS, V1857, P1766, DOI 10.1016/j.bbabio.2016.08.003; Morikawa K, 2006, GENES CELLS, V11, P409, DOI 10.1111/j.1365-2443.2006.00949.x; Oliveira Paulo, 2015, Life-Basel, V5, P130, DOI 10.3390/life5010130; Ow SY, 2009, J PROTEOME RES, V8, P187, DOI 10.1021/pr800285v; PENA MMO, 1995, ARCH MICROBIOL, V163, P337, DOI 10.1007/BF00404206; PENA MMO, 1995, J BIOL CHEM, V270, P22478, DOI 10.1074/jbc.270.38.22478; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Sato N, 2012, MICROBIOL-SGM, V158, P2527, DOI 10.1099/mic.0.060657-0; Schmidt R, 2009, MOL MICROBIOL, V72, P506, DOI 10.1111/j.1365-2958.2009.06666.x; Shcolnick S, 2009, PLANT PHYSIOL, V150, P2045, DOI 10.1104/pp.109.141853; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMITH FE, 1984, CLIN BIOCHEM, V17, P306, DOI 10.1016/S0009-9120(84)90613-1; Theoret JR, 2012, CLIN VACCINE IMMUNOL, V19, P1426, DOI 10.1128/CVI.00151-12; Yamamoto Y, 2002, J BACTERIOL, V184, P2931, DOI 10.1128/JB.184.11.2931-2939.2002; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200	59	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16635	16646		10.1074/jbc.RA118.002425	http://dx.doi.org/10.1074/jbc.RA118.002425			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30171072	Green Published, hybrid			2022-12-28	WOS:000448515100008
J	Matsui, T; Sugiyama, R; Sakanashi, K; Tamura, Y; Iida, M; Nambu, Y; Higuchi, T; Suematsu, M; Ikeda-Saito, M				Matsui, Toshitaka; Sugiyama, Ryota; Sakanashi, Kenta; Tamura, Yoko; Iida, Masaki; Nambu, Yukari; Higuchi, Tsunehiko; Suematsu, Makoto; Ikeda-Saito, Masao			Hydrogen sulfide bypasses the rate-limiting oxygen activation of heme oxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme oxygenase; hydrogen sulfide; enzyme mechanism; protein chemistry; metalloenzyme; iron metabolism; porphyrin; cell signaling; thiol	CARBON-MONOXIDE; DEGRADATION; VERDOHEME; H2S; BILIRUBIN; OXIDATION; ROLES; CO; ANTIOXIDANT; INDUCTION	Discovery of unidentified protein functions is of biological importance because it often provides new paradigms for many research areas. Mammalian heme oxygenase (HO) enzyme catalyzes the O-2-dependent degradation of heme into carbon monoxide (CO), iron, and biliverdin through numerous reaction intermediates. Here, we report that H2S, a gaseous signaling molecule, is part of a novel reaction pathway that drastically alters HO's products, reaction mechanism, and catalytic properties. Our prediction of this interplay is based on the unique reactivity of H2S with one of the HO intermediates. We found that in the presence of H2S, HO produces new linear tetrapyrroles, which we identified as isomers of sulfur-containing biliverdin (SBV), and that only H2S, but not GSH, cysteine, and polysulfides, induces SBV formation. As BV is converted to bilirubin (BR), SBV is enzymatically reduced to sulfur-containing bilirubin (SBR), which shares similar properties such as antioxidative effects with normal BR. SBR was detected in culture media of mouse macrophages, confirming the existence of this H2S-induced reaction in mammalian cells. H2S reacted specifically with a ferric verdoheme intermediate of HO, and verdoheme cleavage proceeded through an O-2-independent hydrolysis-like mechanism. This change in activation mode diminished O-2 dependence of the overall HO activity, circumventing the rate-limiting O-2 activation of HO. We propose that H2S could largely affect O-2 sensing by mammalian HO, which is supposed to relay hypoxic signals by decreasing CO output to regulate cellular functions. Moreover, the novel H2S-induced reaction identified here helps sustain HO's heme-degrading and antioxidant-generating capacity under highly hypoxic conditions.	[Matsui, Toshitaka; Sugiyama, Ryota; Sakanashi, Kenta; Tamura, Yoko; Iida, Masaki; Nambu, Yukari; Ikeda-Saito, Masao] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Higuchi, Tsunehiko] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Shinjyuku Ku, Shinano Machi, Tokyo 1608582, Japan	Tohoku University; Nagoya City University; Keio University	Matsui, T; Ikeda-Saito, M (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan.	toshitaka.matsui.d5@tohoku.ac.jp; mis2@tagen.tohoku.ac.jp	Higuchi, Tsunehiko/Y-3111-2018; Suematsu, Makoto/O-5762-2018; Suematsu, Makoto/I-8135-2013; Ikeda-Saito, Masao/A-5992-2008; Matsui, Toshitaka/B-1570-2008	Higuchi, Tsunehiko/0000-0002-3586-4680; Suematsu, Makoto/0000-0002-7165-6336; Suematsu, Makoto/0000-0002-7165-6336; Matsui, Toshitaka/0000-0003-3865-8468; Ikeda-Saito, Masao/0000-0002-0562-3616	Japan Society for the Promotion of Science (JSPS) [2412006, 24350081, 23550186, 25109504, 15K05555, 15H00912, 17H04000]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Takeda Science Foundation; Strategic Alliance Project for the Creation of Nano-Materials; MEXT, Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Strategic Alliance Project for the Creation of Nano-Materials; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research 2412006 and 24350081 (to M. I.-S.); 23550186, 25109504, 15K05555, and 15H00912 (to T. M.); and 17H04000 (to T. H.) from the Japan Society for the Promotion of Science (JSPS) and Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; by Takeda Science Foundation; and by Strategic Alliance Project for the Creation of Nano-Materials, and Nano-devices and Nano-systems from MEXT, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Abe K, 1996, J NEUROSCI, V16, P1066; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; BOSMA PJ, 1994, J BIOL CHEM, V269, P17960; Bostelaar T, 2016, J AM CHEM SOC, V138, P8476, DOI 10.1021/jacs.6b03456; de Montellano PRO, 2000, CURR OPIN CHEM BIOL, V4, P221; Filipovic MR, 2018, CHEM REV, V118, P377, DOI 10.1021/acs.chemrev.7b00205; FUHRHOP JH, 1977, LIEBIGS ANN CHEM, P360; Fujii H, 2001, J AM CHEM SOC, V123, P6475, DOI 10.1021/ja010490a; Hayashi S, 1999, CIRC RES, V85, P663, DOI 10.1161/01.RES.85.8.663; JOHNSON EA, 1970, BIOCHIM BIOPHYS ACTA, V207, P30, DOI 10.1016/0005-2795(70)90134-0; Kabe Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11030; Kajimura M, 2010, ANTIOXID REDOX SIGN, V13, P157, DOI 10.1089/ars.2009.2657; Kimura H, 2011, AMINO ACIDS, V41, P113, DOI 10.1007/s00726-010-0510-x; LaMattina JW, 2016, P NATL ACAD SCI USA, V113, P12138, DOI 10.1073/pnas.1603209113; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Liu Y, 2000, J BIOL CHEM, V275, P5297, DOI 10.1074/jbc.275.8.5297; Liu Y, 1997, J BIOL CHEM, V272, P6909, DOI 10.1074/jbc.272.11.6909; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Marohnic CC, 2011, ARCH BIOCHEM BIOPHYS, V513, P42, DOI 10.1016/j.abb.2011.06.008; Matera KM, 1996, J BIOL CHEM, V271, P6618, DOI 10.1074/jbc.271.12.6618; Matera KM, 1997, BIOCHEMISTRY-US, V36, P4909, DOI 10.1021/bi962321m; Matsui T, 2005, J BIOL CHEM, V280, P36833, DOI 10.1074/jbc.M503529200; Matsui T, 2005, J BIOL CHEM, V280, P2981, DOI 10.1074/jbc.M410263200; Matsui T, 2008, J AM CHEM SOC, V130, P4220, DOI 10.1021/ja710495z; Matsui T, 2016, P NATL ACAD SCI USA, V113, P3779, DOI 10.1073/pnas.1523333113; Matsui T, 2010, ACCOUNTS CHEM RES, V43, P240, DOI 10.1021/ar9001685; Migita CT, 1998, J BIOL CHEM, V273, P945, DOI 10.1074/jbc.273.2.945; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; Nambu S, 2013, J BIOL CHEM, V288, P10101, DOI 10.1074/jbc.M112.448399; Nishida M, 2012, NAT CHEM BIOL, V8, P714, DOI [10.1038/NCHEMBIO.1018, 10.1038/nchembio.1018]; Park JH, 2006, BIOCHEM BIOPH RES CO, V351, P146, DOI 10.1016/j.bbrc.2006.10.008; Paul BD, 2012, NAT REV MOL CELL BIO, V13, DOI 10.1038/nrm3391-c2; Peng YJ, 2017, P NATL ACAD SCI USA, V114, P1413, DOI 10.1073/pnas.1620717114; Peng YJ, 2014, P NATL ACAD SCI USA, V111, P1174, DOI 10.1073/pnas.1322172111; Peng YJ, 2010, P NATL ACAD SCI USA, V107, P10719, DOI 10.1073/pnas.1005866107; SAITO S, 1982, P NATL ACAD SCI-BIOL, V79, P1393, DOI 10.1073/pnas.79.5.1393; Shiota M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03899-1; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; SUEMATSU M, 1995, J CLIN INVEST, V96, P2431, DOI 10.1172/JCI118300; Sun D, 2000, ACTA CRYSTALLOGR D, V56, P1180, DOI 10.1107/S0907444900008520; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Uchida T, 2017, DALTON T, V46, P8104, DOI 10.1039/c7dt01562c; Ulijasz AT, 2011, CURR OPIN PLANT BIOL, V14, P498, DOI 10.1016/j.pbi.2011.06.002; WILKS A, 1993, J BIOL CHEM, V268, P22357; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; YOSHIDA T, 1978, J BIOL CHEM, V253, P4230; Yuan GX, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005846	48	11	11	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16931	16939		10.1074/jbc.RA118.004641	http://dx.doi.org/10.1074/jbc.RA118.004641			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30237172	hybrid, Green Published			2022-12-28	WOS:000448515100032
J	Zheng, SQ; Chiu, H; Boudreau, J; Papanicolaou, T; Bendena, W; Ian, CS				Zheng, Shanqing; Chiu, Hilton; Boudreau, Jeffrey; Papanicolaou, Tony; Bendena, William; Ian Chin-Sang			A functional study of all 40 Caenorhabditis elegans insulin-like peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin; insulin-like growth factor (IGF); Caenorhabditis elegans (C; elegans); aging; cell division; C; elegans; dauer formation; fat accumulation; insulin like peptides; L1 arrest	C-ELEGANS; ENVIRONMENTAL CUES; RECEPTOR; PROTEINS; GROWTH; DISTINCT; ARREST; FAMILY; MEMBER; ACTS	The human genome encodes 10 insulin-like genes, whereas the Caenorhabditis elegans genome remarkably encodes 40 insulin-like genes. Knockout strategies to determine the roles of all the insulin/insulin-like peptide ligands (INS) in C. elegans has been challenging due to functional redundancy. Here, we individually overexpressed each of the 40 ins genes pan-neuronally, and monitored multiple phenotypes including: L1 arrest life span, neuroblast divisions under L1 arrest, dauer formation, and fat accumulation, as readouts to characterize the functions of each INS in vivo. Of the 40 INS peptides, we found functions for 35 INS peptides and functionally categorized each as agonists, antagonists, or of pleiotropic function. In particular, we found that 9 of 16 agonistic INS peptides shortened L1 arrest life span and promoted neuroblast divisions during L1 arrest. Our study revealed that a subset of -class INS peptides that contain a distinct F peptide sequence are agonists. Our work is the first to categorize the structures of INS peptides and relate these structures to the functions of all 40 INS peptides in vivo. Our findings will promote the study of insulin function on development, metabolism, and aging-related diseases.	[Zheng, Shanqing; Chiu, Hilton; Boudreau, Jeffrey; Papanicolaou, Tony; Bendena, William; Ian Chin-Sang] Queens Univ, Dept Biol, 116 Barrie St, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Ian, CS (corresponding author), Queens Univ, Dept Biol, 116 Barrie St, Kingston, ON K7L 3N6, Canada.	chinsang@queensu.ca		Zheng, Shanqing/0000-0002-5039-0196	Natural Sciences and Engineering Research Council of Canada [NSERC 249779]; Canadian Institutes of Health Research Grant [CIHR 130541]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant NSERC 249779 and Canadian Institutes of Health Research Grant CIHR 130541. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ailion M, 2003, GENETICS, V165, P127; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Anisimov VN, 2013, CRIT REV ONCOL HEMAT, V87, P201, DOI 10.1016/j.critrevonc.2013.01.005; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Armakolas A, 2015, MOL MED, V21, P167, DOI 10.2119/molmed.2014.00222; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Baugh LR, 2013, GENETICS, V194, P539, DOI 10.1534/genetics.113.150847; BRENNER S, 1974, GENETICS, V77, P71; Chen YT, 2014, DEV BIOL, V394, P314, DOI 10.1016/j.ydbio.2014.08.002; Chin-Sang ID, 1999, CELL, V99, P781, DOI 10.1016/S0092-8674(00)81675-X; Clark SG, 2003, DEVELOPMENT, V130, P3781, DOI 10.1242/dev.00571; Cornils A, 2011, DEVELOPMENT, V138, P1183, DOI 10.1242/dev.060905; de Abreu DAF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004225; Delaney CE, 2017, DEVELOPMENT, V144, P1273, DOI 10.1242/dev.145722; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Dlakic M, 2002, CURR BIOL, V12, pR155, DOI 10.1016/S0960-9822(02)00729-7; Duret L, 1998, GENOME RES, V8, P348, DOI 10.1101/gr.8.4.348; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Fukuyama M, 2015, CURR BIOL, V25, P1241, DOI 10.1016/j.cub.2015.03.016; Fukuyama M, 2012, BIOL OPEN, V1, P929, DOI 10.1242/bio.2012836; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Gonzalez JP, 2009, BIOSYSTEMS, V95, P7, DOI 10.1016/j.biosystems.2008.06.003; Horikawa M, 2010, MOL CELL ENDOCRINOL, V323, P183, DOI 10.1016/j.mce.2010.03.004; Hou NS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00143; Hua QX, 2003, GENE DEV, V17, P826, DOI 10.1101/gad.1058003; Hung WL, 2014, DEVELOPMENT, V141, P1767, DOI 10.1242/dev.103846; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Kaplan REW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005731; Kawano T, 2000, BIOCHEM BIOPH RES CO, V273, P431, DOI 10.1006/bbrc.2000.2971; Kodama E, 2006, GENE DEV, V20, P2955, DOI 10.1101/gad.1479906; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Matsunaga Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2168, DOI 10.1271/bbb.120540; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Murphy Coleen T, 2013, WormBook, P1, DOI 10.1895/wormbook.1.164.1; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007; Ritter AD, 2013, GENOME RES, V23, P954, DOI 10.1101/gr.150466.112; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Wahren J, 2000, AM J PHYSIOL-ENDOC M, V278, pE759, DOI 10.1152/ajpendo.2000.278.5.E759; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Zheng SQ, 2016, METHODS MOL BIOL, P307, DOI 10.1007/978-1-4939-3299-3_17	49	39	39	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16912	16922		10.1074/jbc.RA118.004542	http://dx.doi.org/10.1074/jbc.RA118.004542			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30206121	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000448515100030
J	Elkhadragy, L; Alsaran, H; Morel, M; Long, WW				Elkhadragy, Lobna; Alsaran, Hadel; Morel, Marion; Long, Weiwen			Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular signal-regulated kinase (ERK); cell migration; cell invasion; lung cancer; mitogen-activated protein kinase (MAPK); activation loop phosphorylation	PROTEIN-KINASES; EXPRESSION; MIGRATION; PATHWAY; SIGNAL; MICE; COACTIVATOR; PROGRESSION; CARCINOMA; MAPKS	ERK3 is an atypical mitogen-activated protein kinase (MAPK) that has recently gained interest for its role in promoting cancer cell migration and invasion. However, the molecular regulation of ERK3 functions in cancer cells is largely unknown. ERK3 has a single phospho-acceptor site (Ser(189)) in its activation motif rather than the TXY conserved in conventional MAPKs such as ERK1/2. Although dual phosphorylation of the TXY motif is known to be critical for the activation of conventional MAPKs, the role of Ser(189) phosphorylation in ERK3 activity and its function in cancer cells remain elusive. In this study, we revealed that activation loop phosphorylation is important for ERK3 in promoting cancer cell invasiveness, as the S189A mutation greatly decreased the ability of ERK3 to promote migration and invasion of lung cancer cells. Interestingly, a catalytically inactive ERK3 mutant was still capable of increasing migration and invasion, although to a lesser extent compared with WT ERK3, suggesting that ERK3 promotes cancer cell invasiveness by both kinase-dependent and kinase-independent mechanisms. To elucidate how the S189A mutation reduces the invasiveness-promoting ability of ERK3, we tested its effect on the kinase activity of ERK3 toward steroid receptor coactivator 3 (SRC3), a recently identified substrate of ERK3 critical for cancer cell invasiveness. Compared with ERK3, ERK3-S189A exhibited a dramatic decrease in kinase activity toward SRC3 and a concomitantly reduced ability to stimulate matrix metalloproteinase expression. Taken together, our study unravels the importance of Ser(189) phosphorylation for intramolecular regulation of ERK3 kinase activity and invasiveness-promoting ability in lung cancer cells.	[Elkhadragy, Lobna; Alsaran, Hadel; Morel, Marion; Long, Weiwen] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Long, WW (corresponding author), 112 Diggs Lab,3640 Colonel Glenn Hwy, Dayton, OH 45435 USA.	weiwen.long@wright.edu	Elkhadragy, Lobna/ABD-1314-2020; Morel, Marion/X-4104-2019	Elkhadragy, Lobna/0000-0001-8956-298X; Morel, Marion/0000-0002-1439-5360	Wright State University; NCI, National Institutes of Health [1R01CA193264-01]; Biomedical Sciences Ph.D. Program of Wright State University; NATIONAL CANCER INSTITUTE [R01CA193264] Funding Source: NIH RePORTER	Wright State University; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biomedical Sciences Ph.D. Program of Wright State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a start-up fund of Wright State University and NCI, National Institutes of Health grant 1R01CA193264-01 (to W. L.) and by the Biomedical Sciences Ph.D. Program of Wright State University (to L. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Mahdi R, 2015, CELL ADHES MIGR, V9, P483, DOI 10.1080/19336918.2015.1112485; Alsaran H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15135-9; Bian K, 2016, ONCOTARGET, V7, P6665, DOI 10.18632/oncotarget.6682; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cheng M, 1996, J BIOL CHEM, V271, P8951, DOI 10.1074/jbc.271.15.8951; Coulombe P, 2002, ANAL BIOCHEM, V310, P219, DOI 10.1016/S0003-2697(02)00319-6; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Crowe DL, 2004, INT J ONCOL, V24, P1159; De la Mota-Peynado A, 2011, J BIOL CHEM, V286, P13603, DOI 10.1074/jbc.M110.181743; Deleris P, 2008, J CELL PHYSIOL, V217, P778, DOI 10.1002/jcp.21560; Deleris P, 2011, J BIOL CHEM, V286, P6470, DOI 10.1074/jbc.M110.181529; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Julien C, 2003, J BIOL CHEM, V278, P42615, DOI 10.1074/jbc.M302724200; Klinger S, 2009, P NATL ACAD SCI USA, V106, P16710, DOI 10.1073/pnas.0900919106; Kostenko Sergiy, 2012, J Mol Signal, V7, P9, DOI 10.1186/1750-2187-7-9; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Liang B, 2005, WORLD J GASTROENTERO, V11, P623, DOI 10.3748/wjg.v11.i5.623; Ling SB, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0424-0; Long WW, 2012, J CLIN INVEST, V122, P1869, DOI 10.1172/JCI61492; Marquis M, 2014, MOL CELL BIOL, V34, P3374, DOI 10.1128/MCB.01701-13; Marquis M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086681; Perander M, 2017, SCI REP-UK, V7, DOI 10.1038/srep43471; Rai R, 2004, ORAL ONCOL, V40, P705, DOI 10.1016/j.oraloncology.2004.01.010; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Wang W, 2014, J CELL PHYSIOL, V229, P1529, DOI 10.1002/jcp.24596; Xiang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111410; Yan J, 2006, ACTA PHARMACOL SIN, V27, P387, DOI 10.1111/j.1745-7254.2006.00315.x; Yan J, 2008, CANCER RES, V68, P5460, DOI 10.1158/0008-5472.CAN-08-0955	32	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16193	16205		10.1074/jbc.RA118.003699	http://dx.doi.org/10.1074/jbc.RA118.003699			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30166347	hybrid, Green Published			2022-12-28	WOS:000447833600008
J	Madigan, JP; Hou, F; Ye, LL; Hu, JC; Dong, AP; Tempel, W; Yohe, ME; Randazzo, PA; Jenkins, LMM; Gottesman, MM; Tong, YF				Madigan, James P.; Hou, Feng; Ye, Linlei; Hu, Jicheng; Dong, Aiping; Tempel, Wolfram; Yohe, Marielle E.; Randazzo, Paul A.; Jenkins, Lisa M. Miller; Gottesman, Michael M.; Tong, Yufeng			The tuberous sclerosis complex subunit TBC1D7 is stabilized by Akt phosphorylation-mediated 14-3-3 binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphorylation; Akt PKB; 14-3-3 protein; E3 ubiquitin ligase; protein stability; ubiquitylation (ubiquitination); tuberous sclerosis complex (TSC); mTORC1; phospho-switch	PROTEIN-KINASE-B; UBIQUITIN LIGASES; STRUCTURAL BASIS; DOMAIN FAMILY; BETA-TRCP; INSULIN; PHOSPHATASE; ACTIVATION; MODEL; IDENTIFICATION	The tuberous sclerosis complex (TSC) is a negative regulator of mTOR complex 1, a signaling node promoting cellular growth in response to various nutrients and growth factors. However, several regulators in TSC signaling still await discovery and characterization. Using pulldown and MS approaches, here we identified the TSC complex member, TBC1 domain family member 7 (TBC1D7), as a binding partner for PH domain and leucine-rich repeat protein phosphatase 1 (PHLPP1), a negative regulator of Akt kinase signaling. Most TBC domain-containing proteins function as Rab GTPase-activating proteins (RabGAPs), but the crystal structure of TBC1D7 revealed that it lacks residues critical for RabGAP activity. Sequence analysis identified a putative site for both Akt-mediated phosphorylation and 14-3-3 binding at Ser-124, and we found that Akt phosphorylates TBC1D7 at Ser-124. However, this phosphorylation had no effect on the binding of TBC1D7 to TSC1, but stabilized TBC1D7. Moreover, 14-3-3 protein both bound and stabilized TBC1D7 in a growth factor-dependent manner, and a phospho-deficient substitution, S124A, prevented this interaction. The crystal structure of 14-3-3 in complex with a phospho-Ser-124 TBC1D7 peptide confirmed the direct interaction between 14-3-3 and TBC1D7. The sequence immediately upstream of Ser-124 aligned with a canonical -TrCP degron, and we found that the E3 ubiquitin ligase -TrCP2 ubiquitinates TBC1D7 and decreases its stability. Our findings reveal that Akt activity determines the phosphorylation status of TBC1D7 at the phospho-switch Ser-124, which governs binding to either 14-3-3 or -TrCP2, resulting in increased or decreased stability of TBC1D7, respectively.	[Madigan, James P.; Jenkins, Lisa M. Miller; Gottesman, Michael M.] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Yohe, Marielle E.] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Randazzo, Paul A.] NCI, Lab Cell & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hou, Feng; Hu, Jicheng; Dong, Aiping; Tempel, Wolfram; Tong, Yufeng] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Ye, Linlei] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5G 1L7, Canada; [Tong, Yufeng] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; Structural Genomics Consortium; University of Toronto; University of Windsor	Gottesman, MM (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.; Tong, YF (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.; Tong, YF (corresponding author), Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada.	mgottesman@nih.gov; yufeng.tong@uwindsor.ca	Jenkins, Lisa/AAI-2490-2021	Tong, Yufeng/0000-0001-7740-1812; Gottesman, Michael/0000-0001-8908-2097	United States Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [ZICBC011430] Funding Source: NIH RePORTER	United States Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Amy K. Wernimont and John R. Walker for critical review of the TBC1D7 and 14-3-3 zeta crystal structures, respectively. Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source, is operated by UChicago Argonne, LLC, for the United States Department of Energy Office of Biological and Environmental Research under contract DE-AC02-06CH11357. We also thank George Leiman (Laboratory of Cell Biology) for editorial assistance.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Agarwal NK, 2014, ONCOTARGET, V5, P815, DOI 10.18632/oncotarget.1774; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bhogaraju S, 2014, PROTEINS, V82, P2282, DOI 10.1002/prot.24597; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Chen CH, 2012, MOL CANCER RES, V10, P1319, DOI 10.1158/1541-7786.MCR-12-0189; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conner SH, 2006, BIOCHEM J, V399, P427, DOI 10.1042/BJ20061077; Cowtan K., 2006, INT TABLES CRYSTALLO, P705; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fiordalisi JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064309; Fischer B, 2016, NAT STRUCT MOL BIOL, V23, P965, DOI 10.1038/nsmb.3297; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gabernet-Castello C, 2013, MOL BIOL CELL, V24, P1574, DOI 10.1091/mbc.E12-07-0557; Gai ZC, 2016, J MOL CELL BIOL, V8, P411, DOI 10.1093/jmcb/mjw001; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gavriljuk K, 2012, P NATL ACAD SCI USA, V109, P21348, DOI 10.1073/pnas.1214431110; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Grochulski P, 2011, J SYNCHROTRON RADIAT, V18, P681, DOI 10.1107/S0909049511019431; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; Lee EK, 2014, ONCOGENE, V33, P2011, DOI 10.1038/onc.2013.144; Li XF, 2004, J BIOL CHEM, V279, P34201, DOI 10.1074/jbc.M405179200; Liao Y, 2010, AM J TRANSL RES, V2, P19; Lima AJS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093940; Lopez-Pajares V, 2008, J BIOL CHEM, V283, P13707, DOI 10.1074/jbc.M710030200; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mosca R, 2008, NUCLEIC ACIDS RES, V36, pW42, DOI 10.1093/nar/gkn197; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakashima A, 2007, BIOCHEM BIOPH RES CO, V361, P218, DOI 10.1016/j.bbrc.2007.07.011; Newton AC, 2014, ANNU REV PHARMACOL, V54, P537, DOI 10.1146/annurev-pharmtox-011112-140338; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Qin JY, 2016, J BIOL CHEM, V291, P8591, DOI 10.1074/jbc.M115.701870; Reiterer V, 2017, BIOCHEM SOC T, V45, P449, DOI 10.1042/BST20160279; Reiterer V, 2014, TRENDS CELL BIOL, V24, P489, DOI 10.1016/j.tcb.2014.03.008; Ren SX, 2018, J CELL BIOL, V217, P517, DOI 10.1083/jcb.201706027; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Rodgers JT, 2011, MOL CELL, V41, P471, DOI 10.1016/j.molcel.2011.02.007; Sato N, 2010, GENE CHROMOSOME CANC, V49, P353, DOI 10.1002/gcc.20747; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Short JD, 2010, MOL CARCINOGEN, V49, P429, DOI 10.1002/mc.20613; Sierecki E, 2014, BIOCHEMISTRY-US, V53, P3971, DOI 10.1021/bi500428j; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Takeda K, 2013, GENES CELLS, V18, P369, DOI 10.1111/gtc.12043; Tempel W, 2008, PROTEINS, V71, P497, DOI 10.1002/prot.21885; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Toker Alex, 2014, Advances in Biological Regulation, V55, P28, DOI 10.1016/j.jbior.2014.04.001; Tong YF, 2014, METHODS MOL BIOL, V1140, P179, DOI 10.1007/978-1-4939-0354-2_14; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Zhu G, 2015, ONCOGENE, V34, P5971, DOI 10.1038/onc.2015.45	89	8	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16142	16159		10.1074/jbc.RA118.003525	http://dx.doi.org/10.1074/jbc.RA118.003525			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30143532	Green Published, hybrid			2022-12-28	WOS:000447833600002
J	Eisinger, KRT; Woolfrey, KM; Swanson, SP; Schnell, SA; Meitzen, J; Dell'Acqua, M; Mermelstein, PG				Eisinger, Katherine R. Tonn; Woolfrey, Kevin M.; Swanson, Samuel P.; Schnell, Stephen A.; Meitzen, John; Dell'Acqua, Mark; Mermelstein, Paul G.			Palmitoylation of caveolin-1 is regulated by the same DHHC acyltransferases that modify steroid hormone receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						estrogen receptor; post-translational modification (PTM); protein palmitoylation; caveolin; membrane protein; DHHC	PROTEIN PALMITOYLATION; ESTROGEN-RECEPTORS; ALPHA; LOCALIZATION; NUMBER; TARGET	Palmitoylation is a reversible post-translational addition of a 16-carbon lipid chain involved in trafficking and compartmentalizing target proteins. It is important for many cellular functions, including signaling via membrane-localized estrogen receptors (ERs). Within the nervous system, palmitoylation of ER is necessary for membrane surface localization and mediation of downstream signaling through the activation of metabotropic glutamate receptors (mGluRs). Substitution of the single palmitoylation site on ER alpha prevents its physical association with the integral membrane protein caveolin-1 (CAV1), required for the formation of the ER/mGluR signaling complex. Interestingly, siRNA knockdown of either of two palmitoyl acyltransferases, zinc finger DHHC type-containing 7 (DHHC7) or DHHC21, also eliminates this signaling mechanism. Because ER has only one palmitoylation site, we hypothesized that one of these DHHCs palmitoylates CAV1. We investigated this possibility by using an acyl-biotin exchange assay in HEK293 cells in conjunction with DHHC overexpression and found that DHHC7 increases CAV1 palmitoylation. Substitution of the palmitoylation sites on CAV1 eliminated this effect but did not disrupt the ability of the DHHC enzyme to associate with CAV1. In contrast, siRNA-mediated knockdown of DHHC7 alone was not sufficient to decrease CAV1 palmitoylation but rather required simultaneous knockdown of DHHC21. These findings provide additional information about the overall influence of palmitoylation on the membrane-initiated estrogen signaling pathway and highlight the importance of considering the influence of palmitoylation on other CAV1-dependent processes.	[Eisinger, Katherine R. Tonn; Swanson, Samuel P.; Schnell, Stephen A.; Mermelstein, Paul G.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Eisinger, Katherine R. Tonn; Mermelstein, Paul G.] Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA; [Woolfrey, Kevin M.; Dell'Acqua, Mark] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Meitzen, John] North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of North Carolina; North Carolina State University	Mermelstein, PG (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	pmerm@umn.edu		Eisinger, Katherine/0000-0002-3548-5381	National Institutes of Health [R01DA035008, R01DA041808, R01NS040701, R01MH109471, T32DA007234]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007234, R01DA041808, R01DA035008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants R01DA035008 and R01DA041808 (to P. G. M.), R01NS040701 (to M. L. D.), and R01MH109471 (to J. M.). K. R. T. E. was supported by National Institutes of Health Grant T32DA007234 (to P. G. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acconcia F, 2004, BIOCHEM BIOPH RES CO, V316, P878, DOI 10.1016/j.bbrc.2004.02.129; Blaskovic S, 2014, CHEM PHYS LIPIDS, V180, P44, DOI 10.1016/j.chemphyslip.2014.02.001; Boulware MI, 2007, J NEUROSCI, V27, P9941, DOI 10.1523/JNEUROSCI.1647-07.2007; Boulware MI, 2005, J NEUROSCI, V25, P5066, DOI 10.1523/JNEUROSCI.1427-05.2005; Brigidi GS, 2013, JOVE-J VIS EXP, DOI 10.3791/50031; Brigidi GS, 2014, NAT NEUROSCI, V17, P522, DOI 10.1038/nn.3657; Chatterjee M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10867; Christensen A, 2012, ENDOCRINOLOGY, V153, P3872, DOI 10.1210/en.2012-1312; Cornil CA, 2012, FRONT NEUROENDOCRIN, V33, P425, DOI 10.1016/j.yfrne.2012.08.003; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Eisenberg S, 2013, BIOCHEM SOC T, V41, P79, DOI 10.1042/BST20120268; Eisinger KRT, 2018, STEROIDS, V133, P53, DOI 10.1016/j.steroids.2017.11.013; Fernandez-Rojo MA, 2016, TRENDS MOL MED, V22, P889, DOI 10.1016/j.molmed.2016.08.007; Fukata Y, 2016, CURR TOP MEMBR, V77, P97, DOI 10.1016/bs.ctm.2015.10.003; Fukata Y, 2013, J CELL BIOL, V202, P145, DOI 10.1083/jcb.201302071; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Galbiati F, 1999, J BIOL CHEM, V274, P5843, DOI 10.1074/jbc.274.9.5843; Globa AK, 2017, CURR OPIN NEUROBIOL, V45, P210, DOI 10.1016/j.conb.2017.02.016; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Greaves J, 2009, MOL MEMBR BIOL, V26, P67, DOI 10.1080/09687680802620351; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Head BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015697; Hedges VL, 2018, ENDOCRINOLOGY, V159, P1328, DOI 10.1210/en.2018-00039; Jayachandran M, 2001, AM J PHYSIOL-HEART C, V281, pH1327, DOI 10.1152/ajpheart.2001.281.3.H1327; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kassan A, 2017, J NEUROPHYSIOL, V117, P436, DOI 10.1152/jn.00481.2016; Lai JB, 2013, J BIOL CHEM, V288, P22862, DOI 10.1074/jbc.M113.458794; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Luoma JI, 2008, MOL CELL ENDOCRINOL, V290, P8, DOI 10.1016/j.mce.2008.04.005; Meitzen J, 2019, STEROIDS, V142, P21, DOI 10.1016/j.steroids.2017.09.012; Meitzen J, 2013, ENDOCRINOLOGY, V154, P4293, DOI 10.1210/en.2013-1172; Mukherjee R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090918; Parat MO, 2001, J BIOL CHEM, V276, P15776, DOI 10.1074/jbc.M006722200; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Pedram A, 2012, MOL BIOL CELL, V23, P188, DOI 10.1091/mbc.E11-07-0638; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Razani B, 2001, J BIOL CHEM, V276, P38121; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seredynski AL, 2015, J NEUROSCI, V35, P13110, DOI 10.1523/JNEUROSCI.2056-15.2015; Stern CM, 2010, CELL MOL LIFE SCI, V67, P3785, DOI 10.1007/s00018-010-0447-y; Tabatadze N, 2013, ENDOCRINOLOGY, V154, P819, DOI 10.1210/en.2012-1870; Turi A, 2001, CELL BIOL INT, V25, P785, DOI 10.1006/cbir.2001.0769; Woolfrey KM, 2015, J NEUROSCI, V35, P442, DOI 10.1523/JNEUROSCI.2243-14.2015; Yang JX, 2015, J NEUROSCI, V35, P36, DOI 10.1523/JNEUROSCI.1161-14.2015; Zhu Q, 2004, J UROLOGY, V171, P467, DOI 10.1097/01.ju.0000099480.18735.49; Zschocke J, 2002, J BIOL CHEM, V277, P38772, DOI 10.1074/jbc.M205664200	48	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15901	15911		10.1074/jbc.RA118.004167	http://dx.doi.org/10.1074/jbc.RA118.004167			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30158247	Green Published, hybrid			2022-12-28	WOS:000447256000014
J	Chen, JY; Parekh, M; Seliman, H; Bakshinskaya, D; Dai, W; Kwan, K; Chen, KY; Liu, AYC				Chen, Justin Y.; Parekh, Miloni; Seliman, Hadear; Bakshinskaya, Dariya; Dai, Wei; Kwan, Kelvin; Chen, Kuang Yu; Liu, Alice Y. C.			Heat shock promotes inclusion body formation of mutant huntingtin (mHtt) and alleviates mHtt-induced transcription factor dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Huntington's disease; aggregation; heat shock protein (HSP); chaperone; heat shock factor protein 1 (HSF1); neurodegeneration; HSP chaperones; heat shock; inclusion bodies; polyQ-mHtt protein; transcription factor sequestration; CREB	INTRINSICALLY DISORDERED PROTEINS; GENE-EXPRESSION; NUCLEOCYTOPLASMIC TRANSPORT; NEURODEGENERATIVE DISORDERS; INTRANUCLEAR INCLUSIONS; POLYGLUTAMINE DISEASES; NEURAL DIFFERENTIATION; AGGREGATES SEQUESTER; DIPLOID FIBROBLASTS; QUALITY-CONTROL	PolyQ-expanded huntingtin (mHtt) variants form aggregates, termed inclusion bodies (IBs), in individuals with and models of Huntington's disease (HD). The role of IB versus diffusible mHtt in neurotoxicity remains unclear. Using a ponasterone (PA)-inducible cell model of HD, here we evaluated the effects of heat shock on the appearance and functional outcome of Htt103Q(Exon1)-EGFP expression. Quantitative image analysis indicated that 80-90% of this mHtt protein initially appears as diffuse signals in the cytosol, with IBs forming at high mHtt expression. A 2-h heat shock during the PA induction reduced the diffuse signal, but greatly increased mHtt IB formation in both cytosol and nucleus. Dose- and time-dependent mHtt expression suggested that nucleated polymerization drives IB formation. RNA-mediated knockdown of heat shock protein 70 (HSP70) and heat shock cognate 70 protein (HSC70) provided evidence for their involvement in promoting diffuse mHtt to form IBs. Reporter gene assays assessing the impacts of diffuse versus IB mHtt showed concordance of diffuse mHtt expression with the repression of heat shock factor 1, cAMP-responsive element-binding protein (CREB), and NF-B activity. CREB repression was reversed by heat shock coinciding with mHtt IB formation. In an embryonic striatal neuron-derived HD model, the chemical chaperone sorbitol similarly promoted the structuring of diffuse mHtt into IBs and supported cell survival under stress. Our results provide evidence that mHtt IB formation is a chaperone-supported cellular coping mechanism that depletes diffusible mHtt conformers, alleviates transcription factor dysfunction, and promotes neuron survival.	[Chen, Justin Y.; Parekh, Miloni; Seliman, Hadear; Bakshinskaya, Dariya; Dai, Wei; Kwan, Kelvin; Liu, Alice Y. C.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Chen, Kuang Yu] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Chen, Justin Y.] Univ N Carolina, Joint Dept Biomed Engn, Raleigh, NC 27695 USA; [Chen, Justin Y.] North Carolina State Univ, Raleigh, NC 27695 USA; [Parekh, Miloni] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19140 USA; [Bakshinskaya, Dariya] Univ Calif Berkeley, Helen Wills Neurosci Inst, 132 Barker Hall, Berkeley, CA 94720 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of North Carolina; University of North Carolina; North Carolina State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of California System; University of California Berkeley	Liu, AYC (corresponding author), 604 Allison Rd, Piscataway, NJ 08854 USA.	liu@dls.rutgers.edu		Chen, Kuang Yu/0000-0002-5629-7785; Liu, Alice Y./0000-0002-6984-1671	Chemistry and Chemical Biology Fund of Rutgers [800177]; National Institutes of Health [R01 5DC15000]; Aresty Research Fellowships from Rutgers University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC015000] Funding Source: NIH RePORTER	Chemistry and Chemical Biology Fund of Rutgers; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aresty Research Fellowships from Rutgers University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by internal University funding (to A. Y. C. L.), the Chemistry and Chemical Biology Fund 800177 of Rutgers (to K. Y. C.), and National Institutes of Health Grant R01 5DC15000 (to K. K.). M. P., H. S., and D. B. were supported by Aresty Research Fellowships from Rutgers University while working on this research project. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Ami D, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-17; Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Arrasate M, 2012, EXP NEUROL, V238, P1, DOI 10.1016/j.expneurol.2011.12.013; Arvanitis DN, 2007, J NEUROCHEM, V103, P216, DOI 10.1111/j.1471-4159.2007.04704.x; Baldo B, 2012, J BIOL CHEM, V287, P1406, DOI 10.1074/jbc.M111.294801; Bersuker K, 2013, J BIOL CHEM, V288, P23633, DOI 10.1074/jbc.C113.481945; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Cattaneo E, 1998, J NEUROSCI RES, V53, P223, DOI 10.1002/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7; Chafekar SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037929; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Duennwald ML, 2011, PRION, V5, P285, DOI [10.4161/pri.5.4.18071, 10.4161/pri.18071]; Duncan Emma J, 2015, Subcell Biochem, V78, P243, DOI 10.1007/978-3-319-11731-7_12; Dyson HJ, 2016, BIOPHYS J, V110, P1013, DOI 10.1016/j.bpj.2016.01.030; Ehrlich ME, 2012, NEUROTHERAPEUTICS, V9, P270, DOI 10.1007/s13311-012-0112-2; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Finkbeiner S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007476; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gomez-Pastor R, 2018, NAT REV MOL CELL BIO, V19, P4, DOI 10.1038/nrm.2017.73; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Halliday M, 2014, J BIOL CHEM, V289, P19862, DOI 10.1074/jbc.R114.568477; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Jancic D, 2009, CEREB CORTEX, V19, P2535, DOI 10.1093/cercor/bhp004; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Karagoz GE, 2015, TRENDS BIOCHEM SCI, V40, P117, DOI 10.1016/j.tibs.2014.12.002; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kundrat L, 2010, BIOCHEMISTRY-US, V49, P7428, DOI 10.1021/bi100386w; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Levine ZA, 2015, P NATL ACAD SCI USA, V112, P2758, DOI 10.1073/pnas.1418155112; Lindberg I, 2015, J NEUROSCI, V35, P13853, DOI 10.1523/JNEUROSCI.2600-15.2015; Liu A Y, 1996, EXS, V77, P393; LIU AYC, 1989, J BIOL CHEM, V264, P12037; LIU AYC, 1991, J CELL PHYSIOL, V149, P560, DOI 10.1002/jcp.1041490327; Liu DJ, 2014, J CELL PHYSIOL, V229, P1224, DOI 10.1002/jcp.24556; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Margulis J, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00218; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Morimoto RI, 2006, NEW ENGL J MED, V355, P2254, DOI 10.1056/NEJMcibr065573; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; Naik V, 2016, MOL BIOTECHNOL, V58, P251, DOI 10.1007/s12033-016-9923-4; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; OMALLEY K, 1985, MOL CELL BIOL, V5, P3476, DOI 10.1128/MCB.5.12.3476; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Oza J, 2008, CELL STRESS CHAPERON, V13, P73, DOI 10.1007/s12192-008-0013-9; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Pugazhenthi S, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-60; Rajesh D, 2003, J BIOL CHEM, V278, P35968, DOI 10.1074/jbc.M303280200; Reijonen S, 2010, CELL MOL LIFE SCI, V67, P1929, DOI 10.1007/s00018-010-0305-y; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sabareesan AT, 2016, J MOL BIOL, V428, P3935, DOI 10.1016/j.jmb.2016.08.015; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Sarah Kishinevsky AC, 2013, J ALZHEMERS DIS S10, ps10, DOI DOI 10.4172/2161-0460.S10-007; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schmit JD, 2011, BIOPHYS J, V100, P450, DOI 10.1016/j.bpj.2010.11.041; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Sontag EM, 2014, CURR OPIN CELL BIOL, V26, P139, DOI 10.1016/j.ceb.2013.12.006; SORGER PK, 1987, EMBO J, V6, P993, DOI 10.1002/j.1460-2075.1987.tb04850.x; Street TO, 2006, P NATL ACAD SCI USA, V103, P17064, DOI 10.1073/pnas.0606236103; Tan Z, 2015, MOL PSYCHIATR, V20, P1286, DOI 10.1038/mp.2015.81; Todd TW, 2013, MOL CELLS, V36, P185, DOI 10.1007/s10059-013-0167-x; Treusch S, 2009, CELL CYCLE, V8, P1668, DOI 10.4161/cc.8.11.8503; Uversky VN, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00018; van Hagen M, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3745-z; Vujanac M, 2005, TRAFFIC, V6, P214, DOI 10.1111/j.1600-0854.2005.00266.x; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; Wolfe KJ, 2013, MOL BIOL CELL, V24, P3588, DOI 10.1091/mbc.E13-06-0315; Wolfe KJ, 2011, SEMIN CELL DEV BIOL, V22, P476, DOI 10.1016/j.semcdb.2011.03.011; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P793, DOI 10.1001/archneur.57.6.793; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Yang JX, 2008, BRAIN RES, V1203, P39, DOI 10.1016/j.brainres.2008.01.082; Zhang YJ, 2016, NAT NEUROSCI, V19, P668, DOI 10.1038/nn.4272; Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009	86	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15581	15593		10.1074/jbc.RA118.002933	http://dx.doi.org/10.1074/jbc.RA118.002933			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30143534	Green Published, hybrid			2022-12-28	WOS:000446549200022
J	Horiuchi, M; Kuga, T; Saito, Y; Nagano, M; Adachi, J; Tomonaga, T; Yamaguchi, N; Nakayama, Y				Horiuchi, Maria; Kuga, Takahisa; Saito, Youhei; Nagano, Maiko; Adachi, Jun; Tomonaga, Takeshi; Yamaguchi, Naoto; Nakayama, Yuji			The tyrosine kinase v-Src causes mitotic slippage by phosphorylating an inhibitory tyrosine residue of Cdk1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Src; cyclin-dependent kinase (CDK); phosphorylation; mitosis; cell cycle; Cdk1; mitotic slippage; pTyr-15; v-Src; cancer; microtubule-targeting agent; spindle checkpoint; tyrosine kinase	M-PHASE PROGRESSION; CYTOKINESIS FAILURE; FAMILY KINASES; CELL-CYCLE; SPINDLE FORMATION; CANCER-CELLS; IN-VIVO; C-SRC; ACTIVATION; MITOSIS	The nonreceptor tyrosine kinase v-Src is an oncogene first identified in Rous sarcoma virus. The oncogenic effects of v-Src have been intensively studied; however, its effects on chromosomal integrity are not fully understood. Here, using HeLa S3/v-Src cells having inducible v-Src expression, we found that v-Src causes mitotic slippage in addition to cytokinesis failure, even when the spindle assembly checkpoint is not satisfied because of the presence of microtubule-targeting agents. v-Src's effect on mitotic slippage was also observed in cells after a knockdown of C-terminal Src kinase (Csk), a protein-tyrosine kinase that inhibits Src-family kinases and was partially inhibited by PP2, an Src-family kinase inhibitor. Proteomic analysis and in vitro kinase assay revealed that v-Src phosphorylates cyclin-dependent kinase 1 (Cdk1) at Tyr-15. This phosphorylation attenuated Cdk1 kinase activity, resulting in a decrease in the phosphorylation of Cdk1 substrates. Furthermore, v-Src-induced mitotic slippage reduced the sensitivity of the cells to microtubule-targeting agents, and cells that survived the microtubule-targeting agents exhibited polyploidy. These results suggest that v-Src causes mitotic slippage by attenuating Cdk1 kinase activity via direct phosphorylation of Cdk1 at Tyr-15. On the basis of these findings, we propose a model for v-Src-induced oncogenesis, in which v-Src-promoted mitotic slippage due to Cdk1 phosphorylation generates genetic diversity via abnormal cell division of polyploid cells and also increases the tolerance of cancer cells to microtubule-targeting agents.	[Horiuchi, Maria; Kuga, Takahisa; Saito, Youhei; Nakayama, Yuji] Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Kyoto 6078414, Japan; [Nagano, Maiko; Adachi, Jun; Tomonaga, Takeshi] Natl Inst Biomed Innovat Hlth & Nutr, Lab Proteome Res, Osaka 5670085, Japan; [Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Mol Cell Biol, Chiba 2608675, Japan	Kyoto Pharmaceutical University; Chiba University	Nakayama, Y (corresponding author), Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Kyoto 6078414, Japan.	nakayama@mb.kyoto-phu.ac.jp	Adachi, Jun/H-2813-2014; Kuga, Takahisa/AAX-9334-2020	Adachi, Jun/0000-0003-1220-3246; Nakayama, Yuji/0000-0001-7882-0066; Saito, Youhei/0000-0002-8545-6925	Japan Society for the Promotion of Science [16K08253, 25460076]; Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University); Promotion and Mutual Aid Corporation for Private Schools of Japan (Chiba University); Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; MEXT [S1511024L, S1311035]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University); Promotion and Mutual Aid Corporation for Private Schools of Japan (Chiba University); Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science 16K08253 and 25460076, a grant from the Promotion and Mutual Aid Corporation for Private Schools of Japan (Kyoto Pharmaceutical University and Chiba University), the Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research (to T. K. and Y. S.), and the MEXT-Supported Program for the Strategic Research Foundation at Private Universities Grants S1511024L (to T. K.) and S1311035 (to Y. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi J, 2014, J PROTEOME RES, V13, P5461, DOI 10.1021/pr500845u; Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Borgne A, 1996, J BIOL CHEM, V271, P27847, DOI 10.1074/jbc.271.44.27847; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; Chow JPH, 2011, MOL CELL BIOL, V31, P1478, DOI 10.1128/MCB.00891-10; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Deibler RW, 2010, MOL CELL, V37, P753, DOI 10.1016/j.molcel.2010.02.023; DUNPHY WG, 1991, CELL, V67, P189, DOI 10.1016/0092-8674(91)90582-J; Fincham VJ, 2000, MOL CELL BIOL, V20, P6518, DOI 10.1128/MCB.20.17.6518-6536.2000; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hauck CR, 2002, J BIOL CHEM, V277, P12487, DOI 10.1074/jbc.C100760200; Honda T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19599-1; Honda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep38751; Hu CK, 2008, J CELL BIOL, V181, P195, DOI 10.1083/jcb.200711105; Ikeuchi M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060871; Iwamoto E, 2016, J CELL BIOCHEM, V117, P1340, DOI 10.1002/jcb.25424; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1991, CANCER RES, V51, P2212; Kakae K, 2017, CELL SIGNAL, V30, P19, DOI 10.1016/j.cellsig.2016.11.014; Kasahara K, 2007, J BIOL CHEM, V282, P5327, DOI 10.1074/jbc.M608396200; Kesavan KP, 2002, J BIOL CHEM, V277, P14666, DOI 10.1074/jbc.M111911200; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; KREK W, 1991, EMBO J, V10, P305, DOI 10.1002/j.1460-2075.1991.tb07951.x; Kuga T, 2007, ARCH BIOCHEM BIOPHYS, V466, P116, DOI 10.1016/j.abb.2007.07.002; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Masuda T, 2009, MOL CELL PROTEOMICS, V8, P2770, DOI 10.1074/mcp.M900240-MCP200; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; MORGAN DO, 1989, CELL, V57, P775, DOI 10.1016/0092-8674(89)90792-7; Nakayama Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040811; Nakayama Y, 2014, J CELL BIOCHEM, V115, P763, DOI 10.1002/jcb.24720; Nakayama Y, 2012, J BIOL CHEM, V287, P24905, DOI 10.1074/jbc.M112.341578; Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007; Narumi R, 2012, J PROTEOME RES, V11, P5311, DOI 10.1021/pr3005474; Ng MM, 2005, DEV CELL, V9, P781, DOI 10.1016/j.devcel.2005.11.002; Niiya F, 2005, J BIOL CHEM, V280, P36502, DOI 10.1074/jbc.M508007200; O'Farrell PH, 2001, TRENDS CELL BIOL, V11, P512, DOI 10.1016/S0962-8924(01)02142-0; Ohnishi H, 2001, P NATL ACAD SCI USA, V98, P10930, DOI 10.1073/pnas.191368198; Okamoto M, 2016, J CELL BIOCHEM, V117, P894, DOI 10.1002/jcb.25373; Ozlu N, 2010, MOL CELL PROTEOMICS, V9, P336, DOI 10.1074/mcp.M900308-MCP200; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; Soeda S, 2013, EXP CELL RES, V319, P1382, DOI 10.1016/j.yexcr.2013.02.023; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Zheng XM, 2001, EMBO J, V20, P6037, DOI 10.1093/emboj/20.21.6037	55	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15524	15537		10.1074/jbc.RA118.002784	http://dx.doi.org/10.1074/jbc.RA118.002784			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30135207	Green Published, hybrid			2022-12-28	WOS:000446549200018
J	Adachi, M; Noji, M; So, M; Sasahara, K; Kardos, J; Naiki, H; Goto, Y				Adachi, Masayuki; Noji, Masahiro; So, Masatomo; Sasahara, Kenji; Kardos, Jozsef; Naiki, Hironobu; Goto, Yuji			Aggregation-phase diagrams of beta(2)-microglobulin reveal temperature and salt effects on competitive formation of amyloids versus amorphous aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; protein aggregation; fluorescence; protein folding; calorimetry; beta2-microglobulin; phase transition; solubility; structural dynamics; supersaturation	ISOTHERMAL TITRATION CALORIMETRY; PROTEIN MISFOLDING DISEASES; THERMODYNAMIC ANALYSIS; COLD DENATURATION; THERMAL RESPONSE; FIBRIL FORMATION; SUPERSATURATION; HEAT; POLYMORPHISM; MECHANISM	Several serious diseases are associated with crystal-like amyloid fibrils or glass-like amorphous aggregates of denatured proteins. However, protein aggregation involving both types of aggregates has not yet been elucidated in much detail. Using a protein associated with dialysis-related amyloidosis, beta(2)-microglobulin (beta 2m), we previously demonstrated that amyloid fibrils and amorphous aggregates form competitively depending on salt (NaCl) concentration. To examine the generality of the underlying competitive mechanisms, we herein investigated the effects of heat on acid-denatured beta 2m at pH 2. Using thioflavin fluorescence, CD, and light scattering analysis along with atomic force microscopy imaging, we found that the temperature-dependent aggregation of beta 2m markedly depends on NaCl concentration. Stepwise transitions from monomers to amyloids and then back to monomers were observed at low NaCl concentrations. Amorphous aggregates formed rapidly at ambient temperatures at high NaCl concentrations, but the transition from amorphous aggregates to amyloids occurred only as the temperature increased. Combining the data from the temperature- and NaCl-dependent transitions, we constructed a unified phase diagram of conformational states, indicating a parabolic solubility curve with a minimum NaCl concentration at ambient temperatures. Although amyloid fibrils formed above this solubility boundary, amorphous aggregates dominated in regions distant from this boundary. Kinetic competition between supersaturation-limited slow amyloid fibrillation and supersaturation-unlimited fast amorphous aggregation deformed the phase diagram, with amyloid regions disappearing with fast titration rates. We conclude that phase diagrams combining thermodynamics and kinetics data provide a comprehensive view of beta 2m aggregation exhibiting severe hysteresis depending on the heat- or salt-titration rates.	[Adachi, Masayuki; Noji, Masahiro; So, Masatomo; Sasahara, Kenji; Goto, Yuji] Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan; [Kardos, Jozsef] Eotvos Lorand Univ, Dept Biochem, ELTE NAP Neuroimmunol Res Grp, H-1117 Budapest, Hungary; [Naiki, Hironobu] Univ Fukui, Fac Med Sci, Fukui 9101193, Japan	Osaka University; Eotvos Lorand University; University of Fukui	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	gtyj8126@protein.osaka-u.ac.jp	Naiki, Hironobu/G-5599-2014; Kardos, József/J-1035-2017	Kardos, József/0000-0002-2135-2932; Noji, Masahiro/0000-0002-9707-035X; So, Masatomo/0000-0002-4815-4995; Goto, Yuji/0000-0003-1221-1270	Cooperative Research Program for the Institute for Protein Research, Osaka University [CR-16-02, ICR-18-02]; Japan Society for the Promotion of Science (JSPS) KAKENHI [15H04362, 15K14458, 17K07363, 17K15074]; MEXT KAKENHI Grants [16H00836, 17H06352]; SENTAN from Japan Agency for Medical Research and Development, AMED; Hungarian National Research, Development and Innovation Office [K_120391, TET_16-1-2016-0197, 2017-1.2.1-NKP-2017-00002]	Cooperative Research Program for the Institute for Protein Research, Osaka University; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI Grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SENTAN from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Hungarian National Research, Development and Innovation Office	This work was supported by Cooperative Research Program for the Institute for Protein Research, Osaka University Grants CR-16-02 and ICR-18-02; by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 15H04362, 15K14458, 17K07363, and 17K15074; by MEXT KAKENHI Grants 16H00836 and 17H06352; and by the SENTAN from Japan Agency for Medical Research and Development, AMED. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Hungarian National Research, Development and Innovation Office Grants K_120391, TET_16-1-2016-0197, 2017-1.2.1-NKP-2017-00002).	Adachi M, 2015, J BIOL CHEM, V290, P18134, DOI 10.1074/jbc.M115.648139; Andersen CB, 2010, J MOL BIOL, V397, P932, DOI 10.1016/j.jmb.2010.02.012; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; FREIRE E, 1994, METHOD ENZYMOL, V240, P502; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Ikenoue T, 2014, ANGEW CHEM INT EDIT, V53, P7799, DOI 10.1002/anie.201403815; Ikenoue T, 2014, P NATL ACAD SCI USA, V111, P6654, DOI 10.1073/pnas.1322602111; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jeppesen MD, 2010, BIOPHYS CHEM, V149, P40, DOI 10.1016/j.bpc.2010.03.016; Kardos J, 2004, J BIOL CHEM, V279, P55308, DOI 10.1074/jbc.M409677200; Kardos J, 2011, BIOCHEMISTRY-US, V50, P3211, DOI 10.1021/bi2000017; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; Miti T, 2015, BIOMACROMOLECULES, V16, P326, DOI 10.1021/bm501521r; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Muta H, 2014, J BIOL CHEM, V289, P18228, DOI 10.1074/jbc.M114.566950; Nitani A, 2017, J BIOL CHEM, V292, P21219, DOI 10.1074/jbc.M117.813097; Pedersen Jesper Sondergaard, 2010, J Diabetes Sci Technol, V4, P1357; PRIVALOV PL, 1986, J MOL BIOL, V190, P487, DOI 10.1016/0022-2836(86)90017-3; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Sasahara K, 2005, J MOL BIOL, V352, P700, DOI 10.1016/j.jmb.2005.07.033; Sasahara K, 2008, BIOCHEMISTRY-US, V47, P2650, DOI 10.1021/bi701968g; Sasahara K, 2007, J MOL BIOL, V372, P981, DOI 10.1016/j.jmb.2007.06.088; Sasahara K, 2007, BIOCHEMISTRY-US, V46, P3286, DOI 10.1021/bi602403v; Sasahara K, 2006, BIOCHEMISTRY-US, V45, P8760, DOI 10.1021/bi0606748; Sasahara K, 2009, J MOL BIOL, V389, P584, DOI 10.1016/j.jmb.2009.04.026; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; So M, 2016, CURR OPIN STRUC BIOL, V36, P32, DOI 10.1016/j.sbi.2015.11.009; Stranks SD, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051907; Surmacz-Chwedoruk W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086320; Tycko R, 2014, PROTEIN SCI, V23, P1528, DOI 10.1002/pro.2544; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109	42	24	24	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14775	14785		10.1074/jbc.RA118.004683	http://dx.doi.org/10.1074/jbc.RA118.004683			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30077972	Green Published, hybrid			2022-12-28	WOS:000446155000015
J	Ballak, DB; Li, SZ; Cavalli, G; Stahl, JL; Tengesdal, IW; van Diepen, JA; Kluck, V; Swartzwelter, B; Azam, T; Tack, CJ; Stienstra, R; Mandrup-Poulsen, T; Seals, DR; Dinarello, CA				Ballak, Dov B.; Li, Suzhao; Cavalli, Giulio; Stahl, Jonathan L.; Tengesdal, Isak W.; van Diepen, Janna A.; Kluck, Viola; Swartzwelter, Benjamin; Azam, Tania; Tack, Cees J.; Stienstra, Rinke; Mandrup-Poulsen, Thomas; Seals, Douglas R.; Dinarello, Charles A.			Interleukin-37 treatment of mice with metabolic syndrome improves insulin sensitivity and reduces pro-inflammatory cytokine production in adipose tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipose tissue; inflammation; cytokine; drug development; insulin resistance; glucose metabolism; mouse; type 2 diabetes; cellular research; mouse model	HIGH-FAT DIET; TYPE-2 DIABETES-MELLITUS; BETA-CELL PROLIFERATION; PLACEBO-CONTROLLED TRIAL; NECROSIS-FACTOR-ALPHA; RECEPTOR ANTAGONIST; INNATE INFLAMMATION; FAMILY-MEMBERS; IL-37 REQUIRES; FOOD-INTAKE	Obesity and the metabolic syndrome are characterized by chronic, low-grade inflammation mainly originating from expanding adipose tissue and resulting in inhibition of insulin signaling and disruption of glycemic control. Transgenic mice expressing human interleukin 37 (IL-37), an anti-inflammatory cytokine of the IL-1 family, are protected against metabolic syndrome when fed a high-fat diet (HFD) containing 45% fat. Here, we examined whether treatment with recombinant IL-37 ameliorates established insulin resistance and obesity-induced inflammation. WT mice were fed a HFD for 22 weeks and then treated daily with IL-37 (1 g/mouse) during the last 2 weeks. Compared with vehicle only-treated mice, IL-37-treated mice exhibited reduced insulin in the plasma and had significant improvements in glucose tolerance and in insulin content of the islets. The IL-37 treatment also increased the levels of circulating IL-1 receptor antagonist. Cultured adipose tissues revealed that IL-37 treatment significantly decreases spontaneous secretions of IL-1, tumor necrosis factor (TNF), and CXC motif chemokine ligand 1 (CXCL-1). We also fed mice a 60% fat diet with concomitant daily IL-37 for 2 weeks and observed decreased secretion of IL-1, TNF, and IL-6 and reduced intracellular levels of IL-1 in the liver and adipose tissue, along with improved plasma glucose clearance. Compared with vehicle treatment, these IL-37-treated mice had no apparent weight gain. In human adipose tissue cultures, the presence of 50 pm IL-37 reduced spontaneous release of TNF and 50% of lipopolysaccharide-induced TNF. These findings indicate that IL-37's anti-inflammatory effects can ameliorate established metabolic disturbances during obesity.	[Ballak, Dov B.; Li, Suzhao; Cavalli, Giulio; Tengesdal, Isak W.; Kluck, Viola; Swartzwelter, Benjamin; Azam, Tania; Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [Ballak, Dov B.; Seals, Douglas R.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Stahl, Jonathan L.; Mandrup-Poulsen, Thomas] Univ Copenhagen, Dept Biomed Sci, DK-1165 Copenhagen, Denmark; [van Diepen, Janna A.; Tack, Cees J.; Stienstra, Rinke; Dinarello, Charles A.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 Nijmegen, Netherlands; [Stienstra, Rinke] Wageningen Univ, Div Human Nutr, NL-6525 Wageningen, Netherlands	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; University of Copenhagen; Radboud University Nijmegen; Wageningen University & Research	Dinarello, CA (corresponding author), Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA.	cdinare333@aol.com	van Diepen, Janna/ABG-9508-2021; Tack, Cees J/A-2368-2014; Ballak, Dov B/E-1188-2017; Kluck, Viola/H-3768-2017	van Diepen, Janna/0000-0001-9091-1075; Swartzwelter, Benjamin/0000-0002-6283-5199; Stahl-Meyer, Jonathan/0000-0002-9476-5455; Kluck, Viola/0000-0003-2802-2239	National Institutes of Health (NIH) [AI-15614]; Interleukin Foundation; Glenn/AFAR postdoctoral fellowship; Prof. Dr. Terpstra Award from the Dutch Union of Diabetes Research; American Heart Association postdoctoral fellowship; Colorado Clinical and Translational Sciences Institute (CCTSI) CO-Pilot Mentored Faculty award; NIH [AI128443]; MSD/EFSD program; VIDI grant from the Netherlands Organization for Scientific Research; NIH Grants [AG-013038, RO1 HL107120]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015614, R56AI015614] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interleukin Foundation; Glenn/AFAR postdoctoral fellowship; Prof. Dr. Terpstra Award from the Dutch Union of Diabetes Research; American Heart Association postdoctoral fellowship(American Heart Association); Colorado Clinical and Translational Sciences Institute (CCTSI) CO-Pilot Mentored Faculty award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSD/EFSD program; VIDI grant from the Netherlands Organization for Scientific Research; NIH Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies are supported by National Institutes of Health (NIH) Grant AI-15614 (to C. A. D.) and the Interleukin Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Glenn/AFAR postdoctoral fellowship, the Interleukin Foundation, and the Prof. Dr. Terpstra Award from the Dutch Union of Diabetes Research.; Supported by an American Heart Association postdoctoral fellowship, a Colorado Clinical and Translational Sciences Institute (CCTSI) CO-Pilot Mentored Faculty award, and NIH Grant AI128443.; Supported by the Interleukin Foundation.; Supported by a grant from the MSD/EFSD program and a VIDI grant from the Netherlands Organization for Scientific Research.; Supported by NIH Grants AG-013038 and RO1 HL107120.	Abdullah A, 2011, INT J EPIDEMIOL, V40, P985, DOI 10.1093/ije/dyr018; Ballak DB, 2015, CYTOKINE, V75, P280, DOI 10.1016/j.cyto.2015.05.005; Ballak DB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5711; Bernal-Mizrachi E, 2014, DIABETES, V63, P819, DOI 10.2337/db13-1146; Boni-Schnetzler M, 2018, CELL REP, V22, P1774, DOI 10.1016/j.celrep.2018.01.063; Boon MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074083; Cavalli G, 2017, P NATL ACAD SCI USA, V114, P2313, DOI 10.1073/pnas.1619011114; Cavalli G, 2016, RHEUMATOLOGY, V55, P2220, DOI 10.1093/rheumatology/kew325; Cavelti-Weder C, 2012, DIABETES CARE, V35, P1654, DOI 10.2337/dc11-2219; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Dinarello CA, 2016, EUR J IMMUNOL, V46, P1067, DOI 10.1002/eji.201545828; Dinarello CA, 2010, CURR OPIN ENDOCRINOL, V17, P314, DOI 10.1097/MED.0b013e32833bf6dc; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Gao D, 2014, AM J PHYSIOL-ENDOC M, V307, pE289, DOI 10.1152/ajpendo.00430.2013; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; He JY, 2006, MOL ENDOCRINOL, V20, P114, DOI 10.1210/me.2005-0107; He M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014205; Hensen J, 2013, DIABETES METAB, V39, P524, DOI 10.1016/j.diabet.2013.07.003; Hong TP, 2000, EUR CYTOKINE NETW, V11, P193; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Juge-Aubry CE, 2003, DIABETES, V52, P1104, DOI 10.2337/diabetes.52.5.1104; Kroder G, 1996, J CLIN INVEST, V97, P1471, DOI 10.1172/JCI118569; Kulkarni RN, 2012, DIABETES, V61, P2205, DOI 10.2337/db12-0018; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee Y, 2010, MAGN RESON MED, V64, P72, DOI 10.1002/mrm.22409; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Leontieva OV, 2014, AGING CELL, V13, P616, DOI 10.1111/acel.12211; Levin N, 1996, P NATL ACAD SCI USA, V93, P1726, DOI 10.1073/pnas.93.4.1726; Li SZ, 2015, P NATL ACAD SCI USA, V112, P2497, DOI 10.1073/pnas.1424626112; Lunding L, 2015, ALLERGY, V70, P366, DOI 10.1111/all.12566; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Moretti S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004462; Moschen AR, 2011, MOL MED, V17, P840, DOI 10.2119/molmed.2010.00108; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Nold-Petry CA, 2015, NAT IMMUNOL, V16, P354, DOI 10.1038/ni.3103; Nov O, 2010, ENDOCRINOLOGY, V151, P4247, DOI 10.1210/en.2010-0340; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Ridker PM, 2012, CIRCULATION, V126, P2739, DOI 10.1161/CIRCULATIONAHA.112.122556; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Shiwa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135554; Somm E, 2005, DIABETES, V54, P3503, DOI 10.2337/diabetes.54.12.3503; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Sun G, 2010, DIABETOLOGIA, V53, P924, DOI 10.1007/s00125-010-1692-1; ter Horst KW, 2015, INT J OBESITY, V39, P1703, DOI 10.1038/ijo.2015.125; Timper K, 2015, J DIABETES COMPLICAT, V29, P955, DOI 10.1016/j.jdiacomp.2015.05.019; Tynan GA, 2014, DIABETES, V63, P2037, DOI 10.2337/db13-1476; Um JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029524; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wiedemann MSF, 2013, AM J PHYSIOL-ENDOC M, V305, pE388, DOI 10.1152/ajpendo.00179.2013; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zeng QC, 2017, P NATL ACAD SCI USA, V114, P1631, DOI 10.1073/pnas.1619667114; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	65	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14224	14236		10.1074/jbc.RA118.003698	http://dx.doi.org/10.1074/jbc.RA118.003698			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30006351	hybrid, Green Published			2022-12-28	WOS:000444671500004
J	Mangione, PP; Verona, G; Corazza, A; Marcoux, J; Canetti, D; Giorgetti, S; Raimondi, S; Stoppini, M; Esposito, M; Relini, A; Canale, C; Valli, M; Marchese, L; Faravelli, G; Obici, L; Hawkins, PN; Taylor, GW; Gillmore, JD; Pepys, MB; Bellotti, V				Mangione, P. Patrizia; Verona, Guglielmo; Corazza, Alessandra; Marcoux, Julien; Canetti, Diana; Giorgetti, Sofia; Raimondi, Sara; Stoppini, Monica; Esposito, Marilena; Relini, Annalisa; Canale, Claudio; Valli, Maurizia; Marchese, Loredana; Faravelli, Giulia; Obici, Laura; Hawkins, Philip N.; Taylor, Graham W.; Gillmore, Julian D.; Pepys, Mark B.; Bellotti, Vittorio			Plasminogen activation triggers transthyretin amyloidogenesis in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; protein aggregation; protease; tissue plasminogen activator (tPA); fibril; amyloid fibrillogenesis; amyloidogenesis; mechano-enzymatic mechanism; systemic amyloidosis; transthyretin	FAMILIAL AMYLOID POLYNEUROPATHY; CARDIAC AMYLOIDOSIS; FIBRIL FORMATION; TAFAMIDIS; CLEAVAGE; TRIAL	Systemic amyloidosis is a usually fatal disease caused by extracellular accumulation of abnormal protein fibers, amyloid fibrils, derived by misfolding and aggregation of soluble globular plasma protein precursors. Both WT and genetic variants of the normal plasma protein transthyretin (TTR) form amyloid, but neither the misfolding leading to fibrillogenesis nor the anatomical localization of TTR amyloid deposition are understood. We have previously shown that, under physiological conditions, trypsin cleaves human TTR in a mechano-enzymatic mechanism that generates abundant amyloid fibrils in vitro. In sharp contrast, the widely used in vitro model of denaturation and aggregation of TTR by prolonged exposure to pH 4.0 yields almost no clearly defined amyloid fibrils. However, the exclusive duodenal location of trypsin means that this enzyme cannot contribute to systemic extracellular TTR amyloid deposition in vivo. Here, we therefore conducted a bioinformatics search for systemically active tryptic proteases with appropriate tissue distribution, which unexpectedly identified plasmin as the leading candidate. We confirmed that plasmin, just as trypsin, selectively cleaves human TTR between residues 48 and 49 under physiological conditions in vitro. Truncated and full-length protomers are then released from the native homotetramer and rapidly aggregate into abundant fibrils indistinguishable from ex vivo TTR amyloid. Our findings suggest that physiological fibrinolysis is likely to play a critical role in TTR amyloid formation in vivo. Identification of this surprising intersection between two hitherto unrelated pathways opens new avenues for elucidating the mechanisms of TTR amyloidosis, for seeking susceptibility risk factors, and for therapeutic innovation.	[Mangione, P. Patrizia; Verona, Guglielmo; Corazza, Alessandra; Canetti, Diana; Esposito, Marilena; Taylor, Graham W.; Pepys, Mark B.; Bellotti, Vittorio] UCL, Div Med, Ctr Amyloidosis & Acute Phase Prot, Wolfson Drug Discovery Unit, London NW3 2PF, England; [Mangione, P. Patrizia; Giorgetti, Sofia; Raimondi, Sara; Stoppini, Monica; Valli, Maurizia; Marchese, Loredana; Faravelli, Giulia; Bellotti, Vittorio] Univ Pavia, Inst Biochem, Dept Mol Med, I-27100 Pavia, Italy; [Corazza, Alessandra] Univ Udine, Dept Med DAME, I-33100 Udine, Italy; [Corazza, Alessandra] Ist Nazl Biostrutture & Biosistemi, I-00136 Rome, Italy; [Marcoux, Julien] Univ Toulouse, CNRS, UPS, Inst Pharmacol & Biol Struct, F-31000 Toulouse, France; [Relini, Annalisa] Univ Genoa, Dept Chem & Ind Chem, I-16146 Genoa, Italy; [Canale, Claudio] Univ Genoa, Dept Phys, I-16146 Genoa, Italy; [Obici, Laura] Fdn IRCCS Policlin San Matteo, Amyloidosis Res & Treatment Ctr, I-27100 Pavia, Italy; [Hawkins, Philip N.; Gillmore, Julian D.; Pepys, Mark B.] UCL, Natl Amyloidosis Ctr, London NW3 2PF, England; [Hawkins, Philip N.; Gillmore, Julian D.; Pepys, Mark B.] Royal Free Hosp, London NW3 2PF, England; [Esposito, Marilena] Univ Naples Federico II, Dept Chem Sci, I-80126 Naples, Italy	University of London; University College London; University of Pavia; University of Udine; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Genoa; University of Genoa; IRCCS Fondazione San Matteo; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Naples Federico II	Bellotti, V (corresponding author), Rowland Hill St, London NW3 2PF, England.	v.bellotti@ucl.ac.uk	Relini, Annalisa/AHC-3105-2022; Corazza, Alessandra/AGB-1457-2022; Giorgetti, Sofia/AAD-4341-2019; Verona, Guglielmo/AAH-9802-2019; Taylor, Graham Walter/R-4811-2019; Obici, Laura/AAC-3060-2019; Bellotti, Vittorio/A-6201-2014	Corazza, Alessandra/0000-0003-2272-1928; Giorgetti, Sofia/0000-0001-9438-6511; Verona, Guglielmo/0000-0001-8100-3876; Taylor, Graham Walter/0000-0002-9672-8463; Obici, Laura/0000-0001-7468-700X; Canale, Claudio/0000-0002-7582-6849; CANETTI, DIANA/0000-0001-5292-8124; RELINI, ANNALISA/0000-0002-4040-9279; Mangione, Palma/0000-0003-0260-1400; Marcoux, Julien/0000-0001-7321-7436; Bellotti, Vittorio/0000-0001-8678-662X; Faravelli, Giulia/0000-0002-7348-9404	University College London Technology Fund; University College London Amyloidosis Research Fund; United Kingdom Medical Research Council [MR/K000187/1]; Rosetrees Trust/Royal Free Charity PhD programme [M427]; Cariplo Foundation [2013 0964, 2014 0700]; Italian Ministry of Health Ricerca Finalizzata [RF 2013 02355259]; Italian Ministry of Research and University Dipartimenti di Eccellenza 2018-2022 grant; Istituto Nazionale di Biostrutture e Biosistemi; MRC [MR/K000187/1, G0901596, G7900510] Funding Source: UKRI	University College London Technology Fund; University College London Amyloidosis Research Fund; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rosetrees Trust/Royal Free Charity PhD programme; Cariplo Foundation(Fondazione Cariplo); Italian Ministry of Health Ricerca Finalizzata(Ministry of Health, Italy); Italian Ministry of Research and University Dipartimenti di Eccellenza 2018-2022 grant; Istituto Nazionale di Biostrutture e Biosistemi; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by investment from the University College London Technology Fund and by the University College London Amyloidosis Research Fund, the United Kingdom Medical Research Council Grant MR/K000187/1, the Rosetrees Trust/Royal Free Charity PhD programme M427, the Cariplo Foundation Projects 2013 0964 and 2014 0700, the Italian Ministry of Health Ricerca Finalizzata RF 2013 02355259, the Italian Ministry of Research and University Dipartimenti di Eccellenza 2018-2022 grant to the Molecular Medicine Department (University of Pavia), and the Istituto Nazionale di Biostrutture e Biosistemi. Core support for the Wolfson Drug Discovery Unit is provided by the United Kingdom National Institute for Health Research Biomedical Research Centre and Unit Funding Scheme via the UCLH/UCL Biomedical Research Centre. The authors declare that they have no conflicts of interest with the contents of this article.	Adams D, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0948-5; Benson M. D., 2017, ORPHANET J RARE D S1, V12, P165; Benson MD, 2003, BEST PRACT RES CL RH, V17, P909, DOI 10.1016/j.berh.2003.09.001; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Gillmore JD, 2016, CIRCULATION, V133, P2404, DOI 10.1161/CIRCULATIONAHA.116.021612; Hammarstrom P, 2001, SCIENCE, V293, P2459, DOI 10.1126/science.1062245; Ihse E, 2013, AMYLOID, V20, P142, DOI 10.3109/13506129.2013.797890; Jacobson DR, 1997, NEW ENGL J MED, V336, P466, DOI 10.1056/NEJM199702133360703; Klimtchuk ES, 2018, P NATL ACAD SCI USA, V115, pE6428, DOI 10.1073/pnas.1802977115; Liu CZ, 2008, PROTEIN EXPRES PURIF, V61, P31, DOI 10.1016/j.pep.2008.05.007; Mangione PP, 2014, P NATL ACAD SCI USA, V111, P1539, DOI 10.1073/pnas.1317488111; Marcoux J, 2015, EMBO MOL MED, V7, P1337, DOI 10.15252/emmm.201505357; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Pepys MB, 2009, J PATHOL, V217, P1, DOI 10.1002/path.2467; Plante-Bordeneuve V, 2017, J NEUROL, V264, P268, DOI 10.1007/s00415-016-8337-3; PUCHTLER H, 1985, Applied Pathology, V3, P5; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Ruberg FL, 2012, CIRCULATION, V126, P1286, DOI 10.1161/CIRCULATIONAHA.111.078915; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Tucker HM, 2000, J NEUROSCI, V20, P3937; Verona G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00338-x; Weiss C, 1998, MED SCI SPORT EXER, V30, P246, DOI 10.1097/00005768-199802000-00012	26	45	45	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14192	14199		10.1074/jbc.RA118.003990	http://dx.doi.org/10.1074/jbc.RA118.003990			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30018138	Green Published, hybrid			2022-12-28	WOS:000444671500001
J	Dhabal, S; Das, P; Biswas, P; Kumari, P; Yakubenko, VP; Kundu, S; Cathcart, MK; Kundu, M; Biswas, K; Bhattacharjee, A				Dhabal, Sukhamoy; Das, Pradip; Biswas, Pritam; Kumari, Priyanka; Yakubenko, Valentin P.; Kundu, Suman; Cathcart, Martha K.; Kundu, Manjari; Biswas, Kaushik; Bhattacharjee, Ashish			Regulation of monoamine oxidase A (MAO-A) expression, activity, and function in IL-13-stimulated monocytes and A549 lung carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						monoamine oxidase A; monocyte; cytokine; inflammation; cell migration; gene expression; 15-lipoxygenase; A549 lung cancer cells; alternative activation; gene regulation; human monocyte; signal transducer and activator of transcription; peroxisome proliferator-activated receptor	15-LIPOXYGENASE GENE-EXPRESSION; CENTRIFUGAL ELUTRIATION CCE; PERIPHERAL-BLOOD MONOCYTES; BRONCHIAL EPITHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; PPAR-GAMMA; ALTERNATIVE ACTIVATION; MACROPHAGE ACTIVATION; ENRICHED FRACTIONS; CANCER METASTASIS	Monoamine oxidase A (MAO-A) is a mitochondrial flavoenzyme implicated in the pathogenesis of atherosclerosis and inflammation and also in many neurological disorders. MAO-A also has been reported as a potential therapeutic target in prostate cancer. However, the regulatory mechanisms controlling cytokine-induced MAO-A expression in immune or cancer cells remain to be identified. Here, we show that MAO-A expression is co-induced with 15-lipoxygenase (15-LO) in interleukin 13 (IL-13)-activated primary human monocytes and A549 non-small cell lung carcinoma cells. We present evidence that MAO-A gene expression and activity are regulated by signal transducer and activator of transcription 1, 3, and 6 (STAT1, STAT3, and STAT6), early growth response 1 (EGR1), and cAMP-responsive element-binding protein (CREB), the same transcription factors that control IL-13-dependent 15-LO expression. We further established that in both primary monocytes and in A549 cells, IL-13-stimulated MAO-A expression, activity, and function are directly governed by 15-LO. In contrast, IL-13-driven expression and activity of MAO-A was 15-LO-independent in U937 promonocytic cells. Furthermore, we demonstrate that the 15-LO-dependent transcriptional regulation of MAO-A in response to IL-13 stimulation in monocytes and in A549 cells is mediated by peroxisome proliferator-activated receptor (PPAR) and that signal transducer and activator of transcription 6 (STAT6) plays a crucial role in facilitating the transcriptional activity of PPAR. We further report that the IL-13-STAT6-15-LO-PPAR axis is critical for MAO-A expression, activity, and function, including migration and reactive oxygen species generation. Altogether, these results have major implications for the resolution of inflammation and indicate that MAO-A may promote metastatic potential in lung cancer cells.	[Dhabal, Sukhamoy; Das, Pradip; Biswas, Pritam; Kumari, Priyanka; Bhattacharjee, Ashish] Natl Inst Technol Durgapur, Dept Biotechnol, Mahatma Gandhi Ave, Burdwan 713209, W Bengal, India; [Yakubenko, Valentin P.; Kundu, Suman; Cathcart, Martha K.] Case Western Reserve Univ, Dept Cell Biol, Lerner Res Inst, Cleveland Clin, Cleveland, OH 44195 USA; [Yakubenko, Valentin P.; Kundu, Suman; Cathcart, Martha K.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44195 USA; [Kundu, Manjari; Biswas, Kaushik] Bose Inst, Div Mol Med, Kolkata 700054, W Bengal, India; [Yakubenko, Valentin P.] East Tennessee State Univ, Dept Biomed Sci, James H Quillen Coll Med, Johnson City, TN 37614 USA	National Institute of Technology (NIT System); National Institute of Technology Durgapur; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Department of Science & Technology (India); Bose Institute; East Tennessee State University	Bhattacharjee, A (corresponding author), Natl Inst Technol, Dept Biotechnol, Durgapur 713209, W Bengal, India.	ashish15lo@yahoo.com	Biswas, Kaushik/AAR-1446-2020	Biswas, Kaushik/0000-0003-2502-9515	Department of Biotechnology, Government of India; SERB, Government of India [SERB/SR/SO/HS-093/2013]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); SERB, Government of India	This work was supported by Ramalingaswami Fellowship (to A. B.) by the Department of Biotechnology, Government of India, and by Research Grant SERB/SR/SO/HS-093/2013 from SERB, Government of India. The authors declare that they have no conflicts of interest with the contents of this article.	Adeghate E, 2004, NEUROTOXICOLOGY, V25, P167, DOI 10.1016/S0161-813X(03)00091-3; Bhattacharjee A, 2006, J IMMUNOL, V177, P3771, DOI 10.4049/jimmunol.177.6.3771; Bhattacharjee A, 2013, FREE RADICAL BIO MED, V54, P1, DOI 10.1016/j.freeradbiomed.2012.10.553; Bhattacharjee A, 2011, J BIOL CHEM, V286, P36709, DOI 10.1074/jbc.M111.291492; Bhattacharjee A, 2010, J IMMUNOL, V185, P5211, DOI 10.4049/jimmunol.1000514; Bianchi P, 2005, CIRCULATION, V112, P3297, DOI 10.1161/CIRCULATIONAHA.104.528133; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Brown CD, 2001, INFLAMM RES, V50, P321, DOI 10.1007/PL00000251; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Cao H, 2016, ONCOTARGET, V7, P61183, DOI 10.18632/oncotarget.11282; Carnevale KA, 2001, J IMMUNOL, V167, P3414, DOI 10.4049/jimmunol.167.6.3414; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cathcart M.K., 2014, INFLAMM CELL SIGNAL, V1, DOI [10.14800/ics.161, DOI 10.14800/ICS.161]; Cathcart MK, 2000, FREE RADICAL BIO MED, V28, P1726, DOI 10.1016/S0891-5849(00)00230-6; Chaitidis P, 2005, MED SCI MONITOR, V11, pBR259; Chaitidis P, 2005, CYTOKINE, V30, P366, DOI 10.1016/j.cyto.2005.02.004; Chaitidis P, 2004, J IMMUNOL, V173, P4821, DOI 10.4049/jimmunol.173.8.4821; Coatrieux C, 2007, FREE RADICAL BIO MED, V43, P80, DOI 10.1016/j.freeradbiomed.2007.03.036; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Czimmerer Z, 2012, IMMUNOBIOLOGY, V217, P1301, DOI 10.1016/j.imbio.2012.08.270; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; FOLCIK VA, 1995, J CLIN INVEST, V96, P504, DOI 10.1172/JCI118062; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Grote K, 2004, J BIOL CHEM, V279, P55675, DOI 10.1074/jbc.M406532200; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Kaludercic N, 2011, BBA-MOL CELL RES, V1813, P1323, DOI 10.1016/j.bbamcr.2010.09.010; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kundu S, 2013, J LIPID RES, V54, P436, DOI 10.1194/jlr.M031914; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lin YC, 2017, SCI REP-UK, V7, DOI 10.1038/srep46338; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Meyer JH, 2006, ARCH GEN PSYCHIAT, V63, P1209, DOI 10.1001/archpsyc.63.11.1209; Mishra RS, 2008, J EXP MED, V205, P347, DOI 10.1084/jem.20071243; Moskvitina T A, 2001, Med Sci Monit, V7, P17; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Naoi M, 2006, J NEURAL TRANSM-SUPP, P67; NASSAR GM, 1994, J BIOL CHEM, V269, P27631; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ou XM, 2006, P NATL ACAD SCI USA, V103, P10923, DOI 10.1073/pnas.0601515103; PANAGIOTIDIS G, 1993, METABOLISM, V42, P1398, DOI 10.1016/0026-0495(93)90189-U; Pchejetski D, 2007, CIRC RES, V100, P41, DOI 10.1161/01.RES.0000253900.66640.34; Robbesyn F, 2003, FASEB J, V17, P743, DOI 10.1096/fj.02-0240fje; Rosen RL, 1996, BLOOD, V88, P1206, DOI 10.1182/blood.V88.4.1206.bloodjournal8841206; Roy B, 1998, J BIOL CHEM, V273, P32023, DOI 10.1074/jbc.273.48.32023; Roy B, 2002, J LEUKOCYTE BIOL, V72, P580; Schwartz TL, 2013, CNS SPECTRUMS, V18, P22, DOI 10.1017/S1092852913000734; Scrutton NS, 2004, NAT PROD REP, V21, P722, DOI 10.1039/b306788m; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shih JC, 1999, POL J PHARMACOL, V51, P25; SINGER TP, 1995, FASEB J, V9, P605, DOI 10.1096/fasebj.9.8.7768351; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Valley MP, 2006, ANAL BIOCHEM, V359, P238, DOI 10.1016/j.ab.2006.09.035; WAHL LM, 1984, CELL IMMUNOL, V85, P373, DOI 10.1016/0008-8749(84)90251-X; WAHL SM, 1984, CELL IMMUNOL, V85, P384, DOI 10.1016/0008-8749(84)90252-1; Wang CC, 2011, J BIOL CHEM, V286, P28322, DOI 10.1074/jbc.M111.241422; Wang LH, 2000, BLOOD, V95, P1249, DOI 10.1182/blood.V95.4.1249.004k39_1249_1257; Wittwer J, 2007, PROSTAG LEUKOTR ESS, V77, P67, DOI 10.1016/j.plefa.2007.08.001; Wouters J, 1998, CURR MED CHEM, V5, P137; Wu JB, 2017, CANCER CELL, V31, P368, DOI 10.1016/j.ccell.2017.02.003; Wu JB, 2014, J CLIN INVEST, V124, P2891, DOI 10.1172/JCI70982; Wu Ning, 2010, J Thorac Dis, V2, P76; Xu B, 2004, J BIOL CHEM, V279, P15954, DOI 10.1074/jbc.M400413200; Xu B, 2003, MOL CELL BIOL, V23, P3918, DOI 10.1128/MCB.23.11.3918-3928.2003; Yakubenko VP, 2013, J BIOL CHEM, V288, P2778, DOI 10.1074/jbc.M112.381343; Yakubenko VP, 2011, CIRC RES, V108, P544, DOI 10.1161/CIRCRESAHA.110.231803; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9; Zhao JM, 2009, AM J RESP CRIT CARE, V179, P782, DOI 10.1164/rccm.200811-1744OC	71	15	15	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14040	14064		10.1074/jbc.RA118.002321	http://dx.doi.org/10.1074/jbc.RA118.002321			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30021838	hybrid, Green Published			2022-12-28	WOS:000444070700027
J	Gupta, S; Kelow, S; Wang, L; Andrake, MD; Dunbrack, RL; Kruger, WD				Gupta, Sapna; Kelow, Simon; Wang, Liqun; Andrake, Mark D.; Dunbrack, Roland L., Jr.; Kruger, Warren D.			Mouse modeling and structural analysis of the p.G307S mutation in human cystathionine -synthase (CBS) reveal effects on CBS activity but not stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inborn error of metabolism; mouse genetics; structural model; methionine; pyridoxal phosphate; missense mutation; bortezomib; pyridoxine; cystathionine -synthase; transsulfuration pathway; sulfur metabolism; p; G307S; homocystinuria	BETA-SYNTHASE; GENE-EXPRESSION; MOLECULAR-BASIS; DEFICIENCY; HEME; HOMOCYSTINURIA; PROTEIN; ACTIVATION; RESCUE; CHARMM	Mutations in the cystathionine -synthase (CBS) gene are the cause of classical homocystinuria, the most common inborn error in sulfur metabolism. The p.G307S mutation is the most frequent cause of CBS deficiency in Ireland, which has the highest prevalence of CBS deficiency in Europe. Individuals homozygous for this mutation tend to be severely affected and are pyridoxine nonresponsive, but the molecular basis for the strong effects of this mutation is unclear. Here, we characterized a transgenic mouse model lacking endogenous Cbs and expressing human p.G307S CBS protein from a zinc-inducible metallothionein promoter (Tg-G307S Cbs(-/-)). Unlike mice expressing other mutant CBS alleles, the Tg-G307S transgene could not efficiently rescue neonatal lethality of Cbs(-/-) in a C57BL/6J background. In a C3H/HeJ background, zinc-induced Tg-G307S Cbs(-/-) mice expressed high levels of p.G307S CBS in the liver, and this protein variant forms multimers, similarly to mice expressing WT human CBS. However, the p.G307S enzyme had no detectable residual activity. Moreover, treating mice with proteasome inhibitors failed to significantly increase CBS-specific activity. These findings indicated that the G307S substitution likely affects catalytic function as opposed to causing a folding defect. Using molecular dynamics simulation techniques, we found that the G307S substitution likely impairs catalytic function by limiting the ability of the tyrosine at position 308 to assume the proper conformational state(s) required for the formation of the pyridoxal-cystathionine intermediate. These results indicate that the p.G307S CBS is stable but enzymatically inert and therefore unlikely to respond to chaperone-based therapy.	[Gupta, Sapna; Wang, Liqun; Andrake, Mark D.; Dunbrack, Roland L., Jr.; Kruger, Warren D.] Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave, Philadelphia, PA 19111 USA; [Kelow, Simon] Univ Penn, Dept Biochem & Mol Biophys, Philadelphia, PA 19104 USA	Fox Chase Cancer Center; University of Pennsylvania	Kruger, WD (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave, Philadelphia, PA 19111 USA.	warren.kruger@fccc.edu	Kruger, Warren/Y-2541-2018; Dunbrack, Roland/ABG-7141-2020	kruger, warren/0000-0002-4990-3695; Andrake, Mark/0000-0003-2957-4350	National Institutes of Health [R01 DK101404, GM 098772, R35 GM122517]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098772, R35GM122517, R01GM111819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 DK101404 (to W. D. K.), GM 098772 (to W. D. K.), and R35 GM122517 (to R. L. D.) and an appropriation from the Commonwealth of Pennsylvania. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akahoshi N, 2008, HUM MOL GENET, V17, P1994, DOI 10.1093/hmg/ddn097; Banerjee R, 2003, BBA-PROTEINS PROTEOM, V1647, P30, DOI 10.1016/S1570-9639(03)00044-X; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; DUNBRACK RL, 1994, NAT STRUCT BIOL, V1, P334, DOI 10.1038/nsb0594-334; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Ereno-Orbea J, 2014, P NATL ACAD SCI USA, V111, pE3845, DOI 10.1073/pnas.1414545111; Ereno-Orbea J, 2013, P NATL ACAD SCI USA, V110, pE3790, DOI 10.1073/pnas.1313683110; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P81, DOI 10.1016/S0006-291X(75)80297-X; GALLAGHER PM, 1995, HUM MUTAT, V6, P177, DOI 10.1002/humu.1380060211; Gaustadnes M, 2002, HUM MUTAT, V20, P117, DOI 10.1002/humu.10104; Gupta S, 2008, HUM MUTAT, V29, P1048, DOI 10.1002/humu.20773; Gupta S, 2017, HUM MUTAT, V38, P863, DOI 10.1002/humu.23240; Gupta S, 2013, HUM MUTAT, V34, P1085, DOI 10.1002/humu.22335; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k; HU FL, 1993, HUM MOL GENET, V2, P1857, DOI 10.1093/hmg/2.11.1857; Jhee KH, 2005, ANTIOXID REDOX SIGN, V7, P813, DOI 10.1089/ars.2005.7.813; Kim CE, 1997, HUM MOL GENET, V6, P2213, DOI 10.1093/hmg/6.13.2213; Kopecka J, 2011, J INHERIT METAB DIS, V34, P39, DOI 10.1007/s10545-010-9087-5; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; Kruger WD, 2003, HUM MUTAT, V22, P434, DOI 10.1002/humu.10290; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodha PH, 2009, BIOCHEM CELL BIOL, V87, P531, DOI [10.1139/O09-003, 10.1139/o09-003]; Majtan T, 2008, J BIOL CHEM, V283, P34588, DOI 10.1074/jbc.M805928200; McCorvie TJ, 2014, J BIOL CHEM, V289, P36018, DOI 10.1074/jbc.M114.610782; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Melenovska P, 2015, J INHERIT METAB DIS, V38, P287, DOI 10.1007/s10545-014-9781-9; Moat Stuart J, 2004, Hum Mutat, V23, P206, DOI 10.1002/humu.9214; Moorthie S, 2014, J INHERIT METAB DIS, V37, P889, DOI 10.1007/s10545-014-9729-0; Mudd SH, 2011, AM J MED GENET C, V157C, P3, DOI 10.1002/ajmg.c.30293; PALMITER RD, 1993, MOL CELL BIOL, V13, P5266, DOI 10.1128/MCB.13.9.5266; Pazicni S, 2005, BIOCHEMISTRY-US, V44, P16785, DOI 10.1021/bi051305z; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pey AL, 2016, FEBS LETT, V590, P4461, DOI 10.1002/1873-3468.12488; Shan XY, 1998, NAT GENET, V19, P91, DOI 10.1038/ng0598-91; Shan XY, 2001, HUM MOL GENET, V10, P635, DOI 10.1093/hmg/10.6.635; Singh LR, 2007, MOL GENET METAB, V91, P335, DOI 10.1016/j.ymgme.2007.04.011; Singh LR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000807; Singh LR, 2009, J BIOL CHEM, V284, P4238, DOI 10.1074/jbc.M806387200; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 2002, BIOCHEMISTRY-US, V41, P10454, DOI 10.1021/bi026052d; Theobald DL, 2006, BIOINFORMATICS, V22, P2171, DOI 10.1093/bioinformatics/btl332; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vicente JB, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8940321; Wang LQ, 2005, HUM MOL GENET, V14, P2201, DOI 10.1093/hmg/ddi224; Wang LQ, 2004, CIRC RES, V94, P1318, DOI 10.1161/01.RES.0000129182.46440.4a; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Wei QO, 2010, PROTEINS, V78, P2058, DOI 10.1002/prot.22722; Xu QF, 2011, NUCLEIC ACIDS RES, V39, pD761, DOI 10.1093/nar/gkq1059; Yap S, 1998, J INHERIT METAB DIS, V21, P738, DOI 10.1023/A:1005445132327	53	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13921	13931		10.1074/jbc.RA118.002164	http://dx.doi.org/10.1074/jbc.RA118.002164			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30030379	hybrid, Green Published			2022-12-28	WOS:000444070700018
J	Sohn, JH; Lee, YK; Han, JS; Jeon, YG; Kim, JI; Choe, SS; Kim, SJ; Yoo, HJ; Kim, JB				Sohn, Jee Hyung; Lee, Yun Kyung; Han, Ji Seul; Jeon, Yong Geun; Kim, Jong In; Choe, Sung Sik; Kim, Su Jung; Yoo, Hyun Ju; Kim, Jae Bum			Perilipin 1 (Plin1) deficiency promotes inflammatory responses in lean adipose tissue through lipid dysregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; lipolysis; prostaglandin; insulin resistance; lipid metabolism; adipose tissue inflammation; adipose tissue macrophage; Plin1	DIET-INDUCED OBESITY; MEDIATED ADIPOCYTE LIPOLYSIS; ACTIVATED PROTEIN-KINASE; HORMONE-SENSITIVE LIPASE; INSULIN-RESISTANCE; NORMAL-WEIGHT; METABOLICALLY HEALTHY; HEPATIC STEATOSIS; STORAGE DROPLETS; SKELETAL-MUSCLE	Lipid droplets are specialized cellular organelles that contain neutral lipid metabolites and play dynamic roles in energy homeostasis. Perilipin 1 (Plin1), one of the major lipid droplet-binding proteins, is highly expressed in adipocytes. In mice, Plin1 deficiency impairs peripheral insulin sensitivity, accompanied with reduced fat mass. However, the mechanisms underlying insulin resistance in lean Plin1 knockout (Plin1(-/-)) mice are largely unknown. The current study demonstrates that Plin1 deficiency promotes inflammatory responses and lipolysis in adipose tissue, resulting in insulin resistance. M1-type adipose tissue macrophages (ATMs) were higher in Plin1(-/-) than in Plin1(+/+) mice on normal chow diet. Moreover, using lipidomics analysis, we discovered that Plin1(-/-) adipocytes promoted secretion of pro-inflammatory lipid metabolites such as prostaglandins, which potentiated monocyte migration. In lean Plin1(-/-) mice, insulin resistance was relieved by macrophage depletion with clodronate, implying that elevated pro-inflammatory ATMs might be attributable for insulin resistance under Plin1 deficiency. Together, these data suggest that Plin1 is required to restrain fat loss and pro-inflammatory responses in adipose tissue by reducing futile lipolysis to maintain metabolic homeostasis.	[Sohn, Jee Hyung; Lee, Yun Kyung; Han, Ji Seul; Jeon, Yong Geun; Kim, Jong In; Choe, Sung Sik; Kim, Jae Bum] Seoul Natl Univ, Inst Mol Biol & Genet, Dept Biol Sci, Natl Creat Res Initiat Ctr Adipose Tissue Remodel, KS-013 Seoul, South Korea; [Kim, Su Jung; Yoo, Hyun Ju] Univ Ulsan, Coll Med, Dept Convergence Med, Asan Inst Life Sci,Asan Med Ctr, KS-013 Seoul, South Korea	Seoul National University (SNU); University of Ulsan	Kim, JB (corresponding author), Seoul Natl Univ, Dept Biol Sci, Natl Creat Res Initiat Ctr Adipose Tissue Remodel, Inst Mol Biol & Genet, San 56-1, Seoul 151742, South Korea.	jaebkim@snu.ac.kr	Lee, Yun Kyung/AFE-1810-2022; Lee, Yun Kyung/AAK-1675-2021; JEON, YONGGEUN/ABE-4093-2021; Lee, Yun Kyung/AAE-9520-2022	Lee, Yun Kyung/0000-0002-6476-0135; Jeon, Yong Geun/0000-0002-1422-9151; KIM, Jae Bum/0000-0003-2337-6935; Sohn, Jee Hyung/0000-0003-2739-134X	National Research Foundation of Korea (NRF) - South Korea government, Ministry of Science, ICT, and Future Planning [2011-0018312]; Brain Korea 21 program	National Research Foundation of Korea (NRF) - South Korea government, Ministry of Science, ICT, and Future Planning; Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the South Korea government, Ministry of Science, ICT, and Future Planning number 2011-0018312. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Brain Korea 21 program.	Ayache S, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-40; Batista ML, 2012, CYTOKINE, V57, P9, DOI 10.1016/j.cyto.2011.10.008; Batista ML, 2016, J CACHEXIA SARCOPENI, V7, P37, DOI 10.1002/jcsm.12037; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Carman GM, 2012, J BIOL CHEM, V287, P2272, DOI 10.1074/jbc.R111.323931; Chan KL, 2015, J BIOL CHEM, V290, P16979, DOI 10.1074/jbc.M115.646992; Choe SS, 2014, DIABETES, V63, P3359, DOI 10.2337/db13-1965; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; De Lorenzo A, 2007, AM J CLIN NUTR, V85, P40, DOI 10.1093/ajcn/85.1.40; de Matos-Neto EM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00629; Feng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024358; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Gaidhu MP, 2010, AM J PHYSIOL-CELL PH, V298, pC961, DOI 10.1152/ajpcell.00547.2009; Gandotra S, 2011, NEW ENGL J MED, V364, P740, DOI 10.1056/NEJMoa1007487; Gartung A, 2016, J BIOL CHEM, V291, P16001, DOI 10.1074/jbc.M116.725937; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; HADVARY P, 1988, BIOCHEM J, V256, P357, DOI 10.1042/bj2560357; Ham M, 2016, DIABETES, V65, P2624, DOI 10.2337/db16-0060; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; Hoo RLC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40657; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu XQ, 2016, J LIPID RES, V57, P663, DOI 10.1194/jlr.M066530; Huh JY, 2017, DIABETES, V66, P835, DOI 10.2337/db16-1122; Iglesias J, 2016, J LIPID RES, V57, P131, DOI 10.1194/jlr.D058438; Indulekha K, 2015, DIABETES TECHNOL THE, V17, P134, DOI 10.1089/dia.2014.0202; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim M, 2013, METABOLISM, V62, P554, DOI 10.1016/j.metabol.2012.10.006; Kimmel AR, 2016, ANNU REV NUTR, V36, P471, DOI 10.1146/annurev-nutr-071813-105410; KLEIN S, 1990, J CLIN INVEST, V86, P1403, DOI 10.1172/JCI114854; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kwon Hyokjoon, 2013, Front Endocrinol (Lausanne), V4, P71, DOI 10.3389/fendo.2013.00071; Langlois D, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-169; Lee JH, 2016, J BIOL CHEM, V291, P20315, DOI 10.1074/jbc.M116.740464; Li PP, 2015, NAT MED, V21, P239, DOI 10.1038/nm.3800; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Martin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046242; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Montgomery MK, 2018, DIABETES, V67, P594, DOI 10.2337/db17-0923; Najt CP, 2016, AM J PHYSIOL-GASTR L, V310, pG726, DOI 10.1152/ajpgi.00436.2015; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Petersen KF, 2002, AM J CARDIOL, V90, p11G; Porporato PE, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.3; Savage DB, 2009, DIS MODEL MECH, V2, P554, DOI 10.1242/dmm.002907; Schoiswohl G, 2015, ENDOCRINOLOGY, V156, P3610, DOI 10.1210/en.2015-1322; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Succurro E, 2008, OBESITY, V16, P1881, DOI 10.1038/oby.2008.308; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamamoto K, 2018, ATHEROSCLEROSIS, V269, P192, DOI 10.1016/j.atherosclerosis.2018.01.019; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035; ZHANG S.-Q., 2018, NATURE COMMUNICATION, V9, P1, DOI DOI 10.3389/fimmu.2018.00467; Zhou P. L., 2017, J CELL BIOCHEM, DOI [10.1002/jbc.26493, DOI 10.1002/JBC.26493]; Zou LQ, 2016, BBA-MOL BASIS DIS, V1862, P182, DOI 10.1016/j.bbadis.2015.10.024	67	44	49	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13974	13988		10.1074/jbc.RA118.003541	http://dx.doi.org/10.1074/jbc.RA118.003541			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30042231	Green Published, hybrid			2022-12-28	WOS:000444070700022
J	Terada, M; Suzuki, G; Nonaka, T; Kametani, F; Tamaoka, A; Hasegawa, M				Terada, Makoto; Suzuki, Genjiro; Nonaka, Takashi; Kametani, Fuyuki; Tamaoka, Akira; Hasegawa, Masato			The effect of truncation on prion-like properties of -synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein aggregation; alpha-synuclein (a-synuclein); amyloid; electron microscopy (EM); fibril; immunohistochemistry; neurodegenerative disease; Parkinson's disease; Western blot; neurodegeneration; polymorphs; prion-like; truncation; protein truncation; protein structure; prion; neurodegeneration	HUMAN ALPHA-SYNUCLEIN; C-TERMINAL REGION; PARKINSONS-DISEASE; IN-VITRO; FIBRIL FORMATION; NEURODEGENERATIVE-DISEASES; INTRACELLULAR INCLUSIONS; STRUCTURAL-PROPERTIES; PROTEOLYTIC CLEAVAGE; MEMBRANE-BINDING	Increasing evidence suggests that -synuclein (S) aggregates in brains of individuals with Parkinson's disease and dementia with Lewy bodies can spread in a prion-like manner. Although the initial S nuclei are pivotal in determining S fibril polymorphs and resulting phenotypes, it is not clear how the initial fibril seeds are generated. Previous studies have shown that S truncation might have an important role in S aggregation. However, little is known about how this truncation influences S's propagation properties. In the present study, we generated S fibrils from a series of truncated human S constructs, characterized their structures and conformational stabilities, and investigated their ability to convert the conformation of full-length S in vitro, in cultured cells, and in WT mice. We show that both C- and N-terminal truncations of human S induce fibril polymorphs and exhibit different cross-seeding activities. N-terminally 10- or 30-residue-truncated human S fibrils induced more abundant S pathologies than WT fibrils in mice, whereas other truncated fibrils induced less abundant pathologies. Biochemical analyses of these truncated fibrils revealed that N-terminal 10- or 30-residue truncations of human S change the fibril conformation in a manner that increases their structural compatibility with WT mouse S fibrils and reduces their stability. C-terminally 20-residue-truncated fibrils displayed enhanced seeding activity in vitro. Our findings imply that truncation of S can influence its prion-like pathogenicity, resulting in phenotypic diversity of -synucleinopathies.	[Terada, Makoto; Suzuki, Genjiro; Nonaka, Takashi; Kametani, Fuyuki; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Terada, Makoto; Tamaoka, Akira] Univ Tsukuba, Fac Med, Dept Neurol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan	Tokyo Metropolitan Institute of Medical Science; University of Tsukuba	Terada, M; Hasegawa, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.; Terada, M (corresponding author), Univ Tsukuba, Fac Med, Dept Neurol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	mterada-tuk@umin.ac.jp; hasegawa-ms@igakuken.or.jp	Kametani, Fuyuki/G-4752-2011	Kametani, Fuyuki/0000-0001-9125-7001	Ministry of Education, Culture, Sports, Science, and Technology [JP26117005]; Japan Society for the Promotion of Science [JP23228004]; Japan Agency for Medical Research and Development (AMED) [JP14533254]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology Grants-in-Aid for Scientific Research (KAKENHI) Grant JP26117005 (to M. H.), Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI) Grant JP23228004 (to M. H.), and Japan Agency for Medical Research and Development (AMED) Grant-in-Aid for research on Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) Grant JP14533254 (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Baba M, 1998, AM J PATHOL, V152, P879; Bae EJ, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.84; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Dehay B, 2013, MOVEMENT DISORD, V28, P725, DOI 10.1002/mds.25462; Fares MB, 2014, HUM MOL GENET, V23, P4491, DOI 10.1093/hmg/ddu165; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Ghosh D, 2014, BIOCHEMISTRY-US, V53, P6419, DOI 10.1021/bi5010365; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Iwata A, 2003, HUM MOL GENET, V12, P2625, DOI 10.1093/hmg/ddg283; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kellie JF, 2014, SCI REP-UK, V4, DOI 10.1038/srep05797; Kessler JC, 2003, BIOCHEMISTRY-US, V42, P672, DOI 10.1021/bi020429y; Kim KS, 2012, J BIOL CHEM, V287, P24862, DOI 10.1074/jbc.M112.348128; Lee HJ, 2002, J BIOL CHEM, V277, P48976, DOI 10.1074/jbc.M208192200; Lee SJ, 2015, NATURE, V522, P296, DOI 10.1038/nature14526; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Levitan K, 2011, J MOL BIOL, V411, P329, DOI 10.1016/j.jmb.2011.05.046; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Lin S, 2016, P NATL ACAD SCI USA, V113, P2023, DOI 10.1073/pnas.1518442113; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Luk KC, 2016, CELL REP, V16, P3373, DOI 10.1016/j.celrep.2016.08.053; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Ma MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep37130; Masuda M, 2006, FEBS LETT, V580, P1775, DOI 10.1016/j.febslet.2006.02.032; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; McLean PJ, 2002, NEUROSCI LETT, V323, P219, DOI 10.1016/S0304-3940(02)00154-4; Meuvis J, 2010, BIOCHEMISTRY-US, V49, P9345, DOI 10.1021/bi1010927; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Michell AW, 2007, CELL TRANSPLANT, V16, P461, DOI 10.3727/000000007783464911; Muntane G, 2012, NEUROSCIENCE, V200, P106, DOI 10.1016/j.neuroscience.2011.10.042; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Nonaka T, 2005, BIOCHEMISTRY-US, V44, P361, DOI 10.1021/bi0485528; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Oikawa T, 2016, J BIOL CHEM, V291, P15046, DOI 10.1074/jbc.M116.736355; Oueslati Abid, 2014, Exp Neurobiol, V23, P324, DOI 10.5607/en.2014.23.4.324; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Peelaerts W, 2016, J NEUROCHEM, V139, P256, DOI 10.1111/jnc.13595; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Porcari R, 2015, J BIOL CHEM, V290, P2395, DOI 10.1074/jbc.M114.610527; Prasad K, 2012, BRAIN PATHOL, V22, P811, DOI 10.1111/j.1750-3639.2012.00597.x; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Qin Z, 2007, BIOCHEMISTRY-US, V46, P13322, DOI 10.1021/bi7014053; Rospigliosi CC, 2009, J MOL BIOL, V388, P1022, DOI 10.1016/j.jmb.2009.03.065; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sacino AN, 2017, J NEUROCHEM, V140, P662, DOI 10.1111/jnc.13743; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Sevlever D, 2008, BIOCHEMISTRY-US, V47, P9678, DOI 10.1021/bi800699v; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; Tsuji H, 2012, BRAIN, V135, P3380, DOI 10.1093/brain/aws230; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Ulrih NP, 2008, BBA-MOL BASIS DIS, V1782, P581, DOI 10.1016/j.bbadis.2008.07.004; Uversky Vladimir N, 2017, F1000Res, V6, P525, DOI 10.12688/f1000research.10536.1; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Xu L, 2017, ACS CHEM NEUROSCI, V8, P837, DOI 10.1021/acschemneuro.6b00406; Yonetani M, 2009, J BIOL CHEM, V284, P7940, DOI 10.1074/jbc.M807482200; Zhang ZT, 2017, NAT STRUCT MOL BIOL, V24, P632, DOI 10.1038/nsmb.3433; Zibaee S, 2007, J MOL BIOL, V374, P454, DOI 10.1016/j.jmb.2007.09.039	73	47	47	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13910	13920		10.1074/jbc.RA118.001862	http://dx.doi.org/10.1074/jbc.RA118.001862			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30030380	hybrid, Green Published			2022-12-28	WOS:000444070700017
J	Quinn, SM; Howsmon, DP; Hahn, J; Gilbert, SP				Quinn, Sean M.; Howsmon, Daniel P.; Hahn, Juergen; Gilbert, Susan P.			Kinesin-2 heterodimerization alters entry into a processive run along the microtubule but not stepping within the run	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						computational biology; intracellular trafficking; microtubule; neuron; mathematical modeling; ATPase; pre-steady-state kinetics; processivity; ciliogenesis; intraflagellar transport	LEFT-RIGHT ASYMMETRY; HAND-OVER-HAND; SUPERFAMILY PROTEIN; ORGANELLE TRANSPORT; NEURONAL POLARITY; ACCESSORY SUBUNIT; KIF3A SUBUNIT; COILED-COIL; MOTOR; MOUSE	Heterodimeric KIF3AC and KIF3AB, two members of the mammalian kinesin-2 family, generate force for microtubule plus end-directed cargo transport. However, the advantage of heterodimeric kinesins over homodimeric ones is not well-understood. We showed previously that microtubule association for entry into a processive run was similar in rate for KIF3AC and KIF3AB at approximate to 7.0 m(-1) s(-1). Yet, for engineered homodimers of KIF3AA and KIF3BB, this constant is significantly faster at 11 m(-1) s(-1) and much slower for KIF3CC at 2.1 m(-1) s(-1). These results led us to hypothesize that heterodimerization of KIF3A with KIF3C and KIF3A with KIF3B altered the intrinsic catalytic properties of each motor domain. Here, we tested this hypothesis by using presteady-state stopped-flow kinetics and mathematical modeling. Surprisingly, the modeling revealed that the catalytic properties of KIF3A and KIF3B/C were altered upon microtubule binding, yet each motor domain retained its relative intrinsic kinetics for ADP release and subsequent ATP binding and the nucleotide-promoted transitions thereafter. These results are consistent with the interpretation that for KIF3AB, each motor head is catalytically similar and therefore each step is approximately equivalent. In contrast, for KIF3AC the results predict that the processive steps will alternate between a fast step for KIF3A followed by a slow step for KIF3C resulting in asymmetric stepping during a processive run. This study reveals the impact of heterodimerization of the motor polypeptides for microtubule association to start the processive run and the fundamental differences in the motile properties of KIF3C compared with KIF3A and KIF3B.	[Quinn, Sean M.; Gilbert, Susan P.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol Sci, Troy, NY 12180 USA; [Howsmon, Daniel P.; Hahn, Juergen] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Hahn, Juergen] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biomed Engn, Troy, NY 12180 USA; [Howsmon, Daniel P.] Univ Texas Austin, 201 East 24th St,Stop C0200, Austin, TX 78712 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of Texas System; University of Texas Austin	Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol Sci, Troy, NY 12180 USA.; Hahn, J (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Biol Engn, Troy, NY 12180 USA.; Hahn, J (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biomed Engn, Troy, NY 12180 USA.	hahnj@rpi.edu; sgilbert@rpi.edu	Hahn, Juergen/H-8025-2019	Hahn, Juergen/0000-0002-1078-4203	NIGMS, National Institutes of Health [R01-AI110642, R37-GM054141]; Rensselaer Presidential Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054141] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Rensselaer Presidential Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grants R01-AI110642 (to J.H.) and R37-GM054141 (to S.P.G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Rensselaer Presidential Fellowship.	Albracht CD, 2016, J BIOL CHEM, V291, P23248, DOI 10.1074/jbc.M116.752196; Albracht CD, 2014, J BIOL CHEM, V289, P27836, DOI 10.1074/jbc.M114.583914; Andreasson JOL, 2015, CURR BIOL, V25, P1166, DOI 10.1016/j.cub.2015.03.013; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Bentley M, 2016, NAT REV NEUROSCI, V17, P611, DOI 10.1038/nrn.2016.100; Brunnbauer M, 2010, P NATL ACAD SCI USA, V107, P10460, DOI 10.1073/pnas.1005177107; Carpenter BS, 2015, J CELL SCI, V128, P1034, DOI 10.1242/jcs.162552; Chen GY, 2015, J BIOL CHEM, V290, P10274, DOI 10.1074/jbc.M114.628032; Chien A, 2017, ELIFE, V6, DOI 10.7554/eLife.28606; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; Doodhi H, 2009, BIOCHEMISTRY-US, V48, P2248, DOI 10.1021/bi8018338; Drummond IA, 2012, CURR OPIN CELL BIOL, V24, P24, DOI 10.1016/j.ceb.2011.12.007; Gaudin R, 2012, J CELL BIOL, V199, P467, DOI 10.1083/jcb.201201144; Gilbert SP, 2018, J BIOL CHEM, V293, P4510, DOI 10.1074/jbc.R117.001324; Gindhart JG, 1996, TRENDS CELL BIOL, V6, P415, DOI 10.1016/S0962-8924(96)20037-6; Gumy LF, 2013, J NEUROSCI, V33, P11329, DOI 10.1523/JNEUROSCI.5221-12.2013; Guzik-Lendrum S, 2017, BIOPHYS J, V113, P1845, DOI 10.1016/j.bpj.2017.09.015; Guzik-Lendrum S, 2015, BIOPHYS J, V109, P1472, DOI 10.1016/j.bpj.2015.08.004; Hirokawa N, 2012, CURR OPIN CELL BIOL, V24, P31, DOI 10.1016/j.ceb.2012.01.002; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hoeprich GJ, 2014, BIOPHYS J, V106, P1691, DOI 10.1016/j.bpj.2014.02.034; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Huang CF, 2012, TRAFFIC, V13, P549, DOI 10.1111/j.1600-0854.2011.01325.x; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ichinose S, 2015, NEURON, V87, P1022, DOI 10.1016/j.neuron.2015.08.008; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Krzysiak TC, 2008, J BIOL CHEM, V283, P2078, DOI 10.1074/jbc.M708354200; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lindhout DA, 2004, BIOPOLYMERS, V75, P367, DOI 10.1002/bip.20150; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Milic B, 2017, P NATL ACAD SCI USA, V114, pE6830, DOI 10.1073/pnas.1708157114; Muresan V, 1998, MOL BIOL CELL, V9, P637, DOI 10.1091/mbc.9.3.637; Nakagawa T, 1997, P NATL ACAD SCI USA, V94, P9654, DOI 10.1073/pnas.94.18.9654; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Park JH, 2018, CURR OPIN NEUROBIOL, V51, P95, DOI 10.1016/j.conb.2018.03.001; Rank KC, 2012, J CELL BIOL, V197, P957, DOI 10.1083/jcb.201201132; Ruane PT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27456; Sardella M, 1998, GENOMICS, V47, P405, DOI 10.1006/geno.1997.5123; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Schroeder HW, 2012, BIOPHYS J, V103, P48, DOI 10.1016/j.bpj.2012.05.037; Shimizu K, 1998, J BIOL CHEM, V273, P6591, DOI 10.1074/jbc.273.12.6591; Stepp WL, 2017, EMBO REP, V18, P1947, DOI 10.15252/embr.201744097; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tas RP, 2017, NEURON, V96, P1264, DOI 10.1016/j.neuron.2017.11.018; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Wedaman KP, 1996, J CELL BIOL, V132, P371, DOI 10.1083/jcb.132.3.371; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yang ZH, 1998, MOL BIOL CELL, V9, P249, DOI 10.1091/mbc.9.2.249; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Zhang PW, 2016, J BIOL CHEM, V291, P4407, DOI 10.1074/jbc.M115.705970; Zhao CT, 2012, P NATL ACAD SCI USA, V109, P2388, DOI 10.1073/pnas.1116035109	58	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13389	13400		10.1074/jbc.RA118.002767	http://dx.doi.org/10.1074/jbc.RA118.002767			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29991594	Green Published, hybrid			2022-12-28	WOS:000443375500004
J	Krammer, EM; Bouckaert, JMJ				Krammer, Eva-Maria; Bouckaert, Julie Maria Jozefa			Norovirus devours human milk oligosaccharides rich in alpha-fucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							BLOOD GROUP ANTIGENS	Human norovirus binding to histo-blood group antigens (HBGAs) is thought to direct their entry into host cells. However, the glycan epitopes characteristic of HBGAs are also present on oligosaccharides abundant in human milk. In this issue of JBC, Hanisch et al. compared norovirus binding to human gastric mucins and human milk oligosaccharides, finding those bound most avidly are rich in alpha-fucose. Mimicry of these epitopes with alpha-fucose multivalently displayed on other carbohydrate scaffolds successfully scavenged this prevalent virus, providing new insights into norovirus biology and clues for future therapeutic development.	[Bouckaert, Julie Maria Jozefa] CNRS, UMR8576, UGSF, 50 Ave Halley, F-59658 Villeneuve Dascq, France; UdeLille, 50 Ave Halley, F-59658 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Bouckaert, JMJ (corresponding author), CNRS, UMR8576, UGSF, 50 Ave Halley, F-59658 Villeneuve Dascq, France.	julie.bouckaert@univ-lille.fr	; Krammer, Eva-Maria/H-2543-2013	Bouckaert, Julie/0000-0001-8112-1442; Krammer, Eva-Maria/0000-0002-4821-2550	H2020-MSC [750280]; CNRS, HiCare Grant from Agence Nationale de la Recherche (ANR) [ANR-17-CE07-0028-03]; ITN GlycoVax Grant from H2020-MSC [675671]	H2020-MSC; CNRS, HiCare Grant from Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); ITN GlycoVax Grant from H2020-MSC	Recipient of H2020-MSC funding under Grant 750280.; Recipient of funding from CNRS, HiCare Grant ANR-17-CE07-0028-03 from Agence Nationale de la Recherche (ANR), and ITN GlycoVax Grant 675671 from H2020-MSC.	Bode L, 2015, EARLY HUM DEV, V91, P619, DOI 10.1016/j.earlhumdev.2015.09.001; Hanisch FG, 2018, J BIOL CHEM, V293, P11955, DOI 10.1074/jbc.RA117.001369; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Liu YH, 1998, J HISTOCHEM CYTOCHEM, V46, P69, DOI 10.1177/002215549804600109; Lonardi Emanuela, 2013, Biology (Basel), V2, P894, DOI 10.3390/biology2030894; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Rademacher C, 2011, CHEM-EUR J, V17, P7442, DOI 10.1002/chem.201003432; Schroten H, 2016, J VIROL, V90, P5855, DOI 10.1128/JVI.00317-16	8	3	3	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11966	11967		10.1074/jbc.H118.004336	http://dx.doi.org/10.1074/jbc.H118.004336			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	30054292	Green Published, hybrid			2022-12-28	WOS:000440134500027
J	Kim, S; Lee, KS; Choi, S; Kim, J; Lee, DK; Park, M; Park, W; Kim, TH; Hwang, JY; Won, MH; Lee, H; Ryoo, S; Ha, KS; Kwon, YG; Kim, YM				Kim, Suji; Lee, Kyu-Sun; Choi, Seunghwan; Kim, Joohwan; Lee, Dong-Keon; Park, Minsik; Park, Wonjin; Kim, Tae-Hoon; Hwang, Jong Yun; Won, Moo-Ho; Lee, Hansoo; Ryoo, Sungwoo; Ha, Kwon-Soo; Kwon, Young-Guen; Kim, Young-Myeong			NF-kappa B-responsive miRNA-31-5p elicits endothelial dysfunction associated with preeclampsia via down-regulation of endothelial nitric-oxide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; TNF-ALPHA; HYPERTENSION; EXPRESSION; EXOSOMES; CELLS; WOMEN; MICRORNA-335; PREGNANCY; PROTEINS	Inflammatory cytokines, including tumor necrosis factor-alpha (TNF alpha), were elevated in patients with cardiovascular diseases and are also considered as crucial factors in the pathogenesis of preeclampsia; however, the underlying pathogenic mechanism has not been clearly elucidated. This study provides novel evidence that TNF alpha leads to endothelial dysfunction associated with hypertension and vascular remodeling in preeclampsia through down-regulation of endothelial nitric-oxide synthase (eNOS) by NF-kappa B-dependent biogenesis of microRNA (miR)-31-5p, which targets eNOS mRNA. In this study, we found that miR-31-5p was up-regulated in sera from patients with preeclampsia and in human endothelial cells treated with TNF alpha. TNF alpha-mediated induction of miR-31-5p was blocked by an NF-kappa B inhibitor and NF-kappa B p65 knockdown but not by mitogen- activated protein kinase (MAPK) and phosphatidylinositol 3-kinase inhibitors, indicating that NF-kappa B is essential for biogenesis of miR-31-5p. The treatment of human endothelial cells with TNF alpha or miR-31-5p mimics decreased endothelial nitricoxide synthase (eNOS) mRNA stability without affecting eNOS promoter activity, resulting in inhibition of eNOS expression and NO/cGMP production through blocking of the functional activity of the eNOSmRNA3'-UTR. Moreover, TNF alpha and miR-31-5p mimic evoked endothelial dysfunction associated with defects in angiogenesis, trophoblastic invasion, and vasorelaxation in an ex vivo cultured model of human placental arterial vessels, which are typical features of preeclampsia. These results suggest that NF-kappa B-responsive miR-31-5p elicits endothelial dysfunction, hypertension, and vascular remodeling via post-transcriptional down-regulation ofeNOSand is a molecular risk factor in the pathogenesis and development of preeclampsia.	[Kim, Suji; Lee, Kyu-Sun; Choi, Seunghwan; Kim, Joohwan; Lee, Dong-Keon; Park, Minsik; Park, Wonjin; Kim, Tae-Hoon; Ha, Kwon-Soo; Kim, Young-Myeong] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon 24341, Gangwon Do, South Korea; [Hwang, Jong Yun] Kangwon Natl Univ, Sch Med, Dept Obstet & Gynecol, Chunchon 24341, Gangwon Do, South Korea; [Won, Moo-Ho] Kangwon Natl Univ, Sch Med, Dept Neurobiol, Chunchon 24341, Gangwon Do, South Korea; [Lee, Hansoo; Ryoo, Sungwoo] Kangwon Natl Univ, Coll Nat Sci, Dept Biol, Chunchon 24341, Gangwon Do, South Korea; [Kwon, Young-Guen] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University; Yonsei University	Kim, YM (corresponding author), Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon 24341, Gangwon Do, South Korea.	ymkim@kangwon.ac.kr	Ha, Kwon-Soo/AAU-4417-2020	Ha, Kwon-Soo/0000-0002-4219-1787	National Research Foundation of Korea (NRF) [2016M3A9B6903103]; Korea Government (MSIP)	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea Government (MSIP)	This work was supported by National Research Foundation of Korea (NRF) Grant 2016M3A9B6903103 funded by the Korea Government (MSIP). The authors declare that they have no conflicts of interest with the contents of this article.	Alexander BT, 2002, AM J HYPERTENS, V15, P170, DOI 10.1016/S0895-7061(01)02255-5; BAYLIS C, 1992, J CLIN INVEST, V90, P278, DOI 10.1172/JCI115849; Cartwright JE, 2005, EXP CELL RES, V304, P328, DOI 10.1016/j.yexcr.2004.11.013; Choi S, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.193; Conrad KP, 1998, AM J REPROD IMMUNOL, V40, P102; Cuhlmann S, 2011, CIRC RES, V108, P950, DOI 10.1161/CIRCRESAHA.110.233841; de Jager SCA, 2017, EUR J PHARMACOL, V816, P129, DOI 10.1016/j.ejphar.2017.09.012; Diejomaoh MFE, 2003, GYNECOL OBSTET INVES, V56, P197, DOI 10.1159/000074452; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; Fichtlscherer S, 2001, CIRCULATION, V104, P3023, DOI 10.1161/hc5001.101749; Fu QZ, 2015, INT J MOL MED, V36, P1417, DOI 10.3892/ijmm.2015.2355; Gangwar RS, 2018, AM J HYPERTENS, V31, P150, DOI 10.1093/ajh/hpx197; Henderson JT, 2014, ANN INTERN MED, V161, P613, DOI [10.7326/L14-5020-4, 10.7326/L14-5020-5]; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Jiang F, 2015, MOL MED REP, V12, P5383, DOI 10.3892/mmr.2015.4018; Kim J, 2017, FREE RADICAL BIO MED, V104, P185, DOI 10.1016/j.freeradbiomed.2017.01.010; Laresgoiti-Servitje E, 2013, J LEUKOCYTE BIOL, V94, P247, DOI 10.1189/jlb.1112603; Lee KS, 2014, BIOCHEM BIOPH RES CO, V448, P101, DOI 10.1016/j.bbrc.2014.04.079; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li F, 2012, J AM SOC NEPHROL, V23, P652, DOI 10.1681/ASN.2011040369; Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P132, DOI 10.1016/S1089-8603(02)00127-1; Li Y, 2016, REPROD SCI, V23, P1402, DOI 10.1177/1933719116641760; Liu XJ, 2011, J BIOL CHEM, V286, P42371, DOI 10.1074/jbc.M111.261065; Luppi P, 2006, AM J REPROD IMMUNOL, V56, P135, DOI 10.1111/j.1600-0897.2006.00386.x; Marin V, 2001, J IMMUNOL METHODS, V254, P183, DOI 10.1016/S0022-1759(01)00408-2; Martinez EC, 2017, J MOL CELL CARDIOL, V112, P27, DOI 10.1016/j.yjmcc.2017.08.013; Moore MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9864; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; Pankratz F, 2018, CIRC RES, V122, P417, DOI 10.1161/CIRCRESAHA.117.311428; Peracoli JC, 2007, AM J REPROD IMMUNOL, V57, P177, DOI 10.1111/j.1600-0897.2006.00455.x; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Salomon C, 2017, J CLIN ENDOCR METAB, V102, P3182, DOI 10.1210/jc.2017-00672; Sarker S, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-204; Shaamash AH, 2000, INT J GYNECOL OBSTET, V68, P207, DOI 10.1016/S0020-7292(99)00213-1; Shah TJ, 2007, AM J OBSTET GYNECOL, V196, P48, DOI 10.1016/j.ajog.2006.08.038; Sladek SM, 1997, AM J PHYSIOL-REG I, V272, pR441, DOI 10.1152/ajpregu.1997.272.2.R441; Sunderland NS, 2011, CYTOKINE, V56, P192, DOI 10.1016/j.cyto.2011.06.003; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tian FJ, 2014, CARDIOVASC RES, V103, P100, DOI 10.1093/cvr/cvu070; Vargas A, 2014, FASEB J, V28, P3703, DOI 10.1096/fj.13-239053; Vaughan JE, 2012, HYPERTENS PREGNANCY, V31, P243, DOI 10.3109/10641955.2011.642436; Walford G, 2003, J THROMB HAEMOST, V1, P2112, DOI 10.1046/j.1538-7836.2003.00345.x; Yan S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8652; Yentrapalli R, 2017, INT J RADIAT BIOL, V93, P569, DOI 10.1080/09553002.2017.1294772; Zhai DS, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.03.022	45	54	58	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18989	19000		10.1074/jbc.RA118.005197	http://dx.doi.org/10.1074/jbc.RA118.005197			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30279269	Green Published, hybrid			2022-12-28	WOS:000458467400014
J	Masai, H; Kakusho, N; Fukatsu, R; Ma, Y; Iida, K; Kanoh, Y; Nagasawa, K				Masai, Hisao; Kakusho, Naoko; Fukatsu, Rino; Ma, Yue; Iida, Keisuke; Kanoh, Yutaka; Nagasawa, Kazuo			Molecular architecture of G-quadruplex structures generated on duplex Rif1-binding sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA replication; nucleic acid; nucleic acid structure; chromosomes; G-quadruplex; DNase I; non-B DNA; nuclease footprinting; Rif1; S1 nuclease	DNA G-QUADRUPLEX; REPLICATION-TIMING PROGRAM; DOUBLE-STRANDED DNA; HUMAN GENOME; I-MOTIF; GLOBAL REGULATOR; REPEAT SEQUENCES; PROMOTER REGION; FISSION YEAST; RIF1	G-quadruplexes (G4s) are four-stranded DNA structures comprising stacks of four guanines, are prevalent in genomes, and have diverse biological functions in various chromosomal structures. A conserved protein, Rap1-interacting factor 1 (Rif1) from fission yeast (Schizosaccharomyces pombe), binds to Rif1-binding sequence (Rif1BS) and regulates DNA replication timing. Rif1BS is characterized by the presence of multiple G-tracts, often on both strands, and their unusual spacing. Although previous studies have suggested generation of G4-like structures on duplex Rif1BS, its precise molecular architecture remains unknown. Using gel-shift DNA binding assays and DNA footprinting with various nuclease probes, we show here that both of the Rif1BS strands adopt specific higher-order structures upon heat denaturation. We observed that the structure generated on the G-strand is consistent with a G4 having unusually long loop segments and that the structure on the complementary C-strand does not have an intercalated motif (i-motif). Instead, we found that the formation of the C-strand structure depends on the G4 formation on the G-strand. Thus, the higher-order structure generated at Rif1BS involved both DNA strands, and in some cases, G4s may form on both of these strands. The presence of multiple G-tracts permitted the formation of alternative structures when some G-tracts were mutated or disrupted by deazaguanine replacement, indicating the robust nature of DNA higher-order structures generated at Rif1BS. Our results provide general insights into DNA structures generated at G4-forming sequences on duplex DNA.	[Masai, Hisao; Kakusho, Naoko; Fukatsu, Rino; Kanoh, Yutaka] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Setagaya Ku, Tokyo 1568506, Japan; [Ma, Yue; Nagasawa, Kazuo] Tokyo Univ Agr & Technol, Fac Technol, Dept Biotechnol & Life Sci, Tokyo 1848588, Japan; [Iida, Keisuke] Chiba Univ, Grad Sch Sci, Dept Chem, Mol Chiral Res Ctr,Synthet Organ Chem, Chiba 2638522, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo University of Agriculture & Technology; Chiba University	Masai, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Setagaya Ku, Tokyo 1568506, Japan.	masai-hs@igakuken.or.jp	Nagasawa, Kazuo/B-9959-2013	Nagasawa, Kazuo/0000-0002-0437-948X; Masai, Hisao/0000-0003-1268-5302	JSPS KAKENHI [23247031, 26251004, 24114520, 25125724]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (Grants-in-Aid for Scientific Research (A) 23247031 and 26251004 and Grants-in-Aid for Scientific Research on Priority Areas "non-coding RNA" and "Genome Adaptation" 24114520 and 25125724, respectively (to H.M.). The authors declare that they have no conflicts of interest with the contents of this article.	AHMED S, 1994, NAT STRUCT BIOL, V1, P83, DOI 10.1038/nsb0294-83; Besnard E, 2012, NAT STRUCT MOL BIOL, V19, P837, DOI 10.1038/nsmb.2339; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cahoon LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003074; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; Carle CM, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005842; Cayrou C, 2011, GENOME RES, V21, P1438, DOI 10.1101/gr.121830.111; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Chen MC, 2018, NATURE, V558, P465, DOI 10.1038/s41586-018-0209-9; Clynes D, 2013, CURR OPIN GENET DEV, V23, P289, DOI 10.1016/j.gde.2013.01.005; Collie GW, 2011, CHEM SOC REV, V40, P5867, DOI 10.1039/c1cs15067g; Cornacchia D, 2012, EMBO J, V31, P3678, DOI 10.1038/emboj.2012.214; Day HA, 2014, BIOORGAN MED CHEM, V22, P4407, DOI 10.1016/j.bmc.2014.05.047; Dhakal S, 2012, BIOPHYS J, V102, P2575, DOI 10.1016/j.bpj.2012.04.024; Foti R, 2016, MOL CELL, V61, P260, DOI 10.1016/j.molcel.2015.12.001; Hansel-Hertsch R, 2017, NAT REV MOL CELL BIO, V18, P279, DOI 10.1038/nrm.2017.3; Hansel-Hertsch R, 2016, NAT GENET, V48, P1267, DOI 10.1038/ng.3662; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Hayano M, 2012, GENE DEV, V26, P137, DOI 10.1101/gad.178491.111; Heddi B, 2015, P NATL ACAD SCI USA, V112, P9608, DOI 10.1073/pnas.1422605112; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Kaiser CE, 2017, J AM CHEM SOC, V139, P8522, DOI 10.1021/jacs.7b02046; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Kanoh Y, 2015, NAT STRUCT MOL BIOL, V22, P889, DOI 10.1038/nsmb.3102; Kruisselbrink E, 2008, CURR BIOL, V18, P900, DOI 10.1016/j.cub.2008.05.013; LEROY JL, 1994, NUCLEIC ACIDS RES, V22, P1600, DOI 10.1093/nar/22.9.1600; Maizels N, 2015, EMBO REP, V16, P910, DOI 10.15252/embr.201540607; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; MANZINI G, 1994, NUCLEIC ACIDS RES, V22, P4634, DOI 10.1093/nar/22.22.4634; Miyoshi D, 2002, BIOCHEMISTRY-US, V41, P15017, DOI 10.1021/bi020412f; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Peace JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098501; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Sabouri N, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0101-5; Sahakyan AB, 2017, NAT STRUCT MOL BIOL, V24, P243, DOI 10.1038/nsmb.3367; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; Tarsounas M, 2013, J MOL BIOL, V425, P4782, DOI 10.1016/j.jmb.2013.09.026; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Uno S, 2012, METHODS, V57, P214, DOI 10.1016/j.ymeth.2012.06.016; Yamazaki S, 2013, TRENDS GENET, V29, P449, DOI 10.1016/j.tig.2013.05.001; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180; YU A, 1995, NUCLEIC ACIDS RES, V23, P4055, DOI 10.1093/nar/23.20.4055; Zeraati M, 2018, NAT CHEM, V10, P631, DOI 10.1038/s41557-018-0046-3; Zheng KW, 2010, NUCLEIC ACIDS RES, V38, P327, DOI 10.1093/nar/gkp898	50	10	10	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17033	17049		10.1074/jbc.RA118.005240	http://dx.doi.org/10.1074/jbc.RA118.005240			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30217821	Green Published, hybrid			2022-12-28	WOS:000449466500007
J	Wagstaff, BA; Rejzek, M; Field, RA				Wagstaff, Ben A.; Rejzek, Martin; Field, Robert A.			Identification of a Kdn biosynthesis pathway in the haptophyte Prymnesium parvum suggests widespread sialic acid biosynthesis among microalgae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						algae; sialic acid; carbohydrate biosynthesis; bioinformatics; carbohydrate processing; enzyme; glycobiology; KDN; Prymnesium parvum	IONIZATION-MASS-SPECTROMETRY; DEAMINATED NEURAMINIC ACID; JELLY COAT; 2-KETO-3-DEOXY-D-GLYCERO-D-GALACTO-NONONIC ACID; EMILIANIA-HUXLEYI; VIRUS; NUCLEOTIDE; CHAINS; SUGARS; POLYSIALOGLYCOPROTEIN	Sialic acids are a family of more than 50 structurally distinct acidic sugars on the surface of all vertebrate cells where they terminate glycan chains and are exposed to many interactions with the surrounding environment. In particular, sialic acids play important roles in cell-cell and host-pathogen interactions. The sialic acids or related nonulosonic acids have been observed in Deuterostome lineages, Eubacteria, and Archaea but are notably absent from plants. However, the structurally related C8 acidic sugar 3-deoxy-d-manno-2-octulosonic acid (Kdo) is present in Gram-negative bacteria and plants as a component of bacterial lipopolysaccharide and pectic rhamnogalacturonan II in the plant cell wall. Until recently, sialic acids were not thought to occur in algae, but as in plants, Kdo has been observed in algae. Here, we report the de novo biosynthesis of the deaminated sialic acid, 3-deoxy-d-glycero-d-galacto-2-nonulosonic acid (Kdn), in the toxin-producing microalga Prymnesium parvum. Using biochemical methods, we show that this alga contains CMP-Kdn and identified and recombinantly expressed the P. parvum genes encoding Kdn-9-P synthetase and CMP-Kdn synthetase enzymes that convert mannose-6-P to CMP-Kdn. Bioinformatics analysis revealed sequences related to those of the two P. parvum enzymes, suggesting that sialic acid biosynthesis is likely more widespread among microalgae than previously thought and that this acidic sugar may play a role in host-pathogen interactions involving microalgae. Our findings provide evidence that P. parvum has the biosynthetic machinery for de novo production of the deaminated sialic acid Kdn and that sialic acid biosynthesis may be common among microalgae.	[Wagstaff, Ben A.; Rejzek, Martin; Field, Robert A.] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Field, RA (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	rob.field@jic.ac.uk		Field, Rob/0000-0001-8574-0275; Rejzek, Martin/0000-0002-5091-544X	Research Councils UK [BB/j004561/1]; Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC Industrial CASE Ph. D. studentship - Environment Agency; BBSRC [BBS/E/J/000C0618] Funding Source: UKRI	Research Councils UK(UK Research & Innovation (UKRI)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Industrial CASE Ph. D. studentship - Environment Agency(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grant BB/j004561/1 from the Research Councils UK and the Biotechnology and Biological Sciences Research Council (BBSRC) and by a BBSRC Industrial CASE Ph. D. studentship supported by the Environment Agency. The authors declare that they have no conflicts of interest with the contents of this article.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; BECKER D, 1990, PROTOPLASMA, V156, P103, DOI 10.1007/BF01666511; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Blix G, 1936, H-S Z PHYSIOL CHEM, V240, P43, DOI 10.1515/bchm2.1936.240.1-2.43; Crocker PR, 2001, TRENDS IMMUNOL, V22, P337, DOI 10.1016/S1471-4906(01)01930-5; Daughtry KD, 2013, BIOCHEMISTRY-US, V52, P5372, DOI 10.1021/bi400659k; Edvardsen B., 1998, NATO ASI SERIES G, V41, P192; Fulton JM, 2014, ENVIRON MICROBIOL, V16, P1137, DOI 10.1111/1462-2920.12358; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Graneli E, 2012, HARMFUL ALGAE, V14, P260, DOI 10.1016/j.hal.2011.10.024; Guo MX, 1996, J APPL PHYCOL, V8, P111, DOI 10.1007/BF02186313; Hao J, 2006, BIOCHEM J, V397, P195, DOI 10.1042/BJ20052034; Hao JJ, 2005, BIOCHEM BIOPH RES CO, V338, P1507, DOI 10.1016/j.bbrc.2005.10.113; HARA S, 1988, ANAL CHIM ACTA, V215, P267, DOI 10.1016/S0003-2670(00)85285-X; Hems ES, 2018, CARBOHYD RES, V463, P14, DOI 10.1016/j.carres.2018.04.008; Inoue S, 1996, J BIOL CHEM, V271, P24341, DOI 10.1074/jbc.271.40.24341; Inoue S, 1998, J BIOL CHEM, V273, P27199, DOI 10.1074/jbc.273.42.27199; IWASAKI M, 1990, J BIOL CHEM, V265, P2596; Janouskovec J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059001; KAARTVEDT S, 1991, CAN J FISH AQUAT SCI, V48, P2316, DOI 10.1139/f91-272; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keeling PJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001889; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Kenyon JJ, 2015, GLYCOBIOLOGY, V25, P644, DOI 10.1093/glycob/cwv007; KIMURA M, 1994, J BIOL CHEM, V269, P32138; Klein A, 1997, GLYCOBIOLOGY, V7, P421, DOI 10.1093/glycob/7.3.421; KNIREL YA, 1989, CARBOHYD RES, V188, P145, DOI 10.1016/0008-6215(89)84067-4; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; La Scola B, 2003, SCIENCE, V299, P2033; Leblanc K, 2009, BIOGEOSCIENCES, V6, P2155, DOI 10.5194/bg-6-2155-2009; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; NADANO D, 1986, J BIOL CHEM, V261, P1550; Pabst M, 2010, ANAL CHEM, V82, P9782, DOI 10.1021/ac101975k; PLANCKE Y, 1995, EUR J BIOCHEM, V231, P434, DOI 10.1111/j.1432-1033.1995.tb20716.x; Rabina J, 2001, GLYCOCONJUGATE J, V18, P799, DOI 10.1023/A:1021107602535; Radaev S, 2000, J BIOL CHEM, V275, P9476, DOI 10.1074/jbc.275.13.9476; Rejzek M, 2017, METHOD ENZYMOL, V597, P209, DOI 10.1016/bs.mie.2017.06.005; Roelke DL, 2016, HYDROBIOLOGIA, V764, P29, DOI 10.1007/s10750-015-2273-6; Rose SL, 2014, ENVIRON MICROBIOL, V16, P1150, DOI 10.1111/1462-2920.12357; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schatz D, 2014, NEW PHYTOL, V204, P854, DOI 10.1111/nph.13008; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Schoemann V, 2005, J SEA RES, V53, P43, DOI 10.1016/j.seares.2004.01.008; Shashkov AS, 2002, CARBOHYD RES, V337, P2255, DOI 10.1016/S0008-6215(02)00188-X; Short SM, 2012, ENVIRON MICROBIOL, V14, P2253, DOI 10.1111/j.1462-2920.2012.02706.x; Southard GM, 2010, J AM WATER RESOUR AS, V46, P14, DOI 10.1111/j.1752-1688.2009.00387.x; Stencel-Baerenwald JE, 2014, NAT REV MICROBIOL, V12, P739, DOI 10.1038/nrmicro3346; STRECKER G, 1992, EUR J BIOCHEM, V207, P995, DOI 10.1111/j.1432-1033.1992.tb17135.x; STRECKER G, 1992, FEBS LETT, V298, P39, DOI 10.1016/0014-5793(92)80018-C; Sundaram AK, 2004, BIOCHEM J, V383, P83, DOI 10.1042/BJ20040218; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; TERADA T, 1993, J BIOL CHEM, V268, P2640; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; Varki A, 2017, ESSENTIALS GLYCOBIOL, V2015-2017; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Wagstaff B. A., 2017, VIRUSES, V9, pE40; Wagstaff BA, 2018, BIOCHEM SOC T, V46, P413, DOI [10.1042/BST20170393, 10.1042/bst20170393]; Wagstaff BA, 2015, CARBOHYD RES, V404, P17, DOI 10.1016/j.carres.2014.12.005; Wang LB, 2008, CHEM BIOL, V15, P893, DOI 10.1016/j.chembiol.2008.08.005; Wilhelm SW, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005752; Wilson WH, 2002, J MAR BIOL ASSOC UK, V82, P369, DOI 10.1017/S002531540200560X; YARIV J, 1961, J GEN MICROBIOL, V24, P165, DOI 10.1099/00221287-24-2-165	65	8	8	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16277	16290		10.1074/jbc.RA118.004921	http://dx.doi.org/10.1074/jbc.RA118.004921			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30171074	Green Published, hybrid			2022-12-28	WOS:000447833600014
J	Zuo, YA; Wang, PF; Sun, JF; Guo, SC; Wang, GQ; Zuo, T; Fan, SL; Zhou, P; Liang, MF; Shi, XL; Wang, XQ; Zhang, LQ				Zuo, Yanan; Wang, Pengfei; Sun, Jianfeng; Guo, Shichun; Wang, Guiqin; Zuo, Teng; Fan, Shilong; Zhou, Paul; Liang, Mifang; Shi, Xuanling; Wang, Xinquan; Zhang, Linqi			Complementary recognition of the receptor-binding site of highly pathogenic H5N1 influenza viruses by two human neutralizing antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						influenza; influenza virus; monoclonal antibody; structural biology; X-ray crystallography; vaccine development; virology; mutagenesis; infectious disease; antigenic variation; escape mutants; H5N1; HPAI; neutralizing antibodies; receptor-binding site; antiviral vaccine	HEMAGGLUTININ MEMBRANE GLYCOPROTEIN; A VIRUSES; PROCESSING ENDOPROTEASES; AIRBORNE TRANSMISSION; MONOCLONAL-ANTIBODY; ANTIGENIC STRUCTURE; UNIVERSAL VACCINE; ESCAPE MUTANTS; HONG-KONG; INFECTION	The highly pathogenic avian influenza virus H5N1 is a major threat to global public health and therefore a high-priority target of current vaccine development. The receptor-binding site (RBS) on the globular head of hemagglutinin (HA) in the viral envelope is one of the major target sites for antibody recognition against H5N1 and other influenza viruses. Here, we report the identification and characterization of a pair of human RBS-specific antibodies, designated FLD21.140 and AVFluIgG03, that are mutually complementary in their neutralizing activities against a diverse panel of H5N1 viruses. Crystallographic analysis and site-directed mutagenesis revealed that the two antibodies share a similar RBS-binding mode, and their individual specificities are governed by residues at positions 133a, 144, and 145. Specifically, FLD21.140 preferred Leu-133a/Lys-144/Ser-145, whereas AVFluIgG03 favored Ser-133a/Thr-144/Pro-145 residue triplets, both of which perfectly matched the most prevalent residues in viruses from epidemic-originating regions. Of note, according to an analysis of 3758 H5 HA sequences available in the Influenza Virus Database at the National Center for Biotechnology Information, the residues Leu-133a/Ser-133a and Ser-145/Pro-145 constituted more than 87.6 and 99.3% of all residues at these two positions, respectively. Taken together, our results provide a structural understanding for the neutralizing complementarity of these two antibodies and improve our understanding of the RBS-specific antibody response against H5N1 infection in humans.	[Zuo, Yanan; Zuo, Teng; Shi, Xuanling; Zhang, Linqi] Tsinghua Univ, Comprehens AIDS Res Ctr, Collaborat Innovat Ctr Diag & Treatment Infect Di, Dept Basic Med Sci,Sch Med, Beijing 100084, Peoples R China; [Wang, Pengfei; Sun, Jianfeng; Fan, Shilong; Wang, Xinquan] Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci,Key Lab Prot Sci,Minist Educ, Beijing 100084, Peoples R China; [Guo, Shichun] Tsinghua Univ, Dept Comp Sci, Beijing 100084, Peoples R China; [Liang, Mifang] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing 100084, Peoples R China; [Wang, Guiqin; Zhou, Paul] Chinese Acad Sci, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai 200031, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University; Tsinghua University; Tsinghua University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Zhang, LQ (corresponding author), Tsinghua Univ, Comprehens AIDS Res Ctr, Collaborat Innovat Ctr Diag & Treatment Infect Di, Dept Basic Med Sci,Sch Med, Beijing 100084, Peoples R China.; Wang, XQ (corresponding author), Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci,Key Lab Prot Sci,Minist Educ, Beijing 100084, Peoples R China.	xinquanwang@mail.tsinghua.edu.cn; zhanglinqi@tsinghua.edu.cn	ZHANG, LIN/GYD-9123-2022	Fan, Shilong/0000-0001-9272-2438	National Natural Science Foundation of China [81530065, 81661128042, 31470751, U1405228]; Ministry of Science and Technology of the People's Republic of China [2016YFD0500307, 2012ZX10001-004, 2012ZX10001-006, 2012ZX10001-009, 2017ZX10201-101, 2014CB542500-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China Grants 81530065, 81661128042, 31470751, and U1405228 and by Ministry of Science and Technology of the People's Republic of China Grants 2016YFD0500307, 2012ZX10001-004, 2012ZX10001-006, 2012ZX10001-009, 2017ZX10201-101, and 2014CB542500-03. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chiu C, 2015, CURR TOP MICROBIOL, V386, P381, DOI 10.1007/82_2014_425; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira HL, 2010, AVIAN DIS, V54, P565, DOI 10.1637/8750-033009-ResNote.1; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Gronsang D, 2017, ARCH VIROL, V162, P2257, DOI 10.1007/s00705-017-3350-0; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; He F., 2013, INFLUENZA RES TREAT, V2013, P1; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hong MS, 2013, J VIROL, V87, P12471, DOI 10.1128/JVI.01388-13; HORIMOTO T, 1994, J VIROL, V68, P6074, DOI 10.1128/JVI.68.9.6074-6078.1994; Hu HX, 2012, J VIROL, V86, P2978, DOI 10.1128/JVI.06665-11; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Itoh Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004192; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4614; Lee PS, 2012, P NATL ACAD SCI USA, V109, P17040, DOI 10.1073/pnas.1212371109; Li CKF, 2013, CURR OPIN IMMUNOL, V25, P470, DOI 10.1016/j.coi.2013.07.005; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ohkura T, 2012, BIOCHEM BIOPH RES CO, V418, P38, DOI 10.1016/j.bbrc.2011.12.108; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perdue ML, 1997, VIRUS RES, V49, P173, DOI 10.1016/S0168-1702(97)01468-8; PHILPOTT M, 1990, J VIROL, V64, P2941, DOI 10.1128/JVI.64.6.2941-2947.1990; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Prabakaran M, 2010, J VIROL, V84, P11822, DOI 10.1128/JVI.00891-10; Prabhu N, 2009, ANTIVIR THER, V14, P911, DOI 10.3851/IMP1413; Qian MR, 2013, J VIROL, V87, P3571, DOI 10.1128/JVI.01292-12; Rudneva IA, 2010, VIRAL IMMUNOL, V23, P181, DOI 10.1089/vim.2009.0086; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Schmidt AG, 2015, CELL, V161, P1026, DOI 10.1016/j.cell.2015.04.028; Simmons CP, 2007, FUTURE VIROL, V2, P325, DOI 10.1371/journal.pmed.0040178; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; STEINER DF, 1992, J BIOL CHEM, V267, P23435; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Tan YR, 2015, J VIROL, V89, P3712, DOI 10.1128/JVI.03014-14; Tharakaraman K, 2013, CELL, V153, P1475, DOI 10.1016/j.cell.2013.05.035; Tian HY, 2015, P NATL ACAD SCI USA, V112, P172, DOI 10.1073/pnas.1405216112; To KKW, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.24; Tsibane T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003067; Velkov T, 2013, MOL IMMUNOL, V56, P705, DOI 10.1016/j.molimm.2013.07.010; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; Webster RG, 2007, AVIAN DIS, V51, P269, DOI 10.1637/7641-050206R.1; Webster RG, 2005, ARCH VIROL, P117; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Winarski KL, 2015, P NATL ACAD SCI USA, V112, P9346, DOI 10.1073/pnas.1502762112; Wu RP, 2014, ANTIVIR RES, V106, P13, DOI 10.1016/j.antiviral.2014.03.005; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Xu R, 2013, NAT STRUCT MOL BIOL, V20, P363, DOI 10.1038/nsmb.2500; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Zuo T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9855	70	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16503	16517		10.1074/jbc.RA118.004604	http://dx.doi.org/10.1074/jbc.RA118.004604			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30154240	Green Published, hybrid			2022-12-28	WOS:000447833600031
J	Grinberg, IR; Lundin, D; Sahlin, M; Crona, M; Berggren, G; Hofer, A; Sjoberg, BM				Grinberg, Inna Rozman; Lundin, Daniel; Sahlin, Margareta; Crona, Mikael; Berggren, Gustav; Hofer, Anders; Sjoberg, Britt-Marie			A glutaredoxin domain fused to the radical-generating subunit of ribonucleotide reductase (RNR) functions as an efficient RNR reductant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribonucleotide reductase; allosteric regulation; oxidation-reduction (redox); radical; manganese; ATP-cone; dATP inhibition; dithiol-monothiol; glutaredoxin; tetramers	ESCHERICHIA-COLI; INTERESTING ENZYME; THIOREDOXIN; COFACTOR; PROTEIN; WORLD; GLUTATHIONE; MECHANISM; SYSTEMS; THIOL	Class I ribonucleotide reductase (RNR) consists of a catalytic subunit (NrdA) and a radical-generating subunit (NrdB) that together catalyze reduction of ribonucleotides to their corresponding deoxyribonucleotides. NrdB from the firmicute Facklamia ignava is a unique fusion protein with N-terminal addons of a glutaredoxin (Grx) domain followed by an ATP-binding domain, the ATP cone. Grx, usually encoded separately from the RNR operon, is a known RNR reductant. We show that the fused Grx domain functions as an efficient reductant of the F. ignava class I RNR via the common dithiol mechanism and, interestingly, also via a monothiol mechanism, although less efficiently. To our knowledge, a Grx that uses both of these two reaction mechanisms has not previously been observed with a native substrate. The ATP cone is in most RNRs an N-terminal domain of the catalytic subunit. It is an allosteric on/off switch promoting ribonucleotide reduction in the presence of ATP and inhibiting RNR activity in the presence of dATP. We found that dATP bound to the ATP cone of F. ignava NrdB promotes formation of tetramers that cannot form active complexes with NrdA. The ATP cone bound two dATP molecules but only one ATP molecule. F. ignava NrdB contains the recently identified radical-generating cofactor Mn-III/Mn-IV. We show that NrdA from F. ignava can form a catalytically competent RNR with the Mn-III/Mn-IV-containing NrdB from the flavobacterium Leeuwenhoekiella blandensis. In conclusion, F. ignava NrdB is fused with a Grx functioning as an RNR reductant and an ATP cone serving as an on/off switch.	[Grinberg, Inna Rozman; Lundin, Daniel; Sahlin, Margareta; Crona, Mikael; Sjoberg, Britt-Marie] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Crona, Mikael] Swedish Orphan Biovitrum AB, SE-11276 Stockholm, Sweden; [Berggren, Gustav] Uppsala Univ, Dept Chem, SE-75236 Uppsala, Sweden; [Hofer, Anders] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden	Stockholm University; Swedish Orphan Biovitrum; Uppsala University; Umea University	Sjoberg, BM (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	britt-marie.sjoberg@dbb.su.se	Berggren, Gustav/H-8659-2013	Berggren, Gustav/0000-0002-6717-6612; Hofer, Anders/0000-0003-2890-2957; Sjoberg, Britt-Marie/0000-0001-5953-3360	Swedish Cancer Society [CAN 2016/670]; Swedish Research Council [2016-01920, 621-2014-5670]; Wenner-Gren Foundations grant; Carl Trygger Foundation; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [213-2014-880]; European Research Council [714102]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Wenner-Gren Foundations grant; Carl Trygger Foundation; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); European Research Council(European Research Council (ERC)European Commission)	This work was supported by Swedish Cancer Society Grant CAN 2016/670 (to B.-M. S.), Swedish Research Council Grant 2016-01920 (to B.-M. S.), a Wenner-Gren Foundations grant (to B.-M. S.), and a Carl Trygger Foundation grant (to A. H.). Work in the laboratory of G. B. is supported by Swedish Research Council Grant 621-2014-5670; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning Grant 213-2014-880; and European Research Council Grant 714102. The authors declare that they have no conflicts of interest with the contents of this article.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Avval FZ, 2009, J BIOL CHEM, V284, P8233, DOI 10.1074/jbc.M809338200; Begas P, 2015, CHEM SCI, V6, P3788, DOI 10.1039/c5sc01051a; Berggren G, 2017, METALLOPROTEIN ACTIV, DOI [10.1002/9781119951438.eibc2480, DOI 10.1002/9781119951438.EIBC2480]; BERGLUND O, 1975, J BIOL CHEM, V250, P7450; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Collins MD, 1998, J CLIN MICROBIOL, V36, P2146, DOI 10.1128/JCM.36.7.2146-2148.1998; Collins MD, 1997, INT J SYST BACTERIOL, V47, P880, DOI 10.1099/00207713-47-3-880; Cotruvo JA, 2013, J AM CHEM SOC, V135, P4027, DOI 10.1021/ja312457t; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; Crona M., 2010, THESIS; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fahey RC, 2013, BBA-GEN SUBJECTS, V1830, P3182, DOI 10.1016/j.bbagen.2012.10.006; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; Grinberg IR, 2018, ELIFE, V7, DOI 10.7554/eLife.31529; Haft DH, 2018, NUCLEIC ACIDS RES, V46, pD851, DOI 10.1093/nar/gkx1068; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hogbom M, 2004, SCIENCE, V305, P245, DOI 10.1126/science.1098419; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Jiang W, 2007, SCIENCE, V316, P1188, DOI 10.1126/science.1141179; Jonna VR, 2015, J BIOL CHEM, V290, P17339, DOI 10.1074/jbc.M115.649624; Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044; Kaufman SL, 1996, ANAL CHEM, V68, P1895, DOI 10.1021/ac951128f; Kingry LC, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00035; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lillig CH, 2013, ANTIOXID REDOX SIGN, V18, P1654, DOI 10.1089/ars.2012.5007; Lundin Daniel, 2015, Life-Basel, V5, P604, DOI 10.3390/life5010604; Mashamaite LN, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140157; Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753; Mathews CK, 2018, FASEB J, V32, P4067, DOI 10.1096/fj.201800790R; Mathews CK, 2016, STRUCTURE, V24, P843, DOI 10.1016/j.str.2016.05.006; Rahmati E, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofw272; Reichard P, 2010, BIOCHEM BIOPH RES CO, V396, P19, DOI 10.1016/j.bbrc.2010.02.108; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; Rose HR, 2018, BIOCHEMISTRY-US, V57, P2679, DOI 10.1021/acs.biochem.8b00247; Sengupta Rajib, 2014, World J Biol Chem, V5, P68, DOI 10.4331/wjbc.v5.i1.68; Srinivas V., 2018, BIORXIV; Stubbe J, 2000, CURR OPIN STRUC BIOL, V10, P731, DOI 10.1016/S0959-440X(00)00153-6; Torrents E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00052; Ukuwela AA, 2018, CHEM SCI, V9, P1173, DOI 10.1039/c7sc04416j; VlamisGardikas A, 1997, J BIOL CHEM, V272, P11236; ZHENG M, 1994, INORG CHEM, V33, P382, DOI 10.1021/ic00080a030	46	9	9	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15889	15900		10.1074/jbc.RA118.004991	http://dx.doi.org/10.1074/jbc.RA118.004991			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30166338	Green Published, hybrid			2022-12-28	WOS:000447256000013
J	Kumaraswamy, A; Mamidi, A; Desai, P; Sivagnanam, A; Perumalsamy, LR; Ramakrishnan, C; Gromiha, M; Rajalingam, K; Mahalingam, S				Kumaraswamy, Anbarasu; Mamidi, Anitha; Desai, Pavitra; Sivagnanam, Ananthi; Perumalsamy, Lakshmi Revathi; Ramakrishnan, Chandrasekaran; Gromiha, Michael; Rajalingam, Krishnaraj; Mahalingam, Sundarasamy			The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ras protein; Myc (c-Myc); tumor cell biology; tumor suppressor gene; ubiquitination (ubiquitination); cell-penetrating peptide (CPP); cell cycle; cell proliferation; cancer; transcription factor; colony forming assay; MAX; Peptide inhibitor; Ras effectors; RASSF7	FREE-ENERGY CALCULATIONS; MOLECULAR-MECHANICS; PHOSPHOLIPASE A(2); UBIQUITIN LIGASE; CONTINUUM MODELS; LEUCINE-ZIPPER; FORCE-FIELDS; CELL-DEATH; PROTEIN; CANCER	c-Myc is a proto-oncogene controlling expression of multiple genes involved in cell growth and differentiation. Although the functional role of c-Myc as a transcriptional regulator has been intensively studied, targeting this protein in cancer remains a challenge. Here, we report a trimodal regulation of c-Myc function by the Ras effector, Ras-association domain family member 7 (RASSF7), a nonenzymatic protein modulating protein-protein interactions to regulate cell proliferation. Using HEK293T and HeLa cell lines, we provide evidence that RASSF7 destabilizes the c-Myc protein by promoting Cullin4B-mediated polyubiquitination and degradation. Furthermore, RASSF7 competed with MYC-associated factor X (MAX) in the formation of a heterodimeric complex with c-Myc and attenuated its occupancy on target gene promoters to regulate transcription. Consequently, RASSF7 inhibited c-Myc-mediated oncogenic transformation, and an inverse correlation between the expression levels of the RASSF7 and c-Myc genes was evident in human cancers. Furthermore, we found that RASSF7 interacts with c-Myc via its RA and leucine zipper (LZ) domains and LZ domain peptide is sufficient to inhibit c-Myc function, suggesting that this peptide might be used to target oncogenic c-Myc. These results unveil that RASSF7 and c-Myc are functionally linked in the control of tumorigenesis and open up potential therapeutic avenues for targeting the undruggable c-Myc protein in a subset of human cancers.	[Kumaraswamy, Anbarasu; Mamidi, Anitha; Desai, Pavitra; Sivagnanam, Ananthi; Perumalsamy, Lakshmi Revathi; Mahalingam, Sundarasamy] Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Natl Canc Tissue Biobank,Lab Mol Cell Biol, Madras 600036, Tamil Nadu, India; [Ramakrishnan, Chandrasekaran; Gromiha, Michael] Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Prot Bioinformat Lab, Madras 600036, Tamil Nadu, India; [Rajalingam, Krishnaraj] Univ Med Ctr Mainz, Inst Immunol, MSU FZI, JGU, D-55131 Mainz, Germany	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Mahalingam, S (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Lab Mol Cell Biol, Rm 403, Madras 600036, Tamil Nadu, India.	mahalingam@iitm.ac.in	Chandrasekaran, Ramakrishnan/AAP-6328-2021; Kumaraswamy, Anbarasu/Q-2208-2019; Gromiha, Michael/H-8493-2019	Kumaraswamy, Anbarasu/0000-0002-9997-7430; Chandrasekaran, Ramakrishnan/0000-0003-4622-2496; Sivagnanam, Ananthi/0000-0002-4777-587X	Department of Science and Technology from the Government of India [VI-D&P/411/2012-2013/TDT (G)]	Department of Science and Technology from the Government of India	This work was supported by Department of Science and Technology Grant VI-D&P/411/2012-2013/TDT (G) from the Government of India (to S. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Amati B, 2004, P NATL ACAD SCI USA, V101, P8843, DOI 10.1073/pnas.0403046101; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Berg T, 2002, P NATL ACAD SCI USA, V99, P3830, DOI 10.1073/pnas.062036999; Bidwell GL, 2009, EXPERT OPIN DRUG DEL, V6, P1033, DOI 10.1517/17425240903143745; Bidwell GL, 2005, MOL CANCER THER, V4, P1076, DOI 10.1158/1535-7163.MCT-04-0253; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Camarda R, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00035; Choi SH, 2010, GENE DEV, V24, P1236, DOI 10.1101/gad.1920310; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dang CV, 1999, MOL CELL BIOL, V19, P1; Datta D, 2015, J BIOL CHEM, V290, P21536, DOI 10.1074/jbc.M115.637280; Djos A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-40; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ehrkamp Anja, 2013, Cancers (Basel), V5, P639, DOI 10.3390/cancers5020639; Gabay M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014241; Gade P, 2012, METHODS MOL BIOL, V809, P85, DOI 10.1007/978-1-61779-376-9_6; Gulsen T, 2016, DEV BIOL, V409, P502, DOI 10.1016/j.ydbio.2015.11.001; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hutter S, 2017, GENES-BASEL, V8, DOI 10.3390/genes8040107; Jiang H, 2009, MOL PHARMACOL, V76, P491, DOI 10.1124/mol.109.054858; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Karthik IP, 2018, J BIOL CHEM, V293, P5624, DOI 10.1074/jbc.RA117.000623; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Leung IWL, 1998, J BIOL CHEM, V273, P32408, DOI 10.1074/jbc.273.49.32408; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Malempati S, 2006, LEUKEMIA, V20, P1572, DOI 10.1038/sj.leu.2404317; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; MOSHIER JA, 1993, CANCER RES, V53, P2618; Nero TL, 2014, NAT REV CANCER, V14, P248, DOI 10.1038/nrc3690; Patra SK, 2008, EXP CELL RES, V314, P1193, DOI 10.1016/j.yexcr.2008.01.012; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Peter S, 2014, EMBO MOL MED, V6, P1525, DOI 10.15252/emmm.201403927; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Poole CJ, 2017, GENES-BASEL, V8, DOI 10.3390/genes8050142; Ramakrishnan C, 2010, J PHYS CHEM B, V114, P13463, DOI 10.1021/jp102073f; Ramakrishnan C, 2014, CHEM BIOL DRUG DES, V84, P379, DOI 10.1111/cbdd.12332; Recino A, 2010, BIOCHEM J, V430, P207, DOI 10.1042/BJ20100883; Sabnis HS, 2017, GENES-BASEL, V8, DOI 10.3390/genes8040114; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sherwood V, 2008, MOL BIOL CELL, V19, P1772, DOI 10.1091/mbc.E07-07-0652; Shin YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14269; Shinawi T, 2012, EPIGENETICS-US, V7, P211, DOI 10.4161/epi.7.3.19222; Suryaraja R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.91; Takahashi S, 2011, CELL DEATH DIFFER, V18, P645, DOI 10.1038/cdd.2010.137; Thoompumkal IJ, 2016, CELL CYCLE, V15, P3251, DOI 10.1080/15384101.2016.1242534; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; Underhill-Day N, 2011, EPIGENETICS-US, V6, P284, DOI 10.4161/epi.6.3.14108; Volodko N, 2014, FEBS LETT, V588, P2671, DOI 10.1016/j.febslet.2014.02.041; Vos MD, 2006, METHOD ENZYMOL, V407, P311, DOI 10.1016/S0076-6879(05)07026-6; Wan Q, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav019; Wang JM, 2006, CURR COMPUT-AID DRUG, V2, P287, DOI 10.2174/157340906778226454; Wang W, 2001, ANNU REV BIOPH BIOM, V30, P211, DOI 10.1146/annurev.biophys.30.1.211; Whitfield JR, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00010; Young S. Y., 2003, MOL CELL, V11, P1177, DOI [10.1016/S1097-2765(03)00173-4, DOI 10.1016/S1097-2765(03)00173-4]; Zenonos K, 2013, WORLD J GASTRO ONCOL, V5, P97, DOI 10.4251/wjgo.v5.i5.97	58	6	7	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15691	15705		10.1074/jbc.RA118.004452	http://dx.doi.org/10.1074/jbc.RA118.004452			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30139745	Green Published, hybrid			2022-12-28	WOS:000446549200031
J	De Nardo, D; Balka, KR; Gloria, YC; Rao, VR; Latz, E; Masters, SL				De Nardo, Dominic; Balka, Katherine R.; Gloria, Yamel Cardona; Rao, Vikram R.; Latz, Eicke; Masters, Seth L.			Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; Toll-like receptor (TLR); inflammation; myeloid differentiation primary response gene (88) (MYD88); macrophage; interleukin-1 receptor-associated kinase; IRAK4; IRAK1; myddosome; scaffold protein; NF-kappaB	ACTIVATION; AUTOPHOSPHORYLATION; INDUCTION; MYD88; TRAF6; ENDOCYTOSIS; INHIBITORS; MECHANISM; REDUNDANT; RESPONSES	Toll-like receptors (TLRs) form part of the host innate immune system, in which they act as sensors of microbial and endogenous danger signals. Upon TLR activation, the intracellular Toll/interleukin-1 receptor domains of TLR dimers initiate oligomerization of a multiprotein signaling platform comprising myeloid differentiation primary response 88 (MyD88) and members of the interleukin-1 receptor-associated kinase (IRAK) family. Formation of this myddosome complex initiates signal transduction pathways, leading to the activation of transcription factors and the production of inflammatory cytokines. To date, little is known about the assembly and disassembly of the myddosome and about the mechanisms by which these complexes mediate multiple downstream signaling pathways. Here, we isolated myddosome complexes from whole-cell lysates of TLR-activated primary mouse macrophages and from IRAK reporter macrophages to examine the kinetics of myddosome assembly and disassembly. Using a selective inhibitor of IRAK4's kinase activity, we found that whereas TLR cytokine responses were ablated, myddosome formation was stabilized in the absence of IRAK4's kinase activity. Of note, IRAK4 inhibition had only a minimal effect on NF-B and mitogen-activated protein kinase (MAPK) signaling. In summary, our results indicate that IRAK4 has a critical scaffold function in myddosome formation and that its kinase activity is dispensable for myddosome assembly and activation of the NF-B and MAPK pathways but is essential for MyD88-dependent production of inflammatory cytokines. Our findings suggest that the scaffold function of IRAK4 may be an attractive target for treating inflammatory and autoimmune diseases.	[De Nardo, Dominic; Balka, Katherine R.; Masters, Seth L.] Walter & Eliza Hall Inst Med Res, Inflammat Div, 1G Royal Parade, Parkville, Vic 3052, Australia; [De Nardo, Dominic; Masters, Seth L.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Gloria, Yamel Cardona; Latz, Eicke] Univ Bonn, Univ Hosp, Inst Innate Immun, Sigmund Freud Str 25, D-53127 Bonn, Germany; [Rao, Vikram R.] Pfizer Inc, Inflammat & Immunol, Cambridge, MA 02139 USA; [Latz, Eicke] Univ Massachusetts, Med Sch, Dept Infect Dis & Immunol, Worcester, MA 01605 USA; [Latz, Eicke] German Ctr Neurodegenerat Dis, D-53175 Bonn, Germany; [Gloria, Yamel Cardona] Univ Tubingen, Dept Immunol, Mor Morgenstelle 15, D-72076 Tubingen, Germany	Walter & Eliza Hall Institute; University of Melbourne; University of Bonn; Pfizer; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen	De Nardo, D (corresponding author), Walter & Eliza Hall Inst Med Res, Inflammat Div, 1G Royal Parade, Parkville, Vic 3052, Australia.	denardo.d@wehi.edu.au	Latz, Eicke/H-3951-2014; Masters, Seth L/N-2886-2013	Latz, Eicke/0000-0003-1488-5666; Masters, Seth L/0000-0003-4763-576X; Balka, Katherine/0000-0003-0643-3360; De Nardo, Dominic/0000-0002-7045-4695	BONFOR research commission (University of Bonn, Germany); National Institutes of Health [1R01AR066808-01A1]; Excellence Cluster Immuno-Sensation; German Research Foundation [TRR83, TRR57, SFB1123]; NHMRC [1144282, 1142354, 1099262]; Sylvia and Charles Viertel Foundation; HHMI-Wellcome International Research Scholarship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066808] Funding Source: NIH RePORTER	BONFOR research commission (University of Bonn, Germany); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Excellence Cluster Immuno-Sensation; German Research Foundation(German Research Foundation (DFG)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation; HHMI-Wellcome International Research Scholarship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded in part by grant support from the BONFOR research commission (University of Bonn, Germany) (to D.D.N.); National Institutes of Health Grant 1R01AR066808-01A1, the Excellence Cluster Immuno-Sensation, and German Research Foundation Grants TRR83, 57, and SFB1123 (to E. L.); and NHMRC Grants 1144282, 1142354, and 1099262, the Sylvia and Charles Viertel Foundation, and an HHMI-Wellcome International Research Scholarship (to S. L. M.). V. R. is a paid employee of Pfizer Inc. E. L. is a co-founder and consultant to IFM Therapeutics. S. L. M. is a consultant to GlaxoSmithKline. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cheng H, 2007, BIOCHEM BIOPH RES CO, V352, P609, DOI 10.1016/j.bbrc.2006.11.068; Cushing L, 2017, J BIOL CHEM, V292, P18689, DOI 10.1074/jbc.M117.796912; Cushing L, 2014, J BIOL CHEM, V289, P10865, DOI 10.1074/jbc.M113.544809; De Nardo D, 2018, METHODS MOL BIOL, V1784, P35, DOI 10.1007/978-1-4939-7837-3_4; De Nardo D, 2017, ADV EXP MED BIOL, V1024, P1, DOI 10.1007/978-981-10-5987-2_1; De Nardo D, 2015, CYTOKINE, V74, P181, DOI 10.1016/j.cyto.2015.02.025; De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784; De Nardo D, 2009, CELL SIGNAL, V21, P246, DOI 10.1016/j.cellsig.2008.10.009; Dossang ACG, 2016, SCI REP-UK, V6, DOI 10.1038/srep37267; Ferrao R, 2014, MOL CELL, V55, P891, DOI 10.1016/j.molcel.2014.08.006; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gloria YC, 2018, METHODS MOL BIOL, V1714, P97, DOI 10.1007/978-1-4939-7519-8_7; Hu J, 2002, J IMMUNOL, V168, P3910, DOI 10.4049/jimmunol.168.8.3910; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawagoe T, 2007, J EXP MED, V204, P1013, DOI 10.1084/jem.20061523; Kelly PN, 2015, J EXP MED, V212, P2189, DOI 10.1084/jem.20151074; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Kubo-Murai M, 2008, J BIOCHEM, V143, P295, DOI 10.1093/jb/mvm234; Kuglstatter A, 2007, J IMMUNOL, V178, P2641, DOI 10.4049/jimmunol.178.5.2641; Latty SL, 2018, ELIFE, V7, DOI 10.7554/eLife.31377; Lee KL, 2017, J MED CHEM, V60, P5521, DOI 10.1021/acs.jmedchem.7b00231; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lye E, 2004, J BIOL CHEM, V279, P40653, DOI 10.1074/jbc.M402666200; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Nanda SK, 2016, J IMMUNOL, V197, P4266, DOI 10.4049/jimmunol.1600788; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Pauls E, 2013, J IMMUNOL, V191, P2717, DOI 10.4049/jimmunol.1203268; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Qin JZ, 2004, J BIOL CHEM, V279, P26748, DOI 10.1074/jbc.M400785200; Seganish WM, 2016, EXPERT OPIN THER PAT, V26, P917, DOI 10.1080/13543776.2016.1202926; Song KW, 2009, MOL IMMUNOL, V46, P1458, DOI 10.1016/j.molimm.2008.12.012; Strickson S, 2017, P NATL ACAD SCI USA, V114, pE3481, DOI 10.1073/pnas.1702367114; Sun J, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aab2191; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Vollmer S, 2017, BIOCHEM J, V474, P2027, DOI 10.1042/BCJ20170097; Wang L, 2017, P NATL ACAD SCI USA, V114, P13507, DOI 10.1073/pnas.1714386114; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Wolz OO, 2018, METHODS MOL BIOL, V1714, P119, DOI 10.1007/978-1-4939-7519-8_8; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	47	52	53	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15195	15207		10.1074/jbc.RA118.003314	http://dx.doi.org/10.1074/jbc.RA118.003314			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30076215	Green Published, hybrid			2022-12-28	WOS:000445998400020
J	Chen, M; Zhang, H; Shi, ZB; Li, YH; Zhang, XM; Gao, ZY; Zhou, L; Ma, J; Xu, Q; Guan, JM; Cheng, YF; Jiao, S; Zhou, ZC				Chen, Min; Zhang, Hui; Shi, Zhubing; Li, Yehua; Zhang, Xiaoman; Gao, Ziyang; Zhou, Li; Ma, Jian; Xu, Qi; Guan, Jingmin; Cheng, Yunfeng; Jiao, Shi; Zhou, Zhaocai			The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hippo pathway; crystal structure; molecular evolution; pancreatic cancer; MST1 (Mammalian Sterile 20-like kinase 1); MOB4; MST4; STRIPAK; Hippo signaling	ORGAN SIZE CONTROL; CELL-PROLIFERATION; KINASE MST4; STRIPAK COMPLEXES; HUMAN MOB1; PROTEIN; PHOSPHORYLATION; ACTIVATION; PROMOTES; GROWTH	The mammalian STE20-like protein kinase 1 (MST1)-MOB kinase activator 1 (MOB1) complex has been shown to suppress the oncogenic activity of Yes-associated protein (YAP) in the mammalian Hippo pathway, which is involved in the development of multiple tumors, including pancreatic cancer (PC). However, it remains unclear whether other MST-MOB complexes are also involved in regulating Hippo-YAP signaling and have potential roles in PC. Here, we report that mammalian STE20-like kinase 4 (MST4), a distantly related ortholog of the MST1 kinase, forms a complex with MOB4 in a phosphorylation-dependent manner. We found that the overall structure of the MST4-MOB4 complex resembles that of the MST1-MOB1 complex, even though the two complexes exhibited opposite biological functions in PC. In contrast to the tumor-suppressor effect of the MST1-MOB1 complex, the MST4-MOB4 complex promoted growth and migration of PANC-1 cells. Moreover, expression levels of MST4 and MOB4 were elevated in PC and were positively correlated with each other, whereas MST1 expression was down-regulated. Because of divergent evolution of key interface residues, MST4 and MOB4 could disrupt assembly of the MST1-MOB1 complex through alternative pairing and thereby increased YAP activity. Collectively, these findings identify the MST4-MOB4 complex as a noncanonical regulator of the Hippo-YAP pathway with an oncogenic role in PC. Our findings highlight that although MST-MOB complexes display some structural conservation, they functionally diverged during their evolution.	[Chen, Min; Zhang, Hui; Shi, Zhubing; Li, Yehua; Zhang, Xiaoman; Gao, Ziyang; Ma, Jian; Xu, Qi; Guan, Jingmin; Jiao, Shi; Zhou, Zhaocai] Univ Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol, Chinese Acad Sci,State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Zhou, Li; Zhou, Zhaocai] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Cheng, Yunfeng] Fudan Univ, Zhongshan Hosp, Dept Hematol, Shanghai 200032, Peoples R China; [Cheng, Yunfeng] Fudan Univ, Zhongshan Hosp, Inst Clin Sci, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Fudan University; Fudan University	Jiao, S; Zhou, ZC (corresponding author), 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	jiaoshi@sibcb.ac.cn; zczhou@sibcb.ac.cn	Shi, Zhubing/F-9490-2010	Shi, Zhubing/0000-0002-9624-4960	National Key R&D Program of China [2017YFA0504504]; National Natural Science Foundation of China [31470868, 81725014, 91542125]; Youth Innovation Promotion Association of the Chinese Academy of Sciences; "Strategic Priority Research Program" [XDB19020202]; China Postdoctoral Science Foundation [2018T110414]; SA-SIBS Scholarship Program	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association of the Chinese Academy of Sciences; "Strategic Priority Research Program"(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); SA-SIBS Scholarship Program	This work was supported by National Key R&D Program of China Grant 2017YFA0504504; National Natural Science Foundation of China Grants 31470868, 81725014, and 91542125; the Youth Innovation Promotion Association of the Chinese Academy of Sciences; "Strategic Priority Research Program" Grant XDB19020202; and China Postdoctoral Science Foundation funded project, 2018T110414. This work was also supported by the SA-SIBS Scholarship Program. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Bae SJ, 2017, ELIFE, V6, DOI [10.7554/eLife.30278.001, 10.7554/eLife.30278]; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baillat G, 2001, MOL BIOL CELL, V12, P663, DOI 10.1091/mbc.12.3.663; Cho CY, 2016, ONCOTARGET, V7, P14586, DOI 10.18632/oncotarget.7542; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Gloerich M, 2012, NAT CELL BIOL, V14, P793, DOI 10.1038/ncb2537; Gomez M, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-22; Gordon J, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-54; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Haeberle AM, 2006, J COMP NEUROL, V495, P336, DOI 10.1002/cne.20895; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Huang TZ, 2017, CANCER CELL, V32, P840, DOI 10.1016/j.ccell.2017.11.005; Hwang JY, 2014, INT J BIOCHEM CELL B, V47, P118, DOI 10.1016/j.biocel.2013.11.021; Jiao S, 2015, NAT IMMUNOL, V16, P246, DOI 10.1038/ni.3097; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Li XY, 2017, ONCOTARGET, V8, P16356, DOI 10.18632/oncotarget.14633; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Madsen CD, 2015, NAT CELL BIOL, V17, P68, DOI 10.1038/ncb3083; Ni LS, 2015, GENE DEV, V29, P1416, DOI 10.1101/gad.264929.115; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Rock JM, 2013, SCIENCE, V340, P871, DOI 10.1126/science.1235822; Schroeder MC, 2012, SEMIN CELL DEV BIOL, V23, P803, DOI 10.1016/j.semcdb.2012.06.001; Shi Z, 2016, ONCOGENE, V35, P4549, DOI 10.1038/onc.2016.9; Shi ZB, 2013, STRUCTURE, V21, P449, DOI 10.1016/j.str.2013.01.007; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Stavridi ES, 2003, STRUCTURE, V11, P1163, DOI 10.1016/S0969-2126(03)00182-5; Sung V, 2003, CANCER RES, V63, P3356; Tang FY, 2014, CANCER RES, V74, P3779, DOI 10.1158/0008-5472.CAN-13-3430; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Thompson BJ, 2015, J CELL BIOL, V210, P871, DOI 10.1083/jcb.201507005; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yuan P, 2017, CANCER RES, V77, P100, DOI 10.1158/0008-5472.CAN-16-1898; Yuan YL, 2016, MOL MED REP, V13, P237, DOI 10.3892/mmr.2015.4550; Zhang M, 2013, STRUCTURE, V21, P680, DOI 10.1016/j.str.2013.02.015; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zhao X, 2017, CANCER LETT, V402, P61, DOI 10.1016/j.canlet.2017.05.015	53	39	40	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14455	14469		10.1074/jbc.RA118.003279	http://dx.doi.org/10.1074/jbc.RA118.003279			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30072378	hybrid, Green Published			2022-12-28	WOS:000444671500024
J	Silverstein, N; Sliman, A; Stockner, T; Kanner, BI				Silverstein, Nechama; Sliman, Alaa; Stockner, Thomas; Kanner, Baruch I.			Both reentrant loops of the sodium-coupled glutamate transporters contain molecular determinants of cation selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurotransmitter transport; glutamate; site-directed mutagenesis; membrane transporter reconstitution; computational biology; amino acid transport; electrogenic process; ion selectivity; molecular dynamics simulations; reentry	AMINOBUTYRIC-ACID TRANSPORTER; RAT-BRAIN; SUBSTRATE INTERACTIONS; ASPARTATE TRANSPORTER; INDIVIDUAL SUBUNITS; MEMBRANE-VESICLES; BINDING; ION; EXPRESSION; MUTATION	In the brain, glutamate transporters terminate excitatory neurotransmission by removing this neurotransmitter from the synapse via cotransport with three sodium ions into the surrounding cells. Structural studies have identified the binding sites of the three sodium ions in glutamate transporters. The residue side-chains directly interact with the sodium ions at the Na1 and Na3 sites and are fully conserved from archaeal to eukaryotic glutamate transporters. The Na2 site is formed by three main-chain oxygens on the extracellular reentrant hairpin loop HP2 and one on transmembrane helix 7. A glycine residue on HP2 is located closely to the three main-chain oxygens in all glutamate transporters, except for the astroglial transporter GLT-1, which has a serine residue at that position. Unlike for WT GLT-1, substitution of the serine residue to glycine enables sustained glutamate transport also when sodium is replaced by lithium. Here, using functional and simulation studies, we studied the role of this serine/glycine switch on cation selectivity of substrate transport. Our results indicate that the side-chain oxygen of the serine residues can form a hydrogen bond with a main-chain oxygen on transmembrane helix 7. This leads to an expansion of the Na2 site such that water can participate in sodium coordination at Na2. Furthermore, we found other molecular determinants of cation selectivity on the nearby HP1 loop. We conclude that subtle changes in the composition of the two reentrant hairpin loops determine the cation specificity of acidic amino acid transport by glutamate transporters.	[Stockner, Thomas] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringerstr 13A, A-1090 Vienna, Austria; [Silverstein, Nechama; Sliman, Alaa; Kanner, Baruch I.] Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Fac Med, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel	Medical University of Vienna; Hebrew University of Jerusalem	Stockner, T (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringerstr 13A, A-1090 Vienna, Austria.; Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Fac Med, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel.	thomas.stockner@meduniwien.ac.at; baruch.kanner@mail.huji.ac.il	Stockner, Thomas/A-9509-2014	Stockner, Thomas/0000-0002-7071-8283	National Institutes of Health Grant from the NINDS [NS 16708]; United States-Israel Binational Science Foundation [2011268]; Austrian Science Fund (FWF) [F3524]; European Union [CM1306]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708] Funding Source: NIH RePORTER	National Institutes of Health Grant from the NINDS; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Union(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS 16708 from the NINDS, United States-Israel Binational Science Foundation Grant 2011268 (to B. I. K.), Austrian Science Fund (FWF) for project F3524, and the European Union-sponsored COST Action CM1306 (to T. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bastug T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033058; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Canul-Tec JC, 2017, NATURE, V544, P446, DOI 10.1038/nature22064; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ewers D, 2013, P NATL ACAD SCI USA, V110, P12486, DOI 10.1073/pnas.1300772110; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Guskov A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13420; Huang S, 2009, J BIOL CHEM, V284, P4510, DOI 10.1074/jbc.M808495200; Huang ZJ, 2010, BIOPHYS J, V99, P1416, DOI 10.1016/j.bpj.2010.06.052; Jensen S, 2013, NAT STRUCT MOL BIOL, V20, P1224, DOI 10.1038/nsmb.2663; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Menaker D, 2006, J NEUROCHEM, V99, P20, DOI 10.1111/j.1471-4159.2006.04003.x; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Silverstein N, 2015, J BIOL CHEM, V290, P28988, DOI 10.1074/jbc.M115.682666; Silverstein N, 2013, J BIOL CHEM, V288, P964, DOI 10.1074/jbc.M112.403576; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Venkatesan S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004551; Verdon G, 2014, ELIFE, V3, DOI 10.7554/eLife.02283; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	54	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14200	14209		10.1074/jbc.RA118.003261	http://dx.doi.org/10.1074/jbc.RA118.003261			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30026234	Green Published, hybrid			2022-12-28	WOS:000444671500002
J	Canalis, E; Yu, J; Schilling, L; Yee, SP; Zanotti, S				Canalis, Ernesto; Yu, Jungeun; Schilling, Lauren; Yee, Siu-Pok; Zanotti, Stefano			The lateral meningocele syndrome mutation causes marked osteopenia in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Notch receptor; bone; osteoblast; osteoclast; osteocyte; bone loss; lateral meningocele syndrome; Lehman syndrome; osteopenia; skeletal abnormalities	HAJDU-CHENEY-SYNDROME; NOTCH SIGNALING PATHWAY; ZINC-FINGER TARGETER; BONE LOSS; OSTEOBLAST DIFFERENTIATION; LYMPHOBLASTIC-LEUKEMIA; TRUNCATING MUTATIONS; OSTEOCYTE APOPTOSIS; HUMAN-CELLS; LAST EXON	Lateral meningocele syndrome (LMS) is a rare genetic disorder characterized by neurological complications and osteoporosis. LMS is associated with mutations in exon 33 of NOTCH3 leading to a truncated protein lacking sequences for NOTCH3 degradation and presumably causing NOTCH3 gain of function. To create a mouse model reproducing human LMS-associated mutations, we utilized CRISPR/Cas9 to introduce a tandem termination codon at bases 6691-6696 (ACCAAGTAATGA) and verified this mutation (Notch3(tm1.1Ecan)) by DNA sequencing of F1 mice. One-month-old male and female heterozygous Notch3(tm1.1Ecan) mice had cancellous and cortical bone osteopenia but exhibited no obvious neurological alterations, and histopathology of multiple organs revealed no abnormalities. Microcomputed tomography of these mutants revealed a 35-60% decrease in cancellous bone volume associated with a reduction in trabecular number and decreased connectivity. During maturation, cancellous and cortical bones were restored in female but not in male mice, which exhibited cancellous bone osteopenia at 4 months. Cancellous bone histomorphometry revealed increased osteoblast and osteocyte numbers and a modest increase in osteoclast surface and bone formation rate. Notch3(tm1.1Ecan) calvarial osteoblasts had increased proliferation and increased bone -carboxyglutamate protein (Bglap) and TNF superfamily member 11 (Tnfsf11) mRNA levels and lower Tnfrsf11b levels. Tnfsf11 mRNA was increased in osteocyte-rich femora from Notch3(tm1.1Ecan) mice. Cultures of bone marrow-derived macrophages from Notch3(tm1.1Ecan) mice revealed increased osteoclast formation, particularly in cocultures with osteoblasts from Notch3(tm1.1Ecan) mice. In conclusion, the Notch3(tm1.1Ecan) mutation causes osteopenia despite an increase in osteoblast proliferation and function and is associated with enhanced Tnfsf11 expression in osteoblasts and osteocytes.	[Canalis, Ernesto; Yu, Jungeun; Schilling, Lauren; Zanotti, Stefano] UConn Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA; [Canalis, Ernesto; Zanotti, Stefano] UConn Hlth, Dept Med, Farmington, CT 06030 USA; [Yee, Siu-Pok] UConn Hlth, Dept Cell Biol, Farmington, CT 06030 USA; [Canalis, Ernesto; Yu, Jungeun; Schilling, Lauren; Zanotti, Stefano] UConn Hlth, UConn Musculoskeletal Inst, Farmington, CT 06030 USA; [Yee, Siu-Pok] UConn Hlth, Ctr Mouse Genome Modificat, Farmington, CT 06030 USA; [Zanotti, Stefano] Sanofi, Rare Dis, Framingham, MA 01701 USA	Sanofi-Aventis	Canalis, E (corresponding author), UConn Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA.; Canalis, E (corresponding author), UConn Hlth, Dept Med, Farmington, CT 06030 USA.; Canalis, E (corresponding author), UConn Hlth, UConn Musculoskeletal Inst, Farmington, CT 06030 USA.	canalis@uchc.edu			NIAMS from the National Institutes of Health [AR063049, AR072987]; NIDDK from the National Institutes of Health [DK045227]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063049, R01AR072987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER	NIAMS from the National Institutes of Health; NIDDK from the National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIAMS Grants AR063049 and AR072987 and NIDDK Grant DK045227 from the National Institutes of Health (all to E. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Avela K, 2011, AM J MED GENET A, V155A, P595, DOI 10.1002/ajmg.a.33510; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Bellavia D, 2008, ONCOGENE, V27, P5092, DOI 10.1038/onc.2008.230; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Breit S, 2006, BLOOD, V108, P1151, DOI 10.1182/blood-2005-12-4956; Canalis E, 2017, ENDOCRINOLOGY, V158, P730, DOI 10.1210/en.2016-1787; Canalis E, 2016, J BIOL CHEM, V191, P1538, DOI 10.1074/jbc.M115.685453; Canalis E, 2014, BONE, V64, P273, DOI 10.1016/j.bone.2014.04.028; Canalis E, 2013, J BIOL CHEM, V288, P25614, DOI 10.1074/jbc.M113.470492; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; Cordle J, 2008, J BIOL CHEM, V283, P11785, DOI 10.1074/jbc.M708424200; Delgado-Calle J, 2016, CANCER RES, V76, P1089, DOI 10.1158/0008-5472.CAN-15-1703; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Dou XW, 2017, J DENT RES, V96, P347, DOI 10.1177/0022034516680349; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Gripp KW, 2015, AM J MED GENET A, V167, P271, DOI 10.1002/ajmg.a.36863; Gripp KW, 2011, AM J MED GENET A, V155A, P1773, DOI 10.1002/ajmg.a.34075; Gripp KW, 1997, AM J MED GENET, V70, P229; Halleux C, 2012, METHODS MOL BIOL, V816, P55, DOI 10.1007/978-1-61779-415-5_5; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Isidor B, 2011, NAT GENET, V43, P306, DOI 10.1038/ng.778; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Joutel A, 2011, BIOESSAYS, V33, P73, DOI 10.1002/bies.201000093; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kovall RA, 2008, ONCOGENE, V27, P5099, DOI 10.1038/onc.2008.223; Kovall RA, 2007, CURR OPIN STRUC BIOL, V17, P117, DOI 10.1016/j.sbi.2006.11.004; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; LEHMAN RAW, 1977, J PEDIATR-US, V90, P49, DOI 10.1016/S0022-3476(77)80763-4; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; McCright B, 2001, DEVELOPMENT, V128, P491; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagy TR, 2001, J BONE MINER RES, V16, P1682, DOI 10.1359/jbmr.2001.16.9.1682; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; Novack DV, 2007, CELL METAB, V6, P254, DOI 10.1016/j.cmet.2007.09.007; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Plotkin LI, 2015, J BIOL CHEM, V290, P18934, DOI 10.1074/jbc.M115.642090; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rossi D, 2012, J EXP MED, V209, P1537, DOI 10.1084/jem.20120904; Sanchez-Irizarry C, 2004, MOL CELL BIOL, V24, P9265, DOI 10.1128/MCB.24.21.9265-9273.2004; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang YQ, 2008, J BONE MINER RES, V23, P260, DOI 10.1359/JBMR.071013; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Williams Adam, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.top087536; Wu J, 2007, TRENDS BIOCHEM SCI, V32, P477, DOI 10.1016/j.tibs.2007.09.002; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yesil P, 2009, ISLETS, V1, P185, DOI 10.4161/isl.1.3.9556; Yuan ZY, 2012, J BIOL CHEM, V287, P34904, DOI 10.1074/jbc.M112.403287; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140; Zanotti S, 2017, BONE, V103, P159, DOI 10.1016/j.bone.2017.06.027; Zanotti S, 2017, J BIOL CHEM, V292, P12232, DOI 10.1074/jbc.M117.786129; Zanotti S, 2016, ENDOCR REV, V37, P223, DOI 10.1210/er.2016-1002; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09; Zhang ZY, 2010, AM J PATHOL, V177, P1459, DOI 10.2353/ajpath.2010.090476	81	22	23	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14165	14177		10.1074/jbc.RA118.004242	http://dx.doi.org/10.1074/jbc.RA118.004242			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30042232	hybrid, Green Published			2022-12-28	WOS:000444070700037
J	Zhu, QW; Chang, A; Xu, A; Luo, KX				Zhu, Qingwei; Chang, Amanda; Xu, Albert; Luo, Kunxin			The regulatory protein SnoN antagonizes activin/Smad2 protein signaling and thereby promotes adipocyte differentiation and obesity in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						activin; SMAD transcription factor; transforming growth factor (TGF-); obesity; adipocyte; differentiation; adipose tissue; SKI like proto-oncogene; SKIL; Smad2; SnoN; adipose tissue	GROWTH-FACTOR-BETA; HUMAN ADIPOSE-TISSUE; DIET-INDUCED OBESITY; TGF-BETA; INSULIN-RESISTANCE; TUMOR-SUPPRESSOR; STEM-CELL; TRANSCRIPTIONAL CONTROL; MAMMALIAN DEVELOPMENT; ENERGY-EXPENDITURE	Ski-related oncogene SnoN (SnoN or SKIL) regulates multiple signaling pathways in a tissue- and developmental stage-dependent manner and has broad functions in embryonic angiogenesis, mammary gland alveologenesis, cancer, and aging. Here, we report that SnoN also plays a critical role in white adipose tissue (WAT) development by regulating mesenchymal stem cell (MSC) self-renewal and differentiation. We found that SnoN promotes MSC differentiation in the adipocyte lineage by antagonizing activin A/Smad2, but not TGF/Smad3 signaling. Mice lacking SnoN or expressing a mutant SnoN defective in binding to the Smads were protected from high-fat diet-induced obesity and insulin resistance, and MSCs lacking a functional SnoN exhibited defective differentiation. We further demonstrated that activin, via Smad2, appears to be the major regulator of WAT development in vivo. We also noted that activin A is abundantly expressed in WAT and adipocytes through an autocrine mechanism and promotes MSC self-renewal and inhibits adipogenic differentiation by inducing expression of the gene encoding the homeobox transcription factor Nanog. Of note, SnoN repressed activin/Smad2 signaling and activin A expression, enabling expression of adipocyte-specific transcription factors and promoting adipogenic differentiation. In conclusion, our study has revealed that SnoN plays an important in vivo role in adipocyte differentiation and WAT development in vivo by decreasing activity in the activin/Smad2 signaling pathway.	[Zhu, Qingwei; Chang, Amanda; Luo, Kunxin] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Luo, Kunxin] Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA; [Xu, Albert] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Luo, KX (corresponding author), Univ Calif Berkeley, Dept Mol Cell Biol, 382 Li Ka Shing Ctr 3370, Berkeley, CA 94720 USA.	kluo@berkeley.edu		Xu, Albert/0000-0001-5938-561X	Department of Defense CDMRP BCRP [W81XWH-15-1-0051]	Department of Defense CDMRP BCRP(United States Department of Defense)	This work was supported by Department of Defense CDMRP BCRP Grant W81XWH-15-1-0051 (to K. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Alessi MC, 2000, DIABETES, V49, P1374, DOI 10.2337/diabetes.49.8.1374; Castoldi A, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00637; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Clouthier DE, 1997, J CLIN INVEST, V100, P2697, DOI 10.1172/JCI119815; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Fain JN, 2005, METABOLISM, V54, P1546, DOI 10.1016/j.metabol.2005.05.024; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Ferguson CA, 1998, GENE DEV, V12, P2636, DOI 10.1101/gad.12.16.2636; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Grafe I, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022202; Gu ZY, 1998, GENE DEV, V12, P844, DOI 10.1101/gad.12.6.844; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Heyer J, 1999, P NATL ACAD SCI USA, V96, P12595, DOI 10.1073/pnas.96.22.12595; Hirai S, 2005, MOL CELL ENDOCRINOL, V232, P21, DOI 10.1016/j.mce.2005.01.001; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; IGNOTZ RA, 1985, P NATL ACAD SCI USA, V82, P8530, DOI 10.1073/pnas.82.24.8530; Jahchan NS, 2012, DEVELOPMENT, V139, P3147, DOI 10.1242/dev.079616; Jahchan NS, 2010, CURR OPIN PHARMACOL, V10, P670, DOI 10.1016/j.coph.2010.08.006; JEOUNG DI, 1995, BIOCHEM BIOPH RES CO, V216, P964, DOI 10.1006/bbrc.1995.2714; Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06; Lin YS, 2009, DIS MARKERS, V27, P23, DOI [10.1155/2009/529253, 10.3233/DMA-2009-0643]; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; MATZUK MM, 1995, NATURE, V374, P354, DOI 10.1038/374354a0; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pan D, 2012, AGING CELL, V11, P902, DOI 10.1111/j.1474-9726.2012.00857.x; Pan D, 2009, EMBO J, V28, P3500, DOI 10.1038/emboj.2009.250; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Sakaki-Yumoto M, 2013, J BIOL CHEM, V288, P18546, DOI 10.1074/jbc.M112.446591; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shen JJ, 2009, MOL ENDOCRINOL, V23, P113, DOI 10.1210/me.2007-0322; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; Song JW, 1999, DEV BIOL, V213, P157, DOI 10.1006/dbio.1999.9370; Stewart WC, 2011, OBESITY, V19, P1731, DOI 10.1038/oby.2011.66; Tan CK, 2011, DIABETES, V60, P464, DOI 10.2337/db10-0801; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; TORTI FM, 1989, J CELL BIOL, V108, P1105, DOI 10.1083/jcb.108.3.1105; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yusuf B, 2013, DEV GROWTH DIFFER, V55, P330, DOI 10.1111/dgd.12043; Zamani N, 2011, ENDOCR REV, V32, P387, DOI 10.1210/er.2010-0018; Zaragosi LE, 2010, DIABETES, V59, P2513, DOI 10.2337/db10-0013; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06; Zhu QW, 2016, DEV CELL, V37, P399, DOI 10.1016/j.devcel.2016.05.002; Zhu QW, 2013, J CELL BIOL, V202, P937, DOI 10.1083/jcb.201208113; Zhu QW, 2012, FEBS LETT, V586, P1971, DOI 10.1016/j.febslet.2012.03.005	64	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14100	14111		10.1074/jbc.RA118.003678	http://dx.doi.org/10.1074/jbc.RA118.003678			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30030373	hybrid, Green Published			2022-12-28	WOS:000444070700031
J	Mary, C; Fouillen, A; Bessette, B; Nanci, A; Baron, C				Mary, Charline; Fouillen, Aurelien; Bessette, Benoit; Nanci, Antonio; Baron, Christian			Interaction via the N terminus of the type IV secretion system (T4SS) protein VirB6 with VirB10 is required for VirB2 and VirB5 incorporation into T-pili and for T4SS function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane protein; protein secretion; virulence factor; bacterial pathogenesis; bacteria; Agrobacterium tumefaciens; protein-protein interaction; T-pilus; type IV secretion system; virulence	CORE COMPONENT VIRB8; INCN PLASMID PKM101; AGROBACTERIUM-TUMEFACIENS; DNA SUBSTRATE; PERIPLASMIC DOMAIN; MACHINERY; APPARATUS; MEMBRANES; PATHWAY; BIOLOGY	Many bacterial pathogens employ multicomponent protein complexes such as type IV secretion systems (T4SSs) to transfer virulence factors into host cells. Here we studied the interaction between two essential T4SS components: the very hydrophobic inner membrane protein VirB6, which may be a component of the translocation channel, and VirB10, which links the inner and outer bacterial membranes. To map the interaction site between these two T4SS components, we conducted alanine scanning and deleted six-amino acid stretches from the N-terminal periplasmic domain of VirB6 from Brucella suis. Using the bacterial two-hybrid system to analyze the effects of these alterations on the VirB6-VirB10 interaction, we identified the amino acid regions 16-21 and 28-33 and Leu-18 in VirB6 as being required for this interaction. SDS-PAGE coupled with Western blotting of cell lysates and native PAGE of detergent-extracted membrane proteins revealed that the corresponding VirB6 residues in Agrobacterium tumefaciens (Phe-20 and amino acids 18-23 and 30-35) modulate the stability of both VirB6 and VirB5. However, the results from immuno-EM and super-resolution microscopy suggested that these regions and residues are not required for membrane association or for polar localization of VirB6. The six-amino acid deletions in the N terminus of VirB6 abolished pilus formation and virulence of A. tumefaciens, and the corresponding deletions in the VirB6 homolog TraD from the plasmid pKM101-T4SS abrogated plasmid transfer. Our results indicate that specific residues of the VirB6 N-terminal domain are required for VirB6 stabilization, its interaction with VirB10, and the incorporation of VirB2 and VirB5 into T-pili.	[Mary, Charline; Fouillen, Aurelien; Bessette, Benoit; Nanci, Antonio; Baron, Christian] Univ Montreal, Fac Med, Dept Biochem & Mol Med, Pavillon Roger Gaudry,CP 6128,CP 6128, Montreal, PQ H3C 3J7, Canada; [Fouillen, Aurelien; Nanci, Antonio] Univ Montreal, Fac Dent Med, Dept Stomatol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Baron, C (corresponding author), Univ Montreal, Fac Med, Dept Biochem & Mol Med, Pavillon Roger Gaudry,CP 6128,CP 6128, Montreal, PQ H3C 3J7, Canada.	christian.baron@umontreal.ca	Fouillen, Aurelien/P-7002-2019	Fouillen, Aurelien/0000-0002-0326-9932; Mary, Charline/0000-0003-3056-8839; Nanci, Antonio/0000-0003-0616-843X; Baron, Christian/0000-0002-0132-2111	Canadian Institutes of Health Research [MOP-84239]; NSERC-CREATE program on the Cellular Dynamics of Macromolecular Complexes; Canada Foundation for Innovation; Fonds de recherche du Quebec-Sante; Canada Research Chair in Calcified Tissues, Biomaterials, and Structural Imaging	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NSERC-CREATE program on the Cellular Dynamics of Macromolecular Complexes; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Canada Research Chair in Calcified Tissues, Biomaterials, and Structural Imaging	This work was supported by grants from the Canadian Institutes of Health Research (MOP-84239 to C.B.), the NSERC-CREATE program on the Cellular Dynamics of Macromolecular Complexes (to C.B.), the Canada Foundation for Innovation, and the Fonds de recherche du Quebec-Sante (to C.B.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Canada Research Chair in Calcified Tissues, Biomaterials, and Structural Imaging.	Atmakuri K, 2004, MOL MICROBIOL, V54, P1199, DOI 10.1111/j.1365-2958.2004.04345.x; Banta LM, 2011, J BACTERIOL, V193, P2566, DOI 10.1128/JB.00038-11; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Cascales E, 2013, J BACTERIOL, V195, P2691, DOI 10.1128/JB.00114-13; Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Giraldo AMV, 2015, FEBS LETT, V589, P1883, DOI 10.1016/j.febslet.2015.05.051; Giraldo AMV, 2012, BIOCHEMISTRY-US, V51, P3881, DOI 10.1021/bi300298v; Gordon JE, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.PLAS-0010-2013; Hapfelmeier S, 2000, J BACTERIOL, V182, P4505, DOI 10.1128/JB.182.16.4505-4511.2000; Jakubowski SJ, 2009, MOL MICROBIOL, V71, P779, DOI 10.1111/j.1365-2958.2008.06565.x; Jakubowski SJ, 2004, J MOL BIOL, V341, P961, DOI 10.1016/j.jmb.2004.06.052; Jakubowski SJ, 2003, J BACTERIOL, V185, P2867, DOI 10.1128/JB.185.9.2867-2878.2003; Judd PK, 2005, P NATL ACAD SCI USA, V102, P11498, DOI 10.1073/pnas.0505290102; Judd PK, 2005, MOL MICROBIOL, V55, P115, DOI 10.1111/j.1365-2958.2004.04378.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Krall L, 2002, P NATL ACAD SCI USA, V99, P11405, DOI 10.1073/pnas.172390699; LANGER PJ, 1981, MOL GEN GENET, V182, P268, DOI 10.1007/BF00269669; Low HH, 2014, NATURE, V508, P550, DOI 10.1038/nature13081; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Paschos A, 2011, INFECT IMMUN, V79, P1033, DOI 10.1128/IAI.00993-10; Redzej A, 2017, EMBO J, V36, P3080, DOI 10.15252/embj.201796629; Sagulenko E, 2001, J BACTERIOL, V183, P5813, DOI 10.1128/JB.183.20.5813-5825.2001; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P5563, DOI 10.1128/JB.181.18.5563-5571.1999; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P7485, DOI 10.1128/JB.181.24.7485-7492.1999; Sharifahmadian M, 2017, FEBS LETT, V591, P2491, DOI 10.1002/1873-3468.12770; Sivanesan D, 2010, BIOCHEMISTRY-US, V49, P4483, DOI 10.1021/bi902201y; THORSTENSON YR, 1993, J BACTERIOL, V175, P5233, DOI 10.1128/JB.175.16.5233-5241.1993; Trokter M, 2014, CURR OPIN STRUC BIOL, V27, P16, DOI 10.1016/j.sbi.2014.02.006; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; VAN LAREBEKE N, 1974, NATURE, V252, P169, DOI 10.1038/252169a0; WINANS SC, 1985, J BACTERIOL, V161, P402, DOI 10.1128/JB.161.1.402-410.1985; Yuan Q, 2005, J BIOL CHEM, V280, P26349, DOI 10.1074/jbc.M502347200; ZINONI F, 1990, P NATL ACAD SCI USA, V87, P4660, DOI 10.1073/pnas.87.12.4660; Zupan J, 2000, PLANT J, V23, P11, DOI 10.1046/j.1365-313x.2000.00808.x	38	6	8	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13415	13426		10.1074/jbc.RA118.002751	http://dx.doi.org/10.1074/jbc.RA118.002751			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29976757	Green Published, hybrid			2022-12-28	WOS:000443375500006
J	Ge, YH; Borne, E; Stewart, S; Hansen, MR; Arturo, EC; Jaffe, EK; Voelz, VA				Ge, Yunhui; Borne, Elias; Stewart, Shannon; Hansen, Michael R.; Arturo, Emilia C.; Jaffe, Eileen K.; Voelz, Vincent A.			Simulations of the regulatory ACT domain of human phenylalanine hydroxylase (PAH) unveil its mechanism of phenylalanine binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular dynamics; ligand-binding protein; kinetics; allosteric regulation; conformational change; binding pathways; ligand binding kinetics; Markov state models; phenylketonuria; phenylalanine hydroxylase; molecular simulation; conformational selection	STRUCTURAL BASIS; MODEL; IDENTIFICATION; DIMERIZATION; SYSTEM; SITE; JUMP	Phenylalanine hydroxylase (PAH) regulates phenylalanine (Phe) levels in mammals to prevent neurotoxicity resulting from high Phe concentrations as observed in genetic disorders leading to hyperphenylalaninemia and phenylketonuria. PAH senses elevated Phe concentrations by transient allosteric Phe binding to a protein-protein interface between ACT domains of different subunits in a PAH tetramer. This interface is present in an activated PAH (A-PAH) tetramer and absent in a resting-state PAH (RS-PAH) tetramer. To investigate this allosteric sensing mechanism, here we used the GROMACS molecular dynamics simulation suite on the Folding@home computing platform to perform extensive molecular simulations and Markov state model (MSM) analysis of Phe binding to ACT domain dimers. These simulations strongly implicated a conformational selection mechanism for Phe association with ACT domain dimers and revealed protein motions that act as a gating mechanism for Phe binding. The MSMs also illuminate a highly mobile hairpin loop, consistent with experimental findings also presented here that the PAH variant L72W does not shift the PAH structural equilibrium toward the activated state. Finally, simulations of ACT domain monomers are presented, in which spontaneous transitions between resting-state and activated conformations are observed, also consistent with a mechanism of conformational selection. These mechanistic details provide detailed insight into the regulation of PAH activation and provide testable hypotheses for the development of new allosteric effectors to correct structural and functional defects in PAH.	[Ge, Yunhui; Voelz, Vincent A.] Temple Univ, Dept Chem, Philadelphia, PA 19122 USA; [Borne, Elias; Stewart, Shannon; Hansen, Michael R.; Arturo, Emilia C.; Jaffe, Eileen K.] Temple Univ Hlth Syst, Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Arturo, Emilia C.] Drexel Univ, Coll Med, Philadelphia, PA 19129 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Drexel University	Voelz, VA (corresponding author), Temple Univ, Dept Chem, Philadelphia, PA 19122 USA.	voelz@temple.edu	Ge, Yunhui/I-1514-2018; Arturo, Emilia/ABA-8516-2020; Voelz, Vincent/HCI-4181-2022	Ge, Yunhui/0000-0002-3946-1440; Arturo, Emilia/0000-0002-6911-129X; Voelz, Vincent/0000-0002-1054-2124	National Institutes of Health [1R01GM123296-01, 1S10OD020095-01, 1R01NS100081, P30CA006927]; National Science Foundation [CNS-09-58854]; BioMarin Pharmaceuticals; National PKU Alliance; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100081] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020095] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); BioMarin Pharmaceuticals; National PKU Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants 1R01GM123296-01 (to V.A.V.), 1S10OD020095-01, 1R01NS100081 (to E.K.J.), and P30CA006927 (to Fox Chase Cancer Center) and in part by the National Science Foundation through Major Research Instrumentation Grant CNS-09-58854. The in vitro studies were also supported by the National PKU Alliance and BioMarin Pharmaceuticals. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Arturo EC, 2016, P NATL ACAD SCI USA, V113, P2394, DOI 10.1073/pnas.1516967113; Bowman GR, 2015, P NATL ACAD SCI USA, V112, P2734, DOI 10.1073/pnas.1417811112; Carluccio C, 2016, J BIOMOL STRUCT DYN, V34, P497, DOI 10.1080/07391102.2015.1052016; Carluccio C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079482; Case D. A., 2017, AMBER 2017; Daubner SC, 1997, BIOCHEMISTRY-US, V36, P11574, DOI 10.1021/bi9711137; Erlandsen H, 1999, MOL GENET METAB, V68, P103, DOI 10.1006/mgme.1999.2922; Gjetting T, 2001, AM J HUM GENET, V68, P1353, DOI 10.1086/320604; Gu S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003767; GUILLAIN F, 1970, J AM CHEM SOC, V92, P5534, DOI 10.1021/ja00721a051; Harrigan MP, 2017, BIOPHYS J, V112, P10, DOI 10.1016/j.bpj.2016.10.042; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Huang XH, 2014, ADV EXP MED BIOL, V797, P107, DOI 10.1007/978-94-007-7606-7_9; Jaffe EK, 2017, MOL GENET METAB, V121, P289, DOI 10.1016/j.ymgme.2017.06.005; Jaffe EK, 2013, ARCH BIOCHEM BIOPHYS, V530, P73, DOI 10.1016/j.abb.2012.12.017; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; KNAPPSKOG PM, 1995, BIOCHEMISTRY-US, V34, P11790, DOI 10.1021/bi00037a017; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Kokh DB, 2018, J CHEM THEORY COMPUT, V14, P3859, DOI 10.1021/acs.jctc.8b00230; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Leandro J, 2017, FEBS OPEN BIO, V7, P195, DOI 10.1002/2211-5463.12175; Li DW, 2010, ANGEW CHEM INT EDIT, V49, P6778, DOI 10.1002/anie.201001898; Li J, 2011, ARCH BIOCHEM BIOPHYS, V505, P250, DOI 10.1016/j.abb.2010.10.009; Li J, 2010, BIOCHEMISTRY-US, V49, P3327, DOI 10.1021/bi1001294; Malmstrom RD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8588; McGibbon RT, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4916292; Meisburger SP, 2016, J AM CHEM SOC, V138, P6506, DOI 10.1021/jacs.6b01563; Metzner P, 2009, MULTISCALE MODEL SIM, V7, P1192, DOI 10.1137/070699500; Naritomi Y, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4834695; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Noe F, 2009, P NATL ACAD SCI USA, V106, P19011, DOI 10.1073/pnas.0905466106; Oleinikovas V, 2016, J AM CHEM SOC, V138, P14257, DOI 10.1021/jacs.6b05425; Pang XD, 2017, ANNU REV BIOPHYS, V46, P105, DOI 10.1146/annurev-biophys-070816-033639; Patel D, 2016, SCI REP-UK, V6, DOI 10.1038/srep23748; Paul F, 2018, J PHYS CHEM B, V122, P5649, DOI 10.1021/acs.jpcb.7b12146; Perez-Hernandez G, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4811489; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIPS RS, 1984, BIOCHEMISTRY-US, V23, P3836, DOI 10.1021/bi00312a007; Plattner N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8653; Schwantes CR, 2013, J CHEM THEORY COMPUT, V9, P2000, DOI 10.1021/ct300878a; SHIMAN R, 1979, J BIOL CHEM, V254, P1300; Shirts M, 2000, SCIENCE, V290, P1903, DOI 10.1126/science.290.5498.1903; Shirts MR, 2001, PHYS REV LETT, V86, P4983, DOI 10.1103/PhysRevLett.86.4983; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Stanley N, 2016, SCI REP-UK, V6, DOI 10.1038/srep22639; Voelz VA, 2010, J AM CHEM SOC, V132, P1526, DOI 10.1021/ja9090353; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Zhang SN, 2016, J BIOL CHEM, V291, P7418, DOI 10.1074/jbc.M115.709998; Zhang SN, 2014, BIOCHEMISTRY-US, V53, P6625, DOI 10.1021/bi501109s	52	13	13	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19532	19543		10.1074/jbc.RA118.004909	http://dx.doi.org/10.1074/jbc.RA118.004909			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30287685	Green Published, hybrid			2022-12-28	WOS:000454294900003
J	Mana-Capelli, S; McCollum, D				Mana-Capelli, Sebastian; McCollum, Dannel			Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hippo pathway; LATS (Warts; Wts); mechanotransduction; cell signaling; Yes-associated protein (YAP); protein kinase; mammalian sterile 20-like kinase 1 (MST1); mammalian sterile 20-like kinase 2 (MST2); Salvador (Sav); scaffold protein; AMOT; angiomotin; MOB1; SAV1	F-ACTIN; FAMILY PROTEINS; PATHWAY; YAP; DROSOPHILA; PHOSPHORYLATION; ACTIVATION; COMPLEX; BINDING; GROWTH	The Hippo pathway controls cell proliferation, differentiation, and survival by regulating the Yes-associated protein (YAP) transcriptional coactivator in response to various stimuli, including the mechanical environment. The major YAP regulators are the LATS1/2 kinases, which phosphorylate and inhibit YAP. LATS1/2 are activated by phosphorylation on a hydrophobic motif (HM) outside of the kinase domain by MST1/2 and other kinases. Phosphorylation of the HM motif then triggers autophosphorylation of the kinase in the activation loop to fully activate the kinase, a process facilitated by MOB1. The angiomotin family of proteins (AMOT, AMOTL1, and AMOTL2) bind LATS1/2 and promote its kinase activity and YAP phosphorylation through an unknown mechanism. Here we show that angiomotins increase Hippo signaling through multiple mechanisms. We found that, by binding LATS1/2, SAV1, and YAP, angiomotins function as a scaffold that connects LATS1/2 to both its activator SAV1-MST1 and its target YAP. Deletion of all three angiomotins reduced the association of LATS1 with SAV1-MST1 and decreased MST1/2-mediated LATS1/2-HM phosphorylation. Angiomotin deletion also reduced LATS1/2's ability to associate with and phosphorylate YAP. In addition, we found that angiomotins have an unexpected function along with MOB1 to promote autophosphorylation of LATS1/2 on the activation loop motif independent of HM phosphorylation. These results indicate that angiomotins enhance Hippo signaling by stimulating LATS1/2 autophosphorylation and by connecting LATS1/2 with both its activator SAV1-MST1/2 and its substrate YAP.	[Mana-Capelli, Sebastian; McCollum, Dannel] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	McCollum, D (corresponding author), Univ Massachusetts, Sch Med, 364 Plantat St, Worcester, MA 01605 USA.	dannel.mccollum@umassmed.edu			National Institutes of Health [RO1 GM058406]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant RO1 GM058406 (to D. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110; Bae SJ, 2017, ELIFE, V6, DOI [10.7554/eLife.30278.001, 10.7554/eLife.30278]; Cairns L, 2018, J BIOL CHEM, V293, P5532, DOI 10.1074/jbc.RA117.000923; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chan SW, 2013, J BIOL CHEM, V288, P37296, DOI 10.1074/jbc.M113.527598; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Dai XM, 2013, J BIOL CHEM, V288, P34041, DOI 10.1074/jbc.M113.518019; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Hainer SJ, 2015, GENE DEV, V29, P362, DOI 10.1101/gad.253534.114; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; Hoa L, 2016, CELL SIGNAL, V28, P488, DOI 10.1016/j.cellsig.2016.02.012; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Jagannathan R, 2016, MOL CELL BIOL, V36, P2526, DOI 10.1128/MCB.00136-16; Kawahara M, 2008, BLOOD, V112, P3856, DOI 10.1182/blood-2007-09-111773; Kim MJ, 2016, EMBO REP, V17, P64, DOI 10.15252/embr.201540809; Leung CY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3251; Li YJ, 2015, CELL RES, V25, P801, DOI 10.1038/cr.2015.69; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Ma HH, 2012, MOL CELL PROTEOMICS, V11, P501, DOI 10.1074/mcp.O111.016246; Mana-Capelli S, 2014, MOL BIOL CELL, V25, P1676, DOI 10.1091/mbc.E13-11-0701; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Moleirinho S, 2017, ELIFE, V6, DOI 10.7554/eLife.23966; Ni LS, 2015, GENE DEV, V29, P1416, DOI 10.1101/gad.264929.115; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Plouffe SW, 2016, MOL CELL, V64, P993, DOI 10.1016/j.molcel.2016.10.034; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zheng YG, 2015, DEV CELL, V34, P642, DOI 10.1016/j.devcel.2015.08.014	47	40	42	5	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18230	18241		10.1074/jbc.RA118.004187	http://dx.doi.org/10.1074/jbc.RA118.004187			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30266805	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000451375200017
J	Wang, J; Shen, T; Zhu, WQ; Dou, LY; Gu, H; Zhang, LL; Yang, ZY; Chen, HY; Zhou, Q; Sanchez, ER; Field, LJ; Mayo, LD; Xie, ZW; Xiao, DY; Lin, X; Shou, WN; Yong, WD				Wang, Jun; Shen, Tao; Zhu, Wuqiang; Dou, Longyu; Gu, Hao; Zhang, Lingling; Yang, Zhenyun; Chen, Hanying; Zhou, Qi; Sanchez, Edwin R.; Field, Loren J.; Mayo, Lindsey D.; Xie, Zhongwen; Xiao, Deyong; Lin, Xia; Shou, Weinian; Yong, Weidong			Protein phosphatase 5 and the tumor suppressor p53 down-regulate each other's activities in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						p53; cancer; gene knockout; protein serine; threonine phosphatase (PSP); protein phosphorylation; protein phosphatase 5; transcriptional regulation; tumorigenesis; posttranslational regulation; cell stress	NEGATIVE FEEDBACK-REGULATION; WILD-TYPE P53; GLUCOCORTICOID-RECEPTOR; INDUCED PHOSPHORYLATION; IONIZING-RADIATION; OXIDATIVE STRESS; DIRECT BINDING; ACTS UPSTREAM; DNA-BINDING; ACTIVATION	Protein phosphatase 5 (PP5), a serine/threonine phosphatase, has a wide range of biological functions and exhibits elevated expression in tumor cells. We previously reported that pp5-deficient mice have altered ataxia-telangiectasia mutated (ATM)-mediated signaling and function. However, this regulation was likely indirect, as ATM is not a known PP5 substrate. In the current study, we found that pp5-deficient mice are hypersensitive to genotoxic stress. This hypersensitivity was associated with the marked up-regulation of the tumor suppressor tumor protein p53 and its downstream targets cyclin-dependent kinase inhibitor 1A (p21), MDM2 proto-oncogene (MDM2), and phosphatase and tensin homolog (PTEN) in pp5-deficient tissues and cells. These observations suggested that PP5 plays a role in regulating p53 stability and function. Experiments conducted with p53(+/-)pp5(+/-) or p53(+/-)pp5(-/-) mice revealed that complete loss of PP5 reduces tumorigenesis in the p53(+/-) mice. Biochemical analyses further revealed that PP5 directly interacts with and dephosphorylates p53 at multiple serine/threonine residues, resulting in inhibition of p53-mediated transcriptional activity. Interestingly, PP5 expression was significantly up-regulated in p53-deficient cells, and further analysis of pp5 promoter activity revealed that p53 strongly represses PP5 transcription. Our results suggest a reciprocal regulatory interplay between PP5 and p53, providing an important feedback mechanism for the cellular response to genotoxic stress.	[Wang, Jun; Dou, Longyu; Gu, Hao; Zhang, Lingling; Yong, Weidong] Chinese Acad Med Sci, Inst Lab Anim Sci, Comparat Med Ctr, Beijing 100021, Peoples R China; [Zhu, Wuqiang; Yang, Zhenyun; Chen, Hanying; Zhou, Qi; Field, Loren J.; Mayo, Lindsey D.; Shou, Weinian; Yong, Weidong] Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Wang, Jun; Xie, Zhongwen] Anhui Agr Univ, Sch Life Sci, Hefei 230036, Anhui, Peoples R China; [Shen, Tao; Lin, Xia] Baylor Coll Med, DeBakey Dept Surg, Houston, TX 77030 USA; [Sanchez, Edwin R.] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Xiao, Deyong] Fountain Valley Inst Life Sci, Dalian 116023, Peoples R China; [Xiao, Deyong] Fountain Valley Biomed Technol Co, Dalian 116023, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Indiana University System; Indiana University Bloomington; Anhui Agricultural University; Baylor College of Medicine; University System of Ohio; University of Toledo	Yong, WD (corresponding author), Chinese Acad Med Sci, Inst Lab Anim Sci, Comparat Med Ctr, Beijing 100021, Peoples R China.; Shou, WN; Yong, WD (corresponding author), Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.	wshou@iu.edu; wyong@cnilas.org	zhang, lingling/HDM-2189-2022		Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences [CIFMS2017-I2M-3-015]; National Natural Science Foundation of China [NSFC81272273, NSFC31571207]; National Institutes of Health [R01HL181092, P01HL134599]; Fountain Valley Life Science Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132927, P01HL134599] Funding Source: NIH RePORTER	Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fountain Valley Life Science Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences Grant CIFMS2017-I2M-3-015, National Natural Science Foundation of China Grants NSFC81272273 (to W. Y.) and NSFC31571207 (to Z. X.), National Institutes of Health Grants R01HL181092 and P01HL134599 (to W. S.), and the Fountain Valley Life Science Fund (to D. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004; Amable L, 2011, J BIOL CHEM, V286, P40413, DOI 10.1074/jbc.M111.244053; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Atiye J, 2005, GENE CHROMOSOME CANC, V42, P158, DOI 10.1002/gcc.20120; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; BARTON GJ, 1994, EUR J BIOCHEM, V220, P225, DOI 10.1111/j.1432-1033.1994.tb18618.x; Chen MX, 1997, FEBS LETT, V400, P136, DOI 10.1016/S0014-5793(96)01427-5; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; Crescenzi E, 2013, J BIOL CHEM, V288, P16212, DOI 10.1074/jbc.M112.435149; CUMMINGS J, 1991, EUR J CANCER, V27, P532, DOI 10.1016/0277-5379(91)90209-V; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Dean DA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-6; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; Dumble Melissa L, 2003, Methods Mol Biol, V234, P29; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; FISCELLA M, 1993, ONCOGENE, V8, P1519; Freie B, 2003, BLOOD, V102, P4146, DOI 10.1182/blood-2003-03-0971; Golden T, 2008, CANCER METAST REV, V27, P169, DOI 10.1007/s10555-008-9125-z; Golden T, 2008, BBA-MOL BASIS DIS, V1782, P259, DOI 10.1016/j.bbadis.2008.01.004; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hinds TD, 2011, J BIOL CHEM, V286, P42911, DOI 10.1074/jbc.M111.311662; Johnson RA, 2001, J BIOL CHEM, V276, P27716, DOI 10.1074/jbc.C100121200; Kang H, 2001, BIOCHEMISTRY-US, V40, P10485, DOI 10.1021/bi010999i; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li DWC, 2006, ONCOGENE, V25, P3006, DOI 10.1038/sj.onc.1209334; Li LW, 2000, J BIOL CHEM, V275, P2410, DOI 10.1074/jbc.275.4.2410; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Luo KT, 2017, EMBO J, V36, P1434, DOI 10.15252/embj.201695669; Mayo LD, 2005, J BIOL CHEM, V280, P25953, DOI 10.1074/jbc.M503026200; McKay BC, 1998, ONCOGENE, V17, P545, DOI 10.1038/sj.onc.1201963; McKenzie L, 2010, CELL CYCLE, V9, P4200, DOI 10.4161/cc.9.20.13532; McVean M, 2000, CARCINOGENESIS, V21, P633, DOI 10.1093/carcin/21.4.633; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Messner DJ, 2006, J CELL BIOCHEM, V99, P241, DOI 10.1002/jcb.20919; Mi J, 2009, MOL CANCER THER, V8, P135, DOI 10.1158/1535-7163.MCT-08-0457; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Munugalavadla V, 2007, BLOOD, V110, P1612, DOI 10.1182/blood-2006-10-053058; Oberoi J, 2016, P NATL ACAD SCI USA, V113, P9009, DOI 10.1073/pnas.1603059113; Pazdrak K, 2016, J IMMUNOL, V197, P3782, DOI 10.4049/jimmunol.1601029; PU Y, 1995, J APPL TOXICOL, V15, P477, DOI 10.1002/jat.2550150609; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; SCHEIDTMANN KH, 1991, MOL CELL BIOL, V11, P1996, DOI 10.1128/MCB.11.4.1996; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Sekine Y, 2012, MOL CELL, V48, P692, DOI 10.1016/j.molcel.2012.09.018; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sluss HK, 2004, MOL CELL BIOL, V24, P976, DOI 10.1128/MCB.24.3.976-984.2004; St Clair S, 2004, MOL CELL, V16, P725; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; TAKENAKA I, 1995, J BIOL CHEM, V270, P5405, DOI 10.1074/jbc.270.10.5405; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Urban G, 2001, J BIOL CHEM, V276, P27638, DOI 10.1074/jbc.M103512200; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Woo RA, 1998, NATURE, V394, P700, DOI 10.1038/29343; Yang ZY, 2009, MOL CELL BIOL, V29, P4376, DOI 10.1128/MCB.01330-08; Yang ZC, 2006, MOL ENDOCRINOL, V20, P2682, DOI 10.1210/me.2006-0024; Yong WD, 2007, J BIOL CHEM, V282, P14690, DOI 10.1074/jbc.C700019200; Zhang J, 2005, MOL CELL BIOL, V25, P9910, DOI 10.1128/MCB.25.22.9910-9919.2005; Zhang Y, 2009, J BIOL CHEM, V284, P24542, DOI 10.1074/jbc.M109.021469; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700; Zuo Z, 1998, J BIOL CHEM, V273, P12250, DOI 10.1074/jbc.273.20.12250	72	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18218	18229		10.1074/jbc.RA118.004256	http://dx.doi.org/10.1074/jbc.RA118.004256			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30262665	Green Published, hybrid			2022-12-28	WOS:000451375200016
J	Gong, WB; Hu, WH; Xu, LN; Wu, HW; Wu, S; Zhang, H; Wang, JF; Jones, GW; Perrett, S				Gong, Weibin; Hu, Wanhui; Xu, Linan; Wu, Huiwen; Wu, Si; Zhang, Hong; Wang, Jinfeng; Jones, Gary W.; Perrett, Sarah			The C-terminal GGAP motif of Hsp70 mediates substrate recognition and stress response in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; chaperone; heat shock protein (HSP); nuclear magnetic resonance (NMR); protein structure; Saccharomyces cerevisiae; stress response; SUMO-interacting motif (SIM); prion; proline-rich motif	MOLECULAR CHAPERONE DNAK; HEAT-SHOCK RESPONSE; PRION PROTEIN URE2; SACCHAROMYCES-CEREVISIAE; IN-VITRO; ALPHA-SYNUCLEIN; BINDING DOMAIN; NOE ASSIGNMENT; NMR; HEAT-SHOCK-PROTEIN-70	The allosteric coupling of the highly conserved nucleotide- and substrate-binding domains of Hsp70 has been studied intensively. In contrast, the role of the disordered, highly variable C-terminal region of Hsp70 remains unclear. In many eukaryotic Hsp70s, the extreme C-terminal EEVD motif binds to the tetratricopeptide-repeat domains of Hsp70 co-chaperones. Here, we discovered that the TVEEVD sequence of Saccharomyces cerevisiae cytoplasmic Hsp70 (Ssa1) functions as a SUMO-interacting motif. A second C-terminal motif of approximate to 15 amino acids between the -helical lid and the extreme C terminus, previously identified in bacterial and eukaryotic organellar Hsp70s, is known to enhance chaperone function by transiently interacting with folding clients. Using structural analysis, interaction studies, fibril formation assays, and in vivo functional assays, we investigated the individual contributions of the -helical bundle and the C-terminal disordered region of Ssa1 in the inhibition of fibril formation of the prion protein Ure2. Our results revealed that although the -helical bundle of the Ssa1 substrate-binding domain (SBD) does not directly bind to Ure2, the SBD enhances the ability of Hsp70 to inhibit fibril formation. We found that a 20-residue C-terminal motif in Ssa1, containing GGAP and GGAP-like tetrapeptide repeats, can directly bind to Ure2, the Hsp40 co-chaperone Ydj1, and -synuclein, but not to the SUMO-like protein SMT3 or BSA. Deletion or substitution of the Ssa1 GGAP motif impaired yeast cell tolerance to temperature and cell-wall damage stress. This study highlights that the C-terminal GGAP motif of Hsp70 is important for substrate recognition and mediation of the heat shock response.	[Gong, Weibin; Hu, Wanhui; Wu, Huiwen; Wu, Si; Zhang, Hong; Wang, Jinfeng; Perrett, Sarah] Chinese Acad Sci, Inst Biophys, Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Hu, Wanhui; Wu, Huiwen; Wu, Si; Zhang, Hong; Perrett, Sarah] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Xu, Linan; Jones, Gary W.] Maynooth Univ, Dept Biol, Maynooth W23 W6R7, Kildare, Ireland; [Hu, Wanhui] ShanghaiTech Univ, iHuman Inst, Ren Bldg,393 Middle Huaxia Rd, Shanghai 201210, Peoples R China; [Wu, Huiwen] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Maynooth University; ShanghaiTech University; Scripps Research Institute	Jones, GW (corresponding author), Leeds Beckett Univ, Sch Clin & Appl Sci, Ctr Biomed Sci Res, Portland Bldg,City Campus, Leeds LS1 3HE, W Yorkshire, England.; Perrett, S (corresponding author), Chinese Acad Sci, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.	Gary.Jones@leedsbeckett.ac.uk; sarah.perrett@cantab.net	Perrett, Sarah/AAS-9483-2020	Perrett, Sarah/0000-0003-0137-0997; Jones, Gary/0000-0002-7565-934X; Xu, Linan/0000-0003-3912-6586	National Key R&D Program of China [2017YFA0504000]; National Natural Science Foundation of China [31570780, 31200578, 31470747, 31770829, 31300631, 21673278]; Beijing Natural Science Foundation [5172026]; National Laboratory of Biomacromolecules; Chinese Academy of Sciences Centre of Excellence in Biomacromolecules; John and Pat Hume Ph.D. scholarship from Maynooth University; Science Foundation Ireland [SFI/13/ISCA/2845]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Laboratory of Biomacromolecules; Chinese Academy of Sciences Centre of Excellence in Biomacromolecules; John and Pat Hume Ph.D. scholarship from Maynooth University; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by National Key R&D Program of China Grant 2017YFA0504000; National Natural Science Foundation of China Grants 31570780, 31200578, 31470747, 31770829, 31300631, and 21673278; Beijing Natural Science Foundation Grant 5172026; funds from the National Laboratory of Biomacromolecules and the Chinese Academy of Sciences Centre of Excellence in Biomacromolecules; a John and Pat Hume Ph.D. scholarship from Maynooth University (to L.X.); and Science Foundation Ireland Grant SFI/13/ISCA/2845 (to the G. W. J. laboratory). The authors declare that they have no conflicts of interest with the contents of this article.	Alderson TR, 2016, STRUCTURE, V24, P1014, DOI 10.1016/j.str.2016.05.011; Aron R, 2005, GENETICS, V169, P1873, DOI 10.1534/genetics.104.037242; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bush GL, 1996, J CELL BIOL, V135, P1229, DOI 10.1083/jcb.135.5.1229; Cherkasov V, 2013, CURR BIOL, V23, P2452, DOI 10.1016/j.cub.2013.09.058; Cho ES, 2012, J ENVIRON BIOL, V33, P609; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Cui ZX, 2010, FISH SHELLFISH IMMUN, V28, P56, DOI 10.1016/j.fsi.2009.09.018; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL, 2002, PYMOL USERS MANUAL; Demand J, 1998, MOL CELL BIOL, V18, P2023, DOI 10.1128/MCB.18.4.2023; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Fu WD, 2013, FISH SHELLFISH IMMUN, V34, P1306, DOI 10.1016/j.fsi.2013.02.027; Gao XC, 2012, J BIOL CHEM, V287, P6044, DOI 10.1074/jbc.M111.294728; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hu WH, 2015, BIOMOL NMR ASSIGN, V9, P329, DOI 10.1007/s12104-015-9603-5; Huang CJ, 2006, J MOL BIOL, V364, P323, DOI 10.1016/j.jmb.2006.08.062; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones G, 2004, MOL CELL BIOL, V24, P3928, DOI 10.1128/MCB.24.9.3928-3937.2004; Jones GW, 2003, GENETICS, V163, P495; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; Krzewska J, 2006, EMBO J, V25, P822, DOI 10.1038/sj.emboj.7600985; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li JZ, 2006, BIOCHEM J, V398, P353, DOI 10.1042/BJ20060618; Lian HY, 2007, J BIOL CHEM, V282, P11931, DOI 10.1074/jbc.M606856200; Lian HY, 2006, BBA-PROTEINS PROTEOM, V1764, P535, DOI 10.1016/j.bbapap.2005.11.016; Lyons RE, 1998, INT J PARASITOL, V28, P1041, DOI 10.1016/S0020-7519(98)00074-5; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Mayer MP, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00058; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Peisker K, 2010, BBA-MOL CELL RES, V1803, P662, DOI 10.1016/j.bbamcr.2010.03.005; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Pemberton S, 2011, J BIOL CHEM, V286, P34690, DOI 10.1074/jbc.M111.261321; Perrett S, 1999, J MOL BIOL, V290, P331, DOI 10.1006/jmbi.1999.2872; Piano A, 2005, GENE, V361, P119, DOI 10.1016/j.gene.2005.06.034; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Savistchenko J, 2008, J BIOL CHEM, V283, P15732, DOI 10.1074/jbc.M800728200; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; Schlumpberger M, 2001, MOL CELL BIOL, V21, P7035, DOI 10.1128/MCB.21.20.7035-7046.2001; Schwimmer C, 2002, MOL CELL BIOL, V22, P3590, DOI 10.1128/MCB.22.11.3590-3598.2002; Sharma D, 2008, GENETICS, V179, P1301, DOI 10.1534/genetics.108.089458; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Sheng WY, 2002, PROTEIN SCI, V11, P1482, DOI 10.1110/ps.0201602; Smock RG, 2011, J BIOL CHEM, V286, P31821, DOI 10.1074/jbc.M111.265835; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Wen DH, 2014, J PROTEOME RES, V13, P3571, DOI 10.1021/pr4012848; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wu SJ, 2001, BIOCHEM J, V359, P419, DOI 10.1042/0264-6021:3590419; Xu LQ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0410; Xu LA, 2018, CELL MOL LIFE SCI, V75, P1445, DOI 10.1007/s00018-017-2698-3; Yu HY, 2015, FEBS LETT, V589, P2825, DOI 10.1016/j.febslet.2015.07.040; Yu HY, 2015, J MOL BIOL, V427, P1632, DOI 10.1016/j.jmb.2015.02.007; Zhang H, 2016, J BIOL CHEM, V291, P6967, DOI 10.1074/jbc.M115.673608; Zhang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103518; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	68	17	17	4	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17663	17675		10.1074/jbc.RA118.002691	http://dx.doi.org/10.1074/jbc.RA118.002691			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30228181	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000450409500001
J	Patel, MP; Hu, LY; Brown, CA; Sun, ZZ; Adamski, CJ; Stojanoski, V; Sankaran, B; Prasad, BVV; Palzkill, T				Patel, Meha P.; Hu, Liya; Brown, Cameron A.; Sun, Zhizeng; Adamski, Carolyn J.; Stojanoski, Vlatko; Sankaran, Banumathi; Prasad, B. V. Venkataram; Palzkill, Timothy			Synergistic effects of functionally distinct substitutions in -lactamase variants shed light on the evolution of bacterial drug resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug resistance; enzyme kinetics; enzyme catalysis; protein evolution; protein structure; protein stability; protein drug interaction; conformational change; antibiotic resistance; -lactamase	TEM-1 BETA-LACTAMASE; ESCHERICHIA-COLI; ACTIVE-SITE; CRYSTALLOGRAPHIC STRUCTURE; CEFTAZIDIME RESISTANCE; ANTIBIOTIC-RESISTANCE; MOLECULAR REPLACEMENT; GLOBAL SUPPRESSOR; CRYSTAL-STRUCTURE; CLONED GENES	The CTX-M -lactamases have emerged as the most widespread extended-spectrum -lactamases (ESBLs) in Gram-negative bacteria. These enzymes rapidly hydrolyze cefotaxime, but not the related cephalosporin, ceftazidime. ESBL variants have evolved, however, that provide enhanced ceftazidime resistance. We show here that a natural variant at a nonactive site, i.e. second-shell residue N106S, enhances enzyme stability but reduces catalytic efficiency for cefotaxime and ceftazidime and decreases resistance levels. However, when the N106S variant was combined with an active-site variant, D240G, that enhances enzyme catalytic efficiency, but decreases stability, the resultant double mutant exhibited higher resistance levels than predicted on the basis of the phenotypes of each variant. We found that this epistasis is due to compensatory effects, whereby increased stability provided by N106S overrides its cost of decreased catalytic activity. X-ray structures of the variant enzymes in complex with cefotaxime revealed conformational changes in the active-site loop spanning residues 103-106 that were caused by the N106S substitution and relieve steric strain to stabilize the enzyme, but also alter contacts with cefotaxime and thereby reduce catalytic activity. We noted that the 103-106 loop conformation in the N106S-containing variants is different from that of WT CTX-M but nearly identical to that of the non-ESBL, TEM-1 -lactamase, having a serine at the 106 position. Therefore, residue 106 may serve as a switch that toggles the conformations of the 103-106 loop. When it is serine, the loop is in the non-ESBL, TEM-like conformation, and when it is asparagine, the loop is in a CTX-M-like, cefotaximase-favorable conformation.	[Patel, Meha P.] Baylor Coll Med, Interdept Grad Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Hu, Liya; Adamski, Carolyn J.; Stojanoski, Vlatko; Prasad, B. V. Venkataram; Palzkill, Timothy] Baylor Coll Med, Verna Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Patel, Meha P.; Brown, Cameron A.; Sun, Zhizeng; Adamski, Carolyn J.; Stojanoski, Vlatko; Palzkill, Timothy] Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA; [Sankaran, Banumathi] Lawrence Berkeley Natl Lab, Dept Mol Biophys & Integrated Bioimaging, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Palzkill, T (corresponding author), One Baylor Plaza, Houston, TX 77030 USA.	timothyp@bcm.edu		Brown, Cameron/0000-0002-8886-1328	NIGMS from the National Institutes of Health [P30 GM124169-01]; Department of Energy Office of Science User Facility [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM124169] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021832] Funding Source: NIH RePORTER	NIGMS from the National Institutes of Health; Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Hiram Gilbert for discussions and comments on the manuscript. The ALS-ENABLE beamlines are supported in part by NIGMS Grant P30 GM124169-01 from the National Institutes of Health. The Advanced Light Source is a Department of Energy Office of Science User Facility under Contract No. DE-AC02-05CH11231.	Adamski CJ, 2015, BIOCHEMISTRY-US, V54, P447, DOI 10.1021/bi501195g; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; AMANN E, 1983, GENE, V25, P167, DOI 10.1016/0378-1119(83)90222-6; Bar-Even A, 2015, BIOCHEMISTRY-US, V54, P4969, DOI 10.1021/acs.biochem.5b00621; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Blomberg R, 2013, NATURE, V503, P418, DOI 10.1038/nature12623; Bonnet R, 2001, ANTIMICROB AGENTS CH, V45, P2269, DOI 10.1128/AAC.45.8.2269-2275.2001; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Bonomo Robert A, 2017, Cold Spring Harb Perspect Med, V7, DOI 10.1101/cshperspect.a025239; Brereton AE, 2016, PROTEIN SCI, V25, P926, DOI 10.1002/pro.2883; Brown NG, 2010, J MOL BIOL, V404, P832, DOI 10.1016/j.jmb.2010.10.008; Campbell E, 2016, NAT CHEM BIOL, V12, P944, DOI [10.1038/NCHEMBIO.2175, 10.1038/nchembio.2175]; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Chellapa GD, 2015, PROTEINS, V83, P1687, DOI 10.1002/prot.24854; Chen Y, 2005, J MOL BIOL, V348, P349, DOI 10.1016/j.jmb.2005.02.010; D'Andrea MM, 2013, INT J MED MICROBIOL, V303, P305, DOI 10.1016/j.ijmm.2013.02.008; Dellus-Gur E, 2015, J MOL BIOL, V427, P2396, DOI 10.1016/j.jmb.2015.05.011; Delmas J, 2006, ANTIMICROB AGENTS CH, V50, P731, DOI 10.1128/AAC.50.2.731-738.2006; Delmas J, 2010, J MOL BIOL, V400, P108, DOI 10.1016/j.jmb.2010.04.062; Doucet N, 2007, PROTEINS, V69, P340, DOI 10.1002/prot.21485; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FONZE E, 1995, ACTA CRYSTALLOGR D, V51, P682, DOI 10.1107/S0907444994014496; Gonzalez MM, 2016, MOL BIOL EVOL, V33, P1768, DOI 10.1093/molbev/msw052; Hart KM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12965; Huang WZ, 1997, P NATL ACAD SCI USA, V94, P8801, DOI 10.1073/pnas.94.16.8801; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; Jimenez-Oses G, 2014, NAT CHEM BIOL, V10, P431, DOI 10.1038/nchembio.1503; Perez-Llarena FJ, 2011, ANTIMICROB AGENTS CH, V55, P4361, DOI 10.1128/AAC.00298-11; Kimura S, 2004, ANTIMICROB AGENTS CH, V48, P1454, DOI 10.1128/AAC.48.5.1454-1460.2004; Lim D, 2001, NAT STRUCT BIOL, V8, P848, DOI 10.1038/nsb1001-848; Livermore DM, 2006, TRENDS MICROBIOL, V14, P413, DOI 10.1016/j.tim.2006.07.008; Marciano DC, 2008, J MOL BIOL, V384, P151, DOI 10.1016/j.jmb.2008.09.009; Mehta SC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004949; MOBASHERY S, 1986, J BIOL CHEM, V261, P7879; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Novais A, 2008, ANTIMICROB AGENTS CH, V52, P2377, DOI 10.1128/AAC.01658-07; Otten R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03562-9; Palzkill T, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00016; Patel MP, 2017, BIOCHEMISTRY-US, V56, P3443, DOI 10.1021/acs.biochem.7b00176; Patel MP, 2015, ANTIMICROB AGENTS CH, V59, P6741, DOI 10.1128/AAC.00618-15; Perez F, 2007, CURR OPIN PHARMACOL, V7, P459, DOI 10.1016/j.coph.2007.08.003; Petrosino J, 1999, J BIOL CHEM, V274, P2394, DOI 10.1074/jbc.274.4.2394; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRATT RF, 1986, J AM CHEM SOC, V108, P5328, DOI 10.1021/ja00277a044; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Scholtz J. M., 1989, PROTEIN STRUCTURE PR; Shimamura T, 2002, J BIOL CHEM, V277, P46601, DOI 10.1074/jbc.M207884200; Sideraki V, 2001, P NATL ACAD SCI USA, V98, P283, DOI 10.1073/pnas.011454198; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P290, DOI 10.1038/nsb0396-290; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P688, DOI 10.1038/nsb0896-688; Studer RA, 2014, P NATL ACAD SCI USA, V111, P2223, DOI 10.1073/pnas.1310811111; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vandavasi VG, 2016, J MED CHEM, V59, P474, DOI 10.1021/acs.jmedchem.5b01215; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiao H, 2015, P NATL ACAD SCI USA, V112, P6961, DOI 10.1073/pnas.1507741112; Yang G, 2016, BIOCHEMISTRY-US, V55, P4583, DOI 10.1021/acs.biochem.6b00561	61	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17971	17984		10.1074/jbc.RA118.003792	http://dx.doi.org/10.1074/jbc.RA118.003792			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30275013	Green Published, hybrid			2022-12-28	WOS:000450409500025
J	Subedi, GP; Barb, AW				Subedi, Ganesh P.; Barb, Adam W.			CD16a with oligomannose-type N-glycans is the only "low-affinity" Fc gamma receptor that binds the IgG crystallizable fragment with high affinity in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fc receptor; Fc-gamma receptor; antibody; N-linked glycosylation; post-translational modification (PTM)	LINKED OLIGOSACCHARIDE; GLYCOSYLATION PATTERN; RHEUMATOID-ARTHRITIS; IMMUNOGLOBULIN G1; ANTIBODY; CARBOHYDRATE; GLYCOFORMS; CYTOTOXICITY; RITUXIMAB; CELLS	Fc receptors (FcRs) bind circulating IgG (IgG1) at the surface of leukocytes. Antibodies clustered at the surface of a targeted particle trigger a protective immune response through activating FcRs. Three recent reports indicate that the composition of the asparagine-linked carbohydrate chains (N-glycans) of FcRIIIa/CD16a impacted IgG1-binding affinity. Here we determined how N-glycan composition affected the affinity of the low-affinity FcRs for six homogeneous IgG1 Fc N-glycoforms (G0, G0F, G2, G2F, A2G2, and A2G2F). Surprisingly, CD16a with oligomannose N-glycans bound to IgG1 Fc (A2G2) with a K-D = 1.0 +/- 0.1 nm. This affinity represents a 51-fold increase over the affinity measured for CD16a with complex-type N-glycans (51 +/- 8 nm) and is comparable with the affinity of FcRI/CD64, the sole high-affinity FcR. CD16a N-glycan composition accounted for increases in binding affinity for the other IgG1 Fc glycoforms tested (10-50-fold). This remarkable sensitivity could only be eliminated by preventing glycosylation at Asn(162) with an Asn-to-Gln mutation; mutations at the four other N-glycosylation sites preserved tighter binding in the Man5 glycoform. None of the other low-affinity FcRs showed more than a 3.1-fold increase upon modifying the receptor N-glycan composition, including CD16b, which differs from CD16a by only four amino acid residues. This result indicates that CD16a is unique among the low-affinity FcRs, and modifying only the glycan composition of both the IgG1 Fc ligand and receptor provides a 400-fold range in affinities.	[Subedi, Ganesh P.; Barb, Adam W.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, 4210 Mol Biol Bldg, Ames, IA 50011 USA	Iowa State University	Barb, AW (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, 4210 Mol Biol Bldg, Ames, IA 50011 USA.	abarb@iastate.edu		Barb, Adam/0000-0003-3290-8649	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115489] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM115489] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Dall'Ozzo S, 2004, CANCER RES, V64, P4664, DOI 10.1158/0008-5472.CAN-03-2862; Dekkers G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00877; Edberg JC, 1997, J IMMUNOL, V159, P3849; Estupina P, 2017, ONCOTARGET, V8, P37061, DOI 10.18632/oncotarget.15715; Falconer DJ, 2018, ACS CHEM BIOL, V13, P2179, DOI 10.1021/acschembio.8b00342; Ferrara C, 2006, J BIOL CHEM, V281, P5032, DOI 10.1074/jbc.M510171200; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Golay J, 2013, BLOOD, V122, P3482, DOI 10.1182/blood-2013-05-504043; Guu SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178927; Hayes JM, 2017, MOL CELL PROTEOMICS, V16, P1770, DOI 10.1074/mcp.M117.066944; Hayes JM, 2014, J PROTEOME RES, V13, P5471, DOI 10.1021/pr500414q; Kapur R, 2014, BLOOD, V123, P471, DOI 10.1182/blood-2013-09-527978; Kristic J, 2014, J GERONTOL A-BIOL, V69, P779, DOI 10.1093/gerona/glt190; Liu D, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1161-1; Lux A, 2013, J IMMUNOL, V190, P4315, DOI 10.4049/jimmunol.1200501; Menni C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082558; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Nimmerjahn F, 2015, TRENDS IMMUNOL, V36, P325, DOI 10.1016/j.it.2015.04.005; NOSE M, 1983, P NATL ACAD SCI-BIOL, V80, P6632, DOI 10.1073/pnas.80.21.6632; Okeley NM, 2013, P NATL ACAD SCI USA, V110, P5404, DOI 10.1073/pnas.1222263110; Oliva KD, 2018, J BIOL CHEM, V293, P3490, DOI 10.1074/jbc.H118.001955; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Park DI, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17500-0; Patel KR, 2018, J BIOL CHEM, V293, P3477, DOI 10.1074/jbc.RA117.001207; Peschke B, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00646; Pezer M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33198; Reddy V, 2017, RHEUMATOLOGY, V56, P1227, DOI 10.1093/rheumatology/kex067; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Russell AC, 2017, GLYCOBIOLOGY, V27, P501, DOI 10.1093/glycob/cwx022; Sakae Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13845-8; Shibata-Koyama M, 2009, GLYCOBIOLOGY, V19, P126, DOI 10.1093/glycob/cwn110; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; STANLEY P, 1975, P NATL ACAD SCI USA, V72, P3323, DOI 10.1073/pnas.72.9.3323; Stork ACJ, 2014, J NEUROL NEUROSUR PS, V85, P916, DOI 10.1136/jnnp-2013-306958; Subedi GP, 2017, BIOCHEMISTRY-US, V56, P3174, DOI 10.1021/acs.biochem.7b00392; Subedi GP, 2016, MABS-AUSTIN, V8, P1512, DOI 10.1080/19420862.2016.1218586; Subedi GP, 2015, JOVE-J VIS EXP, DOI 10.3791/53568; Subedi GP, 2015, STRUCTURE, V23, P1573, DOI 10.1016/j.str.2015.06.015; Subedi GP, 2014, STRUCTURE, V22, P1478, DOI 10.1016/j.str.2014.08.002; TAI T, 1975, BIOCHEM BIOPH RES CO, V65, P968, DOI 10.1016/S0006-291X(75)80480-3; Takahashi N, 2002, GLYCOBIOLOGY, V12, P507, DOI 10.1093/glycob/cwf063; Vuckovic F, 2016, CLIN CANCER RES, V22, P3078, DOI 10.1158/1078-0432.CCR-15-1867; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Yagi H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21145-y; Yamaguchi Y, 2006, BBA-GEN SUBJECTS, V1760, P693, DOI 10.1016/j.bbagen.2005.10.002; Zeck A, 2011, J PROTEOME RES, V10, P3031, DOI 10.1021/pr1012653	51	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16842	16850		10.1074/jbc.RA118.004998	http://dx.doi.org/10.1074/jbc.RA118.004998			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30213862	hybrid, Green Published			2022-12-28	WOS:000448515100024
J	Trotman, JB; Agana, BA; Giltmier, AJ; Wysocki, VH; Schoenberg, DR				Trotman, Jackson B.; Agana, Bernice A.; Giltmier, Andrew J.; Wysocki, Vicki H.; Schoenberg, Daniel R.			RNA-binding proteins and heat-shock protein 90 are constituents of the cytoplasmic capping enzyme interactome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA-binding protein; RNA processing; heat shock protein 90 (HSP90); proteomics; gene expression; capping enzyme; cytoplasmic capping; protein interactome; RNA stability; RNGTT	CAP HOMEOSTASIS; MAMMALIAN-CELLS; HSP90; IDENTIFICATION; TRANSCRIPTOME; REVEALS; CLIENTS	The N-7-methylguanosine cap is added in the nucleus early in gene transcription and is a defining feature of eukaryotic mRNAs. Mammalian cells also possess cytoplasmic machinery for restoring the cap at uncapped or partially degraded RNA 5 ends. Central to both pathways is capping enzyme (CE) (RNA guanylyltransferase and 5-phosphatase (RNGTT)), a bifunctional, nuclear and cytoplasmic enzyme. CE is recruited to the cytoplasmic capping complex by binding of a C-terminal proline-rich sequence to the third Src homology 3 (SH3) domain of NCK adapter protein 1 (NCK1). To gain broader insight into the cellular context of cytoplasmic recapping, here we identified the protein interactome of cytoplasmic CE in human U2OS cells through two complementary approaches: chemical cross-linking and recovery with cytoplasmic CE and protein screening with proximity-dependent biotin identification (BioID). This strategy unexpectedly identified 66 proteins, 52 of which are RNA-binding proteins. We found that CE interacts with several of these proteins independently of RNA, mediated by sequences within its N-terminal triphosphatase domain, and we present a model describing how CE-binding proteins may function in defining recapping targets. This analysis also revealed that CE is a client protein of heat shock protein 90 (HSP90). Nuclear and cytoplasmic CEs were exquisitely sensitive to inhibition of HSP90, with both forms declining significantly following treatment with each of several HSP90 inhibitors. Importantly, steady-state levels of capped mRNAs decreased in cells treated with the HSP90 inhibitor geldanamycin, raising the possibility that the cytotoxic effect of these drugs may partially be due to a general reduction in translatable mRNAs.	[Trotman, Jackson B.; Agana, Bernice A.; Giltmier, Andrew J.; Wysocki, Vicki H.; Schoenberg, Daniel R.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Trotman, Jackson B.; Agana, Bernice A.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Trotman, Jackson B.; Giltmier, Andrew J.; Schoenberg, Daniel R.] Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA; [Agana, Bernice A.; Wysocki, Vicki H.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Trotman, Jackson B.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Trotman, Jackson B.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Schoenberg, DR (corresponding author), Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA.	schoenberg.3@osu.edu	Schoenberg, Daniel/J-3423-2019	Schoenberg, Daniel/0000-0003-4570-1946; Trotman, Jackson/0000-0003-3133-2393	NATIONAL CANCER INSTITUTE [T32CA217824, P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084177] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA217824, P30 CA016058] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aregger M, 2017, RNA BIOL, V14, P11, DOI 10.1080/15476286.2016.1251540; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen PS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03443-z; Chu C, 2008, MOL CELL BIOL, V28, P5829, DOI 10.1128/MCB.00021-08; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Fang QM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6513; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Gonatopoulos-Pournatzis T, 2011, MOL CELL, V44, P585, DOI 10.1016/j.molcel.2011.08.041; Ignatochkina AV, 2015, P NATL ACAD SCI USA, V112, P6967, DOI 10.1073/pnas.1424909112; Jiao XF, 2013, MOL CELL, V50, P104, DOI 10.1016/j.molcel.2013.02.017; Karagoz GE, 2015, TRENDS BIOCHEM SCI, V40, P117, DOI 10.1016/j.tibs.2014.12.002; Kiss DL, 2016, NUCLEIC ACIDS RES, V44, P304, DOI 10.1093/nar/gkv1460; Kiss DL, 2015, FEBS LETT, V589, P279, DOI 10.1016/j.febslet.2014.12.009; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Mercer TR, 2010, GENOME RES, V20, P1639, DOI 10.1101/gr.112128.110; Milek M, 2017, GENOME RES, V27, P1344, DOI 10.1101/gr.218438.116; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Mukherjee C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001933; Mukherjee C, 2012, CELL REP, V2, P674, DOI 10.1016/j.celrep.2012.07.011; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Otsuka Y, 2009, MOL CELL BIOL, V29, P2155, DOI 10.1128/MCB.01325-08; Ramanathan A, 2016, NUCLEIC ACIDS RES, V44, P7511, DOI 10.1093/nar/gkw551; Rohl A, 2013, TRENDS BIOCHEM SCI, V38, P253, DOI 10.1016/j.tibs.2013.02.003; Song MG, 2010, MOL CELL, V40, P423, DOI 10.1016/j.molcel.2010.10.010; Srinivasa S, 2015, METHODS, V89, P91, DOI 10.1016/j.ymeth.2015.05.006; Tago K, 2004, MOL CELL ENDOCRINOL, V213, P131, DOI 10.1016/j.mce.2003.10.057; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Trendel J., 2018, BIORXIV, DOI [10.1101/329995, DOI 10.1101/329995]; Trotman JB, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2767; Trotman JB, 2017, NUCLEIC ACIDS RES, V45, P10726, DOI 10.1093/nar/gkx801; ULLRICH SJ, 1989, J BIOL CHEM, V264, P6810; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Youn JY, 2018, MOL CELL, V69, P517, DOI 10.1016/j.molcel.2017.12.020; Zuehlke AD, 2018, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0527	35	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16596	16607		10.1074/jbc.RA118.004973	http://dx.doi.org/10.1074/jbc.RA118.004973			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30166341	Green Published, hybrid			2022-12-28	WOS:000448515100005
J	Young, PA; Senkal, CE; Suchanek, AL; Grevengoed, TJ; Lin, DD; Zhao, LY; Crunk, AE; Klett, EL; Fullekrug, J; Obeid, LM; Coleman, RA				Young, Pamela A.; Senkal, Can E.; Suchanek, Amanda L.; Grevengoed, Trisha J.; Lin, Dennis D.; Zhao, Liyang; Crunk, Amanda E.; Klett, Eric L.; Fuellekrug, Joachim; Obeid, Lina M.; Coleman, Rosalind A.			Long-chain acyl-CoA synthetase 1 interacts with key proteins that activate and direct fatty acids into niche hepatic pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein-protein interaction; ceramide synthase; -oxidation; peroxisome; lipid droplet; mitochondria; hepatocyte; acyl-CoA synthetase-1; BioID; SNAP23	TANDEM MASS-SPECTROMETRY; CONTAINING 3 ACBD3; LIPID DROPLETS; BETA-OXIDATION; SUBCELLULAR-LOCALIZATION; MITOCHONDRIAL FUSION; INTERACTION NETWORKS; INSULIN SENSITIVITY; STATISTICAL-MODEL; MAMMALIAN-CELLS	Fatty acid channeling into oxidation or storage modes depends on physiological conditions and hormonal signaling. However, the directionality of this channeling may also depend on the association of each of the five acyl-CoA synthetase isoforms with specific protein partners. Long-chain acyl-CoA synthetases (ACSLs) catalyze the conversion of long-chain fatty acids to fatty acyl-CoAs, which are then either oxidized or used in esterification reactions. In highly oxidative tissues, ACSL1 is located on the outer mitochondrial membrane (OMM) and directs fatty acids into mitochondria for -oxidation. In the liver, however, about 50% of ACSL1 is located on the endoplasmic reticulum (ER) where its metabolic function is unclear. Because hepatic fatty acid partitioning is likely to require the interaction of ACSL1 with other specific proteins, we used an unbiased protein interaction technique, BioID, to discover ACSL1-binding partners in hepatocytes. We targeted ACSL1 either to the ER or to the OMM of Hepa 1-6 cells as a fusion protein with the Escherichia coli biotin ligase, BirA*. Proteomic analysis identified 98 proteins that specifically interacted with ACSL1 at the ER, 55 at the OMM, and 43 common to both subcellular locations. We found subsets of peroxisomal and lipid droplet proteins, tethering proteins, and vesicle proteins, uncovering a dynamic role for ACSL1 in organelle and lipid droplet interactions. Proteins involved in lipid metabolism were also identified, including acyl-CoA-binding proteins and ceramide synthase isoforms 2 and 5. Our results provide fundamental and detailed insights into protein interaction networks that control fatty acid metabolism.	[Young, Pamela A.; Suchanek, Amanda L.; Grevengoed, Trisha J.; Lin, Dennis D.; Zhao, Liyang; Crunk, Amanda E.; Klett, Eric L.; Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Klett, Eric L.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Senkal, Can E.; Obeid, Lina M.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Fuellekrug, Joachim] Heidelberg Univ, Otto Meyerhof Zentrum, Heidelberg Univ Hosp, Mol Cell Biol Lab,Internal Med 4, D-69120 Heidelberg, Germany	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Ruprecht Karls University Heidelberg	Coleman, RA (corresponding author), Univ N Carolina, Dept Nutr, Michael Hooker Res Ctr 2301, Dauer Dr, Chapel Hill, NC 27599 USA.	rcoleman@unc.edu	Grevengoed, Trisha/AAA-3980-2021; Suchanek, Amanda/HCI-3855-2022; Crunk, Amanda/AGF-2426-2022	Crunk, Amanda/0000-0001-8168-0172; Zhao, Liyang/0000-0003-1960-0199	National Institutes of Health [DK59935, DK56598, DK107481, GM097741]; German Research Foundation (DFG) [FU 340/5-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107481, R56DK056598, R01DK056598, R01DK059935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK59935 and DK56598 (to R. A. C.), DK107481 (to E. L. K.), and GM097741 (to L. M. O.) and German Research Foundation (DFG) Grant FU 340/5-1 (to J. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Airola Michael V, 2013, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-7091-1368-4_3; Bernardes A, 2013, J MOL BIOL, V425, P2878, DOI 10.1016/j.jmb.2013.05.010; Bersuker K, 2018, DEV CELL, V44, P97, DOI 10.1016/j.devcel.2017.11.020; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bollu LR, 2014, CELL CYCLE, V13, P2415, DOI 10.4161/cc.29338; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Bowman TA, 2016, MOL METAB, V5, P210, DOI 10.1016/j.molmet.2016.01.001; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Costello JL, 2017, J CELL BIOL, V216, P331, DOI 10.1083/jcb.201607055; Cronan JE, 2005, J NUTR BIOCHEM, V16, P416, DOI 10.1016/j.jnutbio.2005.03.017; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Fan JJ, 2010, PROG LIPID RES, V49, P218, DOI 10.1016/j.plipres.2009.12.003; Ferdinandusse S, 2015, HUM MOL GENET, V24, P361, DOI 10.1093/hmg/ddu448; Frahm Jennifer L, 2011, J Proteomics Bioinform, V4, P129; Gosejacob D, 2016, J BIOL CHEM, V291, P6989, DOI 10.1074/jbc.M115.691212; Grevengoed TJ, 2015, FASEB J, V29, P4641, DOI 10.1096/fj.15-272732; Grevengoed TJ, 2015, J LIPID RES, V56, P1572, DOI 10.1194/jlr.M059717; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Hua R, 2017, J CELL BIOL, V216, P367, DOI 10.1083/jcb.201608128; Jagerstrom S, 2009, CELL BIOL INT, V33, P934, DOI 10.1016/j.cellbi.2009.06.011; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Killion EA, 2018, MOL METAB, V9, P43, DOI 10.1016/j.molmet.2018.01.012; Klett EL, 2017, J LIPID RES, V58, P884, DOI 10.1194/jlr.M072512; Kuerschner L, 2005, NAT METHODS, V2, P39, DOI 10.1038/NMETH728; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Lee K, 2011, J BIOL CHEM, V286, P25655, DOI 10.1074/jbc.M111.228692; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Li LO, 2015, DIABETES, V64, P23, DOI 10.2337/db13-1070; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; Lin Y, 2016, MOL ENDOCRINOL, V30, P234, DOI 10.1210/me.2015-1281; Liu J, 2003, J STEROID BIOCHEM, V85, P275, DOI 10.1016/S0960-0760(03)00213-9; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Merrick BA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006007; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Papadopoulos V, 2007, MOL CELL ENDOCRINOL, V265, P59, DOI 10.1016/j.mce.2006.12.004; POLOKOFF MA, 1978, J BIOL CHEM, V253, P7173; Poppelreuther M, 2012, J LIPID RES, V53, P888, DOI 10.1194/jlr.M024562; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Sadh K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183022; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; Schaffler A, 2005, NAT CLIN PRACT GASTR, V2, P273, DOI 10.1038/ncpgasthep0186; Schumacher MM, 2015, ELIFE, V4, DOI [10.7554/eLife.05560, 10.7554/eLife.04490]; Senkal CE, 2017, CELL METAB, V25, P686, DOI 10.1016/j.cmet.2017.02.010; Senthivinayagam S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073696; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shinoda Y, 2012, FEBS LETT, V586, P3024, DOI 10.1016/j.febslet.2012.06.050; Steinberg SJ, 1999, BIOCHEM BIOPH RES CO, V257, P615, DOI 10.1006/bbrc.1999.0510; Strauss JA, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12662; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tani M, 2007, J BIOL CHEM, V282, P10047, DOI 10.1074/jbc.M611249200; Tomiuk S, 2000, J BIOL CHEM, V275, P5710, DOI 10.1074/jbc.275.8.5710; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; Vogel K, 1999, BIOCHEM BIOPH RES CO, V258, P407, DOI 10.1006/bbrc.1999.0652; WATKINS PA, 1991, ARCH BIOCHEM BIOPHYS, V289, P329, DOI 10.1016/0003-9861(91)90419-J; Watkins PA, 1996, J LIPID RES, V37, P2288; Watkins PA, 2012, BBA-MOL BASIS DIS, V1822, P1411, DOI 10.1016/j.bbadis.2012.02.010; Wendel AA, 2013, J BIOL CHEM, V288, P27299, DOI 10.1074/jbc.M113.485219; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Yagita Y, 2017, J BIOL CHEM, V292, P691, DOI 10.1074/jbc.M116.760090; Zhan TZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045087; Zhong SS, 2015, CANCER RES, V75, P1801, DOI 10.1158/0008-5472.CAN-14-2005	72	44	44	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16724	16740		10.1074/jbc.RA118.004049	http://dx.doi.org/10.1074/jbc.RA118.004049			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30190326	Green Published, hybrid			2022-12-28	WOS:000448515100015
J	Bera, S; Pandey, KK; Aihara, H; Grandgenett, DP				Bera, Sibes; Pandey, Krishan K.; Aihara, Hideki; Grandgenett, Duane P.			Differential assembly of Rous sarcoma virus tetrameric and octameric intasomes is regulated by the C-terminal domain and tail region of integrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-protein interaction; retrovirus; integrase; human immunodeficiency virus (HIV); DNA enzyme; HIV; strand-transfer inhibitors; intasome; integrase tetrameric and octameric stable synaptic complex; Rous sarcoma virus; viral integration; strand-transfer complex	FULL-SITE INTEGRATION; STRAND TRANSFER INHIBITORS; VIRAL-DNA ENDS; SYNAPTIC COMPLEX; TYPE-1 INTEGRASE; IN-VITRO; CONCERTED INTEGRATION; RETROVIRUS INTEGRASE; CRYSTAL-STRUCTURE; HIV-1 INTEGRASE	Retrovirus integrase (IN) catalyzes the concerted integration of linear viral DNA ends into chromosomes. The atomic structures of five different retrovirus IN-DNA complexes, termed intasomes, have revealed varying IN subunit compositions ranging from tetramers to octamers, dodecamers, and hexadecamers. Intasomes containing two IN-associated viral DNA ends capable of concerted integration are termed stable synaptic complexes (SSC), and those formed with a viral/target DNA substrate representing the product of strand-transfer reactions are strand-transfer complexes (STC). Here, we investigated the mechanisms associated with the assembly of the Rous sarcoma virus SSC and STC. C-terminal truncations of WT IN (286 residues) indicated a role of the last 18 residues (tail region) in assembly of the tetrameric and octameric SSC, physically stabilized by HIV-1 IN strand-transfer inhibitors. Fine mapping through C-terminal truncations and site-directed mutagenesis suggested that at least three residues (Asp-268-Thr-270) past the last -strand in the C-terminal domain (CTD) are necessary for assembly of the octameric SSC. In contrast, the assembly of the octameric STC was independent of the last 18 residues of IN. Single-site substitutions in the CTD affected the assembly of the SSC, but not necessarily of the STC, suggesting that STC assembly may depend less on specific interactions of the CTD with viral DNA. Additionally, we demonstrate that trans-communication between IN dimer-DNA complexes facilitates the association of native long-terminal repeat (LTR) ends with partially defective LTR ends to produce a hybrid octameric SSC. The differential assembly of the tetrameric and octameric SSC improves our understanding of intasomes.	[Bera, Sibes; Pandey, Krishan K.; Grandgenett, Duane P.] St Louis Univ, Hlth Sci Ctr, Dept Mol Microbiol & Immunol, Inst Mol Virol, St Louis, MO 63104 USA; [Aihara, Hideki] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Saint Louis University; University of Minnesota System; University of Minnesota Twin Cities	Grandgenett, DP (corresponding author), St Louis Univ, Hlth Sci Ctr, Dept Mol Microbiol & Immunol, Inst Mol Virol, St Louis, MO 63104 USA.	Duane.Grandgenett@health.slu.edu		Pandey, Krishan/0000-0002-3973-9844	National Institutes of Health [AI127197, GM118047]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI127196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole and in part, by National Institutes of Health Grants AI127197 (to D. G.) and GM118047 (to H. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anstett K, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0360-7; Anstett K, 2015, J VIROL, V89, P4681, DOI 10.1128/JVI.03485-14; Ballandras-Colas A, 2017, SCIENCE, V355, P93, DOI 10.1126/science.aah7002; Ballandras-Colas A, 2016, NATURE, V530, P358, DOI 10.1038/nature16955; Bera S, 2005, BIOCHEMISTRY-US, V44, P15106, DOI 10.1021/bi0508340; Bera S, 2011, J MOL BIOL, V410, P831, DOI 10.1016/j.jmb.2011.01.043; Bera S, 2009, J MOL BIOL, V389, P183, DOI 10.1016/j.jmb.2009.04.007; Brown HEV, 1999, J VIROL, V73, P9011, DOI 10.1128/JVI.73.11.9011-9020.1999; Chen HM, 2001, MOL CELL BIOL, V21, P6758, DOI 10.1128/MCB.21.20.6758-6767.2001; Chen HM, 1999, J BIOL CHEM, V274, P17358, DOI 10.1074/jbc.274.24.17358; Chiu R, 2003, J VIROL, V77, P6482, DOI 10.1128/JVI.77.11.6482-6492.2003; Chiu R, 2000, J VIROL, V74, P8292, DOI 10.1128/JVI.74.18.8292-8298.2000; Engelman A, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0024-2014; Engelman AN, 2017, CURR OPIN STRUC BIOL, V47, P23, DOI 10.1016/j.sbi.2017.04.005; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; HORTON R, 1988, J VIROL, V62, P2067, DOI 10.1128/JVI.62.6.2067-2075.1988; HORTON R, 1991, J VIROL, V65, P1141, DOI 10.1128/JVI.65.3.1141-1148.1991; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Lutzke RAP, 1998, J VIROL, V72, P4841, DOI 10.1128/JVI.72.6.4841-4848.1998; Mackler RM, 2018, JOVE-J VIS EXP, DOI 10.3791/57453; Masuda T, 1998, J VIROL, V72, P8396, DOI 10.1128/JVI.72.10.8396-8402.1998; McCord M, 1999, VIROLOGY, V259, P392, DOI 10.1006/viro.1999.9782; McCord M, 1998, PROTEIN EXPRES PURIF, V14, P167, DOI 10.1006/prep.1998.0954; Mesplede T, 2014, J ANTIMICROB CHEMOTH, V69, P2733, DOI 10.1093/jac/dku199; Pandey KK, 2017, J BIOL CHEM, V292, P5018, DOI 10.1074/jbc.M116.773382; Pandey KK, 2014, J BIOL CHEM, V289, P19648, DOI 10.1074/jbc.M114.573311; Pandey KK, 2010, BIOCHEMISTRY-US, V49, P8376, DOI 10.1021/bi100514s; Passos DO, 2017, SCIENCE, V355, P89, DOI 10.1126/science.aah5163; Quashie PK, 2012, J VIROL, V86, P2696, DOI 10.1128/JVI.06591-11; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056892; Vora A, 2004, J BIOL CHEM, V279, P18670, DOI 10.1074/jbc.M314270200; Vora A, 2001, J VIROL, V75, P3556, DOI 10.1128/JVI.75.8.3556-3567.2001; Vora AC, 1997, J BIOL CHEM, V272, P23938, DOI 10.1074/jbc.272.38.23938; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Yin ZQ, 2016, NATURE, V530, P362, DOI 10.1038/nature16950; Yin ZQ, 2012, PROTEIN SCI, V21, P1849, DOI 10.1002/pro.2166; Zhou HB, 2001, J VIROL, V75, P1359, DOI 10.1128/JVI.75.3.1359-1370.2001	39	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16440	16452		10.1074/jbc.RA118.004768	http://dx.doi.org/10.1074/jbc.RA118.004768			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30185621	hybrid, Green Published			2022-12-28	WOS:000447833600026
J	Colecchia, D; Dapporto, F; Tronnolone, S; Salvini, L; Chiariello, M				Colecchia, David; Dapporto, Francesca; Tronnolone, Serena; Salvini, Laura; Chiariello, Mario			MAPK15 is part of the ULK complex and controls its activity to regulate early phases of the autophagic process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; vesicles; trafficking; mitogen-activated protein kinase (MAPK); cell signaling	MAMMALIAN AUTOPHAGY; CELL-PROLIFERATION; C-JUN; KINASE; PROTEIN; PHOSPHORYLATION; CANCER; IDENTIFICATION; INHIBITION; PRINCIPLES	Autophagy, a pathway for bulk protein degradation and removal of damaged organelles, represents one of the major responses of cells to stress, thereby exerting a strict control on their correct functioning. Consequently, this process has been involved in the pathogenesis and therapeutic responses of several human diseases. Mitogen-activated protein (MAP) kinase 15 (MAPK15) is an atypical member of the MAP kinase family that recently emerged as a key modulator of autophagy and, through this, of cell transformation. Still, no information is available about signaling pathways mediating the effect of MAPK15 on this process, nor is it known which phase of autophagosome biogenesis is affected by this MAP kinase. Here, we demonstrate that MAPK15 stimulated 5-AMP-activated protein kinase-dependent activity of UNC-51-like kinase 1 (ULK1), the only protein kinase among the ATG-related proteins, toward downstream substrates and signaling intermediates. Importantly, MAPK15 directly interacted with the ULK1 complex and mediated ULK1 activation induced by starvation, a classical stimulus for the autophagic process. In turn, ULK1 and its highly homologous protein ULK2 are able to transduce MAPK15 signals stimulating early phases of autophagosomal biogenesis in a multikinase cascade that offers numerous potential targets for future therapeutic intervention in cancer and other autophagy-related human diseases.	[Colecchia, David; Chiariello, Mario] CNR, IFC, I-53100 Siena, Italy; [Colecchia, David; Dapporto, Francesca; Tronnolone, Serena; Chiariello, Mario] ISPRO, CRL, Unit Signal Transduct, I-53100 Siena, Italy; [Dapporto, Francesca] Univ Siena, I-53100 Siena, Italy; [Salvini, Laura] Toscana Life Sci Fdn, I-53100 Siena, Italy; [Colecchia, David] TargImmune Therapeut, Hochbergerstr 60c, CH-4057 Basel, Switzerland	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Siena	Chiariello, M (corresponding author), CNR, IFC, I-53100 Siena, Italy.; Chiariello, M (corresponding author), ISPRO, CRL, Unit Signal Transduct, I-53100 Siena, Italy.	mario.chiariello@cnr.it	Colecchia, David/AAS-8110-2021; Chiariello, Mario/O-3642-2014	Chiariello, Mario/0000-0001-8434-5177; Salvini, Laura/0000-0002-2923-8157	Regione Toscana, Istituto Toscano Tumori (ITT)	Regione Toscana, Istituto Toscano Tumori (ITT)	We acknowledge the support of Regione Toscana, Istituto Toscano Tumori (ITT). We thank Laura Tinti for technical assistance and instrumental support.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Cerone MA, 2011, CANCER RES, V71, P3328, DOI 10.1158/0008-5472.CAN-10-2734; Chude CI, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061279; Colecchia D, 2018, AUTOPHAGY, V14, P930, DOI 10.1080/15548627.2017.1388475; Colecchia D, 2015, AUTOPHAGY, V11, P1790, DOI 10.1080/15548627.2015.1084454; Colecchia D, 2012, AUTOPHAGY, V8, P1724, DOI 10.4161/auto.21857; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Dorsey FC, 2009, J PROTEOME RES, V8, P5253, DOI 10.1021/pr900583m; Egan DF, 2015, MOL CELL, V59, P285, DOI 10.1016/j.molcel.2015.05.031; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Gan WJ, 2017, BMC CELL BIOL, V18, DOI 10.1186/s12860-017-0138-8; Groehler AL, 2010, J CELL BIOL, V190, P575, DOI 10.1083/jcb.201002124; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Iavarone C, 2006, J BIOL CHEM, V281, P10567, DOI 10.1074/jbc.M513397200; Jin DH, 2015, ONCOTARGET, V6, P20190, DOI 10.18632/oncotarget.4171; Joo JH, 2016, MOL CELL, V62, P491, DOI 10.1016/j.molcel.2016.04.020; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klevernic IV, 2009, FEBS LETT, V583, P680, DOI 10.1016/j.febslet.2009.01.011; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Klionsky DJ, 2014, AUTOPHAGY, V10, P185, DOI 10.4161/auto.27367; Lim J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004987; Lin MG, 2016, CURR OPIN CELL BIOL, V39, P61, DOI 10.1016/j.ceb.2016.02.010; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Papinski D, 2016, J MOL BIOL, V428, P1725, DOI 10.1016/j.jmb.2016.03.030; Puente C, 2016, J BIOL CHEM, V291, P6026, DOI 10.1074/jbc.M115.689646; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rossi M, 2016, ONCOTARGET, V7, P20981, DOI 10.18632/oncotarget.8044; Rossi M, 2011, J BIOL CHEM, V286, P8507, DOI 10.1074/jbc.M110.179523; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Strambi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052011; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wang B, 2017, CURR OPIN CELL BIOL, V45, P47, DOI 10.1016/j.ceb.2017.02.011; Xu YM, 2010, CANCER RES, V70, P3218, DOI 10.1158/0008-5472.CAN-09-4306; Zachari M, 2017, ESSAYS BIOCHEM, V61, P585, DOI 10.1042/EBC20170021; Zhang L, 2018, J MED CHEM, V61, P6491, DOI 10.1021/acs.jmedchem.7b01684	44	9	11	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15962	15976		10.1074/jbc.RA118.002527	http://dx.doi.org/10.1074/jbc.RA118.002527			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30131341	hybrid, Green Published			2022-12-28	WOS:000447256000018
J	Wright, FA; Bonzerato, CG; Sliter, DA; Wojcikiewicz, RJH				Wright, Forrest A.; Bonzerato, Caden G.; Sliter, Danielle A.; Wojcikiewicz, Richard J. H.			The erlin2 T65I mutation inhibits erlin1/2 complex-mediated inositol 1,4,5-trisphosphate receptor ubiquitination and phosphatidylinositol 3-phosphate binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inositol trisphosphate receptor (InsP3R); ubiquitylation (ubiquitination); phosphatidylinositol phosphatase; endoplasmic reticulum (ER); endoplasmic-reticulum-associated protein degradation (ERAD); erlin1; erlin2; mutation; phospholipid signaling; spastic paraplegia	HEREDITARY SPASTIC PARAPLEGIA; DOMAIN-CONTAINING PROTEINS; DOMINANT SENSORY ATAXIA; ENDOPLASMIC-RETICULUM; AUTOPHAGOSOME BIOGENESIS; DEGRADATION; RNF170; CELLS; MECHANISMS; DISEASE	The erlin1/2 complex is a approximate to 2-MDa endoplasmic reticulum membrane-located ensemble of the approximate to 40-kDa type II membrane proteins erlin1 and erlin2. The best defined function of this complex is to mediate the ubiquitination of activated inositol 1,4,5-trisphosphate receptors (IP(3)Rs) and their subsequent degradation. However, it remains unclear how mutations of the erlin1/2 complex affect its cellular function and cause cellular dysfunction and diseases such as hereditary spastic paraplegia. Here, we used gene editing to ablate erlin1 or erlin2 expression to better define their individual roles in the cell and examined the functional effects of a spastic paraplegia-linked mutation to erlin2 (threonine to isoleucine at position 65; T65I). Our results revealed that erlin2 is the dominant player in mediating the interaction between the erlin1/2 complex and IP(3)Rs and that the T65I mutation dramatically inhibits this interaction and the ability of the erlin1/2 complex to promote IP3R ubiquitination and degradation. Remarkably, we also discovered that the erlin1/2 complex specifically binds to phosphatidylinositol 3-phosphate, that erlin2 binds this phospholipid much more strongly than does erlin1, that the binding is inhibited by T65I mutation of erlin2, and that multiple determinants within the erlin2 polypeptide comprise the phosphatidylinositol 3-phosphate-binding site. Overall, these results indicate that erlin2 is the primary mediator of the cellular roles of the erlin1/2 complex and that disease-linked mutations of erlin2 can affect both IP3R processing and lipid binding.	[Wright, Forrest A.; Bonzerato, Caden G.; Wojcikiewicz, Richard J. H.] SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA; [Sliter, Danielle A.] NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Wright, Forrest A.] Ichor Therapeut Inc, La Fayette, NY 13084 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wojcikiewicz, RJH (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	wojcikir@upstate.edu		Bonzerato, Caden/0000-0001-6380-8320	National Institutes of Health [DK107944, GM121621]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK107944 and GM121621. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Saif A, 2012, ANN NEUROL, V72, P510, DOI 10.1002/ana.23641; Alazami AM, 2011, NEUROGENETICS, V12, P333, DOI 10.1007/s10048-011-0291-8; Alzayady KJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad6281; Ande SR, 2009, BIOCHEM BIOPH RES CO, V390, P1023, DOI 10.1016/j.bbrc.2009.10.101; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Berridge MJ, 2016, PHYSIOL REV, V96, P1261, DOI 10.1152/physrev.00006.2016; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Carlsson SR, 2015, J CELL SCI, V128, P193, DOI 10.1242/jcs.141036; Cheng JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4207; Choy CH, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700121; Christie DA, 2011, MOL CELL BIOL, V31, P3845, DOI 10.1128/MCB.05393-11; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Dreveny I, 2004, BIOCHEM SOC T, V32, P715, DOI 10.1042/BST0320715; Egorova PA, 2018, FEBS J, V285, P3547, DOI 10.1111/febs.14366; Fan GZ, 2015, NATURE, V527, P336, DOI 10.1038/nature15249; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Huber MD, 2013, J CELL BIOL, V203, P427, DOI 10.1083/jcb.201305076; Inoue T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006439; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Lu JP, 2011, J BIOL CHEM, V286, P24426, DOI 10.1074/jbc.M111.251983; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Marat AL, 2016, EMBO J, V35, P561, DOI 10.15252/embj.201593564; MONKAWA T, 1995, J BIOL CHEM, V270, P14700, DOI 10.1074/jbc.270.24.14700; Nascimbeni AC, 2017, AUTOPHAGY, V13, P1602, DOI 10.1080/15548627.2017.1341465; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; Pearce MMP, 2007, J BIOL CHEM, V282, P20104, DOI 10.1074/jbc.M701862200; Pearce MMP, 2009, J BIOL CHEM, V284, P10433, DOI 10.1074/jbc.M809801200; Printsev I, 2017, J MEMBRANE BIOL, V250, P379, DOI 10.1007/s00232-016-9931-0; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Rungaldier S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178646; Rydning SL, 2018, EUR J NEUROL, V25, P943, DOI 10.1111/ene.13625; Sliter DA, 2008, J BIOL CHEM, V283, P35319, DOI 10.1074/jbc.M807288200; Tian WT, 2016, CHINESE MED J-PEKING, V129, P2759, DOI 10.4103/0366-6999.193444; Tunca C, 2018, EUR J HUM GENET, V26, P745, DOI 10.1038/s41431-018-0107-5; Valdmanis PN, 2011, BRAIN, V134, P602, DOI 10.1093/brain/awq329; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wakil SM, 2013, EUR J MED GENET, V56, P43, DOI 10.1016/j.ejmg.2012.10.003; Wang GH, 2012, BIOCHEM J, V446, P415, DOI 10.1042/BJ20112050; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 2003, J BIOL CHEM, V278, P940, DOI 10.1074/jbc.M206607200; Wright FA, 2016, PROG MOL BIOL TRANSL, V141, P141, DOI 10.1016/bs.pmbts.2016.02.004; Wright FA, 2015, J BIOL CHEM, V290, P13948, DOI 10.1074/jbc.M115.655043; Yildirim Y, 2011, HUM MOL GENET, V20, P1886, DOI 10.1093/hmg/ddr070	47	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15706	15714		10.1074/jbc.RA118.004547	http://dx.doi.org/10.1074/jbc.RA118.004547			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30135210	Green Published, hybrid			2022-12-28	WOS:000446549200032
J	Huang, J; Alnajjar, KS; Mahmoud, MM; Eckenroth, B; Doublie, S; Sweasy, JB				Huang, Ji; Alnajjar, Khadijeh S.; Mahmoud, Mariam M.; Eckenroth, Brian; Doublie, Sylvie; Sweasy, Joann B.			The nature of the DNA substrate influences pre-catalytic conformational changes of DNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						FRET; kinetics; conformational change; DNA polymerase; crystal structure; 5-phosphate; gap size; polymerase	HIV REVERSE-TRANSCRIPTASE; RESONANCE ENERGY-TRANSFER; INDUCED FIT; GAPPED DNA; CRYSTAL-STRUCTURES; EXCISION-REPAIR; DOMAIN MOTIONS; BETA FIDELITY; KINETIC-DATA; MECHANISM	DNA polymerase (Pol ) is essential for maintaining genomic integrity. During short-patch base excision repair (BER), Pol incorporates a nucleotide into a single-gapped DNA substrate. Pol may also function in long-patch BER, where the DNA substrate consists of larger gap sizes or 5-modified downstream DNA. We have recently shown that Pol fills small gaps in DNA during microhomology-mediated end-joining as part of a process that increases genomic diversity. Our previous results with single-nucleotide gapped DNA show that Pol undergoes two pre-catalytic conformational changes upon binding to the correct nucleotide substrate. Here we use FRET to investigate nucleotide incorporation of Pol with various DNA substrates. The results show that increasing the gap size influences the fingers closing step by increasing its reverse rate. However, the 5-phosphate group has a more significant effect. The absence of the 5-phosphate decreases the DNA binding affinity of Pol and results in a conformationally more open binary complex. Moreover, upon addition of the correct nucleotide in the absence of 5-phosphate, a slow fingers closing step is observed. Interestingly, either increasing the gap size or removing the 5-phosphate group results in loss of the noncovalent step. Together, these results suggest that the character of the DNA substrate impacts the nature and rates of pre-catalytic conformational changes of Pol . Our results also indicate that conformational changes are important for the fidelity of DNA synthesis by Pol .	[Huang, Ji; Alnajjar, Khadijeh S.; Mahmoud, Mariam M.; Sweasy, Joann B.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Sweasy, Joann B.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Eckenroth, Brian; Doublie, Sylvie] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Huang, Ji] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA	Yale University; Yale University; University of Vermont; Northwestern University	Sweasy, JB (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA.; Sweasy, JB (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA.	joann.sweasy@yale.edu		Doublie, Sylvie/0000-0002-6294-5304; Alnajjar, Khadijeh/0000-0002-0219-6807; Eckenroth, Brian/0000-0003-4818-311X	NCI, National Institutes of Health [R01 CA080830]; NATIONAL CANCER INSTITUTE [R01CA080830, T32CA193200] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health Grant R01 CA080830 (to J.B.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn JW, 1998, BIOCHEM J, V331, P79, DOI 10.1042/bj3310079; Alnajjar KS, 2017, BIOCHEMISTRY-US, V56, P2096, DOI 10.1021/acs.biochem.6b01230; Arndt JW, 2001, BIOCHEMISTRY-US, V40, P5368, DOI 10.1021/bi002176j; Bakhtina M, 2009, BIOCHEMISTRY-US, V48, P3197, DOI 10.1021/bi802119f; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 2009, J BIOL CHEM, V284, P31680, DOI 10.1074/jbc.M109.029843; Berlow RB, 2012, J MOL BIOL, V419, P171, DOI 10.1016/j.jmb.2012.03.013; Bose-Basu B, 2004, BIOCHEMISTRY-US, V43, P8911, DOI 10.1021/bi049641n; Brown JA, 2011, DNA REPAIR, V10, P24, DOI 10.1016/j.dnarep.2010.09.005; Cadet J, 2010, FREE RADICAL BIO MED, V49, P9, DOI 10.1016/j.freeradbiomed.2010.03.025; Chagovetz AM, 1997, J BIOL CHEM, V272, P27501, DOI 10.1074/jbc.272.44.27501; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Garcia-Diaz M, 2004, MOL CELL, V13, P561, DOI 10.1016/S1097-2765(04)00061-9; Gates KS, 2009, CHEM RES TOXICOL, V22, P1747, DOI 10.1021/tx900242k; HARAN G, 1992, P NATL ACAD SCI USA, V89, P11764, DOI 10.1073/pnas.89.24.11764; Heiner Z, 2009, APPL OPTICS, V48, P4610, DOI 10.1364/AO.48.004610; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; Kellinger MW, 2011, BIOCHEMISTRY-US, V50, P5008, DOI 10.1021/bi200204m; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Kim SJ, 2003, J BIOL CHEM, V278, P5072, DOI 10.1074/jbc.M208472200; Mahmoud MM, 2017, BIOCHEMISTRY-US, V56, P5550, DOI 10.1021/acs.biochem.7b00869; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Moscato B, 2016, BIOCHEMISTRY-US, V55, P382, DOI 10.1021/acs.biochem.5b01213; Patel PH, 2001, J MOL BIOL, V308, P823, DOI 10.1006/jmbi.2001.4619; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; PRASAD R, 1994, J BIOL CHEM, V269, P18096; Reed AJ, 2017, J AM CHEM SOC, V139, P465, DOI 10.1021/jacs.6b11258; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; Shock DD, 2017, NAT CHEM BIOL, V13, P1074, DOI [10.1038/nchembio.2450, 10.1038/NCHEMBIO.2450]; SIEDLECKI JA, 1980, NUCLEIC ACIDS RES, V8, P361, DOI 10.1093/nar/8.2.361; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; Sucato CA, 2008, BIOCHEMISTRY-US, V47, P870, DOI 10.1021/bi7014162; Sucato CA, 2007, BIOCHEMISTRY-US, V46, P461, DOI 10.1021/bi061517b; Towle-Weicksel JB, 2014, J BIOL CHEM, V289, P16541, DOI 10.1074/jbc.M114.561878; WANG TSF, 1980, BIOCHEMISTRY-US, V19, P1782, DOI 10.1021/bi00550a009; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Yang W, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0118-2; Zhong XJ, 1997, BIOCHEMISTRY-US, V36, P11891, DOI 10.1021/bi963181j	47	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15084	15094		10.1074/jbc.RA118.004564	http://dx.doi.org/10.1074/jbc.RA118.004564			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30068550	Green Published, hybrid			2022-12-28	WOS:000445998400012
J	Wang, C; Ke, YP; Liu, SY; Pan, SR; Liu, ZY; Zhang, H; Fan, ZC; Zhou, CY; Liu, JC; Wang, F				Wang, Cong; Ke, Yuepeng; Liu, Shaoyou; Pan, Sharon; Liu, Ziying; Zhang, Hui; Fan, Zhichao; Zhou, Changyi; Liu, Junchen; Wang, Fen			Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-kappa B signaling in prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast growth factor (FGF); prostate cancer; inflammation; NF-kappa B (NF-KB); tyrosine-protein kinase (tyrosine kinase); tumor promoter; tumor cell biology; receptor tyrosine kinase; mouse genetics; ectopic FGF signaling; tumor microenvironment	ANDROGEN RECEPTOR; ACTIVATION; KINASE; PATHWAYS; TAK1; ANGIOGENESIS; RESISTANCE; EXPRESSION; INVASION; ALPHA	Initiation of expression of fibroblast growth factor receptor 1 (FGFR1) concurrent with loss of FGFR2 expression is a well-documented event in the progression of prostate cancer (PCa). Although it is known that some FGFR isoforms confer advantages in cell proliferation and survival, the mechanism by which the subversion of different FGFR isoforms contributes to PCa progression is incompletely understood. Here, we report that fibroblast growth factor (FGF) promotes NF-kappa B signaling in PCa cells and that this increase is associated with FGFR1 expression. Disruption of FGFR1 kinase activity abrogated both FGF activity and NF-kappa B signaling in PCa cells. Of note, the three common signaling pathways downstream of FGFR1 kinase, extracellular signal-regulated kinase 1/2 (ERK1/2), phosphoinositide 3-kinase (PI3K/AKT), and phosphoinositide phospholipase C gamma(PLC gamma), were not required for FGF-mediated NF-kappa B signaling. Instead, transforming growth factor beta-activating kinase 1 (TAK1), a central regulator of the NF-kappa B pathway, was required for FGFR1 to stimulate NF-kappa B signaling. Moreover, we found that FGFR1 promotes NF-kappa B signaling in PCa cells by reducing TAK1 degradation and thereby supporting sustained NF-kappa B activation. Consistently, Fgfr1 ablation in the transgenic adenocarcinoma of the mouse prostate (TRAMP) model reduced inflammation in the tumor microenvironment. In contrast, activation of the FGFR1 kinase in the juxtaposition of chemical-induced dimerization (CID) and kinase 1 (JOCK1) mouse model increased inflammation. As inflammation plays an important role in PCa initiation and progression, these findings suggest that ectopically expressed FGFR1 promotes PCa progression, at least in part, by increasing inflammation in the tumor microenvironment.	[Wang, Cong; Liu, Ziying; Fan, Zhichao] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325000, Zhejiang, Peoples R China; [Wang, Cong; Ke, Yuepeng; Liu, Shaoyou; Liu, Ziying; Zhang, Hui; Zhou, Changyi; Liu, Junchen; Wang, Fen] Texas A&M Univ, Coll Med, Inst Biosci & Technol, College Stn, TX 77843 USA; [Liu, Shaoyou] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Guangzhou 510000, Guangdong, Peoples R China; [Pan, Sharon] Seattle Childrens Hosp, Div Gastroenterol & Hepatol, Seattle, WA 98105 USA; [Zhang, Hui] South China Univ Technol, Affiliated Hosp 2, Guangzhou 510641, Guangdong, Peoples R China; [Zhou, Changyi] Jimei Univ, Coll Food & Bioengn, Xiamen 361021, Peoples R China	Wenzhou Medical University; Texas A&M University System; Texas A&M University College Station; Guangzhou Medical University; Seattle Children's Hospital; South China University of Technology; Jimei University	Wang, C (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325000, Zhejiang, Peoples R China.; Wang, F (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX 77030 USA.	cwang@wmu.edu.cn; fwang@ibt.tamhsc.edu		Liu, Shaoyou/0000-0001-5544-1661; Liu, Junchen/0000-0003-2765-9780	National Institutes of Health [CA96824, DE023106, TAMU1400302, CPRIT 110555]; National Natural Science Foundation of China [81101712, 31371470, 81270761]; Natural Science Foundation of Zhejiang Province of China [LY16H140004]; NATIONAL CANCER INSTITUTE [R01CA096824, R56CA096824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R56DE023106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants CA96824, DE023106, TAMU1400302, and CPRIT 110555 (to F. W.); a gift from Agilent Technologies; National Natural Science Foundation of China Grants 81101712, 31371470, and 81270761; and Natural Science Foundation of Zhejiang Province of China Grant LY16H140004 (to C. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Ahmed N, 2011, NAT IMMUNOL, V12, P1176, DOI 10.1038/ni.2157; AVTANDILOV GG, 1989, ARK PATOL, V51, P81; Bushdid PB, 2001, DEV BIOL, V237, P107, DOI 10.1006/dbio.2001.0356; Byrd VM, 1999, J IMMUNOL, V162, P5853; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Corn PG, 2013, CLIN CANCER RES, V19, P5856, DOI 10.1158/1078-0432.CCR-13-1550; Cui J, 2014, HUM VACC IMMUNOTHER, V10, P3270, DOI 10.4161/21645515.2014.979640; Demaria S, 2010, J IMMUNOTHER, V33, P335, DOI 10.1097/CJI.0b013e3181d32e74; Ebelt K, 2008, PROSTATE, V68, P1, DOI 10.1002/pros.20661; Fan YH, 2012, CELL SIGNAL, V24, P1381, DOI 10.1016/j.cellsig.2012.02.017; Fan YH, 2010, J BIOL CHEM, V285, P5347, DOI 10.1074/jbc.M109.076976; Flati V, 2006, INT J IMMUNOPATH PH, V19, P761, DOI 10.1177/039463200601900406; Fradet V, 2004, CLIN CANCER RES, V10, P8460, DOI 10.1158/1078-0432.CCR-04-0764; Gannon PO, 2009, J IMMUNOL METHODS, V348, P9, DOI 10.1016/j.jim.2009.06.004; Gasparian AV, 2002, J CELL SCI, V115, P141; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirata Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010205; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Huang YQ, 2015, INT J BIOL SCI, V11, P948, DOI 10.7150/ijbs.12468; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang JH, 2012, CLIN EXP METASTAS, V29, P165, DOI 10.1007/s10585-011-9439-z; Jin R, 2015, ONCOGENE, V34, P3700, DOI 10.1038/onc.2014.302; Kanaya S, 2013, BONE, V56, P398, DOI 10.1016/j.bone.2013.06.031; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Lee MS, 2012, METABOLISM, V61, P1142, DOI 10.1016/j.metabol.2012.01.012; Lin YS, 2007, DEVELOPMENT, V134, P723, DOI 10.1242/dev.02765; Liu J, 2016, ONCOGENE, V35, P1750, DOI 10.1038/onc.2015.239; Liu MH, 2015, INT J CARDIOL, V185, P320, DOI 10.1016/j.ijcard.2015.03.165; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; Nadiminty N, 2013, MOL CANCER THER, V12, P1629, DOI 10.1158/1535-7163.MCT-13-0027; Niu JG, 2007, J BIOL CHEM, V282, P6001, DOI 10.1074/jbc.M606878200; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Salazar L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086470; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Strasner A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00128; Tang CH, 2007, J CELL PHYSIOL, V211, P45, DOI 10.1002/jcp.20896; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Vandermoere F, 2005, ONCOGENE, V24, P5482, DOI 10.1038/sj.onc.1208713; Wang C, 2013, J BIOL CHEM, V288, P22174, DOI 10.1074/jbc.M113.463620; Wang F, 1999, BIOCHEMISTRY-US, V38, P160, DOI 10.1021/bi981758m; Wang F., 2013, MOL ONCOLOGY CAUSES, P186; Wang JH, 2011, CANCER RES, V71, P1325, DOI 10.1158/0008-5472.CAN-10-2210; Wu CT, 2012, J MOL MED, V90, P1343, DOI 10.1007/s00109-012-0916-x; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Zhang YY, 2008, DEVELOPMENT, V135, P775, DOI 10.1242/dev.009910	51	27	28	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14839	14849		10.1074/jbc.RA118.002907	http://dx.doi.org/10.1074/jbc.RA118.002907			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30093411	hybrid, Green Published			2022-12-28	WOS:000446155000020
J	Lam, KH; Xue, CL; Sun, KL; Zhang, HW; Lam, WWL; Zhu, ZY; Ng, JTY; Sause, WE; Lertsethtakarn, P; Lau, KF; Ottemann, KM; Au, SWN				Lam, Kwok Ho; Xue, Chaolun; Sun, Kailei; Zhang, Huawei; Lam, Wendy Wai Ling; Zhu, Zeyu; Ng, Juliana Tsz Yan; Sause, William E.; Lertsethtakarn, Paphavee; Lau, Kwok Fai; Ottemann, Karen M.; Au, Shannon Wing Ngor			Three SpoA-domain proteins interact in the creation of the flagellar type III secretion system in Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular motor; protein structure; protein-protein interaction; protein assembly; protein export; bacterial motility; flagellar motor switch complex; SpoA domain; type III secretion system; virulence factor; flagellum; Fli protein; Helicobacter pylori; SpoA domain; FliY	C-RING; CRYSTAL-STRUCTURE; TORQUE RING; ROTOR; COMPLEX; MOTOR; FLIY; CHEMOTAXIS; ORGANIZATION; MECHANISM	Bacterial flagella are rotary nanomachines that contribute to bacterial fitness in many settings, including host colonization. The flagellar motor relies on the multiprotein flagellar motor-switch complex to govern flagellum formation and rotational direction. Different bacteria exhibit great diversity in their flagellar motors. One such variation is exemplified by the motor-switch apparatus of the gastric pathogen Helicobacter pylori, which carries an extra switch protein, FliY, along with the more typical FliG, FliM, and FliN proteins. All switch proteins are needed for normal flagellation and motility in H. pylori, but the molecular mechanism of their assembly is unknown. To fill this gap, we examined the interactions among these proteins. We found that the C-terminal SpoA domain of FliY (FliY(C)) is critical to flagellation and forms heterodimeric complexes with the FliN and FliM SpoA domains, which are -sheet domains of type III secretion system proteins. Surprisingly, unlike in other flagellar switch systems, neither FliY nor FliN self-associated. The crystal structure of the FliY(C)-FliN(C) complex revealed a saddle-shaped structure homologous to the FliN-FliN dimer of Thermotoga maritima, consistent with a FliY-FliN heterodimer forming the functional unit. Analysis of the FliY(C)-FliN(C) interface indicated that oppositely charged residues specific to each protein drive heterodimer formation. Moreover, both FliY(C)-FliM(C) and FliY(C)-FliN(C) associated with the flagellar regulatory protein FliH, explaining their important roles in flagellation. We conclude that H. pylori uses a FliY-FliN heterodimer instead of a homodimer and creates a switch complex with SpoA domains derived from three distinct proteins.	[Lam, Kwok Ho; Xue, Chaolun; Sun, Kailei; Zhang, Huawei; Lam, Wendy Wai Ling; Zhu, Zeyu; Ng, Juliana Tsz Yan; Lau, Kwok Fai; Au, Shannon Wing Ngor] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Fac Sci, Shatin, Hong Kong, Peoples R China; [Xue, Chaolun; Zhang, Huawei; Lam, Wendy Wai Ling; Au, Shannon Wing Ngor] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen 518057, Peoples R China; [Sause, William E.; Lertsethtakarn, Paphavee; Ottemann, Karen M.] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Lam, Kwok Ho] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Lertsethtakarn, Paphavee] Armed Forces Res Inst Med Sci, Dept Enter Dis, Bangkok 10400, Thailand	Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; University of California System; University of California Santa Cruz; University of California System; University of California Irvine; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Au, SWN (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Fac Sci, Shatin, Hong Kong, Peoples R China.; Au, SWN (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen 518057, Peoples R China.	shannon-au@cuhk.edu.hk	zhang, huawei/S-6761-2019	zhang, huawei/0000-0002-5625-5809; LAM, KWOK HO/0000-0002-7173-6600; Lau, Kwok-Fai/0000-0002-0193-1152	National Natural Science Foundation of China [31370713]; Hong Kong Research Grants Council [N_CUHK454/13]; University Grants Committee One-Off Special Equipment Grant [SEG CUHK08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050000] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Research Grants Council(Hong Kong Research Grants Council); University Grants Committee One-Off Special Equipment Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Natural Science Foundation of China Grant 31370713, Hong Kong Research Grants Council Grant N_CUHK454/13, and University Grants Committee One-Off Special Equipment Grant SEG CUHK08. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Beeby M, 2016, P NATL ACAD SCI USA, V113, pE1917, DOI 10.1073/pnas.1518952113; BERG HC, 1979, NATURE, V278, P349, DOI 10.1038/278349a0; BISCHOFF DS, 1992, MOL MICROBIOL, V6, P2715, DOI 10.1111/j.1365-2958.1992.tb01448.x; Boneca IG, 2008, APPL ENVIRON MICROB, V74, P2095, DOI 10.1128/AEM.01348-07; Brown PN, 2007, J BACTERIOL, V189, P305, DOI 10.1128/JB.01281-06; Brown PN, 2005, J BACTERIOL, V187, P2890, DOI 10.1128/JB.187.8.2890-2902.2005; Brown PN, 2002, EMBO J, V21, P3225, DOI 10.1093/emboj/cdf332; Bzymek KP, 2012, BIOCHEMISTRY-US, V51, P1669, DOI 10.1021/bi201792p; Chen SY, 2011, EMBO J, V30, P2972, DOI 10.1038/emboj.2011.186; Donahue JP, 2000, MOL MICROBIOL, V37, P1066, DOI 10.1046/j.1365-2958.2000.02036.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fadouloglou VE, 2004, P NATL ACAD SCI USA, V101, P70, DOI 10.1073/pnas.0304579101; Gonzalez-Pedrajo B, 2006, MOL MICROBIOL, V60, P984, DOI 10.1111/j.1365-2958.2006.05149.x; Hauser R, 2014, MOL CELL PROTEOMICS, V13, P1318, DOI 10.1074/mcp.O113.033571; Josenhans C, 2014, MOL MICROBIOL, V91, P6, DOI 10.1111/mmi.12427; Kholod N, 2001, BIOTECHNIQUES, V31, P322, DOI 10.2144/01312st03; Kojima S, 2004, BIOCHEMISTRY-US, V43, P26, DOI 10.1021/bi035405l; Lam KH, 2013, MOL MICROBIOL, V88, P798, DOI 10.1111/mmi.12222; Lam KH, 2012, STRUCTURE, V20, P315, DOI 10.1016/j.str.2011.11.020; Lee LK, 2010, NATURE, V466, P996, DOI 10.1038/nature09300; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Lowenthal AC, 2009, J BACTERIOL, V191, P7147, DOI 10.1128/JB.00749-09; Lowenthal AC, 2009, MICROBIOL-SGM, V155, P1181, DOI 10.1099/mic.0.021857-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDowell MA, 2016, MOL MICROBIOL, V99, P749, DOI 10.1111/mmi.13267; McMurry JL, 2006, BIOCHEMISTRY-US, V45, P11790, DOI 10.1021/bi0605890; Minamino T, 2015, TRENDS MICROBIOL, V23, P267, DOI 10.1016/j.tim.2014.12.011; Minamino T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000616; Minamino T, 2009, MOL MICROBIOL, V74, P1471, DOI 10.1111/j.1365-2958.2009.06946.x; Minamino T, 2008, CURR OPIN STRUC BIOL, V18, P693, DOI 10.1016/j.sbi.2008.09.006; Notti RQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8125; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SY, 2006, P NATL ACAD SCI USA, V103, P11886, DOI 10.1073/pnas.0602811103; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Paul K, 2006, J BACTERIOL, V188, P2502, DOI 10.1128/JB.188.7.2502-2511.2006; Paul K, 2011, EMBO J, V30, P2962, DOI 10.1038/emboj.2011.188; Pittman MS, 2001, MICROBIOL-SGM, V147, P2493, DOI 10.1099/00221287-147-9-2493; Qin Z, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00695-16; Raddi G, 2012, J BACTERIOL, V194, P1299, DOI 10.1128/JB.06474-11; Sarkar MK, 2010, P NATL ACAD SCI USA, V107, P9370, DOI 10.1073/pnas.1000935107; Senesi S, 2002, MICROBIOL-SGM, V148, P1785, DOI 10.1099/00221287-148-6-1785; Silversmith RE, 2010, CURR OPIN MICROBIOL, V13, P177, DOI 10.1016/j.mib.2010.01.004; Sircar R, 2013, J BIOL CHEM, V288, P13493, DOI 10.1074/jbc.M112.445171; Stock D, 2012, CURR OPIN BIOTECH, V23, P545, DOI 10.1016/j.copbio.2012.01.008; Szurmant H, 2004, J BIOL CHEM, V279, P21787, DOI 10.1074/jbc.M311497200; Thomas D, 2001, J BACTERIOL, V183, P6404, DOI 10.1128/JB.183.21.6404-6412.2001; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Thomas DR, 1999, P NATL ACAD SCI USA, V96, P10134, DOI 10.1073/pnas.96.18.10134; Vartanian AS, 2012, J BIOL CHEM, V287, P35779, DOI 10.1074/jbc.C112.378380; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhao RH, 1996, J MOL BIOL, V261, P195, DOI 10.1006/jmbi.1996.0452	55	6	7	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13961	13973		10.1074/jbc.RA118.002263	http://dx.doi.org/10.1074/jbc.RA118.002263			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	29991595	Green Published, hybrid			2022-12-28	WOS:000444070700021
J	Lamriben, L; Oster, ME; Tamura, T; Tian, WH; Yang, Z; Clausen, H; Hebert, DN				Lamriben, Lydia; Oster, Michela E.; Tamura, Taku; Tian, Weihua; Yang, Zhang; Clausen, Henrik; Hebert, Daniel N.			EDEM1's mannosidase-like domain binds ERAD client proteins in a redox-sensitive manner and possesses catalytic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); endoplasmic reticulum-associated protein degradation (ERAD); protein folding; oxidation-reduction (redox); protein degradation; intrinsically disordered protein; 1 antitrypsin (A1AT); ER degradation-enhancing mannosidase-like 1 protein (EDEM1); ERdj5	RETICULUM-ASSOCIATED DEGRADATION; INTRINSICALLY DISORDERED REGIONS; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MISFOLDED PROTEINS; MAMMALIAN GLYCOPROTEINS; Z VARIANT; RECOGNITION; CALNEXIN; PATHWAY	Endoplasmic reticulum (ER) degradation-enhancing -mannosidase-like 1 protein (EDEM1) is a protein quality control factor that was initially proposed to recognize N-linked glycans on misfolded proteins through its mannosidase-like domain (MLD). However, recent studies have demonstrated that EDEM1 binds to some misfolded proteins in a glycan-independent manner, suggesting a more complex binding landscape for EDEM1. In this study, we have identified a thiol-dependent substrate interaction between EDEM1 and the (1)-antitrypsin ER-associated protein degradation (ERAD) clients Z and NHK, specifically through the single Cys residue on Z/NHK (Cys(256)), required for binding under stringent detergent conditions. In addition to the thiol-dependent interaction, the presence of weaker protein-protein interactions was confirmed, suggestive of bipartite client-binding properties. About four reactive thiols on EDEM1 were identified and were not directly responsible for the observed redox-sensitive binding by EDEM1. Moreover, a protein construct comprising the EDEM1 MLD had thiol-dependent binding properties along with its active glycan-trimming activities. Lastly, we identified an additional intrinsically disordered region (IDR) located at the C terminus of EDEM1 in addition to its previously identified N-terminal IDR. We also determined that both IDRs are required for binding to the ERAD component ERdj5 as an interaction with ERdj5 was not observed with the MLD alone. Together, our findings indicate that EDEM1 employs different binding modalities to interact with ERAD clients and ER quality control (ERQC) machinery partners and that some of these properties are shared with its homologues EDEM2 and EDEM3.	[Lamriben, Lydia; Oster, Michela E.; Tamura, Taku; Hebert, Daniel N.] Univ Massachusetts, Dept Biochem & Mol Biol, 240 Thatcher Rd, Amherst, MA 01003 USA; [Lamriben, Lydia; Hebert, Daniel N.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA; [Tian, Weihua; Yang, Zhang; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark; [Tamura, Taku] Akita Univ, Fac Engn Sci, Dept Life Sci, 1-1 Tegata Gakuenmachi, Akita 0108502, Japan	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Copenhagen; Akita University	Hebert, DN (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 240 Thatcher Rd, Amherst, MA 01003 USA.	dhebert@biochem.umass.edu	Tian, Weihua/AAC-8919-2022; clausen, henrik/AAD-8016-2021; Yang, Zhang/I-8934-2016	Oster, Michela Elisabetta del Re/0000-0001-9556-018X; Tian, Weihua/0000-0003-2357-3947; Tamura, Taku/0000-0001-6074-9273; Hebert, Daniel/0000-0003-1537-4446; Clausen, Henrik/0000-0002-0915-5055; Yang, Zhang/0000-0002-4756-5813	National Institutes of Health [GM086874]; National Institutes of Health Chemistry-Biology Interface Program Training Grant [T32GM008515]; Danish National Research Foundation [DNRF107]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008515, R01GM086874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Chemistry-Biology Interface Program Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish National Research Foundation(Danmarks Grundforskningsfond); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM086874 (to D. N. H.), National Institutes of Health Chemistry-Biology Interface Program Training Grant T32GM008515 (to L. L.), and Danish National Research Foundation Grant DNRF107 (to H. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Braakman Ineke, 2017, Curr Protoc Protein Sci, V90, DOI 10.1002/cpps.43; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Ermonval M, 2001, GLYCOBIOLOGY, V11, P565, DOI 10.1093/glycob/11.7.565; Fredrickson EK, 2011, MOL BIOL CELL, V22, P2384, DOI 10.1091/mbc.E11-03-0256; Frenkel Z, 2003, J BIOL CHEM, V278, P34119, DOI 10.1074/jbc.M305929200; Gnann A, 2004, MOL BIOL CELL, V15, P4125, DOI 10.1091/mbc.e04-01-0024; Gulow K, 2002, J CELL SCI, V115, P2443; Han DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107371; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Jang BY, 2015, INT J MOL MED, V35, P870, DOI 10.3892/ijmm.2015.2109; Jansen G, 2012, MOL CELL PROTEOMICS, V11, P710, DOI 10.1074/mcp.M111.016550; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Khodayari N, 2017, J CELL BIOCHEM, V118, P3090, DOI 10.1002/jcb.26069; Kosmaoglou M, 2009, J CELL SCI, V122, P4465, DOI 10.1242/jcs.055228; Lamriben L, 2016, TRAFFIC, V17, P308, DOI 10.1111/tra.12358; Le Fourn V, 2009, CELL MOL LIFE SCI, V66, P1434, DOI 10.1007/s00018-009-9038-1; Marin MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042998; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Merulla J, 2013, TRAFFIC, V14, P767, DOI 10.1111/tra.12068; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Ninagawa S, 2015, J CELL BIOL, V211, P775, DOI 10.1083/jcb.201504109; Ninagawa S, 2014, J CELL BIOL, V206, P347, DOI 10.1083/jcb.201404075; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Parodi A., 2015, ESSENTIALS GLYCOBIOL; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Reed BJ, 2015, J BIOL CHEM, V290, P20601, DOI 10.1074/jbc.M115.650952; Ronzoni R, 2016, HUM MOL GENET, V25, P642, DOI 10.1093/hmg/ddv501; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Schulz MA, 2018, GLYCOBIOLOGY, V28, P542, DOI 10.1093/glycob/cwy022; Shenkman M, 2013, J BIOL CHEM, V288, P2167, DOI 10.1074/jbc.M112.438275; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sokolowska I, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0047-7; Tamura T, 2011, J BIOL CHEM, V286, P24906, DOI 10.1074/jbc.M111.243998; Tannous A, 2015, SEMIN CELL DEV BIOL, V41, P79, DOI 10.1016/j.semcdb.2014.12.001; Timms RT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11786; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Vallee F, 2000, EMBO J, V19, P581, DOI 10.1093/emboj/19.4.581; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126; Yu SY, 2018, J BIOL CHEM, V293, P10663, DOI 10.1074/jbc.RA118.003129	48	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13932	13945		10.1074/jbc.RA118.004183	http://dx.doi.org/10.1074/jbc.RA118.004183			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30021839	Green Published, hybrid			2022-12-28	WOS:000444070700019
J	Yin, RH; Zhou, LT; Gao, N; Li, Z; Zhao, LY; Shang, FN; Wu, MY; Zhao, JH				Yin, Ronghua; Zhou, Lutan; Gao, Na; Li, Zi; Zhao, Longyan; Shang, Feineng; Wu, Mingyi; Zhao, Jinhua			Oligosaccharides from depolymerized fucosylated glycosaminoglycan: Structures and minimum size for intrinsic factor Xase complex inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						natural product; carbohydrate chemistry; carbohydrate structure; chemical modification; drug discovery; oligosaccharide; thrombosis	CUCUMBER STICHOPUS-JAPONICUS; CHONDROITIN SULFATE; SEA-CUCUMBER; ANTICOAGULANT ACTIVITIES; FUCOSE BRANCHES; HOLOTHURIAN GLYCOSAMINOGLYCAN; TENASE COMPLEX; BODY-WALL; HEPARIN; POLYSACCHARIDE	Fucosylated glycosaminoglycan (FG), a structurally complex glycosaminoglycan found up to now exclusively in sea cucumbers, has distinct anticoagulant properties, notably a strong inhibitory activity of intrinsic factor Xase complex (FXase). Knowledge of the FG structures could facilitate the development of a clinically effective intrinsic FXase inhibitor for anticoagulant drugs. Here, a new fucosylated glycosaminoglycan was obtained from the widely traded sea cucumber Bohadschia argus. The precise structure was deduced as {4)-[l-Fuc3S4S--(13)-]-d-GlcA--(13)-d-GalNAc4S6S--(1} through analysis of its chemical properties and homogeneous oligosaccharides purified from its -eliminative depolymerized products. The B. argus FG with mostly 3,4-di-O-sulfated fucoses expands our knowledge on FG structural types. This -elimination process, producing oligosaccharides with well-defined structures, is a powerful tool for analyzing the structure of complex FGs. Among these oligosaccharides, an octasaccharide displayed potent FXase inhibitory activity. Compared with oligosaccharides with various degrees of polymerization (3n and 3n - 1), our analyses reveal that the purified octasaccharide is the minimum structural unit responsible for the potent selective FXase inhibition, because the d-talitol in the nonsaccharide is unnecessary. The octasaccharide with 2,4-di-O-sulfated fucoses is more potent than that of one with 3,4-di-O-sulfated fucoses. Thus, sulfation patterns can play an important role in the inhibition of intrinsic factor Xase complex.	[Yin, Ronghua; Zhou, Lutan; Gao, Na; Li, Zi; Zhao, Longyan; Shang, Feineng; Wu, Mingyi; Zhao, Jinhua] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China; [Yin, Ronghua; Zhou, Lutan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, MY; Zhao, JH (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China.	mingyiwu_tju@yahoo.com; zhao.jinhua@yahoo.com	Zhao, Jinhua/GYV-4433-2022	Zhao, Longyan/0000-0001-9999-3433; Wu, Mingyi/0000-0002-7764-458X	National Natural Science Foundation of China [81673330, 81773737]; Yunnan Provincial Science and Technology Department [2016FA050, 2010CI116]; Kunming Institute of Botany [KIB2017011]; Chinese Academy of Sciences Youth Innovation Promotion Association [2017435]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Science and Technology Department; Kunming Institute of Botany; Chinese Academy of Sciences Youth Innovation Promotion Association	This work was supported in part by National Natural Science Foundation of China Grants 81673330 and 81773737, Yunnan Provincial Science and Technology Department Grants 2016FA050 and 2010CI116, Kunming Institute of Botany Grant KIB2017011, and Chinese Academy of Sciences Youth Innovation Promotion Association Grant 2017435. The authors declare that they have no conflicts of interest with the contents of this article.	CASU B, 1975, CARBOHYD RES, V39, P168, DOI 10.1016/S0008-6215(00)82654-3; Chen SG, 2013, BBA-GEN SUBJECTS, V1830, P3054, DOI 10.1016/j.bbagen.2013.01.001; Chen SG, 2011, CARBOHYD POLYM, V83, P688, DOI 10.1016/j.carbpol.2010.08.040; Fonseca RJC, 2010, THROMB HAEMOSTASIS, V103, P994, DOI 10.1160/TH09-10-0734; Gao N, 2015, CARBOHYD POLYM, V127, P427, DOI 10.1016/j.carbpol.2015.04.002; Huang Y, 2015, ANAL CHEM, V87, P592, DOI 10.1021/ac503248k; Kariya Y, 1997, CARBOHYD RES, V297, P273, DOI 10.1016/S0008-6215(96)00258-3; KARIYA Y, 1990, J BIOL CHEM, V265, P5081; Kitazato K, 1996, THROMB RES, V84, P111, DOI 10.1016/0049-3848(96)00166-1; KURACHI K, 1976, BIOCHEMISTRY-US, V15, P373, DOI 10.1021/bi00647a021; Li XM, 2017, J AGR FOOD CHEM, V65, P9315, DOI 10.1021/acs.jafc.7b03867; Liu J, 2017, INT J BIOL MACROMOL, V98, P786, DOI 10.1016/j.ijbiomac.2017.01.149; Luo L, 2013, MAR DRUGS, V11, P399, DOI 10.3390/md11020399; Mizumoto S, 2013, GLYCOBIOLOGY, V23, P155, DOI 10.1093/glycob/cws137; Mourao PAS, 1996, J BIOL CHEM, V271, P23973, DOI 10.1074/jbc.271.39.23973; Murase T, 2010, CARBOHYD RES, V345, P1702, DOI 10.1016/j.carres.2010.05.020; PHILIPS KD, 1973, CARBOHYD RES, V30, P281, DOI 10.1016/S0008-6215(00)81814-5; Pomin VH, 2014, MAR DRUGS, V12, P232, DOI 10.3390/md12010232; Rand MD, 1996, BLOOD, V88, P3432, DOI 10.1182/blood.V88.9.3432.bloodjournal8893432; Santos GRC, 2017, GLYCOBIOLOGY, V27, P625, DOI 10.1093/glycob/cwx031; Santos GRC, 2015, GLYCOBIOLOGY, V25, P1043, DOI 10.1093/glycob/cwv044; Shang FN, 2018, EUR J MED CHEM, V148, P423, DOI 10.1016/j.ejmech.2018.02.047; Sheehan JP, 2006, BLOOD, V107, P3876, DOI 10.1182/blood-2005-07-3043; Ustyuzhanina NE, 2017, CARBOHYD POLYM, V164, P8, DOI 10.1016/j.carbpol.2017.01.034; Ustyuzhanina NE, 2016, CARBOHYD POLYM, V153, P399, DOI 10.1016/j.carbpol.2016.07.076; VIEIRA RP, 1991, J BIOL CHEM, V266, P13530; Wu MY, 2015, EUR J MED CHEM, V92, P257, DOI 10.1016/j.ejmech.2014.12.054; Wu MY, 2012, CARBOHYD POLYM, V87, P862, DOI 10.1016/j.carbpol.2011.08.082; YOSHIDA K, 1992, TETRAHEDRON LETT, V33, P4959, DOI 10.1016/S0040-4039(00)61245-5; Yu F, 2007, J AM CHEM SOC, V129, P13288, DOI 10.1021/ja075272h; Zhao LY, 2015, P NATL ACAD SCI USA, V112, P8284, DOI 10.1073/pnas.1504229112	31	34	35	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14089	14099		10.1074/jbc.RA118.003809	http://dx.doi.org/10.1074/jbc.RA118.003809			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30030375	hybrid, Green Published			2022-12-28	WOS:000444070700030
J	Dodd, RB				Dodd, Roger B.			An exTREMe disruption in Alzheimer's cleanup	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							DISEASE	Partial loss-of-function variants in the TREM2 immune receptor are associated with increased risk for Alzheimer's disease (AD) and other forms of neurodegenerative disease, but the molecular bases for these connections are unknown. Three new structures of WT and R47H mutant TREM2 immunoglobulin-like (Ig-like) domain now reveal that R47 functions to correctly position elements of the ligand-binding surface. Intriguingly, the authors also demonstrate a disruption of receptor oligomerization by the R47H mutation, suggesting a role for ligand-induced clustering in receptor signaling and resultant plaque clearance.	[Dodd, Roger B.] MedImmune, Dept Antibody Discovery & Prot Engn, Sir Aaron Klug Bldg,Granta Pk, Cambridge CB21 6GH, England	AstraZeneca; Medimmune	Dodd, RB (corresponding author), MedImmune, Dept Antibody Discovery & Prot Engn, Sir Aaron Klug Bldg,Granta Pk, Cambridge CB21 6GH, England.	doddr@MedImmune.com		Dodd, Roger/0000-0003-4268-1863				Cheng-Hathaway PJ, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0262-8; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kober DL, 2016, ELIFE, V5, DOI 10.7554/eLife.20391; Lee CYD, 2018, NEURON, V97, P1032, DOI 10.1016/j.neuron.2018.02.002; Song WM, 2018, J EXP MED, V215, P745, DOI 10.1084/jem.20171529; Sudom A, 2018, J BIOL CHEM, V293, P12634, DOI 10.1074/jbc.RA118.002352; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Zhao YJ, 2018, NEURON, V97, P1023, DOI 10.1016/j.neuron.2018.01.031	10	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12647	12648		10.1074/jbc.H118.004271	http://dx.doi.org/10.1074/jbc.H118.004271			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	30097493	hybrid, Green Published			2022-12-28	WOS:000441408500028
J	Folgueras, AR; Fueyo, A; Garcia-Suarez, O; Cox, J; Astudillo, A; Tortorella, P; Campestre, C; Gutierrez-Fernandez, A; Fanjul-Fernandez, M; Pennington, CJ; Edwards, DR; Overall, CM; Lopez-Otin, C				Folgueras, Alicia R.; Fueyo, Antonio; Garcia-Suarez, Olivia; Cox, Jennifer; Astudillo, Aurora; Tortorella, Paolo; Campestre, Cristina; Gutierrez-Fernandez, Ana; Fanjul-Fernandez, Miriam; Pennington, Caroline J.; Edwards, Dylan R.; Overall, Christopher M.; Lopez-Otin, Carlos			Collagenase-2 deficiency or inhibition impairs experimental autoimmune encephalomyelitis in mice (vol 283, pg 9465, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Edwards, Dylan R/B-4734-2009; Gutierrez-Fernandez, Ana/AAS-9954-2021; Fueyo, Antonio/ABH-3243-2020	Edwards, Dylan R/0000-0002-3292-2064; Gutierrez-Fernandez, Ana/0000-0002-9287-8843; Fueyo, Antonio/0000-0002-7121-9398				Folgueras AR, 2008, J BIOL CHEM, V283, P9465, DOI 10.1074/jbc.M709522200	1	0	0	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11968	11969		10.1074/jbc.AAC118.004703	http://dx.doi.org/10.1074/jbc.AAC118.004703			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	30054293	Green Published, hybrid			2022-12-28	WOS:000440134500028
J	Liu, Y; Sumpter, DJT				Liu, Yu; Sumpter, David J. T.			Mathematical modeling reveals spontaneous emergence of self-replication in chemical reaction systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOCATALYTIC SETS; ORIGIN; EVOLUTION; LIFE; EVOLVABILITY; ORGANIZATION; NETWORKS	Explaining the origin of life requires us to elucidate how self-replication arises. To be specific, how can a self-replicating entity develop spontaneously from a chemical reaction system in which no reaction is self-replicating? Previously proposed mathematical models either supply an explicit framework for a minimal living system or consider only catalyzed reactions, and thus fail to provide a comprehensive theory. Here, we set up a general mathematical model for chemical reaction systems that properly accounts for energetics, kinetics, and the conservation law. We found that 1) some systems are collectively catalytic, a mode whereby reactants are transformed into end products with the assistance of intermediates (as in the citric acid cycle), whereas some others are self-replicating, that is, different parts replicate each other and the system self-replicates as a whole (as in the formose reaction, in which sugar is replicated from form-aldehyde); 2) side reactions do not always inhibit such systems; 3) randomly chosen chemical universes (namely random artificial chemistries) often contain one or more such systems; 4) it is possible to construct a self-replicating system in which the entropy of some parts spontaneously decreases, in a manner similar to that discussed by Schrodinger; and 5) complex self-replicating molecules can emerge spontaneously and relatively easily from simple chemical reaction systems through a sequence of transitions. Together, these results start to explain the origins of prebiotic evolution.	[Liu, Yu; Sumpter, David J. T.] Uppsala Univ, Dept Math, S-75105 Uppsala, Sweden	Uppsala University	Liu, Y (corresponding author), Uppsala Univ, Dept Math, S-75105 Uppsala, Sweden.	yu.ernest.liu@hotmail.com	Liu, Yu/AAE-2161-2019	Liu, Yu/0000-0003-2640-6490	Erasmus Mundus Action 2 program (Lotus III Scholarship) - European Commission	Erasmus Mundus Action 2 program (Lotus III Scholarship) - European Commission	Supported by the Erasmus Mundus Action 2 program (Lotus III Scholarship), funded by the European Commission.	Alberty RA, 2004, J BIOL CHEM, V279, P27831, DOI 10.1074/jbc.X400003200; Amend JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0255; Ashkenasy G, 2004, P NATL ACAD SCI USA, V101, P10872, DOI 10.1073/pnas.0402674101; Atkins P, 2014, ATKINS PHYS CHEM, P185; Banzhaf W, 2015, ARTIFICIAL CHEMISTRIES, P111; Branscomb E, 2013, BBA-BIOENERGETICS, V1827, P62, DOI 10.1016/j.bbabio.2012.10.003; Cavicchioli R, 2002, ASTROBIOLOGY, V2, P281, DOI 10.1089/153110702762027862; Czaran T, 2015, J THEOR BIOL, V381, P39, DOI 10.1016/j.jtbi.2015.06.002; Dittrich P, 2001, ARTIF LIFE, V7, P225, DOI 10.1162/106454601753238636; Dittrich P, 2007, B MATH BIOL, V69, P1199, DOI 10.1007/s11538-006-9130-8; England JL, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4818538; FARMER JD, 1986, PHYSICA D, V22, P50, DOI 10.1016/0167-2789(86)90233-2; FONTANA W, 1994, B MATH BIOL, V56, P1; Ganti T., 2003, PRINCIPLES LIFE, P4; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Hordijk W, 2004, J THEOR BIOL, V227, P451, DOI 10.1016/j.jtbi.2003.11.020; Hordijk W, 2018, NEW J PHYS, V20, DOI 10.1088/1367-2630/aa9fcd; Hordijk W, 2017, BIOSYSTEMS, V152, P1, DOI 10.1016/j.biosystems.2016.12.002; Hordijk W, 2016, J MATH CHEM, V54, P1997, DOI 10.1007/s10910-016-0666-z; Hordijk W, 2016, ORIGINS LIFE EVOL B, V46, P233, DOI 10.1007/s11084-015-9471-0; Hordijk W, 2013, BIOSCIENCE, V63, P877, DOI 10.1525/bio.2013.63.11.6; Hordijk W, 2012, ACTA BIOTHEOR, V60, P379, DOI 10.1007/s10441-012-9165-1; Jain S, 2001, P NATL ACAD SCI USA, V98, P543, DOI 10.1073/pnas.021545098; KAUFFMAN SA, 1986, J THEOR BIOL, V119, P1, DOI 10.1016/S0022-5193(86)80047-9; Kim HJ, 2011, J AM CHEM SOC, V133, P9457, DOI 10.1021/ja201769f; KOPP LE, 1972, J BIOL CHEM, V247, P3564; Kun A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r51; Levy M, 2003, P NATL ACAD SCI USA, V100, P6416, DOI 10.1073/pnas.1130145100; Li L, 2013, J BIOL CHEM, V288, P26856, DOI 10.1074/jbc.M113.496125; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; Martin WF, 2014, SCIENCE, V344, P1092, DOI 10.1126/science.1251653; MAVROVOUNIOTIS ML, 1991, J BIOL CHEM, V266, P14440; Maynard Smith J, 1995, MAJOR TRANSITIONS EV, P41; Mix LJ, 2006, ASTROBIOLOGY, V6, P735; Morowitz HJ, 2000, P NATL ACAD SCI USA, V97, P7704, DOI 10.1073/pnas.110153997; Nghe P, 2015, MOL BIOSYST, V11, P3206, DOI 10.1039/c5mb00593k; Rasmussen S, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0440; Ricardo A, 2004, SCIENCE, V303, P196, DOI 10.1126/science.1092464; Robertson M.P., 2012, COLD SPRING HARB PER, V4, P4, DOI DOI 10.1101/CSHPERSPECT.A003608; RUSSELL MJ, 1993, TERRA NOVA, V5, P343, DOI 10.1111/j.1365-3121.1993.tb00267.x; Schmidt M, 2010, BIOESSAYS, V32, P322, DOI 10.1002/bies.200900147; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Segre D, 1998, ORIGINS LIFE EVOL B, V28, P501, DOI 10.1023/A:1006583712886; SIEVERS D, 1994, NATURE, V369, P221, DOI 10.1038/369221a0; Smith Joshua I, 2014, J Syst Chem, V5, P2; Sousa Filipa L, 2015, J Syst Chem, V6, P4; STADLER PF, 1993, PHYSICA D, V63, P378, DOI 10.1016/0167-2789(93)90118-K; Steel M, 2000, APPL MATH LETT, V13, P91, DOI 10.1016/S0893-9659(99)00191-3; Szathmary E, 1999, MG BEH ECOL, P31; Szathmary E, 2005, TOP CURR CHEM, V259, P167, DOI 10.1007/tcc001; SZATHMARY E, 1995, P ROY SOC B-BIOL SCI, V260, P279, DOI 10.1098/rspb.1995.0092; Szathmary E, 2006, PHILOS T R SOC B, V361, P1761, DOI 10.1098/rstb.2006.1912; Szilagyi A, 2017, LIFE-BASEL, V7, DOI 10.3390/life7040048; Vaidya N, 2012, NATURE, V491, P72, DOI 10.1038/nature11549; Vasas V, 2015, J THEOR BIOL, V381, P29, DOI 10.1016/j.jtbi.2015.06.047; Vasas V, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-1; Vasas V, 2010, P NATL ACAD SCI USA, V107, P1470, DOI 10.1073/pnas.0912628107; WACHTERSHAUSER G, 1990, P NATL ACAD SCI USA, V87, P200, DOI 10.1073/pnas.87.1.200; WACHTERSHAUSER G, 1988, MICROBIOL REV, V52, P452; Wills P, 2000, NEW ENGL COMPL SYST, P613	60	12	12	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18854	18863		10.1074/jbc.RA118.003795	http://dx.doi.org/10.1074/jbc.RA118.003795			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30282809	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000458467400004
J	Betancourt-Solis, MA; Desai, T; McNew, JA				Betancourt-Solis, Miguel A.; Desai, Tanvi; McNew, James A.			The atlastin membrane anchor forms an intramembrane hairpin that does not span the phospholipid bilayer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; HOMOTYPIC FUSION; STRUCTURAL BASIS; COMMON PATHWAY; PROTEINS; REQUIRES; RECONSTITUTION; GENERATION; MECHANISM; SNARE	The endoplasmic reticulum (ER) is composed of flattened sheets and interconnected tubules that extend throughout the cytosol and makes physical contact with all other cytoplasmic organelles. This cytoplasmic distribution requires continuous remodeling. These discrete ER morphologies require specialized proteins that drive and maintain membrane curvature. The GTPase atlastin is required for homotypic fusion of ER tubules. All atlastin homologs possess a conserved domain architecture consisting of a GTPase domain, a three-helix bundle middle domain, a hydrophobic membrane anchor, and a C-terminal cytosolic tail. Here, we examined several Drosophila-human atlastin chimeras to identify functional domains of human atlastin-1 in vitro. Although all chimeras could hydrolyze GTP, only chimeras containing the human C-terminal tail, hydrophobic segments, or both could fuse membranes in vitro. We also determined that co-reconstitution of atlastin with reticulon does not influence GTPase activity or membrane fusion. Finally, we found that both human and Drosophila atlastin hydrophobic membrane anchors do not span the membrane, but rather form two intramembrane hairpin loops. The topology of these hairpins remains static during membrane fusion and does not appear to play an active role in lipid mixing.	[Betancourt-Solis, Miguel A.; Desai, Tanvi; McNew, James A.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA	Rice University	McNew, JA (corresponding author), Rice Univ, Dept BioSci, 6100 Main St,MS601, Houston, TX 77005 USA.	mcnew@rice.edu	Desai, Tanvi/AAH-7038-2021; McNew, James/ABD-8081-2020; McNew, James/AAV-4911-2020	McNew, James/0000-0001-8459-3664; Desai, Tanvi/0000-0003-2571-5910; Betancourt-Solis, Miguel Alberto/0000-0001-8041-4120	National Institutes of Health [GM101377]; Virginia and L. E. Simmons Family Foundation; Hamill Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia and L. E. Simmons Family Foundation; Hamill Foundation	Supported by National Institutes of Health Grant GM101377, the Virginia and L. E. Simmons Family Foundation, and the Hamill Foundation. To whom correspondence should be addressed: Dept. of BioSciences, Rice University, 6100 Main St., Rice University, MS601, Houston, TX 77005. Tel.: 713-348-3133; E-mail: mcnew@rice.edu.	Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Blackstone Craig, 2018, Handb Clin Neurol, V148, P633, DOI 10.1016/B978-0-444-64076-5.00041-7; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Blijleven JS, 2016, SEMIN CELL DEV BIOL, V60, P78, DOI 10.1016/j.semcdb.2016.07.007; Byrnes LJ, 2013, EMBO J, V32, P369, DOI 10.1038/emboj.2012.353; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Chen S, 2015, P NATL ACAD SCI USA, V112, P418, DOI 10.1073/pnas.1423026112; Chen SL, 2012, NAT CELL BIOL, V14, P707, DOI 10.1038/ncb2523; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; English AR, 2009, CURR OPIN CELL BIOL, V21, P596, DOI 10.1016/j.ceb.2009.04.004; Evans K, 2006, P NATL ACAD SCI USA, V103, P10666, DOI 10.1073/pnas.0510863103; Faust JE, 2015, J BIOL CHEM, V290, P4772, DOI 10.1074/jbc.M114.601823; Fink JK, 2006, CURR NEUROL NEUROSCI, V6, P65, DOI 10.1007/s11910-996-0011-1; Fink JK, 2014, SEMIN NEUROL, V34, P293, DOI 10.1055/s-0034-1386767; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Hu JJ, 2016, SEMIN CELL DEV BIOL, V60, P105, DOI 10.1016/j.semcdb.2016.06.001; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Hubner CA, 2014, BRAIN, V137, P3109, DOI 10.1093/brain/awu287; Klebe S, 2015, REV NEUROL-FRANCE, V171, P505, DOI 10.1016/j.neurol.2015.02.017; Kornak U, 2014, BRAIN, V137, P683, DOI 10.1093/brain/awt357; Kozlov MM, 2014, CURR OPIN CELL BIOL, V29, P53, DOI 10.1016/j.ceb.2014.03.006; Lee Y, 2008, NEUROBIOL AGING, V29, P84, DOI 10.1016/j.neurobiolaging.2006.09.004; Liu TY, 2015, P NATL ACAD SCI USA, V112, pE1851, DOI 10.1073/pnas.1504368112; Liu TY, 2012, P NATL ACAD SCI USA, V109, pE2146, DOI 10.1073/pnas.1208385109; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Mcnew JA, 2008, CHEM REV, V108, P1669, DOI 10.1021/cr0782325; McNew JA, 2013, ANNU REV CELL DEV BI, V29, P529, DOI 10.1146/annurev-cellbio-101512-122328; Montenegro G, 2012, J CLIN INVEST, V122, P538, DOI 10.1172/JCI60560; Morin-Leisk J, 2011, J CELL BIOL, V195, P605, DOI 10.1083/jcb.201105006; Moss B, 2016, SEMIN CELL DEV BIOL, V60, P89, DOI 10.1016/j.semcdb.2016.07.015; Moss TJ, 2011, P NATL ACAD SCI USA, V108, P11133, DOI 10.1073/pnas.1105056108; Moss TJ, 2011, TRENDS CELL BIOL, V21, P416, DOI 10.1016/j.tcb.2011.03.009; Noreau A, 2014, EXP CELL RES, V325, P18, DOI 10.1016/j.yexcr.2014.02.021; O'Donnell JP, 2018, J BIOL CHEM, V293, P687, DOI 10.1074/jbc.RA117.000380; O'Donnell JP, 2017, STRUCTURE, V25, P997, DOI 10.1016/j.str.2017.05.007; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Pendin D, 2011, CURR OPIN CELL BIOL, V23, P435, DOI 10.1016/j.ceb.2011.04.007; Powers RE, 2017, NATURE, V543, P257, DOI 10.1038/nature21387; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057; Rothman JE, 2014, ANGEW CHEM INT EDIT, V53, P12676, DOI 10.1002/anie.201402380; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Scott BL, 2003, METHOD ENZYMOL, V372, P274; Shemesh T, 2014, P NATL ACAD SCI USA, V111, pE5243, DOI 10.1073/pnas.1419997111; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Summerville JB, 2016, J CELL SCI, V129, P1635, DOI 10.1242/jcs.184929; Voeltz GK, 2007, NAT REV MOL CELL BIO, V8, P258, DOI 10.1038/nrm2119; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wakefield S, 2006, CELL MOL LIFE SCI, V63, P2027, DOI 10.1007/s00018-006-6142-3; Wang S, 2016, ELIFE, V5, DOI 10.7554/eLife.14211; White JM, 1995, COLD SPRING HARB SYM, V60, P581, DOI 10.1101/SQB.1995.060.01.062; White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389; Wu FY, 2015, PROTEIN CELL, V6, P139, DOI 10.1007/s13238-014-0118-0; Yalcin B, 2017, ELIFE, V6, DOI 10.7554/eLife.23882; Yang YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-234; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758; Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	63	19	20	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18514	18524		10.1074/jbc.RA118.003812	http://dx.doi.org/10.1074/jbc.RA118.003812			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30287684	Green Published, hybrid			2022-12-28	WOS:000458467300009
J	Kuhnle, S; Martinez-Noel, G; Leclere, F; Hayes, SD; Harper, JW; Howley, PM				Kuhnle, Simone; Martinez-Noel, Gustavo; Leclere, Flavien; Hayes, Sebastian D.; Harper, J. Wade; Howley, Peter M.			Angelman syndrome-associated point mutations in the Zn2+-binding N-terminal (AZUL) domain of UBE3A ubiquitin ligase inhibit binding to the proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autism; proteasome; estrogen receptor; Wnt signaling; E3 ubiquitin ligase; Angelman syndrome; AZUL domain; E6AP; PSMD4; UBE3A	HUMAN-PAPILLOMAVIRUS TYPE-16; PROTEIN-DEGRADATION; DEVELOPMENTAL DELAY; MULTIUBIQUITIN CHAIN; E6 ONCOPROTEIN; 26S PROTEASOME; AUTISM; E6-AP; COMPLEX; MODEL	Deregulation of the HECT ubiquitin ligase UBE3A/E6AP has been implicated in Angelman syndrome as well as autism spectrum disorders. We and others have previously identified the 26S proteasome as one of the major UBE3A-interacting protein complexes. Here, we characterize the interaction of UBE3A and the proteasomal subunit PSMD4 (Rpn10/S5a). We map the interaction to the highly conserved Zn2+-binding N-terminal (AZUL) domain of UBE3A, the integrity of which is crucial for binding to PSMD4. Interestingly, two Angelman syndrome point mutations that affect the AZUL domain show an impaired ability to bind PSMD4. Although not affecting the ubiquitin ligase or the estrogen receptor -mediated transcriptional regulation activities, these AZUL domain mutations prevent UBE3A from stimulating the Wnt/-catenin signaling pathway. Taken together, our data indicate that impaired binding to the 26S proteasome and consequential deregulation of Wnt/-catenin signaling might contribute to the functional defect of these mutants in Angelman syndrome.	[Kuhnle, Simone; Martinez-Noel, Gustavo; Leclere, Flavien; Howley, Peter M.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Hayes, Sebastian D.; Harper, J. Wade] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Hayes, Sebastian D.] Agios Pharmaceut, 88 Sidney St, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Agios Pharmaceuticals	Howley, PM (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, NRB, Rm 950,77 Ave Louis Pasteur, Boston, MA 02115 USA.	peter_howley@hms.harvard.edu		Kuhnle, Simone/0000-0001-9382-3142; Howley, Peter/0000-0002-8668-9579; HAYES, SEBASTIAN/0000-0002-2383-9461	National Institutes of Health [R35CA197262, AG011085]; German Research Foundation (Deutsche Forschungsgemeinschaft) Scholarship [KU 3196/2-1]; NATIONAL CANCER INSTITUTE [R35CA197262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (Deutsche Forschungsgemeinschaft) Scholarship(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R35CA197262 (to P. M. H) and AG011085 (to J. W. H.) and German Research Foundation (Deutsche Forschungsgemeinschaft) Scholarship Grant KU 3196/2-1 (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altun M, 2010, J BIOL CHEM, V285, P39597, DOI 10.1074/jbc.M110.129718; ANGELMAN H, 1965, DEV MED CHILD NEUROL, V7, P681; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Chang CY, 1999, MOL CELL BIOL, V19, P8226; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Cheron G, 2005, NEUROSCIENCE, V130, P631, DOI 10.1016/j.neuroscience.2004.09.013; Cooper EM, 2004, J BIOL CHEM, V279, P41208, DOI 10.1074/jbc.M401302200; Demsar J, 2013, J MACH LEARN RES, V14, P2349; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Fang P, 1999, HUM MOL GENET, V8, P129, DOI 10.1093/hmg/8.1.129; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; Harlalka GV, 2013, J MED GENET, V50, P65, DOI 10.1136/jmedgenet-2012-101367; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hogart A, 2010, NEUROBIOL DIS, V38, P181, DOI 10.1016/j.nbd.2008.08.011; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Jacobson AD, 2014, MOL BIOL CELL, V25, P1824, DOI 10.1091/mbc.E13-10-0585; Karpova A, 2006, J NEUROSCI, V26, P4949, DOI 10.1523/JNEUROSCI.4573-05.2006; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kredel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004391; Kremers GJ, 2007, BIOCHEMISTRY-US, V46, P3775, DOI 10.1021/bi0622874; Kuhnle S, 2013, P NATL ACAD SCI USA, V110, P8888, DOI 10.1073/pnas.1302792110; Kuhnle S, 2011, J BIOL CHEM, V286, P19410, DOI 10.1074/jbc.M110.205211; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Kwan V, 2016, J NEURODEV DISORD, V8, DOI 10.1186/s11689-016-9176-3; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lee SY, 2014, CELL MOL LIFE SCI, V71, P2747, DOI 10.1007/s00018-013-1526-7; Lemak A, 2011, J BIOMOL NMR, V51, P185, DOI 10.1007/s10858-011-9552-y; Li L, 2006, J BIOL CHEM, V281, P1978, DOI 10.1074/jbc.M508545200; Lichtig H, 2010, VIROLOGY, V396, P47, DOI 10.1016/j.virol.2009.10.011; Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Malzac P, 1998, AM J HUM GENET, V62, P1353, DOI 10.1086/301877; Martinez-Noel G, 2018, J MOL BIOL, V430, P1024, DOI 10.1016/j.jmb.2018.01.021; Martinez-Noel G, 2012, MOL CELL BIOL, V32, P3095, DOI 10.1128/MCB.00201-12; Martinez-Zapien D, 2016, NATURE, V529, P541, DOI 10.1038/nature16481; Miura K, 2002, NEUROBIOL DIS, V9, P149, DOI 10.1006/nbdi.2001.0463; Moncla A, 1999, EUR J HUM GENET, V7, P131, DOI 10.1038/sj.ejhg.5200258; Mueller O Thomas, 2008, Hum Genet, V124, P304; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Noor A, 2015, HUM MUTAT, V36, P689, DOI 10.1002/humu.22800; PHELPS WC, 1991, J VIROL, V65, P6922, DOI 10.1128/JVI.65.12.6922-6930.1991; Puffenberger EG, 2012, HUM MUTAT, V33, P1639, DOI 10.1002/humu.22237; Ramamoorthy Sivapriya, 2008, Nucl Recept Signal, V6, pe006, DOI 10.1621/nrs.06006; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; Rougeulle C, 1997, NAT GENET, V17, P14, DOI 10.1038/ng0997-14; Sadikovic B, 2014, HUM MUTAT, V35, P1407, DOI 10.1002/humu.22687; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1992, J VIROL, V66, P5100, DOI 10.1128/JVI.66.8.5100-5105.1992; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Sominsky S, 2014, VIROLOGY, V468, P510, DOI 10.1016/j.virol.2014.09.007; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Subbaiah VK, 2016, ONCOGENE, V35, P2062, DOI 10.1038/onc.2015.268; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tai HC, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00012; Tan MJA, 2012, P NATL ACAD SCI USA, V109, pE1473, DOI 10.1073/pnas.1205991109; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tomaic V, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.572; Tomaic V, 2013, VIROLOGY, V446, P389, DOI 10.1016/j.virol.2013.08.016; Uchiki T, 2009, J BIOL CHEM, V284, P12622, DOI 10.1074/jbc.M900556200; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074; WILLIAMS CA, 1995, AM J MED GENET, V56, P237, DOI 10.1002/ajmg.1320560224; Wu Y, 2008, P NATL ACAD SCI USA, V105, P12399, DOI 10.1073/pnas.0805291105; Yamamoto Y, 1997, GENOMICS, V41, P263, DOI 10.1006/geno.1997.4617; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Yi JJ, 2017, J BIOL CHEM, V292, P12503, DOI 10.1074/jbc.M117.788448; Yi JJ, 2015, CELL, V162, P795, DOI 10.1016/j.cell.2015.06.045; Zanier K, 2013, SCIENCE, V339, P694, DOI 10.1126/science.1229934	85	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18387	18399		10.1074/jbc.RA118.004653	http://dx.doi.org/10.1074/jbc.RA118.004653			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30257870	hybrid, Green Published			2022-12-28	WOS:000451375200029
J	Ndeh, D; Munoz, JM; Cartmell, A; Bulmer, D; Wills, C; Henrissat, B; Gray, J				Ndeh, Didier; Munoz, Jose Munoz; Cartmell, Alan; Bulmer, David; Wills, Corinne; Henrissat, Bernard; Gray, Joseph			The human gut microbe Bacteroides thetaiotaomicron encodes the founding member of a novel glycosaminoglycan-degrading polysaccharide lyase family PL29	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chondroitin sulfate; hyaluronan; hyaluronate lyase; carbohydrate metabolism; bacterial metabolism; polysaccharide; CAZymes; cell surface enzyme; glycosaminoglycan degradation; human gut microbiota; PL29	CHONDROITIN SULFATE; STERCORIS HJ-15; PROTEOGLYCANS; BACTERIUM; SYMBIONT; GLYCAN; GROWTH; ABC; OLIGOSACCHARIDES; TETRASACCHARIDES	Glycosaminoglycans (GAGs) and GAG-degrading enzymes have wide-ranging applications in the medical and biotechnological industries. The former are also an important nutrient source for select species of the human gut microbiota (HGM), a key player in host-microbial interactions. How GAGs are metabolized by the HGM is therefore of interest and has been extensively investigated in the model human gut microbe Bacteroides thetaiotaomicron. The presence of as-yet uncharacterized GAG-inducible genes in its genome and of related species, however, is testament to our incomplete understanding of this process. Nevertheless, it presents a potential opportunity for the discovery of additional GAG-degrading enzymes. Here, we investigated a gene of unknown function (BT_3328) from the chondroitin sulfate (CS) utilization locus of B. thetaiotaomicron. NMR and UV spectroscopic assays revealed that it encodes a novel polysaccharide lyase (PL), hereafter referred to as BtCDH, reflecting its source (B. thetaiotaomicron (Bt)) and its ability to degrade the GAGs CS, dermatan sulfate (DS), and hyaluronic acid (HA). When incubated with HA, BtCDH generated a series of unsaturated HA sugars, including (4,5)UA-GlcNAc, (4,5)UA-GlcNAc-GlcA-GlcNac, (4,5)UA-[GlcNAc-GlcA](2)-GlcNac, and (4,5)UA-[GlcNAc-GlcA](3)-GlcNac, as end products and hence was classed as endo-acting. A combination of genetic and biochemical assays revealed that BtCDH localizes to the cell surface of B. thetaiotaomicron where it enables extracellular GAG degradation. BtCDH homologs were also detected in several other HGM species, and we therefore propose that it represents the founding member of a new polysaccharide lyase family (PL29). The current discovery also contributes new insights into CS metabolism by the HGM.	[Ndeh, Didier; Cartmell, Alan; Bulmer, David; Gray, Joseph] Newcastle Univ, Inst Cell & Mol Biosci, Med Sch, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Munoz, Jose Munoz] Northumbria Univ, Dept Appl Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Bulmer, David] Newcastle Univ, Med Sch, Bioimaging Unit, William Leech Bldg, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Wills, Corinne] Sch Nat & Environm Sci, Bedson Bldg,Kings Rd, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Henrissat, Bernard] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biol, F-13288 Marseille, France; [Henrissat, Bernard] INRA, Architecture & Fonct Macromol Biol USC1408, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 23218, Saudi Arabia	Newcastle University - UK; Northumbria University; Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; King Abdulaziz University	Ndeh, D (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Med Sch, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	Didier.Ndeh@newcastle.ac.uk	Henrissat, Bernard/J-2475-2012; Munoz-Munoz, Jose/G-3506-2016	Henrissat, Bernard/0000-0002-3434-8588; Ndeh, Didier/0000-0001-7875-1638; Gray, Joseph/0000-0003-2338-0301; Bulmer, David/0000-0003-0157-9790; Cartmell, Alan/0000-0002-5512-249X; Munoz-Munoz, Jose/0000-0003-0010-948X	European Union's Seventh Framework Program Grant FP/2007/2013; European Research Council [322820]	European Union's Seventh Framework Program Grant FP/2007/2013; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the European Union's Seventh Framework Program Grant FP/2007/2013 and European Research Council Grant Agreement 322820. The authors declare that they have no conflicts of interest with the contents of this article.	Vazquez JA, 2013, MAR DRUGS, V11, P747, DOI 10.3390/md11030747; Cartmell A, 2017, P NATL ACAD SCI USA, V114, P7037, DOI 10.1073/pnas.1704367114; CHENG QO, 1995, J BACTERIOL, V177, P3721, DOI 10.1128/jb.177.13.3721-3727.1995; DAVIDSON S, 1990, J BIOL CHEM, V265, P12324; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Elmabrouk ZH, 2011, PROTEINS, V79, P965, DOI 10.1002/prot.22938; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Gill S, 2010, ANAT REC, V293, P968, DOI 10.1002/ar.21094; Hamai A, 1997, J BIOL CHEM, V272, P9123; Han WJ, 2014, J BIOL CHEM, V289, P27886, DOI 10.1074/jbc.M114.590752; Hong SW, 2002, EUR J BIOCHEM, V269, P2934, DOI 10.1046/j.1432-1033.2002.02967.x; Huckerby TN, 2001, EUR J BIOCHEM, V268, P1181, DOI 10.1046/j.1432-1327.2001.01948.x; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Lemmnitzer K, 2016, ANAL METHODS-UK, V8, P8483, DOI 10.1039/c6ay02531e; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Malavaki CJ, 2008, ANAL BIOCHEM, V374, P213, DOI 10.1016/j.ab.2007.11.006; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Muthusamy A, 2004, GLYCOBIOLOGY, V14, P635, DOI 10.1093/glycob/cwh077; Ndeh D, 2018, FEMS MICROBIOL REV, V42, P146, DOI 10.1093/femsre/fuy002; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Pomin VH, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11010027; Pudlo NA, 2015, MBIO, V6, DOI 10.1128/mBio.01282-15; Raghavan V, 2015, J BACTERIOL, V197, P1538, DOI 10.1128/JB.00010-15; Raghavan V, 2014, MOL MICROBIOL, V93, P1010, DOI 10.1111/mmi.12714; Rani A, 2016, J MOL CATAL B-ENZYM, V134, P215, DOI 10.1016/j.molcatb.2016.11.001; Shaya D, 2008, BIOCHEMISTRY-US, V47, P6650, DOI 10.1021/bi800353g; Shim KW, 2008, PROTEIN EXPRES PURIF, V58, P222, DOI 10.1016/j.pep.2007.11.014; Silva C, 2015, ANAL CHIM ACTA, V885, P207, DOI 10.1016/j.aca.2015.05.034; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Terrapon N, 2015, BIOINFORMATICS, V31, P647, DOI 10.1093/bioinformatics/btu716; Tuncil YE, 2017, MBIO, V8, DOI [10.1128/mBio.01068-17, 10.1128/mbio.01068-17]; Ulmer JE, 2014, J BIOL CHEM, V289, P24289, DOI 10.1074/jbc.M114.573303; Wight Thomas N., 1992, Current Opinion in Cell Biology, V4, P793, DOI 10.1016/0955-0674(92)90102-I	38	19	20	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17906	17916		10.1074/jbc.RA118.004510	http://dx.doi.org/10.1074/jbc.RA118.004510			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30262663	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000450409500020
J	Godfrey, TC; Wildman, BJ; Beloti, MM; Kemper, AG; Ferraz, EP; Roy, B; Rehan, M; Afreen, LH; Kim, E; Lengner, CJ; Hassan, Q				Godfrey, Tanner C.; Wildman, Benjamin J.; Beloti, Marcio M.; Kemper, Austin G.; Ferraz, Emanuela P.; Roy, Bhaskar; Rehan, Mohammad; Afreen, Lubana H.; Kim, Eddy; Lengner, Christopher J.; Hassan, Quamarul			The microRNA-23a cluster regulates the developmental HoxA cluster function during osteoblast differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone; osteoblast; epigenetics; microRNA (miRNA); gene regulation; Bone epigenetics; H3K27 acetylation; HoxA cluster; miR-23a cluster; osteoblast differentiation; homeobox; transcription factor	MESENCHYMAL STEM-CELLS; BONE-FORMATION; MESSENGER-RNA; OSTEOGENIC DIFFERENTIATION; HOMEOTIC TRANSFORMATIONS; TARGETED DISRUPTIONS; LINEAGE COMMITMENT; COMPOUND MUTANTS; LIMB DEVELOPMENT; AXIAL SKELETON	MicroRNAs (miRs) and Hox transcription factors have decisive roles in postnatal bone formation and homeostasis. In silico analysis identified extensive interaction between HOXA cluster mRNA and microRNAs from the miR-23a cluster. However, Hox regulation by the miR-23a cluster during osteoblast differentiation remains undefined. We examined this regulation in preosteoblasts and in a novel miR-23a cluster knockdown mouse model. Overexpression and knockdown of the miR-23a cluster in preosteoblasts decreased and increased, respectively, the expression of the proteins HOXA5, HOXA10, and HOXA11; these proteins' mRNAs exhibited significant binding with the miR-23a cluster miRNAs, and miRNA 3-UTR reporter assays confirmed repression. Importantly, during periods correlating with development and differentiation of bone cells, we found an inverse pattern of expression between HoxA factors and members of the miR-23a cluster. HOXA5 and HOXA11 bound to bone-specific promoters, physically interacted with transcription factor RUNX2, and regulated bone-specific genes. Depletion of HOXA5 or HOXA11 in preosteoblasts also decreased cellular differentiation. Additionally, stable overexpression of the miR-23a cluster in osteoblasts decreased the recruitment of HOXA5 and HOXA11 to osteoblast gene promoters, significantly inhibiting histone H3 acetylation. Heterozygous miR-23a cluster knockdown female mice (miR-23a Cl-WT/ZIP) had significantly increased trabecular bone mass when compared with WT mice. Furthermore, miR-23a cluster knockdown in calvarial osteoblasts of these mice increased the recruitment of HOXA5 and HOXA11, with a substantial enrichment of promoter histone H3 acetylation. Taken together, these findings demonstrate that the miR-23a cluster is required for maintaining stage-specific HoxA factor expression during osteogenesis.	[Godfrey, Tanner C.; Wildman, Benjamin J.; Kemper, Austin G.; Roy, Bhaskar; Rehan, Mohammad; Afreen, Lubana H.; Kim, Eddy; Hassan, Quamarul] Univ Alabama Birmingham, Sch Dent, Dept Oral & Maxillofacial Surg, RNA Biol & Epigenet Lab, Birmingham, AL 35294 USA; [Beloti, Marcio M.; Ferraz, Emanuela P.] Univ Sao Paulo, Sch Dent Ribeirao Preto, BR-14040904 Ribeirao Preto, SP, Brazil; [Lengner, Christopher J.] Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA; [Lengner, Christopher J.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA	University of Alabama System; University of Alabama Birmingham; Universidade de Sao Paulo; University of Pennsylvania; University of Pennsylvania	Hassan, Q (corresponding author), Sch Dent, Inst Oral Hlth Res, Dept Oral & Maxillofacial Surg, 1919 7th Ave S, Birmingham, AL 35233 USA.	hassank@uab.edu	Ferraz, Emanuela/J-9441-2012	Ferraz, Emanuela/0000-0001-6833-4865	NIAMS, National Institutes of Health [1R01AR069578]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069578] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIAMS, National Institutes of Health, Grant 1R01AR069578. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Alexander R, 2011, EXPERT OPIN THER TAR, V15, P623, DOI 10.1517/14728222.2011.561317; Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Bae YJ, 2012, HUM MOL GENET, V21, P2991, DOI 10.1093/hmg/dds129; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Boulet AM, 2002, DEV BIOL, V249, P96, DOI 10.1006/dbio.2002.0755; Brend T, 2003, DEVELOPMENT, V130, P2717, DOI 10.1242/dev.00471; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Carapuco M, 2005, GENE DEV, V19, P2116, DOI 10.1101/gad.338705; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Favier B, 1996, DEVELOPMENT, V122, P449; Gaur T, 2010, DEV BIOL, V340, P10, DOI 10.1016/j.ydbio.2010.01.008; Gindin Y, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00233; Gordon JAR, 2010, MOL CELL BIOL, V30, P3531, DOI 10.1128/MCB.00889-09; Grunhagen J, 2015, J BONE MINER RES, V30, P796, DOI 10.1002/jbmr.2412; Hassan MQ, 2007, MOL CELL BIOL, V27, P3337, DOI 10.1128/MCB.01544-06; Hassan MQ, 2015, BONE, V81, P746, DOI 10.1016/j.bone.2015.05.026; Hassan MQ, 2012, J BIOL CHEM, V287, P42084, DOI 10.1074/jbc.M112.377515; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Heair HM, 2015, MOL CELL BIOL, V35, P3116, DOI 10.1128/MCB.00093-15; HORAN GSB, 1995, GENE DEV, V9, P1667, DOI 10.1101/gad.9.13.1667; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; JEANNOTTE L, 1993, GENE DEV, V7, P2085, DOI 10.1101/gad.7.11.2085; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Kato RB, 2014, J CELL PHYSIOL, V229, P1690, DOI 10.1002/jcp.24614; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; KOSTIC D, 1994, MECH DEVELOP, V46, P231, DOI 10.1016/0925-4773(94)90073-6; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Leucht P, 2008, DEVELOPMENT, V135, P2845, DOI 10.1242/dev.023788; Li H, 2015, CELL DEATH DIFFER, V22, P1935, DOI 10.1038/cdd.2015.99; Li T, 2016, INT J BIOCHEM CELL B, V72, P55, DOI 10.1016/j.biocel.2016.01.004; Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Lipsky PE, 2010, NAT REV RHEUMATOL, V6, P179, DOI [10.1038/nrrheum.2010.50, 10.1038/nrrheum.2009.266, 10.1038/nrrheum.2009.270, 10.1038/nrrheum.2010.38, 10.1038/nrrheum.2010.112]; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Liu P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32112; Mansfield JH, 2012, CURR TOP DEV BIOL, V99, P31, DOI 10.1016/B978-0-12-387038-4.00002-1; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Mizoguchi F, 2010, J CELL BIOCHEM, V109, P866, DOI 10.1002/jcb.22228; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nelson CE, 1996, DEVELOPMENT, V122, P1449; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Qin YW, 2017, J BIOL CHEM, V292, P11021, DOI 10.1074/jbc.M116.770941; Rijli FM, 1997, CURR OPIN GENET DEV, V7, P481, DOI 10.1016/S0959-437X(97)80074-3; Rux DR, 2017, J BONE MINER RES, V32, P1750, DOI 10.1002/jbmr.3166; Rux DR, 2017, DEV DYNAM, V246, P310, DOI 10.1002/dvdy.24482; Salsi V, 2006, J BIOL CHEM, V281, P1992, DOI 10.1074/jbc.M510900200; Salsi V, 2008, DEV BIOL, V317, P497, DOI 10.1016/j.ydbio.2008.02.048; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Taylor Sarah E B, 2014, Bonekey Rep, V3, P585, DOI 10.1038/bonekey.2014.80; Wei JW, 2012, J CELL BIOL, V197, P509, DOI 10.1083/jcb.201201057; Weilner S, 2015, BONE, V79, P43, DOI 10.1016/j.bone.2015.05.027; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Wu QX, 2012, J BIOL CHEM, V287, P25173, DOI 10.1074/jbc.M112.362053; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400; Zeng HC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15000; Zhang LA, 2011, CELL STEM CELL, V8, P294, DOI 10.1016/j.stem.2011.01.014; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108	72	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17646	17660		10.1074/jbc.RA118.003052	http://dx.doi.org/10.1074/jbc.RA118.003052			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30242124	Green Published, hybrid			2022-12-28	WOS:000449799000027
J	Cox, RM; Toots, M; Yoon, JJ; Sourimant, J; Ludeke, B; Fearns, R; Bourque, E; Patti, J; Lee, E; Vernachio, J; Plemper, RK				Cox, Robert M.; Toots, Mart; Yoon, Jeong-Joong; Sourimant, Julien; Ludeke, Barbara; Fearns, Rachel; Bourque, Elyse; Patti, Joseph; Lee, Edward; Vernachio, John; Plemper, Richard K.			Development of an allosteric inhibitor class blocking RNA elongation by the respiratory syncytial virus polymerase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antiviral agent; viral polymerase; drug development; medicinal chemistry; animal virus; RdRp; respiratory disease; respiratory syncytial virus; RNA-dependent RNA polymerase	ENTRY INHIBITORS; INFLUENZA-VIRUS; DRUG DISCOVERY; YOUNG-CHILDREN; MESSENGER-RNA; L PROTEIN; REPLICATION; SOLUBILITY; METABOLISM; INFECTION	Respiratory syncytial virus (RSV) represents a significant health threat to infants and to elderly or immunocompromised individuals. There are currently no vaccines available to prevent RSV infections, and disease management is largely limited to supportive care, making the identification and development of effective antiviral therapeutics against RSV a priority. To identify effective chemical scaffolds for managing RSV disease, we conducted a high-throughput anti-RSV screen of a 57,000-compound library. We identified a hit compound that specifically blocked activity of the RSV RNA-dependent RNA polymerase (RdRp) complex, initially with moderate low-micromolar potency. Mechanistic characterization in an in vitro RSV RdRp assay indicated that representatives of this compound class block elongation of RSV RNA products after initial extension by up to three nucleotides. Synthetic hit-to-lead exploration yielded an informative 3D quantitative structure-activity relationship (3D-QSAR) model and resulted in analogs with more than 20-fold improved potency and selectivity indices (SIs) of >1,000. However, first-generation leads exhibited limited water solubility and poor metabolic stability. A second optimization strategy informed by the 3D-QSAR model combined with in silico pharmacokinetics (PK) predictions yielded an advanced lead, AVG-233, that demonstrated nanomolar activity against both laboratory-adapted RSV strains and clinical RSV isolates. This anti-RSV activity extended to infection of established cell lines and primary human airway cells. PK profiling in mice revealed 34% oral bioavailability of AVG-233 and sustained high drug levels in the circulation after a single oral dose of 20 mg/kg. This promising first-in-class lead warrants further development as an anti-RSV drug.	[Cox, Robert M.; Toots, Mart; Yoon, Jeong-Joong; Sourimant, Julien; Plemper, Richard K.] Georgia State Univ, Inst Biomed Sci, Atlanta, GA 30303 USA; [Ludeke, Barbara; Fearns, Rachel] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Patti, Joseph; Lee, Edward; Vernachio, John] Aviragen Therapeut, Alpharetta, GA 30009 USA	University System of Georgia; Georgia State University; Boston University	Plemper, RK (corresponding author), Georgia State Univ, Inst Biomed Sci, Atlanta, GA 30303 USA.	rplemper@gsu.edu		Fearns, Rachel/0000-0003-0783-7498; Sourimant, Julien/0000-0002-1660-1666	NIAID, National Institutes of Health (NIH) [AI071002]; NICHD, NIH [HD079327]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD079327] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071002] Funding Source: NIH RePORTER	NIAID, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by NIAID, National Institutes of Health (NIH), Grant AI071002 and NICHD, NIH, Grant HD079327 (to R. K. P.). J. P., E. L., J. V., and R. K. P. are co-inventors on a patent application covering the use of the AVG-233 compound class for antiviral therapy. This study could affect their personal financial status. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdolmaleki A, 2017, CURR DRUG TARGETS, V18, P556, DOI 10.2174/1389450117666160101120822; Afonso CL, 2016, ARCH VIROL, V161, P2351, DOI 10.1007/s00705-016-2880-1; AHERNE W, 1970, J CLIN PATHOL, V23, P7, DOI 10.1136/jcp.23.1.7; Ali J, 2012, J CHEM INF MODEL, V52, P420, DOI 10.1021/ci200387c; ANDERSON LJ, 1990, J INFECT DIS, V161, P640, DOI 10.1093/infdis/161.4.640; Antoni D, 2015, INT J MOL SCI, V16, P5517, DOI 10.3390/ijms16035517; Asakawa N, 2012, INT J MED CHEM, V2012, DOI 10.1155/2012/498931; Baker KA, 1999, MOL CELL, V3, P309, DOI 10.1016/S1097-2765(00)80458-X; Cherkasov A, 2014, J MED CHEM, V57, P4977, DOI 10.1021/jm4004285; Cianci C, 2004, ANTIMICROB AGENTS CH, V48, P413, DOI 10.1128/AAC.48.2.413-422.2004; COLLINS PL, 1995, P NATL ACAD SCI USA, V92, P11563, DOI 10.1073/pnas.92.25.11563; Cox R, 2016, EXPERT OPIN DRUG DIS, V11, P543, DOI 10.1517/17460441.2016.1174212; Cox RM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602350; CRAMER RD, 1988, J AM CHEM SOC, V110, P5959, DOI 10.1021/ja00226a005; Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717; Dang NL, 2016, BIOINFORMATICS, V32, P3183, DOI 10.1093/bioinformatics/btw350; Delaney JS, 2004, J CHEM INF COMP SCI, V44, P1000, DOI 10.1021/ci034243x; DeVincenzo JP, 2014, NEW ENGL J MED, V371, P711, DOI 10.1056/NEJMoa1401184; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; Dixon SL, 2006, J COMPUT AID MOL DES, V20, P647, DOI 10.1007/s10822-006-9087-6; Doak BC, 2014, CHEM BIOL, V21, P1115, DOI 10.1016/j.chembiol.2014.08.013; Domachowske JB, 1999, CLIN MICROBIOL REV, V12, P298, DOI 10.1128/CMR.12.2.298; Duprex WP, 1999, J VIROL, V73, P9568, DOI 10.1128/JVI.73.11.9568-9575.1999; Eglen R, 2011, ASSAY DRUG DEV TECHN, V9, P108, DOI 10.1089/adt.2010.0305; El Saleeby CM, 2011, J INFECT DIS, V204, P996, DOI 10.1093/infdis/jir494; GROOTHUIS JR, 1990, J PEDIATR-US, V117, P792, DOI 10.1016/S0022-3476(05)83347-5; GROSFELD H, 1995, J VIROL, V69, P5677, DOI 10.1128/JVI.69.9.5677-5686.1995; Heylen E, 2017, BIOCHEM PHARMACOL, V127, P1, DOI 10.1016/j.bcp.2016.09.014; Hotard AL, 2012, VIROLOGY, V434, P129, DOI 10.1016/j.virol.2012.09.022; Jacob RT, 2012, J BIOMOL SCREEN, V17, P1080, DOI 10.1177/1087057112450186; Jimenez-Somarribas A, 2017, J MED CHEM, V60, P2305, DOI 10.1021/acs.jmedchem.6b01568; Klebe G, 1999, J COMPUT AID MOL DES, V13, P1, DOI 10.1023/A:1008047919606; Krumm SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008517; Krumm SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020069; Lewis DFV, 2008, EXPERT OPIN DRUG MET, V4, P1181, DOI 10.1517/17425255.4.9.1181 ; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; LUGO RA, 1993, CLIN PHARMACY, V12, P95; Makhuri FR, 2015, EUR J PHARM SCI, V78, P151, DOI 10.1016/j.ejps.2015.07.011; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ndungu JM, 2012, J MED CHEM, V55, P4220, DOI 10.1021/jm201699w; Nie QD, 2018, CHEM BIOL DRUG DES, V92, P1750, DOI 10.1111/cbdd.13344; Noton SL, 2015, J VIROL, V89, P7786, DOI 10.1128/JVI.00530-15; Noton SL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002980; Peterson LA, 2013, CHEM RES TOXICOL, V26, P6, DOI 10.1021/tx3003824; Rydberg P, 2010, ACS MED CHEM LETT, V1, P96, DOI 10.1021/ml100016x; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Shiri F, 2019, ARAB J CHEM, V12, P2150, DOI 10.1016/j.arabjc.2014.11.063; Stokes KL, 2011, J VIROL, V85, P5782, DOI 10.1128/JVI.01693-10; Sun AM, 2011, ACS MED CHEM LETT, V2, P798, DOI 10.1021/ml200125r; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tiong-Yip CL, 2014, ANTIMICROB AGENTS CH, V58, P3867, DOI 10.1128/AAC.02540-14; Wang GY, 2015, J MED CHEM, V58, P1862, DOI 10.1021/jm5017279; Wang W, 2014, CURR PHARM BIOTECHNO, V15, P691, DOI 10.2174/138920101508140930153336; Wassermann AM, 2015, NAT CHEM BIOL, V11, P958, DOI 10.1038/nchembio.1936; Weisshaar M, 2016, J VIROL, V90, P7368, DOI 10.1128/JVI.00898-16; Xiong H, 2013, BIOORG MED CHEM LETT, V23, P6789, DOI 10.1016/j.bmcl.2013.10.018; Yan D, 2015, BIOCHEMISTRY-US, V54, P5589, DOI 10.1021/acs.biochem.5b00623; Yan D, 2014, P NATL ACAD SCI USA, V111, pE3441, DOI 10.1073/pnas.1405198111; Yan D, 2013, J VIROL, V87, P11076, DOI 10.1128/JVI.01425-13; Yang JJ, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0137-3; Yoon JJ, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00766-18;e00766-18; YU QZ, 1995, J VIROL, V69, P2412, DOI 10.1128/JVI.69.4.2412-2419.1995	63	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16761	16777		10.1074/jbc.RA118.004862	http://dx.doi.org/10.1074/jbc.RA118.004862			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30206124	Green Published, hybrid			2022-12-28	WOS:000448515100018
J	Nie, MZ; Bal, MS; Liu, J; Yang, ZF; Rivera, C; Wu, XR; Hoenderop, JGJ; Bindels, RJM; Marciano, DK; Wolf, MTF				Nie, Mingzhu; Bal, Manjot S.; Liu, Jie; Yang, Zhufeng; Rivera, Carolina; Wu, Xue-Ru; Hoenderop, Joost G. J.; Bindels, Rene J. M.; Marciano, Denise K.; Wolf, Matthias T. F.			Uromodulin regulates renal magnesium homeostasis through the ion channel transient receptor potential melastatin 6 (TRPM6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; magnesium; endocytosis; nephrology; electrophysiology; kidney; TRPM6; uromodulin; distal tubule	TAMM-HORSFALL PROTEIN; TYPE-2 DIABETES-MELLITUS; DISTAL CONVOLUTED TUBULE; LOW SERUM MAGNESIUM; DIETARY MAGNESIUM; ATHEROSCLEROSIS-RISK; KIDNEY-DISEASE; SECONDARY HYPOCALCEMIA; MEDIATED ENDOCYTOSIS; METABOLIC SYNDROME	Up to 15% of the population have mild to moderate chronic hypomagnesemia, which is associated with type 2 diabetes mellitus, hypertension, metabolic syndrome, and chronic kidney disease. The kidney is the key organ for magnesium homeostasis, but our understanding of renal magnesium regulation is very limited. Uromodulin (UMOD) is the most abundant urinary protein in humans, and here we report that UMOD has a role in renal magnesium homeostasis. Umod-knockout (Umod(-/-)) mice excreted more urinary magnesium than WT mice and displayed up-regulation of genes promoting magnesium absorption. The majority of magnesium is absorbed in the thick ascending limb. However, both mouse strains responded similarly to the diuretic agent furosemide, indicating appropriate function of the thick ascending limb in the Umod(-/-) mice. Magnesium absorption is fine-tuned in the distal convoluted tubule (DCT) via the apical magnesium channel transient receptor potential melastatin 6 (TRPM6). We observed decreased apical Trpm6 staining in the DCT of Umod(-/-) mice. Applying biotinylation assays and whole-cell patch-clamp recordings, we found that UMOD enhances TRPM6 cell-surface abundance and current density from the extracellular space. UMOD physically interacted with TRPM6 and thereby impaired dynamin-dependent TRPM6 endocytosis. WT mice fed a low-magnesium diet had an increased urinary UMOD secretion compared with the same mice on a regular diet. Our results suggest that increased urinary UMOD secretion in low-magnesium states reduces TRPM6 endocytosis and thereby up-regulates TRPM6 cell-surface abundance to defend against further urinary magnesium losses.	[Nie, Mingzhu; Bal, Manjot S.; Liu, Jie; Rivera, Carolina; Wolf, Matthias T. F.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Yang, Zhufeng; Marciano, Denise K.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Hoenderop, Joost G. J.; Bindels, Rene J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Radboud Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; New York University; New York University; Radboud University Nijmegen	Wolf, MTF (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	matthias.wolf@utsouthwestern.edu	Bindels, René JM/B-9824-2013	Bindels, René JM/0000-0003-1167-1339; Wu, Xue-Ru/0000-0001-6058-6291; Wolf, Matthias/0000-0003-3577-3014; Marciano, Denise/0000-0003-0612-4664	National Institutes of Health [K08DK095994-04, R03DK111776-01, P30DK079328, R01DK009478]; Children's Health System, Dallas; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK111776, R01DK099478, K08DK095994, P30DK079328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Health System, Dallas; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08DK095994-04 (to M. T. F. W.), R03DK111776-01 (to M. T. F. W.), P30DK079328 (to M. T. F. W. and D. K. M.), and R01DK009478 (to D. K. M.) and the Children's Health System, Dallas (to M. T. F. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnaud MJ, 2008, BRIT J NUTR, V99, pS24, DOI 10.1017/S000711450800682X; Bachmann S, 2005, AM J PHYSIOL-RENAL, V288, pF559, DOI 10.1152/ajprenal.00143.2004; BACHMANN S, 1991, RENAL PHYSIOL BIOCH, V14, P236; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; BRUNETTE MG, 1974, AM J PHYSIOL, V227, P891, DOI 10.1152/ajplegacy.1974.227.4.891; Cao G, 2008, CURR BIOL, V18, P168, DOI 10.1016/j.cub.2007.12.058; Cao G, 2009, J BIOL CHEM, V284, P14788, DOI 10.1074/jbc.M808752200; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; CHERNOW B, 1989, CHEST, V95, P391, DOI 10.1378/chest.95.2.391; Corica F, 2006, J AM COLL NUTR, V25, P210, DOI 10.1080/07315724.2006.10719534; Corre T, 2018, J AM SOC NEPHROL, V29, P335, DOI 10.1681/ASN.2017030267; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; de Baaij JHF, 2013, AM J PHYSIOL-RENAL, V305, pF1563, DOI 10.1152/ajprenal.00322.2013; Del Gobbo LC, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-23; Delgado GE, 2017, J AM SOC NEPHROL, V28, P2201, DOI 10.1681/ASN.2016111162; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Devuyst O, 2017, NAT REV NEPHROL, V13, P525, DOI 10.1038/nrneph.2017.101; Dey R, 2015, CLIN EXP NEPHROL, V19, P1054, DOI 10.1007/s10157-015-1097-z; Elin RJ, 2010, MAGNESIUM RES, V23, pS194, DOI 10.1684/mrh.2010.0213; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Franz KB, 2004, J AM COLL NUTR, V23, p738S, DOI 10.1080/07315724.2004.10719418; Glauser A, 2000, NEPHROL DIAL TRANSPL, V15, P1580, DOI 10.1093/ndt/15.10.1580; GOODALL AA, 1980, BIOCHEM J, V189, P533, DOI 10.1042/bj1890533; Groenestege WMT, 2007, J CLIN INVEST, V117, P2260, DOI 10.1172/JCI31680; Groenestege WMT, 2006, J AM SOC NEPHROL, V17, P1035, DOI 10.1681/ASN.2005070700; Guerrero-Romero F, 2016, J PEDIATR-US, V168, P93, DOI 10.1016/j.jpeds.2015.09.050; Han J, 2013, KIDNEY INT, V83, P733, DOI 10.1038/ki.2012.449; Haudek KC, 2010, GLYCOBIOLOGY, V20, P1199, DOI 10.1093/glycob/cwq097; Hirschler V, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22989; Hoenderop JGJ, 2008, PHYSIOLOGY, V23, P32, DOI 10.1152/physiol.00039.2007; Hoorn EJ, 2011, NAT MED, V17, P1304, DOI 10.1038/nm.2497; Huerta MG, 2005, DIABETES CARE, V28, P1175, DOI 10.2337/diacare.28.5.1175; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Kao WHL, 1999, ARCH INTERN MED, V159, P2151, DOI 10.1001/archinte.159.18.2151; Kemter E, 2013, HUM MOL GENET, V22, P4148, DOI 10.1093/hmg/ddt263; Kemter E, 2009, AM J PHYSIOL-RENAL, V297, pF1391, DOI 10.1152/ajprenal.00261.2009; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kottgen A, 2010, J AM SOC NEPHROL, V21, P337, DOI 10.1681/ASN.2009070725; Kurstjens S, 2017, EUR J ENDOCRINOL, V176, P11, DOI 10.1530/EJE-16-0517; Lameris ALL, 2013, PFLUG ARCH EUR J PHY, V465, P1613, DOI 10.1007/s00424-013-1306-0; Lech M, 2012, INT J MOL SCI, V13, P10113, DOI 10.3390/ijms130810113; Lee CT, 2007, AM J PHYSIOL-RENAL, V293, pF1231, DOI 10.1152/ajprenal.00038.2007; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Leiherer A, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005798; Liao FZ, 1998, AM HEART J, V136, P480, DOI 10.1016/S0002-8703(98)70224-8; Lima MD, 2009, DIABETES RES CLIN PR, V83, P257, DOI 10.1016/j.diabres.2008.11.019; Liu Y, 2018, AM J PHYSIOL-RENAL, V314, pF1062, DOI 10.1152/ajprenal.00233.2017; Liu Y, 2010, AM J PHYSIOL-RENAL, V299, pF469, DOI 10.1152/ajprenal.00243.2010; Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134; Mo L, 2007, AM J PHYSIOL-RENAL, V293, pF1935, DOI 10.1152/ajprenal.00383.2007; Mutig K, 2011, J BIOL CHEM, V286, P30200, DOI 10.1074/jbc.M111.222968; Nair AV, 2012, P NATL ACAD SCI USA, V109, P11324, DOI 10.1073/pnas.1113811109; Nestler A, 2014, PREGNANCY HYPERTENS, V4, P41, DOI 10.1016/j.preghy.2013.09.003; Nie MZ, 2016, J AM SOC NEPHROL, V27, P3447, DOI 10.1681/ASN.2015101100; Nio J, 2006, HISTOCHEM CELL BIOL, V126, P45, DOI 10.1007/s00418-005-0142-5; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Peters KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074355; Pham PCT, 2007, CLIN J AM SOC NEPHRO, V2, P366, DOI 10.2215/CJN.02960906; Pham PCT, 2014, INT J NEPHROL RENOV, V7, P219, DOI 10.2147/IJNRD.S42054; Picard N, 2005, J AM SOC NEPHROL, V16, P3602, DOI 10.1681/ASN.2004110923; Posadas-Sanchez R, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0143-3; Rampoldi L, 2003, HUM MOL GENET, V12, P3369, DOI 10.1093/hmg/ddg353; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Rebholz CM, 2016, AM J NEPHROL, V44, P381, DOI 10.1159/000450861; Renigunta A, 2011, J BIOL CHEM, V286, P2224, DOI 10.1074/jbc.M110.149880; Sakaguchi Y, 2014, KIDNEY INT, V85, P174, DOI 10.1038/ki.2013.327; Santambrogio S, 2008, BIOCHEM BIOPH RES CO, V370, P410, DOI 10.1016/j.bbrc.2008.03.099; Sarrafzadegan N, 2016, NUTRITION, V32, P409, DOI 10.1016/j.nut.2015.09.014; Schimatschek HF, 2001, MAGNESIUM RES, V14, P283; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmiedl A, 2003, MAGNESIUM RES, V16, P192; Schmitt R, 2004, HISTOCHEM CELL BIOL, V121, P319, DOI 10.1007/s00418-004-0638-4; Song YQ, 2004, DIABETES CARE, V27, P59, DOI 10.2337/diacare.27.1.59; Thebault S, 2009, J AM SOC NEPHROL, V20, P78, DOI 10.1681/ASN.2008030327; Tin A, 2015, KIDNEY INT, V87, P820, DOI 10.1038/ki.2014.331; Tokonami N., 2018, KIDNEY INT, VS0085-2538; Torffvit O, 2004, NEPHRON PHYSIOL, V97, pp31, DOI [DOI 10.1159/000077600, 10.1159/000077600]; Trudu M, 2013, NAT MED, V19, P1655, DOI 10.1038/nm.3384; van Angelen AA, 2013, NEPHROL DIAL TRANSPL, V28, P2983, DOI 10.1093/ndt/gft358; van Angelen AA, 2013, NEPHROL DIAL TRANSPL, V28, P879, DOI 10.1093/ndt/gfs499; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Walder RY, 2009, HUM MOL GENET, V18, P4367, DOI 10.1093/hmg/ddp392; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Wang LJ, 2006, MOL CELL PROTEOMICS, V5, P560, DOI 10.1074/mcp.D500013-MCP200; WHANG R, 1990, JAMA-J AM MED ASSOC, V263, P3063, DOI 10.1001/jama.263.22.3063; Witkowski M, 2011, MAGNESIUM RES, V24, P163, DOI 10.1684/mrh.2011.0292; Wolf MTF, 2013, KIDNEY INT, V84, P130, DOI 10.1038/ki.2013.63; Ying WZ, 1998, KIDNEY INT, V54, P1150, DOI 10.1046/j.1523-1755.1998.00117.x	90	22	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16488	16502		10.1074/jbc.RA118.003950	http://dx.doi.org/10.1074/jbc.RA118.003950			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30139743	hybrid, Green Published			2022-12-28	WOS:000447833600030
J	Park, AM; Tsunoda, I; Yoshie, O				Park, Ah-Mee; Tsunoda, Ikuo; Yoshie, Osamu			Heat shock protein 27 promotes cell cycle progression by down-regulating E2F transcription factor 4 and retinoblastoma family protein p130	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; E2F transcription factor; small heat shock protein (sHsp); cellular senescence; cell proliferation; transcription repressor; cyclin A2; cyclin B1; cyclin B2; HSPB1	SECRETORY PHENOTYPE; PROTEASOMAL DEGRADATION; INDUCED APOPTOSIS; GENE-EXPRESSION; IN-VITRO; SENESCENCE; HSP27; CANCER; ARREST; HEAT-SHOCK-PROTEIN-27	Heat shock protein 27 (HSP27) protects cells under stress. Here, we demonstrate that HSP27 also promotes cell cycle progression of MRC-5 human lung fibroblast cells. Serum starvation for 24 h induced G(1) arrest in these cells, and upon serum refeeding, the cells initiated cell cycle progression accompanied by an increase in HSP27 protein levels. HSP27 levels peaked at 12 h, and transcriptional up-regulation of six G(2)/M-related genes (CCNA2, CCNB1, CCNB2, CDC25C, CDCA3, and CDK1) peaked at 24-48 h. siRNA-mediated HSP27 silencing in proliferating MRC-5 cells induced G(2) arrest coinciding with down-regulation of these six genes. Of note, the promoters of all of these genes have the cell cycle-dependent element and/or the cell cycle gene-homology region. These promoter regions are known to be bound by the E2F family proteins (E2F-1 to E2F-8) and retinoblastoma (RB) family proteins (RB1, p107, and p130), among which E2F-4 and p130 were strongly up-regulated in HSP27-knockdown cells. E2F-4 or p130 knockdown concomitant with the HSP27 knockdown rescued MRC-5 cells from G(2) arrest and up-regulated the six cell cycle genes. Moreover, we observed cellular senescence in MRC-5 cells on day 3 after the HSP27 knockdown, as evidenced by increased senescence-associated beta-gal activity and up-regulated inflammatory cytokines. The cellular senescence was also suppressed by the concomitant knockdown of E2F-4/HSP27 or p130/HSP27. Our findings indicate that HSP27 promotes cell cycle progression of MRC-5 cells by suppressing expression of the transcriptional repressors E2F-4 and p130.	[Park, Ah-Mee; Tsunoda, Ikuo; Yoshie, Osamu] Kindai Univ, Fac Med, Dept Microbiol, 377-2 Ohnohigashi, Osaka 5898511, Japan; [Yoshie, Osamu] Hlth & Kampo Inst, 1-11-10 Murasakiyama, Sendai, Miyagi 9813205, Japan	Kindai University (Kinki University)	Park, AM (corresponding author), Kindai Univ, Fac Med, Dept Microbiol, 377-2 Ohnohigashi, Osaka 5898511, Japan.	ampk@med.kindai.ac.jp	Tsunoda, Ikuo/B-4722-2008; Park, Ah-Mee/AAS-2545-2020	Tsunoda, Ikuo/0000-0003-1798-714X; Park, Ah-Mee/0000-0001-8453-3872; Yoshie, Osamu/0000-0003-4353-5809	Japan Science and Technology Agency (CREST Program); Novartis Pharma Research Grants 2017; NIGMS, National Institutes of Health, COBRE Grant [P30-GM110703];  [JP15K08975]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110703] Funding Source: NIH RePORTER	Japan Science and Technology Agency (CREST Program)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Novartis Pharma Research Grants 2017; NIGMS, National Institutes of Health, COBRE Grant; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by Grant-in-Aid for Scientific Research C JP15K08975 (B) (to A. M. P.), a grant from the Japan Science and Technology Agency (CREST Program) (to O. Y.), Novartis Pharma Research Grants 2017 (to A. M. P. and I. T.), and NIGMS, National Institutes of Health, COBRE Grant P30-GM110703 (to I. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acunzo J, 2014, CURR DRUG TARGETS, V15, P423, DOI 10.2174/13894501113146660230; Arrigo AP, 2017, CELL STRESS CHAPERON, V22, P517, DOI 10.1007/s12192-017-0765-1; Blagosklonny MV, 2014, CELL CYCLE, V13, P3628, DOI 10.4161/15384101.2014.985507; Bukrinsky M, 2004, DNA CELL BIOL, V23, P223, DOI 10.1089/104454904773819806; Burban A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01171-y; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Christians ES, 2012, INT J BIOCHEM CELL B, V44, P1632, DOI 10.1016/j.biocel.2012.06.006; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Deng WJ, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0283-8; Friedman MJ, 2009, J BIOL CHEM, V284, P27944, DOI 10.1074/jbc.M109.037937; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Georgakilas AG, 2017, TRENDS MOL MED, V23, P310, DOI 10.1016/j.molmed.2017.02.001; Gire V, 2015, CELL CYCLE, V14, P297, DOI 10.1080/15384101.2014.1000134; Gudkov AV, 2005, BIOCHEM BIOPH RES CO, V331, P726, DOI 10.1016/j.bbrc.2005.03.153; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hayashi N, 2012, CELL DEATH DIFFER, V19, P990, DOI 10.1038/cdd.2011.184; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; Horman S, 1999, INT J CANCER, V82, P574, DOI 10.1002/(SICI)1097-0215(19990812)82:4<574::AID-IJC17>3.0.CO;2-L; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Leontieva OV, 2012, CELL CYCLE, V11, P4642, DOI 10.4161/cc.22937; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Liu XW, 2004, AM J PHYSIOL-HEART C, V286, pH933, DOI 10.1152/ajpheart.00759.2003; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; O'Callaghan-Sunol C, 2007, CANCER RES, V67, P11779, DOI 10.1158/0008-5472.CAN-07-2441; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Parcellier A, 2006, FASEB J, V20, P1179, DOI 10.1096/fj.05-4184fje; Park AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148998; Plesca D, 2007, CELL CYCLE, V6, P1147, DOI 10.4161/cc.6.10.4259; Rocchi P, 2006, BJU INT, V98, P1082, DOI 10.1111/j.1464-410X.2006.06425.x; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Shin JS, 2008, INT J ONCOL, V32, P435; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Terzi MY, 2016, MOL BIOL REP, V43, P1213, DOI 10.1007/s11033-016-4065-0; Thurlings I, 2016, METHODS MOL BIOL, V1342, P71, DOI 10.1007/978-1-4939-2957-3_4; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Wettstein G, 2012, INT J BIOCHEM CELL B, V44, P1680, DOI 10.1016/j.biocel.2012.05.024; Williams GH, 2012, J PATHOL, V226, P352, DOI 10.1002/path.3022; Wu JM, 2017, TRENDS PHARMACOL SCI, V38, P226, DOI 10.1016/j.tips.2016.11.009; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhou XM, 2006, MECH AGEING DEV, V127, P779, DOI 10.1016/j.mad.2006.07.003; Zhu ZK, 2010, MOL PHARMACEUT, V7, P1283, DOI 10.1021/mp100073s	53	7	8	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15815	15826		10.1074/jbc.RA118.003310	http://dx.doi.org/10.1074/jbc.RA118.003310			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30166342	Green Published, hybrid			2022-12-28	WOS:000447256000006
J	Rangarajan, S; He, YA; Chen, YH; Kerzic, MC; Ma, BY; Gowthaman, R; Pierce, BG; Nussinov, R; Mariuzza, RA; Orban, J				Rangarajan, Sneha; He, Yanan; Chen, Yihong; Kerzic, Melissa C.; Ma, Buyong; Gowthaman, Ragul; Pierce, Brian G.; Nussinov, Ruth; Mariuzza, Roy A.; Orban, John			Peptide-MHC (pMHC) binding to a human antiviral T cell receptor induces long-range allosteric communication between pMHC- and CD3-binding sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						T cell receptor (TCR); major histocompatibility complex (MHC); allosteric regulation; nuclear magnetic resonance (NMR); molecular dynamics; adaptive immunity; conformational change; T cell activation; signaling	BETA FG LOOP; ANTIGEN RECEPTOR; STRUCTURAL BASIS; CONFORMATIONAL ENTROPY; MOLECULAR-DYNAMICS; PROTEIN; RECOGNITION; ACTIVATION; COMPLEX; NMR	T cells generate adaptive immune responses mediated by the T cell receptor (TCR)-CD3 complex comprising an TCR heterodimer noncovalently associated with three CD3 dimers. In early T cell activation, alpha beta TCR engagement by peptide-major histocompatibility complex (pMHC) is first communicated to the CD3 signaling apparatus of the TCR-CD3 complex, but the underlying mechanism is incompletely understood. It is possible that pMHC binding induces allosteric changes in TCR conformation or dynamics that are then relayed to CD3. Here, we carried out NMR analysis and molecular dynamics (MD) simulations of both the alpha and beta chains of a human antiviral TCR (A6) that recognizes the Tax antigen from human T cell lymphotropic virus-1 bound to the MHC class I molecule HLA-A2. We observed pMHC-induced NMR signal perturbations in the TCR variable (V) domains that propagated to three distinct sites in the constant (C) domains: 1) the C beta FG loop projecting from the V beta/C beta interface; 2) a cluster of C beta residues near the C beta alpha A helix, a region involved in interactions with CD3; and 3) the C alpha AB loop at the membrane-proximal base of the TCR. A biological role for each of these allosteric sites is supported by previous mutational and functional studies of TCR signaling. Moreover, the pattern of long-range, ligand-induced changes in TCR A6 revealed by NMR was broadly similar to that predicted by the MD simulations. We propose that the unique structure of the TCR beta chain enables allosteric communication between the TCR-binding sites for pMHC and CD3.	[Rangarajan, Sneha; He, Yanan; Chen, Yihong; Kerzic, Melissa C.; Gowthaman, Ragul; Pierce, Brian G.; Mariuzza, Roy A.; Orban, John] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; [Rangarajan, Sneha; Gowthaman, Ragul; Pierce, Brian G.; Mariuzza, Roy A.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [He, Yanan; Orban, John] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Ma, Buyong; Nussinov, Ruth] NCI, Canc & Inflammat Program, Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mariuzza, RA; Orban, J (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	rmariuzz@umd.edu; jorban@umd.edu	Ma, Buyong/F-9491-2011; Pierce, Brian/AAB-8965-2022	Ma, Buyong/0000-0002-7383-719X; Pierce, Brian/0000-0003-4821-0368; Nussinov, Ruth/0000-0002-8115-6415; Gowthaman, Ragul/0000-0002-0008-6401	University of Maryland; National Institute of Standards and Technology; W.M. Keck Foundation; NATIONAL CANCER INSTITUTE [ZIABC010440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI129893] Funding Source: NIH RePORTER	University of Maryland; National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Daniel R. Scott (National Institute of Standards and Technology) for the gift of TCR A6 expression plasmids. The NMR facility is jointly supported by the University of Maryland, the National Institute of Standards and Technology, and a grant from the W.M. Keck Foundation. All simulations were performed using the high-performance computational facilities of the Biowulf PC/Linux cluster at the National Institutes of Health, Bethesda, Maryland (https://hpc.nih.gov/systems/).	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Baker BM, 2001, IMMUNITY, V14, P681, DOI 10.1016/S1074-7613(01)00160-1; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; Berjanskii MV, 2008, J BIOMOL NMR, V40, P31, DOI 10.1007/s10858-007-9208-0; Birnbaum ME, 2012, IMMUNOL REV, V250, P82, DOI 10.1111/imr.12006; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Brameshuber M, 2018, NAT IMMUNOL, V19, P487, DOI 10.1038/s41590-018-0092-4; Brazin KN, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00441; Chavent M, 2016, STRUCTURE, V24, P337, DOI 10.1016/j.str.2015.11.008; Conway P, 2014, PROTEIN SCI, V23, P47, DOI 10.1002/pro.2389; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Gil D, 2005, J EXP MED, V201, P517, DOI 10.1084/jem.20042036; Goddard T.D., 2004, SPARKY 3; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Hawse WF, 2012, J IMMUNOL, V188, P5819, DOI 10.4049/jimmunol.1200952; He YN, 2015, J BIOL CHEM, V290, P19796, DOI 10.1074/jbc.M115.663799; Hoffmann T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004244; Huang J, 2013, IMMUNITY, V39, P846, DOI 10.1016/j.immuni.2013.08.036; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kuhns MS, 2012, IMMUNOL REV, V250, P120, DOI 10.1111/imr.12000; Kuhns MS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00159; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malissen B, 2015, ANNU REV IMMUNOL, V33, P539, DOI 10.1146/annurev-immunol-032414-112158; Mallis RJ, 2015, P NATL ACAD SCI USA, V112, P8373, DOI 10.1073/pnas.1504971112; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; McLeish TCB, 2015, BIOPHYS J, V109, P1240, DOI 10.1016/j.bpj.2015.08.009; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Natarajan A, 2016, CELL REP, V14, P2833, DOI 10.1016/j.celrep.2016.02.081; Natarajan K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15260; Nussinov R, 2013, ANNU REV BIOPHYS, V42, P169, DOI 10.1146/annurev-biophys-083012-130257; O'Donoghue GP, 2013, ELIFE, V2, DOI 10.7554/eLife.00778; Pang SS, 2010, NATURE, V467, P844, DOI 10.1038/nature09448; Pierce BG, 2013, PROTEIN SCI, V22, P35, DOI 10.1002/pro.2181; Ramaprasad ASE, 2017, J AM CHEM SOC, V139, P17508, DOI 10.1021/jacs.7b09268; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sasada T, 2002, J EXP MED, V195, P1419, DOI 10.1084/jem.20020119; Scott DR, 2011, J MOL BIOL, V414, P385, DOI 10.1016/j.jmb.2011.10.006; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Touma M, 2006, J IMMUNOL, V176, P6812, DOI 10.4049/jimmunol.176.11.6812; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; von Boehmer H, 2014, CANCER IMMUNOL RES, V2, P592, DOI 10.1158/2326-6066.CIR-14-0070; Wand AJ, 2013, CURR OPIN STRUC BIOL, V23, P75, DOI 10.1016/j.sbi.2012.11.005; Wang JH, 2012, IMMUNOL REV, V250, P102, DOI 10.1111/j.1600-065X.2012.01161.x; Wucherpfennig KW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005140; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yin YY, 2012, IMMUNOL REV, V250, P32, DOI 10.1111/imr.12002	65	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15991	16005		10.1074/jbc.RA118.003832	http://dx.doi.org/10.1074/jbc.RA118.003832			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30135211	hybrid, Green Published			2022-12-28	WOS:000447256000020
J	Wong, LLL; Scott, DJ; Hossain, MA; Kaas, Q; Rosengren, KJ; Bathgate, RAD				Wong, Lilian L. L.; Scott, Daniel James; Hossain, Mohammed Akhter; Kaas, Quentin; Rosengren, K. Johan; Bathgate, Ross A. D.			Distinct but overlapping binding sites of agonist and antagonist at the relaxin family peptide 3 (RXFP3) receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						relaxin; G protein-coupled receptor (GPCR); site-directed mutagenesis; molecular modeling; molecular docking; relaxin-3; RXFP3	NUCLEUS INCERTUS; PHARMACOLOGICAL CHARACTERIZATION; MACACA-FASCICULARIS; CHIMERIC PEPTIDE; MESSENGER-RNA; FORCE-FIELD; CHAIN; GPCR142; BRAIN; LIGAND	The relaxin-3 neuropeptide activates the relaxin family peptide 3 (RXFP3) receptor to modulate stress, appetite, and cognition. RXFP3 shows promise as a target for treating neurological disorders, but realization of its clinical potential requires development of smaller RXFP3-specific drugs that can penetrate the blood-brain barrier. Designing such drugs is challenging and requires structural knowledge of agonist- and antagonist-binding modes. Here, we used structure-activity data for relaxin-3 and a peptide RXFP3 antagonist termed R3 B1-22R to guide receptor mutagenesis and develop models of their binding modes. RXFP3 residues were alanine-substituted individually and in combination and tested in cell-based binding and functional assays to refine models of agonist and antagonist binding to active- and inactive-state homology models of RXFP3, respectively. These models suggested that both agonists and antagonists interact with RXFP3 via similar residues in their B-chain central helix. The models further suggested that the B-chain Trp(27) inserts into the binding pocket of RXFP3 and interacts with Trp(138) and Lys(271), the latter through a salt bridge with the C-terminal carboxyl group of Trp(27) in relaxin-3. R3 B1-22R, which does not contain Trp(27), used a non-native Arg(23) residue to form cation-pi and salt-bridge interactions with Trp(138) and Glu(141) in RXFP3, explaining a key contribution of Arg(23) to affinity. Overall, relaxin-3 and R3 B1-22R appear to share similar binding residues but may differ in binding modes, leading to active and inactive RXFP3 conformational states, respectively. These mechanistic insights may assist structure-based drug design of smaller relaxin-3 mimetics to manage neurological disorders.	[Wong, Lilian L. L.; Scott, Daniel James; Hossain, Mohammed Akhter; Bathgate, Ross A. D.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Scott, Daniel James; Bathgate, Ross A. D.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Hossain, Mohammed Akhter] Univ Melbourne, Sch Chem, Parkville, Vic 3052, Australia; [Kaas, Quentin] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Rosengren, K. Johan] Univ Queensland, Fac Med, Sch Biomed Sci, Brisbane, Qld 4072, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; University of Queensland; University of Queensland	Bathgate, RAD (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia.; Rosengren, KJ (corresponding author), Univ Queensland, Fac Med, Sch Biomed Sci, St Lucia, Qld 4072, Australia.	j.rosengren@uq.edu.au; bathgate@florey.edu.au	Bathgate, Ross/ABE-6471-2020; Rosengren, K. Johan/P-4450-2016; Kaas, Quentin/J-8727-2014; Scott, Daniel/B-9880-2017	Bathgate, Ross/0000-0001-6301-861X; Rosengren, K. Johan/0000-0002-5007-8434; Hossain, Mohammed/0000-0002-9961-0006; Wong, Lilian/0000-0001-9925-928X; Kaas, Quentin/0000-0001-9988-6152; Scott, Daniel/0000-0001-6332-2793	National Health and Medical Research Council (NHMRC) of Australia [1066369, 1065481]; Victorian Government Operational Infrastructure Support Program; Melbourne Research Scholarship (MRS); Melbourne International Fee Remission Scholarship (MIFRS); NHMRC Dementia Fellowship; Australian Research Council Future Fellowship; NHMRC Research Fellowship	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government Operational Infrastructure Support Program; Melbourne Research Scholarship (MRS); Melbourne International Fee Remission Scholarship (MIFRS); NHMRC Dementia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council); NHMRC Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) of Australia Project Grants 1066369 and 1065481 (to R. A. D. B. and K. J. R.) and the Victorian Government Operational Infrastructure Support Program. K. J. R. and R. A. D. B. are inventors on Australian Patent 2010904046 and United States patent application 13/821726, Modified Relaxin B Chain Peptides.; Supported by the Melbourne Research Scholarship (MRS) and Melbourne International Fee Remission Scholarship (MIFRS).; Supported by an NHMRC Dementia Fellowship.; Supported by an Australian Research Council Future Fellowship.; Supported by an NHMRC Research Fellowship.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Asada H, 2018, NAT STRUCT MOL BIOL, V25, P570, DOI 10.1038/s41594-018-0079-8; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Banerjee A, 2010, NEUROPHARMACOLOGY, V58, P145, DOI 10.1016/j.neuropharm.2009.06.019; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Bathgate Ross A D, 2013, Front Endocrinol (Lausanne), V4, P13, DOI 10.3389/fendo.2013.00013; BEDARKAR S, 1977, NATURE, V270, P449, DOI 10.1038/270449a0; Burazin TCD, 2002, J NEUROCHEM, V82, P1553, DOI 10.1046/j.1471-4159.2002.01114.x; Case D. A., 2018, AMBER 2019; Chen JC, 2005, J PHARMACOL EXP THER, V312, P83, DOI 10.1124/jpet.104.073486; CHEN WB, 1995, ANAL BIOCHEM, V226, P349, DOI 10.1006/abio.1995.1235; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Donizetti A, 2009, DEV GROWTH DIFFER, V51, P715, DOI 10.1111/j.1440-169X.2009.01131.x; Haugaard-Jonsson LM, 2008, J BIOL CHEM, V283, P23811, DOI 10.1074/jbc.M800489200; Haugaard-Kedstrom LM, 2015, AMINO ACIDS, V47, P1267, DOI 10.1007/s00726-015-1961-x; Haugaard-Kedstrom LM, 2018, J BIOL CHEM, V293, P15765, DOI 10.1074/jbc.RA118.002611; Haugaard-Kedstrom LM, 2011, J AM CHEM SOC, V133, P4965, DOI 10.1021/ja110567j; Hojo K, 2016, J MED CHEM, V59, P7445, DOI 10.1021/acs.jmedchem.6b00265; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Hossain MA, 2008, J BIOL CHEM, V283, P17287, DOI 10.1074/jbc.M801911200; Hossain MA, 2009, CHEM BIOL DRUG DES, V73, P46, DOI 10.1111/j.1747-0285.2008.00756.x; Hu MJ, 2016, AMINO ACIDS, V48, P2227, DOI 10.1007/s00726-016-2260-x; Hulme EC, 2013, TRENDS PHARMACOL SCI, V34, P67, DOI 10.1016/j.tips.2012.11.002; Jayakody T, 2016, PEPTIDES, V84, P44, DOI 10.1016/j.peptides.2016.08.001; Kuei C, 2007, J BIOL CHEM, V282, P25425, DOI 10.1074/jbc.M701416200; Liu CL, 2005, MOL PHARMACOL, V67, P231, DOI 10.1124/mol.104.006700; Liu CL, 2003, J BIOL CHEM, V278, P50765, DOI 10.1074/jbc.M308996200; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Ma S, 2007, NEUROSCIENCE, V144, P165, DOI 10.1016/j.neuroscience.2006.08.072; Ma S, 2009, J COMP NEUROL, V517, P856, DOI 10.1002/cne.22197; Ma S, 2009, LEARN MEMORY, V16, P730, DOI 10.1101/lm.1438109; Ma SR, 2009, ANN NY ACAD SCI, V1160, P256, DOI 10.1111/j.1749-6632.2009.03954.x; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Matsumoto M, 2000, GENE, V248, P183, DOI 10.1016/S0378-1119(00)00123-2; McGowan BM, 2006, REGUL PEPTIDES, V136, P72, DOI 10.1016/j.regpep.2006.04.009; McGowan BMC, 2009, ANN NY ACAD SCI, V1160, P250, DOI 10.1111/j.1749-6632.2008.03796.x; Patil NA, 2017, BRIT J PHARMACOL, V174, P950, DOI 10.1111/bph.13684; Rosengren KJ, 2009, ANN NY ACAD SCI, V1160, P20, DOI 10.1111/j.1749-6632.2009.03833.x; Rosengren KJ, 2006, J BIOL CHEM, V281, P5845, DOI 10.1074/jbc.M511210200; Ryan PJ, 2013, P NATL ACAD SCI USA, V110, P20789, DOI 10.1073/pnas.1317807110; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shabanpoor F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082567; Shabanpoor F, 2012, J MED CHEM, V55, P1671, DOI 10.1021/jm201505p; Smith CM, 2010, J COMP NEUROL, V518, P4016, DOI 10.1002/cne.22442; Stoddart LA, 2014, BRIT J PHARMACOL, V171, P3827, DOI 10.1111/bph.12739; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Sutton SW, 2004, NEUROENDOCRINOLOGY, V80, P298, DOI 10.1159/000083656; Wang XY, 2014, FEBS J, V281, P2927, DOI 10.1111/febs.12830; Wassenaar TA, 2015, J CHEM THEORY COMPUT, V11, P2144, DOI 10.1021/acs.jctc.5b00209; Wassenaar TA, 2014, J CHEM THEORY COMPUT, V10, P676, DOI 10.1021/ct400617g; Watanabe Y, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00050; Wilkinson TN, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-14; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zhang HT, 2015, CELL, V161, P833, DOI 10.1016/j.cell.2015.04.011; Zhang WJ, 2014, AMINO ACIDS, V46, P1393, DOI 10.1007/s00726-014-1705-3	59	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15777	15789		10.1074/jbc.RA118.002645	http://dx.doi.org/10.1074/jbc.RA118.002645			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30131340	hybrid, Green Published			2022-12-28	WOS:000447256000003
J	Raba, DA; Rosas-Lemus, M; Menzer, WM; Li, C; Fang, X; Liang, PD; Tuz, K; Minh, DDL; Juarez, O				Raba, Daniel A.; Rosas-Lemus, Monica; Menzer, William M.; Li, Chen; Fang, Xuan; Liang, Pingdong; Tuz, Karina; Minh, David D. L.; Juarez, Oscar			Characterization of the Pseudomonas aeruginosa NQR complex, a bacterial proton pump with roles in autopoisoning resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Pseudomonas aeruginosa (P; aeruginosa); ubiquinone; proton pump; respiratory chain; bacterial metabolism; inhibition mechanism; quorum sensing; antibacterial compound; autotoxicity; HQNO; Na plus -NQR; quinolone; respiratory enzyme	NADH-QUINONE OXIDOREDUCTASE; NA+-TRANSLOCATING NADH; MARINE VIBRIO-ALGINOLYTICUS; UBIQUINONE-BINDING-SITE; DRIVEN ION-PUMP; NADHQUINONE OXIDOREDUCTASE; CYSTIC-FIBROSIS; RESPIRATORY-CHAIN; ELECTRON-TRANSFER; MEMBRANE-PROTEIN	Pseudomonas aeruginosa is a Gram-negative bacterium responsible for a large number of nosocomial infections. The P. aeruginosa respiratory chain contains the ion-pumping NADH:ubiquinone oxidoreductase (NQR). This enzyme couples the transfer of electrons from NADH to ubiquinone to the pumping of sodium ions across the cell membrane, generating a gradient that drives essential cellular processes in many bacteria. In this study, we characterized P. aeruginosa NQR (Pa-NQR) to elucidate its physiologic function. Our analyses reveal that Pa-NQR, in contrast with NQR homologues from other bacterial species, is not a sodium pump, but rather a completely new form of proton pump. Homology modeling and molecular dynamics simulations suggest that cation selectivity could be determined by the exit ion channels. We also show that Pa-NQR is resistant to the inhibitor 2-n-heptyl-4-hydroxyquinoline N-oxide (HQNO). HQNO is a quinolone secreted by P. aeruginosa during infection that acts as a quorum sensing agent and also has bactericidal properties against other bacteria. Using comparative analysis and computational modeling of the ubiquinone-binding site, we identified the specific residues that confer resistance toward this inhibitor. In summary, our findings indicate that Pa-NQR is a proton pump rather than a sodium pump and is highly resistant against the P. aeruginosa-produced compound HQNO, suggesting an important role in the adaptation against autotoxicity. These results provide a deep understanding of the metabolic role of NQR in P. aeruginosa and provide insight into the structural factors that determine the functional specialization in this family of respiratory complexes.	[Raba, Daniel A.; Rosas-Lemus, Monica; Menzer, William M.; Fang, Xuan; Liang, Pingdong; Tuz, Karina; Juarez, Oscar] IIT, Dept Biol Sci, Chicago, IL 60616 USA; [Menzer, William M.; Li, Chen; Minh, David D. L.] IIT, Dept Chem, Chicago, IL 60616 USA	Illinois Institute of Technology; Illinois Institute of Technology	Juarez, O (corresponding author), IIT, Robert A Pritzker Sci Ctr, 3101 S Dearborn St, Chicago, IL 60616 USA.	ojuarez@iit.edu	Fang, Xuan/CAG-5381-2022; Minh, David/A-4655-2009; Rosas-Lemus, Monica/U-4691-2019	Fang, Xuan/0000-0001-6394-4015; Minh, David/0000-0002-4802-2618; Tuz, Karina/0000-0002-1669-4612; Juarez, Oscar/0000-0002-2915-8413; Liang, Pingdong/0000-0002-8950-5755; Menzer, William/0000-0001-5052-3158; Raba, Daniel/0000-0003-4334-0008	National Institutes of Health [R15GM114781]; Illinois Institute of Technology; CONACYT; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM114781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Illinois Institute of Technology; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R15GM114781 (to D. D. L. M.), startup funds from the Illinois Institute of Technology (to O. J.), and CONACYT (to M. R.-L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; APELL HJ, 1987, BIOCHIM BIOPHYS ACTA, V903, P480, DOI 10.1016/0005-2736(87)90055-1; Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; Arlehamn CSL, 2010, J BIOL CHEM, V285, P10508, DOI 10.1074/jbc.M109.067298; Babin BM, 2017, MBIO, V8, DOI 10.1128/mBio.01593-17; Barquera B, 2001, FEBS LETT, V492, P45, DOI 10.1016/S0014-5793(01)02224-4; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Barquera B, 2014, J BIOENERG BIOMEMBR, V46, P289, DOI 10.1007/s10863-014-9565-9; Barr HL, 2015, EUR RESPIR J, V46, P1046, DOI 10.1183/09031936.00225214; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2002, BBA-BIOENERGETICS, V1556, P113, DOI 10.1016/S0005-2728(02)00342-0; Brandt U, 2011, BBA-BIOENERGETICS, V1807, P1364, DOI 10.1016/j.bbabio.2011.04.006; Bucher D, 2010, BIOPHYS J, V98, pL47, DOI 10.1016/j.bpj.2010.01.064; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; Cole SJ, 2014, INFECT IMMUN, V82, P2048, DOI 10.1128/IAI.01652-14; CRAMER CJ, 1992, J COMPUT AID MOL DES, V6, P629, DOI 10.1007/BF00126219; Crouzet M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180341; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Dibrov P, 2017, CAN J PHYSIOL PHARM, V95, P595, DOI 10.1139/cjpp-2016-0505; Eastman P, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005659; Fang XM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186905; Filiatrault MJ, 2006, INFECT IMMUN, V74, P4237, DOI 10.1128/IAI.02014-05; FRIEDRICH T, 1995, FEBS LETT, V367, P107, DOI 10.1016/0014-5793(95)00548-N; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Guina T, 2003, P NATL ACAD SCI USA, V100, P2771, DOI 10.1073/pnas.0435846100; Haussler S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000166; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hazan R, 2016, CURR BIOL, V26, P195, DOI 10.1016/j.cub.2015.11.056; Heikal A, 2014, MOL MICROBIOL, V91, P950, DOI 10.1111/mmi.12507; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Ito T, 2017, J BIOL CHEM, V292, P7727, DOI 10.1074/jbc.M117.781393; JARVIS WR, 1992, J ANTIMICROB CHEMOTH, V29, P19, DOI 10.1093/jac/29.suppl_A.19; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Juarez O, 2012, BBA-BIOENERGETICS, V1817, P1823, DOI 10.1016/j.bbabio.2012.03.017; Juarez O, 2012, J BIOL CHEM, V287, P25678, DOI 10.1074/jbc.M112.366088; Juarez O, 2011, J BIOL CHEM, V286, P26383, DOI 10.1074/jbc.M111.257873; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Kamath KS, 2016, J PROTEOME RES, V15, P2152, DOI 10.1021/acs.jproteome.6b00058; Kang JW, 2007, J BIOCHEM MOL BIOL, V40, P53; Kerscher Stefan, 2008, V45, P185, DOI 10.1007/400_2007_028; Kojima S, 1999, J BACTERIOL, V181, P1927, DOI 10.1128/JB.181.6.1927-1930.1999; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Liang PD, 2018, J BIOL CHEM, V293, P510, DOI 10.1074/jbc.M117.797209; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Lummen P, 1998, BBA-BIOENERGETICS, V1364, P287, DOI 10.1016/S0005-2728(98)00034-6; Mahler J, 2012, INORG CHEM, V51, P425, DOI 10.1021/ic2018693; MATSUSHITA K, 1984, BIOCHEMISTRY-US, V23, P4703, DOI 10.1021/bi00315a028; MATSUSHITA K, 1983, J BIOCHEM-TOKYO, V93, P1137, DOI 10.1093/oxfordjournals.jbchem.a134239; Merrell DS, 2002, MOL MICROBIOL, V43, P1471, DOI 10.1046/j.1365-2958.2002.02857.x; MEUNIER B, 1995, BIOCHEMISTRY-US, V34, P1076, DOI 10.1021/bi00003a044; Minato Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097083; Mitchell G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-33; Mittal Rahul, 2009, J Infect Public Health, V2, P101, DOI 10.1016/j.jiph.2009.08.003; Muras V, 2016, J BACTERIOL, V198, P2307, DOI 10.1128/JB.00342-16; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Neehaubl Y, 2013, BIOCHEMISTRY-US, V52, P3085, DOI 10.1021/bi4000386; Neehaul Y, 2012, BIOCHEMISTRY-US, V51, P4072, DOI 10.1021/bi300343u; Orazi G, 2017, MBIO, V8, DOI 10.1128/mBio.00873-17; PARKER VH, 1965, BIOCHEM J, V97, P658, DOI 10.1042/bj0970658; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Rasamiravaka T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/759348; Reyes-Prieto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096696; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHAFFAR BPH, 1989, MIKROCHIM ACTA, V3, P109; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SEGEL IH, 1993, ENZYME KINETICS BEHA, P957; Shea ME, 2015, BIOCHEMISTRY-US, V54, P490, DOI 10.1021/bi501266e; Shea ME, 2013, J BIOL CHEM, V288, P31241, DOI 10.1074/jbc.M113.510776; SKULACHEV VP, 1984, TRENDS BIOCHEM SCI, V9, P483, DOI 10.1016/0968-0004(84)90317-7; Steuber J, 2015, BIOL CHEM, V396, P1015, DOI 10.1515/hsz-2015-0128; Steuber J, 2014, NATURE, V516, P62, DOI 10.1038/nature14003; Tuz K, 2017, J BIOL CHEM, V292, P3039, DOI [10.1074/jbc.M116.770982, 10.1074/jbc.m116.770982]; Tuz K, 2015, J BIOL CHEM, V290, P20009, DOI 10.1074/jbc.M115.658773; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020; WARREN JW, 1989, ARCH INTERN MED, V149, P1535, DOI 10.1001/archinte.149.7.1535; Williams HD, 2007, ADV MICROB PHYSIOL, V52, P1, DOI 10.1016/S0065-2911(06)52001-6; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; YAGI T, 1991, J BIOENERG BIOMEMBR, V23, P211, DOI 10.1007/BF00762218; Yoshikawa K, 1999, J ANTIBIOT, V52, P182, DOI 10.7164/antibiotics.52.182; Zemke AC, 2016, CURR BIOL, V26, pR80, DOI 10.1016/j.cub.2015.12.018; Zhou WD, 1999, BIOCHEMISTRY-US, V38, P16246, DOI 10.1021/bi991664s	101	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15664	15677		10.1074/jbc.RA118.003194	http://dx.doi.org/10.1074/jbc.RA118.003194			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30135204	hybrid, Green Published			2022-12-28	WOS:000446549200029
J	Ecsedi, P; Billington, N; Palfy, G; Gogl, G; Kiss, B; Bulyaki, E; Bodor, A; Sellers, JR; Nyitray, L				Ecsedi, Peter; Billington, Neil; Palfy, Gyula; Gogl, Gergo; Kiss, Bence; Bulyaki, Eva; Bodor, Andrea; Sellers, James R.; Nyitray, Laszlo			Multiple S100 protein isoforms and C-terminal phosphorylation contribute to the paralog-selective regulation of nonmuscle myosin 2 filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium-binding protein; myosin; protein phosphorylation; electron microscopy (EM); nuclear magnetic resonance (NMR); TIRF microscopy; protein-protein interaction; S100 protein microscopy; total internal reflection fluorescence (TIRF); molecular motor; structural protein	HEAVY-CHAIN PHOSPHORYLATION; LYMPH-NODE METASTASIS; SMOOTH-MUSCLE MYOSIN; TUMOR-SUPPRESSOR; CELL-MIGRATION; LIGHT-CHAIN; II ISOFORMS; KINASE-C; KINETIC CHARACTERIZATION; NMII-A	Nonmuscle myosin 2 (NM2) has three paralogs in mammals, NM2A, NM2B, and NM2C, which have both unique and overlapping functions in cell migration, formation of cell-cell adhesions, and cell polarity. Their assembly into homo- and heterotypic bipolar filaments in living cells is primarily regulated by phosphorylation of the N-terminally bound regulatory light chain. Here, we present evidence that the equilibrium between these filaments and single NM2A and NM2B molecules can be controlled via S100 calcium-binding protein interactions and phosphorylation at the C-terminal end of the heavy chains. Furthermore, we show that in addition to S100A4, other members of the S100 family can also mediate disassembly of homotypic NM2A filaments. Importantly, these proteins can selectively remove NM2A molecules from heterotypic filaments. We also found that tail phosphorylation (at Ser-1956 and Ser-1975) of NM2B by casein kinase 2, as well as phosphomimetic substitutions at sites targeted by protein kinase C (PKC) and transient receptor potential cation channel subfamily M member 7 (TRPM7), down-regulates filament assembly in an additive fashion. Tail phosphorylation of NM2A had a comparatively minor effect on filament stability. S100 binding and tail phosphorylation therefore preferentially disassemble NM2A and NM2B, respectively. These two distinct mechanisms are likely to contribute to the temporal and spatial sorting of the two NM2 paralogs within heterotypic filaments. The existence of multiple NM2A-depolymerizing S100 paralogs offers the potential for diverse regulatory inputs modulating NM2A filament disassembly in cells and provides functional redundancy under both physiological and pathological conditions.	[Ecsedi, Peter; Gogl, Gergo; Kiss, Bence; Bulyaki, Eva; Nyitray, Laszlo] Eotvos Lorand Univ, Dept Biochem, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary; [Palfy, Gyula; Bodor, Andrea] Eotvos Lorand Univ, Inst Chem, Lab Struct Chem & Biol, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary; [Bulyaki, Eva] Eotvos Lorand Univ, Dept Biochem, ELTE NAP Neuroimmunol Res Grp, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary; [Billington, Neil; Sellers, James R.] NHLBI, Lab Physiol, NIH, Bldg 10, Bethesda, MD 20892 USA	Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Nyitray, L (corresponding author), Eotvos Lorand Univ, Dept Biochem, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary.; Sellers, JR (corresponding author), NHLBI, Lab Physiol, NIH, Bldg 10, Bethesda, MD 20892 USA.	sellersj@nhlbi.nih.gov; nyitray@elte.hu	Nyitray, László/AAE-5910-2020; Kiss, Bence/AAF-1808-2020; Gogl, Gergo/ABH-4309-2020; Bodor, Andrea/AAL-7854-2020; Ecsédi, Péter/AAF-3212-2021	Nyitray, László/0000-0003-4717-5994; Gogl, Gergo/0000-0002-8597-3711; Bodor, Andrea/0000-0002-7422-298X; Ecsédi, Péter/0000-0002-4700-125X; Kiss, Bence/0000-0001-5810-5858; Bulyaki, Eva/0000-0003-3119-8059; Billington, Neil/0000-0003-2306-0228; Palfy, Gyula/0000-0003-1590-5331	National Research, Development and Innovation Office, Hungary [K_124900, K_120391, FIEK_16-1-2016-0005, 2017-1.2.1-NKP-2017-00002]; MedInProt Program of the Hungarian Academy of Sciences; National Institutes of Health [HL001786]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001786] Funding Source: NIH RePORTER	National Research, Development and Innovation Office, Hungary; MedInProt Program of the Hungarian Academy of Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Research, Development and Innovation Office, Hungary, Grants K_124900, K_120391, FIEK_16-1-2016-0005, and 2017-1.2.1-NKP-2017-00002, and by the MedInProt Program of the Hungarian Academy of Sciences. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant HL001786. To whom correspondence may be addressed. E-mail: sellersj@nhlbi.nih.gov.	Badyal SK, 2011, J MOL BIOL, V405, P1004, DOI 10.1016/j.jmb.2010.11.036; Barry S, 2013, CLIN EXP METASTAS, V30, P251, DOI 10.1007/s10585-012-9532-y; Beach JR, 2017, NAT CELL BIOL, V19, P85, DOI 10.1038/ncb3463; Beach JR, 2015, EXP CELL RES, V334, P2, DOI 10.1016/j.yexcr.2015.01.012; Beach JR, 2014, CURR BIOL, V24, P1160, DOI 10.1016/j.cub.2014.03.071; Beach JR, 2011, P NATL ACAD SCI USA, V108, P17991, DOI 10.1073/pnas.1106499108; Billington N, 2015, CURR BIOL, V25, P942, DOI 10.1016/j.cub.2015.02.012; Billington N, 2013, J BIOL CHEM, V288, P33398, DOI 10.1074/jbc.M113.499848; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; Bronckart Y, 2001, HISTOL HISTOPATHOL, V16, P707, DOI 10.14670/HH-16.707; Bulk E, 2009, CLIN CANCER RES, V15, P22, DOI 10.1158/1078-0432.CCR-08-0953; Chai JY, 2012, WORLD J GASTROENTERO, V18, P3931, DOI 10.3748/wjg.v18.i30.3931; Chivu-Economescu M, 2010, HEPATO-GASTROENTEROL, V57, P1453; Clark K, 2008, J MOL BIOL, V378, P790, DOI 10.1016/j.jmb.2008.02.057; Dahan I, 2014, J CELL SCI, V127, P295, DOI 10.1242/jcs.127357; Dahan I, 2012, MOL BIOL CELL, V23, P591, DOI 10.1091/mbc.E11-01-0015; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Du M, 2012, J BIOL CHEM, V287, P15330, DOI 10.1074/jbc.M112.349787; Dulyaninova NG, 2007, MOL BIOL CELL, V18, P3144, DOI 10.1091/mbc.E06-11-1056; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; El-Rifai W, 2002, CANCER RES, V62, P6823; Elliott PR, 2012, STRUCTURE, V20, P654, DOI 10.1016/j.str.2012.02.002; Even-Faitelson L, 2006, MOL BIOL CELL, V17, P2869, DOI 10.1091/mbc.e05-11-1001; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Ford HL, 1997, BIOCHEMISTRY-US, V36, P16321, DOI 10.1021/bi971182l; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Hauschild A, 1999, ONCOLOGY-BASEL, V56, P338, DOI 10.1159/000011989; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Huang LY, 2011, WORLD J GASTROENTERO, V17, P69, DOI 10.3748/wjg.v17.i1.69; IKEBE M, 1986, J BIOL CHEM, V261, P36; Juanes-Garcia A, 2015, J CELL BIOL, V209, P23, DOI 10.1083/jcb.201407059; KATSURAGAWA Y, 1989, EUR J BIOCHEM, V184, P611, DOI 10.1111/j.1432-1033.1989.tb15057.x; Kiss B, 2016, FEBS J, V283, P2164, DOI 10.1111/febs.13728; Kiss B, 2012, P NATL ACAD SCI USA, V109, P6048, DOI 10.1073/pnas.1114732109; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; KRIAJEVSKA MV, 1994, J BIOL CHEM, V269, P19679; Lee KH, 2018, P NATL ACAD SCI USA, V115, pE1991, DOI 10.1073/pnas.1715247115; Li ZH, 2003, BIOCHEMISTRY-US, V42, P14258, DOI 10.1021/bi0354379; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Liu X, 2017, P NATL ACAD SCI USA, V114, pE6516, DOI 10.1073/pnas.1702375114; Ludowyke RI, 2006, J IMMUNOL, V177, P1492, DOI 10.4049/jimmunol.177.3.1492; Ma Xuefei, 2014, Bioarchitecture, V4, P88, DOI 10.4161/bioa.29766; Malashkevich VN, 2008, BIOCHEMISTRY-US, V47, P5111, DOI 10.1021/bi702537s; Masuda T, 2016, INT J ONCOL, V48, P975, DOI 10.3892/ijo.2016.3329; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Melli L, 2018, ELIFE, V7, DOI 10.7554/eLife.32871; Milton DL, 2011, P NATL ACAD SCI USA, V108, P1421, DOI 10.1073/pnas.1011784108; Murakami N, 1998, BIOCHEMISTRY-US, V37, P1989, DOI 10.1021/bi971959a; Murakami N, 1995, BIOCHEMISTRY-US, V34, P16046, DOI 10.1021/bi00049a019; MURAKAMI N, 1984, J BIOCHEM-TOKYO, V95, P651, DOI 10.1093/oxfordjournals.jbchem.a134654; Murakami N, 2000, BIOCHEMISTRY-US, V39, P11441, DOI 10.1021/bi000347e; Nagy A, 2013, J BIOL CHEM, V288, P709, DOI 10.1074/jbc.M112.424671; Nakasawa T, 2005, BIOCHEMISTRY-US, V44, P174, DOI 10.1021/bi048807h; NIEDERMAN R, 1975, J CELL BIOL, V67, P72, DOI 10.1083/jcb.67.1.72; Pasapera AM, 2015, CURR BIOL, V25, P175, DOI 10.1016/j.cub.2014.11.043; Perez D, 2007, J INVEST SURG, V20, P181, DOI 10.1080/08941930701366349; Petrosyan A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31962; Raab M, 2012, J CELL BIOL, V199, P669, DOI 10.1083/jcb.201205056; Rai V, 2017, J BIOL CHEM, V292, P3099, DOI 10.1074/jbc.M116.733402; Ronen D, 2009, J BIOL CHEM, V284, P24948, DOI 10.1074/jbc.M109.023754; Rosenberg MM, 2013, J BIOL CHEM, V288, P9779, DOI 10.1074/jbc.M112.430173; Rosenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001496; Rosenfeld SS, 2003, J BIOL CHEM, V278, P27449, DOI 10.1074/jbc.M302555200; Saitoh T, 2001, FEBS LETT, V509, P365, DOI 10.1016/S0014-5793(01)03186-6; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; SCHOLEY JM, 1980, NATURE, V287, P233, DOI 10.1038/287233a0; Schramek D, 2014, SCIENCE, V343, P309, DOI 10.1126/science.1248627; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Shutova MS, 2017, J CELL BIOL, V216, P2877, DOI 10.1083/jcb.201705167; Shutova MS, 2014, CURR BIOL, V24, P1958, DOI 10.1016/j.cub.2014.07.070; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; St-Denis N, 2015, J PROTEOMICS, V118, P49, DOI 10.1016/j.jprot.2014.10.020; Streicher WW, 2010, BIOPHYS CHEM, V151, P181, DOI 10.1016/j.bpc.2010.06.003; Tian T, 2017, DISCOV MED, V23, P235; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Visser D, 2013, CELL CALCIUM, V54, P404, DOI 10.1016/j.ceca.2013.09.003; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang F, 2000, BIOCHEMISTRY-US, V39, P5555, DOI 10.1021/bi000133x; Wang GZ, 2006, CANCER RES, V66, P1199, DOI 10.1158/0008-5472.CAN-05-2605; Wei CL, 2012, CURR OPIN CELL BIOL, V24, P254, DOI 10.1016/j.ceb.2011.12.002; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wolf S, 2011, AMINO ACIDS, V41, P849, DOI 10.1007/s00726-010-0623-2; Yammani RR, 2012, BBA-MOL BASIS DIS, V1822, P600, DOI 10.1016/j.bbadis.2012.01.006; Zimmer D. B., 2010, CARDIOVASC PSYCHIAT, V2010, DOI DOI 10.1155/2010/728052	88	7	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14850	14867		10.1074/jbc.RA118.004277	http://dx.doi.org/10.1074/jbc.RA118.004277			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30087119	hybrid, Green Published			2022-12-28	WOS:000446155000021
J	Han, X; Yoshizaki, K; Miyazaki, K; Arai, C; Funada, K; Yuta, T; Tian, T; Chiba, Y; Saito, K; Iwamoto, T; Yamada, A; Takahashi, I; Fukumoto, S				Han, Xue; Yoshizaki, Keigo; Miyazaki, Kanako; Arai, Chieko; Funada, Keita; Yuta, Tomomi; Tian, Tian; Chiba, Yuta; Saito, Kan; Iwamoto, Tsutomu; Yamada, Aya; Takahashi, Ichiro; Fukumoto, Satoshi			The transcription factor NKX2-3 mediates p21 expression and ectodysplasin-A signaling in the enamel knot for cusp formation in tooth development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tooth; development; cell proliferation; tissue-specific transcription factor; transcription regulation; cell differentiation; dental growth; Nkx2-3; odontogenesis	LUNG-THYROID SYNDROME; EDA GENE; MISSENSE MUTATION; HOMEOBOX GENES; CELLS; TEETH; SPLEEN; DIFFERENTIATION; IDENTIFICATION; MORPHOGENESIS	Tooth morphogenesis is initiated by reciprocal interactions between the ectoderm and neural crest-derived mesenchyme. During tooth development, tooth cusps are regulated by precise control of proliferation of cell clusters, termed enamel knots, that are present among dental epithelial cells. The interaction of ectodysplasin-A (EDA) with its receptor, EDAR, plays a critical role in cusp formation by these enamel knots, and mutations of these genes is a cause of ectodermal dysplasia. It has also been reported that deficiency in Nkx2-3, encoding a member of the NK2 homeobox family of transcription factors, leads to cusp absence in affected teeth. However, the molecular role of NKX2-3 in tooth morphogenesis is not clearly understood. Using gene microarray analysis in mouse embryos, we found that Nkx2-3 is highly expressed during tooth development and increased during the tooth morphogenesis, especially during cusp formation. We also demonstrate that NKX2-3 is a target molecule of EDA and critical for expression of the cell cycle regulator p21 in the enamel knot. Moreover, NKX2-3 activated the bone morphogenetic protein (BMP) signaling pathway by up-regulating expression levels of Bmp2 and Bmpr2 in dental epithelium and decreased the expression of the dental epithelial stem cell marker SRY box 2 (SOX2). Together, our results indicate that EDA/NKX2-3 signaling is essential for enamel knot formation during tooth morphogenesis in mice.	[Han, Xue; Yoshizaki, Keigo; Miyazaki, Kanako; Arai, Chieko; Funada, Keita; Yuta, Tomomi; Tian, Tian; Takahashi, Ichiro] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Orthodont & Dentofacial Orthoped, Fukuoka 8128582, Japan; [Chiba, Yuta; Saito, Kan; Yamada, Aya; Fukumoto, Satoshi] Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Pediat Dent, Sendai, Miyagi 9808575, Japan; [Iwamoto, Tsutomu] Tokushima Univ Hosp, Dept Pediat Dent, Tokushima 7700042, Japan	Kyushu University; Tohoku University; Tokushima University	Fukumoto, S (corresponding author), Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Pediat Dent, Sendai, Miyagi 9808575, Japan.; Yoshizaki, K (corresponding author), Kyushu Univ, Grad Sch Dent, Div Oral Hlth Growth & Dev, Sect Orthodont & Dentofacial Orthoped, Fukuoka 8128582, Japan.	yosizaki@dent.kyushu-u.ac.jp; fukumoto@dent.tohoku.ac.jp	Iwamoto, Tsutomu/AAA-6597-2019; Saito, Kan/AFS-5564-2022; Iwamoto, Tsutomu/AAI-8952-2021; Saito, Kan/AAG-3507-2020	Iwamoto, Tsutomu/0000-0001-8472-605X; Saito, Kan/0000-0002-2151-6204; Saito, Kan/0000-0002-2151-6204; Fukumoto, Satoshi/0000-0002-5046-6891; Yoshizaki, Keigo/0000-0002-0598-5879; Chiba, Yuta/0000-0001-5414-4411; HAN, XUE/0000-0001-9728-8159	 [18H03012];  [17K19765];  [15H05688];  [16H07065];  [15K11359];  [16H05548];  [17H01606]	; ; ; ; ; ; 	This work was supported in part by Grants-in-Aid for Scientific Research 18H03012, 17K19765, and 15H05688 (to K.Y.); 16H07065 (to K.M.); 15K11359 (to K.S.); 16H05548 (to A.Y.); and 17H01606 (to S.F.). The authors declare that they have no conflicts of interest with the contents of this article.	Arai C, 2017, SCI REP-UK, V7, DOI 10.1038/srep45181; Arakaki M, 2012, J BIOL CHEM, V287, P10590, DOI 10.1074/jbc.M111.285874; Benazet JD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001339; Biben C, 2002, INT J DEV BIOL, V46, P415; Carre A, 2009, HUM MOL GENET, V18, P2266, DOI 10.1093/hmg/ddp162; Caton J, 2009, J ANAT, V214, P502, DOI 10.1111/j.1469-7580.2008.01014.x; Czompoly T, 2011, J IMMUNOL, V186, P6981, DOI 10.4049/jimmunol.1003770; Du W, 2017, J BIOL CHEM, V292, P15062, DOI 10.1074/jbc.M117.785923; Feng JS, 2011, CELLS TISSUES ORGANS, V194, P216, DOI 10.1159/000324644; Ferguson BM, 1997, HUM MOL GENET, V6, P1589, DOI 10.1093/hmg/6.9.1589; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Guillot L, 2010, HUM MUTAT, V31, pE1146, DOI 10.1002/humu.21183; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Jernvall J, 1998, DEVELOPMENT, V125, P161; Jia SH, 2016, DEV BIOL, V420, P110, DOI 10.1016/j.ydbio.2016.10.001; Juuri E, 2013, EUR J ORAL SCI, V121, P509, DOI 10.1111/eos.12095; Juuri E, 2013, DEVELOPMENT, V140, P1424, DOI 10.1242/dev.089599; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kieri CF, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-57; Kimura R, 2009, AM J HUM GENET, V85, P528, DOI 10.1016/j.ajhg.2009.09.006; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Li JY, 2015, DEV CELL, V33, P125, DOI 10.1016/j.devcel.2015.02.021; LUMSDEN AGS, 1988, DEVELOPMENT, V103, P155; MACKENZIE A, 1992, DEVELOPMENT, V115, P403; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Miyazaki K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152206; Mostowska A, 2006, J HUM GENET, V51, P262, DOI 10.1007/s10038-005-0353-6; Mues G, 2010, EUR J HUM GENET, V18, P19, DOI 10.1038/ejhg.2009.127; Pabst O, 1999, DEVELOPMENT, V126, P2215; Pabst O, 2000, EMBO J, V19, P2015, DOI 10.1093/emboj/19.9.2015; Pispa J, 1999, DEV BIOL, V216, P521, DOI 10.1006/dbio.1999.9514; Rasool M, 2008, J HUM GENET, V53, P894, DOI 10.1007/s10038-008-0323-x; Robles EF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11889; Song S, 2009, J DENT RES, V88, P126, DOI 10.1177/0022034508328627; Stanfel MN, 2005, CELL MOL BIOL, V51, pOL785, DOI 10.1170/92; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Tao R, 2006, J HUM GENET, V51, P498, DOI 10.1007/s10038-006-0389-2; Tarlinton D, 2003, J IMMUNOL, V170, P4002, DOI 10.4049/jimmunol.170.8.4002; THESLEFF I, 1981, DIFFERENTIATION, V18, P75, DOI 10.1111/j.1432-0436.1981.tb01107.x; Thesleff I, 2001, Adv Dent Res, V15, P14; Thesleff I, 1997, MECH DEVELOP, V67, P111, DOI 10.1016/S0925-4773(97)00115-9; Tickle C, 2015, J ANAT, V227, P418, DOI 10.1111/joa.12361; Tucker AS, 2004, DEV BIOL, V268, P185, DOI 10.1016/j.ydbio.2003.12.019; VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Wang CC, 2000, DEV BIOL, V224, P152, DOI 10.1006/dbio.2000.9749; Yoshizaki K, 2008, J BIOL CHEM, V283, P3385, DOI 10.1074/jbc.M704913200; Yoshizaki K, 2017, J BIOL CHEM, V292, P13531, DOI 10.1074/jbc.M117.780866; Zeng BH, 2017, GENES-BASEL, V8, DOI 10.3390/genes8100259; Zouvelou V, 2009, J EXP ZOOL PART B, V312B, P361, DOI 10.1002/jez.b.21262	53	15	15	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14572	14584		10.1074/jbc.RA118.003373	http://dx.doi.org/10.1074/jbc.RA118.003373			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30089653	Green Published, hybrid			2022-12-28	WOS:000446155000001
J	Taguchi, Y; Lu, L; Marrero-Winkens, C; Otaki, H; Nishida, N; Schatzl, HM				Taguchi, Yuzuru; Lu, Li; Marrero-Winkens, Cristobal; Otaki, Hiroki; Nishida, Noriyuki; Schatzl, Hermann M.			Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrPSc (vol 293, pg 12730, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													; Otaki, Hiroki/A-4604-2011	Schatzl, Hermann/0000-0003-4972-8740; Otaki, Hiroki/0000-0002-0556-8434	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076853] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS076853] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		TAGUCHI YZ, 2018, DISULFIDE CROSSLINK	1	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14925	14925		10.1074/jbc.AAC118.005526	http://dx.doi.org/10.1074/jbc.AAC118.005526			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30242041	Green Published, hybrid			2022-12-28	WOS:000446155000027
J	Smock, RG; Blackburn, ME; Gierasch, LM				Smock, Robert G.; Blackburn, Mandy E.; Gierasch, Lila M.			Conserved, disordered C terminus of DnaK enhances cellular survival upon stress and DnaK in vitro chaperone activity (vol 286, pg 31821, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction															NIGMS NIH HHS [R35 GM118161] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118161] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		SMOCK RG, 2011, IN VITRO, V286, P31821, DOI DOI 10.1074/JBC.AAC118.005458	1	1	1	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14295	14295		10.1074/jbc.AAC118.005458	http://dx.doi.org/10.1074/jbc.AAC118.005458			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30217867	Green Published, hybrid			2022-12-28	WOS:000444671500011
J	Mittal, C; Culbertson, SJ; Shogren-Knaak, MA				Mittal, Chitvan; Culbertson, Sannie J.; Shogren-Knaak, Michael A.			Distinct requirements of linker DNA and transcriptional activators in promoting SAGA-mediated nucleosome acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; acetylation; histone modification; transcription factor; gene regulation; enzyme; epigenetics; SAGA family; Spt-Ada-Gcn5 acetyltransferase	TATA-BINDING PROTEIN; HISTONE ACETYLTRANSFERASE ACTIVITY; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; IN-VIVO; CONFORMATIONAL FLEXIBILITY; RECOMBINANT HISTONES; H2B DEUBIQUITINATION; COACTIVATOR COMPLEX; YEAST	The Spt-Ada-Gcn5 acetyltransferase (SAGA) family of transcriptional coactivators are prototypical nucleosome acetyltransferase complexes that regulate multiple steps in gene transcription. The size and complexity of both the SAGA enzyme and the chromatin substrate provide numerous opportunities for regulating the acetylation process. To better probe this regulation, here we developed a bead-based nucleosome acetylation assay to characterize the binding interactions and kinetics of acetylation with different nucleosomal substrates and the full SAGA complex purified from budding yeast (Saccharomyces cerevisiae). We found that SAGA-mediated nucleosome acetylation is stimulated up to 9-fold by DNA flanking the nucleosome, both by facilitating the binding of SAGA and by accelerating acetylation turnover. This stimulation required that flanking DNA is present on both sides of the nucleosome and that one side is >15 bp long. The Gal4-VP16 transcriptional activator fusion protein could also augment nucleosome acetylation up to 5-fold. However, contrary to our expectations, this stimulation did not appear to occur by stabilizing the binding of SAGA toward nucleosomes containing an activator-binding site. Instead, increased acetylation turnover by SAGA stimulated nucleosome acetylation. These results suggest that the Gal4-VP16 transcriptional activator directly stimulates acetylation via a dual interaction with both flanking DNA and SAGA. Altogether, these findings uncover several critical mechanisms of SAGA regulation by chromatin substrates.	[Mittal, Chitvan; Culbertson, Sannie J.; Shogren-Knaak, Michael A.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Mittal, Chitvan] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Culbertson, Sannie J.] Harvard Med Sch, Div Genet, Boston, MA 02115 USA	Iowa State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Harvard Medical School	Shogren-Knaak, MA (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	knaak@iastate.edu	Mittal, Chitvan/GSN-2531-2022		American Cancer Society Research Scholar Grant [1206501]; Gary Roewe Research Award	American Cancer Society Research Scholar Grant(American Cancer Society); Gary Roewe Research Award	This work was supported in part by American Cancer Society Research Scholar Grant 1206501 (to M.A.S.-K.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by a Gary Roewe Research Award.	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Balasubramanian R, 2002, J BIOL CHEM, V277, P7989, DOI 10.1074/jbc.M110849200; BARLEV NA, 1995, J BIOL CHEM, V270, P19337, DOI 10.1074/jbc.270.33.19337; Sanz AB, 2016, NUCLEIC ACIDS RES, V44, P7159, DOI 10.1093/nar/gkw324; BERGER SL, 1992, CELL, V70, P251, DOI 10.1016/0092-8674(92)90100-Q; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; Blacketer MJ, 2010, J BIOL CHEM, V285, P34597, DOI 10.1074/jbc.M110.140061; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Cianfrocco MA, 2013, CELL, V152, P120, DOI 10.1016/j.cell.2012.12.005; Dechassa ML, 2008, MOL CELL BIOL, V28, P6010, DOI 10.1128/MCB.00693-08; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Durand A, 2014, STRUCTURE, V22, P1553, DOI 10.1016/j.str.2014.07.017; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Elmlund H, 2009, STRUCTURE, V17, P1442, DOI 10.1016/j.str.2009.09.007; FASSLER JS, 1988, GENETICS, V118, P203; Fersht A., 1999, STRUCTURE MECH PROTE, P139; Garcia-Oliver E, 2012, BBA-GENE REGUL MECH, V1819, P555, DOI 10.1016/j.bbagrm.2011.11.011; Ghosh S, 2011, MOL CELL BIOL, V31, P190, DOI 10.1128/MCB.00317-10; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Guillemette B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001354; Han Y, 2014, EMBO J, V33, P2534, DOI 10.15252/embj.201488638; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Hassan AH, 2007, BIOCHEM J, V402, P125, DOI 10.1042/BJ20060907; Hong MQ, 2008, STRUCTURE, V16, P1019, DOI 10.1016/j.str.2008.03.015; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; KOBAYASHI N, 1995, MOL CELL BIOL, V15, P6465; Kohler A, 2010, CELL, V141, P606, DOI 10.1016/j.cell.2010.04.026; Koehler C, 2014, J BIOL CHEM, V289, P8989, DOI 10.1074/jbc.M113.500868; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Laprade L, 2007, GENETICS, V177, P2007, DOI 10.1534/genetics.107.081976; Lee KK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.40; Li S, 2008, P NATL ACAD SCI USA, V105, P18243, DOI 10.1073/pnas.0804530105; Liang SD, 1996, MOL CELL BIOL, V16, P3773; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1999, METH MOL B, V119, P1; McMahon SJ, 2005, P NATL ACAD SCI USA, V102, P8478, DOI 10.1073/pnas.0503493102; Mittal C, 2014, ANAL BIOCHEM, V457, P51, DOI 10.1016/j.ab.2014.04.024; Morgan MT, 2016, SCIENCE, V351, P725, DOI 10.1126/science.aac5681; Morris SA, 2007, J BIOL CHEM, V282, P7632, DOI 10.1074/jbc.M607909200; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Nedialkov YA, 2004, ARCH BIOCHEM BIOPHYS, V425, P77, DOI 10.1016/j.abb.2004.03.002; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Nguyen-Huynh NT, 2015, PROTEIN SCI, V24, P1232, DOI 10.1002/pro.2676; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; PARTHUN MR, 1990, J BIOL CHEM, V265, P209; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Qian CM, 2005, NAT STRUCT MOL BIOL, V12, P1078, DOI 10.1038/nsmb1022; Ranjan A, 2013, CELL, V154, P1232, DOI 10.1016/j.cell.2013.08.005; Ringel AE, 2015, P NATL ACAD SCI USA, V112, pE5461, DOI 10.1073/pnas.1508449112; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Sassa A, 2013, JOVE-J VIS EXP, DOI 10.3791/50695; Sermwittayawong D, 2006, EMBO J, V25, P3791, DOI 10.1038/sj.emboj.7601265; Setiaputra D, 2015, J BIOL CHEM, V290, P10057, DOI 10.1074/jbc.M114.624684; SILVERMAN N, 1994, P NATL ACAD SCI USA, V91, P11665, DOI 10.1073/pnas.91.24.11665; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; STADTMAN ER, 1957, METHOD ENZYMOL, V3, P931, DOI 10.1016/S0076-6879(57)03481-3; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; Vignali M, 2000, EMBO J, V19, P2629, DOI 10.1093/emboj/19.11.2629; Vojnic E, 2011, NAT STRUCT MOL BIOL, V18, P404, DOI 10.1038/nsmb.1997; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Wu PYJ, 2004, MOL CELL, V15, P199, DOI 10.1016/j.molcel.2004.06.005; Wu PYJ, 2002, MOL CELL BIOL, V22, P5367, DOI 10.1128/MCB.22.15.5367-5379.2002; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170	81	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13736	13749		10.1074/jbc.RA118.004487	http://dx.doi.org/10.1074/jbc.RA118.004487			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30054274	Green Published, hybrid			2022-12-28	WOS:000443375500032
J	Slaughter, MJ; Shanle, EK; McFadden, AW; Hollis, ES; Suttle, LE; Strahl, BD; Davis, IJ				Slaughter, Mariesa J.; Shanle, Erin K.; McFadden, Andrew W.; Hollis, Emily S.; Suttle, Lindsey E.; Strahl, Brian D.; Davis, Ian J.			PBRM1 bromodomains variably influence nucleosome interactions and cellular function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; chromatin; chromatin regulation; chromatin structure; histones; histone acetylation; histone methylation; histone modification; bromodomain; PBRM1; BAF180	RENAL-CARCINOMA; HISTONE MODIFICATIONS; PROTEIN BRD4; CHROMATIN; ACETYLATION; RECOGNITION; TARGETS; FAMILY; LIGAND; DOMAIN	Chromatin remodelers use bromodomains (BDs) to recognize histones. Polybromo 1 (PBRM1 or BAF180) is hypothesized to function as the nucleosome-recognition subunit of the PBAF chromatin-remodeling complex and is frequently mutated in clear cell renal cell carcinoma (ccRCC). Previous studies have applied in vitro methods to explore the binding specificities of the six individual PBRM1 BDs. However, BD targeting to histones and the influence of neighboring BD on nucleosome recognition have not been well characterized. Here, using histone microarrays and intact nucleosomes to investigate the histone-binding characteristics of the six PBRM1 BDs individually and combined, we demonstrate that BD2 and BD4 of PBRM1 mediate binding to acetylated histone peptides and to modified recombinant and cellular nucleosomes. Moreover, we show that neighboring BDs variably modulate these chromatin interactions, with BD1 and BD5 enhancing nucleosome interactions of BD2 and BD4, respectively, whereas BD3 attenuated these interactions. We also found that binding pocket missense mutations in BD4 observed in ccRCC disrupt PBRM1-chromatin interactions and that these mutations in BD4, but not similar mutations in BD2, in the context of full-length PBRM1, accelerate ccRCC cell proliferation. Taken together, our biochemical and mutational analyses have identified BD4 as being critically important for maintaining proper PBRM1 function and demonstrate that BD4 mutations increase ccRCC cell growth. Because of the link between PBRM1 status and sensitivity to immune checkpoint inhibitor treatment, these data also suggest the relevance of BD4 as a potential clinical target.	[Slaughter, Mariesa J.; Strahl, Brian D.; Davis, Ian J.] Univ N Carolina, Dept Genet, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Slaughter, Mariesa J.; McFadden, Andrew W.; Hollis, Emily S.; Suttle, Lindsey E.; Strahl, Brian D.; Davis, Ian J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Shanle, Erin K.; Strahl, Brian D.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Davis, Ian J.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Davis, IJ (corresponding author), Univ N Carolina, Dept Genet, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.; Davis, IJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Davis, IJ (corresponding author), Univ N Carolina, Dept Pediat, Chapel Hill, NC 27514 USA.	ian_davis@med.unc.edu		Davis, Ian/0000-0002-1552-0960; Suttle, Lindsey/0000-0002-5870-4479	National Institutes of Health [CA166447, CA198482, GM126900]; CornHammond Fund for Pediatric Oncology; University of North Carolina Lineberger Developmental Grants; Institutional Research and Academic Career Development Award - National Institute of General Medical Sciences, division of Training, Workforce Development, and Diversity [GM000678]; NATIONAL CANCER INSTITUTE [R01CA198482, R01CA166447, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000678, R35GM126900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CornHammond Fund for Pediatric Oncology; University of North Carolina Lineberger Developmental Grants; Institutional Research and Academic Career Development Award - National Institute of General Medical Sciences, division of Training, Workforce Development, and Diversity; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA166447 (I.J.D.), CA198482 (I.J.D. and B.D.S.), and GM126900 (B.D.S.); the CornHammond Fund for Pediatric Oncology (I.J.D.) and a University of North Carolina Lineberger Developmental Grants. This work was also supported by Institutional Research and Academic Career Development Award GM000678 (to E.K.S.) granted by the National Institute of General Medical Sciences, division of Training, Workforce Development, and Diversity. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chandrasekaran R, 2007, BIOCHEM BIOPH RES CO, V355, P661, DOI 10.1016/j.bbrc.2007.01.193; Charlop-Powers Z, 2010, CELL RES, V20, P529, DOI 10.1038/cr.2010.43; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chowdhury B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153718; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Durinck S, 2015, NAT GENET, V47, P13, DOI 10.1038/ng.3146; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Fuchs SM, 2011, CURR BIOL, V21, P53, DOI 10.1016/j.cub.2010.11.058; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao WH, 2017, P NATL ACAD SCI USA, V114, P1027, DOI 10.1073/pnas.1619726114; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Lin YJ, 2008, PROTEIN SCI, V17, P2174, DOI 10.1110/ps.037580.108; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Muller S, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001992; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Porter EG, 2017, J BIOL CHEM, V292, P2601, DOI 10.1074/jbc.M116.746875; Rothbart SB, 2012, METHOD ENZYMOL, V512, P107, DOI 10.1016/B978-0-12-391940-3.00006-8; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, P NATL ACAD SCI USA, V104, P2086, DOI 10.1073/pnas.0610993104; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9	34	19	19	4	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13592	13603		10.1074/jbc.RA118.003381	http://dx.doi.org/10.1074/jbc.RA118.003381			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29986887	Green Published, hybrid			2022-12-28	WOS:000443375500019
J	Rimer, JM; Lee, J; Holley, CL; Crowder, RJ; Chen, DL; Hanson, PI; Ory, DS; Schaffer, JE				Rimer, Jamie M.; Lee, Jiyeon; Holley, Christopher L.; Crowder, Robert J.; Chen, Delphine L.; Hanson, Phyllis, I; Ory, Daniel S.; Schaffer, Jean E.			Long-range function of secreted small nucleolar RNAs that direct 2 '-O-methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFECTED MACROPHAGES; NUCLEAR IMPORT; IN-VITRO; CELLS; MICRORNAS; MICROPARTICLES; EXPRESSION; MECHANISM; SNORNP; SNRNA	Small nucleolar RNAs (snoRNAs) are noncoding RNAs that guide chemical modifications of structural RNAs. Whereas snoRNAs primarily localize in the nucleolus, where their canonical function is to target nascent ribosomal RNAs for 2'-O-methylation, recent studies provide evidence that snoRNAs traffic out of the nucleus. Furthermore, RNA-Seq data indicate that extracellular vesicles released from cells contain snoRNAs. However, it is not known whether snoRNA secretion is regulated or whether secreted snoRNAs are functional. Here, we show that inflammation stimulates secretion of Rpl13a snoRNAs U32a (SNORD32a), U33 (SNORD33), U34 (SNORD34), and U35a (SNORD35a) from cultured macrophages, in mice, and in human subjects. Secreted snoRNAs co-fractionate with extracellular vesicles and are taken up by recipient cells. In a murine parabiosis model, we demonstrate that snoRNAs travel through the circulation to function in distant tissues. These findings support a previously unappreciated link between inflammation and snoRNA secretion in mice and humans and uncover a potential role for secreted snoRNAs in cell-cell communication.	[Rimer, Jamie M.; Lee, Jiyeon; Holley, Christopher L.; Crowder, Robert J.; Chen, Delphine L.; Ory, Daniel S.; Schaffer, Jean E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Chen, Delphine L.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Hanson, Phyllis, I] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Schaffer, JE (corresponding author), Washington Univ, Sch Med, 660 S Euclid Ave,Campus Box 8086, St Louis, MO 63110 USA.	jschaff@wustl.edu	Holley, Christopher/T-1312-2019; Holley, Christopher/ABB-6677-2020	Holley, Christopher/0000-0002-2870-3352; Lee, Jiyeon/0000-0002-8952-7938	National Institutes of Health [R01 DK064989, P30 DK020579, T32 HL007081]; Fondation Leducq [12CVD04]; Doris Duke Clinical Investigator Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108357, R01DK064989, P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122434] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); Doris Duke Clinical Investigator Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01 DK064989, P30 DK020579, and T32 HL007081 and Fondation Leducq Grant 12CVD04. The clinical trial supporting this work was funded by a Doris Duke Clinical Investigator Award (to D. L. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; BASERGA SJ, 1992, GENE DEV, V6, P1120, DOI 10.1101/gad.6.6.1120; Berardocco M, 2017, ONCOTARGET, V8, P82920, DOI 10.18632/oncotarget.20503; Brandis KA, 2013, J BIOL CHEM, V288, P35703, DOI 10.1074/jbc.M113.488577; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen DL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191783; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Darwich AS, 2014, DRUG METAB DISPOS, V42, P2016, DOI 10.1124/dmd.114.058404; Dong ZW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks698; Dupuis-Sandoval F, 2015, WIRES RNA, V6, P381, DOI 10.1002/wrna.1284; Feng JL, 2009, GENE, V437, P14, DOI 10.1016/j.gene.2009.01.017; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Helwa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170628; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; Holley CL, 2015, J BIOL CHEM, V290, P11741, DOI 10.1074/jbc.M115.637413; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Jinn S, 2015, CELL METAB, V21, P855, DOI 10.1016/j.cmet.2015.04.010; Kamran P, 2013, JOVE-J VIS EXP, DOI 10.3791/50556; Kaur S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20936-7; Kiss T, 2006, COLD SPRING HARB SYM, V71, P407, DOI 10.1101/sqb.2006.71.025; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Lane RE, 2015, SCI REP-UK, V5, DOI 10.1038/srep07639; Lee JY, 2016, J CLIN INVEST, V126, P4616, DOI 10.1172/JCI88069; Lefebvre FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep27680; Li MW, 2017, J BIOL CHEM, V292, P20228, DOI 10.1074/jbc.M117.818146; Magami Y, 2002, LIVER, V22, P419, DOI 10.1034/j.1600-0676.2002.01702.x; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; Saha S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13096; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Scruggs BS, 2012, MOL CELL BIOL, V32, P4092, DOI 10.1128/MCB.00022-12; Shi MM, 1999, IMMUNOLOGY, V97, P309; Sienna N, 1996, EXP CELL RES, V227, P98, DOI 10.1006/excr.1996.0254; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Singh PP, 2012, J IMMUNOL, V189, P777, DOI 10.4049/jimmunol.1103638; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Terns MP, 2002, GENE EXPRESSION, V10, P17; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valleron W, 2012, BLOOD, V120, P3997, DOI 10.1182/blood-2012-06-438135; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Walters SB, 2013, J IMMUNOL, V190, P669, DOI 10.4049/jimmunol.1201856; Watkins NJ, 2007, MOL CELL BIOL, V27, P7018, DOI 10.1128/MCB.00516-07; Watkins NJ, 2004, MOL CELL, V16, P789, DOI 10.1016/j.molcel.2004.11.012; Wei ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01196-x; Yang LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115293; Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035; Zhang Y, 2012, CELL MOL IMMUNOL, V9, P489, DOI 10.1038/cmi.2012.33; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	49	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13284	13296		10.1074/jbc.RA118.003410	http://dx.doi.org/10.1074/jbc.RA118.003410			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29980600	Green Published, hybrid			2022-12-28	WOS:000442730200026
J	Miggin, SM; Kinsella, BT				Miggin, Sinead M.; Kinsella, B. Therese			RETRACTION: Investigation of the mechanisms of G protein: Effector coupling by the human and mouse prostacyclin receptors. Identification of critical species-dependent differences (Retraction of Vol 277, Pg 27053, 2002)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Miggin SM, 2002, J BIOL CHEM, V277, P27053, DOI 10.1074/jbc.M203353200	1	0	0	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12285	12285		10.1074/jbc.W118.004804	http://dx.doi.org/10.1074/jbc.W118.004804			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	30076257	Green Published, hybrid			2022-12-28	WOS:000440803200027
J	Oliva, JL; Zarich, N; Martinez, N; Jorge, R; Castrillo, A; Azanedo, M; Garcia-Vargas, S; Gutierrez-Eisman, S; Juarranz, A; Bosca, L; Gutkind, JS; Rojas, JM				Oliva, Jose Luis; Zarich, Natasha; Martinez, Natalia; Jorge, Rocio; Castrillo, Antonio; Azanedo, Marta; Garcia-Vargas, Susana; Gutierrez-Eisman, Silvia; Juarranz, Angeles; Bosca, Lisardo; Gutkind, J. Silvio; Rojas, Jose M.			RETRACTION: The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras (Retraction of Vol 279, Pg 33480, 2004)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482				Oliva JL, 2004, J BIOL CHEM, V279, P33480, DOI 10.1074/jbc.M404058200	1	0	0	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11651	11651		10.1074/jbc.W118.004644	http://dx.doi.org/10.1074/jbc.W118.004644			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	30030386	hybrid, Green Published			2022-12-28	WOS:000439449700035
J	Kendra, JA; Advani, VM; Chen, B; Briggs, JW; Zhu, JY; Bress, HJ; Pathy, SM; Dinman, JD				Kendra, Joseph A.; Advani, Vivek M.; Chen, Bin; Briggs, Joseph W.; Zhu, Jinyi; Bress, Hannah J.; Pathy, Sushrut M.; Dinman, Jonathan D.			Functional and structural characterization of the chikungunya virus translational recoding signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alphavirus; RNA; chemical modification; molecular dynamics; chikungunya virus; antiviral treatment; programmed frameshift; recoding; RNA secondary structure; TCR signal	SELECTIVE 2'-HYDROXYL ACYLATION; OPAL TERMINATION CODON; RNA STRUCTURE-ANALYSIS; MURINE LEUKEMIA-VIRUS; SINGLE NUCLEOTIDE RESOLUTION; PRIMER EXTENSION SHAPE; STOP CODON; VERTICAL TRANSMISSION; SINDBIS VIRUS; MOSAIC-VIRUS	Climate change and human globalization have spurred the rapid spread of mosquito-borne diseases to naive populations. One such emerging virus of public health concern is chikungunya virus (CHIKV), a member of the Togaviridae family, genus Alphavirus. CHIKV pathogenesis is predominately characterized by acute febrile symptoms and severe arthralgia, which can persist in the host long after viral clearance. CHIKV has also been implicated in cases of acute encephalomyelitis, and its vertical transmission has been reported. Currently, no FDA-approved treatments exist for this virus. Recoding elements help expand the coding capacity in many viruses and therefore represent potential therapeutic targets in antiviral treatments. Here, we report the molecular and structural characterization of two CHIKV translational recoding signals: a termination codon read-through (TCR) element located between the nonstructural protein 3 and 4 genes and a programmed -1 ribosomal frameshift (-1 PRF) signal located toward the 3 end of the CHIKV 6K gene. Using Dual-Luciferase and immunoblot assays in HEK293T and U87MG mammalian cell lines, we validated and genetically characterized efficient TCR and -1 PRF. Analyses of RNA chemical modification data with selective 2-hydroxyl acylation and primer extension (SHAPE) assays revealed that CHIKV -1 PRF is stimulated by a tightly structured, triple-stem hairpin element, consistent with previous observations in alphaviruses, and that the TCR signal is composed of a single large multibulged hairpin element. These findings illuminate the roles of RNA structure in translational recoding and provide critical information relevant for design of live-attenuated vaccines against CHIKV and related viruses.	[Kendra, Joseph A.; Advani, Vivek M.; Chen, Bin; Briggs, Joseph W.; Dinman, Jonathan D.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Advani, Vivek M.; Zhu, Jinyi; Bress, Hannah J.; Pathy, Sushrut M.] Univ Maryland, Year Innovat & Res Experience Program 1, College Pk, MD 20742 USA; [Advani, Vivek M.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Hale Bldg Transformat Med,60 Fenwood Rd, Boston, MA 02115 USA; [Briggs, Joseph W.] US FDA, Div Microbiol Devices CDRH VIR1, Off Vitro Diagnost & Radiol Hlth, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Harvard University; Brigham & Women's Hospital; US Food & Drug Administration (FDA)	Dinman, JD (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	dinman@umd.edu	Kendra, Joseph/AAA-1844-2020; Advani, Vivek/L-1827-2019	Advani, Vivek/0000-0002-0584-8989; Dinman, Jonathan/0000-0002-2402-9698; Kendra, Joseph/0000-0001-5886-7377	Defense Threat Reduction Agency [HDTRA1-13-1-0005]; NIGMS, National Institutes of Health (NIH) [R01 GM117177]; NHLBI, NIH [R01HL119439]; First-year Innovation and Research Experience (FIRE) Program at University of Maryland, College Park; Howard Hughes Medical Institute/University of Maryland College Park; NIH Institutional Training Grant [2T32AI051967-06A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI051967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117177] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); First-year Innovation and Research Experience (FIRE) Program at University of Maryland, College Park; Howard Hughes Medical Institute/University of Maryland College Park; NIH Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Defense Threat Reduction Agency Grant HDTRA1-13-1-0005; NIGMS, National Institutes of Health (NIH) Grant R01 GM117177; NIH Institutional Training Grant 2T32AI051967-06A1 (to J. A. K.); NHLBI, NIH Grant R01HL119439 (to J. W. B.); and the First-year Innovation and Research Experience (FIRE) Program at University of Maryland, College Park (to V. M. A.). Part of this work was made possible by an undergraduate fellowship from the Howard Hughes Medical Institute/University of Maryland College Park (to J. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamson CS, 2003, VIROLOGY, V314, P488, DOI 10.1016/S0042-6822(03)00485-9; Atkins GJ., 2013, ISRN VIROL, V2013, P1, DOI [10.5402/2013/861912, DOI 10.5402/2013/861912]; Atkins JF, 2016, NUCLEIC ACIDS RES, V44, P7007, DOI 10.1093/nar/gkw530; Bandeira AC, 2016, IDCases, V5, P57, DOI 10.1016/j.idcr.2016.07.008; Barry JK, 2002, P NATL ACAD SCI USA, V99, P11133, DOI 10.1073/pnas.162223099; Belew AT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-339; BRIERLEY I, 1995, J GEN VIROL, V76, P1885, DOI 10.1099/0022-1317-76-8-1885; Brizzi K, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0561-1; Cardona-Correa SE, 2017, REV CHIL PEDIATR-CHI, V88, P285, DOI 10.4067/S0370-41062017000200015; Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289; Chung BYW, 2010, J MOL BIOL, V397, P448, DOI 10.1016/j.jmb.2010.01.044; Csibra E, 2014, J VIROL, V88, P10364, DOI 10.1128/JVI.00898-14; DINMAN JD, 1992, J VIROL, V66, P3669, DOI 10.1128/JVI.66.6.3669-3676.1992; Dinman JD, 1998, TRENDS BIOTECHNOL, V16, P190, DOI 10.1016/S0167-7799(97)01167-0; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Firth AE, 2011, NUCLEIC ACIDS RES, V39, P6679, DOI 10.1093/nar/gkr224; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-108; Gao F, 2016, NUCLEIC ACIDS RES, V44, P878, DOI 10.1093/nar/gkv1241; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gorchakov R, 2012, J VIROL, V86, P6084, DOI 10.1128/JVI.06449-11; Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025; Green L, 2015, J GEN VIROL, V96, P3411, DOI 10.1099/jgv.0.000284; JACKS T, 1990, CURR TOP MICROBIOL, V157, P93; Jacobs JL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh157; Jones JE, 2017, MBIO, V8, DOI 10.1128/mBio.01456-17; Kendra JA, 2017, J VIROL, V91, DOI 10.1128/JVI.01766-16; Kuhlmann MM, 2016, J VIROL, V90, P8575, DOI 10.1128/JVI.01129-16; LEMM JA, 1990, J VIROL, V64, P3001, DOI 10.1128/JVI.64.6.3001-3011.1990; LI GP, 1989, J VIROL, V63, P1326, DOI 10.1128/JVI.63.3.1326-1337.1989; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lopinski JD, 2000, MOL CELL BIOL, V20, P1095, DOI 10.1128/MCB.20.4.1095-1103.2000; Loughran G, 2017, RNA, V23, P1285, DOI 10.1261/rna.061051.117; Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09; Melton JV, 2002, J BIOL CHEM, V277, P46923, DOI 10.1074/jbc.M207847200; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Moomau C, 2016, J BIOL CHEM, V291, P15788, DOI 10.1074/jbc.M116.735613; Myles KM, 2006, J VIROL, V80, P4992, DOI 10.1128/JVI.80.10.4992-4997.2006; Napthine S, 2003, EMBO J, V22, P3941, DOI 10.1093/emboj/cdg365; Newburn LR, 2015, VIROLOGY, V479, P434, DOI 10.1016/j.virol.2015.02.032; Newburn LR, 2014, VIROLOGY, V450, P258, DOI 10.1016/j.virol.2013.12.006; Nicholson BL, 2014, NAT REV MICROBIOL, V12, P493, DOI 10.1038/nrmicro3288; Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904; Paul CP, 2001, J MOL BIOL, V310, P987, DOI 10.1006/jmbi.2001.4801; Plant EP, 2005, PLOS BIOL, V3, P1012, DOI 10.1371/journal.pbio.0030172; Plant EP, 2005, NUCLEIC ACIDS RES, V33, P1825, DOI 10.1093/nar/gki329; Plant EP, 2013, VIRUSES-BASEL, V5, P279, DOI 10.3390/v5010279; Plant EP, 2010, J VIROL, V84, P4330, DOI 10.1128/JVI.02480-09; Ramsey J, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080228; Ramsey J, 2017, J VIROL, V91, DOI 10.1128/JVI.02000-16; Ross R., 1956, J HYG LOND, V54, P177, DOI DOI 10.1017/S0022172400044442; Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004199; Schuller AP, 2018, NAT REV MOL CELL BIO, V19, P526, DOI 10.1038/s41580-018-0011-4; Shehu-Xhilaga M, 2001, J VIROL, V75, P1834, DOI 10.1128/JVI.75.4.1834-1841.2001; Smola MJ, 2015, NAT PROTOC, V10, P1643, DOI 10.1038/nprot.2015.103; Snyder JE, 2013, J VIROL, V87, P8511, DOI 10.1128/JVI.00449-13; SOMOGYI P, 1993, MOL CELL BIOL, V13, P6931, DOI 10.1128/MCB.13.11.6931; STRAUSS EG, 1983, P NATL ACAD SCI-BIOL, V80, P5271, DOI 10.1073/pnas.80.17.5271; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tajima Y, 2011, VIROLOGY, V417, P169, DOI 10.1016/j.virol.2011.05.012; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596	66	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17536	17545		10.1074/jbc.RA118.005606	http://dx.doi.org/10.1074/jbc.RA118.005606			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30242123	Green Published, hybrid			2022-12-28	WOS:000449799000018
J	Kida, Y; Sakaguchi, M				Kida, Yuichiro; Sakaguchi, Masao			Interaction mapping of the Sec61 translocon identifies two Sec61 regions interacting with hydrophobic segments in translocating chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane biogenesis; endoplasmic reticulum (ER); protein translocation; protein import; transmembrane domain; membrane protein; protein sorting; protein synthesis; protein secretion; protein-protein interaction; membrane insertion; membrane integration; Sec translocon; signal sequence	ENDOPLASMIC-RETICULUM TRANSLOCON; SIGNAL SEQUENCE RECOGNITION; MEMBRANE-PROTEIN INSERTION; SUPPRESSOR MUTATIONS; TRANSMEMBRANE-HELIX; PAUSE TRANSFER; ER MEMBRANE; CHANNEL; COMPLEX; TOPOGENESIS	Many proteins in organelles of the secretory pathway, as well as secretory proteins, are translocated across and inserted into the endoplasmic reticulum membrane by the Sec61 translocon, a protein-conducting channel. The channel consists of 10 transmembrane (TM) segments of the Sec61 subunit and possesses an opening between TM2b and TM7, termed the lateral gate. Structural and biochemical analyses of complexes of Sec61 and its ortholog SecY have revealed that the lateral gate is the exit for signal sequences and TM segments of translocating polypeptides to the lipid bilayer and also involved in the recognition of such hydrophobic sequences. Moreover, even marginally hydrophobic (mH) segments insufficient for membrane integration can be transiently stalled in surrounding Sec61 regions and cross-linked to them, but how the Sec61 translocon accommodates these mH segments remains unclear. Here, we used Cys-scanned variants of human Sec61 expressed in cultured 293-H cells to examine which channel regions associate with mH segments. A TM segment in a ribosome-associated polypeptide was mainly cross-linked to positions at the lateral gate, whereas an mH segment in a nascent chain was cross-linked to the Sec61 pore-interior positions at TM5 and TM10, as well as the lateral gate. Of note, cross-linking at position 180 in TM5 of Sec61 was reduced by an I179A substitution. We therefore conclude that at least two Sec61 regions, the lateral gate and the pore-interior site around TM5, interact with mH segments and are involved in accommodating them.	[Kida, Yuichiro; Sakaguchi, Masao] Univ Hyogo, Grad Sch Life Sci, 3-2-1 Kouto, Kamigori, Hyogo 6781297, Japan	University of Hyogo	Sakaguchi, M (corresponding author), Univ Hyogo, Grad Sch Life Sci, 3-2-1 Kouto, Kamigori, Hyogo 6781297, Japan.; Kida, Y (corresponding author), TechnoPro R&D Co, TechnoPro Inc, Kita Ku, 1-11-4 Umeda, Osaka, Japan.	ykida@sci.u-hyogo.ac.jp; sakag@sci.u-hyogo.ac.jp		Sakaguchi, Masao/0000-0002-2772-0492				Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; CHUCK SL, 1992, CELL, V68, P9, DOI 10.1016/0092-8674(92)90202-N; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; De Marothy MT, 2015, PROTEIN SCI, V24, P1057, DOI 10.1002/pro.2698; EMR SD, 1981, CELL, V23, P79, DOI 10.1016/0092-8674(81)90272-5; Fujita H, 2010, MOL BIOL CELL, V21, P2045, DOI 10.1091/mbc.E09-12-1060; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Gumbart JC, 2013, J AM CHEM SOC, V135, P2291, DOI 10.1021/ja310777k; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Junne T, 2007, J BIOL CHEM, V282, P33201, DOI 10.1074/jbc.M707219200; Junne T, 2010, MOL BIOL CELL, V21, P1662, DOI 10.1091/mbc.E10-01-0060; Kida Y, 2000, J CELL BIOL, V150, P719, DOI 10.1083/jcb.150.4.719; Kida Y, 2007, J CELL BIOL, V179, P1441, DOI 10.1083/jcb.200707050; Kida Y, 2016, MOL BIOL CELL, V27, P930, DOI 10.1091/mbc.E15-09-0672; Kida Y, 2010, MOL BIOL CELL, V21, P418, DOI 10.1091/mbc.E09-08-0738; Kivlen MH, 1997, J LIPID RES, V38, P1149; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KUROIWA T, 1991, J BIOL CHEM, V266, P9251; Li L, 2016, NATURE, V531, P395, DOI 10.1038/nature17163; Lu Y, 1998, J BIOL CHEM, V273, P568, DOI 10.1074/jbc.273.1.568; MacKinnon AL, 2014, ELIFE, V3, DOI 10.7554/eLife.01483; Mandon EC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013342; Ojemalm K, 2012, MOL CELL, V45, P529, DOI 10.1016/j.molcel.2011.12.024; Onishi Y, 2013, J MOL BIOL, V425, P3205, DOI 10.1016/j.jmb.2013.05.023; OSBORNE RS, 1993, EMBO J, V12, P3391, DOI 10.1002/j.1460-2075.1993.tb06013.x; Ota K, 1998, MOL CELL, V2, P495, DOI 10.1016/S1097-2765(00)80149-5; Park E, 2014, NATURE, V506, P102, DOI 10.1038/nature12720; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Rapoport TA, 2017, ANNU REV CELL DEV BI, V33, P369, DOI 10.1146/annurev-cellbio-100616-060439; Reithinger JH, 2014, J BIOL CHEM, V289, P15845, DOI 10.1074/jbc.M113.533794; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; Trueman SF, 2012, J CELL BIOL, V199, P907, DOI 10.1083/jcb.201207163; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Voorhees RM, 2016, CURR OPIN CELL BIOL, V41, P91, DOI 10.1016/j.ceb.2016.04.009; Voorhees RM, 2016, SCIENCE, V351, P88, DOI 10.1126/science.aad4992; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Yabuki T, 2013, MOL BIOL CELL, V24, P3123, DOI 10.1091/mbc.E13-04-0210; Zhang X, 2014, ANNU REV BIOPHYS, V43, P381, DOI 10.1146/annurev-biophys-051013-022653	42	1	1	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17050	17060		10.1074/jbc.RA118.003219	http://dx.doi.org/10.1074/jbc.RA118.003219			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30213864	Green Published, hybrid			2022-12-28	WOS:000449466500008
J	Herwaldt, EJ; Rivett, ED; White, AJ; Hegg, EL				Herwaldt, Emily J.; Rivett, Elise D.; White, Antoineen J.; Hegg, Eric L.			Cox15 interacts with the cytochrome bc(1) dimer within respiratory supercomplexes as well as in the absence of cytochrome c oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome c oxidase (complex IV); membrane protein; mitochondria; respiratory chain; Saccharomyces cerevisiae; Cox15; cytochrome bc1 (complex III); heme a synthase; mitochondrial respiratory supercomplexes; protein-protein interaction	YEAST MITOCHONDRIA; SACCHAROMYCES-CEREVISIAE; CARRIER PROTEINS; TIM23 MACHINERY; ASSEMBLY FACTOR; ENZYME COMPLEX; INNER MEMBRANE; BARTH-SYNDROME; HUMAN-CELLS; HEME	The heme a molecule is an obligatory cofactor in the terminal enzyme complex of the electron transport chain, cytochrome c oxidase. Heme a is synthesized from heme o by a multi-spanning inner membrane protein, heme a synthase (Cox15 in the yeast Saccharomyces cerevisiae). The insertion of heme a is critical for cytochrome c oxidase function and assembly, but this process has not been fully elucidated. To improve our understanding of heme a insertion into cytochrome c oxidase, here we investigated the protein-protein interactions that involve Cox15 in S. cerevisiae. In addition to observing Cox15 in homooligomeric complexes, we found that a portion of Cox15 also associates with the mitochondrial respiratory supercomplexes. When supercomplex formation was abolished, as in the case of stalled cytochrome bc(1) or cytochrome c oxidase assembly, Cox15 maintained an interaction with select proteins from both respiratory complexes. In the case of stalled cytochrome bc(1) assembly, Cox15 interacted with the late-assembling cytochrome c oxidase subunit, Cox13. When cytochrome c oxidase assembly was stalled, Cox15 unexpectedly maintained its interaction with the cytochrome bc(1) protein, Cor1. Our results indicate that Cox15 and Cor1 continue to interact in the cytochrome bc(1) dimer even in the absence of supercomplexes or when the supercomplexes are destabilized. These findings reveal that Cox15 not only associates with respiratory supercomplexes, but also interacts with the cytochrome bc(1) dimer even in the absence of cytochrome c oxidase.	[Herwaldt, Emily J.; Rivett, Elise D.; White, Antoineen J.; Hegg, Eric L.] Michigan State Univ, Dept Biochem & Mol Biol, 603 Wilson Rd,Rm 510A, E Lansing, MI 48824 USA	Michigan State University	Hegg, EL (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, 603 Wilson Rd,Rm 510A, E Lansing, MI 48824 USA.	erichegg@msu.edu		Hegg, Eric/0000-0003-2055-5495	National Institutes of Health [R01GM101386]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in full by National Institutes of Health Grant R01GM101386. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bareth B, 2013, MOL CELL BIOL, V33, P4128, DOI 10.1128/MCB.00747-13; Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003; Bestwick M, 2010, MOL CELL BIOL, V30, P172, DOI 10.1128/MCB.00869-09; Bianchi C, 2004, J BIOL CHEM, V279, P36562, DOI 10.1074/jbc.M405135200; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Brown KR, 2004, BIOCHEMISTRY-US, V43, P8616, DOI 10.1021/bi049056m; Bundschuh FA, 2009, J BIOL CHEM, V284, P25735, DOI 10.1074/jbc.M109.040295; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896; Conte A, 2015, BBA-MOL CELL RES, V1853, P987, DOI 10.1016/j.bbamcr.2015.02.006; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Cui TZ, 2014, J BIOL CHEM, V289, P6133, DOI 10.1074/jbc.M113.523688; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Dienhart MK, 2008, MOL BIOL CELL, V19, P3934, DOI 10.1091/mbc.E08-04-0402; DOWHAN W, 1985, EMBO J, V4, P179, DOI 10.1002/j.1460-2075.1985.tb02334.x; Fontanesi F, 2008, HUM MOL GENET, V17, P775, DOI 10.1093/hmg/ddm349; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Frazier AE, 2003, MOL CELL BIOL, V23, P7818, DOI 10.1128/MCB.23.21.7818-7828.2003; GENNIS R, 1995, SCIENCE, V269, P1063, DOI 10.1126/science.7652553; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hederstedt L, 2012, BBA-BIOENERGETICS, V1817, P920, DOI 10.1016/j.bbabio.2012.03.025; Hildenbeutel M, 2014, J CELL BIOL, V205, P511, DOI 10.1083/jcb.201401009; Hildenbeutel M, 2012, J MOL BIOL, V423, P590, DOI 10.1016/j.jmb.2012.07.018; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Khalimonchuk O, 2012, J BIOL CHEM, V287, P26715, DOI 10.1074/jbc.M112.377200; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; Kim HJ, 2012, BBA-MOL CELL RES, V1823, P1604, DOI 10.1016/j.bbamcr.2012.04.008; Lange H, 1999, J BIOL CHEM, V274, P18989, DOI 10.1074/jbc.274.27.18989; Lazarou M, 2009, FEBS J, V276, P6701, DOI 10.1111/j.1742-4658.2009.07384.x; Levchenko M, 2016, BBA-MOL CELL RES, V1863, P1624, DOI 10.1016/j.bbamcr.2016.04.007; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marechal A, 2012, BBA-BIOENERGETICS, V1817, P620, DOI 10.1016/j.bbabio.2011.08.011; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Nijtmans LGJ, 2001, FEBS LETT, V498, P46, DOI 10.1016/S0014-5793(01)02447-4; Pierrel F, 2008, MOL CELL BIOL, V28, P4927, DOI 10.1128/MCB.00057-08; Saddar S, 2008, J BIOL CHEM, V283, P6677, DOI 10.1074/jbc.M708440200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Stuart RA, 2009, METHOD ENZYMOL, V456, P191, DOI 10.1016/S0076-6879(08)04411-X; Stuart RA, 2008, J BIOENERG BIOMEMBR, V40, P411, DOI 10.1007/s10863-008-9168-4; Swenson S, 2016, J BIOL CHEM, V291, P10411, DOI 10.1074/jbc.M115.707539; TAANMAN JW, 1993, J BIOL CHEM, V268, P18754; Taylor NG, 2017, J BIOL CHEM, V292, P1815, DOI 10.1074/jbc.M116.766980; Timon-Gomez A, 2018, SEMIN CELL DEV BIOL, V76, P163, DOI 10.1016/j.semcdb.2017.08.055; van der Laan M, 2006, CURR BIOL, V16, P2271, DOI 10.1016/j.cub.2006.10.025; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wang ZH, 2009, J BIOL CHEM, V284, P839, DOI 10.1074/jbc.M804167200; Wiedemann N, 2007, J CELL BIOL, V179, P1115, DOI 10.1083/jcb.200709087; Zara V, 2007, FEBS J, V274, P4526, DOI 10.1111/j.1742-4658.2007.05982.x; Zee JM, 2006, BIOCHEM CELL BIOL, V84, P859, DOI 10.1139/O06-201; Zhuang JY, 2006, BIOCHEMISTRY-US, V45, P12530, DOI 10.1021/bi060565t	59	7	7	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16426	16439		10.1074/jbc.RA118.002496	http://dx.doi.org/10.1074/jbc.RA118.002496			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30181213	Green Published, hybrid			2022-12-28	WOS:000447833600025
J	Nelson, KJ; Bolduc, JA; Wu, HZ; Collins, JA; Burke, EA; Reisz, JA; Klomsiri, C; Wood, ST; Yammani, RR; Poole, LB; Furdui, CM; Loeser, RF				Nelson, Kimberly J.; Bolduc, Jesalyn A.; Wu, Hanzhi; Collins, John A.; Burke, Elizabeth A.; Reisz, Julie A.; Klomsiri, Chananat; Wood, Scott T.; Yammani, Raghunatha R.; Poole, Leslie B.; Furdui, Cristina M.; Loeser, Richard F.			H2O2 oxidation of cysteine residues in c-Jun N-terminal kinase 2 (JNK2) contributes to redox regulation in human articular chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitogen-activated protein kinase (MAPK); redox regulation; redox signaling; chondrocyte; integrin; reactive oxygen species (ROS); hydrogen peroxide; c-Jun N-terminal kinase (JNK); disulfide; cellular redox status	SIGNAL-TRANSDUCTION PATHWAY; ACTIVATED PROTEIN-KINASE; FIBRONECTIN FRAGMENTS; OSTEOARTHRITIC CARTILAGE; CRYSTAL-STRUCTURE; SULFENIC ACIDS; EXPRESSION; BINDING; STRESS; ALPHA-5-BETA-1	Reactive oxygen species (ROS), in particular H2O2, regulate intracellular signaling through reversible oxidation of reactive protein thiols present in a number of kinases and phosphatases. H2O2 has been shown to regulate mitogen-activated protein kinase (MAPK) signaling depending on the cellular context. We report here that in human articular chondrocytes, the MAPK family member c-Jun N-terminal kinase 2 (JNK2) is activated by fibronectin fragments and low physiological levels of H2O2 and inhibited by oxidation due to elevated levels of H2O2. The kinase activity of affinity-purified, phosphorylated JNK2 from cultured chondrocytes was reversibly inhibited by 5-20 m H2O2. Using dimedone-based chemical probes that react specifically with sulfenylated cysteines (RSOH), we identified Cys-222 in JNK2, a residue not conserved in JNK1 or JNK3, as a redox-reactive site. MS analysis of human recombinant JNK2 also detected further oxidation at Cys-222 and other cysteines to sulfinic (RSO2H) or sulfonic (RSO3H) acid. H2O2 treatment of JNK2 resulted in detectable levels of peptides containing intramolecular disulfides between Cys-222 and either Cys-213 or Cys-177, without evidence of dimer formation. Substitution of Cys-222 to alanine rendered JNK2 insensitive to H2O2 inhibition, unlike C177A and C213A variants. Two other JNK2 variants, C116A and C163A, were also resistant to oxidative inhibition. Cumulatively, these findings indicate differential regulation of JNK2 signaling dependent on H2O2 levels and point to key cysteine residues regulating JNK2 activity. As levels of intracellular H2O2 rise, a switch occurs from activation to inhibition of JNK2 activity, linking JNK2 regulation to the redox status of the cell.	[Nelson, Kimberly J.; Klomsiri, Chananat; Poole, Leslie B.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Wu, Hanzhi; Burke, Elizabeth A.; Reisz, Julie A.; Klomsiri, Chananat; Yammani, Raghunatha R.; Furdui, Cristina M.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Bolduc, Jesalyn A.; Collins, John A.; Wood, Scott T.; Loeser, Richard F.] Univ N Carolina, Div Rheumatol Allergy & Immunol, Chapel Hill, NC 27515 USA; [Bolduc, Jesalyn A.; Collins, John A.; Wood, Scott T.; Loeser, Richard F.] Univ N Carolina, Thurston Arthrit Res Ctr, 3300 Thurston Bldg,CB7280, Chapel Hill, NC 27515 USA; [Burke, Elizabeth A.] NIH, Undiagnosed Dis Program, Bldg 10, Bethesda, MD 20892 USA; [Reisz, Julie A.] Univ Colorado, Dept Biochem & Mol Genet, Anschutz Med Campus, Aurora, CO 80045 USA; [Wood, Scott T.] South Dakota Sch Mines & Technol, Dept Nano Sci & Engn, Rapid City, SD 57701 USA	Wake Forest University; Wake Forest University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; University of Colorado System; University of Colorado Anschutz Medical Campus; South Dakota School Mines & Technology	Loeser, RF (corresponding author), Univ N Carolina, Thurston Arthrit Res Ctr, 3300 Thurston Bldg,CB7280, Chapel Hill, NC 27515 USA.	richard_loeser@med.unc.edu	Wood, Scott/I-6133-2019	Wood, Scott/0000-0002-6747-0547; Bolduc, Jesalyn/0000-0002-3950-7453; Wu, Hanzhi/0000-0001-7822-4432; Poole, Leslie/0000-0003-0334-7328; Furdui, Cristina M./0000-0003-3771-7999; Yammani, Raghunatha/0000-0003-2278-8911; Nelson, Kimberly/0000-0003-2464-7696	Wake Forest Baptist Comprehensive Cancer Center Proteomics and Metabolomics Shared Resource - NCI, National Institutes of Health, Cancer Center Support Grant [P30 CA012197]; Mass Spectrometry Facility in the Chemistry Department at Wake Forest University - National Science Foundation; NATIONAL CANCER INSTITUTE [R33CA177461, P30CA012197, R33CA126659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR049003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R33ES025645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG032796, R01AG044034] Funding Source: NIH RePORTER	Wake Forest Baptist Comprehensive Cancer Center Proteomics and Metabolomics Shared Resource - NCI, National Institutes of Health, Cancer Center Support Grant; Mass Spectrometry Facility in the Chemistry Department at Wake Forest University - National Science Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Bruce King for supplying the DCP-Bio1, Harold Erickson for providing the plasmid construct to produce the FN7-10 fibronectin fragment, and Roger Davis for contributing the pcDNA3-FLAG-JNK2 plasmid. We also thank Dr. Susan Chubinskaya, the Gift of Hope Organ and Tissue Donor Network, and the National Disease Research Interchange for providing donor tissue as well as Robert Currin and the University of North Carolina Hooker Imaging core for assistance with confocal microscopy. We acknowledge the support of the Wake Forest Baptist Comprehensive Cancer Center Proteomics and Metabolomics Shared Resource, supported by the NCI, National Institutes of Health, Cancer Center Support Grant P30 CA012197, and the Mass Spectrometry Facility in the Chemistry Department at Wake Forest University, supported in part by the National Science Foundation.	Antunes F, 2017, REDOX BIOL, V13, P1, DOI 10.1016/j.redox.2017.04.039; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; Chen XF, 2017, ACS CHEM BIOL, V12, P2201, DOI 10.1021/acschembio.7b00444; Clancy R, 2001, OSTEOARTHR CARTILAGE, V9, P294, DOI 10.1053/joca.2000.0388; Collins JA, 2016, J BIOL CHEM, V291, P6641, DOI 10.1074/jbc.M115.693523; Cui J, 2005, J BIOL CHEM, V280, P9913, DOI 10.1074/jbc.M412165200; Del Carlo M, 2007, FREE RADICAL BIO MED, V42, P1350, DOI 10.1016/j.freeradbiomed.2007.01.035; Devarie-Baez NO, 2016, FREE RADICAL RES, V50, P172, DOI 10.3109/10715762.2015.1090571; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Forsyth CB, 2002, ARTHRITIS RHEUM, V46, P2368, DOI 10.1002/art.10502; Giannoni E, 2014, ANTIOXID REDOX SIGN, V20, P2011, DOI 10.1089/ars.2013.5525; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Han ZN, 2002, ARTHRITIS RHEUM, V46, P818, DOI 10.1002/art.10104; Haque A, 2011, CELL, V147, P185, DOI 10.1016/j.cell.2011.08.036; Heppner DE, 2016, J BIOL CHEM, V291, P23282, DOI 10.1074/jbc.M116.749028; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Homandberg GA, 1998, OSTEOARTHR CARTILAGE, V6, P231, DOI 10.1053/joca.1998.0116; Homandberg GA, 2002, OSTEOARTHR CARTILAGE, V10, P938, DOI 10.1053/joca.2002.0854; HUHTALA P, 1995, J CELL BIOL, V129, P867, DOI 10.1083/jcb.129.3.867; Ismail HM, 2016, ARTHRITIS RHEUMATOL, V68, P1165, DOI 10.1002/art.39547; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Keyes JD, 2017, FREE RADICAL BIO MED, V112, P534, DOI 10.1016/j.freeradbiomed.2017.08.018; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Kim YJ, 2006, CANCER RES, V66, P7136, DOI 10.1158/0008-5472.CAN-05-4446; Klatt P, 1999, J BIOL CHEM, V274, P15857, DOI 10.1074/jbc.274.22.15857; Klomsiri C, 2011, ANTIOXID REDOX SIGN, V14, P1065, DOI 10.1089/ars.2010.3376; Kuglstatter A, 2010, BIOORG MED CHEM LETT, V20, P5217, DOI 10.1016/j.bmcl.2010.06.157; Labunskyy VM, 2013, ANTIOXID REDOX SIGN, V19, P1362, DOI 10.1089/ars.2012.4891; Liu F, 2015, NAT METHODS, V12, P1179, DOI 10.1038/nmeth.3603; Liu F, 2014, MOL CELL PROTEOMICS, V13, P2776, DOI 10.1074/mcp.O114.039057; Liu RM, 2010, J BIOL CHEM, V285, P16239, DOI 10.1074/jbc.M110.111732; Loeser RF, 2003, ARTHRITIS RHEUM, V48, P2188, DOI 10.1002/art.11209; Loeser RF, 2003, J BIOL CHEM, V278, P24577, DOI 10.1074/jbc.M304530200; Nadeau PJ, 2007, MOL BIOL CELL, V18, P3903, DOI 10.1091/mbc.E07-05-0491; Nadeau PJ, 2009, MOL BIOL CELL, V20, P3628, DOI 10.1091/mbc.E09-03-0211; Nelson KJ, 2010, METHOD ENZYMOL, V473, P95, DOI 10.1016/S0076-6879(10)73004-4; Nelson KJ, 2008, BIOCHEMISTRY-US, V47, P12860, DOI 10.1021/bi801718d; Nitta RT, 2008, J BIOL CHEM, V283, P34935, DOI 10.1074/jbc.M804970200; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Poole LB, 1996, BIOCHEMISTRY-US, V35, P56, DOI 10.1021/bi951887s; Poole LB, 2007, BIOCONJUGATE CHEM, V18, P2004, DOI 10.1021/bc700257a; Pulai JI, 2005, J IMMUNOL, V174, P5781, DOI 10.4049/jimmunol.174.9.5781; Reisz JA, 2013, FEBS J, V280, P6150, DOI 10.1111/febs.12535; Shaw D, 2008, J MOL BIOL, V383, P885, DOI 10.1016/j.jmb.2008.08.086; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Templeton DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015012; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Wani R, 2011, P NATL ACAD SCI USA, V108, P10550, DOI 10.1073/pnas.1011665108; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Wood ST, 2016, ARTHRITIS RHEUMATOL, V68, P117, DOI 10.1002/art.39326; Yoshizumi M, 2000, J BIOL CHEM, V275, P11706, DOI 10.1074/jbc.275.16.11706; Zack MD, 2006, ARTHRITIS RHEUM, V54, P2912, DOI 10.1002/art.22045; Zhang DH, 2012, ORG LETT, V14, P3396, DOI 10.1021/ol301370s; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010	58	17	18	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16376	16389		10.1074/jbc.RA118.004613	http://dx.doi.org/10.1074/jbc.RA118.004613			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30190325	Green Published, hybrid			2022-12-28	WOS:000447833600021
J	Albrett, AM; Ashby, LV; Dickerhof, N; Kettle, AJ; Winterbourn, CC				Albrett, Amelia M.; Ashby, Louisa, V; Dickerhof, Nina; Kettle, Anthony J.; Winterbourn, Christine C.			Heterogeneity of hypochlorous acid production in individual neutrophil phagosomes revealed by a rhodamine-based probe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myeloperoxidase; neutrophil; oxidative stress; phagocytosis; host-pathogen interaction; hypobromous; hypochlorous	HYDROGEN-PEROXIDE; MYELOPEROXIDASE; SUPEROXIDE; BACTERIAL; CHLORINATION; PHAGOCYTOSIS; PROTEINS; CHLORAMINE; INHIBITORS; DYNAMICS	The rhodamine-based probe R19-S has been shown to react with hypochlorous acid (HOCl) to yield fluorescent R19, but not with some other oxidants including hydrogen peroxide. Here, we further examined the specificity of R19-S and used it for real-time monitoring of HOCl production in neutrophil phagosomes. We show that it also reacts rapidly with hypobromous acid, bromamines, and hypoiodous acid, indicating that R19-S responds to these reactive halogen species as well as HOCl. Hypothiocyanous acid and taurine chloramine were unreactive, however, and ammonia chloramine and dichloramine reacted only very slowly. MS analyses revealed additional products from the reaction of HOCl with R19-S, including a chlorinated species as a minor product. Of note, phagocytosis of opsonized zymosan or Staphylococcus aureus by neutrophils was accompanied by an increase in R19 fluorescence. This increase depended on NADPH oxidase and myeloperoxidase activities, and detection of chlorinated R19-S confirmed its specificity for HOCl. Using live-cell imaging to track individual phagosomes in single neutrophils, we observed considerable heterogeneity among the phagosomes in the time from ingestion of a zymosan particle to when fluorescence was first detected, ranging from 1 to >30 min. However, once initiated, the subsequent fluorescence increase was uniform, reaching a similar maximum in approximate to 10 min. Our results confirm the utility of R19-S for detecting HOCl in real-time and provide definitive evidence that isolated neutrophils produce HOCl in phagosomes. The intriguing variability in the onset of HOCl production among phagosomes identified here could influence the way they kill ingested bacteria.	[Albrett, Amelia M.; Ashby, Louisa, V; Dickerhof, Nina; Kettle, Anthony J.; Winterbourn, Christine C.] Univ Otago Christchurch, Ctr Free Rad Res, Dept Pathol & Biomed Sci, Christchurch 8140, New Zealand; [Albrett, Amelia M.] Landcare Res, POB 69040, Lincoln 7640, New Zealand	Landcare Research - New Zealand	Winterbourn, CC (corresponding author), Univ Otago Christchurch, Dept Pathol & Biomed Sci, POB 4345, Christchurch 8140, New Zealand.	christine.winterbourn@otago.ac.nz	Ashby, Louisa/GRN-9388-2022	Ashby, Louisa/0000-0001-8247-096X; Dickerhof, Nina/0000-0003-2269-4595; Kettle, Tony/0000-0002-8218-7766; Winterbourn, Christine/0000-0003-4160-572X	Health Research Council of New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by the Health Research Council of New Zealand. The authors declare that they have no conflicts of interest with the contents of this article.	Allen Lee-Ann H., 2007, V412, P273, DOI 10.1007/978-1-59745-467-4_18; Chapman ALP, 2002, J BIOL CHEM, V277, P9757, DOI 10.1074/jbc.M106134200; Chen XQ, 2016, NAT PROTOC, V11, P1219, DOI 10.1038/nprot.2016.062; Chen X, 2011, CHEM COMMUN, V47, P4373, DOI 10.1039/c1cc10589b; Coker MSA, 2008, CHEM RES TOXICOL, V21, P2334, DOI 10.1021/tx800232v; Foote JR, 2017, JOVE-J VIS EXP, DOI 10.3791/55107; Forbes LV, 2018, ANAL BIOCHEM, V544, P13, DOI 10.1016/j.ab.2017.12.022; Forbes LV, 2013, J BIOL CHEM, V288, P36636, DOI 10.1074/jbc.M113.507756; Green JN, 2017, FREE RADICAL BIO MED, V113, P363, DOI 10.1016/j.freeradbiomed.2017.10.343; Green JN, 2014, FREE RADICAL BIO MED, V77, P49, DOI 10.1016/j.freeradbiomed.2014.08.013; Heikkila R.E., 1985, HDB METHODS OXYGEN R, P387; Hurst JK, 2012, FREE RADICAL BIO MED, V53, P508, DOI 10.1016/j.freeradbiomed.2012.05.008; Jiang Q, 1997, J BIOL CHEM, V272, P32767, DOI 10.1074/jbc.272.52.32767; Jiang Q, 1997, CHEM RES TOXICOL, V10, P1080, DOI 10.1021/tx9700984; KETTLE AJ, 1994, J BIOL CHEM, V269, P17146; KETTLE AJ, 1988, BIOCHEM J, V252, P529, DOI 10.1042/bj2520529; Kettle AJ, 2011, FREE RADICAL BIO MED, V51, P2190, DOI 10.1016/j.freeradbiomed.2011.09.019; Klebanoff SJ, 2013, J LEUKOCYTE BIOL, V93, P185, DOI 10.1189/jlb.0712349; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Koide Y, 2011, J AM CHEM SOC, V133, P5680, DOI 10.1021/ja111470n; Li XJ, 2009, MOL BIOL CELL, V20, P1520, DOI 10.1091/mbc.E08-06-0620; Nagy P, 2009, CHEM RES TOXICOL, V22, P1833, DOI 10.1021/tx900249d; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Rosen H, 2002, J BIOL CHEM, V277, P30463, DOI 10.1074/jbc.M202331200; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; Schwartz J, 2009, J IMMUNOL, V183, P2632, DOI 10.4049/jimmunol.0804110; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; SEGAL AW, 1980, J CELL BIOL, V85, P42, DOI 10.1083/jcb.85.1.42; Soubhye J, 2017, J MED CHEM, V60, P6563, DOI 10.1021/acs.jmedchem.7b00285; Thomas E L, 1986, Methods Enzymol, V132, P585; Tiden AK, 2011, J BIOL CHEM, V286, P37578, DOI 10.1074/jbc.M111.266981; Tlili A, 2011, FREE RADICAL BIO MED, V50, P438, DOI 10.1016/j.freeradbiomed.2010.11.024; Winterbourn CC, 2016, ANNU REV BIOCHEM, V85, P765, DOI 10.1146/annurev-biochem-060815-014442; Winterbourn CC, 2013, ANTIOXID REDOX SIGN, V18, P642, DOI 10.1089/ars.2012.4827; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Yan Y, 2010, ANAL CHEM, V82, P9775, DOI 10.1021/ac101929q; Zhang Z, 2011, TALANTA, V85, P779, DOI 10.1016/j.talanta.2011.04.078; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zheng W, 2015, J PHARMACOL EXP THER, V353, P288, DOI 10.1124/jpet.114.221788	40	26	27	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15715	15724		10.1074/jbc.RA118.004789	http://dx.doi.org/10.1074/jbc.RA118.004789			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30135208	Green Published, hybrid			2022-12-28	WOS:000446549200033
J	Zhang, YJ; Tan, LR; Yang, QY; Li, CY; Liou, YE				Zhang, Yajun; Tan, Lora; Yang, Qiaoyun; Li, Chenyu; Liou, Yih-Cherng			The microtubule-associated protein HURP recruits the centrosomal protein TACC3 to regulate K-fiber formation and support chromosome congression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitotic spindle; microtubule-associated protein (MAP); chromosomes; kinetochore; cell division; chromosome congression; HURP; kinetochore fiber; mitotic spindle; TACC3	ENSURE SPINDLE STABILITY; GTP-BOUND RAN; AURORA-A; KINETOCHORE MICROTUBULES; MITOTIC SPINDLES; IMPORTIN-BETA; SOMATIC-CELLS; CLATHRIN; MITOSIS; PHOSPHORYLATION	Kinetochore fibers (K-fibers) are microtubule bundles attached to chromosomes. Efficient K-fiber formation is required for chromosome congression, crucial for faithful chromosome segregation in cells. However, the mechanisms underlying K-fiber formation before chromosome biorientation remain unclear. Depletion of hepatoma up-regulated protein (HURP), a RanGTP-dependent microtubule-associated protein localized on K-fibers, has been shown to result in low-efficiency K-fiber formation. Therefore, here we sought to identify critical interaction partners of HURP that may modulate this function. Using co-immunoprecipitation and bimolecular fluorescence complementation assays, we determined that HURP interacts directly with the centrosomal protein transforming acidic coiled coil-containing protein 3 (TACC3), a centrosomal protein, both in vivo and in vitro through the HURP1-625 region. We found that HURP is important for TACC3 function during kinetochore microtubule assembly at the chromosome region in prometaphase. Moreover, HURP regulates stable lateral kinetochore attachment and chromosome congression in early mitosis by modulation of TACC3. These findings provide new insight into the coordinated regulation of K-fiber formation and chromosome congression in prometaphase by microtubule-associated proteins.	[Zhang, Yajun; Tan, Lora; Yang, Qiaoyun; Li, Chenyu; Liou, Yih-Cherng] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore; [Liou, Yih-Cherng] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117573, Singapore	National University of Singapore; National University of Singapore	Liou, YE (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.; Liou, YE (corresponding author), Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117573, Singapore.	dbslyc@nus.edu.sg		Liou, Yih-Cherng/0000-0003-0149-6856	NMRC of the Ministry of Education, Singapore [MOE-T2-1-113, R-154-000-A15-114]	NMRC of the Ministry of Education, Singapore	This work is supported in part by grants from NMRC, Tier2 (MOE-T2-1-113) and Tier 1 (R-154-000-A15-114) of the Ministry of Education, Singapore (to Y.-C. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Albee AJ, 2006, J BIOL CHEM, V281, P38293, DOI 10.1074/jbc.M607203200; Booth DG, 2011, EMBO J, V30, P906, DOI 10.1038/emboj.2011.15; Burgess SG, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005345; Cai S, 2009, NAT CELL BIOL, V11, P832, DOI 10.1038/ncb1890; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Cheeseman LP, 2013, J CELL SCI, V126, P2102, DOI 10.1242/jcs.124834; Cheeseman Liam P, 2011, Commun Integr Biol, V4, P409, DOI 10.4161/cib.4.4.15250; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Foraker AB, 2012, J CELL BIOL, V198, P591, DOI 10.1083/jcb.201205116; Fu WX, 2013, P NATL ACAD SCI USA, V110, P15295, DOI 10.1073/pnas.1312382110; Fu WX, 2011, CELL RES, V21, P1655, DOI 10.1038/cr.2011.106; Fu WX, 2010, J CELL SCI, V123, P3645, DOI 10.1242/jcs.075911; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Gergely F, 2000, P NATL ACAD SCI USA, V97, P14352, DOI 10.1073/pnas.97.26.14352; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Hancock WO, 2014, NAT REV MOL CELL BIO, V15, P615, DOI 10.1038/nrm3853; Hood FE, 2013, J CELL BIOL, V202, P463, DOI 10.1083/jcb.201211127; Hood Fiona E, 2011, Bioarchitecture, V1, P105; Iemura K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7447; Kalinina I, 2013, NAT CELL BIOL, V15, P82, DOI 10.1038/ncb2640; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Li CY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10597; Li CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18773; Lin CH, 2010, J CELL BIOL, V189, P1097, DOI 10.1083/jcb.200911120; Lioutas A, 2013, EMBO REP, V14, P829, DOI 10.1038/embor.2013.109; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; MCDONALD KL, 1992, J CELL BIOL, V118, P369, DOI 10.1083/jcb.118.2.369; McEwen BF, 1997, J CELL BIOL, V137, P1567, DOI 10.1083/jcb.137.7.1567; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rieder CL, 2005, CHROMOSOMA, V114, P310, DOI 10.1007/s00412-005-0028-2; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Royle SJ, 2012, J CELL SCI, V125, P19, DOI 10.1242/jcs.094607; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Santarella RA, 2007, J MOL BIOL, V365, P1587, DOI 10.1016/j.jmb.2006.10.064; Shyu YJ, 2008, NAT PROTOC, V3, P588, DOI 10.1038/nprot.2008.16; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Singh P, 2014, J BIOL CHEM, V289, P31719, DOI 10.1074/jbc.M114.575100; Song L, 2014, MOL CELL, V53, P179, DOI 10.1016/j.molcel.2013.12.022; Tan SJ, 2008, J CELL BIOL, V182, P27, DOI 10.1083/jcb.200712080; Tanaka K, 2013, CELL MOL LIFE SCI, V70, P559, DOI 10.1007/s00018-012-1057-7; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Tarantino N, 2014, J CELL BIOL, V204, P231, DOI 10.1083/jcb.201307172; Thakur HC, 2014, J BIOL CHEM, V289, P74, DOI 10.1074/jbc.M113.532333; Torosantucci L, 2008, MOL BIOL CELL, V19, P1873, DOI 10.1091/mbc.E07-10-1050; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; Ulisse S, 2007, ENDOCR-RELAT CANCER, V14, P827, DOI 10.1677/ERC-07-0053; Wong J, 2008, MOL BIOL CELL, V19, P2083, DOI 10.1091/mbc.E07-10-1088; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Wu JM, 2013, P NATL ACAD SCI USA, V110, pE1779, DOI 10.1073/pnas.1220523110; Ye F, 2011, CURR BIOL, V21, P1584, DOI 10.1016/j.cub.2011.08.024; Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	63	3	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15733	15747		10.1074/jbc.RA118.003676	http://dx.doi.org/10.1074/jbc.RA118.003676			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30054275	Green Published, hybrid			2022-12-28	WOS:000446549200035
J	Jorge, AM; Schneider, J; Unsleber, S; Xia, GQ; Mayer, C; Peschel, A				Jorge, Ana Maria; Schneider, Jonathan; Unsleber, Sandra; Xia, Guoqing; Mayer, Christoph; Peschel, Andreas			Staphylococcus aureus counters phosphate limitation by scavenging wall teichoic acids from other staphylococci via the teichoicase GlpQ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphodiesterases; teichoic acid; Staphylococcus aureus (S-aureus); glycerophospholipid; glycerol; GlpQ; glycerophosphodiesterase; pathogen; ribitol-5-phosphate; teichoicase	REGULATORY NETWORK; GLYCEROPHOSPHODIESTERASE; BACTERIA; GLYCOSYLATION; INSIGHTS; REGULON; ROLES	Staphylococcus aureus is part of the human nasal and skin microbiomes along with other bacterial commensals and opportunistic pathogens. Nutrients are scarce in these habitats, demanding effective nutrient acquisition and competition strategies. How S. aureus copes with phosphate limitation is still unknown. Wall teichoic acid (WTA), a polyol-phosphate polymer, could serve as a phosphate source, but whether S. aureus can utilize it during phosphate starvation remains unknown. S. aureus secretes a glycerophosphodiesterase, GlpQ, that cleaves a broad variety of glycerol-3-phosphate (GroP) headgroups of deacylated phospholipids, providing this bacterium with GroP as a carbon and phosphate source. Here we demonstrate that GlpQ can also use glycerophosphoglycerol derived from GroP WTA from coagulase-negative Staphylococcus lugdunensis, Staphylococcus capitis, and Staphylococcus epidermidis, which share the nasal and skin habitats with S. aureus. Therefore, S. aureus GlpQ is the first reported WTA-hydrolyzing enzyme, or teichoicase, from Staphylococcus. Activity assays revealed that unmodified WTA is the preferred GlpQ substrate, and the results from MS analysis suggested that GlpQ uses an exolytic cleavage mechanism. Importantly, GlpQ did not hydrolyze the ribitol-5-phosphate WTA polymers of S. aureus, underscoring its role in interspecies competition rather than in S. aureus cell wall homeostasis or WTA recycling. glpQ expression was strongly up-regulated under phosphate limitation, and GlpQ allowed S. aureus to grow in the presence of GroP WTA as the sole phosphate source. Our study reveals a novel and unprecedented strategy of S. aureus for acquiring phosphate from bacterial competitors under the phosphate-limiting conditions in the nasal or skin environments.	[Jorge, Ana Maria; Schneider, Jonathan; Xia, Guoqing; Peschel, Andreas] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Infect Biol Dept, D-72076 Tubingen, Germany; [Jorge, Ana Maria; Schneider, Jonathan; Xia, Guoqing; Peschel, Andreas] Univ Tubingen, German Ctr Infect Res, Partner Site Tubingen, D-72076 Tubingen, Germany; [Unsleber, Sandra; Mayer, Christoph] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Microbiol Biotechnol Dept, D-72076 Tubingen, Germany; [Xia, Guoqing] Univ Manchester, Manchester Acad, Fac Biol Med & Hlth, Hlth Sci Ctr,Div Infection,Immun & Resp Med, Manchester M13 9PL, Lancs, England	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; German Center for Infection Research; Eberhard Karls University of Tubingen; University of Manchester	Jorge, AM (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Infect Biol Dept, D-72076 Tubingen, Germany.; Jorge, AM (corresponding author), Univ Tubingen, German Ctr Infect Res, Partner Site Tubingen, D-72076 Tubingen, Germany.	ana.jorge@mikrobio.uni-tuebingen.de	Mayer, Christoph/S-8666-2017; Xia, Guoqing/C-2365-2015	Mayer, Christoph/0000-0003-4731-4851; Peschel, Andreas/0000-0002-3209-8626; Xia, Guoqing/0000-0003-4492-9156	Medical Faculty of the University of Tubingen [F1433261]; German Research Council [TRR34, TRR156, SFB766, GRK1708]; German Center for Infection Research	Medical Faculty of the University of Tubingen; German Research Council(German Research Foundation (DFG)); German Center for Infection Research	This work was financed by grants from the Medical Faculty of the University of Tubingen (F1433261 to A. M. J.) and from the German Research Council (TRR34 and TRR156 to A. P. and SFB766 and GRK1708 to C. M. and A. P.) and from the German Center for Infection Research (to A. J. and A. P.). The authors declare that they have no conflicts of interest with the contents of this article. The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.	Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Brown S, 2012, P NATL ACAD SCI USA, V109, P18909, DOI 10.1073/pnas.1209126109; Burke W., 2014, HEALTH-LONDON, V6, P720, DOI DOI 10.4236/HEALTH.2014.68093; Byrd AL, 2018, NAT REV MICROBIOL, V16, P143, DOI 10.1038/nrmicro.2017.157; Corda D, 2014, FEBS J, V281, P998, DOI 10.1111/febs.12699; Cornelissen A, 2016, J BIOL CHEM, V291, P16816, DOI 10.1074/jbc.M116.728279; ENDL J, 1984, ARCH MICROBIOL, V137, P272, DOI 10.1007/BF00414557; ENDL J, 1983, ARCH MICROBIOL, V135, P215, DOI 10.1007/BF00414483; GRANT WD, 1979, J BACTERIOL, V137, P35, DOI 10.1128/JB.137.1.35-43.1979; Jenni R, 1998, ARCH MICROBIOL, V170, P171, DOI 10.1007/s002030050630; Jorge AM, 2017, MOL MICROBIOL, V103, P229, DOI 10.1111/mmi.13552; Kelliher JL, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00631-17; Kolata J, 2011, PROTEOMICS, V11, P3914, DOI 10.1002/pmic.201000760; Krismer B, 2017, NAT REV MICROBIOL, V15, P675, DOI 10.1038/nrmicro.2017.104; Krismer B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003862; KUSSER W, 1984, FEBS LETT, V166, P301, DOI 10.1016/0014-5793(84)80100-3; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; LORIN MI, 1972, J LAB CLIN MED, V80, P275; Myers CL, 2016, J BIOL CHEM, V291, P26066, DOI 10.1074/jbc.M116.760447; Myers CL, 2015, J BIOL CHEM, V290, P19133, DOI 10.1074/jbc.M115.662866; Park YD, 2014, ARCH ORAL BIOL, V59, P1, DOI 10.1016/j.archoralbio.2013.10.006; Peschel A, 1996, FEMS MICROBIOL LETT, V137, P279; PORTALE AA, 1987, J CLIN INVEST, V80, P1147, DOI 10.1172/JCI113172; PROMPT CA, 1978, NEPHRON, V20, P4, DOI 10.1159/000181189; Sadovskaya I, 2004, CARBOHYD RES, V339, P1467, DOI 10.1016/j.carres.2004.03.017; Santos-Beneit F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00402; Schade J, 2016, FEBS LETT, V590, P3758, DOI 10.1002/1873-3468.12288; Stentzel S, 2015, J PROTEOMICS, V128, P1, DOI 10.1016/j.jprot.2015.06.018; Watson SP, 1998, J BACTERIOL, V180, P1750, DOI 10.1128/JB.180.7.1750-1758.1998; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Winstel V, 2015, MBIO, V6, DOI 10.1128/mBio.00632-15; Winstel V, 2014, MBIO, V5, DOI 10.1128/mBio.00869-14; Winstel V, 2014, INT J MED MICROBIOL, V304, P215, DOI 10.1016/j.ijmm.2013.10.009; Winstel V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3345; WISE EM, 1972, P NATL ACAD SCI USA, V69, P233, DOI 10.1073/pnas.69.1.233; Xia GQ, 2010, J BIOL CHEM, V285, P13405, DOI 10.1074/jbc.M109.096172; Xiang Y, 2009, MOL CELL, V34, P375, DOI 10.1016/j.molcel.2009.04.009; Zipperer A, 2016, NATURE, V535, P511, DOI 10.1038/nature18634	38	17	17	9	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14916	14924		10.1074/jbc.RA118.004584	http://dx.doi.org/10.1074/jbc.RA118.004584			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30068554	Green Published, hybrid			2022-12-28	WOS:000446155000026
J	Min, XS; Weiszmann, J; Johnstone, S; Wang, W; Yu, XC; Romanow, W; Thibault, S; Li, Y; Wang, ZL				Min, Xiaoshan; Weiszmann, Jennifer; Johnstone, Sheree; Wang, Wei; Yu, Xinchao; Romanow, William; Thibault, Stephen; Li, Yang; Wang, Zhulun			Agonistic beta-Klotho antibody mimics fibroblast growth factor 21 (FGF21) functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystallography; antibody; fibroblast growth factor (FGF); metabolism; electron microscopy (EM); -Klotho; agonist; antibody; binding	PROTEIN; MOUSE; RECEPTOR; BIOLOGY; ANALOG; FGF19	Fibroblast growth factor 21 (FGF21), an endocrine hormone in the FGF family, plays a critical role in regulating metabolic homeostasis and has emerged as a therapeutic target for metabolic diseases, including Type 2 diabetes mellitus. FGF21 functions through a receptor complex that consists of an FGF receptor (FGFR) and a co-receptor beta-Klotho. Here, we identify and biochemically and structurally characterize 39F7, a high-affinity agonistic monoclonal antibody (mAb) against beta-Klotho that mimics FGF21 function. The co-crystal structure of beta-Klotho KL1 domain in complex with 39F7 Fab revealed that the recognition of 39F7 is centered on Trp-295 of beta-Klotho in a FGF21 noncompetitive manner. KL1 adopts a (beta/alpha)(8) TIM barrel fold which resembles that of beta-glycosylceramidase, but lacks molecular features for enzymatic activity, suggesting that KL1 functions as a scaffold protein instead. In vitro characterization demonstrated that, although 39F7 does not compete with FGF21, it is specific for beta-Klotho/FGFR1c activation. Furthermore, the agonistic activity of 39F7 required the full IgG molecule to be bivalent, suggesting that 39F7 functions by promoting receptor/co-receptor dimerization. Supported by negative stain EM analysis of full-length beta-Klotho, we propose a molecular model wherein the agonistic antibody 39F7 acts in a beta-Klotho- and FGFR1c-dependent manner, mimicking FGF21 activity. More importantly, 39F7 offers promising therapeutic potential in the axis of FGF21 signaling as an antibody therapy alternative to FGF21 analogs for treatment of metabolic diseases.	[Min, Xiaoshan; Johnstone, Sheree; Wang, Wei; Yu, Xinchao; Romanow, William; Thibault, Stephen; Wang, Zhulun] Amgen Inc, Amgen Discovery Res, Dept Therapeut Discovery, San Francisco, CA 94080 USA; [Weiszmann, Jennifer; Li, Yang] Amgen Inc, Amgen Discovery Res, Dept Cardiometab Disorders, San Francisco, CA 94080 USA	Amgen; Amgen	Min, XS; Wang, ZL (corresponding author), 1120 Vet Blvd, San Francisco, CA 94080 USA.; Li, Y (corresponding author), Surrozen Inc, 171 Oyster Point Blvd,Ste 400, San Francisco, CA 94080 USA.	xmin@amgen.com; yangln3101@gmail.com; zwang@amgen.com			National Institutes of Health, National Institute of General Medical Sciences; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]	National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE))	We thank Amgen Therapeutic Discovery group for the contribution of reagents. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Belov AA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015958; Blake RC, 1999, ANAL BIOCHEM, V272, P123, DOI 10.1006/abio.1999.4176; BonDurant LD, 2018, ANNU REV NUTR, V38, P173, DOI 10.1146/annurev-nutr-071816-064800; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen GZ, 2018, NATURE, V553, P461, DOI 10.1038/nature25451; Crunkhorn S, 2013, NAT REV DRUG DISCOV, V12, P825, DOI 10.1038/nrd4157; Degirolamo C, 2016, NAT REV DRUG DISCOV, V15, P51, DOI 10.1038/nrd.2015.9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Foltz IN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004690; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Glass TR, 2014, ANAL BIOCHEM, V456, P38, DOI 10.1016/j.ab.2014.04.011; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Goetz R, 2012, J BIOL CHEM, V287, P29134, DOI 10.1074/jbc.M112.342980; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Kuro-o M, 2012, ADV EXP MED BIOL, V728, P25, DOI 10.1007/978-1-4614-0887-1_2; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Lee S, 2018, NATURE, V553, P501, DOI 10.1038/nature25010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Smith R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061432; So WY, 2016, MED RES REV, V36, P672, DOI 10.1002/med.21390; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Talukdar S, 2016, CELL METAB, V23, P427, DOI 10.1016/j.cmet.2016.02.001; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tohyama O, 2004, J BIOL CHEM, V279, P9777, DOI 10.1074/jbc.M312392200; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wu XL, 2012, ADV EXP MED BIOL, V728, P195, DOI 10.1007/978-1-4614-0887-1_13; Zhang J, 2016, SEMIN CELL DEV BIOL, V53, P144, DOI 10.1016/j.semcdb.2015.09.007	37	16	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14678	14688		10.1074/jbc.RA118.004343	http://dx.doi.org/10.1074/jbc.RA118.004343			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30068552	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000446155000009
J	Royer, L; Herzog, JJ; Kenny, K; Tzvetkova, B; Cochrane, JC; Marr, MT; Paradis, S				Royer, Leandro; Herzog, Josiah J.; Kenny, Katelyn; Tzvetkova, Boriana; Cochrane, Jesse C.; Marr, Michael T.; Paradis, Suzanne			The Ras-like GTPase Rem2 is a potent inhibitor of calcium/calmodulin-dependent kinase II activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; Ca2+; calmodulin-dependent protein kinase II (CaMKII); GTPase; inhibitor; phosphorylation; autophosphorylation; Rem2; RGK family	LONG-TERM POTENTIATION; CALCIUM-CHANNELS; RGK PROTEINS; REGULATORY PHOSPHORYLATION; POSTSYNAPTIC DENSITY; DENDRITIC COMPLEXITY; IN-VIVO; CAMKII; BINDING; BETA	Ca2+/calmodulin-dependent protein kinase II (CaMKII) is a well-characterized, abundant protein kinase that regulates a diverse set of functions in a tissue-specific manner. For example, in heart muscle, CaMKII regulates Ca2+ homeostasis, whereas in neurons, CaMKII regulates activity-dependent dendritic remodeling and long-term potentiation (LTP), a neurobiological correlate of learning and memory. Previously, we identified the GTPase Rem2 as a critical regulator of dendrite branching and homeostatic plasticity in the vertebrate nervous system. Here, we report that Rem2 directly interacts with CaMKII and potently inhibits the activity of the intact holoenzyme, a previously unknown Rem2 function. Our results suggest that Rem2 inhibition involves interaction with both the CaMKII hub domain and substrate recognition domain. Moreover, we found that Rem2-mediated inhibition of CaMKII regulates dendritic branching in cultured hippocampal neurons. Lastly, we report that substitution of two key amino acid residues in the Rem2 N terminus (Arg-79 and Arg-80) completely abolishes its ability to inhibit CaMKII. We propose that our biochemical findings will enable further studies unraveling the functional significance of Rem2 inhibition of CaMKII in cells.	[Royer, Leandro; Herzog, Josiah J.; Kenny, Katelyn; Tzvetkova, Boriana; Marr, Michael T.; Paradis, Suzanne] Brandeis Univ, Dept Biol, 415 South St, Waltham, MA 02454 USA; [Marr, Michael T.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, 415 South St, Waltham, MA 02454 USA; [Paradis, Suzanne] Brandeis Univ, Volen Ctr Complex Syst, 415 South St, Waltham, MA 02454 USA; [Paradis, Suzanne] Brandeis Univ, Natl Ctr Behav Genom, 415 South St, Waltham, MA 02454 USA; [Cochrane, Jesse C.] Massachusetts Gen Hosp, Dept Mol Biol & Genet, Boston, MA 02114 USA; [Cochrane, Jesse C.] Harvard Med Sch, Boston, MA 02114 USA	Brandeis University; Brandeis University; Brandeis University; Brandeis University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Marr, MT; Paradis, S (corresponding author), Brandeis Univ, Dept Biol, 415 South St, Waltham, MA 02454 USA.; Marr, MT (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, 415 South St, Waltham, MA 02454 USA.; Paradis, S (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, 415 South St, Waltham, MA 02454 USA.; Paradis, S (corresponding author), Brandeis Univ, Natl Ctr Behav Genom, 415 South St, Waltham, MA 02454 USA.	mmarr@brandeis.edu; paradis@brandeis.edu	Cochrane, Jesse/P-4036-2019		National Institutes of Health [R01 NS065856, R21NS102661, R01GM117034]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS102661, R01NS065856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01 NS065856 (to S. P.), R21NS102661 (to M. T. M. and S. P.), and R01GM117034 (to M. T. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abiria SA, 2010, J NEUROCHEM, V112, P150, DOI 10.1111/j.1471-4159.2009.06436.x; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Beguin P, 2005, BIOCHEM J, V390, P67, DOI 10.1042/BJ20050414; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Bers DM, 2009, J CARDIOVASC PHARM, V54, P180, DOI 10.1097/FJC.0b013e3181a25078; Bostrom SL, 2009, BIOCHEM BIOPH RES CO, V390, P1154, DOI 10.1016/j.bbrc.2009.10.107; Buraei Z, 2015, CURR MOL PHARMACOL, V8, P180, DOI 10.2174/1874467208666150507105613; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0; Chao LH, 2011, CELL, V146, P732, DOI 10.1016/j.cell.2011.07.038; Chao LH, 2010, NAT STRUCT MOL BIOL, V17, P264, DOI 10.1038/nsmb.1751; Correll RN, 2008, CELL SIGNAL, V20, P400, DOI 10.1016/j.cellsig.2007.10.029; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Finlin BS, 2000, BIOCHEM J, V347, P223, DOI 10.1042/0264-6021:3470223; Flynn R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041185; Flynn R, 2010, CHANNELS, V4, P434, DOI 10.4161/chan.4.6.12865; Ghiretti AE, 2014, TRENDS NEUROSCI, V37, P399, DOI 10.1016/j.tins.2014.05.003; Ghiretti AE, 2014, J NEUROSCI, V34, P392, DOI 10.1523/JNEUROSCI.1328-13.2014; Ghiretti AE, 2013, J NEUROSCI, V33, P6504, DOI 10.1523/JNEUROSCI.3861-12.2013; Ghiretti AE, 2011, DEV NEUROBIOL, V71, P374, DOI 10.1002/dneu.20868; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; HASHIMOTO Y, 1987, J BIOL CHEM, V262, P8051; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Jenkins MA, 2010, J NEUROSCI, V30, P5125, DOI 10.1523/JNEUROSCI.4367-09.2010; Jiang X, 2008, P NATL ACAD SCI USA, V105, P341, DOI 10.1073/pnas.0710213105; Jiao YX, 2011, J BIOL CHEM, V286, P24806, DOI 10.1074/jbc.M110.216010; Kenny K, 2017, MOL CELL NEUROSCI, V85, P190, DOI 10.1016/j.mcn.2017.10.004; Kiianitsa K, 2003, ANAL BIOCHEM, V321, P266, DOI 10.1016/S0003-2697(03)00461-5; Kowarz E, 2015, BIOTECHNOL J, V10, P647, DOI 10.1002/biot.201400821; Lin YC, 2008, P NATL ACAD SCI USA, V105, P15791, DOI 10.1073/pnas.0804399105; Lisman J, 2015, BRAIN RES, V1621, P51, DOI 10.1016/j.brainres.2014.12.010; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Magupalli VG, 2013, J BIOL CHEM, V288, P4637, DOI 10.1074/jbc.M112.369058; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Moore AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078822; Moore AR, 2018, ELIFE, V7, DOI 10.7554/eLife.33092; Mullasseril P, 2007, J NEUROCHEM, V103, P357, DOI 10.1111/j.1471-4159.2007.04744.x; OCHIISHI T, 1994, BRAIN RES, V659, P179, DOI 10.1016/0006-8993(94)90877-X; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Redmond L, 2005, CELL CALCIUM, V37, P411, DOI 10.1016/j.ceca.2005.01.009; Reymond P, 2012, ACTA CRYSTALLOGR F, V68, P626, DOI 10.1107/S1744309112013541; Sasson Y, 2011, J MOL BIOL, V413, P372, DOI 10.1016/j.jmb.2011.08.017; Song B, 2010, J BIOL CHEM, V285, P41122, DOI 10.1074/jbc.M110.130351; Strack S, 2000, J BIOL CHEM, V275, P25061, DOI 10.1074/jbc.C000319200; Stratton M, 2014, ELIFE, V3, DOI 10.7554/eLife.01610; Stratton MM, 2013, CURR OPIN STRUC BIOL, V23, P292, DOI 10.1016/j.sbi.2013.04.002; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Yang TT, 2013, BBA-BIOMEMBRANES, V1828, P1644, DOI 10.1016/j.bbamem.2012.10.005; Zhabotinsky AM, 2000, BIOPHYS J, V79, P2211, DOI 10.1016/S0006-3495(00)76469-1	54	8	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14798	14811		10.1074/jbc.RA118.003560	http://dx.doi.org/10.1074/jbc.RA118.003560			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30072381	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000446155000017
J	Liu, SX; Zhang, FF; Wang, Y; Wang, H; Chen, XJ; Hu, Y; Chen, M; Lan, SJ; Wang, CH; Cao, JX; Hu, X; Tan, F				Liu, Shuxian; Zhang, Fangfei; Wang, Yan; Wang, Han; Chen, Xiaojian; Hu, Yue; Chen, Ming; Lan, Shujue; Wang, Chenhong; Cao, Jiaxin; Hu, Xin; Tan, Feng			Characterization of the molecular mechanism of the autophagy-related Atg8-Atg3 protein interaction in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Toxoplasma gondii; autophagy; protein complex; protein domain; protein-protein interaction; AlphaScreen; Atg3; Atg8; Atg8 family-interacting motif; peptide assay	CRYSTAL-STRUCTURE; ATG8; IDENTIFICATION; RECOGNITION; CYTOPLASM; SYSTEM; ENZYME	Toxoplasmosis is caused by an obligate intracellular parasite, the protozoan Toxoplasma gondii. Discovery of novel drugs against T. gondii infection could circumvent the toxicity of existing drugs and T. gondii resistance to current treatments. The autophagy-related protein 8 (Atg8)-Atg3 interaction in T. gondii is a promising drug target because of its importance for regulating Atg8 lipidation. We reported previously that TgAtg8 and TgAtg3 interact directly. Here we validated that substitutions of conserved residues of TgAtg8 interacting with the Atg8 family-interacting motif (AIM) in Atg3 disrupt the TgAtg8-TgAtg3 interaction and reduce TgAtg8 lipidation and autophagosome formation. These findings were consistent with results reported previously for Plasmodium Atg8, suggesting functional conservation of Atg8 in Toxoplasma and Plasmodium. Moreover, using peptide and AlphaScreen assays, we identified the AIM sequence in TgAtg3 that binds TgAtg8. We determined that the core TgAtg3 AIM contains a Phe(239)-Ala(240)-Asp(241)-Ile(242) ((239)FADI(242)) signature distinct from the (WLLP108)-W-105 signature in the AIM of Plasmodium Atg3. Furthermore, an alanine-scanning assay revealed that the TgAtg8-TgAtg3 interaction in T. gondii also depends strongly on several residues surrounding the core TgAtg3 AIM, such as Asn(238), Asp(243), and Cys(244). These results indicate that distinct AIMs in Atg3 contribute to differences between Toxoplasma and Plasmodium Atg8-Atg3 interactions. By elucidating critical residues involved in the TgAtg8-TgAtg3 interaction, our work paves the way for the discovery of potential anti-toxoplasmosis drugs. The quantitative and straightforward AlphaScreen assay developed here may enable high-throughput screening for small molecules disrupting the TgAtg8-TgAtg3 interaction.	[Liu, Shuxian; Wang, Yan; Wang, Han; Hu, Yue; Tan, Feng] Wenzhou Med Univ, Sch Basic Med Sci, Dept Parasitol, Wenzhou 325035, Zhejiang, Peoples R China; [Zhang, Fangfei] Wenzhou Med Univ, Renji Coll, Wenzhou 325035, Zhejiang, Peoples R China; [Chen, Xiaojian] Wenzhou Med Univ, Affiliated Hosp 2, Dept Clin Lab, Wenzhou 325027, Zhejiang, Peoples R China; [Chen, Xiaojian] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325027, Zhejiang, Peoples R China; [Chen, Ming; Lan, Shujue] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Chem Biol Core Facil, Shanghai 200031, Peoples R China; [Wang, Chenhong] Wenzhou Med Univ, Sch Clin Med Sci 2, Wenzhou 325035, Zhejiang, Peoples R China; [Cao, Jiaxin] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou 325035, Zhejiang, Peoples R China; [Hu, Xin] Wenzhou Med Univ, Sch Med Lab Sci, Wenzhou 325035, Zhejiang, Peoples R China; [Hu, Xin] Wenzhou Med Univ, Sch Life Sci, Wenzhou 325035, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Tan, F (corresponding author), Wenzhou Med Univ, Sch Basic Med Sci, Dept Parasitol, Wenzhou 325035, Zhejiang, Peoples R China.; Hu, X (corresponding author), Wenzhou Med Univ, Sch Med Lab Sci, Wenzhou 325035, Zhejiang, Peoples R China.; Hu, X (corresponding author), Wenzhou Med Univ, Sch Life Sci, Wenzhou 325035, Zhejiang, Peoples R China.	gail529@163.com; tanfengsong@163.com		Zhang, Fangfei/0000-0003-4806-1972	National Natural Science Foundation of China [81672052, 81702024]; Zhejiang Natural Science Funds for Distinguished Young Scientists Grant [LR17H190001]; Commonwealth Technology Application Project Program of Zhejiang Province [2015C33129]; Natural Science Foundation of Zhejiang Province Grant [LY16H190007]; Zhejiang Xinmiao Talent Plan Grant [2017R413062, 2017R413019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Funds for Distinguished Young Scientists Grant; Commonwealth Technology Application Project Program of Zhejiang Province; Natural Science Foundation of Zhejiang Province Grant(Natural Science Foundation of Zhejiang Province); Zhejiang Xinmiao Talent Plan Grant	This work was supported by National Natural Science Foundation of China Grant 81672052 and Zhejiang Natural Science Funds for Distinguished Young Scientists Grant LR17H190001 (to F. T.), National Natural Science Foundation of China Grant 81702024 and Commonwealth Technology Application Project Program of Zhejiang Province Grant 2015C33129 (to X. H.), Natural Science Foundation of Zhejiang Province Grant LY16H190007 (to X. C.), Zhejiang Xinmiao Talent Plan Grant 2017R413062 (to S. L.), as well as Zhejiang Xinmiao Talent Plan Grant 2017R413019 (to F. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Canon-Franco WA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-427; Besteiro S, 2012, MOL BIOCHEM PARASIT, V184, P1, DOI 10.1016/j.molbiopara.2012.04.001; Besteiro S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002416; Brennan RC, 2011, CANCER RES, V71, P4205, DOI 10.1158/0008-5472.CAN-11-0058; Chen D, 2016, ACTA TROP, V153, P79, DOI 10.1016/j.actatropica.2015.09.013; de Late PL, 2017, BIOMED J, V40, P23, DOI 10.1016/j.bj.2017.01.001; Dickson MA, 2013, ANN ONCOL, V24, P252, DOI 10.1093/annonc/mds275; Ghosh D, 2012, CELL MICROBIOL, V14, P589, DOI 10.1111/j.1462-5822.2011.01745.x; Hain AUP, 2016, CHEMMEDCHEM, V11, P900, DOI 10.1002/cmdc.201500515; Hain AUP, 2014, J MED CHEM, V57, P4521, DOI 10.1021/jm401675a; Hain AUP, 2012, J STRUCT BIOL, V180, P551, DOI 10.1016/j.jsb.2012.09.001; Ho KH, 2009, AUTOPHAGY, V5, P461, DOI 10.4161/auto.5.4.7696; Hurley JH, 2014, CELL, V157, P300, DOI 10.1016/j.cell.2014.01.070; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jayabalasingham B, 2014, AUTOPHAGY, V10, P269, DOI 10.4161/auto.27166; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kitamura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042977; Kong-Hap MA, 2013, AUTOPHAGY, V9, P1334, DOI 10.4161/auto.25189; Koopmann R, 2009, AUTOPHAGY, V5, P1085, DOI 10.4161/auto.5.8.9611; Lavine MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042107; Leveque MF, 2015, MBIO, V6, DOI 10.1128/mBio.01446-15; Li XZ, 2016, PARASITOLOGY, V143, P639, DOI 10.1017/S0031182015001985; Luder CGK, 2001, TRENDS PARASITOL, V17, P480, DOI 10.1016/S1471-4922(01)02093-1; Luder CGK, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-116; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Reece SE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002320; Rudin CM, 2012, CLIN CANCER RES, V18, P3163, DOI 10.1158/1078-0432.CCR-11-3090; Sinai AP, 2012, TRENDS PARASITOL, V28, P358, DOI 10.1016/j.pt.2012.06.006; Slobodkin MR, 2013, ESSAYS BIOCHEM, V55, P51, DOI [10.1042/bse0550051, 10.1042/BSE0550051]; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Sullivan WJ, 2012, FEMS MICROBIOL REV, V36, P717, DOI 10.1111/j.1574-6976.2011.00305.x; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Tomlins AM, 2013, AUTOPHAGY, V9, P1540, DOI 10.4161/auto.25832; ULLMAN EF, 1994, P NATL ACAD SCI USA, V91, P5426, DOI 10.1073/pnas.91.12.5426; Varberg JM, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01489-17; Walker DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067047; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Weiss LM, 2009, INT J PARASITOL, V39, P895, DOI 10.1016/j.ijpara.2009.02.004; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670	44	5	5	1	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14545	14556		10.1074/jbc.RA118.002614	http://dx.doi.org/10.1074/jbc.RA118.002614			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30026233	Green Published, hybrid			2022-12-28	WOS:000444671500031
J	Zinskie, JA; Ghosh, A; Trainor, BM; Shedlovskiy, D; Pestov, DG; Shcherbik, N				Zinskie, Jessica A.; Ghosh, Arnab; Trainor, Brandon M.; Shedlovskiy, Daniel; Pestov, Dimitri G.; Shcherbik, Natalia			Iron-dependent cleavage of ribosomal RNA during oxidative stress in the yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA; RNA degradation; ribosome; reactive oxygen species (ROS); oxidative stress; iron; iron metabolism; cell death; yeast; Fenton reaction; glutaredoxin; iron homeostasis	GRX5 MONOTHIOL GLUTAREDOXIN; HYDROGEN-PEROXIDE; CELL-DEATH; FENTON REACTIONS; DNA-DAMAGE; VITAMIN-C; LIFE-SPAN; METAL-ION; KEY ROLE; APOPTOSIS	Stress-induced strand breaks in rRNA have been observed in many organisms, but the mechanisms by which they originate are not well-understood. Here we show that a chemical rather than an enzymatic mechanism initiates rRNA cleavages during oxidative stress in yeast (Saccharomyces cerevisiae). We used cells lacking the mitochondrial glutaredoxin Grx5 to demonstrate that oxidant-induced cleavage formation in 25S rRNA correlates with intracellular iron levels. Sequestering free iron by chemical or genetic means decreased the extent of rRNA degradation and relieved the hypersensitivity of grx5 cells to the oxidants. Importantly, subjecting purified ribosomes to an in vitro iron/ascorbate reaction precisely recapitulated the 25S rRNA cleavage pattern observed in cells, indicating that redox activity of the ribosome-bound iron is responsible for the strand breaks in the rRNA. In summary, our findings provide evidence that oxidative stress-associated rRNA cleavages can occur through rRNA strand scission by redox-active, ribosome-bound iron that potentially promotes Fenton reaction-induced hydroxyl radical production, implicating intracellular iron as a key determinant of the effects of oxidative stress on ribosomes. We propose that iron binding to specific ribosome elements primes rRNA for cleavages that may play a role in redox-sensitive tuning of the ribosome function in stressed cells.	[Zinskie, Jessica A.; Ghosh, Arnab; Trainor, Brandon M.; Shedlovskiy, Daniel; Pestov, Dimitri G.; Shcherbik, Natalia] Rowan Univ, Dept Cell Biol & Neurosci, Stratford, NJ 08084 USA; [Trainor, Brandon M.] Rowan Univ, Grad Sch Biomed Sci, Stratford, NJ 08084 USA	Rowan University; Rowan University	Shcherbik, N (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Cell Biol & Neurosci, 2 Med Ctr Dr, Stratford, NJ 08084 USA.	shcherna@rowan.edu	GHOSH, ARNAB/J-2299-2019	GHOSH, ARNAB/0000-0003-1952-1044; Pestov, Dimitri/0000-0002-1425-9879	National Institutes of Health [R01GM114308]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM114308 (to N. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; Almeida T, 2008, MOL BIOL CELL, V19, P865, DOI 10.1091/mbc.E07-06-0604; Alves R, 2004, PROTEINS, V57, P481, DOI 10.1002/prot.20228; Athavale SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038024; Belli G, 2002, J BIOL CHEM, V277, P37590, DOI 10.1074/jbc.M201688200; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Berens C, 1998, CHEM BIOL, V5, P163, DOI 10.1016/S1074-5521(98)90061-8; Bogdan AR, 2016, TRENDS BIOCHEM SCI, V41, P274, DOI 10.1016/j.tibs.2015.11.012; Bonawitz ND, 2006, MOL CELL BIOL, V26, P4818, DOI 10.1128/MCB.02360-05; Bray M. S., 2018, FERROUS IRON FOLDS R, DOI [10.1101/256958, DOI 10.1101/256958]; Campanella A, 2004, HUM MOL GENET, V13, P2279, DOI 10.1093/hmg/ddh232; Cazzola M, 2003, BLOOD, V101, P1996, DOI 10.1182/blood-2002-07-2006; Chen XJ, 2017, J ORAL PATHOL MED, V46, P332, DOI 10.1111/jop.12502; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Deutscher MP, 2009, PROG MOL BIOL TRANSL, V85, P369, DOI 10.1016/S0079-6603(08)00809-X; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P372, DOI 10.1089/ars.2012.4886; Ding QX, 2006, NEUROCHEM RES, V31, P705, DOI 10.1007/s11064-006-9071-5; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Erental A, 2014, MBIO, V5, DOI 10.1128/mBio.01426-14; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Gomez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111585; GRAF E, 1984, J BIOL CHEM, V259, P3620; Henle ES, 1999, J BIOL CHEM, V274, P962, DOI 10.1074/jbc.274.2.962; Honda K, 2005, J BIOL CHEM, V280, P20978, DOI 10.1074/jbc.M500526200; HOUGE G, 1993, FEBS LETT, V315, P16, DOI 10.1016/0014-5793(93)81123-H; Hsiao CL, 2013, NAT CHEM, V5, P525, DOI [10.1038/NCHEM.1649, 10.1038/nchem.1649]; Huang HH, 2015, EMBO J, V34, P154, DOI 10.15252/embj.201489083; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Kent T, 2009, RNA, V15, P14, DOI 10.1261/rna.1384709; KHAN MMT, 1967, J AM CHEM SOC, V89, P4176, DOI 10.1021/ja00992a036; Kim SJ, 2016, CELL DIV, V11, DOI 10.1186/s13008-016-0024-3; King KL, 2000, CELL DEATH DIFFER, V7, P994, DOI 10.1038/sj.cdd.4400731; Laporte D, 2012, J EXP BOT, V63, P503, DOI 10.1093/jxb/err301; LATHAM JA, 1989, SCIENCE, V245, P276, DOI 10.1126/science.2501870; LEE TS, 1948, J AM CHEM SOC, V70, P3596, DOI 10.1021/ja01191a015; Lill R, 2014, CURR OPIN MICROBIOL, V22, P111, DOI 10.1016/j.mib.2014.09.015; Ma J, 2012, P NATL ACAD SCI USA, V109, P8417, DOI 10.1073/pnas.1120045109; Mahaseth T, 2017, MUTAT RES-REV MUTAT, V773, P274, DOI 10.1016/j.mrrev.2016.08.006; Mansour FH, 2013, ANAL BIOCHEM, V441, P18, DOI 10.1016/j.ab.2013.06.008; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; MORGAN AR, 1976, NUCLEIC ACIDS RES, V3, P1139, DOI 10.1093/nar/3.5.1139; Mroczek S, 2008, NUCLEIC ACIDS RES, V36, P2874, DOI 10.1093/nar/gkm1100; Muhlenhoff U, 2015, EUR J CELL BIOL, V94, P292, DOI 10.1016/j.ejcb.2015.05.003; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Narendrula R, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2197-1; Oikawa S, 1998, BBA-GENE STRUCT EXPR, V1399, P19, DOI 10.1016/S0167-4781(98)00092-X; Okafor CD, 2017, NUCLEIC ACIDS RES, V45, P3634, DOI 10.1093/nar/gkx171; Padmanabhan PK, 2012, CELL DEATH DIFFER, V19, P1972, DOI 10.1038/cdd.2012.85; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; Pestov Dimitri G, 2008, Curr Protoc Cell Biol, VChapter 22, DOI 10.1002/0471143030.cb2211s39; Petrov AS, 2011, RNA, V17, P291, DOI 10.1261/rna.2390311; Rakauskaite R, 2006, MOL CELL BIOL, V26, P8992, DOI 10.1128/MCB.01311-06; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; SAMUNI A, 1983, EUR J BIOCHEM, V137, P119, DOI 10.1111/j.1432-1033.1983.tb07804.x; Shcherbik N, 2016, NUCLEIC ACIDS RES, V44, P6840, DOI 10.1093/nar/gkw566; Shcherbik N, 2013, TRAFFIC, V14, P1209, DOI 10.1111/tra.12122; Shedlovskiy D, 2017, RNA BIOL, V14, P1722, DOI 10.1080/15476286.2017.1345417; Shedlovskiy D, 2017, J BIOL CHEM, V292, P18469, DOI 10.1074/jbc.M117.800003; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Stefan L, 2012, NUCLEIC ACIDS RES, V40, P8759, DOI 10.1093/nar/gks581; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Tamarit J, 2006, ANAL BIOCHEM, V351, P149, DOI 10.1016/j.ab.2005.12.001; Tamarit J, 2003, J BIOL CHEM, V278, P25745, DOI 10.1074/jbc.M303477200; Martinez-Pastor MT, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2215-8; Topf U, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02694-8; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5469, DOI 10.1073/pnas.83.15.5469; Vilella F, 2004, COMP FUNCT GENOM, V5, P328, DOI 10.1002/cfg.406; Wang MS, 2015, RNA, V21, P1240, DOI 10.1261/rna.051169.115; WANG Y, 1989, NUCLEIC ACIDS RES, V17, P6915, DOI 10.1093/nar/17.17.6915; Willi J, 2018, NUCLEIC ACIDS RES, V46, P1945, DOI 10.1093/nar/gkx1308; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X	73	17	17	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14237	14248		10.1074/jbc.RA118.004174	http://dx.doi.org/10.1074/jbc.RA118.004174			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30021840	hybrid, Green Published			2022-12-28	WOS:000444671500005
J	Bedford, MT				Bedford, Mark T.			Screening for histone codebreakers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							DOMAIN; H3	The lysine methyltransferase NSD2 is overexpressed and carries gain-of-function mutations in a number of different cancers, making it an attractive therapeutic target. However, no specific small molecule inhibitors have been identified for this enzyme, responsible for depositing the H3K36me2 mark on histones. A new study reports a robust platform for high-throughput screening (HTS) assays to facilitate this discovery.	[Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA	University of Texas System; UTMD Anderson Cancer Center	Bedford, MT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA.	mtbedford@mdanderson.org		bedford, mark/0000-0002-8899-1050	NIGMS NIH HHS [R01 GM126421] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM126421] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Coussens NP, 2018, J BIOL CHEM, V293, P13750, DOI 10.1074/jbc.RA118.004274; Hudlebusch HR, 2011, CLIN CANCER RES, V17, P2919, DOI 10.1158/1078-0432.CCR-10-1302; Jaffe JD, 2013, NAT GENET, V45, P1386, DOI 10.1038/ng.2777; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Oyer JA, 2014, LEUKEMIA, V28, P198, DOI 10.1038/leu.2013.204; Sankaran SM, 2016, J BIOL CHEM, V291, P8465, DOI 10.1074/jbc.M116.720748; Shen C, 2015, CURR OPIN ONCOL, V27, P57, DOI 10.1097/CCO.0000000000000151; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412	10	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13766	+		10.1074/jbc.H118.005132	http://dx.doi.org/10.1074/jbc.H118.005132			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30171150	hybrid, Green Published			2022-12-28	WOS:000443375500034
J	Chen, KQ; Singh, VK; Tang, P; Bao, ZY; He, TZ; Xiang, Y; Gong, WH; Yoshimura, T; Le, YY; Tessarollo, L; Chen, X; Wang, JM				Chen, Keqiang; Singh, Vijay K.; Tang, Peng; Bao, Zhiyao; He, Tianzhen; Xiang, Yi; Gong, Wanghua; Yoshimura, Teizo; Le, Yingying; Tessarollo, Lino; Chen, Xin; Wang, Ji Ming			Deficiency in Fpr2 results in reduced numbers of Lin(-)cKit(+)Sca1(+) myeloid progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mouse; bone marrow; myeloid cell; proliferation; cytokine; c-KIT; Fpr2; Lin(-)c-Kit(+)Sca1(+)cells; SCF	HEMATOPOIETIC STEM-CELLS; C-KIT LIGAND; ESCHERICHIA-COLI BACTEREMIA; FORMYL-PEPTIDE RECEPTORS; BONE-MARROW; FORMYLPEPTIDE RECEPTOR; PERIPHERAL-BLOOD; DENDRITIC CELLS; LIPOXIN A(4); SELF-RENEWAL	The Lin(-)c-Kit(+) Sca-1(+) cell population in the bone marrow (BM) serves as the direct precursor for differentiation of myeloid cells. In this study, we report that deficiency in Fpr2, a G protein-coupled chemoattractant receptor in mice, is associated with reduced BM nucleated cells, including CD31(+)Ly6C(+) (granulocytes and monocytes), CD31(-)/Ly6C(int) (granuloid cells), and CD31(-)/Ly6C(high) (predominantly monocytes) cells. In particular, the number of Lin(-)c-Kit(+)Sca-1(+) (LKS) cells was reduced in Fpr2(-/-) mouse BM. This was supported by observations of the reduced incorporation of intraperitoneally injected bromodeoxyuridine by cells in the c-Kit(+) population from Fpr2(-/-) mouse BM. Purified c-Kit(+) cells from Fpr2(-/-) mice showed reduced expansion when cultured in vitro with stem cell factor (SCF). SCF/c-Kit-mediated phosphorylation of P38, STAT1, Akt (Thr-308), and Akt (Ser-473) was also significantly reduced in c-Kit(+) cells from Fpr2(-/-) mice. Furthermore, Fpr2 agonists enhanced SCF-induced proliferation of c-Kit(+) cells. Colony-forming unit assays revealed that CFU-granulocyte-macrophage formation of BM cells from Fpr2(-/-) mice was significantly reduced. After heat-inactivated bacterial stimulation in the airway, the expansion of c-kit(+) Sca-1(+) cells in BM and recruitment of Ly6G(+) cells to the lungs and CD11b(+)Ly6C(+)TNF(+) cells to the spleen of Fpr2(-/-) mice was significantly reduced. These results demonstrate an important role for Fpr2 in the development of myeloid lineage precursors in mouse BM.	[Chen, Keqiang; Tang, Peng; Bao, Zhiyao; Gong, Wanghua; Wang, Ji Ming] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Tessarollo, Lino] NCI, Mouse Canc Genet Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Singh, Vijay K.; Yoshimura, Teizo] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Armed Forces Radiobiol Res Inst, Dept Pharmacol & Mol Therapeut, Bethesda, MD 20814 USA; [Tang, Peng] Third Mil Med Univ, Southwest Hosp, Dept Breast Surg, Chongqing 400038, Peoples R China; [Bao, Zhiyao; Xiang, Yi] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pulm & Crit Care Med, Shanghai 200025, Peoples R China; [He, Tianzhen; Chen, Xin] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau 999078, Peoples R China; [Gong, Wanghua] Leidos Biomed Res Inc, Basic Res Program, Frederick, MD 21702 USA; [Yoshimura, Teizo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol & Expt Med, Okayama 7008558, Japan; [Le, Yingying] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uniformed Services University of the Health Sciences - USA; United States Department of Defense; Army Medical University; Shanghai Jiao Tong University; University of Macau; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Okayama University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, JM (corresponding author), NCI, Canc & Inflammat Program, Ctr Canc Res, Bldg 560,Rm 31-76, Frederick, MD 21702 USA.	wangji@mail.nih.gov	Singh, Vijay/GWZ-8972-2022; Le, Yingying/L-9785-2017; Chen, Xin n/a/I-6601-2015	Singh, Vijay/0000-0002-6631-3849; Le, Yingying/0000-0002-7990-3899; Chen, Xin n/a/0000-0002-2628-4027	NCI, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of the NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZICBC011265] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded in part by federal funds from the NCI, National Institutes of Health, under Contract HHSN261200800001E and supported in part by the Intramural Research Program of the NCI, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akala OO, 2006, CURR OPIN GENET DEV, V16, P496, DOI 10.1016/j.gde.2006.08.011; AVRAHAM H, 1992, BLOOD, V79, P365; Barthlen W, 1999, SURGERY, V126, P41, DOI 10.1067/msy.1999.99060; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; BROXMEYER HE, 1991, CANCER CELL-MON REV, V3, P480; BROXMEYER HE, 1995, EXP HEMATOL, V23, P1121; Chen KD, 2013, J CLIN INVEST, V123, P1694, DOI 10.1172/JCI65569; Chen KQ, 2014, J BIOL CHEM, V289, P17553, DOI 10.1074/jbc.M113.535674; Chen KQ, 2013, J BIOL CHEM, V288, P16262, DOI 10.1074/jbc.M113.450635; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Devosse T, 2009, J IMMUNOL, V182, P4974, DOI 10.4049/jimmunol.0803128; Duarte RF, 2000, BLOOD, V96, P3422; Fehniger TA, 1997, BLOOD, V90, P3647, DOI 10.1182/blood.V90.9.3647; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Gehling UM, 1997, EXP HEMATOL, V25, P1125; Grafte-Faure S, 2000, CYTOKINE, V12, P1, DOI 10.1006/cyto.1999.0520; HARTMANN DW, 1981, J CELL PHYSIOL, V109, P17, DOI 10.1002/jcp.1041090103; HENDRIE PC, 1991, EXP HEMATOL, V19, P1031; HOFFMAN R, 1993, STEM CELLS, V11, P76; HORIE M, 1995, EXP HEMATOL, V23, P168; Hu JY, 2001, J LEUKOCYTE BIOL, V70, P155; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Iribarren P, 2005, IMMUNOL RES, V31, P165, DOI 10.1385/IR:31:3:165; Jung SK, 2014, J BIOL CHEM, V289, P35839, DOI 10.1074/jbc.M114.585513; KELLER JR, 1995, BLOOD, V86, P1757, DOI 10.1182/blood.V86.5.1757.bloodjournal8651757; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kular J, 2015, J BIOL CHEM, V290, P1729, DOI 10.1074/jbc.M114.567966; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Levy BD, 2002, NAT MED, V8, P1018, DOI 10.1038/nm748; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; Liu MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090613; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Liu XW, 2012, NAT IMMUNOL, V13, P457, DOI 10.1038/ni.2258; Liu Y, 2013, CANCER RES, V73, P550, DOI 10.1158/0008-5472.CAN-12-2290; MCNIECE IK, 1991, EXP HEMATOL, V19, P226; Migeotte I, 2005, J EXP MED, V201, P83, DOI 10.1084/jem.20041277; MORSTYN G, 1994, ONCOLOGY, V51, P205, DOI 10.1159/000227335; OKADA S, 1991, BLOOD, V78, P1706; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Santangelo S, 2001, ANN SURG, V233, P97, DOI 10.1097/00000658-200101000-00015; Sharma S, 2006, STEM CELLS DEV, V15, P755, DOI 10.1089/scd.2006.15.755; Shin MK, 2011, J BIOL CHEM, V286, P17133, DOI 10.1074/jbc.M110.197772; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sui XW, 1998, BLOOD, V92, P1142, DOI 10.1182/blood.V92.4.1142.416k42_1142_1149; Swamydas M., 2015, CURR PROTOC IMMUNOL, V110, P3, DOI DOI 10.1002/0471142735.im0320s110; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Uittenbogaart CH, 1996, IMMUNOL LETT, V52, P45, DOI 10.1016/0165-2478(96)02580-1; Viswanathan A, 2007, STEM CELLS, V25, P1263, DOI 10.1634/stemcells.2006-0522; Wang J, 2007, CLIN HEMORHEOL MICRO, V37, P291; Xiang Y, 2016, AM J CANCER RES, V6, P2599; Yang D, 2000, J IMMUNOL, V165, P2694, DOI 10.4049/jimmunol.165.5.2694; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Young SM, 2006, CELL SIGNAL, V18, P608, DOI 10.1016/j.cellsig.2005.06.005; Zhang P, 2008, STEM CELLS, V26, P1778, DOI 10.1634/stemcells.2007-1027; Zhang P, 2009, J IMMUNOL, V182, P1568, DOI 10.4049/jimmunol.182.3.1568	58	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13452	13463		10.1074/jbc.RA118.002683	http://dx.doi.org/10.1074/jbc.RA118.002683			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30018139	Green Published, hybrid			2022-12-28	WOS:000443375500009
J	Mookerjee, SA; Gerencser, AA; Nicholls, DG; Brand, MD				Mookerjee, Shona A.; Gerencser, Akos A.; Nicholls, David G.; Brand, Martin D.			Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurements (vol 292, pg 7189, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Mookerjee SA, 2017, J BIOL CHEM, V292, P7189, DOI 10.1074/jbc.M116.774471	1	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12649	12652		10.1074/jbc.AAC118.004855	http://dx.doi.org/10.1074/jbc.AAC118.004855			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	30097494	Green Published, hybrid			2022-12-28	WOS:000441408500029
J	Basso, E; Rigotto, G; Zucchetti, AE; Pozzan, T				Basso, Emy; Rigotto, Giulia; Zucchetti, Andres E.; Pozzan, Tullio			Slow activation of fast mitochondrial Ca2+ uptake by cytosolic Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; calcium transport; calcium channel; channel activation; protein complex; calcium overload; MCU; MICU1; MICU2; uniporter	RAT-KIDNEY MITOCHONDRIA; CALCIUM UNIPORTER; LIVER MITOCHONDRIA; PRACTICAL GUIDE; MCU ACTIVITY; MICU1; CELL; TRANSPORT; EXCHANGER; MEMBRANE	Mitochondrial Ca2+ uptake through the mitochondrial Ca2+ uniporter (MCU) is a tightly controlled process that sustains cell functions mainly by fine-tuning oxidative metabolism to cellular needs. The kinetics of Ca2+ fluxes across the mitochondrial membranes have been studied both in vitro and in vivo for many years, and the discovery of the molecular components of the MCU has further clarified that this Ca2+ uptake mechanism is based on a complex system subject to elaborate layers of controls. Alterations in the speed or capacity of the in-and-out pathways can have detrimental consequences for both the organelle and the cell, impairing cellular metabolism and ultimately causing cell death. Here, we report that pretreatment of deenergized mitochondria with low-micromolar Ca2+ concentrations for a few minutes markedly increases the speed of mitochondrial Ca2+ uptake upon re-addition of an oxidizable substrate. We found that this phenomenon is sensitive to alterations in the level of the MCU modulator proteins mitochondrial calcium uptake 1 (MICU1) and 2 (MICU2), and is accompanied by changes in the association of MICU1-MICU2 complexes with MCU. This increased Ca2+ uptake capacity, occurring under conditions mimicking those during ischemia/reperfusion in vivo, could lead to a massive amount of Ca2+ entering the mitochondrial matrix even at relatively low levels of cytosolic Ca2+. We conclude that the phenomenon uncovered here represents a potential threat of mitochondrial Ca2+ overload to the cell.	[Basso, Emy; Pozzan, Tullio] CNR, Dept Biomed Sci, Neurosci Inst, Padua Sect, I-35131 Padua, Italy; [Rigotto, Giulia; Pozzan, Tullio] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Zucchetti, Andres E.] PSL Res Univ, Inst Curie, INSERM, U932, 26 Rue Ulm, F-75248 Paris 05, France; [Pozzan, Tullio] Venetian Inst Mol Med, I-35129 Padua, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Padua; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Veneto Institute Molecular Medicine	Basso, E (corresponding author), CNR, Dept Biomed Sci, Neurosci Inst, Padua Sect, I-35131 Padua, Italy.	emy.basso@cnr.it	Basso, Emy/F-7687-2015	Basso, Emy/0000-0003-2962-7213; Rigotto, Giulia/0000-0003-4292-9179; Zucchetti, Andres Ernesto/0000-0001-7067-1182	Euro-bioimaging European Strategy Forum on Research Infrastructures (ESFRI) platform [688945, DSB.AD008.008]	Euro-bioimaging European Strategy Forum on Research Infrastructures (ESFRI) platform	We thank Diego De Stefani for kindly providing recombinant DNA for the expression of MCU, MICU1, and MICU2 constructs (both WT and mutated); Fabiana Perocchi for kindly providing MICU1-KO cells; Giuseppe Cannino for suggestions on blue native PAGE; and Valeria Petronilli, Cristina Fasolato, Paola Pizzo, Riccardo Filadi, Diana Pendin, Elisa Greotti, and Paulo MagalhAes for helpful advice and suggestions on this work. Maintenance of the instruments for imaging utilized in this work has been supported by the Euro-bioimaging European Strategy Forum on Research Infrastructures (ESFRI) platform (under funding project ID is 688945, Grant DSB.AD008.008).D	Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BERS DM, 1994, METHOD CELL BIOL, V40, P3; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Boyman L, 2013, J MOL CELL CARDIOL, V59, P205, DOI 10.1016/j.yjmcc.2013.03.012; Brini M, 1999, MICROSC RES TECHNIQ, V46, P380, DOI 10.1002/(SICI)1097-0029(19990915)46:6<380::AID-JEMT6>3.0.CO;2-Y; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; De Stefani D, 2016, ANNU REV BIOCHEM, V85, P161, DOI 10.1146/annurev-biochem-060614-034216; De Stefani D, 2015, BBA-MOL CELL RES, V1853, P2006, DOI 10.1016/j.bbamcr.2015.04.008; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Kamer KJ, 2014, EMBO REP, V15, P299, DOI 10.1002/embr.201337946; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Konig T, 2016, MOL CELL, V64, P148, DOI 10.1016/j.molcel.2016.08.020; KRONER H, 1986, ARCH BIOCHEM BIOPHYS, V251, P525, DOI 10.1016/0003-9861(86)90360-7; KRONER H, 1986, BIOL CHEM H-S, V367, P483, DOI 10.1515/bchm3.1986.367.1.483; Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851; Luongo TS, 2017, NATURE, V545, P93, DOI 10.1038/nature22082; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; MIYATA H, 1991, AM J PHYSIOL, V261, pH1123, DOI 10.1152/ajpheart.1991.261.4.H1123; Montero M, 2004, BIOCHEM J, V384, P19, DOI 10.1042/BJ20040990; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; NICHOLLS D, 1982, BIOCHIM BIOPHYS ACTA, V683, P57, DOI 10.1016/0304-4173(82)90013-1; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Park MK, 2001, EMBO J, V20, P1863, DOI 10.1093/emboj/20.8.1863; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Pendin D, 2014, CELL CALCIUM, V55, P139, DOI 10.1016/j.ceca.2014.02.008; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Petrungaro C, 2015, CELL METAB, V22, P721, DOI 10.1016/j.cmet.2015.08.019; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; POZZAN T, 1977, BIOCHEMISTRY-US, V16, P5618, DOI 10.1021/bi00644a036; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Szabadkai G, 2003, J BIOL CHEM, V278, P15153, DOI 10.1074/jbc.M300180200; Tsai MF, 2016, ELIFE, V5, DOI 10.7554/eLife.15545; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; Wang LL, 2014, EMBO J, V33, P594, DOI 10.1002/embj.201386523	41	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17081	17094		10.1074/jbc.RA118.002332	http://dx.doi.org/10.1074/jbc.RA118.002332			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30228190	Green Published, hybrid			2022-12-28	WOS:000449466500011
J	Hinchy, EC; Gruszczyk, AV; Willows, R; Navaratnam, N; Hall, AR; Bates, G; Bright, TP; Krieg, T; Carling, D; Murphy, MP				Hinchy, Elizabeth C.; Gruszczyk, Anja V.; Willows, Robin; Navaratnam, Naveenan; Hall, Andrew R.; Bates, Georgina; Bright, Thomas P.; Krieg, Thomas; Carling, David; Murphy, Michael P.			Mitochondria-derived ROS activate AMP-activated protein kinase (AMPK) indirectly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); reactive oxygen species (ROS); mitochondria; hydrogen peroxide; redox signaling	HYDROGEN-PEROXIDE; ENERGY SENSOR; MECHANISMS; PEROXIREDOXIN; CELLS; MUSCLE	Mitochondrial reactive oxygen species (ROS) production is a tightly regulated redox signal that transmits information from the organelle to the cell. Other mitochondrial signals, such as ATP, are sensed by enzymes, including the key metabolic sensor and regulator, AMP-activated protein kinase (AMPK). AMPK responds to the cellular ATP/AMP and ATP/ADP ratios by matching mitochondrial ATP production to demand. Previous reports proposed that AMPK activity also responds to ROS, by ROS acting on redox-sensitive cysteine residues (Cys-299/Cys-304) on the AMPK subunit. This suggests an appealing model in which mitochondria fine-tune AMPK activity by both adenine nucleotide-dependent mechanisms and by redox signals. Here we assessed whether physiological levels of ROS directly alter AMPK activity. To this end we added exogenous hydrogen peroxide (H2O2) to cells and utilized the mitochondria-targeted redox cycler MitoParaquat to generate ROS within mitochondria without disrupting oxidative phosphorylation. Mitochondrial and cytosolic thiol oxidation was assessed by measuring peroxiredoxin dimerization and by redox-sensitive fluorescent proteins. Replacing the putative redox-active cysteine residues on AMPK 1 with alanines did not alter the response of AMPK to H2O2. In parallel with measurements of AMPK activity, we measured the cell ATP/ADP ratio. This allowed us to separate the effects on AMPK activity due to ROS production from those caused by changes in this ratio. We conclude that AMPK activity in response to redox changes is not due to direct action on AMPK itself, but is a secondary consequence of redox effects on other processes, such as mitochondrial ATP production.	[Hinchy, Elizabeth C.; Gruszczyk, Anja V.; Hall, Andrew R.; Bates, Georgina; Bright, Thomas P.; Murphy, Michael P.] Univ Cambridge, MRC Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Cambridge Biomed Campus, Cambridge CB2 0XY, England; [Gruszczyk, Anja V.] Addenbrookes Hosp, Univ Dept Surg, Cambridge CB2 0QQ, England; [Gruszczyk, Anja V.] Addenbrookes Hosp, Cambridge NIHR Biomed Res Ctr, Cambridge CB2 0QQ, England; [Willows, Robin; Navaratnam, Naveenan; Carling, David] Imperial Coll, Hammersmith Hosp, MRC London Inst Med Sci, London W12 0NN, England; [Krieg, Thomas] Univ Cambridge, Addenbrookes Hosp, Dept Med, Hills Rd, Cambridge CB2 0QQ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Imperial College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Murphy, MP (corresponding author), MRC Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England.	mpm@mrc-mbu.cam.ac.uk	Carling, David/F-1943-2014; Murphy, Michael/C-2120-2009	Carling, David/0000-0002-2316-1830; Murphy, Michael/0000-0003-1115-9618; Krieg, Thomas/0000-0002-5192-580X	Medical Research Council UK [MC_UU_00015/ 3, MC_US_A654_5QB10]; Wellcome Trust [110159/ Z/ 15/ Z]; MRC [MC_UU_00015/3] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council UK Grants MC_UU_ 00015/ 3 (to M.P.M.) and MC_US_A654_5QB10 (to D.C.) and Wellcome Trust Investigator Award 110159/ Z/ 15/ Z (to M.P.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht SC, 2011, CELL METAB, V14, P819, DOI 10.1016/j.cmet.2011.10.010; Auciello FR, 2014, FEBS LETT, V588, P3361, DOI 10.1016/j.febslet.2014.07.025; Buskiewicz IA, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf1933; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Chouchani ET, 2016, CELL METAB, V23, P254, DOI 10.1016/j.cmet.2015.12.009; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475; Day AM, 2012, MOL CELL, V45, P398, DOI 10.1016/j.molcel.2011.11.027; Dietz KJ, 2002, J EXP BOT, V53, P1321, DOI 10.1093/jexbot/53.372.1321; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hardie DG, 2017, SCIENCE, V357, P455, DOI 10.1126/science.aao1913; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, TRENDS BIOCHEM SCI, V36, P470, DOI 10.1016/j.tibs.2011.06.004; Hardie DG, 2016, ACTA PHARM SIN B, V6, P1, DOI 10.1016/j.apsb.2015.06.002; Hardie DG, 2000, METH MOL B, V99, P63; Hart PC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7053; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Langendorf CG, 2015, CELL RES, V25, P5, DOI 10.1038/cr.2014.163; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Mungai PT, 2011, MOL CELL BIOL, V31, P3531, DOI 10.1128/MCB.05124-11; Murphy MP, 2012, ANTIOXID REDOX SIGN, V16, P476, DOI 10.1089/ars.2011.4289; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Peskin AV, 2010, BIOCHEM J, V432, P313, DOI 10.1042/BJ20101156; Riquier S, 2014, REDOX BIOL, V2, P777, DOI 10.1016/j.redox.2014.06.001; Robb EL, 2015, FREE RADICAL BIO MED, V89, P883, DOI 10.1016/j.freeradbiomed.2015.08.021; Scialo F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009; Shao D, 2014, CELL METAB, V19, P232, DOI 10.1016/j.cmet.2013.12.013; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Sobotta MC, 2013, FREE RADICAL BIO MED, V60, P325, DOI 10.1016/j.freeradbiomed.2013.02.017; van Leeuwen LAG, 2017, FREE RADICAL BIO MED, V108, P374, DOI 10.1016/j.freeradbiomed.2017.03.037; Vissers M. C. M., 2018, HYDROGEN PEROXIDE ME; Willows R, 2017, BIOCHEM J, V474, P1741, DOI 10.1042/BCJ20170046; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Zhang CS, 2017, NATURE, V548, P112, DOI 10.1038/nature23275; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685	43	157	161	11	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17208	17217		10.1074/jbc.RA118.002579	http://dx.doi.org/10.1074/jbc.RA118.002579			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30232152	Green Published, hybrid			2022-12-28	WOS:000449466500020
J	Choppara, S; Ganga, S; Manne, R; Dutta, P; Singh, S; Santra, MK				Choppara, Srinadh; Ganga, Sankaran; Manne, Rajeshkumar; Dutta, Parul; Singh, Shailza; Santra, Manas Kumar			The SCFFBXO46 ubiquitin ligase complex mediates degradation of the tumor suppressor FBXO31 and thereby prevents premature cellular senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; E3 ubiquitin ligase; flow cytometry; post-translational modification (PTM); post-transcriptional regulation; protein motif; protein turnover; ubiquitin ligase; ubiquitylation (ubiquitination); ATM; cell cycle; F-box protein; senescence; ubiquitination	BOX PROTEIN FBXO31; PROTEASOME-DEPENDENT DEGRADATION; PATHWAY PROMOTES PHOSPHORYLATION; CYCLIN D1 DEGRADATION; DNA-DAMAGE RESPONSE; F-BOX; E3 LIGASE; STRUCTURE PREDICTION; CANCER; ACTIVATION	The tumor suppressor F-box protein 31 (FBXO31) is indispensable for maintaining genomic stability. Its levels drastically increase following DNA damage, leading to cyclin D1 and MDM2 degradation and G(1) and G(2)/M arrest. Prolonged arrest in these phases leads to cellular senescence. Accordingly, FBXO31 needs to be kept at low basal levels in unstressed conditions for normal cell cycle progression during growth and development. However, the molecular mechanism maintaining these basal FBXO31 levels has remained unclear. Here, we identified the F-box family SCF-E3 ubiquitin ligase FBXO46 (SCFFBXO46) as an important proteasomal regulator of FBXO31 and found that FBXO46 helps maintain basal FBXO31 levels under unstressed conditions and thereby prevents premature senescence. Using molecular docking and mutational studies, we showed that FBXO46 recognizes an RXXR motif located at the FBXO31 C terminus to direct its polyubiquitination and thereby proteasomal degradation. Furthermore, FBXO46 depletion enhanced the basal levels of FBXO31, resulting in senescence induction. In response to genotoxic stress, ATM (ataxia telangiectasia-mutated) Ser/Thr kinase-mediated phosphorylation of FBXO31 at Ser-278 maintained FBXO31 levels. In contrast, activated ATM phosphorylated FBXO46 at Ser-21/Ser-67, leading to its degradation via FBXO31. Thus, ATM-catalyzed phosphorylation after DNA damage governs FBXO31 levels and FBXO46 degradation via a negative feedback loop. Collectively, our findings reveal that FBXO46 is a crucial proteasomal regulator of FBXO31 and thereby prevents senescence in normal growth conditions. They further indicate that FBXO46-mediated regulation of FBXO31 is abrogated following genotoxic stress to promote increased FBXO31 levels for maintenance of genomic stability.	[Choppara, Srinadh; Ganga, Sankaran; Manne, Rajeshkumar; Dutta, Parul; Singh, Shailza; Santra, Manas Kumar] Natl Ctr Cell Sci, NCCS Complex,Ganeshkhind Rd, Pune 411007, Maharashtra, India; [Choppara, Srinadh; Manne, Rajeshkumar; Dutta, Parul] Savitribai Phule Pune Univ, Dept Biotechnol, Ganeshkhind Rd, Pune 411007, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Savitribai Phule Pune University	Santra, MK (corresponding author), Natl Ctr Cell Sci, NCCS Complex,Ganeshkhind Rd, Pune 411007, Maharashtra, India.	manas@nccs.res.in	Manne, Rajesh Kumar/ABB-1342-2021		Department of Biotechnology Grant [BT/PR6690/GBD/27/475/2012]; National Centre for Cell Science, Department of Biotechnology, Ministry of Science and Technology, Government of India	Department of Biotechnology Grant; National Centre for Cell Science, Department of Biotechnology, Ministry of Science and Technology, Government of India	This work was supported by Department of Biotechnology Grant BT/PR6690/GBD/27/475/2012 (to M. K. S.) and in part by the National Centre for Cell Science, Department of Biotechnology, Ministry of Science and Technology, Government of India (to M. K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Bassermann F, 2010, CELL DEATH DIFFER, V17, P78, DOI 10.1038/cdd.2009.104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brichese L, 2002, EXP CELL RES, V278, P101, DOI 10.1006/excr.2002.5563; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Choppara S, 2018, P NATL ACAD SCI USA, V115, P998, DOI 10.1073/pnas.1705954115; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; de Zoeten EF, 2009, J BIOL CHEM, V284, P5709, DOI 10.1074/jbc.M807322200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; He W, 2014, ONCOGENE, V33, P3004, DOI 10.1038/onc.2013.256; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Jeffery JM, 2017, ONCOGENE, V36, P1012, DOI 10.1038/onc.2016.268; JENTSCH S, 1995, CELL, V82, P881, DOI 10.1016/0092-8674(95)90021-7; Jia LJ, 2009, PIGM CELL MELANOMA R, V22, P518, DOI 10.1111/j.1755-148X.2009.00611.x; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Johansson P, 2014, J BIOL CHEM, V289, P18514, DOI 10.1074/jbc.M114.559930; Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kumar R, 2005, CANCER RES, V65, P11304, DOI 10.1158/0008-5472.CAN-05-0936; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Leung KT, 2008, CARCINOGENESIS, V29, P544, DOI 10.1093/carcin/bgm294; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Liu DY, 2016, ONCOTARGETS THER, V9, P5245, DOI 10.2147/OTT.S110969; Liu J, 2014, J BIOL CHEM, V289, P21508, DOI 10.1074/jbc.M114.560342; Liu YW, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.150; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Malonia SK, 2015, P NATL ACAD SCI USA, V112, P8632, DOI 10.1073/pnas.1510929112; Manne RK, 2017, NEOPLASIA, V19, P483, DOI 10.1016/j.neo.2017.02.013; Marechal A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012716; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Sabin Rebecca J, 2011, Genome Integr, V2, P7, DOI 10.1186/2041-9414-2-7; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; Shiloh Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.296pe73; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vadhvani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057530; Vandenberghe LH, 2006, NAT MED, V12, P967, DOI 10.1038/nm1445; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wang GC, 2012, CHIN J CANCER, V31, P169, DOI 10.5732/cjc.011.10319; Wei SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047298; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Xu J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14002; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zhang XC, 2014, ONCOTARGET, V5, P6178, DOI 10.18632/oncotarget.2183; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou ZA, 2016, CELL DIV, V11, DOI 10.1186/s13008-016-0021-6	56	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16291	16306		10.1074/jbc.RA118.005354	http://dx.doi.org/10.1074/jbc.RA118.005354			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30171069	hybrid, Green Published			2022-12-28	WOS:000447833600015
J	Merriman, C; Li, H; Li, HL; Fu, D				Merriman, Chengfeng; Li, Hua; Li, Huilin; Fu, Dax			Highly specific monoclonal antibodies for allosteric inhibition and immunodetection of the human pancreatic zinc transporter ZnT8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						zinc; transport; monoclonal antibody; inhibitor; pancreatic islet; diabetes; drug discovery; ZnT8; mAb; drug screening; pancreatic beta-cells; HTRF; therapeutic target	GENOME-WIDE ASSOCIATION; EM STRUCTURE DETERMINATION; INSULIN-SECRETION; BETA-CELL; GLUCOSE-HOMEOSTASIS; DIABETES RISK; ZN2+; MICE; IDENTIFICATION; EXPRESSION	Solute carrier family 30 member 8 (SLC30A8), encoding the pancreatic zinc transporter ZnT8, is a susceptibility gene for type 2 diabetes (T2D). Reducing ZnT8 transport activity or down-regulating its cellular expression is hypothesized to be an antidiabetogenic strategy mimicking the protective effect of SLC30A8 haploinsufficiency in humans. However, research tools to inhibit ZnT8 activity and measure cellular ZnT8 levels are not available. Here, we report the identification of two anti-ZnT8 mAbs applicable to addressing these unmet needs. Both mAbs exhibited subnanomolar affinities for human ZnT8 and were selective against homologous zinc transporters with distinct cross-species reactivities and epitope recognition. We showed that antigen-binding fragments (Fabs) protected ZnT8 from unfolding and inhibited ZnT8-mediated zinc transport in proteoliposomes. Negative-stain EM revealed a ternary binding complex of a ZnT8 monomer and two different Fabs at a 1:1:1 stoichiometry. Moreover, dual bindings of two different mAbs to a single ZnT8 protein multiplied the individual anti-ZnT8 specificities, enabling quantification of cellular ZnT8 levels by homogeneous time-resolved fluorescence (HTRF). Our results demonstrate the utilities of the two generated mAbs as allosteric inhibitors and highly specific biosensors of human ZnT8.	[Merriman, Chengfeng; Fu, Dax] Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA; [Li, Hua; Li, Huilin] Van Andel Res Inst, CryoEM Struct Biol Lab, Grand Rapids, MI 49503 USA	Johns Hopkins University; Van Andel Institute	Fu, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	dfu3@jhmi.edu		Li, Huilin/0000-0001-8085-8928; Fu, Dax/0000-0002-2663-1316	National Institutes of Health Shared Instrumentation Grant [S10OD016374]; National Institutes of Health [S10 OD016315, S10 RR13777001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065137] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016315, S10OD016374] Funding Source: NIH RePORTER	National Institutes of Health Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Hao Zhang from the Flow Cytometry and Immunology Core Facility at the Johns Hopkins Bloomberg School of Public Health for assistance in data acquisition and analysis. We also thank Barbara Smith from the microscopy facility of the Johns Hopkins University School of Medicine for assistance in cell imaging. The Zeiss confocal microscope was funded through National Institutes of Health Shared Instrumentation Grant S10OD016374. The MoFlo XDP cell sorter was funded through National Institutes of Health Grants S10 OD016315 and S10 RR13777001.	Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Boesgaard TW, 2008, DIABETOLOGIA, V51, P816, DOI 10.1007/s00125-008-0955-6; Bonnefond A, 2015, CELL METAB, V21, P357, DOI 10.1016/j.cmet.2014.12.020; Cherezov V, 2008, STRUCTURE, V16, P1378, DOI 10.1016/j.str.2008.05.014; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Degorce Francois, 2009, Curr Chem Genomics, V3, P22, DOI 10.2174/1875397300903010022; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; Friend SH, 2014, SCIENCE, V344, P970, DOI 10.1126/science.1255648; Hoch E, 2012, P NATL ACAD SCI USA, V109, P7202, DOI 10.1073/pnas.1200362109; Huang Q, 2017, J BIOL CHEM, V292, P4034, DOI 10.1074/jbc.M116.772152; Kambe T, 2014, CELL MOL LIFE SCI, V71, P3281, DOI 10.1007/s00018-014-1617-0; Kleiner S, 2018, P NATL ACAD SCI USA, V115, pE7642, DOI 10.1073/pnas.1721418115; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Lemaire K, 2012, J DIABETES INVEST, V3, P202, DOI 10.1111/j.2040-1124.2012.00199.x; Li L, 2017, DIABETES, V66, P551, DOI 10.2337/db16-0323; Lim HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024653; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Merriman C, 2018, J BIOL CHEM, V293, P579, DOI 10.1074/jbc.RA117.000195; Merriman C, 2016, J BIOL CHEM, V291, P26950, DOI 10.1074/jbc.M116.764605; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Parsons DS, 2018, FEBS J, V285, P1237, DOI 10.1111/febs.14402; Pearson E, 2014, NAT GENET, V46, P323, DOI 10.1038/ng.2934; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pound LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040972; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; Prasad RB, 2015, GENES-BASEL, V6, P87, DOI 10.3390/genes6010087; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rutter GA, 2010, ISLETS, V2, P49, DOI 10.4161/isl.2.1.10259; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tamaki M, 2013, J CLIN INVEST, V123, P4513, DOI 10.1172/JCI68807; Vyas NK, 2002, BIOCHEMISTRY-US, V41, P13575, DOI 10.1021/bi0261387; Wong WP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00394-3; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	43	8	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16206	16216		10.1074/jbc.RA118.005136	http://dx.doi.org/10.1074/jbc.RA118.005136			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30181214	Green Published, hybrid			2022-12-28	WOS:000447833600009
J	Ward, MG; Li, G; Hao, MM				Ward, Meliza G.; Li, Ge; Hao, Mingming			Apoptotic beta-cells induce macrophage reprogramming under diabetic conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; macrophage; beta cell (B-cell); islet; lysosome; glucose; apoptosis; inflammation	INFLAMMASOME ACTIVATION; NLRP3 INFLAMMASOME; INSULIN; IL-1-BETA; MECHANISM; AUTOPHAGY; CRYSTALS; ACCUMULATION; PHENOTYPE; FUSION	Type 2 diabetes mellitus (T2DM) occurs when insulin-producing pancreatic -cells fail to secrete sufficient insulin to compensate for insulin resistance. As T2DM progresses, apoptotic -cells need to be removed by macrophages through efferocytosis that is anti-inflammatory by nature. Paradoxically, infiltrating macrophages are a main source of inflammatory cytokines that leads to T2DM. It is unclear how apoptotic -cells impact macrophage function. We show under diabetic conditions, phagocytosis of apoptotic -cells causes lysosomal permeabilization and generates reactive oxygen species that lead to inflammasome activation and cytokine secretion in macrophages. Efferocytosis-induced lipid accumulation transforms islet macrophages into foam cell-like outside the context of atherosclerosis. Our study suggests that whereas macrophages normally play a protective anti-inflammatory role, the increasing demand of clearing apoptotic cells may trigger them to undergo proinflammatory reprogramming as T2DM progresses. This shift in the balance between opposing macrophage inflammatory responses could contribute to chronic inflammation involved in metabolic diseases. Our study highlights the importance of preserving macrophage lysosomal function as a therapeutic intervention for diabetes progression.	[Ward, Meliza G.; Li, Ge; Hao, Mingming] Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10065 USA	Cornell University	Hao, MM (corresponding author), 1300 York Ave, New York, NY 10065 USA.	mhao@med.cornell.edu		Hao, Mingming/0000-0003-4677-5111	Cornell University, Weill Cornell Graduate School of Medical Sciences	Cornell University, Weill Cornell Graduate School of Medical Sciences	This work was supported by Cornell University, Weill Cornell Graduate School of Medical Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	BIDANI A, 1995, J LEUKOCYTE BIOL, V57, P275, DOI 10.1002/jlb.57.2.275; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e; Carter JD, 2009, BIOL PROCED ONLINE, V11, P3, DOI 10.1007/s12575-009-9021-0; Cousin SP, 2001, ENDOCRINOLOGY, V142, P229, DOI 10.1210/en.142.1.229; Cucak H, 2014, J LEUKOCYTE BIOL, V95, P149, DOI 10.1189/jlb.0213075; Dinarello CA, 2010, CURR OPIN ENDOCRINOL, V17, P314, DOI 10.1097/MED.0b013e32833bf6dc; Diwu ZJ, 1999, CHEM BIOL, V6, P411, DOI 10.1016/S1074-5521(99)80059-3; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dunn Kenneth, 2003, Methods Cell Biol, V72, P389, DOI 10.1016/S0091-679X(03)72019-6; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Emanuel R, 2014, ARTERIOSCL THROM VAS, V34, P1942, DOI 10.1161/ATVBAHA.114.303342; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Green DR, 2016, CELL DEATH DIFFER, V23, P915, DOI 10.1038/cdd.2015.172; Haka AS, 2016, J LIPID RES, V57, P980, DOI 10.1194/jlr.M064089; HALBAN PA, 1991, DIABETOLOGIA, V34, P767, DOI 10.1007/BF00408349; HALBAN PA, 1987, DIABETOLOGIA, V30, P348, DOI 10.1007/BF00299029; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; HOWELL SL, 1984, DIABETOLOGIA, V26, P319; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Korns D, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00057; Kuehnel W., 2003, COLOR ATLAS CYTOLOGY; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; MONTGOMERY RR, 1991, J IMMUNOL, V147, P3087; ORCI L, 1984, J CELL BIOL, V98, P222, DOI 10.1083/jcb.98.1.222; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Prencipe G, 2014, J AM SOC NEPHROL, V25, P1163, DOI 10.1681/ASN.2013060653; Re F, 2011, PROG INFLAMM RES SER, P85, DOI 10.1007/978-3-0348-0148-5_6; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056; Sergin I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15750; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; SILVA JA, 1995, CIRCULATION, V92, P1731, DOI 10.1161/01.CIR.92.7.1731; Song AP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19248-7; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Tabas I, 2016, CIRC RES, V118, P653, DOI 10.1161/CIRCRESAHA.115.306256; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Van Opdenbosch N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4209; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Westwell-Roper C, 2014, IMMUNOL CELL BIOL, V92, P314, DOI 10.1038/icb.2014.4; Youm YH, 2011, ENDOCRINOLOGY, V152, P4039, DOI 10.1210/en.2011-1326; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Zhang X., 2017, J DIABETES RES, V2017	51	13	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16160	16173		10.1074/jbc.RA118.004565	http://dx.doi.org/10.1074/jbc.RA118.004565			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30213857	Green Published, hybrid			2022-12-28	WOS:000447833600003
J	Harris, BD; Schreiter, J; Chevrier, M; Jordan, JL; Walter, MR				Harris, Bethany D.; Schreiter, Jessica; Chevrier, Marc; Jordan, Jarrat L.; Walter, Mark R.			Human interferon-epsilon and interferon-kappa exhibit low potency and low affinity for cell-surface IFNAR and the poxvirus antagonist B18R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon; receptor structure-function; recombinant protein expression; viral protein; protein complex; protein-protein interaction; structure-function; B18R; IFNAR; IFNE; IFN	JAK-STAT PATHWAY; I-INTERFERON; ESCHERICHIA-COLI; ALPHA RECEPTOR; EXPRESSION; VIRUS; IDENTIFICATION; GENES; BETA; ACTIVATION	IFNE epsilon and IFN kappa are interferons that induce microbial immunity at mucosal surfaces and in the skin. They are members of the type-I interferon (IFN) family, which consists of 16 different IFNs, that all signal through the common IFNAR1/IFNAR2 receptor complex. Although IFN epsilon and IFN kappa have unique expression and functional properties, their biophysical properties have not been extensively studied. In this report, we describe the expression, purification, and characterization of recombinant human IFN epsilon and IFN kappa. In cellular assays, IFN epsilon and IFN kappa exhibit similar to 1000-fold lower potency than IFN alpha 2 and IFN omega. The reduced potency of IFN epsilon and IFN kappa are consistent with their weak affinity for the IFNAR2 receptor chain. Despite reduced IFNAR2-binding affinities, IFN epsilon and IFN epsilon exhibit affinities for the IFNAR1 chain that are similar to other IFN subtypes. As observed for cellular IFNAR2 receptor, the poxvirus antagonist, B18R, also exhibits reduced affinity for IFN epsilon and IFN kappa, relative to the other IFNs. Taken together, our data suggest IFN epsilon and IFN kappa are specialized IFNs that have evolved to weakly bind to the IFNAR2 chain, which allows innate protection of the mucosa and skin and limits neutralization of IFN epsilon and IFN kappa biological activities by viral IFN antagonists.	[Harris, Bethany D.; Walter, Mark R.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35243 USA; [Schreiter, Jessica; Chevrier, Marc; Jordan, Jarrat L.] Janssen Res & Dev LLC, Raritan, NJ 08869 USA	University of Alabama System; University of Alabama Birmingham; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Walter, MR (corresponding author), 845 19th St South,Rm 509, Birmingham, AL 35243 USA.	walter@uab.edu		Jordan, Jarrat/0000-0002-0699-3774	Alliance for Lupus Research; Janssen Research & Development, LLC	Alliance for Lupus Research; Janssen Research & Development, LLC	This work was supported by a Novel Research Grant from the Alliance for Lupus Research and a Research Grant from Janssen Research & Development, LLC. The authors declare that they have no conflicts of interest with the contents of this article.	Abdulhaqq SA, 2016, MUCOSAL IMMUNOL, V9, P1027, DOI 10.1038/mi.2015.116; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; COLAMONICI OR, 1994, J BIOL CHEM, V269, P3518; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; Couret J, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0185-z; de Goer de Herve M. G., 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019366, DOI 10.1371/JOURNAL.PONE.0019366]; Delgoffe GM, 2014, NAT MED, V20, P236, DOI 10.1038/nm.3493; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Deshpande A, 2013, PROTEIN SCI, V22, P1100, DOI 10.1002/pro.2285; Domanski P, 1997, J BIOL CHEM, V272, P26388, DOI 10.1074/jbc.272.42.26388; Foster GR, 2010, DRUGS, V70, P147, DOI 10.2165/11531990-000000000-00000; Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321; Garcia-Minambres A, 2017, IMMUNOL CELL BIOL, V95, P478, DOI 10.1038/icb.2016.123; Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009; Gray RC, 2007, J LEUKOCYTE BIOL, V81, P1075, DOI 10.1189/jlb.1006606; Hardy MP, 2004, GENOMICS, V84, P331, DOI 10.1016/j.ygeno.2004.03.003; Herzer K, 2009, CANCER RES, V69, P855, DOI 10.1158/0008-5472.CAN-08-2831; Huang JY, 2007, P NATL ACAD SCI USA, V104, P9822, DOI 10.1073/pnas.0610352104; Il Yoon S, 2007, PROTEIN EXPRES PURIF, V53, P132, DOI 10.1016/j.pep.2006.12.001; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005; Kirkwood J, 2002, SEMIN ONCOL, V29, P18, DOI 10.1053/sonc.2002.33078; Kuruganti S, 2014, PROTEIN EXPRES PURIF, V103, P75, DOI 10.1016/j.pep.2014.08.010; LaFleur DW, 2001, J BIOL CHEM, V276, P39765, DOI 10.1074/jbc.M102502200; Lavoie TB, 2011, CYTOKINE, V56, P282, DOI 10.1016/j.cyto.2011.07.019; Li T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00697; Liu YW, 2014, NAT MED, V20, P272, DOI 10.1038/nm.3485; LOH JE, 1992, EMBO J, V11, P1351, DOI 10.1002/j.1460-2075.1992.tb05180.x; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Pfeffer LM, 1998, CANCER RES, V58, P2489; Piehler J, 1999, J MOL BIOL, V289, P57, DOI 10.1006/jmbi.1999.2726; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Radhakrishnan R, 1996, STRUCTURE, V4, P1453, DOI 10.1016/S0969-2126(96)00152-9; Reiser J, 2011, J VIROL, V85, P11372, DOI 10.1128/JVI.05279-11; Richter MF, 1998, J BIOL CHEM, V273, P24723, DOI 10.1074/jbc.273.38.24723; Samarajiwa SA, 2014, J IMMUNOL, V192, P4425, DOI 10.4049/jimmunol.1302388; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stifter SA, 2018, J BIOL CHEM, V293, P3168, DOI 10.1074/jbc.M117.800755; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Tasker C, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88255; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Walter MR, 2004, ADV PROTEIN CHEM, V68, P171; Yang CH, 2007, J IMMUNOL, V178, P986, DOI 10.4049/jimmunol.178.2.986; Zhao WL, 2007, J IMMUNOL, V179, P463, DOI 10.4049/jimmunol.179.1.463	54	13	14	7	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16057	16068		10.1074/jbc.RA118.003617	http://dx.doi.org/10.1074/jbc.RA118.003617			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30171073	Green Published, hybrid			2022-12-28	WOS:000447256000025
J	Fukushima, M; Dasgupta, D; Mauer, AS; Kakazu, E; Nakao, K; Malhi, H				Fukushima, Masanori; Dasgupta, Debanjali; Mauer, Amy S.; Kakazu, Eiji; Nakao, Kazuhiko; Malhi, Harmeet			StAR-related lipid transfer domain 11 (STARD11)-mediated ceramide transport mediates extracellular vesicle biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular vesicles; exosome (vesicle); ceramide; lipid trafficking; endoplasmic reticulum (ER); endosome; lipotoxicity; lipid metabolism; hepatocyte; lipotoxicity; palmitate	PROTEIN CERT; MULTIVESICULAR ENDOSOMES; ENDOPLASMIC-RETICULUM; STRUCTURAL BASIS; FFAT MOTIF; TRAFFICKING; EXOSOMES; RELEASE; CELLS; HEPATOCYTES	Extracellular vesicles are important carriers of cellular materials and have critical roles in cell-to-cell communication in both health and disease. Ceramides are implicated in extracellular vesicle biogenesis, yet the cellular machinery that mediates the formation of ceramide-enriched extracellular vesicles remains unknown. We demonstrate here that the ceramide transport protein StAR-related lipid transfer domain 11 (STARD11) mediates the release of palmitate-stimulated extracellular vesicles having features consistent with exosomes. Using palmitate as a model of lipotoxic diseases and as a substrate for ceramide biosynthesis in human and murine liver cell lines and primary mouse hepatocytes, we found that STARD11-deficient cells release fewer extracellular vesicles. Moreover, STARD11 reciprocally regulated exosome ceramide enrichment and cellular ceramide depletion. We further observed that in STARD11 knockout cells intracellular ceramide accumulates and that this apparent inability to transfer cellular ceramide into extracellular vesicles reduces cellular viability. Using endogenous markers, we uncovered structural and functional colocalization of the endoplasmic reticulum (ER), STARD11, and multivesicular bodies. This colocalization increased following palmitate treatment, suggesting a functional association that may mediate ceramide trafficking from the ER to the multivesicular body. However, the size and number of multivesicular bodies were comparable in WT and STARD11-knockout cells. In conclusion, we propose a model of how STARD11 mediates ceramide trafficking in palmitate-treated cells and stimulates exosome biogenesis.	[Fukushima, Masanori; Dasgupta, Debanjali; Mauer, Amy S.; Kakazu, Eiji; Malhi, Harmeet] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Fukushima, Masanori; Nakao, Kazuhiko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Hepatol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan; [Kakazu, Eiji] Tohoku Univ Hosp, Div Gastroenterol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan	Mayo Clinic; Nagasaki University; Tohoku University	Malhi, H (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	malhi.harmeet@mayo.edu	Dasgupta, Debanjali/AGT-9408-2022	Dasgupta, Debanjali/0000-0001-8307-9719; Malhi, Harmeet/0000-0002-0882-4990	NIDDK, National Institutes of Health [P30DK084567, U24DK100469, UL1TR000135]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111378, U24DK100469, P30DK084567] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Dr. Gregory J. Gores for critical review of the manuscript and Dr. Kentaro Hanada for the gift of GFP-hCERT. CD63-mCherry was a gift from Dr. Mark McNiven, and CD63-GFP was from Addgene. We are also grateful to Dr. David Katzmann and Dr. Brian Davies for useful discussions and insight into MVB formation, and Courtney Hoover for outstanding administrative support. The optical microscopy core of the Mayo Clinic Center for Cell Signaling was supported by Grant P30DK084567 from the NIDDK, National Institutes of Health. The Mayo Clinic Metabolomics Core was supported by Grants U24DK100469 and UL1TR000135 from the NIDDK, National Institutes of Health.	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; De Almeida IT, 2002, CLIN NUTR, V21, P219, DOI 10.1054/clnu.2001.0529; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Friedman JR, 2013, MOL BIOL CELL, V24, P1030, DOI 10.1091/mbc.E12-10-0733; Ghossoub R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4477; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2014, BBA-MOL CELL BIOL L, V1841, P704, DOI 10.1016/j.bbalip.2013.06.006; Hirsova P, 2016, HEPATOLOGY, V64, P2219, DOI 10.1002/hep.28814; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kakazu E, 2016, J LIPID RES, V57, P233, DOI 10.1194/jlr.M063412; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; KOK JW, 1990, EUR J CELL BIOL, V53, P173; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Kumagai K, 2014, J BIOL CHEM, V289, P10748, DOI 10.1074/jbc.M113.528380; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Obata Y, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99680; Pickersgill L, 2007, J BIOL CHEM, V282, P12583, DOI 10.1074/jbc.M611157200; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Stuffers S, 2009, TRAFFIC, V10, P925, DOI 10.1111/j.1600-0854.2009.00920.x; Sugiki T, 2012, J BIOL CHEM, V287, P33706, DOI 10.1074/jbc.M112.367730; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Verma VK, 2016, J HEPATOL, V64, P651, DOI 10.1016/j.jhep.2015.11.020; Zhang JD, 1999, J CELL BIOL, V145, P99, DOI 10.1083/jcb.145.1.99	37	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15277	15289		10.1074/jbc.RA118.002587	http://dx.doi.org/10.1074/jbc.RA118.002587			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30139741	Green Published, hybrid			2022-12-28	WOS:000445998400027
J	Wang, MX; Yuan, ZL; Xie, R; Ma, YL; Liu, XH; Yu, XC				Wang, Mengxi; Yuan, Zenglin; Xie, Rong; Ma, Yinliang; Liu, Xiuhua; Yu, Xiaochun			Structure-function analyses reveal the mechanism of the ARH3-dependent hydrolysis of ADP-ribosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation; protein crystallization; structural biology; crystal structure; DNA damage; DNA damage response; DNA repair	POLY(ADP-RIBOSE); RIBOSE; FAMILY; REVERSIBILITY; INSIGHTS; SERINE	ADP-ribosylation of proteins plays key roles in multiple biological processes, including DNA damage repair. Recent evidence suggests that serine is an important acceptor for ADP-ribosylation, and that serine ADP-ribosylation is hydrolyzed by ADP-ribosylhydrolase 3 (ARH3 or ADPRHL2). However, the structural details in ARH3-mediated hydrolysis remain elusive. Here, we determined the structure of ARH3 in a complex with ADP-ribose (ADPR). Our analyses revealed a group of acidic residues in ARH3 that keep two Mg2+ ions at the catalytic center for hydrolysis of Ser-linked ADP-ribosyl group. In particular, dynamic conformational changes involving Glu(41) were observed in the catalytic center. Our observations suggest that Mg2+ ions together with Glu(41) and water351 are likely to mediate the cleavage of the glycosidic bond in the serine-ADPR substrate. Moreover, we found that ADPR is buried in a groove and forms multiple hydrogen bonds with the main chain and side chains of ARH3 residues. On the basis of these structural findings, we used site-directed mutagenesis to examine the functional roles of key residues in the catalytic pocket of ARH3 in mediating the hydrolysis of ADP-ribosyl from serine and DNA damage repair. Moreover, we noted that ADPR recognition is essential for the recruitment of ARH3 to DNA lesions. Taken together, our study provides structural and functional insights into the molecular mechanism by which ARH3 hydrolyzes the ADP-ribosyl group from serine and contributes to DNA damage repair.	[Wang, Mengxi; Xie, Rong; Ma, Yinliang; Liu, Xiuhua; Yu, Xiaochun] Hebei Univ, Coll Life Sci, Baoding 071000, Hebei, Peoples R China; [Yuan, Zenglin] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Xie, Rong; Ma, Yinliang; Yu, Xiaochun] Beckman Res Inst, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA	Hebei University; Shandong University; City of Hope; Beckman Research Institute of City of Hope	Liu, XH; Yu, XC (corresponding author), Hebei Univ, Coll Life Sci, Baoding 071000, Hebei, Peoples R China.; Yu, XC (corresponding author), Beckman Res Inst, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA.	liuxiuhua_2004@163.com; xyu@coh.org	Yuan, Zenglin/M-8378-2016	Yuan, Zenglin/0000-0003-0517-8249	National Natural Science Foundation of China [81672794, 31570305, 31572269]; "100 Talents Plan" of Hebei Province [E2016100014]; Foundation of Hebei Educational committee [SLRC2017023]; NCI, National Institutes of Health [CA130899, CA132755, CA187209]; NIGMS, National Institutes of Health [GM108467]; Leukemia and Lymphoma Society [1325-15]; NATIONAL CANCER INSTITUTE [R01CA187209, R01CA132755, R01CA130899] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "100 Talents Plan" of Hebei Province; Foundation of Hebei Educational committee; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation of China Grants 81672794, 31570305, and 31572269, the "100 Talents Plan" of Hebei Province Grant E2016100014, Foundation of Hebei Educational committee Grant SLRC2017023, NCI, National Institutes of Health Grants CA130899, CA132755, and CA187209, NIGMS, National Institutes of Health Grant GM108467, and Leukemia and Lymphoma Society Grant 1325-15. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abplanalp J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02253-1; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barkauskaite E, 2015, MOL CELL, V58, P935, DOI 10.1016/j.molcel.2015.05.007; Berthold CL, 2009, P NATL ACAD SCI USA, V106, P14247, DOI 10.1073/pnas.0905906106; Bonfiglio JJ, 2017, MOL CELL, V65, P932, DOI 10.1016/j.molcel.2017.01.003; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Butepage M, 2015, CELLS-BASEL, V4, P569, DOI 10.3390/cells4040569; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fontana P, 2017, ELIFE, V6, DOI 10.7554/eLife.28533; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hottiger MO, 2015, ANNU REV BIOCHEM, V84, P227, DOI 10.1146/annurev-biochem-060614-034506; Jankevicius G, 2013, NAT STRUCT MOL BIOL, V20, P508, DOI 10.1038/nsmb.2523; Kasamatsu A, 2011, J BIOL CHEM, V286, P21110, DOI 10.1074/jbc.M111.237636; Kraus WL, 2015, MOL CELL, V58, P902, DOI 10.1016/j.molcel.2015.06.006; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leidecker O, 2016, NAT CHEM BIOL, V12, P998, DOI 10.1038/nchembio.2180; Leung AKL, 2014, J CELL BIOL, V205, P613, DOI 10.1083/jcb.201402114; Liu C, 2017, NUCLEIC ACIDS RES, V45, P8129, DOI 10.1093/nar/gkx565; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Mashimo M, 2016, CURR PROTEIN PEPT SC, V17, P633, DOI 10.2174/1389203717666160419144603; Mashimo M, 2014, DNA REPAIR, V23, P88, DOI 10.1016/j.dnarep.2014.03.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOSS J, 1985, P NATL ACAD SCI USA, V82, P5603, DOI 10.1073/pnas.82.17.5603; Mueller-Dieckmann C, 2006, P NATL ACAD SCI USA, V103, P15026, DOI 10.1073/pnas.0606762103; Ono T, 2006, P NATL ACAD SCI USA, V103, P16687, DOI 10.1073/pnas.0607911103; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palazzo L, 2018, ELIFE, V7, DOI 10.7554/eLife.34334; Palazzo L, 2017, FEBS J, V284, P2932, DOI 10.1111/febs.14078; Perina D, 2014, DNA REPAIR, V23, P4, DOI 10.1016/j.dnarep.2014.05.003; Sharifi R, 2013, EMBO J, V32, P1225, DOI 10.1038/emboj.2013.51; Slade D, 2011, NATURE, V477, P616, DOI 10.1038/nature10404; Tucker JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050889; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Vyas S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5426	35	16	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14470	14480		10.1074/jbc.RA118.004284	http://dx.doi.org/10.1074/jbc.RA118.004284			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30045870	Green Published, hybrid			2022-12-28	WOS:000444671500025
J	Schopfer, LM; Lockridge, O				Schopfer, Lawrence M.; Lockridge, Oksana			Chlorpyrifos oxon promotes tubulin aggregation via isopeptide cross-linking between diethoxyphospho-Lys and Glu or Asp: Implications for neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tubulin; neurotoxin; protein misfolding; mass spectrometry (MS); Western blot; crosslink; isopeptide; neurotoxicity; organophosphate; protein aggregation	CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; PHOSPHOROFLUORIDATE (DFP)-TREATED HEN; ORGANOPHOSPHORUS NERVE AGENTS; LOW-LEVEL EXPOSURE; MASS-SPECTROMETRY; MICROTUBULE STRUCTURES; BINDING; BRAIN; PHOSPHORYLATION; PESTICIDE	Exposure to organophosphorus toxicants (OP) can have chronic adverse effects that are not explained by inhibition of acetylcholinesterase, the cause of acute OP toxicity. We therefore hypothesized that OP-induced chronic illness is initiated by the formation of organophosphorus adducts on lysine residues in proteins, followed by protein cross-linking and aggregation. Here, Western blots revealed that exposure to the OP chlorpyrifos oxon converted porcine tubulin from its original 55-kDa mass to high-molecular-weight aggregates. Liquid chromatography-tandem MS analysis of trypsin-digested samples identified several diethoxyphospho-lysine residues in the OP-treated tubulin. Using a search approach based on the Batch Tag program, we identified cross-linked peptides and found that these chemically activated lysines reacted with acidic amino acid residues creating -glutamyl-E-lysine or aspartyl-E-lysine isopeptide bonds between - and -tubulin. Of note, these cross-linked tubulin molecules accounted for the high-molecular-weight aggregates. To the best of our knowledge, this is the first report indicating that chlorpyrifos oxon-exposed tubulin protein forms intermolecular cross-links with other tubulin molecules, resulting in high-molecular-weight protein aggregates. It is tempting to speculate that chronic illness from OP exposure may be explained by a mechanism that starts with OP adduct formation on protein lysines followed by protein cross-linking. We further speculate that OP-modified or cross-linked tubulin can impair axonal transport, reduce neuron connections, and result in neurotoxicity.	[Schopfer, Lawrence M.; Lockridge, Oksana] Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Schopfer, LM; Lockridge, O (corresponding author), Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE 68198 USA.	lmschopf@unmc.edu; olockrid@unmc.edu		Lockridge, Oksana/0000-0002-8345-3640	Fred and Pamela Buffett Cancer Center Support Grant from the National Institutes of Health, NCI [P30CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER	Fred and Pamela Buffett Cancer Center Support Grant from the National Institutes of Health, NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Fred and Pamela Buffett Cancer Center Support Grant P30CA036727 from the National Institutes of Health, NCI. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALLISON RD, 1981, J BIOL CHEM, V256, P2988; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Brady ST, 2017, NEUROBIOL DIS, V105, P273, DOI 10.1016/j.nbd.2017.04.010; Brown MA, 1998, J APPL TOXICOL, V18, P393, DOI 10.1002/(SICI)1099-1263(199811/12)18:6<393::AID-JAT528>3.0.CO;2-0; Bui-Nguyen TM, 2014, J PROTEOME RES, V13, P3583, DOI 10.1021/pr5000076; Casida JE, 2004, CHEM RES TOXICOL, V17, P983, DOI 10.1021/tx0499259; CHAIKEN IM, 1969, J BIOL CHEM, V244, P4247; Chalkley RJ, 2005, MOL CELL PROTEOMICS, V4, P1189, DOI 10.1074/mcp.D500001-MCP200; Chen SG, 2013, J PHARMACOL EXP THER, V344, P531, DOI 10.1124/jpet.112.201368; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Choudhary S, 2001, BRAIN RES, V897, P60, DOI 10.1016/S0006-8993(00)03222-4; Crow BS, 2014, ANAL CHEM, V86, P10397, DOI 10.1021/ac502886c; Eyer F, 2009, BIOCHEM PHARMACOL, V78, P531, DOI 10.1016/j.bcp.2009.05.004; Gearhart DA, 2007, TOXICOL APPL PHARM, V218, P20, DOI 10.1016/j.taap.2006.10.008; Grigoryan H, 2008, CHEM-BIOL INTERACT, V175, P180, DOI 10.1016/j.cbi.2008.04.013; Grigoryan H, 2009, ANAL BIOCHEM, V394, P92, DOI 10.1016/j.ab.2009.07.008; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Gupta RP, 1999, ARCH BIOCHEM BIOPHYS, V365, P268, DOI 10.1006/abbi.1999.1165; GUPTA RP, 1995, NEUROCHEM RES, V20, P1095, DOI 10.1007/BF00995565; Hancock DB, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-6; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hayden KM, 2010, NEUROLOGY, V74, P1524, DOI 10.1212/WNL.0b013e3181dd4423; Hernandez CM, 2015, NEUROTOXICOLOGY, V47, P17, DOI 10.1016/j.neuro.2015.01.002; Jiang W, 2010, TOXICOL SCI, V115, P183, DOI 10.1093/toxsci/kfq032; John H, 2018, FORENSIC TOXICOL, V36, P61, DOI 10.1007/s11419-017-0376-7; John H, 2010, ANAL BIOANAL CHEM, V398, P2677, DOI 10.1007/s00216-010-4076-y; Kamel F, 2007, AM J EPIDEMIOL, V165, P364, DOI 10.1093/aje/kwk024; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2011, TRENDS BIOCHEM SCI, V36, P227, DOI 10.1016/j.tibs.2010.09.007; Li B, 2007, ANAL BIOCHEM, V361, P263, DOI 10.1016/j.ab.2006.11.018; Liu M, 2013, ANAL CHEM, V85, P5900, DOI 10.1021/ac400666p; Lockridge O, 2010, CHEM-BIOL INTERACT, V187, P344, DOI 10.1016/j.cbi.2010.03.002; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lotti Marcello, 2005, Toxicol Rev, V24, P37, DOI 10.2165/00139709-200524010-00003; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Meyer A, 2003, ENVIRON HEALTH PERSP, V111, P1871, DOI 10.1289/ehp.6468; MURACHI T, 1965, BIOCHEMISTRY-US, V4, P2815, DOI 10.1021/bi00888a036; MURACHI T, 1970, J BIOCHEM-TOKYO, V68, P239, DOI 10.1093/oxfordjournals.jbchem.a129351; Nemes Z, 2005, ANAL BIOCHEM, V342, P1, DOI 10.1016/j.ab.2004.10.015; Nemes Z, 2004, FASEB J, V18, P1135, DOI 10.1096/fj.04-1493fje; Noort D, 2009, ARCH TOXICOL, V83, P1031, DOI 10.1007/s00204-009-0456-5; Onder S, 2018, CHEM RES TOXICOL, V31, P520, DOI 10.1021/acs.chemrestox.8b00083; Onder S, 2017, CHEM RES TOXICOL, V30, P2218, DOI 10.1021/acs.chemrestox.7b00288; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rauh VA, 2006, PEDIATRICS, V118, pE1845, DOI 10.1542/peds.2006-0338; Rauh VA, 2015, NEUROTOXICOLOGY, V51, P80, DOI 10.1016/j.neuro.2015.09.004; Rauh VA, 2012, P NATL ACAD SCI USA, V109, P7871, DOI 10.1073/pnas.1203396109; Recktenwald CV, 2016, J BIOL CHEM, V291, P13580, DOI 10.1074/jbc.M116.726406; Richardson RJ, 2013, CHEM-BIOL INTERACT, V203, P238, DOI 10.1016/j.cbi.2012.10.024; Ross SM, 2013, CRIT REV TOXICOL, V43, P21, DOI 10.3109/10408444.2012.738645; Sanger F., 1963, P CHEM SOC, V5, P76; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Schmidt C, 2014, ANAL BIOANAL CHEM, V406, P5171, DOI 10.1007/s00216-014-7706-y; Schuh RA, 2002, TOXICOL APPL PHARM, V182, P176, DOI 10.1006/taap.2002.9445; Speed HE, 2012, TOXICOL SCI, V125, P196, DOI 10.1093/toxsci/kfr253; TARCSA E, 1990, ANAL BIOCHEM, V186, P135, DOI 10.1016/0003-2697(90)90586-X; Trnka MJ, 2014, MOL CELL PROTEOMICS, V13, P420, DOI 10.1074/mcp.M113.034009; Williams NH, 2007, ARCH TOXICOL, V81, P627, DOI 10.1007/s00204-007-0191-8; Zamponi E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188340	59	15	15	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13566	13577		10.1074/jbc.RA118.004172	http://dx.doi.org/10.1074/jbc.RA118.004172			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30006344	Green Published, hybrid			2022-12-28	WOS:000443375500017
J	Gari, RRS; Seelheim, P; Marsh, B; Kiessling, V; Creutz, CE; Tamm, LK				Gari, Raghavendar Reddy Sanganna; Seelheim, Patrick; Marsh, Brendan; Kiessling, Volker; Creutz, Carl E.; Tamm, Lukas K.			Quaternary structure of the small amino acid transporter OprG from Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						outer membrane; membrane protein; Pseudomonas aeruginosa (P; aeruginosa); transporter; atomic force microscopy (AFM); single-molecule biophysics; fluorescence; chemical modification	OUTER-MEMBRANE PROTEIN; WEAKLY STABLE REGIONS; PROLINE RESIDUES; BETA-BARREL; PORIN; RESISTANCE; DOMAINS; GENES; FORMS; OMPW	Pseudomonas aeruginosa is an opportunistic human pathogen that causes nosocomial infections. The P. aeruginosa outer membrane contains specific porins that enable substrate uptake, with the outer membrane protein OprG facilitating transport of small, uncharged amino acids. However, the pore size of an eight-stranded -barrel monomer of OprG is too narrow to accommodate even the smallest transported amino acid, glycine, raising the question of how OprG facilitates amino acid uptake. Pro-92 of OprG is critically important for amino acid transport, with a P92A substitution inhibiting transport and the NMR structure of this variant revealing that this substitution produces structural changes in the barrel rim and restricts loop motions. OprG may assemble into oligomers in the outer membrane (OM) whose subunit interfaces could form a transport channel. Here, we explored the contributions of the oligomeric state and the extracellular loops to OprG's function. Using chemical cross-linking to determine the oligomeric structures of both WT and P92A OprG in native outer membranes and atomic force microscopy, and single-molecule fluorescence of the purified proteins reconstituted into lipid bilayers, we found that both protein variants form oligomers, supporting the notion that subunit interfaces in the oligomer could provide a pathway for amino acid transport. Furthermore, performing transport assays with loop-deleted OprG variants, we found that these variants also can transport small amino acids, indicating that the loops are not solely responsible for substrate transport. We propose that OprG functions as an oligomer and that conformational changes in the barrel-loop region might be crucial for its activity.	[Gari, Raghavendar Reddy Sanganna; Seelheim, Patrick; Kiessling, Volker; Tamm, Lukas K.] Univ Virginia, Ctr Cell & Membrane Physiol, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Creutz, Carl E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Marsh, Brendan] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 OWA, England	University of Virginia; University of Virginia; University of Cambridge	Tamm, LK (corresponding author), Univ Virginia, Ctr Cell & Membrane Physiol, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	lkt2e@virginia.edu			National Institutes of Health [R01 GM051329]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051329] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM051329. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benz R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143557; Blackburn MR, 2018, GLYCOBIOLOGY, V28, P108, DOI 10.1093/glycob/cwx096; BRANDL CJ, 1986, P NATL ACAD SCI USA, V83, P917, DOI 10.1073/pnas.83.4.917; Catel-Ferreira M, 2016, FEBS LETT, V590, P224, DOI 10.1002/1873-3468.12050; CHUNG SH, 1991, J NEUROSCI METH, V40, P71, DOI 10.1016/0165-0270(91)90118-J; Clifton LA, 2015, ANGEW CHEM INT EDIT, V54, P11952, DOI 10.1002/anie.201504287; CONSLER TG, 1991, BIOCHEMISTRY-US, V30, P1291, DOI 10.1021/bi00219a019; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381; EPANECHN.VA, 1969, THEOR PROBAB APPL+, V14, P153, DOI 10.1137/1114019; Gari RRS, 2013, J BIOL CHEM, V288, P16848, DOI 10.1074/jbc.M113.471870; Gensberg K, 1999, J ANTIMICROB CHEMOTH, V43, P607, DOI 10.1093/jac/43.4.607; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hancock REW, 2002, ANNU REV MICROBIOL, V56, P17, DOI 10.1146/annurev.micro.56.012302.160310; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Kang CI, 2003, CLIN INFECT DIS, V37, P745, DOI 10.1086/377200; Kiessling V, 2006, BIOPHYS J, V91, P3313, DOI 10.1529/biophysj.106.091421; Kim KH, 2012, PROTEIN SCI, V21, P751, DOI 10.1002/pro.2069; Kucharska I, 2015, STRUCTURE, V23, P2234, DOI 10.1016/j.str.2015.10.009; Marsh BP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19379-x; MASUDA N, 1995, ANTIMICROB AGENTS CH, V39, P645, DOI 10.1128/AAC.39.3.645; McPhee JB, 2009, FEMS MICROBIOL LETT, V296, P241, DOI 10.1111/j.1574-6968.2009.01651.x; Mitchell LA, 2013, ACS SYNTH BIOL, V2, P473, DOI 10.1021/sb300131w; Muller DJ, 2008, NAT NANOTECHNOL, V3, P261, DOI 10.1038/nnano.2008.100; Naveed H, 2014, CURR PHARM DESIGN, V20, P1268, DOI 10.2174/13816128113199990071; Naveed H, 2009, P NATL ACAD SCI USA, V106, P12735, DOI 10.1073/pnas.0902169106; Nitao LK, 1998, BIOCHEMISTRY-US, V37, P16704, DOI 10.1021/bi9817212; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Pi J, 1998, J BACTERIOL, V180, P5515, DOI 10.1128/JB.180.21.5515-5519.1998; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; ROCQUE WJ, 1989, BIOCHEMISTRY-US, V28, P3738, DOI 10.1021/bi00435a017; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Schwarzer TS, 2017, PROTEIN EXPRES PURIF, V132, P171, DOI 10.1016/j.pep.2017.01.012; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; SMITH AW, 1989, NUCLEIC ACIDS RES, V17, P10509, DOI 10.1093/nar/17.24.10509; Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0; Subburaj Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9042; Touw DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015016; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Visudtiphole V, 2005, BIOCHEM J, V392, P375, DOI 10.1042/BJ20051257; YATES JM, 1989, FEMS MICROBIOL LETT, V58, P259	44	3	3	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17267	17277		10.1074/jbc.RA118.004461	http://dx.doi.org/10.1074/jbc.RA118.004461			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30237175	Green Published, hybrid			2022-12-28	WOS:000449466500025
J	Jin, CS; Barone, A; Boren, T; Teneberg, S				Jin, Chunsheng; Barone, Angela; Boren, Thomas; Teneberg, Susann			Helicobacter pylori-binding nonacid glycosphingolipids in the human stomach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Helicobacter pylori; mass spectrometry (MS); glycolipid structure; adhesin; carbohydrate structure; glycoconjugate; virulence factor; gastric mucosa; glycosphingolipid characterization; H; pylori BabA adhesin; Human gastric glycosphingolipids; microbial adhesion	GROUP-RELATED ANTIGENS; BLOOD-GROUP ANTIGENS; SIALYL-LEWIS-X; MASS-SPECTROMETRY; EPITHELIAL-CELLS; SMALL-INTESTINE; EXPRESSION; GENE; RECEPTOR; ADHESIN	Helicobacter pylori has a number of well-characterized carbohydrate-binding adhesins (BabA, SabA, and LabA) that promote adhesion to the gastric mucosa. In contrast, information on the glycoconjugates present in the human stomach remains unavailable. Here, we used MS and binding of carbohydrate-recognizing ligands to characterize the glycosphingolipids of three human stomachs from individuals with different blood group phenotypes (O(Rh-)P, A(Rh+)P, and A(Rh+)p), focusing on compounds recognized by H. pylori. We observed a high degree of structural complexity, and the composition of glycosphingolipids differed among individuals with different blood groups. The type 2 chain was the dominating core chain of the complex glycosphingolipids in the human stomach, in contrast to the complex glycosphingolipids in the human small intestine, which have mainly a type 1 core. H. pylori did not bind to the O(Rh-)P stomach glycosphingolipids, whose major complex glycosphingolipids were neolactotetraosylceramide, the Le(x), Le(a), and H type 2 pentaosylceramides, and the Le(y) hexaosylceramide. Several H. pylori-binding compounds were present among the A(Rh+)P and A(Rh+)p stomach glycosphingolipids. Ligands for BabA-mediated binding of H. pylori were the Le(b) hexaosylceramide, the H type 1 pentaosylceramide, and the A type 1/ALe(b) heptaosylceramide. Additional H. pylori-binding glycosphingolipids recognized by BabA-deficient strains were lactosylceramide, lactotetraosylceramide, the x(2) pentaosylceramide, and neolactohexaosylceramide. Our characterization of human gastric receptors required for H. pylori adhesion provides a basis for the development of specific compounds that inhibit the binding of this bacterium to the human gastric mucosa.	[Jin, Chunsheng; Barone, Angela; Teneberg, Susann] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden; [Boren, Thomas; Teneberg, Susann] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden	University of Gothenburg; Umea University	Teneberg, S (corresponding author), Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, POB 440, S-40530 Gothenburg, Sweden.	Susann.Teneberg@medkem.gu.se						Angstrom J, 1998, GLYCOBIOLOGY, V8, P297, DOI 10.1093/glycob/8.4.297; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Azevedo NF, 2009, HELICOBACTER, V14, P1, DOI 10.1111/j.1523-5378.2009.00703.x; Barone A, 2013, J BIOL CHEM, V288, P10035, DOI 10.1074/jbc.M112.436162; Benktander J, 2018, VIRULENCE, V9, P738, DOI 10.1080/21505594.2018.1440171; Benktander J, 2012, J BIOL CHEM, V287, P31712, DOI 10.1074/jbc.M112.387654; BJORK S, 1987, J BIOL CHEM, V262, P6758; de Mattos CCB, 2017, INFECT GENET EVOL, V53, P167, DOI 10.1016/j.meegid.2017.05.025; BREIMER ME, 1980, FEBS LETT, V118, P209, DOI 10.1016/0014-5793(80)80220-1; Breimer ME, 2012, GLYCOBIOLOGY, V22, P1721, DOI 10.1093/glycob/cws115; Chai WG, 2001, ANAL CHEM, V73, P651, DOI 10.1021/ac0010126; Chester MA, 1998, EUR J BIOCHEM, V257, P293; Ciopraga J, 2000, J BIOCHEM, V128, P855, DOI 10.1093/oxfordjournals.jbchem.a022824; Cooling L, 2015, CLIN MICROBIOL REV, V28, P801, DOI 10.1128/CMR.00109-14; Mattos Luiz Carlos de, 2016, Rev. Bras. Hematol. Hemoter., V38, P331, DOI 10.1016/j.bjhh.2016.07.005; Dossumbekova A, 2006, J INFECT DIS, V194, P1346, DOI 10.1086/508426; FALK KE, 1979, FEBS LETT, V101, P273, DOI 10.1016/0014-5793(79)81024-8; Fei YY, 2011, ANAL CHEM, V83, P6336, DOI 10.1021/ac201260c; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; Gupta VR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000073; HOLGERSSON J, 1991, J BIOCHEM-TOKYO, V110, P120, DOI 10.1093/oxfordjournals.jbchem.a123530; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Javaheri A, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.189; Johansson MM, 2015, GLYCOCONJUGATE J, V32, P393, DOI 10.1007/s10719-015-9604-8; Karlsson H, 2010, GLYCOBIOLOGY, V20, P1103, DOI 10.1093/glycob/cwq070; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; KARLSSON KA, 1973, BIOCHIM BIOPHYS ACTA, V306, P317, DOI 10.1016/0005-2760(73)90237-3; KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640; Koniger V, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.188; KOERNER TAW, 1983, BIOCHEMISTRY-US, V22, P2676, DOI 10.1021/bi00280a014; Lai CH, 2008, INFECT IMMUN, V76, P3293, DOI 10.1128/IAI.00365-08; LINGWOOD CA, 1992, INFECT IMMUN, V60, P2470, DOI 10.1128/IAI.60.6.2470-2474.1992; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; MARCUS DM, 1976, P NATL ACAD SCI USA, V73, P3263, DOI 10.1073/pnas.73.9.3263; Marginean MO, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007612; Miller-Podraza H, 2005, J BIOL CHEM, V280, P19695, DOI 10.1074/jbc.M412688200; MOLLICONE R, 1985, LAB INVEST, V53, P219; MOLLICONE R, 1986, GLYCOCONJUGATE J, V3, P187, DOI 10.1007/BF01049376; Moonens K, 2016, CELL HOST MICROBE, V19, P55, DOI 10.1016/j.chom.2015.12.004; MURATA K, 1992, AM J CLIN PATHOL, V98, P67, DOI 10.1093/ajcp/98.1.67; Odenbreit S, 2002, INT J MED MICROBIOL, V292, P257, DOI 10.1078/1438-4221-00205; Odenbreit S, 1999, MOL MICROBIOL, V31, P1537, DOI 10.1046/j.1365-2958.1999.01300.x; Pieters RJ, 2011, ADV EXP MED BIOL, V715, P227, DOI 10.1007/978-94-007-0940-9_14; Roche N, 2007, MICROBES INFECT, V9, P605, DOI 10.1016/j.micinf.2007.01.023; Rossez Y, 2014, J INFECT DIS, V210, P1286, DOI 10.1093/infdis/jiu239; SAKAMOTO J, 1989, CANCER RES, V49, P745; SAMUELSSON BE, 1990, METHOD ENZYMOL, V193, P623, DOI 10.1016/0076-6879(90)93442-N; Schraw W, 2002, J BIOL CHEM, V277, P34642, DOI 10.1074/jbc.M203466200; Sezgin E, 2017, NAT REV MOL CELL BIO, V18, P361, DOI 10.1038/nrm.2017.16; Sheu BS, 2006, AM J GASTROENTEROL, V101, P36, DOI 10.1111/j.1572-0241.2006.00358.x; TENEBERG S, 1994, J BIOL CHEM, V269, P8554; Teneberg S, 2002, J BIOL CHEM, V277, P19709, DOI 10.1074/jbc.M201113200; Teneberg S, 2009, TOP CURR CHEM, V288, P121, DOI 10.1007/128_2008_14; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; TORRADO J, 1989, AM J CLIN PATHOL, V91, P249, DOI 10.1093/ajcp/91.3.249; Waldi D., 1962, DUNNSCHICHT CHROMATO, P496; Wang F, 2014, CANCER LETT, V345, P196, DOI 10.1016/j.canlet.2013.08.016	57	8	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17248	17266		10.1074/jbc.RA118.004854	http://dx.doi.org/10.1074/jbc.RA118.004854			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30232154	Green Published, hybrid			2022-12-28	WOS:000449466500024
J	Pan, WT; Zhang, NS; Liu, WJ; Liu, JB; Zhou, LQ; Liu, Y; Yang, M				Pan, Wenting; Zhang, Nasha; Liu, Wenjuan; Liu, Jibing; Zhou, Liqing; Liu, Yang; Yang, Ming			The long noncoding RNA GAS8-AS1 suppresses hepatocarcinogenesis by epigenetically activating the tumor suppressor GAS8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						long noncoding RNA (long ncRNA; lncRNA); hepatocellular carcinoma; histone modification; tumor suppressor gene; apoptosis; GAS8; GAS8-AS1; MLL1; WDR5; epigenetics	H3K4 METHYLTRANSFERASE ACTIVITY; PRIMARY CILIARY DYSKINESIA; DYNEIN REGULATORY COMPLEX; MIXED-LINEAGE LEUKEMIA; HEPATOCELLULAR-CARCINOMA; LNCRNA HOTAIR; CANCER; MLL1; MUTATIONS; WDR5	Long noncoding RNAs (lncRNAs) are vital players in cancers, including hepatocellular carcinoma (HCC). We previously identified an lncRNA, GAS8-AS1, that is located in intron 2 of GAS8. However, its involvement in HCC is still largely unknown. In this study, we report that both GAS8-AS1 and its host gene GAS8 act as HCC tumor suppressors. We found that expression of GAS8-AS1 or GAS8 is significantly decreased in HCC tissues and is associated with a poor prognosis among HCC patients. Interestingly, lncRNA GAS8-AS1 could promote GAS8 transcription. We detected a CpG island in the GAS8 promoter, but lncRNA GAS8-AS1 did not affect DNA methylation at this GAS8 promoter site. Moreover, we identified two GAS8-AS1-interacting proteins, mixed-lineage leukemia 1 (MLL1), a histone 3 Lys-4 (H3K4) methyltransferase, and its partner WD-40 repeat protein 5 (WDR5). RNA pulldown, ChIP, and RNA immunoprecipitation assays revealed that GAS8-AS1 is required for maintaining the GAS8 promoter in an open chromatin state by recruiting the MLL1/WDR5 complex and for enhancing RNA polymerase II activity and GAS8 transcription. Of note, GAS8-AS1-dependent GAS8 hyperactivation inhibited malignant transformation of hepatocytes. Our results provide important insights into how lncRNA GAS8-AS1 suppresses HCC development and suggest potential strategies for treating patients with liver cancer.	[Pan, Wenting] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100096, Peoples R China; [Pan, Wenting; Zhang, Nasha; Liu, Wenjuan; Liu, Jibing; Liu, Yang; Yang, Ming] Shandong Univ, Shandong Acad Med Sci, Shandong Canc Hosp, Shandong Prov Key Lab Radiat Oncol,Canc Res Ctr, Jinan 250117, Shandong, Peoples R China; [Zhou, Liqing] Huaian 2 Hosp, Dept Radiat Oncol, Huaian 223002, Jiangsu, Peoples R China	Beijing University of Chemical Technology; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Jinan	Yang, M (corresponding author), Shandong Univ, Shandong Acad Med Sci, Shandong Canc Hosp, Shandong Prov Key Lab Radiat Oncol,Canc Res Ctr, Jinan 250117, Shandong, Peoples R China.	aaryoung@yeah.net	liu, wen/HGE-3071-2022; Yang, Ming/G-4705-2012	Yang, Ming/0000-0002-7722-7487				Alicea-Velazquez NL, 2016, J BIOL CHEM, V291, P22357, DOI 10.1074/jbc.M116.752626; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Cao F, 2014, MOL CELL, V53, P247, DOI 10.1016/j.molcel.2013.12.001; Chojnacki S, 2017, NUCLEIC ACIDS RES, V45, pW550, DOI 10.1093/nar/gkx273; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hill KL, 2000, J BIOL CHEM, V275, P39369, DOI 10.1074/jbc.M006907200; Jeanson L, 2016, HUM MUTAT, V37, P776, DOI 10.1002/humu.23005; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Lewis WR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006220; Mattick JS, 2015, NAT STRUCT MOL BIOL, V22, P5, DOI 10.1038/nsmb.2942; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Muppirala UK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-489; Nishimura N, 2008, ARCH BIOCHEM BIOPHYS, V474, P136, DOI 10.1016/j.abb.2008.03.032; Olbrich H, 2015, AM J HUM GENET, V97, P546, DOI 10.1016/j.ajhg.2015.08.012; Pan WT, 2016, HUM MOL GENET, V25, P1875, DOI 10.1093/hmg/ddw056; Pan WT, 2016, MOL CARCINOGEN, V55, P90, DOI 10.1002/mc.22261; Peng WX, 2017, ONCOGENE, V36, P5661, DOI 10.1038/onc.2017.184; Ren YL, 2017, J BIOL CHEM, V292, P17939, DOI 10.1074/jbc.M116.773978; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Sanfilippo PG, 2014, CLIN EXP OPHTHALMOL, V42, P78, DOI 10.1111/ceo.12150; Tragante V, 2014, GENET EPIDEMIOL, V38, P275, DOI 10.1002/gepi.21802; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang XY, 2015, J BIOL CHEM, V290, P3925, DOI 10.1074/jbc.M114.596866; Wheeler HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021920; Whitmore SA, 1998, GENOMICS, V52, P325, DOI 10.1006/geno.1998.5457; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yang XY, 2016, AM J HUM GENET, V99, P275, DOI 10.1016/j.ajhg.2016.05.029; Yeh SD, 2002, J BIOL CHEM, V277, P6311, DOI 10.1074/jbc.M106941200; Zhang XJ, 2014, CARCINOGENESIS, V35, P2062, DOI 10.1093/carcin/bgu103; Zhu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep31969	38	35	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17154	17165		10.1074/jbc.RA118.003055	http://dx.doi.org/10.1074/jbc.RA118.003055			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30228180	hybrid, Green Published			2022-12-28	WOS:000449466500016
J	Checco, JW; Zhang, G; Yuan, WD; Le, ZW; Jing, J; Sweedler, JV				Checco, James W.; Zhang, Guo; Yuan, Wang-ding; Le, Zi-wei; Jing, Jian; Sweedler, Jonathan V.			Aplysia allatotropin-related peptide and its newly identified d-amino acid-containing epimer both activate a receptor and a neuronal target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						post-translational modification (PTM); neuropeptide; peptide hormone; cell signaling; G protein-coupled receptor (GPCR); mass spectrometry (MS); allatotropin; d-amino acid-containing peptides; isomerization	CRUSTACEAN HYPERGLYCEMIC HORMONE; AMINOPEPTIDASE-LIKE ACTIVITY; BAG CELL PEPTIDE; CONTAINING NEUROPEPTIDE; 7-TRANSMEMBRANE RECEPTORS; EXCITATORY PEPTIDE; MOLECULAR-CLONING; MANDUCA-SEXTA; ISOMERIZATION; CALIFORNICA	l- to d-residue isomerization is a post-translational modification (PTM) present in neuropeptides, peptide hormones, and peptide toxins from several animals. In most cases, the d-residue is critical for the biological function of the resulting d-amino acid-containing peptide (DAACP). Here, we provide an example in native neuropeptides in which the DAACP and its all-l-amino acid epimer are both active at their newly identified receptor in vitro and at a neuronal target associated with feeding behavior. On the basis of sequence similarity to a known DAACP from cone snail venom, we hypothesized that allatotropin-related peptide (ATRP), a neuropeptide from the neuroscience model organism Aplysia californica, may form multiple diastereomers in the Aplysia central nervous system. We determined that ATRP exists as a d-amino acid-containing peptide (d2-ATRP) and identified a specific G protein-coupled receptor as an ATRP receptor. Interestingly, unlike many previously reported DAACPs and their all-l-residue analogs, both l-ATRP and d2-ATRP were potent agonists of this receptor and active in electrophysiological experiments. Finally, d2-ATRP was much more stable than its all-l-residue counterpart in Aplysia plasma, suggesting that in the case of ATRP, the primary role of the l- to d-residue isomerization may be to protect this peptide from aminopeptidase activity in the extracellular space. Our results indicate that l- to d-residue isomerization can occur even in an all-l-residue peptide with a known biological activity and that in some cases, this PTM may help modulate peptide signal lifetime in the extracellular space rather than activity at the cognate receptor.	[Checco, James W.; Sweedler, Jonathan V.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Zhang, Guo; Yuan, Wang-ding; Le, Zi-wei; Jing, Jian] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Inst Brain Sci,Adv Inst Life Sci,Sch Life Sci, Collaborat Innovat Ctr Chem Life Sci,Jiangsu Engn, Nanjing 210046, Jiangsu, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Nanjing University	Sweedler, JV (corresponding author), Univ Illinois, Dept Chem, Urbana, IL 61801 USA.; Jing, J (corresponding author), Nanjing Univ, Sch Life Sci, Nanjing 210046, Jiangsu, Peoples R China.	jingj01@live.com; jsweedle@illinois.edu	Sweedler, Jonathan V/A-9405-2009; Checco, James W./AAY-3374-2020	Sweedler, Jonathan V/0000-0003-3107-9922; Checco, James W./0000-0003-1165-6163; Zhang, Guo/0000-0002-6828-5968; Jing, Jian/0000-0003-1422-143X	National Institutes of Health from the National Institute on Drug Abuse [P30 DA018310]; National Institutes of Health from the NINDS [R01 NS031609]; National Resource for Aplysia - Public Health Service [P40 OD010952]; National Natural Science Foundation of China [31671097, 31371104, J1103512, J1210026]; Beckman Institute Postdoctoral Fellowship - Beckman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010952] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute on Drug Abuse; National Institutes of Health from the NINDS; National Resource for Aplysia - Public Health Service; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beckman Institute Postdoctoral Fellowship - Beckman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant P30 DA018310 from the National Institute on Drug Abuse and National Institutes of Health Grant R01 NS031609 from the NINDS (to J. V. S.); by the National Resource for Aplysia, funded by Public Health Service Grant P40 OD010952; and by National Natural Science Foundation of China Grants 31671097 and 31371104 (to J. J.), J1103512, and J1210026 (to the School of Life Sciences). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by a Beckman Institute Postdoctoral Fellowship, funded by a Beckman Foundation gift to the Beckman Institute for Advanced Science and Technology at the University of Illinois at Urbana-Champaign.	Bai L, 2013, J BIOL CHEM, V288, P32837, DOI 10.1074/jbc.M113.486670; Bauknecht P, 2015, CELL REP, V12, P684, DOI 10.1016/j.celrep.2015.06.052; BAWAB W, 1992, BIOCHEM J, V286, P967, DOI 10.1042/bj2860967; BRANTON WD, 1978, NATURE, V274, P70, DOI 10.1038/274070a0; Broichhagen J, 2015, ANGEW CHEM INT EDIT, V54, P15565, DOI 10.1002/anie.201506384; Buczek O, 2005, J BIOL CHEM, V280, P4247, DOI 10.1074/jbc.M405835200; Checco JW, 2018, ACS CHEM BIOL, V13, P1343, DOI 10.1021/acschembio.8b00167; Donnelly D, 2012, BRIT J PHARMACOL, V166, P27, DOI 10.1111/j.1476-5381.2011.01687.x; Dutertre S, 2006, FEBS LETT, V580, P3860, DOI 10.1016/j.febslet.2006.06.011; Dutertre S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4521; Elekonich MM, 2003, PEPTIDES, V24, P1623, DOI 10.1016/j.peptides.2003.08.011; ERSPAMER V, 1989, P NATL ACAD SCI USA, V86, P5188, DOI 10.1073/pnas.86.13.5188; Alzugaray ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077520; Ewing MA, 2008, ANAL CHEM, V80, P2874, DOI 10.1021/ac7025173; Fricker LD, 2018, PHARMACOL THERAPEUT, V185, P26, DOI 10.1016/j.pharmthera.2017.11.006; HECK SD, 1994, SCIENCE, V266, P1065, DOI 10.1126/science.7973665; HURWITZ I, 1994, J NEUROPHYSIOL, V71, P1514, DOI 10.1152/jn.1994.71.4.1514; Iwakoshi E, 2000, PEPTIDES, V21, P623, DOI 10.1016/S0196-9781(00)00201-1; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Jia CX, 2014, ANAL CHEM, V86, P2972, DOI 10.1021/ac4033824; Jing JA, 2010, J NEUROSCI, V30, P16545, DOI 10.1523/JNEUROSCI.4264-10.2010; KAMATANI Y, 1989, BIOCHEM BIOPH RES CO, V160, P1015, DOI 10.1016/S0006-291X(89)80103-2; KATAOKA H, 1989, SCIENCE, V243, P1481, DOI 10.1126/science.243.4897.1481; Kohlbacher O, 2007, BIOINFORMATICS, V23, pE191, DOI 10.1093/bioinformatics/btl299; Livnat I, 2016, ANAL CHEM, V88, P11868, DOI 10.1021/acs.analchem.6b03658; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; MILLER SM, 1995, DRUG DEVELOP RES, V35, P20, DOI 10.1002/ddr.430350105; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; Mirabeau O, 2013, P NATL ACAD SCI USA, V110, pE2028, DOI 10.1073/pnas.1219956110; Morishita F, 1997, BIOCHEM BIOPH RES CO, V240, P354, DOI 10.1006/bbrc.1997.7659; Morishita F, 2012, PEPTIDES, V38, P291, DOI 10.1016/j.peptides.2012.08.025; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; Ollivaux C, 2009, FEBS J, V276, P4790, DOI 10.1111/j.1742-4658.2009.07180.x; Pisarewicz K, 2005, J AM CHEM SOC, V127, P6207, DOI 10.1021/ja050088m; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; RICHTER K, 1987, SCIENCE, V238, P200, DOI 10.1126/science.3659910; Robinson SD, 2017, GEN COMP ENDOCR, V244, P11, DOI 10.1016/j.ygcen.2015.07.012; ROTHMAN BS, 1992, J BIOL CHEM, V267, P25135; Santini MS, 2007, J EXP BIOL, V210, P1986, DOI 10.1242/jeb.004291; Serrano L, 2003, J EXP BIOL, V206, P979, DOI 10.1242/jeb.00178; Sheeley SA, 2005, ANALYST, V130, P1198, DOI 10.1039/b504717j; Shigeto M, 2008, J PHARMACOL SCI, V108, P274, DOI 10.1254/jphs.08090FP; Soyez D, 2000, J BIOL CHEM, V275, P37870, DOI 10.1074/jbc.M007302200; SOYEZ D, 1994, J BIOL CHEM, V269, P18295; SQUIRE CR, 1991, J BIOL CHEM, V266, P22355; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; Tao YQ, 2014, ANAL CHEM, V86, P9733, DOI 10.1021/ac502296c; Tao YQ, 2012, ANAL CHEM, V84, P6814, DOI 10.1021/ac3013434; Torres AM, 2002, FEBS LETT, V524, P172, DOI 10.1016/S0014-5793(02)03050-8; Trinquet E, 2006, ANAL BIOCHEM, V358, P126, DOI 10.1016/j.ab.2006.08.002; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; VEENSTRA JA, 1994, J EXP BIOL, V188, P347; Verlinden H, 2015, J INSECT PHYSIOL, V80, P2, DOI 10.1016/j.jinsphys.2015.04.004; Wickham L, 1999, COMP BIOCHEM PHYS B, V124, P429, DOI 10.1016/S0305-0491(99)00136-4; Wisner A, 2006, P NATL ACAD SCI USA, V103, P17979, DOI 10.1073/pnas.0605865103; Wood DE, 2002, J NEUROSCI, V22, P4185, DOI 10.1523/JNEUROSCI.22-10-04185.2002; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; YASUDA A, 1994, GEN COMP ENDOCR, V95, P387, DOI 10.1006/gcen.1994.1138; Zappulla JP, 1999, J NEUROSCI, V19, P4280	60	18	18	4	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16862	16873		10.1074/jbc.RA118.004367	http://dx.doi.org/10.1074/jbc.RA118.004367			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30194283	Green Published, hybrid			2022-12-28	WOS:000448515100026
J	Franco, LVR; Su, CH; McStay, GP; Yu, GJ; Tzagoloff, A				Franco, Leticia Veloso R.; Su, Chen-Hsien; McStay, Gavin P.; Yu, George J.; Tzagoloff, Alexander			Cox2p of yeast cytochrome oxidase assembles as a stand-alone subunit with the Cox1p and Cox3p modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; cytochrome c oxidase (complex IV); yeast genetics; mitochondrial respiratory chain complex; mitochondrial DNA (mtDNA); cytochrome oxidase assembly; Cox2p module; biogenesis; Saccharomyces cerevisiae	MITOCHONDRIAL PROTEIN-SYNTHESIS; C-OXIDASE; SACCHAROMYCES-CEREVISIAE; INNER MEMBRANE; ATP SYNTHASE; TRANSLATION; MATURATION; HEME; SUPERCOMPLEX; BIOGENESIS	Cytochrome oxidase (COX) is a hetero-oligomeric complex of the mitochondrial inner membrane that reduces molecular oxygen to water, a reaction coupled to proton transfer from the mitochondrial matrix to the intermembrane space. In the yeast Saccharomyces cerevisiae, COX is composed of 11-13 different polypeptide subunits. Here, using pulse labeling of mitochondrial gene products in isolated yeast mitochondria, combined with purification of tagged COX subunits and ancillary factors, we studied the Cox2p assembly intermediates. Analysis of radiolabeled Cox2p obtained in pulldown assays by native gel electrophoresis revealed the existence of several assembly intermediates, the largest of which had an estimated mass of 450-550 kDa. None of the other known subunits of COX were present in these Cox2p intermediates. This was also true for the several ancillary factors having still undefined functions in COX assembly. In agreement with earlier evidence, Cox18p and Cox20p, previously shown to be involved in processing and in membrane insertion of the Cox2p precursor, were found to be associated with the two largest Cox2p intermediates. A small fraction of the Cox2p module contained Sco1p and Coa6p, which have been implicated in metalation of the binuclear copper site on this subunit. Our results indicate that following its insertion into the mitochondrial inner membrane, Cox2p assembles as a stand-alone protein with the compositionally more complex Cox1p and Cox3p modules.	[Franco, Leticia Veloso R.; Su, Chen-Hsien; Yu, George J.; Tzagoloff, Alexander] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [McStay, Gavin P.] Staffordshire Univ, Dept Biol Sci, Stoke On Trent ST4 2DF, Staffs, England	Columbia University; Staffordshire University	Tzagoloff, A (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	spud@columbia.edu	McStay, Gavin/K-9574-2013; Franco, Leticia/J-2531-2012	McStay, Gavin/0000-0003-1363-8719; 	National Institutes of Health [5R01GM111864]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 5R01GM111864. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aich A, 2018, ELIFE, V7, DOI 10.7554/eLife.32572; Baertling F, 2015, HUM MUTAT, V36, P34, DOI 10.1002/humu.22715; Bareth B, 2013, MOL CELL BIOL, V33, P4128, DOI 10.1128/MCB.00747-13; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Bonnefoy Nathalie, 2007, Methods Mol Biol, V372, P153, DOI 10.1007/978-1-59745-365-3_11; Bourens M, 2017, J BIOL CHEM, V292, P7774, DOI 10.1074/jbc.M117.778514; Carlson CG, 2003, J BIOL CHEM, V278, P3770, DOI 10.1074/jbc.M209893200; Church C, 2005, J BIOL CHEM, V280, P1854, DOI 10.1074/jbc.M410726200; Church C, 1996, J BIOL CHEM, V271, P18499, DOI 10.1074/jbc.271.31.18499; DECOSTER E, 1990, MOL GEN GENET, V224, P111, DOI 10.1007/BF00259457; Elliott LE, 2012, GENETICS, V190, P559, DOI 10.1534/genetics.111.135665; Esser K, 1996, MOL GEN GENET, V252, P437, DOI 10.1007/s004380050248; Fontanesi F, 2011, J BIOL CHEM, V286, P555, DOI 10.1074/jbc.M110.188805; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; Fox TD, 2012, GENETICS, V192, P1203, DOI 10.1534/genetics.112.141267; Ghosh A, 2016, HUM MOL GENET, V25, P660, DOI 10.1093/hmg/ddv503; Glerum DM, 1996, J BIOL CHEM, V271, P20531, DOI 10.1074/jbc.271.34.20531; Hell K, 2000, J BIOL CHEM, V275, P4571, DOI 10.1074/jbc.275.7.4571; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Kim HJ, 2012, BBA-MOL CELL RES, V1823, P1604, DOI 10.1016/j.bbamcr.2012.04.008; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levchenko M, 2016, BBA-MOL CELL RES, V1863, P1624, DOI 10.1016/j.bbamcr.2016.04.007; Lode A, 2000, FEBS LETT, V485, P19, DOI 10.1016/S0014-5793(00)02176-1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCEWEN JE, 1993, CURR GENET, V23, P9, DOI 10.1007/BF00336742; McStay GP, 2013, J BIOL CHEM, V288, P26546, DOI 10.1074/jbc.M113.498592; McStay GP, 2013, MOL BIOL CELL, V24, P440, DOI 10.1091/mbc.E12-10-0749; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Nittis T, 2001, J BIOL CHEM, V276, P42520, DOI 10.1074/jbc.M107077200; Mayorga JP, 2016, J BIOL CHEM, V291, P9343, DOI 10.1074/jbc.M116.721985; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Saracco SA, 2002, MOL BIOL CELL, V13, P1122, DOI 10.1091/mbc.01-12-0580; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Strecker V, 2016, BBA-MOL CELL RES, V1863, P1643, DOI 10.1016/j.bbamcr.2016.04.012; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Su CH, 2017, J BIOL CHEM, V292, P16277, DOI 10.1074/jbc.M117.801811; Su CH, 2014, J BIOL CHEM, V289, P31605, DOI 10.1074/jbc.M114.602706; Taylor NG, 2017, J BIOL CHEM, V292, P1815, DOI 10.1074/jbc.M116.766980; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Wharton DC., 1967, METHOD ENZYMOL, P245; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yoshikawa S, 2006, BBA-BIOENERGETICS, V1757, P395, DOI 10.1016/j.bbabio.2006.04.028	51	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16899	16911		10.1074/jbc.RA118.004138	http://dx.doi.org/10.1074/jbc.RA118.004138			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30224355	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000448515100029
J	Rotwein, P				Rotwein, Peter			The insulin-like growth factor 2 gene and locus in nonmammalian vertebrates: Organizational simplicity with duplication but limited divergence in fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin-like growth factor (IGF); genomics; gene structure; gene expression; genetics; phylogenetics; gene annotation; gene evolution; gene phylogeny; genetic database; vertebrate speciation	FACTOR SYSTEM GENES; FACTOR-II GENE; IGF-II; ALLELIC EXPRESSION; H19 GENE; MOUSE; ZEBRAFISH; EVOLUTION; GENOME; MUSCLE	The small, secreted peptide, insulin-like growth factor 2 (IGF2), is essential for fetal and prenatal growth in humans and other mammals. Human IGF2 and mouse Igf2 genes are located within a conserved linkage group and are regulated by parental imprinting, with IGF2/Igf2 being expressed from the paternally derived chromosome, and H19 from the maternal chromosome. Here, data retrieved from genomic and gene expression repositories were used to examine the Igf2 gene and locus in 8 terrestrial vertebrates, 11 ray-finned fish, and 1 lobe-finned fish representing > 500 million years of evolutionary diversification. The analysis revealed that vertebrate Igf2 genes are simpler than their mammalian counterparts, having fewer exons and lacking multiple gene promoters. Igf2 genes are conserved among these species, especially in protein-coding regions, and IGF2 proteins also are conserved, although less so in fish than in terrestrial vertebrates. The Igf2 locus in terrestrial vertebrates shares additional genes with its mammalian counterparts, including tyrosine hydroxylase (Th), insulin (Ins), mitochondrial ribosomal protein L23 (Mrpl23), and troponin T3, fast skeletal type (Tnnt3), and both Th and Mrpl23 are present in the Igf2 locus in fish. Taken together, these observations support the idea that a recognizable Igf2 was present in the earliest vertebrate ancestors, but that other features developed and diversified in the gene and locus with speciation, especially in mammals. This study also highlights the need for correcting inaccuracies in genome databases to maximize our ability to accurately assess contributions of individual genes and multigene families toward evolution, physiology, and disease.	[Rotwein, Peter] Texas Tech Hlth Univ, Hlth Sci Ctr, Dept Biomed Sci, Paul L Foster Sch Med, El Paso, TX 79905 USA		Rotwein, P (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Paul L Foster Sch Med, 5001 El Paso Dr, El Paso, TX 79905 USA.	peter.rotwein@ttuhsc.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	National Institutes of Health Research [R01 DK042748-28]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Research Grant R01 DK042748-28 (to P.R.). The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Acuna-Hidalgo R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1110-1; Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Amaral IPG, 2012, J EXP BIOL, V215, P3895, DOI 10.1242/jeb.068908; Azzi S, 2014, CURR OPIN ENDOCRINOL, V21, P30, DOI 10.1097/MED.0000000000000037; Baron J, 2015, NAT REV ENDOCRINOL, V11, P735, DOI 10.1038/nrendo.2015.165; Bartolomei MS, 2008, NAT GENET, V40, P932, DOI 10.1038/ng0808-932; BLUNDELL TL, 1980, NATURE, V287, P781, DOI 10.1038/287781a0; Butter F, 2010, EMBO REP, V11, P305, DOI 10.1038/embor.2010.6; Cazzola M, 2000, BLOOD, V95, P3280, DOI 10.1182/blood.V95.11.3280.011k41_3280_3288; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Darling DC, 1996, GEN COMP ENDOCR, V102, P283, DOI 10.1006/gcen.1996.0071; Das R, 2015, BIOCHEM SOC T, V43, P1057, DOI 10.1042/BST20150078; DAUGHADAY WH, 1985, GEN COMP ENDOCR, V59, P316, DOI 10.1016/0016-6480(85)90384-3; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Eggermann Thomas, 2010, Pediatr Endocrinol Rev, V8, P86; Fedorova L, 2003, GENETICA, V118, P123, DOI 10.1023/A:1024145407467; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; Gholami M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094509; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; GILL G, 1994, CURR BIOL, V4, P374, DOI 10.1016/S0960-9822(00)00084-1; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; HAMPTON B, 1989, J BIOL CHEM, V264, P19155; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; Holzenberger M, 1997, J NEUROSCI, V17, P6974; Huang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066160; Ishihara K, 2000, GENOME RES, V10, P664, DOI 10.1101/gr.10.5.664; Kadakia R, 2016, HORM RES PAEDIAT, V85, P75, DOI 10.1159/000443500; Katsanis N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1107-9; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Koski LB, 2000, MOL REPROD DEV, V56, P345, DOI 10.1002/1098-2795(200007)56:3&lt;345::AID-MRD3&gt;3.0.CO;2-1; Kozak M, 2000, GENOMICS, V70, P396, DOI 10.1006/geno.2000.6412; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Livingstone C, 2014, CLIN ENDOCRINOL, V80, P773, DOI 10.1111/cen.12446; Livingstone C, 2013, ENDOCR-RELAT CANCER, V20, pR321, DOI 10.1530/ERC-13-0231; Manolio TA, 2017, CELL, V169, P6, DOI 10.1016/j.cell.2017.03.005; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; Monk D, 2006, HUM MOL GENET, V15, P1259, DOI 10.1093/hmg/ddl041; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Nolan CM, 2001, DEV GENES EVOL, V211, P179, DOI 10.1007/s004270000132; Nordin M, 2014, CELL PROLIFERAT, V47, P189, DOI 10.1111/cpr.12106; Nornberg BF, 2016, GEN COMP ENDOCR, V226, P36, DOI 10.1016/j.ygcen.2015.12.017; O'Neill MJ, 2000, DEV GENES EVOL, V210, P18, DOI 10.1007/PL00008182; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pierce AL, 2010, J ENDOCRINOL, V204, P331, DOI 10.1677/JOE-09-0338; Pierce AL, 2011, J ENDOCRINOL, V211, P201, DOI 10.1530/JOE-10-0456; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Quintana-Murci L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1093-y; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Richards MP, 2005, COMP BIOCHEM PHYS A, V141, P76, DOI 10.1016/j.cbpb.2005.04.006; Rotwein P, 1999, CONT ENDOCRINOL, V17, P19; ROTWEIN P, 1990, DNA CELL BIOL, V9, P725, DOI 10.1089/dna.1990.9.725; Rotwein P, 2018, ENDOCRINOLOGY, V159, P2288, DOI 10.1210/en.2018-00259; Rotwein P, 2018, PHYSIOL GENOMICS, V50, P425, DOI 10.1152/physiolgenomics.00030.2018; Rotwein P, 2018, J BIOL CHEM, V293, P4324, DOI 10.1074/jbc.RA117.001573; Rotwein P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189642; Schrader M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045463; Schwartz TS, 2016, INTEGR COMP BIOL, V56, P171, DOI 10.1093/icb/icw046; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Smits G, 2008, NAT GENET, V40, P971, DOI 10.1038/ng.168; Song CL, 2013, GENET MOL RES, V12, P4500, DOI 10.4238/2013.May.6.3; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; SUSSENBACH JS, 1993, ADV EXP MED BIOL, V343, P63; SUSSENBACH JS, 1992, GROWTH REGULAT, V2, P1; Tang SQ, 2010, ANIM BIOTECHNOL, V21, P104, DOI 10.1080/10495390903328090; Venditti C, 2011, NATURE, V479, P393, DOI 10.1038/nature10516; Venditti C, 2010, TRENDS ECOL EVOL, V25, P14, DOI 10.1016/j.tree.2009.06.010; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wallis M, 2009, GROWTH HORM IGF RES, V19, P12, DOI 10.1016/j.ghir.2008.05.001; White YAR, 2009, ENDOCRINOLOGY, V150, P4366, DOI 10.1210/en.2009-0356; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Yokomine T, 2001, CYTOGENET CELL GENET, V93, P109, DOI 10.1159/000056960; YOOWARREN H, 1988, MOL CELL BIOL, V8, P4707, DOI 10.1128/MCB.8.11.4707; Yuan YM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00094-y	81	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15912	15932		10.1074/jbc.RA118.004861	http://dx.doi.org/10.1074/jbc.RA118.004861			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30154247	hybrid, Green Published			2022-12-28	WOS:000447256000015
J	Sierra-Valdez, F; Azumaya, CM; Romero, LO; Nakagawa, T; Cordero-Morales, JF				Sierra-Valdez, Francisco; Azumaya, Caleigh M.; Romero, Luis O.; Nakagawa, Terunaga; Cordero-Morales, Julio F.			Structure-function analyses of the ion channel TRPC3 reveal that its cytoplasmic domain allosterically modulates channel gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; transient receptor potential channels (TRP channels); calcium channel; structural biology; electrophysiology; cryo-electron microscopy; vascular biology; neurotransmitter; GSK-1702934A; TRPC3	INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; ELECTRON CRYOMICROSCOPY STRUCTURE; SYNAPTIC-TRANSMISSION; POTENTIAL CHANNELS; CEREBELLAR-ATAXIA; CALMODULIN; ACTIVATION; MUTATION; CELLS	The transient receptor potential ion channels support Ca2+ permeation in many organs, including the heart, brain, and kidney. Genetic mutations in transient receptor potential cation channel subfamily C member 3 (TRPC3) are associated with neurodegenerative diseases, memory loss, and hypertension. To better understand the conformational changes that regulate TRPC3 function, we solved the cryo-EM structures for the full-length human TRPC3 and its cytoplasmic domain (CPD) in the apo state at 5.8- and 4.0-angstrom resolution, respectively. These structures revealed that the TRPC3 transmembrane domain resembles those of other TRP channels and that the CPD is a stable module involved in channel assembly and gating. We observed the presence of a C-terminal domain swap at the center of the CPD where horizontal helices (HHs) transition into a coiled-coil bundle. Comparison of TRPC3 structures revealed that the HHs can reside in two distinct positions. Electrophysiological analyses disclosed that shortening the length of the C-terminal loop connecting the HH with the TRP helices increases TRPC3 activity and that elongating the length of the loop has the opposite effect. Our findings indicate that the C-terminal loop affects channel gating by altering the allosteric coupling between the cytoplasmic and transmembrane domains. We propose that molecules that target the HH may represent a promising strategy for controlling TRPC3-associated neurological disorders and hypertension.	[Sierra-Valdez, Francisco; Romero, Luis O.; Cordero-Morales, Julio F.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Azumaya, Caleigh M.; Nakagawa, Terunaga] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA; [Nakagawa, Terunaga] Vanderbilt Univ, Struct Biol Ctr, Sch Med, Nashville, TN 37232 USA; [Nakagawa, Terunaga] Vanderbilt Univ, Vanderbilt Brain Inst, Sch Med, Nashville, TN 37232 USA	University of Tennessee System; University of Tennessee Health Science Center; Vanderbilt University; Vanderbilt University; Vanderbilt University	Cordero-Morales, JF (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA.; Nakagawa, T (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Vanderbilt Brain Inst, Ctr Struct Biol,Sch Med, 702 Light Hall, Nashville, TN 37232 USA.	terunaga.nakagawa@vanderbilt.edu; jcordero@uthsc.edu		Sierra-Valdez, Francisco J/0000-0002-7803-9701; Cordero Morales, Julio/0000-0002-6505-5403; Romero, Luis/0000-0001-9855-7592	National Institutes of Health [R01 HD061543, 1-R01GM125629-01]; Vanderbilt University Trans-Institutional Program; American Heart Association [15SDG25700146]; National Institutes of Health Molecular Biophysics Training Program Grant [T32 GM008320]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061543] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM125629, T32GM008320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Trans-Institutional Program; American Heart Association(American Heart Association); National Institutes of Health Molecular Biophysics Training Program Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 HD061543, the Vanderbilt University Trans-Institutional Program, and other internal funding (to T.N.); American Heart Association Grant 15SDG25700146 and National Institutes of Health Grant 1-R01GM125629-01 (to J.C.-M.); and National Institutes of Health Molecular Biophysics Training Program Grant T32 GM008320 to Walter Chazin (to C.M.A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alvarez-Miguel I, 2017, J PHYSIOL-LONDON, V595, P1497, DOI 10.1113/JP273327; Autzen HE, 2018, SCIENCE, V359, P228, DOI 10.1126/science.aar4510; Azumaya CM, 2018, J BIOL CHEM, V293, P10381, DOI 10.1074/jbc.RA118.003183; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Berg AP, 2007, J NEUROSCI, V27, P8845, DOI 10.1523/JNEUROSCI.0551-07.2007; Biyani N, 2017, J STRUCT BIOL, V198, P124, DOI 10.1016/j.jsb.2017.03.007; Broker-Lai J, 2017, EMBO J, V36, P2770, DOI 10.15252/embj.201696369; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Di A, 2010, CURR OPIN PHARMACOL, V10, P127, DOI 10.1016/j.coph.2009.11.010; Duan J., 2018, BIORXIV282715, DOI [10.1101/282715, DOI 10.1101/282715]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan C, 2018, ELIFE, V7, DOI 10.7554/eLife.36852; Fogel BL, 2015, MOVEMENT DISORD, V30, P284, DOI 10.1002/mds.26096; Greger IH, 2017, NEURON, V94, P713, DOI 10.1016/j.neuron.2017.04.009; Guo JT, 2017, NATURE, V552, P205, DOI 10.1038/nature24997; Hartmann J, 2008, NEURON, V59, P392, DOI 10.1016/j.neuron.2008.06.009; Hasan R, 2017, SCI REP-UK, V7, DOI 10.1038/srep45098; Heeringa SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007771; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Inoue R, 2006, CIRC RES, V99, P119, DOI 10.1161/01.RES.0000233356.10630.8a; Jin P, 2017, NATURE, V547, P118, DOI 10.1038/nature22981; Kim Y, 2012, J NEUROSCI, V32, P11414, DOI 10.1523/JNEUROSCI.6446-11.2012; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lichtenegger M, 2018, NAT CHEM BIOL, V14, P396, DOI 10.1038/s41589-018-0015-6; Lichtenegger M, 2014, HANDB EXP PHARMACOL, V222, P67, DOI 10.1007/978-3-642-54215-2_4; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Madej MG, 2018, PFLUG ARCH EUR J PHY, V470, P213, DOI 10.1007/s00424-018-2107-2; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Mottl AK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-104; Neuner SM, 2015, BEHAV BRAIN RES, V281, P69, DOI 10.1016/j.bbr.2014.12.018; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2010, PFLUG ARCH EUR J PHY, V460, P437, DOI 10.1007/s00424-010-0788-2; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Santin S, 2009, NEPHROL DIAL TRANSPL, V24, P3089, DOI 10.1093/ndt/gfp229; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schleifer H, 2012, BRIT J PHARMACOL, V167, P1712, DOI 10.1111/j.1476-5381.2012.02126.x; Sekerkova G, 2013, J NEUROSCI, V33, P19689, DOI 10.1523/JNEUROSCI.2294-13.2013; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tang QL, 2018, CELL RES, V28, P746, DOI 10.1038/s41422-018-0038-2; Trebak M, 2005, MOL PHARMACOL, V67, P558, DOI 10.1124/mol.104.007252; Vinayagam D, 2018, ELIFE, V7, DOI 10.7554/eLife.36615; Winkler PA, 2017, NATURE, V552, P200, DOI 10.1038/nature24674; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Xi Q, 2008, CIRC RES, V102, P1118, DOI 10.1161/CIRCRESAHA.108.173948; Yin Y, 2018, SCIENCE, V359, P237, DOI 10.1126/science.aan4325; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou FW, 2008, J NEUROSCI, V28, P473, DOI 10.1523/JNEUROSCI.3978-07.2008; Zhou HB, 2014, ELIFE, V3, DOI 10.7554/eLife.02536	59	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16102	16114		10.1074/jbc.RA118.005066	http://dx.doi.org/10.1074/jbc.RA118.005066			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30139744	Green Published, hybrid			2022-12-28	WOS:000447256000030
J	Tegowski, M; Fan, C; Baldwin, AS				Tegowski, Matthew; Fan, Cheng; Baldwin, Albert S.			Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G(1) arrest independent of DRD2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; STAT3; interleukin 6 (IL-6); G protein-coupled receptor (GPCR); dopamine receptor; apoptosis; cell signaling; G(1) arrest; self-renewal; thioridazine; cell viability; DRD2; proliferation	DOPAMINE-RECEPTOR ANTAGONIST; TUMOR-INITIATING CELLS; ENDOGENOUS CATECHOLAMINES; ACTIVATION; GROWTH; EXPRESSION; CHEMOTHERAPY; PROLIFERATION; LYMPHOCYTES; RESISTANCE	Thioridazine is an antipsychotic that has been shown to induce cell death and inhibit self-renewal in a broad spectrum of cancer cells. The mechanisms by which these effects are mediated are currently unknown but are presumed to result from the inhibition of dopamine receptor 2 (DRD2). Here we show that the self-renewal of several, but not all, triple-negative breast cancer cell lines is inhibited by thioridazine. The inhibition of self-renewal by thioridazine in these cells is mediated by DRD2 inhibition. Further, we demonstrate that DRD2 promotes self-renewal in these cells via a STAT3- and IL-6-dependent mechanism. We also show that thioridazine induces a G(1) arrest and a loss in cell viability in all tested cell lines. However, the reduction in proliferation and cell viability is independent of DRD2 and STAT3. Our results indicate that although there are cell types in which DRD2 inhibition results in inhibition of STAT3 and self-renewal, the dramatic block in cancer cell proliferation across many cell lines caused by thioridazine treatment is independent of DRD2 inhibition.	[Tegowski, Matthew; Baldwin, Albert S.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Tegowski, Matthew; Fan, Cheng; Baldwin, Albert S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, 450 West Dr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Baldwin, AS (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, 450 West Dr, Chapel Hill, NC 27599 USA.	abaldwin@med.unc.edu			NCI, National Institutes of Health [R35CA197684]; NATIONAL CANCER INSTITUTE [R35CA197684] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health Grant R35CA197684 (to A.S.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee K, 2016, INT J CANCER, V138, P2570, DOI 10.1002/ijc.29923; Basu B, 2010, J BIOL CHEM, V285, P27026, DOI 10.1074/jbc.M110.144022; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; BERGQUIST J, 1994, P NATL ACAD SCI USA, V91, P12912, DOI 10.1073/pnas.91.26.12912; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Bodei S, 2009, N-S ARCH PHARMACOL, V379, P413, DOI 10.1007/s00210-008-0384-6; Cheng HW, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.77; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Cosentino M, 2007, BLOOD, V109, P632, DOI 10.1182/blood-2006-01-028423; Dethlefsen C, 2013, BREAST CANCER RES TR, V138, P657, DOI 10.1007/s10549-013-2488-z; Dolma S, 2016, CANCER CELL, V29, P859, DOI 10.1016/j.ccell.2016.05.002; Edwards H, 2018, CELL CYCLE, V17, P277, DOI 10.1080/15384101.2017.1421035; Greer Yoshimi Endo, 2018, Oncotarget, V9, P18454, DOI 10.18632/oncotarget.24862; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Gwynne WD, 2017, ONCOTARGET, V8, P32101, DOI 10.18632/oncotarget.16646; Heo TH, 2016, ONCOTARGET, V7, P15460, DOI 10.18632/oncotarget.7102; Hsia HC, 2017, J BIOL CHEM, V292, P5405, DOI 10.1074/jbc.M116.771964; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Jandaghi P, 2016, GASTROENTEROLOGY, V151, P1218, DOI 10.1053/j.gastro.2016.08.040; Josefsson E, 1996, IMMUNOLOGY, V88, P140, DOI 10.1046/j.1365-2567.1996.d01-653.x; Kendellen MF, 2014, ONCOGENE, V33, P1297, DOI 10.1038/onc.2013.64; Kline CLB, 2018, NEOPLASIA, V20, P80, DOI 10.1016/j.neo.2017.10.002; Kokkinou I, 2009, J NEUROIMMUNOL, V216, P51, DOI 10.1016/j.jneuroim.2009.09.001; Konkalmatt PR, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85888; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Kumari N, 2016, TUMOR BIOL, V37, P11553, DOI 10.1007/s13277-016-5098-7; LAJINESS ME, 1993, J PHARMACOL EXP THER, V267, P1573; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Levite M, 2016, ACTA PHYSIOL, V216, P42, DOI 10.1111/apha.12476; Li J, 2014, ONCOTARGET, V5, P882, DOI 10.18632/oncotarget.1801; Luo YQ, 1999, BRAIN RES, V850, P21, DOI 10.1016/S0006-8993(99)02021-1; Madhukar N. S., 2017, BIORXIV, DOI [10.1101/134973, DOI 10.1101/134973]; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; McKenna F, 2002, J NEUROIMMUNOL, V132, P34, DOI 10.1016/S0165-5728(02)00280-1; Mei F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042746; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nakano K, 2009, INT IMMUNOL, V21, P645, DOI 10.1093/intimm/dxp033; Oh K, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3473; Perou CM, 2010, ONCOLOGIST, V15, P39, DOI 10.1634/theoncologist.2010-S5-39; Prabhu VV, 2015, CANCER RES, V75, P1423, DOI 10.1158/0008-5472.CAN-13-3451; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Sonnenblick A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0416-2; Staniszewska AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052608; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stojanovic T, 2017, AMINO ACIDS, V49, P1101, DOI 10.1007/s00726-017-2408-3; STROBL JS, 1992, J PHARMACOL EXP THER, V263, P186; Wei W, 2014, STEM CELLS, V32, P2571, DOI 10.1002/stem.1752; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yin T, 2015, MOL MED REP, V12, P4103, DOI 10.3892/mmr.2015.3967; Yoon S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.188078; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yue H., 2016, BIOMED RES INT, V2016, DOI [10.1155/2016/6709828, DOI 10.1155/2016/6709828]; Zahalka AH, 2017, SCIENCE, V358, P321, DOI 10.1126/science.aah5072; Zhang C, 2017, ONCOL REP, V37, P1168, DOI 10.3892/or.2016.5313; Zhang YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038745	60	35	35	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15977	15990		10.1074/jbc.RA118.003719	http://dx.doi.org/10.1074/jbc.RA118.003719			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30131338	Green Published, hybrid			2022-12-28	WOS:000447256000019
J	Kim, SY; Zhang, FM; Gong, WH; Chen, KQ; Xia, K; Liu, F; Gross, R; Wang, JM; Linhardt, RJ; Cotten, ML				Kim, So Young; Zhang, Fuming; Gong, Wanghua; Chen, Keqiang; Xia, Kai; Liu, Fei; Gross, Richard; Wang, Ji Ming; Linhardt, Robert J.; Cotten, Myriam L.			Copper regulates the interactions of antimicrobial piscidin peptides from fish mast cells with formyl peptide receptors and heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemotaxis; copper; glycosaminoglycan; heparin; histidine; host defense; surface plasmon resonance (SPR); antimicrobial peptide (AMP); formyl peptide receptors; piscidin	HOST-DEFENSE PEPTIDES; ACIDOPHILIC GRANULOCYTES; MOLECULAR RECOGNITION; GILTHEAD SEABREAM; BACTERIA; IMMUNE; LL-37; GLYCOSAMINOGLYCANS; INFLAMMATION; CATHELICIDIN	Phagocytic cells in fish secrete antimicrobial peptides (AMPs) such as piscidins, glycosaminoglycans such as heparin, and copper ions as first-line immune defenses. Recently, we established that Cu2+ coordination by piscidins 1 (P1) and 3 (P3) enhances their antibacterial activity against membranes and DNA. Interestingly, we noted that physicochemical similarities exist between both piscidins and other AMPs that interact with heparin and induce immune-cell chemotaxis through formyl peptide receptors (FPRs) involved in innate immunity. Thus, we postulated that P1 and P3 interact with heparin and FPRs but that these interactions distinctively depend on Cu2+. Here, we investigate the interactome potentiated by piscidins, heparin, FPR, and Cu2+. Utilizing FPR-transfected cells and neutrophils, we demonstrate that both piscidins exclusively use FPR1 and FPR2 to induce chemotaxis and that Cu2+ reduces their chemotaxis induction. P1 is more effective at activating FPR1 than P3 and other known AMP ligands. Furthermore, the expression of Fpr2 on the surface of neutrophils is down-regulated by both peptides. Copper conjugation of the peptides does not further increase down-regulation, suggesting that the conformational changes induced by the metal translate into reduced FPR efficacy without altering the binding affinity. Using surface plasmon resonance, we show that piscidin-heparin interactions are Cu2+-dependent and reduced at the acidic pH of phagosomes. Although heparin decreases the antimicrobial activity of P3-Cu2+, it does not affect bacterial killing by P1-Cu2+. Copper's effects on modulating the micromolar-range interactions of both piscidins with FPR and heparin suggest that the interactome of these distinct immune agents plays an important role in innate immunity. The interactions between diverse host-defense molecules uncovered here may help inform the design of novel therapeutics to treat immune-related diseases.	[Kim, So Young; Linhardt, Robert J.] Rensselaer Polytech Inst, Biochem & Biophys Grad Program, Troy, NY 12180 USA; [Zhang, Fuming; Xia, Kai; Liu, Fei; Gross, Richard; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, 110 8th St, Troy, NY 12180 USA; [Zhang, Fuming; Xia, Kai; Liu, Fei; Gross, Richard; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Zhang, Fuming; Xia, Kai; Liu, Fei; Gross, Richard; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, 110 8th St, Troy, NY 12180 USA; [Zhang, Fuming; Xia, Kai; Liu, Fei; Gross, Richard; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Zhang, Fuming; Xia, Kai; Liu, Fei; Gross, Richard; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Gong, Wanghua] Leidos Biomed Res Inc, Basic Res Program, Frederick, MD 21702 USA; [Chen, Keqiang; Wang, Ji Ming] NCI Frederick, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Cotten, Myriam L.] Coll William & Mary, Dept Appl Sci, 540 Landrum Dr, Williamsburg, VA 23185 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Dept Chem & Chem Biol, 110 8th St, Troy, NY 12180 USA.; Zhang, FM (corresponding author), Rensselaer Polytech Inst, Dept Chem & Biol Engn, 110 8th St, Troy, NY 12180 USA.; Zhang, FM; Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.; Cotten, ML (corresponding author), Coll William & Mary, Dept Appl Sci, 540 Landrum Dr, Williamsburg, VA 23185 USA.	zhangf2@rpi.edu; linhar@rpi.edu; mcotten@wm.edu		Gross, Richard/0000-0002-5050-3162; Cotten, Myriam/0000-0002-6732-1736	National Science Foundation CAREER [CHE-0832571, MCB-1716608]; NATIONAL CANCER INSTITUTE [ZIABC010015] Funding Source: NIH RePORTER	National Science Foundation CAREER(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Science Foundation CAREER Grants CHE-0832571 and MCB-1716608 (to M. L. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aisenbrey C, 2006, J BIOL CHEM, V281, P7708, DOI 10.1074/jbc.M513151200; Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Baccari GC, 2011, INT REV CEL MOL BIO, V290, P1, DOI 10.1016/B978-0-12-386037-8.00006-5; Baranska-Rybak W, 2006, J ANTIMICROB CHEMOTH, V57, P260, DOI 10.1093/jac/dki460; Bergsson G, 2009, J IMMUNOL, V183, P543, DOI 10.4049/jimmunol.0803959; Besold AN, 2016, J BIOL INORG CHEM, V21, P137, DOI 10.1007/s00775-016-1335-1; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; Bufe B, 2012, J BIOL CHEM, V287, P33644, DOI 10.1074/jbc.M112.375774; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CHAO WL, 1991, J GEN APPL MICROBIOL, V37, P363, DOI 10.2323/jgam.37.363; Chekmenev EY, 2006, BBA-BIOMEMBRANES, V1758, P1359, DOI 10.1016/j.bbamem.2006.03.034; Chekmenev EY, 2006, J AM CHEM SOC, V128, P5308, DOI 10.1021/ja058385e; Chen KD, 2013, J CLIN INVEST, V123, P1694, DOI 10.1172/JCI65569; Chen WF, 2015, BIOMATERIALS, V53, P1, DOI 10.1016/j.biomaterials.2015.02.069; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Chuang WL, 2000, BIOCHEMISTRY-US, V39, P3542, DOI 10.1021/bi9926025; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; Corminboeuf O, 2015, J MED CHEM, V58, P537, DOI 10.1021/jm501051x; Corrales J, 2010, DEV COMP IMMUNOL, V34, P331, DOI 10.1016/j.dci.2009.11.004; Crivellato E, 2015, METHODS MOL BIOL, V1220, P11, DOI 10.1007/978-1-4939-1568-2_2; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; Dezfuli BS, 2012, DEV COMP IMMUNOL, V36, P174, DOI 10.1016/j.dci.2011.06.017; Di Nardo A, 2003, J IMMUNOL, V170, P2274, DOI 10.4049/jimmunol.170.5.2274; Durr M, 2002, INFECT IMMUN, V70, P6515, DOI 10.1128/IAI.70.12.6515-6517.2002; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; El Meskini R, 2003, J BIOL CHEM, V278, P12278, DOI 10.1074/jbc.M211413200; Festa RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002887; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Flengsrud R, 2010, THROMB RES, V126, pE409, DOI 10.1016/j.thromres.2010.07.004; Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hayden RM, 2015, J PHYS CHEM B, V119, P15235, DOI 10.1021/acs.jpcb.5b09685; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Jeske WP, 2007, CLIN APPL THROMB-HEM, V13, P137, DOI 10.1177/1076029606298982; Kaneider NC, 2007, THESCIENTIFICWORLDJO, V7, P1832, DOI 10.1100/tsw.2007.285; KREIL G, 1984, METHOD ENZYMOL, V106, P218; Lauth X, 2002, J BIOL CHEM, V277, P5030, DOI 10.1074/jbc.M109173200; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Lee E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114453; Libardo MDJ, 2017, FEBS J, V284, P3662, DOI [10.1111/febs.14262, 10.1111/febs.14263]; Lide D. R, 2004, CRC HDB CHEM PHYS RE, V85th; Linhardt RJ, 2004, ACCOUNTS CHEM RES, V37, P431, DOI 10.1021/ar030138x; Maccari F, 2015, CARBOHYD POLYM, V129, P143, DOI 10.1016/j.carbpol.2015.04.059; Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004; Mao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083268; Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Mulero I, 2008, DEV COMP IMMUNOL, V32, P1531, DOI 10.1016/j.dci.2008.05.015; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; Noga EJ, 2003, DRUG NEWS PERSPECT, V16, P87, DOI 10.1358/dnp.2003.16.2.829325; Ordovas-Montanes J, 2015, TRENDS IMMUNOL, V36, P578, DOI 10.1016/j.it.2015.08.007; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Park YJ, 2016, BMB REP, V49, P520, DOI 10.5483/BMBRep.2016.49.9.098; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Peng KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050263; Perrin BS, 2014, J AM CHEM SOC, V136, P3491, DOI 10.1021/ja411119m; Pundir P, 2014, MUCOSAL IMMUNOL, V7, P177, DOI 10.1038/mi.2013.37; Rakers S, 2013, J INVEST DERMATOL, V133, P1140, DOI 10.1038/jid.2012.503; Rittner HL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000362; Ruangsri J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-46; Salger SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159423; Sauer RS, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-10; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Sepulcre MP, 2002, CELL TISSUE RES, V308, P97, DOI 10.1007/s00441-002-0531-1; Silphaduang U, 2006, DIS AQUAT ORGAN, V72, P241, DOI 10.3354/dao072241; Silphaduang U, 2001, NATURE, V414, P268, DOI 10.1038/35104690; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Stoy H, 2015, GENES DIS, V2, P108, DOI 10.1016/j.gendis.2015.02.005; Sun BJ, 2007, J FISH DIS, V30, P335, DOI 10.1111/j.1365-2761.2007.00789.x; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Wang GS, 2013, PHARMACEUTICALS-BASE, V6, P728, DOI 10.3390/ph6060728; Weyers A, 2013, FEBS J, V280, P2285, DOI 10.1111/febs.12165; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744	76	26	27	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15381	15396		10.1074/jbc.RA118.001904	http://dx.doi.org/10.1074/jbc.RA118.001904			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30158246	hybrid, Green Published			2022-12-28	WOS:000446549200005
J	Shende, R; Wong, SSW; Rapole, S; Beau, R; Ibrahim-Granet, O; Monod, M; Guhrs, KH; Pal, JK; Latge, JP; Madan, T; Aimanianda, V; Sahu, A				Shende, Rajashri; Wong, Sarah Sze Wah; Rapole, Srikanth; Beau, Remi; Ibrahim-Granet, Oumaima; Monod, Michel; Guhrs, Karl-Heinz; Pal, Jayanta Kumar; Latge, Jean-Paul; Madan, Taruna; Aimanianda, Vishukumar; Sahu, Arvind			Aspergillus fumigatus conidial metalloprotease Mep1p cleaves host complement proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						complement system; complement; Aspergillus; infectious disease; inflammation; Aspergillus fumigatus; complement system; immune evasion; metalloprotease; phagocytosis	ALKALINE PROTEASE; SECRETED PROTEASES; IMMUNE EVASION; FACTOR-H; C3; BINDING; IDENTIFICATION; GENE; DEGRADATION; ACTIVATION	Innate immunity in animals including humans encompasses the complement system, which is considered an important host defense mechanism against Aspergillus fumigatus, one of the most ubiquitous opportunistic human fungal pathogens. Previously, it has been shown that the alkaline protease Alp1p secreted from A. fumigatus mycelia degrades the complement components C3, C4, and C5. However, it remains unclear how the fungal spores (i.e. conidia) defend themselves against the activities of the complement system immediately after inhalation into the lung. Here, we show that A. fumigatus conidia contain a metalloprotease Mep1p, which is released upon conidial contact with collagen and inactivates all three complement pathways. In particular, Mep1p efficiently inactivated the major complement components C3, C4, and C5 and their activation products (C3a, C4a, and C5a) as well as the pattern-recognition molecules MBL and ficolin-1, either by directly cleaving them or by cleaving them to a form that is further broken down by other proteases of the complement system. Moreover, incubation of Mep1p with human serum significantly inhibited the complement hemolytic activity and conidial opsonization by C3b and their subsequent phagocytosis by macrophages. Together, these results indicate that Mep1p associated with and released from A. fumigatus conidia likely facilitates early immune evasion by disarming the complement defense in the human host.	[Shende, Rajashri; Sahu, Arvind] Natl Ctr Cell Sci, Complement Biol Lab, SP Pune Univ Campus, Pune 411007, Maharashtra, India; [Rapole, Srikanth] Natl Ctr Cell Sci, Prote Lab, SP Pune Univ Campus, Pune 411007, Maharashtra, India; [Shende, Rajashri; Pal, Jayanta Kumar] Dr DY Patil Vidyapeeth, Dr DY Patil Biotechnol & Bioinformat Inst, Pune 411033, Maharashtra, India; [Wong, Sarah Sze Wah; Beau, Remi; Latge, Jean-Paul; Aimanianda, Vishukumar] Inst Pasteur, Unite Aspergillus, F-75015 Paris, France; [Wong, Sarah Sze Wah; Aimanianda, Vishukumar] Inst Pasteur, Unite Rech Mycol Mol, F-75015 Paris, France; [Ibrahim-Granet, Oumaima] Inst Pasteur, Unite Rech Cytokines & Inflammat, F-75015 Paris, France; [Monod, Michel] CHU Vaudois, Lab Mycol, Serv Dermatol, CH-1011 Lausanne, Switzerland; [Guhrs, Karl-Heinz] Leibniz Inst Aging, Fritz Lipmann Inst, D-07745 Jena, Germany; [Madan, Taruna] ICMR Natl Inst Res Reprod Hlth, Bombay 400012, Maharashtra, India	Savitribai Phule Pune University; Savitribai Phule Pune University; Dr DY Patil Vidyapeeth Pune; Dr D Y Patil Biotechnology & Bioinformatics Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH)	Aimanianda, V (corresponding author), Inst Pasteur, Unite Aspergillus, F-75015 Paris, France.; Sahu, A (corresponding author), Natl Ctr Cell Sci, SP Pune Univ Campus, Pune 411007, Maharashtra, India.	vkumar@pasteur.fr; arvindsahu@nccs.res.in	Aimanianda, Vishukumar/E-9204-2011; Wong, Sarah/AAX-5103-2020; Wong, Sarah/DOH-8455-2022	Aimanianda, Vishukumar/0000-0001-5813-7497; Wong, Sarah/0000-0002-9440-1774; Sahu, Arvind/0000-0003-1664-2422; Pal, Jayanta/0000-0003-1840-6458	bilateral COMASPIN grant from the Department of Science and Technology (DST) India; l'Agence Nationale de la Recherche (ANR) France; Department of Science and Technology; l'Agence Nationale de la Recherche	bilateral COMASPIN grant from the Department of Science and Technology (DST) India; l'Agence Nationale de la Recherche (ANR) France(French National Research Agency (ANR)); Department of Science and Technology(Department of Science & Technology (India)); l'Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported in part by a bilateral COMASPIN grant from the Department of Science and Technology (DST) India and l'Agence Nationale de la Recherche (ANR) France (to A. S., T. M., and V. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a research fellowship from the Department of Science and Technology. A part of this work was done in partial fulfillment of the Ph.D. thesis to be submitted to the Dr. D. Y. Patil Vidyapeeth, Pune, India.; Supported by post-doctoral fellowship from the l'Agence Nationale de la Recherche.	Abad A, 2010, REV IBEROAM MICOL, V27, P155, DOI 10.1016/j.riam.2010.10.003; Agarwal R, 2013, CLIN EXP ALLERGY, V43, P850, DOI 10.1111/cea.12141; Al-Bader N, 2016, VIRULENCE, V7, P950, DOI 10.1080/21505594.2016.1231278; Askew DS, 2008, CURR OPIN MICROBIOL, V11, P331, DOI 10.1016/j.mib.2008.05.009; Askew DS, 2014, MYCOPATHOLOGIA, V178, P321, DOI 10.1007/s11046-014-9819-4; Beggah S, 2000, MICROBIOL-UK, V146, P2765, DOI 10.1099/00221287-146-11-2765; Behnsen J, 2008, INFECT IMMUN, V76, P820, DOI 10.1128/IAI.01037-07; Behnsen J, 2010, INFECT IMMUN, V78, P3585, DOI 10.1128/IAI.01353-09; Bolger MS, 2007, AM J PHYSIOL-LUNG C, V292, pL748, DOI 10.1152/ajplung.00127.2006; Borg-von Zepelin M, 1998, MOL MICROBIOL, V28, P543, DOI 10.1046/j.1365-2958.1998.00815.x; Braem SGE, 2015, J INNATE IMMUN, V7, P364, DOI 10.1159/000369493; Cadena J, 2016, INFECT DIS CLIN N AM, V30, P125, DOI 10.1016/j.idc.2015.10.015; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; Del Tordello E, 2014, P NATL ACAD SCI USA, V111, P427, DOI 10.1073/pnas.1321556111; Dunkelberger JR, 2010, MOL IMMUNOL, V47, P2176, DOI 10.1016/j.molimm.2010.05.008; Escobar N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00438; FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856; Fernandez D, 2013, ACTA CRYSTALLOGR D, V69, P1946, DOI 10.1107/S0907444913017642; Fraga TR, 2014, J INFECT DIS, V209, P876, DOI 10.1093/infdis/jit569; Gazendam RP, 2016, IMMUNOL REV, V273, P299, DOI 10.1111/imr.12454; Gresnigt MS, 2013, J IMMUNOL, V190, P5629, DOI 10.4049/jimmunol.1202601; Hartmann T, 2011, MOL MICROBIOL, V82, P917, DOI 10.1111/j.1365-2958.2011.07868.x; HECTOR RF, 1990, INFECT IMMUN, V58, P1476, DOI 10.1128/IAI.58.5.1476-1478.1990; Heeger PS, 2012, IMMUNOBIOLOGY, V217, P216, DOI 10.1016/j.imbio.2011.06.004; Heinekamp T, 2015, SEMIN IMMUNOPATHOL, V37, P141, DOI 10.1007/s00281-014-0465-1; HENWICK S, 1993, J LAB CLIN MED, V122, P27; JATONOGAY K, 1994, MOL MICROBIOL, V14, P917, DOI 10.1111/j.1365-2958.1994.tb01327.x; Jusko M, 2015, J IMMUNOL, V195, P2231, DOI 10.4049/jimmunol.1402892; Jusko M, 2012, J IMMUNOL, V188, P2338, DOI 10.4049/jimmunol.1101240; Koneru L, 2016, BIOL CHEM; KOZEL TR, 1989, INFECT IMMUN, V57, P3412, DOI 10.1128/IAI.57.11.3412-3417.1989; Laarman AJ, 2011, J IMMUNOL, V186, P6445, DOI 10.4049/jimmunol.1002948; Lazovic Biljana, 2012, Med Arch, V66, P420, DOI 10.5455/medarh.2012.66.420-422; Lyubchenko T, 2005, J IMMUNOL, V174, P3264, DOI 10.4049/jimmunol.174.6.3264; MARKARYAN A, 1994, INFECT IMMUN, V62, P2149, DOI 10.1128/IAI.62.6.2149-2157.1994; MONOD M, 1991, J MED MICROBIOL, V35, P23, DOI 10.1099/00222615-35-1-23; MONOD M, 1993, INFECT IMMUN, V61, P4099, DOI 10.1128/IAI.61.10.4099-4104.1993; MONOD M, 1993, FEMS MICROBIOL LETT, V106, P39, DOI 10.1111/j.1574-6968.1993.tb05932.x; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; MOUTAOUAKIL M, 1993, J MED MICROBIOL, V39, P393, DOI 10.1099/00222615-39-5-393; Mullick J, 2005, J VIROL, V79, P12382, DOI 10.1128/JVI.79.19.12382-12393.2005; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Pangburn MK, 2008, VACCINE, V26, pI15, DOI 10.1016/j.vaccine.2008.11.023; Paulussen C, 2017, MICROB BIOTECHNOL, V10, P296, DOI 10.1111/1751-7915.12367; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; Pidde-Queiroz G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002519; Rambach G, 2005, MICROBES INFECT, V7, P1285, DOI 10.1016/j.micinf.2005.04.014; Rambach G, 2010, MOL IMMUNOL, V47, P1438, DOI 10.1016/j.molimm.2010.02.010; Rattan A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006248; Rawal N, 2000, J IMMUNOL, V164, P1379, DOI 10.4049/jimmunol.164.3.1379; Rosbjerg A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00473; Roy RM, 2013, MBIO, V4, DOI 10.1128/mBio.00162-13; SAHU A, 1994, J BIOL CHEM, V269, P28997; Sahu A, 1998, J IMMUNOL, V160, P5596; Schmidtchen A, 2003, MICROB PATHOGENESIS, V34, P47, DOI 10.1016/S0882-4010(02)00197-3; Sharon H, 2009, INFECT IMMUN, V77, P4051, DOI 10.1128/IAI.00426-09; Singh AK, 2006, J BIOL CHEM, V281, P23119, DOI 10.1074/jbc.M603085200; SIRAKOVA TD, 1994, INFECT IMMUN, V62, P4208, DOI 10.1128/IAI.62.10.4208-4218.1994; Svoboda E, 2015, IMMUNOL LETT, V168, P13, DOI 10.1016/j.imlet.2015.08.009; THAU N, 1994, INFECT IMMUN, V62, P4380, DOI 10.1128/IAI.62.10.4380-4388.1994; Tsai HF, 1997, MOL MICROBIOL, V26, P175, DOI 10.1046/j.1365-2958.1997.5681921.x; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; van den Elsen JMH, 2011, SCIENCE, V332, P608, DOI 10.1126/science.1201954; Vogl G, 2008, MOL IMMUNOL, V45, P1485, DOI 10.1016/j.molimm.2007.08.011; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Warris A, 2014, J INFECTION, V69, pS36, DOI 10.1016/j.jinf.2014.07.011; WASHBURN RG, 1986, J INFECT DIS, V154, P944, DOI 10.1093/infdis/154.6.944; Wetsel RA, 2000, CONT IMMUN, V9, P113	68	20	20	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15538	15555		10.1074/jbc.RA117.001476	http://dx.doi.org/10.1074/jbc.RA117.001476			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30139746	Green Published, hybrid			2022-12-28	WOS:000446549200019
J	Koenis, DS; Medzikovic, L; Vos, M; Beldman, TJ; van Loenen, PB; van Tiel, CM; Hamers, AAJ; Rubio, IO; de Waard, V; de Vries, CJM				Koenis, Duco S.; Medzikovic, Lejla; Vos, Mariska; Beldman, Thijs J.; van Loenen, Pieter B.; van Tiel, Claudia M.; Hamers, Anouk A. J.; Rubio, Iker Otermin; de Waard, Vivian; de Vries, Carlie J. M.			Nur77 variants solely comprising the amino-terminal domain activate hypoxia-inducible factor-1 and affect bone marrow homeostasis in mice and humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypoxia-inducible factor (HIF); bone marrow; homeostasis; gene knockout; nuclear receptor; transcription factor; liver; Nur77; transcript variant	STEM-CELL MOBILIZATION; NUCLEAR RECEPTOR NUR77; COLONY-STIMULATING FACTOR; HIF-1-ALPHA; PROGENITOR; PATHWAY	Gene targeting via homologous recombination can occasionally result in incomplete disruption of the targeted gene. Here, we show that a widely used Nur77-deficient transgenic mouse model expresses a truncated protein encoding for part of the N-terminal domain of nuclear receptor Nur77. This truncated Nur77 protein is absent in a newly developed Nur77-deficient mouse strain generated using Cre-Lox recombination. Comparison of these two mouse strains using immunohistochemistry, flow cytometry, and colony-forming assays shows that homologous recombination-derived Nur77-deficient mice, but not WT or Cre-Lox-derived Nur77-deficient mice, suffer from liver immune cell infiltrates, loss of splenic architecture, and increased numbers of bone marrow hematopoietic stem cells and splenic colony-forming cells with age. Mechanistically, we demonstrate that the truncated Nur77 N-terminal domain protein maintains the stability and activity of hypoxia-inducible factor (HIF)-1, a transcription factor known to regulate bone marrow homeostasis. Additionally, a previously discovered, but uncharacterized, human Nur77 transcript variant that encodes solely for its N-terminal domain, designated TR3, can also stabilize and activate HIF-1. Meta-analysis of publicly available microarray data sets shows that TR3 is highly expressed in human bone marrow cells and acute myeloid leukemia samples. In conclusion, our study provides evidence that a transgenic mouse model commonly used to study the biological function of Nur77 has several major drawbacks, while simultaneously identifying the importance of nongenomic Nur77 activity in the regulation of bone marrow homeostasis.	[Koenis, Duco S.; Medzikovic, Lejla; Vos, Mariska; Beldman, Thijs J.; van Loenen, Pieter B.; van Tiel, Claudia M.; Hamers, Anouk A. J.; Rubio, Iker Otermin; de Waard, Vivian; de Vries, Carlie J. M.] Univ Amsterdam, Acad Med Ctr, Amsterdam Cardiovasc Sci, Dept Med Biochem, K1-113,Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands; [Hamers, Anouk A. J.] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA	University of Amsterdam; Academic Medical Center Amsterdam; La Jolla Institute for Immunology	de Vries, CJM (corresponding author), Univ Amsterdam, Acad Med Ctr, Amsterdam Cardiovasc Sci, Dept Med Biochem, K1-113,Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	c.j.devries@amc.uva.nl		Koenis, Duco Steven/0000-0002-7213-0950	Academic Medical Center (Amsterdam, The Netherlands); Dutch Heart Foundation [CVON2014-11]; Netherlands CardioVascular Research Initiative [CVON2011-19]	Academic Medical Center (Amsterdam, The Netherlands)(Netherlands Government); Dutch Heart Foundation(Netherlands Heart Foundation); Netherlands CardioVascular Research Initiative	This research was supported by the Academic Medical Center (Amsterdam, The Netherlands), the Dutch Heart Foundation (CVON2014-11 "RECONNECT"), and the Netherlands CardioVascular Research Initiative (CVON2011-19 "GENIUS"). The authors declare that they have no conflicts of interest with the contents of this article.	Cao XH, 2004, MOL CELL BIOL, V24, P9705, DOI 10.1128/MCB.24.22.9705-9725.2004; DAVIS IJ, 1994, MOL CELL BIOL, V14, P3469, DOI 10.1128/MCB.14.5.3469; Eaves CJ, 2015, BLOOD, V125, P2605, DOI 10.1182/blood-2014-12-570200; Forristal CE, 2015, LEUKEMIA, V29, P1366, DOI 10.1038/leu.2015.8; Hamers AAJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2469-9; Hamers AAJ, 2012, CIRC RES, V110, P428, DOI 10.1161/CIRCRESAHA.111.260760; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hug N, 2016, NUCLEIC ACIDS RES, V44, P1483, DOI 10.1093/nar/gkw010; Kikuchi H, 2009, CANCER RES, V69, P8499, DOI 10.1158/0008-5472.CAN-09-2213; Kikuta T, 2000, EXP HEMATOL, V28, P311, DOI 10.1016/S0301-472X(99)00151-4; Kim CH, 2010, J BLOOD MED, V1, P13, DOI 10.2147/JBM.S7224; Kurakula K, 2015, J IMMUNOL, V195, P1388, DOI 10.4049/jimmunol.1401714; Kurakula K, 2014, BBA-MOL CELL RES, V1843, P2543, DOI 10.1016/j.bbamcr.2014.06.010; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Lei H, 1996, DEVELOPMENT, V122, P3195; Li XM, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0085-0; Medzikovic L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15404; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Richards MK, 2003, BLOOD, V102, P3562, DOI 10.1182/blood-2003-02-0593; Ross J, 2009, BLOOD, V114, P1283, DOI 10.1182/blood-2009-02-203240; Ryan MA, 2010, NAT MED, V16, P1141, DOI 10.1038/nm.2217; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Thompson Kenneth W, 2015, Oncoscience, V2, P349; Xing ZL, 2006, BLOOD, V108, P2190, DOI 10.1182/blood-2005-12-010272; Yoo YG, 2007, ONCOGENE, V26, P3823, DOI 10.1038/sj.onc.1210149; Yoo YG, 2004, J BIOL CHEM, V279, P53365, DOI 10.1074/jbc.M408554200	34	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15070	15083		10.1074/jbc.RA118.002720	http://dx.doi.org/10.1074/jbc.RA118.002720			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30111591	hybrid, Green Published			2022-12-28	WOS:000445998400011
J	Chua, NK; Brown, AJ				Chua, Ngee Kiat; Brown, Andrew J.			Mallostery: Filling a niche between quality and metabolic control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							HMG-COA REDUCTASE; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; REGULATED DEGRADATION; STEROL; CHOLESTEROL; YEAST	To be, or not to be ... What determines the destruction of a protein in response to metabolic cues? In the current issue of JBC, Wangeline and Hampton shed new light on this existential question by studying the classic case of HMGCR (Hmg2 in yeast), the rate-limiting step in sterol synthesis, and find a metabolic cue that causes "allosteric misfolding" and subsequent destruction of the protein, a concept they name mallostery.	[Chua, Ngee Kiat; Brown, Andrew J.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Biosci South E26, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Brown, AJ (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Biosci South E26, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au	Chua, Ngee Kiat/AAG-6793-2021	Chua, Ngee Kiat/0000-0003-2785-2767				Chua NK, 2017, J BIOL CHEM, V292, P19959, DOI 10.1074/jbc.M117.794230; FAUST JR, 1982, P NATL ACAD SCI-BIOL, V79, P5205, DOI 10.1073/pnas.79.17.5205; Garza RM, 2009, J BIOL CHEM, V284, P35368, DOI 10.1074/jbc.M109.023994; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Johnson BM, 2018, SEMIN CELL DEV BIOL, V81, P121, DOI 10.1016/j.semcdb.2017.10.019; Prabhu AV, 2016, J BIOL CHEM, V291, P8363, DOI 10.1074/jbc.M115.699546; ROITELMAN J, 1992, J BIOL CHEM, V267, P25264; Schumacher MM, 2018, J BIOL CHEM, V293, P312, DOI 10.1074/jbc.RA117.000423; Wangeline MA, 2018, J BIOL CHEM, V293, P14937, DOI 10.1074/jbc.RA118.001808; Wangeline MA, 2017, ANNU REV CELL DEV BI, V33, P467, DOI 10.1146/annurev-cellbio-111315-125036	10	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14951	14952		10.1074/jbc.H118.005031	http://dx.doi.org/10.1074/jbc.H118.005031			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30242042	hybrid, Green Published			2022-12-28	WOS:000446155000030
J	Fleischhacker, AS; Ragsdale, SW				Fleischhacker, Angela S.; Ragsdale, Stephen W.			An unlikely heme chaperone confirmed at last	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; NITRIC-OXIDE	Labile heme, as opposed to heme that is tightly bound within proteins, is thought to require a chaperone to be trafficked within the cell due to its cytotoxicity, but the identity of this chaperone was not known. A new study reveals that an unlikely protein, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), is a heme chaperone that binds and transfers labile heme to downstream target proteins. These results provide a new framework for understanding heme homeostasis and raise intriguing questions regarding the intersection of heme transport, carbohydrate metabolism, and intracellular signaling.	[Fleischhacker, Angela S.; Ragsdale, Stephen W.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ragsdale, SW (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu	Fleischhacker, Angela/AAN-3275-2021		NIGMS, National Institutes of Health [GM R01-123513]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123513] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant GM R01-123513 (to S. W. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chakravarti R, 2010, P NATL ACAD SCI USA, V107, P18004, DOI 10.1073/pnas.1008133107; Fleischhacker AS, 2018, ANTIOXID REDOX SIGN, V29, P1841, DOI 10.1089/ars.2017.7368; Ghosh A, 2018, P NATL ACAD SCI USA, V115, pE1117, DOI 10.1073/pnas.1717993115; Ghosh A, 2014, J BIOL CHEM, V289, P15259, DOI 10.1074/jbc.M114.559393; Hanna DA, 2016, P NATL ACAD SCI USA, V113, P7539, DOI 10.1073/pnas.1523802113; Huang Y, 2017, ARCH BIOCHEM BIOPHYS, V619, P54, DOI 10.1016/j.abb.2017.03.005; Reddi AR, 2016, ACCOUNTS CHEM RES, V49, P1104, DOI 10.1021/acs.accounts.5b00553; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Sweeny EA, 2018, J BIOL CHEM, V293, P14557, DOI 10.1074/jbc.RA118.004169	9	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14569	14570		10.1074/jbc.H118.005247	http://dx.doi.org/10.1074/jbc.H118.005247			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30217868	Green Published, hybrid			2022-12-28	WOS:000444671500033
J	Wang, Y; Jiang, JB; Gao, YC; Sun, Y; Dai, JF; Wu, Y; Qu, D; Ma, G; Fang, XY				Wang, Yan; Jiang, Jingbo; Gao, Yachao; Sun, Yang; Dai, Jianfeng; Wu, Yang; Qu, Di; Ma, Gang; Fang, Xianyang			Staphylococcus epidermidis small basic protein (Sbp) forms amyloid fibrils, consistent with its function as a scaffolding protein in biofilms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; small-angle X-ray scattering (SAXS); electron microscopy (EM); atomic force microscopy (AFM); confocal microscopy; accumulated associated protein; biofilm formation; extracellular matrix protein; small basic protein; Staphylococcus epidermidis	INTRINSICALLY DISORDERED PROTEINS; X-RAY-SCATTERING; BIOLOGICAL MACROMOLECULES; INTERCELLULAR-ADHESION; STRUCTURAL BASIS; RESOLUTION; MECHANISMS; INFECTION; SYSTEM	Biofilms are communities of microbes embedded in a microbial extracellular matrix. Their formation is considered the main virulence mechanism enabling the opportunistic bacterial pathogen Staphylococcus epidermidis to cause devastating nosocomial, implant-associated infections. Biofilms often contain proteins, and an 18-kDa protein called small basic protein (Sbp) recently was discovered in the S. epidermidis biofilm matrix and may serve as a scaffolding protein in both polysaccharide intercellular adhesin (PIA)-dependent and accumulation-associated protein (Aap)-dependent biofilm formations. In Aap-mediated biofilm formation, Sbp colocalizes with Domain-B of Aap, implying that Sbp directly interacts with Aap's Domain-B. However, the structure of Sbp and its interaction with Aap, as well as the molecular mechanism underlying Sbp's roles in biofilm formation, are incompletely understood. In this work, we used small-angle X-ray scattering (SAXS), NMR, analytical size-exclusion chromatography, and isothermal titration calorimetry analyses to determine the Sbp structure and characterize its interaction with Aap's Domain-B. We found that Sbp is monomeric and partially folded in solution, and, unexpectedly, we observed no direct interactions between Sbp and Aap Domain-B. Instead, we noted that Sbp forms amyloid fibrils both in vitro and in vivo. Atomic force, transmission electron, and confocal fluorescence microscopy methods confirmed the formation of Sbp amyloid fibrils and revealed their morphology. Taken together, the Sbp amyloid fibril structures identified here may account for Sbp's role as a scaffolding protein in the S. epidermidis biofilm matrix.	[Wang, Yan; Jiang, Jingbo; Gao, Yachao; Sun, Yang; Fang, Xianyang] Tsinghua Univ, Sch Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China; [Dai, Jianfeng] Soochow Univ, Inst Biol, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Peoples R China; [Dai, Jianfeng] Soochow Univ, Inst Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Peoples R China; [Wu, Yang; Qu, Di] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Med Mol Virol, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China; [Wu, Yang; Qu, Di] Fudan Univ, Shanghai Med Coll, Minist Publ Hlth, Dept Med Microbiol & Parasitol, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China; [Ma, Gang] Hebei Univ, Coll Chem & Environm Sci, Key Lab Analyt Sci & Technol Hebei Prov, Minist Educ,Key Lab Med Chem & Mol Diag, Baoding 071002, Peoples R China	Tsinghua University; Soochow University - China; Soochow University - China; Fudan University; Fudan University; Hebei University	Fang, XY (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China.	fangxy@tsinghua.edu.cn	Qu, Di/AAO-4590-2020; Dai, Jianfeng/ACP-1114-2022	Wang, Yan/0000-0002-0452-6750; Fang, Xianyang/0000-0001-9432-9736; dai, jianfeng/0000-0002-1871-8390	National Key Research and Development Program of China [2016YFA0500700]; China Youth 1000-Talent Program of the State Council of China; Beijing Advanced Innovation Center for Structural Biology; Tsinghua-Peking Joint Center for Life Sciences	National Key Research and Development Program of China; China Youth 1000-Talent Program of the State Council of China; Beijing Advanced Innovation Center for Structural Biology; Tsinghua-Peking Joint Center for Life Sciences	This work was supported by National Key Research and Development Program of China Grant 2016YFA0500700, the China Youth 1000-Talent Program of the State Council of China, the Beijing Advanced Innovation Center for Structural Biology, and the Tsinghua-Peking Joint Center for Life Sciences (to X. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilera P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00035; Allison DG, 2003, BIOFOULING, V19, P139, DOI 10.1038/nrmicro2415; Barbu EM, 2014, MOL MICROBIOL, V94, P172, DOI 10.1111/mmi.12750; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Buttner H, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00014; Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conrady DG, 2013, P NATL ACAD SCI USA, V110, pE202, DOI 10.1073/pnas.1208134110; Conrady DG, 2008, P NATL ACAD SCI USA, V105, P19456, DOI 10.1073/pnas.0807717105; Cremades N, 2018, NEUROBIOL DIS, V109, P178, DOI 10.1016/j.nbd.2017.07.009; Decker R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004735; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DePas WH, 2012, RES MICROBIOL, V163, P592, DOI 10.1016/j.resmic.2012.10.009; Dragos A, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030060; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Dutta A, 2016, BIOPHYS CHEM, V217, P32, DOI 10.1016/j.bpc.2016.07.006; Espargaro A, 2015, VIRUS RES, V207, P127, DOI 10.1016/j.virusres.2015.03.001; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fong JNC, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0004-2014; Frousios KK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-44; Geoghegan JA, 2010, J BACTERIOL, V192, P5663, DOI 10.1128/JB.00628-10; Gibson DL, 2007, MICROBIOL-SGM, V153, P1131, DOI 10.1099/mic.0.2006/000935-0; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hartman K, 2013, PEERJ, V1, DOI 10.7717/peerj.5; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kosol S, 2013, MOLECULES, V18, P10802, DOI 10.3390/molecules180910802; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lee G, 2015, SCI REP-UK, V5, DOI 10.1038/srep16220; Maury CPJ, 2009, J INTERN MED, V265, P329, DOI 10.1111/j.1365-2796.2008.02068.x; Missineo A, 2014, INFECT IMMUN, V82, P2448, DOI 10.1128/IAI.01542-14; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Oli MW, 2012, MICROBIOL-SGM, V158, P2903, DOI 10.1099/mic.0.060855-0; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Paharik AE, 2016, VIRULENCE MECHANISMS OF BACTERIAL PATHOGENS, 5 EDITION, P529, DOI 10.1128/microbiolspec.VMBF-0022-2015; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Romero D, 2014, INT MICROBIOL, V17, P65, DOI 10.2436/20.1501.01.208; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Sarroukh R, 2013, BBA-BIOMEMBRANES, V1828, P2328, DOI 10.1016/j.bbamem.2013.04.012; Schaeffer CR, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00165-16; Schaeffer CR, 2015, INFECT IMMUN, V83, P214, DOI 10.1128/IAI.02177-14; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Sciacca MFM, 2012, BIOCHEMISTRY-US, V51, P7676, DOI 10.1021/bi3009888; Speziale P, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00171; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Taglialegna A, 2016, J BACTERIOL, V198, P2579, DOI 10.1128/JB.00122-16; Taglialegna A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005711; Uversky VN, 2010, EXPERT REV PROTEOMIC, V7, P543, DOI [10.1586/epr.10.36, 10.1586/EPR.10.36]; Van Mellaert L, 2012, EXPERT REV VACCINES, V11, P319, DOI [10.1586/ERV.11.190, 10.1586/erv.11.190]; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang JB, 2009, J MOL BIOL, V393, P717, DOI 10.1016/j.jmb.2009.08.001; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	57	12	14	0	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14296	14311		10.1074/jbc.RA118.002448	http://dx.doi.org/10.1074/jbc.RA118.002448			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30049797	Green Published, hybrid			2022-12-28	WOS:000444671500012
J	Santos, MF; Rappa, G; Karbanova, J; Kurth, T; Corbeil, D; Lorico, A				Santos, Mark F.; Rappa, Germana; Karbanova, Jana; Kurth, Thomas; Corbeil, Denis; Lorico, Aurelio			VAMP-associated protein-A and oxysterol-binding protein-related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear envelope; endosome; nuclear transport; cancer biology; exosome (vesicle); extracellular vesicles; nucleus; late endosome; ORP3; oxysterol-binding related protein; VAP-A; VOR complex; endocytosis; vesicle-associated membrane protein	MEMBRANE CONTACT SITES; EXTRACELLULAR VESICLES; ENDOPLASMIC-RETICULUM; MEDIATED TRANSFER; PLASMA-MEMBRANE; ER; VAP; CELLS; ORP1L; TETHER	The endocytic pathway plays an instrumental role in recycling internalized molecules back to the plasma membrane or in directing them to lysosomes for degradation. We recently reported a new role of endosomes-the delivery of components from extracellular vesicles (EVs) to the nucleoplasm of recipient cells. Using indirect immunofluorescence, FRET, immunoisolation techniques, and RNAi, we report here a tripartite protein complex (referred to as the VOR complex) that is essential for the nuclear transfer of EV-derived components by orchestrating the specific localization of late endosomes into nucleoplasmic reticulum. We found that the VOR complex contains the endoplasmic reticulum-localized vesicle-associated membrane protein (VAMP)-associated protein A (VAP-A), the cytoplasmic oxysterol-binding protein-related protein 3 (ORP3), and late endosome-associated small GTPase Rab7. The silencing of VAP-A or ORP3 abrogated the association of Rab7-positive late endosomes with nuclear envelope invaginations and, hence, the transport of endocytosed EV-derived components to the nucleoplasm of recipient cells. We conclude that the VOR complex can be targeted to inhibit EV-mediated intercellular communication, which can have therapeutic potential for managing cancer in which the release of EVs is dysregulated.	[Santos, Mark F.; Rappa, Germana; Corbeil, Denis; Lorico, Aurelio] Roseman Univ, Coll Med, Roseman Canc Ctr, 10530 Discovery Dr, Las Vegas, NV 89135 USA; [Santos, Mark F.; Rappa, Germana; Corbeil, Denis; Lorico, Aurelio] Roseman Univ, Coll Med, Dept Pathol, 10530 Discovery Dr, Las Vegas, NV 89135 USA; [Karbanova, Jana; Kurth, Thomas; Corbeil, Denis] Tech Univ Dresden, Biotechnol Ctr, Tatzberg 47-49, D-01307 Dresden, Germany; [Kurth, Thomas; Corbeil, Denis] Tech Univ Dresden, Ctr Mol & Cellular Bioengn, DFG Ctr Regenerat Therapies, Tatzberg 47-49, D-01307 Dresden, Germany; [Lorico, Aurelio] Mediterranean Inst Oncol Fdn, Via Penninazzo 11, I-95029 Viagrande, Italy	Technische Universitat Dresden; German Research Foundation (DFG); Technische Universitat Dresden	Lorico, A (corresponding author), Roseman Univ, Coll Med, Roseman Canc Ctr, 10530 Discovery Dr, Las Vegas, NV 89135 USA.; Lorico, A (corresponding author), Roseman Univ, Coll Med, Dept Pathol, 10530 Discovery Dr, Las Vegas, NV 89135 USA.; Corbeil, D (corresponding author), Tech Univ Dresden, Biotechnol Ctr BIOTEC, Tissue Engn Lab, Tatzberg 47-49, D-01307 Dresden, Germany.	denis.corbeil@tu-dresden.de; alorico@roseman.edu	Corbeil, Denis/AFL-1008-2022; Lorico, Aurelio/AAG-8095-2021; Corbeil, Denis/A-6519-2010	Lorico, Aurelio/0000-0003-0644-7375; Kurth, Thomas/0000-0001-5624-1717; Karbanova, Jana/0000-0001-7687-0983	European Regional Development Fund	European Regional Development Fund(European Commission)	We thank Fabio Anzanello for skilled technical assistance; Kyle Choi and Matthew Stein for assistance with CLSM; Susanne Kretschmar from the Electron Microscopy/Histology (EMH) Facility at the BIOTEC (Dresden, Germany) for support with immunogold EM; Oystein Fodstad for FEMX-I cells; Eivind Hovig for sharing unpublished data; and Yuri Lazebnik for critical review of the manuscript. The European Regional Development Fund supports the EMH Facility.	Alpy F, 2013, J CELL SCI, V126, P5500, DOI 10.1242/jcs.139295; Audas TE, 2012, MOL CELL, V45, P147, DOI 10.1016/j.molcel.2011.12.012; Cai J, 2013, J MOL CELL BIOL, V5, P227, DOI 10.1093/jmcb/mjt011; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Desrochers LM, 2016, DEV CELL, V37, P301, DOI 10.1016/j.devcel.2016.04.019; Dong R, 2016, CELL, V166, P408, DOI 10.1016/j.cell.2016.06.037; Dovrat S, 2014, MOL ONCOL, V8, P894, DOI 10.1016/j.molonc.2014.03.011; Drozdz MM, 2017, NUCLEUS-PHILA, V8, P34, DOI 10.1080/19491034.2016.1252893; Eisenberg-Bord M, 2016, DEV CELL, V39, P395, DOI 10.1016/j.devcel.2016.10.022; Fais S, 2016, ACS NANO, V10, P3886, DOI 10.1021/acsnano.5b08015; Fischer AH, 2003, AM J PATHOL, V163, P1091, DOI 10.1016/S0002-9440(10)63468-2; FODSTAD O, 1988, CANCER RES, V48, P4382; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; Ivanusic D, 2014, BIOTECHNIQUES, V57, P188, DOI 10.2144/000114215; Johansson M, 2005, MOL BIOL CELL, V16, P5480, DOI 10.1091/mbc.E05-03-0189; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Jorgens DM, 2017, J CELL SCI, V130, P177, DOI 10.1242/jcs.190967; Kanada M, 2015, P NATL ACAD SCI USA, V112, pE1433, DOI 10.1073/pnas.1418401112; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Lehto M, 2005, EXP CELL RES, V310, P445, DOI 10.1016/j.yexcr.2005.08.003; Lehto M, 2008, J CELL SCI, V121, P695, DOI 10.1242/jcs.016964; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Lux K, 2005, J VIROL, V79, P11776, DOI 10.1128/JVI.79.18.11776-11787.2005; Maas SLN, 2017, TRENDS CELL BIOL, V27, P172, DOI 10.1016/j.tcb.2016.11.003; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Murphy SE, 2016, BBA-MOL CELL BIOL L, V1861, P952, DOI 10.1016/j.bbalip.2016.02.009; Nunukova A, 2015, INT J MOL MED, V36, P65, DOI 10.3892/ijmm.2015.2210; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Raiborg C, 2015, EMBO J, V34, P1848, DOI 10.15252/embj.201591481; Raiborg C, 2015, NATURE, V520, P234, DOI 10.1038/nature14359; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rappa G, 2017, ONCOTARGET, V8, P14443, DOI 10.18632/oncotarget.14804; Rappa G, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-62; Rappa G, 2008, STEM CELLS, V26, P3008, DOI 10.1634/stemcells.2008-0601; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Rowland AA, 2014, CELL, V159, P1027, DOI 10.1016/j.cell.2014.10.023; Saita S, 2009, J BIOL CHEM, V284, P13766, DOI 10.1074/jbc.M807938200; Sarko DK, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00082; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Soung YH, 2017, CANCERS, V9, DOI 10.3390/cancers9010008; Stoica R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4996; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Kant R, 2013, J LIPID RES, V54, P2153, DOI 10.1194/jlr.M037325; Waldenstrom A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034653; Weber-Boyvat M, 2015, EXP CELL RES, V331, P278, DOI 10.1016/j.yexcr.2014.10.019; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhou TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019599	55	36	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13834	13848		10.1074/jbc.RA118.003725	http://dx.doi.org/10.1074/jbc.RA118.003725			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30018135	hybrid, Green Published			2022-12-28	WOS:000444070700009
J	Kuusk, S; Bissaro, B; Kuusk, P; Forsberg, Z; Eijsink, VGH; Sorlie, M; Valjamae, P				Kuusk, Silja; Bissaro, Bastien; Kuusk, Piret; Forsberg, Zarah; Eijsink, Vincent G. H.; Sorlie, Morten; Valjamae, Priit			Kinetics of H2O2-driven degradation of chitin by a bacterial lytic polysaccharide monooxygenase. (vol 293, pg 523, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Bissaro, Bastien/AAI-6814-2020; BISSARO, Bastien/AAL-7130-2021; Forsberg, Zarah/AAM-2395-2020					Kuusk S, 2018, J BIOL CHEM, V293, P523, DOI 10.1074/jbc.M117.817593	1	5	5	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12284	12284		10.1074/jbc.AAC118.004796	http://dx.doi.org/10.1074/jbc.AAC118.004796			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	30076256	hybrid, Green Published			2022-12-28	WOS:000440803200026
J	Gupta, R; Nguyen, DC; Schaid, MD; Lei, X; Balamurugan, AN; Wong, GW; Kim, JA; Koltes, JE; Kimple, ME; Bhatnagar, S				Gupta, Rajesh; Nguyen, Dan C.; Schaid, Michael D.; Lei, Xia; Balamurugan, Appakalai N.; Wong, G. William; Kim, Jeong-a; Koltes, James E.; Kimple, Michelle E.; Bhatnagar, Sushant			Complement 1q-like-3 protein inhibits insulin secretion from pancreatic beta-cells via the cell adhesion G protein-coupled receptor BAI3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (B-cell); insulin secretion; cyclic AMP (cAMP); G protein-coupled receptor (GPCR); second messenger; brain angiogenesis inhibitor 3; complement 1q-like 3; glucagon-like peptide-1; obesity; type 2 diabetes	GLUCAGON-LIKE PEPTIDE-1; DPP-4 INHIBITORS; GLYCEMIC CONTROL; ADIPOSE-TISSUE; CTRP FAMILY; GLUCOSE; AGONISTS; SULFONYLUREA; EXPRESSION; OBESITY	Secreted proteins are important metabolic regulators in both healthy and disease states. Here, we sought to investigate the mechanism by which the secreted protein complement 1q-like-3 (C1ql3) regulates insulin secretion from pancreatic -cells, a key process affecting whole-body glucose metabolism. We found that C1ql3 predominantly inhibits exendin-4- and cAMP-stimulated insulin secretion from mouse and human islets. However, to a lesser extent, C1ql3 also reduced insulin secretion in response to KCl, the potassium channel blocker tolbutamide, and high glucose. Strikingly, C1ql3 did not affect insulin secretion stimulated by fatty acids, amino acids, or mitochondrial metabolites, either at low or submaximal glucose concentrations. Additionally, C1ql3 inhibited glucose-stimulated cAMP levels, and insulin secretion stimulated by exchange protein directly activated by cAMP-2 and protein kinase A. These results suggest that C1ql3 inhibits insulin secretion primarily by regulating cAMP signaling. The cell adhesion G protein-coupled receptor, brain angiogenesis inhibitor-3 (BAI3), is a C1ql3 receptor and is expressed in -cells and in mouse and human islets, but its function in -cells remained unknown. We found that siRNA-mediated Bai3 knockdown in INS1(832/13) cells increased glucose-stimulated insulin secretion. Furthermore, incubating the soluble C1ql3-binding fragment of the BAI3 protein completely blocked the inhibitory effects of C1ql3 on insulin secretion in response to cAMP. This suggests that BAI3 mediates the inhibitory effects of C1ql3 on insulin secretion from pancreatic -cells. These findings demonstrate a novel regulatory mechanism by which C1ql3/BAI3 signaling causes an impairment of insulin secretion from -cells, possibly contributing to the progression of type 2 diabetes in obesity.	[Gupta, Rajesh; Nguyen, Dan C.; Kim, Jeong-a; Bhatnagar, Sushant] Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA; [Gupta, Rajesh; Nguyen, Dan C.; Kim, Jeong-a; Bhatnagar, Sushant] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA; [Koltes, James E.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Schaid, Michael D.; Kimple, Michelle E.] Univ Wisconsin, Interdisciplinary Grad Program Nutr Sci, Madison, WI 53706 USA; [Kimple, Michelle E.] Univ Wisconsin, Dept Med, Div Endocrinol Diabet & Metab, Madison, WI 53705 USA; [Kimple, Michelle E.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53705 USA; [Schaid, Michael D.; Kimple, Michelle E.] William S Middleton Mem Vet Adm Med Ctr, Res Serv, Madison, WI 53705 USA; [Balamurugan, Appakalai N.] Univ Louisville, Dept Surg, Louisville, KY 40202 USA; [Lei, Xia; Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Lei, Xia; Wong, G. William] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Iowa State University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Louisville; Johns Hopkins University; Johns Hopkins University	Bhatnagar, S (corresponding author), 1825 Univ Blvd,SHEL 1203, Birmingham, AL 35294 USA.	sushantbhatnagar@uabmc.edu		Bhatnagar, Sushant/0000-0002-2917-8588	National Institutes of Health NLM traineeship Grant [T15 LM007359]; National Institutes of Health NIDDK [4 R00 DK95975-03, DK084171]; Diabetes Research Center (DRC) [P30 DK079626]; National Institutes of Health NHLBI [R01HL128695]; DRC [P30 DK079626]; American Diabetes Association (ADA) [ADA1-18-PDF-103]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626, R01DK084171, R00DK095975] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007359] Funding Source: NIH RePORTER	National Institutes of Health NLM traineeship Grant; National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Diabetes Research Center (DRC); National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DRC; American Diabetes Association (ADA)(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was was supported by National Institutes of Health NLM traineeship Grant T15 LM007359 (to J.E.K.). This work was also supported by National Institutes of Health NIDDK Grant 4 R00 DK95975-03 and Diabetes Research Center (DRC) Grant P30 DK079626 (to S.B.); National Institutes of Health NHLBI Grant R01HL128695 and DRC Grant P30 DK079626 (to J.K.); Postdoctoral fellowship ADA1-18-PDF-103 from the American Diabetes Association (ADA) (to R.G.); and National Institutes of Health NIDDK DK084171 (to G.W.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aschner P, 2006, DIABETES CARE, V29, P2632, DOI 10.2337/dc06-0703; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; BAYERDORFFER E, 1994, LEBER MAGEN DARM, V24, P228; Bhatnagar S, 2014, J BIOL CHEM, V289, P25276, DOI 10.1074/jbc.M114.575985; Bhatnagar S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002323; Bhatnagar S, 2009, J BIOL CHEM, V284, P10023, DOI 10.1074/jbc.M808818200; Bolliger MF, 2011, P NATL ACAD SCI USA, V108, P2534, DOI 10.1073/pnas.1019577108; Brunton S, 2014, INT J CLIN PRACT, V68, P557, DOI 10.1111/ijcp.12361; Byerly MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062862; CERASI E, 1967, ACTA ENDOCRINOL-COP, V55, P278, DOI 10.1530/acta.0.0550278; Collet- Gaudillat C., 2012, J DIABETES MELLITUS, V2, P118; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; DAVIS SN, 1993, METABOLISM, V42, P30, DOI 10.1016/0026-0495(93)90168-N; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Duman JG, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8301737; Dyachok O, 2008, CELL METAB, V8, P26, DOI 10.1016/j.cmet.2008.06.003; Fadaei R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168773; Furman B, 2010, ADV EXP MED BIOL, V654, P281, DOI 10.1007/978-90-481-3271-3_13; Ghai R, 2007, IMMUNOBIOLOGY, V212, P253, DOI 10.1016/j.imbio.2006.11.001; Halimi S, 2008, DIABETES METAB, V34, pS91, DOI 10.1016/S1262-3636(08)73400-1; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Hayes MG, 2007, DIABETES, V56, P3033, DOI 10.2337/db07-0482; Heinitz S, 2018, DIABETES-METAB RES, V34, DOI 10.1002/dmrr.2953; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Herbst KJ, 2011, CHEM BIOL, V18, P243, DOI 10.1016/j.chembiol.2010.12.007; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Kakegawa W, 2015, NEURON, V85, P316, DOI 10.1016/j.neuron.2014.12.020; Kee HJ, 2004, FEBS LETT, V569, P307, DOI 10.1016/j.febslet.2004.06.011; Kim JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002127; Kimple ME, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.40; Kimple ME, 2013, DIABETES, V62, P1904, DOI 10.2337/db12-0769; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Martinelli DC, 2016, NEURON, V91, P1034, DOI 10.1016/j.neuron.2016.07.002; Miura Y, 2003, AM J PHYSIOL-ENDOC M, V285, pE1001, DOI 10.1152/ajpendo.00005.2003; Nenquin M, 2016, DIABETES OBES METAB, V18, P698, DOI 10.1111/dom.12607; Neuman JC, 2017, DIABETES, V66, P1572, DOI 10.2337/db16-1362; Nicholls DG, 2016, PHYSIOL REV, V96, P1385, DOI 10.1152/physrev.00009.2016; Pinkney J, 2010, THER CLIN RISK MANAG, V6, P401, DOI 10.2147/TCRM.S7313; Pratley Richard E, 2008, Rev Diabet Stud, V5, P73, DOI 10.1900/RDS.2008.5.73; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Ramos LS, 2008, J GEN PHYSIOL, V132, P329, DOI 10.1085/jgp.200810044; Raz I, 2006, DIABETOLOGIA, V49, P2564, DOI 10.1007/s00125-006-0416-z; Ressl S, 2015, STRUCTURE, V23, P688, DOI 10.1016/j.str.2015.01.019; Ross SA, 2013, CURR MED RES OPIN, V29, P1617, DOI 10.1185/03007995.2013.837817; Rutter GA, 2015, BIOCHEM J, V466, P203, DOI 10.1042/BJ20141384; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Seino S, 2012, DIABETOLOGIA, V55, P2096, DOI 10.1007/s00125-012-2562-9; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Seldin MM, 2014, REV ENDOCR METAB DIS, V15, P111, DOI 10.1007/s11154-013-9255-7; Shanaki M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168082; Sigoillot SM, 2015, CELL REP, V10, P820, DOI 10.1016/j.celrep.2015.01.034; Tengholm A, 2012, UPSALA J MED SCI, V117, P355, DOI 10.3109/03009734.2012.724732; Tian G, 2011, DIABETES, V60, P1535, DOI 10.2337/db10-1087; Tomlinson B, 2016, EXPERT OPIN INV DRUG, V25, P145, DOI 10.1517/13543784.2016.1123249; Traub S, 2017, CELL REP, V18, P3192, DOI 10.1016/j.celrep.2017.03.005; Vasu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101005; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Zhang CL, 2009, SCIENCE, V325, P607, DOI 10.1126/science.1172256	63	16	16	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18086	18098		10.1074/jbc.RA118.005403	http://dx.doi.org/10.1074/jbc.RA118.005403			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30228187	Green Published, hybrid			2022-12-28	WOS:000451375200006
J	Shen, C; Liu, YH; Yu, HJ; Gulbranson, DR; Kogut, I; Bilousova, G; Zhang, C; Stowell, MHB; Shen, JS				Shen, Chong; Liu, Yinghui; Yu, Haijia; Gulbranson, Daniel R.; Kogut, Igor; Bilousova, Ganna; Zhang, Chen; Stowell, Michael H. B.; Shen, Jingshi			The N-peptide-binding mode is critical to Munc18-1 function in synaptic exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane fusion; membrane reconstitution; membrane function; SNARE proteins; organelle; membrane proteins; vesicle transport; exocytosis; SM protein; synaptic transmission; Munc18; N-peptide	MEMBRANE-FUSION; TERMINAL PEPTIDE; VESICLE DOCKING; SNARE; SYNTAXIN; PROTEIN; ACTIVATION; MECHANISMS; MUTATIONS; CELLS	Sec1/Munc18 (SM) proteins promote intracellular vesicle fusion by binding to N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs). A key SNARE-binding mode of SM proteins involves the N-terminal peptide (N-peptide) motif of syntaxin, a SNARE subunit localized to the target membrane. In in vitro membrane fusion assays, inhibition of N-peptide motif binding previously has been shown to abrogate the stimulatory function of Munc18-1, a SM protein involved in synaptic exocytosis in neurons. The physiological role of the N-peptide-binding mode, however, remains unclear. In this work, we addressed this key question using a clogged Munc18-1 protein, in which an ectopic copy of the syntaxin N-peptide motif was directly fused to Munc18-1. We found that the ectopic N-peptide motif blocks the N-peptide-binding pocket of Munc18-1, preventing the latter from binding to the native N-peptide motif on syntaxin-1. In a reconstituted system, we observed that clogged Munc18-1 is defective in promoting SNARE zippering. When introduced into induced neuronal cells (iN cells) derived from human pluripotent stem cells, clogged Munc18-1 failed to mediate synaptic exocytosis. As a result, both spontaneous and evoked synaptic transmission was abolished. These genetic findings provide direct evidence for the crucial role of the N-peptide-binding mode of Munc18-1 in synaptic exocytosis. We suggest that clogged SM proteins will also be instrumental in defining the physiological roles of the N-peptide-binding mode in other vesicle-fusion pathways.	[Shen, Chong; Liu, Yinghui; Yu, Haijia; Gulbranson, Daniel R.; Stowell, Michael H. B.; Shen, Jingshi] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Liu, Yinghui; Yu, Haijia] Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Coll Life Sci, Nanjing 210023, Jiangsu, Peoples R China; [Kogut, Igor; Bilousova, Ganna] Univ Colorado, Dept Dermatol, Sch Med, Aurora, CO 80045 USA; [Kogut, Igor; Bilousova, Ganna] Univ Colorado, Charles C Gates Ctr Regenerat Med, Sch Med, Aurora, CO 80045 USA; [Zhang, Chen] Capital Med Univ, Sch Basic Med Sci, Beijing 100069, Peoples R China	University of Colorado System; University of Colorado Boulder; Nanjing Normal University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Capital Medical University	Yu, HJ; Shen, JS (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.; Yu, HJ (corresponding author), Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Coll Life Sci, Nanjing 210023, Jiangsu, Peoples R China.	haijiayu@gmail.com; jingshi.shen@colorado.edu	Gulbranson, Daniel/AAE-4338-2020; Gulbranson, Daniel/AAE-4807-2020; Yu, Haijia/GXV-5159-2022	Yu, Haijia/0000-0002-7193-8034; STOWELL, MICHAEL/0000-0001-7250-1419	National Basic Research Program of China [2017YFA0105201]; National Science Foundation of China [31871425, 31670842]; National Institutes of Health [GM126960, DK095367]; University of Colorado seed grant; American Heart Association predoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI135473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095367, R56DK095367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM126960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG061829] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado seed grant; American Heart Association predoctoral fellowship(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Basic Research Program of China Grant 2017YFA0105201 and National Science Foundation of China Grant 31670842 (both to C. Z.), National Science Foundation of China Grant 31871425 (to H. Y.), National Institutes of Health Grants GM126960 and DK095367 (both to J. S.), a University of Colorado seed grant (to J. S.), and an American Heart Association predoctoral fellowship (to D. R. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahfeldt T, 2012, NAT CELL BIOL, V14, P209, DOI 10.1038/ncb2411; Baker RW, 2016, NAT REV MOL CELL BIO, V17, P465, DOI 10.1038/nrm.2016.65; Baker RW, 2015, SCIENCE, V349, P1111, DOI 10.1126/science.aac7906; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Furgason MLM, 2009, P NATL ACAD SCI USA, V106, P14303, DOI 10.1073/pnas.0902976106; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; Gulbranson DR, 2017, P NATL ACAD SCI USA, V114, pE8224, DOI 10.1073/pnas.1712176114; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; Johnson JR, 2009, BIOCHEM J, V418, P73, DOI 10.1042/BJ20081956; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Lai Y, 2017, NEURON, V95, P591, DOI 10.1016/j.neuron.2017.07.004; Lee YK, 2014, METHOD ENZYMOL, V538, P35, DOI 10.1016/B978-0-12-800280-3.00003-7; Lobingier BT, 2014, ELIFE, V3, DOI 10.7554/eLife.02272; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Ma L, 2015, ELIFE, V4, DOI 10.7554/eLife.09580; Malintan NT, 2009, J BIOL CHEM, V284, P21637, DOI 10.1074/jbc.M109.013508; McEwen JM, 2008, MOL BIOL CELL, V19, P3836, DOI 10.1091/mbc.E08-02-0160; Meijer M, 2012, EMBO J, V31, P2156, DOI 10.1038/emboj.2012.72; Munch AS, 2016, J NEUROSCI, V36, P6881, DOI 10.1523/JNEUROSCI.0007-16.2016; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Parisotto D, 2012, J BIOL CHEM, V287, P31041, DOI 10.1074/jbc.M112.386805; Park S, 2016, MOL BIOL CELL, V27, P669, DOI 10.1091/mbc.E15-09-0638; Patzke C, 2015, J CLIN INVEST, V125, P3560, DOI 10.1172/JCI78612; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; Rao LJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02636-4; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722; Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Rodkey TL, 2008, MOL BIOL CELL, V19, P5422, DOI 10.1091/mbc.E08-05-0538; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shen C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9852; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Shin YK, 2013, P NATL ACAD SCI USA, V110, P14116, DOI 10.1073/pnas.1313749110; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1989, NEURON, V2, P1475, DOI 10.1016/0896-6273(89)90193-1; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Xu H, 2011, P NATL ACAD SCI USA, V108, P17325, DOI 10.1073/pnas.1113888108; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Yu HJ, 2018, P NATL ACAD SCI USA, V115, pE8421, DOI 10.1073/pnas.1802645115; Yu HJ, 2016, P NATL ACAD SCI USA, V113, P4362, DOI 10.1073/pnas.1517259113; Yu HJ, 2015, J AM CHEM SOC, V137, P12873, DOI 10.1021/jacs.5b08306; Yu HJ, 2013, P NATL ACAD SCI USA, V110, pE3271, DOI 10.1073/pnas.1311232110; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zhou P, 2013, NEURON, V80, P470, DOI 10.1016/j.neuron.2013.09.010; Zhou P, 2013, EMBO J, V32, P159, DOI 10.1038/emboj.2012.307	66	4	4	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18309	18317		10.1074/jbc.RA118.005254	http://dx.doi.org/10.1074/jbc.RA118.005254			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30275014	Green Published, hybrid			2022-12-28	WOS:000451375200022
J	Vickers, C; Liu, F; Abe, K; Salama-Alber, O; Jenkins, M; Springate, CMK; Burke, JE; Withers, SG; Boraston, AB				Vickers, Chelsea; Liu, Feng; Abe, Kento; Salama-Alber, Orly; Jenkins, Meredith; Springate, Christopher M. K.; Burke, John E.; Withers, Stephen G.; Boraston, Alisdair B.			Endo-fucoidan hydrolases from glycoside hydrolase family 107 (GH107) display structural and mechanistic similarities to -l-fucosidases from GH29	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						polysaccharide; glycoside hydrolase; enzyme catalysis; enzyme; X-ray crystallography; enzyme mechanism	ALPHA-L-FUCOSIDASE; SULFATED POLYSACCHARIDES; MOLECULAR-BASIS; CATALYTIC MECHANISM; BROWN SEAWEEDS; HYDROLYSIS; ENZYME; FUCANS; BETA; DEGRADATION	Fucoidans are chemically complex and highly heterogeneous sulfated marine fucans from brown macro algae. Possessing a variety of physicochemical and biological activities, fucoidans are used as gelling and thickening agents in the food industry and have anticoagulant, antiviral, antitumor, antibacterial, and immune activities. Although fucoidan-depolymerizing enzymes have been identified, the molecular basis of their activity on these chemically complex polysaccharides remains largely uninvestigated. In this study, we focused on three glycoside hydrolase family 107 (GH107) enzymes: MfFcnA and two newly identified members, P5AFcnA and P19DFcnA, from a bacterial species of the genus Psychromonas. Using carbohydrate-PAGE, we show that P5AFcnA and P19DFcnA are active on fucoidans that differ from those depolymerized by MfFcnA, revealing differential substrate specificity within the GH107 family. Using a combination of X-ray crystallography and NMR analyses, we further show that GH107 family enzymes share features of their structures and catalytic mechanisms with GH29 -l-fucosidases. However, we found that GH107 enzymes have the distinction of utilizing a histidine side chain as the proposed acid/base catalyst in its retaining mechanism. Further interpretation of the structural data indicated that the active-site architectures within this family are highly variable, likely reflecting the specificity of GH107 enzymes for different fucoidan substructures. Together, these findings begin to illuminate the molecular details underpinning the biological processing of fucoidans.	[Vickers, Chelsea; Abe, Kento; Salama-Alber, Orly; Jenkins, Meredith; Burke, John E.; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC 8W 3P6, Canada; [Liu, Feng; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Springate, Christopher M. K.] ARC Med Devices Inc, Richmond, BC V6X 2T4, Canada; [Abe, Kento] Univ Toronto, Dept Mol Genet, Rm 4396,Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada	University of Victoria; University of British Columbia; University of Toronto	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC 8W 3P6, Canada.	boraston@uvic.ca	Burke, John/H-3922-2019; Withers, Stephen G/I-7229-2019	Burke, John/0000-0001-7904-9859; Withers, Stephen G/0000-0002-6722-5701; Boraston, Alisdair/0000-0001-6417-0592	Department of Energy Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; NIGMS; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER	Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Dr. Mark Okon for great help with NMR spectroscopy. We thank the beamline staff at the Stanford Synchrotron Research Laboratory BL7-1. SSRL is a Directorate of Stanford Linear Accelerator Center National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program P41RR001209, and the NIGMS.	Ale MT, 2013, RSC ADV, V3, P8131, DOI 10.1039/c3ra23373a; Ale MT, 2011, MAR DRUGS, V9, P2106, DOI 10.3390/md9102106; Anastyuk SD, 2009, CARBOHYD RES, V344, P779, DOI 10.1016/j.carres.2009.01.023; ANGSTWURM K, 1995, NEUROSCI LETT, V191, P1, DOI 10.1016/0304-3940(95)11541-4; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Barbeyron T, 2008, INT J SYST EVOL MICR, V58, P2107, DOI 10.1099/ijs.0.65674-0; Berteau O, 2002, GLYCOBIOLOGY, V12, P273, DOI 10.1093/glycob/12.4.273; Bilan MI, 2010, CARBOHYD RES, V345, P2038, DOI 10.1016/j.carres.2010.07.009; Bilan MI, 2006, CARBOHYD RES, V341, P238, DOI 10.1016/j.carres.2005.11.009; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Burmeister WP, 2000, J BIOL CHEM, V275, P39385, DOI 10.1074/jbc.M006796200; Chevolot L, 1999, CARBOHYD RES, V319, P154, DOI 10.1016/S0008-6215(99)00127-5; Chevolot L, 2001, CARBOHYD RES, V330, P529, DOI 10.1016/S0008-6215(00)00314-1; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Colin S, 2006, GLYCOBIOLOGY, V16, P1021, DOI 10.1093/glycob/cwl029; CONCHIE J, 1950, J CHEM SOC, P827, DOI 10.1039/jr9500000827; Daniel R, 1999, CARBOHYD RES, V322, P291, DOI 10.1016/S0008-6215(99)00223-2; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Descamps V, 2006, MAR BIOTECHNOL, V8, P27, DOI 10.1007/s10126-005-5107-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eneyskaya EV, 2001, GLYCOCONJUGATE J, V18, P827, DOI 10.1023/A:1021163720282; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Ficko-Blean E, 2015, ACTA CRYSTALLOGR D, V71, P209, DOI 10.1107/S1399004714025024; Fowler ML, 2016, PROTEIN SCI, V25, P826, DOI 10.1002/pro.2879; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Guillotin L, 2014, BIOCHEMISTRY-US, V53, P1447, DOI 10.1021/bi400951q; Hehemann JH, 2012, J BIOL CHEM, V287, P13985, DOI 10.1074/jbc.M112.345645; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Jiao GL, 2011, MAR DRUGS, V9, P196, DOI 10.3390/md9020196; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Macdonald SS, 2015, J BIOL CHEM, V290, P4887, DOI 10.1074/jbc.M114.621110; MCCLURE MO, 1992, AIDS RES HUM RETROV, V8, P19, DOI 10.1089/aid.1992.8.19; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhail JA, 2017, STRUCTURE, V25, P121, DOI 10.1016/j.str.2016.11.016; Munoz-Munoz J, 2017, P NATL ACAD SCI USA, V114, P4936, DOI 10.1073/pnas.1701130114; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nieman CE, 2003, BIOCHEMISTRY-US, V42, P8054, DOI 10.1021/bi034293v; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATANKAR MS, 1993, J BIOL CHEM, V268, P21770; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Preobrazhenskaya ME, 1997, BIOCHEM MOL BIOL INT, V43, P443; Sakurama H, 2012, J BIOL CHEM, V287, P16709, DOI 10.1074/jbc.M111.333781; Siempelkamp BD, 2017, J BIOL CHEM, V292, P12256, DOI 10.1074/jbc.M117.789263; SOEDA S, 1994, JPN J CANCER RES, V85, P1144, DOI 10.1111/j.1349-7006.1994.tb02920.x; Sulzenbacher G, 2004, J BIOL CHEM, V279, P13119, DOI 10.1074/jbc.M313783200; Takayama M., 2002, U.S. Patent, Patent No. [No. US 6,489,155 B1, 6489155]; TANAKA K, 1970, FEBS LETT, V9, P45, DOI 10.1016/0014-5793(70)80307-6; Vishchuk OS, 2011, CARBOHYD RES, V346, P2769, DOI 10.1016/j.carres.2011.09.034; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Watts AG, 2003, J AM CHEM SOC, V125, P7532, DOI 10.1021/ja0344967; Yang YH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004169; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Yip VLY, 2004, J AM CHEM SOC, V126, P8354, DOI 10.1021/ja047632w; ZABLACKIS E, 1990, BOT MAR, V33, P273, DOI 10.1515/botm.1990.33.3.273	56	23	23	2	61	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18296	18308		10.1074/jbc.RA118.005134	http://dx.doi.org/10.1074/jbc.RA118.005134			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30282808	Green Published, hybrid			2022-12-28	WOS:000451375200021
J	Wang, L; Iwasaki, Y; Andra, KK; Pandey, K; Menon, AK; Butikofer, P				Wang, Lei; Iwasaki, Yugo; Andra, Kiran K.; Pandey, Kalpana; Menon, Anant K.; Butikofer, Peter			Scrambling of natural and fluorescently tagged phosphatidylinositol by reconstituted G protein-coupled receptor and TMEM16 scramblases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); liposome; phosphatidylinositol; Phospholipase C; glycerophospholipid; membrane transport; scramblase; TMEM16	SPIN-LABELED PHOSPHOLIPIDS; FLIP-FLOP; TRANSBILAYER DISTRIBUTION; ASYMMETRIC DISTRIBUTION; RAPID FLIP; MEMBRANE; PHOSPHATIDYLCHOLINE; FLIPPASES; PHOSPHATIDYLETHANOLAMINE; BIOSYNTHESIS	Members of the G protein-coupled receptor and TMEM16 (transmembrane protein 16) protein families are phospholipid scramblases that facilitate rapid, bidirectional movement of phospholipids across a membrane bilayer in an ATP-independent manner. On reconstitution into large unilamellar vesicles, these proteins scramble more than 10,000 lipids/protein/s as measured with co-reconstituted fluorescent nitrobenzoxadiazole (NBD)-labeled phospholipids. Although NBD-labeled phospholipids are ubiquitously used as reporters of scramblase activity, it remains unclear whether the NBD modification influences the quantitative outcomes of the scramblase assay. We now report a refined biochemical approach for measuring the activity of scramblase proteins with radiolabeled natural phosphatidylinositol ([H-3]PI) and exploiting the hydrolytic activity of bacterial PI-specific phospholipase C (PI-PLC) to detect the transbilayer movement of PI. PI-PLC rapidly hydrolyzed 50% of [H-3]PI in large symmetric, unilamellar liposomes, corresponding to the lipid pool in the outer leaflet. On reconstitution of a crude preparation of yeast endoplasmic reticulum scramblase, purified bovine opsin, or purified Nectria haematococca TMEM16, the extent of [H-3]PI hydrolysis increased, indicating that [H-3]PI from the inner leaflet had been scrambled to the outer leaflet. Using transphosphatidylation, we synthesized acyl-NBD-PI and used it to compare our PI-PLC-based assay with conventional fluorescence-based methods. Our results revealed quantitative differences between the two assays that we attribute to the specific features of the assays themselves rather than to the nature of the phospholipid. In summary, we have developed an assay that measures scrambling of a chemically unmodified phospholipid by a reconstituted scramblase.	[Wang, Lei; Butikofer, Peter] Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland; [Wang, Lei] Univ Bern, Grad Sch Cellular & Biochem Sci, CH-3012 Bern, Switzerland; [Iwasaki, Yugo] Nagoya Univ, Grad Sch Bioagr Sci, Lab Mol Biotechnol, Furo Cho, Nagoya, Aichi 4648601, Japan; [Andra, Kiran K.; Pandey, Kalpana; Menon, Anant K.] Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA	University of Bern; University of Bern; Nagoya University; Cornell University	Butikofer, P (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.; Menon, AK (corresponding author), Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA.	akm2003@med.cornell.edu; peter.buetikofer@ibmm.unibe.ch	Wang, Lei/D-7812-2019; Pandey, Kalpana/GNW-5078-2022; Menon, Anant/AAN-8663-2021	Wang, Lei/0000-0001-7103-9402; Menon, Anant/0000-0001-6924-2698; Pandey, Kalpana/0000-0002-7048-0690	Velux Foundation [881]; Swiss National Science Foundation [31003A_169355]; National Institutes of Health [EY028314, GM106717]; NATIONAL EYE INSTITUTE [R21EY028314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106717] Funding Source: NIH RePORTER	Velux Foundation(Velux Fonden); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant 881 from the Velux Foundation (to P. B. and A. K. M.) and in part by Swiss National Science Foundation Grant 31003A_169355 (to P. B.) and National Institutes of Health Grants EY028314 and GM106717 (to A. K. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahyayauch H, 2015, BIOPHYS J, V108, P1672, DOI 10.1016/j.bpj.2015.02.020; BACKER JM, 1987, NATURE, V327, P341, DOI 10.1038/327341a0; BALLAS LM, 1980, BIOCHIM BIOPHYS ACTA, V602, P578, DOI 10.1016/0005-2736(80)90336-3; BISHOP WR, 1985, CELL, V42, P51, DOI 10.1016/S0092-8674(85)80100-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; BUTIKOFER P, 1990, J BIOL CHEM, V265, P16035; Chalat M, 2012, J BIOL CHEM, V287, P15523, DOI 10.1074/jbc.M112.343038; Chang QL, 2004, BIOCHEMISTRY-US, V43, P10710, DOI 10.1021/bi049063a; CHAP HJ, 1977, BIOCHIM BIOPHYS ACTA, V467, P146, DOI 10.1016/0005-2736(77)90192-4; Chauhan N, 2016, BBA-MOL CELL BIOL L, V1861, P757, DOI 10.1016/j.bbalip.2016.02.025; Coleman JA, 2013, BBA-MOL CELL BIOL L, V1831, P555, DOI 10.1016/j.bbalip.2012.10.006; COLEMAN R, 1978, J CELL BIOL, V76, P245, DOI 10.1083/jcb.76.1.245; Damnjanovic J, 2016, BIOTECHNOL BIOENG, V113, P62, DOI 10.1002/bit.25697; Devaux PF, 2002, CHEM PHYS LIPIDS, V116, P115, DOI 10.1016/S0009-3084(02)00023-3; Ernst OP, 2015, PHOTOCH PHOTOBIO SCI, V14, P1922, DOI 10.1039/c5pp00195a; Goren MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6115; Griffith OH, 1999, BBA-MOL CELL BIOL L, V1441, P237, DOI 10.1016/S1388-1981(99)00153-5; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Hessel E, 2000, EUR J BIOCHEM, V267, P1473, DOI 10.1046/j.1432-1327.2000.01147.x; Hessel E, 2001, J BIOL CHEM, V276, P2538, DOI 10.1074/jbc.M009061200; HIGGINS JA, 1989, BIOCHEM J, V259, P913, DOI 10.1042/bj2590913; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KUCHLER K, 1986, J BACTERIOL, V165, P901, DOI 10.1128/jb.165.3.901-910.1986; Larsen J, 2011, J AM CHEM SOC, V133, P10685, DOI 10.1021/ja203984j; Lee BC, 2016, BIOPHYS J, V111, P1919, DOI 10.1016/j.bpj.2016.09.032; Lee SY, 2009, J MOL BIOL, V387, P1055, DOI 10.1016/j.jmb.2009.02.034; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Marx U, 2000, BIOPHYS J, V78, P2628, DOI 10.1016/S0006-3495(00)76807-X; Masayama A, 2009, CHEMBIOCHEM, V10, P559, DOI 10.1002/cbic.200800651; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; MCNAMEE MG, 1973, BIOCHEMISTRY-US, V12, P2951, DOI 10.1021/bi00740a001; Menon AK, 2000, CURR BIOL, V10, P241, DOI 10.1016/S0960-9822(00)00356-0; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; Montigny C, 2016, BBA-MOL CELL BIOL L, V1861, P767, DOI 10.1016/j.bbalip.2015.12.020; Morra G, 2018, STRUCTURE, V26, P356, DOI 10.1016/j.str.2017.11.020; Muraki M, 2016, J BIOSCI BIOENG, V122, P276, DOI 10.1016/j.jbiosc.2016.02.011; Pandey K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16842-z; Ploier B, 2016, JOVE-J VIS EXP, DOI 10.3791/54635; Ploier B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12832; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Pomorski T, 1996, J CELL SCI, V109, P687; Pomorski TG, 2016, PROG LIPID RES, V64, P69, DOI 10.1016/j.plipres.2016.08.003; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sanyal S, 2008, BIOCHEMISTRY-US, V47, P7937, DOI 10.1021/bi800723n; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; TSAI KH, 1975, NATURE, V253, P554, DOI 10.1038/253554a0; Vehring S, 2007, EUKARYOT CELL, V6, P1625, DOI 10.1128/EC.00198-07; Vishwakarma RA, 2005, ORG BIOMOL CHEM, V3, P1275, DOI 10.1039/b500300h; VOLWERK JJ, 1990, BIOCHEMISTRY-US, V29, P8056, DOI 10.1021/bi00487a010; Watanabe R, 2018, P NATL ACAD SCI USA, V115, P3066, DOI 10.1073/pnas.1717956115; WOLF DE, 1992, BIOCHEMISTRY-US, V31, P2865, DOI 10.1021/bi00126a004; WU G, 1993, BIOCHEMISTRY-US, V32, P879, DOI 10.1021/bi00054a020; Zhou C, 1997, BIOCHEMISTRY-US, V36, P347, DOI 10.1021/bi960601w	60	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18318	18327		10.1074/jbc.RA118.004213	http://dx.doi.org/10.1074/jbc.RA118.004213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30287690	hybrid, Green Published			2022-12-28	WOS:000451375200023
J	Hayashi, Y; Nemoto-Sasaki, Y; Matsumoto, N; Hama, K; Tanikawa, T; Oka, S; Saeki, T; Kumasaka, T; Koizumi, T; Arai, S; Wada, I; Yokoyama, K; Sugiura, T; Yamashita, A				Hayashi, Yasuhiro; Nemoto-Sasaki, Yoko; Matsumoto, Naoki; Hama, Kotaro; Tanikawa, Takashi; Oka, Saori; Saeki, Tadaaki; Kumasaka, Tatsuya; Koizumi, Takanori; Arai, Seisuke; Wada, Ikuo; Yokoyama, Kazuaki; Sugiura, Takayuki; Yamashita, Atsushi			Complex formation of sphingomyelin synthase 1 with glucosylceramide synthase increases sphingomyelin and decreases glucosylceramide levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sphingolipid; ceramide; dimerization; Golgi; protein domain; fusion protein; glucosylceramide synthase (GCS); lipid metabolism; sphingomyelin synthase 1 (SMS1); sterile -motif (SAM) domain	BIMOLECULAR FLUORESCENCE COMPLEMENTATION; GLYCOSPHINGOLIPID SYNTHESIS; ENDOPLASMIC-RETICULUM; LIVING CELLS; SAM DOMAIN; EXPRESSION CLONING; LIPID MICRODOMAINS; PLASMA-MEMBRANE; CERAMIDE; GOLGI	Sphingolipids, including sphingomyelin (SM) and glucosylceramide (GlcCer), are generated by the addition of a polar head group to ceramide (Cer). Sphingomyelin synthase 1 (SMS1) and glucosylceramide synthase (GCS) are key enzymes that catalyze the conversion of Cer to SM and GlcCer, respectively. GlcCer synthesis has been postulated to occur mainly in cis-Golgi, and SM synthesis is thought to occur in medial/trans-Golgi; however, SMS1 and GCS are known to partially co-localize in cisternae, especially in medial/trans-Golgi. Here, we report that SMS1 and GCS can form a heteromeric complex, in which the N terminus of SMS1 and the C terminus of GCS are in close proximity. Deletion of the N-terminal sterile -motif of SMS1 reduced the stability of the SMS1-GCS complex, resulting in a significant reduction in SM synthesis in vivo. In contrast, chemical-induced heterodimerization augmented SMS1 activity, depending on an increase in the amount and stability of the complex. Fusion of the SMS1 N terminus to the GCS C terminus via linkers of different lengths increased SM synthesis and decreased GlcCer synthesis in vivo. These results suggest that formation of the SMS1-GCS heteromeric complex increases SM synthesis and decreases GlcCer synthesis. Importantly, this regulation of relative Cer levels by the SMS1-GCS complex was confirmed by CRISPR/Cas9-mediated knockout of SMS1 or GCS combined with pharmacological inhibition of Cer transport protein in HEK293T cells. Our findings suggest that complex formation between SMS1 and GCS is part of a critical mechanism controlling the metabolic fate of Cer in the Golgi.	[Hayashi, Yasuhiro; Nemoto-Sasaki, Yoko; Matsumoto, Naoki; Hama, Kotaro; Tanikawa, Takashi; Oka, Saori; Saeki, Tadaaki; Kumasaka, Tatsuya; Koizumi, Takanori; Yokoyama, Kazuaki; Sugiura, Takayuki; Yamashita, Atsushi] Teikyo Univ, Fac Pharma Sci, Tokyo 1738605, Japan; [Arai, Seisuke; Wada, Ikuo] Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Cell Sci, Fukushima, Fukushima 9601295, Japan	Teikyo University; Fukushima Medical University	Yamashita, A (corresponding author), Teikyo Univ, Fac Pharma Sci, Itabashi Ku, Kaga 2-11-1, Tokyo 1738605, Japan.	ayamashi@pharm.teikyo-u.ac.jp			Japan Society for the Promotion of Science [15K18868, 18K06635, 15K07946]; Japan Foundation for Applied Enzymology; Science Research Promotion Fund from the Japan Private School Promotion Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Foundation for Applied Enzymology; Science Research Promotion Fund from the Japan Private School Promotion Foundation	This work was supported in part by Grant-in-Aid for Young Scientists (B) 15K18868 (to Y. H.) and Grants-in-Aid for Scientific Research (C) 18K06635 (to Y. H.) and 15K07946 (to A. Y.) from the Japan Society for the Promotion of Science. This work was also supported in part by funds from the Japan Foundation for Applied Enzymology (to Y. H.) and by the Science Research Promotion Fund from the Japan Private School Promotion Foundation (to Y. H., K. H., K. Y., and A. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama M, 2017, J DERMATOL SCI, V88, P3, DOI 10.1016/j.jdermsci.2017.06.002; Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5; Barrera FN, 2003, J BIOL CHEM, V278, P46878, DOI 10.1074/jbc.M307846200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cabukusta B, 2017, SCI REP-UK, V7, DOI 10.1038/srep41290; Chu BB, 2015, CELL, V161, P291, DOI 10.1016/j.cell.2015.02.019; Contreras FX, 2005, BIOPHYS J, V88, P348, DOI 10.1529/biophysj.104.050690; Contreras FX, 2003, J BIOL CHEM, V278, P37169, DOI 10.1074/jbc.M303206200; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hayashi Y, 2017, J BIOL CHEM, V292, P1122, DOI 10.1074/jbc.M116.746602; Hayashi Y, 2014, J BIOL CHEM, V289, P30842, DOI 10.1074/jbc.M114.574285; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Ichikawa S, 1996, P NATL ACAD SCI USA, V93, P4638, DOI 10.1073/pnas.93.10.4638; Ishibashi Y, 2018, BIOCHEM BIOPH RES CO, V499, P1011, DOI 10.1016/j.bbrc.2018.04.039; Ishibashi Y, 2013, BBA-MOL CELL BIOL L, V1831, P1475, DOI 10.1016/j.bbalip.2013.06.001; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Karginov AV, 2010, NAT BIOTECHNOL, V28, P743, DOI 10.1038/nbt.1639; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kiyokawa E, 2005, J BIOL CHEM, V280, P24072, DOI 10.1074/jbc.M502244200; Klayman LM, 2017, J BIOL CHEM, V292, P1773, DOI 10.1074/jbc.M116.750430; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Marks DL, 1999, J BIOL CHEM, V274, P451, DOI 10.1074/jbc.274.1.451; Marks DL, 2001, J BIOL CHEM, V276, P26492, DOI 10.1074/jbc.M102612200; Mitsutake S, 2007, BIOCHEM BIOPH RES CO, V359, P622, DOI 10.1016/j.bbrc.2007.05.160; Mitsutake S, 2013, VITAM HORM, V91, P271, DOI 10.1016/B978-0-12-407766-9.00012-2; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Nagaya H, 2002, MOL BIOL CELL, V13, P302, DOI 10.1091/mbc.01-05-0255; Ozalp C, 2005, DRUG METAB DISPOS, V33, P1382, DOI 10.1124/dmd.105.005538; Qiao F, 2004, CELL, V118, P163, DOI 10.1016/j.cell.2004.07.010; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; Sprong H, 2001, J CELL BIOL, V155, P369, DOI 10.1083/jcb.200106104; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yang W, 2008, J BIOL CHEM, V283, P8643, DOI 10.1074/jbc.M709824200; Yasuda S, 2003, J BIOL CHEM, V278, P4176, DOI 10.1074/jbc.M209602200; Yasuda S, 2001, J BIOL CHEM, V276, P43994, DOI 10.1074/jbc.M104884200; Yeang C, 2008, BBA-MOL CELL BIOL L, V1781, P610, DOI 10.1016/j.bbalip.2008.07.002	54	14	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17505	17522		10.1074/jbc.RA118.002048	http://dx.doi.org/10.1074/jbc.RA118.002048			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30242129	hybrid, Green Published			2022-12-28	WOS:000449799000016
J	Hamilton, J; Brustovetsky, T; Rysted, JE; Lin, ZH; Usachev, YM; Brustovetsky, N				Hamilton, James; Brustovetsky, Tatiana; Rysted, Jacob E.; Lin, Zhihong; Usachev, Yuriy M.; Brustovetsky, Nickolay			Deletion of mitochondrial calcium uniporter incompletely inhibits calcium uptake and induction of the permeability transition pore in brain mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; calcium; mitochondrial permeability transition (MPT); mitochondrial membrane potential; cyclophilin D; ion channel; energy metabolism; respiration	RAT-KIDNEY MITOCHONDRIA; YAC128 MOUSE MODEL; HEART-MITOCHONDRIA; CA2+ UNIPORTER; NA+/CA2+ EXCHANGE; CORTICAL-NEURONS; HUNTINGTONS-DISEASE; ESSENTIAL COMPONENT; LIVER MITOCHONDRIA; RYANODINE RECEPTOR	Ca2+ influx into mitochondria is mediated by the mitochondrial calcium uniporter (MCU), whose identity was recently revealed as a 40-kDa protein that along with other proteins forms the mitochondrial Ca2+ uptake machinery. The MCU is a Ca2+-conducting channel spanning the inner mitochondrial membrane. Here, deletion of the MCU completely inhibited Ca2+ uptake in liver, heart, and skeletal muscle mitochondria. However, in brain nonsynaptic and synaptic mitochondria from neuronal somata/glial cells and nerve terminals, respectively, the MCU deletion slowed, but did not completely block, Ca2+ uptake. Under resting conditions, brain MCU-KO mitochondria remained polarized, and in brain MCU-KO mitochondria, the electrophoretic Ca2+ ionophore ETH129 significantly accelerated Ca2+ uptake. The residual Ca2+ uptake in brain MCU-KO mitochondria was insensitive to inhibitors of mitochondrial Na+/Ca2+ exchanger and ryanodine receptor (CGP37157 and dantrolene, respectively), but was blocked by the MCU inhibitor Ru360. Respiration of WT and MCU-KO brain mitochondria was similar except that for mitochondria that oxidized pyruvate and malate, Ca2+ more strongly inhibited respiration in WT than in MCU-KO mitochondria. Of note, the MCU deletion significantly attenuated but did not completely prevent induction of the permeability transition pore (PTP) in brain mitochondria. Expression level of cyclophilin D and ATP content in mitochondria, two factors that modulate PTP induction, were unaffected by MCU-KO, whereas ADP was lower in MCU-KO than in WT brain mitochondria. Our results suggest the presence of an MCU-independent Ca2+ uptake pathway in brain mitochondria that mediates residual Ca2+ influx and induction of PTP in a fraction of the mitochondrial population.	[Hamilton, James; Brustovetsky, Tatiana; Brustovetsky, Nickolay] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr,Med Sci Bldg,Rm 547, Indianapolis, IN 46202 USA; [Brustovetsky, Nickolay] Indiana Univ, Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Rysted, Jacob E.; Lin, Zhihong; Usachev, Yuriy M.] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Iowa	Brustovetsky, N (corresponding author), Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr,Med Sci Bldg,Rm 547, Indianapolis, IN 46202 USA.	nbrous@iu.edu		Rysted, Jacob/0000-0001-5632-4176; Usachev, Yuriy/0000-0002-6948-4627; Brustovetsky, Nickolay/0000-0002-6564-2560	National Institutes of Health [R01 NS087068, R01 NS096246, R01 NS098772]; Indiana Traumatic Spinal Cord & Brain Injury Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS096246, R01NS098772, R01NS087068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana Traumatic Spinal Cord & Brain Injury Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01 NS087068 and R01 NS096246 (to Y. U.) and R01 NS098772 (to N. B.). This study was supported in part by a grant from the Indiana Traumatic Spinal Cord & Brain Injury Research Fund (to N. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; Bondarenko AI, 2014, PFLUG ARCH EUR J PHY, V466, P1411, DOI 10.1007/s00424-013-1383-0; Bondarenko AI, 2013, PFLUG ARCH EUR J PHY, V465, P997, DOI 10.1007/s00424-013-1224-1; Brustovetsky N, 2003, J NEUROSCI, V23, P4858; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Brustovetsky N, 2016, WILEY SER NEUROPH, P3; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Chaudhuri D, 2013, ELIFE, V2, DOI 10.7554/eLife.00704; Chinopoulos C, 2018, NEUROCHEM INT, V117, P49, DOI 10.1016/j.neuint.2017.06.010; COX DA, 1993, J BIOL CHEM, V268, P938; COX DA, 1993, TRENDS PHARMACOL SCI, V14, P408, DOI 10.1016/0165-6147(93)90063-P; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; De Stefani D, 2015, BBA-MOL CELL RES, V1853, P2006, DOI 10.1016/j.bbamcr.2015.04.008; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Di Paola M, 2006, BBA-BIOENERGETICS, V1757, P1330, DOI 10.1016/j.bbabio.2006.03.024; Foskett JK, 2015, J MOL CELL CARDIOL, V78, P3, DOI 10.1016/j.yjmcc.2014.11.015; Griffiths EJ, 1999, FEBS LETT, V453, P400, DOI 10.1016/S0014-5793(99)00726-7; Hamilton J, 2015, HUM MOL GENET, V24, P4862, DOI 10.1093/hmg/ddv209; Hoyt KR, 1998, MOL PHARMACOL, V53, P742, DOI 10.1124/mol.53.4.742; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; Izzo V, 2016, TRENDS CELL BIOL, V26, P655, DOI 10.1016/j.tcb.2016.04.006; Jakob R, 2014, NEUROSCI LETT, V575, P7, DOI 10.1016/j.neulet.2014.05.026; Jung DW, 2004, ANAL BIOCHEM, V324, P258, DOI 10.1016/j.ab.2003.10.029; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Kiedrowski L, 1999, MOL PHARMACOL, V56, P619, DOI 10.1124/mol.56.3.619; KIEDROWSKI L, 1995, MOL PHARMACOL, V47, P140; KIMMICH GA, 1975, ANAL BIOCHEM, V69, P187, DOI 10.1016/0003-2697(75)90580-1; Li T, 2010, BBA-BIOENERGETICS, V1797, P52, DOI 10.1016/j.bbabio.2009.07.012; Li V, 2009, EXP NEUROL, V218, P171, DOI 10.1016/j.expneurol.2009.02.007; Luongo TS, 2015, CELL REP, V12, P23, DOI 10.1016/j.celrep.2015.06.017; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mammucari C, 2015, CELL REP, V10, P1269, DOI 10.1016/j.celrep.2015.01.056; Mnatsakanyan N, 2017, J BIOENERG BIOMEMBR, V49, P13, DOI 10.1007/s10863-016-9652-1; MOORE CL, 1971, BIOCHEM BIOPH RES CO, V42, P298, DOI 10.1016/0006-291X(71)90102-1; Nichols M, 2017, J CEREBR BLOOD F MET, V37, P3027, DOI 10.1177/0271678X16682250; Nieminen AL, 1996, NEUROSCIENCE, V75, P993; NOVGORODOV SA, 1992, J BIOL CHEM, V267, P16274; OESTREICHER AB, 1969, BIOCHIM BIOPHYS ACTA, V180, P45, DOI 10.1016/0005-2728(69)90192-3; Oxenoid K, 2016, NATURE, V533, P269, DOI 10.1038/nature17656; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Pellman JJ, 2015, J NEUROCHEM, V134, P652, DOI 10.1111/jnc.13165; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; PRESTIPINO G, 1993, ANAL BIOCHEM, V210, P119, DOI 10.1006/abio.1993.1160; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Schinder AF, 1996, J NEUROSCI, V16, P6125; Smets I, 2004, AM J PHYSIOL-RENAL, V286, pF784, DOI 10.1152/ajprenal.00284.2003; SPECTOR AA, 1969, J LIPID RES, V10, P56; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; VASINGTON FD, 1972, BIOCHIM BIOPHYS ACTA, V256, P43, DOI 10.1016/0005-2728(72)90161-2; VODYANOY I, 1993, BIOPHYS J, V65, P2097, DOI 10.1016/S0006-3495(93)81245-1; Wang GJ, 1996, J NEUROPHYSIOL, V76, P1611, DOI 10.1152/jn.1996.76.3.1611; WHITE RJ, 1995, J NEUROSCI, V15, P1318; White RJ, 1996, J NEUROSCI, V16, P5688; WOJTCZAK AB, 1969, BIOCHIM BIOPHYS ACTA, V172, P52, DOI 10.1016/0005-2728(69)90091-7; WOJTCZAK L, 1969, BIOCHIM BIOPHYS ACTA, V191, P10, DOI 10.1016/0005-2744(69)90310-6; YING WL, 1991, BIOCHEMISTRY-US, V30, P4949, DOI 10.1021/bi00234a016; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	67	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15652	15663		10.1074/jbc.RA118.002926	http://dx.doi.org/10.1074/jbc.RA118.002926			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30154242	Green Published, hybrid			2022-12-28	WOS:000446549200028
J	Morosov, X; Davoudi, CF; Baumgart, M; Brocker, M; Bott, M				Morosov, Xenia; Davoudi, Cedric-Farhad; Baumgart, Meike; Brocker, Melanie; Bott, Michael			The copper-deprivation stimulon of Corynebacterium glutamicum comprises proteins for biogenesis of the actinobacterial cytochrome bc(1)-aa(3) supercomplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome oxidase; copper; Actinobacteria; respiratory chain; complex; respiration; CtiP; CopC; copper starvation; cytochrome aa(3); cytochrome c; protein assembly	CU-A CENTER; RESPIRATORY-CHAIN; ANAEROBIC GROWTH; PSEUDOMONAS-SYRINGAE; FERMENTING BACTERIUM; NITRATE RESPIRATION; MOLECULAR ANALYSIS; OXIDASE ACTIVITY; EXPRESSION; RESISTANCE	Aerobic respiration in Corynebacterium glutamicum involves a cytochrome bc(1)-aa(3) supercomplex with a diheme cytochrome c(1), which is the only c-type cytochrome in this species. This organization is considered as typical for aerobic Actinobacteria. Whereas the biogenesis of heme-copper type oxidases like cytochrome aa(3) has been studied extensively in -proteobacteria, yeast, and mammals, nothing is known about this process in Actinobacteria. Here, we searched for assembly proteins of the supercomplex by identifying the copper-deprivation stimulon, which might include proteins that insert copper into cytochrome aa(3). Using gene expression profiling, we found two copper starvation-induced proteins for supercomplex formation. The Cg2699 protein, named CtiP, contained 16 predicted transmembrane helices, and its sequence was similar to that of the copper importer CopD of Pseudomonas syringae in the N-terminal half and to the cytochrome oxidase maturation protein CtaG of Bacillus subtilis in its C-terminal half. CtiP deletion caused a growth defect similar to that produced by deletion of subunit I of cytochrome aa(3), increased copper tolerance, triggered expression of the copper-deprivation stimulon under copper sufficiency, and prevented co-purification of the supercomplex subunits. The secreted Cg1884 protein, named CopC, had a C-terminal transmembrane helix and contained a Cu(II)-binding motif. Its absence caused a conditional growth defect, increased copper tolerance, and also prevented co-purification of the supercomplex subunits. CtiP and CopC are conserved among aerobic Actinobacteria, and we propose a model of their functions in cytochrome aa(3) biogenesis. Furthermore, we found that the copper-deprivation response involves additional regulators besides the ECF sigma factor SigC.	[Morosov, Xenia; Davoudi, Cedric-Farhad; Baumgart, Meike; Brocker, Melanie; Bott, Michael] Forschungszentrum Julich, Inst Bio & Geosci IBG Biotechnol 1, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Bott, M (corresponding author), Forschungszentrum Julich, Inst Bio & Geosci IBG Biotechnol 1, D-52425 Julich, Germany.	m.bott@fz-juelich.de	Bott, Michael/E-8004-2011; Baumgart, Meike/ABA-7414-2020; Baumgart, Meike/GWC-5464-2022	Bott, Michael/0000-0002-4701-8254; Baumgart, Meike/0000-0002-9874-1151; 	Northrhine-Westfalia (NRW) Research School BioStruct	Northrhine-Westfalia (NRW) Research School BioStruct	Supported by the Northrhine-Westfalia (NRW) Research School BioStruct.	ABE S, 1967, J GEN APPL MICROBIOL, V13, P279, DOI 10.2323/jgam.13.279; Abicht HK, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.607127; Abriata LA, 2008, NAT CHEM BIOL, V4, P599, DOI 10.1038/nchembio.110; Arnesano F, 2003, P NATL ACAD SCI USA, V100, P3814, DOI 10.1073/pnas.0636904100; Banci L, 2005, P NATL ACAD SCI USA, V102, P3994, DOI 10.1073/pnas.0406150102; Bellmann A, 2001, MICROBIOL-SGM, V147, P1765, DOI 10.1099/00221287-147-7-1765; Bengtsson J, 2004, MICROBIOL-SGM, V150, P415, DOI 10.1099/mic.0.26691-0; Binder S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r40; Bott M, 2003, J BIOTECHNOL, V104, P129, DOI 10.1016/S0168-1656(03)00144-5; BOTT M, 1990, MOL MICROBIOL, V4, P2147, DOI 10.1111/j.1365-2958.1990.tb00576.x; Burkovski A, 2015, CORYNEBACTERIUM GLUTAMICUM: FROM SYSTEMS BIOLOGY TO BIOTECHNOLOGICAL APPLICATIONS, P1; Castiglioni E, 1997, REV SCI INSTRUM, V68, P4288, DOI 10.1063/1.1148344; CHA JS, 1991, P NATL ACAD SCI USA, V88, P8915, DOI 10.1073/pnas.88.20.8915; CHA JS, 1993, APPL ENVIRON MICROB, V59, P1671, DOI 10.1128/AEM.59.5.1671-1674.1993; COOKSEY DA, 1994, FEMS MICROBIOL REV, V14, P381, DOI 10.1016/0168-6445(94)90056-6; Eggeling L., 2005, HDB CORYNEBACTERIUM, DOI 10.1201/9781420039696; EIKMANNS BJ, 1991, GENE, V102, P93, DOI 10.1016/0378-1119(91)90545-M; Ekici S, 2012, MBIO, V3, DOI 10.1128/mBio.00293-11; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Frangipani E, 2008, J BACTERIOL, V190, P6706, DOI 10.1128/JB.00450-08; Frunzke J, 2008, MOL MICROBIOL, V67, P305, DOI 10.1111/j.1365-2958.2007.06020.x; Gao BL, 2012, MICROBIOL MOL BIOL R, V76, P66, DOI 10.1128/MMBR.05011-11; Graf S, 2016, SCI REP-UK, V6, DOI 10.1038/srep34098; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Hanssler Eva, 2008, P183; Hill BC, 2012, BBA-BIOENERGETICS, V1817, P948, DOI 10.1016/j.bbabio.2011.09.006; Hiser L, 2000, J BIOL CHEM, V275, P619, DOI 10.1074/jbc.275.1.619; HUBBARD JA, 1989, ARCH MICROBIOL, V151, P300, DOI 10.1007/BF00406555; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kabus A, 2007, APPL ENVIRON MICROB, V73, P861, DOI 10.1128/AEM.01818-06; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Kao WC, 2016, BBA-BIOENERGETICS, V1857, P1705, DOI 10.1016/j.bbabio.2016.07.009; KEILHAUER C, 1993, J BACTERIOL, V175, P5595, DOI 10.1128/JB.175.17.5595-5603.1993; Khalfaoui-Hassani B, 2018, MBIO, V9, DOI 10.1128/mBio.00065-18; Kim MS, 2015, J BIOL CHEM, V290, P14350, DOI 10.1074/jbc.M114.624312; Kishikawa J, 2010, J BIOSCI BIOENG, V110, P42, DOI 10.1016/j.jbiosc.2009.12.006; Koch-Koerfges A, 2013, BBA-BIOENERGETICS, V1827, P699, DOI 10.1016/j.bbabio.2013.02.004; Kusumoto K, 2000, ARCH MICROBIOL, V173, P390, DOI 10.1007/s002030000161; Lewin GR, 2016, ANNU REV MICROBIOL, V70, P235, DOI 10.1146/annurev-micro-102215-095748; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; LOFERER H, 1993, EMBO J, V12, P3373, DOI 10.1002/j.1460-2075.1993.tb06011.x; Ma Z, 2009, BIOCHEMISTRY-US, V48, P3325, DOI 10.1021/bi900115w; Matsoso LG, 2005, J BACTERIOL, V187, P6300, DOI 10.1128/JB.187.18.6300-6308.2005; Megehee JA, 2006, MICROBIOL-SGM, V152, P823, DOI 10.1099/mic.0.28723-0; Michel A, 2015, APPL ENVIRON MICROB, V81, P7496, DOI 10.1128/AEM.02413-15; Moker N, 2004, MOL MICROBIOL, V54, P420, DOI 10.1111/j.1365-2958.2004.04249.x; Niebisch A, 2003, J BIOL CHEM, V278, P4339, DOI 10.1074/jbc.M210499200; Niebisch A, 2001, ARCH MICROBIOL, V175, P282, DOI 10.1007/s002030100262; Nishimura T, 2007, APPL MICROBIOL BIOT, V75, P889, DOI 10.1007/s00253-007-0879-y; Nyvltova E., 2017, ENCY INORGANIC BIOIN, P1; Oertel D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123413; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Sambrook J., 2001, MOL CLONING LAB MANU; Sawers RG, 2016, ADV MICROB PHYSIOL, V68, P1, DOI 10.1016/bs.ampbs.2016.02.004; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schaffer S, 2001, ELECTROPHORESIS, V22, P4404, DOI 10.1002/1522-2683(200112)22:20<4404::AID-ELPS4404>3.0.CO;2-2; Schelder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022143; Schendzielorz G, 2014, ACS SYNTH BIOL, V3, P21, DOI 10.1021/sb400059y; Sone N, 2001, BBA-BIOENERGETICS, V1503, P279, DOI 10.1016/S0005-2728(00)00205-X; SUGIYAMA Y, 1973, AGR BIOL CHEM TOKYO, V37, P1837, DOI 10.1080/00021369.1973.10860919; Sutcliffe IC, 2002, MICROBIOL-SGM, V148, P2065, DOI 10.1099/00221287-148-7-2065; Takeno S, 2007, APPL MICROBIOL BIOT, V75, P1173, DOI 10.1007/s00253-007-0926-8; Teramoto H, 2015, APPL MICROBIOL BIOT, V99, P3505, DOI 10.1007/s00253-015-6373-z; Thompson AK, 2012, BBA-BIOENERGETICS, V1817, P955, DOI 10.1016/j.bbabio.2012.01.003; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; Toyoda K, 2016, MOL MICROBIOL, V100, P486, DOI 10.1111/mmi.13330; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; von Wachenfeldt C, 2001, BACILLUS SUBTILIS IT, P163; Vrljic M, 1996, MOL MICROBIOL, V22, P815, DOI 10.1046/j.1365-2958.1996.01527.x; Yukawa H., 2013, CORYNEBACTERIUM GLUT	72	14	14	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15628	15640		10.1074/jbc.RA118.004117	http://dx.doi.org/10.1074/jbc.RA118.004117			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30154248	Green Published, hybrid			2022-12-28	WOS:000446549200026
J	Arguello, T; Kohrer, C; RajBhandary, UL; Moraes, CT				Arguello, Tania; Kohrer, Caroline; RajBhandary, Uttam L.; Moraes, Carlos T.			Mitochondrial methionyl N-formylation affects steady-state levels of oxidative phosphorylation complexes and their organization into supercomplexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein synthesis; transfer RNA (tRNA); mitochondria; mitochondrial disease; mitochondrial DNA (mtDNA); methionine; gene knockout; N-formylation	INITIATOR TRANSFER-RNA; PROTEIN-SYNTHESIS; FUNCTIONAL-CHARACTERIZATION; MAMMALIAN MITOCHONDRIA; MTFMT MUTATION; CULTURED-CELLS; IN-VIVO; TRANSLATION; GENE; INITIATION-FACTOR-2	N-Formylation of the Met-tRNA(Met) by the nuclearly encoded mitochondrial methionyl-tRNA formyltransferase (MTFMT) has been found to be a key determinant of protein synthesis initiation in mitochondria. In humans, mutations in the MTFMT gene result in Leigh syndrome, a progressive and severe neurometabolic disorder. However, the absolute requirement of formylation of Met-tRNA(Met) for protein synthesis in mammalian mitochondria is still debated. Here, we generated a Mtfmt-KO mouse fibroblast cell line and demonstrated that N-formylation of the first methionine via fMet-tRNA(Met) by MTFMT is not an absolute requirement for initiation of protein synthesis. However, it differentially affected the efficiency of synthesis of mtDNA-coded polypeptides. Lack of methionine N-formylation did not compromise the stability of these individual subunits but had a marked effect on the assembly and stability of the OXPHOS complexes I and IV and on their supercomplexes. In summary, N-formylation is not essential for mitochondrial protein synthesis but is critical for efficient synthesis of several mitochondrially encoded peptides and for OXPHOS complex stability and assembly into supercomplexes.	[Arguello, Tania; Moraes, Carlos T.] Univ Miami, Sch Med, Dept Neurol, 1420 NW 9th Ave, Miami, FL 33136 USA; [Kohrer, Caroline; RajBhandary, Uttam L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Kohrer, Caroline] Moderna Therapeut, Cambridge, MA 02139 USA	University of Miami; Massachusetts Institute of Technology (MIT)	Moraes, CT (corresponding author), Univ Miami, Sch Med, Dept Neurol, 1420 NW 9th Ave, Miami, FL 33136 USA.	cmoraes@med.miami.edu	Moraes, Carlos/AAT-3818-2021		National Institutes of Health [5R01EY010804, 1R01AG036871, 1R01NS079965, GM17151]; NATIONAL EYE INSTITUTE [R01EY010804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM017151, F32GM017151, R56GM017151, R01GM017151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants 5R01EY010804, 1R01AG036871, and 1R01NS079965 (to C. T. M.) and GM17151 (to U. L. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Supported by a minority supplement to National Institutes of Health Grant 5R01EY010804.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Arguello T, 2015, GENESIS, V53, P695, DOI 10.1002/dvg.22899; Diaz F., 2009, CURR PROTOC HUM GENE, V19, P4, DOI [DOI 10.1002/0471142905.HG1904S63, 10.1002/0471142905.hg1904s63]; Fernandez-Silva P, 2007, METHOD CELL BIOL, V80, P571, DOI 10.1016/S0091-679X(06)80028-2; Gottlieb RA, 2000, METHOD ENZYMOL, V322, P213; GUILLON JM, 1992, J BACTERIOL, V174, P4294, DOI 10.1128/JB.174.13.4294-4301.1992; Haack TB, 2014, MOL GENET METAB, V111, P342, DOI 10.1016/j.ymgme.2013.12.010; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; Hinttala R, 2015, HUM MOL GENET, V24, P4103, DOI 10.1093/hmg/ddv149; Kohrer C, 2008, METHODS, V44, P129, DOI 10.1016/j.ymeth.2007.10.006; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; Kuzmenko A, 2014, BIOCHIMIE, V100, P132, DOI 10.1016/j.biochi.2013.07.024; La Piana R, 2017, NEUROGENETICS, V18, P97, DOI 10.1007/s10048-016-0506-0; Li Y, 2000, J BACTERIOL, V182, P2886, DOI 10.1128/JB.182.10.2886-2892.2000; LIAO HX, 1991, J BIOL CHEM, V266, P20714; Mai N, 2017, CELL TISSUE RES, V367, P5, DOI 10.1007/s00441-016-2456-0; Neeve VCM, 2013, MITOCHONDRION, V13, P743, DOI 10.1016/j.mito.2013.03.002; Newton DT, 1999, J BIOL CHEM, V274, P22143, DOI 10.1074/jbc.274.32.22143; Oates A, 2016, PEDIATR TRANSPLANT, V20, P1000, DOI 10.1111/petr.12758; Rabiet MJ, 2005, EUR J IMMUNOL, V35, P2486, DOI 10.1002/eji.200526338; RAJBHANDARY UL, 1994, J BACTERIOL, V176, P547, DOI 10.1128/jb.176.3.547-552.1994; Sasarman F, 2012, METHODS MOL BIOL, V837, P207, DOI 10.1007/978-1-61779-504-6_14; SCHOFIEL.P, 1968, BIOCHIM BIOPHYS ACTA, V155, P410, DOI 10.1016/0005-2787(68)90185-8; Sinha A, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.610626; Spencer AC, 2004, NUCLEIC ACIDS RES, V32, P5464, DOI 10.1093/nar/gkh886; Takeuchi N, 1998, J BIOL CHEM, V273, P15085, DOI 10.1074/jbc.273.24.15085; Tibbetts AS, 2003, J BIOL CHEM, V278, P31774, DOI 10.1074/jbc.M304962200; Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010; Vanunu M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15618-9; Walker JE, 2009, METHOD ENZYMOL, V456, P111, DOI 10.1016/S0076-6879(08)04406-6	33	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15021	15032		10.1074/jbc.RA118.003838	http://dx.doi.org/10.1074/jbc.RA118.003838			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30087118	Green Published, hybrid			2022-12-28	WOS:000445998400007
J	Kokoszka, ME; Kall, SL; Khosla, S; McGinnis, JE; Lavie, A; Kay, BK				Kokoszka, Malgorzata E.; Kall, Stefanie L.; Khosla, Sehar; McGinnis, Jennifer E.; Lavie, Arnon; Kay, Brian K.			Identification of two distinct peptide-binding pockets in the SH3 domain of human mixed-lineage kinase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phage display; protein-protein interaction; Src homology 3 domain (SH3 domain); ligand-binding protein; affinity selection; alanine scanning; combinatorial peptides; n-Src insert; mixed-lineage protein kinase; MLK3 SH3 domain-interacting peptide	HEPATITIS-C VIRUS; PHAGE-DISPLAY; PROTEIN INTERACTIONS; ACTIVATION LOOP; NS5A PROTEIN; SRC; RECOGNITION; PROLINE; LIGANDS; MOTIF	Mixed-lineage kinase 3 (MLK3; also known as MAP3K11) is a Ser/Thr protein kinase widely expressed in normal and cancerous tissues, including brain, lung, liver, heart, and skeletal muscle tissues. Its Src homology 3 (SH3) domain has been implicated in MLK3 autoinhibition and interactions with other proteins, including those from viruses. The MLK3 SH3 domain contains a six-amino-acid insert corresponding to the n-Src insert, suggesting that MLK3 may bind additional peptides. Here, affinity selection of a phage-displayed combinatorial peptide library for MLK3's SH3 domain yielded a 13-mer peptide, designated MLK3 SH3-interacting peptide (MIP). Unlike most SH3 domain peptide ligands, MIP contained a single proline. The 1.2- crystal structure of the MIP-bound SH3 domain revealed that the peptide adopts a -hairpin shape, and comparison with a 1.5- apo SH3 domain structure disclosed that the n-Src loop in SH3 undergoes an MIP-induced conformational change. A 1.5- structure of the MLK3 SH3 domain bound to a canonical proline-rich peptide from hepatitis C virus nonstructural 5A (NS5A) protein revealed that it and MIP bind the SH3 domain at two distinct sites, but biophysical analyses suggested that the two peptides compete with each other for SH3 binding. Moreover, SH3 domains of MLK1 and MLK4, but not MLK2, also bound MIP, suggesting that the MLK1-4 family may be differentially regulated through their SH3 domains. In summary, we have identified two distinct peptide-binding sites in the SH3 domain of MLK3, providing critical insights into mechanisms of ligand binding by the MLK family of kinases.	[Kokoszka, Malgorzata E.; Khosla, Sehar; McGinnis, Jennifer E.; Kay, Brian K.] Univ Illinois, Dept Biol Sci, 900 S Ashland Ave, Chicago, IL 60607 USA; [Kall, Stefanie L.; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kay, BK (corresponding author), Univ Illinois, Dept Biol Sci, 900 S Ashland Ave, Chicago, IL 60607 USA.	bkay@uic.edu		Lavie, Arnon/0000-0001-5591-8722	Chicago Biomedical Consortium; Searle Funds at the Chicago Community Trust; National Institutes of Health [R01EB013685]; National Institutes of Health from NIDCR Grant [DE018381]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE018381] Funding Source: NIH RePORTER	Chicago Biomedical Consortium; Searle Funds at the Chicago Community Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from NIDCR Grant; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Chicago Biomedical Consortium with support from the Searle Funds at the Chicago Community Trust (to B. K. K.), National Institutes of Health Grant R01EB013685 (to A. L.), and National Institutes of Health T32 training support from NIDCR Grant DE018381 (to S. L. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amako Y, 2013, J BIOL CHEM, V288, P24753, DOI 10.1074/jbc.M113.491985; Azuaga A. I., 2015, SH DOMAINS STRUCTURE, P35; Bacarizo J, 2015, J STRUCT BIOL, V189, P67, DOI 10.1016/j.jsb.2014.11.004; Biesova Z, 1997, ONCOGENE, V14, P233, DOI 10.1038/sj.onc.1200822; Carducci M, 2012, BIOTECHNOL ADV, V30, P4, DOI 10.1016/j.biotechadv.2011.06.012; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Douangamath A, 2002, MOL CELL, V10, P1007, DOI 10.1016/S1097-2765(02)00749-9; Du Y, 2005, J BIOL CHEM, V280, P42984, DOI 10.1074/jbc.M502671200; GALLO KA, 1994, J BIOL CHEM, V269, P15092; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Hennigan RF, 2013, ONCOGENE, V32, P1135, DOI 10.1038/onc.2012.135; Houimel M, 2009, J LEUKOCYTE BIOL, V85, P728, DOI 10.1189/jlb.0608380; Huang RH, 2012, METHODS, V58, P10, DOI 10.1016/j.ymeth.2012.08.008; ING YL, 1994, ONCOGENE, V9, P1745; Ivarsson Y, 2014, P NATL ACAD SCI USA, V111, P2542, DOI 10.1073/pnas.1312296111; Jadwin JA, 2012, FEBS LETT, V586, P2586, DOI 10.1016/j.febslet.2012.04.019; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kaneko T, 2011, TRENDS BIOCHEM SCI, V36, P183, DOI 10.1016/j.tibs.2010.12.001; Kang H, 2000, EMBO J, V19, P2889, DOI 10.1093/emboj/19.12.2889; Karkkainen S, 2006, EMBO REP, V7, P186, DOI 10.1038/sj.embor.7400596; Kay BK, 1998, DRUG DISCOV TODAY, V3, P370, DOI 10.1016/S1359-6446(98)01220-3; Kay BK, 2000, FEBS LETT, V480, P55, DOI 10.1016/S0014-5793(00)01778-6; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Kokoszka M. E., 2015, PHAGE DISPLAY BIOTEC, P229; Kokoszka ME, 2015, METHODS MOL BIOL, V1248, P173, DOI 10.1007/978-1-4939-2020-4_12; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leung IWL, 2001, J BIOL CHEM, V276, P1961, DOI 10.1074/jbc.M004092200; Liu Q, 2003, MOL CELL, V11, P471, DOI 10.1016/S1097-2765(03)00046-7; Macdonald A, 2004, J GEN VIROL, V85, P721, DOI 10.1099/vir.0.19691-0; Matoskova B, 1996, ONCOGENE, V12, P2679; Matoskova B, 1996, ONCOGENE, V12, P2563; Mayer BJ, 2015, NAT REV MOL CELL BIO, V16, P691, DOI 10.1038/nrm4068; Mongiovi AM, 1999, EMBO J, V18, P5300, DOI 10.1093/emboj/18.19.5300; Morfini GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065235; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida M, 2001, EMBO J, V20, P2995, DOI 10.1093/emboj/20.12.2995; Oligino L, 1997, J BIOL CHEM, V272, P29046, DOI 10.1074/jbc.272.46.29046; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Rana Ajay, 2013, Genes Cancer, V4, P334, DOI 10.1177/1947601913485415; RAULF F, 1989, J NEUROSCI RES, V24, P81, DOI 10.1002/jnr.490240112; Rouka E, 2015, J BIOL CHEM, V290, P25275, DOI 10.1074/jbc.M115.637207; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Scholle MD, 2005, COMB CHEM HIGH T SCR, V8, P545, DOI 10.2174/1386207054867337; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SPARKS AB, 1994, J BIOL CHEM, V269, P23853; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Tan SL, 1999, P NATL ACAD SCI USA, V96, P5533, DOI 10.1073/pnas.96.10.5533; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Vacratsis PO, 2000, J BIOL CHEM, V275, P27893; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VIGUERA AR, 1994, BIOCHEMISTRY-US, V33, P10925, DOI 10.1021/bi00202a011; Zhan Y, 2011, ONCOGENE, V30, P781, DOI 10.1038/onc.2010.453; Zhang H, 2001, J BIOL CHEM, V276, P45598, DOI 10.1074/jbc.M107176200; Zhang HF, 2004, J BIOL CHEM, V279, P44955, DOI 10.1074/jbc.M407617200; Zhong J, 2007, J BIOL CHEM, V282, P24246, DOI 10.1074/jbc.M703422200	63	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13553	13565		10.1074/jbc.RA117.000262	http://dx.doi.org/10.1074/jbc.RA117.000262			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29980598	hybrid, Green Published			2022-12-28	WOS:000443375500016
J	Randak, CO				Randak, Christoph O.			An elusive adenylate cyclase complicit in cholera is exposed	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CRYSTAL-STRUCTURE; TOXIN	The intestinal consequences of cholera enterotoxin are caused by activation of the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel through the actions of an as-yet-unknown adenylate cyclase. A new study hunts down this elusive enzyme, showing that mouse and human intestinal epithelium functionally and structurally pair adenylate cyclase isoform 6 (AC6) with CFTR. These findings provide important insights into the molecular mechanisms underlying the robust pathological activation of CFTR activity and promise new opportunities to treat cholera.	[Randak, Christoph O.] Univ Iowa, Pappajohn Biomed Inst, Stead Family Dept Pediat, 6336 PBDB, Iowa City, IA 52242 USA; [Randak, Christoph O.] Univ Iowa, Pappajohn Biomed Inst, Lung Biol & Cyst Fibrosis Res Ctr, 6336 PBDB, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Randak, CO (corresponding author), Univ Iowa, Pappajohn Biomed Inst, Stead Family Dept Pediat, 6336 PBDB, Iowa City, IA 52242 USA.; Randak, CO (corresponding author), Univ Iowa, Pappajohn Biomed Inst, Lung Biol & Cyst Fibrosis Res Ctr, 6336 PBDB, Iowa City, IA 52242 USA.	christoph-randak@uiowa.edu		Randak, Christoph/0000-0003-3264-4137	National Institutes of Health [R01DK107489]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by National Institutes of Health Grant R01DK107489.	CASSEL D, 1978, P NATL ACAD SCI USA, V75, P2669, DOI 10.1073/pnas.75.6.2669; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Li CY, 2010, INTEGR BIOL-UK, V2, P161, DOI [10.1039/B924455G, 10.1039/b924455g]; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Thomas A, 2018, J BIOL CHEM, V293, P12949, DOI 10.1074/jbc.RA118.003378; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456	10	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12960	12961		10.1074/jbc.H118.004669	http://dx.doi.org/10.1074/jbc.H118.004669			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	30120153	hybrid, Green Published			2022-12-28	WOS:000442203500030
J	Llamazares, M; Cal, S; Quesada, V; Lopez-Otin, C				Llamazares, Maria; Cal, Santiago; Quesada, Victor; Lopez-Otin, Carlos			Identification and characterization of ADAMTS-20 defines a novel subfamily of metalloproteinases-disintegrins with multiple thrombospondin-1 repeats and a unique GON domain ( vol 278, pg 13382, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Llamazares-Prada, Maria/ABX-0849-2022					Llamazares M, 2003, J BIOL CHEM, V278, P13382, DOI 10.1074/jbc.M211900200	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11785	11785		10.1074/jbc.AAC118.004702	http://dx.doi.org/10.1074/jbc.AAC118.004702			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	30054291	Green Published, hybrid			2022-12-28	WOS:000440134500012
J	Kumar, A; Gupta, C; Nair, DT; Salunke, DM				Kumar, Ashish; Gupta, Chitra; Nair, Deepak T.; Salunke, Dinakar M.			MP-4 contributes to snake venom neutralization by Mucuna pruriens seeds through an indirect antibody-mediated mechanism (Expression of Concern of Vol 291, Pg 11373, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		Kumar A, 2016, J BIOL CHEM, V291, P11373, DOI 10.1074/jbc.M115.699173	1	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11253	11253		10.1074/jbc.EC118.001735	http://dx.doi.org/10.1074/jbc.EC118.001735			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	30006388	hybrid, Green Published			2022-12-28	WOS:000438882800037
J	Polyviou, D; Machelett, MM; Hitchcock, A; Baylay, AJ; MacMillan, F; Moore, CM; Bibby, TS; Tews, I				Polyviou, Despo; Machelett, Moritz M.; Hitchcock, Andrew; Baylay, Alison J.; MacMillan, Fraser; Moore, C. Mark; Bibby, Thomas S.; Tews, Ivo			Structural and functional characterization of IdiA/FutA (Tery_3377), an iron-binding protein from the ocean diazotroph Trichodesmium erythraeum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; X-ray crystallography; iron; cyanobacteria; microscopy; diazotroph; iron deficiency	PHOTOSYNTHETIC ELECTRON-TRANSPORT; GREEN FLUORESCENT PROTEIN; MOLECULAR ASSESSMENT; THYLAKOID MEMBRANES; SIGNAL PEPTIDES; PHOTOSYSTEM-II; TAT PATHWAY; SYNECHOCYSTIS; STRESS; IDIA	Atmospheric nitrogen fixation by photosynthetic cyanobacteria (diazotrophs) strongly influences oceanic primary production and in turn affects global biogeochemical cycles. Species of the genus Trichodesmium are major contributors to marine diazotrophy, accounting for a significant proportion of the fixed nitrogen in tropical and subtropical oceans. However, Trichodesmium spp. are metabolically constrained by the availability of iron, an essential element for both the photosynthetic apparatus and the nitrogenase enzyme. Survival strategies in low-iron environments are typically poorly characterized at the molecular level, because these bacteria are recalcitrant to genetic manipulation. Here, we studied a homolog of the iron deficiency-induced A (IdiA)/ferric uptake transporter A (FutA) protein, Tery_3377, which has been used as an in situ iron-stress biomarker. IdiA/FutA has an ambiguous function in cyanobacteria, with its homologs hypothesized to be involved in distinct processes depending on their cellular localization. Using signal sequence fusions to GFP and heterologous expression in the model cyanobacterium Synechocystis sp. PCC 6803, we show that Tery_3377 is targeted to the periplasm by the twin-arginine translocase and can complement the deletion of the native Synechocystis ferric-iron ABC transporter periplasmic binding protein (FutA2). EPR spectroscopy revealed that purified recombinant Tery_3377 has specificity for iron in the Fe3+ state, and an X-ray crystallography-determined structure uncovered a functional iron substrate-binding domain, with Fe3+ pentacoordinated by protein and buffer ligands. Our results support assignment of Tery_3377 as a functional FutA subunit of an Fe3+ ABC transporter but do not rule out dual IdiA function.	[Polyviou, Despo; Machelett, Moritz M.; Hitchcock, Andrew; Baylay, Alison J.; Moore, C. Mark; Bibby, Thomas S.] Univ Southampton, Natl Oceanog Ctr Southampton, Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; [Machelett, Moritz M.; Tews, Ivo] Univ Southampton, Inst Life Sci, Fac Nat & Environm Sci, Dept Biol Sci, Southampton SO17 1BJ, Hants, England; [MacMillan, Fraser] Univ East Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England; [Hitchcock, Andrew] Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England	NERC National Oceanography Centre; University of Southampton; University of Southampton; University of East Anglia; University of Sheffield	Tews, I (corresponding author), Univ Southampton, Inst Life Sci, Fac Nat & Environm Sci, Dept Biol Sci, Southampton SO17 1BJ, Hants, England.	Ivo.Tews@soton.ac.uk	Hitchcock, Andrew/AAM-2855-2020; MacMillan, Fraser/AAM-4483-2020; MacMillan, Fraser/B-7619-2011	Hitchcock, Andrew/0000-0001-6572-434X; MacMillan, Fraser/0000-0002-2410-4790; MacMillan, Fraser/0000-0002-2410-4790; Moore, Mark/0000-0002-9541-6046; Tews, Ivo/0000-0002-4704-1139; Baylay, Alison/0000-0002-0814-0740; Bibby, Thomas/0000-0003-1743-473X	Natural Environment Research Council (NERC); Graduate School of the National Oceanography Centre Southampton; A.G. Leventis Foundation; National Oceanography Centre and Biological Sciences, University of Southampton	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Graduate School of the National Oceanography Centre Southampton; A.G. Leventis Foundation; National Oceanography Centre and Biological Sciences, University of Southampton	This work was supported by a studentship from Natural Environment Research Council (NERC) (to D.P.), funds from the Graduate School of the National Oceanography Centre Southampton (to D.P.) and A.G. Leventis Foundation (to D.P.), and a studentship from the National Oceanography Centre and Biological Sciences, University of Southampton (to M.M.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Achilles KM, 2003, LIMNOL OCEANOGR, V48, P2250, DOI 10.4319/lo.2003.48.6.2250; Aldridge C, 2008, MOL MICROBIOL, V70, P140, DOI 10.1111/j.1365-2958.2008.06401.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Badarau A, 2008, J BIOL CHEM, V283, P12520, DOI 10.1074/jbc.M709907200; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Blaby-Haas CE, 2012, BBA-MOL CELL RES, V1823, P1531, DOI 10.1016/j.bbamcr.2012.04.010; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cereda A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091484; Chappell PD, 2010, ENVIRON MICROBIOL, V12, P13, DOI 10.1111/j.1462-2920.2009.02026.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Exss-Sonne P, 2000, PHOTOSYNTH RES, V63, P145, DOI 10.1023/A:1006322925324; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Fulda S, 2000, EUR J BIOCHEM, V267, P5900, DOI 10.1046/j.1432-1327.2000.01642.x; Garg S, 2007, J PHYCOL, V43, P978, DOI 10.1111/j.1529-8817.2007.00394.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hansel CM, 2016, LIMNOL OCEANOGR, V61, P1188, DOI 10.1002/lno.10266; Hollingshead S, 2012, J BIOL CHEM, V287, P27823, DOI 10.1074/jbc.M112.352526; Huang F, 2002, MOL CELL PROTEOMICS, V1, P956, DOI 10.1074/mcp.M200043-MCP200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh H, 2001, PLANT CELL PHYSIOL, V42, P823, DOI 10.1093/pcp/pce106; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Koropatkin N, 2007, J BIOL CHEM, V282, P27468, DOI 10.1074/jbc.M704136200; Kranzler C, 2014, ISME J, V8, P409, DOI 10.1038/ismej.2013.161; Kranzler C, 2011, ENVIRON MICROBIOL, V13, P2990, DOI 10.1111/j.1462-2920.2011.02572.x; Kustka AB, 2005, LIMNOL OCEANOGR, V50, P1172, DOI 10.4319/lo.2005.50.4.1172; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; MacGregor-Chatwin C, 2017, PLANT CELL, V29, P1119, DOI 10.1105/tpc.17.00071; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michel KP, 2004, PHYSIOL PLANTARUM, V120, P36, DOI 10.1111/j.0031-9317.2004.0229.x; MICHEL KP, 1992, Z NATURFORSCH C, V47, P867; Moore J.K., 2007, BIOGEOSCIENCES, V4, P1241, DOI [10.5194/bgd-4-1241-2007, DOI 10.5194/BGD-4-1241-2007, DOI 10.5194/bgd-4-1241-2007]; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Raven JA, 1999, PHOTOSYNTH RES, V60, P111, DOI 10.1023/A:1006282714942; Richier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035571; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rivers AR, 2009, ENVIRON MICROBIOL, V11, P382, DOI 10.1111/j.1462-2920.2008.01778.x; Rubin M, 2011, NAT GEOSCI, V4, P529, DOI 10.1038/NGEO1181; Scheepers GH, 2016, FEBS LETT, V590, P4393, DOI 10.1002/1873-3468.12445; Shaked Y, 2005, LIMNOL OCEANOGR, V50, P872, DOI 10.4319/lo.2005.50.3.0872; Shi T, 2007, ENVIRON MICROBIOL, V9, P2945, DOI 10.1111/j.1462-2920.2007.01406.x; Shouldice SR, 2004, J BACTERIOL, V186, P3903, DOI 10.1128/JB.186.12.3903-3910.2004; Singh AK, 2003, PLANT PHYSIOL, V132, P1825, DOI 10.1104/pp.103.024018; Skolnick S, 2007, BBA-BIOENERGETICS, V1767, P814, DOI 10.1016/j.bbabio.2006.11.015; Snow JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142626; Spence E, 2003, MOL MICROBIOL, V48, P1481, DOI 10.1046/j.1365-2958.2003.03519.x; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; Tolle J, 2002, MICROBIOL-SGM, V148, P3293, DOI 10.1099/00221287-148-10-3293; Tom-Yew SAL, 2005, J BIOL CHEM, V280, P9283, DOI 10.1074/jbc.M412479200; Waldron KJ, 2007, J BIOL CHEM, V282, P3837, DOI 10.1074/jbc.M609916200; Walworth N, 2015, P NATL ACAD SCI USA, V112, P4251, DOI 10.1073/pnas.1422332112; Wang SP, 2014, ACTA CRYSTALLOGR D, V70, P196, DOI 10.1107/S1399004713026333; Webb EA, 2001, APPL ENVIRON MICROB, V67, P5444, DOI 10.1128/AEM.67.12.5444-5452.2001; Webb EA, 2007, LIMNOL OCEANOGR, V52, P2221, DOI 10.4319/lo.2007.52.5.2221; Westberry TK, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002673; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766	63	10	10	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18099	18109		10.1074/jbc.RA118.001929	http://dx.doi.org/10.1074/jbc.RA118.001929			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30217820	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000451375200007
J	Walter, F; O'Brien, A; Concannon, CG; Dussmann, H; Prehn, JHM				Walter, Franziska; O'Brien, Aisling; Concannon, Caoimhin G.; Duessmann, Heiko; Prehn, Jochen H. M.			ER stress signaling has an activating transcription factor 6 (ATF6)-dependent "off-switch"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); unfolded protein response (UPR); c-Jun N-terminal kinase (JNK); imaging; protein misfolding; stress response; X-box binding protein 1 (XBP1); APY29; ATF6; high content imaging; IRE1; UPR reporters; fluorescent reporter; cell death; GRP78; lentivirus	MESSENGER-RNA; IRE1-ALPHA; ATF6; IRE1; SINGLE; ATF6-ALPHA; INHIBITION; CLEAVAGE; RATHER; GENES	In response to an accumulation of unfolded proteins in the endoplasmic reticulum (ER) lumen, three ER transmembrane signaling proteins, inositol-requiring enzyme 1 (IRE1), PRKR-like ER kinase (PERK), and activating transcription factor 6 (ATF6), are activated. These proteins initiate a signaling and transcriptional network termed the unfolded protein response (UPR), which re-establishes cellular proteostasis. When this restoration fails, however, cells undergo apoptosis. To investigate cross-talk between these different UPR enzymes, here we developed a high-content live cell screening platform to image fluorescent UPR-reporter cell lines derived from human SH-SY5Y neuroblastoma cells in which different ER stress signaling proteins were silenced through lentivirus-delivered shRNA constructs. We observed that loss of ATF6 expression results in uncontrolled IRE1-reporter activity and increases X box-binding protein 1 (XBP1) splicing. Transient increases in both IRE1 mRNA and IRE1 protein levels were observed in response to ER stress, suggesting that IRE1 up-regulation is a general feature of ER stress signaling and was further increased in cells lacking ATF6 expression. Moreover, overexpression of the transcriptionally active N-terminal domain of ATF6 reversed the increases in IRE1 levels. Furthermore, inhibition of IRE1 kinase activity or of downstream JNK activity prevented an increase in IRE1 levels during ER stress, suggesting that IRE1 transcription is regulated through a positive feed-forward loop. Collectively, our results indicate that from the moment of activation, IRE1 signaling during ER stress has an ATF6-dependent off-switch.	[Walter, Franziska; O'Brien, Aisling; Concannon, Caoimhin G.; Duessmann, Heiko; Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Ctr Syst Med, 123 St Stephens Green, Dublin 6, Ireland	Royal College of Surgeons - Ireland	Prehn, JHM (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Ctr Syst Med, 123 St Stephens Green, Dublin 6, Ireland.	jprehn@rcsi.ie		Dussmann, Heiko/0000-0002-3582-8057; Walter, Franziska/0000-0003-4396-6131	Science Foundation Ireland Investigator Award [13/IA/1881]	Science Foundation Ireland Investigator Award(Science Foundation Ireland)	This work was supported by the Science Foundation Ireland Investigator Award 13/IA/1881 (to J. H. M. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Guo FJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.194; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Nolan K, 2016, EUR J NEUROSCI, V43, P640, DOI 10.1111/ejn.13160; Ramapathiran L, 2014, J CELL SCI, V127, P609, DOI 10.1242/jcs.137158; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Sun SY, 2015, NAT CELL BIOL, V17, P1546, DOI 10.1038/ncb3266; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tsuru A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24217; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter F, 2015, CELL DEATH DIFFER, V22, P1502, DOI 10.1038/cdd.2014.241; Wang LK, 2012, NAT CHEM BIOL, V8, P982, DOI [10.1038/NCHEMBIO.1094, 10.1038/nchembio.1094]; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	32	38	41	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18270	18284		10.1074/jbc.RA118.002121	http://dx.doi.org/10.1074/jbc.RA118.002121			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30287689	hybrid, Green Published			2022-12-28	WOS:000451375200019
J	Petes, C; Mintsopoulos, V; Finnen, RL; Banfield, BW; Gee, K				Petes, Carlene; Mintsopoulos, Victoria; Finnen, Renee L.; Banfield, Bruce W.; Gee, Katrina			The effects of CD14 and IL-27 on induction of endotoxin tolerance in human monocytes and macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; cytokine action; Toll-like receptor 4 (TLR4); lipopolysaccharide (LPS); NF-B; CD14; endotoxin tolerance; interleukin-27 (IL-27); monocytes; macrophages	NECROSIS-FACTOR-ALPHA; KAPPA-B; IRAK-M; UP-REGULATION; IL-12 FAMILY; INFLAMMATORY RESPONSES; SIGNAL-TRANSDUCTION; NEGATIVE REGULATION; TLR4 ENDOCYTOSIS; RECEPTOR CD14	Upon repeated exposure to endotoxin or lipopolysaccharide (LPS), myeloid cells enter a refractory state called endotoxin tolerance as a homeostatic mechanism. In innate immune cells, LPS is recognized by co-receptors Toll-like receptor 4 (TLR4) and CD-14 to initiate an inflammatory response for subsequent cytokine production. One such cytokine, interleukin (IL)-27, is produced by myeloid cells in response to bacterial infection. In monocytes, IL-27 has proinflammatory functions such as up-regulating TLR4 expression for enhanced LPS-mediated cytokine production; alternatively, IL-27 induces inhibitory functions in activated macrophages. This study investigated the effects of IL-27 on the induction of endotoxin tolerance in models of human monocytes compared with macrophages. Our data demonstrate that IL-27 inhibits endotoxin tolerance by up-regulating cell surface TLR4 expression and soluble CD14 production to mediate stability of the surface LPS-TLR4-CD14 complex in THP-1 cells. In contrast, elevated basal expression of membrane-bound CD14 in phorbol 12-myristate 13-acetate (PMA)-THP-1 cells, primary monocytes, and primary macrophages may promote CD14-mediated endocytosis and be responsible for the preservation of an endotoxin-tolerized state in the presence of IL-27. Overall, the efficacy of IL-27 in inhibiting endotoxin tolerance in human THP-1 monocytes and PMA-THP-1 macrophages is affected by membrane-bound and soluble CD14 expression.	[Petes, Carlene; Mintsopoulos, Victoria; Finnen, Renee L.; Banfield, Bruce W.; Gee, Katrina] Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St,Botterell Hall 738, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Gee, K (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St,Botterell Hall 738, Kingston, ON K7L 3N6, Canada.	kgee@queensu.ca		Gee, Katrina/0000-0002-7535-2882	Natural Sciences and Engineering Research Council of Canada (NSERC) [342168, 418719]; Ontario Graduate Scholarship; Dr. Robert John Wilson graduate fellowship; NSERC; NSERC undergraduate student research award; Canadian Institutes of Health Research [93804]; Canada Foundation for Innovation [16389]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Dr. Robert John Wilson graduate fellowship; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC undergraduate student research award(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by Grants 342168 (to K. G.) and 418719 (to B. W. B.) from the Natural Sciences and Engineering Research Council of Canada (NSERC). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an Ontario Graduate Scholarship, a Dr. Robert John Wilson graduate fellowship, and an NSERC postgraduate supplement D (PGS D).; Supported by an NSERC undergraduate student research award.; Supported by Operating Grant 93804 from the Canadian Institutes of Health Research and Grant 16389 from the Canada Foundation for Innovation.	AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678; BAZIL V, 1991, J IMMUNOL, V147, P1567; Biswas S. K., 2012, IMMUNOSUPPRESSION RO, P21; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; BUFLER P, 1995, EUR J IMMUNOL, V25, P604, DOI 10.1002/eji.1830250244; Cao J, 2014, THORAX, V69, P926, DOI 10.1136/thoraxjnl-2014-205777; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Cavaillon JM, 2003, J ENDOTOXIN RES, V9, P101, DOI 10.1179/096805103125001487; Chen J, 2010, P NATL ACAD SCI USA, V107, P19438, DOI 10.1073/pnas.1007816107; Chen RF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-340; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; d'Almeida SM, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1178025; del Fresno C, 2007, J ENDOTOXIN RES, V13, P39, DOI 10.1177/0968051907078623; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Deschner J, 2003, ARCH MICROBIOL, V179, P430, DOI 10.1007/s00203-003-0548-1; Draisma A, 2009, CRIT CARE MED, V37, P1261, DOI 10.1097/CCM.0b013e31819c3c67; El Gazzar M, 2007, J BIOL CHEM, V282, P26857, DOI 10.1074/jbc.M704584200; Escoll P, 2003, BIOCHEM BIOPH RES CO, V311, P465, DOI 10.1016/j.bbrc.2003.10.019; Finberg RW, 2004, J ENDOTOXIN RES, V10, P413, DOI 10.1179/096805104225006273; Fitzgerald KA, 2004, MICROBES INFECT, V6, P1361, DOI 10.1016/j.micinf.2004.08.015; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Guzzo C, 2012, J IMMUNOL, V188, P864, DOI 10.4049/jimmunol.1101912; Guzzo C, 2010, J BIOL CHEM, V285, P24404, DOI 10.1074/jbc.M110.112599; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Holscher C, 2005, J IMMUNOL, V174, P3534, DOI 10.4049/jimmunol.174.6.3534; Huber R, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/9570129; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Ivashkiv LB, 2011, EUR J IMMUNOL, V41, P2477, DOI 10.1002/eji.201141783; Iyer SS, 2010, J IMMUNOL, V185, P6599, DOI 10.4049/jimmunol.1002041; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kalliolias GD, 2008, J IMMUNOL, V180, P6325, DOI 10.4049/jimmunol.180.9.6325; Kalliolias GD, 2010, J IMMUNOL, V185, P7047, DOI 10.4049/jimmunol.1001290; Kamakura M, 2006, BIOCHEM BIOPH RES CO, V349, P1372, DOI 10.1016/j.bbrc.2006.09.004; Karimi Y, 2017, CYTOKINE, V95, P7, DOI 10.1016/j.cyto.2017.01.017; Kim D, 2014, MOL IMMUNOL, V57, P210, DOI 10.1016/j.molimm.2013.09.009; Kitchens RL, 2003, J LIPID RES, V44, P2339, DOI 10.1194/jlr.M300228-JLR200; Kitchens RL, 2001, J CLIN INVEST, V108, P485, DOI 10.1172/JCI200113139; Kox M, 2011, CRIT CARE MED, V39, P1866, DOI 10.1097/CCM.0b013e3182190d5d; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lin YW, 2016, J INNATE IMMUN, V8, P97, DOI 10.1159/000433539; Lopez-Collazo E, 2013, CRIT CARE, V17, DOI 10.1186/cc13110; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Molle C, 2007, J IMMUNOL, V178, P7607, DOI 10.4049/jimmunol.178.12.7607; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Pearl JE, 2004, J IMMUNOL, V173, P7490, DOI 10.4049/jimmunol.173.12.7490; PEDRON T, 1995, J IMMUNOL, V155, P1460; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Petes C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00256; Petes C, 2017, J LEUKOCYTE BIOL, V102, P83, DOI 10.1189/jlb.3A0316-098R; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Rackov G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00493; Rajaiah R, 2015, P NATL ACAD SCI USA, V112, P8391, DOI 10.1073/pnas.1424980112; Rinchai D, 2012, EUR J IMMUNOL, V42, P3280, DOI 10.1002/eji.201242526; Ruckerl D, 2006, IMMUNOBIOLOGY, V211, P427, DOI 10.1016/j.imbio.2006.05.008; Santucci MB, 2003, INT IMMUNOPHARMACOL, V3, P1657, DOI 10.1016/S1567-5769(03)00202-9; Scicluna BP, 2012, CRIT CARE, V16, DOI 10.1186/cc11893; Shalova IN, 2015, IMMUNITY, V42, P484, DOI 10.1016/j.immuni.2015.02.001; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Shen H, 2008, J IMMUNOL, V181, P1849, DOI 10.4049/jimmunol.181.3.1849; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shin HJ, 2007, MOL CELLS, V24, P119; Shive CL, 2015, AIDS, V29, P1263, DOI 10.1097/QAD.0000000000000735; Shuto T, 2005, BIOCHEM BIOPH RES CO, V338, P1402, DOI 10.1016/j.bbrc.2005.10.102; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; West MA, 2008, J TRAUMA, V65, P893, DOI 10.1097/TA.0b013e3181877fde; Wheeler DS, 2008, SHOCK, V30, P267, DOI 10.1097/shk.0b013e318162c190; Wong HR, 2013, SHOCK, V40, P382, DOI 10.1097/SHK.0b013e3182a67632; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Wu XH, 2015, INT J IMMUNOPATH PH, V28, P351, DOI 10.1177/0394632015593228; Wynick C, 2016, J INTERF CYTOK RES, V36, P477, DOI 10.1089/jir.2015.0134; Xie CL, 2016, INT J MOL MED, V38, P148, DOI 10.3892/ijmm.2016.2583; Xiong YB, 2011, J LEUKOCYTE BIOL, V90, P1141, DOI 10.1189/jlb.0611273; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Zanoni I, 2017, IMMUNITY, V47, P697, DOI 10.1016/j.immuni.2017.09.010; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhang GL, 2000, J ENDOTOXIN RES, V6, P453, DOI 10.1179/096805100101532414; Ziegler-Heitbrock L, 2001, J ENDOTOXIN RES, V7, P219, DOI 10.1177/09680519010070030401; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; ZIEGLERHEITBROCK HWL, 1994, J BIOL CHEM, V269, P17001	93	13	14	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17631	17645		10.1074/jbc.RA118.003501	http://dx.doi.org/10.1074/jbc.RA118.003501			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30242126	Green Published, hybrid			2022-12-28	WOS:000449799000026
J	Nguyen, TT; Sabat, G; Sussman, MR				Nguyen, Thao T.; Sabat, Grzegorz; Sussman, Michael R.			In vivo cross-linking supports a head-to-tail mechanism for regulation of the plant plasma membrane P-type H+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						H plus -ATPase; protein cross-linking; mass spectrometry (MS); protein-protein interaction; Arabidopsis thaliana	SINGLE-POINT MUTATIONS; YEAST; PHOSPHORYLATION; DOMAIN; ACTIVATION; TRANSPORT; BINDING; ENZYME; REGION; PMA1P	In higher plants, a P-type proton-pumping ATPase generates the proton-motive force essential for the function of all other transporters and for proper growth and development. X-ray crystallographic studies of the plant plasma membrane proton pump have provided information on amino acids involved in ATP catalysis but provided no information on the structure of the C-terminal regulatory domain. Despite progress in elucidating enzymes involved in the signaling pathways that activate or inhibit this pump, the site of interaction of the C-terminal regulatory domain with the catalytic domains remains a mystery. Genetic studies have pointed to amino acids in various parts of the protein that may be involved, but direct chemical evidence for which ones are specifically interacting with the C terminus is lacking. In this study, we used in vivo cross-linking experiments with a photoreactive unnatural amino acid, p-benzoylphenylalanine, and tandem MS to obtain direct evidence that the C-terminal regulatory domain interacts with amino acids located within the N-terminal actuator domain. Our observations are consistent with a mechanism in which intermolecular, rather than intramolecular, interactions are involved. Our model invokes a head-to-tail organization of ATPase monomers in which the C-terminal domain of one ATPase molecule interacts with the actuator domain of another ATPase molecule. This model serves to explain why cross-linked peptides are found only in dimers and trimers, and it is consistent with prior studies suggesting that within the membrane the protein can be organized as homopolymers, including dimers, trimers, and hexamers.	[Nguyen, Thao T.; Sabat, Grzegorz; Sussman, Michael R.] Univ Wisconsin, Biotechnol Ctr, Madison, WI 53706 USA; [Nguyen, Thao T.; Sussman, Michael R.] Univ Wisconsin, Biochem Dept, Madison, WI 53706 USA; [Nguyen, Thao T.] Univ Wisconsin, Morgridge Fdn, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sussman, MR (corresponding author), Univ Wisconsin, Biotechnol Ctr, Madison, WI 53706 USA.; Sussman, MR (corresponding author), Univ Wisconsin, Biochem Dept, Madison, WI 53706 USA.	msussman@wisc.edu	Nguyen, Thao/T-5373-2019	Sabat, Grzegorz/0000-0001-7668-7767	National Science Foundation [MCB-1713899]; Basic Energy Sciences Grant from the Department of Energy [DEFG02-88ER13938]	National Science Foundation(National Science Foundation (NSF)); Basic Energy Sciences Grant from the Department of Energy(United States Department of Energy (DOE))	This work was supported in part by Basic Energy Sciences Grant DEFG02-88ER13938 (to M.R.S.) from the Department of Energy and by National Science Foundation Grant MCB-1713899 (to M.R.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Auer M, 1999, J MOL BIOL, V287, P961, DOI 10.1006/jmbi.1999.2652; Axelsen KB, 1999, BIOCHEMISTRY-US, V38, P7227, DOI 10.1021/bi982482l; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Baunsgaard L, 1996, PLANT J, V10, P451, DOI 10.1046/j.1365-313X.1996.10030451.x; BOWMAN BJ, 1985, J BIOL CHEM, V260, P8726; BRISKIN DP, 1985, PLANT PHYSIOL, V78, P642, DOI 10.1104/pp.78.3.642; CHADWICK CC, 1987, ARCH BIOCHEM BIOPHYS, V252, P348, DOI 10.1016/0003-9861(87)90041-5; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Chin JW, 2002, CHEMBIOCHEM, V3, P1135, DOI 10.1002/1439-7633(20021104)3:11<1135::AID-CBIC1135>3.0.CO;2-M; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; DUFOUR JP, 1980, EUR J BIOCHEM, V105, P145, DOI 10.1111/j.1432-1033.1980.tb04484.x; Fuglsang AT, 2007, PLANT CELL, V19, P1617, DOI 10.1105/tpc.105.035626; Fuglsang AT, 2003, J BIOL CHEM, V278, P42266, DOI 10.1074/jbc.M306707200; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; GOORMAGHTIGH E, 1986, J BIOL CHEM, V261, P7466; Haruta M, 2014, SCIENCE, V343, P408, DOI 10.1126/science.1244454; Iacobucci C, 2017, ANAL CHEM, V89, P7832, DOI 10.1021/acs.analchem.7b02316; Justesen BH, 2013, J BIOL CHEM, V288, P26419, DOI 10.1074/jbc.M112.446948; Kanczewska J, 2005, P NATL ACAD SCI USA, V102, P11675, DOI 10.1073/pnas.0504498102; Kinoshita T, 1999, EMBO J, V18, P5548, DOI 10.1093/emboj/18.20.5548; Krishnamurthy M, 2011, ACS CHEM BIOL, V6, P1321, DOI 10.1021/cb200308e; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lee MCS, 2002, J BIOL CHEM, V277, P22395, DOI 10.1074/jbc.M200450200; Merlot S, 2007, EMBO J, V26, P3216, DOI 10.1038/sj.emboj.7601750; Morsomme P, 1996, EMBO J, V15, P5513, DOI 10.1002/j.1460-2075.1996.tb00936.x; Morsomme P, 2000, BBA-BIOMEMBRANES, V1465, P1, DOI 10.1016/S0005-2736(00)00128-0; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; Niittylae T, 2007, MOL CELL PROTEOMICS, V6, P1711, DOI 10.1074/mcp.M700164-MCP200; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; PALMGREN MG, 1990, J BIOL CHEM, V265, P13423; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Pettelkau J, 2013, J AM SOC MASS SPECTR, V24, P1969, DOI 10.1007/s13361-013-0734-6; Piette AS, 2011, J BIOL CHEM, V286, P18474, DOI 10.1074/jbc.M110.211953; Portillo F, 1997, FEBS LETT, V402, P136, DOI 10.1016/S0014-5793(96)01515-3; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; Speth C, 2010, EUR J CELL BIOL, V89, P145, DOI 10.1016/j.ejcb.2009.10.015; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145	42	11	12	4	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17095	17106		10.1074/jbc.RA118.003528	http://dx.doi.org/10.1074/jbc.RA118.003528			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30217814	Green Published, hybrid			2022-12-28	WOS:000449466500012
J	Orta, G; de la Vega-Beltran, JL; Martin-Hidalgo, D; Santi, CM; Visconti, PE; Darszon, A				Orta, Gerardo; de la Vega-Beltran, Jose Luis; Martin-Hidalgo, David; Santi, Celia M.; Visconti, Pablo E.; Darszon, Alberto			CatSper channels are regulated by protein kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sperm; AMP; protein kinase A (PKA); calcium channel; calcium imaging; electrophysiology; capacitation; CatSper cation channel; male fertility; reproductive biology; sperm motility; cAMP; calcium	SOLUBLE ADENYLYL-CYCLASE; NUCLEOTIDE-GATED CHANNELS; MOUSE SPERM CAPACITATION; CA2+ ENTRY; TYROSINE PHOSPHORYLATION; MALE-FERTILITY; CALCIUM; SPERMATOZOA; PROGESTERONE; MOTILITY	Mammalian sperm must undergo capacitation as a preparation for entering into hyperactivated motility, undergoing the acrosome reaction, and acquiring fertilizing ability. One of the initial capacitation events occurs when sperm encounter an elevated HCO3- concentration. This anion activates the atypical adenylyl cyclase Adcy10, increases intracellular cAMP, and stimulates protein kinase A (PKA). Moreover, an increase in intracellular Ca2+ concentration ([Ca2+](i)) is essential for sperm capacitation. Although a cross-talk between cAMP-dependent pathways and Ca2+ clearly plays an essential role in sperm capacitation, the connection between these signaling events is incompletely understood. Here, using three different approaches, we found that CatSper, the main sperm Ca2+ channel characterized to date, is up-regulated by a cAMP-dependent activation of PKA in mouse sperm. First, HCO3- and the PKA-activating permeable compound 8-Br-cAMP induced an increase in [Ca2+](i), which was blocked by the PKA peptide inhibitor PKI, and H89, another PKA inhibitor, also abrogated the 8-Br-cAMP response. Second, HCO3- increased the membrane depolarization induced upon divalent cation removal by promoting influx of monovalent cations through CatSper channels, which was inhibited by PKI, H89, and the CatSper blocker HC-056456. Third, electrophysiological patch clamp, whole-cell recordings revealed that CatSper activity is up-regulated by HCO3- and by direct cAMP injection through the patch-clamp pipette. The activation by HCO3- and cAMP was also blocked by PKI, H89, Rp-cAMPS, and HC-056456, and electrophysiological recordings in sperm from CatSper-KO mice confirmed CatSper's role in these activation modes. Our results strongly suggest that PKA-dependent phosphorylation regulates [Ca2+](i) homeostasis by activating CatSper channel complexes.	[Darszon, Alberto] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62250, Morelos, Mexico; [Martin-Hidalgo, David; Visconti, Pablo E.] Univ Massachusetts, Dept Vet & Anim Sci, Integrated Sci Bldg, Amherst, MA 01003 USA; [Santi, Celia M.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Santi, Celia M.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA	Universidad Nacional Autonoma de Mexico; University of Massachusetts System; University of Massachusetts Amherst; Washington University (WUSTL); Washington University (WUSTL)	Darszon, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62250, Morelos, Mexico.; Visconti, PE (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Integrated Sci Bldg, Amherst, MA 01003 USA.	pvisconti@vasci.umass.edu; darszon@ibt.unam.mx	Hidalgo, David Martín/I-2840-2015; Hidalgo, David Martín/N-4005-2019	Hidalgo, David Martín/0000-0002-6787-0006; Hidalgo, David Martín/0000-0002-6787-0006; Darszon, Alberto/0000-0002-2502-0505	Eunice Kennedy Shriver NICHD, National Institutes of Health [RO1 HD38082]; Consejo Nacional de Ciencia y Tecnologia from Mexico (CONACyT) [Fronteras 71 39908-Q, CB 2015/255914]; Direccion General de Asuntos del Personal Academico of the Universidad Nacional Autonoma de Mexico (DGAPA-UNAM) [IN205516]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038082] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Consejo Nacional de Ciencia y Tecnologia from Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico of the Universidad Nacional Autonoma de Mexico (DGAPA-UNAM); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by Eunice Kennedy Shriver NICHD, National Institutes of Health Grant RO1 HD38082 (to P. E. V), by Consejo Nacional de Ciencia y Tecnologia Grants Fronteras 71 39908-Q and CB 2015/255914 from Mexico (CONACyT) (to A. D.), and by Direccion General de Asuntos del Personal Academico of the Universidad Nacional Autonoma de Mexico (DGAPA-UNAM) Grants IN205516 (to A. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; BELL D, 1994, J MOL CELL CARDIOL, V26, P1439, DOI 10.1006/jmcc.1994.1163; Bhoumik A, 2014, CELL BIOCHEM BIOPHYS, V70, P1177, DOI 10.1007/s12013-014-0038-x; Brenker C, 2012, EMBO J, V31, P1654, DOI 10.1038/emboj.2012.30; Burton KA, 2007, PHYSIOLOGY, V22, P40, DOI 10.1152/physiol.00034.2006; Calinescu O, 2015, BIOL CHEM, V396, P1091, DOI 10.1515/hsz-2014-0278; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Carlson AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006844; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chung JJ, 2017, ELIFE, V6, DOI [10.7554/eLife.23082, 10.7547/elife.23082.001]; Chung JJ, 2014, CELL, V157, P808, DOI 10.1016/j.cell.2014.02.056; Cisneros-Mejorado A, 2014, ANDROLOGY-US, V2, P145, DOI 10.1111/j.2047-2927.2013.00169.x; Cisneros-Mejorado A, 2012, FEBS LETT, V586, P149, DOI 10.1016/j.febslet.2011.12.006; Cohen R, 2014, DEV CELL, V28, P310, DOI 10.1016/j.devcel.2014.01.005; Darszon A, 2012, CELL TISSUE RES, V349, P749, DOI 10.1007/s00441-012-1397-5; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; Ernesto JI, 2015, J CELL BIOL, V210, P1213, DOI 10.1083/jcb.201412041; ESPINOSA F, 1995, FEBS LETT, V372, P119, DOI 10.1016/0014-5793(95)00962-9; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; FRASER LR, 1987, J REPROD FERTIL, V81, P77, DOI 10.1530/jrf.0.0810077; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Jansen V, 2015, ELIFE, V4, DOI 10.7554/eLife.05161; Kilic F, 2009, J AM CHEM SOC, V131, P4027, DOI 10.1021/ja808334f; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Liao ZD, 2011, CHANNELS, V5, P115, DOI 10.4161/chan.5.2.14195; Lishko PV, 2012, ANNU REV PHYSIOL, V74, P453, DOI 10.1146/annurev-physiol-020911-153258; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Lishko PV, 2010, J PHYSIOL-LONDON, V588, P4667, DOI 10.1113/jphysiol.2010.194142; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; Mannowetz N, 2017, P NATL ACAD SCI USA, V114, P5743, DOI 10.1073/pnas.1700367114; Navarrete FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33589; Navarrete FA, 2015, J CELL PHYSIOL, V230, P1758, DOI 10.1002/jcp.24873; Navarro B, 2011, P NATL ACAD SCI USA, V108, P14342, DOI 10.1073/pnas.1111695108; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; ROTHERMEL JD, 1984, J BIOL CHEM, V259, P5294; Smith JF, 2013, P NATL ACAD SCI USA, V110, P6823, DOI 10.1073/pnas.1216588110; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; Suarez SS, 2008, INT J DEV BIOL, V52, P455, DOI 10.1387/ijdb.072527ss; Sun XH, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0281-2; Tateno H, 2013, P NATL ACAD SCI USA, V110, P18543, DOI 10.1073/pnas.1317113110; Torres-Flores V, 2011, HUM REPROD, V26, P2626, DOI 10.1093/humrep/der237; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wang D, 2007, P NATL ACAD SCI USA, V104, P9325, DOI 10.1073/pnas.0611296104; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0; Wiesner B, 1998, J CELL BIOL, V142, P473, DOI 10.1083/jcb.142.2.473; Xia JS, 2007, BIOL REPROD, V77, P551, DOI 10.1095/biolreprod.107.061358; Xia JS, 2009, BIOL REPROD, V80, P1092, DOI 10.1095/biolreprod.108.074039; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044	52	42	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16830	16841		10.1074/jbc.RA117.001566	http://dx.doi.org/10.1074/jbc.RA117.001566			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30213858	Green Published, hybrid			2022-12-28	WOS:000448515100023
J	Shares, BH; Busch, M; White, N; Shum, L; Eliseev, RA				Shares, Brianna H.; Busch, Melanie; White, Noelle; Shum, Laura; Eliseev, Roman A.			Active mitochondria support osteogenic differentiation by stimulating beta-catenin acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta-catenin; mitochondria; acetylation; mesenchymal stem cells (MSCs); osteoblast; osteogenesis; bone marrow mesenchymal stem cells; acetylation	MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTORS; REGENERATION; PROGENITORS; ROLES	Bone marrow stromal (a.k.a. mesenchymal stem) cells (BMSCs) can differentiate into osteoblasts (OBs), adipocytes, or chondrocytes. As BMSCs undergo OB differentiation, they up-regulate mitochondrial oxidative phosphorylation (OxPhos). Here, we investigated the mechanism(s) connecting mitochondrial OxPhos to OB differentiation. First, we found that treating BMSC-like C3H10T1/2 cells with an OxPhos inhibitor reduces their osteogenic potential. Interestingly, ATP levels were not reduced, as glycolysis compensated for the decreased OxPhos. Thus, mitochondria support OB differentiation not only by supplying ATP, but also by other mechanisms. To uncover these mechanisms, we stimulated OxPhos in C3H10T1/2 cells by replacing media glucose with galactose and observed that this substitution increases both OxPhos and osteogenesis even in the absence of osteoinducers. beta-Catenin, an important signaling pathway in osteogenesis, was found to be responsive to OxPhos stimulation. beta-Catenin activity is maintained by acetylation, and mitochondria generate the acetyl donor acetyl-CoA, which upon entering the Krebs cycle is converted to citrate capable of exiting mitochondria. Cytosolic citrate is converted back to acetyl-CoA by ATP citrate lyase (ACLY). We found that inhibiting ACLY with SB204990 (SB) reverses the galactose-induced beta-catenin activity and OB differentiation. This suggested that acetylation is involved in beta-catenin activation after forced OxPhos stimulation, and using immunoprecipitation, we indeed detected SB-sensitive beta-catenin acetylation. Both beta-catenin acetylation and activity increased during osteoinduction coincident with OxPhos activation. These findings suggest that active mitochondria support OB differentiation by promoting beta-catenin acetylation and thus activity.	[Shares, Brianna H.; Busch, Melanie; White, Noelle; Shum, Laura; Eliseev, Roman A.] Univ Rochester, Ctr Musculoskeletal Res, Rochester, NY 14624 USA	University of Rochester	Eliseev, RA (corresponding author), Univ Rochester, Ctr Musculoskeletal Res, Rochester, NY 14624 USA.	roman_eliseev@urmc.rochester.edu		Shum, Laura/0000-0002-0167-4133	University of Rochester Department of Orthopedics; National Institutes of Health through NIAMS [K01 AR064610, R01 AR072601]; National Center for Advancing Translational Sciences (NCATS) [UL1 TR000042]; NCATS [TL1-TR000096]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000096, UL1TR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR072601, K01AR064610] Funding Source: NIH RePORTER	University of Rochester Department of Orthopedics; National Institutes of Health through NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the University of Rochester Department of Orthopedics as well as the National Institutes of Health through NIAMS Grants K01 AR064610 and R01 AR072601 and National Center for Advancing Translational Sciences (NCATS) Grant UL1 TR000042) (to R.A.E.) and NCATS Grant TL1-TR000096 (to L.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker N, 2015, BONE, V70, P37, DOI 10.1016/j.bone.2014.10.014; Bianco P, 2015, DEVELOPMENT, V142, P1023, DOI 10.1242/dev.102210; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Cherry C, 2016, TRENDS MOL MED, V22, P391, DOI 10.1016/j.molmed.2016.03.009; Chocarro-Calvo A, 2013, MOL CELL, V49, P474, DOI 10.1016/j.molcel.2012.11.022; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Esen E, 2013, CELL METAB, V17, P745, DOI 10.1016/j.cmet.2013.03.017; Forni MF, 2016, STEM CELLS, V34, P743, DOI 10.1002/stem.2248; Gao CX, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-13; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Jing H, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0231-0; Kadam Prashant, 2010, Int J Ayurveda Res, V1, P55, DOI 10.4103/0974-7788.59946; Karner CM, 2018, BONE, V115, P2, DOI 10.1016/j.bone.2017.08.008; Karner CM, 2016, J BIOL CHEM, V291, P13028, DOI 10.1074/jbc.M115.708578; Lecka-Czernik B, 2015, J BONE MINER RES, V30, P1356, DOI 10.1002/jbmr.2574; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Loeffler J, 2018, TRENDS ENDOCRIN MET, V29, P99, DOI 10.1016/j.tem.2017.11.008; Lu JL, 2016, ONCOTARGET, V7, P37471, DOI 10.18632/oncotarget.9650; Majidinia M, 2018, J CELL PHYSIOL, V233, P2937, DOI 10.1002/jcp.26042; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Pearce NJ, 1998, BIOCHEM J, V334, P113, DOI 10.1042/bj3340113; Pietila M, 2010, TISSUE ENG PART C-ME, V16, P435, DOI 10.1089/ten.tec.2009.0247; Raouf A, 2000, ONCOGENE, V19, P6455, DOI 10.1038/sj.onc.1204037; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sandhir R, 2017, BBA-MOL BASIS DIS, V1863, P1090, DOI 10.1016/j.bbadis.2016.10.020; Shum LC, 2016, STEM CELLS DEV, V25, P114, DOI 10.1089/scd.2015.0193; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Valenti MT, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010041; Wan C, 2010, ANN NY ACAD SCI, V1192, P322, DOI 10.1111/j.1749-6632.2009.05238.x; Warburg O., 1925, J CANCER RES CLIN, V9, P148, DOI [10.1158/jcr.1925.148, DOI 10.1158/JCR.1925.148]; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928	32	71	74	4	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16019	16027		10.1074/jbc.RA118.004102	http://dx.doi.org/10.1074/jbc.RA118.004102			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30150300	hybrid, Green Published			2022-12-28	WOS:000447256000022
J	Salgado-Polo, F; Fish, A; Matsoukas, MT; Heidebrecht, T; Keune, WJ; Perrakis, A				Salgado-Polo, Fernando; Fish, Alex; Matsoukas, Minos-Timotheos; Heidebrecht, Tatjana; Keune, Willem-Jan; Perrakis, Anastassis			Lysophosphatidic acid produced by autotaxin acts as an allosteric modulator of its catalytic efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; lysophospholipid; phosphodiesterases; enzyme kinetics; molecular dynamics; ATX; ENPP2; LPA; allostery; phospholipase; phospholipid turnover; autotaxin	LYSOPHOSPHOLIPASE-D; SPHINGOSINE 1-PHOSPHATE; STRUCTURAL BASIS; KINETIC-DATA; BINDING; INHIBITORS; PHOSPHODIESTERASE; DISCOVERY; SUBSTRATE; ACTIVATION	Autotaxin (ATX) is a secreted glycoprotein and the only member of the ectonucleotide pyrophosphatase/phosphodiesterase family that converts lysophosphatidylcholine (LPC) into lysophosphatidic acid (LPA). LPA controls key responses, such as cell migration, proliferation, and survival, implicating ATX-LPA signaling in various (patho)physiological processes and establishing it as a drug target. ATX structural and functional studies have revealed an orthosteric and an allosteric site, called the pocket and the tunnel, respectively. However, the mechanisms in allosteric modulation of ATX's activity as a lysophospholipase D are unclear. Here, using the physiological LPC substrate, a new fluorescent substrate, and diverse ATX inhibitors, we revisited the kinetics and allosteric regulation of the ATX catalytic cycle, dissecting the different steps and pathways leading to LPC hydrolysis. We found that ATX activity is stimulated by LPA and that LPA activates ATX lysophospholipase D activity by binding to the ATX tunnel. A consolidation of all experimental kinetics data yielded a comprehensive catalytic model supported by molecular modeling simulations and suggested a positive feedback mechanism that is regulated by the abundance of the LPA products activating hydrolysis of different LPC species. Our results complement and extend the current understanding of ATX hydrolysis in light of the allosteric regulation by ATX-produced LPA species and have implications for the design and application of both orthosteric and allosteric ATX inhibitors.	[Salgado-Polo, Fernando; Fish, Alex; Matsoukas, Minos-Timotheos; Heidebrecht, Tatjana; Keune, Willem-Jan; Perrakis, Anastassis] Netherlands Canc Inst, Dept Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Matsoukas, Minos-Timotheos] Univ Patras, Dept Pharm, Patras 26504, Greece	Netherlands Cancer Institute; University of Patras	Perrakis, A (corresponding author), Netherlands Canc Inst, Dept Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	a.perrakis@nki.nl	Matsoukas, Minos-Timotheos/B-8746-2012; Perrakis, Anastassis/E-8704-2013	Matsoukas, Minos-Timotheos/0000-0002-4642-8163; Perrakis, Anastassis/0000-0002-1151-6227; Salgado-Polo, Fernando/0000-0001-8362-5281	NWO-TOP Grant [700.10.354]	NWO-TOP Grant	The early part of this work was supported by NWO-TOP Grant 700.10.354 (to A. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Albers HMHG, 2012, CHEM REV, V112, P2593, DOI 10.1021/cr2003213; Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107; Barbayianni E, 2015, PROG LIPID RES, V58, P76, DOI 10.1016/j.plipres.2015.02.001; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Benesch MGK, 2015, J LIPID RES, V56, P1134, DOI 10.1194/jlr.M057661; Bollen M, 2000, CRIT REV BIOCHEM MOL, V35, P393, DOI 10.1080/10409230091169249; Cavalli S, 2010, CHEMBIOCHEM, V11, P2311, DOI 10.1002/cbic.201000349; Desroy N, 2017, J MED CHEM, V60, P3580, DOI 10.1021/acs.jmedchem.7b00032; Ferguson CG, 2006, ORG LETT, V8, P2023, DOI 10.1021/ol060414i; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Gierse J, 2010, J PHARMACOL EXP THER, V334, P310, DOI 10.1124/jpet.110.165845; Hausmann J, 2016, J STRUCT BIOL, V195, P199, DOI 10.1016/j.jsb.2016.06.002; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Hausmann J, 2010, ACTA CRYSTALLOGR F, V66, P1130, DOI 10.1107/S1744309110032938; Houben AJS, 2013, J BIOL CHEM, V288, P510, DOI 10.1074/jbc.M112.358416; IMAMURA S, 1978, J BIOCHEM-TOKYO, V83, P677, DOI 10.1093/oxfordjournals.jbchem.a131960; Jansen S, 2005, J CELL SCI, V118, P3081, DOI 10.1242/jcs.02438; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Joncour A, 2017, J MED CHEM, V60, P7371, DOI 10.1021/acs.jmedchem.7b00647; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Kato K, 2016, NAT STRUCT MOL BIOL, V23, P395, DOI 10.1038/nsmb.3200; Keune WJ, 2017, J MED CHEM, V60, P2006, DOI 10.1021/acs.jmedchem.6b01743; Keune WJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11248; Koike S, 2006, GENES CELLS, V11, P133, DOI 10.1111/j.1365-2443.2006.00924.x; Kremer AE, 2010, GASTROENTEROLOGY, V139, P1008, DOI 10.1053/j.gastro.2010.05.009; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lynch K. R., 2013, Patent No. [US8,378,100, 8378100]; Moolenaar WH, 2011, NAT REV MOL CELL BIO, V12, P674, DOI 10.1038/nrm3188; MUNDER PG, 1979, SPRINGER SEMIN IMMUN, V2, P187, DOI 10.1007/BF01891668; Nikitopoulou I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070941; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Perrakis A, 2014, J LIPID RES, V55, P1010, DOI 10.1194/jlr.R046391; Saunders LP, 2011, J BIOL CHEM, V286, P30130, DOI 10.1074/jbc.M111.246884; Shah P, 2016, BIOORG MED CHEM LETT, V26, P5403, DOI 10.1016/j.bmcl.2016.10.036; Stein AJ, 2015, MOL PHARMACOL, V88, P982, DOI 10.1124/mol.115.100404; Takakusa H, 2002, J AM CHEM SOC, V124, P1653, DOI 10.1021/ja011251q; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; van Meeteren LA, 2005, J BIOL CHEM, V280, P21155, DOI 10.1074/jbc.M413183200; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Wu T, 2014, FASEB J, V28, P861, DOI 10.1096/fj.13-232868	43	22	22	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14312	14327		10.1074/jbc.RA118.004450	http://dx.doi.org/10.1074/jbc.RA118.004450			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30026231	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000444671500013
J	Kriegel, AJ; Terhune, SS; Greene, AS; Noon, KR; Pereckas, MS; Liang, MY				Kriegel, Alison J.; Terhune, Scott S.; Greene, Andrew S.; Noon, Kathleen R.; Pereckas, Michael S.; Liang, Mingyu			Isomer-specific effect of microRNA miR-29b on nuclear morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); microRNA mechanism; proteomics; mitosis; nuclear organization; ADP; ATP translocase 2; nuclei; ribonucleoprotein	PROTEIN COMPLEX; MESSENGER-RNAS; CELLS; TRANSLATION; FIBROSIS; LEUKEMIA; REVEALS; MIR-382	Targeting mRNAs via seed region pairing is the canonical mechanism by which microRNAs (miRNAs) regulate cellular functions and disease processes. Emerging evidence suggests miRNAs might also act through other mechanisms. miRNA isomers that contain identical seed region sequences, such as miR-29a and miR-29b, provide naturally occurring, informative models for identifying those miRNA effects that are independent of seed region pairing. miR-29a and miR-29b are both expressed in HeLa cells, and miR-29b has been reported to localize to the nucleus in early mitosis because of unique nucleotide sequences on its 3 end. Here, we sought to better understand the mechanism of miR-29b nuclear localization and its function in cell division. We hypothesized that its nuclear localization may be facilitated by protein-miRNA interactions unique to miR-29b. Specific blockade of miR-29b resulted in striking nuclear irregularities not observed following miR-29a blockade. We also observed that miR-29b, but not miR-29a, is enriched in the nucleus and perinuclear clusters during mitosis. Targeted proteomic analysis of affinity-purified samples identified several proteins interacting with synthetic oligonucleotides mimicking miR-29b, but these proteins did not interact with miR-29a. One of these proteins, ADP/ATP translocase 2 (ANT2), known to be involved in mitotic spindle formation, colocalized with miR-29b in perinuclear clusters independently of Argonaute 2. Of note, ANT2 knockdown resulted in nuclear irregularities similar to those observed following miR-29b blockade and prevented nuclear uptake of endogenous miR-29b. Our findings reveal that miR-29 regulates nuclear morphology during mitosis and that this critical function is unique to the miR-29b isoform.	[Kriegel, Alison J.; Greene, Andrew S.; Liang, Mingyu] Med Coll Wisconsin, Dept Physiol, Ctr Syst Mol Med, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Terhune, Scott S.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Terhune, Scott S.; Greene, Andrew S.; Noon, Kathleen R.; Pereckas, Michael S.] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Kriegel, AJ; Liang, MY (corresponding author), Med Coll Wisconsin, Dept Physiol, Ctr Syst Mol Med, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	akriegel@mcw.edu; mliang@mcw.edu	Liang, Mingyu/A-2331-2008; Greene, Andrew S/B-9696-2015	Greene, Andrew/0000-0002-3191-2112	National Institutes of Health [HL111580, HL082798, HL121233, HL125409, HL128332]; Biotechnology and Bioengineering Center at Medical College of Wisconsin; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121233, R01HL128332, R01HL125409, P01HL082798, R21HL111580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Bioengineering Center at Medical College of Wisconsin; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL111580 (to M. L. and A. J. K.); HL082798, HL121233, and HL125409 (to M. L.); and HL128332 (to A. J. K.) and by a grant from the Biotechnology and Bioengineering Center at Medical College of Wisconsin (to M. L. and A. J. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cristea IM, 2006, J BIOL CHEM, V281, P30269, DOI 10.1074/jbc.M603980200; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fukuda R, 2005, P NATL ACAD SCI USA, V102, P15213, DOI 10.1073/pnas.0507184102; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Guo YE, 2014, RNA, V20, P985, DOI 10.1261/rna.045054.114; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hinchcliffe EH, 2014, INT REV CEL MOL BIO, V313, P179, DOI 10.1016/B978-0-12-800177-6.00006-2; Huang J, 1996, CANCER LETT, V106, P29, DOI 10.1016/0304-3835(96)04293-0; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Ito S, 2010, MOL CELL, V39, P632, DOI 10.1016/j.molcel.2010.07.029; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P237, DOI 10.1152/physiolgenomics.00141.2011; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P259, DOI 10.1152/physiolgenomics.00173.2011; Kriegel AJ, 2010, NUCLEIC ACIDS RES, V38, P8338, DOI 10.1093/nar/gkq718; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Liu Y, 2010, HYPERTENSION, V55, P974, DOI 10.1161/HYPERTENSIONAHA.109.144428; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Moorman NJ, 2008, CELL HOST MICROBE, V3, P253, DOI 10.1016/j.chom.2008.03.002; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Orom UA, 2007, METHODS, V43, P162, DOI 10.1016/j.ymeth.2007.04.007; PEARSON EC, 1986, J CLIN PATHOL, V39, P99, DOI 10.1136/jcp.39.1.99; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Weber A, 2010, CELL ONCOL, V32, P121, DOI 10.3233/CLO-2009-0509	27	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14080	14088		10.1074/jbc.RA117.001705	http://dx.doi.org/10.1074/jbc.RA117.001705			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30006350	Green Published, hybrid			2022-12-28	WOS:000444070700029
J	Elnatan, D; Agard, DA				Elnatan, Daniel; Agard, David A.			Calcium binding to a remote site can replace magnesium as cofactor for mitochondrial Hsp90 (TRAP1) ATPase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; heat shock protein 90 (Hsp90); mitochondria; calcium-binding protein; ATPase; ATP hydrolysis; magnesium cofactor; TNF receptor-associated protein 1	PERMEABILITY TRANSITION PORE; MOLECULAR CHAPERONE HSP90; IN-VIVO; CYCLE; HYDROLYSIS; PHOSPHORYLATION; RESPIRATION	The Hsp90 molecular chaperones are ATP-dependent enzymes that maintain protein homeostasis and regulate many essential cellular processes. Higher eukaryotes have organelle-specific Hsp90 paralogs that are adapted to each subcellular environment. The mitochondrial Hsp90, TNF receptor-associated protein 1 (TRAP1), supports the folding and activity of electron transport components and is increasingly appreciated as a critical player in mitochondrial signaling. Calcium plays a well-known and important regulatory role in mitochondria where it can accumulate to much higher concentrations than in the cytoplasm. Surprisingly, we found here that calcium can replace magnesium, the essential enzymatic cofactor, to support TRAP1 ATPase activity. Anomalous X-ray diffraction experiments revealed a calcium-binding site within the TRAP1 nucleotide-binding pocket located near the ATP -phosphate and completely distinct from the magnesium-binding site adjacent to the - and -phosphates. In the presence of magnesium, ATP hydrolysis by TRAP1, as with other Hsp90s, was noncooperative, whereas calcium binding resulted in cooperative hydrolysis by the two protomers within the Hsp90 dimer. The structural data suggested a mechanism for this cooperative behavior. Because of the cooperativity, at high ATP concentrations, ATPase activity was higher with calcium, whereas the converse was observed at low ATP concentrations. Integrating these observations, we propose a model in which the divalent cation choice can control switching between noncooperative and cooperative TRAP1 ATPase mechanisms in response to varying ATP concentrations. This switching may facilitate coordination between cellular energetics, mitochondrial signaling, and protein homeostasis via alterations in the TRAP1 ATP-driven cycle and its consequent effects on different mitochondrial clients.	[Agard, David A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Agard, DA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	agard@msg.ucsf.edu		Elnatan, Daniel/0000-0002-8359-0522	National Institutes of Health Protein Structure Initiative-Biology Grant [U01 GM098254]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM098254, T32GM007810] Funding Source: NIH RePORTER	National Institutes of Health Protein Structure Initiative-Biology Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Protein Structure Initiative-Biology Grant U01 GM098254 and the Howard Hughes Medical Institute. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Butler EK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002488; Chae YC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3139; Choe H, 2002, J MOL BIOL, V324, P691, DOI 10.1016/S0022-2836(02)01131-2; Costa AC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.205; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Elnatan D, 2017, ELIFE, V6, DOI 10.7554/eLife.25235; Frey S, 2007, J BIOL CHEM, V282, P35612, DOI 10.1074/jbc.M704647200; Gout E, 2014, P NATL ACAD SCI USA, V111, pE4560, DOI 10.1073/pnas.1406251111; Hearnshaw SJ, 2015, ACTA CRYSTALLOGR D, V71, P996, DOI 10.1107/S1399004715002916; Hirshberg M, 1998, BIOCHEMISTRY-US, V37, P10381, DOI 10.1021/bi980428z; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Lavery LA, 2014, MOL CELL, V53, P330, DOI 10.1016/j.molcel.2013.12.023; Leskovar A, 2008, J BIOL CHEM, V283, P11677, DOI 10.1074/jbc.M709516200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Partridge JR, 2014, ELIFE, V3, DOI 10.7554/eLife.03487; Rasola A, 2014, TRENDS CELL BIOL, V24, P455, DOI 10.1016/j.tcb.2014.03.005; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Soroka J, 2012, MOL CELL, V45, P517, DOI 10.1016/j.molcel.2011.12.031; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Sung N, 2016, P NATL ACAD SCI USA, V113, P2952, DOI 10.1073/pnas.1516167113; Thorn A, 2011, J APPL CRYSTALLOGR, V44, P1285, DOI [10.1107/S00218898110417681285, 10.1107/S0021889811041768]; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolf SG, 2017, ELIFE, V6, DOI 10.7554/eLife.29929; Xiang F, 2010, FEBS J, V277, P1929, DOI 10.1111/j.1742-4658.2010.07615.x; Yoshida S, 2013, P NATL ACAD SCI USA, V110, pE1604, DOI 10.1073/pnas.1220659110; Zhao RM, 2005, BIOCHEM CELL BIOL, V83, P703, DOI 10.1139/O05-158	33	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13717	13724		10.1074/jbc.RA118.003562	http://dx.doi.org/10.1074/jbc.RA118.003562			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29991590	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000443375500030
J	Amin, MA; McKenney, RJ; Varma, D				Amin, Mohammed A.; McKenney, Richard J.; Varma, Dileep			Antagonism between the dynein and Ndc80 complexes at kinetochores controls the stability of kinetochoremicrotubule attachments during mitosis. (vol 293, pg 5755, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Amin MA, 2018, J BIOL CHEM, V293, P5755, DOI 10.1074/jbc.RA117.001699	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10825	10825		10.1074/jbc.AAC118.004421	http://dx.doi.org/10.1074/jbc.AAC118.004421			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29980652	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000437828400035
J	Fernandez-Zapata, J; Perez-Castano, R; Aranda, J; Colizzi, F; Polanco, MC; Orozco, M; Padmanabhan, S; Elias-Arnanz, M				Fernandez-Zapata, Jesus; Perez-Castano, Ricardo; Aranda, Juan; Colizzi, Francesco; Carmen Polanco, Maria; Orozco, Modesto; Padmanabhan, S.; Elias-Arnanz, Montserrat			Plasticity in oligomerization, operator architecture, and DNA binding in the mode of action of a bacterial B-12-based photoreceptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenosylcobalamin (AdoCbl); photoreceptor; protein-DNA interaction; bacterial signal transduction; bacterial transcription; oxidative stress; Bacillus megaterium; CarH; light sensor; photoregulation; Spx	CRYSTAL-STRUCTURE; STRUCTURAL MECHANISM; MYXOCOCCUS-XANTHUS; OXIDATIVE-STRESS; GENE-REGULATION; PROTEIN; FAMILY; INACTIVATION; PARAMETERS; EXPRESSION	Newly discovered bacterial photoreceptors called CarH sense light by using 5-deoxyadenosylcobalamin (AdoCbl). They repress their own expression and that of genes for carotenoid synthesis by binding in the dark to operator DNA as AdoCbl-bound tetramers, whose light-induced disassembly relieves repression. High-resolution structures of Thermus thermophilus CarH(Tt) have provided snapshots of the dark and light states and have revealed a unique DNA-binding mode whereby only three of four DNA-binding domains contact an operator comprising three tandem direct repeats. To gain further insights into CarH photoreceptors and employing biochemical, spectroscopic, mutational, and computational analyses, here we investigated CarH(Bm) from Bacillus megaterium. We found that apoCarH(Bm), unlike monomeric apoCarH(Tt), is an oligomeric molten globule that forms DNA-binding tetramers in the dark only upon AdoCbl binding, which requires a conserved W-X-9-EH motif. Light relieved DNA binding by disrupting CarH(Bm) tetramers to dimers, rather than to monomers as with CarH(Tt). CarH(Bm) operators resembled that of CarH(Tt), but were larger by one repeat and overlapped with the -35 or -10 promoter elements. This design persisted in a six-repeat, multipartite operator we discovered upstream of a gene encoding an Spx global redox-response regulator whose photoregulated expression links photooxidative and general redox responses in B. megaterium. Interestingly, CarH(Bm) recognized the smaller CarH(Tt) operator, revealing an adaptability possibly related to the linker bridging the DNA- and AdoCbl-binding domains. Our findings highlight a remarkable plasticity in the mode of action of B-12-based CarH photoreceptors, important for their biological functions and development as optogenetic tools.	[Fernandez-Zapata, Jesus; Padmanabhan, S.] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain; [Perez-Castano, Ricardo; Carmen Polanco, Maria; Elias-Arnanz, Montserrat] Univ Murcia, Dept Genet & Microbiol, CSIC,Fac Biol, Unidad Asociada,Inst Quim Fis Rocasolano,Area Gen, E-30100 Murcia, Spain; [Aranda, Juan; Colizzi, Francesco; Orozco, Modesto] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Aranda, Juan; Colizzi, Francesco; Orozco, Modesto] Joint BSC IRB Res Program Computat Biol, Baldiri Reixac 10-12, Barcelona 08028, Spain; [Orozco, Modesto] Univ Barcelona, Dept Biochem & Biomed, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Murcia; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona	Padmanabhan, S (corresponding author), CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain.; Elias-Arnanz, M (corresponding author), Univ Murcia, Dept Genet & Microbiol, CSIC,Fac Biol, Unidad Asociada,Inst Quim Fis Rocasolano,Area Gen, E-30100 Murcia, Spain.	padhu@iqfr.csic.es; melias@um.es	Padmanabhan, S./E-8943-2017; Moratalla, Juan Aranda/A-6888-2016; Moratalla, Juan Aranda/G-3376-2017; Elias-Arnanz, Montserrat/H-4707-2015; Polanco, Maria Carmen/H-5571-2015	Moratalla, Juan Aranda/0000-0001-9385-4651; Moratalla, Juan Aranda/0000-0001-9385-4651; Padmanabhan, S./0000-0002-8772-0152; Elias-Arnanz, Montserrat/0000-0003-1980-3092; Perez-Castano, Ricardo/0000-0003-3220-4297; Fernandez-Zapata, Jesus/0000-0002-7686-5591; Polanco, Maria Carmen/0000-0002-5968-5791; Orozco Lopez, Modesto/0000-0002-8608-3278; Colizzi, Francesco/0000-0001-5601-1452	Ministerio de Economia y Competitividad-Spain - European Union Fondo Europeo de Desarrollo Regional (FEDER) funds [BFU2015-67968-C2-1-P, BFU2015-67968-C2-2-P, BIO2015-64802-R]; Juan de la Cierva; European Research Council grant ERC SimDNA; European Union Marie Curie fellowship; Fundacion Seneca-Spain [19429/PI/14]	Ministerio de Economia y Competitividad-Spain - European Union Fondo Europeo de Desarrollo Regional (FEDER) funds; Juan de la Cierva(Instituto de Salud Carlos III); European Research Council grant ERC SimDNA(European Research Council (ERC)); European Union Marie Curie fellowship(European Commission); Fundacion Seneca-Spain(Fundacion Seneca)	This work was supported by Ministerio de Economia y Competitividad-Spain Grants BFU2015-67968-C2-1-P co-financed with the European Union Fondo Europeo de Desarrollo Regional (FEDER) funds (to M. E.-A.), BFU2015-67968-C2-2-P (to S. P.), and BIO2015-64802-R (to M. O.), and Ph.D. fellowships (to J. F.-Z and R. P.-C.), a Juan de la Cierva contract (to J. A.), the European Research Council grant ERC SimDNA (to M. O.), a European Union Marie Curie fellowship (to F. C.), and Fundacion Seneca-Spain Grant 19429/PI/14 (to M. E.-A.). The authors declare that they have no conflicts of interest with the contents of this article.	Baldwin RL, 2013, CURR OPIN STRUC BIOL, V23, P4, DOI 10.1016/j.sbi.2012.11.004; Barendt S, 2013, MICROBIOLOGYOPEN, V2, P695, DOI 10.1002/mbo3.109; Biedendieck R, 2011, METHOD ENZYMOL, V500, P165, DOI 10.1016/B978-0-12-385118-5.00010-4; Birukou I, 2014, NUCLEIC ACIDS RES, V42, P2774, DOI 10.1093/nar/gkt1215; Case DA, 2014, AMBER 14; Chatelle C, 2018, ACS SYNTH BIOL, V7, P1349, DOI 10.1021/acssynbio.7b00450; CRAIG ML, 1995, BIOCHEMISTRY-US, V34, P15624, DOI 10.1021/bi00048a004; Diez AI, 2013, EUR BIOPHYS J BIOPHY, V42, P463, DOI 10.1007/s00249-013-0897-x; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Elias-Arnanz M, 2011, CURR OPIN MICROBIOL, V14, P128, DOI 10.1016/j.mib.2010.12.009; Flock T, 2014, CURR OPIN STRUC BIOL, V26, P62, DOI 10.1016/j.sbi.2014.05.007; Fuxreiter M, 2011, TRENDS BIOCHEM SCI, V36, P415, DOI 10.1016/j.tibs.2011.04.006; Gallego-Garcia A, 2017, SCI REP-UK, V7, DOI 10.1038/srep43240; Gao YF, 2017, P NATL ACAD SCI USA, V114, P12560, DOI 10.1073/pnas.1716721114; Garcia-Moreno D, 2009, J BACTERIOL, V191, P3108, DOI 10.1128/JB.01737-08; Glaeser J, 2011, ADV MICROB PHYSIOL, V58, P141, DOI 10.1016/B978-0-12-381043-4.00004-0; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; Iniesta AA, 2012, J BACTERIOL, V194, P5875, DOI 10.1128/JB.01110-12; Ivani I, 2016, NAT METHODS, V13, P55, DOI [10.1038/nmeth.3658, 10.1038/NMETH.3658]; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jost M, 2015, NATURE, V526, P536, DOI 10.1038/nature14950; Jost M, 2015, BIOCHEMISTRY-US, V54, P3231, DOI 10.1021/acs.biochem.5b00416; Kainrath S, 2017, ANGEW CHEM INT EDIT, V56, P4608, DOI 10.1002/anie.201611998; Kutta RJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8907; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Ortiz-Guerrero JM, 2011, P NATL ACAD SCI USA, V108, P7565, DOI 10.1073/pnas.1018972108; Meiser P, 2006, P NATL ACAD SCI USA, V103, P19128, DOI 10.1073/pnas.0606039103; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Newberry KJ, 2004, J BIOL CHEM, V279, P20356, DOI 10.1074/jbc.M400960200; Newberry KJ, 2005, P NATL ACAD SCI USA, V102, P15839, DOI 10.1073/pnas.0506592102; Padmanabhan S, 2017, ANNU REV BIOCHEM, V86, P485, DOI 10.1146/annurev-biochem-061516-044500; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Park DM, 2014, MBIO, V5, DOI 10.1128/mBio.01684-14; Perez-Marin MC, 2008, MOL MICROBIOL, V67, P804, DOI 10.1111/j.1365-2958.2007.06086.x; Philips SJ, 2015, SCIENCE, V349, P877, DOI 10.1126/science.aaa9809; Purcell EB, 2008, CURR OPIN MICROBIOL, V11, P168, DOI 10.1016/j.mib.2008.02.014; Rohl CA, 1997, BIOCHEMISTRY-US, V36, P8435, DOI 10.1021/bi9706677; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schmid F. Z., 1997, PROTEIN STRUCTURE PR, P261; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Takano H, 2015, J BACTERIOL, V197, P2301, DOI 10.1128/JB.02528-14; Takano H, 2011, J BACTERIOL, V193, P2451, DOI 10.1128/JB.01125-10; vanLeeuwen HC, 1997, EMBO J, V16, P2043, DOI 10.1093/emboj/16.8.2043; Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j; Vuzman D, 2010, BIOPHYS J, V99, P1202, DOI 10.1016/j.bpj.2010.06.007; Wang R, 2017, P NATL ACAD SCI USA, V114, P5912, DOI 10.1073/pnas.1621350114; Watanabe S, 2008, P NATL ACAD SCI USA, V105, P4121, DOI 10.1073/pnas.0709188105; WEBER G, 1964, J BIOL CHEM, V239, P1415; WITTCHEN KD, 1995, APPL MICROBIOL BIOT, V42, P871, DOI 10.1007/s002530050345; Ziegelhoffer EC, 2009, NAT REV MICROBIOL, V7, P856, DOI 10.1038/nrmicro2237; Zuber P, 2009, ANNU REV MICROBIOL, V63, P575, DOI 10.1146/annurev.micro.091208.073241	55	8	8	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17888	17905		10.1074/jbc.RA118.004838	http://dx.doi.org/10.1074/jbc.RA118.004838			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30262667	Green Published, hybrid			2022-12-28	WOS:000450409500019
J	McCartney, CSE; Ye, QL; Campbell, RL; Davies, PL				McCartney, Christian-Scott E.; Ye, Qilu; Campbell, Robert L.; Davies, Peter L.			Insertion sequence 1 from calpain-3 is functional in calpain-2 as an internal propeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calpain; cysteine protease; muscular dystrophy; protease inhibitor; structure-function; protein engineering; calpain-2; calpain-3; p94; calpastatin; insertion sequence 1 (IS1); propeptide; p94; calpain inhibitor; limb-girdle muscular dystrophy; protease	MUSCLE-SPECIFIC CALPAIN; GIRDLE MUSCULAR-DYSTROPHY; HAND CA2+-BINDING PROTEINS; CALCIUM-DEPENDENT PROTEASE; SKELETAL-MUSCLE; EF-HAND; ACTIVE-SITE; MU-CALPAIN; ECCENTRIC EXERCISE; CRYSTAL-STRUCTURE	Calpains are intracellular, calcium-activated cysteine proteases. Calpain-3 is abundant in skeletal muscle, where its mutation-induced loss of function causes limb-girdle muscular dystrophy type 2A. Unlike the small subunit-containing calpain-1 and -2, the calpain-3 isoform homodimerizes through pairing of its C-terminal penta-EF-hand domain. It also has two unique insertion sequences (ISs) not found in the other calpains: IS1 within calpain-3's protease core and IS2 just prior to the penta-EF-hand domain. Production of either native or recombinant full-length calpain-3 to characterize the function of these ISs is challenging. Therefore, here we used recombinant rat calpain-2 as a stable surrogate and inserted IS1 into its equivalent position in the protease core. As it does in calpain-3, IS1 occupied the catalytic cleft and restricted the enzyme's access to substrate and inhibitors. Following activation by Ca2+, IS1 was rapidly cleaved by intramolecular autolysis, permitting the enzyme to freely accept substrate and inhibitors. The surrogate remained functional until extensive intermolecular autoproteolysis inactivated the enzyme, as is typical of calpain-2. Although the small-molecule inhibitors E-64 and leupeptin limited intermolecular autolysis of the surrogate, they did not block the initial intramolecular cleavage of IS1, establishing its role as a propeptide. Surprisingly, the large-molecule calpain inhibitor, calpastatin, completely blocked enzyme activity, even with IS1 intact. We suggest that calpastatin is large enough to oust IS1 from the catalytic cleft and take its place. We propose an explanation for why calpastatin can inhibit calpain-2 bearing the IS1 insertion but cannot inhibit WT calpain-3.	[McCartney, Christian-Scott E.; Ye, Qilu; Campbell, Robert L.; Davies, Peter L.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Davies, PL (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.	daviesp@queensu.ca		Davies, Peter/0000-0002-8026-7818; Campbell, Robert/0000-0002-5473-5876	Canadian Institutes of Health Research Grant [MOP74681]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP74681. The authors declare that they have no conflicts of interest with the contents of this article.	Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Betts R, 2004, BIOCHEMISTRY-US, V43, P2596, DOI 10.1021/bi0359832; Betts R, 2003, J BIOL CHEM, V278, P7800, DOI 10.1074/jbc.M208350200; Branca D, 1999, EUR J BIOCHEM, V265, P839, DOI 10.1046/j.1432-1327.1999.00817.x; Campbell RL, 2012, BIOCHEM J, V447, P335, DOI 10.1042/BJ20120921; Chou JS, 2011, BBA-PROTEINS PROTEOM, V1814, P864, DOI 10.1016/j.bbapap.2011.04.007; Cohen N, 2006, PROTEOMICS, V6, P6075, DOI 10.1002/pmic.200600199; CONG JY, 1989, J BIOL CHEM, V264, P10096; CRAWFORD C, 1987, BIOCHEM J, V248, P579, DOI 10.1042/bj2480579; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Cuerrier D, 2006, BIOCHEMISTRY-US, V45, P7446, DOI 10.1021/bi060425j; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Cuerrier D, 2007, J BIOL CHEM, V282, P9600, DOI 10.1074/jbc.M610372200; De Tullio R, 2003, BIOCHEM J, V375, P689, DOI 10.1042/BJ20030706; DEMARTINO GN, 1986, J BIOL CHEM, V261, P2047; Diaz BEG, 2006, BIOCHEMISTRY-US, V45, P3714, DOI 10.1021/bi051917j; Diaz BG, 2004, J BIOL CHEM, V279, P27656, DOI 10.1074/jbc.M313290200; Elce JS, 2000, METH MOL B, V144, P47; ELCE JS, 1995, PROTEIN ENG, V8, P843, DOI 10.1093/protein/8.8.843; EMORI Y, 1988, J BIOL CHEM, V263, P2364; Fanin M, 2007, J MED GENET, V44, P38, DOI 10.1136/jmg.2006.044859; Fanin M, 2004, HUM MUTAT, V24, P52, DOI 10.1002/humu.20058; Fanin M, 2003, AM J PATHOL, V163, P1929, DOI 10.1016/S0002-9440(10)63551-1; Fanin M, 2015, MUSCLE NERVE, V52, P163, DOI 10.1002/mus.24682; Federici C, 1999, ARCH BIOCHEM BIOPHYS, V363, P237, DOI 10.1006/abbi.1998.1091; Fukiage C, 2002, J BIOL CHEM, V277, P20678, DOI 10.1074/jbc.M200697200; Garnham CP, 2009, BIOCHEMISTRY-US, V48, P3457, DOI 10.1021/bi900130u; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GRAHAMSIEGENTHALER K, 1994, J BIOL CHEM, V269, P30457; Guyon JR, 2003, MUSCLE NERVE, V28, P472, DOI 10.1002/mus.10465; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Hanna RA, 2007, FEBS LETT, V581, P2894, DOI 10.1016/j.febslet.2007.05.035; Hauerslev S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-43; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Jia ZC, 2001, BIOPHYS J, V80, P2590, DOI 10.1016/S0006-3495(01)76229-7; Kanzaki K, 2017, J APPL PHYSIOL, V122, P396, DOI 10.1152/japplphysiol.00270.2016; Kanzaki K, 2014, J MUSCLE RES CELL M, V35, P179, DOI 10.1007/s10974-014-9378-9; KAWASAKI H, 1989, J BIOCHEM, V106, P274, DOI 10.1093/oxfordjournals.jbchem.a122844; Kinbara K, 1998, BIOCHEM PHARMACOL, V56, P415; Kinbara K, 1998, BIOCHEM J, V335, P589, DOI 10.1042/bj3350589; Kiss R, 2008, BIOCHEMISTRY-US, V47, P6936, DOI 10.1021/bi800201a; Kramerova I, 2004, HUM MOL GENET, V13, P1373, DOI 10.1093/hmg/ddh153; Kramerova I, 2007, BBA-MOL BASIS DIS, V1772, P128, DOI 10.1016/j.bbadis.2006.07.002; Labeit S, 1997, CIRC RES, V80, P290, DOI 10.1161/01.RES.80.2.290; Li QS, 2006, BIOCHEMISTRY-US, V45, P701, DOI 10.1021/bi052077b; Ma H, 1998, INVEST OPHTH VIS SCI, V39, P454; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Maki M, 2012, FEBS J, V279, P1414, DOI 10.1111/j.1742-4658.2012.08560.x; Moldoveanu T, 2004, J MOL BIOL, V343, P1313, DOI 10.1016/j.jmb.2004.09.016; Moldoveanu T, 2004, J BIOL CHEM, V279, P6106, DOI 10.1074/jbc.M310460200; Moldoveanu T, 2001, BBA-PROTEIN STRUCT M, V1545, P245, DOI 10.1016/S0167-4838(00)00286-7; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Moldoveanu T, 2008, NATURE, V456, P404, DOI 10.1038/nature07353; Murphy RM, 2006, AM J PHYSIOL-CELL PH, V290, pC116, DOI 10.1152/ajpcell.00291.2005; Murphy RM, 2007, J APPL PHYSIOL, V103, P926, DOI 10.1152/japplphysiol.01422.2006; Murphy RM, 2011, J APPL PHYSIOL, V111, P1448, DOI 10.1152/japplphysiol.00441.2011; Murphy RM, 2010, CLIN EXP PHARMACOL P, V37, P385, DOI 10.1111/j.1440-1681.2009.05310.x; Murphy RM, 2009, J APPL PHYSIOL, V106, P2068, DOI 10.1152/japplphysiol.00239.2009; Murphy RM, 2009, J BIOL CHEM, V284, P7811, DOI 10.1074/jbc.M808655200; Nakamura Y, 1999, EXP EYE RES, V69, P155, DOI 10.1006/exer.1998.0686; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Yasuko, 2007, Biotechnology Journal, V2, P565, DOI 10.1002/biot.200700018; Ono Y, 2006, J BIOL CHEM, V281, P18519, DOI 10.1074/jbc.M601029200; Ono Y, 2016, NAT REV DRUG DISCOV, V15, P854, DOI 10.1038/nrd.2016.212; Ono Y, 2015, DATA BRIEF, V5, P366, DOI 10.1016/j.dib.2015.09.021; Ono Y, 2016, BIOCHIMIE, V122, P169, DOI 10.1016/j.biochi.2015.09.010; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Pantoja-Melendez CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170280; Partha SK, 2014, FEBS J, V281, P3138, DOI 10.1111/febs.12849; Piluso G, 2005, J MED GENET, V42, P686, DOI 10.1136/jmg.2004.028738; Qian J, 2008, J MED CHEM, V51, P5264, DOI 10.1021/jm800045t; Ravulapalli R, 2005, BIOCHEM J, V388, P585, DOI 10.1042/BJ20041821; Ravulapalli R, 2009, FEBS J, V276, P973, DOI 10.1111/j.1742-4658.2008.06833.x; Rey MA, 2002, FEBS LETT, V532, P401, DOI 10.1016/S0014-5793(02)03722-5; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; SORIMACHI H, 1990, BIOL CHEM H-S, V371, P171; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; SORIMACHI H, 1993, J BIOL CHEM, V268, P10593; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; SUZUKI K, 1991, BIOMED BIOCHIM ACTA, V50, P483; TAKANO E, 1988, BIOCHEMISTRY-US, V27, P1964, DOI 10.1021/bi00406a024; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; Thompson VF, 2003, BBA-PROTEINS PROTEOM, V1648, P140, DOI 10.1016/S1570-9639(03)00115-8; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Ye QL, 2018, J BIOL CHEM, V293, P4056, DOI 10.1074/jbc.RA117.001097; YOSHIMURA N, 1983, J BIOL CHEM, V258, P8883	87	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17716	17730		10.1074/jbc.RA118.004803	http://dx.doi.org/10.1074/jbc.RA118.004803			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30254072	Green Published, hybrid			2022-12-28	WOS:000450409500005
J	Sugiura, M; Nakahara, M; Yamada, C; Arakawa, T; Kitaoka, M; Fushinobu, S				Sugiura, Masayuki; Nakahara, Moe; Yamada, Chihaya; Arakawa, Takatoshi; Kitaoka, Motomitsu; Fushinobu, Shinya			Identification, functional characterization, and crystal structure determination of bacterial levoglucosan dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dehydrogenase; nicotinamide adenine dinucleotide (NADH); X-ray crystallography; bacterial metabolism; enzyme kinetics; Gfo; Idh; MocA family; l- sorbose; levoglucosan; scyllo-inositol dehydrogenase	GLUCOSE-FRUCTOSE OXIDOREDUCTASE; COMPLETE GENOME SEQUENCE; 1,5-ANHYDRO-D-FRUCTOSE REDUCTASE; ZYMOMONAS-MOBILIS; STRAIN SPHE3; SP NOV.; X-RAY; ARTHROBACTER; 1,6-ANHYDRO-BETA-D-GLUCOPYRANOSE; BIOCONVERSION	Levoglucosan is the 1,6-anhydrosugar of d-glucose formed by pyrolysis of glucans and is found in the environment and industrial waste. Two types of microbial levoglucosan metabolic pathways are known. Although the eukaryotic pathway involving levoglucosan kinase has been well-studied, the bacterial pathway involving levoglucosan dehydrogenase (LGDH) has not been well-investigated. Here, we identified and cloned the lgdh gene from the bacterium Pseudarthrobacter phenanthrenivorans and characterized the recombinant protein. The enzyme exhibited high substrate specificity toward levoglucosan and NAD(+) for the oxidative reaction and was confirmed to be LGDH. LGDH also showed weak activities (approximate to 4%) toward l-sorbose and 1,5-anhydro-d-glucitol. The reverse (reductive) reaction using 3-keto-levoglucosan and NADH exhibited significantly lower K-m and higher k(cat) values than those of the forward reaction. The crystal structures of LGDH in the apo and complex forms with NADH, NADH + levoglucosan, and NADH + l-sorbose revealed that LGDH has a typical fold of Gfo/Idh/MocA family proteins, similar to those of scyllo-inositol dehydrogenase, aldose-aldose oxidoreductase, 1,5-anhydro-d-fructose reductase, and glucose-fructose oxidoreductase. The crystal structures also disclosed that the active site of LGDH is distinct from those of these enzymes. The LGDH active site extensively recognized the levoglucosan molecule with six hydrogen bonds, and the C3 atom of levoglucosan was closely located to the C4 atom of NADH nicotinamide. Our study is the first molecular characterization of LGDH, providing evidence for C3-specific oxidation and representing a starting point for future biotechnological use of LGDH and levoglucosan-metabolizing bacteria.	[Sugiura, Masayuki; Nakahara, Moe; Yamada, Chihaya; Arakawa, Takatoshi; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Yamada, Chihaya; Arakawa, Takatoshi; Fushinobu, Shinya] Univ Tokyo, Collaborat Res Inst Innovat Microbiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Kitaoka, Motomitsu] Natl Agr & Food Res Org, Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	University of Tokyo; University of Tokyo; National Agriculture & Food Research Organization - Japan	Fushinobu, S (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Kitaoka, Motomitsu/R-1536-2019; Arakawa, Takatoshi/K-9739-2013; Fushinobu, Shinya/E-4987-2011	Kitaoka, Motomitsu/0000-0002-0083-1838; Arakawa, Takatoshi/0000-0001-6496-5440; Fushinobu, Shinya/0000-0003-1346-6435	Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED); JSPS-KAKENHI [15H02443]	Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); JSPS-KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED) and JSPS-KAKENHI (15H02443 to S. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Bacik JP, 2016, IUBMB LIFE, V68, P700, DOI 10.1002/iub.1533; Bacik JP, 2015, J BIOL CHEM, V290, P26638, DOI 10.1074/jbc.M115.674614; Busse HJ, 2016, INT J SYST EVOL MICR, V66, P9, DOI 10.1099/ijsem.0.000702; CLARKE AR, 1989, TRENDS BIOCHEM SCI, V14, P101, DOI 10.1016/0968-0004(89)90131-X; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Dambe TR, 2006, BIOCHEMISTRY-US, V45, P10030, DOI 10.1021/bi052589q; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fukano K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198010; GUILBAULT GG, 1965, ANAL CHEM, V37, P1219, DOI 10.1021/ac60229a011; HAKALA MT, 1956, J BIOL CHEM, V221, P191; Hamaguchi N., 2015, Journal of Applied Glycoscience, V62, P7; Holbrook JJ., 1975, ENZYMES, P191; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Iwazaki S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22496-2; Kallimanis A, 2009, INT J SYST EVOL MICR, V59, P275, DOI 10.1099/ijs.0.000984-0; Kallimanis A, 2011, STAND GENOMIC SCI, V4, P123, DOI 10.4056/sigs.1393494; Kingston RL, 1996, STRUCTURE, V4, P1413, DOI 10.1016/S0969-2126(96)00149-9; KITAMURA Y, 1991, AGR BIOL CHEM TOKYO, V55, P523, DOI 10.1080/00021369.1991.10870618; KITAMURA Y, 1991, AGR BIOL CHEM TOKYO, V55, P515, DOI 10.1080/00021369.1991.10870617; Kitaoka M, 2017, J APPL GLYOSCI, V64, P99, DOI 10.5458/jag.jag.JAG-2017_013; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAKSHMANAN CM, 1969, IND ENG CHEM PROD RD, V8, P261, DOI 10.1021/i360031a010; Layton DS, 2011, BIORESOURCE TECHNOL, V102, P8318, DOI 10.1016/j.biortech.2011.06.011; Lian JN, 2013, BIORESOURCE TECHNOL, V133, P183, DOI 10.1016/j.biortech.2013.01.031; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKAHARA K, 1994, BIOSCI BIOTECH BIOCH, V58, P2193, DOI 10.1271/bbb.58.2193; Nakamura A, 2015, INT J SYST EVOL MICR, V65, P3878, DOI 10.1099/ijsem.0.000508; Nakatsu CH, 2013, STAND GENOMIC SCI, V9, P106, DOI 10.4056/sigs.4438185; Nurizzo D, 2001, BIOCHEMISTRY-US, V40, P13857, DOI 10.1021/bi011355d; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schkolnik G, 2006, ANAL BIOANAL CHEM, V385, P26, DOI 10.1007/s00216-005-0168-5; Schu M, 2013, ACTA CRYSTALLOGR F, V69, P844, DOI 10.1107/S1744309113019490; Shimizu T, 2012, J BIOL CHEM, V287, P40448, DOI 10.1074/jbc.M112.403055; Smrcok L, 2006, ACTA CRYSTALLOGR B, V62, P912, DOI 10.1107/S010876810602489X; Taberman H, 2016, PROTEIN SCI, V25, P778, DOI 10.1002/pro.2877; Taberman H, 2015, BIOCHEM J, V472, P297, DOI 10.1042/BJ20150681; Ul Islam Z, 2015, J IND MICROBIOL BIOT, V42, P1557, DOI 10.1007/s10295-015-1687-5; Uriarte I, 2018, CHEMPHYSCHEM, V19, P766, DOI 10.1002/cphc.201701242; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vancampenhout K, 2012, SOIL BIOL BIOCHEM, V50, P40, DOI 10.1016/j.soilbio.2012.03.005; Vicente A, 2013, ATMOS ENVIRON, V71, P295, DOI 10.1016/j.atmosenv.2013.01.062; Vikram S, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00058-13; Wallner P, 2013, INT J HYG ENVIR HEAL, V216, P280, DOI 10.1016/j.ijheh.2012.05.001; YASUI T, 1991, AGR BIOL CHEM TOKYO, V55, P1927, DOI 10.1080/00021369.1991.10870881; You C, 2018, SCI TOTAL ENVIRON, V616, P1533, DOI 10.1016/j.scitotenv.2017.10.160	45	13	13	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17375	17386		10.1074/jbc.RA118.004963	http://dx.doi.org/10.1074/jbc.RA118.004963			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30224354	hybrid, Green Published			2022-12-28	WOS:000449799000006
J	Calderon, BM; Conn, GL				Calderon, Brenda M.; Conn, Graeme L.			A human cellular noncoding RNA activates the antiviral protein 2 '-5 '-oligoadenylate synthetase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN OLIGOADENYLATE SYNTHETASE; PKR ACTIVATION; KINASE PKR; TRANSLATION; INHIBITION; REVEALS; DSRNA; ROLES; REGULATORS; INFECTION	The 2'-5'-oligoadenylate synthetase (OAS) family of enzymes sense cytosolic dsRNA, a potent signal of viral infection. In response to dsRNA binding, OAS proteins synthesize the second messenger 2'-5'-linked oligoadenylate that activates the latent ribonuclease L (RNase L). RNase L-mediated degradation of viral and cellular RNAs effectively halts viral replication and further stimulates innate immune responses by inducing type I interferon. The OAS/RNase L pathway is therefore central in innate immune recognition and promotion of antiviral host responses. However, the potential for specific RNA sequences or structures to drive OAS1 activation and the molecular mechanisms by which they act are not currently fully understood. Moreover, the cellular regulators of OAS activity are not well defined. Here, we demonstrate that the human cellular noncoding RNA 886 (nc886) activates OAS1 both in vitro and in human A549 cells. We show that a unique structure present only in one of the two structural conformers adopted by nc886 drives potent OAS1 activation. In contrast, the conformer lacking this unique structure activated OAS1 only very weakly. We also found that formation of this OAS1-activating structural motif depends on the nucleotides in the apical-most loop of nc886 and the adjacent helix. These findings identify a cellular RNA capable of activating the OAS/RNase L pathway in human cells and illustrate the importance of structural elements, and their context, in potentiating OAS1 activity.	[Calderon, Brenda M.; Conn, Graeme L.] Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA; [Calderon, Brenda M.] Emory Univ, Sch Med, Grad Program Biochem Cell & Dev Biol BCDB, Atlanta, GA 30322 USA	Emory University; Emory University	Conn, GL (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	gconn@emory.edu		Calderon, Brenda/0000-0003-1130-0386; Conn, Graeme/0000-0002-2419-380X	Emory University Research Council (URC); ARCS Foundation; BCDB NIGMS Training Grant from the National Institutes of Health [T32-GM008367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER	Emory University Research Council (URC); ARCS Foundation; BCDB NIGMS Training Grant from the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an award from the Emory University Research Council (URC) ( to G.L.C.), a scholarship from the ARCS Foundation (to B.M.C.), and by BCDB NIGMS Training Grant T32-GM008367 from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2017, ELIFE; Banerjee S, 2015, ONCOTARGET, V6, P44360, DOI 10.18632/oncotarget.6246; Banerjee S, 2014, MBIO, V5, DOI 10.1128/mBio.00856-14; Brennan-Laun SE, 2014, J INTERF CYTOK RES, V34, P275, DOI 10.1089/jir.2013.0147; Calderon BM, 2017, RNA, V23, P557, DOI 10.1261/rna.060269.116; Chow J, 2015, VIROLOGY, V479, P104, DOI 10.1016/j.virol.2015.02.051; Cohen-Chalamish S, 2009, NAT CHEM BIOL, V5, P896, DOI 10.1038/nchembio.234; Dalet A, 2015, FEBS LETT, V589, P1539, DOI 10.1016/j.febslet.2015.05.006; Deo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092545; Donovan J, 2017, RNA, V23, P1660, DOI 10.1261/rna.062000.117; Donovan J, 2015, P NATL ACAD SCI USA, V112, P3949, DOI 10.1073/pnas.1419409112; Donovan J, 2013, P NATL ACAD SCI USA, V110, P1652, DOI 10.1073/pnas.1218528110; Han YC, 2012, CELL REP, V2, P902, DOI 10.1016/j.celrep.2012.09.004; Harries LW, 2012, BIOCHEM SOC T, V40, P902, DOI 10.1042/BST20120020; Hartmann R, 1998, J BIOL CHEM, V273, P3236, DOI 10.1074/jbc.273.6.3236; Huang H, 2014, MOL CELL, V53, P221, DOI 10.1016/j.molcel.2013.12.025; Jeon SH, 2012, FEBS LETT, V586, P3477, DOI 10.1016/j.febslet.2012.07.076; JUSTESEN J, 1992, ANAL BIOCHEM, V207, P90, DOI 10.1016/0003-2697(92)90506-3; Kim Y, 2014, GENE DEV, V28, P1310, DOI 10.1101/gad.242644.114; Kodym R, 2009, BIOCHEM BIOPH RES CO, V388, P317, DOI 10.1016/j.bbrc.2009.07.167; Kristiansen H, 2011, J INTERF CYTOK RES, V31, P41, DOI 10.1089/jir.2010.0107; Kunkeaw N, 2013, ONCOGENE, V32, P3722, DOI 10.1038/onc.2012.382; Kwon YC, 2013, FEBS LETT, V587, P156, DOI 10.1016/j.febslet.2012.11.010; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Lee K, 2011, RNA, V17, P1076, DOI 10.1261/rna.2701111; Li YZ, 2016, P NATL ACAD SCI USA, V113, P2241, DOI 10.1073/pnas.1519657113; Linpinsel J. L., 2012, RECOMBINANT VITRO RN, P43; Marchal JA, 2014, FASEB J, V28, P1965, DOI 10.1096/fj.13-248294; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; Mattick JS, 2011, FEBS LETT, V585, P1600, DOI 10.1016/j.febslet.2011.05.001; McKenna SA, 2007, J MOL BIOL, V372, P103, DOI 10.1016/j.jmb.2007.06.028; McKenna SA, 2006, J MOL BIOL, V358, P1270, DOI 10.1016/j.jmb.2006.03.003; Meng H, 2012, J MOL BIOL, V422, P635, DOI 10.1016/j.jmb.2012.06.017; Nussbaum JM, 2002, NUCLEIC ACIDS RES, V30, P1205, DOI 10.1093/nar/30.5.1205; Osman F, 1999, GENE DEV, V13, P3280, DOI 10.1101/gad.13.24.3280; Rath S, 2015, P NATL ACAD SCI USA, V112, P15916, DOI 10.1073/pnas.1513034112; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Siddiqui MA, 2015, INT J MOL SCI, V16, P17611, DOI 10.3390/ijms160817611; Tsutsui-Takeuchi M, 2015, IMMUNOL RES, V61, P240, DOI 10.1007/s12026-014-8617-x; Vachon VK, 2016, VIRUS RES, V212, P39, DOI 10.1016/j.virusres.2015.06.018; Vachon VK, 2015, NUCLEIC ACIDS RES, V43, P544, DOI 10.1093/nar/gku1289; Wahid AM, 2008, J BIOL CHEM, V283, P17485, DOI 10.1074/jbc.M802300200; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wilson JL, 2014, J BIOL CHEM, V289, P23233, DOI 10.1074/jbc.M114.550046; Yim HCH, 2016, CELL RES, V26, P367, DOI 10.1038/cr.2016.11; Youssef OA, 2015, P NATL ACAD SCI USA, V112, P5023, DOI 10.1073/pnas.1424044112; Zhu JZ, 2014, IMMUNITY, V40, P936, DOI 10.1016/j.immuni.2014.05.007	48	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16115	16124		10.1074/jbc.RA118.004747	http://dx.doi.org/10.1074/jbc.RA118.004747			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30126839	hybrid, Green Published			2022-12-28	WOS:000447256000031
J	Paschkowsky, S; Recinto, SJ; Young, JC; Bondar, AN; Munter, LM				Paschkowsky, Sandra; Recinto, Sherilyn Junelle; Young, Jason C.; Bondar, Ana-Nicoleta; Munter, Lisa Marie			Membrane cholesterol as regulator of human rhomboid protease RHBDL4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						rhomboid protease; amyloid precursor protein (APP); cholesterol; cholesterol-binding protein; low-density lipoprotein (LDL); Alzheimer's disease; neurodegeneration; cholesterol pulldown; cholesterol recognition amino acid consensus sequence (CRAC); intramembrane proteolysis; large APP C-terminal fragments	AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; INTRAMEMBRANE PROTEOLYSIS; DENSITY-LIPOPROTEIN; NEURONAL-ACTIVITY; CULTURED-CELLS; BETA-SECRETASE; IN-VITRO; STATINS; IDENTIFICATION	In the last decade, intramembrane proteases have gained increasing attention because of their many links to various diseases. Nevertheless, our understanding as to how they function or how they are regulated is still limited, especially when it comes to human homologues. In this regard, here we sought to unravel mechanisms of regulation of the protease rhomboid-like protein-4 (RHBDL4), one of five active human serine intramembrane proteases. In view of our recent finding that human RHBDL4 efficiently cleaves the amyloid precursor protein (APP), a key protein in the pathology of Alzheimer's disease, we used established reagents to modulate the cellular cholesterol content and analyzed the effects of this modulation on RHBDL4-mediated processing of endogenous APP. We discovered that lowering membrane cholesterol levels increased the levels of RHBDL4-specific endogenous APP fragments, whereas high cholesterol levels had the opposite effect. Direct binding of cholesterol to APP did not mediate these modulating effects of cholesterol. Instead, using homology modeling, we identified two potential cholesterol-binding motifs in the transmembrane helices 3 and 6 of RHBDL4. Substitution of the essential tyrosine residues of the potential cholesterol-binding motifs to alanine increased the levels of endogenous APP C-terminal fragments, reflecting enhanced RHBDL4 activity. In summary, we provide evidence that the activity of RHBDL4 is regulated by cholesterol likely through a direct binding of cholesterol to the enzyme.	[Paschkowsky, Sandra; Recinto, Sherilyn Junelle; Munter, Lisa Marie] McGill Univ, Dept Pharmacol & Therapeut, Bellini Life Sci Complex, Montreal, PQ H3G 081, Canada; [Paschkowsky, Sandra; Recinto, Sherilyn Junelle; Munter, Lisa Marie] McGill Univ, Cell Informat Syst Grp, Bellini Life Sci Complex, Montreal, PQ H3G 081, Canada; [Young, Jason C.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Young, Jason C.] McGill Univ, Grp Rech Axe Sur Struct Prot, Montreal, PQ, Canada; [Bondar, Ana-Nicoleta] Free Univ Berlin, Dept Phys Theoret Mol Biophys, Arnimallee 14, D-14195 Berlin, Germany	McGill University; McGill University	Munter, LM (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Bellini Life Sci Complex, Montreal, PQ H3G 081, Canada.; Munter, LM (corresponding author), McGill Univ, Cell Informat Syst Grp, Bellini Life Sci Complex, Montreal, PQ H3G 081, Canada.	lisa.munter@mcgill.ca		Munter, Lisa/0000-0001-5736-1462; Recinto, Sherilyn Junelle/0000-0001-9632-1201	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2015-04645]; Canada Foundation of Innovation Leaders Opportunity Fund [CFI-LOF 32565]; Alzheimer Society of Canada Young Investigator Award [PT-58872, 17-02]; Fonds d'Innovation Pfizer-FRQS sur la Maladie d'Alzheimer et les Maladies Apparente'es [31288]; McGill Faculty of Medicine Incentive; Scottish Rite Charitable Foundation of Canada; Natural Sciences and Engineering Research Council of Canada; Freie Universitat Berlin within the Excellence Initiative of the German Research Foundation	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation of Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Alzheimer Society of Canada Young Investigator Award; Fonds d'Innovation Pfizer-FRQS sur la Maladie d'Alzheimer et les Maladies Apparente'es; McGill Faculty of Medicine Incentive; Scottish Rite Charitable Foundation of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Freie Universitat Berlin within the Excellence Initiative of the German Research Foundation(German Research Foundation (DFG))	This work was supported in part by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant RGPIN-2015-04645 (to L. M. M.); Canada Foundation of Innovation Leaders Opportunity Fund CFI-LOF 32565; Alzheimer Society of Canada Young Investigator Award PT-58872 and Research Grant 17-02; Fonds d'Innovation Pfizer-FRQS sur la Maladie d'Alzheimer et les Maladies Apparente'es no. 31288; McGill Faculty of Medicine Incentive funding; and an award from The Scottish Rite Charitable Foundation of Canada. The authors declare that they have no conflicts of interest with the contents of this article.; Received an Natural Sciences and Engineering Research Council of Canada Undergraduate Student Research Award (USRA) summer student stipend.; Supported in part by the Freie Universitat Berlin within the Excellence Initiative of the German Research Foundation.	Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Arutyunova E, 2017, METHOD ENZYMOL, V584, P395, DOI 10.1016/bs.mie.2016.11.002; Baier CJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00069; Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Bondar AN, 2009, STRUCTURE, V17, P395, DOI 10.1016/j.str.2008.12.017; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Civitarese AE, 2010, CELL METAB, V11, P412, DOI 10.1016/j.cmet.2010.04.004; Cole SL, 2005, J BIOL CHEM, V280, P18755, DOI 10.1074/jbc.M413895200; Das A, 2014, ELIFE, V3, DOI 10.7554/eLife.02882; Dusterhoft S, 2017, BBA-MOL CELL RES, V1864, P2200, DOI 10.1016/j.bbamcr.2017.04.016; Fantini J, 2016, SCI REP-UK, V6, DOI 10.1038/srep21907; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; FERRERI K, 1992, ENDOCRINOLOGY, V131, P2059, DOI 10.1210/en.131.5.2059; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Frears ER, 1999, NEUROREPORT, V10, P1699, DOI 10.1097/00001756-199906030-00014; Gal Z, 2015, BBA-BIOMEMBRANES, V1848, P477, DOI 10.1016/j.bbamem.2014.11.006; Gbelcova H, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-126; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang J, 2016, EMBO J, V35, P2332, DOI 10.15252/embj.201693923; Janowski BA, 2002, P NATL ACAD SCI USA, V99, P12675, DOI 10.1073/pnas.202471599; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim J, 2015, BIOCHEM BIOPH RES CO, V468, P606, DOI 10.1016/j.bbrc.2015.10.165; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kojro E, 2010, J ALZHEIMERS DIS, V20, P1215, DOI 10.3233/JAD-2010-091621; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lemberg MK, 2016, SEMIN CELL DEV BIOL, V60, P29, DOI 10.1016/j.semcdb.2016.06.022; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Miller LJ, 2004, ANN PHARMACOTHER, V38, P91, DOI 10.1345/aph.1D104; Moin SM, 2012, ELIFE, V1, DOI 10.7554/eLife.00173; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Paschkowsky S, 2018, J MEMBRANE BIOL, V251, P369, DOI 10.1007/s00232-017-0008-5; Paschkowsky S, 2016, J BIOL CHEM, V291, P21903, DOI 10.1074/jbc.M116.753582; Pierrot N, 2013, EMBO MOL MED, V5, P608, DOI 10.1002/emmm.201202215; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01795-14; Shi G, 2011, HUM MOL GENET, V20, P1966, DOI 10.1093/hmg/ddr077; Sidera C, 2005, J NEUROL SCI, V229, P269, DOI 10.1016/j.jns.2004.11.044; Spinazzi M, 2016, SEMIN CELL DEV BIOL, V60, P19, DOI 10.1016/j.semcdb.2016.07.034; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2014, CELL REP, V8, P1241, DOI 10.1016/j.celrep.2014.07.039; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Walder K, 2005, DIABETOLOGIA, V48, P459, DOI 10.1007/s00125-005-1675-9; Wang HZ, 2015, BIOCHEMISTRY-US, V54, P2806, DOI 10.1021/acs.biochem.5b00329; Wang YC, 2007, J MOL BIOL, V374, P1104, DOI 10.1016/j.jmb.2007.10.014; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; Wolozin B, 2001, P NATL ACAD SCI USA, V98, P5371, DOI 10.1073/pnas.101123198; Wunderle L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27342	57	9	9	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15556	15568		10.1074/jbc.RA118.002640	http://dx.doi.org/10.1074/jbc.RA118.002640			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30143535	hybrid, Green Published			2022-12-28	WOS:000446549200020
J	Liu, ZY; Wang, CC; Li, YC; Zhao, CY; Li, TZ; Li, D; Zhang, SN; Liu, C				Liu, Zhenying; Wang, Chuchu; Li, Yichen; Zhao, Chunyu; Li, Tongzhou; Li, Dan; Zhang, Shengnan; Liu, Cong			Mechanistic insights into the switch of alpha B-crystallin chaperone activity and self-multimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystallin; amyloid-synuclein; molecular chaperone; protein misfolding; protein structure; protein aggregation; Tau protein (Tau); alpha B-crystallin; protein quality control	HEAT-SHOCK PROTEINS; EYE LENS TRANSPARENCY; SOLID-STATE NMR; SYNUCLEIN AGGREGATION; MASS-SPECTROMETRY; HSP27; DOMAIN; TAU; PHOSPHORYLATION; POLYDISPERSITY	alpha B-Crystallin (alpha Bc) is a small heat shock protein that protects cells against abnormal protein aggregation and disease-related degeneration. alpha Bc is also a major structural protein that forms polydisperse multimers that maintain the liquid-like property of the eye lens. However, the relationship and regulation of the two functions have yet to be explored. Here, by combining NMR spectroscopy and multiple biophysical approaches, we found that alpha Bc uses a conserved beta 4/beta 8 surface of the central alpha-crystallin domain to bind alpha-synuclein and Tau proteins and prevent them from aggregating into pathological amyloids. We noted that this amyloid-binding surface can also bind the C-terminal IPI motif of alpha Bc, which mediates alpha Bc multimerization and weakens its chaperone activity. We further show that disruption of the IPI binding impairs alpha Bc self-multimerization but enhances its chaperone activity. Our work discloses the structural mechanism underlying the regulation of alpha Bc chaperone activity and self-multimerization and sheds light on the different functions of alpha Bc in antagonizing neurodegeneration and maintaining eye lens liquidity.	[Liu, Zhenying; Wang, Chuchu; Zhao, Chunyu; Li, Tongzhou; Zhang, Shengnan; Liu, Cong] Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, Shanghai 201210, Peoples R China; [Li, Yichen; Li, Dan] Shanghai Jiao Tong Univ, Bio X Inst, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Liu, Zhenying; Wang, Chuchu; Zhao, Chunyu; Li, Tongzhou] Univ Chinese Acad Sci, 19 A Yuquan Rd, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, SN; Liu, C (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, Shanghai 201210, Peoples R China.	zhangshengnan@sioc.ac.cn; liulab@sioc.ac.cn		Zhao, Chunyu/0000-0003-0168-2130; Liu, Zhenying/0000-0002-0035-7486; Wang, Chuchu/0000-0003-2015-7331	Major State Basic Research Development Program [2016YFA0501902]; National Natural Science Foundation (NSF) of China [31470748]; Chinese Academy of Sciences; The "1000 Talents Plan" of China	Major State Basic Research Development Program(National Basic Research Program of China); National Natural Science Foundation (NSF) of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); The "1000 Talents Plan" of China	This work was supported by Major State Basic Research Development Program Grant 2016YFA0501902, National Natural Science Foundation (NSF) of China Grant 31470748, the Chinese Academy of Sciences, and The "1000 Talents Plan" of China. The authors declare that they have no conflicts of interest with the contents of this article.	Abisambra JF, 2010, J NEUROSCI, V30, P15374, DOI 10.1523/JNEUROSCI.3155-10.2010; Ahmad MF, 2008, J MOL BIOL, V375, P1040, DOI 10.1016/j.jmb.2007.11.019; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Baldwin AJ, 2011, STRUCTURE, V19, P1855, DOI 10.1016/j.str.2011.09.015; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; Bermel W, 2006, J AM CHEM SOC, V128, P3918, DOI 10.1021/ja0582206; Bjorkdahl C, 2008, J NEUROSCI RES, V86, P1343, DOI 10.1002/jnr.21589; Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108; Chen GF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02056-4; Clark AR, 2012, INT J BIOCHEM CELL B, V44, P1687, DOI 10.1016/j.biocel.2012.02.015; Cox D, 2018, J BIOL CHEM, V293, P4486, DOI 10.1074/jbc.M117.813865; Cox D, 2017, CELL STRESS CHAPERON, V22, P589, DOI 10.1007/s12192-017-0785-x; Cox D, 2016, J BIOL CHEM, V291, P22618, DOI 10.1074/jbc.M116.739250; Daebel V, 2012, J AM CHEM SOC, V134, P13982, DOI 10.1021/ja305470p; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Delbecq SP, 2012, EMBO J, V31, P4587, DOI 10.1038/emboj.2012.318; Ding JN, 2015, SCI REP-UK, V5, DOI 10.1038/srep16856; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; Eliezer D, 2005, BIOCHEMISTRY-US, V44, P1026, DOI 10.1021/bi048953n; FAGERHOLM PP, 1981, EXP EYE RES, V33, P615, DOI 10.1016/S0014-4835(81)80101-7; Fusco G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4827; Gabrielson JP, 2007, ANAL BIOCHEM, V361, P24, DOI 10.1016/j.ab.2006.11.012; Gidalevitz T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009704; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hilton GR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0405; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; Jehle S, 2010, NAT STRUCT MOL BIOL, V17, P1037, DOI 10.1038/nsmb.1891; Jehle S, 2009, J MOL BIOL, V385, P1481, DOI 10.1016/j.jmb.2008.10.097; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lindberg I, 2015, J NEUROSCI, V35, P13853, DOI 10.1523/JNEUROSCI.2600-15.2015; Liu ZY, 2017, PROTEIN PEPTIDE LETT, V24, P315, DOI 10.2174/0929866524666170206122616; Lopez-Gonzalez I, 2014, NEUROPATHOLOGY, V34, P517, DOI 10.1111/neup.12134; LOWE J, 1992, J PATHOL, V166, P61, DOI 10.1002/path.1711660110; Mainz A, 2015, NAT STRUCT MOL BIOL, V22, P898, DOI 10.1038/nsmb.3108; Makley LN, 2015, SCIENCE, V350, P674, DOI 10.1126/science.aac9145; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Mymrikov EV, 2012, CELL STRESS CHAPERON, V17, P157, DOI 10.1007/s12192-011-0296-0; Pasta SY, 2004, MOL VIS, V10, P655; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Rajagopal P, 2015, ELIFE, V4, DOI 10.7554/eLife.07304; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; Renkawek K, 1999, NEUROREPORT, V10, P2273, DOI 10.1097/00001756-199908020-00009; SHINOHARA H, 1993, J NEUROL SCI, V119, P203, DOI 10.1016/0022-510X(93)90135-L; Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203; Soper MT, 2013, PHYS CHEM CHEM PHYS, V15, P8952, DOI 10.1039/c3cp50721a; Tardieu A, 1998, INT J BIOL MACROMOL, V22, P211, DOI 10.1016/S0141-8130(98)00018-X; TARDIEU A, 1988, ANNU REV BIOPHYS BIO, V17, P47; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Treweek TM, 2015, CELL MOL LIFE SCI, V72, P429, DOI 10.1007/s00018-014-1754-5; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; ZANTEMA A, 1992, J BIOL CHEM, V267, P12936; Zhao L, 2015, NATURE, V523, P607, DOI 10.1038/nature14650	62	32	35	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14880	14890		10.1074/jbc.RA118.004034	http://dx.doi.org/10.1074/jbc.RA118.004034			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30076220	Green Published, hybrid			2022-12-28	WOS:000446155000023
J	Cameron, SR; Nandi, S; Kahn, TG; Barrasa, JI; Stenberg, P; Schwartz, YB				Cameron, Sarina R.; Nandi, Soumyadeep; Kahn, Tatyana G.; Barrasa, Juan I.; Stenberg, Per; Schwartz, Yuri B.			PTE, a novel module to target Polycomb Repressive Complex 1 to the human cyclin D2 (CCND2) oncogene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						polycomb; epigenetics; gene silencing; chromatin; oncogene; cyclin D2; polycomb targeting; PRC1	HISTONE METHYLTRANSFERASE ACTIVITY; GENOME-WIDE; TRANSCRIPTION FACTORS; H2A UBIQUITYLATION; RESPONSE ELEMENT; GENE-EXPRESSION; GROUP PROTEINS; ENZYMATIC-ACTIVITY; CELL IDENTITY; CPG ISLANDS	Polycomb group proteins are essential epigenetic repressors. They form multiple protein complexes of which two kinds, PRC1 and PRC2, are indispensable for repression. Although much is known about their biochemical properties, how mammalian PRC1 and PRC2 are targeted to specific genes is poorly understood. Here, we establish the cyclin D2 (CCND2) oncogene as a simple model to address this question. We provide the evidence that the targeting of PRC1 to CCND2 involves a dedicated PRC1-targeting element (PTE). The PTE appears to act in concert with an adjacent cytosine-phosphate-guanine (CpG) island to arrange for the robust binding of PRC1 and PRC2 to repressed CCND2. Our findings pave the way to identify sequence-specific DNA-binding proteins implicated in the targeting of mammalian PRC1 complexes and provide novel link between polycomb repression and cancer.	[Cameron, Sarina R.; Nandi, Soumyadeep; Kahn, Tatyana G.; Barrasa, Juan I.; Stenberg, Per; Schwartz, Yuri B.] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Nandi, Soumyadeep; Stenberg, Per] Umea Univ, Computat Life Sci Cluster CLiC, S-90187 Umea, Sweden; [Stenberg, Per] FOI Swedish Def Res Agcy, Div Chem Biol Radioact & Nucl CBRN Secur & Def, S-90621 Umea, Sweden	Umea University; Umea University; FOI - Swedish Defence Research Agency	Schwartz, YB (corresponding author), Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden.	yuri.schwartz@umu.se			Ake Wiberg Foundation; Magnus Bergvall Foundation; Cancerfonden; Swedish Research Council; Umea Universitet Insamlingsstiftelsen; Strategic Research grant from the Medical Faculty, Umea University; Knut and Alice Wallenberg Foundation; Kempestiftelserna	Ake Wiberg Foundation; Magnus Bergvall Foundation; Cancerfonden(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea Universitet Insamlingsstiftelsen; Strategic Research grant from the Medical Faculty, Umea University; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Kempestiftelserna	This work was supported in part by grants from Ake Wiberg and Magnus Bergvall Foundations (to P. S.), grants from Cancerfonden, Swedish Research Council, and Umea Universitet Insamlingsstiftelsen and a Strategic Research grant from the Medical Faculty, Umea University (to Y. B. S.), and grants from Knut and Alice Wallenberg Foundation and Kempestiftelserna to EpiCoN (to Y. B. S. and P. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Akasaka T, 2001, DEVELOPMENT, V128, P1587; Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112; Ballare C, 2012, NAT STRUCT MOL BIOL, V19, P1257, DOI 10.1038/nsmb.2434; Bel S, 1998, DEVELOPMENT, V125, P3543; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Bowman SK, 2014, ELIFE, V3, DOI 10.7554/eLife.02833; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brockdorff N, 2013, RNA, V19, P429, DOI 10.1261/rna.037598.112; Burns KH, 2003, MOL ENDOCRINOL, V17, P2053, DOI 10.1210/me.2003-0038; Cai L, 2013, MOL CELL, V49, P571, DOI 10.1016/j.molcel.2012.11.026; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Ciferri C, 2012, ELIFE, V1, DOI 10.7554/eLife.00005; Cole AM, 2010, CANCER RES, V70, P8149, DOI 10.1158/0008-5472.CAN-10-0315; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dietrich N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002494; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enderle D, 2011, GENOME RES, V21, P216, DOI 10.1101/gr.114348.110; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fong CY, 2011, STEM CELL REV REP, V7, P1, DOI 10.1007/s12015-010-9166-x; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Geisler SJ, 2015, DEVELOPMENT, V142, P2876, DOI 10.1242/dev.120030; Hagstrom K, 1997, GENETICS, V146, P1365; Hodgson JW, 2001, MOL CELL BIOL, V21, P4528, DOI 10.1128/MCB.21.14.4528-4543.2001; Horard B, 2000, MOL CELL BIOL, V20, P3187, DOI 10.1128/MCB.20.9.3187-3197.2000; Illingworth RS, 2015, GENE DEV, V29, P1897, DOI 10.1101/gad.268151.115; Isono K, 2005, MOL CELL BIOL, V25, P6694, DOI 10.1128/MCB.25.15.6694-6706.2005; Jermann P, 2014, P NATL ACAD SCI USA, V111, pE3415, DOI 10.1073/pnas.1400672111; Kahn TG, 2006, J BIOL CHEM, V281, P29064, DOI 10.1074/jbc.M605430200; Kahn TG, 2016, NUCLEIC ACIDS RES, V44, P10132, DOI 10.1093/nar/gkw701; Kahn TG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004495; Kassis JA, 2013, ADV GENET, V81, P83, DOI 10.1016/B978-0-12-407677-8.00003-8; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kloet SL, 2016, NAT STRUCT MOL BIOL, V23, P682, DOI 10.1038/nsmb.3248; Kohler C, 2010, CURR OPIN GENET DEV, V20, P541, DOI 10.1016/j.gde.2010.04.015; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133j, 10.1021/cb400133J]; Koppens M, 2016, ONCOGENE, V35, P1341, DOI 10.1038/onc.2015.195; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lee HG, 2015, GENOME RES, V25, P1170, DOI 10.1101/gr.188920.114; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Liu YB, 2012, NUCLEIC ACIDS RES, V40, P8227, DOI 10.1093/nar/gks587; Loubiere V, 2016, NAT GENET, V48, P1436, DOI 10.1038/ng.3671; Lynch MD, 2012, EMBO J, V31, P317, DOI 10.1038/emboj.2011.399; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Mermelshtein A, 2005, BRIT J CANCER, V93, P338, DOI 10.1038/sj.bjc.6602709; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nandi S, 2013, NUCLEIC ACIDS RES, V41, P8822, DOI 10.1093/nar/gkt578; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Pengelly AR, 2015, GENE DEV, V29, P1487, DOI 10.1101/gad.265439.115; Pengelly AR, 2013, SCIENCE, V339, P698, DOI 10.1126/science.1231382; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pherson M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700944; Philip P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-97; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Riising EM, 2014, MOL CELL, V55, P347, DOI 10.1016/j.molcel.2014.06.005; Scelfo A, 2015, FEBS J, V282, P1703, DOI 10.1111/febs.13112; Schaaf CA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003560; Schorderet P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003951; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stenberg P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-158; Taherbhoy AM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8621; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Touzet H, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-15; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Xu BW, 2015, BLOOD, V125, P346, DOI 10.1182/blood-2014-06-581082; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yu M, 2012, MOL CELL, V45, P330, DOI 10.1016/j.molcel.2011.11.032	90	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14342	14358		10.1074/jbc.RA118.005010	http://dx.doi.org/10.1074/jbc.RA118.005010			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30068546	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000444671500015
J	Lee, J; Xu, Y; Zhang, T; Cui, L; Saidi, L; Ye, Y				Lee, Juhyung; Xu, Yue; Zhang, Ting; Cui, Lei; Saidi, Layla; Ye, Yihong			Secretion of misfolded cytosolic proteins from mammalian cells is independent of chaperone-mediated autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein misfolding; protein secretion; chaperone; autophagy; endosome; lysosome; -synuclein; chaperone-mediated autophagy; CMA; DNAJC5; CSP; misfolding-associated protein secretion; MAPS; protein quality control; unconventional protein secretion; UPS	NEURODEGENERATIVE DISEASES; UNCONVENTIONAL SECRETION; QUALITY CONTROL; KAPPA-B; LYSOSOMES; DEGRADATION	In eukaryotic cells, elimination of misfolded proteins is essential for maintaining protein homeostasis and cell viability. Misfolding-associated protein secretion (MAPS) is a protein quality-control mechanism that exports misfolded cytosolic proteins via a compartment characteristic of late endosomes, but how cytosolic proteins enter this compartment is unclear. Because chaperone-mediated autophagy (CMA) is a known mechanism that imports cytosolic proteins bearing a specific CMA motif to lysosomes for degradation and because late endosomes and lysosomes overlap significantly in mammalian cells, we determined here whether CMA is involved in targeting protein cargoes to the lumen of late endosomes in MAPS. Using HEK293T and COS-7 cells and immunoblotting and -staining and coimmunoprecipitation methods, we show that, unlike CMA, the secretion of misfolded proteins in MAPS does not require cargo unfolding, is inhibited by serum starvation, and is not dependent on the CMA motif in cargo. Intriguingly, knockdown of lysosome-associated membrane protein 2 (LAMP2), which consists of three isoforms, including a variant proposed to form a protein channel on lysosomes for CMA, attenuated MAPS. However, this could not be attributed to the proposed channel function of the LAMP2a isoform because overexpression of a cytosolic MAPS stimulator, DnaJ heat shock protein family (Hsp40) member C5 (DNAJC5), fully rescued the secretion defect associated with LAMP2 deficiency. We conclude that, in MAPS, cargoes use a CMA-independent mechanism to enter a nondegradative prelysosomal compartment.	[Lee, Juhyung; Xu, Yue; Saidi, Layla; Ye, Yihong] NIDDK, Lab Mol Biol, NIH, Bethesda, MD 20892 USA; [Zhang, Ting] Southern Univ Sci & Technol, SUSTech Acad Adv Interdisciplinary Studies, Shenzhen 518055, Peoples R China; [Cui, Lei] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Hematol & Oncol Lab, Beijing 100045, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Southern University of Science & Technology; Capital Medical University	Ye, Y (corresponding author), NIDDK, Lab Mol Biol, NIH, Bethesda, MD 20892 USA.	yihongy@mail.nih.gov			Intramural Research Program of the NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075145] Funding Source: NIH RePORTER	Intramural Research Program of the NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the NIDDK, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Chen JS, 2010, J BIOL CHEM, V285, P25458, DOI 10.1074/jbc.M110.139345; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 1998, MOL BIOL CELL, V9, P1995, DOI 10.1091/mbc.9.8.1995; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Czlapinski JL, 2008, J AM CHEM SOC, V130, P13186, DOI 10.1021/ja8037728; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; Fontaine SN, 2016, EMBO J, V35, P1537, DOI 10.15252/embj.201593489; HOMEWOOD CA, 1972, NATURE, V235, P50, DOI 10.1038/235050a0; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Lee JG, 2016, NAT CELL BIOL, V18, P765, DOI 10.1038/ncb3372; Li J, 2016, ELIFE, V5, DOI 10.7554/eLife.21635; Li XR, 2016, NAT CELL BIOL, V18, P404, DOI 10.1038/ncb3324; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Pu J, 2017, J CELL BIOL, V216, P4183, DOI 10.1083/jcb.201703094; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Takeuchi T, 2015, P NATL ACAD SCI USA, V112, pE2497, DOI 10.1073/pnas.1412651112; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Wolff S, 2014, CELL, V157, P52, DOI 10.1016/j.cell.2014.03.007; Xu Y, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0012-7; Ye YH, 2018, SEMIN CELL DEV BIOL, V83, P29, DOI 10.1016/j.semcdb.2018.03.006; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	24	10	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14359	14370		10.1074/jbc.RA118.003660	http://dx.doi.org/10.1074/jbc.RA118.003660			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30072379	hybrid, Green Published			2022-12-28	WOS:000444671500016
J	Poudel, S; Yao, JH; Kemp, MG; Leffak, M				Poudel, Sumeet; Yao, Jianhong; Kemp, Michael G.; Leffak, Michael			Interaction between DUE-B and Treslin is required to load Cdc45 on chromatin in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA replication; checkpoint control; chromatin regulation; DNA-protein interaction; DNA damage response	ELEMENT-BINDING PROTEIN; REPLICATION CHECKPOINT CONTROL; CHROMOSOMAL DNA-REPLICATION; CYCLIN-DEPENDENT KINASE; INITIATION; TOPBP1; DAMAGE; YEAST; SLD3; RECRUITMENT	A key step in the initiation of eukaryotic DNA replication is the binding of the activator protein Cdc45 to promote MCM helicase unwinding of the origin template. We show here that the c-myc origin DNA unwinding element-binding protein, DUE-B, interacts in HeLa cells with the replication initiation protein Treslin to allow Cdc45 loading onto chromatin. The chromatin loading of DUE-B and Treslin are mutually dependent, and the DUE-B-Treslin interaction is cell cycle-regulated to peak as cells exit G(1) phase prior to the initiation of replication. The conserved C-terminal domain of DUE-B is required for its binding to TopBP1, Treslin, Cdc45, and the MCM2-7 complex, as well as for the efficient loading of Treslin, Cdc45, and TopBP1 on chromatin. These results suggest that DUE-B acts to identify origins by MCM binding and serves as a node for replication protein recruitment and Cdc45 transfer to the prereplication complex.	[Poudel, Sumeet; Yao, Jianhong; Leffak, Michael] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Kemp, Michael G.] Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton	Leffak, M (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	michael.leffak@wright.edu	Kemp, Michael G./AAT-1545-2021	Kemp, Michael G./0000-0001-8203-0745	Wright State University Biomedical Sciences Ph.D. Program; National Institutes of Health, NIGMS [GM099874, GM122976]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122976, R01GM099874] Funding Source: NIH RePORTER	Wright State University Biomedical Sciences Ph.D. Program; National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Wright State University Biomedical Sciences Ph.D. Program and by grants GM099874 and GM122976 from the National Institutes of Health, NIGMS (to M. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; Casper JM, 2005, J BIOL CHEM, V280, P13071, DOI 10.1074/jbc.M404754200; Chowdhury A, 2010, MOL CELL BIOL, V30, P1495, DOI 10.1128/MCB.00710-09; Douglas ME, 2018, NATURE, V555, P265, DOI 10.1038/nature25787; Fu YV, 2010, CURR BIOL, V20, pR515, DOI 10.1016/j.cub.2010.05.033; Gao YZ, 2014, J BIOL CHEM, V289, P35987, DOI 10.1074/jbc.M114.589119; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Guo C, 2015, MOL CELL, V57, P492, DOI 10.1016/j.molcel.2014.12.003; Hashimoto Y, 2003, EMBO J, V22, P2526, DOI 10.1093/emboj/cdg238; Hassan BH, 2013, J BIOL CHEM, V288, P18903, DOI 10.1074/jbc.M113.475517; Jares P, 2000, GENE DEV, V14, P1528; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kemp M, 2007, J BIOL CHEM, V282, P10441, DOI 10.1074/jbc.M609632200; Kim JH, 2014, TOP CURR CHEM, V344, P119, DOI 10.1007/128_2013_479; Kumagai A, 2017, MOL BIOL CELL, V28, P2998, DOI 10.1091/mbc.E17-07-0448; Kumagai A, 2011, J CELL BIOL, V193, P995, DOI 10.1083/jcb.201102003; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Leung CCY, 2013, STRUCTURE, V21, P1450, DOI 10.1016/j.str.2013.06.015; Liu K, 2017, P NATL ACAD SCI USA, V114, pE3766, DOI 10.1073/pnas.1619832114; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; Mu RL, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00344-17; Noguchi Y, 2017, P NATL ACAD SCI USA, V114, pE9529, DOI 10.1073/pnas.1712537114; Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000; Ohashi E, 2014, DNA REPAIR, V21, P1, DOI 10.1016/j.dnarep.2014.05.001; Sanchez-Pulido L, 2010, CURR BIOL, V20, pR509, DOI 10.1016/j.cub.2010.05.021; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Sansam CG, 2018, GENE DEV, V32, P224, DOI 10.1101/gad.306464.117; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; Yan S, 2006, J CELL BIOL, V173, P181, DOI 10.1083/jcb.200601076	33	1	1	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14497	14506		10.1074/jbc.RA118.004519	http://dx.doi.org/10.1074/jbc.RA118.004519			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30037903	Green Published, hybrid			2022-12-28	WOS:000444671500027
J	Yuan, JM; Ng, WH; Yap, JJ; Chia, B; Huang, XC; Wang, M; Hu, JC				Yuan, Jimin; Ng, Wan Hwa; Yap, Jiajun; Chia, Brandon; Huang, Xuchao; Wang, Mei; Hu, Jiancheng			The AMPK inhibitor overcomes the paradoxical effect of RAF inhibitors through blocking phospho-Ser-621 in the C terminus of CRAF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cancer therapy; cell signaling; drug resistance; cancer biology; 14-3-3; AMP-activated protein kinase; paradoxical activation; RAF inhibitor; RAF kinase	ACTIVATED PROTEIN-KINASE; WILD-TYPE; DEPENDENT MECHANISM; RAF/MEK/ERK PATHWAY; B-RAF; BRAF; CANCER; HETERODIMERIZATION; PHOSPHORYLATION; OLIGOMERIZATION	The dimerization-driven paradoxical activation of RAF proto-oncogene Ser/Thr kinase (RAF) is the predominant cause of drug resistance and toxicity in cancer therapies with RAF inhibitors. The scaffold protein 14-3-3, which binds to the RAF C terminus, is essential for RAF activation under physiological conditions, but the molecular basis is unclear. Here we investigated whether and how 14-3-3 regulates the dimerization-driven transactivation of the RAF isoform CRAF by RAF inhibitors and affects drug resistance and toxicity by virtue of the dominant role of CRAF in these processes. We demonstrated that 14-3-3 enhances the dimerization-driven transactivation of CRAF by stabilizing CRAF dimers. Further, we identified AMP-activated protein kinase (AMPK) and CRAF itself as two putative kinases that redundantly phosphorylate CRAF's C terminus and thereby control its association with 14-3-3. Next, we determined whether the combinatory inhibition of AMPK and CRAF could overcome the paradoxical effect of RAF inhibitors. We found that the AMPK inhibitor (AMPKi) not only blocked the RAF inhibitor-driven paradoxical activation of ERK signaling and cellular overgrowth in Ras-mutated cancer cells by blocking phosphorylation of Ser-621 in CRAF but also reduced the formation of drug-resistant clones of BRAF(V600E)-mutated cancer cells. Last, we investigated whether 14-3-3 binding to the C terminus of CRAF is required for CRAF catalytic activity and observed that it was dispensable in vivo. Altogether, our study unravels the molecular mechanism by which 14-3-3 regulates dimerization-driven RAF activation and identified AMPKi as a potential agent to counteract drug resistance and adverse effects of RAF inhibitors in cancer therapies.	[Yuan, Jimin; Ng, Wan Hwa; Yap, Jiajun; Chia, Brandon; Huang, Xuchao; Hu, Jiancheng] Natl Canc Ctr Singapore, Div Cellular & Mol Res, 11 Hosp Dr, Singapore 169610, Singapore; [Wang, Mei; Hu, Jiancheng] Duke NUS Med Sch, Canc & Stem Cell Program, 8 Coll Rd, Singapore 169857, Singapore	National Cancer Centre Singapore (NCCS); National University of Singapore	Hu, JC (corresponding author), Natl Canc Ctr Singapore, Div Cellular & Mol Res, 11 Hosp Dr, Singapore 169610, Singapore.; Hu, JC (corresponding author), Duke NUS Med Sch, Canc & Stem Cell Program, 8 Coll Rd, Singapore 169857, Singapore.	hu.jiancheng@nccs.com.sg	Hu, Jiancheng/ABE-8133-2021	Hu, Jiancheng/0000-0003-1615-0030; Wang, Mei/0000-0001-6887-6840	National Cancer Centre Singapore Research Fund (NCCRF) Startup Grant NCCRF-SUG-JH; National Cancer Centre Singapore Research Fund (NCCRF) Bridging Grant [NCCRF-YR2016-JUL-BG1]; National Cancer Centre Singapore Research Fund (NCCRF) Pilot/Exploratory Project [NCCRF-YR2017-JULPG3]; Duke-NUS Khoo Bridge Funding Award [Duke-NUS-KBrFA/2017/0003]; SingHealth Foundation Startup Grant [SHF/FG692S/2016]; Asia Fund for Cancer Research Grant [AFCR2017/2019-JH]	National Cancer Centre Singapore Research Fund (NCCRF) Startup Grant NCCRF-SUG-JH; National Cancer Centre Singapore Research Fund (NCCRF) Bridging Grant; National Cancer Centre Singapore Research Fund (NCCRF) Pilot/Exploratory Project; Duke-NUS Khoo Bridge Funding Award; SingHealth Foundation Startup Grant; Asia Fund for Cancer Research Grant	This study was supported by National Cancer Centre Singapore Research Fund (NCCRF) Startup Grant NCCRF-SUG-JH, Bridging Grant NCCRF-YR2016-JUL-BG1, and Pilot/Exploratory Project Grant NCCRF-YR2017-JULPG3, Duke-NUS Khoo Bridge Funding Award Duke-NUS-KBrFA/2017/0003, SingHealth Foundation Startup Grant SHF/FG692S/2016, and Asia Fund for Cancer Research Grant AFCR2017/2019-JH. The authors declare that they have no conflicts of interest with the contents of this article.	Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Cseh B, 2014, FEBS LETT, V588, P2398, DOI 10.1016/j.febslet.2014.06.025; Desideri E, 2015, CELL, V161, P967, DOI 10.1016/j.cell.2015.04.045; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Hu JC, 2008, MOL IMMUNOL, V45, P1825, DOI 10.1016/j.molimm.2007.11.002; Hu J, 2015, MOL CELL BIOL, V35, P264, DOI 10.1128/MCB.00943-14; Hu JC, 2014, J IMMUNOL, V193, P85, DOI 10.4049/jimmunol.1300429; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Hu JC, 2011, P NATL ACAD SCI USA, V108, P6067, DOI 10.1073/pnas.1102554108; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Luo ZJ, 1996, NATURE, V383, P181, DOI 10.1038/383181a0; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mischak H, 1996, MOL CELL BIOL, V16, P5409; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Noble C, 2008, MOL CELL, V31, P862, DOI 10.1016/j.molcel.2008.08.026; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Shaw AS, 2014, MOL CELL BIOL, V34, P1538, DOI 10.1128/MCB.00057-14; Shen CH, 2013, MOL CELL, V52, P161, DOI 10.1016/j.molcel.2013.08.044; Sprenkle AB, 1997, FEBS LETT, V403, P254, DOI 10.1016/S0014-5793(97)00062-8; Taylor SS, 2013, BIOCHEM SOC T, V41, P981, DOI 10.1042/BST20130120; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang XX, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005147; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yuan J., 2017, 101101229849 BOIRXIV, DOI [10. 1101/229849, DOI 10.1101/229849]; Yuan JM, 2018, ONCOGENE, V37, P5719, DOI 10.1038/s41388-018-0365-2	38	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14276	14284		10.1074/jbc.RA118.004597	http://dx.doi.org/10.1074/jbc.RA118.004597			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30030377	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000444671500009
J	Liu, Y; Peng, WQ; Guo, YY; Liu, Y; Tang, QQ; Guo, L				Liu, Yuan; Peng, Wan-Qiu; Guo, Ying-Ying; Liu, Yang; Tang, Qi-Qun; Guo, Liang			Kruppel-like factor 10 (KLF10) is transactivated by the transcription factor C/EBP and involved in early 3T3-L1 preadipocyte differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipogenesis; Kruppel-like factor (KLF); CCAAT-enhancer-binding protein (C; EBP); cell proliferation; transcription regulation; histone deacetylase 1 (HDAC1); adipose tissue; 3T3-L1 preadipocytes; adipocyte differentiation; C; EBP; Kruppel-like factor (KLF); mitotic clonal expansion	MITOTIC CLONAL EXPANSION; ADIPOCYTE DIFFERENTIATION; ADIPOGENESIS; BETA; OBESITY; ALPHA; GENE; EXPRESSION; CELL; ACTIVATION	Adipose tissue stores energy and plays an important role in energy homeostasis. CCAAT/enhancer-binding protein (C/EBP) is an important early transcription factor for 3T3-L1 preadipocyte differentiation, facilitating mitotic clonal expansion (MCE) and transactivating C/EBP and peroxisome proliferator-activated receptor- (PPAR) to promote adipogenesis. C/EBP is induced early, but the expression of antimitotic C/EBP and PPAR is not induced until approximate to 48 h. The delayed expression of C/EBP and PPAR is thought to ensure MCE progression, but the molecular mechanism for this delay remains elusive. Here, we show that the zinc-finger transcription factor Kruppel-like factor 10 (KLF10) is induced after adipogenic induction and that its expression positively correlates with that of C/EBP but inversely correlates with expression of C/EBP and PPAR. C/EBP bound to the KLF10 promoter and transactivated its expression during MCE. KLF10 overexpression in 3T3-L1 preadipocyte repressed adipogenesis and decreased C/EBP and PPAR expression, whereas siRNA-mediated down-regulation of KLF10 enhanced adipogenesis and increased C/EBP and PPAR expression. Luciferase assays revealed an inhibitory effect of KLF10 on C/EBP promoter activity. Using promoter deletion and mutation analysis, we identified a KLF10-binding site within the proximal promoter region of C/EBP. Furthermore, KLF10 interacted with and recruited histone deacetylase 1 (HDAC1) to the C/EBP promoter, decreasing acetylated histone H4 on the C/EBP promoter and inactivating C/EBP transcription. Because C/EBP can transactivate PPAR, our results suggest a mechanism by which expression of C/EBP and PPAR is delayed via KLF10 expression and shed light on the negative feedback loop for C/EBP-regulated adipogenesis in 3T3-L1 preadipocyte.	[Tang, Qi-Qun; Guo, Liang] Fudan Univ, Key Lab Metab & Mol Med, Minist Educ,Dept Biochem & Mol Biol,Sch Basic Med, Inst Stem Cell Res & Regenerat Med,Inst Biomed Sc, Shanghai 200032, Peoples R China; Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Tang, QQ; Guo, L (corresponding author), Fudan Univ, Key Lab Metab & Mol Med, Minist Educ,Dept Biochem & Mol Biol,Sch Basic Med, Inst Stem Cell Res & Regenerat Med,Inst Biomed Sc, Shanghai 200032, Peoples R China.	qqtang@shmu.edu.cn; liangguo@fudan.edu.cn		Guo, Liang/0000-0001-7353-8336	National Natural Science Foundation [81730021, 31571471, 31370027]; Ministry of Science and Technology of the People's Republic of China [2013CB530601]; 985 Project [985 III-YFX0302]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); 985 Project(Jilin UniversityXiamen University)	This work was supported by the National Natural Science Foundation Grants 81730021 (to Q.-Q. T.), 31571471 (to Q.-Q. T.), and 31370027 (to L. G.) and the Ministry of Science and Technology of the People's Republic of China Grant 2013CB530601 (to Q.-Q. T.). The department is supported by 985 Project 985 III-YFX0302. The authors declare that they have no conflicts of interest with the contents of this article.	Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Brey CW, 2009, INT J BIOL SCI, V5, P622; Chen JL, 2018, INT NURS REV, V65, P217, DOI 10.1111/inr.12371; Rafols ME, 2014, ENDOCRINOL NUTR, V61, P100, DOI 10.1016/j.endonu.2013.03.011; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Grundy SM, 2016, J INVEST MED, V64, P1082, DOI 10.1136/jim-2016-000155; Guillaumond F, 2010, MOL CELL BIOL, V30, P3059, DOI 10.1128/MCB.01141-09; Guo L, 2012, CELL DEATH DIFFER, V19, P1917, DOI 10.1038/cdd.2012.75; Guo L, 2017, J CLIN INVEST, V127, P4449, DOI 10.1172/JCI96324; Guo L, 2016, MOL CELL BIOL, V36, P2553, DOI 10.1128/MCB.00227-16; Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957; Guo L, 2013, MOL CELL BIOL, V33, P3180, DOI 10.1128/MCB.00193-13; Hawse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019429; Hopwood B, 2009, BONE, V44, P87, DOI 10.1016/j.bone.2008.08.120; Jiang Y, 2014, J PROTEOME RES, V13, P1307, DOI 10.1021/pr401292p; Kuzmochka C, 2014, ENDOCRINOLOGY, V155, P4762, DOI 10.1210/en.2014-1565; Li D, 2005, J BIOL CHEM, V280, P26941, DOI 10.1074/jbc.M500463200; Li SF, 2013, AM J PHYSIOL-ENDOC M, V304, pE990, DOI 10.1152/ajpendo.00608.2012; Li Z, 2018, OSTEOARTHR CARTILAGE, V26, P966, DOI 10.1016/j.joca.2018.04.002; Mishra VK, 2017, CANCER RES, V77, P2387, DOI 10.1158/0008-5472.CAN-16-2589; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Pei H, 2011, CELL DEATH DIFFER, V18, P315, DOI 10.1038/cdd.2010.100; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Shukla AP, 2015, J CARDIOPULM REHABIL, V35, P81, DOI 10.1097/HCR.0000000000000112; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Subramaniam M, 2010, BIOFACTORS, V36, P8, DOI 10.1002/biof.67; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Xiao TF, 2015, STEM CELL REP, V5, P856, DOI 10.1016/j.stemcr.2015.09.007; Xiong YN, 2014, AM J PHYSIOL-REG I, V307, pR608, DOI 10.1152/ajpregu.00085.2014; Yamamoto K, 2010, BIOCHEM BIOPH RES CO, V400, P175, DOI 10.1016/j.bbrc.2010.08.039; Yang XY, 2017, DIABETOLOGIA, V60, P2443, DOI 10.1007/s00125-017-4412-2; Yu JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13884; Zhang YY, 2012, MOL ENDOCRINOL, V26, P798, DOI 10.1210/me.2011-1287; Zhang YY, 2011, MOL BIOL CELL, V22, P2165, DOI 10.1091/mbc.E10-11-0912; Zhang ZW, 2013, ACTA BIOCH BIOPH SIN, V45, P280, DOI 10.1093/abbs/gmt010	42	20	24	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14012	14021		10.1074/jbc.RA118.004401	http://dx.doi.org/10.1074/jbc.RA118.004401			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30026232	hybrid, Green Published			2022-12-28	WOS:000444070700025
J	Dong, XC; Ghoshal, K; Majumder, S; Yadav, SP; Jacob, ST				Dong, Xiaocheng; Ghoshal, Kalpana; Majumder, Sarmila; Yadav, Satya P.; Jacob, Samson T.			RETRACTION: Mitochondrial transcription factor A and its downstream targets are up-regulated in a rat hepatoma (Retraction of Vol 277, Pg 43309, 2002)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Dong XC, 2002, J BIOL CHEM, V277, P43309, DOI 10.1074/jbc.M206958200	1	1	1	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12947	12947		10.1074/jbc.W118.004969	http://dx.doi.org/10.1074/jbc.W118.004969			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	30120151	Green Published, hybrid			2022-12-28	WOS:000442203500027
J	Teng, L; Bennett, E; Cai, CX				Teng, Lei; Bennett, Edward; Cai, Chuanxi			Preconditioning c-Kit-positive human cardiac stem cells with a nitric oxide donor enhances cell survival through activation of survival signaling pathways (vol 291, pg 9733, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Cai, Chuanxi/AAW-1488-2020					Teng L, 2016, J BIOL CHEM, V291, P9733, DOI 10.1074/jbc.M115.687806	1	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12619	12619		10.1074/jbc.AAC118.004922	http://dx.doi.org/10.1074/jbc.AAC118.004922			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	30097492	Green Published, hybrid			2022-12-28	WOS:000441408500025
J	Igarashi, K; Kashiwagi, K				Igarashi, Kazuei; Kashiwagi, Keiko			Effects of polyamines on protein synthesis and growth of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RNA-POLYMERASE; DIFFERENTIAL STIMULATION; SIGMA(38) SUBUNIT; STRUCTURAL-CHANGE; GENE-EXPRESSION; CELL VIABILITY; RIBOSOMAL-RNA; SPERMIDINE; BINDING; PUTRESCINE	The polyamines (PA) putrescine, spermidine, and spermine have numerous roles in the growth of both prokaryotic and eukaryotic cells. For example, it is well known that putrescine and spermidine are strongly involved in proliferation and viability of Escherichia coli cells. Studies of polyamine functions and distributions in E. coli cells have revealed that polyamines mainly exist as an RNA-polyamine complex. Polyamines stimulate the assembly of 30S ribosomal subunits and thereby increase general protein synthesis 1.5- to 2.0-fold. Moreover, these studies have shown that polyamines stimulate synthesis of 20 different proteins at the level of translation, which are strongly involved in cell growth and viability. The genes encoding these 20 different proteins were termed as the "polyamine modulon." We here review the mechanism of activation of 30S ribosomal subunits and stimulation of specific proteins. Other functions of polyamines in E. coli are also described.	[Igarashi, Kazuei] Chiba Univ, Amine Pharma Res Inst, Chuo Ku, Innovat Plaza,1-8-15, Chiba, Chiba 2600856, Japan; [Kashiwagi, Keiko] Chiba Inst Sci, Fac Pharm, 15-8 Shiomi Cho, Choshi, Chiba 2800025, Japan	Chiba University	Igarashi, K (corresponding author), Chiba Univ, Amine Pharma Res Inst, Chuo Ku, Innovat Plaza,1-8-15, Chiba, Chiba 2600856, Japan.	iga16077@faculty.chiba-u.jp			Ministry of Education, Science, Sports and Culture, Japan	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture, Japan. This article is part of a series on "Polyamines," written in honor of Dr. Herbert Tabor's 100th birthday. The authors declare that they have no conflicts of interest with the contents of this article.	Antognoni F, 1999, J BIOL CHEM, V274, P1942, DOI 10.1074/jbc.274.4.1942; Arenas FA, 2010, BIOCHEM BIOPH RES CO, V398, P690, DOI 10.1016/j.bbrc.2010.07.002; BAKKER EP, 1981, J BACTERIOL, V147, P820, DOI 10.1128/JB.147.3.820-826.1981; CARPER SW, 1991, J BIOL CHEM, V266, P12439; CASHEL M, 1975, ANNU REV MICROBIOL, V29, P301, DOI 10.1146/annurev.mi.29.100175.001505; Chasteen TG, 2009, FEMS MICROBIOL REV, V33, P820, DOI 10.1111/j.1574-6976.2009.00177.x; Chattopadhyay MK, 2015, J BIOL CHEM, V290, P17809, DOI 10.1074/jbc.M115.655688; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; CUNNINGHAMRUNDLES S, 1975, J BACTERIOL, V124, P791, DOI 10.1128/JB.124.2.791-799.1975; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; ECHANDI G, 1975, BIOCHEM BIOPH RES CO, V67, P1185, DOI 10.1016/0006-291X(75)90798-6; FURUCHI T, 1991, J BIOL CHEM, V266, P20928; HAFNER EW, 1979, J BIOL CHEM, V254, P2419; Higashi K, 2008, J BIOL CHEM, V283, P32989, DOI 10.1074/jbc.M806027200; Higashi K, 2008, J BACTERIOL, V190, P872, DOI 10.1128/JB.01505-07; Hirokawa G, 2005, RNA, V11, P1317, DOI 10.1261/rna.2520405; IGARASHI K, 1980, BIOCHEM BIOPH RES CO, V96, P678, DOI 10.1016/0006-291X(80)91408-4; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; IGARASHI K, 1981, EUR J BIOCHEM, V113, P587, DOI 10.1111/j.1432-1033.1981.tb05103.x; IGARASHI K, 1975, BIOCHEM BIOPH RES CO, V67, P407, DOI 10.1016/0006-291X(75)90330-7; IGARASHI K, 1974, EUR J BIOCHEM, V48, P495, DOI 10.1111/j.1432-1033.1974.tb03790.x; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Igarashi K, 2015, IUBMB LIFE, V67, P160, DOI 10.1002/iub.1363; Igarashi K, 2010, PLANT PHYSIOL BIOCH, V48, P506, DOI 10.1016/j.plaphy.2010.01.017; KASHIWAGI K, 1990, J BIOL CHEM, V265, P8387; KASHIWAGI K, 1992, P NATL ACAD SCI USA, V89, P4529, DOI 10.1073/pnas.89.10.4529; Kashiwagi K, 2018, METHODS MOL BIOL, V1694, P325, DOI 10.1007/978-1-4939-7398-9_27; Michael AJ, 2016, J BIOL CHEM, V291, P14896, DOI 10.1074/jbc.R116.734780; MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; OGASAWARA T, 1989, J BIOCHEM-TOKYO, V105, P164, DOI 10.1093/oxfordjournals.jbchem.a122633; Oshima T, 2002, MOL MICROBIOL, V45, P673, DOI 10.1046/j.1365-2958.2002.03037.x; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; Park MH, 1997, BIOL SIGNAL, V6, P115; Pegg AE, 2016, J BIOL CHEM, V291, P14904, DOI 10.1074/jbc.R116.731661; QUIGLEY GJ, 1978, P NATL ACAD SCI USA, V75, P64, DOI 10.1073/pnas.75.1.64; Raj VS, 2001, J BACTERIOL, V183, P4493, DOI 10.1128/JB.183.15.4493-4498.2001; Sakamoto A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124883; Sakamoto A, 2012, INT J BIOCHEM CELL B, V44, P1877, DOI 10.1016/j.biocel.2012.07.010; Sambrook J., 2001, MOL CLONING LAB MANU, P746; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; SOUZU H, 1986, BIOCHIM BIOPHYS ACTA, V861, P361, DOI 10.1016/0005-2736(86)90439-6; Sugiyama S, 2016, INT J BIOCHEM CELL B, V76, P87, DOI 10.1016/j.biocel.2016.05.003; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR H, 1980, J BACTERIOL, V144, P952, DOI 10.1128/JB.144.3.952-956.1980; TABOR H, 1964, PHARMACOL REV, V16, P245; TABOR H, 1982, P NATL ACAD SCI-BIOL, V79, P7087, DOI 10.1073/pnas.79.23.7087; Terui Y, 2012, INT J BIOCHEM CELL B, V44, P412, DOI 10.1016/j.biocel.2011.11.017; THOMAS T, 1995, J STEROID BIOCHEM, V54, P89, DOI 10.1016/0960-0760(95)00126-K; THOMAS TJ, 1994, BIOCHEM J, V298, P485, DOI 10.1042/bj2980485; WATANABE S, 1991, J BIOL CHEM, V266, P20803; WATANABE Y, 1981, BIOCHIM BIOPHYS ACTA, V656, P134, DOI 10.1016/0005-2787(81)90078-2; WATANABE Y, 1983, BIOCHIM BIOPHYS ACTA, V740, P362, DOI 10.1016/0167-4781(83)90083-0; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Yoshida M, 2004, J BIOL CHEM, V279, P46008, DOI 10.1074/jbc.M404393200; Yoshida M, 2002, J BIOL CHEM, V277, P37139, DOI 10.1074/jbc.M206668200; Yoshida M, 1999, J BIOL CHEM, V274, P22723, DOI 10.1074/jbc.274.32.22723	60	36	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18702	18709		10.1074/jbc.TM118.003465	http://dx.doi.org/10.1074/jbc.TM118.003465			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30108177	hybrid, Green Published			2022-12-28	WOS:000458467300025
J	Pimviriyakul, P; Chaiyen, P				Pimviriyakul, Panu; Chaiyen, Pimchai			A complete bioconversion cascade for dehalogenation and denitration by bacterial flavin-dependent enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; CHLOROPHENOL 4-MONOOXYGENASE TFTD; DEGRADATION GENE-CLUSTER; OXYGEN ACTIVATION; ESCHERICHIA-COLI; REDUCED FLAVIN; 2,4,6-TRICHLOROPHENOL DEGRADATION; ACINETOBACTER-BAUMANNII; NITROAROMATIC COMPOUNDS; OXIDOREDUCTASE TFTC	Halogenated phenol and nitrophenols are toxic compounds that are widely accumulated in the environment. Enzymes in the had operon from the bacterium Ralstonia pickettii DTP0602 have the potential for application as biocatalysts in the degradation of many of these toxic chemicals. HadA monooxygenase previously was identified as a two-component reduced FAD (FADH(-))-utilizing monooxygenase with dual activities of dehalogenation and denitration. However, the partner enzymes of HadA, that is, the flavin reductase and quinone reductase that provide the FADH(-) for HadA and reduce quinone to hydroquinone, remain to be identified. In this report, we overexpressed and purified the flavin reductases, HadB and HadX, to investigate their functional and catalytic properties. Our results indicated that HadB is an FMN-dependent quinone reductase that converts the quinone products from HadA to hydroquinone compounds that are more stable and can be assimilated by downstream enzymes in the pathway. Transient kinetics indicated that HadB prefers NADH and menadione as the electron donor and acceptor, respectively. We found that HadX is an FAD-bound flavin reductase, which can generate FADH(-) for HadA to catalyze dehalogenation or denitration reactions. Thermodynamic and transient kinetic experiments revealed that HadX prefers to bind FAD over FADH(-) and that HadX can transfer FADH(-) from HadX to HadA via free diffusion. Moreover, HadX rapidly catalyzed NADH-mediated reduction of flavin and provided the FADH(-) for a monooxygenase of a different system. Combination of all three flavin-dependent enzymes, i.e. HadA/HadB/HadX, reconstituted an effective dehalogenation and denitration cascade, which may be useful for future bioremediation applications.	[Pimviriyakul, Panu; Chaiyen, Pimchai] Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn, Wangchan Valley 21210, Rayong, Thailand; [Pimviriyakul, Panu] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 14000, Thailand; [Pimviriyakul, Panu] Mahidol Univ, Fac Sci, Ctr Excellence Prot & Enzyme Technol, Bangkok 14000, Thailand	Vidyasirimedhi Institute of Science & Technology; Mahidol University; Mahidol University	Chaiyen, P (corresponding author), Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn, Wangchan Valley 21210, Rayong, Thailand.	pimchai.chaiyen@vistec.ac.th	Chaiyen, Pimchai/R-5052-2019	Chaiyen, Pimchai/0000-0002-8533-1604; Pimviriyakul, Panu/0000-0002-0410-0610	Thailand Research Fund [RTA5980001]; Vidyasirimedhi Institute of Science and Technology (VISTEC); Development and Promotion of Science and Technology Talents Project (DPST) Scholarship from VISTEC; VISTEC	Thailand Research Fund(Thailand Research Fund (TRF)); Vidyasirimedhi Institute of Science and Technology (VISTEC); Development and Promotion of Science and Technology Talents Project (DPST) Scholarship from VISTEC; VISTEC	This work was supported by The Thailand Research Fund Grant RTA5980001, a grant from Vidyasirimedhi Institute of Science and Technology (VISTEC) (to P. C.), and Development and Promotion of Science and Technology Talents Project (DPST) Scholarship and postdoctoral fellowship from VISTEC (to P. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Arora PK, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-31; Arora PK, 2014, J HAZARD MATER, V266, P42, DOI 10.1016/j.jhazmat.2013.12.011; Baron R, 2009, P NATL ACAD SCI USA, V106, P10603, DOI 10.1073/pnas.0903809106; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Belchik SM, 2008, J BACTERIOL, V190, P1615, DOI 10.1128/JB.01697-07; Blaza JN, 2017, SCI REP-UK, V7, DOI 10.1038/srep40165; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Cho SY, 2017, BIORESOURCE TECHNOL, V245, P1800, DOI 10.1016/j.biortech.2017.05.006; Collins FA, 2018, BIOCHEMISTRY-US, V57, P3493, DOI 10.1021/acs.biochem.8b00255; Deller S, 2008, CELL MOL LIFE SCI, V65, P141, DOI 10.1007/s00018-007-7300-y; Filisetti L, 2005, FEBS LETT, V579, P2817, DOI 10.1016/j.febslet.2005.04.019; Filisetti L, 2003, J BIOL CHEM, V278, P296, DOI 10.1074/jbc.M209689200; Flores E, 2018, BIOCHEMISTRY-US, V57, P3050, DOI 10.1021/acs.biochem.8b00090; Gadda G, 2012, BIOCHEMISTRY-US, V51, P2662, DOI 10.1021/bi300227d; Gisi MR, 2003, J BACTERIOL, V185, P2786, DOI 10.1128/JB.185.9.2786-2792.2003; Gonzalez CF, 2005, J BIOL CHEM, V280, P22590, DOI 10.1074/jbc.M501654200; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Hatta T, 1999, J BIOSCI BIOENG, V87, P267, DOI 10.1016/S1389-1723(99)80030-9; Hatta T, 2012, BIOSCI BIOTECH BIOCH, V76, P892, DOI 10.1271/bbb.110843; Igbinosa EO, 2013, SCI WORLD J, DOI [10.1155/2013/460215, 10.1155/2013/798096]; Jarrom D, 2009, BIOCHEMISTRY-US, V48, P7665, DOI 10.1021/bi900674m; Karci A, 2014, CHEMOSPHERE, V99, P1, DOI 10.1016/j.chemosphere.2013.10.034; Kirchner U, 2003, J BIOL CHEM, V278, P47545, DOI 10.1074/jbc.M307397200; Kishko I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043902; Kitagawa W, 2004, J BACTERIOL, V186, P4894, DOI 10.1128/JB.186.15.4894-4902.2004; Lam LKM, 2012, BIOCHEMISTRY-US, V51, P5014, DOI 10.1021/bi300477z; Leferink NGH, 2009, J BIOL CHEM, V284, P4392, DOI 10.1074/jbc.M808202200; Louie TM, 2003, BIOCHEMISTRY-US, V42, P7509, DOI 10.1021/bi034092r; Luanloet T, 2015, FEBS J, V282, P3107, DOI 10.1111/febs.13220; McDonald CA, 2011, J AM CHEM SOC, V133, P16809, DOI 10.1021/ja2081873; Miseviciene L, 2006, ACTA BIOCHIM POL, V53, P569; Nijvipakul S, 2008, J BACTERIOL, V190, P1531, DOI 10.1128/JB.01660-07; Nijvipakul S, 2010, BIOCHEMISTRY-US, V49, P9241, DOI 10.1021/bi1009985; Olaniran AO, 2011, CHEMOSPHERE, V83, P1297, DOI 10.1016/j.chemosphere.2011.04.009; Otto K, 2004, J BACTERIOL, V186, P5292, DOI 10.1128/JB.186.16.5292-5302.2004; Patridge EV, 2006, J BACTERIOL, V188, P3498, DOI 10.1128/JB.188.10.3498-3506.2006; Payne KAP, 2015, NATURE, V517, P513, DOI 10.1038/nature13901; Pera-Titus M, 2004, APPL CATAL B-ENVIRON, V47, P219, DOI 10.1016/j.apcatb.2003.09.010; Perry LL, 2007, J BACTERIOL, V189, P7563, DOI 10.1128/JB.01849-06; Phongsak T, 2012, J BIOL CHEM, V287, P26213, DOI 10.1074/jbc.M112.354472; Pimviriyakul P, 2018, CHEM SCI, V9, DOI 10.1039/c8sc01482e; Pimviriyakul P, 2017, J BIOL CHEM, V292, P4818, DOI 10.1074/jbc.M116.774448; Pitsawong W, 2014, J BIOL CHEM, V289, P15203, DOI 10.1074/jbc.M113.547117; Rau J, 2003, APPL ENVIRON MICROB, V69, P3448, DOI 10.1128/AEM.69.6.3448-3455.2003; Romero E, 2018, CHEM REV, V118, P1742, DOI 10.1021/acs.chemrev.7b00650; Ross D, 2004, DRUG METAB REV, V36, P639, DOI 10.1081/DMR-200033465; Sollner S, 2007, FEBS J, V274, P1328, DOI 10.1111/j.1742-4658.2007.05682.x; Sollner S, 2009, BIOCHEMISTRY-US, V48, P8636, DOI 10.1021/bi900734a; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sucharitakul J, 2005, BIOCHEMISTRY-US, V44, P10434, DOI 10.1021/bi050615e; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Sucharitakul J, 2016, FEBS J, V283, P860, DOI 10.1111/febs.13636; Sucharitakul J, 2014, ARCH BIOCHEM BIOPHYS, V555, P33, DOI 10.1016/j.abb.2014.05.009; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Takeo M, 2008, J BACTERIOL, V190, P7367, DOI 10.1128/JB.00742-08; TEDESCHI G, 1995, J BIOL CHEM, V270, P1198, DOI 10.1074/jbc.270.3.1198; Tinikul R, 2013, BIOCHEMISTRY-US, V52, P6834, DOI 10.1021/bi4006545; Valiauga B, 2017, ARCH BIOCHEM BIOPHYS, V614, P14, DOI 10.1016/j.abb.2016.12.005; Valton J, 2006, J BIOL CHEM, V281, P27, DOI 10.1074/jbc.M506146200; Valton J, 2004, J BIOL CHEM, V279, P44362, DOI 10.1074/jbc.M407722200; Valton J, 2008, J BIOL CHEM, V283, P10287, DOI 10.1074/jbc.M709730200; Visitsatthawong S, 2015, J AM CHEM SOC, V137, P9363, DOI 10.1021/jacs.5b04328; Webb BN, 2010, J BIOL CHEM, V285, P2014, DOI 10.1074/jbc.M109.056135; Wongnate T, 2014, J AM CHEM SOC, V136, P241, DOI 10.1021/ja4088055; XUN LY, 1992, J BACTERIOL, V174, P5745, DOI 10.1128/JB.174.17.5745-5747.1992; Yamamoto K, 2011, J BIOSCI BIOENG, V111, P687, DOI 10.1016/j.jbiosc.2011.01.016; Yeh E, 2005, P NATL ACAD SCI USA, V102, P3960, DOI 10.1073/pnas.0500755102; Zaborina O, 1998, J BACTERIOL, V180, P4667, DOI 10.1128/JB.180.17.4667-4675.1998; Zhao GH, 2008, BIOCHEMISTRY-US, V47, P9124, DOI 10.1021/bi8008642	72	14	14	7	39	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18525	18539		10.1074/jbc.RA118.005538	http://dx.doi.org/10.1074/jbc.RA118.005538			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30282807	hybrid, Green Published			2022-12-28	WOS:000458467300010
J	Zhu, ZQ; Chung, YM; Sergeeva, O; Kepe, V; Berk, M; Li, JN; Ko, HK; Li, ZF; Petro, M; DiFilippo, FP; Lee, Z; Sharifi, N				Zhu, Ziqi; Chung, Yoon-Mi; Sergeeva, Olga; Kepe, Vladimir; Berk, Michael; Li, Jianneng; Ko, Hyun-Kyung; Li, Zhenfei; Petro, Marianne; DiFilippo, Frank P.; Lee, Zhenghong; Sharifi, Nima			Loss of dihydrotestosterone-inactivation activity promotes prostate cancer castration resistance detectable by functional imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						steroid; steroid hormone receptor; steroidogenesis; metabolism; metabolic regulation; androgen; uridine 5'-diphospho-glucuronosyltransferase (UDP-glucuronosyltransferase); castration-resistant prostate cancer; nuclear medicine; PET; prostate cancer	ANDROGEN RECEPTOR; UDP-GLUCURONOSYLTRANSFERASES; TESTOSTERONE; GLUCURONIDATION; PROGRESSION; ABIRATERONE; METASTASIS; EXPRESSION	Androgens such as testosterone and dihydrotestosterone are a critical driver of prostate cancer progression. Cancer resistance to androgen deprivation therapies ensues when tumors engage metabolic processes that produce sustained androgen levels in the tissue. However, the molecular mechanisms involved in this resistance process are unclear, and functional imaging modalities that predict impending resistance are lacking. Here, using the human LNCaP and C4-2 cell line models of prostate cancer, we show that castration treatment-sensitive prostate cancer cells that normally have an intact glucuronidation pathway that rapidly conjugates and inactivates dihydrotestosterone and thereby limits androgen signaling, become glucuronidation deficient and resistant to androgen deprivation. Mechanistically, using CRISPR/Cas9-mediated gene ablation, we found that loss of UDP glucuronosyltransferase family 2 member B15 (UGT2B15) and UGT2B17 is sufficient to restore free dihydrotestosterone, sustained androgen signaling, and development of castration resistance. Furthermore, loss of glucuronidation enzymatic activity was also detectable with a nonsteroid glucuronidation substrate. Of note, glucuronidation-incompetent cells and the resultant loss of intracellular conjugated dihydrotestosterone were detectable in vivo by F-18-dihydrotestosterone PET. Together, these findings couple a mechanism with a functional imaging modality to identify impending castration resistance in prostate cancers.	[Zhu, Ziqi; Chung, Yoon-Mi; Berk, Michael; Li, Jianneng; Ko, Hyun-Kyung; Li, Zhenfei; Petro, Marianne; Sharifi, Nima] Cleveland Clin, Genitourinary Malignancies Res Ctr, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA; [Kepe, Vladimir; DiFilippo, Frank P.] Cleveland Clin, Dept Nucl Med, Imaging Inst, Cleveland, OH 44195 USA; [Sharifi, Nima] Cleveland Clin, Dept Urol, Glickman Urol & Kidney Inst, Cleveland, OH 44195 USA; [Sharifi, Nima] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Oncol, Cleveland, OH 44195 USA; [Sergeeva, Olga; Lee, Zhenghong] Case Western Reserve Univ, Dept Radiol, Cleveland, OH 44124 USA; [Lee, Zhenghong] Case Western Reserve Univ, Biomed Engn, Cleveland, OH 44124 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Sharifi, N (corresponding author), Cleveland Clin, Genitourinary Malignancies Res Ctr, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA.; Sharifi, N (corresponding author), Cleveland Clin, Dept Urol, Glickman Urol & Kidney Inst, Cleveland, OH 44195 USA.; Sharifi, N (corresponding author), Cleveland Clin, Taussig Canc Inst, Dept Hematol & Oncol, Cleveland, OH 44195 USA.	sharifn@ccf.org	Zhu, Ziqi/B-5063-2014; Berk, Michael/M-7891-2013; Sergeeva, Olga/AAE-1869-2019	Zhu, Ziqi/0000-0001-8066-2052; Berk, Michael/0000-0002-5554-6946; Li, Zhenfei/0000-0001-6520-431X	Howard Hughes Medical Institute Physician-Scientist Early Career Award; Prostate Cancer Foundation Challenge Award; National Institutes of Health NCI [R01CA168899, R01CA172382, R01CA190289]; NCI [5R01CA204373]; Congressionally Directed Medical Research Programs, Prostate Cancer Research Program Award [PC141550]; NATIONAL CANCER INSTITUTE [R01CA190289, R01CA172382, R01CA204373, R01CA168899] Funding Source: NIH RePORTER	Howard Hughes Medical Institute Physician-Scientist Early Career Award(Howard Hughes Medical Institute); Prostate Cancer Foundation Challenge Award; National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Congressionally Directed Medical Research Programs, Prostate Cancer Research Program Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Howard Hughes Medical Institute Physician-Scientist Early Career Award and a Prostate Cancer Foundation Challenge Award (to N. S.), National Institutes of Health NCI Grants R01CA168899, R01CA172382, and R01CA190289 (to N. S.), NCI Grant 5R01CA204373 (to Z. L.), and Congressionally Directed Medical Research Programs, Prostate Cancer Research Program Award PC141550 (to Z. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Asim M, 2008, ONCOGENE, V27, P3596, DOI 10.1038/sj.onc.1211016; Attard G, 2016, LANCET, V387, P70, DOI 10.1016/S0140-6736(14)61947-4; Bao BY, 2008, PROSTATE, V68, P839, DOI 10.1002/pros.20749; Barbier O, 2008, BEST PRACT RES CL EN, V22, P259, DOI 10.1016/j.beem.2008.01.001; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Carreira S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009448; Chang KH, 2013, CELL, V154, P1074, DOI 10.1016/j.cell.2013.07.029; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; Dai C, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a030452; Feldman JL, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.4_suppl.56; Fizazi K, 2017, NEW ENGL J MED, V377, P352, DOI 10.1056/NEJMoa1704174; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gillessen S, 2018, EUR UROL, V73, P178, DOI 10.1016/j.eururo.2017.06.002; Harmon SA, 2017, J CLIN ONCOL, V35, P2829, DOI 10.1200/JCO.2017.72.2348; Huggins C, 1941, CANCER RES, V1, P293; James ND, 2017, NEW ENGL J MED, V377, P338, DOI 10.1056/NEJMoa1702900; Krueckl SL, 2004, CANCER RES, V64, P8620, DOI 10.1158/0008-5472.CAN-04-2446; Larson SM, 2004, J NUCL MED, V45, P366; Li JN, 2017, ELIFE, V6, DOI 10.7554/eLife.20183; Li ZF, 2016, NATURE, V533, P547, DOI 10.1038/nature17954; Li ZF, 2015, NATURE, V523, P347, DOI 10.1038/nature14406; LIU AJ, 1992, J MED CHEM, V35, P2113, DOI 10.1021/jm00089a024; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Romanel A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac9511; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarkar S, 2014, ONCOGENE, V33, P26, DOI 10.1038/onc.2012.561; Sten T, 2009, DRUG METAB DISPOS, V37, P417, DOI 10.1124/dmd.108.024844; TEPHLY TR, 1994, DRUG METAB DISPOS, V22, P713; THALMANN GN, 1994, CANCER RES, V54, P2577; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Turgeon D, 2001, ENDOCRINOLOGY, V142, P778, DOI 10.1210/en.142.2.778; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Wu JB, 2017, CANCER CELL, V31, P368, DOI 10.1016/j.ccell.2017.02.003	36	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17829	17837		10.1074/jbc.RA118.004846	http://dx.doi.org/10.1074/jbc.RA118.004846			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30262668	Green Published, hybrid			2022-12-28	WOS:000450409500014
J	Ying, GX; Boldt, K; Ueffing, M; Gerstner, CD; Frederick, JM; Baehr, W				Ying, Guoxin; Boldt, Karsten; Ueffing, Marius; Gerstner, Cecilia D.; Frederick, Jeanne M.; Baehr, Wolfgang			The small GTPase RAB28 is required for phagocytosis of cone outer segments by the murine retinal pigmented epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						small GTPase; retinal degeneration; photoreceptor; phagocytosis; gene knockout; retina; cone-rod dystrophy; RAB28; retinal pigmented epithelium; disc shedding	ROD DYSTROPHY; MOUSE RETINA; RCS RAT; GENE; PHOTORECEPTOR; MUTATION; CELLS; TRAFFICKING; PROTEIN; MERTK	RAB28, a member of the RAS oncogene family, is a ubiquitous, farnesylated, small GTPase of unknown function present in photoreceptors and the retinal pigmented epithelium (RPE). Nonsense mutations of the human RAB28 gene cause recessive cone-rod dystrophy 18 (CRD18), characterized by macular hyperpigmentation, progressive loss of visual acuity, RPE atrophy, and severely attenuated cone and rod electroretinography (ERG) responses. In an attempt to elucidate the disease-causing mechanism, we generated Rab28(-/-) mice by deleting exon 3 and truncating RAB28 after exon 2. We found that Rab28(-/-) mice recapitulate features of the human dystrophy (i.e. they exhibited reduced cone and rod ERG responses and progressive retina degeneration). Cones of Rab28(-/-) mice extended their outer segments (OSs) to the RPE apical processes and formed enlarged, balloon-like distal tips before undergoing degeneration. The visual pigment content of WT and Rab28(-/-) cones was comparable before the onset of degeneration. Cone phagosomes were almost absent in Rab28(-/-) mice, whereas rod phagosomes displayed normal levels. A protein-protein interaction screen identified several RAB28-interacting proteins, including the prenyl-binding protein phosphodiesterase 6 -subunit (PDE6D) and voltage-gated potassium channel subfamily J member 13 (KCNJ13) present in the RPE apical processes. Of note, the loss of PDE6D prevented delivery of RAB28 to OSs. Taken together, these findings reveal that RAB28 is required for shedding and phagocytosis of cone OS discs.	[Ying, Guoxin; Gerstner, Cecilia D.; Frederick, Jeanne M.; Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA; [Boldt, Karsten; Ueffing, Marius] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Elfriede Aulhorn Str 7, D-72076 Tubingen, Germany; [Baehr, Wolfgang] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ying, GX; Baehr, W (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA.	g.ying@utah.edu; wbaehr@hsc.utah.edu			National Institutes of Health [EY08123, EY019298, EY014800-039003]; Research to Prevent Blindness (New York); Tistou & Charlotte Kerstan Stiftung (Tubingen, Germany); RPB Senior Investigator award; RPB Nelson Trust award; NATIONAL EYE INSTITUTE [R01EY008123, R01EY019298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (New York)(Research to Prevent Blindness (RPB)); Tistou & Charlotte Kerstan Stiftung (Tubingen, Germany); RPB Senior Investigator award; RPB Nelson Trust award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants EY08123 and EY019298 (to W. B.) and EY014800-039003 (NEI core grant); by unrestricted grants to the University of Utah Department of Ophthalmology from Research to Prevent Blindness (New York); and by the Tistou & Charlotte Kerstan Stiftung (Tubingen, Germany). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of an RPB Senior Investigator award and an RPB Nelson Trust award. To whom correspondence may be addressed: Dept. of Ophthalmology and Visual Sciences, University of Utah Health Science Center, 65 Mario Capecchi Dr., Salt Lake City, UT 84132. Tel.: 801-585-6643. E-mail: wbaehr@hsc.utah.edu.	Ait-Ali N, 2015, CELL, V161, P817, DOI 10.1016/j.cell.2015.03.023; ANDERSON DH, 1980, EXP EYE RES, V30, P559, DOI 10.1016/0014-4835(80)90040-8; Antrobus R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018218; Audo I, 2018, HUM MUTAT, V39, P887, DOI 10.1002/humu.23431; Brauers A, 1996, EUR J BIOCHEM, V237, P833, DOI 10.1111/j.1432-1033.1996.0833p.x; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Coleman JA, 2014, J CELL SCI, V127, P1138, DOI 10.1242/jcs.145052; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; DONNELLY P, 1994, HUM MOL GENET, V3, P1017, DOI 10.1093/hmg/3.6.1017; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; FISHER SK, 1983, INVEST OPHTH VIS SCI, V24, P844; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Gloeckner Christian Johannes, 2009, Methods Mol Biol, V564, P359, DOI 10.1007/978-1-60761-157-8_21; Hall MO, 2001, EXP EYE RES, V73, P509, DOI 10.1006/exer.2001.1062; Hanke-Gogokhia C, 2016, J BIOL CHEM, V291, P7142, DOI 10.1074/jbc.M115.710954; HOGAN MJ, 1974, NATURE, V252, P305, DOI 10.1038/252305a0; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Jensen VL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006469; Jiang JQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055729, 10.1371/journal.pone.0068482]; Kocaoglu OP, 2016, BIOMED OPT EXPRESS, V7, P4554, DOI 10.1364/BOE.7.004554; Kusaka S, 2001, J PHYSIOL-LONDON, V531, P27, DOI 10.1111/j.1469-7793.2001.0027j.x; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Lee GI, 2017, OPHTHALMIC GENET, V38, P587, DOI 10.1080/13816810.2017.1301965; Lee SH, 2008, FEBS LETT, V582, P4107, DOI 10.1016/j.febslet.2008.11.008; LONG KO, 1986, EXP EYE RES, V43, P193, DOI 10.1016/S0014-4835(86)80087-2; Lumb JH, 2011, J CELL SCI, V124, P3771, DOI 10.1242/jcs.079178; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mustafi D, 2011, FASEB J, V25, P3157, DOI 10.1096/fj.11-186767; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Omori Y, 2015, GENES CELLS, V20, P408, DOI 10.1111/gtc.12233; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Riveiro-Alvarez R, 2015, JAMA OPHTHALMOL, V133, P133, DOI 10.1001/jamaophthalmol.2014.4266; Roosing S, 2013, AM J HUM GENET, V93, P110, DOI 10.1016/j.ajhg.2013.05.005; Ruggiero L, 2012, P NATL ACAD SCI USA, V109, P8145, DOI 10.1073/pnas.1121101109; Ryeom SW, 1996, J CELL SCI, V109, P387; Seixas E, 2013, TRAFFIC, V14, P871, DOI 10.1111/tra.12072; Sergouniotis PI, 2011, AM J HUM GENET, V89, P183, DOI 10.1016/j.ajhg.2011.06.002; Shelby SJ, 2015, EXP EYE RES, V140, P28, DOI 10.1016/j.exer.2015.08.006; STEINBERG RH, 1977, PHILOS T ROY SOC B, V277, P459, DOI 10.1098/rstb.1977.0028; Thomas S, 2014, HUM MUTAT, V35, P137, DOI 10.1002/humu.22470; Tolmachova T, 1999, GENE, V239, P109, DOI 10.1016/S0378-1119(99)00371-6; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Wu S, 2008, NAT PROTOC, V3, P1056, DOI 10.1038/nprot.2008.70; Ying GX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161236; Ying GX, 2014, J NEUROSCI, V34, P6377, DOI 10.1523/JNEUROSCI.0067-14.2014; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104; Zhong H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08366; Zhou Z, 2017, FEBS LETT, V591, P88, DOI 10.1002/1873-3468.12509; Zhu XM, 2002, MOL VIS, V8, P462	56	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17546	17558		10.1074/jbc.RA118.005484	http://dx.doi.org/10.1074/jbc.RA118.005484			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30228185	Green Published, hybrid			2022-12-28	WOS:000449799000019
J	Regeenes, R; Silva, PN; Chang, HH; Arany, EJ; Shukalyuk, AI; Audet, J; Kilkenny, DM; Rocheleau, JV				Regeenes, Romario; Silva, Pamuditha N.; Chang, Huntley H.; Arany, Edith J.; Shukalyuk, Andrey I.; Audet, Julie; Kilkenny, Dawn M.; Rocheleau, Jonathan V.			Fibroblast growth factor receptor 5 (FGFR5) is a co-receptor for FGFR1 that is up-regulated in beta-cells by cytokine-induced inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast growth factor receptor (FGFR); fibroblast growth factor (FGF); beta cell (B-cell); islet; fluorescence resonance energy transfer (FRET); pancreas; diabetes; inflammation; metabolism; cytokine	NONOBESE DIABETIC MICE; LIVING CELLS; KLOTHO-BETA; PROTEINS; FRET; ACTIVATION; EXPRESSION; MICROSCOPY; INSULITIS; COMPLEX	Fibroblast growth factor receptor-1 (FGFR1) activity at the plasma membrane is tightly controlled by the availability of co-receptors and competing receptor isoforms. We have previously shown that FGFR1 activity in pancreatic beta-cells modulates a wide range of processes, including lipid metabolism, insulin processing, and cell survival. More recently, we have revealed that co-expression of FGFR5, a receptor isoform that lacks a tyrosine-kinase domain, influences FGFR1 responses. We therefore hypothesized that FGFR5 is a co-receptor to FGFR1 that modulates responses to ligands by forming a receptor heterocomplex with FGFR1. We first show here increased FGFR5 expression in the pancreatic islets of nonobese diabetic (NOD) mice and also in mouse and human islets treated with proinflammatory cytokines. Using siRNA knockdown, we further report that FGFR5 and FGFR1 expression improves beta-cell survival. Co-immunoprecipitation and quantitative live-cell imaging to measure the molecular interaction between FGFR5 and FGFR1 revealed that FGFR5 forms a mixture of ligand-independent homodimers (approximate to 25%) and homotrimers (approximate to 75%) at the plasma membrane. Interestingly, co-expressed FGFR5 and FGFR1 formed heterocomplexes with a 2:1 ratio and subsequently responded to FGF2 by forming FGFR5/FGFR1 signaling complexes with a 4:2 ratio. Taken together, our findings identify FGFR5 as a co-receptor that is up-regulated by inflammation and promotes FGFR1-induced survival, insights that reveal a potential target for intervention during beta-cell pathogenesis.	[Regeenes, Romario; Silva, Pamuditha N.; Chang, Huntley H.; Shukalyuk, Andrey I.; Audet, Julie; Kilkenny, Dawn M.; Rocheleau, Jonathan V.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Arany, Edith J.] Western Univ, Dept Pathol & Lab Med, London, ON N6A 3K7, Canada; [Arany, Edith J.] St Josephs Hlth Care, Lawson Hlth Res Inst, London, ON N6A 6K1, Canada; [Audet, Julie] Univ Toronto, Dept Chem Engn, Toronto, ON M5S 3E5, Canada; [Rocheleau, Jonathan V.] Univ Toronto, Dept Physiol, Toronto, ON M5S 3H7, Canada; [Rocheleau, Jonathan V.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5G 2C4, Canada	University of Toronto; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Rocheleau, JV (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.	Jon.Rocheleau@utoronto.ca	Arany, Edith/AAK-2159-2020; Arany, Edith/C-3464-2013	Arany, Edith/0000-0001-9994-8958; Rocheleau, Jonathan/0000-0002-1760-2564; Chang, Huntley/0000-0003-3181-8019; Audet, Julie/0000-0002-5599-6074				Arany E, 2004, DIABETOLOGIA, V47, P1831, DOI 10.1007/s00125-004-1535-z; Baker MS, 2003, J SURG RES, V110, P295, DOI 10.1016/S0022-4804(03)00027-1; Broussard JA, 2013, NAT PROTOC, V8, P265, DOI 10.1038/nprot.2012.147; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; Cameron WD, 2016, NAT METHODS, V13, P352, DOI [10.1038/NMETH.3764, 10.1038/nmeth.3764]; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Erhardt P, 1999, MOL CELL BIOL, V19, P5308; Fosang AJ, 2015, J BIOL CHEM, V290, P29692, DOI 10.1074/jbc.E115.000002; Gerber SD, 2009, DEV BIOL, V335, P106, DOI 10.1016/j.ydbio.2009.08.019; Hart AW, 2000, NATURE, V408, P864, DOI 10.1038/35048589; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Kilkenny DM, 2016, VITAM HORM, V101, P17, DOI 10.1016/bs.vh.2016.02.008; Kilkenny DM, 2008, MOL ENDOCRINOL, V22, P196, DOI 10.1210/me.2007-0241; Kim I, 2001, BBA-GENE STRUCT EXPR, V1518, P152, DOI 10.1016/S0167-4781(00)00282-7; Kin T, 2008, TRANSPL INT, V21, P1029, DOI 10.1111/j.1432-2277.2008.00719.x; LEITER EH, 1987, AM J PATHOL, V128, P380; Makino S, 1980, Jikken Dobutsu, V29, P1; Ming AYK, 2012, J BIOL CHEM, V287, P19997, DOI 10.1074/jbc.M111.325670; MIYAZAKI T, 1990, NATURE, V345, P722, DOI 10.1038/345722a0; Petersen LG, 2006, DIABETOLOGIA, V49, P1864, DOI 10.1007/s00125-006-0296-2; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Rieckmann T, 2008, EXP CELL RES, V314, P1071, DOI 10.1016/j.yexcr.2007.10.029; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Silva PN, 2016, LAB CHIP, V16, P2921, DOI 10.1039/c6lc00345a; Silva PN, 2013, J BIOL CHEM, V288, P17859, DOI 10.1074/jbc.M112.440677; Sleeman M, 2001, GENE, V271, P171, DOI 10.1016/S0378-1119(01)00518-2; Steinberg F, 2010, J BIOL CHEM, V285, P2193, DOI 10.1074/jbc.M109.058248; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Sun MY, 2012, BIOPHYS J, V103, P2379, DOI 10.1016/j.bpj.2012.10.028; Trueb B, 2006, INT J MOL MED, V17, P617; Trueb B, 2003, J BIOL CHEM, V278, P33857, DOI 10.1074/jbc.M300281200; Trueb B, 2011, CELL MOL LIFE SCI, V68, P951, DOI 10.1007/s00018-010-0576-3; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Wang H, 2005, DIABETOLOGIA, V48, P720, DOI 10.1007/s00125-005-1692-8; Wiedemann M, 2000, GENOMICS, V69, P275, DOI 10.1006/geno.2000.6332; Yeow EKL, 2007, BIOPHYS J, V92, P3098, DOI [10.1529/biophysj.106.099424, 10.1529/biophysj. 106.099424]	36	19	20	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17218	17228		10.1074/jbc.RA118.003036	http://dx.doi.org/10.1074/jbc.RA118.003036			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30217817	Green Published, hybrid			2022-12-28	WOS:000449466500021
J	Sheehe, JL; Bonev, AD; Schmoker, AM; Ballif, BA; Nelson, MT; Moon, TM; Dostmann, WR				Sheehe, Jessica L.; Bonev, Adrian D.; Schmoker, Anna M.; Ballif, Bryan A.; Nelson, Mark T.; Moon, Thomas M.; Dostmann, Wolfgang R.			Oxidation of cysteine 117 stimulates constitutive activation of the type I alpha cGMP-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic GMP (cGMP); oxidation-reduction (redox); protein kinase G (PKG); potassium channel; signal transduction; AGC kinases; cGMP-dependent protein kinase; allostery; constitutive activation	BLOOD-PRESSURE; BINDING; PHOSPHORYLATION; IDENTIFICATION; SUBUNIT; CHANNEL; BETA; PKG; HYPERTENSION; PHOSPHATASE	The type I cGMP-dependent protein kinase (PKG I) is an essential regulator of vascular tone. It has been demonstrated that the type I isoform can be constitutively activated by oxidizing conditions. However, the amino acid residues implicated in this phenomenon are not fully elucidated. To investigate the molecular basis for this mechanism, we studied the effects of oxidation using recombinant WT, truncated, and mutant constructs of PKG I. Using an in vitro assay, we observed that oxidation with hydrogen peroxide (H2O2) resulted in constitutive, cGMP-independent activation of PKG I. PKG I C42S and a truncation construct that does not contain Cys-42 (53) were both constitutively activated by H2O2. In contrast, oxidation of PKG I C117S maintained its cGMP-dependent activation characteristics, although oxidized PKG I C195S did not. To corroborate these results, we also tested the effects of our constructs on the PKG I-specific substrate, the large conductance potassium channel (K-Ca 1.1). Application of WT PKG I activated by either cGMP or H2O2 increased the open probabilities of the channel. Neither cGMP nor H2O2 activation of PKG I C42S significantly increased channel open probabilities. Moreover, cGMP-stimulated PKG I C117S increased K-Ca 1.1 activity, but this effect was not observed under oxidizing conditions. Finally, we observed that PKG I C42S caused channel flickers, indicating dramatically altered K-Ca 1.1 channel characteristics compared with channels exposed to WT PKG I. Cumulatively, these results indicate that constitutive activation of PKG I proceeds through oxidation of Cys-117 and further suggest that the formation of a sulfur acid is necessary for this phenotype.	[Sheehe, Jessica L.; Bonev, Adrian D.; Nelson, Mark T.; Dostmann, Wolfgang R.] Univ Vermont, Larner Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; [Schmoker, Anna M.; Ballif, Bryan A.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [Moon, Thomas M.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	University of Vermont; University of Vermont; University of Arizona	Dostmann, WR (corresponding author), Univ Vermont, Larner Coll Med, Dept Pharmacol, Burlington, VT 05405 USA.; Moon, TM (corresponding author), Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA.	thomasmoon@email.arizona.edu; wolfgang.dostmann@uvm.edu	; Moon, Thomas/F-4896-2013	Schmoker, Anna/0000-0003-2830-5650; Nelson, Mark/0000-0002-6608-8784; Moon, Thomas/0000-0003-1568-8808	Vermont Genetics Network through National Institutes of Health (NIH) from the INBRE program of NIGMS [8P20GM103449]; NIH from the COBRE Program of the National Center for Research Resources [5 P30 RR032135]; NIGMS [8 P30 GM103498]; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR032135] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131181, R01HL121706, T32HL007594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103498, P20GM103449] Funding Source: NIH RePORTER	Vermont Genetics Network through National Institutes of Health (NIH) from the INBRE program of NIGMS; NIH from the COBRE Program of the National Center for Research Resources; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Werner Tegge (Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany) for synthesizing the W15 peptide substrate used in the phosphotransferase assays. Mass spectrometry was supported by the Vermont Genetics Network through National Institutes of Health (NIH) Grant 8P20GM103449 from the INBRE program of NIGMS. SDS-PAGE experiments were imaged with support from NIH Grants 5 P30 RR032135 from the COBRE Program of the National Center for Research Resources and 8 P30 GM103498 from NIGMS. We also thank the Hondal Laboratory at the University of Vermont for helpful discussions and use of resources.	AITKEN A, 1984, BIOCHIM BIOPHYS ACTA, V790, P219, DOI 10.1016/0167-4838(84)90025-6; ALIOUA A, 1995, AM J PHYSIOL-LUNG C, V268, pL1057, DOI 10.1152/ajplung.1995.268.6.L1057; Alverdi V, 2008, J MOL BIOL, V375, P1380, DOI 10.1016/j.jmb.2007.11.053; Blanton RM, 2013, J GERONTOL A-BIOL, V68, P1351, DOI 10.1093/gerona/glt042; Brewer TF, 2015, ANNU REV BIOCHEM, V84, P765, DOI 10.1146/annurev-biochem-060614-034018; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Casteel DE, 2005, J BIOL CHEM, V280, P38211, DOI 10.1074/jbc.M507021200; Chan SL, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/793630; Chan SL, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00133; Dostmann WRG, 2000, P NATL ACAD SCI USA, V97, P14772, DOI 10.1073/pnas.97.26.14772; FEIL R, 1995, BIOCHEMISTRY-US, V34, P13152, DOI 10.1021/bi00040a029; Francis SH, 1996, J BIOL CHEM, V271, P20748, DOI 10.1074/jbc.271.34.20748; Friebe A, 2003, CIRC RES, V93, P96, DOI 10.1161/01.RES.0000082524.34487.31; Fukao M, 1999, J BIOL CHEM, V274, P10927, DOI 10.1074/jbc.274.16.10927; Gray SP, 2016, ARTERIOSCL THROM VAS, V36, P295, DOI 10.1161/ATVBAHA.115.307012; Han J, 1996, ANAL BIOCHEM, V234, P107, DOI 10.1006/abio.1996.0059; HEIL WG, 1987, EUR J BIOCHEM, V168, P117, DOI 10.1111/j.1432-1033.1987.tb13395.x; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Kalyanaraman H, 2017, J BIOL CHEM, V292, P8262, DOI 10.1074/jbc.C117.787358; Karplus PA, 2015, FREE RADICAL BIO MED, V80, P183, DOI 10.1016/j.freeradbiomed.2014.10.009; Kato M, 2012, J BIOL CHEM, V287, P41342, DOI 10.1074/jbc.M112.421040; Khavandi K, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf6625; Kim JJ, 2016, STRUCTURE, V24, P710, DOI 10.1016/j.str.2016.03.009; Kim YM, 2017, AM J PHYSIOL-CELL PH, V312, pC749, DOI 10.1152/ajpcell.00346.2016; Kyle BD, 2013, FASEB J, V27, P2027, DOI 10.1096/fj.12-223669; LANDGRAF W, 1991, J BIOL CHEM, V266, P16305; Lee E, 2007, J MOL BIOL, V373, P1198, DOI 10.1016/j.jmb.2007.08.049; Moon TM, 2018, J BIOL CHEM, V293, P7916, DOI 10.1074/jbc.RA117.000647; Moon TM, 2015, CHEM BIOL, V22, P1653, DOI 10.1016/j.chembiol.2015.11.005; Muller PM, 2012, FREE RADICAL BIO MED, V53, P1574, DOI 10.1016/j.freeradbiomed.2012.08.011; Nakamura T, 2015, J CLIN INVEST, V125, P2468, DOI 10.1172/JCI80275; Nausch LWM, 2008, P NATL ACAD SCI USA, V105, P365, DOI 10.1073/pnas.0710387105; Osborne BW, 2011, STRUCTURE, V19, P1317, DOI 10.1016/j.str.2011.06.012; Patel D, 2017, ADV EXP MED BIOL, V967, P227, DOI 10.1007/978-3-319-63245-2_13; Prysyazhna O, 2012, NAT MED, V18, P286, DOI 10.1038/nm.2603; Qin LY, 2015, BIOCHEMISTRY-US, V54, P4419, DOI 10.1021/acs.biochem.5b00572; Rashdan NA, 2015, AM J PHYSIOL-HEART C, V309, pH1655, DOI 10.1152/ajpheart.00408.2015; Rudyk O, 2012, CIRCULATION, V126, P287, DOI 10.1161/CIRCULATIONAHA.112.101287; Ruth P, 1997, J BIOL CHEM, V272, P10522; RUTH P, 1991, EUR J BIOCHEM, V202, P1339, DOI 10.1111/j.1432-1033.1991.tb16509.x; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Schiffrin EL, 2012, HYPERTENSION, V59, P367, DOI 10.1161/HYPERTENSIONAHA.111.187021; Schlossmann Jens, 2009, V191, P163, DOI 10.1007/978-3-540-68964-5_9; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sun XG, 2005, MOL PHARMACOL, V67, P631, DOI 10.1124/mol.104.007724; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tan ZJ, 2012, J PHARMACEUT BIOMED, V59, P167, DOI 10.1016/j.jpba.2011.09.034; Warren EAK, 2015, SCI REP-UK, V5, DOI 10.1038/srep16929; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yuen S, 2011, J BIOL CHEM, V286, P37274, DOI 10.1074/jbc.M111.282905; Yuen SL, 2014, ARCH BIOCHEM BIOPHYS, V562, P37, DOI 10.1016/j.abb.2014.08.011; Zhou GP, 2011, PROTEIN PEPTIDE LETT, V18, P966, DOI 10.2174/0929866511107010966	53	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16791	16802		10.1074/jbc.RA118.004363	http://dx.doi.org/10.1074/jbc.RA118.004363			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30206122	hybrid, Green Published			2022-12-28	WOS:000448515100020
J	Smith, RP; Mohanty, B; Mowlaboccus, S; Paxman, JJ; Williams, ML; Headey, SJ; Wang, GQ; Subedi, P; Doak, BC; Kahler, CM; Scanlon, MJ; Heras, B				Smith, Roxanne P.; Mohanty, Biswaranjan; Mowlaboccus, Shakeel; Paxman, Jason J.; Williams, Martin L.; Headey, Stephen J.; Wang, Geqing; Subedi, Pramod; Doak, Bradley C.; Kahler, Charlene M.; Scanlon, Martin J.; Heras, Begona			Structural and biochemical insights into the disulfide reductase mechanism of DsbD, an essential enzyme for neisserial pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microbial pathogenesis; enzyme mechanism; electron transfer; protein folding; protein structure; crystallography; disulfide; DsbD; Neisseria gonorrhoeae	BACTERIAL-CELL ENVELOPE; MEMBRANE-PROTEIN DSBD; N-TERMINAL DOMAIN; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; BOND ISOMERASE; IN-VIVO; X-RAY; OXIDOREDUCTASE	The worldwide incidence of neisserial infections, particularly gonococcal infections, is increasingly associated with antibiotic-resistant strains. In particular, extensively drug-resistant Neisseria gonorrhoeae strains that are resistant to third-generation cephalosporins are a major public health concern. There is a pressing clinical need to identify new targets for the development of antibiotics effective against Neisseria-specific processes. In this study, we report that the bacterial disulfide reductase DsbD is highly prevalent and conserved among Neisseria spp. and that this enzyme is essential for survival of N. gonorrhoeae. DsbD is a membrane-bound protein that consists of two periplasmic domains, n-DsbD and c-DsbD, which flank the transmembrane domain t-DsbD. In this work, we show that the two functionally essential periplasmic domains of Neisseria DsbD catalyze electron transfer reactions through unidirectional interdomain interactions, from reduced c-DsbD to oxidized n-DsbD, and that this process is not dictated by their redox potentials. Structural characterization of the Neisseria n- and c-DsbD domains in both redox states provides evidence that steric hindrance reduces interactions between the two periplasmic domains when n-DsbD is reduced, thereby preventing a futile redox cycle. Finally, we propose a conserved mechanism of electron transfer for DsbD and define the residues involved in domain-domain recognition. Inhibitors of the interaction of the two DsbD domains have the potential to be developed as anti-neisserial agents.	[Smith, Roxanne P.; Paxman, Jason J.; Wang, Geqing; Subedi, Pramod; Heras, Begona] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia; [Mohanty, Biswaranjan; Williams, Martin L.; Headey, Stephen J.; Doak, Bradley C.; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Melbourne, Vic 3052, Australia; [Mowlaboccus, Shakeel; Kahler, Charlene M.] Univ Western Australia, Sch Biomed Sci, Marshall Ctr Infect Dis Res & Training, Perth, WA 6907, Australia	La Trobe University; Monash University; University of Western Australia	Scanlon, MJ (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Melbourne, Vic 3052, Australia.; Heras, B (corresponding author), La Trobe Univ, Dept Biochem & Genet, Melbourne, Vic 3086, Australia.	martin.scanlon@monash.edu; b.heras@latrobe.edu.au	Doak, Bradley C/A-4313-2013; Paxman, Jason/T-6932-2019; Kahler, Charlene M/H-5159-2014; Subedi, Pramod/AAV-6214-2021	Doak, Bradley C/0000-0001-8422-675X; Paxman, Jason/0000-0002-1418-5910; Kahler, Charlene M/0000-0003-4322-3055; Williams, Martin/0000-0002-9483-3008; Smith, Roxanne P./0000-0001-5520-7939; Headey, Stephen/0000-0001-8015-7064; Scanlon, Martin/0000-0002-9230-7506; Mowlaboccus, Shakeel/0000-0001-9408-6068; Wang, Geqing/0000-0002-9419-8657; Subedi, Pramod/0000-0002-3390-9830; Heras, Begona/0000-0003-3469-7988	Australian Research Council [DP150102287]; National Health and Medical Research Council [APP1099151, APP546003]; Australian Research Council Future Fellowship [FT130100580]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council)	This work was supported by Australian Research Council Project Grant DP150102287 and National Health and Medical Research Council Project Grant APP1099151. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Health and Medical Research Council Grant APP546003.; Supported by Australian Research Council Future Fellowship FT130100580.	Adams LA, 2015, ANGEW CHEM INT EDIT, V54, P2179, DOI 10.1002/anie.201410341; Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Arts IS, 2015, FEBS LETT, V589, P1559, DOI 10.1016/j.febslet.2015.04.057; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho SH, 2013, ANTIOXID REDOX SIGN, V18, P1690, DOI 10.1089/ars.2012.4962; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Depuydt M, 2011, ANTIOXID REDOX SIGN, V15, P49, DOI 10.1089/ars.2010.3575; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ezraty B, 2017, NAT REV MICROBIOL, V15, P385, DOI 10.1038/nrmicro.2017.26; Goulding CW, 2002, BIOCHEMISTRY-US, V41, P6920, DOI 10.1021/bi016038l; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Kim JH, 2003, FEBS LETT, V543, P164, DOI 10.1016/S0014-5793(03)00434-4; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar P, 2011, MOL MICROBIOL, V79, P1557, DOI 10.1111/j.1365-2958.2011.07546.x; Kurz M, 2009, ANTIOXID REDOX SIGN, V11, P1485, DOI [10.1089/ars.2008.2420, 10.1089/ARS.2008.2420]; MacFadden DR, 2018, LANCET INFECT DIS, V18, P599, DOI 10.1016/S1473-3099(18)30274-3; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mavridou DAI, 2011, J BIOL CHEM, V286, P24943, DOI 10.1074/jbc.M111.236141; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Messens J, 2007, J BIOL CHEM, V282, P31302, DOI 10.1074/jbc.M705236200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace CN, 1998, J MOL BIOL, V279, P271, DOI 10.1006/jmbi.1998.1760; Piek S, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00162; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Quinternet M, 2008, BIOCHEMISTRY-US, V47, P12710, DOI 10.1021/bi801343c; Ren GP, 2009, J BIOL CHEM, V284, P10150, DOI 10.1074/jbc.M809509200; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Smith RP, 2018, ACTA CRYSTALLOGR F, V74, P31, DOI 10.1107/S2053230X17017800; Smith RP, 2017, BIOMOL NMR ASSIGN, V11, P181, DOI 10.1007/s12104-017-9743-x; Smith RP, 2016, MOLECULES, V21, DOI 10.3390/molecules21070811; Stewart EJ, 1999, EMBO J, V18, P5963, DOI 10.1093/emboj/18.21.5963; Stirnimann CU, 2006, J MOL BIOL, V358, P829, DOI 10.1016/j.jmb.2006.02.030; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; Tinsley CR, 2004, J BIOL CHEM, V279, P27078, DOI 10.1074/jbc.M313404200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	49	7	7	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16559	16571		10.1074/jbc.RA118.004847	http://dx.doi.org/10.1074/jbc.RA118.004847			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30181210	hybrid, Green Published			2022-12-28	WOS:000448515100002
J	Duggimpudi, S; Kloetgen, A; Maney, SK; Munch, PC; Hezaveh, K; Shaykhalishahi, H; Hoyer, W; McHardy, AC; Lang, PA; Borkhardt, A; Hoell, JI				Duggimpudi, Sujitha; Kloetgen, Andreas; Maney, Sathish Kumar; Munch, Philipp C.; Hezaveh, Kebria; Shaykhalishahi, Hamed; Hoyer, Wolfgang; McHardy, Alice C.; Lang, Philipp A.; Borkhardt, Arndt; Hoell, Jessica, I			Transcriptome-wide analysis uncovers the targets of the RNA-binding protein MSI2 and effects of MSI2's RNA-binding activity on IL-6 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						post-transcriptional regulation; RNA-binding protein; leukemia; interleukin 6 (IL-6); Janus kinase (JAK); Janus kinase (JAK); STAT signaling; mitogen-activated protein kinase (MAPK); mitogen-activated protein kinase (MAPK) signaling; phosphorylation; cancer; Musashi 2; cancer and Musashi2; PAR-CLIP	ACUTE MYELOID-LEUKEMIA; FACTOR-MEDIATED INTERACTION; HEPATOCYTE GROWTH-FACTOR; PAR-CLIP; PHOSPHATIDYLINOSITOL 3-KINASE; REGULATED EXPRESSION; GENE-EXPRESSION; IDENTIFICATION; CANCER; HEMATOPOIESIS	The RNA-binding protein Musashi 2 (MSI2) has emerged as an important regulator in cancer initiation, progression, and drug resistance. Translocations and deregulation of the MSI2 gene are diagnostic of certain cancers, including chronic myeloid leukemia (CML) with translocation t(7;17), acute myeloid leukemia (AML) with translocation t(10;17), and some cases of B-precursor acute lymphoblastic leukemia (pB-ALL). To better understand the function of MSI2 in leukemia, the mRNA targets that are bound and regulated by MSI2 and their MSI2-binding motifs need to be identified. To this end, using photoactivatable ribonucleoside cross-linking and immunoprecipitation (PAR-CLIP) and the multiple EM for motif elicitation (MEME) analysis tool, here we identified MSI2's mRNA targets and the consensus RNA-recognition element (RRE) motif recognized by MSI2 (UUAG). Of note, MSI2 knockdown altered the expression of several genes with roles in eukaryotic initiation factor 2 (eIF2), hepatocyte growth factor (HGF), and epidermal growth factor (EGF) signaling pathways. We also show that MSI2 regulates classic interleukin-6 (IL-6) signaling by promoting the degradation of the mRNA of IL-6 signal transducer (IL6ST or GP130), which, in turn, affected the phosphorylation statuses of signal transducer and activator of transcription 3 (STAT3) and the mitogen-activated protein kinase ERK. In summary, we have identified multiple MSI2-regulated mRNAs and provided evidence that MSI2 controls IL6ST activity that control oncogenic signaling networks. Our findings may help inform strategies for unraveling the role of MSI2 in leukemia to pave the way for the development of targeted therapies.	[Duggimpudi, Sujitha; Kloetgen, Andreas; Hezaveh, Kebria; Borkhardt, Arndt; Hoell, Jessica, I] Heinrich Heine Univ, Dept Pediat Oncol Hematol & Clin Immunol, Ctr Child & Adolescent Hlth, Med Fac, Moorenstr 5, D-40225 Dusseldorf, Germany; [Maney, Sathish Kumar; Lang, Philipp A.] Heinrich Heine Univ, Dept Mol Med 2, Univ Str 1, D-40225 Dusseldorf, Germany; [Kloetgen, Andreas; Munch, Philipp C.; McHardy, Alice C.] Heinrich Heine Univ, Dept Algorithm Bioinformat, Univ Str 1, D-40225 Dusseldorf, Germany; [Kloetgen, Andreas; Munch, Philipp C.; McHardy, Alice C.] Helmholtz Ctr Infect Res, Computat Biol Infect Res, Inhoffenstr 7, D-38124 Braunschweig, Germany; [Shaykhalishahi, Hamed; Hoyer, Wolfgang] Heinrich Heine Univ, Inst Phys Biol, Univ Str 1, D-40225 Dusseldorf, Germany; [Kloetgen, Andreas] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Maney, Sathish Kumar] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, Rontgenstr 20, D-48149 Munster, Germany; [Hezaveh, Kebria] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Shaykhalishahi, Hamed] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada	Helmholtz Association; Helmholtz-Center for Infection Research; Heinrich Heine University Dusseldorf; New York University; Max Planck Society; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Hoell, JI (corresponding author), Heinrich Heine Univ, Dept Pediat Oncol Hematol & Clin Immunol, Ctr Child & Adolescent Hlth, Med Fac, Moorenstr 5, D-40225 Dusseldorf, Germany.	Jessica.hoell@med.uni-duesseldorf.de	McHardy, Alice/ABF-2322-2020; Hoyer, Wolfgang/H-6193-2013	McHardy, Alice/0000-0003-2370-3430; Hoyer, Wolfgang/0000-0003-4301-5416; Kloetgen, Andreas/0000-0003-0991-4442	Heinrich-Heine University Dusseldorf Forschungskommission [17/2013]; Dusseldorf School of Oncology; Comprehensive Cancer Center Dusseldorf/Deutsche Krebshilfe; Medical Faculty HHU Dusseldorf; Deutsche Forschungsgemeinschaft [HO 5456/3-1]	Heinrich-Heine University Dusseldorf Forschungskommission; Dusseldorf School of Oncology; Comprehensive Cancer Center Dusseldorf/Deutsche Krebshilfe; Medical Faculty HHU Dusseldorf; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Heinrich-Heine University Dusseldorf Forschungskommission 17/2013, the Dusseldorf School of Oncology (funded by the Comprehensive Cancer Center Dusseldorf/Deutsche Krebshilfe and the Medical Faculty HHU Dusseldorf), and the Deutsche Forschungsgemeinschaft HO 5456/3-1. The authors declare that they have no conflicts of interest with the contents of this article.	Aly RM, 2015, INT J LAB HEMATOL, V37, P272, DOI 10.1111/ijlh.12284; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aplan PD, 2006, TRENDS GENET, V22, P46, DOI 10.1016/j.tig.2005.10.002; Ascano M, 2012, WIRES RNA, V3, P159, DOI 10.1002/wrna.1103; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barbouti A, 2003, CANCER RES, V63, P1202; Bennett CG, 2016, NUCLEIC ACIDS RES, V44, P3788, DOI 10.1093/nar/gkw207; Byers RJ, 2011, BLOOD, V118, P2857, DOI 10.1182/blood-2011-04-346767; Collins CT, 2016, ONCOGENE, V35, P1090, DOI 10.1038/onc.2015.174; Collins C, 2014, P NATL ACAD SCI USA, V111, P9899, DOI 10.1073/pnas.1402238111; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Du YH, 2014, INT J MOL SCI, V15, P17065, DOI 10.3390/ijms150917065; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Hafner M, 2012, METHODS, V58, P94, DOI 10.1016/j.ymeth.2012.08.006; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ichikawa M, 2013, INT J HEMATOL, V97, P726, DOI 10.1007/s12185-013-1347-3; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kloetgen A, 2016, PEERJ, V4, DOI 10.7717/peerj.2619; Kloetgen A, 2015, BRIEF FUNCT GENOMICS, V14, P102, DOI 10.1093/bfgp/elu020; Kudinov AE, 2016, P NATL ACAD SCI USA, V113, P6955, DOI 10.1073/pnas.1513616113; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15456; Madonna R, 2013, J CARDIOVASC MED, V14, P249, DOI 10.2459/JCM.0b013e3283542017; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Micol JB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15429; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Park SM, 2014, J EXP MED, V211, P71, DOI 10.1084/jem.20130736; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Saleki R, 2015, LEUKEMIA LYMPHOMA, V56, P1137, DOI 10.3109/10428194.2014.947611; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Spitzer J, 2014, METHOD ENZYMOL, V539, P113, DOI 10.1016/B978-0-12-420120-0.00008-6; Spitzer J, 2013, METHOD ENZYMOL, V529, P99, DOI 10.1016/B978-0-12-418687-3.00008-2; Sutherland JM, 2013, ADV EXP MED BIOL, V786, P233, DOI 10.1007/978-94-007-6621-1_13; Tian J, 2016, INTRACTABLE RARE DIS, V5, P76, DOI 10.5582/irdr.2015.01049; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7517; Yu CF, 2002, J BIOL CHEM, V277, P19382, DOI 10.1074/jbc.M200732200; Yu CF, 2001, J BIOL CHEM, V276, P32552, DOI 10.1074/jbc.M104493200; Zearfoss NR, 2014, J BIOL CHEM, V289, P35530, DOI 10.1074/jbc.M114.597112; Zhang HJ, 2014, EXP CELL RES, V320, P119, DOI 10.1016/j.yexcr.2013.09.009; Zhang YW, 2003, J CELL BIOCHEM, V88, P408, DOI 10.1002/jcb.10358	48	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15359	15369		10.1074/jbc.RA118.002243	http://dx.doi.org/10.1074/jbc.RA118.002243			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30126842	Green Published, hybrid			2022-12-28	WOS:000446549200003
J	Robinson, AE; Lowe, JE; Koh, EI; Henderson, JP				Robinson, Anne E.; Lowe, Jessica E.; Koh, Eun-Ik; Henderson, Jeffrey P.			Uropathogenic enterobacteria use the yersiniabactin metallophore system to acquire nickel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						siderophore; nickel; metal homeostasis; metalloenzyme; transport metal; metallophore; nutritional immunity; nutritional passivation; uropathogen	HIGH-PATHOGENICITY ISLAND; ESCHERICHIA-COLI; TRACT-INFECTION; SIDEROPHORE; KLEBSIELLA; BINDING; COPPER; IDENTIFICATION; TRANSPORT; PESTIS	Invasive Gram-negative bacteria often express multiple virulence-associated metal ion chelators to combat host-mediated metal deficiencies. Escherichia coli, Klebsiella, and Yersinia pestis isolates encoding the Yersinia high pathogenicity island (HPI) secrete yersiniabactin (Ybt), a metallophore originally shown to chelate iron ions during infection. However, our recent demonstration that Ybt also scavenges copper ions during infection led us to question whether it might be capable of retrieving other metals as well. Here, we find that uropathogenic E. coli also use Ybt to bind extracellular nickel ions. Using quantitative MS, we show that the canonical metal-Ybt import pathway internalizes the resulting Ni-Ybt complexes, extracts the nickel, and releases metal-free Ybt back to the extracellular space. We find that E. coli and Klebsiella direct the nickel liberated from this pathway to intracellular nickel enzymes. Thus, Ybt may provide access to nickel that is inaccessible to the conserved NikABCDE permease system. Nickel should be considered alongside iron and copper as a plausible substrate for Ybt-mediated metal import by enterobacteria during human infections.	[Robinson, Anne E.; Lowe, Jessica E.; Koh, Eun-Ik; Henderson, Jeffrey P.] Washington Univ, Ctr Womens Infect Dis Res, Dept Mol Microbiol, Div Infect Dis Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Henderson, JP (corresponding author), Washington Univ, Sch Med, 660 S Euclid Ave, St Louis, MO 63110 USA.	hendersonj@wustl.edu	Henderson, Jeffrey P/D-3337-2015	Robinson, Anne/0000-0003-1641-397X; Lowe, Jessica/0000-0002-0295-3978	NIDDK, National Institutes of Health [R01DK099534, R01DK111930]; Mr. and Mrs. Spencer T. Olin Fellowship for Women in Graduate Study; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111930, R01DK099534] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mr. and Mrs. Spencer T. Olin Fellowship for Women in Graduate Study; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grants R01DK099534 and R01DK111930 (to J. P. H.). The authors declare that they have no conflicts of interest with the contents of this article. The funders had no role in study design, data collection and interpretation, or in the decision to submit the work for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Mr. and Mrs. Spencer T. Olin Fellowship for Women in Graduate Study.	Bachman MA, 2011, INFECT IMMUN, V79, P3309, DOI 10.1128/IAI.05114-11; BARRY AL, 1969, APPL MICROBIOL, V18, P156, DOI 10.1128/AEM.18.2.156-158.1969; BENDER RA, 1977, J BACTERIOL, V129, P1001, DOI 10.1128/JB.129.2.1001-1009.1977; Bleriot C, 2011, J BACTERIOL, V193, P3785, DOI 10.1128/JB.05032-11; Bobrov AG, 2017, METALLOMICS, V9, P757, DOI 10.1039/c7mt00126f; Bobrov AG, 2014, MOL MICROBIOL, V93, P759, DOI 10.1111/mmi.12693; Brumbaugh AR, 2015, INFECT IMMUN, V83, P1443, DOI 10.1128/IAI.02904-14; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Cherrier MV, 2008, BIOCHEMISTRY-US, V47, P9937, DOI 10.1021/bi801051y; Chivers PT, 2012, METALLOMICS, V4, P1043, DOI 10.1039/c2mt20139a; Chivers PT, 2000, J BIOL CHEM, V275, P19735, DOI 10.1074/jbc.M002232200; CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Czaja CA, 2009, J INFECT DIS, V200, P528, DOI 10.1086/600385; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fetherston JD, 1996, MOL MICROBIOL, V22, P315, DOI 10.1046/j.1365-2958.1996.00118.x; Fetherston JD, 1999, MOL MICROBIOL, V32, P289, DOI 10.1046/j.1365-2958.1999.01348.x; GEST H, 1954, BACTERIOL REV, V18, P43, DOI 10.1128/MMBR.18.1.43-73.1954; Ghssein G, 2016, SCIENCE, V352, P1105, DOI 10.1126/science.aaf1018; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Hagan EC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001187; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Higgins KA, 2012, BIOCHEMISTRY-US, V51, P7816, DOI 10.1021/bi300981m; HOPFER SM, 1989, ANN CLIN LAB SCI, V19, P161; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Koh EI, 2017, NAT CHEM BIOL, V13, P1016, DOI [10.1038/nchembio.2441, 10.1038/NCHEMBIO.2441]; Koh EI, 2016, INFECT IMMUN, V84, P1312, DOI 10.1128/IAI.01211-15; Koh EI, 2015, METALLOMICS, V7, P1011, DOI 10.1039/c4mt00341a; Lacasse MJ, 2016, BIOCHEMISTRY-US, V55, P6821, DOI 10.1021/acs.biochem.6b00706; Leitch S, 2007, J AM CHEM SOC, V129, P5085, DOI 10.1021/ja068505y; Lhospice S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16765-9; Li YJ, 2009, CHEM REV, V109, P4617, DOI 10.1021/cr900010n; Liu Q, 2007, J BACTERIOL, V189, P7593, DOI 10.1128/JB.01096-06; Lukacik P, 2012, P NATL ACAD SCI USA, V109, P9857, DOI 10.1073/pnas.1203472109; Lv HT, 2014, J PROTEOME RES, V13, P1397, DOI 10.1021/pr4009749; Lv HT, 2011, J PROTEOME RES, V10, P5547, DOI 10.1021/pr200756n; Macomber L, 2007, J BACTERIOL, V189, P1616, DOI 10.1128/JB.01357-06; Macomber L, 2011, MOL MICROBIOL, V82, P1291, DOI 10.1111/j.1365-2958.2011.07891.x; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; McDowall JS, 2014, P NATL ACAD SCI USA, V111, pE3948, DOI 10.1073/pnas.1407927111; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Moscatello NJ, 2017, BIOTECHNOL PROGR, V33, P1548, DOI 10.1002/btpr.2542; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Nakashige TG, 2017, J AM CHEM SOC, V139, P8828, DOI 10.1021/jacs.7b01212; Ohlemacher SI, 2017, J CLIN INVEST, V127, P4018, DOI 10.1172/JCI92464; OSKARSSON A, 1979, ACTA PHARMACOL TOX, V45, P306; Pelludat C, 2003, J BACTERIOL, V185, P5648, DOI 10.1128/JB.185.18.5648-5653.2003; Perry RD, 1999, MICROBIOL-UK, V145, P1181, DOI 10.1099/13500872-145-5-1181; Robinson AE, 2018, FUTURE MICROBIOL, V13, P813, DOI 10.2217/fmb-2017-0295; Rodrigue A, 2005, J BACTERIOL, V187, P2912, DOI 10.1128/JB.187.8.2912-2916.2005; Schauer K, 2007, MOL MICROBIOL, V63, P1054, DOI 10.1111/j.1365-2958.2006.05578.x; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Shields-Cutler RR, 2015, J BIOL CHEM, V290, P15949, DOI 10.1074/jbc.M115.645812; Sieniawska CE, 2012, ANN CLIN BIOCHEM, V49, P341, DOI 10.1258/acb.2011.011179; Stahler FN, 2006, INFECT IMMUN, V74, P3845, DOI 10.1128/IAI.02025-05; Subashchandrabose S, 2014, P NATL ACAD SCI USA, V111, P18327, DOI 10.1073/pnas.1415959112; VANSOESTBERGEN M, 1972, CLIN CHEM, V18, P1478; Wang SC, 2010, BIOCHEMISTRY-US, V49, P6635, DOI 10.1021/bi100685k; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; WU LF, 1991, GENE, V107, P37; Zeer-Wanklyn CJ, 2017, CURR OPIN CHEM BIOL, V37, P80, DOI 10.1016/j.cbpa.2017.01.014	62	24	24	3	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					14953	14961		10.1074/jbc.RA118.004483	http://dx.doi.org/10.1074/jbc.RA118.004483			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30108176	Green Published, hybrid			2022-12-28	WOS:000445998400001
J	Wu, D; De Wever, V; Derua, R; Winkler, C; Beullens, M; Van Eynde, A; Bollen, M				Wu, Dan; De Wever, Veerle; Derua, Rita; Winkler, Claudia; Beullens, Monique; Van Eynde, Aleyde; Bollen, Mathieu			A substrate-trapping strategy for protein phosphatase PP1 holoenzymes using hypoactive subunit fusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphoprotein phosphatase 1 (PP1); enzyme; substrate specificity; signal transduction; phosphatase; MYPT1; NIPP1; PNUTS; RepoMan; substrate mapping	CATALYTIC SUBUNIT; PHOSPHORYLATION SITES; REGULATORY SUBUNIT; NUCLEAR INHIBITOR; SPLICING FACTORS; REPO-MAN; NIPP1; IDENTIFICATION; KINASE; SPECIFICITY	The protein Ser/Thr phosphatase PP1 catalyzes an important fraction of protein dephosphorylation events and forms highly specific holoenzymes through an association with regulatory interactors of protein phosphatase one (RIPPOs). The functional characterization of individual PP1 holoenzymes is hampered by the lack of straightforward strategies for substrate mapping. Because efficient substrate recruitment often involves binding to both PP1 and its associated RIPPO, here we examined whether PP1-RIPPO fusions can be used to trap substrates for further analysis. Fusions of an hypoactive point mutant of PP1 and either of four tested RIPPOs accumulated in HEK293T cells with their associated substrates and were co-immunoprecipitated for subsequent identification of the substrates by immunoblotting or MS analysis. Hypoactive fusions were also used to study RIPPOs themselves as substrates for associated PP1. In contrast, substrate trapping was barely detected with active PP1-RIPPO fusions or with nonfused PP1 or RIPPO subunits. Our results suggest that hypoactive fusions of PP1 subunits represent an easy-to-use tool for substrate identification of individual holoenzymes.	[Wu, Dan; De Wever, Veerle; Winkler, Claudia; Beullens, Monique; Van Eynde, Aleyde; Bollen, Mathieu] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Biosignaling & Therapeut, Leuven, Belgium; [Derua, Rita] Katholieke Univ Leuven, Dept Cellular & Mol Med, Prot Phosphorylat & Prote Lab, Leuven, Belgium; [Derua, Rita] Univ Leuven, SyBioMa, B-3000 Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven	Bollen, M (corresponding author), Katholieke Univ Leuven, Campus Gasthuisberg,Herestr 49,O&N1,PB901, B-3000 Leuven, Belgium.	Mathieu.Bollen@kuleuven.be			Fund for Scientific Research Flanders [G.078717N, G.0B9917N]; Flemish Concerted Research Action Grant [GOA 15/016]	Fund for Scientific Research Flanders(FWO); Flemish Concerted Research Action Grant	This work was supported by Fund for Scientific Research Flanders Grants G.078717N and G.0B9917N and Flemish Concerted Research Action Grant GOA 15/016. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; BEULLENS M, 1992, J BIOL CHEM, V267, P16538; Beullens M, 1999, J BIOL CHEM, V274, P14053, DOI 10.1074/jbc.274.20.14053; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Boudrez A, 2000, J BIOL CHEM, V275, P25411, DOI 10.1074/jbc.M001676200; Boudrez A, 2002, J BIOL CHEM, V277, P31834, DOI 10.1074/jbc.M204427200; Ciurciu A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003885; EGLOFF MP, 1995, J MOL BIOL, V254, P942, DOI 10.1006/jmbi.1995.0667; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Jagiello I, 2000, J CELL SCI, V113, P3761; Kumeta H, 2008, J BIOMOL NMR, V40, P219, DOI 10.1007/s10858-008-9222-x; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Lee JH, 2010, J BIOL CHEM, V285, P24466, DOI 10.1074/jbc.M110.109801; Liang FB, 2007, MOL BIOSYST, V3, P308, DOI 10.1039/b700704n; Liu CWY, 1999, J BIOL CHEM, V274, P29470, DOI 10.1074/jbc.274.41.29470; Minnebo N, 2013, NUCLEIC ACIDS RES, V41, P842, DOI 10.1093/nar/gks1255; O'Connell N, 2012, STRUCTURE, V20, P1746, DOI 10.1016/j.str.2012.08.003; Oberoi J, 2016, P NATL ACAD SCI USA, V113, P9009, DOI 10.1073/pnas.1603059113; Peng AM, 2010, CURR BIOL, V20, P387, DOI 10.1016/j.cub.2010.01.020; Qian J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10215; Qian JB, 2013, CURR BIOL, V23, P1136, DOI 10.1016/j.cub.2013.05.017; Qian JB, 2011, CURR BIOL, V21, P766, DOI 10.1016/j.cub.2011.03.047; Ragusa MJ, 2011, FEBS LETT, V585, P36, DOI 10.1016/j.febslet.2010.11.022; Tanuma N, 2008, J BIOL CHEM, V283, P35805, DOI 10.1074/jbc.M805468200; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Trinkle-Mulcahy L, 1999, J CELL SCI, V112, P157; Usui H, 1998, FEBS LETT, V430, P312, DOI 10.1016/S0014-5793(98)00684-X; Vagnarelli P, 2011, DEV CELL, V21, P328, DOI 10.1016/j.devcel.2011.06.020; Van Dessel N, 2010, NUCLEIC ACIDS RES, V38, P7500, DOI 10.1093/nar/gkq643; Vulsteke V, 1997, J BIOL CHEM, V272, P32972, DOI 10.1074/jbc.272.52.32972; Winkler C, 2018, J CELL SCI, V131, DOI 10.1242/jcs.214932; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Zhang J, 1996, BIOCHEMISTRY-US, V35, P6276, DOI 10.1021/bi952954l	35	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15152	15162		10.1074/jbc.RA118.004132	http://dx.doi.org/10.1074/jbc.RA118.004132			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30115685	hybrid, Green Published			2022-12-28	WOS:000445998400017
J	Yu, WT; Zhan, Y; Xue, BX; Dong, YP; Wang, YF; Jiang, P; Wang, AB; Sun, YJ; Yang, Y				Yu, Wanting; Zhan, Yang; Xue, Boxin; Dong, Yanpeng; Wang, Yanfeng; Jiang, Ping; Wang, Aibing; Sun, Yujie; Yang, Yi			Highly efficient cellular uptake of a cell-penetrating peptide (CPP) derived from the capsid protein of porcine circovirus type 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell-penetrating peptide (CPP); membrane; permeability; endocytosis; intracellular trafficking; cellular uptake; membrane permeability; nuclear localization signal (NLS); porcine circovirus virus (PCV); protein delivery; transport vector; capsid protein; Circoviridae	HEPARAN-SULFATE; TAT PEPTIDE; NUCLEAR-LOCALIZATION; ORF2 PROTEIN; ENDOCYTOSIS; DELIVERY; MEMBRANE; CLATHRIN; VIRUS; PORCINE-CIRCOVIRUS-2	Porcine circovirus type 2 (PCV2) is one of the smallest, nonenveloped, single-stranded DNA viruses. The PCV2 capsid protein (Cap) is the sole viral structural protein and main antigenic determinant. Previous sequence analysis has revealed that the N terminus of the PCV2 Cap contains a nuclear localization signal (NLS) enriched in positively charged residues. Here, we report that PCV2's NLS can function as a cell-penetrating peptide (CPP). We observed that this NLS can carry macromolecules, e.g. enhanced GFP (EGFP), into cells when they are fused to the NLS, indicating that it can function as a CPP, similar to the classical CPP derived from HIV type 1 transactivator of transcription protein (HIV TAT). We also found that the first 17 residues of the NLS (NLS-A) have a key role in cellular uptake. In addition to entering cells via multiple endocytic processes, NLS-A was also rapidly internalized via direct translocation enabled by increased membrane permeability and was evenly distributed throughout cells when its concentration in cell cultures was 10 m. Of note, cellular NLS-A uptake was approximate to 10 times more efficient than that of HIV TAT. We inferred that the externalized NLS of the PCV2 Cap may accumulate to a high concentration (10 m) at a local membrane area, increasing membrane permeability to facilitate viral entry into the cell to release its genome into a viral DNA reproduction center. We conclude that NLS-A has potential as a versatile vehicle for shuttling foreign molecules into cells, including pharmaceuticals for therapeutic interventions.	[Yu, Wanting; Zhan, Yang; Wang, Aibing; Yang, Yi] Hunan Agr Univ, Coll Vet Med, Key Lab Anim Vaccine & Prot Engn, Changsha 410128, Hunan, Peoples R China; [Yu, Wanting; Zhan, Yang; Wang, Aibing; Yang, Yi] Hunan Agr Univ, Coll Vet Med, LFP, Changsha 410128, Hunan, Peoples R China; [Yu, Wanting; Zhan, Yang; Wang, Aibing; Yang, Yi] Hunan Agr Univ, Coll Vet Med, RCRV, Changsha 410128, Hunan, Peoples R China; [Xue, Boxin; Sun, Yujie] Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr BIOPIC, State Key Lab Membrane Biol, Beijing 100871, Peoples R China; [Dong, Yanpeng; Jiang, Ping] Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China; [Wang, Yanfeng] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China	Hunan Agricultural University; Hunan Agricultural University; Hunan Agricultural University; Peking University; Nanjing Agricultural University; Tsinghua University	Yang, Y (corresponding author), Hunan Agr Univ, Coll Vet Med, LFP, Changsha 410128, Hunan, Peoples R China.; Yang, Y (corresponding author), Hunan Agr Univ, Coll Vet Med, RCRV, Changsha 410128, Hunan, Peoples R China.; Sun, YJ (corresponding author), Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr BIOPIC, State Key Lab Membrane Biol, Beijing 100871, Peoples R China.	sun_yujie@pku.edu.cn; yiyang@hunau.edu.cn	Zhan, Yang/GRO-0311-2022; Yu, Wanting/ABB-9794-2021	Yang, Yi/0000-0003-2502-1011	National Nature Science Foundation of China [31270819, 31571432, 21573013]; National Key Research and Development Program of China [2017YFA0505300]; Talent Input Project of Hunan Agricultural University [540490317006]; Hunan Provincial Key Laboratory of Protein Engineering in Animal Vaccines [2017TP1014]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Talent Input Project of Hunan Agricultural University; Hunan Provincial Key Laboratory of Protein Engineering in Animal Vaccines	This work was supported by the National Nature Science Foundation of China (Grants 31270819, 31571432, and 21573013), the National Key Research and Development Program of China (Grant 2017YFA0505300), the Talent Input Project of Hunan Agricultural University (Grant 540490317006), and the Hunan Provincial Key Laboratory of Protein Engineering in Animal Vaccines (Grant 2017TP1014). The authors declare that they have no conflicts of interest with the contents of this article.	Abes R, 2007, BIOCHEM SOC T, V35, P775, DOI 10.1042/BST0350775; Beach NM, 2011, J VIROL, V85, P4591, DOI 10.1128/JVI.02294-10; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brock R, 2014, BIOCONJUGATE CHEM, V25, P863, DOI 10.1021/bc500017t; Chen B, 2008, LANGMUIR, V24, P11866, DOI 10.1021/la802048s; Christianson HC, 2014, MATRIX BIOL, V35, P51, DOI 10.1016/j.matbio.2013.10.004; Cleal K, 2013, CURR PHARM DESIGN, V19, P2878; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; DOUGLAS JL, 1994, CELL GROWTH DIFFER, V5, P475; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Erazo-Oliveras A, 2014, NAT METHODS, V11, P861, DOI [10.1038/NMETH.2998, 10.1038/nmeth.2998]; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; Jones AT, 2012, J CONTROL RELEASE, V161, P582, DOI 10.1016/j.jconrel.2012.04.003; Jones SW, 2005, BRIT J PHARMACOL, V145, P1093, DOI 10.1038/sj.bjp.0706279; Kaplan IM, 2005, J CONTROL RELEASE, V107, P571, DOI 10.1016/j.jconrel.2004.10.018; Kawaguchi Y, 2016, BIOCONJUGATE CHEM, V27, P1119, DOI 10.1021/acs.bioconjchem.6b00082; Khayat R, 2011, J VIROL, V85, P7856, DOI 10.1128/JVI.00737-11; Koren E, 2012, TRENDS MOL MED, V18, P385, DOI 10.1016/j.molmed.2012.04.012; Levitan I, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00065; Liu QG, 2001, VIROLOGY, V285, P91, DOI 10.1006/viro.2001.0922; Mahe D, 2000, J GEN VIROL, V81, P1815, DOI 10.1099/0022-1317-81-7-1815; Melikov K, 2005, CELL MOL LIFE SCI, V62, P2739, DOI 10.1007/s00018-005-5293-y; Mishra A, 2008, ANGEW CHEM INT EDIT, V47, P2986, DOI 10.1002/anie.200704444; Mishra A, 2011, P NATL ACAD SCI USA, V108, P16883, DOI 10.1073/pnas.1108795108; Misinzo G, 2009, VIRUS RES, V139, P1, DOI 10.1016/j.virusres.2008.09.005; Misinzo G, 2006, J VIROL, V80, P3487, DOI 10.1128/JVI.80.7.3487-3494.2006; Misinzo G, 2005, J GEN VIROL, V86, P2057, DOI 10.1099/vir.0.80652-0; Misinzo G, 2008, J VIROL, V82, P1128, DOI 10.1128/JVI.01229-07; Najjar K, 2017, BIOCONJUGATE CHEM, V28, P2932, DOI 10.1021/acs.bioconjchem.7b00560; Nakase I, 2009, MOL THER, V17, P1868, DOI 10.1038/mt.2009.192; Palinski R, 2017, J VIROL, V91, DOI [10.1128/JVI.01879-16, 10.1128/jvi.01879-16]; Rapoport M, 2009, EXPERT OPIN DRUG DEL, V6, P453, DOI [10.1517/17425240902887029, 10.1517/17425240902887029 ]; Reissmann S, 2014, J PEPT SCI, V20, P760, DOI 10.1002/psc.2672; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Ruan G, 2007, J AM CHEM SOC, V129, P14759, DOI 10.1021/ja074936k; Segales J, 2013, VET MICROBIOL, V165, P13, DOI 10.1016/j.vetmic.2012.12.033; Shuai JB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-341; TISCHER I, 1974, ZBL BAKT-INT J MED M, V226, P153; TISCHER I, 1982, NATURE, V295, P64, DOI 10.1038/295064a0; Phan TG, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0642-z; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wagstaff KM, 2007, BIOCHEM J, V406, P185, DOI 10.1042/BJ20070505; Wang ND, 2016, J GEN VIROL, V97, P3331, DOI 10.1099/jgv.0.000634; Wittrup A, 2009, J BIOL CHEM, V284, P32959, DOI 10.1074/jbc.M109.036129	46	22	25	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15221	15232		10.1074/jbc.RA118.004823	http://dx.doi.org/10.1074/jbc.RA118.004823			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30108178	hybrid, Green Published			2022-12-28	WOS:000445998400022
J	Kemp, JP; Brieher, WM				Kemp, James Peter, Jr.; Brieher, William M.			The actin filament bundling protein -actinin-4 actually suppresses actin stress fibers by permitting actin turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cofilin; tropomyosin; epithelial cell; migration; kidney; focal adhesions; -actinin; contractility; motility; paxillin; stress fibers	FOCAL ADHESION MATURATION; ALPHA-ACTININ; F-ACTIN; IN-VITRO; EXTRACELLULAR-MATRIX; STRUCTURAL PROTEIN; ENDOTHELIAL-CELLS; BINDING AFFINITY; PROXIMAL TUBULES; BOWMANS CAPSULE	Cells organize actin filaments into contractile bundles known as stress fibers that resist mechanical stress, increase cell adhesion, remodel the extracellular matrix, and maintain tissue integrity. -actinin is an actin filament bundling protein that is thought to be essential for stress fiber formation and stability. However, previous studies have also suggested that -actinin might disrupt fibers, making the true function of this biomolecule unclear. Here we use fluorescence imaging to show that kidney epithelial cells depleted of -actinin-4 via shRNA or CRISPR/Cas9, or expressing a disruptive mutant make more massive stress fibers that are less dynamic than those in WT cells, leading to defects in cell motility and wound healing. The increase in stress fiber mass and stability can be explained, in part, by increased loading of the filament component tropomyosin onto stress fibers in the absence of -actinin, as monitored via immunofluorescence. We show using imaging and cosedimentation that -actinin and tropomyosin compete for binding to F-actin and that tropomyosin shields actin filaments from cofilin-mediated disassembly in vitro and in cells. Perturbing tropomyosin in cells lacking -actinin-4 results in a complete loss of stress fibers. Our results with -actinin-4 on stress fiber organization are the opposite of what might have been predicted from previous in vitro biochemistry and further highlight how the complex interactions of multiple proteins competing for filament binding lead to unexpected functions for actin-binding proteins in cells.	[Kemp, James Peter, Jr.; Brieher, William M.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Kemp, James Peter, Jr.] Univ N Carolina, Integrat Program Biol & Genome Sci IBGS, Chapel Hill, NC 27599 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of North Carolina; University of North Carolina Chapel Hill	Brieher, WM (corresponding author), MC-123,601 S Goodwin Ave, Urbana, IL 61801 USA.	wbrieher@illinois.edu		Brieher, William/0000-0002-3168-6688; Kemp, James/0000-0003-1975-1149	National Institutes of Health [R01-GM106106]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01-GM106106 (to W. M. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; BADLEY R A, 1980, Journal of Muscle Research and Cell Motility, V1, P5, DOI 10.1007/BF00711922; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; BERNSTEIN BW, 1982, CELL MOTIL CYTOSKEL, V2, P1, DOI 10.1002/cm.970020102; Bonet C, 2010, EUR BIOPHYS J BIOPHY, V39, P1143, DOI 10.1007/s00249-009-0566-2; Burridge K, 2016, EXP CELL RES, V343, P14, DOI 10.1016/j.yexcr.2015.10.029; CALOF AL, 1991, J CELL BIOL, V115, P779, DOI 10.1083/jcb.115.3.779; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Ciobanasu C, 2013, EUR J CELL BIOL, V92, P339, DOI 10.1016/j.ejcb.2013.10.009; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; DRABIKOWSKI W, 1968, EUR J BIOCHEM, V5, P209, DOI 10.1111/j.1432-1033.1968.tb00359.x; Elam WA, 2013, BIOCHEM BIOPH RES CO, V438, P728, DOI 10.1016/j.bbrc.2013.07.109; Ennomani H, 2016, CURR BIOL, V26, P616, DOI 10.1016/j.cub.2015.12.069; Feng YF, 2013, EXP CELL RES, V319, P1124, DOI 10.1016/j.yexcr.2013.02.009; Fukumoto M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120616; GABBIANI G, 1975, LAB INVEST, V32, P227; Gateva G, 2017, CURR BIOL, V27, P705, DOI 10.1016/j.cub.2017.01.018; GOLL DE, 1972, J MOL BIOL, V67, P469, DOI 10.1016/0022-2836(72)90464-0; Goto K, 1998, CELL STRUCT FUNCT, V23, P73, DOI 10.1247/csf.23.73; Gunning PW, 2015, J CELL SCI, V128, P2965, DOI 10.1242/jcs.172502; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; HERMAN IM, 1981, J CELL BIOL, V90, P84, DOI 10.1083/jcb.90.1.84; Hiraiwa T, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.188101; Hu SQ, 2017, NAT CELL BIOL, V19, P133, DOI 10.1038/ncb3466; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; ISENBERG G, 1976, CELL TISSUE RES, V166, P427; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Katoh K, 1998, MOL BIOL CELL, V9, P1919, DOI 10.1091/mbc.9.7.1919; KAWAMURA M, 1970, J BIOCHEM-TOKYO, V68, P577, DOI 10.1093/oxfordjournals.jbchem.a129388; KOJIMA H, 1994, P NATL ACAD SCI USA, V91, P12962, DOI 10.1073/pnas.91.26.12962; Kovac B, 2013, J CELL SCI, V126, P263, DOI 10.1242/jcs.115063; KREIS TE, 1980, CELL, V22, P555, DOI 10.1016/0092-8674(80)90365-7; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; LAZARIDES E, 1975, CELL, V6, P289, DOI 10.1016/0092-8674(75)90180-4; Lenz M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.238107; MACIVER SK, 1991, J CELL BIOL, V115, P1611, DOI 10.1083/jcb.115.6.1611; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MARUYAMA K, 1965, J BIOCHEM-TOKYO, V58, P13, DOI 10.1093/oxfordjournals.jbchem.a128158; McCullough BR, 2008, J MOL BIOL, V381, P550, DOI 10.1016/j.jmb.2008.05.055; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; McFadden WM, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005811; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Meacci G, 2016, MOL BIOL CELL, V27, P3471, DOI 10.1091/mbc.E16-02-0107; Mulholland DJ, 1999, TISSUE CELL, V31, P610, DOI 10.1054/tice.1999.0075; MURAKAMI T, 1991, CELL STRUCT FUNCT, V16, P231, DOI 10.1247/csf.16.231; Murrell M, 2015, NAT REV MOL CELL BIO, V16, P486, DOI 10.1038/nrm4012; Murrell MP, 2012, P NATL ACAD SCI USA, V109, P20820, DOI 10.1073/pnas.1214753109; Nadkarni AV, 2014, CURR BIOL, V24, P2749, DOI 10.1016/j.cub.2014.09.048; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; PAVALKO FM, 1991, J CELL BIOL, V114, P481, DOI 10.1083/jcb.114.3.481; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Piccinini F, 2016, BIOINFORMATICS, V32, P955, DOI 10.1093/bioinformatics/btv686; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Roca-Cusachs P, 2013, P NATL ACAD SCI USA, V110, pE1361, DOI 10.1073/pnas.1220723110; Rosenblatt J, 1997, J CELL BIOL, V136, P1323, DOI 10.1083/jcb.136.6.1323; Ross-Macdonald P, 2008, MOL CANCER THER, V7, P3490, DOI 10.1158/1535-7163.MCT-08-0826; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Shao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013921; Stam S, 2017, P NATL ACAD SCI USA, V114, pE10037, DOI 10.1073/pnas.1708625114; TANAKA K, 1977, JPN CIRC J, V41, P1329; Tang VW, 2013, J CELL BIOL, V203, P815, DOI 10.1083/jcb.201304143; Tang VW, 2012, J CELL BIOL, V196, P115, DOI 10.1083/jcb.201103116; Weins A, 2007, P NATL ACAD SCI USA, V104, P16080, DOI 10.1073/pnas.0702451104; WILLINGHAM MC, 1977, CELL, V10, P375, DOI 10.1016/0092-8674(77)90024-1; WONG AJ, 1983, SCIENCE, V219, P867, DOI 10.1126/science.6681677; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yu-Kemp HC, 2016, J BIOL CHEM, V291, P658, DOI 10.1074/jbc.C115.689265	76	16	17	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14520	14533		10.1074/jbc.RA118.004345	http://dx.doi.org/10.1074/jbc.RA118.004345			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30049798	hybrid, Green Published			2022-12-28	WOS:000444671500029
J	Nguyen, TQ; Aumont-Nicaise, M; Andreani, J; Velours, C; Chenon, M; Vilela, F; Geneste, C; Varela, PF; Llinas, P; Menetrey, J				Nguyen, T. Quyen; Aumont-Nicaise, Magali; Andreani, Jessica; Velours, Christophe; Chenon, Melanie; Vilela, Fernando; Geneste, Clementine; Varela, Paloma F.; Llinas, Paola; Menetrey, Julie			Characterization of the binding mode of JNK-interacting protein 1 (JIP1) to kinesin-light chain 1 (KLC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						isothermal titration calorimetry (ITC); protein-protein interaction; kinesin; protein engineering; site-directed mutagenesis; alcadein; MST; SH2D6; TPR domain; Y-acidic motif; JNK-interacting protein 1; kinesin light chain; TorsinA; autoinhibitory LFP-acidic motif; motor protein	SEQUENCE; CARGO; PERFORMANCE; TRANSPORT; DATABASE	JIP1 was first identified as scaffold protein for the MAP kinase JNK and is a cargo protein for the kinesin1 molecular motor. JIP1 plays significant and broad roles in neurons, mainly as a regulator of kinesin1-dependent transport, and is associated with human pathologies such as cancer and Alzheimer disease. JIP1 is specifically recruited by the kinesin-light chain 1 (KLC1) of kinesin1, but the details of this interaction are not yet fully elucidated. Here, using calorimetry, we extensively biochemically characterized the interaction between KLC1 and JIP1. Using various truncated fragments of the tetratricopeptide repeat (TPR) domain of KLC1, we narrowed down its JIP1-binding region and identified seven KLC1 residues critical for JIP1 binding. These isothermal titration calorimetry (ITC)-based binding data enabled us to footprint the JIP1-binding site on KLC1-TPR. This footprint was used to uncover the structural basis for the marginal inhibition of JIP1 binding by the autoinhibitory LFP-acidic motif of KLC1, as well as for the competition between JIP1 and another cargo protein of kinesin1, the W-acidic motif-containing alcadein-. Also, we examined the role of each of these critical residues of KLC1 for JIP1 binding in light of the previously reported crystal structure of the KLC1-TPR:JIP1 complex. Finally, sequence search in eukaryotic genomes identified several proteins, among which is SH2D6, that exhibit a motif similar to the KLC1-binding motif of JIP1. Overall, our extensive biochemical characterization of the KLC:JIP1 interaction, as well as identification of potential KLC1-binding partners, improves the understanding of how this growing family of cargos is recruited to kinesin1 by KLC1.	[Nguyen, T. Quyen; Velours, Christophe; Chenon, Melanie; Vilela, Fernando; Varela, Paloma F.; Llinas, Paola; Menetrey, Julie] Univ Paris Sud, CNRS, LEBS, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France; [Nguyen, T. Quyen; Aumont-Nicaise, Magali; Andreani, Jessica; Velours, Christophe; Chenon, Melanie; Vilela, Fernando; Geneste, Clementine; Varela, Paloma F.; Llinas, Paola; Menetrey, Julie] Univ Paris Saclay, Univ Paris Sud, Inst Integrat Biol Cell I2BC, Commissariat Energie Atom,CNRS, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Llinas, P; Menetrey, J (corresponding author), Univ Paris Sud, CNRS, LEBS, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.; Llinas, P; Menetrey, J (corresponding author), Univ Paris Saclay, Univ Paris Sud, Inst Integrat Biol Cell I2BC, Commissariat Energie Atom,CNRS, F-91198 Gif Sur Yvette, France.	paola.llinas@i2bc.paris-saclay.fr; julie.menetrey@i2bc.paris-saclay.fr	Ménétrey, Julie/AAM-6408-2021; Varela, Paloma/AFT-0478-2022	Varela, Paloma/0000-0001-5078-7102; Andreani, Jessica/0000-0003-4435-9093; MENETREY, Julie/0000-0003-0091-8842; Vilela, Fernando/0000-0002-1593-5648	French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; ARC [SFI20121205592, DOC20160603834]; Canceropole Ile-de-France Grant [2013-2-AD-06-UP 6-1]	French Infrastructure for Integrated Structural Biology (FRISBI); ARC(Australian Research Council); Canceropole Ile-de-France Grant	This work was supported by French Infrastructure for Integrated Structural Biology (FRISBI) Grant ANR-10-INSB-05-01 and by ARC Grant SFI20121205592 (to J. M.) as well as Canceropole Ile-de-France Grant 2013-2-AD-06-UP 6-1 and ARC Grant DOC20160603834 (to T.Q.N.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; DeLano W.L, PYMOL MOL GRAPHICS S; Dey G, 2015, CELL REP, V10, P993, DOI 10.1016/j.celrep.2015.01.025; Dodding MP, 2011, EMBO J, V30, P4523, DOI 10.1038/emboj.2011.326; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faure G, 2012, NUCLEIC ACIDS RES, V40, pD847, DOI 10.1093/nar/gkr845; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hammond JW, 2008, TRAFFIC, V9, P725, DOI 10.1111/j.1600-0854.2008.00722.x; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kamm C, 2004, J BIOL CHEM, V279, P19882, DOI 10.1074/jbc.M401332200; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kawano T, 2012, TRAFFIC, V13, P834, DOI 10.1111/j.1600-0854.2012.01350.x; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; Matsuda S, 2001, J NEUROSCI, V21, P6597; Meyer D, 1999, J BIOL CHEM, V274, P35113, DOI 10.1074/jbc.274.49.35113; Morfini G, 2016, BRAIN RES BULL, V126, P347, DOI 10.1016/j.brainresbull.2016.06.009; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Pernigo S., 2018, BIORXIV, DOI [10.1101/322057, DOI 10.1101/322057]; Pernigo S, 2013, SCIENCE, V340, P356, DOI 10.1126/science.1234264; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Nguyen TQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186354; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whitmarsh AJ, 2006, BIOCHEM SOC T, V34, P828, DOI 10.1042/BST0340828; Yip YY, 2016, P NATL ACAD SCI USA, V113, P2418, DOI 10.1073/pnas.1520817113; Zeke A, 2016, MICROBIOL MOL BIOL R, V80, P793, DOI 10.1128/MMBR.00043-14; Zhu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052393	39	7	7	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13946	13960		10.1074/jbc.RA118.003916	http://dx.doi.org/10.1074/jbc.RA118.003916			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30026235	hybrid, Green Published			2022-12-28	WOS:000444070700020
J	Macdonald-Obermann, JL; Pike, LJ				Macdonald-Obermann, Jennifer L.; Pike, Linda J.			Allosteric regulation of epidermal growth factor (EGF) receptor ligand binding by tyrosine kinase inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epidermal growth factor (EGF); epidermal growth factor receptor (EGFR); tyrosine-protein kinase (tyrosine kinase); growth factor; inhibitor; erlotinib; lapatinib; Ligand binding	C-TERMINAL TAIL; LUNG-CANCER; NEGATIVE COOPERATIVITY; AUTOPHOSPHORYLATION SITES; EXTRACELLULAR DOMAINS; CRYSTAL-STRUCTURE; CARCINOMA-CELLS; PHORBOL ESTERS; ACTIVATION; DIMERIZATION	The epidermal growth factor (EGF) receptor is a classical receptor tyrosine kinase with an extracellular ligand-binding domain and an intracellular kinase domain. Mutations in the EGF receptor have been shown to drive uncontrolled cell growth and are associated with a number of different tumors. Two different types of ATP-competitive EGF receptor tyrosine kinase inhibitors have been identified that bind to either the active (type I) or inactive (type II) conformation of the kinase domain. Despite the fact that both types of inhibitors block tyrosine kinase activity, they exhibit differential efficacies in different tumor types. Here, we show that in addition to inhibiting kinase activity, these inhibitors allosterically modulate ligand binding. Our data suggest that the conformations of the EGF receptor extracellular domain and intracellular kinase domain are coupled and that these conformations exist in equilibrium. Allosteric regulators, such as the small-molecule tyrosine kinase inhibitors, as well as mutations in the EGF receptor itself, shift the conformational equilibrium among the active and inactive species, leading to changes in EGF receptor-binding affinity. Our studies also reveal unexpected positive cooperativity between EGF receptor subunits in dimers formed in the presence of type II inhibitors. These findings indicate that there is strong functional coupling between the intracellular and extracellular domains of this receptor. Such coupling may impact the therapeutic synergy between small-molecule tyrosine kinase inhibitors and monoclonal antibodies in vivo.	[Macdonald-Obermann, Jennifer L.; Pike, Linda J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Pike, LJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	pike@biochem.wustl.edu			NIGMS NIH HHS [R01 GM108785] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108785] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adak S, 2011, J BIOL CHEM, V286, P45146, DOI 10.1074/jbc.M111.274175; Adak S, 2011, J BIOL CHEM, V286, P1545, DOI 10.1074/jbc.M110.182899; Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Bessman NJ, 2014, CELL REP, V9, P1306, DOI 10.1016/j.celrep.2014.10.010; Bose R, 2009, EXP CELL RES, V315, P649, DOI 10.1016/j.yexcr.2008.07.031; Brandes AA, 2008, CLIN CANCER RES, V14, P957, DOI 10.1158/1078-0432.CCR-07-1810; Bublil EM, 2010, FASEB J, V24, P4744, DOI 10.1096/fj.10-166199; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; COKER KJ, 1994, P NATL ACAD SCI USA, V91, P6967, DOI 10.1073/pnas.91.15.6967; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; DORAN DM, 1980, J IMMUNOL METHODS, V39, P155, DOI 10.1016/0022-1759(80)90304-X; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gill K, 2017, J BIOL CHEM, V292, P20744, DOI 10.1074/jbc.M117.802553; HSUAN JJ, 1989, BIOCHEM J, V262, P659, DOI 10.1042/bj2620659; Huang YJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14107; Johns TG, 2004, J BIOL CHEM, V279, P30375, DOI 10.1074/jbc.M401218200; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; KING AC, 1982, J BIOL CHEM, V257, P3053; Kovacs E, 2015, MOL CELL BIOL, V35, P3083, DOI 10.1128/MCB.00248-15; Kozer N, 2014, BIOCHEMISTRY-US, V53, P2594, DOI 10.1021/bi500182x; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Lichtner RB, 2001, CANCER RES, V61, P5790; Lu CF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414391; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Macdonald-Obermann JL, 2009, J BIOL CHEM, V284, P13570, DOI 10.1074/jbc.M109.001487; MAGUN BE, 1980, J BIOL CHEM, V255, P6373; MARGOLIS BL, 1989, J BIOL CHEM, V264, P10667; Mi LZ, 2011, NAT STRUCT MOL BIOL, V18, P984, DOI 10.1038/nsmb.2092; Needham SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13307; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Red Brewer M, 2013, P NATL ACAD SCI USA, V110, pE3595, DOI 10.1073/pnas.1220050110; Schlessinger J, 2003, SCI STKE, P12; Schmitz KR, 2013, STRUCTURE, V21, P1214, DOI 10.1016/j.str.2013.05.008; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; SHOYAB M, 1979, NATURE, V279, P387, DOI 10.1038/279387a0; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Valley CC, 2015, MOL BIOL CELL, V26, P4087, DOI 10.1091/mbc.E15-05-0269; Vivanco I, 2012, CANCER DISCOV, V2, P458, DOI 10.1158/2159-8290.CD-11-0284; Walker F, 2004, J BIOL CHEM, V279, P22387, DOI 10.1074/jbc.M401244200; Wang ZH, 2011, NAT STRUCT MOL BIOL, V18, P1388, DOI 10.1038/nsmb.2168; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Wu P, 2015, TRENDS PHARMACOL SCI, V36, P422, DOI 10.1016/j.tips.2015.04.005; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	59	10	11	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13401	13414		10.1074/jbc.RA118.004139	http://dx.doi.org/10.1074/jbc.RA118.004139			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29997256	Green Published, hybrid			2022-12-28	WOS:000443375500005
J	Molodtsov, V; Murakami, KS				Molodtsov, Vadim; Murakami, Katsuhiko S.			Minimalism and functionality: Structural lessons from the heterodimeric N4 bacteriophage RNA polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA polymerase; DNA transcription; X-ray crystallography; viral transcription; RNA synthesis; N4 phage; transcription complex; X-ray structure; transcription	TRANSCRIPTION INITIATION; CRYSTAL-STRUCTURE; MITOCHONDRIAL; DNA; ELONGATION; TRANSITION; DOMAIN	Genomes of phages, mitochondria, and chloroplasts are transcribed by a diverse group of transcriptional machineries with structurally related single-subunit RNA polymerases (RNAPs). Our understanding of transcription mechanisms of these enzymes is predominantly based on biochemical and structural studies of three most-studied members, transcription factor-independent phage T7 RNAP, transcription factor-dependent phage N4 virion-encapsidated RNAP, and transcription factor-dependent mitochondrial RNAPs (mtRNAP). Although these RNAPs employ completely different mechanisms for promoter recognition and transcription termination, these enzymes are relatively large and formed by single polypeptides. Historically being a model enzyme for studying the mechanisms of transcription by T7-like RNAPs, however, T7 RNAP represents only a small group of RNAPs in this family. The vast majority of T7-like RNAPs are transcription factor-dependent, and several of them are heterodimeric enzymes. Here, we report X-ray crystal structures of transcription complexes of the smallest and heterodimeric form of T7-like RNAP, bacteriophage N4 RNAPII, providing insights into the structural organization of a minimum RNAP in this family. We analyze structural and functional aspects of heterodimeric architecture of N4 RNAPII concerning the mechanisms of transcription initiation and transition to processive RNA elongation. Interestingly, N4 RNAPII maintains the same conformation in promoter-bound and elongation transcription complexes, revealing a novel transcription mechanism for single-subunit RNAPs. This work establishes a structural basis for studying mechanistic aspects of transcription by factor-dependent minimum RNAP.	[Molodtsov, Vadim; Murakami, Katsuhiko S.] Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Molodtsov, V; Murakami, KS (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA.	vum5@psu.edu; kum14@psu.edu		Murakami, Katsuhiko/0000-0003-2244-0501; Molodtsov, Vadim/0000-0003-3002-4794	National Institutes of Health [GM087350]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM087350 (to K. S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAVAYA K, 1989, J BIOL CHEM, V264, P12695; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Basu RS, 2014, J BIOL CHEM, V289, P24549, DOI 10.1074/jbc.M114.584037; Basu RS, 2013, J BIOL CHEM, V288, P3305, DOI 10.1074/jbc.M112.387712; Carter RH, 2003, GENE DEV, V17, P2334, DOI 10.1101/gad.1121403; Cermakian N, 1996, NUCLEIC ACIDS RES, V24, P648, DOI 10.1093/nar/24.4.648; CHAMBERL.M, 1970, NATURE, V228, P227, DOI 10.1038/228227a0; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 2000, CURR OPIN STRUC BIOL, V10, P117, DOI 10.1016/S0959-440X(99)00058-5; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Durniak KJ, 2008, SCIENCE, V322, P553, DOI 10.1126/science.1163433; Gleghorn ML, 2008, MOL CELL, V32, P707, DOI 10.1016/j.molcel.2008.11.010; Hillen HS, 2017, CELL, V171, P1072, DOI 10.1016/j.cell.2017.10.036; Hillen HS, 2017, CELL, V171, P1082, DOI 10.1016/j.cell.2017.09.035; Jeruzalmi D, 1998, EMBO J, V17, P4101, DOI 10.1093/emboj/17.14.4101; Kazmierczak KM, 2002, EMBO J, V21, P5815, DOI 10.1093/emboj/cdf584; Lenneman BR, 2015, BIOMOLECULES, V5, P647, DOI 10.3390/biom5020647; MCALLISTER WT, 1993, MOL MICROBIOL, V10, P1, DOI 10.1111/j.1365-2958.1993.tb00897.x; Murakami KS, 2008, P NATL ACAD SCI USA, V105, P5046, DOI 10.1073/pnas.0712325105; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ringel R, 2011, NATURE, V478, P269, DOI 10.1038/nature10435; ROTHMANDENES LB, 1974, VIROLOGY, V60, P65, DOI 10.1016/0042-6822(74)90366-3; Schwinghammer K, 2013, NAT STRUCT MOL BIOL, V20, P1298, DOI 10.1038/nsmb.2683; Segall-Shapiro TH, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145299; Shis DL, 2013, P NATL ACAD SCI USA, V110, P5028, DOI 10.1073/pnas.1220157110; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; Steitz TA, 2009, CURR OPIN STRUC BIOL, V19, P683, DOI 10.1016/j.sbi.2009.09.001; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tang GQ, 2009, P NATL ACAD SCI USA, V106, P22175, DOI 10.1073/pnas.0906979106; VANDERLAAN K, 1977, VIROLOGY, V76, P596, DOI 10.1016/0042-6822(77)90241-0; Willis SH, 2002, J BACTERIOL, V184, P4952, DOI 10.1128/JB.184.18.4952-4961.2002; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	33	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13616	13625		10.1074/jbc.RA118.003447	http://dx.doi.org/10.1074/jbc.RA118.003447			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29991593	Green Published, hybrid			2022-12-28	WOS:000443375500021
J	Keown, JR; Black, MM; Ferron, A; Yap, M; Barnett, MJ; Pearce, FG; Stoye, JP; Goldstone, DC				Keown, Jeremy R.; Black, Moyra M.; Ferron, Aaron; Yap, Melvyn; Barnett, Michael J.; Pearce, F. Grant; Stoye, Jonathan P.; Goldstone, David C.			A helical LC3-interacting region mediates the interaction between the retroviral restriction factor Trim5 and mammalian autophagy-related ATG8 proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; retrovirus; human immunodeficiency virus (HIV); protein-protein interaction; protein complex; antiviral protein; LC3B; LIR; retroviral restriction factor; Trim5alpha	REGULATE AUTOPHAGY; HUMAN TRIM5-ALPHA; HOST RESTRICTION; HIV-1; MOTIF; RECOGNITION; COMPLEX; FAMILY; REQUIREMENTS; INHIBITION	The retroviral restriction factor tripartite motif-containing 5 (Trim5) acts during the early postentry stages of the retroviral life cycle to block infection by a broad range of retroviruses, disrupting reverse transcription and integration. The mechanism of this restriction is poorly understood, but it has recently been suggested to involve recruitment of components of the autophagy machinery, including members of the mammalian autophagy-related 8 (ATG8) family involved in targeting proteins to the autophagosome. To better understand the molecular details of this interaction, here we utilized analytical ultracentrifugation to characterize the binding of six ATG8 isoforms and determined the crystal structure of the Trim5 Bbox coiled-coil region in complex with one member of the mammalian ATG8 proteins, autophagy-related protein LC3 B (LC3B). We found that Trim5 binds all mammalian ATG8s and that, unlike the typical LC3-interacting region (LIR) that binds to mammalian ATG8s through a -strand motif comprising approximately six residues, LC3B binds to Trim5 via the -helical coiled-coil region. The orientation of the structure demonstrated that LC3B could be accommodated within a Trim5 assembly that can bind the retroviral capsid. However, mutation of the binding interface does not affect retroviral restriction. Comparison of the typical linear -strand LIR with our atypical helical LIR reveals a conservation of the presentation of residues that are required for the interaction with LC3B. This observation expands the range of LC3B-binding proteins to include helical binding motifs and demonstrates a link between Trim5 and components of the autophagosome.	[Keown, Jeremy R.; Black, Moyra M.; Barnett, Michael J.; Goldstone, David C.] Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand; [Ferron, Aaron; Stoye, Jonathan P.] Francis Crick Inst, London NW1 1ST, England; [Pearce, F. Grant] Univ Canterbury, Sch Biol Sci, Christchurch 8041, New Zealand; [Goldstone, David C.] Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand; [Keown, Jeremy R.] Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England	University of Auckland; Francis Crick Institute; University of Canterbury; University of Auckland; University of Oxford	Goldstone, DC (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand.	d.goldstone@auckland.ac.nz	Keown, Jeremy/AAH-4361-2021	Goldstone, David/0000-0003-0069-9408; Ferron, Aaron/0000-0002-5776-7304; Stoye, Jonathan/0000-0003-3377-323X; Keown, Jeremy/0000-0003-0159-9257	Maurice Wilkins Centre for Molecular Biodiscovery, a Centre of Research Excellence - New Zealand government; MRC [MC_U117512710] Funding Source: UKRI	Maurice Wilkins Centre for Molecular Biodiscovery, a Centre of Research Excellence - New Zealand government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Plasmids encoding LC3A-C and GABARAP proteins used for subcloning were a kind gift from Prof. Ren Dobson (University of Canterbury). We acknowledge the New Zealand Synchrotron group for access to the MX Beamlines at the Australian Synchrotron. Access to analytical ultracentrifuge facilities was supported by funds the Maurice Wilkins Centre for Molecular Biodiscovery (to D. C. G.), a Centre of Research Excellence funded by the New Zealand government.	Adams PD, 2013, ANNU REV BIOPHYS, V42, P265, DOI 10.1146/annurev-biophys-083012-130253; Anderson JL, 2006, J VIROL, V80, P9754, DOI 10.1128/JVI.01052-06; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Biris N, 2012, P NATL ACAD SCI USA, V109, P13278, DOI 10.1073/pnas.1203536109; Chauhan S, 2016, DEV CELL, V39, P13, DOI 10.1016/j.devcel.2016.08.003; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; Dodding MP, 2005, J VIROL, V79, P10571, DOI 10.1128/JVI.79.16.10571-10577.2005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Forshey BM, 2005, J VIROL, V79, P869, DOI 10.1128/JVI.79.2.869-875.2005; Goldstone DC, 2014, P NATL ACAD SCI USA, V111, P9609, DOI 10.1073/pnas.1402448111; Imam S, 2016, J VIROL, V90, P3400, DOI 10.1128/JVI.03033-15; Jia XF, 2015, CURR OPIN STRUC BIOL, V31, P106, DOI 10.1016/j.sbi.2015.04.004; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keown JR, 2016, SCI REP-UK, V6, DOI 10.1038/srep26837; Kimura T, 2016, J CELL SCI, V129, P881, DOI 10.1242/jcs.163758; Klionsky DJ, 2014, NAT STRUCT MOL BIOL, V21, P336, DOI 10.1038/nsmb.2787; Kutluay SB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003214; Li YL, 2016, ELIFE, V5, DOI 10.7554/eLife.16269; Mandell MA, 2014, AUTOPHAGY, V10, P2387, DOI 10.4161/15548627.2014.984278; Mandell MA, 2014, DEV CELL, V30, P394, DOI 10.1016/j.devcel.2014.06.013; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McEwan DG, 2015, MOL CELL, V57, P39, DOI 10.1016/j.molcel.2014.11.006; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Ohkura S, 2006, J VIROL, V80, P8554, DOI 10.1128/JVI.00688-06; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Popelka H, 2015, AUTOPHAGY, V11, P2153, DOI 10.1080/15548627.2015.1111503; Rajsbaum R, 2014, J MOL BIOL, V426, P1265, DOI 10.1016/j.jmb.2013.12.005; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Ribeiro CMS, 2016, NATURE, V540, P448, DOI 10.1038/nature20567; Roa A, 2012, J VIROL, V86, P1717, DOI 10.1128/JVI.05811-11; Rogov VV, 2017, EMBO REP, V18, P1382, DOI 10.15252/embr.201643587; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Schrago CG, 2003, MOL BIOL EVOL, V20, P1620, DOI 10.1093/molbev/msg172; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Suzuki H, 2014, STRUCTURE, V22, P47, DOI 10.1016/j.str.2013.09.023; Tareen SU, 2011, VIROLOGY, V409, P113, DOI 10.1016/j.virol.2010.09.018; Uchil PD, 2013, J VIROL, V87, P257, DOI 10.1128/JVI.01804-12; Wagner JM, 2016, ELIFE, V5, DOI [10.7554/elife.16309, 10.7554/eLife.16309]; Weinert C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10819; Yang HT, 2012, P NATL ACAD SCI USA, V109, P18372, DOI 10.1073/pnas.1210903109; Yap MW, 2006, J VIROL, V80, P4061, DOI 10.1128/JVI.80.8.4061-4067.2006; Zaffagnini G, 2016, J MOL BIOL, V428, P1714, DOI 10.1016/j.jmb.2016.02.004	45	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18378	18386		10.1074/jbc.RA118.004202	http://dx.doi.org/10.1074/jbc.RA118.004202			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30282803	Green Published, hybrid			2022-12-28	WOS:000451375200028
J	Mafakheri, S; Florke, RR; Kanngiesser, S; Hartwig, S; Espelage, L; De Wendt, C; Schonberger, T; Hamker, N; Lehr, S; Chadt, A; Al-Hasani, H				Mafakheri, Samaneh; Floerke, Ralf R.; Kanngiesser, Sibylle; Hartwig, Sonja; Espelage, Lena; De Wendt, Christian; Schoenberger, Tina; Hamker, Nele; Lehr, Stefan; Chadt, Alexandra; Al-Hasani, Hadi			AKT and AMP-activated protein kinase regulate TBC1D1 through phosphorylation and its interaction with the cytosolic tail of insulin-regulated aminopeptidase IRAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Type 2 diabetes; skeletal muscle; glucose transporter type 4 (GLUT4); glucose transport; insulin; Rab10; RabGAPs	MOUSE SKELETAL-MUSCLE; STIMULATED GLUT4 TRANSLOCATION; PHOSPHOTYROSINE-BINDING DOMAIN; GLUCOSE-TRANSPORT; AS160; CONTRACTION; SUBSTRATE; TRAFFICKING; ADIPOCYTES; EXERCISE	In skeletal muscle, the Rab GTPase-activating (GAP) protein TBC1D1 is phosphorylated by AKT and AMP-activated protein kinase (AMPK) in response to insulin and muscle contraction. Genetic ablation of Tbc1d1 or mutation of distinct phosphorylation sites impairs intracellular GLUT4 retention and GLUT4 traffic, presumably through alterations of the activation state of downstream Rab GTPases. Previous studies have focused on characterizing the C-terminal GAP domain of TBC1D1 that lacks the known phosphorylation sites, as well as putative regulatory domains. As a result, it has been unclear how phosphorylation of TBC1D1 would regulate its activity. In the present study, we have expressed, purified, and characterized recombinant full-length TBC1D1 in Sf9 insect cells via the baculovirus system. Full-length TBC1D1 showed RabGAP activity toward GLUT4-associated Rab8a, Rab10, and Rab14, indicating similar substrate specificity as the truncated GAP domain. However, the catalytic activity of the full-length TBC1D1 was markedly higher than that of the GAP domain. Although in vitro phosphorylation of TBC1D1 by AKT or AMPK increased 14-3-3 binding, it did not alter the intrinsic RabGAP activity. However, we found that TBC1D1 interacts through its N-terminal PTB domains with the cytoplasmic domain of the insulin-regulated aminopeptidase, a resident protein of GLUT4 storage vesicles, and this binding is disrupted by phosphorylation of TBC1D1 by AKT or AMPK. In summary, our findings suggest that other regions outside the GAP domain may contribute to the catalytic activity of TBC1D1. Moreover, our data indicate that recruitment of TBC1D1 to GLUT4-containing vesicles and not its GAP activity is regulated by insulin and contraction-mediated phosphorylation.	[Mafakheri, Samaneh; Floerke, Ralf R.; Kanngiesser, Sibylle; Hartwig, Sonja; Espelage, Lena; De Wendt, Christian; Schoenberger, Tina; Hamker, Nele; Lehr, Stefan; Chadt, Alexandra; Al-Hasani, Hadi] Heinrich Heine Univ, Med Fac, Inst Clin Biochem & Pathobiochem, German Diabet Ctr,Leibniz Ctr Diabet Res, D-40225 Dusseldorf, Germany; [Mafakheri, Samaneh; Floerke, Ralf R.; Hartwig, Sonja; Espelage, Lena; De Wendt, Christian; Lehr, Stefan; Chadt, Alexandra; Al-Hasani, Hadi] German Ctr Diabet Res DZD, D-85764 Munich, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf	Al-Hasani, H (corresponding author), German Diabet Ctr, Inst Clin Biochem & Pathobiochem, Hennekamp 65, D-40225 Dusseldorf, Germany.	hadi.al-hasani@ddz.uni-duesseldorf.de		Eickelschulte, Samaneh/0000-0002-8040-8393	Deutsche Forschungsgemeinschaft [AL452/4, SFB1116]; EFSD/Lilly European Diabetes Research Program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EFSD/Lilly European Diabetes Research Program	This work was supported in part by Deutsche Forschungsgemeinschaft Grants AL452/4 and SFB1116 and the EFSD/Lilly European Diabetes Research Program (to H. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Hasani H, 1998, J BIOL CHEM, V273, P17504, DOI 10.1074/jbc.273.28.17504; An D, 2010, DIABETES, V59, P1358, DOI 10.2337/db09-1266; Baer K, 2005, BBA-GEN SUBJECTS, V1725, P340, DOI 10.1016/j.bbagen.2005.04.002; Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; Cartee G, 2015, DIABETOLOGIA, V58, P19, DOI 10.1007/s00125-014-3395-5; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Jessen N, 2011, AM J PHYSIOL-ENDOC M, V301, pE164, DOI 10.1152/ajpendo.00042.2011; Jordens I, 2010, MOL BIOL CELL, V21, P2034, DOI 10.1091/mbc.E10-02-0158; Kane S, 2005, BIOCHEM BIOPH RES CO, V335, P175, DOI 10.1016/j.bbrc.2005.07.056; Karunanithi S, 2014, MOL BIOL CELL, V25, P3059, DOI 10.1091/mbc.E14-06-1060; Koumanov F, 2011, J BIOL CHEM, V286, P16574, DOI 10.1074/jbc.M111.226092; Kramer HF, 2007, DIABETES, V56, P2854, DOI 10.2337/db07-0681; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Mafakheri S, 2018, BIOCHEM SOC T, V46, P683, DOI 10.1042/BST20170479; Meyre D, 2008, HUM MOL GENET, V17, P1798, DOI 10.1093/hmg/ddn070; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Park SY, 2011, J BIOL CHEM, V286, P18130, DOI 10.1074/jbc.M110.217323; Park S, 2012, BMB REP, V45, P360, DOI 10.5483/BMBRep.2012.45.6.030; Parvaresch S, 2002, FEBS LETT, V532, P357, DOI 10.1016/S0014-5793(02)03708-0; Peck GR, 2006, MOL ENDOCRINOL, V20, P2576, DOI 10.1210/me.2005-0476; Peck GR, 2009, J BIOL CHEM, V284, P30016, DOI 10.1074/jbc.M109.035568; Pehmoller C, 2009, AM J PHYSIOL-ENDOC M, V297, pE665, DOI 10.1152/ajpendo.00115.2009; Rak A, 2000, EMBO J, V19, P5105, DOI 10.1093/emboj/19.19.5105; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Reed SE, 2013, J CELL SCI, V126, P1931, DOI 10.1242/jcs.104307; Richardson TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063897; Roach WG, 2007, BIOCHEM J, V403, P353, DOI 10.1042/BJ20061798; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2011, J BIOL CHEM, V286, P16541, DOI 10.1074/jbc.C111.228908; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; Szekeres F, 2012, AM J PHYSIOL-ENDOC M, V303, pE524, DOI 10.1152/ajpendo.00605.2011; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Thomas EC, 2018, BIOCHEM J, V475, P2969, DOI 10.1042/BCJ20180475; Treebak JT, 2014, J PHYSIOL-LONDON, V592, P351, DOI 10.1113/jphysiol.2013.266338; Vichaiwong K, 2010, BIOCHEM J, V431, P311, DOI 10.1042/BJ20101100; Will E, 2001, J BIOL CHEM, V276, P12135, DOI 10.1074/jbc.M011451200; Woo JR, 2017, INT J BIOL MACROMOL, V103, P965, DOI 10.1016/j.ijbiomac.2017.05.119; Zhou M, 2007, ANAL CHEM, V79, P7603, DOI 10.1021/ac071584r; Zhou Z, 2017, FEBS LETT, V591, P88, DOI 10.1002/1873-3468.12509	43	21	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17853	17862		10.1074/jbc.RA118.005040	http://dx.doi.org/10.1074/jbc.RA118.005040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30275018	Green Published, hybrid			2022-12-28	WOS:000450409500016
J	Odenwald, MA; Choi, W; Kuo, WT; Singh, G; Sailer, A; Wang, YT; Shen, L; Fanning, AS; Turner, JR				Odenwald, Matthew A.; Choi, Wangsun; Kuo, Wei-Ting; Singh, Gurminder; Sailer, Anne; Wang, Yitang; Shen, Le; Fanning, Alan S.; Turner, Jerrold R.			The scaffolding protein ZO-1 coordinates actomyosin and epithelial apical specializations in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cell adhesion; cell polarity; cell surface; cytoskeleton; intestinal epithelium; myosin; PDZ domain; tight junction; brush border; community border; microvilli; apical specialization	LIGHT-CHAIN KINASE; MEMBRANE-PERMEANT PEPTIDE; ZONULA OCCLUDENS-1 AND-2; TIGHT JUNCTION BARRIER; ACTIN-BINDING REGION; 2,3-BUTANEDIONE MONOXIME; CELL-SHAPE; MYOSIN; OCCLUDIN; LOCALIZATION	Polarized epithelia assemble into sheets that compartmentalize organs and generate tissue barriers by integrating apical surfaces into a single, unified structure. This tissue organization is shared across organs, species, and developmental stages. The processes that regulate development and maintenance of apical epithelial surfaces are, however, undefined. Here, using an intestinal epithelial-specific knockout (KO) mouse and cultured epithelial cells, we show that the tight junction scaffolding protein zonula occludens-1 (ZO-1) is essential for development of unified apical surfaces in vivo and in vitro. We found that U5 and GuK domains of ZO-1 are necessary for proper apical surface assembly, including organization of microvilli and cortical F-actin; however, direct interactions with F-actin through the ZO-1 actin-binding region (ABR) are not required. ZO-1 lacking the PDZ1 domain, which binds claudins, rescued apical structure in ZO-1-deficient epithelia, but not in cells lacking both ZO-1 and ZO-2, suggesting that heterodimerization with ZO-2 restores PDZ1-dependent ZO-1 interactions that are vital to apical surface organization. Pharmacologic F-actin disruption, myosin II motor inhibition, or dynamin inactivation restored apical epithelial structure in vitro and in vivo, indicating that ZO-1 directs epithelial organization by regulating actomyosin contraction and membrane traffic. We conclude that multiple ZO-1-mediated interactions contribute to coordination of epithelial actomyosin function and genesis of unified apical surfaces.	[Odenwald, Matthew A.; Singh, Gurminder; Sailer, Anne; Wang, Yitang; Shen, Le; Turner, Jerrold R.] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Shen, Le] Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Choi, Wangsun; Kuo, Wei-Ting; Singh, Gurminder; Turner, Jerrold R.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Choi, Wangsun; Kuo, Wei-Ting; Singh, Gurminder; Turner, Jerrold R.] Harvard Med Sch, Boston, MA 02115 USA; [Fanning, Alan S.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of Chicago; University of Chicago; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill	Turner, JR (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, 77 Ave Louis Pasteur,BHNRB 730, Boston, MA 02115 USA.	jrturner@bwh.harvard.edu	Wang, Yuan/HHC-1520-2022; Wang, Yanbo/HFZ-8018-2022; wang, yan/GSE-6489-2022; Turner, Jerrold/H-1502-2019; Wang, Yin/HCI-9352-2022; wangwangwang, yuanyaun/HHN-6432-2022; wang, yi/GVT-8516-2022	Shen, Le/0000-0002-4367-5476; Kuo, Wei-Ting/0000-0002-1230-0014	NIDDK, National Institutes of Health (NIH) [F30DK103511, R01DK61931, R01DK68271]; NICHD, NIH [T32HD007009]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061931, F30DK103511, R01DK068271] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health (NIH), Grants F30DK103511 (to M. A. O.) and R01DK61931 and R01DK68271 (to J. R. T.) and NICHD, NIH, Grant T32HD007009 (to M. A. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALLEN TD, 1976, NATURE, V264, P545, DOI 10.1038/264545a0; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; Barfod ET, 2011, MOL BIOL CELL, V22, P634, DOI 10.1091/mbc.E10-06-0514; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Buschmann MM, 2013, MOL BIOL CELL, V24, P3056, DOI 10.1091/mbc.E12-09-0688; Carisey AF, 2018, CURR BIOL, V28, P489, DOI 10.1016/j.cub.2017.12.044; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; Choi W, 2016, J CELL BIOL, V213, P243, DOI 10.1083/jcb.201506115; Chua J, 2009, P NATL ACAD SCI USA, V106, P20770, DOI 10.1073/pnas.0909812106; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; CRAMER LP, 1995, J CELL BIOL, V131, P179, DOI 10.1083/jcb.131.1.179; Crawley SW, 2014, CELL, V157, P433, DOI 10.1016/j.cell.2014.01.067; Dietz ML, 2006, J BIOL CHEM, V281, P20542, DOI 10.1074/jbc.M512463200; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; Etournay R, 2007, J CELL SCI, V120, P2838, DOI 10.1242/jcs.002568; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Fanning AS, 2002, FASEB J, V16, P1835, DOI 10.1096/fj.02-0121fje; Fernandez-Gonzalez R, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2101pe78; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Grosse AS, 2011, DEVELOPMENT, V138, P4423, DOI 10.1242/dev.065789; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Lee CS, 2010, J CELL BIOL, V190, P663, DOI 10.1083/jcb.201003057; Lee JY, 2010, CURR BIOL, V20, P253, DOI 10.1016/j.cub.2009.12.021; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marchiando AM, 2011, GASTROENTEROLOGY, V140, P1208, DOI 10.1053/j.gastro.2011.01.004; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Martin AC, 2014, DEVELOPMENT, V141, P1987, DOI 10.1242/dev.102228; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; McConnell RE, 2009, J CELL BIOL, V185, P1285, DOI 10.1083/jcb.200902147; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Nighot M, 2017, AM J PATHOL, V187, P2698, DOI 10.1016/j.ajpath.2017.08.005; Odenwald MA, 2017, J CELL SCI, V130, P243, DOI 10.1242/jcs.188185; Ostap EM, 2002, J MUSCLE RES CELL M, V23, P305, DOI 10.1023/A:1022047102064; Owens SE, 2005, PHARM RES-DORDR, V22, P703, DOI 10.1007/s11095-005-2584-9; Papadopulos A, 2017, MOL CELL NEUROSCI, V84, P93, DOI 10.1016/j.mcn.2017.05.006; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Plageman TF, 2011, DEVELOPMENT, V138, P5177, DOI 10.1242/dev.067868; Rodgers LS, 2013, J CELL SCI, V126, P1565, DOI 10.1242/jcs.113399; Rodriguez-Fraticelli AE, 2015, NAT CELL BIOL, V17, P241, DOI 10.1038/ncb3106; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; Roland JT, 2011, P NATL ACAD SCI USA, V108, P2789, DOI 10.1073/pnas.1010754108; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Saw TB, 2017, NATURE, V544, P212, DOI 10.1038/nature21718; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; SELLIN LC, 1994, PHARMACOL TOXICOL, V74, P305, DOI 10.1111/j.1600-0773.1994.tb01365.x; Shashikanth N, 2017, COMPR PHYSIOL, V7, P1497, DOI 10.1002/cphy.c170003; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; SIEGMAN MJ, 1994, J MUSCLE RES CELL M, V15, P457, DOI 10.1007/BF00122119; Sourisseau T, 2006, MOL CELL BIOL, V26, P2387, DOI 10.1128/MCB.26.6.2387-2398.2006; Spadaro D, 2017, CURR BIOL, V27, P3783, DOI 10.1016/j.cub.2017.11.014; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Surviladze Z., 2010, PROBE REPORTS NIH MO; Tran DT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10098; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.E04-12-1116; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Vogel GF, 2015, J CELL BIOL, V211, P587, DOI 10.1083/jcb.201506112; Xiao F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021527; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; Yu ASL, 2005, AM J PHYSIOL-CELL PH, V288, pC1231, DOI 10.1152/ajpcell.00581.2004; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107; Yu HYE, 2007, MOL BIOL CELL, V18, P4096, DOI 10.1091/mbc.E06-11-0993; Zemljic-Harpf AE, 2014, J CELL SCI, V127, P1104, DOI 10.1242/jcs.143743; Zihni C, 2017, NAT CELL BIOL, V19, P1049, DOI 10.1038/ncb3592; Zihni C, 2014, J CELL BIOL, V204, P111, DOI 10.1083/jcb.201304064; Zolotarevsky Y, 2002, GASTROENTEROLOGY, V123, P163, DOI 10.1053/gast.2002.34235	80	43	43	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17317	17335		10.1074/jbc.RA118.003908	http://dx.doi.org/10.1074/jbc.RA118.003908			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30242130	hybrid, Green Published			2022-12-28	WOS:000449799000002
J	Weismiller, HA; Murphy, R; Wei, GH; Ma, BY; Nussinov, R; Margittai, M				Weismiller, Hilary A.; Murphy, Rachel; Wei, Guanghong; Ma, Buyong; Nussinov, Ruth; Margittai, Martin			Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Tau protein (Tau); amyloid; conformational change; Alzheimer disease; tauopathy; electron paramagnetic resonance (EPR); fibril; protein aggregation; prion; protein structure; seeding barrier	PAIRED HELICAL FILAMENTS; PROGRESSIVE SUPRANUCLEAR PALSY; AMYLOID FIBRILS; ALPHA-SYNUCLEIN; NEUROFIBRILLARY TANGLES; CASPASE-CLEAVAGE; PRION STRAINS; PROTEIN-TAU; MUTANT-TAU; MUTATIONS	The intracellular deposition of fibrils composed of the microtubule-associated protein Tau is a characteristic feature of Alzheimer's disease (AD) and other fatal neurodegenerative disorders collectively known as tauopathies. Short Tau fibrils spread intracerebrally through transfer between interconnected neurons. Once taken up by a recipient cell, Tau fibrils recruit Tau monomers onto their ends. Based on the number of microtubule-binding repeats, there are two distinct groups of Tau isoforms: three-repeat (3R) Tau and four-repeat (4R) Tau. In AD, all Tau isoforms are deposited, whereas in other tauopathies, only 3R or 4R Tau isoforms are deposited. The molecular basis for these isoform-specific depositions is poorly understood, although conformation-based cross-seeding barriers are key. Here, we used sedimentation assays, EPR spectroscopy, and other structural readouts to better understand the cross-seeding barriers of 4R Tau fibrils. We observed that fibrils formed from truncated Tau (K18), but not full-length Tau (htau40), exhibit a barrier that inhibits 3R Tau recruitment. Investigating an array of differently sized fragments, we found that the Tau C terminus modulates the cross-seeding barrier and that the N terminus plays a synergistic role. Two disease-associated Tau variants, P301S and P301L, also established strong cross-seeding barriers. EPR analysis indicated that fibrils seeded with truncated and mutated Tau, but not htau40, are structurally disordered in the second half of repeat four and onward. These findings suggest that the disorder in this region diminishes the ability of 4R Tau fibrils to recruit 3R Tau monomers, revealing a new mechanism for Tau cross-seeding barriers.	[Weismiller, Hilary A.; Murphy, Rachel; Margittai, Martin] Univ Denver, Dept Chem & Biochem, 2190 East Iliff Ave, Denver, CO 80208 USA; [Wei, Guanghong] Fudan Univ, Dept Phys, State Key Lab Surface Phys, Key Lab Computat Phys Sci,Minist Educ,Collaborat, Shanghai 200433, Peoples R China; [Ma, Buyong; Nussinov, Ruth] NCI, Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, NIH, Frederick, MD 21702 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Inst Mol Med, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel	University of Denver; Fudan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tel Aviv University; Sackler Faculty of Medicine	Margittai, M (corresponding author), Univ Denver, Dept Chem & Biochem, 2190 East Iliff Ave, Denver, CO 80208 USA.	martin.margittai@du.edu	Margittai, Martin/D-5039-2014; Ma, Buyong/F-9491-2011	Margittai, Martin/0000-0003-1903-5927; Ma, Buyong/0000-0002-7383-719X; Wei, Guanghong/0000-0001-5814-3328; Nussinov, Ruth/0000-0002-8115-6415	Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of National Institutes of Health, Frederick National Lab, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG051833] Funding Source: NIH RePORTER	Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health; Intramural Research Program of National Institutes of Health, Frederick National Lab, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. S. S. Eaton and G. R. Eaton for technical support on the DEER measurements and Dr. M. R. Holden for help in the collection of EM images. This project was also supported by Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health under contract HHSN261200800001E. Further support was provided by the Intramural Research Program of National Institutes of Health, Frederick National Lab, Center for Cancer Research.	Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Ayers JI, 2018, BIOL PSYCHIAT, V83, P337, DOI 10.1016/j.biopsych.2017.04.003; Bedrood S, 2012, J BIOL CHEM, V287, P5235, DOI 10.1074/jbc.M111.327817; Berliner L. J., 2000, BIOLOGICAL MAGNETIC; BERLINER LJ, 1982, ANAL BIOCHEM, V119, P450, DOI 10.1016/0003-2697(82)90612-1; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Bibow S, 2011, ANGEW CHEM INT EDIT, V50, P11520, DOI 10.1002/anie.201105493; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collinge J, 2016, NATURE, V539, P217, DOI 10.1038/nature20415; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Delacourte A, 1996, J NEUROPATH EXP NEUR, V55, P159, DOI 10.1097/00005072-199602000-00004; Dinkel PD, 2015, BIOCHEMISTRY-US, V54, P4731, DOI 10.1021/acs.biochem.5b00453; Dinkel PD, 2011, BIOCHEMISTRY-US, V50, P4330, DOI 10.1021/bi2004685; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Fichou Y, 2018, CHEM COMMUN, V54, P4573, DOI 10.1039/c8cc01355a; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; FLAMENT S, 1991, ACTA NEUROPATHOL, V81, P591, DOI 10.1007/BF00296367; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Ghetti B, 2015, NEUROPATH APPL NEURO, V41, P24, DOI 10.1111/nan.12213; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Gross A, 1999, BIOCHEMISTRY-US, V38, P10324, DOI 10.1021/bi990856k; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hasegawa M, 1999, FEBS LETT, V443, P93, DOI 10.1016/S0014-5793(98)01696-2; Iijima M, 1999, NEUROREPORT, V10, P497, DOI 10.1097/00001756-199902250-00010; Irwin DJ, 2016, ANN NEUROL, V79, P272, DOI 10.1002/ana.24559; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2000, BIO MAGN RE, V19, P493; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Karyagina I, 2011, BIOPHYS J, V101, pL1, DOI 10.1016/j.bpj.2011.05.052; KSIEZAKREDING H, 1994, AM J PATHOL, V145, P1496; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2006, J BIOL CHEM, V281, P37820, DOI 10.1074/jbc.M605336200; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meyer V, 2016, J BIOL CHEM, V291, P12271, DOI 10.1074/jbc.M116.715557; Meyer V, 2014, BIOCHEMISTRY-US, V53, P5804, DOI 10.1021/bi501050g; Meyer V, 2014, ANGEW CHEM INT EDIT, V53, P1590, DOI 10.1002/anie.201308473; MILOV AD, 1981, FIZ TVERD TELA+, V23, P975; Miyasaka T, 2001, J NEUROPATH EXP NEUR, V60, P872, DOI 10.1093/jnen/60.9.872; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Narasimhan S, 2017, J NEUROSCI, V37, P11406, DOI 10.1523/JNEUROSCI.1230-17.2017; Pastor P, 2001, ANN NEUROL, V49, P263, DOI 10.1002/1531-8249(20010201)49:2<263::AID-ANA50>3.0.CO;2-K; Pornsuwan S, 2013, ANGEW CHEM INT EDIT, V52, P10290, DOI 10.1002/anie.201304747; Puoti G, 1999, NEUROLOGY, V53, P2173, DOI 10.1212/WNL.53.9.2173; Qiang W, 2017, NATURE, V541, P217, DOI 10.1038/nature20814; Quinn JP, 2018, J ALZHEIMERS DIS, V63, P13, DOI 10.3233/JAD-170959; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Ros R, 2005, ARCH NEUROL-CHICAGO, V62, P1444, DOI 10.1001/archneur.62.9.1444; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P911, DOI 10.1093/jnen/63.9.911; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Siddiqua A, 2010, J BIOL CHEM, V285, P37920, DOI 10.1074/jbc.M110.185728; Siddiqua A, 2012, J AM CHEM SOC, V134, P10271, DOI 10.1021/ja303498q; Strang KH, 2018, J BIOL CHEM, V293, P2408, DOI 10.1074/jbc.M117.815357; Taniguchi-Watanabe S, 2016, ACTA NEUROPATHOL, V131, P267, DOI 10.1007/s00401-015-1503-3; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Williams DR, 2007, BRAIN, V130, P1566, DOI 10.1093/brain/awm104; Yoshida H, 2002, J NEUROCHEM, V80, P548, DOI 10.1046/j.0022-3042.2001.00729.x; Yu X, 2012, J BIOL CHEM, V287, P14950, DOI 10.1074/jbc.M112.340794; Zhang ZT, 2014, NAT MED, V20, P1254, DOI 10.1038/nm.3700	74	26	26	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17336	17348		10.1074/jbc.RA118.005316	http://dx.doi.org/10.1074/jbc.RA118.005316			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30242125	hybrid, Green Published			2022-12-28	WOS:000449799000003
J	Gubbiotti, MA; Seifert, E; Rodeck, U; Hoek, JB; Iozzo, RV				Gubbiotti, Maria A.; Seifert, Erin; Rodeck, Ulrich; Hoek, Jan B.; Iozzo, Renato V.			Metabolic reprogramming of murine cardiomyocytes during autophagy requires the extracellular nutrient sensor decorin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						decorin; autophagy; metabolomics; proteoglycan; extracellular matrix; heart; O-GlcNAcylation; cardiac function; fasting; nutrient sensing	ACTIVATED PROTEIN-KINASE; HYALURONAN SYNTHASE 2; O-GLCNACYLATION; VII COLLAGEN; GROWTH; INHIBITION; BIOLOGY; ROLES; CELLS; PROTEOGLYCAN	The extracellular matrix is a master regulator of tissue homeostasis in health and disease. Here we examined how the small, leucine-rich, extracellular matrix proteoglycan decorin regulates cardiomyocyte metabolism during fasting in vivo. First, we validated in Dcn(-/-) mice that decorin plays an essential role in autophagy induced by fasting. High-throughput metabolomics analyses of cardiac tissue in Dcn(-/-) mice subjected to fasting revealed striking differences in the hexosamine biosynthetic pathway resulting in aberrant cardiac O--N-acetylglycosylation as compared with WT mice. Functionally, Dcn(-/-) mice maintained cardiac function at a level comparable with nonfasted animals whereas fasted WT mice showed reduced ejection fraction. Collectively, our results suggest that reduced sensing of nutrient deprivation in the absence of decorin preempts functional adjustments of cardiac output associated with metabolic reprogramming.	[Gubbiotti, Maria A.; Seifert, Erin; Rodeck, Ulrich; Hoek, Jan B.; Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Gubbiotti, Maria A.; Seifert, Erin; Rodeck, Ulrich; Hoek, Jan B.; Iozzo, Renato V.] Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Seifert, Erin; Hoek, Jan B.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, MitoCare Ctr, Philadelphia, PA 19107 USA; [Rodeck, Ulrich] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.; Iozzo, RV (corresponding author), Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.	renato.iozzo@jefferson.edu	Iozzo, Renato/AAS-1980-2020		National Institutes of Health [RO1 CA39481, RO1 CA47282, RO1 CA164462]; National Institutes of Health Training Grant [T32 AA07463]; NATIONAL CANCER INSTITUTE [R01CA164462, R01CA047282, R01CA039481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by National Institutes of Health Grants RO1 CA39481, RO1 CA47282, and RO1 CA164462 (to R. V. I.) and National Institutes of Health Training Grant T32 AA07463 (to M. A. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreuzzi E, 2017, MATRIX BIOL, V64, P40, DOI 10.1016/j.matbio.2017.04.002; Barallobre-Barreiro J, 2016, CIRCULATION, V134, P817, DOI 10.1161/CIRCULATIONAHA.115.016423; Baskin KK, 2011, CIRC RES, V109, P1153, DOI 10.1161/CIRCRESAHA.111.252742; Bolton K, 2008, INT J OBESITY, V32, P1113, DOI 10.1038/ijo.2008.41; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Buraschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045559; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Chu CT, 2009, METHOD ENZYMOL, V453, P217, DOI 10.1016/S0076-6879(08)04011-1; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Ghadiali RS, 2017, MATRIX BIOL, V59, P54, DOI 10.1016/j.matbio.2016.07.007; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Gubbiotti MA, 2017, MATRIX BIOL, V57-58, P285, DOI 10.1016/j.matbio.2016.09.003; Gubbiotti MA, 2016, MATRIX BIOL, V55, P7, DOI 10.1016/j.matbio.2016.09.009; Gubbiotti MA, 2015, MATRIX BIOL, V48, P6, DOI 10.1016/j.matbio.2015.10.002; Gubbiotti MA, 2015, MATRIX BIOL, V48, P14, DOI 10.1016/j.matbio.2015.09.001; Guo B, 2014, NAT CELL BIOL, V16, P1215, DOI 10.1038/ncb3066; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Iozzo RV, 2011, J BIOL CHEM, V286, P34712, DOI 10.1074/jbc.M111.262766; Iozzo RV, 2011, BIOL EXTRACELL MATR, P197, DOI 10.1007/978-3-642-16555-9_6; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Jahania SM, 2013, J AM COLL SURGEONS, V216, P719, DOI 10.1016/j.jamcollsurg.2012.12.034; Karousou E, 2017, MATRIX BIOL, V59, P3, DOI 10.1016/j.matbio.2016.10.001; Lavandero S, 2015, J CLIN INVEST, V125, P55, DOI 10.1172/JCI73943; Marsh SA, 2013, LIFE SCI, V92, P648, DOI 10.1016/j.lfs.2012.06.011; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morrione A, 2013, FEBS J, V280, P2138, DOI 10.1111/febs.12149; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Naba A, 2016, MATRIX BIOL, V49, P10, DOI 10.1016/j.matbio.2015.06.003; Neill T, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.975645; Neill T, 2015, BIOCHEMISTRY-US, V54, P4583, DOI 10.1021/acs.biochem.5b00653; Neill T, 2014, J BIOL CHEM, V289, P4952, DOI 10.1074/jbc.M113.512566; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Park S, 2014, BIOCHEM BIOPH RES CO, V453, P208, DOI 10.1016/j.bbrc.2014.05.047; Pozzi A, 2017, MATRIX BIOL, V57-58, P1, DOI 10.1016/j.matbio.2016.12.009; Prockop DJ, 2016, MATRIX BIOL, V51, P7, DOI 10.1016/j.matbio.2016.01.010; Randles MJ, 2017, MATRIX BIOL, V57-58, P12, DOI 10.1016/j.matbio.2016.08.006; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; RUDNICKA L, 1994, J CLIN INVEST, V93, P1709, DOI 10.1172/JCI117154; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Suzuki J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1115, DOI 10.1152/ajpendo.91031.2008; Troncoso R, 2014, TRENDS ENDOCRIN MET, V25, P128, DOI 10.1016/j.tem.2013.12.002; Uitto J, 2017, MATRIX BIOL, V57-58, P76, DOI 10.1016/j.matbio.2016.07.009; Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656; Vigetti D, 2014, J BIOL CHEM, V289, P28816, DOI 10.1074/jbc.M114.597401; Vigetti D, 2012, J BIOL CHEM, V287, P35544, DOI 10.1074/jbc.M112.402347; Yang SL, 2006, SHOCK, V25, P600, DOI 10.1097/01.shk.0000209563.07693.db; Yao T, 2016, FEBS OPEN BIO, V6, P707, DOI 10.1002/2211-5463.12076; Young MF, 2016, MATRIX BIOL, V52-54, P1, DOI 10.1016/j.matbio.2016.04.003; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	54	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16940	16950		10.1074/jbc.RA118.004563	http://dx.doi.org/10.1074/jbc.RA118.004563			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30049794	Green Published, hybrid			2022-12-28	WOS:000448515100033
J	Zhu, C; Liu, Y; Hu, L; Yang, M; He, ZG				Zhu, Chen; Liu, Yu; Hu, Lihua; Yang, Min; He, Zheng-Guo			Molecular mechanism of the synergistic activity of ethambutol and isoniazid against Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; drug resistance; mycobacteria; DNA binding protein; DNA-protein interaction; transcription promoter; anti-TB drug; enoyl-ACP reductase; inhA; mycolic acid; transcriptional repression	DRUG-RESISTANCE; BOVIS BCG; EXPRESSION; SMEGMATIS; MUTATIONS; GENETICS; NETWORK	Isoniazid (INH) and ethambutol (EMB) are two major first-line drugs for managing tuberculosis (TB), caused by the microbe Mycobacterium tuberculosis. Although co-use of these two drugs is common in clinical practice, the mechanism for the potential synergistic interplay between them remains unclear. Here, we present first evidence that INH and EMB act synergistically through a transcriptional repressor of the inhA gene, the target gene of INH encoding an enoyl-acyl carrier protein reductase of the fatty acid synthase type II system required for bacterial cell wall integrity. We report that EMB binds a hypothetical transcription factor encoded by the Rv0273c gene, designated here as EtbR. Using DNA footprinting, we found that EtbR specifically recognizes a motif sequence in the upstream region of the inhA gene. Using isothermal titration calorimetry and surface plasmon resonance assays, we observed that EMB binds EtbR in a 1:1 ratio and thereby stimulates its DNA-binding activity. When a nonlethal dose of EMB was delivered in combination with INH, EMB increased the INH susceptibility of cultured M. tuberculosis cells. In summary, EMB induces EtbR-mediated repression of inhA and thereby enhances the mycobactericidal effect of INH. Our findings uncover a molecular mechanism for the synergistic activity of two important anti-TB drugs.	[Zhu, Chen; Liu, Yu; Hu, Lihua; Yang, Min; He, Zheng-Guo] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Key Lab Agr Microbiol, Wuhan 430070, Peoples R China	Huazhong Agricultural University	Yang, M; He, ZG (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China.	yangmin@mail.hzau.edu.cn; he.zhengguo@hotmail.com	He, Zheng-Guo/P-3647-2014					da Silva PEA, 2011, FEMS IMMUNOL MED MIC, V63, P1, DOI 10.1111/j.1574-695X.2011.00831.x; Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; Ando H, 2014, MOL MICROBIOL, V91, P538, DOI 10.1111/mmi.12476; Ando H, 2011, MOL MICROBIOL, V79, P1615, DOI 10.1111/j.1365-2958.2011.07547.x; Bolla JR, 2012, NUCLEIC ACIDS RES, V40, P9340, DOI 10.1093/nar/gks677; Brossier F, 2015, ANTIMICROB AGENTS CH, V59, P4800, DOI 10.1128/AAC.00150-15; Choi WH, 2017, J CLIN MED, V6, DOI 10.3390/jcm6030030; Cui ZL, 2014, ANTIMICROB AGENTS CH, V58, P6837, DOI 10.1128/AAC.03285-14; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Gao CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036255; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; Hu JL, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0556-8; Larsen MH, 2002, MOL MICROBIOL, V46, P453, DOI 10.1046/j.1365-2958.2002.03162.x; Li WH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9330; Liu HC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27489; Liu L, 2014, J BIOL CHEM, V289, P9065, DOI 10.1074/jbc.M113.528919; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3907; Minch KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6829; Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102; Rao MD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.383604; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Yang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13969; Yang M, 2012, NUCLEIC ACIDS RES, V40, P1009, DOI 10.1093/nar/gkr830; Zhang Y, 2015, INT J TUBERC LUNG D, V19, P1276, DOI 10.5588/ijtld.15.0389	27	19	20	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16741	16750		10.1074/jbc.RA118.002693	http://dx.doi.org/10.1074/jbc.RA118.002693			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30185616	Green Published, hybrid			2022-12-28	WOS:000448515100016
J	Cleary, JD; Pattamatta, A; Ranum, LPW				Cleary, John Douglas; Pattamatta, Amrutha; Ranum, Laura P. W.			Repeat-associated non-ATG (RAN) translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						translation; translation initiation; trinucleotide repeat disease; Huntington's disease; myotonic dystrophy; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); C9ORF72 ALS; FTD; mouse models; nucleocytoplasmic transport; RAN translation; spinocerebellar ataxia	AMYOTROPHIC-LATERAL-SCLEROSIS; TREMOR ATAXIA SYNDROME; C9ORF72 HEXANUCLEOTIDE REPEAT; ENDOTHELIAL CORNEAL-DYSTROPHY; NON-AUG TRANSLATION; DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; MICROSATELLITE EXPANSION DISORDERS; BAC TRANSGENIC MICE; MYOTONIC-DYSTROPHY; NUCLEOCYTOPLASMIC TRANSPORT	Microsatellite expansions cause more than 40 neurological disorders, including Huntington's disease, myotonic dystrophy, and C9ORF72 amyotrophic lateral sclerosis/frontotemporal dementia (ALS/FTD). These repeat expansion mutations can produce repeat-associated non-ATG (RAN) proteins in all three reading frames, which accumulate in disease-relevant tissues. There has been considerable interest in RAN protein products and their downstream consequences, particularly for the dipeptide proteins found in C9ORF72 ALS/FTD. Understanding how RAN translation occurs, what cellular factors contribute to RAN protein accumulation, and how these proteins contribute to disease should lead to a better understanding of the basic mechanisms of gene expression and human disease.	[Cleary, John Douglas; Pattamatta, Amrutha; Ranum, Laura P. W.] Univ Florida, Coll Med, Ctr NeuroGenet, Gainesville, FL 32610 USA; [Cleary, John Douglas; Pattamatta, Amrutha; Ranum, Laura P. W.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Ranum, Laura P. W.] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32610 USA; [Cleary, John Douglas; Pattamatta, Amrutha; Ranum, Laura P. W.] Univ Florida, Genet Inst, Gainesville, FL 32610 USA; [Ranum, Laura P. W.] Univ Florida, McKnight Brain Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ranum, LPW (corresponding author), Univ Florida, Ctr NeuroGenet, 2033 Mowry Rd,POB 103610, Gainesville, FL 32610 USA.; Ranum, LPW (corresponding author), Univ Florida, Coll Med, Mol Genet & Microbiol, 2033 Mowry Rd,POB 103610, Gainesville, FL 32610 USA.	ranum@ufl.edu			National Institutes of Health [P01NS058901, R37NS040389, R01NS098819]; ALS Association; Target ALS; Muscular Dystrophy Association; Robert Packard Center for ALS Research; Myotonic Dystrophy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS040389, P01NS058901, R01NS098819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Association; Target ALS; Muscular Dystrophy Association(Muscular Dystrophy Association); Robert Packard Center for ALS Research; Myotonic Dystrophy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants P01NS058901, R37NS040389, and R01NS098819, the ALS Association, Target ALS, Muscular Dystrophy Association, the Robert Packard Center for ALS Research, and the Myotonic Dystrophy Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almeida S, 2013, ACTA NEUROPATHOL, V126, P385, DOI 10.1007/s00401-013-1149-y; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Atanasio A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23204; Ayhan F, 2018, EMBO J, V37, DOI 10.15252/embj.201899023; Bauerlein FJB, 2017, CELL, V171, P179, DOI 10.1016/j.cell.2017.08.009; Banez-Coronel M, 2015, NEURON, V88, P667, DOI 10.1016/j.neuron.2015.10.038; Barker HV, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00195; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Batra R, 2017, CELL, V170, P899, DOI 10.1016/j.cell.2017.07.010; Batra R, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00196; Batra R, 2010, HUM MOL GENET, V19, pR77, DOI 10.1093/hmg/ddq132; Belzil VV, 2013, ACTA NEUROPATHOL, V126, P895, DOI 10.1007/s00401-013-1199-1; Boeynaems S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20877; Bohanna I, 2011, BRAIN IMAGING BEHAV, V5, P171, DOI 10.1007/s11682-011-9121-8; Bott LC, 2016, HUM MOL GENET, V25, P1979, DOI 10.1093/hmg/ddw073; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Broda M, 2005, BIOCHEMISTRY-US, V44, P10873, DOI 10.1021/bi0502339; Buijsen RAM, 2016, HUM REPROD, V31, P158, DOI 10.1093/humrep/dev280; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Castro H, 2017, HUM MOL GENET, V26, P2133, DOI 10.1093/hmg/ddx108; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Cheng HM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005043; Cheng WW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02495-z; Chew J, 2015, SCIENCE, V348, P1151, DOI 10.1126/science.aaa9344; Childs-Disney JL, 2012, ACS CHEM BIOL, V7, P856, DOI 10.1021/cb200408a; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Cho DH, 2007, BBA-MOL BASIS DIS, V1772, P195, DOI 10.1016/j.bbadis.2006.05.013; Chou CC, 2018, NAT NEUROSCI, V21, P228, DOI 10.1038/s41593-017-0047-3; Cleary J. D., 2006, DNA REPLICATION HUMA; Cleary JD, 2013, HUM MOL GENET, V22, pR45, DOI 10.1093/hmg/ddt371; Cleary JD, 2014, CURR OPIN GENET DEV, V26, P6, DOI 10.1016/j.gde.2014.03.002; Cooper-Knock J, 2015, ACTA NEUROPATHOL, V130, P63, DOI 10.1007/s00401-015-1429-9; Cooper-Knock J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127376; Cooper-Knock J, 2014, BRAIN, V137, P2040, DOI 10.1093/brain/awu120; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Coyne AN, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00243; Cristofani R, 2018, CELL STRESS CHAPERON, V23, P1, DOI 10.1007/s12192-017-0806-9; Dansithong W, 2011, EMBO REP, V12, P735, DOI 10.1038/embor.2011.86; Daughters RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000600; Day JW, 2000, NEUROLOGY, V55, P649, DOI 10.1212/WNL.55.5.649; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Disney MD, 2012, ACS CHEM BIOL, V7, P1711, DOI 10.1021/cb300135h; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Du JT, 2015, J BIOL CHEM, V290, P5979, DOI 10.1074/jbc.M114.621607; Elia AE, 2016, EUR J NEUROL, V23, P45, DOI 10.1111/ene.12664; Evers MM, 2015, ADV DRUG DELIVER REV, V87, P90, DOI 10.1016/j.addr.2015.03.008; Fennema-Notestine C, 2004, NEUROLOGY, V63, P989, DOI 10.1212/01.WNL.0000138434.68093.67; Franc DT, 2012, NEUROMUSCULAR DISORD, V22, P483, DOI 10.1016/j.nmd.2012.01.003; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Gao ZH, 2013, HUM GENE THER, V24, P499, DOI 10.1089/hum.2012.212; Gasset-Rosa F, 2017, NEURON, V94, P48, DOI 10.1016/j.neuron.2017.03.027; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Goodwin M, 2014, ADV EXP MED BIOL, V825, P353, DOI 10.1007/978-1-4939-1221-6_10; Green KM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02200-0; Green KM, 2016, BRAIN RES, V1647, P30, DOI 10.1016/j.brainres.2016.04.003; Grima JC, 2017, NEURON, V94, P93, DOI 10.1016/j.neuron.2017.03.023; Groh M, 2014, BIOCHEM SOC T, V42, P1123, DOI 10.1042/BST20140049; Guo Q, 2018, CELL, V172, P696, DOI 10.1016/j.cell.2017.12.030; Haeusler AR, 2016, NAT REV NEUROSCI, V17, P383, DOI 10.1038/nrn.2016.38; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Hagerman P, 2013, ACTA NEUROPATHOL, V126, P1, DOI 10.1007/s00401-013-1138-1; Hagerman PJ, 2015, ANN NY ACAD SCI, V1338, P58, DOI 10.1111/nyas.12693; Hagerman R, 2013, LANCET NEUROL, V12, P786, DOI 10.1016/S1474-4422(13)70125-X; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Hautbergue GM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16063; Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hukema RK, 2015, HUM MOL GENET, V24, P4948, DOI 10.1093/hmg/ddv216; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2010, METHOD ENZYMOL, V470, P119, DOI 10.1016/S0076-6879(10)70006-9; Ishiguro T, 2017, NEURON, V94, P108, DOI 10.1016/j.neuron.2017.02.046; Ishiura H, 2015, J NEUROGENET, V29, P85, DOI 10.3109/01677063.2015.1085980; Jackrel ME, 2014, CELL, V156, P170, DOI 10.1016/j.cell.2013.11.047; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jain A, 2017, NATURE, V546, P243, DOI 10.1038/nature22386; Jiang J, 2016, NEURON, V90, P535, DOI 10.1016/j.neuron.2016.04.006; Jovicic A, 2015, NAT NEUROSCI, V18, P1226, DOI 10.1038/nn.4085; Kaneb HM, 2015, HUM MOL GENET, V24, P1363, DOI 10.1093/hmg/ddu545; Kanekura K, 2016, HUM MOL GENET, V25, P1803, DOI 10.1093/hmg/ddw052; Kearse MG, 2016, MOL CELL, V62, P314, DOI 10.1016/j.molcel.2016.02.034; Khosravi B, 2017, HUM MOL GENET, V26, P790, DOI 10.1093/hmg/ddw432; Kinoshita Y, 2009, J NEUROPATH EXP NEUR, V68, P1184, DOI 10.1097/NEN.0b013e3181bc3bec; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Kong HE, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00128; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Koppers M, 2015, ANN NEUROL, V78, P426, DOI 10.1002/ana.24453; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Kramer NJ, 2018, NAT GENET, V50, P603, DOI 10.1038/s41588-018-0070-7; Kramer NJ, 2016, SCIENCE, V353, P708, DOI 10.1126/science.aaf7791; Krans A, 2016, ANN NEUROL, V80, P871, DOI 10.1002/ana.24800; Kumar A, 2015, GENE, V556, P91, DOI 10.1016/j.gene.2014.11.022; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Labbadia J, 2013, TRENDS BIOCHEM SCI, V38, P378, DOI 10.1016/j.tibs.2013.05.003; Ladd PD, 2007, HUM MOL GENET, V16, P3174, DOI 10.1093/hmg/ddm293; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Leehey Maureen A, 2012, Handb Clin Neurol, V103, P373, DOI 10.1016/B978-0-444-51892-7.00023-1; Lin Y, 2016, CELL, V167, P789, DOI 10.1016/j.cell.2016.10.003; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Liu CR, 2012, CELL, V148, P690, DOI 10.1016/j.cell.2011.12.032; Liu YJ, 2016, NEURON, V90, P521, DOI 10.1016/j.neuron.2016.04.005; Lopez-Gonzalez R, 2016, NEURON, V92, P383, DOI 10.1016/j.neuron.2016.09.015; Mackenzie IR, 2013, ACTA NEUROPATHOL, V126, P859, DOI 10.1007/s00401-013-1181-y; Mackenzie IRA, 2014, ACTA NEUROPATHOL, V127, P347, DOI 10.1007/s00401-013-1232-4; Mann DMA, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-68; May S, 2014, ACTA NEUROPATHOL, V128, P485, DOI 10.1007/s00401-014-1329-4; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Mori K, 2013, ACTA NEUROPATHOL, V126, P881, DOI 10.1007/s00401-013-1189-3; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Nelson DL, 2013, NEURON, V77, P825, DOI 10.1016/j.neuron.2013.02.022; Niimi Y, 2013, NEUROPATHOLOGY, V33, P600, DOI 10.1111/neup.12032; Nishimura AL, 2010, BRAIN, V133, P1763, DOI 10.1093/brain/awq111; O'Rourke JG, 2016, SCIENCE, V351, P1324, DOI 10.1126/science.aaf1064; O'Rourke JG, 2015, NEURON, V88, P892, DOI 10.1016/j.neuron.2015.10.027; Ohki Y, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-016-0146-8; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Orr HT, 2009, J BIOL CHEM, V284, P7405, DOI 10.1074/jbc.R800067200; Paulsen JS, 2010, BRAIN RES BULL, V82, P201, DOI 10.1016/j.brainresbull.2010.04.003; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Pearson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002018; Peters OM, 2015, NEURON, V88, P902, DOI 10.1016/j.neuron.2015.11.018; Pinto BS, 2017, MOL CELL, V68, P479, DOI 10.1016/j.molcel.2017.09.033; Reading SAJ, 2005, PSYCHIAT RES-NEUROIM, V140, P55, DOI 10.1016/j.pscychresns.2005.05.011; Reddy K, 2013, J BIOL CHEM, V288, P9860, DOI 10.1074/jbc.C113.452532; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rohrer JD, 2015, LANCET NEUROL, V14, P291, DOI 10.1016/S1474-4422(14)70233-9; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Rusmini P, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00176; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Schludi MH, 2017, ACTA NEUROPATHOL, V134, P241, DOI 10.1007/s00401-017-1711-0; Schoch KM, 2017, NEURON, V94, P1056, DOI 10.1016/j.neuron.2017.04.010; Schwab SR, 2004, PLOS BIOL, V2, P1774, DOI 10.1371/journal.pbio.0020366; Seixas AI, 2017, AM J HUM GENET, V101, P87, DOI 10.1016/j.ajhg.2017.06.007; Sellier C, 2017, NEURON, V93, P331, DOI 10.1016/j.neuron.2016.12.016; Shi KY, 2017, P NATL ACAD SCI USA, V114, pE1111, DOI 10.1073/pnas.1620293114; Shorter J, 2017, CURR OPIN GENET DEV, V44, P1, DOI 10.1016/j.gde.2017.01.008; Siboni RB, 2015, CELL REP, V13, P2386, DOI 10.1016/j.celrep.2015.11.028; Simone R, 2018, EMBO MOL MED, V10, P22, DOI 10.15252/emmm.201707850; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Soragni E, 2018, INVEST OPHTH VIS SCI, V59, P1888, DOI 10.1167/iovs.17-23265; Starck SR, 2012, SCIENCE, V336, P1719, DOI 10.1126/science.1220270; Su XFA, 2015, GENE DEV, V29, P1006, DOI 10.1101/gad.256404.114; Su ZM, 2014, NEURON, V83, P1043, DOI 10.1016/j.neuron.2014.07.041; Sudria-Lopez E, 2016, ACTA NEUROPATHOL, V132, P145, DOI 10.1007/s00401-016-1581-x; Suhr ST, 2001, J CELL BIOL, V153, P283, DOI 10.1083/jcb.153.2.283; Sullivan PM, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0324-5; Swinnen B, 2018, ACTA NEUROPATHOL, V135, P427, DOI 10.1007/s00401-017-1796-5; Tabet R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02643-5; Takahashi H, 2001, BRAIN RES, V919, P12, DOI 10.1016/S0006-8993(01)02986-9; Tao ZT, 2015, HUM MOL GENET, V24, P2426, DOI 10.1093/hmg/ddv005; Taylor J, 2006, J BIOL CHEM, V281, P2730, DOI 10.1074/jbc.M506751200; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Todd TW, 2016, J NEUROCHEM, V138, P145, DOI 10.1111/jnc.13623; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; TROTTIER Y, 1994, J MED GENET, V31, P377, DOI 10.1136/jmg.31.5.377; van Blitterswijk M, 2012, CURR OPIN NEUROL, V25, P689, DOI 10.1097/WCO.0b013e32835a3efb; Waite AJ, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.016; Walker C, 2017, NAT NEUROSCI, V20, P1225, DOI 10.1038/nn.4604; Wen XM, 2017, NEUROSCI LETT, V636, P16, DOI 10.1016/j.neulet.2016.09.007; Wen XM, 2014, NEURON, V84, P1213, DOI 10.1016/j.neuron.2014.12.010; Westergard T, 2016, CELL REP, V17, P645, DOI 10.1016/j.celrep.2016.09.032; Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362; Wieben ED, 2017, INVEST OPHTH VIS SCI, V58, P343, DOI 10.1167/iovs.16-20900; Wieben ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049083; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Yamakawa M, 2015, HUM MOL GENET, V24, P1630, DOI 10.1093/hmg/ddu576; Yang DJ, 2015, ACTA NEUROPATHOL, V130, P525, DOI 10.1007/s00401-015-1448-6; Yang WY, 2016, ACS CHEM BIOL, V11, P2456, DOI 10.1021/acschembio.6b00147; Yazawa I, 2000, BIOCHEM J, V351, P587, DOI 10.1042/0264-6021:3510587; Yin SY, 2017, CELL REP, V19, P2244, DOI 10.1016/j.celrep.2017.05.056; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zhang YJ, 2016, NAT NEUROSCI, V19, P668, DOI 10.1038/nn.4272; Zhang YJ, 2014, ACTA NEUROPATHOL, V128, P505, DOI 10.1007/s00401-014-1336-5; Zhou QH, 2017, EMBO MOL MED, V9, P687, DOI 10.15252/emmm.201607054; Zu T, 2017, NEURON, V95, P1292, DOI 10.1016/j.neuron.2017.08.039; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108; 2001, CELL DEATH DIFFER, V8, P377, DOI DOI 10.1038/SJ.CDD.4400819	191	53	54	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16127	16141		10.1074/jbc.R118.003237	http://dx.doi.org/10.1074/jbc.R118.003237			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30213863	Green Published, hybrid			2022-12-28	WOS:000447833600001
J	Logeman, BL; Thiele, DJ				Logeman, Brandon L.; Thiele, Dennis J.			Reconstitution of a thermophilic Cu+ importer in vitro reveals intrinsic high-affinity slow transport driving accumulation of an essential metal ion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper; copper transport; metal homeostasis; liposome; thermophile; Ctr1	HUMAN COPPER TRANSPORTER; MITOCHONDRIAL METALLOCHAPERONE SCO1; ZINC TRANSPORTER; SACCHAROMYCES-CEREVISIAE; BIOCHEMICAL-CHARACTERIZATION; STIMULATED ENDOCYTOSIS; MEMBRANE-PROTEINS; HUMAN CTR1; YEAST; ACQUISITION	Acquisition of the trace element copper (Cu) is critical to drive essential eukaryotic processes such as oxidative phosphorylation, iron mobilization, peptide hormone biogenesis, and connective tissue maturation. The Ctr1/Ctr3 family of Cu importers, first discovered in fungi and conserved in mammals, are critical for Cu+ movement across the plasma membrane or mobilization from endosomal compartments. Whereas ablation of Ctr1 in mammals is embryonic lethal, and Ctr1 is critical for dietary Cu absorption, cardiac function, and systemic iron distribution, little is known about the intrinsic contribution of Ctr1 for Cu+ permeation through membranes or its mechanism of action. Here, we identify three members of a Cu+ importer family from the thermophilic fungus Chaetomium thermophilum: Ctr3a and Ctr3b, which function on the plasma membrane, and Ctr2, which likely functions in endosomal Cu mobilization. All three proteins drive Cu and isoelectronic silver (Ag) uptake in cells devoid of Cu+ importers. Transport activity depends on signature amino acid motifs that are conserved and essential for all Ctr1/3 transporters. Ctr3a is stable and amenable to purification and was incorporated into liposomes to reconstitute an in vitro Ag+ transport assay characterized by stopped-flow spectroscopy. Ctr3a has intrinsic high-affinity metal ion transport activity that closely reflects values determined in vivo, with slow turnover kinetics. Given structural models for mammalian Ctr1, Ctr3a likely functions as a low-efficiency Cu+ ion channel. The Ctr1/Ctr3 family may be tuned to import essential yet potentially toxic Cu+ ions at a slow rate to meet cellular needs, while minimizing labile intracellular Cu+ pools.	[Logeman, Brandon L.; Thiele, Dennis J.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA; [Thiele, Dennis J.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Thiele, Dennis J.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Logeman, Brandon L.] Harvard Univ, Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA	Duke University; Duke University; Duke University; Harvard University	Thiele, DJ (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	dennis.thiele@duke.edu		Logeman, Brandon/0000-0002-9975-3541	National Institutes of Health [R01 GM041840, DK074192]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM041840 and DK074192 (to D. J. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Aller SG, 2004, J BIOL CHEM, V279, P53435, DOI 10.1074/jbc.M409421200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Baker ZN, 2017, HUM MOL GENET, V26, P4617, DOI 10.1093/hmg/ddx344; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Bertinato J, 2010, J TRACE ELEM MED BIO, V24, P178, DOI 10.1016/j.jtemb.2010.01.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boulet A, 2018, J BIOL CHEM, V293, P1887, DOI 10.1074/jbc.RA117.000265; Chao Y, 2004, J BIOL CHEM, V279, P12043, DOI 10.1074/jbc.M313510200; Clifford RJ, 2016, J CELL SCI, V129, P1711, DOI 10.1242/jcs.173351; Coudray N, 2013, P NATL ACAD SCI USA, V110, P2140, DOI 10.1073/pnas.1215455110; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1994, J BIOL CHEM, V269, P25660; De Feo CJ, 2010, J MEMBRANE BIOL, V234, P113, DOI 10.1007/s00232-010-9239-4; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehrnstorfer IA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14033; Ehrnstorfer IA, 2014, NAT STRUCT MOL BIOL, V21, P990, DOI 10.1038/nsmb.2904; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Foster AW, 2014, MOL MICROBIOL, V93, P317, DOI 10.1111/mmi.12661; Froschauer EM, 2009, BBA-BIOMEMBRANES, V1788, P1044, DOI 10.1016/j.bbamem.2009.03.004; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Garcia-Santamarina S, 2017, MBIO, V8, DOI [10.1128/mBio.01742-17, 10.1128/mbio.01742-17]; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Haas KL, 2011, J AM CHEM SOC, V133, P4427, DOI 10.1021/ja108890c; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; Hassett R, 2000, BIOCHEM J, V351, P477, DOI 10.1042/0264-6021:3510477; Hays FA, 2010, METHOD ENZYMOL, V470, P695, DOI 10.1016/S0076-6879(10)70029-X; Hlynialuk CJ, 2015, CELL REP, V10, P933, DOI 10.1016/j.celrep.2015.01.019; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208; Kahra D, 2016, BIOPHYS J, V110, P95, DOI 10.1016/j.bpj.2015.11.016; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Kim H, 2009, AM J PHYSIOL-GASTR L, V296, pG356, DOI 10.1152/ajpgi.90632.2008; Kim HS, 2006, ANAL CHIM ACTA, V575, P223, DOI 10.1016/j.aca.2006.05.089; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Krishnamoorthy L, 2016, NAT CHEM BIOL, V12, P586, DOI [10.1038/NCHEMBIO.2098, 10.1038/nchembio.2098]; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; Levy AR, 2014, J PHYS CHEM B, V118, P5832, DOI 10.1021/jp412589b; Lin W, 2010, J BIOL CHEM, V285, P39013, DOI 10.1074/jbc.M110.180620; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; LUKASEWYCZ OA, 1990, ANN NY ACAD SCI, V587, P147, DOI 10.1111/j.1749-6632.1990.tb00142.x; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Madsen E, 2007, ANNU REV NEUROSCI, V30, P317, DOI 10.1146/annurev.neuro.30.051606.094232; Madsen E, 2007, CURR OPIN GASTROEN, V23, P187, DOI 10.1097/MOG.0b013e32801421bb; Martins V, 2012, PLANT CELL PHYSIOL, V53, P1866, DOI 10.1093/pcp/pcs125; Maryon EB, 2013, J BIOL CHEM, V288, P18035, DOI 10.1074/jbc.M112.442426; Maryon EB, 2013, AM J PHYSIOL-CELL PH, V304, pC768, DOI 10.1152/ajpcell.00417.2012; MEDEIROS DM, 1993, P SOC EXP BIOL MED, V203, P262, DOI 10.3181/00379727-203-43599; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Ohrvik H, 2014, ANN NY ACAD SCI, V1314, P32, DOI 10.1111/nyas.12371; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohrvik H, 2016, J BIOL CHEM, V291, P13905, DOI 10.1074/jbc.M116.731281; Pena MMO, 2000, J BIOL CHEM, V275, P33244, DOI 10.1074/jbc.M005392200; Pena MMO, 1998, MOL CELL BIOL, V18, P2514, DOI 10.1128/MCB.18.5.2514; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Pope CR, 2013, P NATL ACAD SCI USA, V110, P20491, DOI 10.1073/pnas.1309820110; Portnoy ME, 2001, MOL GENET GENOMICS, V265, P873, DOI 10.1007/s004380100482; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Ramos D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149516; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Rees EM, 2007, J BIOL CHEM, V282, P21629, DOI 10.1074/jbc.M703397200; Rubino JT, 2011, METALLOMICS, V3, P61, DOI 10.1039/c0mt00044b; Rubino JT, 2012, J INORG BIOCHEM, V107, P129, DOI 10.1016/j.jinorgbio.2011.11.024; Rubino JT, 2010, J BIOL INORG CHEM, V15, P1033, DOI 10.1007/s00775-010-0663-9; Shenberger Y, 2015, J PHYS CHEM B, V119, P4824, DOI 10.1021/acs.jpcb.5b00091; Shingles R, 2004, PLANT PHYSIOL, V135, P145, DOI 10.1104/pp.103.037895; Sinani D, 2007, J BIOL CHEM, V282, P26775, DOI 10.1074/jbc.M703973200; Smith AD, 2017, ANNU REV MICROBIOL, V71, P597, DOI 10.1146/annurev-micro-030117-020444; Sun TS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6550; Wijekoon CJK, 2017, J AM CHEM SOC, V139, P4266, DOI 10.1021/jacs.6b12921; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711; Zhang T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700344; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	89	2	2	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15497	15512		10.1074/jbc.RA118.004802	http://dx.doi.org/10.1074/jbc.RA118.004802			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30131336	Green Published, hybrid			2022-12-28	WOS:000446549200016
J	Gervais, V; Muller, I; Mari, PO; Mourcet, A; Movellan, KT; Ramos, P; Marcoux, J; Guillet, V; Javaid, S; Burlet-Schiltz, O; Czaplicki, G; Milon, A; Giglia-Mari, G				Gervais, Virginie; Muller, Isabelle; Mari, Pierre-Olivier; Mourcet, Amandine; Movellan, Kumar Tekwani; Ramos, Pascal; Marcoux, Julien; Guillet, Valerie; Javaid, Sumaira; Burlet-Schiltz, Odile; Czaplicki, Georges; Milon, Alain; Giglia-Mari, Giuseppina			Small molecule-based targeting of TTD-A dimerization to control TFIIH transcriptional activity represents a potential strategy for anticancer therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein-protein interaction; nuclear magnetic resonance (NMR); drug screening; DNA transcription; cancer; GTF2H5; quantitative imaging; STD-NMR; TFIIH; transcriptional regulation	TRICHOTHIODYSTROPHY GROUP-A; FRAGMENT-BASED APPROACH; REPAIR FACTOR TFIIH; RNA-POLYMERASE-II; DNA-REPAIR; DRUG DISCOVERY; NMR RELAXATION; IN-VIVO; PROTEIN; CANCER	The human transcription factor TFIIH is a large complex composed of 10 subunits that form an intricate network of protein-protein interactions critical for regulating its transcriptional and DNA repair activities. The trichothiodystrophy group A protein (TTD-A or p8) is the smallest TFIIH subunit, shuttling between a free and a TFIIH-bound state. Its dimerization properties allow it to shift from a homodimeric state, in the absence of a functional partner, to a heterodimeric structure, enabling dynamic binding to TFIIH. Recruitment of p8 at TFIIH stabilizes the overall architecture of the complex, whereas p8's absence reduces its cellular steady-state concentration and consequently decreases basal transcription, highlighting that p8 dimerization may be an attractive target for down-regulating transcription in cancer cells. Here, using a combination of molecular dynamics simulations to study p8 conformational stability and a >3000-member library of chemical fragments, we identified small-molecule compounds that bind to the dimerization interface of p8 and provoke its destabilization, as assessed by biophysical studies. Using quantitative imaging of TFIIH in living mouse cells, we found that these molecules reduce the intracellular concentration of TFIIH and its transcriptional activity to levels similar to that observed in individuals with trichothiodystrophy owing to mutated TTD-A. Our results provide a proof of concept of fragment-based drug discovery, demonstrating the utility of small molecules for targeting p8 dimerization to modulate the transcriptional machinery, an approach that may help inform further development in anticancer therapies.	[Gervais, Virginie; Muller, Isabelle; Mourcet, Amandine; Movellan, Kumar Tekwani; Ramos, Pascal; Marcoux, Julien; Guillet, Valerie; Javaid, Sumaira; Burlet-Schiltz, Odile; Czaplicki, Georges; Milon, Alain] Univ Paul Sabatier, Univ Toulouse, CNRS, IPBS, BP-64182, F-31077 Toulouse, France; [Mari, Pierre-Olivier; Giglia-Mari, Giuseppina] Univ Claude Bernard Lyon 1, INSERM, U1217, Inst NeuroMyoGene,CNRS,UMR 5310, F-69008 Lyon, France; [Javaid, Sumaira] Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi 75270, Pakistan; [Movellan, Kumar Tekwani] Max Planck Inst Biophys Chem, Fassberg 11, D-37077 Gottingen, Germany	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Karachi; Max Planck Society	Gervais, V (corresponding author), IPBS, 205 Route Narbonne,BP-64182, F-31077 Toulouse, France.; Giglia-Mari, G (corresponding author), CNRS, Inst NeuroMyoGene, UMR 5310, 08 Ave Rockefeller, F-69008 Lyon, France.	virginie.gervais@ipbs.fr; ambra.mari@univ-lyon1.fr	Mari, Pierre-Olivier/A-1140-2011; Giglia-Mari, Giuseppina/F-5114-2010; Czaplicki, Georges/ABC-7047-2020	Mari, Pierre-Olivier/0000-0001-8548-6203; Giglia-Mari, Giuseppina/0000-0003-2001-1965; Czaplicki, Georges/0000-0001-5348-4107; Tekwani Movellan, Kumar Aaron/0000-0002-8636-0087; Schiltz, Odile/0000-0002-3606-2356; Marcoux, Julien/0000-0001-7321-7436; Gervais, Virginie/0000-0002-1144-6185	Ibisa; CNRS; European structural funds; Region Midi-Pyrenees	Ibisa; CNRS(Centre National de la Recherche Scientifique (CNRS)); European structural funds; Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie)	We acknowledge the use of PICT-Genotoul-Ibisa facility, funded by Ibisa, CNRS, European structural funds, and the Region Midi-Pyrenees and the use of the imaging facility CIQLE (Centre d'imagerie quantitative Lyon-Est, Universite Claude Bernard Lyon 1, Lyon, France). We are grateful to M. Trivedi and K. Rottier for input at the beginning of the project, O. Saurel for NMR support, and L. Mourey for insightful comments during the study. We acknowledge B. Brutscher for support with TRACT experiments, and we thank B. Kieffer and A. Poterszman for stimulating discussions and the generous gift of plasmids.	Alekseev S, 2014, CHEM BIOL, V21, P398, DOI 10.1016/j.chembiol.2013.12.014; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Cala O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063908; Campos-Olivas R, 2011, CURR TOP MED CHEM, V11, P43, DOI 10.2174/156802611793611887; Case DA, 2012, AMBER 12; Coin F, 2006, MOL CELL, V21, P215, DOI 10.1016/j.molcel.2005.10.024; Dahlin JL, 2016, ASSAY DRUG DEV TECHN, V14, P168, DOI 10.1089/adt.2015.674; Dalvit C, 2009, DRUG DISCOV TODAY, V14, P1051, DOI 10.1016/j.drudis.2009.07.013; Daragan VA, 1997, PROG NUCL MAG RES SP, V31, P63, DOI 10.1016/S0079-6565(97)00006-X; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; DeLano W.L, PYMOL MOL GRAPHICS S; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Giglia-Mari G, 2006, PLOS BIOL, V4, P952, DOI 10.1371/journal.pbio.0040156; Giglia-Mari G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000220; Greber BJ, 2017, NATURE, V549, P414, DOI 10.1038/nature23903; Hagenbuchner J, 2016, BIOCHEM PHARMACOL, V107, P1, DOI 10.1016/j.bcp.2015.12.006; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Hashimoto S, 2009, HUM MOL GENET, V18, pR224, DOI 10.1093/hmg/ddp390; Hoogstraten D, 2002, MOL CELL, V10, P1163, DOI 10.1016/S1097-2765(02)00709-8; Imai M, 2009, GENES GENET SYST, V84, P73, DOI 10.1266/ggs.84.73; Johnston SJ, 2015, BBA-REV CANCER, V1855, P183, DOI 10.1016/j.bbcan.2015.02.002; Kainov DE, 2008, NAT STRUCT MOL BIOL, V15, P980, DOI 10.1038/nsmb.1478; Kainov DE, 2010, ACTA CRYSTALLOGR D, V66, P745, DOI 10.1107/S0907444910009844; Lee D, 2006, J MAGN RESON, V178, P72, DOI 10.1016/j.jmr.2005.08.014; Li WW, 2005, J AM CHEM SOC, V127, P6140, DOI 10.1021/ja050974x; Luo J, 2015, MOL CELL, V59, P794, DOI 10.1016/j.molcel.2015.07.016; Mapp AK, 2015, NAT CHEM BIOL, V11, P891, DOI 10.1038/nchembio.1962; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Mourgues S, 2013, P NATL ACAD SCI USA, V110, P17927, DOI 10.1073/pnas.1305009110; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P172, DOI 10.1038/nrd3680; Murray CW, 2010, CURR OPIN STRUC BIOL, V20, P497, DOI 10.1016/j.sbi.2010.04.003; Murray CW, 2009, NAT CHEM, V1, P187, DOI [10.1038/NCHEM.217, 10.1038/nchem.217]; Nakata Y, 2013, J TOXICOL SCI, V38, P325, DOI 10.2131/jts.38.325; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nonnekens J, 2013, J CELL SCI, V126, P3278, DOI 10.1242/jcs.126839; Nonnekens J, 2013, HUM MOL GENET, V22, P2881, DOI 10.1093/hmg/ddt143; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott DE, 2016, NAT REV DRUG DISCOV, V15, P533, DOI 10.1038/nrd.2016.29; Scott DE, 2013, CHEMBIOCHEM, V14, P332, DOI 10.1002/cbic.201200521; Scott DE, 2012, BIOCHEMISTRY-US, V51, P4990, DOI 10.1021/bi3005126; Seetoh WG, 2016, J AM CHEM SOC, V138, P14303, DOI 10.1021/jacs.6b07440; Sheng CQ, 2015, CHEM SOC REV, V44, P8375, DOI 10.1039/c5cs90090e; Silvestre HL, 2013, P NATL ACAD SCI USA, V110, P12984, DOI 10.1073/pnas.1304045110; Theil AF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003431; Theil AF, 2011, MOL CELL BIOL, V31, P3630, DOI 10.1128/MCB.01462-10; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vermeulen W, 2000, NAT GENET, V26, P307, DOI 10.1038/81603; Villicana C, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-18; Vitorino M, 2007, J MOL BIOL, V368, P473, DOI 10.1016/j.jmb.2007.02.020; Zurita M, 2016, J CANCER, V7, P2258, DOI 10.7150/jca.16966	53	9	9	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					14974	14988		10.1074/jbc.RA118.003444	http://dx.doi.org/10.1074/jbc.RA118.003444			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30068551	Green Published, hybrid			2022-12-28	WOS:000445998400004
J	Blain-Hartung, M; Rockwell, NC; Moreno, MV; Martin, SS; Gan, F; Bryant, DA; Lagarias, JC				Blain-Hartung, Matthew; Rockwell, Nathan C.; Moreno, Marcus V.; Martin, Shelley S.; Gan, Fei; Bryant, Donald A.; Lagarias, J. Clark			Cyanobacteriochrome-based photoswitchable adenylyl cyclases (cPACs) for broad spectrum light regulation of cAMP levels in cells (vol 293, pg 8473, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Lagarias, John Clark/L-3139-2013	Lagarias, John Clark/0000-0002-2093-0403	NIGMS NIH HHS [T32 GM007377] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blain-Hartung M, 2018, J BIOL CHEM, V293, P8473, DOI 10.1074/jbc.RA118.002258	1	1	1	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13850	13850		10.1074/jbc.AAC118.005397	http://dx.doi.org/10.1074/jbc.AAC118.005397			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30194257	Green Published, hybrid			2022-12-28	WOS:000444070700011
J	Vella, A; Matveyenko, A				Vella, Adrian; Matveyenko, Aleksey			Walking a fine line between -cell secretion and proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							VARIANTS	Of the many common genetic variants associated with type 2 diabetes, that in TCF7L2 remains the most studied because it has the greatest effect size. However, the mechanism by which this variant alters diabetes risk remains elusive. A new study adds another layer of complexity, suggesting that the effects of TCF7L2 are context-dependent, and highlights a novel interaction that might bias a -cell to a secretory or proliferative phenotype. This in turn might open up new avenues to the restoration of insulin secretion in people with type 2 diabetes.	[Vella, Adrian; Matveyenko, Aleksey] Mayo Clin, Div Endocrinol & Metab, Rochester, MN 55905 USA; [Matveyenko, Aleksey] Mayo Clin, Div Physiol & Biomed Engn, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Vella, A (corresponding author), Mayo Clin, Endocrine Res Unit, 5 Jo 194,200 First St SW, Rochester, MN 55905 USA.	vella.adrian@mayo.edu			NIDDK, National Institutes of Health [DK98468, DK78646, DK116231]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078646, R01DK098468, R01DK116231] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grants DK98468 (to A. M.) and DK78646 and DK116231 (to A. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Bernal-Mizrachi E, 2014, DIABETES, V63, P819, DOI 10.2337/db13-1146; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Klochendler A, 2016, DIABETES, V65, P2081, DOI 10.2337/db16-0003; Nguyen-Tu MS, 2018, J BIOL CHEM, V293, P14178, DOI 10.1074/jbc.RA118.003613; Shah M, 2016, DIABETES, V65, P371, DOI 10.2337/db15-1233; Smushkin G, 2012, DIABETES, V61, P1082, DOI [10.2337/db11-1732, 10.2337/db12-0923]; Talmud PJ, 2015, DIABETES, V64, P1830, DOI 10.2337/db14-1504; Xavier GD, 2017, DIABETOLOGIA, V60, P1043, DOI 10.1007/s00125-017-4242-2; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200	10	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14190	14191		10.1074/jbc.H118.005121	http://dx.doi.org/10.1074/jbc.H118.005121			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30194258	Green Published, hybrid			2022-12-28	WOS:000444070700039
J	White, A; Koelper, A; Russell, A; Larsen, EM; Kim, C; Lavis, LD; Hoops, GC; Johnson, RJ				White, Alex; Koelper, Andrew; Russell, Arielle; Larsen, Erik M.; Kim, Charles; Lavis, Luke D.; Hoops, Geoffrey C.; Johnson, R. Jeremy			Fluorogenic structure activity library pinpoints molecular variations in substrate specificity of structurally homologous esterases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrolase; substrate specificity; fluorescence; chemical biology; carboxylesterase; chemical probes; fluorogenic substrates; structure-activity relationship; serine hydrolase	ALPHA/BETA-HYDROLASE FOLD; SENSITIVE LIPASE FAMILY; MYCOBACTERIUM-TUBERCULOSIS; SERINE HYDROLASES; PROFICIENT ENZYME; TRANSITION-STATE; IDENTIFICATION; SELECTIVITY; INHIBITORS; FINGERPRINTS	Cellular esterases catalyze many essential biological functions by performing hydrolysis reactions on diverse substrates. The promiscuity of esterases complicates assignment of their substrate preferences and biological functions. To identify universal factors controlling esterase substrate recognition, we designed a 32-member structure-activity relationship (SAR) library of fluorogenic ester substrates and used this library to systematically interrogate esterase preference for chain length, branching patterns, and polarity to differentiate common classes of esterase substrates. Two structurally homologous bacterial esterases were screened against this library, refining their previously broad overlapping substrate specificity. Vibrio cholerae esterase ybfF displayed a preference for -position thioethers and ethers, whereas Rv0045c from Mycobacterium tuberculosis displayed a preference for branched substrates with and without thioethers. We determined that this substrate differentiation was partially controlled by individual substrate selectivity residues Tyr-119 in ybfF and His-187 in Rv0045c; reciprocal substitution of these residues shifted each esterase's substrate preference. This work demonstrates that the selectivity of esterases is tuned based on transition state stabilization, identifies thioethers as an underutilized functional group for esterase substrates, and provides a rapid method for differentiating structural isozymes. This SAR library could have multifaceted future applications, including in vivo imaging, biocatalyst screening, molecular fingerprinting, and inhibitor design.	[White, Alex; Koelper, Andrew; Russell, Arielle; Larsen, Erik M.; Hoops, Geoffrey C.; Johnson, R. Jeremy] Butler Univ, Dept Chem & Biochem, 4600 Sunset Ave, Indianapolis, IN 46208 USA; [Kim, Charles; Lavis, Luke D.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA	Butler University; Howard Hughes Medical Institute	Johnson, RJ (corresponding author), Butler Univ, Dept Chem & Biochem, 4600 Sunset Ave, Indianapolis, IN 46208 USA.	rjjohns1@butler.edu		Hoops, Geoffrey/0000-0001-9860-1709	National Institutes of Health [1 R15 GM110641-01A1]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM110641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grant 1 R15 GM110641-01A1.; Supported by the Howard Hughes Medical Institute.	Bachovchin DA, 2012, NAT REV DRUG DISCOV, V11, P52, DOI 10.1038/nrd3620; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Bassett B, 2018, ACS INFECT DIS, V4, P904, DOI 10.1021/acsinfecdis.7b00263; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Breen ME, 2014, ANGEW CHEM INT EDIT, V53, P7010, DOI 10.1002/anie.201311096; Busto E, 2010, CHEM SOC REV, V39, P4504, DOI 10.1039/c003811c; Cai R, 2016, FOOD ANAL METHOD, V9, P1128, DOI 10.1007/s12161-015-0290-8; Carr PD, 2009, PROTEIN PEPTIDE LETT, V16, P1137; Ceccarelli EA, 2008, TRENDS BIOTECHNOL, V26, P117, DOI 10.1016/j.tibtech.2007.11.008; Chapelat J, 2012, EUR J MED CHEM, V57, P1, DOI 10.1016/j.ejmech.2012.08.038; de Freitas RF, 2017, MEDCHEMCOMM, V8, P1970, DOI 10.1039/c7md00381a; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Devamani T, 2016, J AM CHEM SOC, V138, P1046, DOI 10.1021/jacs.5b12209; Dube S, 2017, CHEMBIOCHEM, V18, P1807, DOI 10.1002/cbic.201700278; Eisenthal R, 2007, TRENDS BIOTECHNOL, V25, P247, DOI 10.1016/j.tibtech.2007.03.010; Ellis EE, 2013, CHEMBIOCHEM, V14, P1134, DOI 10.1002/cbic.201300085; Farberg Alexander M, 2016, Biochem Biophys Rep, V7, P415, DOI 10.1016/j.bbrep.2016.07.006; Filippova EV, 2013, J BIOL CHEM, V288, P10522, DOI 10.1074/jbc.M112.446625; Fox RJ, 2009, TRENDS BIOTECHNOL, V27, P137, DOI 10.1016/j.tibtech.2008.12.001; Grognux J, 2004, CHEMBIOCHEM, V5, P826, DOI 10.1002/cbic.200300779; Guo JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013143; Hedge MK, 2012, BBA-PROTEINS PROTEOM, V1824, P1024, DOI 10.1016/j.bbapap.2012.05.009; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Jochens H, 2011, CHEMBIOCHEM, V12, P1508, DOI 10.1002/cbic.201000771; Johnson RJ, 2015, J CHEM EDUC, V92, P385, DOI 10.1021/ed500452f; Johnson TL, 2016, J BACTERIOL, V198, P711, DOI 10.1128/JB.00622-15; Kim S, 2015, CHEM-EUR J, V21, P9645, DOI 10.1002/chem.201501127; Kirby AJ, 2009, FROM ENZYME MODELS TO MODEL ENZYMES, P29; Kolbe K, 2018, ACS INFECT DIS, V4, P458, DOI 10.1021/acsinfecdis.7b00242; Komatsu T, 2013, J AM CHEM SOC, V135, P6002, DOI 10.1021/ja401792d; Komatsu T, 2015, ANAL SCI, V31, P257, DOI 10.2116/analsci.31.257; Kourist R, 2010, CHEMBIOCHEM, V11, P1635, DOI 10.1002/cbic.201000213; Kowalski JR, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.16-02-0089; Kozakov D, 2015, P NATL ACAD SCI USA, V112, pE2585, DOI 10.1073/pnas.1501567112; Larsen EM, 2017, BIOORG MED CHEM LETT, V27, P4544, DOI 10.1016/j.bmcl.2017.08.057; Lavis LD, 2006, ACS CHEM BIOL, V1, P252, DOI 10.1021/cb600132m; Lavis LD, 2014, ACS CHEM BIOL, V9, P855, DOI 10.1021/cb500078u; Lavis LD, 2011, CHEM SCI, V2, P521, DOI 10.1039/c0sc00466a; Lenfant N, 2013, CHEM-BIOL INTERACT, V203, P266, DOI 10.1016/j.cbi.2012.09.003; Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154; Leroy E, 2003, BIOORG MED CHEM LETT, V13, P2105, DOI 10.1016/S0960-894X(03)00377-9; Lewis AK, 2016, NAT CHEM BIOL, V12, P860, DOI [10.1038/NCHEMBIO.2159, 10.1038/nchembio.2159]; Li PY, 2014, J BIOL CHEM, V289, P19031, DOI 10.1074/jbc.M114.574913; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Lukowski JK, 2014, BIOCHEMISTRY-US, V53, P7386, DOI 10.1021/bi501108u; Macarron R, 2011, MOL BIOTECHNOL, V47, P270, DOI 10.1007/s12033-010-9335-9; Maillard N, 2011, ANAL CHEM, V83, P1437, DOI 10.1021/ac102994n; MALINBERDEL J, 1980, CYTOMETRY, V1, P222, DOI 10.1002/cyto.990010308; Martinez-Martinez M, 2018, ACS CHEM BIOL, V13, P225, DOI 10.1021/acschembio.7b00996; McKary MG, 2016, BIOCHEMISTRY-US, V55, P7099, DOI 10.1021/acs.biochem.6b01057; Miller BG, 2000, P NATL ACAD SCI USA, V97, P2011, DOI 10.1073/pnas.030409797; Olguin LF, 2008, J AM CHEM SOC, V130, P16547, DOI 10.1021/ja8047943; Oosterhoff D, 2005, GENE THER, V12, P1011, DOI 10.1038/sj.gt.3302492; Park SY, 2008, J MOL BIOL, V376, P1426, DOI 10.1016/j.jmb.2007.12.062; Patterson AW, 2007, NAT PROTOC, V2, P424, DOI 10.1038/nprot.2007.28; Qian L, 2011, J MOL CATAL B-ENZYM, V73, P22, DOI 10.1016/j.molcatb.2011.07.010; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Rauwerdink A, 2015, ACS CATAL, V5, P6153, DOI 10.1021/acscatal.5b01539; Reymond JL, 2009, CHEM COMMUN, P34, DOI 10.1039/b813732c; Romano D, 2015, BIOTECHNOL ADV, V33, P547, DOI 10.1016/j.biotechadv.2015.01.006; Rosenau F, 2010, FEMS MICROBIOL LETT, V309, P25, DOI 10.1111/j.1574-6968.2010.02017.x; Segal E, 2015, CHEM BIOL, V22, P148, DOI 10.1016/j.chembiol.2014.11.008; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Soellner MB, 2007, J AM CHEM SOC, V129, P9613, DOI 10.1021/ja0727520; Sousa SF, 2015, ACS CATAL, V5, P5877, DOI 10.1021/acscatal.5b00923; Tallman KR, 2016, ACS INFECT DIS, V2, P48, DOI 10.1021/acsinfecdis.6b00135; Tian L, 2012, P NATL ACAD SCI USA, V109, P4756, DOI 10.1073/pnas.1111943109; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Varadi L, 2017, CHEM SOC REV, V46, P4818, DOI 10.1039/c6cs00693k; WOLFENDEN R, 1972, ACCOUNTS CHEM RES, V5, P10, DOI 10.1021/ar50049a002; Wolfenden R, 2006, CHEM REV, V106, P3379, DOI 10.1021/cr050311y; Wolfenden R, 2011, ANNU REV BIOCHEM, V80, P645, DOI 10.1146/annurev-biochem-060409-093051; Wood WJL, 2005, J AM CHEM SOC, V127, P15521, DOI 10.1021/ja0547230; Yang YZ, 2006, HELV CHIM ACTA, V89, P404, DOI 10.1002/hlca.200690041; Zadlo-Dobrowolska A, 2016, ORG BIOMOL CHEM, V14, P9146, DOI 10.1039/c6ob01488g; Zheng XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020506	77	6	6	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13851	13862		10.1074/jbc.RA118.003972	http://dx.doi.org/10.1074/jbc.RA118.003972			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30006352	Green Published, hybrid			2022-12-28	WOS:000444070700012
J	Fanjul-Fernandez, M; Folgueras, AR; Fueyo, A; Balbin, M; Suarez, MF; Fernandez-Garcia, MS; Shapiro, SD; Freije, JMP; Lopez-Otin, C				Fanjul-Fernandez, Miriam; Folgueras, Alicia R.; Fueyo, Antonio; Balbin, Milagros; Suarez, Maria F.; Fernandez-Garcia, M. Soledad; Shapiro, Steven D.; Freije, Jose M. P.; Lopez-Otin, Carlos			Matrix metalloproteinase Mmp-1a is dispensable for normal growth and fertility in mice and promotes lung cancer progression by modulating inflammatory responses (vol 288, pg 1467, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Balbín, Milagros/I-4206-2015; Suárez, María Fernanda Valencia/F-8200-2019; Fueyo, Antonio/ABH-3243-2020; Lopez-Otin, Carlos/AAB-2106-2020; Folgueras, Alicia/B-3281-2017	Balbín, Milagros/0000-0001-5325-0407; Suárez, María Fernanda Valencia/0000-0001-8987-8431; Fueyo, Antonio/0000-0002-7121-9398; Lopez-Otin, Carlos/0000-0001-6964-1904; Folgueras, Alicia/0000-0003-3426-9502				Fanjul-Fernandez M, 2013, J BIOL CHEM, V288, P14647, DOI 10.1074/jbc.M112.439893	1	6	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11970	11970		10.1074/jbc.AAC118.004704	http://dx.doi.org/10.1074/jbc.AAC118.004704			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	30054294	Green Published, hybrid			2022-12-28	WOS:000440134500029
J	Rizzolo, K; Houry, WA				Rizzolo, Kamran; Houry, Walid A.			Multiple functionalities of molecular chaperones revealed through systematic mapping of their interaction networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						proteostasis; proteomics; protein-protein interaction; molecular chaperone; protein assembly; chaperone networks; genetic interaction profiles; genetic interactions; NAJ chaperone complex; physical interactions	QUANTITATIVE-ANALYSIS; GENETIC INTERACTIONS; HEAT-SHOCK; PROTEOSTASIS; BIOLOGY; MAP; MECHANISMS; THROUGHPUT; PROTEOMICS; PROTEINS	Chaperones are a highly interactive group of proteins that function globally in many cellular processes involved in maintaining protein homeostasis. Traditional biochemical assays typically do not provide a complete view of the intricate networks through which chaperones collaborate to promote proteostasis. Recent advances in high-throughput systematic analyses of chaperone interactions have uncovered that chaperones display a remarkable cooperativity in their interactions with numerous client proteins. This cooperativity has been found to be a fundamental aspect of a properly functioning cell. Aberrant formation or improper regulation of these interactions can easily lead to disease states. Herein, we provide an overview of the use of large-scale interaction assays, whether physical (protein-protein) or genetic (epistatic), to study chaperone interaction networks. Importantly, we discuss the ongoing need for such studies to determine the mechanisms by which protein homeostasis is controlled in the cell.	[Rizzolo, Kamran; Houry, Walid A.] Univ Toronto, Dept Biochem, Toronto, ON M5G 1M1, Canada; [Houry, Walid A.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada	University of Toronto; University of Toronto	Houry, WA (corresponding author), Univ Toronto, Fac Med, Dept Biochem, MaRS Ctr, 661 Univ Ave,West Tower,Rm 1612, Toronto, ON M5G 1M1, Canada.	walid.houry@utoronto.ca	Rizzolo, Kamran/AAG-4026-2019	Houry, Walid/0000-0002-1861-3441; Rizzolo, Kamran/0000-0003-2869-9768	Canadian Institutes of Health Research [MOP-93778, MOP-81256]; Canadian Institutes of Health Research Training Program in Protein Folding and Interaction Dynamics, Principles and Diseases Fellowship; University of Toronto Fellowship from the Department of Biochemistry; Ontario Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Training Program in Protein Folding and Interaction Dynamics, Principles and Diseases Fellowship(Canadian Institutes of Health Research (CIHR)); University of Toronto Fellowship from the Department of Biochemistry; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported in part by Canadian Institutes of Health Research Grants MOP-93778 and MOP-81256 (to W. A. H.). This is the seventh article in the JBC Reviews series "Molecular chaperones and protein quality control." The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Canadian Institutes of Health Research Training Program in Protein Folding and Interaction Dynamics, Principles and Diseases Fellowship, by a University of Toronto Fellowship from the Department of Biochemistry, and by an Ontario Graduate Scholarship.	Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Brownridge P, 2013, PROTEOMICS, V13, P1276, DOI 10.1002/pmic.201200412; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Dekker C, 2008, EMBO J, V27, P1827, DOI 10.1038/emboj.2008.108; Diezmann S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002562; Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044; Echtenkamp FJ, 2011, MOL CELL, V43, P229, DOI 10.1016/j.molcel.2011.05.029; Esfahani AH, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005890; Finka A, 2013, CELL STRESS CHAPERON, V18, P591, DOI 10.1007/s12192-013-0413-3; Freilich R, 2018, ACCOUNTS CHEM RES, V51, P940, DOI 10.1021/acs.accounts.8b00036; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Jamuczak AE, 2015, PROTEOMICS, V15, P3126, DOI 10.1002/pmic.201400527; Jarnuczak AF, 2018, MOL OMICS, V14, P37, DOI 10.1039/c7mo00050b; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Joshi S, 2018, NAT REV CANCER, V18, P562, DOI 10.1038/s41568-018-0020-9; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kumar A, 2018, METHODS MOL BIOL, V1709, P275, DOI 10.1007/978-1-4939-7477-1_20; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lindquist S, 2009, COLD SH Q B, V74, P103, DOI 10.1101/sqb.2009.74.043; Mandal AK, 2007, J CELL BIOL, V176, P319, DOI 10.1083/jcb.200604106; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Morris JH, 2014, NAT PROTOC, V9, P2539, DOI 10.1038/nprot.2014.164; Pappenberger G, 2006, J MOL BIOL, V360, P484, DOI 10.1016/j.jmb.2006.05.003; Rizzolo K, 2018, MOL OMICS, V14, P82, DOI [10.1039/c7mo00142h, 10.1039/C7MO00142H]; Rizzolo K, 2017, CELL REP, V20, P2735, DOI 10.1016/j.celrep.2017.08.074; Rodina A, 2016, NATURE, V538, P397, DOI 10.1038/nature19807; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Sharma K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014654; Snider J, 2010, NAT PROTOC, V5, P1281, DOI 10.1038/nprot.2010.83; Sontag EM, 2017, ANNU REV BIOCHEM, V86, P97, DOI 10.1146/annurev-biochem-060815-014616; Suter B, 2008, CURR OPIN BIOTECH, V19, P316, DOI 10.1016/j.copbio.2008.06.005; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tatu U, 1997, J CELL BIOL, V136, P555, DOI 10.1083/jcb.136.3.555; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhu H, 2003, ANNU REV BIOCHEM, V72, P783, DOI 10.1146/annurev.biochem.72.121801.161511	52	7	7	4	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2142	2150		10.1074/jbc.TM118.002805	http://dx.doi.org/10.1074/jbc.TM118.002805			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30194284	Green Published, hybrid			2022-12-28	WOS:000459711400032
J	Coullon, H; Rifflet, A; Wheeler, R; Janoir, C; Boneca, IG; Candela, T				Coullon, Heloise; Rifflet, Aline; Wheeler, Richard; Janoir, Claire; Boneca, Ivo Gomperts; Candela, Thomas			N-Deacetylases required for muramic--lactam production are involved in Clostridium difficile sporulation, germination, and heat resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sporulation; bacteria; bacterial pathogenesis; acetylation; Gram-positive bacteria; infectious disease; microbiology; peptidoglycan; Clostridium difficile; germination; muramic--lactams; N-deacetylase; spore cortex	BACILLUS-SUBTILIS; PEPTIDOGLYCAN STRUCTURE; SPORE CORTEX; GENE; INHIBITORS; INFECTION; RESIDUES; DYNAMICS; HOMOLOG; DISEASE	Spores are produced by many organisms as a survival mechanism activated in response to several environmental stresses. Bacterial spores are multilayered structures, one of which is a peptidoglycan layer called the cortex, containing muramic--lactams that are synthesized by at least two bacterial enzymes, the muramoyl-l-alanine amidase CwlD and the N-deacetylase PdaA. This study focused on the spore cortex of Clostridium difficile, a Gram-positive, toxin-producing anaerobic bacterial pathogen that can colonize the human intestinal tract and is a leading cause of antibiotic-associated diarrhea. Using ultra-HPLC coupled with high-resolution MS, here we found that the spore cortex of the C. difficile 630erm strain differs from that of Bacillus subtilis. Among these differences, the muramic--lactams represented only 24% in C. difficile, compared with 50% in B. subtilis. CD630_14300 and CD630_27190 were identified as genes encoding the C. difficile N-deacetylases PdaA1 and PdaA2, required for muramic--lactam synthesis. In a pdaA1 mutant, only 0.4% of all muropeptides carried a muramic--lactam modification, and muramic--lactams were absent in the cortex of a pdaA1-pdaA2 double mutant. Of note, the pdaA1 mutant exhibited decreased sporulation, altered germination, decreased heat resistance, and delayed virulence in a hamster infection model. These results suggest a much greater role for muramic--lactams in C. difficile than in other bacteria, including B. subtilis. In summary, the spore cortex of C. difficile contains lower levels of muramic--lactams than that of B. subtilis, and PdaA1 is the major N-deacetylase for muramic--lactam biosynthesis in C. difficile, contributing to sporulation, heat resistance, and virulence.	[Coullon, Heloise; Janoir, Claire; Candela, Thomas] Univ Paris Saclay, Univ Paris Sud, UBaPS, EA4043, F-92290 Chatenay Malabry, France; [Rifflet, Aline; Wheeler, Richard; Boneca, Ivo Gomperts] Inst Pasteur, Unite Biol & Genet Paroi Bacterienne, F-75724 Paris, France; [Rifflet, Aline; Wheeler, Richard; Boneca, Ivo Gomperts] INSERM, Equipe Avenir, F-75015 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Candela, T (corresponding author), Univ Paris Sud, Unite Bacteries Pathogenes & Sante, EA 4043, F-92296 Chatenay Malabry, France.	Thomas.candela@u-psud.fr	Boneca, Ivo G/H-1677-2014; Candela, Thomas/ABA-6367-2021; WHEELER, Richard/AAB-8262-2022; Candela, Thomas/AAC-9583-2021	Boneca, Ivo G/0000-0001-8122-509X; WHEELER, Richard/0000-0002-9249-2377; Candela, thomas/0000-0002-4686-2533	French Government's Investissement d'Avenir Program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation	French Government's Investissement d'Avenir Program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation	This work was supported in part by the French Government's Investissement d'Avenir Program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases," Grant ANR-10-LABX-62-IBEID. The authors declare that they have no conflicts of interest with the contents of this article.; Funded by Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation.	Ariyakumaran R, 2015, CHEMBIOCHEM, V16, P1350, DOI 10.1002/cbic.201500091; Atrih A, 1999, MICROBIOL-UK, V145, P1033, DOI 10.1099/13500872-145-5-1033; Atrih A, 2001, J APPL MICROBIOL, V91, P364, DOI 10.1046/j.1365-2672.2001.01394.x; BEAMAN TC, 1982, J BACTERIOL, V150, P870, DOI 10.1128/JB.150.2.870-877.1982; Carlson PE, 2015, ANAEROBE, V33, P64, DOI 10.1016/j.anaerobe.2015.02.003; Carlson PE, 2013, ANAEROBE, V24, P109, DOI 10.1016/j.anaerobe.2013.04.003; Cartman ST, 2012, APPL ENVIRON MICROB, V78, P4683, DOI 10.1128/AEM.00249-12; Cartman ST, 2010, APPL ENVIRON MICROB, V76, P1103, DOI 10.1128/AEM.02525-09; Chibba A, 2012, ORG BIOMOL CHEM, V10, P7103, DOI 10.1039/c2ob26105g; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Dembek M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01793; Dembek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064011; Diaz CR, 2018, ADV EXP MED BIOL, V1050, P227, DOI 10.1007/978-3-319-72799-8_13; Donnelly ML, 2016, J BACTERIOL, V198, P1694, DOI 10.1128/JB.00986-15; Fimlaid KA, 2015, CURR OPIN MICROBIOL, V24, P88, DOI 10.1016/j.mib.2015.01.006; Fukushima T, 2005, J BACTERIOL, V187, P1287, DOI 10.1128/JB.187.4.1287-1292.2005; Fukushima T, 2004, J BIOCHEM, V136, P283, DOI 10.1093/jb/mvh151; Fukushima T, 2002, J BACTERIOL, V184, P6007, DOI 10.1128/JB.184.21.6007-6015.2002; Ghosh S, 2008, J BACTERIOL, V190, P6741, DOI 10.1128/JB.00896-08; Gil F, 2017, ANAEROBE, V45, P3, DOI 10.1016/j.anaerobe.2017.02.018; Gilmore ME, 2004, J BACTERIOL, V186, P80, DOI 10.1128/JB.186.1.80-89.2004; Hall RS, 2007, BIOCHEMISTRY-US, V46, P7953, DOI 10.1021/bi700544c; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Heffron JD, 2011, J BACTERIOL, V193, P125, DOI 10.1128/JB.00869-10; Hong HA, 2017, J INFECT DIS, V216, P1452, DOI 10.1093/infdis/jix488; Hu K, 2006, CAN J MICROBIOL, V52, P935, DOI 10.1139/W06-045; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Janoir C, 2013, INFECT IMMUN, V81, P3757, DOI 10.1128/IAI.00515-13; Jones AM, 2013, J INFECTION, V66, P115, DOI 10.1016/j.jinf.2012.10.019; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; Leggett MJ, 2012, J APPL MICROBIOL, V113, P485, DOI 10.1111/j.1365-2672.2012.05336.x; Lessa FC., 2015, NEW ENGL J MED, V372, P2369, DOI DOI 10.1056/NEJMC1505190; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Loshon CA, 1999, J APPL MICROBIOL, V87, P8, DOI 10.1046/j.1365-2672.1999.00783.x; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Murphy-Benenato KE, 2014, ACS MED CHEM LETT, V5, P1213, DOI 10.1021/ml500210x; Orsburn B, 2008, APPL ENVIRON MICROB, V74, P3328, DOI 10.1128/AEM.02629-07; Paredes-Sabja D, 2014, TRENDS MICROBIOL, V22, P406, DOI 10.1016/j.tim.2014.04.003; Peltier J, 2011, J BIOL CHEM, V286, P29053, DOI 10.1074/jbc.M111.259150; Pereira FC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003782; Permpoonpattana P, 2013, J BACTERIOL, V195, P1492, DOI 10.1128/JB.02104-12; Permpoonpattana P, 2011, INFECT IMMUN, V79, P2295, DOI 10.1128/IAI.00130-11; Popham DL, 1996, J BACTERIOL, V178, P6451, DOI 10.1128/jb.178.22.6451-6458.1996; Popham DL, 1996, P NATL ACAD SCI USA, V93, P15405, DOI 10.1073/pnas.93.26.15405; Quan JY, 2014, METHODS MOL BIOL, V1116, P103, DOI 10.1007/978-1-62703-764-8_8; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; Sadovskaya I, 2017, MBIO, V8, DOI 10.1128/mBio.01303-17; Saujet L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003756; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; SEKIGUCHI J, 1995, J BACTERIOL, V177, P5582, DOI 10.1128/jb.177.19.5582-5589.1995; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Setlow P., 2014, MICROBIOL SPECTR, P201, DOI [DOI 10.1128/MICROBIOLSPEC.TBS-0003-2012, DOI 10.1128/microbiolspec.TBS-0003-2012]; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Terrier MCZ, 2014, WORLD J GASTROENTERO, V20, P7416, DOI 10.3748/wjg.v20.i23.7416; WILSON KH, 1985, J INFECT DIS, V151, P355, DOI 10.1093/infdis/151.2.355; Wu X, 2015, BIOTECHNOL BIOENG, V112, P1365, DOI 10.1002/bit.25565; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	60	12	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18040	18054		10.1074/jbc.RA118.004273	http://dx.doi.org/10.1074/jbc.RA118.004273			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30266804	Green Published, hybrid			2022-12-28	WOS:000451375200003
J	Benoit, CR; Stanton, AE; Tartanian, AC; Motzer, AR; McGaughey, DM; Bond, SR; Brody, LC				Benoit, Courtney R.; Stanton, Abigail E.; Tartanian, Aileen C.; Motzer, Andrew R.; McGaughey, David M.; Bond, Stephen R.; Brody, Lawrence C.			Functional and phylogenetic characterization of noncanonical vitamin B-12-binding proteins in zebrafish suggests involvement in cobalamin transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						zebrafish; one-carbon metabolism; transport; phylogenetics; protein evolution; affinity; cobalamin; transcobalamin; vitamin B12	HUMAN INTRINSIC-FACTOR; NEURAL-TUBE DEFECTS; STRUCTURAL BASIS; HUMAN TRANSCOBALAMIN; DEFICIENCY; BINDING; RECOGNITION; FOLATE; RESOLUTION; RECEPTOR	In humans, transport of food-derived cobalamin (vitamin B-12) from the digestive system into the bloodstream involves three paralogous proteins: transcobalamin (TC), haptocorrin (HC), and intrinsic factor (IF). Each of these proteins contains two domains, an -domain and a -domain, which together form a cleft in which cobalamin binds. Zebrafish (Danio rerio) are thought to possess only a single cobalamin transport protein, referred to as Tcn2, which is a transcobalamin homolog. Here, we used CRISPR/Cas9 mutagenesis to create null alleles of tcn2 in zebrafish. Fish homozygous for tcn2-null alleles were viable and exhibited no obvious developmentally or behaviorally abnormal phenotypes. For this reason, we hypothesized that previously unidentified cobalamin-carrier proteins encoded in the zebrafish genome may provide an additional pathway for cobalamin transport. We identified genes predicted to code for two such proteins, Tcn-beta-a (Tcnba) and Tcn-beta-b (Tcnbb), which differ from all previously characterized cobalamin transport proteins as they lack the -domain. These -domain-only proteins are representative of an undescribed class of cobalamin-carrier proteins that are highly conserved throughout the ray-finned fishes. We observed that the genes encoding the three cobalamin transport homologs, tcn2, tcnba, and tcnbb, are expressed in unique spatial and temporal patterns in the developing zebrafish. Moreover, exogenously expressed recombinant Tcnba and Tcnbb bound cobalamin with high affinity, comparable with binding by full-length Tcn2. Taken together, our results suggest that this noncanonical protein structure has evolved to fully function as a cobalamin-carrier protein, thereby allowing for a compensatory cobalamin transport mechanism in the tcn2(-/-) zebrafish.	[Benoit, Courtney R.; Stanton, Abigail E.; Tartanian, Aileen C.; Motzer, Andrew R.; McGaughey, David M.; Brody, Lawrence C.] NHGRI, Gene & Environm Interact Sect, NIH, Bethesda, MD 20892 USA; [Bond, Stephen R.] NHGRI, Computat & Stat Genom Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Brody, LC (corresponding author), NHGRI, Gene & Environm Interact Sect, NIH, Bethesda, MD 20892 USA.	lbrody@mail.nih.gov		Benoit, Courtney/0000-0002-1334-3323	National Institutes of Health [5R24 RR01744]; Jake Gittlen Cancer Research Foundation; Pennsylvania Tobacco Settlement Fund; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jake Gittlen Cancer Research Foundation; Pennsylvania Tobacco Settlement Fund; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the National Human Genome Research Institute (NHGRI) zebrafish core for experimental and technical guidance, specifically Kevin Bishop, Blake Carrington, and Raman Sood. We also thank Alberto Rissone for the donation of the fabp10a DIG-labeled RNA probe, and Shawn Burgess for consultation and advice. We thank Nadia Houerbi for microscopy imaging and analysis. We thank the Charles River staff for continued care and maintenance of zebrafish lines. We thank the National Heart Lung and Blood Institute (NHLBI) biophysics core for use of their Monolith NT.115 platform for MST experiments. We thank members of the NHLBI biophysics core, Dr. Grzegorz Piszczek and Dr. Di Wu, as well as Nanotemper supporting scientist Nicole Eckart for help in analysis of MST data. We extend gratitude to Faith Pangilinan and David Bernard for editorial contribution. Bio-Atlas is funded by National Institutes of Health Grant 5R24 RR01744, Jake Gittlen Cancer Research Foundation, and Pennsylvania Tobacco Settlement Fund.	Alam A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12100; Alpers D. H., 1999, Chemistry and biochemistry of B12., P411; Andersen CBF, 2010, NATURE, V464, P445, DOI 10.1038/nature08874; Bloch JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184932; Bond SR, 2017, MOL BIOL EVOL, V34, P1543, DOI 10.1093/molbev/msx089; CARDINALE GJ, 1969, ARCH BIOCHEM BIOPHYS, V131, P92, DOI 10.1016/0003-9861(69)90108-8; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fedosov SN, 2006, FEBS J, V273, P4742, DOI 10.1111/j.1742-4658.2006.05478.x; Fedosov Sergey N, 2012, Subcell Biochem, V56, P347, DOI 10.1007/978-94-007-2199-9_18; Fedosov SN, 2005, BIOCHEMISTRY-US, V44, P3604, DOI 10.1021/bi047936v; Furger E, 2013, J BIOL CHEM, V288, P25466, DOI 10.1074/jbc.M113.483271; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Gopinath B, 2013, AM J CLIN NUTR, V98, P129, DOI 10.3945/ajcn.112.057091; GORDON MM, 1991, AM J PHYSIOL, V260, pG736, DOI 10.1152/ajpgi.1991.260.5.G736; Green R, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.40; Greibe E, 2012, J BIOL CHEM, V287, P33917, DOI 10.1074/jbc.M112.398016; Greibe E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035660; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAKAMI N, 1971, NEW ENGL J MED, V285, P1163, DOI 10.1056/NEJM197111182852103; Hansen AC, 2015, AQUACULT NUTR, V21, P507, DOI 10.1111/anu.12342; HIGGINBOTTOM MC, 1978, NEW ENGL J MED, V299, P17; Howe DG, 2013, NUCLEIC ACIDS RES, V41, pD854, DOI 10.1093/nar/gks938; Hunt A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5226; Jung HM, 2017, DEVELOPMENT, V144, P2070, DOI 10.1242/dev.145755; Kalra S, 2004, ARCH BIOCHEM BIOPHYS, V431, P189, DOI 10.1016/j.abb.2004.08.011; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khaire A, 2016, ARCH MED RES, V47, P427, DOI 10.1016/j.arcmed.2016.10.006; LI N, 1995, BIOCHEM BIOPH RES CO, V208, P756, DOI 10.1006/bbrc.1995.1402; Lopes-Marques M, 2015, GENOME BIOL EVOL, V7, P457, DOI 10.1093/gbe/evu289; Mathews FS, 2007, P NATL ACAD SCI USA, V104, P17311, DOI 10.1073/pnas.0703228104; Mills JL, 2012, HUM GENET, V131, P739, DOI 10.1007/s00439-011-1117-3; Molloy AM, 2009, PEDIATRICS, V123, P917, DOI 10.1542/peds.2008-1173; Nasri K, 2015, BIRTH DEFECTS RES A, V103, P1011, DOI 10.1002/bdra.23418; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Peng L, 2016, BIOCHIMIE, V126, P43, DOI 10.1016/j.biochi.2016.05.007; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petryszak R, 2016, NUCLEIC ACIDS RES, V44, pD746, DOI 10.1093/nar/gkv1045; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roman-Garcia P, 2014, J CLIN INVEST, V124, P2988, DOI 10.1172/JCI72606; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; St John JA, 2012, J MOL HISTOL, V43, P615, DOI 10.1007/s10735-012-9462-7; Stangl GI, 2000, J NUTR, V130, P3038, DOI 10.1093/jn/130.12.3038; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; VANTONDER SV, 1975, BRIT J NUTR, V34, P397, DOI 10.1017/S0007114575000463; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; White RJ, 2017, ELIFE, V6, DOI [10.7554/eLife.30860.001, 10.7554/eLife.30860]; Wuerges J, 2006, P NATL ACAD SCI USA, V103, P4386, DOI 10.1073/pnas.0509099103; Wuerges J, 2007, BIOCHEM J, V403, P431, DOI 10.1042/BJ20061394; Yamada K, 2013, J NUTR SCI VITAMINOL, V59, P238; Young PB, 1995, INT J VITAM NUTR RES, V65, P255; Zhang YT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146797	57	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17606	17621		10.1074/jbc.RA118.005323	http://dx.doi.org/10.1074/jbc.RA118.005323			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30237171	hybrid, Green Published			2022-12-28	WOS:000449799000024
J	Kim, WJ; Shea, AE; Kim, JH; Daaka, Y				Kim, Wan-Ju; Shea, Allyson E.; Kim, Joon-Hyung; Daaka, Yehia			Uropathogenic Escherichia coli invades bladder epithelial cells by activating kinase networks in host cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; host-pathogen interaction; secretion; signal transduction; epidermal growth factor receptor (EGFR); conditioned medium; urinary tract infection; uropathogenic E; coli	MEDIATED BACTERIAL INVASION; URINARY-TRACT-INFECTIONS; GROWTH-FACTOR RECEPTOR; FEEDBACK-REGULATION; S-NITROSYLATION; EGFR; CLATHRIN; ENTRY; INVOLVEMENT; PERSISTENCE	Uropathogenic Escherichia coli (UPEC) is the causative bacterium in most urinary tract infections (UTIs). UPEC cells adhere to and invade bladder epithelial cells (BECs) and cause uropathogenicity. Invading UPEC cells may encounter one of several fates, including degradation in the lysosome, expulsion to the extracellular milieu for clearance, or survival as an intracellular bacterial community and quiescent intracellular reservoir that can cause later infections. Here we considered the possibility that UPEC cells secrete factors that activate specific host cell signaling networks to facilitate the UPEC invasion of BECs. Using GFP-based reporters and Western blot analysis, we found that the representative human cystitis isolate E. coli UTI89 and its derivative UTI89FimH, which does not bind to BECs, equally activate phosphatidylinositol 4,5-bisphosphate 3-OH kinase (PI3K), Akt kinase, and mTOR complex (mTORC) 1 and 2 in BECs. We also found that conditioned medium taken from UTI89 and UTI89FimH cultures similarly activates epidermal growth factor receptor (EGFR), PI3K, Akt, and mTORC and that inhibition of EGFR and mTORC2, but not mTORC1, abrogates UTI89 invasion in vitro and in animal models of UTI. Our results reveal a key molecular mechanism of UPEC invasion and the host cells it targets, insights that may have therapeutic utility for managing the ever-increasing number of persistent and chronic UTIs.	[Kim, Wan-Ju; Shea, Allyson E.; Kim, Joon-Hyung; Daaka, Yehia] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Shea, Allyson E.] Univ Michigan, Ann Arbor, MI 48109 USA; [Kim, Joon-Hyung] Kent State Univ, Kent, OH 44240 USA	State University System of Florida; University of Florida; University of Michigan System; University of Michigan; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Daaka, Y (corresponding author), Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA.	ydaaka@ufl.edu		Shea, Allyson/0000-0003-1329-3888	University of Florida; NIAID, National Institutes of Health [R01 AI079014, T32 AI007110]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079014, T32AI007110] Funding Source: NIH RePORTER	University of Florida(University of Florida); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the University of Florida and NIAID, National Institutes of Health Grants R01 AI079014 and T32 AI007110. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson GG, 2004, TRENDS MICROBIOL, V12, P424, DOI 10.1016/j.tim.2004.07.005; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Barber AE, 2013, CLIN INFECT DIS, V57, P719, DOI 10.1093/cid/cit284; Black JB, 2016, SEMIN CELL DEV BIOL, V50, P95, DOI 10.1016/j.semcdb.2015.12.015; Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10; Chang JD, 2004, J BIOL CHEM, V279, P11672, DOI 10.1074/jbc.M309721200; Cohen LJ, 2017, NATURE, V549, P48, DOI 10.1038/nature23874; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Daaka Y., 2004, SCI STKE, V2004, pre2, DOI [10.1126/stke.2162004re2, DOI 10.1126/STKE.2162004RE2]; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Duncan MJ, 2004, J BIOL CHEM, V279, P18944, DOI 10.1074/jbc.M400769200; Eto DS, 2008, CELL MICROBIOL, V10, P2553, DOI 10.1111/j.1462-5822.2008.01229.x; Eto DS, 2006, CELL MICROBIOL, V8, P704, DOI 10.1111/j.1462-5822.2006.00691.x; Foxman B, 2002, AM J MED, V113, p5S; Foxman B, 2014, INFECT DIS CLIN N AM, V28, P1, DOI 10.1016/j.idc.2013.09.003; Freed DM, 2017, CELL, V171, P683, DOI 10.1016/j.cell.2017.09.017; GALAN JE, 1992, NATURE, V357, P588, DOI 10.1038/357588a0; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Gilbert NM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006238; HAGBERG L, 1981, INFECT IMMUN, V31, P564, DOI 10.1128/IAI.31.2.564-570.1981; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; Li QA, 2010, MED MICROBIOL IMMUN, V199, P333, DOI 10.1007/s00430-010-0168-8; Liu PD, 2015, CANCER DISCOV, V5, P1194, DOI 10.1158/2159-8290.CD-15-0460; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Miao YX, 2017, CELL HOST MICROBE, V22, P330, DOI 10.1016/j.chom.2017.08.002; Miao YX, 2016, IMMUNITY, V45, P94, DOI 10.1016/j.immuni.2016.06.023; Mulvey MA, 2002, CELL MICROBIOL, V4, P257, DOI 10.1046/j.1462-5822.2002.00193.x; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Oshiumi H, 2015, CELL REP, V11, P1193, DOI 10.1016/j.celrep.2015.04.047; Paczkowski JE, 2015, TRENDS CELL BIOL, V25, P408, DOI 10.1016/j.tcb.2015.02.005; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Pho MT, 2000, J VIROL, V74, P2288, DOI 10.1128/JVI.74.5.2288-2292.2000; Reis CR, 2015, EMBO J, V34, P2132, DOI 10.15252/embj.201591518; Roxas JL, 2014, AM J PHYSIOL-GASTR L, V307, pG374, DOI 10.1152/ajpgi.00312.2013; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Shin JS, 2000, SCIENCE, V289, P785, DOI 10.1126/science.289.5480.785; Slanina H, 2014, INFECT IMMUN, V82, P1243, DOI 10.1128/IAI.01346-13; Totsika M, 2012, CURR DRUG TARGETS, V13, P1386, DOI 10.2174/138945012803530206; Wang GF, 2006, P NATL ACAD SCI USA, V103, P1295, DOI 10.1073/pnas.0508354103; Wang ZM, 2012, J GEN VIROL, V93, P2109, DOI 10.1099/vir.0.042713-0; Wang ZM, 2011, J CELL BIOL, V192, P101, DOI 10.1083/jcb.201003027; Wu XR, 1996, P NATL ACAD SCI USA, V93, P9630, DOI 10.1073/pnas.93.18.9630; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Zhu WD, 2012, P NATL ACAD SCI USA, V109, P14194, DOI 10.1073/pnas.1117676109; Zowawi HM, 2015, NAT REV UROL, V12, P570, DOI 10.1038/nrurol.2015.199	45	5	9	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16518	16527		10.1074/jbc.RA118.003499	http://dx.doi.org/10.1074/jbc.RA118.003499			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30166343	Green Published, hybrid			2022-12-28	WOS:000447833600032
J	Obermann, WMJ				Obermann, Wolfgang M. J.			A motif in HSP90 and P23 that links molecular chaperones to efficient estrogen receptor alpha methylation by the lysine methyltransferase SMYD2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular chaperone; heat shock protein 90 (HSP90); estrogen receptor; protein methylation; protein folding; post-translational modification (PTM); gel filtration chromatography; P23; SMYD2; gel filtration chromatography	LIGAND-BINDING; MIDDLE DOMAIN; ATP BINDING; PROTEIN; CONTRIBUTES; ACTIVATION; COMPLEX; TARGET	Heat shock protein 90 (HSP90) is a molecular chaperone that supervises folding of cellular signaling proteins such as steroid receptors and many protein kinases. HSP90 relies on ATP hydrolysis for powering a conformational circuit that helps fold the client protein. To that end, HSP90 binds to co-chaperone proteins that regulate ATP hydrolysis rate or interaction with client proteins. Co-chaperones such as P23, cell division cycle 37 (CDC37), or activator of HSP90 ATPase activity 1 (AHA1) interact with the N-terminal or middle domain of HSP90, whereas others, such as HSP70/HSP90-organizing protein (HOP), use tetratricopeptide repeat (TPR) domains to bind the EEVD motif at the very C-terminal end of HSP90. Recently, the lysine methyltransferase SET and MYND domain-containing 2 (SMYD2) has been proposed as an HSP90-binding partner, and interaction analyses indicate that SMYD2 binding to HSP90 is independent of the EEVD motif. Using the amplified luminescence proximity homogeneous assay (Alpha) technique, I identified a new (M/I/L/V)PXL motif at the C termini of HSP90 and P23 that mediates an interaction with SMYD2, and synthetic peptides harboring this motif dissociated this complex. Of note, the HSP90- and P23-dependent client estrogen receptor (ER), was a major methylation target of SMYD2. In a reconstituted system in bacteria, I analyzed HSP90/P23-associated, SMYD2-mediated ER methylation and found that when SMYD2 binds to the molecular chaperones, it considerably increases methylation of Lys-266 in ER. Because methylation represses ER activity, the observed complex formation between SMYD2 and HSP90/P23 may contribute to ER regulation.	[Obermann, Wolfgang M. J.] Ruhr Univ Bochum, Dept Syst Physiol, Univ Str 150, D-44801 Bochum, Germany	Ruhr University Bochum	Obermann, WMJ (corresponding author), Ruhr Univ Bochum, Dept Syst Physiol, Univ Str 150, D-44801 Bochum, Germany.	Wolfgang.Obermann@rub.de	Obermann, Wolfgang/AAN-3896-2020		Mukoviszidose Institut gGmbH (Bonn, Germany) [S03/10]; research and development arm of the German Cystic Fibrosis Association Mukoviszidose e.V.; Ruhr-University Bochum FoRUM Grant [F829]	Mukoviszidose Institut gGmbH (Bonn, Germany); research and development arm of the German Cystic Fibrosis Association Mukoviszidose e.V.; Ruhr-University Bochum FoRUM Grant	This work was supported in part by Mukoviszidose Institut gGmbH (Bonn, Germany) Grant S03/10, the research and development arm of the German Cystic Fibrosis Association Mukoviszidose e.V. (to W. O.), and in part by Ruhr-University Bochum FoRUM Grant F829 (to W. O.). The author declares that he has no conflicts of interest with the contents of this article.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Abu-Farha M, 2011, J MOL CELL BIOL, V3, P301, DOI 10.1093/jmcb/mjr025; Aumais JP, 1997, J BIOL CHEM, V272, P12229, DOI 10.1074/jbc.272.18.12229; Bennesch MA, 2016, NUCLEIC ACIDS RES, V44, P8655, DOI 10.1093/nar/gkw522; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Dhamad AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160312; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Ferguson AD, 2011, STRUCTURE, V19, P1262, DOI 10.1016/j.str.2011.06.011; Fliss AE, 2000, J STEROID BIOCHEM, V72, P223, DOI 10.1016/S0960-0760(00)00037-6; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Ihrig V, 2017, SLAS DISCOV, V22, P923, DOI 10.1177/2472555216688312; Jiang YY, 2014, J MOL BIOL, V426, P3413, DOI 10.1016/j.jmb.2014.02.019; Jiang YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021640; Knoblauch R, 1999, MOL CELL BIOL, V19, P3748; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Nguyen H, 2015, J BIOL CHEM, V290, P13641, DOI 10.1074/jbc.M114.626861; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pratt WB, 2015, ANNU REV PHARMACOL, V55, P353, DOI 10.1146/annurev-pharmtox-010814-124332; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Tripathi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071856; Wang L, 2011, J BIOL CHEM, V286, P38725, DOI 10.1074/jbc.M111.262410; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wu SC, 2009, MOL ENDOCRINOL, V23, P1323, DOI 10.1210/me.2009-0131; Zhang X, 2013, P NATL ACAD SCI USA, V110, P17284, DOI 10.1073/pnas.1307959110	32	15	16	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16479	16487		10.1074/jbc.RA118.003578	http://dx.doi.org/10.1074/jbc.RA118.003578			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30190324	Green Published, hybrid			2022-12-28	WOS:000447833600029
J	Dang, AK; Chaplin, NL; Murtazina, DA; Boehm, U; Clay, CM; Amberg, GC				Dang, An K.; Chaplin, Nathan L.; Murtazina, Dilyara A.; Boehm, Ulrich; Clay, Colin M.; Amberg, Gregory C.			Subplasmalemmal hydrogen peroxide triggers calcium influx in gonadotropes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium imaging; cell signaling; reactive oxygen species (ROS); NADPH oxidase; mitochondria	ARTERIAL SMOOTH-MUSCLE; PROTEIN-KINASE-C; POLYCYSTIC-OVARY-SYNDROME; NEUROENDOCRINE DYSFUNCTION; SIGNALING PATHWAYS; OXIDATIVE STRESS; HORMONE RECEPTOR; CHANNELS; MITOCHONDRIA; ACTIVATION	Gonadotropin-releasing hormone (GnRH) stimulation of its eponymous receptor on the surface of endocrine anterior pituitary gonadotrope cells (gonadotropes) initiates multiple signaling cascades that culminate in the secretion of luteinizing and follicle-stimulating hormones, which have critical roles in fertility and reproduction. Enhanced luteinizing hormone biosynthesis, a necessary event for ovulation, requires a signaling pathway characterized by calcium influx through L-type calcium channels and subsequent activation of the mitogen-activated protein kinase extracellular signal-regulated kinase (ERK). We previously reported that highly localized subplasmalemmal calcium microdomains produced by L-type calcium channels (calcium sparklets) play an essential part in GnRH-dependent ERK activation. Similar to calcium, reactive oxygen species (ROS) are ubiquitous intracellular signaling molecules whose subcellular localization determines their specificity. To investigate the potential influence of oxidant signaling in gonadotropes, here we examined the impact of ROS generation on L-type calcium channel function. Total internal reflection fluorescence (TIRF) microscopy revealed that GnRH induces spatially restricted sites of ROS generation in gonadotrope-derived alpha T3-1 cells. Furthermore, GnRH-dependent stimulation of L-type calcium channels required intracellular hydrogen peroxide signaling in these cells and in primary mouse gonadotropes. NADPH oxidase and mitochondrial ROS generation were each necessary for GnRH-mediated stimulation of L-type calcium channels. Congruently, GnRH increased oxidation within subplasmalemmal mitochondria, and L-type calcium channel activity correlated strongly with the presence of adjacent mitochondria. Collectively, our results provide compelling evidence that NADPH oxidase activity and mitochondria-derived hydrogen peroxide signaling play a fundamental role in GnRH-dependent stimulation of L-type calcium channels in anterior pituitary gonadotropes.	[Dang, An K.; Chaplin, Nathan L.; Murtazina, Dilyara A.; Clay, Colin M.; Amberg, Gregory C.] Colorado State Univ, Dept Biomed Sci, 1617 Campus Delivery, Ft Collins, CO 80523 USA; [Boehm, Ulrich] Saarland Univ, Dept Pharmacol & Toxicol, Ctr Mol Signaling PZMS, Sch Med, D-66421 Homburg, Germany	Colorado State University; Universitatsklinikum des Saarlandes	Amberg, GC (corresponding author), Colorado State Univ, Dept Biomed Sci, 1617 Campus Delivery, Ft Collins, CO 80523 USA.	Gregory.Amberg@colostate.edu		Amberg, Gregory/0000-0001-6094-1185	National Institute of Health [R01HD087347, R01HL111060, R01HD065943, F31HD078090]; Deutsche Forschungsgemeinschaft Grant [SFB894]; Colorado State University College Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065943, R01HD087347, F31HD078090] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111060] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); Colorado State University College Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health Grants R01HD087347 and R01HL111060 (to G.C.A.), R01HD065943 (to C.M.C.), and F31HD078090 (to A.K.D.); Deutsche Forschungsgemeinschaft Grant SFB894 (to U.B.); and the Colorado State University College Research Council (to G.C.A. and C.M.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Addabbo F, 2009, HYPERTENSION, V53, P885, DOI 10.1161/HYPERTENSIONAHA.109.130054; Altenhofer S, 2015, ANTIOXID REDOX SIGN, V23, P406, DOI 10.1089/ars.2013.5814; Amberg GC, 2007, J PHYSIOL-LONDON, V579, P187, DOI 10.1113/jphysiol.2006.124420; Amberg GC, 2010, CIRC RES, V107, P1002, DOI 10.1161/CIRCRESAHA.110.217018; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Chaplin NL, 2015, CIRC RES, V117, P1013, DOI 10.1161/CIRCRESAHA.115.306996; Chaplin NL, 2012, AM J PHYSIOL-CELL PH, V302, pC1382, DOI 10.1152/ajpcell.00222.2011; Chatzaki E, 1996, CANCER RES, V56, P2059; Dang AK, 2014, MOL ENDOCRINOL, V28, P2049, DOI 10.1210/me.2014-1208; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Dikalov SI, 2013, AM J PHYSIOL-HEART C, V305, pH1417, DOI 10.1152/ajpheart.00089.2013; Dikalov SI, 2013, ANTIOXID REDOX SIGN, V19, P1085, DOI 10.1089/ars.2012.4604; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Edwards BS, 2016, ENDOCRINOLOGY, V157, P831, DOI 10.1210/en.2015-1575; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Gianni D, 2010, ACS CHEM BIOL, V5, P981, DOI 10.1021/cb100219n; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Gopalakrishna R, 2008, J BIOL CHEM, V283, P14430, DOI 10.1074/jbc.M801519200; Grosse R, 2000, J BIOL CHEM, V275, P9193, DOI 10.1074/jbc.275.13.9193; HORN F, 1991, MOL ENDOCRINOL, V5, P347, DOI 10.1210/mend-5-3-347; Imai A, 1998, J CLIN ENDOCR METAB, V83, P427, DOI 10.1210/jc.83.2.427; Kim T, 2015, ENDOCRINOLOGY, V156, P2185, DOI 10.1210/en.2014-1709; Knapp LT, 2002, J NEUROSCI, V22, P674, DOI 10.1523/JNEUROSCI.22-03-00674.2002; Knapp LT, 2000, J BIOL CHEM, V275, P24136, DOI 10.1074/jbc.M002043200; Llorente-Folch I, 2015, J PHYSIOL-LONDON, V593, P3447, DOI 10.1113/JP270254; MERELLI F, 1992, ENDOCRINOLOGY, V131, P925, DOI 10.1210/en.131.2.925; Mulvaney JM, 1999, J BIOL CHEM, V274, P29796, DOI 10.1074/jbc.274.42.29796; Mulvaney JM, 2000, J BIOL CHEM, V275, P14182, DOI 10.1074/jbc.275.19.14182; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Navedo MF, 2006, J GEN PHYSIOL, V127, P611, DOI 10.1085/jgp.200609519; Navedo MF, 2005, P NATL ACAD SCI USA, V102, P11112, DOI 10.1073/pnas.0500360102; Nickel A, 2014, J MOL CELL CARDIOL, V73, P26, DOI 10.1016/j.yjmcc.2014.03.011; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Roelfsema F, 2011, METABOLISM, V60, P1227, DOI 10.1016/j.metabol.2010.12.011; Roland AV, 2014, FRONT NEUROENDOCRIN, V35, P494, DOI 10.1016/j.yfrne.2014.04.002; Santo-Domingo Jaime, 2015, World J Biol Chem, V6, P310, DOI 10.4331/wjbc.v6.i4.310; Schroder E, 2008, CURR OPIN PHARMACOL, V8, P153, DOI 10.1016/j.coph.2007.12.012; Solorzano CMB, 2012, STEROIDS, V77, P332, DOI 10.1016/j.steroids.2011.12.007; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; von Minckwitz G, 1998, BIOMED PHARMACOTHER, V52, P122, DOI 10.1016/S0753-3322(98)80090-5; Wen S, 2008, ENDOCRINOLOGY, V149, P2701, DOI 10.1210/en.2007-1502; WINDLE JJ, 1990, MOL ENDOCRINOL, V4, P597, DOI 10.1210/mend-4-4-597; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	43	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16028	16042		10.1074/jbc.RA118.001830	http://dx.doi.org/10.1074/jbc.RA118.001830			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30154243	hybrid, Green Published			2022-12-28	WOS:000447256000023
J	Cai, XL; Zhang, DW; Wang, J; Liu, X; Ouyang, G; Xiao, WH				Cai, Xiaolian; Zhang, Dawei; Wang, Jing; Liu, Xing; Ouyang, Gang; Xiao, Wuhan			Deletion of the fih gene encoding an inhibitor of hypoxia-inducible factors increases hypoxia tolerance in zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypoxia; development; hydroxylase; zebrafish; stress tolerance; fih; hif-1a; hif-1b; hif-2a; hif-2b; factor inhibiting HIF	HIGH-ALTITUDE ADAPTATION; FACTOR 3A FOXO3A; TRANSCRIPTIONAL ACTIVITY; SIGNALING PATHWAY; INDUCED AUTOPHAGY; CELL-DEATH; BECLIN 1; HYDROXYLASE; PHYSIOLOGY; FISHES	Many aerobic organisms have developed molecular mechanism to tolerate hypoxia, but the specifics of these mechanisms remain poorly understood. It is important to develop genetic methods that confer increased hypoxia tolerance to intensively farmed aquatic species, as these are maintained in environments with limited available oxygen. As an asparaginyl hydroxylase of hypoxia-inducible factors (HIFs), factor inhibiting HIF (FIH) inhibits transcriptional activation of hypoxia-inducible genes by blocking the association of HIFs with the transcriptional coactivators CREB-binding protein (CBP) and p300. Therefore, here we sought to test whether fih is involved in regulating hypoxia tolerance in the commonly used zebrafish model. Overexpressing the zebrafish fih gene in epithelioma papulosum cyprini (EPC) cells and embryos, we found that fih inhibits the transcriptional activation of zebrafish HIF- proteins. Using CRISPR/Cas9 to obtain fih-null zebrafish mutants, we noted that the fih deletion makes zebrafish more tolerant of hypoxic conditions than their WT siblings, but does not result in oxygen consumption rates that significantly differ from those of WT fish. Of note, we identified fewer apoptotic cells in adult fih-null zebrafish brains and in fih-null embryos, possibly explaining why the fih-null mutant had greater hypoxia tolerance than the WT. Moreover, the fih deletion up-regulated several hypoxia-inducible genes in fih-null zebrafish exposed to hypoxia. The findings of our study suggest that fih plays a role in hypoxia tolerance by affecting the rate of cellular apoptosis in zebrafish.	[Cai, Xiaolian; Zhang, Dawei; Wang, Jing; Liu, Xing; Ouyang, Gang; Xiao, Wuhan] Chinese Acad Sci, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Hubei, Peoples R China; [Xiao, Wuhan] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan 430072, Hubei, Peoples R China; [Xiao, Wuhan] Minist Agr, Key Lab Aquaculture Dis Control, Wuhan 430072, Hubei, Peoples R China; [Cai, Xiaolian; Xiao, Wuhan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Hubei, Peoples R China.	w-xiao@ihb.ac.cn	Xiao, Wuhan/GLU-7352-2022	cai, xiaolian/0000-0002-6084-1245	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA08010208]; NSFC [31830101, 91631102, 31671315, 31721005]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC))	Supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant XDA08010208) and NSFC Grants 31830101, 91631102, 31671315, and 31721005.	Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bigham AW, 2016, CURR OPIN GENET DEV, V41, P8, DOI 10.1016/j.gde.2016.06.018; Bigham AW, 2014, GENE DEV, V28, P2189, DOI 10.1101/gad.250167.114; Bishop T, 2015, CIRC RES, V117, P65, DOI 10.1161/CIRCRESAHA.117.305109; Breitburg DL, 2009, ANNU REV MAR SCI, V1, P329, DOI 10.1146/annurev.marine.010908.163754; Chen Z, 2014, MOL CELL BIOL, V34, P1085, DOI 10.1128/MCB.00718-13; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Eames SC, 2010, ZEBRAFISH, V7, P205, DOI 10.1089/zeb.2009.0640; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Feng X, 2011, EMBO J, V30, P3397, DOI 10.1038/emboj.2011.248; Fernandez AF, 2018, NATURE, V558, P136, DOI 10.1038/s41586-018-0162-7; Foster WG, 2018, BIOL REPROD, V99, P905, DOI 10.1093/biolre/ioy137; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; Hartman-Ksycinska Anna, 2016, Przegl Epidemiol, V70, P490; Hu H, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006675; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Ivan M, 2017, MOL CELL, V66, P772, DOI 10.1016/j.molcel.2017.06.002; Jing XG, 2018, EXP CELL RES, V368, P174, DOI 10.1016/j.yexcr.2018.04.026; Karttunen S, 2015, J CELL SCI, V128, P225, DOI 10.1242/jcs.158451; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lefevre S, 2014, J FISH BIOL, V84, P705, DOI 10.1111/jfb.12302; Liu X, 2016, J BIOL CHEM, V291, P25692, DOI 10.1074/jbc.M116.745471; Liu X, 2015, J BIOL CHEM, V290, P25933, DOI 10.1074/jbc.M115.663542; Lorenzo FR, 2014, NAT GENET, V46, P951, DOI 10.1038/ng.3067; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Masson N, 2012, EMBO REP, V13, P251, DOI 10.1038/embor.2012.9; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; Prabhakar NR, 2016, PFLUG ARCH EUR J PHY, V468, P71, DOI 10.1007/s00424-015-1719-z; Prabhakar NR, 2015, PHYSIOLOGY, V30, P340, DOI 10.1152/physiol.00022.2015; Pugh CW, 2017, EXP CELL RES, V356, P116, DOI 10.1016/j.yexcr.2017.03.008; Rojas DA, 2007, GENE EXPR PATTERNS, V7, P339, DOI 10.1016/j.modgep.2006.08.002; Scholz CC, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002347; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sowter HM, 2001, CANCER RES, V61, P6669; Tan XM, 2018, CELL TRANSPLANT, V27, P1753, DOI 10.1177/0963689718760486; Tashi T, 2017, J MOL MED, V95, P665, DOI 10.1007/s00109-017-1519-3; Wang J, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx869; Wirawan E, 2012, AUTOPHAGY, V8, P6, DOI 10.4161/auto.8.1.16645; Wu HW, 2015, MOL MED REP, V12, P6467, DOI 10.3892/mmr.2015.4255; Xia SX, 2015, REPROD SCI, V22, P156, DOI 10.1177/1933719114536474; Xiao WH, 2015, SCI CHINA LIFE SCI, V58, P148, DOI 10.1007/s11427-015-4801-z; Zhang E, 2015, CELL PHYSIOL BIOCHEM, V37, P1442, DOI 10.1159/000438513; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001	46	14	16	5	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15370	15380		10.1074/jbc.RA118.003004	http://dx.doi.org/10.1074/jbc.RA118.003004			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30126845	hybrid, Green Published			2022-12-28	WOS:000446549200004
J	Estrellas, KM; Chung, L; Cheug, LA; Sadtler, K; Majumdar, S; Mula, J; Wolf, MT; Elisseeff, JH; Wagner, KR				Estrellas, Kenneth M.; Chung, Liam; Cheug, Lindsay A.; Sadtler, Kaitlyn; Majumdar, Shoumyo; Mula, Jyothi; Wolf, Matthew T.; Elisseeff, Jennifer H.; Wagner, Kathryn R.			Biological scaffold-mediated delivery of myostatin inhibitor promotes a regenerative immune response in an animal model of Duchenne muscular dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						muscle; muscle regeneration; muscular dystrophy; immunology; cytokine; biomaterials; myostatin; mdx; myostatin; extracellular matrix; bioengineering; hydrogel; dystrophin; drug delivery; stem cells	SKELETAL-MUSCLE MASS; HYALURONIC-ACID; CELLS; FIBROSIS; MYOBLASTS; MICE; HYPERTROPHY; ENGRAFTMENT; STRATEGIES; HYDROGELS	Recent studies have reported that the immune system significantly mediates skeletal muscle repair and regeneration. Additionally, biological scaffolds have been shown to play a role in polarizing the immune microenvironment toward pro-myogenic outcomes. Moreover, myostatin inhibitors are known to promote muscle regeneration and ameliorate fibrosis in animal models of Duchenne muscular dystrophy (DMD), a human disease characterized by chronic muscle degeneration. Biological scaffolds and myostatin inhibition can potentially influence immune-mediated regeneration in the dystrophic environment, but have not been evaluated together. Toward this end, here we created an injectable biological scaffold composed of hyaluronic acid and processed skeletal muscle extracellular matrix. This material formed a cytocompatible hydrogel at physiological temperatures in vitro. When injected subfascially above the tibialis anterior muscles of both WT and dystrophic mdx-5(Cv) mice, a murine model of DMD, the hydrogel spreads across the entire muscle before completely degrading at 3 weeks in vivo. We found that the hydrogel is associated with CD206(+) pro-regenerative macrophage polarization and elevated anti-inflammatory cytokine expression in both WT and dystrophic mice. Co-injection of both hydrogel and myostatin inhibitor significantly increased FoxP3(+) regulatory T cell modulation and Foxp3 gene expression in the scaffold immune microenvironment. Finally, delivery of myostatin inhibitor with the hydrogel increased its bioactivity in vivo, and transplantation of immortalized human myoblasts with the hydrogel promoted their survival in vivo. This study identifies a key role for biological scaffolds and myostatin inhibitors in modulating a pro-regenerative immune microenvironment in dystrophic muscle.	[Estrellas, Kenneth M.; Wagner, Kathryn R.] Kennedy Krieger, Hugo W Moser Res Inst, Baltimore, MD 21205 USA; [Estrellas, Kenneth M.; Chung, Liam; Wolf, Matthew T.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Sch Med, Translat Tissue Engn Ctr, 400 N Broadway Rm 5031, Baltimore, MD 21231 USA; [Chung, Liam; Wolf, Matthew T.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Sch Med, Bloomberg Kimmel Inst Canc Immunotherapy, 400 N Broadway Rm 5031, Baltimore, MD 21231 USA; [Cheug, Lindsay A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Sadtler, Kaitlyn] MIT, Dept Chem Engn, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Sadtler, Kaitlyn] Boston Childrens Hosp, Dept Anesthesiol, Boston, MA 02115 USA; [Majumdar, Shoumyo] Otomagnetics LLC, Rockville, MD 20852 USA; [Mula, Jyothi] NCI Frederick, NIH, Frederick, MD 21702 USA; [Wagner, Kathryn R.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Wagner, Kathryn R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Northwestern University; Feinberg School of Medicine; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Johns Hopkins University; Johns Hopkins University	Elisseeff, JH (corresponding author), Johns Hopkins Univ, Sch Med, Translat Tissue Engn Ctr, 400 N Broadway Rm 5031, Baltimore, MD 21231 USA.; Wagner, KR (corresponding author), Kennedy Krieger Inst, Ctr Genet Muscle Disorders, 707 N Broadway Rm 406, Baltimore, MD 21205 USA.	jhe@jhu.edu; wagnerk@kennedykrieger.org	Elisseeff, Jennifer/A-3324-2010	Elisseeff, Jennifer/0000-0002-5066-1996; Estrellas, Kenneth/0000-0003-0413-6258; Wolf, Matthew/0000-0002-0328-2475	Maryland Stem Cell Research Foundation; Team Saij	Maryland Stem Cell Research Foundation; Team Saij	This work was supported by the Maryland Stem Cell Research Foundation and Team Saij. The authors declare that they have no conflicts of interest with the contents of this article.	Acharyya S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012479; Beastrom N, 2011, AM J PATHOL, V179, P2464, DOI 10.1016/j.ajpath.2011.07.009; Bhattacharya I, 2018, CLIN PHARM DRUG DEV, V7, P484, DOI 10.1002/cpdd.386; Bhattacharya I, 2018, J CLIN PHARMACOL, V58, P314, DOI 10.1002/jcph.1015; Borselli C, 2011, BIOMATERIALS, V32, P8905, DOI 10.1016/j.biomaterials.2011.08.019; Bursac N, 2015, ANNU REV BIOMED ENG, V17, P217, DOI 10.1146/annurev-bioeng-071114-040640; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Calve S, 2012, AM J PHYSIOL-CELL PH, V303, pC577, DOI 10.1152/ajpcell.00057.2012; Campbell C, 2017, MUSCLE NERVE, V55, P458, DOI 10.1002/mus.25268; Cezar CA, 2015, ADV DRUG DELIVER REV, V84, P188, DOI 10.1016/j.addr.2014.09.008; Chang CY, 2012, BIOMATERIALS, V33, P8026, DOI 10.1016/j.biomaterials.2012.07.058; Dankbar B, 2015, NAT MED, V21, P1085, DOI 10.1038/nm.3917; Dziki JL, 2016, TISSUE ENG PT A, V22, P1129, DOI 10.1089/ten.tea.2016.0340; Fuoco C, 2015, EMBO MOL MED, V7, P411, DOI 10.15252/emmm.201404062; Gaetani R, 2016, CELL TRANSPLANT, V25, P1653, DOI 10.3727/096368915X689794; Gerard C, 2012, CELL TRANSPLANT, V21, P127, DOI 10.3727/096368911X576018; Griggs RC, 2016, NEUROLOGY, V87, P2123, DOI 10.1212/WNL.0000000000003217; Hardy D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147198; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Holzbaur ELF, 2006, NEUROBIOL DIS, V23, P697, DOI 10.1016/j.nbd.2006.05.009; Kabra H, 2015, ACS BIOMATER SCI ENG, V1, P7, DOI 10.1021/ab500021a; Larkindale J, 2014, MUSCLE NERVE, V49, P431, DOI 10.1002/mus.23942; Lee SJ, 1999, CURR OPIN GENET DEV, V9, P604, DOI 10.1016/S0959-437X(99)00004-0; Li ZB, 2012, J CELL SCI, V125, P3957, DOI 10.1242/jcs.090365; Li ZB, 2008, J BIOL CHEM, V283, P19371, DOI 10.1074/jbc.M802585200; Londhe P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004633; Londhe P, 2011, MOL CELL BIOL, V31, P2854, DOI 10.1128/MCB.05397-11; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Misra S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00201; Moyer AL, 2011, CURR OPIN RHEUMATOL, V23, P568, DOI 10.1097/BOR.0b013e32834bac92; Muir LA, 2016, STEM CELLS DEV, V25, P1559, DOI 10.1089/scd.2016.0136; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Rosenberg AS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7322; Sadtler K, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.40; Sadtler K, 2016, SCIENCE, V352, P366, DOI 10.1126/science.aad9272; Sahenk Z, 2011, CURR RHEUMATOL REP, V13, P199, DOI 10.1007/s11926-011-0178-6; Schiaffino S, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0046-6; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Serrano AL, 2017, SEMIN CELL DEV BIOL, V64, P181, DOI 10.1016/j.semcdb.2016.09.013; Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085; St Andre Michael, 2017, Skelet Muscle, V7, P25, DOI 10.1186/s13395-017-0141-y; Sun Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021073; Thies RS, 2001, GROWTH FACTORS, V18, P251; Tidball JG, 2017, NAT REV IMMUNOL, V17, P165, DOI 10.1038/nri.2016.150; Villalta SA, 2015, RARE DIS, V3, DOI 10.1080/21675511.2015.1010966; Villalta SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009925; Villalta SA, 2011, J IMMUNOL, V187, P5419, DOI 10.4049/jimmunol.1101267; Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338; Wang RT, 2014, PLOS CURR, V6, P1, DOI [DOI 10.1371/CURRENTS.MD.E1E8F2BE7C94, DOI 10.1371/CURRENTS.MD.E1E8F2BE7C949F9FFE81EC6FCA1CCE6A]; Wolf MT, 2015, ADV DRUG DELIVER REV, V84, P208, DOI 10.1016/j.addr.2014.08.011; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x; Zuidema JM, 2014, J BIOMED MATER RES B, V102, P1063, DOI 10.1002/jbm.b.33088	54	13	13	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15594	15605		10.1074/jbc.RA118.004417	http://dx.doi.org/10.1074/jbc.RA118.004417			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30139748	Green Published, hybrid			2022-12-28	WOS:000446549200023
J	Rodionova, IA; Goodacre, N; Do, J; Hosseinnia, A; Babu, M; Uetz, P; Saier, MH				Rodionova, Irina A.; Goodacre, Norman; Do, Jimmy; Hosseinnia, Ali; Babu, Mohan; Uetz, Peter; Saier, Milton H., Jr.			The uridylyltransferase GlnD and tRNA modification GTPase MnmE allosterically control Escherichia coli folylpoly--glutamate synthase FolC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						folate; enzyme kinetics; GTPase; gram-negative bacteria; metabolism; allosteric regulation; cytoplasmic GTP; FolC; G-protein MnmE; tetrahydrofolate polyglutamylation; GlnD; Ugd; MnmE; folate metabolism; amino acid sensing	TRANSPORTER CLASSIFICATION DATABASE; ESSENTIAL GENES; CASCADE CONTROL; PROTEIN; RESISTANCE; SYNTHETASE; SYSTEM; ACID; METABOLISM; REGULATOR	Folate derivatives are important cofactors for enzymes in several metabolic processes. Folate-related inhibition and resistance mechanisms in bacteria are potential targets for antimicrobial therapies and therefore a significant focus of current research. Here, we report that the activity of Escherichia coli poly--glutamyl tetrahydrofolate/dihydrofolate synthase (FolC) is regulated by glutamate/glutamine-sensing uridylyltransferase (GlnD), THF-dependent tRNA modification enzyme (MnmE), and UDP-glucose dehydrogenase (Ugd) as shown by direct in vitro protein-protein interactions. Using kinetics analyses, we observed that GlnD, Ugd, and MnmE activate FolC many-fold by decreasing the K-half of FolC for its substrate l-glutamate. Moreover, FolC inhibited the GTPase activity of MnmE at low GTP concentrations. The growth phenotypes associated with these proteins are discussed. These results, obtained using direct in vitro enzyme assays, reveal unanticipated networks of allosteric regulatory interactions in the folate pathway in E. coli and indicate regulation of polyglutamylated tetrahydrofolate biosynthesis by the availability of nitrogen sources, signaled by the glutamine-sensing GlnD protein.	[Rodionova, Irina A.; Do, Jimmy; Saier, Milton H., Jr.] Univ Calif San Diego, Div Biol Sci, Dept Mol Biol, La Jolla, CA 92093 USA; [Goodacre, Norman; Uetz, Peter] Virginia Commonwealth Univ, Ctr Study Biol Complex, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Hosseinnia, Ali; Babu, Mohan] Univ Regina, Dept Biochem, Regina, SK S4S 0A2, Canada	University of California System; University of California San Diego; Virginia Commonwealth University; University of Regina	Rodionova, IA; Saier, MH (corresponding author), Univ Calif San Diego, Div Biol Sci, Dept Mol Biol, La Jolla, CA 92093 USA.	irodionova@ucsd.edu; msaier@ucsd.edu	Mohan, Babu P./I-7362-2019; Uetz, Peter/A-7119-2012	Uetz, Peter/0000-0001-6194-4927; Saier, Milton/0000-0001-5530-0017; Goodacre, Norman/0000-0003-4995-2822	National Institutes of Health [R01 GM109895]; Natural Sciences and Engineering Research Council of Canada [DG-20234]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM109895 (to M. S. and P. U.) and Natural Sciences and Engineering Research Council of Canada Grant DG-20234 (to M. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Armengod ME, 2012, BIOCHIMIE, V94, P1510, DOI 10.1016/j.biochi.2012.02.019; Austin MU, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-46; Babu M, 2018, NAT BIOTECHNOL, V36, P103, DOI 10.1038/nbt.4024; Babu M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002377; Babu M, 2011, METHODS MOL BIOL, V781, P99, DOI 10.1007/978-1-61779-276-2_7; Bailey LB, 1999, J NUTR, V129, P779, DOI 10.1093/jn/129.4.779; Bailey SW, 2009, P NATL ACAD SCI USA, V106, P15424, DOI 10.1073/pnas.0902072106; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Chen HD, 2013, ANNU REV MICROBIOL, V67, P83, DOI 10.1146/annurev-micro-092412-155751; de Crecy-Lagard V, 2014, COMPUT STRUCT BIOTEC, V10, P41, DOI 10.1016/j.csbj.2014.05.008; de Vries SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017695; Deng ZQ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00194; Fislage M, 2016, BIOPOLYMERS, V105, P568, DOI 10.1002/bip.22813; Forchhammer K, 2016, FEBS J, V283, P425, DOI 10.1111/febs.13584; FRANCIS SH, 1978, ARCH BIOCHEM BIOPHYS, V191, P590, DOI 10.1016/0003-9861(78)90397-1; Gerdes S, 2006, CURR OPIN BIOTECH, V17, P448, DOI 10.1016/j.copbio.2006.08.006; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Green Jacalyn M, 2007, EcoSal Plus, V2, DOI 10.1128/ecosalplus.3.6.3.6; Groisman EA, 1997, J BACTERIOL, V179, P7040, DOI 10.1128/jb.179.22.7040-7045.1997; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lacour S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003053; Lawson CD, 2018, J CELL BIOL, V217, P447, DOI 10.1083/jcb.201612069; Mathieu M, 2005, J BIOL CHEM, V280, P18916, DOI 10.1074/jbc.M413799200; Moon KH, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00778-17; Mouslim C, 2003, J BIOL CHEM, V278, P50588, DOI 10.1074/jbc.M309433200; Nilsson K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175092; Patel TS, 2017, EUR J MED CHEM, V129, P251, DOI 10.1016/j.ejmech.2017.02.012; Podnecky NL, 2017, MBIO, V8, DOI [10.1128/mBio.01357-17, 10.1128/mbio.01357-17]; Prado S, 2013, NUCLEIC ACIDS RES, V41, P6190, DOI 10.1093/nar/gkt320; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Rodionova IA, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00691-17; Rodionova IA, 2017, J BIOL CHEM, V292, P14250, DOI 10.1074/jbc.M117.795294; Rodionova IA, 2015, ENV MICROBIOL REP, V7, P204, DOI 10.1111/1758-2229.12227; Rodionova IA, 2012, J BACTERIOL, V194, P5552, DOI 10.1128/JB.01136-12; Rubin EJ, 2015, ANTIMICROB AGENTS CH, V59, P2051, DOI 10.1128/AAC.05052-14; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Saier MH, 2016, NUCLEIC ACIDS RES, V44, pD372, DOI 10.1093/nar/gkv1103; Sayed AK, 2009, MOL MICROBIOL, V71, P1435, DOI 10.1111/j.1365-2958.2009.06614.x; SHANE B, 1989, VITAM HORM, V45, P263; Sheng Y, 2008, BIOCHEMISTRY-US, V47, P2388, DOI 10.1021/bi701670y; Shippy DC, 2014, INT J MOL SCI, V15, P18267, DOI 10.3390/ijms151018267; SON HS, 1987, J BIOL CHEM, V262, P8690; Soncini FC, 1996, J BACTERIOL, V178, P5092, DOI 10.1128/jb.178.17.5092-5099.1996; Sun XL, 2001, J MOL BIOL, V310, P1067, DOI 10.1006/jmbi.2001.4815; SUTHERLAND IW, 1969, BIOCHEM J, V115, P935, DOI 10.1042/bj1150935; Thakkar SS, 2017, BIOORGAN MED CHEM, V25, P5396, DOI 10.1016/j.bmc.2017.07.057; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wosten MMSM, 2000, CELL, V103, P113, DOI 10.1016/S0092-8674(00)00092-1; Zhang YP, 2010, J BACTERIOL, V192, P2711, DOI 10.1128/JB.01674-09; Zhao F, 2014, ANTIMICROB AGENTS CH, V58, P1479, DOI 10.1128/AAC.01775-13; Zhao Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8661	51	5	5	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15725	15732		10.1074/jbc.RA118.004425	http://dx.doi.org/10.1074/jbc.RA118.004425			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30089654	hybrid, Green Published			2022-12-28	WOS:000446549200034
J	Zou, Y; Uddin, MM; Padmanabhan, S; Zhu, Y; Bu, PL; Vancura, A; Vancurova, I				Zou, Yue; Uddin, Mohammad M.; Padmanabhan, Sveta; Zhu, Yan; Bu, Pengli; Vancura, Ales; Vancurova, Ivana			The proto-oncogene Bcl3 induces immune checkpoint PD-L1 expression, mediating proliferation of ovarian cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oncogene; transcription regulation; ovarian cancer; immunology; interferon; Bcl3; PD-L1	NF-KAPPA-B; CHRONIC LYMPHOCYTIC-LEUKEMIA; ANAPLASTIC LARGE-CELL; ONCOPROTEIN BCL-3; TUMOR MICROENVIRONMENT; NEGATIVE REGULATION; CLASSICAL HODGKIN; GENE-EXPRESSION; P50 HOMODIMERS; T-LYMPHOCYTES	The proto-oncogene Bcl3 induces survival and proliferation in cancer cells; however, its function and regulation in ovarian cancer (OC) remain unknown. Here, we show that Bcl3 expression is increased in human OC tissues. Surprisingly, however, we found that in addition to promoting survival, proliferation, and migration of OC cells, Bcl3 promotes both constitutive and interferon- (IFN)-induced expression of the immune checkpoint molecule PD-L1. The Bcl3 expression in OC cells is further increased by IFN, resulting in increased PD-L1 transcription. The mechanism consists of an IFN-induced, Bcl3- and p300-dependent PD-L1 promoter occupancy by Lys-314/315 acetylated p65 NF-B. Blocking PD-L1 by neutralizing antibody reduces proliferation of OC cells overexpressing Bcl3, suggesting that the pro-proliferative effect of Bcl3 in OC cells is partly mediated by PD-L1. Together, this work identifies PD-L1 as a novel target of Bcl3, and links Bcl3 to IFN signaling and PD-L1-mediated immune escape.	[Zou, Yue; Uddin, Mohammad M.; Padmanabhan, Sveta; Zhu, Yan; Bu, Pengli; Vancura, Ales; Vancurova, Ivana] St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, New York, NY 11439 USA	Saint John's University	Vancurova, I (corresponding author), St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, New York, NY 11439 USA.	vancuroi@stjohns.edu	Bu, Pengli/J-3575-2019	Bu, Pengli/0000-0003-2576-0607; Vancura, Ales/0000-0002-5895-1218; zou, yue/0000-0002-6999-8329	National Institutes of Health [CA202775]; NATIONAL CANCER INSTITUTE [R15CA202775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA202775 (to I. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abiko K, 2015, BRIT J CANCER, V112, P1501, DOI 10.1038/bjc.2015.101; Abiko K, 2013, CLIN CANCER RES, V19, P1363, DOI 10.1158/1078-0432.CCR-12-2199; Annunziata CM, 2010, CANCER-AM CANCER SOC, V116, P3276, DOI 10.1002/cncr.25190; Azuma T, 2008, BLOOD, V111, P3635, DOI 10.1182/blood-2007-11-123141; Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Bouillez A, 2017, ONCOGENE, V36, P4037, DOI 10.1038/onc.2017.47; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Brasier AR, 2001, J BIOL CHEM, V276, P32080, DOI 10.1074/jbc.M102949200; Brenne AT, 2009, EUR J HAEMATOL, V82, P354, DOI 10.1111/j.1600-0609.2009.01225.x; Buerki C, 2008, NUCLEIC ACIDS RES, V36, P1665, DOI 10.1093/nar/gkn003; Bundy DL, 1997, J BIOL CHEM, V272, P33132, DOI 10.1074/jbc.272.52.33132; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang TP, 2014, BBA-MOL CELL RES, V1843, P2620, DOI 10.1016/j.bbamcr.2014.07.012; Chang TP, 2014, METHODS MOL BIOL, V1172, P329, DOI 10.1007/978-1-4939-0928-5_30; Chen X, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.405; Clark CA, 2016, CANCER RES, V76, P6964, DOI 10.1158/0008-5472.CAN-16-0258; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; Duraiswamy J, 2013, CANCER RES, V73, P6900, DOI 10.1158/0008-5472.CAN-13-1550; FRANZOSO G, 1993, EMBO J, V12, P3893, DOI 10.1002/j.1460-2075.1993.tb06067.x; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Gatla HR, 2017, J BIOL CHEM, V292, P5043, DOI 10.1074/jbc.M116.771014; Ge BS, 2003, J IMMUNOL, V171, P4210, DOI 10.4049/jimmunol.171.8.4210; Gowrishankar K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123410; Guan Y, 2011, INT J CANCER, V128, P2274, DOI 10.1002/ijc.25575; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Huang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061602; Huang S, 2000, CANCER RES, V60, P5334; Juvekar A, 2011, MOL CANCER RES, V9, P183, DOI 10.1158/1541-7786.MCR-10-0368; Kashatus D, 2006, GENE DEV, V20, P225, DOI 10.1101/gad.1352206; KERR LD, 1992, GENE DEV, V6, P2352, DOI 10.1101/gad.6.12a.2352; Kim YM, 2008, J VIROL, V82, P11939, DOI 10.1128/JVI.01356-08; Lim SO, 2016, CANCER CELL, V30, P925, DOI 10.1016/j.ccell.2016.10.010; Luo S, 2015, BIOCHEM BIOPH RES CO, V462, P85, DOI 10.1016/j.bbrc.2015.04.023; Mabuchi S, 2004, J BIOL CHEM, V279, P23477, DOI 10.1074/jbc.M313709200; Maeda T, 2018, CANCER RES, V78, P205, DOI 10.1158/0008-5472.CAN-17-1636; Maine CJ, 2014, CANCER IMMUNOL IMMUN, V63, P215, DOI 10.1007/s00262-013-1503-x; Maldonado V, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-152; Martin-Subero JI, 2006, BLOOD, V108, P401, DOI 10.1182/blood-2005-09-3843; Mathas S, 2005, BLOOD, V106, P4287, DOI 10.1182/blood-2004-09-3620; MCKEITHAN TW, 1990, GENE CHROMOSOME CANC, V1, P247, DOI 10.1002/gcc.2870010310; McKeithan TW, 1997, GENE CHROMOSOME CANC, V20, P64, DOI 10.1002/(SICI)1098-2264(199709)20:1<64::AID-GCC10>3.0.CO;2-F; Na SY, 1999, J BIOL CHEM, V274, P28491, DOI 10.1074/jbc.274.40.28491; Nishikori M, 2005, CANCER SCI, V96, P487, DOI 10.1111/j.1349-7006.2005.00078.x; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; Peng J, 2015, CANCER RES, V75, P5034, DOI 10.1158/0008-5472.CAN-14-3098; Puvvada SD, 2010, ONCOLOGY-BASEL, V78, P181, DOI 10.1159/000313697; Rothgiesser KM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-22; Thornburg NJ, 2003, CANCER RES, V63, P8293; Vancurova I, 2018, TRENDS PHARMACOL SCI, V39, P295, DOI 10.1016/j.tips.2017.11.008; Viatour P, 2004, MOL CELL, V16, P35, DOI 10.1016/j.molcel.2004.09.004; Wakefield A, 2013, CANCER RES, V73, P745, DOI 10.1158/0008-5472.CAN-12-1321; Wang VYF, 2017, MOL CELL, V67, P484, DOI 10.1016/j.molcel.2017.06.011; Wang VYF, 2012, CELL REP, V2, P824, DOI 10.1016/j.celrep.2012.08.042; Welsh JB, 2001, P NATL ACAD SCI USA, V98, P1176, DOI 10.1073/pnas.98.3.1176; Westerheide SD, 2001, MOL CELL BIOL, V21, P8428, DOI 10.1128/MCB.21.24.8428-8436.2001; Wu JH, 2016, INT J ONCOL, V49, P2471, DOI 10.3892/ijo.2016.3729; WULCZYN FG, 1992, NATURE, V358, P597, DOI 10.1038/358597a0; Yang J, 2009, MOL CELL BIOL, V29, P4091, DOI 10.1128/MCB.01669-08; Zamora R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-223; ZHANG Q, 1994, MOL CELL BIOL, V14, P3915, DOI 10.1128/MCB.14.6.3915; Zhao H, 2016, ONCOTARGETS THER, V9, P6619, DOI 10.2147/OTT.S118184	68	25	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15483	15496		10.1074/jbc.RA118.004084	http://dx.doi.org/10.1074/jbc.RA118.004084			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30135206	Green Published, hybrid			2022-12-28	WOS:000446549200015
J	Crousilles, A; Dolan, SK; Brear, P; Chirgadze, DY; Welch, M				Crousilles, Audrey; Dolan, Stephen K.; Brear, Paul; Chirgadze, Dimitri Y.; Welch, Martin			Gluconeogenic precursor availability regulates flux through the glyoxylate shunt in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial metabolism; bacterial pathogenesis; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); metabolic regulation; enzyme structure; allosteric regulation; post-translational modification (PTM); gluconeogenesis; acetyl coenzyme A (acetyl-CoA); glyoxylate shunt; isocitrate dehydrogenase; isocitrate lyase; Pseudomonas aeruginosa; enzyme regulation; bacterial virulence; metabolic adaptation	COLI ISOCITRATE DEHYDROGENASE; TRICARBOXYLIC-ACID CYCLE; ESCHERICHIA-COLI; BRANCH POINT; MYCOBACTERIUM-TUBERCULOSIS; MALATE SYNTHASE; LYASE; PHOSPHORYLATION; PATHOGENESIS; PERSISTENCE	The glyoxylate shunt bypasses the oxidative decarboxylation steps of the tricarboxylic acid (TCA) cycle, thereby conserving carbon skeletons for gluconeogenesis and biomass production. In Escherichia coli, carbon flux is redirected through the first enzyme of the glyoxylate shunt, isocitrate lyase (ICL), following phosphorylation and inactivation of the TCA cycle enzyme, isocitrate dehydrogenase (ICD), by the kinase/phosphatase, AceK. In contrast, mycobacterial species lack AceK and employ a phosphorylation-insensitive isocitrate dehydrogenase (IDH), which is allosterically activated by the product of ICL activity, glyoxylate. However, Pseudomonas aeruginosa expresses IDH, ICD, ICL, and AceK, raising the question of how these enzymes are regulated to ensure proper flux distribution between the competing pathways. Here, we present the structure, kinetics, and regulation of ICL, IDH, and ICD from P. aeruginosa. We found that flux partitioning is coordinated through reciprocal regulation of these enzymes, linking distribution of carbon flux to the availability of the key gluconeogenic precursors, oxaloacetate and pyruvate. Specifically, a greater abundance of these metabolites activated IDH and inhibited ICL, leading to increased TCA cycle flux. Regulation was also exerted through AceK-dependent phosphorylation of ICD; high levels of acetyl-CoA (which would be expected to accumulate when oxaloacetate is limiting) stimulated the kinase activity of AceK, whereas high levels of oxaloacetate stimulated its phosphatase activity. In summary, the TCA cycle-glyoxylate shunt branch point in P. aeruginosa has a complex enzymology that is profoundly different from those in other species characterized to date. Presumably, this reflects its predilection for consuming fatty acids, especially during infection scenarios.	[Crousilles, Audrey; Dolan, Stephen K.; Brear, Paul; Chirgadze, Dimitri Y.; Welch, Martin] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England	University of Cambridge	Welch, M (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	mw240@cam.ac.uk	Dolan, Stephen K/O-6542-2018; Welch, Martin/A-6186-2016	Dolan, Stephen K/0000-0002-7391-2137; Welch, Martin/0000-0003-3646-1733; Chirgadze, Dimitri/0000-0001-9942-0993; Brear, Paul/0000-0002-4045-0474; Crousilles, Audrey/0000-0002-3003-3490	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M019411/1]; BBSRC [BB/M019411/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/M019411/1. The authors declare that they have no conflicts of interest with the contents of this article.	Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088368; Britton KL, 2000, STRUCTURE, V8, P349, DOI 10.1016/S0969-2126(00)00117-9; Britton KL, 2001, ACTA CRYSTALLOGR D, V57, P1209, DOI 10.1107/S0907444901008642; Chung JCS, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120131; DEAN AM, 1989, J BIOL CHEM, V264, P20482; Diaz-Perez AL, 2007, FEMS MICROBIOL LETT, V269, P309, DOI 10.1111/j.1574-6968.2007.00654.x; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fahnoe KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051732; Hayes D. B., 1995, SEDNTERP; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; KORNBERG HL, 1957, BIOCHIM BIOPHYS ACTA, V24, P651, DOI 10.1016/0006-3002(57)90268-8; KORNBERG HL, 1966, BIOCHEM J, V99, P1; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAPORTE DC, 1984, J BIOL CHEM, V259, P4068; Lassek C, 2016, PROTEOMICS, V16, P1381, DOI 10.1002/pmic.201500228; Lindsey TL, 2008, MICROBIOL-SGM, V154, P1616, DOI 10.1099/mic.0.2007/014506-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; McVey AC, 2017, BIOCHEMISTRY-US, V56, P5539, DOI 10.1021/acs.biochem.7b00852; Murima P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12527; NIMMO GA, 1984, EUR J BIOCHEM, V141, P409, DOI 10.1111/j.1432-1033.1984.tb08206.x; NIMMO HG, 1986, BIOCHEM J, V234, P317, DOI 10.1042/bj2340317; RITTENHOJW, 1974, ARCH BIOCHEM BIOPHYS, V163, P79, DOI DOI 10.1016/0003-9861(74)90456-1; SCHLOSS JV, 1982, BIOCHEMISTRY-US, V21, P4420, DOI 10.1021/bi00261a035; Sharma V, 2000, NAT STRUCT BIOL, V7, P663, DOI 10.1038/77964; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Stoddard BL, 1998, NAT STRUCT BIOL, V5, P891, DOI 10.1038/2331; WALSH K, 1984, J BIOL CHEM, V259, P9646; WALSH K, 1985, J BIOL CHEM, V260, P8430; Winter G, 2011, METHODS, V55, P81, DOI 10.1016/j.ymeth.2011.06.010; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Yasutake Y, 2002, STRUCTURE, V10, P1637, DOI 10.1016/S0969-2126(02)00904-8; Zhao H., 2013, Curr. Protoc. Protein Sci., DOI [10.1002/0471140864.ps2012s71, DOI 10.1002/0471140864.PS2012S71]; Zheng JM, 2009, ACTA CRYSTALLOGR F, V65, P536, DOI 10.1107/S1744309109014729	36	27	27	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14260	14269		10.1074/jbc.RA118.004514	http://dx.doi.org/10.1074/jbc.RA118.004514			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30030382	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000444671500007
J	Maldifassi, MC; Martin-Sanchez, C; Atienza, G; Cedillo, JL; Arnalich, F; Bordas, A; Zafra, F; Gimenez, C; Extremera, M; Renart, J; Montiel, C				Maldifassi, Maria C.; Martin-Sanchez, Carolina; Atienza, Gema; Cedillo, Jose L.; Arnalich, Francisco; Bordas, Anna; Zafra, Francisco; Gimenez, Cecilio; Extremera, Maria; Renart, Jaime; Montiel, Carmen			Interaction of the 7-nicotinic subunit with its human-specific duplicated dup7 isoform in mammalian cells: Relevance in human inflammatory responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nicotinic acetylcholine receptors (nAChR); inflammation; sepsis; macrophage; protein assembly; -nicotinic subunit; dup7 nicotinic subunit; human sepsis; RAW264; 7 macrophages; GH4C1 cells	NICOTINIC ACETYLCHOLINE-RECEPTOR; ALPHA-7 SUBUNIT; CHRFAM7A GENE; PATHWAY; NERVE; COLOCALIZATION; STIMULATION; EXPRESSION; SCHIZOPHRENIA; REGULATOR	The 7 nicotinic receptor subunit and its partially duplicated human-specific dup7 isoform are coexpressed in neuronal and non-neuronal cells. In these cells, 7 subunits form homopentameric 7 nicotinic acetylcholine receptors (7-nAChRs) implicated in numerous pathologies. In immune cells, 7-nAChRs are essential for vagal control of inflammatory response in sepsis. Recent studies show that the dup7 subunit is a dominant-negative regulator of 7-nAChR activity in Xenopus oocytes. However, its biological significance in mammalian cells, particularly immune cells, remains unexplored, as the duplicated form is indistinguishable from the original subunit in standard tests. Here, using immunocytochemistry, confocal microscopy, coimmunoprecipitation, FRET, flow cytometry, and ELISA, we addressed this challenge in GH4C1 rat pituitary cells and RAW264.7 murine macrophages transfected with epitope- and fluorescent protein-tagged 7 or dup7. We used quantitative RT-PCR of dup7 gene expression levels in peripheral blood mononuclear cells (PBMCs) from patients with sepsis to analyze its relationship with PBMC 7 mRNA levels and with serum concentrations of inflammatory markers. We found that a physical interaction between dup7 and 7 subunits in both cell lines generates heteromeric nAChRs that remain mainly trapped in the endoplasmic reticulum. The dup7 sequestration of 7 subunits reduced membrane expression of functional 7-nAChRs, attenuating their anti-inflammatory capacity in lipopolysaccharide-stimulated macrophages. Moreover, the PBMC's dup7 levels correlated inversely with their 7 levels and directly with the magnitude of the patients' inflammatory state. These results indicate that dup7 probably reduces human vagal anti-inflammatory responses and suggest its involvement in other 7-nAChR-mediated pathophysiological processes.	[Maldifassi, Maria C.; Martin-Sanchez, Carolina; Atienza, Gema; Cedillo, Jose L.; Bordas, Anna; Extremera, Maria; Montiel, Carmen] Univ Autonoma Madrid, Fac Med, Dept Farmacol & Terapeut, Arzobispo Morcillo 4, E-28049 Madrid, Spain; [Renart, Jaime] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, E-28049 Madrid, Spain; [Arnalich, Francisco] Hosp Univ La Paz Madrid, Serv Med Interna, Madrid 28046, Spain; [Zafra, Francisco; Gimenez, Cecilio] Univ Autonoma Madrid, CSIC, Fac Ciencias, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Maldifassi, Maria C.; Martin-Sanchez, Carolina; Atienza, Gema; Cedillo, Jose L.; Arnalich, Francisco; Bordas, Anna; Zafra, Francisco; Gimenez, Cecilio; Extremera, Maria; Renart, Jaime; Montiel, Carmen] Hosp Univ La Paz, Inst Invest Sanitaria, Madrid 28046, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Hospital Universitario La Paz; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Universitario La Paz	Montiel, C (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Farmacol & Terapeut, Arzobispo Morcillo 4, E-28049 Madrid, Spain.	carmen.montiel@uam.es	Renart, Jaime/B-7661-2009; Arnalich, Francisco/K-7723-2014; Arnalich, Francisco/AAF-5924-2021; Gimenez, Cecilio/K-8027-2014	Renart, Jaime/0000-0001-6620-3706; Arnalich, Francisco/0000-0003-2943-0373; Martin Sanchez, Carolina/0000-0003-4687-5884; Gimenez, Cecilio/0000-0001-6726-8405	Ministry of Economy, Industry and Competitiveness, Government of Spain [SAF2011-23575, SAF2014-56623-R, SAF2017-82689-R]; CONICYT, Ministry of Education, Chile; Ministry of Economy, Industry and Competitiveness; Ministry of Education, Culture and Sports, Government of Spain; Autonomous University of Madrid	Ministry of Economy, Industry and Competitiveness, Government of Spain(Spanish Government); CONICYT, Ministry of Education, Chile; Ministry of Economy, Industry and Competitiveness; Ministry of Education, Culture and Sports, Government of Spain; Autonomous University of Madrid	This work was supported in part by Ministry of Economy, Industry and Competitiveness, Government of Spain Grants SAF2011-23575, SAF2014-56623-R, and SAF2017-82689-R (to C. M. and F. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Fellowship Beca Chile from CONICYT, Ministry of Education, Chile.; Recipient of Fellowship Beca FPI from Ministry of Economy, Industry and Competitiveness.; Recipient of Fellowship Beca FPU from Ministry of Education, Culture and Sports, Government of Spain.; Recipient of Fellowship Beca FPI from Autonomous University of Madrid.	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Araud T, 2011, BIOCHEM PHARMACOL, V82, P904, DOI 10.1016/j.bcp.2011.06.018; Arias HR, 2009, INT J BIOCHEM CELL B, V41, P1441, DOI 10.1016/j.biocel.2009.01.013; Baird A, 2016, BBA CLIN, V5, P66, DOI 10.1016/j.bbacli.2015.12.003; Benfante R, 2011, J NEUROIMMUNOL, V230, P74, DOI 10.1016/j.jneuroim.2010.09.008; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bordas A, 2017, ONCOTARGET, V8, P67878, DOI 10.18632/oncotarget.18948; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Casey JP, 2012, HUM GENET, V131, P565, DOI 10.1007/s00439-011-1094-6; Cedillo JL, 2015, J INFECT DIS, V211, P146, DOI 10.1093/infdis/jiu425; Costantini TW, 2015, J LEUKOCYTE BIOL, V97, P247, DOI 10.1189/jlb.4RU0814-381R; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; De Luca V, 2006, ACTA PSYCHIAT SCAND, V114, P211, DOI 10.1111/j.1600-0447.2006.00785.x; de Lucas-Cerrillo AM, 2011, J BIOL CHEM, V286, P594, DOI 10.1074/jbc.M110.180067; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Fasoli F, 2015, CURR TOP BEHAV NEURO, V23, P1, DOI 10.1007/978-3-319-13665-3_1; Freedman R, 2001, AM J MED GENET, V105, P20, DOI 10.1002/1096-8628(20010108)105:1<20::AID-AJMG1047>3.3.CO;2-3; GARCIAGUZMAN M, 1994, BIOCHEMISTRY-US, V33, P15198, DOI 10.1021/bi00254a031; Gault J, 2003, AM J MED GENET B, V123B, P39, DOI 10.1002/ajmg.b.20061; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Hong CJ, 2004, NEUROSCI LETT, V355, P69, DOI 10.1016/j.neulet.2003.10.043; Huston JM, 2007, CRIT CARE MED, V35, P2762, DOI 10.1097/01.CCM.0000288102.15975.BA; Kim TH, 2014, J INFECT DIS, V209, P1668, DOI 10.1093/infdis/jit669; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kracun S, 2008, BRIT J PHARMACOL, V153, P1474, DOI 10.1038/sj.bjp.0707676; Li HB, 2005, ONCOGENE, V24, P4206, DOI 10.1038/sj.onc.1208591; Locke DP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r50; Maldifassi MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108397; Mukherjee J, 2009, J NEUROCHEM, V110, P1885, DOI 10.1111/j.1471-4159.2009.06285.x; Pillai S, 2012, CURR DRUG TARGETS, V13, P671, DOI 10.2174/138945012800398847; Riley B, 2002, GENOMICS, V79, P197, DOI 10.1006/geno.2002.6694; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Schuller HM, 2012, CURR DRUG TARGETS, V13, P680, DOI 10.2174/138945012800398883; Serantes R, 2006, J BIOL CHEM, V281, P14632, DOI 10.1074/jbc.M512489200; Severance EG, 2009, J NEURAL TRANSM, V116, P213, DOI 10.1007/s00702-008-0164-y; Singhal S, 2011, J NANOTECHNOL, V2011, DOI [10.1155/2011/930243, 10.1155/2011/456743]; Solis-Garrido LM, 2004, J BIOL CHEM, V279, P52414, DOI 10.1074/jbc.M408872200; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang Y, 2014, J BIOL CHEM, V289, P26451, DOI 10.1074/jbc.M114.582858; Yang YH, 2015, CELL PHYSIOL BIOCHEM, V36, P2025, DOI 10.1159/000430170; Zhang C, 2016, ONCOTARGET, V7, P59199, DOI 10.18632/oncotarget.10498	48	18	20	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13874	13888		10.1074/jbc.RA118.003443	http://dx.doi.org/10.1074/jbc.RA118.003443			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30006348	Green Published, hybrid			2022-12-28	WOS:000444070700014
J	Kabil, O; Motl, N; Strack, M; Seravalli, J; Metzler-Nolte, N; Banerjee, R				Kabil, Omer; Motl, Nicole; Strack, Martin; Seravalli, Javier; Metzler-Nolte, Nils; Banerjee, Ruma			Mechanism-based inhibition of human persulfide dioxygenase by -glutamyl-homocysteinyl-glycine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrogen sulfide; iron; dioxygenase; enzyme kinetics; enzyme mechanism; ethylmalonic acid; ethylmalonic encephalopathy; persulfide dioxygenase; sulfide oxidation	HYDROGEN-SULFIDE OXIDATION; ETHYLMALONIC ENCEPHALOPATHY; CYSTEINE DIOXYGENASE; CRYSTAL-STRUCTURE; MUTATIONS; ETHE1; ENZYMES; SULFUR; IDENTIFICATION; THIOSULFATE	Hydrogen sulfide (H2S) is a signaling molecule with many beneficial effects. However, its cellular concentration is strictly regulated to avoid toxicity. Persulfide dioxygenase (PDO or ETHE1) is a mononuclear non-heme iron-containing protein in the sulfide oxidation pathway catalyzing the conversion of GSH persulfide (GSSH) to sulfite and GSH. PDO mutations result in the autosomal-recessive disorder ethylmalonic encephalopathy (EE). Here, we developed -glutamyl-homocysteinyl-glycine (GHcySH), in which the cysteinyl moiety in GSH is substituted with homocysteine, as a mechanism-based PDO inhibitor. Human PDO used GHcySH as an alternative substrate and converted it to GHcy-SO2H, mimicking GS-SO2H, the putative oxygenated intermediate formed with the natural substrate. Because GHcy-SO2H contains a C-S bond rather than an S-S bond in GS-SO2H, it failed to undergo the final hydrolysis step in the catalytic cycle, leading to PDO inhibition. We also characterized the biochemical penalties incurred by the L55P, T136A, C161Y, and R163W mutations reported in EE patients. The variants displayed lower iron content (1.4-11-fold) and lower thermal stability (1.2-1.7-fold) than WT PDO. They also exhibited varying degrees of catalytic impairment; the k(cat)/K-m values for R163W, L55P, and C161Y PDOs were 18-, 42-, and 65-fold lower, respectively, and the T136A variant was most affected, with a 200-fold lower k(cat)/K-m. Like WT enzyme, these variants were inhibited by GHcySH. This study provides the first characterization of an intermediate in the PDO-catalyzed reaction and reports on deficits associated with EE-linked mutations that are distal from the active site.	[Kabil, Omer; Motl, Nicole; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Strack, Martin; Metzler-Nolte, Nils] Ruhr Univ Bochum, Inorgan Chem Bioinorgan Chem, D-44801 Bochum, Germany; [Seravalli, Javier] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Seravalli, Javier] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Michigan System; University of Michigan; Ruhr University Bochum; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Metzler-Nolte, Nils/H-7626-2014; Kabil, Omer/AAJ-1435-2020	Metzler-Nolte, Nils/0000-0001-8111-9959; 	National Institutes of Health [GM112455]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM112455 (to R. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blaesi EJ, 2013, BIOCHEMISTRY-US, V52, P6040, DOI 10.1021/bi400825c; Bostelaar T, 2016, J AM CHEM SOC, V138, P8476, DOI 10.1021/jacs.6b03456; Bruijnincx PCA, 2008, CHEM SOC REV, V37, P2716, DOI 10.1039/b707179p; BURLINA AB, 1991, LANCET, V338, P1522, DOI 10.1016/0140-6736(91)92338-3; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Di Meo I, 2011, ANTIOXID REDOX SIGN, V15, P353, DOI 10.1089/ars.2010.3520; FISCHER DS, 1964, CLIN CHEM, V10, P21, DOI 10.1016/0009-8981(64)90210-4; GARCIASILVA MT, 1994, J PEDIATR-US, V125, P843, DOI 10.1016/S0022-3476(94)70093-1; Garrett RM, 1998, P NATL ACAD SCI USA, V95, P6394, DOI 10.1073/pnas.95.11.6394; Henriques BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107157; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Kabil O, 2012, J BIOL CHEM, V287, P44561, DOI 10.1074/jbc.M112.407411; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Libiad M, 2015, J BIOL CHEM, V290, P23579, DOI 10.1074/jbc.M115.675694; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103; Motl N, 2017, J BIOL CHEM, V292, P14026, DOI 10.1074/jbc.M117.790170; NICHOLLS P, 1982, CAN J BIOCHEM CELL B, V60, P613, DOI 10.1139/o82-076; Pettinati I, 2016, TRENDS BIOCHEM SCI, V41, P338, DOI 10.1016/j.tibs.2015.12.007; Pettinati I, 2015, HUM MOL GENET, V24, P2458, DOI 10.1093/hmg/ddv007; ROACH PL, 1995, NATURE, V375, P700, DOI 10.1038/375700a0; Ruetz M, 2017, J BIOL CHEM, V292, P6512, DOI 10.1074/jbc.M116.770370; Sattler SA, 2015, J BIOL CHEM, V290, P18914, DOI 10.1074/jbc.M115.652537; Tiranti V, 2006, J MED GENET, V43, P340, DOI 10.1136/jmg.2005.036210; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001; Vitvitsky V, 2017, J BIOL CHEM, V292, P5584, DOI 10.1074/jbc.M117.774943; Vitvitsky V, 2015, J BIOL CHEM, V290, P8310, DOI 10.1074/jbc.M115.639831; WOOD JL, 1987, METHOD ENZYMOL, V143, P25	30	8	8	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12429	12439		10.1074/jbc.RA118.004096	http://dx.doi.org/10.1074/jbc.RA118.004096			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29980601	Green Published, hybrid			2022-12-28	WOS:000441408500010
J	Yamada, M; Hamaguchi, T				Yamada, Masahito; Hamaguchi, Tsuyoshi			The sulfation code for propagation of neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							AMYLOID ANGIOPATHY	Prion-like propagation of protein aggregates is thought to be an essential feature in many neurodegenerative diseases, but the mechanisms underlying transcellular transfer of protein aggregates remain unclear. Stopschinski et al. now demonstrate that the cellular uptake of tau, A, and -synuclein aggregates mediated by heparan sulfate proteoglycans (HSPGs) varies with distinct glycosaminoglycan chain length and sulfation patterns. The results help us to understand how different protein aggregates propagate, leading to distinct neurodegenerative pathologies.	[Yamada, Masahito; Hamaguchi, Tsuyoshi] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Takara Machi, Kanazawa, Ishikawa 9208640, Japan	Kanazawa University	Yamada, M (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	m-yamada@med.kanazawa-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [JP15K15336, JP17H04194, JP17K09752]; Japan Agency for Medical Research and Development (AMED) [JP16dk0207021h0001, JP17dk0207021h0002]; Ministry of Health, Labour and Welfare, Japan [JPH29-nanchito(nan)-ippan-036]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in-Aid for Scientific Research (Kakenhi) from the Japan Society for the Promotion of Science (JSPS) under Grants JP15K15336 (to M. Y. and T. H.), JP17H04194 (to M. Y. and T. H.), and JP17K09752 (to T. H. and M. Y.), Grants-in-Aid for Research and Development Grants for Dementia from the Japan Agency for Medical Research and Development (AMED) under Grants JP16dk0207021h0001 and JP17dk0207021h0002 (to M. Y. and T. H.), and Grants-in-Aid for the Research Committee of Prion Disease and Slow Virus Infection from the Ministry of Health, Labour and Welfare, Japan, under Grants JPH29-nanchito(nan)-ippan-036 (to M. Y. and T. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Goedert M, 2017, BRAIN, V140, P266, DOI 10.1093/brain/aww230; Hamaguchi T, 2016, ACTA NEUROPATHOL, V132, P313, DOI 10.1007/s00401-016-1588-3; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Ihse E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08720-5; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Mudher A, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0488-7; Stopschinski BE, 2018, J BIOL CHEM, V293, P10826, DOI 10.1074/jbc.RA117.000378; Tsuboi Y, 2009, NEUROPATHOLOGY, V29, P632, DOI 10.1111/j.1440-1789.2009.01058.x; Walker LC, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a024398; Watanabe-Nakayama T, 2016, P NATL ACAD SCI USA, V113, P5835, DOI 10.1073/pnas.1524807113	10	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10841	10842		10.1074/jbc.H118.003970	http://dx.doi.org/10.1074/jbc.H118.003970			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29980653	hybrid, Green Published			2022-12-28	WOS:000437828400037
J	Shao, QY; Trinh, JT; Zeng, LY				Shao, Qiuyan; Trinh, Jimmy T.; Zeng, Lanying			High-resolution studies of lysis-lysogeny decision-making in bacteriophage lambda	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						bacteriophage; biophysics; gene regulation; microscopic imaging; microbiology; bacteriophage lambda; cellular decision-making; lysis-lysogeny; stochasticity; high-resolution imaging; phage voting; phage interaction; gene regulatory network; phage DNA replication	ESCHERICHIA-COLI CHROMOSOME; GENE-EXPRESSION; MESSENGER-RNA; POSITIVE-FEEDBACK; SPATIAL-ORGANIZATION; KINETIC-ANALYSIS; DNA EJECTIONS; PHAGE; CELL; LOCALIZATION	Cellular decision-making guides complex development such as cell differentiation and disease progression. Much of our knowledge about decision-making is derived from simple models, such as bacteriophage lambda infection, in which lambda chooses between the vegetative lytic fate and the dormant lysogenic fate. This paradigmatic system is broadly understood but lacking mechanistic details, partly due to limited resolution of past studies. Here, we discuss how modern technologies have enabled high-resolution examination of lambda decision-making to provide new insights and exciting possibilities in studying this classical system. The advent of techniques for labeling specific DNA, RNA, and proteins in cells allows for molecular-level characterization of events in lambda development. These capabilities yield both new answers and new questions regarding how the isolated lambda genetic circuit acts, what biological events transpire among phages in their natural context, and how the synergy of simple phage macromolecules brings about complex behaviors.	[Shao, Qiuyan; Trinh, Jimmy T.; Zeng, Lanying] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Shao, Qiuyan; Trinh, Jimmy T.; Zeng, Lanying] Texas A&M Univ, Ctr Phage Technol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Zeng, LY (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	lzeng@tamu.edu	Shao, Qiuyan/J-8765-2019	Zeng, Lanying/0000-0002-8074-5824	NIGMS, National Institutes of Health [R01GM107597]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107597] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grant R01GM107597 (to L. Z). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acar M, 2010, SCIENCE, V329, P1656, DOI 10.1126/science.1190544; Alvarez LJ, 2007, BIOTECHNOL BIOENG, V96, P615, DOI 10.1002/bit.21110; Arkin A, 1998, GENETICS, V149, P1633; Bakshi S, 2012, MOL MICROBIOL, V85, P21, DOI 10.1111/j.1365-2958.2012.08081.x; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bednarz M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100876; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Buskila AAA, 2014, RNA BIOL, V11, P1051, DOI 10.4161/rna.36135; Castellana M, 2016, P NATL ACAD SCI USA, V113, P9286, DOI 10.1073/pnas.1604995113; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Cenens W, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005770; Cenens W, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003269; Chen IH, 2017, FOOD CONTROL, V71, P273, DOI 10.1016/j.foodcont.2016.07.003; Cortes MG, 2017, BIOPHYS J, V113, P2110, DOI 10.1016/j.bpj.2017.09.012; Dishari SK, 2015, BIOTECHNOL BIOENG, V112, P2115, DOI 10.1002/bit.25614; Dix JA, 2008, ANNU REV BIOPHYS, V37, P247, DOI 10.1146/annurev.biophys.37.032807.125824; DRESSLER D, 1982, ANNU REV BIOCHEM, V51, P727, DOI 10.1146/annurev.bi.51.070182.003455; Edgar R, 2006, P NATL ACAD SCI USA, V103, P4841, DOI 10.1073/pnas.0601211103; Edgar R, 2008, MOL MICROBIOL, V68, P1107, DOI 10.1111/j.1365-2958.2008.06205.x; Engelberg-Kulka H, 2015, MOL MICROBIOL, V96, P689, DOI 10.1111/mmi.12969; Erez Z, 2017, NATURE, V541, P488, DOI 10.1038/nature21049; Fang XN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05071-1; Fei JY, 2015, SCIENCE, V347, P1371, DOI 10.1126/science.1258849; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; Golding I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098102; Golding I, 2016, ANNU REV VIROL, V3, P453, DOI 10.1146/annurev-virology-110615-042127; Grayson P, 2007, P NATL ACAD SCI USA, V104, P14652, DOI 10.1073/pnas.0703274104; Hansen MMK, 2016, NAT NANOTECHNOL, V11, P191, DOI [10.1038/NNANO.2015.243, 10.1038/nnano.2015.243]; HEINZEL T, 1992, J BIOL CHEM, V267, P4183; HENDRIX RW, 1992, SCIENCE, V258, P1145, DOI 10.1126/science.1439823; Hunter GL, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/6/066501; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kobiler O, 2005, P NATL ACAD SCI USA, V102, P4470, DOI 10.1073/pnas.0500670102; KOURILSKY P, 1974, BIOCHIMIE, V56, P1511; KOURILSKY P, 1973, MOL GEN GENET, V122, P183, DOI 10.1007/BF00435190; KOURILSKY P, 1974, BIOCHIMIE, V56, P1517; Liu XQ, 2013, P NATL ACAD SCI USA, V110, P11928, DOI 10.1073/pnas.1309739110; Llopis PM, 2010, NATURE, V466, P77, DOI 10.1038/nature09152; Lo Svenningsen S, 2014, J BACTERIOL, V196, P3582, DOI 10.1128/JB.01705-14; Lobocka MB, 2004, J BACTERIOL, V186, P7032, DOI 10.1128/JB.186.21.7032-7068.2004; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; Nielsen HJ, 2006, MOL MICROBIOL, V61, P383, DOI 10.1111/j.1365-2958.2006.05245.x; NOVICK SL, 1988, BIOCHEMISTRY-US, V27, P7919, DOI 10.1021/bi00420a050; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Parry BR, 2014, CELL, V156, P183, DOI 10.1016/j.cell.2013.11.028; Ptashne M, 2004, GENETIC SWITCH PHAGE; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Roberts JW, 1998, COLD SPRING HARB SYM, V63, P319, DOI 10.1101/sqb.1998.63.319; ROSNER JL, 1972, VIROLOGY, V48, P679, DOI 10.1016/0042-6822(72)90152-3; Rudner DZ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000307; Schmidt C, 1996, J BACTERIOL, V178, P1099, DOI 10.1128/jb.178.4.1099-1104.1996; Segall-Shapiro TH, 2018, NAT BIOTECHNOL, V36, P352, DOI 10.1038/nbt.4111; Semsey S., 2015, BACTERIOPHAGE, V5, DOI DOI 10.1080/21597081.2015.1012930; Sepulveda LA, 2016, SCIENCE, V351, P1218, DOI 10.1126/science.aad0635; Shao QY, 2018, ISCIENCE, V6, P1, DOI 10.1016/j.isci.2018.07.006; Shao QY, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.395; Shao QY, 2015, BIOPHYS J, V108, P2048, DOI 10.1016/j.bpj.2015.03.027; Shao YP, 2008, GENETICS, V180, P471, DOI 10.1534/genetics.108.090100; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Song RJ, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-69; Spahn C, 2015, METHODS APPL FLUORES, V3, DOI 10.1088/2050-6120/3/1/014005; Spahn C, 2014, J STRUCT BIOL, V185, P243, DOI 10.1016/j.jsb.2014.01.007; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; SUSSKIND MM, 1978, MICROBIOL REV, V42, P385, DOI 10.1128/MMBR.42.2.385-413.1978; Tal A, 2014, P NATL ACAD SCI USA, V111, P7308, DOI 10.1073/pnas.1324066111; Trinh JT, 2018, BIOTECHNOL BIOENG, V115, P1427, DOI 10.1002/bit.26573; Trinh JT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14341; Trinh JT, 2017, FUTURE MICROBIOL, V12, P561, DOI 10.2217/fmb-2017-0048; Van Valen D, 2012, CURR BIOL, V22, P1339, DOI 10.1016/j.cub.2012.05.023; van Zon JS, 2006, BIOPHYS J, V91, P4350, DOI 10.1529/biophysj.106.086157; Vohradsky J, 2017, J THEOR BIOL, V431, P32, DOI 10.1016/j.jtbi.2017.07.024; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Weitz JS, 2008, BIOPHYS J, V95, P2673, DOI 10.1529/biophysj.108.133694; Wirth AJ, 2013, BIOESSAYS, V35, P984, DOI 10.1002/bies.201300080; Wu D, 2010, BIOPHYS J, V99, P1101, DOI 10.1016/j.bpj.2010.06.024; Youngren B, 2000, J BACTERIOL, V182, P3924, DOI 10.1128/JB.182.14.3924-3928.2000; Youngren B, 2014, GENE DEV, V28, P71, DOI 10.1101/gad.231050.113; Zeng LY, 2011, JOVE-J VIS EXP, DOI 10.3791/3363; Zeng LY, 2010, CELL, V141, P682, DOI 10.1016/j.cell.2010.03.034; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	91	16	17	5	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3343	3349		10.1074/jbc.TM118.003209	http://dx.doi.org/10.1074/jbc.TM118.003209			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30242122	Green Published, hybrid			2022-12-28	WOS:000461853900002
J	Bart, AG; Scott, EE				Bart, Aaron G.; Scott, Emily E.			Structures of human cytochrome P450 1A1 with bergamottin and erlotinib reveal active-site modifications for binding of diverse ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; X-ray crystallography; enzyme structure; structure-function; protein structure; cancer; membrane protein; bergamottin; CYP1A1; detoxification; erlotinib; progdrug activation	POLYCYCLIC AROMATIC-HYDROCARBONS; RECEPTOR TYROSINE KINASE; INHIBITOR ERLOTINIB; LUNG-CANCER; P450 1A1; METABOLISM; CYP1A1; ACTIVATION; EXPRESSION; DRUG	Human cytochrome P450 1A1 (CYP1A1) is an extrahepatic enzyme involved in the monooxygenation of structurally diverse compounds ranging from natural products to drugs and protoxins. Because CYP1A1 has a role in human carcinogenesis, inhibiting its activity may potentially aid in cancer chemoprevention, whereas utilizing CYP1A1's oxidative activity could help selectively activate anticancer prodrugs. Such potential therapeutic purposes require detailed knowledge of CYP1A1's interactions with potential ligands. Known CYP1A1 ligands also vary substantially in size, and it has not been apparent from a single existing CYP1A1 structure how larger, structurally diverse ligands are accommodated within the enclosed active site. Here, two new X-ray structures with the natural product furanocoumarin bergamottin (at 2.85 angstrom resolution) and the lung cancer drug erlotinib (3.0 angstrom) revealed binding orientations consistent with the formation of innocuous metabolites and of toxic metabolites, respectively. They also disclosed local changes in the roof of the active site that enlarge the active site and ultimately form a channel to the protein exterior. Although further structural modifications would be required to accommodate the largest CYP1A1 ligands, knowing which components of the active site are malleable provides powerful information for those attempting to use computational approaches to predict compound binding and substrate metabolism by this clinically relevant monooxygenase.	[Bart, Aaron G.; Scott, Emily E.] Univ Michigan, Program Biophys, Ann Arbor, MI 48109 USA; [Scott, Emily E.] Univ Michigan, Dept Med Chem, 428 Church St, Ann Arbor, MI 48109 USA; [Scott, Emily E.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Scott, EE (corresponding author), Univ Michigan, Dept Med Chem, 428 Church St, Ann Arbor, MI 48109 USA.	scottee@umich.edu			National Institutes of Health [R37 GM076343, T32 GM008545]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008545, R37GM076343, P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R37 GM076343 (to E. E. S.) and T32 GM008545. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Androutsopoulos VP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082487; Androutsopoulos VP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-187; Bart AG, 2017, J BIOL CHEM, V292, P20818, DOI 10.1074/jbc.RA117.000220; Bruno RD, 2007, BIOORGAN MED CHEM, V15, P5047, DOI 10.1016/j.bmc.2007.05.046; Cai YN, 1996, CHEM RES TOXICOL, V9, P729, DOI 10.1021/tx950208b; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Chun YJ, 2001, DRUG METAB DISPOS, V29, P389; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DeVore NM, 2009, DRUG METAB DISPOS, V37, P1319, DOI 10.1124/dmd.109.026765; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fortin S, 2017, J MED CHEM, V60, P4963, DOI 10.1021/acs.jmedchem.7b00343; Hamilton M, 2006, CLIN CANCER RES, V12, P2166, DOI 10.1158/1078-0432.CCR-05-2235; He K, 1998, CHEM RES TOXICOL, V11, P252, DOI 10.1021/tx970192k; Hughes AN, 2009, J CLIN ONCOL, V27, P1220, DOI 10.1200/JCO.2008.19.3995; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kent UM, 2006, J PHARMACOL EXP THER, V318, P992, DOI 10.1124/jpet.105.099887; Kim JH, 2004, TOXICOL APPL PHARM, V199, P210, DOI 10.1016/j.taap.2003.11.015; Kiyohara Y, 2013, J AM ACAD DERMATOL, V69, P463, DOI 10.1016/j.jaad.2013.02.025; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Li J, 2007, CLIN CANCER RES, V13, P3731, DOI 10.1158/1078-0432.CCR-07-0088; Li XH, 2010, DRUG METAB DISPOS, V38, P1238, DOI 10.1124/dmd.109.030361; Lin D, 2017, J PHARMACOL EXP THER, V363, P12, DOI 10.1124/jpet.117.243246; Ling J, 2006, DRUG METAB DISPOS, V34, P420, DOI 10.1124/dmd.105.007765; Liu JW, 2013, MOLECULES, V18, P14470, DOI 10.3390/molecules181214470; Liu V, 2007, CHEST, V132, P1042, DOI 10.1378/chest.07-0050; Lu JF, 2006, CLIN PHARMACOL THER, V80, P136, DOI 10.1016/j.clpt.2006.04.007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCLEMORE TL, 1990, J NATL CANCER I, V82, P1333, DOI 10.1093/jnci/82.16.1333; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Olguin-Reyes S, 2012, FOOD CHEM TOXICOL, V50, P3094, DOI 10.1016/j.fct.2012.05.058; OMURA T, 1964, J BIOL CHEM, V239, P2370; OPRIAN DD, 1982, J BIOL CHEM, V257, P8935; Rendic S, 2012, CHEM RES TOXICOL, V25, P1316, DOI 10.1021/tx300132k; Rochat B, 2008, BIOPHARM DRUG DISPOS, V29, P103, DOI 10.1002/bdd.598; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Schwarz D, 2004, BIOCHEM PHARMACOL, V67, P1445, DOI 10.1016/j.bcp.2003.12.023; Shimada T, 2004, CANCER SCI, V95, P1, DOI 10.1111/j.1349-7006.2004.tb03162.x; Stone EL, 2015, BIOORGAN MED CHEM, V23, P6891, DOI 10.1016/j.bmc.2015.09.052; Studier FW, 2014, METHODS MOL BIOL, V1091, P17, DOI 10.1007/978-1-62703-691-7_2; Sutherland M, 2013, MOL CANCER THER, V12, P27, DOI 10.1158/1535-7163.MCT-12-0405; Wacker B, 2007, CLIN CANCER RES, V13, P3913, DOI 10.1158/1078-0432.CCR-06-2610; Walsh AA, 2013, J BIOL CHEM, V288, P12932, DOI 10.1074/jbc.M113.452953; Wang A, 2011, J BIOL CHEM, V286, P5736, DOI 10.1074/jbc.M110.204420; Yakkundi A, 2006, CANCER GENE THER, V13, P598, DOI 10.1038/sj.cgt.7700933; Zhao HM, 2018, DRUG METAB DISPOS, V46, P442, DOI 10.1124/dmd.117.079327	47	27	27	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19201	19210		10.1074/jbc.RA118.005588	http://dx.doi.org/10.1074/jbc.RA118.005588			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30254074	Green Published, hybrid			2022-12-28	WOS:000453537300004
J	Okamoto, M; Fukushima, Y; Kouwaki, T; Daito, T; Kohara, M; Kida, H; Oshiumi, H				Okamoto, Masaaki; Fukushima, Yoshimi; Kouwaki, Takahisa; Daito, Takuji; Kohara, Michinori; Kida, Hiroshi; Oshiumi, Hiroyuki			MicroRNA-451a in extracellular, blood-resident vesicles attenuates macrophage and dendritic cell responses to influenza whole-virus vaccine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; RIG-I; CIRCULATING MICRORNAS; SPLIT-PRODUCT; IMMUNE CELLS; MECHANISM; EXOSOMES; DIFFERENTIATION; RECOGNITION; EXPRESSION	The innate immune system is important for the efficacy of vaccines, but excessive innate immune responses can cause adverse reactions after vaccination. Extracellular vesicles (EVs) are enriched in the blood and can deliver functional RNAs, such as microRNAs (miRNAs), to recipient cells, thereby mediating intercellular communication. However, the role of EVs in controlling the innate immune responses to vaccines has not been fully elucidated. Here, we found that miR-451a is abundant in human serum EVs and that its presence in blood-circulating EVs affects the innate immune responses of macrophages and dendritic cells to inactivated whole-virus vaccines (WV) against influenza. miR-451a in human serum EVs was stable for a week in healthy subjects, and its levels gradually fluctuated over several months. miR-451a within serum EVs was internalized into serum-cultured macrophages and dendritic cells and reduced endogenous 14-3-3 zeta protein levels and decreased the expression of type I IFN and interleukin 6 in response to WV stimulation. miR-451a levels in blood-circulating EVs were positively correlated with intracellular miR-451a levels in mouse splenic CD11c(+) cells and inversely correlated with the innate immune response to inactivated WV in vivo. These findings suggest that miR-451a in circulating EVs is internalized into recipient cells in vivo and that this internalization results in an attenuation of the innate immune response to WV. Moreover, a microarray analysis identified several other miRNAs that affect the macrophage response to inactivated WV. Our results reveal that miR-NAs in circulating EVs significantly modify the responses of macrophages and dendritic cells to inactivated WV.	[Okamoto, Masaaki; Fukushima, Yoshimi; Kouwaki, Takahisa; Oshiumi, Hiroyuki] Kumamoto Univ, Dept Immunol, Grad Sch Med Sci, Fac Life Sci, 1-1-1 Honjo, Kumamoto 8608556, Japan; [Daito, Takuji; Kida, Hiroshi] Hokkaido Univ, Res Ctr Zoonosis Control, GI CoRE Global Stn Zoonosis Control, Kita Ku, North 20,West 10, Sapporo, Hokkaido 0010020, Japan; [Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 1568506, Japan; [Oshiumi, Hiroyuki] Japan Sci & Technol Agcy JST, PRESTO, 1-1-1 Honjo, Kumamoto 8608556, Japan	Kumamoto University; Hokkaido University; Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Kumamoto University	Oshiumi, H (corresponding author), Kumamoto Univ, Dept Immunol, Grad Sch Med Sci, Fac Life Sci, 1-1-1 Honjo, Kumamoto 8608556, Japan.	oshiumi@kumamoto-u.ac.jp		Oshiumi, Hiroyuki/0000-0003-1567-8722	Ministry of Education, Science, and Technology (MEXT); Japan Agency for Medical Research and Development (AMED), JST PREST, Tokyo Metropolitan Government; Takeda Science Foundation; Kao Research Council for the Study of Healthcare Science; NOVARTIS Foundation (Japan) for the Promotion of Science; Uehara Memorial Foundation; Japanese Association for Complement Research; Waksman Foundation of Japan; Daiichi Sankyo Foundation of Life Science	Ministry of Education, Science, and Technology (MEXT); Japan Agency for Medical Research and Development (AMED), JST PREST, Tokyo Metropolitan Government; Takeda Science Foundation(Takeda Science Foundation (TSF)); Kao Research Council for the Study of Healthcare Science; NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Uehara Memorial Foundation(Uehara Memorial Foundation); Japanese Association for Complement Research; Waksman Foundation of Japan(Waksman Foundation of Japan Inc.); Daiichi Sankyo Foundation of Life Science	This work was supported in part by grants-in-aid from the Ministry of Education, Science, and Technology (MEXT), a grant-in-aid from the Japan Agency for Medical Research and Development (AMED), JST PREST, Tokyo Metropolitan Government, the Takeda Science Foundation, Kao Research Council for the Study of Healthcare Science, The NOVARTIS Foundation (Japan) for the Promotion of Science, The Uehara Memorial Foundation, the Japanese Association for Complement Research, the Waksman Foundation of Japan, and the Daiichi Sankyo Foundation of Life Science. The authors declare that they have no conflicts of interest with the contents of this article.	Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andreu Z, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.31655; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Atay S, 2011, AM J REPROD IMMUNOL, V65, P65, DOI 10.1111/j.1600-0897.2010.00880.x; Balusu S, 2016, EMBO MOL MED, V8, P1162, DOI 10.15252/emmm.201606271; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Chang CK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188214; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dinarello CA, 2004, J ENDOTOXIN RES, V10, P201, DOI 10.1179/096805104225006129; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Grasedieck S, 2013, BLOOD, V121, P4977, DOI 10.1182/blood-2013-01-480079; GROSS PA, 1977, NEW ENGL J MED, V296, P567, DOI 10.1056/NEJM197703102961012; GROSS PA, 1977, J INFECT DIS, V136, P623, DOI 10.1093/infdis/136.5.623; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Hur W, 2015, INT J BIOCHEM CELL B, V64, P265, DOI 10.1016/j.biocel.2015.04.016; Koppers-Lalic D, 2014, CELL REP, V8, P1649, DOI 10.1016/j.celrep.2014.08.027; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kouwaki T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030666; Kouwaki T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00335; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Luron L, 2012, EUR J IMMUNOL, V42, P1030, DOI 10.1002/eji.201141969; Moldovan Leni, 2013, Methods Mol Biol, V1024, P129, DOI 10.1007/978-1-62703-453-1_10; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Nguyen TA, 2017, IMMUNITY, V47, P498, DOI 10.1016/j.immuni.2017.08.007; Padovan E, 2002, J LEUKOCYTE BIOL, V71, P669; Pal S, 2011, VIRUS RES, V158, P12, DOI 10.1016/j.virusres.2011.02.017; Patrick DM, 2010, GENE DEV, V24, P1614, DOI 10.1101/gad.1942810; Paul R, 2003, BRAIN, V126, P1873, DOI 10.1093/brain/awg171; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Rhorer J, 2009, VACCINE, V27, P1101, DOI 10.1016/j.vaccine.2008.11.093; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Rosenberger CM, 2012, J IMMUNOL, V189, P5965, DOI 10.4049/jimmunol.1201437; Santangelo L, 2016, CELL REP, V17, P799, DOI 10.1016/j.celrep.2016.09.031; Sato M, 2001, CYTOKINE GROWTH F R, V12, P133, DOI 10.1016/S1359-6101(00)00032-0; Schichl YM, 2009, J BIOL CHEM, V284, P29571, DOI 10.1074/jbc.M109.031237; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Shurtleff MJ, 2016, ELIFE, V5, DOI 10.7554/eLife.19276; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Smyth LA, 2015, IMMUNOLOGY, V144, P197, DOI 10.1111/imm.12390; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Swaminathan S, 2013, BIOCHEM BIOPH RES CO, V434, P228, DOI 10.1016/j.bbrc.2013.03.046; Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365; Uno S, 2011, MICROBIOL IMMUNOL, V55, P783, DOI 10.1111/j.1348-0421.2011.00381.x; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wang YM, 2014, VIROLOGY, V449, P53, DOI 10.1016/j.virol.2013.11.009; Xiang MQ, 2014, BIOCHEM BIOPH RES CO, V454, P210, DOI 10.1016/j.bbrc.2014.10.064; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xie JX, 2017, GENE, V627, P1, DOI 10.1016/j.gene.2017.06.003; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	64	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18585	18600		10.1074/jbc.RA118.003862	http://dx.doi.org/10.1074/jbc.RA118.003862			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30282637	Green Published, hybrid			2022-12-28	WOS:000458467300014
J	Milano, SK; Wang, CY; Erickson, JW; Cerione, RA; Ramachandran, S				Milano, Shawn K.; Wang, Chenyue; Erickson, Jon W.; Cerione, Richard A.; Ramachandran, Sekar			Gain-of-function screen of alpha-transducin identifies an essential phenylalanine residue necessary for full effector activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenylate cyclase (adenylyl cyclase); G protein; G protein-coupled receptor (GPCR); GTPase; rhodopsin; photoreceptor; phosphodiesterases; Gs; phototransduction; transducin; signal transduction	HETEROTRIMERIC G-PROTEIN; CRYSTAL-STRUCTURE; ADENYLYL-CYCLASE; CGMP PHOSPHODIESTERASE; GAMMA-SUBUNIT; STRUCTURAL DETERMINANTS; GUANINE-NUCLEOTIDES; BINDING-SITES; 2.0 ANGSTROM; GS-ALPHA	Two regions on the subunits of heterotrimeric GTP-binding proteins (G-proteins), the Switch II/2 helix (which changes conformation upon GDP-GTP exchange) and the 3 helix, have been shown to contain the binding sites for their effector proteins. However, how the binding of G subunits to their effector proteins is translated into the stimulation of effector activity is still poorly understood. Here, we took advantage of a reconstituted rhodopsin-coupled phototransduction system to address this question and identified a distinct surface and an essential residue on the subunit of the G-protein transducin ((T)) that is necessary to fully activate its effector enzyme, the cGMP phosphodiesterase (PDE). We started with a chimeric G-protein subunit ((T)*) comprising residues mainly from (T) and a short stretch of residues from the G(i1) subunit ((i1)), which only weakly stimulates PDE activity. We then reinstated the (T) residues by systematically replacing the corresponding (i1) residues within (T)* with the aim of fully restoring PDE stimulatory activity. These experiments revealed that the G/4 loop and a phenylalanine residue at position 283 are essential for conferring the (T)* subunit with full PDE stimulatory capability. We further demonstrated that this same region and amino acid within the subunit of the G(s) protein ((s)) are necessary for full adenylyl cyclase activation. These findings highlight the importance of the G/4 loop and of an essential phenylalanine residue within this region on G subunits (T) and (s) as being pivotal for their selective and optimal stimulation of effector activity.	[Milano, Shawn K.; Wang, Chenyue; Erickson, Jon W.; Cerione, Richard A.; Ramachandran, Sekar] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Wang, Chenyue] US Naval Res Lab, 4555 Overlook Ave SW, Washington, DC 20375 USA	Cornell University; Cornell University; United States Department of Defense; United States Navy; Naval Research Laboratory	Cerione, RA (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.; Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu	Ramachandran, Sekar/AAP-2287-2020; Cote, Rick H/G-3363-2013	Ramachandran, Sekar/0000-0002-2243-1368; Cote, Rick H/0000-0002-1573-6526	National Institutes of Health [GM122575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM122575. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Berger AL, 1997, J BIOL CHEM, V272, P2714, DOI 10.1074/jbc.272.5.2714; Berger AL, 1999, BIOCHEMISTRY-US, V38, P1293, DOI 10.1021/bi981683m; BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; Coleman DE, 1998, BIOCHEMISTRY-US, V37, P14376, DOI 10.1021/bi9810306; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; FAWZI AB, 1990, BIOCHEMISTRY-US, V29, P3804, DOI 10.1021/bi00467a030; Gu C, 2002, EUR J BIOCHEM, V269, P413, DOI 10.1046/j.0014-2956.2001.02708.x; Harry A, 1997, J BIOL CHEM, V272, P19017, DOI 10.1074/jbc.272.30.19017; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; ITOH H, 1991, J BIOL CHEM, V266, P16226; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Li QB, 1997, J BIOL CHEM, V272, P21673, DOI 10.1074/jbc.272.35.21673; LIEBMAN PA, 1982, METHOD ENZYMOL, V81, P532; Liu Y, 1996, J BIOL CHEM, V271, P26900, DOI 10.1074/jbc.271.43.26900; Majumdar S, 2006, J BIOL CHEM, V281, P9219, DOI 10.1074/jbc.M513837200; Majumdar S, 2004, J BIOL CHEM, V279, P40137, DOI 10.1074/jbc.M405420200; Min KC, 2000, PROTEIN EXPRES PURIF, V20, P514, DOI 10.1006/prep.2000.1326; Natochin M, 1998, J BIOL CHEM, V273, P21808, DOI 10.1074/jbc.273.34.21808; Natochin M, 1999, J BIOL CHEM, V274, P7865, DOI 10.1074/jbc.274.12.7865; Natochin M, 2000, J BIOL CHEM, V275, P2669, DOI 10.1074/jbc.275.4.2669; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Phillips W. J., 1991, BIOPHYSICAL BIOCH AS, P135, DOI 10.1007/978-1-4757-9513-4; Qureshi BM, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180075; Ramachandran S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.166538; RARICK HM, 1992, SCIENCE, V256, P1031, DOI 10.1126/science.1317058; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Singh G, 2012, BIOCHEMISTRY-US, V51, P3232, DOI 10.1021/bi3001984; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SPICKOFSKY N, 1994, NAT STRUCT BIOL, V1, P771, DOI 10.1038/nsb1194-771; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; TANG WJ, 1995, BIOCHEMISTRY-US, V34, P14563, DOI 10.1021/bi00044a035; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1	40	3	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17941	17952		10.1074/jbc.RA118.003746	http://dx.doi.org/10.1074/jbc.RA118.003746			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30266806	Green Published, hybrid			2022-12-28	WOS:000450409500023
J	Valnohova, J; Kowalski-Jahn, M; Sunahara, RK; Schulte, G				Valnohova, Jana; Kowalski-Jahn, Maria; Sunahara, Roger K.; Schulte, Gunnar			Functional dissection of the N-terminal extracellular domains of Frizzled 6 reveals their roles for receptor localization and Dishevelled recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); Wnt signaling; membrane protein; protein structure; mutagenesis; -catenin; DVL; FZD6; G protein signaling; linker domain	CYSTEINE-RICH DOMAIN; KINASE-I-EPSILON; DEP DOMAIN; G-PROTEIN; STRUCTURAL BASIS; PLANAR POLARITY; PLASMA-MEMBRANE; WNT; PHOSPHORYLATION; SIGNALOSOME	The Frizzled (FZD) proteins belong to class F of G protein-coupled receptors (GPCRs) and are essential for various pathways involving the secreted lipoglycoproteins of the wingless/int-1 (WNT) family. A WNT-binding cysteine-rich domain (CRD) in FZDs is N-terminally located and connected to the seven transmembrane domain-spanning receptor core by a linker domain that has a variable length in different FZD homologs. However, the function and importance of this linker domain are poorly understood. Here we used systematic mutagenesis of FZD(6) to define the minimal N-terminal domain sufficient for receptor surface expression and recruitment of the intracellular scaffold protein Dishevelled (DVL). Further, we identified a triad of evolutionarily conserved cysteines in the FZD linker domain that is crucial for receptor membrane expression and recruitment of DVL. Our results are in agreement with the concept that the conserved cysteines in the linker domain of FZDs assist with the formation of a common secondary structure in this region. We propose that this structure could be involved in agonist binding and receptor activation mechanisms that are similar to the binding and activation mechanisms known for other GPCRs.	[Valnohova, Jana; Kowalski-Jahn, Maria; Schulte, Gunnar] Karolinska Inst, Sect Receptor Biol & Signaling, Dept Physiol & Pharmacol, S-17165 Stockholm, Sweden; [Sunahara, Roger K.] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA	Karolinska Institutet; University of California System; University of California San Diego	Schulte, G (corresponding author), Karolinska Inst, Sect Receptor Biol & Signaling, Dept Physiol & Pharmacol, S-17165 Stockholm, Sweden.	gunnar.schulte@ki.se	Sunahara, Roger/AAJ-8667-2020	Kowalski-Jahn, Maria/0000-0003-1442-3656; Schulte, Gunnar/0000-0002-2700-7013	Karolinska Institutet [2-70/2014-76]; Swedish Research Council [2013-5708, 2015-02899]; Swedish Cancer Society [CAN2014/659, 2017/561]; Knut and Alice Wallenberg Foundation [KAW2008.0149]; Stiftelsen Olle Engkvist Byggmastare [2016/193]; SSMF [2016/193]; Deutsche Forschungsgemeinschaft (German Research Foundation) [KO 5463/1-1]; NIGMS, National Institutes of Health [RO1-GM083118]; Marie Curie ITN WntsApp [608180]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083118] Funding Source: NIH RePORTER	Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); SSMF; Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Marie Curie ITN WntsApp; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from Karolinska Institutet (2-70/2014-76), the Swedish Research Council (2013-5708 and 2015-02899), the Swedish Cancer Society (CAN2014/659 and 2017/561), the Knut and Alice Wallenberg Foundation (KAW2008.0149), Stiftelsen Olle Engkvist Byggmastare (2016/193), SSMF (Travel Grant 2016/193 to J. V.), the Marie Curie ITN WntsApp (Grant 608180), the Deutsche Forschungsgemeinschaft (German Research Foundation, grant KO 5463/1-1), and NIGMS, National Institutes of Health Grant RO1-GM083118 (to R. K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aanstad P, 2009, CURR BIOL, V19, P1034, DOI 10.1016/j.cub.2009.04.053; Arthofer E, 2016, MOL PHARMACOL, V90, P447, DOI 10.1124/mol.116.104919; Bang I, 2018, P NATL ACAD SCI USA, V115, P8787, DOI 10.1073/pnas.1805901115; Bernatik O, 2014, J BIOL CHEM, V289, P23520, DOI 10.1074/jbc.M114.590638; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Bertalovitz Alexander C, 2016, J Mol Signal, V11, P1, DOI 10.5334/1750-2187-11-1; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Byrne EFX, 2016, NATURE, V535, P517, DOI 10.1038/nature18934; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Chen CM, 2004, P NATL ACAD SCI USA, V101, P15961, DOI 10.1073/pnas.0407103101; Chen WS, 2008, CELL, V133, P1093, DOI 10.1016/j.cell.2008.04.048; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; DeBruine ZJ, 2017, BRIT J PHARMACOL, V174, P4564, DOI 10.1111/bph.14048; DeBruine ZJ, 2017, GENE DEV, V31, P916, DOI 10.1101/gad.298331.117; Dijksterhuis JP, 2015, J BIOL CHEM, V290, P6789, DOI 10.1074/jbc.M114.612648; Gammons MV, 2016, J CELL SCI, V129, P3892, DOI 10.1242/jcs.195685; Gammons MV, 2016, MOL CELL, V64, P92, DOI 10.1016/j.molcel.2016.08.026; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200; Grainger S, 2018, WIRES SYST BIOL MED, V10, DOI 10.1002/wsbm.1422; Huang PX, 2018, CELL, V174, P312, DOI 10.1016/j.cell.2018.04.029; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kilander MBC, 2014, CELL SIGNAL, V26, P1943, DOI 10.1016/j.cellsig.2014.05.012; Kilander MBC, 2014, FASEB J, V28, P2293, DOI 10.1096/fj.13-246363; Milhem RM, 2014, INVEST OPHTH VIS SCI, V55, P3423, DOI 10.1167/iovs.14-13885; Mlodzik M, 2016, CURR TOP DEV BIOL, V117, P75, DOI 10.1016/bs.ctdb.2015.11.027; Nakano Y, 2004, MECH DEVELOP, V121, P507, DOI 10.1016/j.mod.2004.04.015; Nile AH, 2017, P NATL ACAD SCI USA, V114, P4147, DOI 10.1073/pnas.1618293114; Omoto Satoshi, 2004, Ophthalmic Genet, V25, P81, DOI 10.1080/13816810490514270; Paclikova P, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00145-17; Pau Milly S, 2015, J Mol Signal, V10, P5, DOI 10.5334/1750-2187-10-6; Petersen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00253-9; Povelones M, 2005, EMBO J, V24, P3493, DOI 10.1038/sj.emboj.7600817; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Rana R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3965; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Strakova K, 2017, CELL SIGNAL, V38, P85, DOI 10.1016/j.cellsig.2017.06.018; Strutt H, 2006, CURR BIOL, V16, P1329, DOI 10.1016/j.cub.2006.04.041; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tauriello DVF, 2012, P NATL ACAD SCI USA, V109, pE812, DOI 10.1073/pnas.1114802109; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Wang CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5896; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wu J, 2008, DEV CELL, V15, P462, DOI 10.1016/j.devcel.2008.08.004; Xie Z, 2018, CELL DEATH DIFFER, V25, P1442, DOI 10.1038/s41418-017-0050-y; Yang SF, 2018, NATURE, V560, P666, DOI 10.1038/s41586-018-0447-x; Zhang K, 2011, J BIOL CHEM, V286, P10210, DOI 10.1074/jbc.M110.194399; Zhang XJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15383; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394	60	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17875	17887		10.1074/jbc.RA118.004763	http://dx.doi.org/10.1074/jbc.RA118.004763			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30237173	Green Published, hybrid			2022-12-28	WOS:000450409500018
J	Pakharukova, N; McKenna, S; Tuittila, M; Paavilainen, S; Malmi, H; Xu, YQ; Parilova, O; Matthews, S; Zavialov, AV				Pakharukova, Natalia; McKenna, Sophie; Tuittila, Minna; Paavilainen, Sari; Malmi, Henri; Xu, Yingqi; Parilova, Olena; Matthews, Steve; Zavialov, Anton V.			Archaic and alternative chaperones preserve pilin folding energy by providing incomplete structural information	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; bacterial adhesion; bacterial pathogenesis; biofilm; protein folding; protein secretion; protein self-assembly; protein structure; X-ray crystallography; nuclear magnetic resonance (NMR); Acinetobacter baumannii; adhesive pili; chaperone-usher pathway; Csu pili; fimbriae	UROPATHOGENIC ESCHERICHIA-COLI; TRIPLE-RESONANCE EXPERIMENTS; DRIVES FIBER FORMATION; DONOR-STRAND EXCHANGE; NMR CHEMICAL-SHIFTS; ACINETOBACTER-BAUMANNII; BIOFILM FORMATION; PILUS BIOGENESIS; USHER PATHWAYS; LARGE PROTEINS	Adhesive pili are external component of fibrous adhesive organelles and help bacteria attach to biotic or abiotic surfaces. The biogenesis of adhesive pili via the chaperone-usher pathway (CUP) is independent of external energy sources. In the classical CUP, chaperones transport assembly-competent pilins in a folded but expanded conformation. During donor-strand exchange, pilins subsequently collapse, producing a tightly packed hydrophobic core and releasing the necessary free energy to drive fiber formation. Here, we show that pilus biogenesis in non-classical, archaic, and alternative CUPs uses a different source of conformational energy. High-resolution structures of the archaic Csu-pili system from Acinetobacter baumannii revealed that non-classical chaperones employ a short donor strand motif that is insufficient to fully complement the pilin fold. This results in chaperone-bound pilins being trapped in a substantially unfolded intermediate. The exchange of this short motif with the longer donor strand from adjacent pilin provides the full steric information essential for folding, and thereby induces a large unfolded-to-folded conformational transition to drive assembly. Our findings may inform the development of anti-adhesion drugs (pilicides) to combat bacterial infections.	[Pakharukova, Natalia; Tuittila, Minna; Paavilainen, Sari; Malmi, Henri; Parilova, Olena; Zavialov, Anton V.] Univ Turku, JBL, Dept Chem, Arcanum, Vatselankatu 2, FIN-20500 Turku, Finland; [McKenna, Sophie; Xu, Yingqi; Matthews, Steve] Imperial Coll London, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England	University of Turku; Imperial College London	Zavialov, AV (corresponding author), Univ Turku, JBL, Arcanum, Vatselankatu 2, FIN-20500 Turku, Finland.	antzav@utu.fi	Pakharukova, Natalia/U-7382-2019; Zavialov, Anton/C-7664-2015	Pakharukova, Natalia/0000-0002-8363-6105; Xu, Yingqi/0000-0001-6861-7355; Zavialov, Anton/0000-0001-6191-5931	Academy of Finland [140959, 273075]; Sigrid Juselius Foundation; MRC [MR/P028225/1] Funding Source: UKRI	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Academy of Finland Grants 140959 and 273075 and Sigrid Juselius Foundation Grant 2014 (to A.V.Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bao R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004316; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Busch A, 2012, PHILOS T R SOC B, V367, P1112, DOI 10.1098/rstb.2011.0206; Cerqueira GM, 2011, IUBMB LIFE, V63, P1055, DOI 10.1002/iub.533; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; De Greve H, 2007, CURR OPIN STRUC BIOL, V17, P506, DOI 10.1016/j.sbi.2007.06.011; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Yu X, 2012, STRUCTURE, V20, P1861, DOI 10.1016/j.str.2012.08.016; Di Yu X, 2012, J MOL BIOL, V417, P294, DOI 10.1016/j.jmb.2012.01.020; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Giraud C, 2012, ENVIRON MICROBIOL, V14, P1805, DOI 10.1111/j.1462-2920.2011.02673.x; Giraud C, 2011, ENVIRON MICROBIOL, V13, P666, DOI 10.1111/j.1462-2920.2010.02372.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hung DL, 1996, EMBO J, V15, P3792, DOI 10.1002/j.1460-2075.1996.tb00753.x; Isidean SD, 2011, VACCINE, V29, P6167, DOI 10.1016/j.vaccine.2011.06.084; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; Li YF, 2009, P NATL ACAD SCI USA, V106, P10793, DOI 10.1073/pnas.0812843106; Monaco S, 2013, J APPL CRYSTALLOGR, V46, P804, DOI 10.1107/S0021889813006195; Moonens K, 2012, MOL MICROBIOL, V86, P82, DOI 10.1111/j.1365-2958.2012.08174.x; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; Pakharukova N, 2018, P NATL ACAD SCI USA, V115, P5558, DOI 10.1073/pnas.1800961115; Pakharukova N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005269; Pakharukova N, 2015, ACTA CRYSTALLOGR F, V71, P770, DOI 10.1107/S2053230X15007955; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Pinkner JS, 2006, P NATL ACAD SCI USA, V103, P17897, DOI 10.1073/pnas.0606795103; Remaut H, 2006, MOL CELL, V22, P831, DOI 10.1016/j.molcel.2006.05.033; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Tamiola K, 2012, BIOCHEM SOC T, V40, P1014, DOI 10.1042/BST20120171; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Tomaras AP, 2008, MICROBIOL-SGM, V154, P3398, DOI 10.1099/mic.0.2008/019471-0; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Verger D, 2006, EMBO REP, V7, P1228, DOI 10.1038/sj.embor.7400833; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wu MM, 2014, MICROBIOL-SGM, V160, P2200, DOI 10.1099/mic.0.080457-0; Zav'yalov V, 2010, FEMS MICROBIOL REV, V34, P317, DOI 10.1111/j.1574-6976.2009.00201.x; Zavialov A, 2007, FEMS MICROBIOL REV, V31, P478, DOI 10.1111/j.1574-6976.2007.00075.x; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9; Zavialvo AV, 2005, BIOCHEM J, V389, P685, DOI 10.1042/BJ20050426; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022	49	2	2	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17070	17080		10.1074/jbc.RA118.004170	http://dx.doi.org/10.1074/jbc.RA118.004170			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30228191	hybrid, Green Published			2022-12-28	WOS:000449466500010
J	Ho, SR; Lin, WC				Ho, Shiuh-Rong; Lin, Weei-Chin			RNF144A sustains EGFR signaling to promote EGF-dependent cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; ubiquitylation (ubiquitination); epidermal growth factor receptor (EGFR); vesicles; trafficking; DNA-dependent serine; threonine protein kinase (DNA-PK); RBR	EPIDERMAL-GROWTH-FACTOR; RECEPTOR TYROSINE KINASES; NEGATIVE BREAST-CANCER; E3 UBIQUITIN LIGASE; PROTEIN-KINASE; NUCLEAR-LOCALIZATION; OWN RECEPTOR; DNA-PKCS; IN-VITRO; ENDOCYTOSIS	RNF144A is a single-pass transmembrane RBR E3 ligase that interacts with and degrades cytoplasmic DNA-PKcs, which is an epidermal growth factor receptor (EGFR)-interacting partner. Interestingly, RNF144A expression is positively correlated with EGFR mRNA and protein levels in several types of cancer. However, the relationship between RNF144A and EGFR is poorly understood. This study reports an unexpected role for RNF144A in the regulation of EGF/EGFR signaling and EGF-dependent cell proliferation. EGFR ligands, but not DNA-damaging agents, induce a DNA-PKcs-independent interaction between RNF144A and EGFR. RNF144A promotes EGFR ubiquitination, maintains EGFR protein, and prolongs EGF/EGFR signaling during EGF stimulation. Moreover, depletion of RNF144A by multiple independent approaches results in a decrease in EGFR expression and EGF/EGFR signaling. RNF144A knockout cells also fail to mount an immediate response to EGF for activation of G(1)/S progression genes. Consequently, depletion of RNF144A reduces EGF-dependent cell proliferation. These defects may be at least in part due to a role for RNF144A in regulating EGFR transport in the intracellular vesicles during EGF treatment.	[Ho, Shiuh-Rong; Lin, Weei-Chin] Baylor Coll Med, Dept Med, Hematol Oncol Sect, Houston, TX 77030 USA; [Lin, Weei-Chin] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Lin, Weei-Chin] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lin, WC (corresponding author), One Baylor Plaza,MS BCM187, Houston, TX 77030 USA.	weeichil@bcm.edu	HO, SHIUH-RONG/M-4728-2019	HO, SHIUH-RONG/0000-0002-9612-722X	National Institutes of Health [R01CA100857, R01CA203824, R01CA138641]; Department of Defense [W81XWH-14-1-0339, W81XWH-14-1-0306]; National Institutes of Health, BCM Oncology Scholars T32 Fellowship [T32CA174647]; NATIONAL CANCER INSTITUTE [R01CA138641, R01CA203824, R21CA198041, T32CA174647, R01CA100857] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Institutes of Health, BCM Oncology Scholars T32 Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01CA100857, R01CA203824, and R01CA138641 and Department of Defense Grants W81XWH-14-1-0339 and W81XWH-14-1-0306. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health, BCM Oncology Scholars T32 Fellowship T32CA174647.	An J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-32; Ayyappan S, 2013, ANTICANCER RES, V33, P4139; Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Baumdick M, 2015, ELIFE, V4, DOI 10.7554/eLife.12223; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; BOMSEL M, 1990, CELL, V62, P719, DOI 10.1016/0092-8674(90)90117-W; Brand TM, 2011, DISCOV MED, V12, P419; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; CLARK AJL, 1985, P NATL ACAD SCI USA, V82, P8374, DOI 10.1073/pnas.82.24.8374; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dittmann K, 2005, RADIOTHER ONCOL, V76, P157, DOI 10.1016/j.radonc.2005.06.022; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; EARP HS, 1986, J BIOL CHEM, V261, P4777; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Ettenberg SA, 2001, J BIOL CHEM, V276, P27677, DOI 10.1074/jbc.M102641200; Friedmann B, 2004, CLIN CANCER RES, V10, P6476, DOI 10.1158/1078-0432.CCR-04-0586; Friedmann BJ, 2006, MOL CANCER THER, V5, P209, DOI 10.1158/1535-7163.MCT-05-0239; GRUENBERG J, 1989, ANNU REV CELL BIOL, V5, P453; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hanada N, 2006, MOL CARCINOGEN, V45, P10, DOI 10.1002/mc.20147; Henriksen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058148; Ho SR, 2015, J BIOL CHEM, V290, P23026, DOI 10.1074/jbc.M115.645499; Ho SR, 2014, P NATL ACAD SCI USA, V111, pE2646, DOI 10.1073/pnas.1323107111; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Kelsall IR, 2013, EMBO J, V32, P2848, DOI 10.1038/emboj.2013.209; KUDLOW JE, 1986, J BIOL CHEM, V261, P4134; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leung L, 2012, THER ADV MED ONCOL, V4, P173, DOI 10.1177/1758834012440015; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lipkowitz S, 2003, BREAST CANCER RES, V5, P8, DOI 10.1186/bcr541; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Miyamoto Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040752; Nakai K, 2016, AM J CANCER RES, V6, P1609; Nakamura N, 2011, MEMBRANES-BASEL, V1, P354, DOI 10.3390/membranes1040354; Oksvold MP, 2002, J CELL SCI, V115, P793; Park SJ, 2017, CELL METAB, V25, P1135, DOI [10.1016/j.cmet.2017.04.008, 10.1016/j.cmet.2017.07.005]; Ray L Bryan, 2017, Science, V356, P1041, DOI 10.1126/science.356.6342.1041-a; Rush JS, 2012, J BIOL CHEM, V287, P712, DOI 10.1074/jbc.M111.294470; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Smit JJ, 2014, EMBO REP, V15, P142, DOI 10.1002/embr.201338166; Spratt DE, 2014, BIOCHEM J, V458, P421, DOI 10.1042/BJ20140006; Szumiel I, 2006, CELL SIGNAL, V18, P1537, DOI 10.1016/j.cellsig.2006.03.010; Takeuchi K, 2011, BIOL PHARM BULL, V34, P1774, DOI 10.1248/bpb.34.1774; Tang H, 2000, J BIOL CHEM, V275, P13420, DOI 10.1074/jbc.275.18.13420; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Wong H, 2013, THER ADV GASTROENTER, V6, P15, DOI 10.1177/1756283X12453636; Wu YH, 2017, CANCER LETT, V400, P79, DOI 10.1016/j.canlet.2017.04.023	58	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16307	16323		10.1074/jbc.RA118.002887	http://dx.doi.org/10.1074/jbc.RA118.002887			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30171075	Green Published, hybrid			2022-12-28	WOS:000447833600016
J	Zhou, Q; An, T; Pham, KTM; Hu, HQ; Li, ZY				Zhou, Qing; An, Tai; Pham, Kieu T. M.; Hu, Huiqing; Li, Ziyin			The CIF1 protein is a master orchestrator of trypanosome cytokinesis that recruits several cytokinesis regulators to the cytokinesis initiation site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; cell division; cytokinesis; tropomyosin; Trypanosoma brucei; CIF1; cleavage furrow; kinesin; KPP1; sleeping sickness	FLAGELLUM ATTACHMENT ZONE; POLO-LIKE KINASE; LIFE-CYCLE; FISSION YEAST; BRUCEI; TROPOMYOSIN; EXPRESSION; MORPHOLOGY; KATANIN; COMPLEX	To proliferate, the parasitic protozoan Trypanosoma brucei undergoes binary fission in a unidirectional manner along the cell's longitudinal axis from the cell anterior toward the cell posterior. This unusual mode of cell division is controlled by a regulatory pathway composed of two evolutionarily conserved protein kinases, Polo-like kinase and Aurora B kinase, and three trypanosome-specific proteins, CIF1, CIF2, and CIF3, which act in concert at the cytokinesis initiation site located at the distal tip of the newly assembled flagellum attachment zone (FAZ). However, additional regulators that function in this cytokinesis signaling cascade remain to be identified and characterized. Using proximity biotinylation, co-immunofluorescence microscopy, and co-immunoprecipitation, we identified 52 CIF1-associated proteins and validated six CIF1-interacting proteins, including the putative protein phosphatase KPP1, the katanin p80 subunit KAT80, the cleavage furrow-localized proteins KLIF and FRW1, and the FAZ tip-localized proteins FAZ20 and FPRC. Further analyses of the functional interplay between CIF1 and its associated proteins revealed a requirement of CIF1 for localization of a set of CIF1-associated proteins, an interdependence between KPP1 and CIF1, and an essential role of katanin in the completion of cleavage furrow ingression. Together, these results suggest that CIF1 acts as a master regulator of cytokinesis in T. brucei by recruiting a cohort of cytokinesis regulatory proteins to the cytokinesis initiation site.	[Zhou, Qing; An, Tai; Pham, Kieu T. M.; Hu, Huiqing; Li, Ziyin] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, McGovern Med Sch, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Li, ZY (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, McGovern Med Sch, Houston, TX 77030 USA.	Ziyin.Li@uth.tmc.edu	Zhou, Qing/I-6223-2019; Zhou, Qing/A-8296-2019	Zhou, Qing/0000-0003-2096-1960; Zhou, Qing/0000-0003-2096-1960; Li, Ziyin/0000-0002-3960-9716	National Institutes of Health [AI101437, AI118736]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118736, R01AI101437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI101437 and AI118736 (to Z.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Benz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030367; Casanova M, 2009, MOL MICROBIOL, V71, P1353, DOI 10.1111/j.1365-2958.2009.06594.x; Cranz-Mileva S, 2015, BIOL OPEN, V4, P1040, DOI 10.1242/bio.012609; Crozier TWM, 2018, MOL CELL PROTEOMICS, V17, P1184, DOI 10.1074/mcp.RA118.000650; de Graffenried CL, 2008, J CELL BIOL, V181, P431, DOI 10.1083/jcb.200708082; de Jong RN, 2008, STRUCTURE, V16, P149, DOI 10.1016/j.str.2007.10.018; Dean S, 2017, TRENDS PARASITOL, V33, P80, DOI 10.1016/j.pt.2016.10.009; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hilton NA, 2018, MOL MICROBIOL, V109, P306, DOI 10.1111/mmi.13986; Hu HQ, 2017, J CELL SCI, V130, P4108, DOI 10.1242/jcs.207134; Hu HQ, 2015, J BIOL CHEM, V290, P30453, DOI 10.1074/jbc.M115.694109; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; Kurasawa Y, 2018, J BIOL CHEM, V293, P10275, DOI 10.1074/jbc.RA118.003113; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Li ZY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000575; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McNally KP, 2000, J CELL SCI, V113, P1623; Morriswood B, 2013, EUKARYOT CELL, V12, P356, DOI 10.1128/EC.00326-12; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Shen SY, 2001, MOL BIOCHEM PARASIT, V113, P171, DOI 10.1016/S0166-6851(00)00383-2; Sunter JD, 2016, TRENDS PARASITOL, V32, P309, DOI 10.1016/j.pt.2015.12.010; Tu XM, 2006, J BIOL CHEM, V281, P9677, DOI 10.1074/jbc.M511504200; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Whitby FG, 2000, PROTEINS, V38, P49; Wier AD, 2013, P NATL ACAD SCI USA, V110, P17290, DOI 10.1073/pnas.1314754110; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zhou Q, 2018, J BIOL CHEM, V293, P8508, DOI 10.1074/jbc.RA118.002106; Zhou Q, 2016, J BIOL CHEM, V291, P14395, DOI 10.1074/jbc.M116.726133; Zhou Q, 2016, P NATL ACAD SCI USA, V113, P3287, DOI 10.1073/pnas.1601596113; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676	38	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16177	16192		10.1074/jbc.RA118.004888	http://dx.doi.org/10.1074/jbc.RA118.004888			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30171070	Green Published, hybrid			2022-12-28	WOS:000447833600007
J	Hans, F; Eckert, M; von Zweydorf, F; Gloeckner, CJ; Kahle, PJ				Hans, Friederike; Eckert, Marita; von Zweydorf, Felix; Gloeckner, Christian Johannes; Kahle, Philipp J.			Identification and characterization of ubiquitinylation sites in TAR DNA-binding protein of 43 kDa (TDP-43)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteasome; protein aggregation; protein phosphorylation; ubiquitylation (ubiquitination); mass spectrometry (MS); site-directed mutagenesis; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); neurodegeneration; frontotemporal dementia; TDP-43	AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; PHOSPHORYLATION-DEPENDENT UBIQUITINATION; NUCLEOCYTOPLASMIC TRANSPORT; TERMINAL FRAGMENTS; PROTEASOME SYSTEM; NUCLEAR IMPORT; DISEASE; ALS; DEGRADATION	TAR DNA-binding protein of 43 kDa (TDP-43) forms pathological aggregates in neurodegenerative diseases, particularly in certain forms of frontotemporal dementia and amyotrophic lateral sclerosis. Pathological modifications of TDP-43 include proteolytic fragmentation, phosphorylation, and ubiquitinylation. A pathognomonic TDP-43 C-terminal fragment (CTF) spanning amino acids 193-414 contains only four lysine residues that could be potentially ubiquitinylated. Here, serial mutagenesis of these four lysines to arginine revealed that not a single residue is responsible for the ubiquitinylation of mCherry-tagged CTF. Removal of all four lysines was necessary to suppress ubiquitinylation. Interestingly, Lys-408 substitution enhanced the pathological phosphorylation of the immediately adjacent serine residues 409/410 in the context of mCherry-CTF. Thus, Lys-408 ubiquitinylation appears to hinder Ser-409/410 phosphorylation in TDP-43 CTF. However, we did not observe the same effect for full-length TDP-43. We extended the mutagenesis study to full-length TDP-43 and performed MS. Ubiquitinylated lysine residues were identified in the nuclear localization sequence (NLS; Lys-84 and Lys-95) and RNA-binding region (mostly Lys-160, Lys-181, and Lys-263). Mutagenesis of Lys-84 confirmed its importance as the major determinant for nuclear import, whereas Lys-95 mutagenesis did not significantly affect TDP-43's nucleo-cytoplasmic distribution, solubility, aggregation, and RNA-processing activities. Nevertheless, the K95A mutant had significantly reduced Ser-409/410 phosphorylation, emphasizing the suspected interplay between TDP-43 ubiquitinylation and phosphorylation. Collectively, our analysis of TDP-43 ubiquitinylation sites indicates that the NLS residues Lys-84 and Lys-95 have more prominent roles in TDP-43 function than the more C-terminal lysines and suggests a link between specific ubiquitinylation events and pathological TDP-43 phosphorylation.	[Hans, Friederike; Eckert, Marita; von Zweydorf, Felix; Gloeckner, Christian Johannes; Kahle, Philipp J.] German Ctr Neurodegenerat Dis DZNE, D-72076 Tubingen, Germany; [Hans, Friederike; Eckert, Marita; Kahle, Philipp J.] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, D-72076 Tubingen, Germany; [Gloeckner, Christian Johannes] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Kahle, PJ (corresponding author), Univ Tubingen, Lab Funct Neurogenet, Dept Neurodegenerat, German Ctr Neurodegenerat Dis, Otfried Muller Str 27, D-72076 Tubingen, Germany.; Kahle, PJ (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Fac Med, Otfried Muller Str 27, D-72076 Tubingen, Germany.	philipp.kahle@uni-tuebingen.de	Gloeckner, Christian Johannes/R-5374-2019	Gloeckner, Christian Johannes/0000-0001-6494-6944	NOMIS Foundation; German Research Foundation (DFG) [KA1675/3-2]; German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association; Hertie Foundation	NOMIS Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association; Hertie Foundation	This work was supported by the NOMIS Foundation, German Research Foundation (DFG) Grant KA1675/3-2, the German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, and the Hertie Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Akutsu M, 2016, J CELL SCI, V129, P875, DOI 10.1242/jcs.183954; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Araki W, 2014, MOL NEUROBIOL, V50, P1049, DOI 10.1007/s12035-014-8644-6; Aulas A, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00423, 10.3389/fncel.2015.00423]; Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x; Buratti E, 2018, EXPERT OPIN THER TAR, V22, P279, DOI 10.1080/14728222.2018.1439923; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Choi JY, 2007, MOL CELL NEUROSCI, V34, P69, DOI 10.1016/j.mcn.2006.10.002; Chou CC, 2018, NAT NEUROSCI, V21, P228, DOI 10.1038/s41593-017-0047-3; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Cohen TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6845; Dammer EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038658; Davidson YS, 2011, ACTA NEUROPATHOL, V122, P703, DOI 10.1007/s00401-011-0879-y; Dormann D, 2012, EMBO J, V31, P4258, DOI 10.1038/emboj.2012.261; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gloeckner Christian Johannes, 2009, Methods Mol Biol, V564, P359, DOI 10.1007/978-1-60761-157-8_21; Hans F, 2014, J BIOL CHEM, V289, P19164, DOI 10.1074/jbc.M114.561704; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Hebron M, 2014, J NEUROCHEM, V129, P350, DOI 10.1111/jnc.12630; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Jadhav Trafina, 2009, J Proteomics Bioinform, V2, P316; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kai M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115111; Kametani F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23281; Kapeli K, 2017, HUM GENET, V136, P1193, DOI 10.1007/s00439-017-1830-7; Kim HJ, 2017, NEURON, V96, P285, DOI 10.1016/j.neuron.2017.07.029; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kinoshita Y, 2009, J NEUROPATH EXP NEUR, V68, P1184, DOI 10.1097/NEN.0b013e3181bc3bec; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lee S, 2015, FEBS LETT, V589, P1825, DOI 10.1016/j.febslet.2015.05.040; Liachko NF, 2010, J NEUROSCI, V30, P16208, DOI 10.1523/JNEUROSCI.2911-10.2010; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Ling H, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.04.011; Marchenko ND, 2010, CELL DEATH DIFFER, V17, P255, DOI 10.1038/cdd.2009.173; Martinez-Lopez N, 2015, ADV EXP MED BIOL, V847, P73, DOI 10.1007/978-1-4939-2404-2_3; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Nishimura AL, 2010, BRAIN, V133, P1763, DOI 10.1093/brain/awq111; Pentecost M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004739; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Ratti A, 2016, J NEUROCHEM, V138, P95, DOI 10.1111/jnc.13625; Ruegsegger C, 2016, BRAIN RES, V1648, P571, DOI 10.1016/j.brainres.2016.03.032; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Seyfried NT, 2010, MOL CELL PROTEOMICS, V9, P705, DOI 10.1074/mcp.M800390-MCP200; Skaug B, 2010, CELL, V143, P187, DOI 10.1016/j.cell.2010.09.033; Suzuki H, 2011, J BIOL CHEM, V286, P13171, DOI 10.1074/jbc.M110.197483; Urushitani M, 2010, J NEUROSCI RES, V88, P784, DOI 10.1002/jnr.22243; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; van Eersel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022850; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Walker AK, 2015, HUM MOL GENET, V24, P7241, DOI 10.1093/hmg/ddv424; Wang P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00088-4; Wang XJ, 2010, NEUROSCI LETT, V469, P112, DOI 10.1016/j.neulet.2009.11.055; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yokota O, 2010, ACTA NEUROPATHOL, V120, P55, DOI 10.1007/s00401-010-0702-1; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33	67	21	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16083	16099		10.1074/jbc.RA118.003440	http://dx.doi.org/10.1074/jbc.RA118.003440			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30120199	Green Published, hybrid			2022-12-28	WOS:000447256000027
J	Koenigsberg, AL; Heldwein, EE				Koenigsberg, Andrea L.; Heldwein, Ekaterina E.			The dynamic nature of the conserved tegument protein UL37 of herpesviruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						herpesvirus; viral protein; multifunctional protein; small-angle X-ray scattering (SAXS); structural model; conformational flexibility; multi-angle light scattering; tegument; Thermofluor	HERPES-SIMPLEX-VIRUS; SMALL-ANGLE SCATTERING; SECONDARY ENVELOPMENT; CAPSID TRANSPORT; NULL MUTATION; GENE-PRODUCT; TYPE-1; RESOLUTION; INTERACTS; ALPHAHERPESVIRUSES	In all herpesviruses, the space between the capsid shell and the lipid envelope is occupied by the unique tegument layer composed of proteins that, in addition to structural roles, play many other roles in the viral replication. UL37 is a highly conserved tegument protein that has activities ranging from virion morphogenesis to directional capsid trafficking to manipulation of the host innate immune response and binds multiple partners. The N-terminal half of UL37 (UL37N) has a compact bean-shaped alpha-helical structure that contains a surface region essential for neuroinvasion. However, no biochemical or structural information is currently available for the C-terminal half of UL37 (UL37C) that mediates most of its interactions with multiple binding partners. Here, we show that the C-terminal half of UL37 from pseudorabies virus UL37C is a conformationally flexible monomer composed of an elongated folded core and an unstructured C-terminal tail. This elongated structure, along with that of its binding partner UL36, explains the nature of filamentous tegument structures bridging the capsid and the envelope. We propose that the dynamic nature of UL37 underlies its ability to perform diverse roles during viral replication.	[Heldwein, Ekaterina E.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; Tufts Univ, Sch Med, Grad Program Mol Microbiol, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA	Tufts University; Tufts University	Heldwein, EE (corresponding author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA.	katya.heldwein@tufts.edu		Heldwein, Ekaterina/0000-0003-3113-6958	National Science Foundation; NIGMS/National Institutes of Health under NSF [DMR-0936384]; NIGMS/National Institutes of Health [GM-103485]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056346, T32AI007422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIGMS/National Institutes of Health under NSF; NIGMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Xuanzong Guo for purifying PreScission protease and Abraham Sonenshein for the use of the Roche LightCycler 480 quantitative PCR machine. We thank MacCHESS BioSAXS staff for help with SAXS data collection and analysis, especially Jesse Hopkins for helpful discussions. We also thank Peter Cherepanov (Francis Crick Institute) for the gift of the GST-PreScission protease expression plasmid and Thomas Schwartz (Massachusetts Institute of Technology) for the gift of LoBSTr cells. Multi-angle light scattering experiments were performed at the Center for Macromolecular Interactions in the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. All software was installed and maintained by SBGrid (47). This work is based upon research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation and NIGMS/National Institutes of Health under NSF award DMR-0936384, using the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by NIGMS/National Institutes of Health Grant GM-103485.	Abaitua F, 2012, J VIROL, V86, P8998, DOI 10.1128/JVI.01209-12; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bucks MA, 2011, VIROLOGY, V416, P42, DOI 10.1016/j.virol.2011.04.018; CAMPBELL MEM, 1984, J MOL BIOL, V180, P1, DOI 10.1016/0022-2836(84)90427-3; Dai XH, 2018, SCIENCE, V360, P47, DOI 10.1126/science.aao7298; Darling AL, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00158; Desai P, 2001, J VIROL, V75, P10259, DOI 10.1128/JVI.75.21.10259-10271.2001; Desai PJ, 2000, J VIROL, V74, P11608, DOI 10.1128/JVI.74.24.11608-11618.2000; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franzosa EA., 2009, EXPT STANDARD CONDIT, P99; Fuchs W, 2004, J VIROL, V78, P11879, DOI 10.1128/JVI.78.21.11879-11889.2004; Galzitskaya OV, 2006, BIOINFORMATICS, V22, P2948, DOI 10.1093/bioinformatics/btl504; Grunewald K, 2003, SCIENCE, V302, P1396, DOI 10.1126/science.1090284; Hollinshead M, 2012, EMBO J, V31, P4204, DOI 10.1038/emboj.2012.262; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; Hsu WL, 2013, PROTEIN SCI, V22, P258, DOI 10.1002/pro.2207; Jambunathan N, 2014, J VIROL, V88, P5927, DOI 10.1128/JVI.00278-14; Kattenhorn LM, 2005, MOL CELL, V19, P547, DOI 10.1016/j.molcel.2005.07.003; Kelly BJ, 2009, VIRUS RES, V145, P173, DOI 10.1016/j.virusres.2009.07.007; Klupp BG, 2002, J VIROL, V76, P3065, DOI 10.1128/JVI.76.6.3065-3071.2002; Klupp BG, 2001, J VIROL, V75, P8927, DOI 10.1128/JVI.75.19.8927-8936.2001; Koenigsberg AL, 2017, J VIROL, V91, DOI 10.1128/JVI.01244-17; Laine RF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6980; Leege T, 2009, J GEN VIROL, V90, P1560, DOI 10.1099/vir.0.010322-0; Liu XQ, 2008, P NATL ACAD SCI USA, V105, P11335, DOI 10.1073/pnas.0801617105; Luxton GWG, 2006, J VIROL, V80, P201, DOI 10.1128/JVI.80.1.201-209.2006; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MCLAUCHLAN J, 1992, J GEN VIROL, V73, P269, DOI 10.1099/0022-1317-73-2-269; Merkley ED, 2014, PROTEIN SCI, V23, P747, DOI 10.1002/pro.2458; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Ortega E, 2016, J BIOL CHEM, V291, P18643, DOI 10.1074/jbc.M116.732909; Owen DJ, 2015, VIRUSES-BASEL, V7, P5084, DOI 10.3390/v7092861; Pasdeloup D, 2013, J VIROL, V87, P2857, DOI 10.1128/JVI.02676-12; Phillips Kevin, 2011, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1028s94; Pitts JD, 2014, J VIROL, V88, P5462, DOI 10.1128/JVI.00163-14; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Richards AL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006741; Schipke J, 2012, J VIROL, V86, P3682, DOI 10.1128/JVI.06432-11; Scrima N, 2015, J BIOL CHEM, V290, P8820, DOI 10.1074/jbc.M114.612838; Smiley JR, 2004, J VIROL, V78, P1063, DOI 10.1128/JVI.78.3.1063-1068.2004; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tamarozzi ER, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010198; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Turcotte S, 2005, J VIROL, V79, P8847, DOI 10.1128/JVI.79.14.8847-8860.2005; Tuukkanen AT, 2016, IUCRJ, V3, P440, DOI 10.1107/S2052252516016018; Vittone V, 2005, J VIROL, V79, P9566, DOI 10.1128/JVI.79.15.9566-9571.2005; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Xue B, 2010, PROTEIN PEPTIDE LETT, V17, P932, DOI 10.2174/092986610791498984; Zhao J, 2016, CELL HOST MICROBE, V20, P770, DOI 10.1016/j.chom.2016.10.011	51	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15827	15839		10.1074/jbc.RA118.004481	http://dx.doi.org/10.1074/jbc.RA118.004481			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30166339	Green Published, hybrid			2022-12-28	WOS:000447256000007
J	Schrader, CU; Heinz, A; Majovsky, P; Mayack, BK; Brinckmann, J; Sippl, W; Schmelzer, CEH				Schraeder, Christoph U.; Heinz, Andrea; Majovsky, Petra; Mayack, Berin Karaman; Brinckmann, Juergen; Sippl, Wolfgang; Schmelzer, Christian E. H.			Elastin is heterogeneously cross-linked	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular matrix protein; elastin; lysyl oxidase; mass spectrometry (MS); protein cross-linking; protein structure; allysine aldol; desmosine; elastin; elastic fibers; lysinonorleucine	LINKING AMINO-ACID; HUMAN SKIN ELASTIN; BOVINE ELASTIN; IN-VITRO; HUMAN TROPOELASTIN; PORCINE AORTA; LYSYL OXIDASE; PROTEIN; PEPTIDES; DOMAIN	Elastin is an essential vertebrate protein responsible for the elasticity of force-bearing tissues such as those of the lungs, blood vessels, and skin. One of the key features required for the exceptional properties of this durable biopolymer is the extensive covalent cross-linking between domains of its monomer molecule tropoelastin. To date, elastin's exact molecular assembly and mechanical properties are poorly understood. Here, using bovine elastin, we investigated the different types of cross-links in mature elastin to gain insight into its structure. We purified and proteolytically cleaved elastin from a single tissue sample into soluble cross-linked and noncross-linked peptides that we studied by high-resolution MS. This analysis enabled the elucidation of cross-links and other elastin modifications. We found that the lysine residues within the tropoelastin sequence were simultaneously unmodified and involved in various types of cross-links with different other domains. The Lys-Pro domains were almost exclusively linked via lysinonorleucine, whereas Lys-Ala domains were found to be cross-linked via lysinonorleucine, allysine aldol, and desmosine. Unexpectedly, we identified a high number of intramolecular cross-links between lysine residues in close proximity. In summary, we show on the molecular level that elastin formation involves random cross-linking of tropoelastin monomers resulting in an unordered network, an unexpected finding compared with previous assumptions of an overall beaded structure.	[Sippl, Wolfgang; Schmelzer, Christian E. H.] Martin Luther Univ Halle Wittenberg, Inst Pharm, D-06120 Halle, Saale, Germany; [Heinz, Andrea] Univ Copenhagen, Dept Pharm, DK-2100 Copenhagen, Denmark; [Majovsky, Petra] Leibniz Inst Plant Biochem, Proteome Analyt Res Grp, D-06120 Halle, Saale, Germany; [Brinckmann, Juergen] Univ Lubeck, Dept Dermatol, Inst Virol & Cell Biol, D-23538 Lubeck, Germany; [Schmelzer, Christian E. H.] Fraunhofer Inst Microstruct Mat & Syst IMWS, Walter Hulse Str 1, D-06120 Halle, Saale, Germany; [Schraeder, Christoph U.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4Z6, Canada; [Mayack, Berin Karaman] Biruni Univ, Fac Pharm, Dept Pharmaceut Chem, TR-34010 Istanbul, Turkey	Martin Luther University Halle Wittenberg; University of Copenhagen; Leibniz Institut fur Pflanzenbiochemie; University of Lubeck; Fraunhofer Gesellschaft; University of Calgary; Biruni University	Schmelzer, CEH (corresponding author), Fraunhofer Inst Microstruct Mat & Syst IMWS, Walter Hulse Str 1, D-06120 Halle, Saale, Germany.	schmelzer@pharmazie.uni-halle.de	Heinz, Andreas/ABB-7736-2020; Schmelzer, Christian/AAG-1246-2019; Sippl, Wolfgang/P-5944-2014; Heinz, Andrea/ABL-8318-2022	Heinz, Andreas/0000-0001-5405-9065; Schmelzer, Christian/0000-0002-1180-0201; Sippl, Wolfgang/0000-0002-5985-9261; Heinz, Andrea/0000-0002-8609-4460	German Research Foundation (DFG) [HE 6190/1-2]; LEO Foundation Center for Cutaneous Drug Delivery Grant [2016-11-01]; European Regional Development Fund of the European Commission; Fraunhofer Internal Programs [Attract 069-608203]	German Research Foundation (DFG)(German Research Foundation (DFG)); LEO Foundation Center for Cutaneous Drug Delivery Grant; European Regional Development Fund of the European Commission; Fraunhofer Internal Programs	This work was supported by the German Research Foundation (DFG) Grant HE 6190/1-2 (to A. H.), LEO Foundation Center for Cutaneous Drug Delivery Grant 2016-11-01 (to A. H.), the European Regional Development Fund of the European Commission (to C. U. S.), and the Fraunhofer Internal Programs under Grant Attract 069-608203 (to C. E. H. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Akagawa M, 1999, ARCH BIOCHEM BIOPHYS, V372, P112, DOI 10.1006/abbi.1999.1462; Akagawa M, 2000, CONNECT TISSUE RES, V41, P131, DOI 10.3109/03008200009067665; Akhtart K, 2011, J BIOL CHEM, V286, P13574, DOI 10.1074/jbc.M110.192088; BAIG KM, 1980, BIOCHEM J, V185, P611, DOI 10.1042/bj1850611; Baldock C, 2011, P NATL ACAD SCI USA, V108, P4322, DOI 10.1073/pnas.1014280108; Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525; Bochicchio B, 2013, BIOMACROMOLECULES, V14, P4278, DOI 10.1021/bm4011529; Broekelmann TJ, 2008, MATRIX BIOL, V27, P631, DOI 10.1016/j.matbio.2008.06.001; BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Chung MIS, 2006, MATRIX BIOL, V25, P492, DOI 10.1016/j.matbio.2006.08.258; Clarke AW, 2006, BIOCHEMISTRY-US, V45, P9989, DOI 10.1021/bi0610092; DAVRIL M, 1976, INT J PEPT PROT RES, V8, P177; DAVRIL M, 1974, FEBS LETT, V43, P331, DOI 10.1016/0014-5793(74)80673-3; Dyksterhuis LB, 2007, MATRIX BIOL, V26, P125, DOI 10.1016/j.matbio.2006.10.002; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; FRANCIS G, 1973, BIOCHEM J, V136, P45, DOI 10.1042/bj1360045; FRANZBLA.C, 1969, BIOCHEMISTRY-US, V8, P2833, DOI 10.1021/bi00835a021; GERBER GE, 1975, BIOCHEM J, V149, P685, DOI 10.1042/bj1490685; GERBER GE, 1974, J BIOL CHEM, V249, P5200; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; GRAY WR, 1973, NATURE, V246, P461, DOI 10.1038/246461a0; Han Yonghua, 2005, Journal of Bioinformatics and Computational Biology, V3, P697; He D, 2007, MATRIX BIOL, V26, P524, DOI 10.1016/j.matbio.2007.05.005; Heinz A, 2014, MATRIX BIOL, V38, P12, DOI 10.1016/j.matbio.2014.07.006; Heinz A, 2013, BBA-GEN SUBJECTS, V1830, P2994, DOI 10.1016/j.bbagen.2013.01.014; Heinz A, 2012, BIOCHIMIE, V94, P192, DOI 10.1016/j.biochi.2011.10.006; Heinz A, 2011, BIOCHIMIE, V93, P187, DOI 10.1016/j.biochi.2010.09.011; Heinz A, 2010, FEBS J, V277, P1939, DOI 10.1111/j.1742-4658.2010.07616.x; HOEVE CAJ, 1974, BIOPOLYMERS, V13, P677, DOI 10.1002/bip.1974.360130404; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; KAGAN HM, 1984, J BIOL CHEM, V259, P1203; Kim J, 2017, J BIOMECH, V61, P199, DOI 10.1016/j.jbiomech.2017.07.011; Kim WM, 2000, MOL CELLS, V10, P498, DOI 10.1007/s10059-000-0498-2; Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200; LENT RW, 1969, BIOCHEMISTRY-US, V8, P2837, DOI 10.1021/bi00835a022; Li B, 2001, J AM CHEM SOC, V123, P11991, DOI 10.1021/ja010363e; Miao M, 2009, MATRIX BIOL, V28, P432, DOI 10.1016/j.matbio.2009.07.003; Mithieux SM, 2005, J STRUCT BIOL, V149, P282, DOI 10.1016/j.jsb.2004.11.005; Moon HJ, 2014, BIOORG CHEM, V57, P231, DOI 10.1016/j.bioorg.2014.07.003; NAKAMURA F, 1992, BIOCHEM BIOPH RES CO, V186, P1533, DOI 10.1016/S0006-291X(05)81581-5; Ongay S, 2013, J AM SOC MASS SPECTR, V24, P83, DOI 10.1007/s13361-012-0504-x; PARTRIDGE SM, 1963, NATURE, V197, P1297, DOI 10.1038/1971297a0; RAJU K, 1987, J BIOL CHEM, V262, P5755; Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008; Rauscher S, 2017, ELIFE, V6, DOI 10.7554/eLife.26526; Rietschel B, 2009, MOL CELL PROTEOMICS, V8, P1029, DOI 10.1074/mcp.M800223-MCP200; RUCKER RB, 1978, AM J CLIN NUTR, V31, P1221, DOI 10.1093/ajcn/31.7.1221; SAGE H, 1979, COMP BIOCHEM PHYS B, V64, P313, DOI 10.1016/0305-0491(79)90277-3; SAGE H, 1982, J INVEST DERMATOL, V79, pS146, DOI 10.1111/1523-1747.ep12546048; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Schmelzer CEH, 2005, J CHROMATOGR A, V1083, P120, DOI 10.1016/j.chroma.2005.06.034; Schmelzer CEH, 2016, BBA-GEN SUBJECTS, V1860, P2169, DOI 10.1016/j.bbagen.2016.05.013; Schmelzer CEH, 2012, FEBS J, V279, P4191, DOI 10.1111/febs.12012; Schmutz C, 2016, EPIDEMIOL INFECT, P1; Schrader CU, 2015, J AM SOC MASS SPECTR, V26, P762, DOI 10.1007/s13361-014-1075-9; Taddese S, 2008, MATRIX BIOL, V27, P420, DOI 10.1016/j.matbio.2008.02.001; Tamburro AM, 2003, BIOCHEMISTRY-US, V42, P13347, DOI 10.1021/bi034837t; Tamburro AM, 2006, BIOCHEMISTRY-US, V45, P9518, DOI 10.1021/bi060289i; Umeda H, 2011, BIOCHEM BIOPH RES CO, V411, P281, DOI 10.1016/j.bbrc.2011.06.124; Wise SG, 2014, ACTA BIOMATER, V10, P1532, DOI 10.1016/j.actbio.2013.08.003; YEH H, 1987, COLLAGEN REL RES, V7, P235	64	29	31	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15107	15119		10.1074/jbc.RA118.004322	http://dx.doi.org/10.1074/jbc.RA118.004322			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30108173	Green Published, hybrid			2022-12-28	WOS:000445998400014
J	Lin, LL; Liang, LN; Yang, X; Sun, H; Li, Y; Pei, DQ; Zheng, H				Lin, Lilong; Liang, Lining; Yang, Xiao; Sun, Hao; Li, Yuan; Pei, Duanqing; Zheng, Hui			The homeobox transcription factor MSX2 partially mediates the effects of bone morphogenetic protein 4 (BMP4) on somatic cell reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						reprogramming; bone morphogenetic protein (BMP); cadherin-1 (CDH1); epithelial cadherin (E-cadherin); GATA transcription factor; Kruppel-like factor 4 (KLF4); homeobox transcription factor; MET; Msx2; Sall4; stem cell	PLURIPOTENT STEM-CELLS; MESENCHYMAL TRANSITION; HUMAN FIBROBLASTS; INDUCTION; EXPRESSION; EVOLUTION; GROWTH; HOX-8; GENE; EMT	Bone morphogenetic proteins (BMPs) induce mesenchymal-epithelial transition (MET) and enhance the generation of induced pluripotent stem cells (iPSCs). However, BMPs are also signaling molecules critical for arresting reprogramming in the pre-iPSC state. In this study, using mouse embryonic fibroblasts, we found that the time- and concentration-dependent effects of BMPs on reprogramming are mediated by Msh homeobox 2 (MSX2), a homeobox-containing transcription factor. BMPs up-regulated Msx2 by activating SMAD1/5, and MSX2 then directly bound to the promoters and up-regulated the expression of the cadherin 1 (Cdh1, also known as E-cadherin), GATA-binding protein 3 (Gata3), and Nanog genes. Cdh1 contributed to BMP4- and MSX2-induced MET and subsequently promoted reprogramming. On the other hand, GATA3 promoted reprogramming, possibly by up-regulating Spalt-like transcription factor 4 (SALL4) expression. As key transcriptional factors in maintaining pluripotency, up-regulation of SALL4 and NANOG enhanced reprogramming. Moreover, the ability of MSX2 to up-regulate Cdh1, Gata3, Nanog, and Sall4 was further potentiated in the presence of Kruppel-like factor 4 (KLF4). However, MSX2 did not mediate the effects of BMP4 signaling on activation of the microRNAs miR-205 and miR-200 or the inhibitory effects that arrested reprogramming in the pre-iPSC state. In conclusion, MSX2 partially mediates the effects of BMP4 signaling during reprogramming, improving our understanding of the role of BMP signaling in MET and of the connection between cell lineage specifiers such as MSX2 and GATA3 and pluripotency.	[Lin, Lilong; Liang, Lining; Yang, Xiao; Sun, Hao; Li, Yuan; Pei, Duanqing; Zheng, Hui] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Joint Sch Life Sci, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Lin, Lilong; Liang, Lining; Yang, Xiao; Sun, Hao; Li, Yuan; Pei, Duanqing; Zheng, Hui] Guangzhou Med Univ, Guangzhou 511436, Guangdong, Peoples R China; [Lin, Lilong; Liang, Lining; Yang, Xiao; Sun, Hao; Li, Yuan; Pei, Duanqing; Zheng, Hui] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Lin, Lilong; Liang, Lining; Yang, Xiao; Sun, Hao; Li, Yuan; Pei, Duanqing; Zheng, Hui] Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Lin, Lilong; Liang, Lining; Yang, Xiao; Sun, Hao; Li, Yuan; Pei, Duanqing; Zheng, Hui] Guangzhou Regenerat Med & Hlth Guangdong Lab GRMH, Guangzhou 510530, Guangdong, Peoples R China; [Lin, Lilong; Liang, Lining; Yang, Xiao; Zheng, Hui] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Guangzhou Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Chinese Academy of Sciences	Zheng, H (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, 190 Kaiyuan Ave, Guangzhou 510530, Guangdong, Peoples R China.	zheng_hui@gibh.ac.cn		Zheng, Hui/0000-0001-6801-0529	National Natural Science Foundation of China [U1601228, 31671475, 31422032, 31421004]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA16000000]; Key Research Program of Frontier Sciences, Chinese Academy of Sciences [QYZDB-SSW-SMC031]; Guangdong Natural Science Foundation [2014A030308002]; Science and Technology Planning Project of Guangdong Province [2017B030314056]; Guangzhou branch of the Supercomputing Center of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Key Research Program of Frontier Sciences, Chinese Academy of Sciences; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; Guangzhou branch of the Supercomputing Center of the Chinese Academy of Sciences	This work was supported by the National Natural Science Foundation of China (U1601228, 31671475, 31422032, and 31421004); the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA16000000); the Key Research Program of Frontier Sciences, Chinese Academy of Sciences (QYZDB-SSW-SMC031); the Guangdong Natural Science Foundation (2014A030308002); and the Science and Technology Planning Project of Guangdong Province (2017B030314056). This work was also supported by the Guangzhou branch of the Supercomputing Center of the Chinese Academy of Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	BELL JR, 1993, GENOMICS, V16, P123, DOI 10.1006/geno.1993.1149; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Cheng SL, 2013, ARTERIOSCL THROM VAS, V33, P1679, DOI 10.1161/ATVBAHA.113.300647; DAVIDSON D, 1995, TRENDS GENET, V11, P405, DOI 10.1016/S0168-9525(00)89124-6; Di Bari MG, 2009, J CELL PHYSIOL, V219, P659, DOI 10.1002/jcp.21712; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li Y, 2010, J CELL BIOCHEM, V111, P1346, DOI 10.1002/jcb.22861; Liang LN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156839; Liu XP, 2013, NAT CELL BIOL, V15, P829, DOI 10.1038/ncb2765; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; MACKENZIE A, 1992, DEVELOPMENT, V115, P403; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Newberry EP, 1997, BIOCHEMISTRY-US, V36, P10451, DOI 10.1021/bi971008x; Richter A, 2014, STEM CELLS, V32, P636, DOI 10.1002/stem.1592; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Shu J, 2015, CELL RES, V25, P169, DOI 10.1038/cr.2015.6; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Wu QQ, 2015, CELL RES, V25, P1314, DOI 10.1038/cr.2015.118; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504	33	3	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14905	14915		10.1074/jbc.RA118.003913	http://dx.doi.org/10.1074/jbc.RA118.003913			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30097516	hybrid, Green Published			2022-12-28	WOS:000446155000025
J	Liu, XJ; Zhang, WJ; Wu, ZJ; Yang, YT; Kang, YJ				Liu, Xiaojuan; Zhang, Wenjing; Wu, Zhijuan; Yang, Yutao; Kang, Y. James			Copper levels affect targeting of hypoxia-inducible factor 1 alpha to the promoters of hypoxia-regulated genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypoxia-inducible factor (HIF); copper; transcription target gene; chromatin immunoprecipitation (ChIP); gene regulation; BNIP3; hypoxia responsive element; IGF2	MYOCARDIAL-ISCHEMIA; BREAST-CANCER; UP-REGULATION; HIF-ALPHA; FACTOR-I; ACTIVATION; EXPRESSION; METHYLATION; COMPLEX; IDENTIFICATION	Hypoxia-inducible factor 1 alpha (HIF-1 alpha) is a transcription factor that regulates cellular responses to hypoxia. It controls the expression of both BCL2/adenovirus E1B 19-kDa protein-interacting protein 3 (BNIP3) and insulin-like growth factor 2 (IGF2). Previous studies have demonstrated that in hypoxia, copper is required for the expression of BNIP3 but not for that of IGF2. Here, using ChIP assays, computational analyses, luciferase reporter assays, and real-time quantitative RT-PCR, we sought to better understand how copper regulates the differential target gene selectivity of HIF-1 alpha. Human umbilical vein endothelial cells (HUVECs) were exposed to CoCl2 or hypoxia conditions to increase HIF-1 alpha accumulation. The binding of HIF-1 alpha to hypoxia-responsive element (HRE) sites in the BNIP3 or IGF2 gene promoter in high- or low-copper conditions was examined. Our analyses revealed three and two potential HRE sites in the BNIP3 and IGF2 promoters, respectively. We identified that HRE (-412/-404) in the BNIP3 promoter and HRE (-354/-347) in the IGF2 promoter are the critical binding sites of HIF-1 alpha. Tetraethelenepentamine (TEPA)-mediated reduction in copper concentration did not affect hypoxia- or CoCl2-induced HIF-1 alpha accumulation. However, the copper reduction did suppress the binding of HIF-1 alpha to the HRE (-412/-404) in BNIP3 but not the binding of HIF-1 alpha to the HRE (-354/-347) in IGF2. In summary, our findings uncovered the mechanistic basis for differential HIF-1 alpha-mediated regulation of BNIP3 and IGF2, indicating that copper regulates target gene selectivity of HIF-1 alpha at least in part by affecting HIF-1 alpha binding to its cognate HRE in the promoters of these two genes.	[Liu, Xiaojuan; Zhang, Wenjing; Wu, Zhijuan; Yang, Yutao; Kang, Y. James] Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China	Sichuan University	Kang, YJ (corresponding author), Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China.	jameskang@vip.163.com		WU, Zhijuan/0000-0001-5878-108X	National Natural Science Foundation of China [81600214, 81230004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 81600214 (to W. Z.) and 81230004 (to Y. J. Kang). The authors declare that they have no conflicts of interest with the contents of this article.	Bacon AL, 2007, ONCOGENE, V26, P132, DOI 10.1038/sj.onc.1209761; Baharvand Maryam, 2014, Biomed J, V37, P331, DOI 10.4103/2319-4170.132888; Balter V, 2015, P NATL ACAD SCI USA, V112, P982, DOI 10.1073/pnas.1415151112; Befani C, 2013, INT J BIOCHEM CELL B, V45, P2359, DOI 10.1016/j.biocel.2013.07.025; CHEVION M, 1993, P NATL ACAD SCI USA, V90, P1102, DOI 10.1073/pnas.90.3.1102; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fedele Anthony O, 2002, Mol Interv, V2, P229, DOI 10.1124/mi.2.4.229; Feng WK, 2009, MOL PHARMACOL, V75, P174, DOI 10.1124/mol.108.051516; Finney L, 2009, CLIN EXP PHARMACOL P, V36, P88, DOI 10.1111/j.1440-1681.2008.04969.x; GLEADLE JM, 1995, AM J PHYSIOL-CELL PH, V268, pC1362, DOI 10.1152/ajpcell.1995.268.6.C1362; GLEADLE JM, 1995, EUR J BIOCHEM, V234, P92, DOI 10.1111/j.1432-1033.1995.092_c.x; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; He WH, 2013, CARDIOVASC TOXICOL, V13, P1, DOI 10.1007/s12012-012-9174-y; Himoto T, 2016, BIOL TRACE ELEM RES, V174, P58, DOI 10.1007/s12011-016-0702-7; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kimura H, 2001, J BIOL CHEM, V276, P2292, DOI 10.1074/jbc.M008398200; Lopez-Haber C, 2016, MOL CELL BIOL, V36, P2011, DOI 10.1128/MCB.00180-16; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; Qiu LY, 2012, J PHARMACOL EXP THER, V342, P561, DOI 10.1124/jpet.112.194662; Rigiracciolo DC, 2015, ONCOTARGET, V6, P34158, DOI 10.18632/oncotarget.5779; Robador PA, 2011, CARDIOVASC RES, V92, P247, DOI 10.1093/cvr/cvr202; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Villar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045708; Wang L, 2016, EXP BIOL MED, V241, P1483, DOI 10.1177/1535370216645412; Xia XB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r113; Yao XS, 2017, CANCER DISCOV, V7, P1284, DOI 10.1158/2159-8290.CD-17-0375; Yu P, 2007, J BIOL CHEM, V282, P35035, DOI 10.1074/jbc.M707557200; Zhang J, 2015, EMBO J, V34, P2953, DOI 10.15252/embj.201591437; Zhang WJ, 2016, METALLOMICS, V8, P654, DOI 10.1039/c5mt00332f; Zhang Z, 2014, METALLOMICS, V6, P1889, DOI 10.1039/c4mt00052h	36	17	19	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14669	14677		10.1074/jbc.RA118.001764	http://dx.doi.org/10.1074/jbc.RA118.001764			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30082314	hybrid, Green Published			2022-12-28	WOS:000446155000008
J	Wangeline, MA; Hampton, RY				Wangeline, Margaret A.; Hampton, Randolph Y.			"Mallostery"-ligand-dependent protein misfolding enables physiological regulation by ERAD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic-reticulum-associated protein degradation; ERAD; ubiquitin; cholesterol regulation; allosteric regulation; protein misfolding; HMG-CoA reductase; HRD pathway; mallostery; chemical chaperones	RETICULUM-ASSOCIATED DEGRADATION; HMG-COA REDUCTASE; ANCHORED UBIQUITIN LIGASE; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; QUALITY-CONTROL; ACCELERATED DEGRADATION; ALLOSTERIC MODULATION; STEROL; DOMAIN; GERANYLGERANYL	HMG-CoA reductase (HMGR) undergoes regulated degradation as part of feedback control of the sterol pathway. In yeast, the stability of the HMGR isozyme Hmg2 is controlled by the 20-carbon isoprenoid geranylgeranyl pyrophosphate (GGPP). Increasing GGPP levels cause more efficient degradation by the HMG-CoA reductase degradation (HRD) pathway, allowing for feedback regulation of HMGR. The HRD pathway is critical for the endoplasmic reticulum (ER)-associated degradation (ERAD) of misfolded ER proteins. Here, we have explored GGPP's role in HRD-dependent Hmg2 degradation. We found that GGPP potently regulates Hmg2 levels in vivo and causes reversible Hmg2 misfolding at nanomolar concentrations in vitro. These GGPP-mediated effects were absent in several stabilized or nonregulated Hmg2 mutants. Consistent with its high potency, GGPP's effects were highly specific such that other structurally related molecules were ineffective in altering Hmg2 structure. For instance, two closely related GGPP analogues, 2F-GGPP and GGSPP, were completely inactive at all concentrations tested. Furthermore, GGSPP antagonized GGPP's effects in vivo and in vitro. Chemical chaperones reversed GGPP's effects on Hmg2 structure and degradation, suggesting that GGPP causes selective Hmg2 misfolding. These results indicate that GGPP functions in a manner similar to an allosteric ligand, causing Hmg2 misfolding through interaction with a reversible, specific binding site. Consistent with this, the Hmg2 protein formed multimers, typical of allosteric proteins. We propose that this "allosteric misfolding," or mallostery, observed here for Hmg2 may be a widely used tactic of biological regulation with potential for development of therapeutic small molecules that induce selective misfolding.	[Wangeline, Margaret A.; Hampton, Randolph Y.] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hampton, RY (corresponding author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rhampton@ucsd.edu			National Institutes of Health [5R37DK051996-18]; National Institutes of Health Cell Molecular Genetics (CMG) Training Grant [5T32GM007240-35]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK051996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cell Molecular Genetics (CMG) Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant 5R37DK051996-18 (to R. Y. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by National Institutes of Health Cell Molecular Genetics (CMG) Training Grant 5T32GM007240-35.	Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Ascenzi P, 2005, BIOCHEM MOL BIOL EDU, V33, P169, DOI 10.1002/bmb.2005.494033032470; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bondeson DP, 2017, ANNU REV PHARMACOL, V57, P107, DOI 10.1146/annurev-pharmtox-010715-103507; Bondeson DP, 2015, NAT CHEM BIOL, V11, P611, DOI [10.1038/NCHEMBIO.1858, 10.1038/nchembio.1858]; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Crews CM, 2010, CHEM BIOL, V17, P551, DOI 10.1016/j.chembiol.2010.05.011; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; Faulkner RA, 2013, J LIPID RES, V54, P1011, DOI 10.1194/jlr.M033639; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Gao Y, 2012, NAT PROD REP, V29, P1153, DOI 10.1039/c2np20059g; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Gardner RG, 1999, EMBO J, V18, P5994, DOI 10.1093/emboj/18.21.5994; Gardner RG, 1999, J BIOL CHEM, V274, P31671, DOI 10.1074/jbc.274.44.31671; Gardner RG, 2001, J BIOL CHEM, V276, P8681, DOI 10.1074/jbc.M007888200; Garza RM, 2009, J BIOL CHEM, V284, P35368, DOI 10.1074/jbc.M109.023994; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Gu X, 2017, J BIOL CHEM, V292, P12653, DOI 10.1074/jbc.M117.793018; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hwang S, 2016, J BIOL CHEM, V291, P13479, DOI 10.1074/jbc.M116.728469; JIANG Y, 1995, J BIOL CHEM, V270, P21793, DOI 10.1074/jbc.270.37.21793; JIANG Y, 1993, NATURE, V366, P84, DOI 10.1038/366084a0; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Lai AC, 2017, NAT REV DRUG DISCOV, V16, P101, DOI 10.1038/nrd.2016.211; Lin FY, 2010, P NATL ACAD SCI USA, V107, P21337, DOI 10.1073/pnas.1010907107; Liu J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004966; Mehnert M, 2010, BIOESSAYS, V32, P905, DOI 10.1002/bies.201000046; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Neal S, 2017, J BIOL CHEM, V292, P3112, DOI 10.1074/jbc.M116.770610; Needham PG, 2013, BBA-MOL CELL RES, V1833, P2447, DOI 10.1016/j.bbamcr.2013.03.018; Nguyen AD, 2009, J BIOL CHEM, V284, P26778, DOI 10.1074/jbc.M109.032342; Nussinov R, 2016, CHEM REV, V116, P6263, DOI 10.1021/acs.chemrev.6b00283; ROITELMAN J, 1984, J BIOL CHEM, V259, P870; ROITELMAN J, 1992, J BIOL CHEM, V267, P25264; Rosenbaum JC, 2011, NUCLEUS-PHILA, V2, P264, DOI 10.4161/nucl.2.4.16118; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Shearer AG, 2004, J BIOL CHEM, V279, P188, DOI 10.1074/jbc.M307734200; Shearer AG, 2005, EMBO J, V24, P149, DOI 10.1038/sj.emboj.7600498; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Stirtan WG, 1997, BIOCHEMISTRY-US, V36, P4552, DOI 10.1021/bi962579c; Theesfeld CL, 2013, J BIOL CHEM, V288, P8519, DOI 10.1074/jbc.M112.404517; Theesfeld CL, 2011, J BIOL CHEM, V286, P26298, DOI 10.1074/jbc.M111.244798; Vashistha N, 2016, P NATL ACAD SCI USA, V113, P5934, DOI 10.1073/pnas.1603079113; Wangeline MA, 2017, ANNU REV CELL DEV BI, V33, P467, DOI 10.1146/annurev-cellbio-111315-125036; Witter DJ, 1996, BIOCHEMISTRY-US, V35, P10454, DOI 10.1021/bi960500y; Wojcikiewicz RJH, 2009, CELL CALCIUM, V46, P147, DOI 10.1016/j.ceca.2009.05.002	57	22	22	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14937	14950		10.1074/jbc.RA118.001808	http://dx.doi.org/10.1074/jbc.RA118.001808			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30018140	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000446155000029
J	Bharati, BK; Mukherjee, R; Chatterji, D				Bharati, Binod K.; Mukherjee, Raju; Chatterji, Dipankar			Substrate-induced domain movement in a bifunctional protein, DcpA, regulates cyclic di-GMP turnover: Functional implications of a highly conserved motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic di-GMP (c-di-GMP); fluorescence resonance energy transfer (FRET); c-di-GMP turnover; DcpA; diguanylate cyclase; phosphodiesterase; domain movement; Forster's distance; second messenger; bacterial virulence; fluorescence anisotropy	RESONANCE ENERGY-TRANSFER; COLI RNA-POLYMERASE; MYCOBACTERIUM-SMEGMATIS; STREPTOCOCCUS-EQUISIMILIS; BACTERIAL 2ND-MESSENGER; PROXIMITY RELATIONSHIP; SPECTROSCOPIC RULER; RESPONSE REGULATOR; BIOFILM FORMATION; OUTPUT DOMAIN	In eubacteria, cyclic di-GMP (c-di-GMP) signaling is involved in virulence, persistence, motility and generally orchestrates multicellular behavior in bacterial biofilms. Intracellular c-di-GMP levels are maintained by the opposing activities of diguanylate cyclases (DGCs) and cognate phosphodiesterases (PDEs). The c-di-GMP homeostasis in Mycobacterium smegmatis is supported by DcpA, a conserved, bifunctional protein with both DGC and PDE activities. DcpA is a multidomain protein whose GAF-GGDEF-EAL domains are arranged in tandem and are required for these two activities. To gain insight into how interactions among these three domains affect DcpA activity, here we studied its domain dynamics using real-time FRET. We demonstrate that substrate binding in DcpA results in domain movement that prompts a switch from an open to a closed conformation and alters its catalytic activity. We found that a single point mutation in the conserved EAL motif (E384A) results in complete loss of the PDE activity of the EAL domain and in a significant decrease in the DGC activity of the GGDEF domain. Structural analyses revealed multiple hydrophobic and aromatic residues around Cys(579) that are necessary for proper DcpA folding and maintenance of the active conformation. On the basis of these observations and taking into account additional bioinformatics analysis of EAL domain-containing proteins, we identified a critical putatively conserved motif, GCXXXQGF, that plays an important role in c-di-GMP turnover. We conclude that a substrate-induced conformational switch involving movement of a loop containing a conserved motif in the bifunctional diguanylate cyclase-phosphodiesterase DcpA controls c-di-GMP turnover in M. smegmatis.	[Bharati, Binod K.; Chatterji, Dipankar] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Mukherjee, Raju] Indian Inst Sci Educ & Res, Dept Biol, Tirupati 517507, Andhra Prades, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science Education & Research (IISER) - Tirupati	Chatterji, D (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	dipankar@iisc.ac.in	Bharati, Binod K./W-6044-2019	Bharati, Binod Kumar/0000-0003-1112-8846	Department of Biotechnology, Government of India; Indian Institute of Science; Council of Scientific and Industrial Research	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Institute of Science; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by the Department of Biotechnology, Government of India. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an Indian Institute of Science research fellowship.; Supported by a Council of Scientific and Industrial Research fellowship.	Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bharati BK, 2013, GENE, V528, P99, DOI 10.1016/j.gene.2013.07.043; Bharati BK, 2012, MICROBIOL-SGM, V158, P1415, DOI 10.1099/mic.0.053892-0; Cantor C.R., 1980, BIOPHYS CHEM; Chen Y, 2012, J BACTERIOL, V194, P5080, DOI 10.1128/JB.01092-12; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Chowdhury RP, 2007, BIOPHYS CHEM, V128, P19, DOI 10.1016/j.bpc.2007.02.005; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; D'Argenio DA, 2004, MICROBIOL-SGM, V150, P2497, DOI 10.1099/mic.0.27099-0; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Feinstein E, 2003, BIOPHYS J, V84, P599, DOI 10.1016/S0006-3495(03)74880-2; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Jain V, 2007, BIOPHYS CHEM, V127, P41, DOI 10.1016/j.bpc.2006.12.003; Jain V, 2006, PROTEIN SCI, V15, P1449, DOI 10.1110/ps.062117006; Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; KUMAR KP, 1990, BIOCHEMISTRY-US, V29, P317, DOI 10.1021/bi00454a003; KUMAR KP, 1992, BIOCHEMISTRY-US, V31, P7519, DOI 10.1021/bi00148a012; Lakowicz J R, 1988, Subcell Biochem, V13, P89; Lakowicz J. R., 1983, PRINCIPALS FLUORESCE; Levet-Paulo M, 2011, J BIOL CHEM, V286, P31136, DOI 10.1074/jbc.M111.231340; Liu N, 2012, BIOCHEMISTRY-US, V51, P2087, DOI 10.1021/bi201753f; Liu N, 2010, MOL BIOSYST, V6, P1557, DOI 10.1039/c002246b; Malone JG, 2007, MICROBIOL-SGM, V153, P980, DOI 10.1099/mic.0.2006/002824-0; Mechold U, 1997, J BACTERIOL, V179, P2658, DOI 10.1128/jb.179.8.2658-2667.1997; Mechold U, 2002, J BACTERIOL, V184, P2878, DOI 10.1128/JB.184.11.2878-2888.2002; Nguyen MN, 2011, NUCLEIC ACIDS RES, V39, pW24, DOI 10.1093/nar/gkr393; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nyitrai M, 2000, J BIOL CHEM, V275, P41143, DOI 10.1074/jbc.M004146200; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Ryan RP, 2006, J BACTERIOL, V188, P8327, DOI 10.1128/JB.01079-06; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Seshasayee ASN, 2010, NUCLEIC ACIDS RES, V38, P5970, DOI 10.1093/nar/gkq382; Sharma IM, 2014, MICROBIOL-SGM, V160, P2304, DOI 10.1099/mic.0.080200-0; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; STEINBERG IZ, 1971, ANNU REV BIOCHEM, V40, P83, DOI 10.1146/annurev.bi.40.070171.000503; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Syal K, 2015, FEBS J, V282, P3773, DOI 10.1111/febs.13373; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tchigvintsev A, 2010, J MOL BIOL, V402, P524, DOI 10.1016/j.jmb.2010.07.050; Wilkins MR, 1999, METH MOL B, V112, P531; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267	58	2	2	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14065	14079		10.1074/jbc.RA118.003917	http://dx.doi.org/10.1074/jbc.RA118.003917			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	29980599	Green Published, hybrid			2022-12-28	WOS:000444070700028
J	Hannan, S; Smart, TG				Hannan, Saad; Smart, Trevor G.			Cell surface expression of homomeric GABA(A) receptors depends on single residues in subunit transmembrane domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GABA receptor; trafficking; homology modeling; receptor; ion channel; homomers; inhibition; receptor assembly	SUBCELLULAR-LOCALIZATION; INTERSUBUNIT CONTACTS; ALPHA-SUBUNITS; A RECEPTORS; IDENTIFICATION; TRAFFICKING; MODULATION; CHANNELS; PHARMACOLOGY; RECOMBINANT	Cell surface expression of type A GABA receptors (GABA(A)Rs) is a critical determinant of the efficacy of inhibitory neurotransmission. Pentameric GABA(A)Rs are assembled from a large pool of subunits according to precise co-assembly rules that limit the extent of receptor structural diversity. These rules ensure that particular subunits, such as 1 and 3, form functional cell surface ion channels when expressed alone in heterologous systems, whereas other brain-abundant subunits, such as and , are retained within intracellular compartments. Why some of the most abundant GABA(A)R subunits fail to form homomeric ion channels is unknown. Normally, surface expression of and subunits requires co-assembly with subunits via interactions between their N-terminal sequences in the endoplasmic reticulum. Here, using molecular biology, imaging, and electrophysiology with GABA(A)R chimeras, we have identified two critical residues in the transmembrane domains of and subunits, which, when substituted for their 1 counterparts, permit cell surface expression as homomers. Consistent with this, substitution of the 1 transmembrane residues for the subunit equivalents reduced surface expression and altered channel gating, highlighting their importance for GABA(A)R trafficking and signaling. Although not ligand-gated, the formation of and homomeric ion channels at the cell surface was revealed by incorporating a mutation that imparts the functional signature of spontaneous channel activity. Our study identifies two single transmembrane residues that enable homomeric GABA(A)R subunit cell surface trafficking and demonstrates that and subunits can form functional ion channels.	[Hannan, Saad; Smart, Trevor G.] UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England	University of London; University College London	Hannan, S; Smart, TG (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	s.hannan@ucl.ac.uk; t.smart@ucl.ac.uk	Hannan, Saad/AAX-6478-2020	Hannan, Saad/0000-0003-4594-0808; Smart, Trevor/0000-0002-9089-5375	MRC [MR/K005537/1] Funding Source: UKRI; Medical Research Council [MR/K005537/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akk G, 2008, MOL PHARMACOL, V74, P614, DOI 10.1124/mol.108.048520; Amin J, 1999, MOL PHARMACOL, V55, P411; AMIN J, 1994, RECEPTOR CHANNEL, V2, P227; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Bollan K, 2003, J BIOL CHEM, V278, P4747, DOI 10.1074/jbc.M210229200; Bollan KA, 2008, MOL CELL NEUROSCI, V37, P610, DOI 10.1016/j.mcn.2007.12.011; BORMANN J, 1995, TRENDS NEUROSCI, V18, P515, DOI 10.1016/0166-2236(95)98370-E; Bracamontes JR, 2014, MOL PHARMACOL, V86, P20, DOI 10.1124/mol.114.092791; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; Connolly CN, 1999, MOL CELL NEUROSCI, V13, P259, DOI 10.1006/mcne.1999.0746; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1996, P NATL ACAD SCI USA, V93, P9899, DOI 10.1073/pnas.93.18.9899; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Davies PA, 1997, BRIT J PHARMACOL, V120, P899, DOI 10.1038/sj.bjp.0700987; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; Gielen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7829; Hannan S, 2013, METHOD ENZYMOL, V521, P109, DOI 10.1016/B978-0-12-391862-8.00006-5; Hannan S, 2012, P NATL ACAD SCI USA, V109, P12171, DOI 10.1073/pnas.1201660109; Has ATC, 2016, SCI REP-UK, V6, DOI 10.1038/srep28674; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Kang JQ, 2009, TRENDS MOL MED, V15, P430, DOI 10.1016/j.molmed.2009.07.003; Klausberger T, 2000, J BIOL CHEM, V275, P8921, DOI 10.1074/jbc.275.12.8921; Klausberger T, 2001, J BIOL CHEM, V276, P16024, DOI 10.1074/jbc.M009508200; Klausberger T, 2001, J NEUROSCI, V21, P9124, DOI 10.1523/JNEUROSCI.21-23-09124.2001; Krishek BJ, 1998, J PHYSIOL-LONDON, V507, P639, DOI 10.1111/j.1469-7793.1998.639bs.x; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Laverty D, 2017, NAT STRUCT MOL BIOL, V24, P977, DOI 10.1038/nsmb.3477; Lummis SCR, 2009, BIOCHEM SOC T, V37, P1343, DOI 10.1042/BST0371343; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miller PS, 2017, NAT STRUCT MOL BIOL, V24, P986, DOI 10.1038/nsmb.3484; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; O'Toole KK, 2011, J BIOL CHEM, V286, P37990, DOI 10.1074/jbc.M111.258012; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramamoorthi K, 2011, TRENDS MOL MED, V17, P452, DOI 10.1016/j.molmed.2011.03.003; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sarto-Jackson I, 2008, MOL MEMBR BIOL, V25, P302, DOI 10.1080/09687680801914516; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; Smart TG, 2015, HDB ION CHANNELS, P345; Smith KS, 2012, NEUROPHARMACOLOGY, V62, P54, DOI 10.1016/j.neuropharm.2011.07.026; Taylor PM, 2000, J NEUROSCI, V20, P1297; Taylor PM, 1999, J NEUROSCI, V19, P6360; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tretter V, 1997, J NEUROSCI, V17, P2728; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x	51	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13427	13439		10.1074/jbc.RA118.002792	http://dx.doi.org/10.1074/jbc.RA118.002792			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29986886	hybrid, Green Published			2022-12-28	WOS:000443375500007
J	Hutt, DM; Mishra, SK; Roth, DM; Larsen, MB; Angles, F; Frizzell, RA; Balch, WE				Hutt, Darren M.; Mishra, Sanjay Kumar; Roth, Daniela Martino; Larsen, Mads Breum; Angles, Frederic; Frizzell, Raymond A.; Balch, William E.			Silencing of the Hsp70-specific nucleotide-exchange factor BAG3 corrects the F508del-CFTR variant by restoring autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cystic fibrosis; cystic fibrosis transmembrane conductance regulator (CFTR); autophagy; 70 kilodalton heat shock protein (Hsp70); protein folding; BAG3; BCL2-associated athanogene; cystic fibrosis; maladaptive stress response	TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN-QUALITY CONTROL; HEAT-SHOCK PROTEINS; CYSTIC-FIBROSIS; SELECTIVE AUTOPHAGY; MISFOLDED PROTEINS; MOLECULAR CHAPERONES; AGGRESOME FORMATION; UBIQUITIN LIGASE; CO-CHAPERONES	The protein chaperones heat shock protein 70 (Hsp70) and Hsp90 are required for de novo folding of proteins and protect against misfolding-related cellular stresses by directing misfolded or slowly folding proteins to the ubiquitin/proteasome system (UPS) or autophagy/lysosomal degradation pathways. Here, we examined the role of the Bcl2-associated athanogene (BAG) family of Hsp70-specific nucleotide-exchange factors in the biogenesis and functional correction of genetic variants of the cystic fibrosis transmembrane conductance regulator (CFTR) whose mutations cause cystic fibrosis (CF). We show that siRNA-mediated silencing of BAG1 and -3, two BAG members linked to the clearance of misfolded proteins via the UPS and autophagy pathways, respectively, leads to functional correction of F508del-CFTR and other disease-associated CFTR variants. BAG3 silencing was the most effective, leading to improved F508del-CFTR stability, trafficking, and restoration of cell-surface function, both alone and in combination with the FDA-approved CFTR corrector, VX-809. We also found that the BAG3 silencing-mediated correction of F508del-CFTR restores the autophagy pathway, which is defective in F508del-CFTR-expressing cells, likely because of the maladaptive stress response in CF pathophysiology. These results highlight the potential therapeutic benefits of targeting the cellular chaperone system to improve the functional folding of CFTR variants contributing to CF and possibly other protein-misfolding-associated diseases.	[Hutt, Darren M.; Roth, Daniela Martino; Angles, Frederic; Balch, William E.] Scripps Res, Skaggs Inst Chem Biol, Dept Mol Med, La Jolla, CA 92037 USA; [Mishra, Sanjay Kumar; Larsen, Mads Breum; Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA; [Mishra, Sanjay Kumar; Larsen, Mads Breum; Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15224 USA	Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Balch, WE (corresponding author), Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA.	webalch@scripps.edu			NHLBI NIH HHS [R01 HL095524] Funding Source: Medline; NIA NIH HHS [P01 AG049665] Funding Source: Medline; NIDDK NIH HHS [R01 DK051870, R01 DK068196] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068196, R01DK051870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG049665] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahner A, 2013, MOL BIOL CELL, V24, P74, DOI 10.1091/mbc.E12-09-0678; Alberti S, 2002, J BIOL CHEM, V277, P45920, DOI 10.1074/jbc.M204196200; Amaral MD, 2015, J CYST FIBROS, V14, P687, DOI 10.1016/j.jcf.2015.09.006; Amaral MD, 2006, J INHERIT METAB DIS, V29, P477, DOI 10.1007/s10545-006-0251-x; Arakawa A, 2010, STRUCTURE, V18, P309, DOI 10.1016/j.str.2010.01.004; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Bagdany M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00444-4; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Balch WE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004499; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; BANERJI J, 1990, P NATL ACAD SCI USA, V87, P2374, DOI 10.1073/pnas.87.6.2374; Bartsch G, 2016, ONCOL REP, V35, P1629, DOI 10.3892/or.2015.4505; Behl C, 2016, TRENDS PHARMACOL SCI, V37, P672, DOI 10.1016/j.tips.2016.04.007; Behl C, 2011, AUTOPHAGY, V7, P795, DOI 10.4161/auto.7.7.15844; Bitzer A, 2016, MOL IMMUNOL, V69, P99, DOI 10.1016/j.molimm.2015.11.004; Briknarova K, 2001, NAT STRUCT BIOL, V8, P349, DOI 10.1038/86236; Brive L, 2001, BIOCHEM BIOPH RES CO, V289, P1099, DOI 10.1006/bbrc.2001.6087; Brockman SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184793; Bruchmann A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-96; Cao YL, 2017, NEUROBIOL AGING, V60, P104, DOI 10.1016/j.neurobiolaging.2017.08.023; Carra S, 2008, AUTOPHAGY, V4, P237, DOI 10.4161/auto.5407; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Coppinger JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037682; Crippa V, 2010, HUM MOL GENET, V19, P3440, DOI 10.1093/hmg/ddq257; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; De Marco M, 2018, SEMIN CELL DEV BIOL, V78, P85, DOI 10.1016/j.semcdb.2017.08.049; De Stefano D, 2014, AUTOPHAGY, V10, P2053, DOI 10.4161/15548627.2014.973737; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Esposito Speranza, 2016, Mol Cell Pediatr, V3, P13, DOI 10.1186/s40348-016-0040-z; Ferrari E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.476; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; Gamerdinger M, 2011, J MOL MED, V89, P1175, DOI 10.1007/s00109-011-0795-6; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Gentilella A, 2011, J BIOL CHEM, V286, P9205, DOI 10.1074/jbc.M110.175836; Gupta MK, 2016, J CELL BIOCHEM, V117, P1813, DOI 10.1002/jcb.25481; Hantouche C, 2017, J BIOL CHEM, V292, P2287, DOI 10.1074/jbc.M116.752618; Holleran JP, 2012, MOL MED, V18, P685, DOI 10.2119/molmed.2012.00001; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Ji CH, 2017, MOL CELLS, V40, P441, DOI 10.14348/molcells.2017.0115; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kalia SK, 2010, CNS NEUROL DISORD-DR, V9, P741; Kley RA, 2016, CURR OPIN NEUROL, V29, P628, DOI 10.1097/WCO.0000000000000357; Klimek C, 2017, J CELL SCI, V130, P2781, DOI 10.1242/jcs.203679; Knezevic T, 2015, HEART FAIL REV, V20, P423, DOI 10.1007/s10741-015-9487-6; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Larsen MB, 2016, METHODS, V96, P40, DOI 10.1016/j.ymeth.2015.09.006; Lei ZN, 2015, NEUROBIOL AGING, V36, P241, DOI 10.1016/j.neurobiolaging.2014.08.012; Li ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153526; Liang JJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006132; Luciani A, 2012, AUTOPHAGY, V8, P1657, DOI 10.4161/auto.21483; Luciani A, 2011, AUTOPHAGY, V7, P104, DOI 10.4161/auto.7.1.13987; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Merabova N, 2015, J CELL PHYSIOL, V230, P831, DOI 10.1002/jcp.24811; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; O'Donnell BM, 2017, CHANNELS, V11, P499, DOI 10.1080/19336950.2017.1357944; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Oliver KE, 2017, CURR OPIN PHARMACOL, V34, P76, DOI 10.1016/j.coph.2017.09.018; Pankow S, 2015, NATURE, V528, P510, DOI 10.1038/nature15729; Perkins LA, 2018, MOL PHARMACEUT, V15, P759, DOI 10.1021/acs.molpharmaceut.7b00928; Qin LX, 2016, CELL MOL BIOL LETT, V21, DOI 10.1186/s11658-016-0020-2; Ratjen F, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.10; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Romani L, 2017, NAT MED, V23, P590, DOI 10.1038/nm.4305; Roth DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001998; Rusmini P, 2016, J MOL NEUROSCI, V58, P348, DOI 10.1007/s12031-015-0675-6; Sala AJ, 2017, J CELL BIOL, V216, P1231, DOI 10.1083/jcb.201612111; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Sosnay PR, 2014, THORAX, V69, P295, DOI 10.1136/thoraxjnl-2013-204903; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Sturner E, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00177; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Sun X, 2008, J CLIN INVEST, V118, P1578, DOI 10.1172/JCI34599; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Tosco A, 2017, CELL DEATH DIFFER, V24, P1305, DOI 10.1038/cdd.2016.43; Tosco A, 2016, CELL DEATH DIFFER, V23, P1380, DOI 10.1038/cdd.2016.22; Tschopp J, 1999, CURR BIOL, V9, pR381, DOI 10.1016/S0960-9822(99)80233-4; Turnbull EL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S11; Veit G, 2016, MOL BIOL CELL, V27, P424, DOI 10.1091/mbc.E14-04-0935; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vij N, 2017, EXPERT OPIN DRUG DEL, V14, P483, DOI 10.1080/17425247.2016.1223040; Villella VR, 2013, AUTOPHAGY, V9, P1431, DOI 10.4161/auto.25517; Villella VR, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00001; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Yin ZY, 2016, MICROB CELL, V3, P457, DOI 10.15698/mic2016.12.546; Yue XT, 2015, ELIFE, V4, DOI 10.7554/eLife.08401; Zhang T, 2015, MOL BIOL CELL, V26, P4438, DOI 10.1091/mbc.E15-06-0354	91	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13682	13695		10.1074/jbc.RA118.002607	http://dx.doi.org/10.1074/jbc.RA118.002607			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29986884	Green Published, hybrid			2022-12-28	WOS:000443375500027
J	Taylor, AA				Taylor, Alexandra A.			Solving the mystery of "leaky" membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							WATER CHANNEL; PROTEIN					alexandraataylor@gmail.com						DENKER BM, 1988, J BIOL CHEM, V263, P15634; JUNG JS, 1994, J BIOL CHEM, V269, P14648; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1993, J BIOL CHEM, V268, P17	4	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12301	12302		10.1074/jbc.CL118.004733	http://dx.doi.org/10.1074/jbc.CL118.004733			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	30076261	Green Published, hybrid			2022-12-28	WOS:000440803200032
J	Gomes, E; Shorter, J				Gomes, Edward; Shorter, James			The molecular language of membraneless organelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						subcellular organelle; organelle; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); RNA binding protein; chaperone; Cajal body; disaggregase; liquid-liquid phase separation; nucleolus; stress granule	PRION-LIKE DOMAINS; AMYOTROPHIC-LATERAL-SCLEROSIS; LIQUID PHASE-SEPARATION; INTRINSICALLY DISORDERED PROTEINS; RNA-BINDING PROTEINS; NUCLEAR IMPORT RECEPTOR; LOW-COMPLEXITY DOMAINS; CELL-FREE FORMATION; N-TERMINAL DOMAIN; POLYMERASE-II	Eukaryotic cells organize their intracellular components into organelles that can be membrane-bound or membraneless. A large number of membraneless organelles, including nucleoli, Cajal bodies, P-bodies, and stress granules, exist as liquid droplets within the cell and arise from the condensation of cellular material in a process termed liquid-liquid phase separation (LLPS). Beyond a mere organizational tool, concentrating cellular components into membraneless organelles tunes biochemical reactions and improves cellular fitness during stress. In this review, we provide an overview of the molecular underpinnings of the formation and regulation of these membraneless organelles. This molecular understanding explains emergent properties of these membraneless organelles and shines new light on neurodegenerative diseases, which may originate from disturbances in LLPS and membraneless organelles.	[Gomes, Edward; Shorter, James] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Shorter, J (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	jshorter@pennmedicine.upenn.edu	Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533	National Institutes of Health [R01GM099836, R21NS090205, R21NS102687]; Muscular Dystrophy Association (MDA); Amyotrophic Lateral Sclerosis Association (ALSA); Target ALS; Life Extension Foundation; Sanofi; Office of the Assistant Secretary of Defense for Health Affairs, through the Amyotrophic Lateral Sclerosis Research Program [W81XWH-17-1-0237]; Robert Packard Center for ALS Research at Johns Hopkins University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS102687, R21NS090205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); Amyotrophic Lateral Sclerosis Association (ALSA); Target ALS; Life Extension Foundation; Sanofi; Office of the Assistant Secretary of Defense for Health Affairs, through the Amyotrophic Lateral Sclerosis Research Program; Robert Packard Center for ALS Research at Johns Hopkins University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health Grants R01GM099836, R21NS090205, and R21NS102687, the Muscular Dystrophy Association (MDA), the Amyotrophic Lateral Sclerosis Association (ALSA), Target ALS, the Life Extension Foundation, Sanofi, the Office of the Assistant Secretary of Defense for Health Affairs, through the Amyotrophic Lateral Sclerosis Research Program under Award No. W81XWH-17-1-0237, and the Robert Packard Center for ALS Research at Johns Hopkins University.	Afroz T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00062-0; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Altmeyer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9088; ASHBURNER M, 1979, CELL, V17, P241, DOI 10.1016/0092-8674(79)90150-8; Aumiller WM, 2016, NAT CHEM, V8, P129, DOI [10.1038/NCHEM.2414, 10.1038/nchem.2414]; Bah A, 2016, J BIOL CHEM, V291, P6696, DOI 10.1074/jbc.R115.695056; Baker JD, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001336; Bakthavachalu B, 2018, NEURON, V98, P754, DOI 10.1016/j.neuron.2018.04.032; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; BANSIL R, 1993, J PHYS IV, V3, P225, DOI 10.1051/jp4:1993119; Becker LA, 2018, NEURON, V98, P673, DOI 10.1016/j.neuron.2018.05.002; Becker LA, 2017, NATURE, V544, P367, DOI 10.1038/nature22038; Berchowitz LE, 2015, CELL, V163, P406, DOI 10.1016/j.cell.2015.08.060; Berry J, 2015, P NATL ACAD SCI USA, V112, pE5237, DOI 10.1073/pnas.1509317112; Bhowmick P, 2015, ADV EXP MED BIOL, V870, P291, DOI 10.1007/978-3-319-20164-1_9; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Boeynaems S, 2017, MOL CELL, V65, P1044, DOI 10.1016/j.molcel.2017.02.013; Bogaert E, 2018, CELL REP, V24, P529, DOI 10.1016/j.celrep.2018.06.070; Boke E, 2016, CELL, V166, P637, DOI 10.1016/j.cell.2016.06.051; BONNER JJ, 1981, DEV BIOL, V86, P409, DOI 10.1016/0012-1606(81)90199-8; Boulay G, 2017, CELL, V171, P163, DOI 10.1016/j.cell.2017.07.036; Bounedjah O, 2014, NUCLEIC ACIDS RES, V42, P8678, DOI 10.1093/nar/gku582; Brady JP, 2017, P NATL ACAD SCI USA, V114, pE8194, DOI 10.1073/pnas.1706197114; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/NPHYS3532, 10.1038/nphys3532]; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Cai J, 2017, SCIENCE, V357, P564, DOI 10.1126/science.aal2674; Carpenter K, 2018, DEV CELL, V45, P392, DOI 10.1016/j.devcel.2018.04.001; Cascarina SM, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007517; Chang CK, 2012, BIOCHEM BIOPH RES CO, V425, P219, DOI 10.1016/j.bbrc.2012.07.071; Cherkasov V, 2013, CURR BIOL, V23, P2452, DOI 10.1016/j.cub.2013.09.058; Cho WK, 2018, SCIENCE, V361, P412, DOI 10.1126/science.aar4199; Chong PA, 2018, J MOL BIOL, V430, P4650, DOI 10.1016/j.jmb.2018.06.014; Chong SS, 2018, SCIENCE, V361, DOI 10.1126/science.aar2555; Chuang E, 2018, J CELL SCI, V131, DOI 10.1242/jcs.189928; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Cremers CM, 2016, MOL CELL, V63, P768, DOI 10.1016/j.molcel.2016.07.016; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Duennwald Martin L, 2012, PLoS Biol, V10, pe1001346, DOI 10.1371/journal.pbio.1001346; Dumetz AC, 2008, BIOPHYS J, V94, P570, DOI 10.1529/biophysj.107.116152; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Endicott SJ, 2018, CURR BIOL, V28, P1643, DOI 10.1016/j.cub.2018.04.014; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; FLORY PJ, 1964, J AM CHEM SOC, V86, P3507, DOI 10.1021/ja01071a023; Flory PJ., 1953, PRINCIPLES POLYM CHE, V672; Ford AF, 2015, CELL, V163, P275, DOI 10.1016/j.cell.2015.09.049; Franzmann TM, 2018, SCIENCE, V359, P47, DOI 10.1126/science.aao5654; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gopal PP, 2017, P NATL ACAD SCI USA, V114, pE2466, DOI 10.1073/pnas.1614462114; Guenther EL, 2018, NAT STRUCT MOL BIOL, V25, P463, DOI 10.1038/s41594-018-0064-2; Guo L, 2018, CELL, V173, P677, DOI 10.1016/j.cell.2018.03.002; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; Harlen KM, 2017, NAT REV MOL CELL BIO, V18, P263, DOI 10.1038/nrm.2017.10; Harrison AF, 2017, BIOCHEM J, V474, P1417, DOI 10.1042/BCJ20160499; Hnisz D, 2017, CELL, V169, P13, DOI 10.1016/j.cell.2017.02.007; Hofweber M, 2018, CELL, V173, P706, DOI 10.1016/j.cell.2018.03.004; Hughes MP, 2018, SCIENCE, V359, P698, DOI 10.1126/science.aan6398; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Jackrel ME, 2014, CELL, V156, P170, DOI 10.1016/j.cell.2013.11.047; Jain A, 2017, NATURE, V546, P243, DOI 10.1038/nature22386; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kee HL, 2012, NAT CELL BIOL, V14, P431, DOI 10.1038/ncb2450; Khan T, 2018, MOL CELL, V71, P155, DOI 10.1016/j.molcel.2018.06.016; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kim S, 2016, P NATL ACAD SCI USA, V113, pE847, DOI 10.1073/pnas.1521521113; Kim Y, 2016, MOL CELL, V63, P865, DOI 10.1016/j.molcel.2016.07.010; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kroschwald S, 2018, CELL REP, V23, P3327, DOI 10.1016/j.celrep.2018.05.041; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Langdon EM, 2018, SCIENCE, V360, P922, DOI 10.1126/science.aar7432; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Leung AKL, 2014, J CELL BIOL, V205, P613, DOI 10.1083/jcb.201402114; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Li XH, 2018, BIOCHEMISTRY-US, V57, P2452, DOI 10.1021/acs.biochem.7b01228; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lin Y, 2016, CELL, V167, P789, DOI 10.1016/j.cell.2016.10.003; Lin Y, 2017, J BIOL CHEM, V292, P19110, DOI 10.1074/jbc.M117.800466; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Liu C, 2017, NUCLEIC ACIDS RES, V45, P8129, DOI 10.1093/nar/gkx565; Luo F, 2018, NAT STRUCT MOL BIOL, V25, P341, DOI 10.1038/s41594-018-0050-8; Mack KL, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00008; Mackenzie IR, 2017, NEURON, V95, P808, DOI 10.1016/j.neuron.2017.07.025; Maharana S, 2018, SCIENCE, V360, P918, DOI 10.1126/science.aar7366; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Mao YTS, 2011, NAT CELL BIOL, V13, P95, DOI 10.1038/ncb2140; March ZM, 2016, BRAIN RES, V1647, P9, DOI 10.1016/j.brainres.2016.02.037; McGurk L, 2018, MOL CELL, V71, P703, DOI 10.1016/j.molcel.2018.07.002; McGurk L, 2014, J NEUROPATH EXP NEUR, V73, P837, DOI 10.1097/NEN.0000000000000102; Milovanovic D, 2018, SCIENCE, V361, P604, DOI 10.1126/science.aat5671; Minhas FUA, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005465; Mitrea DM, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-015-0125-7; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Monahan Z, 2017, EMBO J, V36, P2951, DOI 10.15252/embj.201696394; Murray DT, 2017, CELL, V171, P615, DOI 10.1016/j.cell.2017.08.048; Muschol M, 1997, J CHEM PHYS, V107, P1953, DOI 10.1063/1.474547; NOJIMA S, 1982, POLYM J, V14, P289, DOI 10.1295/polymj.14.289; Nott TJ, 2016, NAT CHEM, V8, P570, DOI [10.1038/NCHEM.2519, 10.1038/nchem.2519]; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Novotny I, 2011, MOL BIOL CELL, V22, P513, DOI 10.1091/mbc.E10-07-0560; Omer A, 2018, EMBO REP, V19, DOI 10.15252/embr.201744722; Oparin A. I., 1938, ORIGINS LIFE EVOL B; Pak CW, 2016, MOL CELL, V63, P72, DOI 10.1016/j.molcel.2016.05.042; Palazzo AF, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00002; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Protter DSW, 2018, CELL REP, V22, P1401, DOI 10.1016/j.celrep.2018.01.036; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Qamar S, 2018, CELL, V173, P720, DOI 10.1016/j.cell.2018.03.056; Racki LR, 2017, P NATL ACAD SCI USA, V114, pE2440, DOI 10.1073/pnas.1615575114; Rai AK, 2018, NATURE, V559, P211, DOI 10.1038/s41586-018-0279-8; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Ryan VH, 2018, MOL CELL, V69, P465, DOI 10.1016/j.molcel.2017.12.022; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Schaffert N, 2004, EMBO J, V23, P3000, DOI 10.1038/sj.emboj.7600296; Schmidt HB, 2016, TRENDS BIOCHEM SCI, V41, P46, DOI 10.1016/j.tibs.2015.11.001; Schmidt HB, 2015, ELIFE, V4, DOI 10.7554/eLife.04251; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shelkovnikova TA, 2014, HUM MOL GENET, V23, P2298, DOI 10.1093/hmg/ddt622; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Shevtsov SP, 2011, NAT CELL BIOL, V13, P167, DOI 10.1038/ncb2157; Shi KY, 2017, P NATL ACAD SCI USA, V114, pE1111, DOI 10.1073/pnas.1620293114; Shin Y, 2017, CELL, V168, P159, DOI 10.1016/j.cell.2016.11.054; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Shorter J, 2017, EMBO J, V36, P2925, DOI 10.15252/embj.201798078; Shorter J, 2017, CELL, V171, P30, DOI 10.1016/j.cell.2017.09.010; Shorter J, 2017, CURR OPIN GENET DEV, V44, P1, DOI 10.1016/j.gde.2017.01.008; Shorter J, 2016, MOL BIOL CELL, V27, P1556, DOI 10.1091/mbc.E15-10-0693; Shorter J, 2016, NAT CHEM, V8, P528, DOI 10.1038/nchem.2534; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Si K, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021774; Smith J, 2016, ELIFE, V5, DOI 10.7554/eLife.21337; Stroberg W, 2018, BIOPHYS J, V115, P3, DOI 10.1016/j.bpj.2018.05.023; Strom AR, 2017, NATURE, V547, P241, DOI 10.1038/nature22989; Strulson CA, 2012, NAT CHEM, V4, P941, DOI [10.1038/NCHEM.1466, 10.1038/nchem.1466]; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Sweeny EA, 2015, MOL CELL, V57, P836, DOI 10.1016/j.molcel.2014.12.021; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; Toombs JA, 2012, P NATL ACAD SCI USA, V109, P6519, DOI 10.1073/pnas.1119366109; Toombs JA, 2010, MOL CELL BIOL, V30, P319, DOI 10.1128/MCB.01140-09; Toretsky JA, 2014, J CELL BIOL, V206, P579, DOI 10.1083/jcb.201404124; Tsoi PS, 2017, ANGEW CHEM INT EDIT, V56, P12590, DOI 10.1002/anie.201706769; Uversky VN, 2017, CURR OPIN STRUC BIOL, V44, P18, DOI 10.1016/j.sbi.2016.10.015; Uversky VN, 2015, FEBS LETT, V589, P15, DOI 10.1016/j.febslet.2014.11.028; Van Treeck B, 2018, P NATL ACAD SCI USA, V115, P2734, DOI 10.1073/pnas.1800038115; Vashist S, 2010, BIOCHEM CELL BIOL, V88, P1, DOI [10.1139/O09-121, 10.1139/o09-121]; Vernon RM, 2018, ELIFE, V7, DOI 10.7554/eLife.31486; Voronina E, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002774; Wallace EWJ, 2015, CELL, V162, P1286, DOI 10.1016/j.cell.2015.08.041; Wang AL, 2018, EMBO J, V37, DOI 10.15252/embj.201797452; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wang Y, 2017, LANGMUIR, V33, P7715, DOI 10.1021/acs.langmuir.7b01693; Wei MT, 2017, NAT CHEM, V9, P1118, DOI [10.1038/NCHEM.2803, 10.1038/nchem.2803]; West JA, 2016, J CELL BIOL, V214, P817, DOI 10.1083/jcb.201601071; Woodruff JB, 2017, CELL, V169, P1066, DOI 10.1016/j.cell.2017.05.028; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040; Yoshizawa T, 2018, CELL, V173, P693, DOI 10.1016/j.cell.2018.03.003; Zeng ML, 2016, CELL, V166, P1163, DOI 10.1016/j.cell.2016.07.008; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017; Zhang YJ, 2013, HUM MOL GENET, V22, P3112, DOI 10.1093/hmg/ddt166; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zobeck KL, 2010, MOL CELL, V40, P965, DOI 10.1016/j.molcel.2010.11.022	174	285	288	27	200	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7115	7127		10.1074/jbc.TM118.001192	http://dx.doi.org/10.1074/jbc.TM118.001192			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30045872	Green Published, hybrid			2022-12-28	WOS:000468402900002
J	Carman, GM				Carman, George M.			Discoveries of the phosphatidate phosphatase genes in yeast published in the Journal of Biological Chemistry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						phosphatidic acid; diacylglycerol; triacylglycerol; phosphatase; lipid; phosphatidate; Saccharomyces cerevisiae; yeast; lipid metabolism; APP1; DPP1; LPP1; PA phosphatase; PAH1	DIACYLGLYCEROL PYROPHOSPHATE PHOSPHATASE; PROTEIN-KINASE-C; CYTIDINE DIPHOSPHATE CHOLINE; CDP-DIGLYCERIDE SYNTHETASE; IN-VIVO FUNCTION; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; PHOSPHOLIPID-SYNTHESIS; ENZYMATIC-SYNTHESIS; NUCLEAR-ENVELOPE	This JBC Review on the discoveries of yeast phosphatidate (PA) phosphatase genes is dedicated to Dr. Herbert Tabor, Editor-in-Chief of the Journal of Biological Chemistry (JBC) for 40 years, on the occasion of his 100th birthday. Here, I reflect on the discoveries of the APP1, DPP1, LPP1, and PAH1 genes encoding all the PA phosphatase enzymes in yeast. PA phosphatase catalyzes PA dephosphorylation to generate diacylglycerol; both substrate and product are key intermediates in the synthesis of membrane phospholipids and triacylglycerol. App1 and Pah1 are peripheral membrane proteins catalyzing an Mg2+-dependent reaction governed by the DXDX(T/V) phosphatase motif. Dpp1 and Lpp1 are integral membrane proteins that catalyze an Mg2+-independent reaction governed by the KX6RP-PSGH-SRX5HX3D phosphatase motif. Pah1 is PA-specific and is the only PA phosphatase responsible for lipid synthesis at the nuclear/endoplasmic reticulum membrane. App1, Dpp1, and Lpp1, respectively, are localized to cortical actin patches and the vacuole and Golgi membranes; they utilize several lipid phosphate substrates, including PA, lyso-PA, and diacylglycerol pyrophosphate. App1 is postulated to be involved in endocytosis, whereas Dpp1 and Lpp1 may be involved in lipid signaling. Pah1 is the yeast lipin homolog of mice and humans. A host of cellular defects and lipid-based diseases associated with loss or overexpression of PA phosphatase in yeast, mice, and humans, highlights its importance to cell physiology.	[Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Dept Food Sci, New Brunswick, NJ 08901 USA; [Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 61 Dudley Rd, New Brunswick, NJ 08901 USA.	gcarman@rutgers.edu		Carman, George/0000-0003-4951-8233	National Institutes of Health from the USPHS [GM028140, GM050679]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM050679] Funding Source: NIH RePORTER	National Institutes of Health from the USPHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM028140 and GM050679 from the USPHS. This JBC Review is part of a collection honoring Herbert Tabor on the occasion of his 100th birthday. The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; AITKEN JF, 1990, J BIOL CHEM, V265, P4711; Aulchenko YS, 2007, DIABETES, V56, P3020, DOI 10.2337/db07-0338; BAELEE MS, 1984, J BIOL CHEM, V259, P857; Barbosa AD, 2015, MOL BIOL CELL, V26, P3641, DOI 10.1091/mbc.E15-03-0173; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; BOGDANOV M, 1995, J BIOL CHEM, V270, P732, DOI 10.1074/jbc.270.2.732; BORKENHAGEN LF, 1957, J BIOL CHEM, V227, P951; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Brindley DN, 2002, BBA-MOL CELL BIOL L, V1582, P33, DOI 10.1016/S1388-1981(02)00135-X; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1979, J BIOL CHEM, V254, P8391; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; CARTER JR, 1966, J LIPID RES, V7, P678; Chae M, 2013, J BIOL CHEM, V288, P6427, DOI 10.1074/jbc.M112.449629; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Chang YF, 2008, PROG LIPID RES, V47, P333, DOI 10.1016/j.plipres.2008.03.004; CHANG YY, 1967, J BIOL CHEM, V242, P516; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; COLEMAN R, 1976, J BIOL CHEM, V251, P4537; COLODZIN M, 1965, J BIOL CHEM, V240, P3771; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; DEEMS RA, 1975, J BIOL CHEM, V250, P9008; Dillon DA, 1997, J BIOL CHEM, V272, P10361; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; DOWHAN W, 1974, J BIOL CHEM, V249, P3079; ESKO JD, 1980, J BIOL CHEM, V255, P4474; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Faulkner A, 1999, J BIOL CHEM, V274, P14831, DOI 10.1074/jbc.274.21.14831; Ferguson PJ, 2005, J MED GENET, V42, P551, DOI 10.1136/jmg.2005.030759; Ferguson PJ, 2007, CURR OPIN RHEUMATOL, V19, P492, DOI 10.1097/BOR.0b013e32825f5492; GREEN PR, 1984, J BIOL CHEM, V259, P4688; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2017, J BIOL CHEM, V292, P13230, DOI 10.1074/jbc.M117.801720; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2004, J BIOL CHEM, V279, P5338, DOI 10.1074/jbc.M311779200; Han GS, 2001, J BIOL CHEM, V276, P10126, DOI 10.1074/jbc.M011421200; Han S, 2012, J BIOL CHEM, V287, P3123, DOI 10.1074/jbc.M111.324350; HANNUN YA, 1987, J BIOL CHEM, V262, P13620; HANNUN YA, 1985, J BIOL CHEM, V260, P39; HENDRICKSON HS, 1984, J BIOL CHEM, V259, P5734; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HJELMSTAD RH, 1990, J BIOL CHEM, V265, P1755; Hsieh LS, 2016, J BIOL CHEM, V291, P9974, DOI 10.1074/jbc.M116.726588; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; ICHO T, 1985, J BIOL CHEM, V260, P2078; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; JARVIS AA, 1984, J BIOL CHEM, V259, P5188; KANFER J, 1964, J BIOL CHEM, V239, P1720; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; KENNEDY EP, 1956, J BIOL CHEM, V222, P185; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; LEHEL C, 1995, J BIOL CHEM, V270, P19651, DOI 10.1074/jbc.270.33.19651; LIGHTNER VA, 1980, J BIOL CHEM, V255, P9413; LIN YP, 1989, J BIOL CHEM, V264, P8641; LIN YP, 1990, J BIOL CHEM, V265, P166; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; LOMBARDO D, 1985, J BIOL CHEM, V260, P7234; Lussier M, 1997, GENETICS, V147, P435; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Maissel A, 2006, CELL SIGNAL, V18, P1127, DOI 10.1016/j.cellsig.2005.09.003; Morris AJ, 2007, BIOCHEM SOC SYMP, V74, P247, DOI 10.1042/BSS2007c20; Munnik T, 1996, J BIOL CHEM, V271, P15708, DOI 10.1074/jbc.271.26.15708; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Ostrander DB, 2001, J BIOL CHEM, V276, P25262, DOI 10.1074/jbc.M103689200; Park Y, 2017, J BIOL CHEM, V292, P19580, DOI 10.1074/jbc.M117.819375; Park Y, 2015, J BIOL CHEM, V290, P25382, DOI 10.1074/jbc.M115.680314; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; PAULUS H, 1960, J BIOL CHEM, V235, P1303; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; RAETZ CRH, 1978, J BIOL CHEM, V253, P3882; Rahman MA, 2018, FEBS J, V285, P1840, DOI 10.1111/febs.14448; Riedel B, 1997, PLANT SCI, V128, P1, DOI 10.1016/S0168-9452(97)00120-9; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Ruiz C, 1999, YEAST, V15, P1001; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; SMITH SW, 1957, J BIOL CHEM, V228, P915; SPARROW CP, 1985, J BIOL CHEM, V260, P2084; Stukey J, 1997, PROTEIN SCI, V6, P469; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Weinberg J, 2012, TRENDS CELL BIOL, V22, P1, DOI 10.1016/j.tcb.2011.09.001; WEISS SB, 1958, J BIOL CHEM, V231, P53; WEISS SB, 1960, J BIOL CHEM, V235, P40; Wiedmann S, 2008, DIABETES, V57, P209, DOI 10.2337/db07-0083; WISSING JB, 1993, PLANT PHYSIOL, V102, P1243, DOI 10.1104/pp.102.4.1243; WISSING JB, 1993, FEBS LETT, V315, P95, DOI 10.1016/0014-5793(93)81141-L; Wu WI, 1996, J BIOL CHEM, V271, P1868, DOI 10.1074/jbc.271.4.1868; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798; Yuan DS, 2000, GENETICS, V156, P45; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003	118	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1681	1689		10.1074/jbc.TM118.004159	http://dx.doi.org/10.1074/jbc.TM118.004159			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30061152	Green Published, hybrid			2022-12-28	WOS:000457879200027
J	Graham, WJ; Putnam, CD; Kolodner, RD				Graham, William J.; Putnam, Christopher D.; Kolodner, Richard D.			The properties of Msh2-Msh6 ATP binding mutants suggest a signal amplification mechanism in DNA mismatch repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; DNA replication; DNA mismatch repair; DNA endonuclease; DNA binding protein; mutagenesis; exonuclease 1; Mlh1-Pms1; Msh2-Msh6; MutS; S; cerevisiae	SACCHAROMYCES-CEREVISIAE MSH2-MSH6; NUCLEOTIDE-BINDING; ESCHERICHIA-COLI; MUTL-ALPHA; DOMINANT MUTATIONS; MISPAIR-BINDING; SLIDING CLAMP; PROTEIN MUTS; MSH6; RECOGNITION	DNA mismatch repair (MMR) corrects mispaired DNA bases and small insertion/deletion loops generated by DNA replication errors. After binding a mispair, the eukaryotic mispair recognition complex Msh2-Msh6 binds ATP in both of its nucleotide-binding sites, which induces a conformational change resulting in the formation of an Msh2-Msh6 sliding clamp that releases from the mispair and slides freely along the DNA. However, the roles that Msh2-Msh6 sliding clamps play in MMR remain poorly understood. Here, using Saccharomyces cerevisiae, we created Msh2 and Msh6 Walker A nucleotide-binding site mutants that have defects in ATP binding in one or both nucleotide-binding sites of the Msh2-Msh6 heterodimer. We found that these mutations cause a complete MMR defect in vivo. The mutant Msh2-Msh6 complexes exhibited normal mispair recognition and were proficient at recruiting the MMR endonuclease Mlh1-Pms1 to mispaired DNA. At physiological (2.5 mm) ATP concentration, the mutant complexes displayed modest partial defects in supporting MMR in reconstituted Mlh1-Pms1-independent and Mlh1-Pms1-dependent MMR reactions in vitro and in activation of the Mlh1-Pms1 endonuclease and showed a more severe defect at low (0.1 mm) ATP concentration. In contrast, five of the mutants were completely defective and one was mostly defective for sliding clamp formation at high and low ATP concentrations. These findings suggest that mispair-dependent sliding clamp formation triggers binding of additional Msh2-Msh6 complexes and that further recruitment of additional downstream MMR proteins is required for signal amplification of mispair binding during MMR.	[Graham, William J.; Putnam, Christopher D.; Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Putnam, Christopher D.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Inst Genom Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu		Putnam, Christopher/0000-0002-6145-1265	National Institutes of Health [F32 CA210407, R01 GM50006]; Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE [F32CA210407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants F32 CA210407 (to W.J.G.) and R01 GM50006 (to R.D.K.) and the Ludwig Institute for Cancer Research (to R.D.K. and C.D.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Alani E, 1997, MOL CELL BIOL, V17, P2436, DOI 10.1128/MCB.17.5.2436; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Antony E, 2006, DNA REPAIR, V5, P153, DOI 10.1016/j.dnarep.2005.08.016; Antony E, 2004, BIOCHEMISTRY-US, V43, P13115, DOI 10.1021/bi049010t; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Bowen N, 2017, P NATL ACAD SCI USA, V114, P3607, DOI 10.1073/pnas.1701753114; Bowen N, 2013, P NATL ACAD SCI USA, V110, P18472, DOI 10.1073/pnas.1318971110; Bowers J, 2000, J MOL BIOL, V302, P327, DOI 10.1006/jmbi.2000.4081; Campbell CS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004327; Cho WK, 2012, STRUCTURE, V20, P1264, DOI 10.1016/j.str.2012.04.017; Cyr JL, 2008, J BIOL CHEM, V283, P31641, DOI 10.1074/jbc.M806018200; Das Gupta R, 2000, NAT GENET, V24, P53, DOI 10.1038/71684; Drotschmann K, 1999, P NATL ACAD SCI USA, V96, P2970, DOI 10.1073/pnas.96.6.2970; Drotschmann K, 2002, DNA REPAIR, V1, P743, DOI 10.1016/S1568-7864(02)00081-2; Durno CA, 2015, EUR J CANCER, V51, P977, DOI 10.1016/j.ejca.2015.02.008; Fishel R, 1998, GENE DEV, V12, P2096, DOI 10.1101/gad.12.14.2096; Fishel R, 2015, J BIOL CHEM, V290, P26395, DOI 10.1074/jbc.R115.660142; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Goellner EM, 2018, NAT STRUCT MOL BIOL, V25, P650, DOI 10.1038/s41594-018-0092-y; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; GORBALENYA AE, 1990, J MOL BIOL, V213, P583, DOI 10.1016/S0022-2836(05)80243-8; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Groothuizen FS, 2015, ELIFE, V4, DOI 10.7554/eLife.06744; Gupta S, 2012, NAT STRUCT MOL BIOL, V19, P72, DOI 10.1038/nsmb.2175; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; Hargreaves VV, 2010, J BIOL CHEM, V285, P9301, DOI 10.1074/jbc.M109.096388; Heinen CD, 2002, CANCER CELL, V1, P469, DOI 10.1016/S1535-6108(02)00073-9; Heinen CD, 2011, J BIOL CHEM, V286, P40287, DOI 10.1074/jbc.M111.297523; Hess MT, 2006, P NATL ACAD SCI USA, V103, P558, DOI 10.1073/pnas.0510078103; Hess MT, 2002, J BIOL CHEM, V277, P25545, DOI 10.1074/jbc.M202282200; Hombauer H, 2011, SCIENCE, V334, P1713, DOI 10.1126/science.1210770; Hombauer H, 2011, CELL, V147, P1040, DOI 10.1016/j.cell.2011.10.025; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hura GL, 2013, P NATL ACAD SCI USA, V110, P17308, DOI 10.1073/pnas.1308595110; Iaccarino I, 2000, J BIOL CHEM, V275, P2080, DOI 10.1074/jbc.275.3.2080; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Javaid S, 2009, MOL CELL, V36, P1086, DOI 10.1016/j.molcel.2009.12.010; Jeon Y, 2016, P NATL ACAD SCI USA, V113, P3281, DOI 10.1073/pnas.1523748113; Jeong C, 2011, NAT STRUCT MOL BIOL, V18, P379, DOI 10.1038/nsmb.2009; Jiricny J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012633; Jones PM, 2013, CRIT REV BIOCHEM MOL, V48, P39, DOI 10.3109/10409238.2012.735644; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kadyrov FA, 2009, P NATL ACAD SCI USA, V106, P8495, DOI 10.1073/pnas.0903654106; Kane MF, 1997, CANCER RES, V57, P808; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li ZD, 2016, DNA REPAIR, V38, P94, DOI 10.1016/j.dnarep.2015.11.019; Liu JQ, 2016, NATURE, V539, P583, DOI 10.1038/nature20562; Lynch HT, 2015, NAT REV CANCER, V15, P181, DOI 10.1038/nrc3878; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Monti MC, 2011, NUCLEIC ACIDS RES, V39, P8052, DOI 10.1093/nar/gkr498; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Piliarik Marek, 2009, V503, P65, DOI 10.1007/978-1-60327-567-5_5; Raschle M, 2002, J BIOL CHEM, V277, P21810, DOI 10.1074/jbc.M108787200; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; Shell SS, 2007, P NATL ACAD SCI USA, V104, P10956, DOI 10.1073/pnas.0704148104; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; Smith CE, 2015, J BIOL CHEM, V290, P21580, DOI 10.1074/jbc.M115.662189; Spies M, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a022657; Srivatsan A, 2014, J BIOL CHEM, V289, P9352, DOI 10.1074/jbc.M114.552190; Studamire B, 1998, MOL CELL BIOL, V18, P7590, DOI 10.1128/MCB.18.12.7590; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; Syngal S, 1999, JAMA-J AM MED ASSOC, V282, P247, DOI 10.1001/jama.282.3.247; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Wang H, 2003, P NATL ACAD SCI USA, V100, P14822, DOI 10.1073/pnas.2433654100; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Waterfall JJ, 2015, NAT GENET, V47, P194, DOI 10.1038/ng.3227; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659; Worth L, 1998, J BIOL CHEM, V273, P23176, DOI 10.1074/jbc.273.36.23176; Yang GZ, 2004, CANCER CELL, V6, P139, DOI 10.1016/j.ccr.2004.06.024; Yoshida T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39618	81	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18055	18070		10.1074/jbc.RA118.005439	http://dx.doi.org/10.1074/jbc.RA118.005439			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30237169	Green Published, hybrid			2022-12-28	WOS:000451375200004
J	Pasupala, N; Morrow, ME; Que, LT; Malynn, BA; Ma, A; Wolberger, C				Pasupala, Nagesh; Morrow, Marie E.; Que, Lauren T.; Malynn, Barbara A.; Ma, Averil; Wolberger, Cynthia			OTUB1 non-catalytically stabilizes the E2 ubiquitin-conjugating enzyme UBE2E1 by preventing its autoubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deubiquitylation (deubiquitination); ubiquitin; ubiquitin thioesterase (OTUB1); ubiquitin-conjugating enzyme (E2 enzyme); histone; UBE2E1	BREAST-CANCER; INHIBITION; BINDING; H2A; MONOUBIQUITINATION; UBIQUITYLATION; DEGRADATION; SPECIFICITY; MECHANISM; TRIGGERS	OTUB1 is a deubiquitinating enzyme that cleaves Lys-48-linked polyubiquitin chains and also regulates ubiquitin signaling through a unique, noncatalytic mechanism. OTUB1 binds to a subset of E2 ubiquitin-conjugating enzymes and inhibits their activity by trapping the E2 approximate to ubiquitin thioester and preventing ubiquitin transfer. The same set of E2s stimulate the deubiquitinating activity of OTUB1 when the E2 is not charged with ubiquitin. Previous studies have shown that, in cells, OTUB1 binds to E2-conjugating enzymes of the UBE2D (UBCH5) and UBE2E families, as well as to UBE2N (UBC13). Cellular roles have been identified for the interaction of OTUB1 with UBE2N and members of the UBE2D family, but not for interactions with UBE2E E2 enzymes. We report here a novel role for OTUB1-E2 interactions in modulating E2 protein ubiquitination. We observe that Otub1(-/-) knockout mice exhibit late-stage embryonic lethality. We find that OTUB1 depletion dramatically destabilizes the E2-conjugating enzyme UBE2E1 (UBCH6) in both mouse and human OTUB1 knockout cell lines. Of note, this effect is independent of the catalytic activity of OTUB1, but depends on its ability to bind to UBE2E1. We show that OTUB1 suppresses UBE2E1 autoubiquitination in vitro and in cells, thereby preventing UBE2E1 from being targeted to the proteasome for degradation. Taken together, we provide evidence that OTUB1 rescues UBE2E1 from degradation in vivo.	[Pasupala, Nagesh; Morrow, Marie E.; Que, Lauren T.; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Malynn, Barbara A.; Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94117 USA	Johns Hopkins University; University of California System; University of California San Francisco	Wolberger, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	cwolberg@jhmi.edu	PASUPALA, NAGESH/O-4611-2018	PASUPALA, NAGESH/0000-0003-4271-8144; Wolberger, Cynthia/0000-0001-8578-2969	National Institutes of Health NIGMS [GM109102]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109102] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NIGMS Grant GM109102 (to C. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Baietti MF, 2016, EMBO MOL MED, V8, P288, DOI 10.15252/emmm.201505972; Banka PA, 2015, J MOL BIOL, V427, P2290, DOI 10.1016/j.jmb.2015.04.011; Berndsen CE, 2011, ANAL BIOCHEM, V418, P102, DOI 10.1016/j.ab.2011.06.034; Bhatnagar S, 2014, NATURE, V516, P116, DOI 10.1038/nature13955; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chen YX, 2017, ONCOTARGET, V8, P11053, DOI 10.18632/oncotarget.14278; Clague MJ, 2015, TRENDS CELL BIOL, V25, P417, DOI 10.1016/j.tcb.2015.03.002; DiBello A, 2016, J MOL BIOL, V428, P4639, DOI 10.1016/j.jmb.2016.09.018; Doudna JA, 2014, METHOD ENZYMOL, V546, pXIX, DOI 10.1016/B978-0-12-801185-0.09983-9; Edelmann MJ, 2010, FEBS J, V277, P2515, DOI 10.1111/j.1742-4658.2010.07665.x; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Fuchs G, 2014, BBA-GENE REGUL MECH, V1839, P694, DOI 10.1016/j.bbagrm.2014.01.002; Goncharov T, 2013, EMBO J, V32, P1103, DOI 10.1038/emboj.2013.62; Herhaus L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3519; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; JENTSCH S, 1990, TRENDS BIOCHEM SCI, V15, P195, DOI 10.1016/0968-0004(90)90161-4; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Karunarathna U, 2016, ONCOGENE, V35, P1433, DOI 10.1038/onc.2015.208; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Li YH, 2014, J BIOL CHEM, V289, P5097, DOI 10.1074/jbc.M113.533109; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Mirza S, 2010, MOL VIS, V16, P2425; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rape M, 2018, NAT REV MOL CELL BIO, V19, P59, DOI 10.1038/nrm.2017.83; Rehman SAA, 2016, MOL CELL, V63, P146, DOI 10.1016/j.molcel.2016.05.009; Sato Y, 2012, J BIOL CHEM, V287, P25860, DOI 10.1074/jbc.M112.364752; Schumacher FR, 2013, J MOL BIOL, V425, P4099, DOI 10.1016/j.jmb.2013.06.039; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stanisic V, 2009, J BIOL CHEM, V284, P16135, DOI 10.1074/jbc.M109.007484; Sun LD, 2016, MOL CELL, V62, P958, DOI 10.1016/j.molcel.2016.04.022; Sun XX, 2012, EMBO J, V31, P576, DOI 10.1038/emboj.2011.434; Takeuchi T, 2005, J BIOCHEM, V138, P711, DOI 10.1093/jb/mvi172; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wheaton K, 2017, J BIOL CHEM, V292, P2893, DOI 10.1074/jbc.M116.749564; Wiener R, 2013, NAT STRUCT MOL BIOL, V20, P1033, DOI 10.1038/nsmb.2655; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Zhao LL, 2018, J BIOL CHEM, V293, P4883, DOI 10.1074/jbc.M117.809533	52	21	22	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18285	18295		10.1074/jbc.RA118.004677	http://dx.doi.org/10.1074/jbc.RA118.004677			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30282802	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000451375200020
J	Cordshagen, A; Busch, W; Winklhofer, M; Nothwang, HG; Hartmann, AM				Cordshagen, Antje; Busch, Wiebke; Winklhofer, Michael; Nothwang, Hans Gerd; Hartmann, Anna-Maria			Phosphoregulation of the intracellular termini of K+-Cl- cotransporter 2 (KCC2) enables flexible control of its activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						potassium transport; post-translational modification (PTM); protein conformation; phosphorylation; evolution; chloride transport; neurophysiology; cation chloride cotransporter; solute carrier family 12 member 5	ALANINE-RICH KINASE; N-ETHYLMALEIMIDE; INHIBITORY NEUROTRANSMISSION; SEQUENCE ALIGNMENT; NEUROPATHIC PAIN; CHLORIDE; ACTIVATION; PHOSPHORYLATION; TRANSPORT; EPILEPSY	The pivotal role of K+-Cl- cotransporter 2 (KCC2) in inhibitory neurotransmission and severe human diseases fosters interest in understanding posttranslational regulatory mechanisms such as (de)phosphorylation. Here, the regulatory role of the five bona fide phosphosites Ser(31), Thr(34), Ser(932), Thr(999), and Thr(1008) was investigated by the use of alanine and aspartate mutants. Tl+-based flux analyses in HEK-293 cells demonstrated increased transport activity for S932D (mimicking phosphorylation) and T1008A (mimicking dephosphorylation), albeit to a different extent. Increased activity was due to changes in intrinsic activity, as it was not caused by increased cell-surface abundance. Substitutions of Ser(31), Thr(34), or Thr(999) had no effect. Additionally, we show that the indirect actions of the known KCC2 activators staurosporine and N-ethylmaleimide (NEM) involved multiple phosphosites. S31D, T34A, S932A/D, T999A, or T1008A/D abrogated staurosporine mediated stimulation, and S31A, T34D, or S932D abolished NEM-mediated stimulation. This demonstrates for the first time differential effects of staurosporine and NEM on KCC2. In addition, the staurosporine-mediated effects involved both KCC2 phosphorylation and dephosphorylation with Ser(932) and Thr(1008) being bona fide target sites. In summary, our data reveal a complex phosphoregulation of KCC2 that provides the transporter with a toolbox for graded activity and integration of different signaling pathways.	[Cordshagen, Antje; Busch, Wiebke; Nothwang, Hans Gerd; Hartmann, Anna-Maria] Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, Ctr Excellence Hearing4all, Neurogenet Grp, D-26111 Oldenburg, Germany; [Winklhofer, Michael] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci IBU, D-26111 Oldenburg, Germany; [Winklhofer, Michael; Nothwang, Hans Gerd; Hartmann, Anna-Maria] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Hartmann, AM (corresponding author), Carl von Ossietzky Univ Oldenburg, Div Neurogenet, D-26111 Oldenburg, Germany.	anna.maria.hartmann@uol.de	Winklhofer, Michael/B-7349-2009	Winklhofer, Michael/0000-0003-1352-9723; Nothwang, Hans Gerd/0000-0001-7695-6437	Deutsche Forschungsgemeinschaft [NO428/14-1, HA 6338/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants NO428/14-1 (to H.G.N.) and HA 6338/2-1 (to A.-M.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Agez M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15739-1; Alessi DR, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005365; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergeron MJ, 2006, J BIOL CHEM, V281, P15959, DOI 10.1074/jbc.M600015200; Bize I, 2000, J MEMBRANE BIOL, V177, P159, DOI 10.1007/s002320001109; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Conway LC, 2017, J BIOL CHEM, V292, P21253, DOI 10.1074/jbc.M117.817841; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Culliford SJ, 2003, CELL PHYSIOL BIOCHEM, V13, P181, DOI 10.1159/000072420; de los Heros P, 2014, BIOCHEM J, V458, P559, DOI 10.1042/BJ20131478; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Friedel P, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0055-17.2017; Friedel P, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0354; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gagnon KB, 2013, AM J PHYSIOL-CELL PH, V304, pC693, DOI 10.1152/ajpcell.00350.2012; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hartmann AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179968; Hartmann AM, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00470; Hartmann AM, 2010, J BIOL CHEM, V285, P23994, DOI 10.1074/jbc.M110.144063; Heubl M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01749-0; HOLM S, 1979, SCAND J STAT, V6, P65; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Inoue K, 2006, J NEUROCHEM, V96, P598, DOI 10.1111/j.1471-4159.2005.03560.x; Inoue K, 2012, J BIOL CHEM, V287, P20839, DOI 10.1074/jbc.M111.319418; JENNINGS ML, 1991, J GEN PHYSIOL, V97, P799, DOI 10.1085/jgp.97.4.799; Kahle KT, 2014, EMBO REP, V15, P766, DOI 10.15252/embr.201438840; Kahle KT, 2014, JAMA NEUROL, V71, P640, DOI 10.1001/jamaneurol.2014.21; Kahle KT, 2013, TRENDS NEUROSCI, V36, P726, DOI 10.1016/j.tins.2013.08.006; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Kim JY, 2012, CELL, V148, P1051, DOI 10.1016/j.cell.2011.12.037; Kopp-Scheinpflug C, 2011, NEURON, V71, P911, DOI 10.1016/j.neuron.2011.06.028; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Lee HHC, 2010, MOL CELL NEUROSCI, V45, P173, DOI 10.1016/j.mcn.2010.06.008; Lytle C, 2002, AM J PHYSIOL-CELL PH, V283, pC1422, DOI 10.1152/ajpcell.00130.2002; Markkanen M, 2017, BRAIN RES, V1675, P87, DOI 10.1016/j.brainres.2017.08.034; Markkanen M, 2014, J COMP NEUROL, V522, P1897, DOI 10.1002/cne.23510; Medina I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00027; Melo Z, 2013, J BIOL CHEM, V288, P31468, DOI 10.1074/jbc.M113.475574; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Merner ND, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00386; Monette MY, 2014, J BIOL CHEM, V289, P7569, DOI 10.1074/jbc.M113.542258; Monette Michelle Y, 2012, J Biol Chem, V287, P2210, DOI 10.1074/jbc.M111.309211; Moore YE, 2017, TRENDS NEUROSCI, V40, P555, DOI 10.1016/j.tins.2017.06.008; Papp E, 2008, NEUROSCIENCE, V154, P677, DOI 10.1016/j.neuroscience.2008.03.072; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Puskarjov M, 2015, NEUROPHARMACOLOGY, V88, P103, DOI 10.1016/j.neuropharm.2014.09.005; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Silayeva L, 2015, P NATL ACAD SCI USA, V112, P3523, DOI 10.1073/pnas.1415126112; Song LY, 2002, MOL BRAIN RES, V103, P91, DOI 10.1016/S0169-328X(02)00190-0; Strange K, 2000, AM J PHYSIOL-CELL PH, V279, pC860, DOI 10.1152/ajpcell.2000.279.3.C860; Titz S, 2015, NEUROPHARMACOLOGY, V95, P321, DOI 10.1016/j.neuropharm.2015.03.026; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190; Uvarov P, 2007, J BIOL CHEM, V282, P30570, DOI 10.1074/jbc.M705095200; Uvarov P, 2009, J BIOL CHEM, V284, P13696, DOI 10.1074/jbc.M807366200; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Watanabe M, 2009, J BIOL CHEM, V284, P27980, DOI 10.1074/jbc.M109.043620; Weber M, 2014, J BIOL CHEM, V289, P18668, DOI 10.1074/jbc.M114.567834; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5	71	14	14	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					16984	16993		10.1074/jbc.RA118.004349	http://dx.doi.org/10.1074/jbc.RA118.004349			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30201606	Green Published, hybrid			2022-12-28	WOS:000449466500003
J	Gu, X; Bridges, MD; Yan, Y; de Waal, PW; Zhou, XE; Suino-Powell, KM; Xu, HE; Hubbell, WL; Melcher, K				Gu, Xin; Bridges, Michael D.; Yan, Yan; de Waal, Parker W.; Zhou, X. Edward; Suino-Powell, Kelly M.; Xu, H. Eric; Hubbell, Wayne L.; Melcher, Karsten			Conformational heterogeneity of the allosteric drug and metabolite (ADaM) site in AMP-activated protein kinase (AMPK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); biophysics; diabetes; metabolic regulation; cancer; ADaM site; DEER	GAMMA-SUBUNIT ISOFORMS; STRUCTURAL BASIS; SKELETAL-MUSCLE; ENERGY SENSOR; GLYCOGEN; BINDING; MECHANISM; A-769662; PHOSPHORYLATION; HOMEOSTASIS	AMP-activated protein kinase (AMPK) is a master regulator of energy homeostasis and a promising drug target for managing metabolic diseases such as type 2 diabetes. Many pharmacological AMPK activators, and possibly unidentified physiological metabolites, bind to the allosteric drug and metabolite (ADaM) site at the interface between the kinase domain (KD) in the -subunit and the carbohydrate-binding module (CBM) in the -subunit. Here, using double electron-electron resonance (DEER) spectroscopy, we demonstrate that the CBM-KD interaction is partially dissociated and the interface highly disordered in the absence of pharmacological ADaM site activators as inferred from a low depth of modulation and broad DEER distance distributions. ADaM site ligands such as 991, and to a lesser degree phosphorylation, stabilize the KD-CBM association and strikingly reduce conformational heterogeneity in the ADaM site. Our findings that the ADaM site, formed by the KD-CBM interaction, can be modulated by diverse ligands and by phosphorylation suggest that it may function as a hub for integrating regulatory signals.	[Gu, Xin; Yan, Yan; de Waal, Parker W.; Zhou, X. Edward; Suino-Powell, Kelly M.; Xu, H. Eric; Melcher, Karsten] Van Andel Res Inst, Ctr Canc & Cell Biol, Grand Rapids, MI 49503 USA; [Bridges, Michael D.; Hubbell, Wayne L.] Univ Calif Los Angeles, UCLA Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Bridges, Michael D.; Hubbell, Wayne L.] Univ Calif Los Angeles, UCLA Sch Med, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Yan, Yan; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, VARI SIMM Ctr,Ctr Struct & Funct Drug Targets, Shanghai 201203, Peoples R China	Van Andel Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Melcher, K (corresponding author), Bostwick Ave Northeast, Grand Rapids, MI 49503 USA.	Karsten.melcher@vai.org	Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021	Melcher, Karsten/0000-0002-9125-4027; Xu, H. Eric/0000-0002-6829-8144	Jules Stein Professorship endowment; Van Andel Research Institute; National Institutes of Health [R01 GM102545, R01 GM129436, R01 EY05216, T33 EY07026, 5P41EB001980, R01 DK071662]; National Natural Science Foundation of China [31300245]; Ministry of Science and Technology (China) [2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, 2013ZX09507001]; Amway (China); NATIONAL EYE INSTITUTE [P30EY000331, R01EY005216, T32EY007026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM129436, R01GM102545] Funding Source: NIH RePORTER	Jules Stein Professorship endowment; Van Andel Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (China)(Ministry of Science and Technology, China); Amway (China); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Jules Stein Professorship endowment (to W.L.H.), Van Andel Research Institute (to H.E.X. and K.M.), National Institutes of Health Grants R01 GM102545 and R01 GM129436 (to K.M.), R01 EY05216, T33 EY07026, and 5P41EB001980 (to W.L.H.), and R01 DK071662 (to H.E.X.), National Natural Science Foundation of China Grant 31300245 (to H.E.X.), Ministry of Science and Technology (China) Grants 2012ZX09301001 and 2012CB910403, 2013CB910600, XDB08020303, and 2013ZX09507001 (to H.E.X.), and Amway (China) (to H.E.X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072851; Altenbach C., 2017, LONGDISTANCES VERSIO; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Calabrese MF, 2014, STRUCTURE, V22, P1161, DOI 10.1016/j.str.2014.06.009; Chen L, 2012, NAT STRUCT MOL BIOL, V19, P716, DOI 10.1038/nsmb.2319; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Fleissner MR, 2009, P NATL ACAD SCI USA, V106, P21637, DOI 10.1073/pnas.0912009106; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Gu X, 2017, J BIOL CHEM, V292, P12653, DOI 10.1074/jbc.M117.793018; Hardie DG, 2017, SCIENCE, V357, P455, DOI 10.1126/science.aao1913; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2013, DIABETES, V62, P2164, DOI 10.2337/db13-0368; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Jin L, 2004, J BIOL CHEM, V279, P42818, DOI 10.1074/jbc.M407096200; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2015, TRENDS BIOCHEM SCI, V40, P628, DOI 10.1016/j.tibs.2015.09.002; Langendorf CG, 2015, CELL RES, V25, P5, DOI 10.1038/cr.2014.163; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li XD, 2015, CELL RES, V25, P50, DOI 10.1038/cr.2014.150; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Ngoei KRW, 2018, CELL CHEM BIOL, V25, P728, DOI 10.1016/j.chembiol.2018.03.008; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Oligschlaeger Y, 2015, J BIOL CHEM, V290, P11715, DOI 10.1074/jbc.M114.633271; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Scott JW, 2015, CHEM BIOL, V22, P705, DOI 10.1016/j.chembiol.2015.05.011; Scott JW, 2014, CHEM BIOL, V21, P619, DOI 10.1016/j.chembiol.2014.03.006; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Shao D, 2014, CELL METAB, V19, P232, DOI 10.1016/j.cmet.2013.12.013; Smith PA, 1998, NUCLEIC ACIDS RES, V26, P1414, DOI 10.1093/nar/26.6.1414; STAPLETON D, 1994, J BIOL CHEM, V269, P29343; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Willows R, 2017, BIOCHEM J, V474, P3059, DOI 10.1042/BCJ20170458; Willows R, 2017, BIOCHEM J, V474, P1741, DOI 10.1042/BCJ20170046; Wu J, 2013, J BIOL CHEM, V288, P35904, DOI 10.1074/jbc.M113.508747; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932	46	9	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					16994	17007		10.1074/jbc.RA118.004101	http://dx.doi.org/10.1074/jbc.RA118.004101			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30206123	Green Published, hybrid			2022-12-28	WOS:000449466500004
J	Osborne, AJ; Nan, RD; Miller, A; Bhatt, JS; Gor, J; Perkins, SJ				Osborne, Amy J.; Nan, Ruodan; Miller, Ami; Bhatt, Jayesh S.; Gor, Jayesh; Perkins, Stephen J.			Two distinct conformations of factor H regulate discrete complement-binding functions in the fluid phase and at cell surfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C3b activity; immune system; innate immunity; solution structure; analytical ultracentrifugation; complement; molecular modeling; surface plasmon resonance (SPR); X-ray scattering; complement regulation; Monte Carlo modeling	HEMOLYTIC-UREMIC SYNDROME; PROTEIN-PROTEIN INTERACTIONS; MEMBRANE COFACTOR PROTEIN; ALTERNATIVE PATHWAY; SELF-ASSOCIATION; SEDIMENTATION-VELOCITY; MACULAR DEGENERATION; NEUTRON-SCATTERING; HEPARAN-SULFATE; FACTOR-I	Factor H (FH) is the major regulator of C3b in the alternative pathway of the complement system in immunity. FH comprises 20 short complement regulator (SCR) domains, including eight glycans, and its Y402H polymorphism predisposes those who carry it to age-related macular degeneration. To better understand FH complement binding and self-association, we have studied the solution structures of both the His-402 and Tyr-402 FH allotypes. Analytical ultracentrifugation revealed that up to 12% of both FH allotypes self-associate, and this was confirmed by small-angle X-ray scattering (SAXS), MS, and surface plasmon resonance analyses. SAXS showed that monomeric FH has a radius of gyration (R-g) of 7.2-7.8 nm and a length of 25 nm. Starting from known structures for the SCR domains and glycans, the SAXS data were fitted using Monte Carlo methods to determine atomistic structures of monomeric FH. The analysis of 29,715 physically realistic but randomized FH conformations resulted in 100 similar best-fit FH structures for each allotype. Two distinct molecular structures resulted that showed either an extended N-terminal domain arrangement with a folded-back C terminus or an extended C terminus and a folded-back N terminus. These two structures are the most accurate to date for glycosylated full-length FH. To clarify FH functional roles in host protection, crystal structures for the FH complexes with C3b and C3dg revealed that the extended N-terminal conformation accounted for C3b fluid-phase regulation, the extended C-terminal conformation accounted for C3d binding, and both conformations accounted for bivalent FH binding to glycosaminoglycans on the target cell surface.	[Osborne, Amy J.; Nan, Ruodan; Miller, Ami; Bhatt, Jayesh S.; Gor, Jayesh; Perkins, Stephen J.] UCL, Dept Struct & Mol Biol, Darwin Bldg,Gower St, London WC1E 6BT, England	University of London; University College London	Perkins, SJ (corresponding author), UCL, Dept Struct & Mol Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@ucl.ac.uk		Osborne, Amy/0000-0001-6869-1176; Perkins, Stephen/0000-0001-9218-9805	Alexion; Mizutani Foundation Award [180218]; CCP-SAS Project through joint EPSRC [EP/K039121/1]; National Science Foundation [CHE-1265821]; MRC [G0801724]; EPSRC [EP/K039121/1] Funding Source: UKRI	Alexion; Mizutani Foundation Award; CCP-SAS Project through joint EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Science Foundation(National Science Foundation (NSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported in part by a Ph.D. studentship grant from Alexion to Complement UK, Mizutani Foundation Award 180218, CCP-SAS Project through joint EPSRC Grant EP/K039121/1, National Science Foundation Grant CHE-1265821, and MRC Grant G0801724. The authors declare that they have no conflicts of interest with the contents of this article.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Armstrong CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep21759; Aslam M, 2001, J MOL BIOL, V309, P1117, DOI 10.1006/jmbi.2001.4720; BARLOW PN, 1992, BIOCHEMISTRY-US, V31, P3626, DOI 10.1021/bi00129a011; BARLOW PN, 1993, J MOL BIOL, V232, P268, DOI 10.1006/jmbi.1993.1381; Benesch JLP, 2009, NATURE, V462, P576, DOI 10.1038/462576a; Bird AC, 2010, J CLIN INVEST, V120, P3033, DOI 10.1172/JCI42437; Blackmore TK, 1996, J IMMUNOL, V157, P5422; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Bok D, 2005, P NATL ACAD SCI USA, V102, P7053, DOI 10.1073/pnas.0502819102; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Clark SJ, 2013, J IMMUNOL, V190, P2049, DOI 10.4049/jimmunol.1201751; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Curtis JE, 2012, COMPUT PHYS COMMUN, V183, P382, DOI 10.1016/j.cpc.2011.09.010; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; David CC, 2014, METHODS MOL BIOL, V1084, P193, DOI 10.1007/978-1-62703-658-0_11; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DISCIPIO RG, 1992, J IMMUNOL, V149, P2592; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; FARRIES TC, 1990, COMPLEMENT INFLAMMAT, V7, P30, DOI 10.1159/000463124; Fenaille F, 2007, GLYCOBIOLOGY, V17, P932, DOI 10.1093/glycob/cwm060; Fernando AN, 2007, J MOL BIOL, V368, P564, DOI 10.1016/j.jmb.2007.02.038; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Fornace ME, 2015, J CHEM THEORY COMPUT, V11, P568, DOI 10.1021/ct5011032; Fung KW, 2016, BIOCHEM J, V473, P4473, DOI 10.1042/BCJ20160744; Geerlings MJ, 2017, MOL IMMUNOL, V84, P65, DOI 10.1016/j.molimm.2016.11.016; Glatter O., 1982, SMALL ANGLE XRAY SCA; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hecker LA, 2010, HUM MOL GENET, V19, P209, DOI 10.1093/hmg/ddp472; Herbert AP, 2007, J BIOL CHEM, V282, P18960, DOI 10.1074/jbc.M609636200; Hocking HG, 2008, J BIOL CHEM, V283, P9475, DOI 10.1074/jbc.M709587200; Hui GK, 2015, BIOCHEM J, V471, P167, DOI 10.1042/BJ20150612; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo SW, 2014, ADV PROTEIN CHEM STR, V96, P235, DOI 10.1016/bs.apcsb.2014.06.002; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Kelly U, 2010, J IMMUNOL, V185, P5486, DOI 10.4049/jimmunol.0903596; Khan S, 2012, BIOCHEM J, V444, P417, DOI 10.1042/BJ20120183; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Knopf PM, 2008, IMMUNOL CELL BIOL, V86, P221, DOI 10.1038/sj.icb.7100147; Kolodziejczyk R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188127; Kuhn S, 1996, EUR J IMMUNOL, V26, P2383, DOI 10.1002/eji.1830261017; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Langford-Smith A, 2014, J INNATE IMMUN, V6, P407, DOI 10.1159/000356513; Law S.K.A., 1995, COMPLEMENT; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Makou E, 2012, J MOL BIOL, V424, P295, DOI 10.1016/j.jmb.2012.09.013; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Morikis D, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P1; Nan RD, 2008, J MOL BIOL, V375, P891, DOI 10.1016/j.jmb.2007.11.015; Nan R, 2010, MOL IMMUNOL, V47, P2263, DOI 10.1016/j.molimm.2010.05.195; Nan R, 2008, J MOL BIOL, V384, P1341, DOI 10.1016/j.jmb.2008.10.030; Narayanan T, 2001, NUCL INSTRUM METH A, V467, P1005, DOI 10.1016/S0168-9002(01)00553-8; Okemefuna AI, 2008, J MOL BIOL, V375, P80, DOI 10.1016/j.jmb.2007.09.026; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; Okemefuna AI, 2009, J MOL BIOL, V391, P98, DOI 10.1016/j.jmb.2009.06.010; Ormsby RJ, 2008, INVEST OPHTH VIS SCI, V49, P1763, DOI 10.1167/iovs.07-1297; Ormsby RJ, 2006, MOL IMMUNOL, V43, P1624, DOI 10.1016/j.molimm.2005.09.012; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Osborne AJ, 2018, J IMMUNOL, V200, P2464, DOI 10.4049/jimmunol.1701695; Pangburn MK, 2009, J IMMUNOL, V182, P1061, DOI 10.4049/jimmunol.182.2.1061; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; PERKINS SJ, 1991, BIOCHEMISTRY-US, V30, P2847, DOI 10.1021/bi00225a017; Perkins SJ, 2008, METHOD CELL BIOL, V84, P375, DOI 10.1016/S0091-679X(07)84013-1; Perkins SJ, 2016, J APPL CRYSTALLOGR, V49, P1861, DOI 10.1107/S160057671601517X; Perkins SJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00126; Perkins SJ, 2012, IMMUNOBIOLOGY, V217, P281, DOI 10.1016/j.imbio.2011.10.003; Perkins SJ, 2010, ADV EXP MED BIOL, V703, P25, DOI 10.1007/978-1-4419-5635-4_3; Perkins SJ, 2010, BIOCHEM SOC T, V38, P894, DOI 10.1042/BST0380894; Perkins SJ, 2009, J R SOC INTERFACE, V6, pS679, DOI 10.1098/rsif.2009.0164.focus; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Prosser BE, 2007, ACTA CRYSTALLOGR F, V63, P480, DOI 10.1107/S1744309107020052; R Development Core Team, 2009, R LANG ENV STAT COMP; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Rodriguez E, 2014, BIOSCIENCE REP, V34, P635, DOI 10.1042/BSR20140117; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saunders RE, 2006, HUM MUTAT, V27, P21, DOI 10.1002/humu.20268; Saunders RE, 2007, HUM MUTAT, V28, P222, DOI 10.1002/humu.20435; Schmidt CQ, 2011, PROTEIN EXPRES PURIF, V76, P254, DOI 10.1016/j.pep.2010.12.002; Schmidt CQ, 2010, J MOL BIOL, V395, P105, DOI 10.1016/j.jmb.2009.10.010; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sharma AK, 1996, P NATL ACAD SCI USA, V93, P10996, DOI 10.1073/pnas.93.20.10996; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIM RB, 1993, METHOD ENZYMOL, V223, P13; Skerka C, 2007, MOL IMMUNOL, V44, P3398, DOI 10.1016/j.molimm.2007.02.012; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Strohmeyer R, 2002, J NEUROIMMUNOL, V131, P135, DOI 10.1016/S0165-5728(02)00272-2; Tanious FA, 2008, METHOD CELL BIOL, V84, P53, DOI 10.1016/S009911-679X(07)84003-9; Thakkinstian A, 2006, HUM MOL GENET, V15, P2784, DOI 10.1093/hmg/ddl220; Toomey CB, 2018, PROG RETIN EYE RES, V62, P38, DOI 10.1016/j.preteyeres.2017.09.001; Tortajada A, 2009, HUM MOL GENET, V18, P3452, DOI 10.1093/hmg/ddp289; Watson MC, 2013, J APPL CRYSTALLOGR, V46, P1171, DOI 10.1107/S002188981301666X; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; Wright DW, 2015, J APPL CRYSTALLOGR, V48, P953, DOI 10.1107/S1600576715007062; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Zetterberg M, 2008, AM J MED GENET B, V147B, P720, DOI 10.1002/ajmg.b.30668; Zhang WH, 2017, J MOL GRAPH MODEL, V73, P179, DOI 10.1016/j.jmgm.2017.02.010	115	9	9	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17166	17187		10.1074/jbc.RA118.004767	http://dx.doi.org/10.1074/jbc.RA118.004767			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30217822	Green Published, hybrid			2022-12-28	WOS:000449466500017
J	Zhang, WX; Xu, JJ; Li, JH; Guo, T; Jiang, D; Feng, X; Ma, XY; He, LL; Wu, WQ; Yin, MX; Ge, L; Wang, ZY; Ho, MS; Zhao, Y; Fei, ZL; Zhang, L				Zhang, Wenxiang; Xu, Jinjin; Li, Jinhui; Guo, Tong; Jiang, Dan; Feng, Xue; Ma, Xueyan; He, Lingli; Wu, Wenqing; Yin, Mengxin; Ge, Ling; Wang, Zuoyun; Ho, Margaret S.; Zhao, Yun; Fei, Zhaoliang; Zhang, Lei			The TEA domain family transcription factor TEAD4 represses murine adipogenesis by recruiting the cofactors VGLL4 and CtBP2 into a transcriptional complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipogenesis; Hippo pathway; Yes-associated protein (YAP); triglyceride; lipid; adipogenesis; CtBP2; Hippo signaling; TEAD4; VGLL4	KRUPPEL-LIKE FACTOR; ADIPOCYTE DIFFERENTIATION; SIGNALING PATHWAY; FUNCTIONAL-ANALYSIS; HIPPO PATHWAY; SIZE-CONTROL; CELL FATE; GROWTH; RECEPTOR; EXPRESSION	The Hippo signaling pathway is known to play an important role in multiple physiological processes, including adipogenesis. However, whether the downstream components of the Hippo pathway are involved in adipogenesis remains unknown. Here we demonstrate that the TEA domain family (TEAD) transcription factors are essential for adipogenesis in murine 3T3-L1 preadipocytes. Knockdown of TEAD1-4 stimulated adipogenesis and increased the expression of adipocyte markers in these cells. Interestingly, we found that the TEAD4 knockdown-mediated adipogenesis proceeded in a Yes-associated protein (YAP)/TAZ (Wwtr1)-independent manner and that adipogenesis suppression in WT cells involved formation of a ternary complex comprising TEAD4 and the transcriptional cofactors C-terminal binding protein 2 (CtBP2) and vestigial-like family member 4 (VGLL4). VGLL4 acted as an adaptor protein that enhanced the interaction between TEAD4 and CtBP2, and this TEAD4-VGLL4-CtBP2 ternary complex dynamically existed at the early stage of adipogenesis. Finally, we verified that TEAD4 directly targets the promoters of major adipogenesis transcription factors such as peroxisome proliferator-activated receptor (PPAR) and adiponectin, C1Q, and collagen domain-containing (Adipoq) during adipogenesis. These findings reveal critical insights into the role of the TEAD4-VGLL4-CtBP2 transcriptional repressor complex in suppression of adipogenesis in murine preadipocytes.	[Zhang, Wenxiang; Xu, Jinjin; Li, Jinhui; Guo, Tong; Feng, Xue; Ma, Xueyan; He, Lingli; Wu, Wenqing; Yin, Mengxin; Ge, Ling; Wang, Zuoyun; Zhao, Yun; Fei, Zhaoliang; Zhang, Lei] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol,Innovat Ctr Cel, State Key Lab Cell Biol,Chinese Acad Sci Ctr Exce, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Jiang, Dan; Ho, Margaret S.; Zhao, Yun; Zhang, Lei] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Fei, ZL; Zhang, L (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol,Innovat Ctr Cel, State Key Lab Cell Biol,Chinese Acad Sci Ctr Exce, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Zhang, L (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.	feiz@sibcb.ac.cn; rayzhang@sibcb.ac.cn	fei, zhaoliang/ADK-2083-2022; Li, Jin/GYQ-5363-2022; He, Lingli/AAD-7675-2022; Ho, Margaret/K-6310-2017	fei, zhaoliang/0000-0002-5400-8126; Ho, Margaret/0000-0002-2387-7564; guo, tong/0000-0002-6415-3378; He, Lingli/0000-0001-8837-7811	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000]; National Key Research and Development Program of China [2017YFA0103601]; National Natural Science Foundation of China [31625017, 31530043]; Cross-and Co-operation in Science and Technology Innovation Team Project of the Chinese Academy of Sciences; Chinese Academy of Sciences/SAFEA International Partnership Program for Creative Research Teams	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cross-and Co-operation in Science and Technology Innovation Team Project of the Chinese Academy of Sciences; Chinese Academy of Sciences/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences)	This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB19000000), the National Key Research and Development Program of China (2017YFA0103601), the National Natural Science Foundation of China (31625017 and 31530043), the Cross-and Co-operation in Science and Technology Innovation Team Project of the Chinese Academy of Sciences, and the Chinese Academy of Sciences/SAFEA International Partnership Program for Creative Research Teams. The authors declare that they have no conflicts of interest with the contents of this article.	Affolter M, 2008, DEV CELL, V15, P11, DOI 10.1016/j.devcel.2008.06.006; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Benhaddou A, 2012, CELL DEATH DIFFER, V19, P220, DOI 10.1038/cdd.2011.87; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Bi PP, 2016, J EXP MED, V213, P2019, DOI 10.1084/jem.20160157; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Dai ZH, 2018, FEBS OPEN BIO, V8, P860, DOI 10.1002/2211-5463.12428; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Floyd ZE, 2003, DIABETES, V52, P308, DOI 10.2337/diabetes.52.2.308; Gao H, 2014, CELL METAB, V19, P981, DOI 10.1016/j.cmet.2014.03.032; Guo T, 2013, CELL RES, V23, P1201, DOI 10.1038/cr.2013.120; Home P, 2012, P NATL ACAD SCI USA, V109, P7362, DOI 10.1073/pnas.1201595109; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jack BHA, 2011, INT J BIOCHEM CELL B, V43, P693, DOI 10.1016/j.biocel.2011.01.017; Jacquemin P, 1996, J BIOL CHEM, V271, P21775, DOI 10.1074/jbc.271.36.21775; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Kiskinis E, 2007, EMBO J, V26, P4831, DOI 10.1038/sj.emboj.7601908; Koontz LM, 2013, DEV CELL, V25, P388, DOI 10.1016/j.devcel.2013.04.021; Lee YH, 2013, CELL MOL LIFE SCI, V70, P3959, DOI 10.1007/s00018-013-1363-8; Li N, 2015, AM J CANCER RES, V5, P1158; Li X, 2006, BIOCHEM BIOPH RES CO, V350, P1, DOI 10.1016/j.bbrc.2006.08.188; Liang S, 2015, INSECT SCI, V22, P587, DOI 10.1111/1744-7917.12164; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; Margoni A, 2012, INT J BIOCHEM CELL B, V44, P475, DOI 10.1016/j.biocel.2011.12.014; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Oliveros J., 2007, VENNY INTERACTIVE TO; Park BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030983; Pobbati AV, 2012, STRUCTURE, V20, P1135, DOI 10.1016/j.str.2012.04.004; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Sarjeant K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008417; Schupp M, 2009, J BIOL CHEM, V284, P9458, DOI 10.1074/jbc.M809498200; Seo E, 2013, CELL REP, V3, P2075, DOI 10.1016/j.celrep.2013.05.029; Song BQ, 2015, CELL PHYSIOL BIOCHEM, V36, P1991, DOI 10.1159/000430167; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Tian W, 2010, P NATL ACAD SCI USA, V107, P7293, DOI 10.1073/pnas.1000293107; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Wang JZ, 2018, AM J TRANSL RES, V10, P998; Wu ZN, 2013, DEV BIOL, V373, P235, DOI 10.1016/j.ydbio.2012.10.031; Yin MX, 2011, J GENET GENOMICS, V38, P471, DOI 10.1016/j.jgg.2011.09.009; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang WJ, 2014, CELL RES, V24, P331, DOI 10.1038/cr.2014.10; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; ZHOU YH, 2016, INT J MOL SCI, V17	59	17	18	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17119	17134		10.1074/jbc.RA118.003608	http://dx.doi.org/10.1074/jbc.RA118.003608			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30209132	hybrid, Green Published			2022-12-28	WOS:000449466500014
J	Wu, CH; Schut, GJ; Poole, FL; Haja, DK; Adams, MWW				Wu, Chang-Hao; Schut, Gerrit J.; Poole, Farris L.; Haja, Dominik K.; Adams, Michael W. W.			Characterization of membrane-bound sulfane reductase: A missing link in the evolution of modern day respiratory complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sulfur; hydrogen sulfide; hydrogenase; oxidation-reduction (redox); membrane energetics; archaea; respiration; Complex I	ARCHAEON PYROCOCCUS-FURIOSUS; ELEMENTAL SULFUR; HYPERTHERMOPHILIC ARCHAEBACTERIUM; F420H2 DEHYDROGENASE; METABOLISM; HYDROGEN; OXIDOREDUCTASE; POLYSULFIDES; FERREDOXIN; PROTEINS	Hyperthermophilic archaea contain a hydrogen gas-evolving,respiratory membrane-bound NiFe-hydrogenase (MBH) that is very closely related to the aerobic respiratory complex I. During growth on elemental sulfur (S degrees), these microorganisms also produce a homologous membrane-bound complex (MBX), which generates H2S. MBX evolutionarily links MBH to complex I, but its catalytic function is unknown. Herein, we show that MBX reduces the sulfane sulfur of polysulfides by using ferredoxin (Fd) as the electron donor, and we rename it membrane-bound sulfane reductase (MBS). Two forms of affinity-tagged MBS were purified from genetically engineered Pyrococcus furiosus (a hyperthermophilic archaea species): the 13-subunit holoenzyme (S-MBS) and a cytoplasmic 4-subunit catalytic subcomplex (C-MBS). S-MBS and C-MBS reduced dimethyl trisulfide (DMTS) with comparable K-m (approximate to 490 m) and V-max values (12 mol/min/mg). The MBS catalytic subunit (MbsL), but not that of complex I (NuoD), retains two of four NiFe-coordinating cysteine residues of MBH. However, these cysteine residues were not involved in MBS catalysis because a mutant P. furiosus strain (MbsLC85A/C385A) grew normally with S degrees. The products of the DMTS reduction and properties of polysulfides indicated that in the physiological reaction, MBS uses Fd (E-o = -480 mV) to reduce sulfane sulfur (E-o -260 mV) and cleave organic (RSnR, n 3) and anionic polysulfides (S-n(2-), n 4) but that it does not produce H2S. Based on homology to MBH, MBS also creates an ion gradient for ATP synthesis. This work establishes the electrochemical reaction catalyzed by MBS that is intermediate in the evolution from proton- to quinone-reducing respiratory complexes.	[Wu, Chang-Hao; Schut, Gerrit J.; Poole, Farris L.; Haja, Dominik K.; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Adams, MWW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	adamsm@uga.edu			Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the Department of Energy [DE-FG05-95ER20175]	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the Department of Energy	This work was supported by Grant DE-FG05-95ER20175 (to M. W. A.) from the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the Department of Energy. The authors declare that they have no conflicts of interest with the contents of this article.	Adams MWW, 2001, J BACTERIOL, V183, P716, DOI 10.1128/JB.183.2.716-724.2001; ALBRACHT SPJ, 1993, BIOCHIM BIOPHYS ACTA, V1144, P221, DOI 10.1016/0005-2728(93)90176-G; AONO S, 1989, J BACTERIOL, V171, P3433, DOI 10.1128/jb.171.6.3433-3439.1989; Arnold T, 2007, BIOTECHNIQUES, V43, P427, DOI 10.2144/000112566; Baumer S, 2000, J BIOL CHEM, V275, P17968, DOI 10.1074/jbc.M000650200; Baumer S, 1998, FEBS LETT, V428, P295, DOI 10.1016/S0014-5793(98)00555-9; BLUMENTALS II, 1990, APPL ENVIRON MICROB, V56, P1255, DOI 10.1128/AEM.56.5.1255-1262.1990; Boyd E.S., 2014, MICROBE, V9, P361; Bridger SL, 2011, J BACTERIOL, V193, P6498, DOI 10.1128/JB.05445-11; BRYANT FO, 1989, J BIOL CHEM, V264, P5070; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Chandrayan SK, 2012, J BIOL CHEM, V287, P3257, DOI 10.1074/jbc.M111.290916; CHEN JS, 1977, ANAL BIOCHEM, V79, P157, DOI 10.1016/0003-2697(77)90390-6; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Dias B, 1998, APPL ENVIRON MICROB, V64, P3320; Enemark JH, 2002, MET IONS BIOL SYST, V39, P621; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; GIGGENBACH W, 1972, INORG CHEM, V11, P1201, DOI 10.1021/ic50112a009; Hedderich R, 1998, FEMS MICROBIOL REV, V22, P353, DOI 10.1111/j.1574-6976.1998.tb00376.x; Isogai A, 2009, J AGR FOOD CHEM, V57, P189, DOI 10.1021/jf802582p; Kang J, 2007, RAPID COMMUN MASS SP, V21, P4065, DOI 10.1002/rcm.3311; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Lipscomb GL, 2009, MOL MICROBIOL, V71, P332, DOI 10.1111/j.1365-2958.2008.06525.x; Liu YC, 2012, ENVIRON MICROBIOL, V14, P2632, DOI 10.1111/j.1462-2920.2012.02783.x; MA K, 1993, P NATL ACAD SCI USA, V90, P5341, DOI 10.1073/pnas.90.11.5341; MA K, 1994, J BACTERIOL, V176, P6509, DOI 10.1128/JB.176.21.6509-6517.1994; Ma KS, 2000, J BACTERIOL, V182, P1864, DOI 10.1128/JB.182.7.1864-1871.2000; McTernan PM, 2014, J BIOL CHEM, V289, P19364, DOI 10.1074/jbc.M114.567255; Nguyen DMN, 2017, J BIOL CHEM, V292, P14603, DOI 10.1074/jbc.M117.794172; Philippot P, 2007, SCIENCE, V317, P1534, DOI 10.1126/science.1145861; PICKERING TL, 1967, J AM CHEM SOC, V89, P2364, DOI 10.1021/ja00986a021; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; Prisner T, 2003, J BIOL INORG CHEM, V8, P419, DOI 10.1007/s00775-002-0432-5; RITZAU M, 1993, LIEBIGS ANN CHEM, P871; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; SCHAUDER R, 1993, ARCH MICROBIOL, V160, P377; SCHICHO RN, 1993, J BACTERIOL, V175, P1823, DOI 10.1128/JB.175.6.1823-1830.1993; Schut GJ, 2007, J BACTERIOL, V189, P4431, DOI 10.1128/JB.00031-07; Schut GJ, 2016, BBA-BIOENERGETICS, V1857, P958, DOI 10.1016/j.bbabio.2016.01.010; Schut GJ, 2013, FEMS MICROBIOL REV, V37, P182, DOI 10.1111/j.1574-6976.2012.00346.x; Schut GJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00163; Schut GJ, 2001, J BACTERIOL, V183, P7027, DOI 10.1128/JB.183.24.7027-7036.2001; Silva PJ, 2000, EUR J BIOCHEM, V267, P6541, DOI 10.1046/j.1432-1327.2000.01745.x; Van Kranendonk MJ, 2006, EARTH-SCI REV, V74, P197, DOI 10.1016/j.earscirev.2005.09.005; Yang H, 2010, MOL MICROBIOL, V77, P1111, DOI 10.1111/j.1365-2958.2010.07275.x; Yu HJ, 2018, CELL, V173, P1636, DOI 10.1016/j.cell.2018.03.071	47	17	17	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16687	16696		10.1074/jbc.RA118.005092	http://dx.doi.org/10.1074/jbc.RA118.005092			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30181217	Green Published, hybrid			2022-12-28	WOS:000448515100012
J	Yao, WY; Shan, ZL; Gu, AH; Fu, MJ; Shi, ZF; Wen, WY				Yao, Weiyi; Shan, Zelin; Gu, Aihong; Fu, Minjie; Shi, Zhifeng; Wen, Wenyu			WW domain-mediated regulation and activation of E3 ubiquitin ligase Suppressor of Deltex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; E3 ubiquitin ligase; ubiquitylation (ubiquitination); Notch protein; protein degradation; autoinhibition; dNdfip; Su(dx)	HECT-DOMAIN; NEDD4 FAMILY; AUTO-INHIBITION; C2 DOMAIN; NOTCH; ITCH; CANCER; PHOSPHORYLATION; AUTOINHIBITION; TRAFFICKING	The Nedd4 family E3 ligases Itch and WWP1/2 play crucial roles in the regulation of cell cycle progression and apoptosis and are closely correlated with cancer development and metastasis. It has been recently shown that the ligase activities of Itch and WWP1/2 are tightly regulated, with the HECT domain sequestered intramolecularly by a linker region connecting WW2 and WW3. Here, we show that a similar autoinhibitory mechanism is utilized by the Drosophila ortholog of Itch and WWP1/2, Suppressor of Deltex (Su(dx)). We show that Su(dx) adopts an inactive steady state with the WW domain region interacting with the HECT domain. We demonstrate that both the linker and preceding WW2 are required for the efficient binding and regulation of Su(dx) HECT. Recruiting the multiple-PY motif-containing adaptor dNdfip via WW domains relieves the inhibitory state of Su(dx) and leads to substrate (e.g. Notch) ubiquitination. Our study demonstrates an evolutionarily conservative mechanism governing the regulation and activation of some Nedd4 family E3 ligases. Our results also suggest a dual regulatory mechanism for specific Notch down-regulation via dNdfip-Su(dx)-mediated Notch ubiquitination.	[Yao, Weiyi; Shan, Zelin; Gu, Aihong; Fu, Minjie; Shi, Zhifeng; Wen, Wenyu] Fudan Univ, Inst Biomed Sci, Huashan Hosp, Dept Neurosurg,Key Lab Med Epigenet & Metab, Shanghai 200040, Peoples R China; [Wen, Wenyu] Fudan Univ, Sch Basic Med Sci, Dept Syst Biol Med, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Wen, WY (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China.	wywen@fudan.edu.cn	Fu, Minjie/GRK-0040-2022	Wen, Wenyu/0000-0002-0798-4730				Aki D, 2015, IMMUNOL REV, V266, P6, DOI 10.1111/imr.12301; Aster JC, 2017, ANNU REV PATHOL-MECH, V12, P245, DOI 10.1146/annurev-pathol-052016-100127; Attali I, 2017, EMBO J, V36, P425, DOI 10.15252/embj.201694314; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bray SJ, 2016, NAT REV MOL CELL BIO, V17, P722, DOI 10.1038/nrm.2016.94; Broix L, 2016, NAT GENET, V48, P1349, DOI 10.1038/ng.3676; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Buetow L, 2016, NAT REV MOL CELL BIO, V17, P626, DOI 10.1038/nrm.2016.91; Chen Z, 2017, MOL CELL, V66, P345, DOI 10.1016/j.molcel.2017.03.020; Cornell M, 1999, GENETICS, V152, P567; Dalton HE, 2011, CELL DEATH DIFFER, V18, P1150, DOI 10.1038/cdd.2010.130; Djiane A, 2011, J CELL BIOL, V192, P189, DOI 10.1083/jcb.201007023; Escobedo A, 2014, STRUCTURE, V22, P1446, DOI 10.1016/j.str.2014.08.016; Fajner V, 2017, FEBS LETT, V591, P2636, DOI 10.1002/1873-3468.12775; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jennings MD, 2007, J BIOL CHEM, V282, P29032, DOI 10.1074/jbc.M703453200; Jung JG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004751; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lorenz S, 2018, BIOL CHEM, V399, P127, DOI 10.1515/hsz-2017-0184; Mari S, 2014, STRUCTURE, V22, P1639, DOI 10.1016/j.str.2014.09.006; Mund T, 2018, J BIOL CHEM, V293, P5200, DOI 10.1074/jbc.RA117.000934; Mund T, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150185; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Nowell CS, 2017, NAT REV CANCER, V17, P145, DOI 10.1038/nrc.2016.145; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Persaud A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005290; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Radtke F, 2013, NAT REV IMMUNOL, V13, P427, DOI 10.1038/nri3445; Rathinam C, 2011, NAT IMMUNOL, V12, P399, DOI 10.1038/ni.2021; Riling C, 2015, J BIOL CHEM, V290, P23875, DOI 10.1074/jbc.M115.649269; Ronchi VP, 2017, J BIOL CHEM, V292, P18006, DOI 10.1074/jbc.M117.813477; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Shan ZL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03077-3; Shaye DD, 2005, DEVELOPMENT, V132, P5081, DOI 10.1242/dev.02076; Shimizu H, 2014, CELL, V157, P1160, DOI 10.1016/j.cell.2014.03.050; Todaro DR, 2017, J BIOL CHEM, V292, P19521, DOI 10.1074/jbc.M117.817882; Wan LX, 2011, MOL CELL, V44, P721, DOI 10.1016/j.molcel.2011.09.024; Wang C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7607; Wang D, 2017, CANCER METAST REV, V36, P683, DOI 10.1007/s10555-017-9703-z; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Zhang W, 2016, MOL CELL, V62, P121, DOI 10.1016/j.molcel.2016.02.005; Zhu K, 2017, EMBO REP, V18, P1618, DOI 10.15252/embr.201744454	48	12	12	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16697	16708		10.1074/jbc.RA118.003781	http://dx.doi.org/10.1074/jbc.RA118.003781			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30213861	hybrid, Green Published			2022-12-28	WOS:000448515100013
J	Balchak, DM; Thompson, RN; Kashlan, OB				Balchak, Deidra M.; Thompson, Rebecca N.; Kashlan, Ossama B.			The epithelial Na+ channel subunit autoinhibitory tract suppresses channel activity by binding the gamma subunit's finger-thumb domain interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteolysis; allosteric regulation; cysteine-mediated cross-linking; protein conformation; epithelial sodium channel (ENaC); autoinhibition; cation channel; finger-thumb domain	SODIUM-CHANNEL; EXTRACELLULAR DOMAIN; HISTIDINE-RESIDUES; SELF-INHIBITION; ALPHA-SUBUNIT; ACTIVATION; ENAC; FURIN; PEPTIDE; SELECTIVITY	Epithelial Na+ channel (ENaC) maturation and activation require proteolysis of both the and subunits. Cleavage at multiple sites in the finger domain of each subunit liberates their autoinhibitory tracts. Synthetic peptides derived from the proteolytically released fragments inhibit the channel, likely by reconstituting key interactions removed by the proteolysis. We previously showed that a peptide derived from the subunit's autoinhibitory sequence (-8) binds at the subunit's finger-thumb domain interface. Despite low sequence similarity between the and subunit finger domains, we hypothesized that a peptide derived from the subunit's autoinhibitory sequence (-11) inhibits the channel through an analogous mechanism. Using Xenopus oocytes, we found here that channels lacking a subunit thumb domain were no longer sensitive to -11, but remained sensitive to -8. We identified finger domain sites in the subunit that dramatically reduced -11 inhibition. Using cysteines and sulfhydryl reactive cross-linkers introduced into both the peptide and the subunit, we also could cross-link -11 to both the finger domain and the thumb domain of the subunit. Our results suggest that -8 and -11 occupy similar binding pockets within their respective subunits, and that proteolysis of the and subunits activate the channel through analogous mechanisms.	[Balchak, Deidra M.; Thompson, Rebecca N.; Kashlan, Ossama B.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, 930 Scaife Hall, Pittsburgh, PA 15261 USA; [Kashlan, Ossama B.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kashlan, OB (corresponding author), Dept Med, S828B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	obk2@pitt.edu			NIDDK, National Institutes of Health [R01 DK098204, P30 DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098204, P30DK079307] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health, Grant R01 DK098204 (to O. B. K.) and the Pittsburgh Center for Kidney Research was supported by NIDDK Grant P30 DK079307, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Ahn YJ, 1999, AM J PHYSIOL-RENAL, V277, pF121, DOI 10.1152/ajprenal.1999.277.1.F121; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bize V, 2007, AM J PHYSIOL-RENAL, V293, pF1137, DOI 10.1152/ajprenal.00100.2007; Blobner BM, 2018, J BIOL CHEM, V293, P4928, DOI 10.1074/jbc.M117.819367; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Butterworth MB, 2012, J BIOL CHEM, V287, P32556, DOI 10.1074/jbc.M112.369520; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Collier DM, 2014, J GEN PHYSIOL, V144, P337, DOI 10.1085/jgp.201411208; Collier DM, 2012, J BIOL CHEM, V287, P40907, DOI 10.1074/jbc.M112.417519; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Frindt G, 2016, J GEN PHYSIOL, V147, P217, DOI 10.1085/jgp.201511533; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; JIANG CW, 1993, SCIENCE, V262, P424, DOI 10.1126/science.8211164; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kashlan OB, 2012, J BIOL CHEM, V287, P20720, DOI 10.1074/jbc.M112.358218; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Kota P, 2012, BIOCHEMISTRY-US, V51, P3460, DOI 10.1021/bi2014773; Krauson AJ, 2013, J BIOL CHEM, V288, P34375, DOI 10.1074/jbc.M113.504324; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Narikiyo T, 2002, J CLIN INVEST, V109, P401, DOI 10.1172/JCI13229; Passero CJ, 2012, AM J PHYSIOL-RENAL, V302, pF1, DOI 10.1152/ajprenal.00330.2011; Passero CJ, 2010, AM J PHYSIOL-RENAL, V299, pF854, DOI 10.1152/ajprenal.00316.2010; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Patel AB, 2012, AM J PHYSIOL-RENAL, V303, pF540, DOI 10.1152/ajprenal.00133.2012; Pearce D, 2015, CLIN J AM SOC NEPHRO, V10, P135, DOI 10.2215/CJN.05760513; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Sheng SH, 2018, J BIOL CHEM, V293, P17582, DOI 10.1074/jbc.RA118.003618; Shi SJ, 2012, J BIOL CHEM, V287, P15439, DOI 10.1074/jbc.M112.346551; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; Winarski KL, 2010, J BIOL CHEM, V285, P26088, DOI 10.1074/jbc.M110.149963; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200	45	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16217	16225		10.1074/jbc.RA118.004362	http://dx.doi.org/10.1074/jbc.RA118.004362			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30131333	Green Published, hybrid			2022-12-28	WOS:000447833600010
J	Mereby, SA; Maehigashi, T; Holler, JM; Kim, DH; Schinazi, RF; Kim, B				Mereby, Sarah A.; Maehigashi, Tatsuya; Holler, Jessica M.; Kim, Dong-Hyun; Schinazi, Raymond F.; Kim, Baek			Interplay of ancestral non-primate lentiviruses with the virus-restricting SAMHD1 proteins of their hosts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lentivirus; SAM domain and HD domain-containing protein 1 (SAMHD1); macrophage; nucleotide; reverse transcription; antiviral defense; proteosomal degradation; dNTPase; immunodeficiency virus	HUMAN-IMMUNODEFICIENCY-VIRUS; INFECTIOUS-ANEMIA VIRUS; HIV-1 INFECTION; REVERSE TRANSCRIPTION; TISSUE MACROPHAGES; DENDRITIC CELLS; GENE-TRANSFER; MOUSE SAMHD1; IN-VIVO; VECTORS	Lentiviruses infect both dividing CD4(+) T cells and nondividing myeloid cells, and the infected myeloid cells serve as long-living viral reservoirs. Host sterile alpha motif- and histidine-aspartate domain-containing protein 1 (SAMHD1) kinetically restricts reverse transcription of primate lentiviruses, including human immunodeficiency virus, type 1 (HIV-1) and simian immunodeficiency virus (SIV), in nondividing myeloid cells. SAMHD1 enforces this restriction through its dNTP triphosphohydrolase (dNTPase) activity that depletes cellular dNTPs. Some primate lentiviruses, such as HIV-2, SIVsm, and SIVagm, counteract SAMHD1 restriction by using their viral accessory proteins (Vpx or Vpr) that induce the proteosomal degradation of SAMHD1 and increase dNTP levels. SAMHD1 is conserved among non-primate mammals such as cats, cows, and horses that also carry their own lentiviruses (feline and bovine immunodeficiency viruses and equine infectious anemia viruses, respectively). However, whether these viruses also target SAMHD1 is unknown. Here, we tested whether these ancestral non-primate lentiviruses also can counteract their host SAMHD1 proteins by promoting their proteosomal degradation. Using biochemical and various cell-based assays, we observed that SAMHD1 proteins from the non-primate host species display dGTP-dependent dNTPase activity, but that the non-primate lentiviruses fail to proteosomally degrade the SAMHD1 proteins of their hosts. Our findings suggest that accessory protein-mediated proteosomal degradation of SAMHD1 did not exist among the ancestral non-primate lentiviruses and was uniquely gained by some primate lentiviruses after their transmission to primate species.	[Mereby, Sarah A.; Maehigashi, Tatsuya; Holler, Jessica M.; Schinazi, Raymond F.; Kim, Baek] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Kim, Dong-Hyun; Kim, Baek] Kyung Hee Univ, Dept Pharm, Seoul 130701, South Korea; [Kim, Baek] Childrens Healthcare Atlanta, Ctr Drug Discovery, Atlanta, GA 30322 USA	Emory University; Kyung Hee University; Children's Healthcare of Atlanta (CHOA)	Kim, B (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.	baek.kim@emory.edu			National Institutes of Health [AI136581, GM104198, MH116695]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI136581, P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH116695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grants AI136581 (to B. K.), GM104198 (to B. K.), and MH116695 (to R. F. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amie SM, 2013, J BIOL CHEM, V288, P25001, DOI 10.1074/jbc.C113.493619; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327; Bhatia S, 2013, INDIAN J VIROL, V24, P332, DOI 10.1007/s13337-013-0165-9; Bonifati S, 2016, VIROLOGY, V495, P92, DOI 10.1016/j.virol.2016.05.002; BRUNNER D, 1989, J VIROL, V63, P5483, DOI 10.1128/JVI.63.12.5483-5488.1989; Buzovetsky O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02783-8; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; ELDER JH, 1992, J VIROL, V66, P1791, DOI 10.1128/JVI.66.3.1791-1794.1992; Foley B. T., 2000, HIV SEQUENCE COMPEND; Fregoso OI, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003496; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Hansen EC, 2014, P NATL ACAD SCI USA, V111, pE1843, DOI 10.1073/pnas.1401706111; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; JACOBS RM, 1994, VET RES COMMUN, V18, P471, DOI 10.1007/BF01839424; Jamburuthugoda VK, 2006, J BIOL CHEM, V281, P13388, DOI 10.1074/jbc.M600291200; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; MACE K, 1989, VIROLOGY, V168, P399, DOI 10.1016/0042-6822(89)90282-1; Mangeot PE, 2000, J VIROL, V74, P8307, DOI 10.1128/JVI.74.18.8307-8315.2000; McIntosh EM, 1996, ACTA BIOCHIM POL, V43, P583; McKay T, 2006, GENE THER, V13, P715, DOI 10.1038/sj.gt.3302715; Oaks JL, 1998, J VIROL, V72, P7263, DOI 10.1128/JVI.72.9.7263-7269.1998; OBRIEN WA, 1994, J LEUKOCYTE BIOL, V56, P273, DOI 10.1002/jlb.56.3.273; OBRIEN WA, 1994, J VIROL, V68, P1258, DOI 10.1128/JVI.68.2.1258-1263.1994; PANG S, 1990, NATURE, V343, P85, DOI 10.1038/343085a0; Patel M, 2013, J GENE MED, V15, P51, DOI 10.1002/jgm.2695; Poeschla EM, 1998, NAT MED, V4, P354, DOI 10.1038/nm0398-354; Ritchey JW, 2001, VET IMMUNOL IMMUNOP, V79, P83, DOI 10.1016/S0165-2427(01)00250-1; Schwefel D, 2015, CELL HOST MICROBE, V17, P489, DOI 10.1016/j.chom.2015.03.004; Schwefel D, 2014, NATURE, V505, P234, DOI 10.1038/nature12815; SELLON DC, 1992, J VIROL, V66, P5906, DOI 10.1128/JVI.66.10.5906-5913.1992; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sommer AFR, 2016, SCI REP-UK, V6, DOI 10.1038/srep26616; Spragg CJ, 2013, P NATL ACAD SCI USA, V110, P21136, DOI 10.1073/pnas.1316839110; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Swanstrom AE, 2018, CURR HIV RES, V16, P29, DOI 10.2174/1570162X15666171124123116; WEINBERG JB, 1991, J EXP MED, V174, P1477, DOI 10.1084/jem.174.6.1477; Weissman D, 1997, NATURE, V389, P981, DOI 10.1038/40173; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; Williams KC, 2002, ANNU REV NEUROSCI, V25, P537, DOI 10.1146/annurev.neuro.25.112701.142822	47	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16402	16412		10.1074/jbc.RA118.004567	http://dx.doi.org/10.1074/jbc.RA118.004567			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30181218	hybrid, Green Published			2022-12-28	WOS:000447833600023
J	Pennington, ER; Sullivan, EM; Fix, A; Dadoo, S; Zeczycki, TN; DeSantis, A; Schlattner, U; Coleman, RA; Chicco, AJ; Brown, DA; Shaikh, SR				Pennington, Edward Ross; Sullivan, E. Madison; Fix, Amy; Dadoo, Sahil; Zeczycki, Tonya N.; DeSantis, Anita; Schlattner, Uwe; Coleman, Rosalind A.; Chicco, Adam J.; Brown, David A.; Shaikh, Saame Raza			Proteolipid domains form in biomimetic and cardiac mitochondrial vesicles and are regulated by cardiolipin concentration but not monolyso-cardiolipin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiolipin; membrane structure; mitochondria; cytochrome c; lipid vesicle; detergent solubilization; giant mitochondrial vesicles; giant unilamellar vesicles; lipid domains; monolyso-cardiolipin	GIANT UNILAMELLAR VESICLES; CREATINE-KINASE ISOENZYMES; LIPID RAFT MIXTURES; BARTH-SYNDROME; CYTOCHROME-C; ISCHEMIA/REPERFUSION INJURY; TETRALINOLEOYL-CARDIOLIPIN; SHOTGUN LIPIDOMICS; ALPHA-SYNUCLEIN; ENZYME-ACTIVITY	Cardiolipin (CL) is an anionic phospholipid mainly located in the inner mitochondrial membrane, where it helps regulate bioenergetics, membrane structure, and apoptosis. Localized, phase-segregated domains of CL are hypothesized to control mitochondrial inner membrane organization. However, the existence and underlying mechanisms regulating these mitochondrial domains are unclear. Here, we first isolated detergent-resistant cardiac mitochondrial membranes that have been reported to be CL-enriched domains. Experiments with different detergents yielded only nonspecific solubilization of mitochondrial phospholipids, suggesting that CL domains are not recoverable with detergents. Next, domain formation was investigated in biomimetic giant unilamellar vesicles (GUVs) and newly synthesized giant mitochondrial vesicles (GMVs) from mouse hearts. Confocal fluorescent imaging revealed that introduction of cytochrome c into membranes promotes macroscopic proteolipid domain formation associated with membrane morphological changes in both GUVs and GMVs. Domain organization was also investigated after lowering tetralinoleoyl-CL concentration and substitution with monolyso-CL, two common modifications observed in cardiac pathologies. Loss of tetralinoleoyl-CL decreased proteolipid domain formation in GUVs, because of a favorable Gibbs-free energy of lipid mixing, whereas addition of monolyso-CL had no effect on lipid mixing. Moreover, murine GMVs generated from cardiac acyl-CoA synthetase-1 knockouts, which have remodeled CL acyl chains, did not perturb proteolipid domains. Finally, lowering the tetralinoleoyl-CL content had a stronger influence on the oxidation status of cytochrome c than did incorporation of monolyso-CL. These results indicate that proteolipid domain formation in the cardiac mitochondrial inner membrane depends on tetralinoleoyl-CL concentration, driven by underlying lipid-mixing properties, but not the presence of monolyso-CL.	[Pennington, Edward Ross; Sullivan, E. Madison; Zeczycki, Tonya N.; DeSantis, Anita] East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27834 USA; [Pennington, Edward Ross; Sullivan, E. Madison; Fix, Amy; Zeczycki, Tonya N.; DeSantis, Anita] East Carolina Univ, Brody Sch Med, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA; [Pennington, Edward Ross; Dadoo, Sahil; Coleman, Rosalind A.; Shaikh, Saame Raza] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Pennington, Edward Ross; Dadoo, Sahil; Coleman, Rosalind A.; Shaikh, Saame Raza] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Schlattner, Uwe] Univ Grenoble Alpes, Lab Fundamental & Appl Bioenerget, INSERM, U1055, Grenoble, France; [Schlattner, Uwe] Univ Grenoble Alpes, SFR Environm & Syst Biol, Grenoble, France; [Chicco, Adam J.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Brown, David A.] Virginia Tech, Corp Res Ctr, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24060 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Colorado State University; Virginia Polytechnic Institute & State University	Shaikh, SR (corresponding author), Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.; Shaikh, SR (corresponding author), Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA.	shaikhsa@email.unc.edu	, PEP-MX Core/AGV-4051-2022; Schlattner, Uwe/D-1267-2009	Schlattner, Uwe/0000-0003-1159-5911; Coleman, Rosalind/0000-0003-4379-3824; Zeczycki, Tonya/0000-0002-5216-1960	National Institutes of Health [R01HL123647]; University of North Carolina, Chapel Hill; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina, Chapel Hill; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R01HL123647 (to D.B. and S.R.S.) and internal funds from the University of North Carolina, Chapel Hill (to S.R.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733; Beales PA, 2011, LANGMUIR, V27, P6107, DOI 10.1021/la104924c; Bergstrom CL, 2013, P NATL ACAD SCI USA, V110, P6269, DOI 10.1073/pnas.1303819110; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown DA, 2013, PHARMACOL THERAPEUT, V140, P258, DOI 10.1016/j.pharmthera.2013.07.005; Chen Q, 2006, FREE RADICAL BIO MED, V40, P976, DOI 10.1016/j.freeradbiomed.2005.10.043; Cheniour M, 2017, BBA-GEN SUBJECTS, V1861, P969, DOI 10.1016/j.bbagen.2017.02.001; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Dudek J, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00090; El Khoury M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10543-3; Epand RF, 2007, J MOL BIOL, V365, P968, DOI 10.1016/j.jmb.2006.10.028; Fernandez MIG, 2004, ANAL BIOCHEM, V328, P174, DOI 10.1016/j.ab.2004.01.020; Grevengoed TJ, 2015, J LIPID RES, V56, P1572, DOI 10.1194/jlr.M059717; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a; He Q, 2014, CHEM PHYS LIPIDS, V179, P75, DOI 10.1016/j.chemphyslip.2013.10.007; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Ikon N, 2017, BBA-BIOMEMBRANES, V1859, P1156, DOI 10.1016/j.bbamem.2017.03.013; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Juhasz J, 2010, BIOCHEM J, V430, P415, DOI [10.1042/Bj20100516, 10.1042/BJ20100516]; Khalifat N, 2008, BIOPHYS J, V95, P4924, DOI 10.1529/biophysj.108.136077; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; Klymchenko AS, 2014, CHEM BIOL, V21, P97, DOI 10.1016/j.chembiol.2013.11.009; Lesnefsky EJ, 2004, AM J PHYSIOL-HEART C, V287, pH258, DOI 10.1152/ajpheart.00348.2003; Liu GY, 2017, J BIOL CHEM, V292, P10672, DOI 10.1074/jbc.M117.783068; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Maniti O, 2009, BIOPHYS J, V96, P2428, DOI 10.1016/j.bpj.2008.12.3911; Mileykovskaya E, 2005, BIOCHEMISTRY-MOSCOW+, V70, P154, DOI 10.1007/s10541-005-0095-2; Mileykovskaya E, 2001, FEBS LETT, V507, P187, DOI 10.1016/S0014-5793(01)02948-9; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Mitsopoulos P, 2015, MOL CELL BIOL, V35, P1838, DOI 10.1128/MCB.00047-15; Mulligan CM, 2014, J GERONTOL A-BIOL, V69, P799, DOI 10.1093/gerona/glt209; Nakamura K, 2013, NEUROTHERAPEUTICS, V10, P391, DOI 10.1007/s13311-013-0182-9; Nichols-Smith S, 2004, BBA-BIOMEMBRANES, V1663, P82, DOI 10.1016/j.bbamem.2004.02.002; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Paradies G, 2015, CLIN LIPIDOL, V10, P415, DOI 10.2217/clp.15.31; Paradies G, 2014, ANTIOXID REDOX SIGN, V20, P1925, DOI 10.1089/ars.2013.5280; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Pennington ER, 2017, BBA-BIOMEMBRANES, V1859, P257, DOI 10.1016/j.bbamem.2016.11.012; Petrosillo G, 2005, BBA-BIOENERGETICS, V1710, P78, DOI 10.1016/j.bbabio.2005.10.003; Rampelt H, 2017, BBA-MOL CELL RES, V1864, P737, DOI 10.1016/j.bbamcr.2016.05.020; Ren MD, 2014, PROG LIPID RES, V55, P1, DOI 10.1016/j.plipres.2014.04.001; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schlattner U, 2000, J BIOL CHEM, V275, P17314, DOI 10.1074/jbc.M001919200; Schlattner U, 2000, BIOL CHEM, V381, P1063, DOI 10.1515/BC.2000.131; Schlattner U, 2014, CHEM PHYS LIPIDS, V179, P32, DOI 10.1016/j.chemphyslip.2013.12.008; Schmid EM, 2015, METHOD CELL BIOL, V128, P319, DOI 10.1016/bs.mcb.2015.02.004; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Schug ZT, 2012, ACTA ONCOL, V51, P301, DOI 10.3109/0284186X.2011.643823; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Shaikh SR, 2014, BIOCHEMISTRY-US, V53, P5589, DOI 10.1021/bi500868g; Shaikh SR, 2009, J NUTR, V139, P1632, DOI 10.3945/jn.109.108720; Shaikh SR, 2001, BBA-BIOMEMBRANES, V1512, P317, DOI 10.1016/S0005-2736(01)00335-2; Shen Z, 2015, BIOMED RES INT, V2015, DOI [10.1155/2015/890717, DOI 10.1155/2015/890717]; Shi YG, 2010, J BIOMED RES, V24, P6, DOI 10.1016/S1674-8301(10)60003-6; Sorice M, 2009, FEBS LETT, V583, P2447, DOI 10.1016/j.febslet.2009.07.018; Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200; Sparagna GC, 2009, J CARDIOVASC PHARM, V53, P290, DOI 10.1097/FJC.0b013e31819b5461; Speer O, 2005, BIOCHEM J, V385, P445, DOI 10.1042/BJ20040386; Stepanyants N, 2015, MOL BIOL CELL, V26, P3104, DOI 10.1091/mbc.E15-06-0330; Sullivan EM, 2018, J BIOL CHEM, V293, P466, DOI [10.1074/jbc.m117.812834, 10.1074/jbc.M117.812834]; Sullivan EM, 2017, J NUTR BIOCHEM, V45, P94, DOI 10.1016/j.jnutbio.2017.04.004; Xu Y, 2005, LAB INVEST, V85, P823, DOI 10.1038/labinvest.3700274; Xu Y, 2016, NAT CHEM BIOL, V12, P641, DOI [10.1038/NCHEMBIO.2113, 10.1038/nchembio.2113]; Ye CQ, 2016, J BIOENERG BIOMEMBR, V48, P113, DOI 10.1007/s10863-014-9591-7	76	11	11	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15933	15946		10.1074/jbc.RA118.004948	http://dx.doi.org/10.1074/jbc.RA118.004948			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30158245	Green Published, hybrid			2022-12-28	WOS:000447256000016
J	Zhang, WP; Shi, YQ; Peng, YX; Zhong, L; Zhu, S; Zhang, WB; Tang, SJ				Zhang, Wenping; Shi, Yuqiang; Peng, Yanxi; Zhong, Ling; Zhu, Shuang; Zhang, Wenbo; Tang, Shao-Jun			Neuron activity-induced Wnt signaling up-regulates expression of brain-derived neurotrophic factor in the pain neural circuit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Wnt signaling; gene expression; neuron; pain; beta-catenin (B-catenin); synapse; brain-derived neurotrophic factor (BDNF)	NEUROPATHIC PAIN; PSYCHIATRIC-DISORDERS; SYNAPTIC-TRANSMISSION; NONCANONICAL PATHWAYS; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; GENE-EXPRESSION; NERVOUS-SYSTEM; BDNF; PATHOGENESIS	Brain-derived neurotrophic factor (BDNF) is a master regulator of synaptic plasticity in various neural circuits of the mammalian central nervous system. Neuron activity-induced BDNF gene expression is regulated through the Ca2+/CREB pathway, but other regulatory factors may also be involved in controlling BDNF levels. We report here that Wnt/-catenin signaling plays a key role in controlling neuron activity-regulated BDNF expression. Using primary cortical cultures, we show that blockade of Wnt/-catenin signaling inhibits the BDNF up-regulation that is induced by activation of the N-methyl-d-aspartic acid (NMDA) receptor and that activation of the Wnt/-catenin signaling pathway stimulates BDNF expression. In vivo, Wnt/-catenin signaling activated BDNF expression and was required for peripheral pain-induced up-regulation of BDNF in the mouse spine. We also found that conditional deletion of one copy of either Wntless (Wls) or -catenin by Nestin-Cre-mediated recombination is sufficient to inhibit the pain-induced up-regulation of BDNF. We further show that the Wnt/-catenin/BDNF axis in the spinal neural circuit plays an important role in regulating capsaicin-induced pain. These results indicate that neuron activity-induced Wnt signaling stimulates BDNF expression in the pain neural circuits. We propose that pain-induced Wnt secretion may provide an additional mechanism for intercellular coordination of BDNF expression in the neural circuit.	[Zhang, Wenping; Shi, Yuqiang; Zhang, Wenbo; Tang, Shao-Jun] Univ Texas Med Branch, Dept Neurosci & Cell Biol, 301 Univ Blvd, Galveston, TX 77555 USA; [Zhu, Shuang; Zhang, Wenbo] Univ Texas Med Branch, Dept Ophthalmol, Galveston, TX 77555 USA; [Zhang, Wenping] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou 310018, Zhejiang, Peoples R China; [Peng, Yanxi; Zhong, Ling] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Peng, Yanxi; Zhong, Ling] Sun Yat Sen Univ, Lab Anim Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Peng, Yanxi] Xiangnan Univ, Basic Med Dept, Chenzhou 423000, Peoples R China; [Zhong, Ling] Shenzhen Ctr ADR Monitoring, Shenzhen 518001, Peoples R China	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Zhejiang Sci-Tech University; Sun Yat Sen University; Sun Yat Sen University	Tang, SJ (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, 301 Univ Blvd, Galveston, TX 77555 USA.	shtang@utmb.edu		Tang, Shao-Jun/0000-0002-6076-5481	National Institutes of Health [R01NS079166, R01DA036165, R01NS095747, R01EY026629]; NATIONAL EYE INSTITUTE [R01EY026629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS095747, R01NS079166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants R01NS079166, R01DA036165 and R01NS095747 (to S. J. T.) and R01EY026629 (to Wenbo Zhang). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andero R, 2014, PROG MOL BIOL TRANSL, V122, P169, DOI 10.1016/B978-0-12-420170-5.00006-4; Avila ME, 2010, J BIOL CHEM, V285, P18939, DOI 10.1074/jbc.M110.103028; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Brault V, 2001, DEVELOPMENT, V128, P1253; Carpenter AC, 2010, GENESIS, V48, P554, DOI 10.1002/dvg.20651; Cerpa W, 2011, J NEUROSCI, V31, P9466, DOI 10.1523/JNEUROSCI.6311-10.2011; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Itokazu T, 2014, NEUROSCI RES, V79, P34, DOI 10.1016/j.neures.2013.12.002; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Khan N, 2015, MOLECULES, V20, P10657, DOI 10.3390/molecules200610657; Li B, 2013, J BIOL CHEM, V288, P13610, DOI 10.1074/jbc.M112.381046; Li YC, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007880; Merighi A, 2008, PROG NEUROBIOL, V85, P297, DOI 10.1016/j.pneurobio.2008.04.004; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Oliva CA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00224; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Shi YQ, 2013, J NEUROIMMUNE PHARM, V8, P956, DOI 10.1007/s11481-013-9474-4; Shi YQ, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-47; Simonetti M, 2014, NEURON, V83, P104, DOI 10.1016/j.neuron.2014.05.037; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wan XZ, 2012, J NEUROSCI, V32, P3910, DOI 10.1523/JNEUROSCI.3916-11.2012; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yi H, 2012, NEUROREPORT, V23, P189, DOI 10.1097/WNR.0b013e32834fab06; Yuan SB, 2015, PAIN, V156, P1311, DOI 10.1097/j.pain.0000000000000177; Yuan SB, 2012, J NEUROIMMUNE PHARM, V7, P904, DOI 10.1007/s11481-012-9370-3; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; Zhang YK, 2013, J CLIN INVEST, V123, P2268, DOI 10.1172/JCI65364; Zhu AF, 2018, CELL SIGNAL, V44, P51, DOI 10.1016/j.cellsig.2018.01.017; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	43	26	29	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15641	15651		10.1074/jbc.RA118.002840	http://dx.doi.org/10.1074/jbc.RA118.002840			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30139740	hybrid, Green Published			2022-12-28	WOS:000446549200027
J	Hoff, S; Epting, D; Falk, N; Schroda, S; Braun, DA; Halbritter, J; Hildebrandt, F; Kramer-Zucker, A; Bergmann, C; Walz, G; Lienkamp, SS				Hoff, Sylvia; Epting, Daniel; Falk, Nathalie; Schroda, Sophie; Braun, Daniela A.; Halbritter, Jan; Hildebrandt, Friedhelm; Kramer-Zucker, Albrecht; Bergmann, Carsten; Walz, Gerd; Lienkamp, Soeren S.			The nucleoside-diphosphate kinase NME3 associates with nephronophthisis proteins and is required for ciliary function during renal development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						primary cilium; kidney; DNA damage response; nucleoside; nucleotide metabolism; Xenopus; zebrafish; ciliopathies; nephronophthisis	LEFT-RIGHT ASYMMETRY; SITUS-INVERSUS; BASAL BODY; ZEBRAFISH PRONEPHROS; MULTICILIATED CELLS; JOUBERT-SYNDROME; NEK-FAMILY; MUTATIONS; CILIOPATHIES; DISEASE	Nephronophthisis (NPH) is an autosomal recessive renal disease leading to kidney failure in children and young adults. The protein products of the corresponding genes (NPHPs) are localized in primary cilia or their appendages. Only about 70% of affected individuals have a mutation in one of 100 renal ciliopathy genes, and no unifying pathogenic mechanism has been identified. Recently, some NPHPs, including NIMA-related kinase 8 (NEK8) and centrosomal protein 164 (CEP164), have been found to act in the DNA-damage response pathway and to contribute to genome stability. Here, we show that NME/NM23 nucleoside-diphosphate kinase 3 (NME3) that has recently been found to facilitate DNA-repair mechanisms binds to several NPHPs, including NEK8, CEP164, and ankyrin repeat and sterile motif domain-containing 6 (ANKS6). Depletion of nme3 in zebrafish and Xenopus resulted in typical ciliopathy-associated phenotypes, such as renal malformations and left-right asymmetry defects. We further found that endogenous NME3 localizes to the basal body and that it associates also with centrosomal proteins, such as NEK6, which regulates cell cycle arrest after DNA damage. The ciliopathy-typical manifestations of NME3 depletion in two vertebrate in vivo models, the biochemical association of NME3 with validated NPHPs, and its localization to the basal body reveal a role for NME3 in ciliary function. We conclude that mutations in the NME3 gene may aggravate the ciliopathy phenotypes observed in humans.	[Hoff, Sylvia; Epting, Daniel; Falk, Nathalie; Schroda, Sophie; Kramer-Zucker, Albrecht; Bergmann, Carsten; Walz, Gerd; Lienkamp, Soeren S.] Univ Freiburg, Fac Med, Med Ctr, Dept Med,Renal Div, D-79106 Freiburg, Germany; [Braun, Daniela A.; Halbritter, Jan; Hildebrandt, Friedhelm] Harvard Med Sch, Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Bergmann, Carsten] Bioscientia, Ctr Human Genet, D-55218 Ingelheim, Germany; [Walz, Gerd; Lienkamp, Soeren S.] Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany	University of Freiburg; Harvard University; Boston Children's Hospital; Harvard Medical School	Lienkamp, SS (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Dept Med,Renal Div, D-79106 Freiburg, Germany.; Lienkamp, SS (corresponding author), Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany.	soeren.lienkamp@uniklinik-freiburg.de	Lienkamp, Soeren/AAH-6296-2020	Lienkamp, Soeren/0000-0003-2963-6865; Halbritter, Jan/0000-0002-1377-9880	National Institutes of Health [DK1068306]; Deutsche Forschungsgemeinschaft (DFG) [KFO 201]; DFG [SFB1140]; Emmy Noether Program of the DFG [LI 1817/2-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Emmy Noether Program of the DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK1068306 (to F. H.), Deutsche Forschungsgemeinschaft (DFG) Grant KFO 201 (to A. K. Z., G. W., and S. S. L.), DFG-funded Grant SFB1140 (Kidney Disease-from Genes to Mechanisms (KIDGEM)) (to S. S. L., C. B., and G. W.), and Emmy Noether Program LI 1817/2-1 of the DFG (to S. S. L). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abeyta A, 2017, CELL CYCLE, V16, P335, DOI 10.1080/15384101.2016.1259038; Bauer H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002567; Betleja E, 2010, CURR BIOL, V20, pR928, DOI 10.1016/j.cub.2010.09.058; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Braun DA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028191; Bredrup C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/j.ajhg.2011.10.001; Burckle C, 2011, HUM MOL GENET, V20, P2611, DOI 10.1093/hmg/ddr164; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Choi HJC, 2013, MOL CELL, V51, P423, DOI 10.1016/j.molcel.2013.08.006; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Epting D, 2015, DEVELOPMENT, V142, P1553, DOI 10.1242/dev.124214; Epting D, 2015, DEVELOPMENT, V142, P174, DOI 10.1242/dev.112250; Epting D, 2010, CIRC RES, V107, P45, DOI 10.1161/CIRCRESAHA.109.213983; Failler M, 2014, AM J HUM GENET, V94, P905, DOI 10.1016/j.ajhg.2014.05.002; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Gorden NT, 2008, AM J HUM GENET, V83, P559, DOI 10.1016/j.ajhg.2008.10.002; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Halbritter J, 2013, AM J HUM GENET, V93, P915, DOI 10.1016/j.ajhg.2013.09.012; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hoff S, 2013, NAT GENET, V45, P951, DOI 10.1038/ng.2681; Hsiau T, 2018, BIORXIV, DOI [10.1101/251082, DOI 10.1101/251082]; Huet D, 2014, ELIFE, V3, DOI 10.7554/eLife.02419; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kee H Lynn, 2013, Cilia, V2, P11, DOI 10.1186/2046-2530-2-11; Lienkamp S, 2010, P NATL ACAD SCI USA, V107, P20388, DOI 10.1073/pnas.1013070107; Liu SM, 2002, DEVELOPMENT, V129, P5839, DOI 10.1242/dev.00173; Macia MS, 2017, AM J HUM GENET, V100, P323, DOI 10.1016/j.ajhg.2016.12.011; Manning DK, 2013, J AM SOC NEPHROL, V24, P100, DOI 10.1681/ASN.2012050490; Marshall WF, 2008, CURR TOP DEV BIOL, V85, P1, DOI 10.1016/S0070-2153(08)00801-6; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Meirelles GV, 2010, J PROTEOME RES, V9, P6298, DOI 10.1021/pr100562w; Nakata K, 2012, CYTOSKELETON, V69, P221, DOI 10.1002/cm.21014; Otto EA, 2008, J AM SOC NEPHROL, V19, P587, DOI 10.1681/ASN.2007040490; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Reish O, 2016, HUM MUTAT, V37, P727, DOI 10.1002/humu.22998; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Roepman R, 2000, HUM MOL GENET, V9, P2095, DOI 10.1093/hmg/9.14.2095; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Shiba D, 2010, CYTOSKELETON, V67, P112, DOI 10.1002/cm.20428; Sivasubramaniam S, 2008, GENE DEV, V22, P587, DOI 10.1101/gad.1627708; Stottmann RW, 2009, DEV BIOL, V335, P166, DOI 10.1016/j.ydbio.2009.08.023; Suizu F, 2016, EMBO J, V35, P1346, DOI 10.15252/embj.201593003; Tay SY, 2010, DEV DYNAM, V239, P527, DOI 10.1002/dvdy.22199; Tsao N, 2016, BIOCHEM J, V473, P1237, DOI 10.1042/BCJ20160122; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Vogel P, 2012, VET PATHOL, V49, P166, DOI 10.1177/0300985811415708; Vogel P, 2010, VET PATHOL, V47, P120, DOI 10.1177/0300985809353553; Wei Q, 2012, NAT CELL BIOL, V14, P950, DOI 10.1038/ncb2560; Wolf MTF, 2015, CURR OPIN PEDIATR, V27, P201, DOI 10.1097/MOP.0000000000000194; Yasunaga T, 2015, J CELL BIOL, V211, P963, DOI 10.1083/jcb.201502043; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178; Zhang BY, 2017, J BIOL CHEM, V292, P1351, DOI 10.1074/jbc.M116.765438; Zhou WB, 2010, AM J PHYSIOL-RENAL, V299, pF55, DOI 10.1152/ajprenal.00043.2010	60	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15243	15255		10.1074/jbc.RA117.000847	http://dx.doi.org/10.1074/jbc.RA117.000847			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30111592	Green Published, hybrid			2022-12-28	WOS:000445998400024
J	Kurup, JT; Kidder, BL				Kurup, Jiji T.; Kidder, Benjamin L.			Identification of H4K20me3-and H3K4me3-associated RNAs using CARIP-Seq expands the transcriptional and epigenetic networks of embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; chromatin; RNA; epigenetics; histone modification; CARIP-Seq; H3K4me3; H4K20me3	LONG NONCODING RNAS; HISTONE LYSINE METHYLATION; BINDING PROTEINS; GENE-EXPRESSION; GENOME INTEGRITY; MESSENGER-RNAS; ACTIVE GENES; CHROMATIN; MOUSE; CHIP	RNA has been shown to interact with various proteins to regulate chromatin dynamics and gene expression. However, it is unknown whether RNAs associate with epigenetic marks such as post-translational modifications of histones, including histone 4 lysine 20 trimethylation (H4K20me3) or trimethylated histone 3 lysine 4 (H3K4me3), to regulate chromatin and gene expression. Here, we used chromatin-associated RNA immunoprecipitation (CARIP) followed by next-generation sequencing (CARIP-Seq) to survey RNAs associated with H4K20me3- and H3K4me3-marked chromatin on a global scale in embryonic stem (ES) cells. We identified thousands of mRNAs and noncoding RNAs that associate with H4K20me3- and H3K4me3-marked chromatin. H4K20me3- and H3K4me3-interacting RNAs are involved in chromatin organization and modification and RNA processing, whereas H4K20me3-only RNAs are involved in cell motility and differentiation, and H3K4me3-only RNAs are involved in metabolic processes and RNA processing. Expression of H3K4me3-associated RNAs is enriched in ES cells, whereas expression of H4K20me3-associated RNAs is enriched in ES cells and differentiated cells. H4K20me3- and H3K4me3-interacting RNAs originate from genes that co-localize with features of active chromatin, including transcriptional machinery and active promoter regions, and the histone modification H3K36me3 in gene body regions. We also found that H4K20me3 and H3K4me3 are associated with distinct gene features including transcripts of greater length and exon number relative to unoccupied transcripts. H4K20me3- and H3K4me3-marked chromatin is also associated with processed RNAs (exon transcripts) relative to unspliced pre-mRNA and ncRNA transcripts. In summary, our results provide evidence that H4K20me3- and H3K4me3-associated RNAs represent a distinct subnetwork of the ES cell transcriptional repertoire.	[Kurup, Jiji T.; Kidder, Benjamin L.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48201 USA; [Kurup, Jiji T.; Kidder, Benjamin L.] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI 48201 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Kidder, BL (corresponding author), Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI 48201 USA.	benjamin.kidder@wayne.edu		Thulaseedhara Kurup, Jiji/0000-0001-6291-3911	NHLBI, National Institutes of Health [1K22HL126842-01A1]; Wayne State University; Karmanos Cancer Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K22HL126842] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wayne State University; Karmanos Cancer Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health Grant 1K22HL126842-01A1 and by funds from the Wayne State University and Karmanos Cancer Institute (to B.L.K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Bierhoff H, 2014, MOL CELL, V54, P675, DOI 10.1016/j.molcel.2014.03.032; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Davidovich C, 2015, MOL CELL, V57, P552, DOI 10.1016/j.molcel.2014.12.017; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di Ruscio A, 2013, NATURE, V503, P371, DOI 10.1038/nature12598; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Fodor BD, 2010, ANNU REV CELL DEV BI, V26, P471, DOI 10.1146/annurev.cellbio.042308.113225; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; He RS, 2017, NUCLEIC ACIDS RES, V45, P6427, DOI 10.1093/nar/gkx251; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hendrickson DG, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0878-3; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson WL, 2017, CURR OPIN CELL BIOL, V46, P102, DOI 10.1016/j.ceb.2017.05.004; Karachentsev D, 2005, GENE DEV, V19, P431, DOI 10.1101/gad.1263005; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; Kelley RL, 2000, CELL, V103, P9, DOI 10.1016/S0092-8674(00)00099-4; Kidder B.L., 2018, J VIS EXP, V135, pe57481, DOI [10.3791/57481, DOI 10.3791/57481]; Kidder BL, 2017, CANCER RES, V77, P6729, DOI 10.1158/0008-5472.CAN-17-0828; Kidder BL, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0115-7; Kidder BL, 2014, METHODS MOL BIOL, V1150, P227, DOI 10.1007/978-1-4939-0512-6_15; Kidder BL, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r32; Kidder BL, 2013, MOL CELL BIOL, V33, P4793, DOI 10.1128/MCB.00692-13; Kidder BL, 2012, NUCLEIC ACIDS RES, V40, P2925, DOI 10.1093/nar/gkr1151; Kidder BL, 2011, NAT IMMUNOL, V12, P918, DOI 10.1038/ni.2117; Kidder BL, 2010, GENOME RES, V20, P458, DOI 10.1101/gr.101469.109; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kornblihtt AR, 2009, NAT STRUCT MOL BIOL, V16, P902, DOI 10.1038/nsmb0909-902; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rao J, 2014, METHODS MOL BIOL, V1150, P215, DOI 10.1007/978-1-4939-0512-6_14; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Xu J., 2018, BIOL OPEN, P7; Xu J, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4886-4; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zhou HL, 2014, NUCLEIC ACIDS RES, V42, P701, DOI 10.1093/nar/gkt875	73	5	6	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15120	15135		10.1074/jbc.RA118.004974	http://dx.doi.org/10.1074/jbc.RA118.004974			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30115682	hybrid, Green Published			2022-12-28	WOS:000445998400015
J	Wang, HB; Dolezal, JM; Kulkarni, S; Lu, J; Mandel, J; Jackson, LE; Alencastro, F; Duncan, AW; Prochownik, EV				Wang, Huabo; Dolezal, James M.; Kulkarni, Sucheta; Lu, Jie; Mandel, Jordan; Jackson, Laura E.; Alencastro, Frances; Duncan, Andrew W.; Prochownik, Edward V.			Myc and ChREBP transcription factors cooperatively regulate normal and neoplastic hepatocyte proliferation in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Myc (c-Myc); hepatocellular carcinoma; Warburg effect; mitochondria; fatty acid oxidation; liver cancer; hepatoblastoma; MondoA; MYC proto-oncogene bHLH transcription factor; Oxphos	ELEMENT-BINDING PROTEIN; FARNESOID-X-RECEPTOR; TYROSINEMIA TYPE-I; CENTER-DOT-MLX; C-MYC; GENE-EXPRESSION; CELL-SIZE; LIVER-REGENERATION; METABOLIC SYNDROME; ENERGY-METABOLISM	Analogous to the c-Myc (Myc)/Max family of bHLH-ZIP transcription factors, there exists a parallel regulatory network of structurally and functionally related proteins with Myc-like functions. Two related Myc-like paralogs, termed MondoA and MondoB/carbohydrate response element-binding protein (ChREBP), up-regulate gene expression in heterodimeric association with the bHLH-ZIP Max-like factor Mlx. Myc is necessary to support liver cancer growth, but not for normal hepatocyte proliferation. Here, we investigated ChREBP's role in these processes and its relationship to Myc. Unlike Myc loss, ChREBP loss conferred a proliferative disadvantage to normal murine hepatocytes, as did the combined loss of ChREBP and Myc. Moreover, hepatoblastomas (HBs) originating in myc(-/-),chrebp(-/-),ormyc(-/-)/chrebp(-/-) backgrounds grew significantly more slowly. Metabolic studies on livers and HBs in all three genetic backgrounds revealed marked differences in oxidative phosphorylation, fatty acid beta-oxidation (FAO), and pyruvate dehydrogenase activity. RNA-Seq of livers and HBs suggested seven distinct mechanisms of Myc-ChREBP target gene regulation. Gene ontology analysis indicated that many transcripts deregulated in the chrebp(-/-) background encode enzymes functioning in glycolysis, the TCA cycle, and beta- and omega-FAO, whereas those dysregulated in the myc(-/-) background encode enzymes functioning in glycolysis, glutaminolysis, and sterol biosynthesis. In the myc(-/-)/chrebp(-/-) background, additional deregulated transcripts included those involved in peroxisomal beta- and alpha-FAO. Finally, we observed that Myc and ChREBP cooperatively up-regulated virtually all ribosomal protein genes. Our findings define the individual and cooperative proliferative, metabolic, and transcriptional roles for the "Extended Myc Network" under both normal and neoplastic conditions.	[Wang, Huabo; Dolezal, James M.; Kulkarni, Sucheta; Lu, Jie; Mandel, Jordan; Jackson, Laura E.; Prochownik, Edward V.] UPMC, Childrens Hosp Pittsburgh, Div Hematol Oncol, Pittsburgh, PA 15224 USA; [Alencastro, Frances; Duncan, Andrew W.] UPMC, Dept Pathol, Pittsburgh, PA 15224 USA; [Duncan, Andrew W.; Prochownik, Edward V.] UPMC, Pittsburgh Liver Ctr, Pittsburgh, PA 15224 USA; [Prochownik, Edward V.] UPMC, Hillman Canc Ctr, Pittsburgh, PA 15224 USA; [Prochownik, Edward V.] Univ Pittsburgh, Med Ctr, Dept Microbiol & Mol Genet, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), UPMC, Rangos Res Ctr, Childrens Hosp Pittsburgh, Div Hematol Oncol, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	procev@chp.edu		Dolezal, James/0000-0002-6788-7203; Duncan, Andrew/0000-0003-4962-4191; Jackson, Laura/0000-0001-9088-576X	The Clinical Scientist Training Program at The University of Pittsburgh School of Medicine; National Institutes of Health [DK103645, CA174713]; NATIONAL CANCER INSTITUTE [R01CA174713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103645] Funding Source: NIH RePORTER	The Clinical Scientist Training Program at The University of Pittsburgh School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health RO1 Grants DK103645 (to A. W. D.) and CA174713 (to E. V. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by The Clinical Scientist Training Program at The University of Pittsburgh School of Medicine.	Allevato M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180147; Anantharaman A, 2011, MOL CELL BIOL, V31, P1332, DOI 10.1128/MCB.01186-10; Arseneault M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44876; Bae JS, 2016, BIOCHEM BIOPH RES CO, V478, P1060, DOI 10.1016/j.bbrc.2016.08.061; Baena E, 2005, P NATL ACAD SCI USA, V102, P7286, DOI 10.1073/pnas.0409260102; BARRETT J, 1992, MOL CELL BIOL, V12, P3130, DOI 10.1128/MCB.12.7.3130; Baudino TA, 2001, MOL CELL BIOL, V21, P691, DOI 10.1128/MCB.21.3.691-702.2001; Billin AN, 2006, CURR TOP MICROBIOL, V302, P255; BIRRER MJ, 1988, MOL CELL BIOL, V8, P2668, DOI 10.1128/MCB.8.6.2668; BIRRER MJ, 1989, MOL CELL BIOL, V9, P2734, DOI 10.1128/MCB.9.6.2734; Carroll PA, 2015, CANCER CELL, V27, P271, DOI 10.1016/j.ccell.2014.11.024; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90; Desbarats L, 1996, GENE DEV, V10, P447, DOI 10.1101/gad.10.4.447; Diolaiti D, 2015, BBA-GENE REGUL MECH, V1849, P484, DOI 10.1016/j.bbagrm.2014.05.016; Dolezal JM, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4178-z; Dolezal JM, 2017, J BIOL CHEM, V292, P10068, DOI 10.1074/jbc.M117.782052; Dubois NC, 2008, DEVELOPMENT, V135, P2455, DOI 10.1242/dev.022707; Duncan AW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000385; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edmunds LR, 2016, ONCOTARGET, V7, P30379, DOI 10.18632/oncotarget.8856; Fernandez D, 2012, CRIT REV IMMUNOL, V32, P321; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Goetzman ES, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00129; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Graves JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013717; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Hamilton MJ, 2015, AIMS BIOPHYS, V2, P794, DOI 10.3934/biophy.2015.4.794; Hart JR, 2014, ONCOTARGET, V5, P12543, DOI 10.18632/oncotarget.3033; Havula E, 2018, CURR OPIN CELL BIOL, V51, P89, DOI 10.1016/j.ceb.2017.12.007; Iaccarino I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071497; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Jackson LE, 2017, CANCER RES, V77, P5795, DOI 10.1158/0008-5472.CAN-17-1325; Jackstadt R, 2015, BBA-GENE REGUL MECH, V1849, P544, DOI 10.1016/j.bbagrm.2014.04.003; Jeong YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022544; Jouihan H, 2012, BIO-PROTOCOL, V2, P223, DOI [10.21769/BioProtoc.223, DOI 10.21769/BIOPROTOC.223, DOI 10.21769/BioProtoc.223]; Kaadige MR, 2009, P NATL ACAD SCI USA, V106, P14878, DOI 10.1073/pnas.0901221106; Kafri M, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow081; Kalkat M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060151; Kassam A, 2003, J BIOL CHEM, V278, P10028, DOI 10.1074/jbc.M208312200; Komura K, 2016, P NATL ACAD SCI USA, V113, P6259, DOI 10.1073/pnas.1600420113; Kulkarni S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182705; KVITTINGEN EA, 1995, J INHERIT METAB DIS, V18, P375, DOI 10.1007/BF00710049; Landay M, 2000, CELL DEATH DIFFER, V7, P697, DOI 10.1038/sj.cdd.4400701; Levens D, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014233; Li F, 2006, CANCER RES, V66, P5608, DOI 10.1158/0008-5472.CAN-05-4242; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Malynn BA, 2000, GENE DEV, V14, P1390; Marguerat S, 2012, TRENDS GENET, V28, P560, DOI 10.1016/j.tig.2012.07.003; Marongiu F, 2014, CELL TISSUE RES, V356, P333, DOI 10.1007/s00441-014-1800-5; Massafra V, 2018, BBA-MOL BASIS DIS, V1864, P45, DOI 10.1016/j.bbadis.2017.10.003; McFerrin LG, 2011, GENOME BIOL EVOL, V3, P915, DOI 10.1093/gbe/evr082; MEHTA R, 1995, CANCER LETT, V93, P85, DOI 10.1016/0304-3835(95)03790-4; Mikawa T, 2015, CELL MOL LIFE SCI, V72, P1881, DOI 10.1007/s00018-015-1840-3; Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016; Muller M, 2016, STEM CELL RES, V16, P349, DOI 10.1016/j.scr.2016.02.005; Muller I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097285; Nebert DW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0431; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; O'Callaghan C, 2017, AGING CELL, V16, P1208, DOI 10.1111/acel.12685; O'Neil NJ, 2017, NAT REV GENET, V18, P613, DOI 10.1038/nrg.2017.47; O'Shea JM, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014258; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; Peterson CW, 2011, FRONT BIOSCI-LANDMRK, V16, P2206, DOI 10.2741/3848; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Poungvarin N, 2015, ENDOCRINOLOGY, V156, P1982, DOI 10.1210/en.2014-1666; PROCHOWNIK EV, 1993, P NATL ACAD SCI USA, V90, P960, DOI 10.1073/pnas.90.3.960; Psathas JN, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014175; Qu AJ, 2014, J HEPATOL, V60, P331, DOI 10.1016/j.jhep.2013.09.024; Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769; Rogulski KR, 2005, P NATL ACAD SCI USA, V102, P18968, DOI 10.1073/pnas.0507902102; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Rushworth Stuart A, 2011, Cancers (Basel), V3, P1605, DOI 10.3390/cancers3021605; Sae-Lee C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147411; Sanders Jennifer A., 2012, BMC Physiology, V12, P1, DOI 10.1186/1472-6793-12-1; Sans CL, 2006, MOL CELL BIOL, V26, P4863, DOI 10.1128/MCB.00657-05; Shi Z, 2015, ANNU REV CELL DEV BI, V31, P31, DOI 10.1146/annurev-cellbio-100814-125346; SHIH HM, 1995, J BIOL CHEM, V270, P21991, DOI 10.1074/jbc.270.37.21991; Soga T, 2013, CANCER SCI, V104, P275, DOI 10.1111/cas.12085; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Suzuki T, 2015, NUTRITION, V31, P877, DOI 10.1016/j.nut.2015.01.005; Tao JY, 2014, GASTROENTEROLOGY, V147, P690, DOI 10.1053/j.gastro.2014.05.004; Tapia C, 2006, AM J SURG PATHOL, V30, P83, DOI 10.1097/01.pas.0000183572.94140.43; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Tseng YY, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.974467; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; van de Ven RAH, 2017, TRENDS MOL MED, V23, P320, DOI 10.1016/j.molmed.2017.02.005; Wanders RJA, 1998, MOL ASPECTS MED, V19, P71, DOI 10.1016/S0098-2997(98)00003-X; Wang HB, 2016, J BIOL CHEM, V291, P26241, DOI 10.1074/jbc.M116.754218; Wang HB, 2015, ONCOTARGET, V6, P15857, DOI 10.18632/oncotarget.4327; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wilde BR, 2015, BRIT J CANCER, V113, P1529, DOI 10.1038/bjc.2015.360; Witte N, 2015, ENDOCRINOLOGY, V156, P4008, DOI 10.1210/EN.2015-1209; Yin XY, 2002, J BIOL CHEM, V277, P19998, DOI 10.1074/jbc.M200860200; Yu ST, 2003, CURR MOL MED, V3, P561, DOI 10.2174/1566524033479537; Zaytseva O, 2017, GENES-BASEL, V8, DOI 10.3390/genes8040118; Zhang P, 2010, MOL ENDOCRINOL, V24, P1274, DOI 10.1210/me.2009-0437; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271; Zirath H, 2013, P NATL ACAD SCI USA, V110, P10258, DOI 10.1073/pnas.1222404110	111	14	15	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14740	14757		10.1074/jbc.RA118.004099	http://dx.doi.org/10.1074/jbc.RA118.004099			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30087120	Green Published, hybrid			2022-12-28	WOS:000446155000013
J	Huang, Y; Leng, TD; Inoue, K; Yang, T; Liu, ML; Horgen, FD; Fleig, A; Li, J; Xiong, ZG				Huang, Yan; Leng, Tian-Dong; Inoue, Koichi; Yang, Tao; Liu, Mingli; Horgen, F. David; Fleig, Andrea; Li, Jun; Xiong, Zhi-Gang			TRPM7 channels play a role in high glucose-induced endoplasmic reticulum stress and neuronal cell apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; transient receptor potential channels (TRP channels); nitric-oxide synthase; endoplasmic reticulum stress (ER stress); glucose; neurodegeneration; oxidative stress; unfolded protein response (UPR); Diabetes; ERS; NOS; NS20Y cell; transient receptor potential melastatin 7 (TRPM7)	INDUCED OXIDATIVE STRESS; NITRIC-OXIDE; ER-STRESS; KEY ROLE; PATHWAY; PROTEIN; KINASE; PROLIFERATION; NEUROTOXICITY; INTERMITTENT	High-glucose (HG) levels and hyperglycemia associated with diabetes are known to cause neuronal damage. The detailed molecular mechanisms, however, remain to be elucidated. Here, we investigated the role of transient receptor potential melastatin 7 (TRPM7) channels in HG-mediated endoplasmic reticulum stress (ERS) and injury of NS20Y neuronal cells. The cells were incubated in the absence or presence of HG for 48 h. We found that mRNA and protein levels of TRPM7 and of ERS-associated proteins, such as C/EBP homologous protein (CHOP), 78-kDa glucose-regulated protein (GRP78), and inducible nitric-oxide synthase (iNOS), increased in HG-treated cells, along with significantly increased TRPM7-associated currents in these cells. Similar results were obtained in cerebral cortical tissue from an insulin-deficiency model of diabetic mice. Moreover, HG treatment of cells activated ERS-associated proapoptotic caspase activity and induced cellular injury. Interestingly, a NOS inhibitor, l-NAME, suppressed the HG-induced increase of TRPM7 expression and cellular injury. siRNA-mediated TRPM7 knockdown or chemical inhibition of TRPM7 activity also suppressed HG-induced ERS and decreased cleaved caspase-12/caspase-3 levels and cell injury. Of note, TRPM7 overexpression increased ERS and cell injury independently of its kinase activity. Taken together, our findings suggest that TRPM7 channel activities play a key role in HG-associated ERS and cytotoxicity through an apoptosis-inducing signaling cascade involving HG, iNOS, TRPM7, ERS proteins, and caspases.	[Huang, Yan; Li, Jun] Anhui Med Univ, Sch Pharm, Hefei 230032, Anhui, Peoples R China; [Huang, Yan; Leng, Tian-Dong; Inoue, Koichi; Yang, Tao; Liu, Mingli; Xiong, Zhi-Gang] Morehouse Sch Med, Neurosci Inst, Atlanta, GA 30310 USA; [Inoue, Koichi] Nagoya City Univ, Grad Sch Med Sci, Dept Integrat Anat, Nagoya, Aichi 4678601, Japan; [Horgen, F. David] Hawaii Pacific Univ, Dept Nat Sci, Kaneohe, HI 96744 USA; [Fleig, Andrea] Queens Med Ctr, Ctr Biomed Res, Lab Cell & Mol Signaling, Honolulu, HI 96813 USA; [Fleig, Andrea] Univ Hawaii, John A Burns Sch Med & Canc Ctr, Honolulu, HI 96813 USA	Anhui Medical University; Morehouse School of Medicine; Nagoya City University; The Queen's Medical Center; University of Hawaii System	Leng, TD; Xiong, ZG (corresponding author), Morehouse Sch Med, Dept Neurobiol, Atlanta, GA 30310 USA.	tleng@msm.edu; zxiong@msm.edu		Fleig, Andrea/0000-0001-8396-7249	National Institutes of Health (NIH) [R01 NS104349, S21MD000101, U54NS083932, P20GM103466, SC3GM 122593]; Research Fund for the Back-up Candidates of the Academic and Technical Leaders of Anhui, China [2015H040]; Young Top Talents Program of Anhui Medical University; Foundation for Distinguished Young Talents in Higher Education of Anhui, China [gxy-qZD2016049]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM122593, P20GM103466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS083932, R01NS104349] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R25MD007589, S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Fund for the Back-up Candidates of the Academic and Technical Leaders of Anhui, China; Young Top Talents Program of Anhui Medical University; Foundation for Distinguished Young Talents in Higher Education of Anhui, China; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by National Institutes of Health (NIH) Grants R01 NS104349, S21MD000101, U54NS083932, P20GM103466, and SC3GM 122593; Research Fund for the Back-up Candidates of the Academic and Technical Leaders of Anhui, China, Grant 2015H040; and Young Top Talents Program of Anhui Medical University and Foundation for Distinguished Young Talents in Higher Education of Anhui, China, Grant gxy-qZD2016049. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; AMANO T, 1972, P NATL ACAD SCI USA, V69, P258, DOI 10.1073/pnas.69.1.258; Aronson D, 2008, ADV CARDIOL, V45, P1, DOI 10.1159/000115118; Askwith T, 2012, EXP NEUROL, V233, P154, DOI 10.1016/j.expneurol.2011.09.010; Bessac BF, 2007, J PHYSIOL-LONDON, V582, P1073, DOI 10.1113/jphysiol.2007.130534; Bolanos JP, 1999, BBA-BIOENERGETICS, V1411, P415, DOI 10.1016/S0005-2728(99)00030-4; Chen HC, 2012, BIOCHEM J, V445, P441, DOI 10.1042/BJ20120248; Coombes E, 2011, ANTIOXID REDOX SIGN, V14, P1815, DOI 10.1089/ars.2010.3549; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Federiuk IF, 2004, COMPARATIVE MED, V54, P252; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; de la Cadena SC, 2014, APOPTOSIS, V19, P414, DOI 10.1007/s10495-013-0930-7; Gaspar JM, 2010, NEUROSCIENCE, V171, P981, DOI 10.1016/j.neuroscience.2010.10.019; Giannini S, 2008, J ENDOCRINOL, V198, P523, DOI 10.1677/JOE-07-0613; Gorman AM, 2012, PHARMACOL THERAPEUT, V134, P306, DOI 10.1016/j.pharmthera.2012.02.003; Goyal MMZA, 2005, BIOTECHNOL PROGR, V21, P70, DOI 10.1021/bp049815s; GROUSE LD, 1980, J BIOL CHEM, V255, P3871; Hanano T, 2004, J PHARMACOL SCI, V95, P403, DOI 10.1254/jphs.FP0040273; Huang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097315; Inoue K, 2010, J BIOL CHEM, V285, P7430, DOI 10.1074/jbc.M109.040485; Inoue K, 2009, CARDIOVASC RES, V83, P547, DOI 10.1093/cvr/cvp153; Jiang J, 2007, CANCER RES, V67, P10929, DOI 10.1158/0008-5472.CAN-07-1121; Kalalian-Moghaddam H, 2013, EUR J PHARMACOL, V698, P259, DOI 10.1016/j.ejphar.2012.10.020; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Leng TD, 2015, CNS NEUROSCI THER, V21, P32, DOI 10.1111/cns.12318; Li YN, 2013, MOL CELL ENDOCRINOL, V370, P78, DOI 10.1016/j.mce.2013.02.015; Li ZG, 2002, BRAIN RES, V946, P221, DOI 10.1016/S0006-8993(02)02887-1; Lim MP, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.52; Liu ML, 2014, CELL SIGNAL, V26, P2773, DOI 10.1016/j.cellsig.2014.08.020; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Meng XF, 2014, MOL NEUROBIOL, V49, P673, DOI 10.1007/s12035-013-8551-2; Mollica MP, 2011, NUTR METAB CARDIOVAS, V21, P222, DOI 10.1016/j.numecd.2010.10.012; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Reinehr R, 2003, FASEB J, V17, P731, DOI 10.1096/fj.02-0915fje; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Ryazanova LV, 2014, SCI REP-UK, V4, DOI 10.1038/srep07599; Sah R, 2013, CIRCULATION, V128, P101, DOI 10.1161/CIRCULATIONAHA.112.000768; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Sun HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079540; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Tomlinson DR, 2008, NAT REV NEUROSCI, V9, P36, DOI 10.1038/nrn2294; Turlova E, 2016, MOL NEUROBIOL, V53, P595, DOI 10.1007/s12035-014-9032-y; Urra H, 2013, BBA-MOL CELL RES, V1833, P3507, DOI 10.1016/j.bbamcr.2013.07.024; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; Visser D, 2013, CELL CALCIUM, V54, P404, DOI 10.1016/j.ceca.2013.09.003; Wang QQ, 2013, CELL STRESS CHAPERON, V18, P367, DOI 10.1007/s12192-012-0390-y; Wuensch T, 2010, DIABETES, V59, P844, DOI 10.2337/db09-1100; Xu XF, 2012, BRAIN RES BULL, V87, P85, DOI 10.1016/j.brainresbull.2011.10.012; Yagihashi S, 2001, BRAIN, V124, P2448, DOI 10.1093/brain/124.12.2448; Ye L, 2011, BRAIN RES, V1411, P57, DOI 10.1016/j.brainres.2011.07.011; Zeng Z, 2015, AM J PHYSIOL-CELL PH, V308, pC308, DOI 10.1152/ajpcell.00275.2013; Zhai YP, 2013, ACTA PHARMACOL SIN, V34, P507, DOI 10.1038/aps.2012.207; Zhang XM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/924327; Zhang YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031631; Zhong YM, 2012, ADV EXP MED BIOL, V723, P285, DOI 10.1007/978-1-4614-0631-0_37; Zierler S, 2011, J BIOL CHEM, V286, P39328, DOI 10.1074/jbc.M111.264341	57	26	28	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14393	14406		10.1074/jbc.RA117.001032	http://dx.doi.org/10.1074/jbc.RA117.001032			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30076216	Green Published, hybrid			2022-12-28	WOS:000444671500019
J	McCormick, CD; Waters, HN; Bezrukov, L; Taginya, R; Parikh, V; Onyekaba, GI; Levine, JA; Demidowich, AP; Yanovski, JA; Blank, PS; Zimmerberg, J				McCormick, Chad D.; Waters, Hang N.; Bezrukov, Ludmila; Taginya, Roxana; Parikh, Viraj; Onyekaba, Ginikanwa I.; Levine, Jordan A.; Demidowich, Andrew P.; Yanovski, Jack A.; Blank, Paul S.; Zimmerberg, Joshua			Subcutaneous adipose tissue imaging of human obesity reveals two types of adipocyte membranes: Insulin-responsive and -nonresponsive	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipose tissue; adipose tissue metabolism; Akt PKB; biostatistics; cellular regulation; insulin; insulin resistance; metabolic syndrome; obesity; subcutaneous fat	METABOLIC SYNDROME; MODEL SELECTION; RESISTANCE; GLUCOSE; GLUT4; FAT; SENSITIVITY; ACTIVATION; VESICLES; PROTEIN	In adipose tissue, resistance to insulin's ability to increase glucose uptake can be induced by multiple factors, including obesity. Impaired insulin action may take place at different spatial loci at the cellular or subcellular level. To begin to understand the spatial response to insulin in human subcutaneous adipose tissue (hSAT), we developed a quantitative imaging method for activation of a major signaling node in the glucoregulatory insulin signaling pathway. After treatment with insulin or control media, biopsied tissues were immunostained for Akt phosphorylation at Thr-308/9 (pAkt) and then imaged by confocal fluorescence microscopy automated to collect a large grid of high resolution fields. In hSAT from 40 men and women with obesity, substantial heterogeneity of pAkt densities in adipocyte membranes were quantified in each image mosaic using a spatial unit of at least twice the size of the point spread function. Statistical analysis of the distribution of pAkt spatial units was best fit as the weighted sum of two separate distributions, corresponding to either a low or high pAkt density. A high pAkt fraction metric was calculated from the fraction of high pAkt distributed units over the total units. Importantly, upon insulin stimulation, tissues from the same biopsy showed either a minimal or a substantial change in the high pAkt fraction. Further supporting a two-state response to insulin stimulation, subjects with similar insulin sensitivity indices are also segregated into either of two clusters identified by the amount of membrane-localized pAkt.	[McCormick, Chad D.; Waters, Hang N.; Bezrukov, Ludmila; Taginya, Roxana; Blank, Paul S.; Zimmerberg, Joshua] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Integrat Biophys, NIH, Bethesda, MD 20892 USA; [Parikh, Viraj; Onyekaba, Ginikanwa I.; Levine, Jordan A.; Demidowich, Andrew P.; Yanovski, Jack A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Obes, NIH, Bethesda, MD 20892 USA; [Yanovski, Jack A.; Zimmerberg, Joshua] US PHS, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); United States Public Health Service	Zimmerberg, J (corresponding author), 10 Ctr Dr,Bldg 10,Room 10D14, Bethesda, MD 20892 USA.	joshz@helix.nih.gov	Blank, Paul/Q-9673-2019	McCormick, Chad/0000-0003-0070-166X	Division of Intramural Research (DIR) of the NICHD, National Institutes of Health [ZIAHD000641, ZIAHD001415]; NICHD DIR Director's Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000641, ZIAHD001415] Funding Source: NIH RePORTER	Division of Intramural Research (DIR) of the NICHD, National Institutes of Health; NICHD DIR Director's Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Division of Intramural Research (DIR) of the NICHD, National Institutes of Health Projects ZIAHD000641 (to J. Y.) and ZIAHD001415 (to J. Z.), with additional support from an NICHD DIR Director's Award. The authors declare that they have no conflicts of interest with the contents of this article. The opinions and assertions expressed herein are those of the authors and are not to be construed as reflecting the views of the USPHS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANDERSON RL, 1995, AM J EPIDEMIOL, V142, P724, DOI 10.1093/aje/142.7.724; Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; BASTARD JP, 1994, JPEN-PARENTER ENTER, V18, P466, DOI 10.1177/0148607194018005466; Beg M, 2017, ELIFE, V6, DOI 10.7554/eLife.26896; Burchfield JG, 2013, TRAFFIC, V14, P259, DOI 10.1111/tra.12035; Busse BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30284; Cizmeci D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083640; Cook SA, 2010, EUR HEART J, V31, P100, DOI 10.1093/eurheartj/ehp396; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Di Camillo B, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0281-4; EPANECHN.VA, 1969, THEOR PROBAB APPL+, V14, P153, DOI 10.1137/1114019; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Garg A, 2004, J CLIN ENDOCR METAB, V89, P4206, DOI 10.1210/jc.2004-0631; Gastaldelli A, 2017, DIABETES, V66, P815, DOI 10.2337/db16-1167; Gil A, 2011, INT J PEDIATR OBES, V6, P13, DOI 10.3109/17477166.2011.604326; GLIEMANN J, 1974, J PHYSIOL-LONDON, V236, P499, DOI 10.1113/jphysiol.1974.sp010449; GLIEMANN J, 1972, ISRAEL J MED SCI, V8, P807; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Hales Craig M, 2017, NCHS Data Brief, P1; Humphrey SJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003085; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; KAHN BB, 1986, ANN NY ACAD SCI, V488, P356; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Korenblat KM, 2008, GASTROENTEROLOGY, V134, P1369, DOI 10.1053/j.gastro.2008.01.075; Koshy Shyny, 2010, J Vis Exp, DOI 10.3791/2429; Lee KY, 2017, DIABETES, V66, P2822, DOI 10.2337/db17-0218; Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9; Liu HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE898, DOI 10.1152/ajpendo.00374.2009; Lizunov VA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119291; Lizunov VA, 2013, DIABETES, V62, P3114, DOI 10.2337/db12-1741; Lizunov VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057559; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Magkos F, 2010, OBESITY, V18, P1510, DOI 10.1038/oby.2010.90; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ninfa Alexander J, 2004, Sci STKE, V2004, ppe20, DOI 10.1126/stke.2322004pe20; Norris DM, 2018, METHODS MOL BIOL, V1713, P193, DOI 10.1007/978-1-4939-7507-5_15; Patel P, 2013, J OBES, V2013, DOI 10.1155/2013/489187; Rask-Madsen C, 2012, ARTERIOSCL THROM VAS, V32, P2052, DOI 10.1161/ATVBAHA.111.241919; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Saltiel AR, 2003, TRAFFIC, V4, P711, DOI 10.1034/j.1600-0854.2003.00119.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; Shao J, 2000, J ENDOCRINOL, V167, P107, DOI 10.1677/joe.0.1670107; Shigematsu S, 2001, J BIOL CHEM, V276, P15292, DOI 10.1074/jbc.M009684200; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Veeriah S, 2014, CANCER RES, V74, P4983, DOI 10.1158/0008-5472.CAN-13-3382; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wang QT, 2017, CIRCULATION, V135, P73, DOI 10.1161/CIRCULATIONAHA.116.022281; Xiong WY, 2010, MOL BIOL CELL, V21, P1375, DOI 10.1091/mbc.E09-08-0751; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361	54	1	1	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14249	14259		10.1074/jbc.RA118.003751	http://dx.doi.org/10.1074/jbc.RA118.003751			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30006347	hybrid, Green Published			2022-12-28	WOS:000444671500006
J	Soll, JM; Brickner, JR; Mudge, MC; Mosammaparast, N				Soll, Jennifer M.; Brickner, Joshua R.; Mudge, Miranda C.; Mosammaparast, Nima			RNA ligase-like domain in activating signal cointegrator 1 complex subunit 1 (ASCC1) regulates ASCC complex function during alkylation damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; alkB; DNA damage response; cell signaling; DNA demethylation	DNA-DAMAGE; OXIDATIVE DEMETHYLATION; ESCHERICHIA-COLI; REPAIR; PROTEIN; 3,N-4-ETHENOCYTOSINE; GLYCOSYLASE; PREDICTION; CONTAINS; CANCER	Multiple DNA damage response (DDR) pathways have evolved to sense the presence of damage and recruit the proper repair factors. We recently reported a signaling pathway induced upon alkylation damage to recruit the AlkB homolog 3, -ketoglutarate-dependent dioxygenase (ALKBH3)-activating signal cointegrator 1 complex subunit 3 (ASCC3) dealkylase-helicase repair complex. As in other DDR pathways, the recruitment of these repair factors is mediated through a ubiquitin-dependent mechanism. However, the machinery that coordinates the proper assembly of this repair complex and controls its recruitment is still poorly defined. Here, we demonstrate that the ASCC1 accessory subunit is important for the regulation of ASCC complex function. ASCC1 interacts with the ASCC complex through the ASCC3 helicase subunit. We find that ASCC1 is present at nuclear speckle foci prior to damage, but leaves the foci in response to alkylation. Strikingly, ASCC1 loss significantly increases ASCC3 foci formation during alkylation damage, yet most of these foci lack ASCC2. These results suggest that ASCC1 coordinates the proper recruitment of the ASCC complex during alkylation, a function that appears to depend on a putative RNA-binding motif near the ASCC1 C terminus. Consistent with its role in alkylation damage signaling and repair, ASCC1 knockout through a CRISPR/Cas9 approach results in alkylation damage sensitivity in a manner epistatic with ASCC3. Together, our results identify a critical regulator of the ALKBH3-ASCC alkylation damage signaling pathway and suggest a potential role for RNA-interacting domains in the alkylation damage response.	[Soll, Jennifer M.; Brickner, Joshua R.; Mudge, Miranda C.; Mosammaparast, Nima] Washington Univ, Dept Pathol & Immunol, Div Lab & Genom Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Mosammaparast, N (corresponding author), Washington Univ, Dept Pathol & Immunol, Campus Box 8118,4939 Childrens Pl, St Louis, MO 63110 USA.	Nima@wustl.edu			National Institutes of Health [R01 CA193318]; Alvin Siteman Cancer Research Fund; Siteman Investment Program; Children's Discovery Institute of St. Louis Children's Hospital Grant [MC-II-2015-453]; Monsanto Company; Cell and Molecular Biology Training Grant from the National Institutes of Health [5T32GM007067-40]; Shawn Hu and Angela Zeng student scholarship; NATIONAL CANCER INSTITUTE [P30CA091842, R01CA193318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alvin Siteman Cancer Research Fund; Siteman Investment Program; Children's Discovery Institute of St. Louis Children's Hospital Grant; Monsanto Company; Cell and Molecular Biology Training Grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shawn Hu and Angela Zeng student scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant R01 CA193318, the Alvin Siteman Cancer Research Fund, the Siteman Investment Program, and the Children's Discovery Institute of St. Louis Children's Hospital Grant MC-II-2015-453 (to N.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a graduate student fellowship from the Monsanto Company.; Supported by Cell and Molecular Biology Training Grant 5T32GM007067-40 from the National Institutes of Health and the Shawn Hu and Angela Zeng student scholarship.	Brickner JR, 2017, NATURE, V551, P389, DOI 10.1038/nature24484; Brown RL, 2003, BIOCHEM BIOPH RES CO, V306, P394, DOI 10.1016/S0006-291X(03)00982-3; Daley JM, 2014, MOL CELL BIOL, V34, P1380, DOI 10.1128/MCB.01639-13; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; Doherty AJ, 2000, NUCLEIC ACIDS RES, V28, P4051, DOI 10.1093/nar/28.21.4051; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; EADIE JS, 1984, NATURE, V308, P201, DOI 10.1038/308201a0; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Fu D, 2012, DNA REPAIR, V11, P46, DOI 10.1016/j.dnarep.2011.10.004; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gold MG, 2008, J MOL BIOL, V375, P1329, DOI 10.1016/j.jmb.2007.11.037; Gros L, 2004, J BIOL CHEM, V279, P17723, DOI 10.1074/jbc.M314010200; Jung DJ, 2002, MOL CELL BIOL, V22, P5203, DOI 10.1128/MCB.22.14.5203-5211.2002; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Konishi N, 2005, CLIN CANCER RES, V11, P5090, DOI 10.1158/1078-0432.CCR-05-0195; KOONIN EV, 1990, FEBS LETT, V268, P231, DOI 10.1016/0014-5793(90)81015-G; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lingaraju GM, 2011, J BIOL CHEM, V286, P13205, DOI 10.1074/jbc.M110.192435; Mazumder R, 2002, NUCLEIC ACIDS RES, V30, P5229, DOI 10.1093/nar/gkf645; Mosammaparast N, 2013, J CELL BIOL, V203, P457, DOI 10.1083/jcb.201302092; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Silverman RH, 2014, J INTERF CYTOK RES, V34, P455, DOI 10.1089/jir.2014.0007; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Soll JM, 2017, TRENDS BIOCHEM SCI, V42, P206, DOI 10.1016/j.tibs.2016.10.001; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tasaki M, 2011, BRIT J CANCER, V104, P700, DOI 10.1038/sj.bjc.6606012; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Xu-Welliver M, 2002, CARCINOGENESIS, V23, P823, DOI 10.1093/carcin/23.5.823; ZAK P, 1994, J BIOL CHEM, V269, P730; Zhao Y, 2015, EMBO J, V34, P1687, DOI 10.15252/embj.201490497	36	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13524	13533		10.1074/jbc.RA117.000114	http://dx.doi.org/10.1074/jbc.RA117.000114			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29997253	Green Published, hybrid			2022-12-28	WOS:000443375500014
J	Sun, B; Wei, JH; Zhong, XW; Guo, WT; Yao, JJ; Wang, RW; Vallmitjana, A; Benitez, R; Hove-Madsen, L; Chen, SRW				Sun, Bo; Wei, Jinhong; Zhong, Xiaowei; Guo, Wenting; Yao, Jinjing; Wang, Ruiwu; Vallmitjana, Alexander; Benitez, Raul; Hove-Madsen, Leif; Chen, S. R. Wayne			The cardiac ryanodine receptor, but not sarcoplasmic reticulum Ca2+-ATPase, is a major determinant of Ca2+ alternans in intact mouse hearts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ryanodine receptor; sarcoplasmic reticulum (SR); endoplasmic reticulum (ER); calcium; calcium ATPase; calcium imaging; calcium intracellular release; Ca2+alternans; Ca2+release refractoriness; intact heart imaging; phospholamban; ventricular tachyarrhythmia; confocal Ca2+ imaging; intact heart imaging; cardiac dysfunction	POLYMORPHIC VENTRICULAR-TACHYCARDIA; T-WAVE ALTERNANS; INTRACELLULAR CALCIUM; MECHANICAL ALTERNANS; ATRIAL MYOCYTES; RAT-HEART; REPOLARIZATION ALTERNANS; CONTENT FLUCTUATIONS; SUDDEN-DEATH; RELEASE	Sarcoplasmic reticulum (SR) Ca2+ cycling is governed by the cardiac ryanodine receptor (RyR2) and SR Ca2+-ATPase (SERCA2a). Abnormal SR Ca2+ cycling is thought to be the primary cause of Ca2+ alternans that can elicit ventricular arrhythmias and sudden cardiac arrest. Although alterations in either RyR2 or SERCA2a function are expected to affect SR Ca2+ cycling, whether and to what extent altered RyR2 or SERCA2a function affects Ca2+ alternans is unclear. Here, we employed a gain-of-function RyR2 variant (R4496C) and the phospholamban-knockout (PLB-KO) mouse model to assess the effect of genetically enhanced RyR2 or SERCA2a function on Ca2+ alternans. Confocal Ca2+ imaging revealed that RyR2-R4496C shortened SR Ca2+ release refractoriness and markedly suppressed rapid pacing-induced Ca2+ alternans. Interestingly, despite enhancing RyR2 function, intact RyR2-R4496C hearts exhibited no detectable spontaneous SR Ca2+ release events during pacing. Unlike for RyR2, enhancing SERCA2a function by ablating PLB exerted a relatively minor effect on Ca2+ alternans in intact hearts expressing RyR2 WT or a loss-of-function RyR2 variant, E4872Q, that promotes Ca2+ alternans. Furthermore, partial SERCA2a inhibition with 3 m 2,5-di-tert-butylhydroquinone (tBHQ) also had little impact on Ca2+ alternans, whereas strong SERCA2a inhibition with 10 m tBHQ markedly reduced the amplitude of Ca2+ transients and suppressed Ca2+ alternans in intact hearts. Our results demonstrate that enhanced RyR2 function suppresses Ca2+ alternans in the absence of spontaneous Ca2+ release and that RyR2, but not SERCA2a, is a key determinant of Ca2+ alternans in intact working hearts, making RyR2 an important therapeutic target for cardiac alternans.	[Sun, Bo; Wei, Jinhong; Zhong, Xiaowei; Guo, Wenting; Yao, Jinjing; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Vallmitjana, Alexander; Benitez, Raul] Univ Politecn Cataluna, Dept Automat Control, ES-08034 Barcelona, Spain; [Hove-Madsen, Leif] Hosp Sant Pau, CSIC, Biomed Res Inst Barcelona IIBB, Barcelona 08025, Spain	Libin Cardiovascular Institute Of Alberta; University of Calgary; Universitat Politecnica de Catalunya; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); Hospital of Santa Creu i Sant Pau	Chen, SRW (corresponding author), 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	swchen@ucalgary.ca	Wei, Jinhong/GWV-0561-2022; Vallmitjana, Alexander/B-5058-2019; Benítez, Raúl/AGO-5018-2022	Wei, Jinhong/0000-0002-5251-9192; Vallmitjana, Alexander/0000-0002-7149-9385; Benítez, Raúl/0000-0002-8782-9406; Hove-Madsen, Leif/0000-0001-5493-3998	Canadian Institutes of Health Research; Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut; Canada Foundation for Innovation (CFI); Heart and Stroke Foundation Chair in Cardiovascular Research; Alberta Innovates-Health Solutions; Spanish Ministry of Economy and Competitiveness (MINECO) [DPI2013-44584-R, SAF2014-58286-C2-1R]; Generalitat de Catalunya [SGR2014-1465]; Alberta Innovates-Health Solutions (AIHS) Fellowship Award; Libin Cardiovascular Institute of Alberta; AIHS Studentship Award; Cumming School of Medicine Postdoctoral Fellowship Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut; Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Heart and Stroke Foundation Chair in Cardiovascular Research; Alberta Innovates-Health Solutions; Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Alberta Innovates-Health Solutions (AIHS) Fellowship Award; Libin Cardiovascular Institute of Alberta; AIHS Studentship Award; Cumming School of Medicine Postdoctoral Fellowship Award	This work was supported by research grants from the Canadian Institutes of Health Research; the Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut; the Canada Foundation for Innovation (CFI); the Heart and Stroke Foundation Chair in Cardiovascular Research; the Alberta Innovates-Health Solutions (to S. R. W. C.); Spanish Ministry of Economy and Competitiveness (MINECO) Grants DPI2013-44584-R (to R.B.) and SAF2014-58286-C2-1R (to L. H. M.), and Generalitat de Catalunya Grant SGR2014-1465 (to L. H. M. and R. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of the Alberta Innovates-Health Solutions (AIHS) Fellowship Award.; Recipient of the Libin Cardiovascular Institute of Alberta and Cumming School of Medicine Postdoctoral Fellowship Award.; Recipient of the AIHS Studentship Award.	Aistrup GL, 2009, CIRC RES, V104, P639, DOI 10.1161/CIRCRESAHA.108.181909; Alvarez-Lacalle E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055042; Armoundas AA, 2002, J AM COLL CARDIOL, V40, P207, DOI 10.1016/S0735-1097(02)01960-5; Bai YL, 2013, CIRC RES, V113, P517, DOI 10.1161/CIRCRESAHA.113.301678; Belevych AE, 2009, CARDIOVASC RES, V84, P387, DOI 10.1093/cvr/cvp246; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Chen B, 2012, CIRC-ARRHYTHMIA ELEC, V5, P841, DOI 10.1161/CIRCEP.111.969733; Chen WQ, 2014, NAT MED, V20, P184, DOI 10.1038/nm.3440; Chudin E, 1999, BIOPHYS J, V77, P2930, DOI 10.1016/S0006-3495(99)77126-2; Cordeiro JM, 2007, AM J PHYSIOL-HEART C, V293, pH3506, DOI 10.1152/ajpheart.00757.2007; Cutler MJ, 2012, CIRCULATION, V126, P2095, DOI 10.1161/CIRCULATIONAHA.111.071480; Cutler MJ, 2009, CIRC-ARRHYTHMIA ELEC, V2, P686, DOI 10.1161/CIRCEP.109.863118; Diaz ME, 2004, CIRC RES, V94, P650, DOI 10.1161/01.RES.0000119923.64774.72; Diaz ME, 2002, CIRC RES, V91, P585, DOI 10.1161/01.RES.0000035527.53514.C2; Edwards JN, 2014, CLIN EXP PHARMACOL P, V41, P524, DOI 10.1111/1440-1681.12231; Eisner DA, 2006, HEART RHYTHM, V3, P743, DOI 10.1016/j.hrthm.2005.12.020; Escobar AL, 2014, CIRC RES, V114, P1369, DOI 10.1161/CIRCRESAHA.114.303823; Faggioni M, 2013, CIRC RES, V112, P689, DOI 10.1161/CIRCRESAHA.111.300076; Fernandez-Velasco M, 2009, CIRC RES, V104, P201, DOI 10.1161/CIRCRESAHA.108.177493; Ferrantini C, 2016, J GEN PHYSIOL, V147, P39, DOI 10.1085/jgp.201511450; Goldhaber JI, 2005, CIRC RES, V96, P459, DOI 10.1161/01.RES.0000156891.66893.83; Huser J, 2000, J PHYSIOL-LONDON, V524, P795, DOI 10.1111/j.1469-7793.2000.00795.x; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2002, CIRC RES, V91, P218, DOI 10.1161/01.RES.0000028455.36940.5E; Kameyama M, 2003, J ELECTROCARDIOL, V36, P125, DOI 10.1054/jelc.2003.50021; Kanaporis G, 2015, CIRC RES, V116, P846, DOI 10.1161/CIRCRESAHA.116.305404; Kang GX, 2010, CIRC RES, V107, P512, DOI 10.1161/CIRCRESAHA.110.221481; Kapur S, 2010, AM J PHYSIOL-HEART C, V299, pH1843, DOI 10.1152/ajpheart.00623.2010; Kapur S, 2009, AM J PHYSIOL-HEART C, V296, pH1491, DOI 10.1152/ajpheart.00539.2008; KIHARA Y, 1991, AM J PHYSIOL, V261, pH1746, DOI 10.1152/ajpheart.1991.261.6.H1746; Kockskamper J, 2005, J PHYSIOL-LONDON, V564, P697, DOI 10.1113/jphysiol.2004.078782; Kornyeyev D, 2012, J MOL CELL CARDIOL, V52, P21, DOI 10.1016/j.yjmcc.2011.09.020; Laurita KR, 2008, PROG BIOPHYS MOL BIO, V97, P332, DOI 10.1016/j.pbiomolbio.2008.02.014; Laurita KR, 2008, J MOL CELL CARDIOL, V44, P31, DOI 10.1016/j.yjmcc.2007.10.012; Llach A, 2011, J PHYSIOL-LONDON, V589, P3247, DOI 10.1113/jphysiol.2010.197715; Lugo CA, 2014, AM J PHYSIOL-HEART C, V306, pH1540, DOI 10.1152/ajpheart.00515.2013; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Narayan SM, 2006, J AM COLL CARDIOL, V47, P269, DOI 10.1016/j.jacc.2005.08.066; Nassal MMJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137359; ORCHARD CH, 1991, CIRC RES, V68, P69, DOI 10.1161/01.RES.68.1.69; Picht E, 2006, CIRC RES, V99, P740, DOI 10.1161/01.RES.0000244002.88813.91; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Qu Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep35625; Qu ZL, 2013, J MOL CELL CARDIOL, V58, P100, DOI 10.1016/j.yjmcc.2012.10.007; Qu ZL, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00154; ROSENBAUM DS, 1994, NEW ENGL J MED, V330, P235, DOI 10.1056/NEJM199401273300402; Rovetti R, 2010, CIRC RES, V106, P1582, DOI 10.1161/CIRCRESAHA.109.213975; Sabir IN, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00126; Shkryl VM, 2012, AM J PHYSIOL-HEART C, V302, pH2310, DOI 10.1152/ajpheart.00079.2012; Stary V, 2016, J APPL PHYSIOL, V120, P865, DOI 10.1152/japplphysiol.00588.2015; Verrier RL, 2013, J ELECTROCARDIOL, V46, P580, DOI 10.1016/j.jelectrocard.2013.07.003; Verrier RL, 2010, J CARDIOVASC PHARM, V55, P544, DOI 10.1097/FJC.0b013e3181d6b781; Wan XP, 2005, J MOL CELL CARDIOL, V39, P419, DOI 10.1016/j.yjmcc.2005.06.004; Wang LG, 2014, CIRC RES, V114, P1410, DOI 10.1161/CIRCRESAHA.114.302505; Wasserstrom JA, 2009, CIRC-HEART FAIL, V2, P223, DOI 10.1161/CIRCHEARTFAILURE.108.811539; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; Wilson LD, 2009, HEART RHYTHM, V6, P251, DOI 10.1016/j.hrthm.2008.11.008; Xie LH, 2008, BIOPHYS J, V95, P3100, DOI 10.1529/biophysj.108.130955; Xie LH, 2009, AM J PHYSIOL-HEART C, V297, pH997, DOI 10.1152/ajpheart.00390.2009; Xie WJ, 2013, J MOL CELL CARDIOL, V64, P120, DOI 10.1016/j.yjmcc.2013.09.003; Zhang JQ, 2014, BIOCHEM J, V461, P99, DOI 10.1042/BJ20140126; Zhong XW, 2016, BIOCHEM J, V473, P3951, DOI 10.1042/BCJ20160606; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406	63	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13650	13661		10.1074/jbc.RA118.003760	http://dx.doi.org/10.1074/jbc.RA118.003760			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29986885	Green Published, hybrid			2022-12-28	WOS:000443375500024
J	Lau, YTK; Baytshtok, V; Howard, TA; Fiala, BM; Johnson, JM; Carter, LP; Baker, D; Lima, CD; Bahl, CD				Lau, Yue-Ting K.; Baytshtok, Vladimir; Howard, Tessa A.; Fiala, Brooke M.; Johnson, JayLee M.; Carter, Lauren P.; Baker, David; Lima, Christopher D.; Bahl, Christopher D.			Discovery and engineering of enhanced SUMO protease enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSION TECHNOLOGY; STRUCTURAL BASIS; SOLUBILITY; COMPLEX; DESIGN; GENOME; SENP2	Small ubiquitin-like modifier (SUMO) is commonly used as a protein fusion domain to facilitate expression and purification of recombinant proteins, and a SUMO-specific protease is then used to remove SUMO from these proteins. Although this protease is highly specific, its limited solubility and stability hamper its utility as an in vitro reagent. Here, we report improved SUMO protease enzymes obtained via two approaches. First, we developed a computational method and used it to re-engineer WT Ulp1 from Saccharomyces cerevisiae to improve protein solubility. Second, we discovered an improved SUMO protease via genomic mining of the thermophilic fungus Chaetomium thermophilum, as proteins from thermophilic organisms are commonly employed as reagent enzymes. Following expression in Escherichia coli, we found that these re-engineered enzymes can be more thermostable and up to 12 times more soluble, all while retaining WT-or-better levels of SUMO protease activity. The computational method we developed to design solubility-enhancing substitutions is based on the RosettaScripts application for the macromolecular modeling suite Rosetta, and it is broadly applicable for the improvement of solution properties of other proteins. Moreover, we determined the X-ray crystal structure of a SUMO protease from C. thermophilum to 1.44 A resolution. This structure revealed that this enzyme exhibits structural and functional conservation with the S. cerevisiae SUMO protease, despite exhibiting only 28% sequence identity. In summary, by re-engineering the Ulp1 protease and discovering a SUMO protease from C. thermophilum, we have obtained proteases that are more soluble, more thermostable, and more efficient than the current commercially available Ulp1 enzyme.	[Lau, Yue-Ting K.; Howard, Tessa A.; Fiala, Brooke M.; Johnson, JayLee M.; Carter, Lauren P.; Baker, David; Bahl, Christopher D.] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Baker, David; Bahl, Christopher D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Baytshtok, Vladimir; Lima, Christopher D.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA; [Lima, Christopher D.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Howard Hughes Med Inst, New York, NY 10065 USA; [Bahl, Christopher D.] Inst Prot Innovat, Boston, MA 02115 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Bahl, CD (corresponding author), Univ Washington, Inst Prot Design, Seattle, WA 98195 USA.; Bahl, CD (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Bahl, CD (corresponding author), Inst Prot Innovat, Boston, MA 02115 USA.	chris.bahl@proteininnovation.org	Bahl, Christopher D/B-9410-2016	Bahl, Christopher D/0000-0002-3652-3693; Lima, Christopher/0000-0002-9163-6092	National Institutes of Health (NIH), NIGMS [P41 GM103403]; DOE Office of Science [DE-AC02-06CH11357]; NIH-ORIP HEI Grant [S10 RR029205]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118080, R01GM065872, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science(United States Department of Energy (DOE)); NIH-ORIP HEI Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Lance Stewart and Dr. Ruud van Deursen for helpful discussions. Work was based in part upon research conducted at NE-CAT beamlines (National Institutes of Health (NIH), NIGMS, Grant P41 GM103403 and NIH-ORIP HEI Grant S10 RR029205). Beamline research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Bhardwaj G, 2016, NATURE, V538, P329, DOI 10.1038/nature19791; Bock T, 2014, NUCLEIC ACIDS RES, V42, P13525, DOI 10.1093/nar/gku1147; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Clegg Robert M., 1995, Current Opinion in Biotechnology, V6, P103, DOI 10.1016/0958-1669(95)80016-6; DEVORE JL, 1987, PROBABILITY STAT ENG; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Jacak R, 2012, PROTEINS, V80, P825, DOI 10.1002/prot.23241; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kellner N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20937; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kramer RM, 2012, BIOPHYS J, V102, P1907, DOI 10.1016/j.bpj.2012.01.060; Li L, 2013, PROTEIN SCI, V22, P1118, DOI 10.1002/pro.2289; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Lima C. D., 2011, United States of America Patent, Patent No. [7910364B2, 7910364]; Lima CD, 2008, J BIOL CHEM, V283, P32045, DOI 10.1074/jbc.M805655200; Marblestone JG, 2006, PROTEIN SCI, V15, P182, DOI 10.1110/ps.051812706; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MIDDAUGH CR, 1979, J BIOL CHEM, V254, P367; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Raghunathan G, 2013, MOL BIOSYST, V9, P2379, DOI 10.1039/c3mb70068b; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Shen LN, 2006, BIOCHEM J, V397, P279, DOI 10.1042/BJ20052030; Shen LN, 2006, NAT STRUCT MOL BIOL, V13, P1069, DOI 10.1038/nsmb1172	32	13	13	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13224	13233		10.1074/jbc.RA118.004146	http://dx.doi.org/10.1074/jbc.RA118.004146			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29976752	hybrid, Green Published			2022-12-28	WOS:000442730200021
J	Thomas, NE; Wu, C; Morrison, EA; Robinson, AE; Werner, JP; Henzler-Wildman, KA				Thomas, Nathan E.; Wu, Chao; Morrison, Emma A.; Robinson, Anne E.; Werner, Josephine P.; Henzler-Wildman, Katherine A.			The C terminus of the bacterial multidrug transporter EmrE couples drug binding to proton release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL-CHANGES; ESCHERICHIA-COLI; LIGAND-BINDING; PROTEIN; DYNAMICS; SITE; MECHANISMS; ANTIPORTER; PLASTICITY; GLUTAMATE	Ion-coupled transporters must regulate access of ions and substrates into and out of the binding site to actively transport substrates and minimize dissipative leak of ions. Within the single-site alternating access model, competitive substrate binding forms the foundation of ion-coupled antiport. Strict competition between substrates leads to stoichiometric antiport without slippage. However, recent NMR studies of the bacterial multidrug transporter EmrE have demonstrated that this multidrug transporter can simultaneously bind drug and proton, which will affect the transport stoichiometry and efficiency of coupled antiport. Here, we investigated the nature of substrate competition in EmrE using multiple methods to measure proton release upon the addition of saturating concentrations of drug as a function of pH. The resulting proton-release profile confirmed simultaneous binding of drug and proton, but suggested that a residue outside EmrE's Glu-14 binding site may release protons upon drug binding. Using NMR-monitored pH titrations, we trace this drug-induced deprotonation event to His-110, EmrE's C-terminal residue. Further NMR experiments disclosed that the C-terminal tail is strongly coupled to EmrE's drug-binding domain. Consideration of our results alongside those from previous studies of EmrE suggests that this conserved tail participates in secondary gating of EmrE-mediated proton/drug transport, occluding the binding pocket of fully protonated EmrE in the absence of drug to prevent dissipative proton transport.	[Thomas, Nathan E.; Werner, Josephine P.; Henzler-Wildman, Katherine A.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Wu, Chao; Morrison, Emma A.; Robinson, Anne E.; Henzler-Wildman, Katherine A.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Morrison, Emma A.] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Robinson, Anne E.] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA	University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL); University of Iowa; Washington University (WUSTL)	Henzler-Wildman, KA (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	henzlerwildm@wisc.edu	WU, CHAO/J-7119-2019	WU, CHAO/0000-0002-9342-1968; Thomas, Nathan/0000-0003-3221-6060; Morrison, Emma/0000-0001-6722-7961; Henzler-Wildman, Katherine/0000-0002-5295-2121; Robinson, Anne/0000-0003-1641-397X	National Institutes of Health [P41GM103399, S10RR02781, S10RR08438, S10RR023438, S10RR025062, S10RR029220]; University of Wisconsin-Madison; NSF [DMB-8415048, OIA-9977486, BIR-9214394]; United States Department of Agriculture (USDA); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025062, S10RR029220, S10RR002781, P41RR002301, S10RR023438, S10RR008438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, R01GM095839, P41GM103399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Madison; NSF(National Science Foundation (NSF)); United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Geoff Chang for the EmrE expression plasmid. This study made use of the National Magnetic Resonance Facility at Madison, which is supported by National Institutes of Health Grant P41GM103399 (NIGMS), old number: P41RR002301. Equipment was purchased with funds from the University of Wisconsin-Madison, the National Institutes of Health (P41GM103399, S10RR02781, S10RR08438, S10RR023438, S10RR025062, S10RR029220), the NSF (DMB-8415048, OIA-9977486, BIR-9214394), and the United States Department of Agriculture (USDA).	Adam Y, 2007, P NATL ACAD SCI USA, V104, P17989, DOI 10.1073/pnas.0704425104; Amadi ST, 2010, J BIOL CHEM, V285, P26710, DOI 10.1074/jbc.M110.132621; Armstrong KM, 2007, BIOPHYS J, V93, P597, DOI 10.1529/biophysj.107.104570; Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1; Bazzone A, 2017, BIOPHYS J, V113, P2736, DOI 10.1016/j.bpj.2017.09.038; Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; Brill S, 2015, J MOL BIOL, V427, P468, DOI 10.1016/j.jmb.2014.11.015; Brill S, 2012, P NATL ACAD SCI USA, V109, P16894, DOI 10.1073/pnas.1211831109; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Cho MK, 2014, J AM CHEM SOC, V136, P8072, DOI 10.1021/ja503145x; Cymer F, 2015, J MOL BIOL, V427, P999, DOI 10.1016/j.jmb.2014.09.014; Dastvan R, 2016, P NATL ACAD SCI USA, V113, P1220, DOI 10.1073/pnas.1520431113; Drew D, 2016, ANNU REV BIOCHEM, V85, P543, DOI 10.1146/annurev-biochem-060815-014520; Elbaz Y, 2008, J BIOL CHEM, V283, P12276, DOI 10.1074/jbc.M710338200; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Gayen A, 2013, ANGEW CHEM INT EDIT, V52, P10321, DOI 10.1002/anie.201303091; Glaubitz C, 2000, FEBS LETT, V480, P127, DOI 10.1016/S0014-5793(00)01916-5; Goldberg RN, 2002, J PHYS CHEM REF DATA, V31, P231, DOI 10.1063/1.1416902; Korkhov VM, 2008, J MOL BIOL, V377, P1094, DOI 10.1016/j.jmb.2008.01.056; Kozlov AG, 2000, PROTEINS, P8; Lloris-Garcera P, 2014, J MOL BIOL, V426, P2246, DOI 10.1016/j.jmb.2014.03.012; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; Morrison EA, 2015, J GEN PHYSIOL, V146, P445, DOI 10.1085/jgp.201511404; Morrison EA, 2014, J BIOL CHEM, V289, P6825, DOI 10.1074/jbc.M113.535328; Morrison EA, 2012, BBA-BIOMEMBRANES, V1818, P814, DOI 10.1016/j.bbamem.2011.12.020; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Ninio S, 2001, J BIOL CHEM, V276, P48250, DOI 10.1074/jbc.M108231200; PELTON JG, 1993, PROTEIN SCI, V2, P543; Robinson AE, 2017, P NATL ACAD SCI USA, V114, pE10083, DOI 10.1073/pnas.1708671114; Rotem D, 2004, J BIOL CHEM, V279, P48787, DOI 10.1074/jbc.M408187200; Schuldiner S, 2001, NEWS PHYSIOL SCI, V16, P130; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Soskine M, 2004, J BIOL CHEM, V279, P9951, DOI 10.1074/jbc.M312853200; Tate CG, 2003, J MOL BIOL, V332, P229, DOI 10.1016/S0022-2836(03)00895-7; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Yerushalmi H, 2000, FEBS LETT, V476, P93, DOI 10.1016/S0014-5793(00)01677-X; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Zomot E, 2018, J MOL BIOL, V430, P1368, DOI 10.1016/j.jmb.2018.02.026	44	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19137	19147		10.1074/jbc.RA118.005430	http://dx.doi.org/10.1074/jbc.RA118.005430			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30287687	hybrid, Green Published			2022-12-28	WOS:000458467400026
J	Sepuru, KM; Nagarajan, B; Desai, UR; Rajarathnam, K				Sepuru, Krishna Mohan; Nagarajan, Balaji; Desai, Umesh R.; Rajarathnam, Krishna			Structural basis, stoichiometry, and thermodynamics of binding of the chemokines KC and MIP2 to the glycosaminoglycan heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosaminoglycan; nuclear magnetic resonance (NMR); isothermal titration calorimetry (ITC); molecular dynamics; heparin; chemokine	MACROPHAGE INFLAMMATORY PROTEIN-2; SOLUTION NMR CHARACTERIZATION; NEUTROPHIL RECRUITMENT; MOLECULAR-BASIS; GENERALIZED BORN; CXC-CHEMOKINES; DIMER BINDING; HOST-DEFENSE; RECEPTOR; LIGAND	Keratinocyte-derived chemokine (KC or mCXCL1) and macrophage inflammatory protein 2 (MIP2 or mCXCL2) play nonredundant roles in trafficking blood neutrophils to sites of infection and injury. The functional responses of KC and MIP2 are intimately coupled to their interactions with glycosaminoglycans (GAGs). GAG interactions orchestrate chemokine concentration gradients and modulate receptor activity, which together regulate neutrophil trafficking. Here, using NMR, molecular dynamics (MD) simulations, and isothermal titration calorimetry (ITC), we characterized the molecular basis of KC and MIP2 binding to the GAG heparin. Both chemokines reversibly exist as monomers and dimers, and the NMR analysis indicates that the dimer binds heparin with higher affinity. The ITC experiments indicate a stoichiometry of two GAGs per KC or MIP2 dimer and that the enthalpic and entropic contributions vary significantly between the two chemokine-heparin complexes. NMR-based structural models of heparin-KC and heparin-MIP2 complexes reveal that different combinations of residues from the N-loop, 40s turn, (3)-strand, and C-terminal helix form a binding surface within a monomer and that both conserved residues and residues unique to a particular chemokine mediate the binding interactions. MD simulations indicate significant residue-specific differences in their contribution to binding and affinity for a given chemokine and between chemokines. On the basis of our observations that KC and MIP2 bind to GAG via distinct molecular interactions, we propose that the differences in these GAG interactions lead to differences in neutrophil recruitment and play nonoverlapping roles in resolution of inflammation.	[Sepuru, Krishna Mohan; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Rajarathnam, Krishna] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Sepuru, Krishna Mohan; Rajarathnam, Krishna] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Nagarajan, Balaji; Desai, Umesh R.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23219 USA; [Nagarajan, Balaji; Desai, Umesh R.] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery & Dev, Richmond, VA 23219 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Virginia Commonwealth University; Virginia Commonwealth University	Rajarathnam, K (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	krrajara@utmb.edu	Sepuru, Krishna Mohan/K-5321-2014	Sepuru, Krishna Mohan/0000-0002-3675-6294	Sealy and Smith Foundation; Sealy Center for Structural Biology and Molecular Biophysics at the University of Texas Medical Branch at Galveston; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI124681] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023576] Funding Source: NIH RePORTER	Sealy and Smith Foundation; Sealy Center for Structural Biology and Molecular Biophysics at the University of Texas Medical Branch at Galveston; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Wang and Dr. Holthauzen for technical support, Emily Lowry and Brigith Penaranda for protein purification, and Dr. Heather Lander for editorial assistance. We also acknowledge the DSealy Center for Structural Biology and Molecular Biophysics at the University of Texas Medical Branch at Galveston for providing research resources. The Sealy Center for Structural Biology and Molecular Biophysics was supported by a Sealy and Smith Foundation grant.	Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Brown AJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01248; Call DR, 2001, SHOCK, V15, P278, DOI 10.1097/00024382-200115040-00005; Case DA, 2014, AMBER 14; Craciun FL, 2010, J IMMUNOL, V185, P6930, DOI 10.4049/jimmunol.1002300; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dutta AK, 2015, METHODS MOL BIOL, V1229, P315, DOI 10.1007/978-1-4939-1714-3_25; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Gandhi NS, 2009, GLYCOBIOLOGY, V19, P1103, DOI 10.1093/glycob/cwp101; Gangavarapu P, 2012, J LEUKOCYTE BIOL, V91, P259, DOI 10.1189/jlb.0511239; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Jin LL, 2014, J IMMUNOL, V193, P3549, DOI 10.4049/jimmunol.1401138; Johnson DJD, 2010, P NATL ACAD SCI USA, V107, P645, DOI 10.1073/pnas.0910144107; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joseph PRB, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170168; Joseph PRB, 2015, BIOCHEM J, V472, P121, DOI 10.1042/BJ20150059; Joseph PRB, 2015, PROTEIN SCI, V24, P81, DOI 10.1002/pro.2590; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Ladbury JE, 2010, NAT REV DRUG DISCOV, V9, P23, DOI 10.1038/nrd3054; LEE J, 1995, J IMMUNOL, V155, P2158; Li LY, 2012, MOL BIOSYST, V8, P1613, DOI 10.1039/c2mb25021g; Luscinskas FW, 2013, BLOOD, V122, P3708, DOI 10.1182/blood-2013-10-531905; Marki A, 2015, J LEUKOCYTE BIOL, V98, P503, DOI 10.1189/jlb.3MR0115-011R; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; Meneghetti MCZ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0589; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Monneau Y, 2016, J LEUKOCYTE BIOL, V99, P935, DOI 10.1189/jlb.3MR0915-440R; Monneau YR, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170133; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; Ojala WH, 1996, J AM CHEM SOC, V118, P2131, DOI 10.1021/ja951121f; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Panitz N, 2016, GLYCOBIOLOGY, V26, P1209, DOI 10.1093/glycob/cww059; Poluri KM, 2013, J BIOL CHEM, V288, P25143, DOI 10.1074/jbc.M113.492579; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Rajarathnam K, 2018, J HISTOCHEM CYTOCHEM, V66, P229, DOI 10.1369/0022155417739864; Rajasekaran D, 2012, BIOCHEMISTRY-US, V51, P5642, DOI 10.1021/bi3001566; Ravindran A, 2013, J BIOL CHEM, V288, P12244, DOI 10.1074/jbc.M112.443762; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Samsonov SA, 2011, J COMPUT AID MOL DES, V25, P477, DOI 10.1007/s10822-011-9433-1; Sankaranarayanan NV, 2018, CURR OPIN STRUC BIOL, V50, P91, DOI 10.1016/j.sbi.2017.12.004; Sarkar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141127; Sawant KV, 2016, SCI REP-UK, V6, DOI 10.1038/srep33123; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sepuru KM, 2016, J BIOL CHEM, V291, P20539, DOI 10.1074/jbc.M116.745265; Sepuru KM, 2016, J BIOL CHEM, V291, P4247, DOI 10.1074/jbc.M115.697888; Sepuru KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093228; Severin IC, 2010, J BIOL CHEM, V285, P17713, DOI 10.1074/jbc.M109.082552; Shao WP, 1998, BIOCHEMISTRY-US, V37, P8303, DOI 10.1021/bi980112r; Shea-Donohue T, 2008, INNATE IMMUN-LONDON, V14, P117, DOI 10.1177/1753425908088724; Tanino Y, 2010, J IMMUNOL, V184, P2677, DOI 10.4049/jimmunol.0903274; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Ziarek JJ, 2013, J BIOL CHEM, V288, P737, DOI 10.1074/jbc.M112.394064; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zwijnenburg PJG, 2003, IMMUNOL LETT, V85, P1, DOI 10.1016/S0165-2478(02)00200-6	63	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17817	17828		10.1074/jbc.RA118.004866	http://dx.doi.org/10.1074/jbc.RA118.004866			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30257866	Green Published, hybrid			2022-12-28	WOS:000450409500013
J	Kilian, N; Choi, JY; Voelker, DR; Ben Mamoun, C				Kilian, Nicole; Choi, Jae-Yeon; Voelker, Dennis R.; Ben Mamoun, Choukri			Role of phospholipid synthesis in the development and differentiation of malaria parasites in the blood	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						malaria; plasmodium; phospholipid metabolism; development; differentiation	FALCIPARUM-INFECTED ERYTHROCYTES; P-TYPE ATPASES; PLASMODIUM-FALCIPARUM; PHOSPHATIDYLSERINE-DECARBOXYLASE; PHOSPHOETHANOLAMINE-METHYLTRANSFERASE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; LIPID-METABOLISM; MEMBRANE PHOSPHATIDYLSERINE; ANTIMALARIAL ACTIVITY	The life cycle of malaria parasites in both their mammalian host and mosquito vector consists of multiple developmental stages that ensure proper replication and progeny survival. The transition between these stages is fueled by nutrients scavenged from the host and fed into specialized metabolic pathways of the parasite. One such pathway is used by Plasmodium falciparum, which causes the most severe form of human malaria, to synthesize its major phospholipids, phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine. Much is known about the enzymes involved in the synthesis of these phospholipids, and recent advances in genetic engineering, single-cell RNA-Seq analyses, and drug screening have provided new perspectives on the importance of some of these enzymes in parasite development and sexual differentiation and have identified targets for the development of new antimalarial drugs. This Minireview focuses on two phospholipid biosynthesis enzymes of P. falciparum that catalyze phosphoethanolamine transmethylation (PfPMT) and phosphatidylserine decarboxylation (PfPSD) during the blood stages of the parasite. We also discuss our current understanding of the biochemical, structural, and biological functions of these enzymes and highlight efforts to use them as antimalarial drug targets.	[Kilian, Nicole; Ben Mamoun, Choukri] Yale Sch Med, Sect Infect Dis, Dept Internal Med, New Haven, CT 06520 USA; [Choi, Jae-Yeon; Voelker, Dennis R.] Natl Jewish Hlth, Basic Sci Sect, Dept Med, Denver, CO 80206 USA	Yale University; National Jewish Health	Ben Mamoun, C (corresponding author), Yale Sch Med, Sect Infect Dis, Dept Internal Med, New Haven, CT 06520 USA.	choukri.benmamoun@yale.edu		Kilian, Nicole/0000-0001-7489-9782	National Institutes of Health [AI097218, GM104485, GM110506, AI123321, R43AI136118]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097218, R43AI136118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grants AI097218 and GM104485.; Supported by National Institutes of Health Grants AI097218, GM110506, AI123321, and R43AI136118. To whom correspondence should be addressed: Dept. of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT 06520. Tel.: 203-737-1972; E-mail: choukri.benmamoun@yale.edu.	Alberge B, 2010, BIOCHEM J, V425, P149, DOI 10.1042/BJ20091119; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Bartoloni A, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.026; Bechtsi DP, 2017, INT J PARASITOL, V47, P425, DOI 10.1016/j.ijpara.2017.03.002; Ben Mamoun C, 2010, DRUG DEVELOP RES, V71, P44, DOI 10.1002/ddr.20347; Bezsonova I, 2013, BIOMOL NMR ASSIGN, V7, P17, DOI 10.1007/s12104-012-9372-3; Biagini GA, 2004, BLOOD, V104, P3372, DOI 10.1182/blood-2004-03-1084; Blasco B, 2017, NAT MED, V23, P917, DOI 10.1038/nm.4381; Bobenchik AM, 2013, P NATL ACAD SCI USA, V110, P18262, DOI 10.1073/pnas.1313965110; Bobenchik AM, 2011, FEMS MICROBIOL REV, V35, P609, DOI 10.1111/j.1574-6976.2011.00267.x; Bobenchik AM, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-4; Brancucci NMB, 2017, CELL, V171, P1532, DOI 10.1016/j.cell.2017.10.020; Burda PC, 2017, MBIO, V8, DOI [10.1128/mBio.00139-17, 10.1128/mbio.00139-17]; Calderaro A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-321; Calzada E, 2016, INT REV CEL MOL BIO, V321, P29, DOI 10.1016/bs.ircmb.2015.10.001; Choi JY, 2018, J BIOL CHEM, V293, P1493, DOI 10.1074/jbc.RA117.000525; Choi JY, 2016, MOL MICROBIOL, V99, P999, DOI 10.1111/mmi.13280; Choi JY, 2015, J BIOL CHEM, V290, P10972, DOI 10.1074/jbc.M115.642413; Choi JY, 2012, J BIOL CHEM, V287, P222, DOI 10.1074/jbc.M111.313676; Choubey V, 2007, ANTIMICROB AGENTS CH, V51, P696, DOI 10.1128/AAC.00919-06; Cooke M, 2017, MOL CARCINOGEN, V56, P1531, DOI 10.1002/mc.22617; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Cyrklaff M, 2011, SCIENCE, V334, P1283, DOI 10.1126/science.1213775; Dechamps S, 2010, J LIPID RES, V51, P81, DOI 10.1194/jlr.M900166-JLR200; Dembo EG, 2006, AM J TROP MED HYG, V74, P730, DOI 10.4269/ajtmh.2006.74.730; Draper SJ, 2018, CELL HOST MICROBE, V24, P43, DOI 10.1016/j.chom.2018.06.008; Eda S, 2002, CELL PHYSIOL BIOCHEM, V12, P373, DOI 10.1159/000067908; Elabbadi N, 1997, BIOCHEM J, V324, P435, DOI 10.1042/bj3240435; ELABBADI N, 1992, ANTIMICROB AGENTS CH, V36, P50, DOI 10.1128/AAC.36.1.50; Emoto K, 2005, J BIOL CHEM, V280, P37901, DOI 10.1074/jbc.M504282200; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; Farine L, 2015, SCI REP-UK, V5, DOI 10.1038/srep16787; Filarsky M, 2018, SCIENCE, V359, P1259, DOI 10.1126/science.aan6042; Flammersfeld A, 2018, INT J MED MICROBIOL, V308, P129, DOI 10.1016/j.ijmm.2017.09.015; Freikman I, 2011, BBA-BIOMEMBRANES, V1808, P2773, DOI 10.1016/j.bbamem.2011.08.014; Gardiner DL, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.01.23; Garg A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09064; Gealt M A, 1989, Curr Top Med Mycol, V3, P218; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Gonzalez-Bulnes P, 2011, J BIOL CHEM, V286, P28940, DOI 10.1074/jbc.M111.268946; Gruring C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1169; Gulati S, 2015, CELL HOST MICROBE, V18, P371, DOI 10.1016/j.chom.2015.08.003; Gupta N, 2005, J BIOL CHEM, V280, P16345, DOI 10.1074/jbc.M501523200; Hanada K, 2002, J EXP MED, V195, P23, DOI 10.1084/jem.20010724; Itoe MA, 2014, CELL HOST MICROBE, V16, P778, DOI 10.1016/j.chom.2014.11.006; Jensen MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17742-y; Kantele A, 2011, CLIN INFECT DIS, V52, P1356, DOI 10.1093/cid/cir180; Kilian N, 2015, BIOL OPEN, V4, P400, DOI 10.1242/bio.201410942; Kwon Y, 2012, INT J MOL SCI, V13, P3176, DOI 10.3390/ijms13033176; Lakshmanan V, 2012, J INFECT DIS, V206, P238, DOI 10.1093/infdis/jis339; Le Roch KG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-513; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lee SG, 2012, J BIOL CHEM, V287, P1426, DOI 10.1074/jbc.M111.315267; Lentz BR, 2003, PROG LIPID RES, V42, P423, DOI 10.1016/S0163-7827(03)00025-0; LI QX, 1988, J BIOL CHEM, V263, P11516; Llinas M, 2017, CELL, V171, P1474, DOI 10.1016/j.cell.2017.11.044; Lutz HU, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00387; Mamoun CB, 2001, MOL MICROBIOL, V39, P26, DOI 10.1046/j.1365-2958.2001.02222.x; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; Mitamura T, 2003, MICROBES INFECT, V5, P545, DOI 10.1016/S1286-4579(03)00070-4; Mohammadi AS, 2018, ANAL CHEM, V90, P8509, DOI 10.1021/acs.analchem.8b01395; Muema JM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2122-8; Nara F, 1999, J ANTIBIOT, V52, P525, DOI 10.7164/antibiotics.52.525; Orikiiriza J, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-017-1174-2; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Pessi G, 2006, FUTURE LIPIDOL, V1, P173, DOI 10.2217/17460875.1.2.173; Phillips MA, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.50; Ramakrishnan S, 2013, PROG LIPID RES, V52, P488, DOI 10.1016/j.plipres.2013.06.003; Reynolds JM, 2008, J BIOL CHEM, V283, P7894, DOI 10.1074/jbc.M709869200; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2009, BBA-MOL CELL BIOL L, V1791, P620, DOI 10.1016/j.bbalip.2009.02.013; Santos JM, 2017, ELIFE, V6, DOI [10.7554/elife.24109, 10.7554/eLife.24109]; SATRE M, 1978, J BIOL CHEM, V253, P479; Schuler MH, 2015, J BIOL CHEM, V290, P26523, DOI 10.1074/jbc.M115.687921; Serran-Aguilera L, 2016, SCI REP-UK, V6, DOI 10.1038/srep33189; Shretta R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1635-5; Sinnis P, 2012, SEMIN IMMUNOPATHOL, V34, P787, DOI 10.1007/s00281-012-0345-5; Smith TK, 2010, MOL BIOCHEM PARASIT, V172, P66, DOI 10.1016/j.molbiopara.2010.04.001; Spycher C, 2006, MOL CELL BIOL, V26, P4074, DOI 10.1128/MCB.00095-06; Srivastava A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006094; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Tuteja R, 2007, FEBS J, V274, P4670, DOI 10.1111/j.1742-4658.2007.05997.x; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Van Voorhis WC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005763; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111; Vial Henri J., 1992, V18, P259; Wein S, 2018, J LIPID RES, V59, P1461, DOI [10.1194/jlr.M085589, 10.1194/jlr.m085589]; WHO, 2017, WORLD MALARIA REPORT; Witola WH, 2006, J BIOL CHEM, V281, P21305, DOI 10.1074/jbc.M603260200; Witola WH, 2008, J BIOL CHEM, V283, P27636, DOI 10.1074/jbc.M804360200; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xu K, 2015, P NATL ACAD SCI USA, V112, pE1782, DOI 10.1073/pnas.1418971112	100	14	15	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17308	17316		10.1074/jbc.R118.003213	http://dx.doi.org/10.1074/jbc.R118.003213			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30287688	hybrid, Green Published			2022-12-28	WOS:000449799000001
J	Shiozaki, Y; Okamura, K; Kohno, S; Keenan, AL; Williams, K; Zhao, XY; Chick, WS; Miyazaki-Anzai, S; Miyazaki, M				Shiozaki, Yuji; Okamura, Kayo; Kohno, Shohei; Keenan, Audrey L.; Williams, Kristina; Zhao, Xiaoyun; Chick, Wallace S.; Miyazaki-Anzai, Shinobu; Miyazaki, Makoto			The CDK9-cyclin T1 complex mediates saturated fatty acid-induced vascular calcification by inducing expression of the transcription factor CHOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); vascular smooth muscle cells; fatty acid; cyclin-dependent kinase (CDK); vascular biology; CDK9; CHOP; ER stress; saturated fatty acids; vascular calcification; kidney disease; renal dysfunction; atherosclerosis; cardiovascular disease	ENDOPLASMIC-RETICULUM STRESS; RNA-POLYMERASE-II; CHRONIC KIDNEY-DISEASE; P-TEFB; SMOOTH-MUSCLE; GENE-EXPRESSION; IN-VITRO; ARTERIAL CALCIFICATION; CELL-DIFFERENTIATION; MAMMALIAN TARGET	Vascular calcification (or mineralization) is a common complication of chronic kidney disease (CKD) and is closely associated with increased mortality and morbidity rates. We recently reported that activation of the activating transcription factor 4 (ATF4) pathway through the saturated fatty acid (SFA)-induced endoplasmic reticulum (ER) stress response plays a causative role in CKD-associated vascular calcification. Here, using mouse models of CKD, we 1) studied the contribution of the proapoptotic transcription factor CCAAT enhancer-binding protein homologous protein (CHOP) to CKD-dependent medial calcification, and 2) we identified an additional regulator of ER stress-mediated CHOP expression. Transgenic mice having smooth muscle cell (SMC)-specific CHOP expression developed severe vascular apoptosis and medial calcification under CKD. Screening of a protein kinase inhibitor library identified 16 compounds, including seven cyclin-dependent kinase (CDK) inhibitors, that significantly suppressed CHOP induction during ER stress. Moreover, selective CDK9 inhibitors and CRISPR/Cas9-mediated CDK9 reduction blocked SFA-mediated induction of CHOP expression, whereas inhibitors of other CDK isoforms did not. Cyclin T1 knockout inhibited SFA-mediated induction of CHOP and mineralization, whereas deletion of cyclin T2 and cyclin K promoted CHOP expression levels and mineralization. Of note, the CDK9-cyclin T1 complex directly phosphorylated and activated ATF4. These results demonstrate that the CDK9-cyclin T1 and CDK9-cyclin T2/K complexes have opposing roles in CHOP expression and CKD-induced vascular calcification. They further reveal that the CDK9-cyclin T1 complex mediates vascular calcification through CHOP induction and phosphorylation-mediated ATF4 activation.	[Shiozaki, Yuji; Okamura, Kayo; Kohno, Shohei; Keenan, Audrey L.; Miyazaki-Anzai, Shinobu; Miyazaki, Makoto] Univ Colorado Denver, Dept Med, Div Renal Dis & Hypertens, Aurora, CO 80045 USA; [Williams, Kristina; Zhao, Xiaoyun; Chick, Wallace S.] Univ Colorado Denver, Dept Cell & Dev Biol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Miyazaki, M (corresponding author), Univ Colorado Denver, Dept Med, Div Renal Dis & Hypertens, Aurora, CO 80045 USA.	makoto.miyazaki@ucdenver.edu	Kohno, Shohei/Z-2926-2019	Kohno, Shohei/0000-0002-7846-6527	NHLBI NIH HHS [R01 HL117062, R01 HL132318, R01 HL133545] Funding Source: Medline; NIDDK NIH HHS [R01 DK096030] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117062, R01HL133545, R01HL132318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096030] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Cai ZJ, 2013, ARTERIOSCL THROM VAS, V33, P2345, DOI 10.1161/ATVBAHA.112.300226; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Cheung KL, 2017, MOL CELL, V65, P1068, DOI 10.1016/j.molcel.2016.12.022; de Azevedo WF, 2002, BIOCHEM BIOPH RES CO, V293, P566; De Falco G, 2008, J CELL PHYSIOL, V215, P276, DOI 10.1002/jcp.21311; Demer LL, 2014, ARTERIOSCL THROM VAS, V34, P715, DOI 10.1161/ATVBAHA.113.302070; Duan XH, 2009, BIOCHEM BIOPH RES CO, V387, P694, DOI 10.1016/j.bbrc.2009.07.085; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Elagib KE, 2008, BLOOD, V112, P4884, DOI 10.1182/blood-2008-03-145722; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Garriga J, 2003, MOL CELL BIOL, V23, P5165, DOI 10.1128/MCB.23.15.5165-5173.2003; Giacinti C, 2006, J CELL PHYSIOL, V206, P807, DOI 10.1002/jcp.20523; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Kaichi S, 2011, J CELL PHYSIOL, V226, P248, DOI 10.1002/jcp.22336; Leucci E, 2007, J CELL PHYSIOL, V212, P411, DOI 10.1002/jcp.21032; Liberman M, 2011, BIOCHEM BIOPH RES CO, V413, P436, DOI 10.1016/j.bbrc.2011.08.114; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Lin X, 2002, J BIOL CHEM, V277, P16873, DOI 10.1074/jbc.M200117200; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Masuda M, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88646; Masuda M, 2015, J CLIN INVEST, V125, P4544, DOI 10.1172/JCI82871; Masuda M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000238; Masuda M, 2012, J LIPID RES, V53, P1543, DOI 10.1194/jlr.M025981; Miyazaki-Anzai S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000949; Miyazaki-Anzai S, 2010, CIRC RES, V106, P1807, DOI 10.1161/CIRCRESAHA.109.212969; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Napolitano G, 1999, AIDS, V13, P1453, DOI 10.1097/00002030-199908200-00003; Nelson PJ, 2003, J ANTIMICROB CHEMOTH, V51, P921, DOI 10.1093/jac/dkg175; New SEP, 2011, CIRC J, V75, P1305, DOI 10.1253/circj.CJ-11-0395; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Price EP, 2007, APPL ENVIRON MICROB, V73, P3431, DOI 10.1128/AEM.02702-06; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Romano G, 2008, CELL CYCLE, V7, P3664, DOI 10.4161/cc.7.23.7122; Ruef J, 1999, CIRCULATION, V100, P659, DOI 10.1161/01.CIR.100.6.659; Shan JX, 2016, NUCLEIC ACIDS RES, V44, P9719, DOI 10.1093/nar/gkw667; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Shao JS, 2007, ANN NY ACAD SCI, V1117, P40, DOI 10.1196/annals.1402.075; Simone C, 2002, ONCOGENE, V21, P4137, DOI 10.1038/sj.onc.1205493; Sowa H., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P326; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Tintut Y, 2002, CIRCULATION, V105, P650, DOI 10.1161/hc0502.102969; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Zhan JK, 2014, CAN J CARDIOL, V30, P568, DOI 10.1016/j.cjca.2013.11.005; Zhao Y, 2015, KIDNEY INT, V88, P711, DOI 10.1038/ki.2015.160; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	57	18	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17008	17020		10.1074/jbc.RA118.004706	http://dx.doi.org/10.1074/jbc.RA118.004706			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30209133	Green Published, hybrid			2022-12-28	WOS:000449466500005
J	Aubol, BE; Serrano, P; Fattet, L; Wuthrich, K; Adams, JA				Aubol, Brandon E.; Serrano, Pedro; Fattet, Laurent; Wuethrich, Kurt; Adams, Joseph A.			Molecular interactions connecting the function of the serine-arginine-rich protein SRSF1 to protein phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphorylation; phosphatase; protein kinase; enzyme kinetics; enzyme mutation	SPLICING FACTOR ASF/SF2; RNA RECOGNITION MOTIF; SR PROTEINS; BACKBONE ASSIGNMENT; CATALYTIC SUBUNIT; SITE SELECTION; RS DOMAIN; APSY-NMR; PHOSPHORYLATION; KINASES	Splicing generates many mRNA strands from a single precursor mRNA, expanding the proteome and enhancing intracellular diversity. Both initial assembly and activation of the spliceosome require an essential family of splicing factors called serine-arginine (SR) proteins. Protein phosphatase 1 (PP1) regulates the SR proteins by controlling phosphorylation of a C-terminal arginine-serine-rich (RS) domain. These modifications are vital for the subcellular localization and mRNA splicing function of the SR protein. Although PP1 has been shown to dephosphorylate the prototype SR protein splicing factor 1 (SRSF1), the molecular nature of this interaction is not understood. Here, using NMR spectroscopy, we identified two electrostatic residues in helix 2 and a hydrophobic residue in helix 1 in the RNA recognition motif 1 (RRM1) of SRSF1 that constitute a binding surface for PP1. Substitution of these residues dissociated SRSF1 from PP1 and enhanced phosphatase activity, reducing phosphorylation in the RS domain. These effects lead to shifts in alternative splicing patterns that parallel increases in SRSF1 diffusion from speckles to the nucleoplasm brought on by regiospecific decreases in RS domain phosphorylation. Overall, these findings establish a molecular and biological connection between PP1-targeted amino acids in an RRM with the phosphorylation state and mRNA-processing function of an SR protein.	[Aubol, Brandon E.; Fattet, Laurent; Adams, Joseph A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Serrano, Pedro; Wuethrich, Kurt] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Wuethrich, Kurt] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Wuethrich, Kurt] Scripps Res Inst, Struct Biol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Adams, JA (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	j2adams@ucsd.edu	FATTET, Laurent/W-8392-2019; Fattet, Laurent/ABH-5434-2020	Fattet, Laurent/0000-0001-5152-4937; Wuthrich, Kurt/0000-0001-8739-6965	National Institutes of Health [GM67969, GM98528]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067969, R01GM098528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM67969 and GM98528. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aubol BE, 2003, P NATL ACAD SCI USA, V100, P12601, DOI 10.1073/pnas.1635129100; Aubol BE, 2018, BIOCHEM J, V475, P677, DOI 10.1042/BCJ20170672; Aubol BE, 2017, J MOL BIOL, V429, P2178, DOI 10.1016/j.jmb.2017.05.022; Aubol BE, 2014, BIOCHEM J, V462, P143, DOI 10.1042/BJ20140494; Aubol BE, 2011, BIOCHEMISTRY-US, V50, P6888, DOI 10.1021/bi2007993; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Cho SY, 2011, P NATL ACAD SCI USA, V108, P8233, DOI 10.1073/pnas.1017700108; Clery A, 2013, P NATL ACAD SCI USA, V110, pE2802, DOI 10.1073/pnas.1303445110; Dauksaite V, 2004, BIOCHEM J, V381, P343, DOI 10.1042/BJ20040408; Duncan PI, 1998, EXP CELL RES, V241, P300, DOI 10.1006/excr.1998.4083; Dutta SK, 2015, J BIOMOL NMR, V61, P47, DOI 10.1007/s10858-014-9881-8; ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993; Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x; Gibbons JA, 2005, J BIOL CHEM, V280, P15903, DOI 10.1074/jbc.M500871200; Gutfreund H., 1995, KINETICS LIFE SCI RE; Hiller S, 2005, P NATL ACAD SCI USA, V102, P10876, DOI 10.1073/pnas.0504818102; Hiller S, 2008, J BIOMOL NMR, V42, P179, DOI 10.1007/s10858-008-9266-y; Jeong S, 2017, MOL CELLS, V40, P1, DOI 10.14348/molcells.2017.2319; Keshwani MM, 2015, BIOCHEM J, V466, P311, DOI 10.1042/BJ20141373; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Ma CT, 2009, J MOL BIOL, V390, P618, DOI 10.1016/j.jmb.2009.05.060; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Muller S, 1998, J MOL BIOL, V283, P383, DOI 10.1006/jmbi.1998.2078; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; PICKING WD, 1991, BIOCHEMISTRY-US, V30, P10280, DOI 10.1021/bi00106a028; Prasad J, 2003, MOL CELL BIOL, V23, P4139, DOI 10.1128/MCB.23.12.4139-4149.2003; Ragusa MJ, 2010, NAT STRUCT MOL BIOL, V17, P459, DOI 10.1038/nsmb.1786; Sacco-Bubulya P, 2002, J CELL BIOL, V156, P425, DOI 10.1083/jcb.200107017; Serrano P, 2016, J MOL BIOL, V428, P2430, DOI 10.1016/j.jmb.2016.04.009; Stojdl DF, 1999, BIOCHEM CELL BIOL, V77, P293, DOI 10.1139/bcb-77-4-293; Velazquez-Dones A, 2005, J BIOL CHEM, V280, P41761, DOI 10.1074/jbc.M504156200; Volk J, 2008, J BIOMOL NMR, V41, P127, DOI 10.1007/s10858-008-9243-5; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014	37	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16751	16760		10.1074/jbc.RA118.004587	http://dx.doi.org/10.1074/jbc.RA118.004587			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30185622	Green Published, hybrid			2022-12-28	WOS:000448515100017
J	Yadav, R; Scott, EE				Yadav, Rahul; Scott, Emily E.			Endogenous insertion of non-native metalloporphyrins into human membrane cytochrome P450 enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane enzyme; cytochrome P450; heme; metalloenzyme; metalloprotein; nuclear magnetic resonance (NMR); metal; porphyrin; protoporphyrin; membrane protein; metal substitution	ESCHERICHIA-COLI; PROXIMAL LIGAND; HEME-PROTEINS; MYOGLOBIN; IRON; HEMOGLOBIN; RESOLUTION; LIGATION; BINDING; P420	Human cytochrome P450 enzymes are membrane-bound heme-containing monooxygenases. As is the case for many heme-containing enzymes, substitution of the metal in the center of the heme can be useful for mechanistic and structural studies of P450 enzymes. For many heme proteins, the iron protoporphyrin prosthetic group can be extracted and replaced with protoporphyrin containing another metal, but human membrane P450 enzymes are not stable enough for this approach. The method reported herein was developed to endogenously produce human membrane P450 proteins with a nonnative metal in the heme. This approach involved coexpression of the P450 of interest, a heme uptake system, and a chaperone in Escherichia coli growing in iron-depleted minimal medium supplemented with the desired trans-metallated protoporphyrin. Using the steroidogenic P450 enzymes CYP17A1 and CYP21A2 and the drug-metabolizing CYP3A4, we demonstrate that this approach can be used with several human P450 enzymes and several different metals, resulting in fully folded proteins appropriate for mechanistic, functional, and structural studies including solution NMR.	[Yadav, Rahul; Scott, Emily E.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Scott, Emily E.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Scott, EE (corresponding author), Univ Michigan, Dept Med Chem, 428 Church St, Ann Arbor, MI 48105 USA.	scottee@umich.edu	Yadav, Rahul/I-3632-2016	Yadav, Rahul/0000-0002-0958-2882	National Institutes of Health Core Grant [S10RR025512]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM076343] Funding Source: NIH RePORTER	National Institutes of Health Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The pHUG plasmid for the heme uptake system was a generous gift from the laboratory of John Olson (Rice University, Houston, TX). The pGro12 plasmid containing the chaperone groES and groEL genes was a gift from Rita Bernhardt (Saarland University, Saarbrucken, Germany). ICP-MS measurements were taken in the Oregon Health and Science University Elemental Analysis Core with partial support from National Institutes of Health Core Grant S10RR025512. NMR spectra were collected either at the Ohio State University Campus Chemical Instrument Center or the University of Michigan BioNMR Core Laboratory.	Brucker EA, 1996, J BIOL CHEM, V271, P25419, DOI 10.1074/jbc.271.41.25419; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Fehl C, 2018, J MED CHEM, V61, P4946, DOI 10.1021/acs.jmedchem.8b00419; Furukawa Y, 2000, BIOCHEMISTRY-US, V39, P10996, DOI 10.1021/bi000874y; GELB MH, 1982, P NATL ACAD SCI-BIOL, V79, P5758, DOI 10.1073/pnas.79.19.5758; Graves PE, 2008, BBA-PROTEINS PROTEOM, V1784, P1471, DOI 10.1016/j.bbapap.2008.04.012; HOFFMAN BM, 1970, P NATL ACAD SCI USA, V67, P637, DOI 10.1073/pnas.67.2.637; KAZANIS S, 1995, J AM CHEM SOC, V117, P6625, DOI 10.1021/ja00129a040; Key HM, 2016, NATURE, V534, P534, DOI 10.1038/nature17968; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lelyveld VS, 2011, J AM CHEM SOC, V133, P649, DOI 10.1021/ja107936d; Martinis SA, 1996, BIOCHEMISTRY-US, V35, P14530, DOI 10.1021/bi961511u; Matta-Camacho E, 2014, J BIOL CHEM, V289, P20054, DOI 10.1074/jbc.M113.545111; Neya S, 2013, INORG CHEM, V52, P7387, DOI 10.1021/ic400078w; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; Petrunak EM, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.610998; Pinter TBJ, 2012, INORG CHEM, V51, P3743, DOI 10.1021/ic202731g; Sabat J, 2009, J AM CHEM SOC, V131, P12186, DOI 10.1021/ja901016a; Stone KL, 2016, INORGANICS, V4, DOI 10.3390/inorganics4020012; Straub Wesley E, 2013, Methods Mol Biol, V987, P107, DOI 10.1007/978-1-62703-321-3_9; Sun YH, 2013, BIOCHEMISTRY-US, V52, P5941, DOI 10.1021/bi400541v; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; WAGNER GC, 1981, J BIOL CHEM, V256, P6262; WAGNER GC, 1981, J BIOL CHEM, V256, P6266; WELLS AV, 1992, BIOCHEMISTRY-US, V31, P4384, DOI 10.1021/bi00133a002; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200	27	7	6	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16623	16634		10.1074/jbc.RA118.005417	http://dx.doi.org/10.1074/jbc.RA118.005417			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30217815	hybrid, Green Published			2022-12-28	WOS:000448515100007
J	Avanzino, BC; Jue, H; Miller, CM; Cheung, E; Fuchs, G; Fraser, CS				Avanzino, Brian C.; Jue, Helen; Miller, Clare M.; Cheung, Emily; Fuchs, Gabriele; Fraser, Christopher S.			Molecular mechanism of poliovirus Sabin vaccine strain attenuation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						poliovirus; eukaryotic translation initiation factor 4G (eIF4G); eukaryotic initiation factor 4A (eIF4A); RNA-binding protein; eukaryotic translation initiation; plus-stranded RNA virus; internal ribosome entry site (IRES); vaccine; virulence	TRACT-BINDING-PROTEIN; INTERNAL RIBOSOME ENTRY; HUMAN NEUROBLASTOMA; ATPASE ACTIVITIES; NONCODING REGION; HELICASE EIF4A; TRANSLATION; INITIATION; RNA; TYPE-3	Recruitment of poliovirus (PV) RNA to the human ribosome requires the coordinated interaction of the viral internal ribosome entry site (IRES) and several host cellular initiation factors and IRES trans-acting factors (ITAFs). Attenuated PV Sabin strains contain point mutations in the PV IRES domain V (dV) that inhibit viral translation. Remarkably, attenuation is most apparent in cells of the central nervous system, but the molecular basis to explain this is poorly understood. The dV contains binding sites for eukaryotic initiation factor 4G (eIF4G) and polypyrimidine tract-binding protein (PTB). Impaired binding of these proteins to the mutant IRESs has been observed, but these effects have not been quantitated. We used a fluorescence anisotropy assay to reveal that the Sabin mutants reduce the equilibrium dissociation constants of eIF4G and PTB to the PV IRES by up to 6-fold. Using the most inhibitory Sabin 3 mutant, we used a real-time fluorescence helicase assay to show that the apparent affinity of an active eIF4G/4A/4B helicase complex for the IRES is reduced by 2.5-fold. The Sabin 3 mutant did not alter the maximum rate of eIF4A-dependent helicase activity, suggesting that this mutant primarily reduces the affinity, rather than activity, of the unwinding complex. To confirm this affinity model of attenuation, we show that eIF4G overexpression in HeLa cells overcomes the attenuation of a Sabin 3 mutant PV-luciferase replicon. Our study provides a quantitative framework for understanding the mechanism of PV Sabin attenuation and provides an explanation for the previously observed cell type-specific translational attenuation.	[Avanzino, Brian C.; Jue, Helen; Fraser, Christopher S.] Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA; [Miller, Clare M.; Cheung, Emily; Fuchs, Gabriele] SUNY Albany, Dept Biol Sci, RNA Inst, Albany, NY 12222 USA	University of California System; University of California Davis; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Fraser, CS (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA.; Fuchs, G (corresponding author), SUNY Albany, Dept Biol Sci, RNA Inst, Albany, NY 12222 USA.	gfuchs@albany.edu; csfraser@ucdavis.edu		Miller, Clare M/0000-0001-8266-6479; Fuchs, Gabriele/0000-0002-6838-2100	NIGMS; National Institutes of Health [R01GM092927]; American Heart Association; Myocarditis Foundation; University at Albany; State University of New York; University at Albany Faculty Research Awards Program (FRAP); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092927] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Myocarditis Foundation; University at Albany; State University of New York; University at Albany Faculty Research Awards Program (FRAP); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01GM092927 (to C. S. F.), an American Heart Association and Myocarditis Foundation predoctoral fellowship (to B. C. A.), and by startup funds from the University at Albany, State University of New York, and the University at Albany Faculty Research Awards Program (FRAP) (to G. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AGOL VI, 1989, J VIROL, V63, P4034, DOI 10.1128/JVI.63.9.4034-4038.1989; ALMOND JW, 1987, ANNU REV MICROBIOL, V41, P153; Avanzino BC, 2017, P NATL ACAD SCI USA, V114, P9611, DOI 10.1073/pnas.1704390114; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; de Breyne S, 2009, P NATL ACAD SCI USA, V106, P9197, DOI 10.1073/pnas.0900153106; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; Goetz C, 2011, FUTURE VIROL, V6, P1045, DOI 10.2217/FVL.11.76; Guest S, 2004, J VIROL, V78, P11097, DOI 10.1128/JVI.78.20.11097-11107.2004; Gutierrez AL, 1997, J VIROL, V71, P3826; Haller AA, 1996, J VIROL, V70, P1467, DOI 10.1128/JVI.70.3.1467-1474.1996; HELLEN CUT, 1994, J VIROL, V68, P941, DOI 10.1128/JVI.68.2.941-950.1994; HELLEN CUT, 1993, P NATL ACAD SCI USA, V90, P7642, DOI 10.1073/pnas.90.16.7642; Hunt SL, 1999, RNA, V5, P344, DOI 10.1017/S1355838299981414; Kafasla P, 2010, EMBO J, V29, P3710, DOI 10.1038/emboj.2010.231; Kaiser C, 2008, RNA, V14, P2170, DOI 10.1261/rna.1171808; Kauder SE, 2004, J CLIN INVEST, V113, P1743, DOI 10.1172/JCI200421323; KAWAMURA N, 1989, J VIROL, V63, P1302, DOI 10.1128/JVI.63.3.1302-1309.1989; LAMONICA N, 1989, J VIROL, V63, P2357, DOI 10.1128/JVI.63.5.2357-2360.1989; Lillevali K, 2001, MECH DEVELOP, V101, P217, DOI 10.1016/S0925-4773(00)00566-9; Malnou CE, 2004, J BIOL CHEM, V279, P10261, DOI 10.1074/jbc.M307806200; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; MOSS EG, 1989, J VIROL, V63, P1884, DOI 10.1128/JVI.63.5.1884-1890.1989; Ochs K, 2003, J VIROL, V77, P115, DOI 10.1128/JVI.77.1.115-122.2003; Ochs K, 2002, J VIROL, V76, P2113, DOI 10.1128/JVI.76.5.2113-2122.2002; Ozes A, 2014, NAT PROTOC, V9, P1645, DOI 10.1038/nprot.2014.112; Ozes AR, 2011, J MOL BIOL, V412, P674, DOI 10.1016/j.jmb.2011.08.004; Ohka S, 2001, Dev Biol (Basel), V105, P51; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; Racaniello V R, 1988, Adv Virus Res, V34, P217, DOI 10.1016/S0065-3527(08)60519-9; SABIN AB, 1985, J INFECT DIS, V151, P420, DOI 10.1093/infdis/151.3.420; Sokabe M, 2017, P NATL ACAD SCI USA, V114, P6304, DOI 10.1073/pnas.1620426114; Sokabe M, 2014, J BIOL CHEM, V289, P31827, DOI 10.1074/jbc.M114.602870; SVITKIN YV, 1985, VIROLOGY, V147, P243, DOI 10.1016/0042-6822(85)90127-8; SVITKIN YV, 1990, VIROLOGY, V175, P103, DOI 10.1016/0042-6822(90)90190-3; Villa N, 2013, J BIOL CHEM, V288, P32932, DOI 10.1074/jbc.M113.517011; Vogt DA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000936; WESTROP GD, 1989, J VIROL, V63, P1338, DOI 10.1128/JVI.63.3.1338-1344.1989	40	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15471	15482		10.1074/jbc.RA118.004913	http://dx.doi.org/10.1074/jbc.RA118.004913			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30126841	hybrid, Green Published			2022-12-28	WOS:000446549200014
J	Wang, T; Reingruber, J; Woodruff, ML; Majumderil, A; Camarena, A; Artemyev, NO; Fain, GL; Chen, J				Wang, Tian; Reingruber, Juergen; Woodruff, Michael L.; Majumderil, Anurima; Camarena, Andres; Artemyev, Nikolai O.; Fain, Gordon L.; Chen, Jeannie			The PDE6 mutation in the rd10 retinal degeneration mouse model causes protein mislocalization and instability and promotes cell death through increased ion influx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photoreceptor; phosphodiesterases; cyclic GMP (cGMP); retinal degeneration; phototransduction; cell death; protein translocation; protein stability; cGMP-gated channels; missense mutation; PDE6; protein transport; protein mislocalization	ROD CGMP-PHOSPHODIESTERASE; RECESSIVE RETINITIS-PIGMENTOSA; NUCLEOTIDE-GATED CHANNEL; BETA-SUBUNIT; OUTER SEGMENTS; SENSITIVE CONDUCTANCE; PHOTORECEPTOR CELLS; RHODOPSIN KINASE; LIGHT ADAPTATION; RESTORES VISION	The retinal degeneration model rd10 contains a missense mutation of the catalytic PDE6 subunit, which hydrolyzes cGMP in response to light. This model produces cell death more slowly than others caused by PDE6 loss of function, making it of particular interest for studying potential therapeutics. We used morphology, biochemistry, and single-cell physiology to examine the mechanism of rd10 degeneration. Our results show that the mutation produces no alteration of Pde6b RNA but does dramatically decrease maximal and basal PDE6 activity, apparently caused by a decrease in protein stability and transport. The enzymatic properties of the remaining mutant PDE6 appear to be nearly normal. We demonstrate that an increase in free cGMP, which would result from decreased PDE6 activity and serve to increase opening of the cGMP-gated channels and calcium influx, is an underlying cause of cell death: degeneration of rd10/Cngb1(-/-) double mutants is slower than the parent rd10 line. Paradoxically, degeneration in rd10/Cngb1(-/-) is also slower than in Cngb1(-/-). This rescue is correlated with a lowering of cGMP content in Cngb1(-/-) retinas and suggests that it may be caused by mislocalization of active PDE6. Single-cell recordings from rd10 rods show that the rates of rise and decay of the response are significantly slower; simulations indicate that these changes are primarily the result of the decrease in PDE6 concentration and rod collecting area. Together, these results provide insights into the complex mechanisms that underlie rd10-mediated retinal degeneration and a cautionary note for analysis of therapeutic interventions.	[Wang, Tian; Camarena, Andres; Chen, Jeannie] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Wang, Tian; Camarena, Andres; Chen, Jeannie] Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, Los Angeles, CA 90089 USA; [Reingruber, Juergen] Ecole Normale Super, Inst Biol, Grp Computat Biol & Appl Math, F-75005 Paris, France; [Woodruff, Michael L.; Fain, Gordon L.] UCLA, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Majumderil, Anurima; Artemyev, Nikolai O.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Fain, Gordon L.] UCLA, David Geffen Sch Med, Jules Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 90095 USA	University of Southern California; University of Southern California; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of California System; University of California Los Angeles; University of Iowa; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chen, J (corresponding author), 1501 San Pablo St,ZNI Rm 227, Los Angeles, CA 90089 USA.	jeannie@usc.edu	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526; Fain, Gordon/0000-0002-9813-0342; Chen, Jeannie/0000-0002-7904-9629; Artemyev, Nikolai/0000-0002-5266-6854; Reingruber, Juergen/0000-0002-7167-8092	National Institutes of Health [EY01844, EY10843, EY027193, EY027387, EY12155]; NATIONAL EYE INSTITUTE [R01EY027387, R01EY027193, R01EY012155, R01EY001844, R37EY001844, R01EY010843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants EY01844 (to G.L.F.), EY10843 (to N.O.A.), and EY027193, EY027387, and EY12155 (to J.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANANT JS, 1992, J BIOL CHEM, V267, P687; ARSHAVSKY VY, 1992, J BIOL CHEM, V267, P24501; BAEHR W, 1979, J BIOL CHEM, V254, P1669; Barhoum R, 2008, NEUROSCIENCE, V155, P698, DOI 10.1016/j.neuroscience.2008.06.042; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1986, J PHYSIOL-LONDON, V371, P115, DOI 10.1113/jphysiol.1986.sp015964; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Boye SL, 2015, HUM GENE THER, V26, P575, DOI 10.1089/hum.2015.053; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Cheguru P, 2014, J NEUROCHEM, V129, P256, DOI 10.1111/jnc.12501; Chen CK, 2015, J GEN PHYSIOL, V145, P213, DOI 10.1085/jgp.201411273; Chen CK, 2012, J NEUROSCI, V32, P15998, DOI 10.1523/JNEUROSCI.1639-12.2012; Chen CK, 2010, J NEUROSCI, V30, P1213, DOI 10.1523/JNEUROSCI.4353-09.2010; Chen J, 2010, J NEUROSCI, V30, P16232, DOI 10.1523/JNEUROSCI.2868-10.2010; COTE RH, 1993, J BIOL CHEM, V268, P17190; Cronin T, 2012, ADV EXP MED BIOL, V723, P129, DOI 10.1007/978-1-4614-0631-0_18; DANCIGER M, 1995, GENOMICS, V30, P1, DOI 10.1006/geno.1995.0001; Davis RJ, 2008, INVEST OPHTH VIS SCI, V49, P5067, DOI 10.1167/iovs.07-1422; Deng WT, 2013, J NEUROSCI, V33, P11745, DOI 10.1523/JNEUROSCI.1536-13.2013; Dong EH, 2017, MOL VIS, V23, P90; Dryja TP, 1999, INVEST OPHTH VIS SCI, V40, P1859; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; Field GD, 2002, NEURON, V35, P733, DOI 10.1016/S0896-6273(02)00822-X; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Gilliam JC, 2012, CELL, V151, P1029, DOI 10.1016/j.cell.2012.10.038; Goc A, 2010, J MOL BIOL, V401, P363, DOI 10.1016/j.jmb.2010.06.044; HAHN LB, 1994, INVEST OPHTH VIS SCI, V35, P1077; Hamer RD, 2005, VISUAL NEUROSCI, V22, P417, DOI 10.1017/S0952523805224045; Hasegawa T, 2016, JPN J OPHTHALMOL, V60, P111, DOI 10.1007/s10384-015-0422-0; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; HURLEY JB, 1981, BIOCHIM BIOPHYS ACTA, V675, P359, DOI 10.1016/0304-4165(81)90026-X; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Koch S, 2012, HUM MOL GENET, V21, P4486, DOI 10.1093/hmg/dds290; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Liu XQ, 2004, P NATL ACAD SCI USA, V101, P13903, DOI 10.1073/pnas.0405160101; Makino CL, 2006, INVEST OPHTH VIS SCI, V47, P2185, DOI 10.1167/iovs.05-1341; Muradov H, 2012, VISION RES, V57, P1, DOI 10.1016/j.visres.2012.01.017; Naarendorp F, 2010, J NEUROSCI, V30, P12495, DOI 10.1523/JNEUROSCI.2186-10.2010; Nikonov S, 2000, J GEN PHYSIOL, V116, P795, DOI 10.1085/jgp.116.6.795; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Nymark S, 2012, J PHYSIOL-LONDON, V590, P2353, DOI 10.1113/jphysiol.2012.228627; Paquet-Durand F, 2011, HUM MOL GENET, V20, P941, DOI 10.1093/hmg/ddq539; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Reingruber J, 2013, P NATL ACAD SCI USA, V110, P19378, DOI 10.1073/pnas.1314030110; Rex TS, 2004, MOL THER, V10, P855, DOI 10.1016/j.ymthe.2004.07.027; Schnetkamp PPM, 2014, CURR TOP MEMBR, V73, P263, DOI 10.1016/B978-0-12-800223-0.00007-4; Scholl HPN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2838; Strettoi E, 2010, P NATL ACAD SCI USA, V107, P18706, DOI 10.1073/pnas.1007644107; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; Vinberg F, 2017, ELIFE, V6, DOI 10.7554/eLife.24550; Wang T, 2017, HUM MOL GENET, V26, P2299, DOI 10.1093/hmg/ddx121; Wang T, 2014, J BIOL CHEM, V289, P29310, DOI 10.1074/jbc.M114.595207; Warren R, 2002, ADV EXP MED BIOL, V514, P205; Wert KJ, 2014, DEV OPHTHALMOL, V53, P33, DOI 10.1159/000357294; Zhang Y, 2009, J CELL SCI, V122, P1192, DOI 10.1242/jcs.042531; ZIMMERMAN AL, 1986, NATURE, V321, P70, DOI 10.1038/321070a0	62	26	26	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15332	15346		10.1074/jbc.RA118.004459	http://dx.doi.org/10.1074/jbc.RA118.004459			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30126843	hybrid, Green Published			2022-12-28	WOS:000446549200001
J	Sun, LN; Ishihara, M; Middleton, DR; Tiemeyer, M; Avci, FY				Sun, Lina; Ishihara, Mayumi; Middleton, Dustin R.; Tiemeyer, Michael; Avci, Fikri Y.			Metabolic labeling of HIV-1 envelope glycoprotein gp120 to elucidate the effect of gp120 glycosylation on antigen uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoprotein; antigen; N-linked glycosylation; click chemistry; metabolic engineering	HUMAN-IMMUNODEFICIENCY-VIRUS; O-LINKED GLYCOSYLATION; MANNOSE-BINDING LECTIN; FREE CLICK CHEMISTRY; MASS-SPECTROMETRY; DC-SIGN; COPPER-FREE; NEUTRALIZING ANTIBODIES; MODIFIED PROTEINS; LIVING ANIMALS	The glycan shield on the envelope glycoprotein gp120 of HIV-1 has drawn immense attention as a vulnerable site for broadly neutralizing antibodies and for its significant impact on host adaptive immune response to HIV-1. Glycosylation sites and glycan composition/structure at each site on gp120 along with the interactions of gp120 glycan shield with broadly neutralizing antibodies have been extensively studied. However, a method for directly and selectively tracking gp120 glycans has been lacking. Here, we integrate metabolic labeling and click chemistry technology with recombinant gp120 expression to demonstrate that gp120 glycans could be specifically labeled and directly detected. Selective labeling of gp120 by N-azidoacetylmannosamine (ManNAz) and N-azidoacetylgalactosamine (GalNAz) incorporation into the gp120 glycan shield was characterized by MS of tryptic glycopeptides. By using metabolically labeled gp120, we investigated the impact of gp120 glycosylation on its interaction with host cells and demonstrated that oligomannose enrichment and sialic acid deficiency drastically enhanced gp120 uptake by bone marrow-derived dendritic cells. Collectively, our data reveal an effective labeling and detection method for gp120, serving as a tool for functional characterization of the gp120 glycans and potentially other glycosylated proteins.	[Sun, Lina; Middleton, Dustin R.; Avci, Fikri Y.] Univ Georgia, Dept Biochem & Mol Biol, Ctr Mol Med, Athens, GA 30602 USA; [Ishihara, Mayumi; Tiemeyer, Michael; Avci, Fikri Y.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Avci, FY (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, Ctr Mol Med, 315 Riverbend Rd, Athens, GA 30602 USA.	avci@uga.edu		Avci, Fikri/0000-0002-1902-7532; Aoki, Mayumi/0000-0002-8368-8546	National Institutes of Health [R01AI123383, P41GM103490]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01AI123383 and P41GM103490. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andre S, 1998, J VIROL, V72, P1497; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Backliwal G, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn423; BARIN F, 1985, SCIENCE, V228, P1094, DOI 10.1126/science.2986291; Behrens AJ, 2017, J VIROL, V91, DOI 10.1128/JVI.01894-16; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burnham-Marusich AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049020; Caminschi I, 2006, INT IMMUNOL, V18, P741, DOI 10.1093/intimm/dxl011; Canis K, 2018, J THROMB HAEMOST, V16, P1592, DOI 10.1111/jth.14204; Cao LW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14954; Chang PV, 2010, P NATL ACAD SCI USA, V107, P1821, DOI 10.1073/pnas.0911116107; Crawford JM, 1999, J VIROL, V73, P10199, DOI 10.1128/JVI.73.12.10199-10207.1999; Cutalo JM, 2004, J AM SOC MASS SPECTR, V15, P1545, DOI 10.1016/j.jasms.2004.07.008; Dube DH, 2006, P NATL ACAD SCI USA, V103, P4819, DOI 10.1073/pnas.0506855103; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Etemad-Moghadam B, 1999, J VIROL, V73, P8873, DOI 10.1128/JVI.73.10.8873-8879.1999; Geijtenbeek TBH, 2003, CURR TOP MICROBIOL, V276, P31; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Go EP, 2013, J PROTEOME RES, V12, P1223, DOI 10.1021/pr300870t; Go EP, 2011, J VIROL, V85, P8270, DOI 10.1128/JVI.05053-11; Guttman M, 2015, ELECTROPHORESIS, V36, P1305, DOI 10.1002/elps.201500054; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; Hart C, 2011, METHODS MOL BIOL, V698, P459, DOI 10.1007/978-1-60761-999-4_33; Hart ML, 2003, J GEN VIROL, V84, P353, DOI 10.1099/vir.0.18734-0; Hart ML, 2002, AIDS RES HUM RETROV, V18, P1311, DOI 10.1089/088922202320886352; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Lai J, 2009, J BIOL CHEM, V284, P11027, DOI 10.1074/jbc.M809698200; Laughlin ST, 2007, NAT PROTOC, V2, P2930, DOI 10.1038/nprot.2007.422; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Li HL, 2008, J IMMUNOL, V180, P4011, DOI 10.4049/jimmunol.180.6.4011; Li HL, 2009, J IMMUNOL, V182, P6369, DOI 10.4049/jimmunol.0804287; Lim JM, 2009, J PROTEOME RES, V8, P673, DOI 10.1021/pr800855f; Luchansky SJ, 2004, BIOCHEMISTRY-US, V43, P12358, DOI 10.1021/bi049274f; Luchansky SJ, 2003, METHOD ENZYMOL, V362, P249; MANCA F, 1992, J IMMUNOL, V148, P2278; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mbua NE, 2013, ANGEW CHEM INT EDIT, V52, P13012, DOI 10.1002/anie.201307095; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; MIZUOCHI T, 1990, J BIOL CHEM, V265, P8519; MOORE JP, 1993, J VIROL, V67, P4785, DOI 10.1128/JVI.67.8.4785-4796.1993; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; Morales JF, 2014, J BIOL CHEM, V289, P20526, DOI 10.1074/jbc.M114.554089; Murin CD, 2014, J VIROL, V88, P10177, DOI 10.1128/JVI.01229-14; Nguyen DG, 2003, EUR J IMMUNOL, V33, P483, DOI 10.1002/immu.200310024; Ning XH, 2008, ANGEW CHEM INT EDIT, V47, P2253, DOI 10.1002/anie.200705456; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Panico M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32956; Park CG, 2001, INT IMMUNOL, V13, P1283, DOI 10.1093/intimm/13.10.1283; Porterfield M, 2014, J PROTEOME RES, V13, P395, DOI 10.1021/pr400422g; Powlesland AS, 2006, J BIOL CHEM, V281, P20440, DOI 10.1074/jbc.M601925200; Pritchard LK, 2015, J VIROL, V89, P8932, DOI 10.1128/JVI.01190-15; Pritchard LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8479; Pritchard LK, 2015, CELL REP, V11, P1604, DOI 10.1016/j.celrep.2015.05.017; Raska M, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-23; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Roper SM, 2013, PROTEOM CLIN APPL, V7, P367, DOI 10.1002/prca.201300006; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sandgren KJ, 2013, J IMMUNOL, V191, P60, DOI 10.4049/jimmunol.1202489; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Struwe WB, 2017, ACS CHEM BIOL, V12, P357, DOI 10.1021/acschembio.6b00854; Sun LN, 2016, GLYCOBIOLOGY, V26, P1029, DOI 10.1093/glycob/cww062; Teo CF, 2014, ANAL BIOCHEM, V464, P70, DOI 10.1016/j.ab.2014.06.010; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Vainauskas S, 2012, CARBOHYD RES, V362, P62, DOI 10.1016/j.carres.2012.09.012; van Montfort T, 2011, J IMMUNOL, V187, P4676, DOI 10.4049/jimmunol.1101876; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Wen YJ, 2011, J VIROL, V85, P1634, DOI 10.1128/JVI.01552-10; Woo CM, 2017, J PROTEOME RES, V16, P1706, DOI 10.1021/acs.jproteome.6b01053; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Xiang Y, 2016, P NATL ACAD SCI USA, V113, pE7890, DOI 10.1073/pnas.1611213113; Zhang X, 2013, MOLECULES, V18, P7145, DOI 10.3390/molecules18067145; Zhou TQ, 2017, CELL REP, V19, P719, DOI 10.1016/j.celrep.2017.04.013; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m	81	7	8	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15178	15194		10.1074/jbc.RA118.004798	http://dx.doi.org/10.1074/jbc.RA118.004798			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30115684	Green Published, hybrid			2022-12-28	WOS:000445998400019
J	Yoshida, T; Tsuge, H				Yoshida, Toru; Tsuge, Hideaki			Substrate N-2 atom recognition mechanism in pierisin family DNA-targeting, guanine-specific ADP-ribosyltransferase ScARP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation; substrate specificity; substrate recognition; structure-function; DNA-protein interaction; crystallography; ADP-ribosylating toxin turn-turn motif; ADP-ribosyltransferase; guanine; pierisin	DIPHTHERIA-TOXIN; COMPLEX STRUCTURE; CRYSTAL-STRUCTURE; MEMBRANE-PROTEIN; TRANSITION-STATE; STRUCTURAL BASIS; CARCINOMA-CELLS; C3 EXOENZYME; IOTA-TOXIN; RIBOSYLATION	ScARP from the bacterium Streptomyces coelicolor belongs to the pierisin family of DNA-targeting ADP-ribosyltransferases (ARTs). These enzymes ADP-ribosylate the N-2 amino groups of guanine residues in DNA to yield N-2-(ADP-ribos-1-yl)-2-deoxyguanosine. Although the structures of pierisin-1 and Scabin were revealed recently, the substrate recognition mechanisms remain poorly understood because of the lack of a substrate-binding structure. Here, we report the apo structure of ScARP and of ScARP bound to NADH and its GDP substrate at 1.50 and 1.57 resolutions, respectively. The bound structure revealed that the guanine of GDP is trapped between N-ribose of NADH and Trp-159. Interestingly, N-2 and N-3 of guanine formed hydrogen bonds with the OE1 and NE2 atoms of Gln-162, respectively. We directly observed that the ADP-ribosylating toxin turn-turn (ARTT)-loop, including Trp-159 and Gln-162, plays a key role in the specificity of DNA-targeting, guanine-specific ARTs as well as protein-targeting ARTs such as the C3 exoenzyme. We propose that the ARTT-loop recognition is a common substrate-recognition mechanism in the pierisin family. Furthermore, this complex structure sheds light on similarities and differences among two subclasses that are distinguished by conserved structural motifs: H-Y-E in the ARTD subfamily and R-S-E in the ARTC subfamily. The spatial arrangements of the electrophile and nucleophile were the same, providing the first evidence for a common reaction mechanism in these ARTs. ARTC (including ScARP) uses the ARTT-loop for substrate recognition, whereas ARTD (represented by Arr) uses the C-terminal helix instead of the ARTT-loop. These observations could help inform efforts to improve ART inhibitors.	[Yoshida, Toru; Tsuge, Hideaki] Kyoto Sangyo Univ, Fac Life Sci, Dept Bioresource & Environm Sci, Kyoto 6038555, Japan; [Yoshida, Toru; Tsuge, Hideaki] Kyoto Sangyo Univ, Inst Prot Dynam, Kyoto 6038555, Japan; [Tsuge, Hideaki] Kyoto Sangyo Univ, Ctr Mol Res Infect Dis, Kyoto 6038555, Japan	Kyoto Sangyo University; Kyoto Sangyo University; Kyoto Sangyo University	Tsuge, H (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Dept Bioresource & Environm Sci, Kyoto 6038555, Japan.; Tsuge, H (corresponding author), Kyoto Sangyo Univ, Inst Prot Dynam, Kyoto 6038555, Japan.; Tsuge, H (corresponding author), Kyoto Sangyo Univ, Ctr Mol Res Infect Dis, Kyoto 6038555, Japan.	tsuge@cc.kyoto-su.ac.jp	Tsuge, Hideaki/ABF-6424-2021	Tsuge, Hideaki/0000-0003-0166-9163	MEXT of Japan [17K15095, 15K08289]	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research, MEXT of Japan, 17K15095 (to T. Y.) and 15K08289 (to H. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; AKTORIES K, 1987, BIOCHEM J, V247, P363, DOI 10.1042/bj2470363; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Aravind L, 2015, CURR TOP MICROBIOL, V384, P3, DOI 10.1007/82_2014_414; Baysarowich J, 2008, P NATL ACAD SCI USA, V105, P4886, DOI 10.1073/pnas.0711939105; Berti PJ, 1997, J AM CHEM SOC, V119, P12079, DOI 10.1021/ja971317a; CASSEL D, 1978, P NATL ACAD SCI USA, V75, P2669, DOI 10.1073/pnas.75.6.2669; COLLIER RJ, 1964, J EXP MED, V120, P1019, DOI 10.1084/jem.120.6.1019; D'Arcy A, 2014, ACTA CRYSTALLOGR F, V70, P1117, DOI 10.1107/S2053230X14015507; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; Dolle C, 2017, FEBS J, V284, P3999, DOI 10.1111/febs.14326; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; HONJO T, 1968, J BIOL CHEM, V243, P3553; Jankevicius G, 2016, MOL CELL, V64, P1109, DOI 10.1016/j.molcel.2016.11.014; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Jorgensen R, 2008, EMBO REP, V9, P802, DOI 10.1038/embor.2008.90; KATADA T, 1982, J BIOL CHEM, V257, P7210; Koyama K, 1996, JPN J CANCER RES, V87, P1259, DOI 10.1111/j.1349-7006.1996.tb03141.x; Luscher B, 2018, CHEM REV, V118, P216, DOI 10.1021/acs.chemrev.7b00122; Lugo MR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194425; Lyons B, 2018, BIOCHEM J, V475, P225, DOI 10.1042/BCJ20170818; Lyons B, 2016, J BIOL CHEM, V291, P11198, DOI 10.1074/jbc.M115.707653; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Munnur D, 2017, FEBS J, V284, P4002, DOI 10.1111/febs.14297; Nakano T, 2006, P NATL ACAD SCI USA, V103, P13652, DOI 10.1073/pnas.0606140103; Nakano T, 2015, CURR TOP MICROBIOL, V384, P127, DOI 10.1007/82_2014_416; Nakano T, 2013, TOXICON, V63, P55, DOI 10.1016/j.toxicon.2012.11.019; Oda T, 2017, J BIOL CHEM, V292, P15445, DOI 10.1074/jbc.M117.776641; OHASHI Y, 1987, J BIOL CHEM, V262, P1430; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Takamura-Enya T, 2004, BIOCHEM BIOPH RES CO, V323, P579, DOI 10.1016/j.bbrc.2004.08.132; Takamura-Enya T, 2001, P NATL ACAD SCI USA, V98, P12414, DOI 10.1073/pnas.221444598; Talhaoui I, 2016, NUCLEIC ACIDS RES, V44, P9279, DOI 10.1093/nar/gkw675; Toda A, 2015, J BIOL CHEM, V290, P19423, DOI 10.1074/jbc.M115.653220; Tsuge H, 2003, J MOL BIOL, V325, P471, DOI 10.1016/S0022-2836(02)01247-0; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Tsuge H, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv094; Tsuge H, 2015, CURR TOP MICROBIOL, V384, P69, DOI 10.1007/82_2014_415; Tsurumura T, 2013, P NATL ACAD SCI USA, V110, P4267, DOI 10.1073/pnas.1217227110; Watanabe M, 1998, JPN J CANCER RES, V89, P556, DOI 10.1111/j.1349-7006.1998.tb03297.x; Zarkovic G, 2018, NUCLEIC ACIDS RES, V46, P2417, DOI 10.1093/nar/gkx1318	43	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13768	13774		10.1074/jbc.AC118.004412	http://dx.doi.org/10.1074/jbc.AC118.004412			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30072382	Green Published, hybrid			2022-12-28	WOS:000444070700001
J	Yosef, G; Arkadash, V; Papo, N				Yosef, Gal; Arkadash, Valeria; Papo, Niv			Targeting the MMP-14/MMP-2/integrin alpha(v)beta(3) axis with multispecific N-TIMP2 based antagonists for cancer therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; BREAST-CARCINOMA CELLS; YEAST SURFACE DISPLAY; FOCAL ADHESION KINASE; TISSUE INHIBITOR; TUMOR ANGIOGENESIS; IN-VITRO; INTEGRIN ALPHA-V-BETA-3; DIRECTED EVOLUTION; ENDOTHELIAL-CELLS	The pathophysiological functions of the signaling molecules matrix metalloproteinase-14 (MMP-14) and integrin alpha(v)beta(3) in various types of cancer are believed to derive from their collaborative activity in promoting invasion, metastasis, and angiogenesis, as shown in vitro and in vivo. The two effectors act in concert in a cell-specific manner through the localization of pro-MMP-2 to the cell surface, where it is processed to intermediate and matured MMP-2. The matured MMP-2 product is localized to the cell surface via its binding to integrin alpha(v)beta(3). The MMP-14/MMP-2/integrin alpha(v)beta(3) axis thus constitutes an attractive putative target for therapeutic interventions, but the development of inhibitors that target this axis remains an unfulfilled task. To address the lack of such multitarget inhibitors, we have established a combinatorial approach that is based on flow cytometry screening of a yeast-displayed N-TIMP2 (N-terminal domain variant of tissue inhibitor of metalloRroteinase-2) mutant library. On the basis of this screening, we generated protein monomers and a heterodimer that contain monovalent and bivalent binding epitopes to MMP-14 and integrin alpha(v)beta(3). Among these proteins, the bi-specific heterodimer, which bound strongly to both MMP-14 and integrin alpha(v)beta(3), exhibited superior ability to inhibit MMP-2 activation and displayed the highest inhibitory activity in cell-based models of a MMP-14-, MMP-2-, and integrin alpha(v)beta(3)-dependent glioblastoma and of endothelial cell invasiveness and endothelial capillary tube formation. These assays enabled us to show the superiority of the combined target effects of the inhibitors and to investigate separately the role each of the three signaling molecules in various malignant processes.	[Papo, Niv] Ben Gurion Univ Negev, Dept Biotechnol Engn, Beer Sheva, Israel; Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Papo, N (corresponding author), Ben Gurion Univ Negev, Dept Biotechnol Engn, Beer Sheva, Israel.	papo@bgu.ac.il			European Research Council [336041]; Israel Science Foundation [615/14]	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation)	This work was supported by European Research Council "Ideas Program" ERC-2013-StG, Contract Grant 336041, and Israel Science Foundation Grant 615/14 (to N.P.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; ALBELDA SM, 1990, CANCER RES, V50, P6757; Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; Anderson GP, 2013, ANAL CHIM ACTA, V786, P132, DOI 10.1016/j.aca.2013.05.010; Arkadash V, 2017, J BIOL CHEM, V292, P3481, DOI 10.1074/jbc.M116.756718; AZZAM HS, 1993, J NATL CANCER I, V85, P1758, DOI 10.1093/jnci/85.21.1758; Babae N, 2014, ONCOTARGET, V5, P6687, DOI 10.18632/oncotarget.2235; Baciu PC, 2003, EXP CELL RES, V291, P167, DOI 10.1016/S0014-4827(03)00387-2; Bahudhanapati H, 2011, J BIOL CHEM, V286, P31761, DOI 10.1074/jbc.M111.253328; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Brouet A, 2001, CIRC RES, V89, P866, DOI 10.1161/hh2201.100319; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Colby DW, 2004, METHOD ENZYMOL, V388, P348; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Decock J, 2011, J CELL MOL MED, V15, P1254, DOI 10.1111/j.1582-4934.2011.01302.x; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Deryugina EI, 2004, TRAFFIC, V5, P627, DOI 10.1111/j.1600-0854.2004.00206.x; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Deryugina EI, 2000, INT J CANCER, V86, P15, DOI 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B; Deshane J, 2003, J BIOL CHEM, V278, P4135, DOI 10.1074/jbc.M205662200; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Elliot S, 2006, INVEST OPHTH VIS SCI, V47, P1696, DOI 10.1167/iovs.05-1258; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Frankowski H, 2012, METHODS MOL BIOL, V814, P221, DOI 10.1007/978-1-61779-452-0_15; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Genis L, 2006, CANCER METAST REV, V25, P77, DOI 10.1007/s10555-006-7891-z; Gonzalo P, 2010, BIOFACTORS, V36, P248, DOI 10.1002/biof.99; Gridelli C, 2016, CLIN LUNG CANCER, V17, P461, DOI 10.1016/j.cllc.2016.04.001; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; Hofmann UB, 2000, J PATHOL, V191, P245; Hofmann UB, 2000, INT J CANCER, V87, P12, DOI 10.1002/1097-0215(20000701)87:1<12::AID-IJC3>3.0.CO;2-A; Husain SR, 2001, INT J CANCER, V92, P168, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1182>3.0.CO;2-N; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Itoh Y, 2004, TRENDS BIOCHEM SCI, V29, P285, DOI 10.1016/j.tibs.2004.04.001; Johanns M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04648-y; Kikuchi R, 2000, BRIT J CANCER, V83, P215; Kumar CC, 2001, CANCER RES, V61, P2232; Kummar S, 2010, NAT REV DRUG DISCOV, V9, P843, DOI 10.1038/nrd3216; Lafleur MA, 2001, BIOCHEM J, V357, P107, DOI 10.1042/0264-6021:3570107; Li RH, 2003, PROTEIN ENG, V16, P65, DOI 10.1093/proeng/gzg002; Li XY, 2008, MOL BIOL CELL, V19, P3221, DOI 10.1091/mbc.E08-01-0016; Lopez-Otin C, 2009, CELL CYCLE, V8, P3657, DOI 10.4161/cc.8.22.9956; Lu KV, 2004, LAB INVEST, V84, P8, DOI 10.1038/labinvest.3700003; May C, 2012, BIOCHEM PHARMACOL, V84, P1105, DOI 10.1016/j.bcp.2012.07.011; McDonagh CF, 2012, MOL CANCER THER, V11, P582, DOI 10.1158/1535-7163.MCT-11-0820; Miles D, 2002, ONCOLOGIST, V7, P13; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; Nakamura H, 1999, CANCER RES, V59, P467; NOMURA H, 1995, CANCER RES, V55, P3263; Nuti E, 2007, CURR PHARM DESIGN, V13, P2087; Ogata H, 2014, ACTA CRYSTALLOGR F, V70, P232, DOI 10.1107/S2053230X13034857; Papo N, 2011, P NATL ACAD SCI USA, V108, P14067, DOI 10.1073/pnas.1016635108; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Sato H, 2010, CANCER SCI, V101, P843, DOI 10.1111/j.1349-7006.2010.01498.x; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Sharabi O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093712; Shen QA, 2010, MOL CANCER RES, V8, P939, DOI 10.1158/1541-7786.MCR-09-0523; Silletti S, 2001, P NATL ACAD SCI USA, V98, P119, DOI 10.1073/pnas.011343298; Srichai M., 2010, INTEGRIN STRUCTURE F; Stefanidakis M, 2006, BLOOD, V108, P1441, DOI 10.1182/blood-2006-02-005363; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Tamura M, 1999, CANCER RES, V59, P442; Toth M, 2001, Methods Mol Med, V57, P163, DOI 10.1385/1-59259-136-1:163; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Yap TA, 2013, J CLIN ONCOL, V31, P1592, DOI 10.1200/JCO.2011.37.6418; Zhang WY, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-52	78	21	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13310	13326		10.1074/jbc.RA118.004406	http://dx.doi.org/10.1074/jbc.RA118.004406			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29986882	hybrid, Green Published			2022-12-28	WOS:000442730200028
J	Gestwicki, JE; Shao, H				Gestwicki, Jason E.; Shao, Hao			Inhibitors and chemical probes for molecular chaperone networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						protein-protein interaction; chemical biology; drug discovery; molecular chaperone; 70 kilodalton heat shock protein (Hsp70); heat shock protein 90 (Hsp90); protein folding; inhibitor; proteostasis; high-throughput screening; small molecule inhibitor	HEAT-SHOCK-PROTEIN; ADENOSINE-DERIVED INHIBITORS; HEAT-SHOCK-PROTEIN-70 HSP70; HSP90 INHIBITOR; ALLOSTERIC SITE; TARGET; CANCER; BINDING; NOVOBIOCIN; REVEALS	The molecular chaperones are central mediators of protein homeostasis. In that role, they engage in widespread protein-protein interactions (PPIs) with each other and with their client proteins. Together, these PPIs form the backbone of a network that ensures proper vigilance over the processes of protein folding, trafficking, quality control, and degradation. The core chaperones, such as the heat shock proteins Hsp60, Hsp70, and Hsp90, are widely expressed in most tissues, yet there is growing evidence that the PPIs among them may be re-wired in disease conditions. This possibility suggests that these PPIs, and perhaps not the individual chaperones themselves, could be compelling drug targets. Indeed, recent efforts have yielded small molecules that inhibit (or promote) a subset of inter-chaperone PPIs. These chemical probes are being used to study chaperone networks in a range of models, and the successes with these approaches have inspired a community-wide objective to produce inhibitors for a broader set of targets. In this Review, we discuss progress toward that goal and point out some of the challenges ahead.	Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gestwicki, JE (corresponding author), UCSF, Sandler Ctr, 675 Nelson Rising Ln, San Francisco, CA 94158 USA.	jason.gestwicki@ucsf.edu			National Institutes of Health [NS059690, AG053619]; Department of Defense; Tau Consortium; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG053619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Tau Consortium; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants NS059690 and AG053619, the Department of Defense, and the Tau Consortium. This is the eighth article in the JBC Reviews series "Molecular chaperones and protein quality control." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abisambra J, 2013, BIOL PSYCHIAT, V74, P367, DOI 10.1016/j.biopsych.2013.02.027; Alagramam KN, 2016, NAT CHEM BIOL, V12, P444, DOI [10.1038/nchembio.2069, 10.1038/NCHEMBIO.2069]; Allan RK, 2006, J BIOL CHEM, V281, P7161, DOI 10.1074/jbc.M512406200; Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; Anyika M, 2016, ACS MED CHEM LETT, V7, P67, DOI 10.1021/acsmedchemlett.5b00331; Arkin MR, 2009, CURR OPIN CHEM BIOL, V13, P284, DOI 10.1016/j.cbpa.2009.05.125; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Assimon VA, 2015, BIOCHEMISTRY-US, V54, P7120, DOI 10.1021/acs.biochem.5b00801; Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; Baell JB, 2018, ACS CHEM BIOL, V13, P36, DOI 10.1021/acschembio.7b00903; Ban HS, 2010, J AM CHEM SOC, V132, P11870, DOI 10.1021/ja104739t; Blagg J, 2017, CANCER CELL, V32, P9, DOI 10.1016/j.ccell.2017.06.005; Bracher A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00010; Brandvold KR, 2015, J MOL BIOL, V427, P2931, DOI 10.1016/j.jmb.2015.05.010; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burlison JA, 2006, J AM CHEM SOC, V128, P15529, DOI 10.1021/ja065793p; Cappello F, 2008, CANCER BIOL THER, V7, P801, DOI 10.4161/cbt.7.6.6281; Cassiano C, 2012, CHEMBIOCHEM, V13, P1953, DOI 10.1002/cbic.201200291; Cesa LC, 2018, J BIOL CHEM, V293, P2370, DOI 10.1074/jbc.RA117.000634; Cesa LC, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00119; Chafekar SM, 2012, ACS CHEM BIOL, V7, P1556, DOI 10.1021/cb300166p; Chang L, 2010, J BIOL CHEM, V285, P21282, DOI 10.1074/jbc.M110.124149; Chapman E, 2009, BIOORG MED CHEM LETT, V19, P811, DOI 10.1016/j.bmcl.2008.12.015; Colvin TA, 2014, CANCER RES, V74, P4731, DOI 10.1158/0008-5472.CAN-14-0747; Crawford LJ, 2011, J CELL COMMUN SIGNAL, V5, P101, DOI 10.1007/s12079-011-0121-7; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; De Leon JT, 2011, P NATL ACAD SCI USA, V108, P11878, DOI 10.1073/pnas.1105160108; Delbecq SP, 2012, EMBO J, V31, P4587, DOI 10.1038/emboj.2012.318; Dougherty PG, 2017, BIOCHEM J, V474, P1109, DOI 10.1042/BCJ20160619; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Faiella L, 2012, MOL BIOSYST, V8, P2637, DOI 10.1039/c2mb25171j; Fewell SW, 2004, J BIOL CHEM, V279, P51131, DOI 10.1074/jbc.M404857200; Freilich R, 2018, ACCOUNTS CHEM RES, V51, P940, DOI 10.1021/acs.accounts.8b00036; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Gaali S, 2016, J MED CHEM, V59, P2410, DOI 10.1021/acs.jmedchem.5b01355; Garbaccio RM, 2016, CELL CHEM BIOL, V23, P10, DOI 10.1016/j.chembiol.2015.11.011; Ghosh S, 2016, ACS MED CHEM LETT, V7, P813, DOI 10.1021/acsmedchemlett.6b00224; Ghosh S, 2015, ACS CHEM BIOL, V10, P577, DOI 10.1021/cb5008713; Gowda NKC, 2018, NAT STRUCT MOL BIOL, V25, P83, DOI 10.1038/s41594-017-0008-2; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hassan AQ, 2015, CHEM BIOL, V22, P87, DOI 10.1016/j.chembiol.2014.11.007; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hishiya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016828; HOLT DA, 1993, J AM CHEM SOC, V115, P9925, DOI 10.1021/ja00075a008; Horowitz S, 2018, CURR OPIN STRUC BIOL, V48, P1, DOI 10.1016/j.sbi.2017.06.009; Howe MK, 2014, CHEM BIOL, V21, P1648, DOI 10.1016/j.chembiol.2014.10.016; Hu D, 2016, ANGEW CHEM INT EDIT, V55, P1387, DOI 10.1002/anie.201509612; Hu Y, 2014, COMPUT STRUCT BIOTEC, V9, DOI 10.5936/csbj.201401003; Huryn DM, 2011, P NATL ACAD SCI USA, V108, P6757, DOI 10.1073/pnas.1015251108; Irwin JJ, 2015, J MED CHEM, V58, P7076, DOI 10.1021/acs.jmedchem.5b01105; Jackson MR, 2013, METHODS MOL BIOL, V1053, P1, DOI 10.1007/978-1-62703-562-0_1; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kampmann M, 2017, CHEM COMMUN, V53, P7162, DOI 10.1039/c7cc02349a; Kang YL, 2014, J MED CHEM, V57, P1188, DOI 10.1021/jm401551n; Kapoor TM, 2017, TRENDS PHARMACOL SCI, V38, P1100, DOI 10.1016/j.tips.2017.09.003; Kityk R, 2018, MOL CELL, V69, P227, DOI 10.1016/j.molcel.2017.12.003; Ko SK, 2015, CHEM BIOL, V22, P391, DOI 10.1016/j.chembiol.2015.02.004; Koldewey P, 2017, J BIOL CHEM, V292, P12010, DOI 10.1074/jbc.R117.796862; Koren J, 2010, J BIOL CHEM, V285, P2498, DOI 10.1074/jbc.M109.057208; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Li XK, 2016, CURR TOP MED CHEM, V16, P2729, DOI 10.2174/1568026616666160413140911; Li XK, 2013, ACS MED CHEM LETT, V4, P1042, DOI 10.1021/ml400204n; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Macias AT, 2011, J MED CHEM, V54, P4034, DOI 10.1021/jm101625x; MacKinnon AL, 2014, ELIFE, V3, DOI 10.7554/eLife.01483; Mainz A, 2015, NAT STRUCT MOL BIOL, V22, P898, DOI 10.1038/nsmb.3108; Makley LN, 2015, SCIENCE, V350, P674, DOI 10.1126/science.aac9145; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Matts RL, 2011, ACS CHEM BIOL, V6, P800, DOI 10.1021/cb200052x; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Molina DM, 2016, ANNU REV PHARMACOL, V56, P141, DOI 10.1146/annurev-pharmtox-010715-103715; Moses MA, 2018, CANCER RES, V78, P4022, DOI 10.1158/0008-5472.CAN-17-3728; Muller S, 2018, ELIFE, V7, DOI 10.7554/eLife.34311; Nagumo Y, 2005, BIOCHEM J, V387, P835, DOI 10.1042/BJ20041355; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; Neckers L, 2018, CELL STRESS CHAPERON, V23, P467, DOI 10.1007/s12192-018-0877-2; Nordin BE, 2015, BIOCHEMISTRY-US, V54, P3024, DOI 10.1021/acs.biochem.5b00148; Ouimet CM, 2018, ANALYST, V143, P1805, DOI [10.1039/c7an02098h, 10.1039/C7AN02098H]; Pacey S, 2011, CLIN CANCER RES, V17, P1561, DOI 10.1158/1078-0432.CCR-10-1927; Parnas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050318; Pettinger J, 2017, ANGEW CHEM INT EDIT, V56, P3536, DOI 10.1002/anie.201611907; Plate L, 2016, ELIFE, V5, DOI 10.7554/eLife.15550; Polson ES, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2718; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Ran X, 2018, CURR OPIN CHEM BIOL, V44, P75, DOI 10.1016/j.cbpa.2018.06.004; Rauch JN, 2017, J MOL BIOL, V429, P128, DOI 10.1016/j.jmb.2016.11.013; Rerole AL, 2011, CANCER RES, V71, P484, DOI 10.1158/0008-5472.CAN-10-1443; Rizzolo K, 2017, CELL REP, V20, P2735, DOI 10.1016/j.celrep.2017.08.074; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Sabnis AJ, 2016, P NATL ACAD SCI USA, V113, P9015, DOI 10.1073/pnas.1603883113; Shao H, 2018, J MED CHEM, V61, P6163, DOI 10.1021/acs.jmedchem.8b00583; Shortt J, 2017, NAT REV CANCER, V17, P160, DOI 10.1038/nrc.2016.148; Shrestha L, 2016, CELL CHEM BIOL, V23, P158, DOI 10.1016/j.chembiol.2015.12.006; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Soergjerd KM, 2013, BIOCHEMISTRY-US, V52, P3532, DOI 10.1021/bi301705c; Sreeramulu S, 2009, ANGEW CHEM INT EDIT, V48, P5853, DOI 10.1002/anie.200900929; Srinivasan SR, 2018, MOL CANCER RES, V16, P58, DOI 10.1158/1541-7786.MCR-17-0408; Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046; Taldone T, 2014, J MED CHEM, V57, P1208, DOI 10.1021/jm401552y; Thompson AD, 2012, ACS CHEM BIOL, V7, P1311, DOI 10.1021/cb300255p; Vasko RC, 2010, ACS MED CHEM LETT, V1, P4, DOI 10.1021/ml900003t; Verba KA, 2016, SCIENCE, V352, P1542, DOI 10.1126/science.aaf5023; Villar EA, 2014, NAT CHEM BIOL, V10, P723, DOI [10.1038/nchembio.1584, 10.1038/NCHEMBIO.1584]; Wadhwa R, 2000, CANCER RES, V60, P6818; Walter GM, 2011, J BIOL CHEM, V286, P40486, DOI 10.1074/jbc.M111.284448; Wang Y, 2015, CHEM COMMUN, V51, P1410, DOI 10.1039/c4cc07284g; Wang YL, 2014, NUCLEIC ACIDS RES, V42, pD1075, DOI 10.1093/nar/gkt978; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wiechmann K, 2017, CELL CHEM BIOL, V24, P614, DOI 10.1016/j.chembiol.2017.04.008; Williamson DS, 2009, J MED CHEM, V52, P1510, DOI 10.1021/jm801627a; Wisen S, 2008, BIOORG MED CHEM LETT, V18, P60, DOI 10.1016/j.bmcl.2007.11.027; Wisen S, 2010, ACS CHEM BIOL, V5, P611, DOI 10.1021/cb1000422; Wruck F, 2018, J MOL BIOL, V430, P438, DOI 10.1016/j.jmb.2017.09.004; Xu Z, 2006, BIOCHEMISTRY-US, V45, P4749, DOI 10.1021/bi0601508; Young ZT, 2016, CELL CHEM BIOL, V23, P992, DOI 10.1016/j.chembiol.2016.04.014; Yu XM, 2005, J AM CHEM SOC, V127, P12778, DOI 10.1021/ja0535864; Yun BG, 2004, BIOCHEMISTRY-US, V43, P8217, DOI 10.1021/bi0497998; Zhang HQ, 2015, STRUCTURE, V23, P472, DOI 10.1016/j.str.2015.01.003; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532; Zhao HP, 2011, J MED CHEM, V54, P3839, DOI 10.1021/jm200148p; Zierer BK, 2014, ANGEW CHEM INT EDIT, V53, P12257, DOI 10.1002/anie.201406578; Zuiderweg ERP, 2017, CELL STRESS CHAPERON, V22, P173, DOI 10.1007/s12192-017-0776-y	128	48	48	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2151	2161		10.1074/jbc.TM118.002813	http://dx.doi.org/10.1074/jbc.TM118.002813			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30213856	Green Published, hybrid			2022-12-28	WOS:000459711400033
J	DeGuire, SM; Ruggeri, FS; Fares, MB; Chiki, A; Cendrowska, U; Dietler, G; Lashuel, HA				DeGuire, Sean M.; Ruggeri, Francesco S.; Fares, Mohamed-Bilal; Chiki, Anass; Cendrowska, Urszula; Dietler, Giovanni; Lashuel, Hilal A.			N-terminal Huntingtin (Htt) phosphorylation is a molecular switch regulating Htt aggregation, helical conformation, internalization, and nuclear targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT HUNTINGTIN; POSTTRANSLATIONAL MODIFICATIONS; FLANKING SEQUENCES; WILD-TYPE; DISEASE; PROTEIN; EXON-1; LOCALIZATION; PATHOGENESIS; CYSTEINE	Huntington's disease is a fatal neurodegenerative disorder resulting from a CAG repeat expansion in the first exon of the gene encoding the Huntingtin protein (Htt). Phosphorylation of this protein region (Httex1) has been shown to play important roles in regulating the structure, toxicity, and cellular properties of N-terminal fragments and full-length Htt. However, increasing evidence suggests that phosphomimetic substitutions in Htt result in inconsistent findings and do not reproduce all aspects of true phosphorylation. Here, we investigated the effects of bona fide phosphorylation at Ser-13 or Ser-16 on the structure, aggregation, membrane binding, and subcellular properties of the Httex1-Q18A variant and compared these effects with those of phosphomimetic substitutions. We show that phosphorylation at either Ser-13 and/or Ser-16 or phosphomimetic substitutions at both these residues inhibit the aggregation of mutant Httex1, but that only phosphorylation strongly disrupts the amphipathic alpha-helix of the N terminus and prompts the internalization and nuclear targeting of preformed Httex1 aggregates. In synthetic peptides, phosphorylation at Ser-13, Ser-16, or both residues strongly disrupted the amphipathic alpha-helix of the N-terminal 17 residues (Nt17) of Httex1 and Nt17 membrane binding. Experiments with peptides bearing different combinations of phosphorylation sites within Nt17 revealed a phosphorylation-dependent switch that regulates the Httex1 structure, involving cross-talk between phosphorylation at Thr-3 and Ser-13 or Ser-16. Our results provide crucial insights into the role of phosphorylation in regulating Httex1 structure and function, and underscore the critical importance of identifying the enzymes responsible for regulating Htt phosphorylation, and their potential as therapeutic targets for managing Huntington's disease.	[DeGuire, Sean M.; Fares, Mohamed-Bilal; Chiki, Anass; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Lab Mol & Chem Biol Neurodegenerat, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Ruggeri, Francesco S.; Cendrowska, Urszula; Dietler, Giovanni] Ecole Polytech Fed Lausanne, Lab Phys Living Matter, Inst Phys Biol Syst, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Lab Mol & Chem Biol Neurodegenerat, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Lashuel, Hilal/M-3500-2017; Ruggeri, Francesco Simone/C-8004-2012	Ruggeri, Francesco Simone/0000-0002-1232-1907; Fares, Mohamed-Bilal/0000-0002-9243-0336	CHDI Foundation [A_7627]; Swiss National Science Foundation [31003A-146680]	CHDI Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by CHDI Foundation Grant A_7627 and Swiss National Science Foundation Grant 31003A-146680. The authors declare that they have no conflicts of interest with the contents of this article.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Ait-Bouziad N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01575-4; Anne SL, 2007, J NEUROSCI, V27, P7318, DOI 10.1523/JNEUROSCI.1831-07.2007; Ansaloni A, 2014, ANGEW CHEM INT EDIT, V53, P1928, DOI 10.1002/anie.201307510; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Babcock DT, 2015, P NATL ACAD SCI USA, V112, pE5427, DOI 10.1073/pnas.1516217112; Blanco-Canosa JB, 2008, ANGEW CHEM INT EDIT, V47, P6851, DOI 10.1002/anie.200705471; Branco-Santos J, 2017, HUM MOL GENET, V26, P3763, DOI 10.1093/hmg/ddx260; Bustos V, 2017, P NATL ACAD SCI USA, V114, P7142, DOI 10.1073/pnas.1705235114; Cariulo C, 2017, P NATL ACAD SCI USA, V114, pE10809, DOI 10.1073/pnas.1705372114; Caron NS, 2013, P NATL ACAD SCI USA, V110, P14610, DOI 10.1073/pnas.1301342110; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; Chen SM, 2001, PROTEIN SCI, V10, P887, DOI 10.1110/ps.42301; Chiki A, 2017, ANGEW CHEM INT EDIT, V56, P5202, DOI 10.1002/anie.201611750; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752; Choudhury KR, 2015, BIOCHEM BIOPH RES CO, V456, P66, DOI 10.1016/j.bbrc.2014.11.035; Cicchetti F, 2014, ANN NEUROL, V76, P31, DOI 10.1002/ana.24174; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Costanzo M, 2013, J CELL SCI, V126, P3678, DOI 10.1242/jcs.126086; Crick SL, 2013, P NATL ACAD SCI USA, V110, P20075, DOI 10.1073/pnas.1320626110; Daldin M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05336-7; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dehay B, 2006, J BIOL CHEM, V281, P35608, DOI 10.1074/jbc.M605558200; Di Pardo A, 2012, P NATL ACAD SCI USA, V109, P3528, DOI 10.1073/pnas.1114502109; Espinoza-Fonseca LM, 2014, MOL BIOSYST, V10, P2693, DOI 10.1039/c4mb00364k; Fares MB, 2014, HUM MOL GENET, V23, P4491, DOI 10.1093/hmg/ddu165; Gentle IE, 2004, BIOCONJUGATE CHEM, V15, P658, DOI 10.1021/bc049965o; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Havel LS, 2011, HUM MOL GENET, V20, P1424, DOI 10.1093/hmg/ddr023; Jayaraman M, 2012, J MOL BIOL, V415, P881, DOI 10.1016/j.jmb.2011.12.010; Kelley NW, 2009, J MOL BIOL, V388, P919, DOI 10.1016/j.jmb.2009.01.032; Lakhani VV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000772; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Lee CC, 2007, BIOCHEMISTRY-US, V46, P12810, DOI 10.1021/bi700806c; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; MacDonald ME, 2003, NEUROMOL MED, V4, P7, DOI 10.1385/NMM:4:1-2:7; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Michalek M, 2013, BIOPHYS J, V105, P699, DOI 10.1016/j.bpj.2013.06.030; Mishra R, 2012, J MOL BIOL, V424, P1, DOI 10.1016/j.jmb.2012.09.011; O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Pandey NK, 2018, J BIOL CHEM, V293, P2597, DOI 10.1074/jbc.M117.813667; Pearce MMP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7768; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Pecho-Vrieseling E, 2014, NAT NEUROSCI, V17, P1064, DOI 10.1038/nn.3761; Rangone H, 2004, EUR J NEUROSCI, V19, P273, DOI 10.1111/j.0953-816X.2003.03131.x; Ratovitski T, 2017, J PROTEOME RES, V16, P2692, DOI 10.1021/acs.jproteome.6b00991; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Ruggeri FS, 2016, SCI REP-UK, V6, DOI 10.1038/srep31155; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; Steffan JS, 2010, CELL CYCLE, V9, P3401, DOI [10.4161/cc.9.17.12718, 10.4161/cc.9.17.12671]; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tan Z, 2015, MOL PSYCHIATR, V20, P1286, DOI 10.1038/mp.2015.81; Tenreiro S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00042; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Trevino RS, 2012, J BIOL CHEM, V287, P29722, DOI 10.1074/jbc.M112.372474; Vieweg S, 2016, J BIOL CHEM, V291, P12074, DOI 10.1074/jbc.M116.713982; Wan Q, 2007, ANGEW CHEM INT EDIT, V46, P9248, DOI 10.1002/anie.200704195; Warner JB, 2017, J AM CHEM SOC, V139, P14456, DOI 10.1021/jacs.7b06659; Yan LZ, 2001, J AM CHEM SOC, V123, P526, DOI 10.1021/ja003265m	67	36	37	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18540	18558		10.1074/jbc.RA118.004621	http://dx.doi.org/10.1074/jbc.RA118.004621			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30185623	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000458467300011
J	Li, QY; Wang, F; Xiao, XZ; Kim, C; Bohon, J; Kiselar, J; Safar, JG; Ma, JY; Surewicz, WK				Li, Qiuye; Wang, Fei; Xiao, Xiangzhu; Kim, Chae; Bohon, Jen; Kiselar, Janna; Safar, Jiri G.; Ma, Jiyan; Surewicz, Witold K.			Structural attributes of mammalian prion infectivity: Insights from studies with synthetic prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN AMYLOID FIBRILS; MASS-SPECTROMETRY; BETA; PARALLEL; CONVERSION; MOLECULES; COFACTOR; DISEASES; DOMAIN; CORE	Prion diseases are neurodegenerative disorders that affect many mammalian species. Mammalian prion proteins (PrPs) can misfold into many different aggregates. However, only a small subpopulation of these structures is infectious. One of the major unresolved questions in prion research is identifying which specific structural features of these misfolded protein aggregates are important for prion infectivity in vivo. Previously, two types of proteinase K-resistant, self-propagating aggregates were generated from the recombinant mouse prion protein in the presence of identical cofactors. Although these two aggregates appear biochemically very similar, they have dramatically different biological properties, with one of them being highly infectious and the other one lacking any infectivity. Here, we used several MS-based structural methods, including hydrogen-deuterium exchange and hydroxyl radical foot-printing, to gain insight into the nature of structural differences between these two PrP aggregate types. Our experiments revealed a number of specific differences in the structure of infectious and noninfectious aggregates, both at the level of the polypeptide backbone and quaternary packing arrangement. In particular, we observed that a high degree of order and stability of beta-sheet structure within the entire region between residues similar to 89 and 227 is a primary attribute of infectious PrP aggregates examined in this study. By contrast, noninfectious PrP aggregates are characterized by markedly less ordered structure up to residue similar to 167. The structural constraints reported here should facilitate development of experimentally based high-resolution structural models of infectiosus mammalian prions.	[Li, Qiuye; Xiao, Xiangzhu; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Kim, Chae; Safar, Jiri G.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Bohon, Jen] Case Western Reserve Univ, Ctr Synchrotron Biosci, Cleveland, OH 44106 USA; [Bohon, Jen; Kiselar, Janna] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Wang, Fei; Ma, Jiyan] Van Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI 49503 USA; [Wang, Fei] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, Houston, TX 77030 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Van Andel Institute; University of Texas System; University of Texas Health Science Center Houston	Surewicz, WK (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	witold.surewicz@case.edu		Ma, Jiyan/0000-0001-7150-1898; Li, Qiuye/0000-0001-7869-8814	National Institutes of Health [P01AI106705, R01NS060729, R01NS103848, R01NS083687, P30EB00998]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI106705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060729, R01NS083687, R01NS103848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants P01AI106705, R01NS060729, R01NS103848, R01NS083687, and P30EB00998. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar-Calvo P, 2017, SCI REP-UK, V7, DOI 10.1038/srep43295; Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Bohon J, 2016, AIP CONF PROC, V1741, DOI 10.1063/1.4952828; Burns-Hamuro LL, 2005, PROTEIN SCI, V14, P2982, DOI 10.1110/ps.051687305; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caughey B, 2001, PHILOS T ROY SOC B, V356, P197, DOI 10.1098/rstb.2000.0765; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2014, J BIOL CHEM, V289, P2643, DOI 10.1074/jbc.M113.520718; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Diaz-Espinoza R, 2012, NAT STRUCT MOL BIOL, V19, P370, DOI 10.1038/nsmb.2266; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Espino JA, 2015, ANAL CHEM, V87, P7971, DOI 10.1021/acs.analchem.5b01888; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; Kim C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04584-z; Kim C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002242; Kiselar J, 2018, ANNU REV BIOPHYS, V47, P315, DOI 10.1146/annurev-biophys-070317-033123; Kiselar JG, 2002, INT J RADIAT BIOL, V78, P101, DOI 10.1080/09553000110094805; Klinger AL, 2014, BIOCHEMISTRY-US, V53, P7724, DOI 10.1021/bi5010409; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Miyagi M, 2008, ANAL CHEM, V80, P6481, DOI 10.1021/ac8009643; Miyagi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017055; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Noble GP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005017; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Rodriguez JA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a031336; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004832; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Surewicz WK, 2011, TOP CURR CHEM, V305, P135, DOI 10.1007/128_2011_165; Theint T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00794-z; Timmes AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071081; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Vazquez-Fernandez E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005835; Wang F, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006491; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wang LW, 2017, MOL CELL PROTEOMICS, V16, P706, DOI 10.1074/mcp.O116.064386; Wang LW, 2011, ANAL CHEM, V83, P7234, DOI 10.1021/ac200567u; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wille H, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7010020; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	55	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18494	18503		10.1074/jbc.RA118.005622	http://dx.doi.org/10.1074/jbc.RA118.005622			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30275016	Green Published, hybrid			2022-12-28	WOS:000458467300007
J	Murphy, K; Llewellyn, K; Wakser, S; Pontasch, J; Samanich, N; Flemer, M; Hensley, K; Kim, DS; Park, J				Murphy, Kelsey; Llewellyn, Killian; Wakser, Samuel; Pontasch, Josef; Samanich, Natasha; Flemer, Matthew; Hensley, Kenneth; Kim, Dong-Shik; Park, Joshua			Mini-GAGR, an intranasally applied polysaccharide, activates the neuronal Nrf2-mediated antioxidant defense system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; antioxidant; nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2); polysaccharide; neurodegeneration; mini-GAGR; BBB-bypassing polysaccharide; antioxidant enzymes; amyloid; tau; oxidative stress	TRANSGENIC MOUSE MODEL; IMPROVES COGNITIVE IMPAIRMENT; PLACEBO-CONTROLLED PHASE-3; DISEASE-LIKE PATHOLOGY; REDUCES A-BETA; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; AMYLOID-BETA; NEUROTROPHIC FACTOR; MEMORY DEFICITS	Oxidative stress triggers and exacerbates neurodegeneration in Alzheimer's disease (AD). Various antioxidants reduce oxidative stress, but these agents have little efficacy due to poor blood-brain barrier (BBB) permeability. Additionally, single-modal antioxidants are easily overwhelmed by global oxidative stress. Activating nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) and its downstream antioxidant system are considered very effective for reducing global oxidative stress. Thus far, only a few BBB-permeable agents activate the Nrf2-dependent antioxidant system. Here, we discovered a BBB-bypassing Nrf2-activating polysaccharide that may attenuate AD pathogenesis. Mini-GAGR, a 0.7-kDa cleavage product of low-acyl gellan gum, increased the levels and activities of Nrf2-dependent antioxidant enzymes, decreased reactive oxygen species (ROS) under oxidative stress in mouse cortical neurons, and robustly protected mitochondria from oxidative insults. Moreover, mini-GAGR increased the nuclear localization and transcriptional activity of Nrf2 similarly to known Nrf2 activators. Mechanistically, mini-GAGR increased the dissociation of Nrf2 from its inhibitor, Kelch-like ECH-associated protein 1 (Keap1), and induced phosphorylation and nuclear translocation of Nrf2 in a protein kinase C (PKC)- and fibroblast growth factor receptor (FGFR1)-dependent manner. Finally, 20-day intranasal treatment of 3xTg-AD mice with 100 nmol of mini-GAGR increased nuclear p-Nrf2 and growth-associated protein 43 (GAP43) levels in hippocampal neurons, reduced p-tau and -amyloid (A) peptide-stained neurons, and improved memory. The BBB-bypassing Nrf2-activating polysaccharide reported here may be effective in reducing oxidative stress and neurodegeneration in AD.	[Murphy, Kelsey; Llewellyn, Killian; Wakser, Samuel; Pontasch, Josef; Samanich, Natasha; Flemer, Matthew; Park, Joshua] Univ Toledo, Coll Med & Life Sci, Dept Neurosci, Toledo, OH 43614 USA; [Hensley, Kenneth] Univ Toledo, Coll Med & Life Sci, Dept Pathol, Toledo, OH 43614 USA; [Kim, Dong-Shik] Univ Toledo, Dept Chem Engn, Coll Engn, Toledo, OH 43607 USA; [Hensley, Kenneth] Arkansas Coll Osteopath Med ARCOM, Dept Biochem Mol & Cell Sci, 7000 Chad Colley Blvd, Ft Smith, AR 72916 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Park, J (corresponding author), Coll Med & Life Sci, Dept Neurosci, 3000 Arlington Ave, Toledo, OH 43614 USA.	joshua.park2@utoledo.edu		Kim, Dong-Shik/0000-0001-9242-385X	National Institutes of Health [5 R21 AG053590-02]; deArce-Koch Memorial Endowment Fund; University of Toledo Medical Research Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG053590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); deArce-Koch Memorial Endowment Fund; University of Toledo Medical Research Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant 5 R21 AG053590-02 and the deArce-Koch Memorial Endowment Fund. This work was also supported by the University of Toledo Medical Research Society and Donald and Gail Klise. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akagi M, 2015, J PHARMACOL SCI, V127, P155, DOI 10.1016/j.jphs.2014.12.015; ANDERSON DMW, 1988, FOOD ADDIT CONTAM, V5, P237, DOI 10.1080/02652038809373701; Banaceur S, 2013, BEHAV BRAIN RES, V240, P197, DOI 10.1016/j.bbr.2012.11.021; Barone E, 2016, FREE RADICAL BIO MED, V91, P127, DOI 10.1016/j.freeradbiomed.2015.12.012; Bell KFS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8066; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Blanchard J, 2010, ACTA NEUROPATHOL, V120, P605, DOI 10.1007/s00401-010-0734-6; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Bolognin S, 2012, ACTA NEUROPATHOL, V123, P133, DOI 10.1007/s00401-011-0908-x; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Carroll JC, 2010, BRAIN RES, V1366, P233, DOI 10.1016/j.brainres.2010.10.009; Christopher K, 2015, METHODSX, V2, P174, DOI 10.1016/j.mex.2015.03.006; Chuang JI, 2015, FREE RADICAL BIO MED, V89, P274, DOI 10.1016/j.freeradbiomed.2015.08.011; Ciesler J., 2013, OPEN J NEUROSCI, V3, P2; Clinton LK, 2007, NEUROBIOL DIS, V28, P76, DOI 10.1016/j.nbd.2007.06.013; Cuadrado A, 2018, REDOX BIOL, V14, P522, DOI 10.1016/j.redox.2017.10.010; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Domanskyi A, 2015, HUM GENE THER, V26, P550, DOI 10.1089/hum.2015.065; Dore S, 1999, ANN NY ACAD SCI, V890, P167, DOI 10.1111/j.1749-6632.1999.tb07991.x; Dumont M, 2009, J NEUROCHEM, V109, P502, DOI 10.1111/j.1471-4159.2009.05970.x; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Fowler JH, 2018, J CEREBR BLOOD F MET, V38, P1354, DOI 10.1177/0271678X17713105; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Fragoulis A, 2017, REDOX BIOL, V12, P843, DOI 10.1016/j.redox.2017.04.024; Frazer ME, 2008, MOL THER, V16, P845, DOI 10.1038/mt.2008.39; Galindo MF, 2010, J NEUROCHEM, V114, P933, DOI 10.1111/j.1471-4159.2010.06814.x; Garcia P, 2010, J NEUROSCI, V30, P7516, DOI 10.1523/JNEUROSCI.4182-09.2010; Ghosh D, 2014, NEUROBIOL AGING, V35, P179, DOI 10.1016/j.neurobiolaging.2013.06.023; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Hirata-Fukae C, 2008, BRAIN RES, V1216, P92, DOI 10.1016/j.brainres.2008.03.079; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Huang JY, 2010, FREE RADICAL BIO MED, V49, P1099, DOI 10.1016/j.freeradbiomed.2010.06.026; Iqbal K, 2011, ACTA NEUROPATHOL, V122, P543, DOI 10.1007/s00401-011-0878-z; IYANAGI T, 1970, BIOCHIM BIOPHYS ACTA, V216, P282, DOI 10.1016/0005-2728(70)90220-3; Jaworski T, 2011, NATURE, V480, pE4, DOI 10.1038/nature10615; Joshi G, 2015, NEUROBIOL AGING, V36, P664, DOI 10.1016/j.neurobiolaging.2014.09.004; Kanninen K, 2008, MOL CELL NEUROSCI, V39, P302, DOI 10.1016/j.mcn.2008.07.010; Kanninen K, 2009, P NATL ACAD SCI USA, V106, P16505, DOI 10.1073/pnas.0908397106; Kapitulnik J, 2009, TRENDS PHARMACOL SCI, V30, P129, DOI 10.1016/j.tips.2008.12.003; Katsouri L, 2015, NEUROBIOL AGING, V36, P821, DOI 10.1016/j.neurobiolaging.2014.10.004; Khan AR, 2017, J CONTROL RELEASE, V268, P364, DOI 10.1016/j.jconrel.2017.09.001; Kim TS, 2006, INT J GERIATR PSYCH, V21, P344, DOI 10.1002/gps.1469; Kiyota T, 2011, P NATL ACAD SCI USA, V108, pE1339, DOI 10.1073/pnas.1102349108; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; La Joie R, 2014, NEURON, V81, P1417, DOI 10.1016/j.neuron.2014.01.026; Leiros M, 2015, NEUROPHARMACOLOGY, V93, P285, DOI 10.1016/j.neuropharm.2015.02.015; Li Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035122; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lipton SA, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.389; Liu YG, 2016, PHARMACOL BIOCHEM BE, V150, P207, DOI 10.1016/j.pbb.2016.11.002; Makani V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149715; MASLIAH E, 1992, BRAIN RES, V593, P323, DOI 10.1016/0006-8993(92)91329-D; Mckee AC, 2008, BRAIN RES, V1207, P225, DOI 10.1016/j.brainres.2008.01.095; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Moreira PI, 2006, J ALZHEIMERS DIS, V9, P101; Murphy KE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061168; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Mylroie H, 2015, CARDIOVASC RES, V106, P509, DOI 10.1093/cvr/cvv131; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Nakajima A, 2015, BEHAV BRAIN RES, V289, P69, DOI 10.1016/j.bbr.2015.04.028; Neymotin A, 2011, FREE RADICAL BIO MED, V51, P88, DOI 10.1016/j.freeradbiomed.2011.03.027; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Pajares M, 2017, REDOX BIOL, V11, P543, DOI 10.1016/j.redox.2017.01.006; Park JJ, 2008, MOL ENDOCRINOL, V22, P989, DOI 10.1210/me.2007-0473; Peng Y, 2010, J NEUROSCI, V30, P8180, DOI 10.1523/JNEUROSCI.0340-10.2010; Pietropaolo S, 2008, BEHAV NEUROSCI, V122, P733, DOI 10.1037/a0012520; Quinti L, 2016, CELL CHEM BIOL, V23, P849, DOI 10.1016/j.chembiol.2016.05.015; Ramsey CP, 2007, J NEUROPATH EXP NEUR, V66, P75, DOI 10.1097/nen.0b013e31802d6da9; Resende R, 2008, FREE RADICAL BIO MED, V44, P2051, DOI 10.1016/j.freeradbiomed.2008.03.012; Rosskothen-Kuhl N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092624; Sandberg M, 2014, NEUROPHARMACOLOGY, V79, P298, DOI 10.1016/j.neuropharm.2013.11.004; Shailasree S, 2015, MOL NEUROBIOL, V51, P119, DOI 10.1007/s12035-014-8700-2; Shin MK, 2014, NEUROBIOL AGING, V35, P990, DOI 10.1016/j.neurobiolaging.2013.10.091; Stack C, 2010, FREE RADICAL BIO MED, V49, P147, DOI 10.1016/j.freeradbiomed.2010.03.017; Stover KR, 2015, BEHAV BRAIN RES, V289, P29, DOI 10.1016/j.bbr.2015.04.012; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Tiwari SK, 2014, CURR MED CHEM, V21, P2610, DOI 10.2174/0929867321666140217125857; Vargas MR, 2005, J BIOL CHEM, V280, P25571, DOI 10.1074/jbc.M501920200; Yacila G, 2014, CURR MED CHEM, V21, P3583, DOI 10.2174/0929867321666140601162710; Yenki P, 2013, J MOL NEUROSCI, V49, P262, DOI 10.1007/s12031-012-9837-y; Zenaro E, 2015, NAT MED, V21, P880, DOI 10.1038/nm.3913; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003; Zhou YY, 2014, INT J NEUROPSYCHOPH, V17, P635, DOI 10.1017/S146114571300148X	88	21	22	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18242	18269		10.1074/jbc.RA117.001245	http://dx.doi.org/10.1074/jbc.RA117.001245			28	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30282635	Green Published, hybrid			2022-12-28	WOS:000451375200018
J	Wang, N; Zou, QA; Xu, JX; Zhang, JC; Liu, JS				Wang, Na; Zou, Qingan; Xu, Jinxin; Zhang, Jiancun; Liu, Jinsong			Ligand binding and heterodimerization with retinoid X receptor alpha (RXR alpha) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear receptor; transcription factor; X-ray crystallography; allosteric regulation; signal transduction; metabolism; conformational change; allostery; Farnesoid X receptor; Retinoid X receptor	NUCLEAR RECEPTOR; CRYSTAL-STRUCTURE; STRUCTURAL DETERMINANTS; ACID; PATHWAYS; COMPLEX; LIVER; ACTIVATION; REVEALS; CAR	Nuclear receptor farnesoid X receptor (FXR) functions as the major bile acid sensor coordinating cholesterol metabolism, lipid homeostasis, and absorption of dietary fats and vitamins. Because of its central role in metabolism, FXR represents an important drug target to manage metabolic and other diseases, such as primary biliary cirrhosis and nonalcoholic steatohepatitis. FXR and nuclear receptor retinoid X receptor (RXR) form a heterodimer that controls the expression of numerous downstream genes. To date, the structural basis and functional consequences of the FXR/RXR heterodimer interaction have remained unclear. Herein, we present the crystal structures of the heterodimeric complex formed between the ligand-binding domains of human FXR and RXR. We show that both FXR and RXR bind to the transcriptional coregulator steroid receptor coactivator 1 with higher affinity when they are part of the heterodimer complex than when they are in their respective monomeric states. Furthermore, structural comparisons of the FXR/RXR heterodimers and the FXR monomers bound with different ligands indicated that both heterodimerization and ligand binding induce conformational changes in the C terminus of helix 11 in FXR that affect the stability of the coactivator binding surface and the coactivator binding in FXR. In summary, our findings shed light on the allosteric signal transduction in the FXR/RXR heterodimer, which may be utilized for future drug development targeting FXR.	[Wang, Na] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Wang, Na; Xu, Jinxin; Zhang, Jiancun; Liu, Jinsong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China; [Wang, Na; Xu, Jinxin; Zhang, Jiancun; Liu, Jinsong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Biocomp, Guangzhou 510530, Guangdong, Peoples R China; [Zou, Qingan; Zhang, Jiancun] Guangzhou Henovcom Biosci Inc, Guangzhou 510530, Guangdong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Liu, JS (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China.; Liu, JS (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Biocomp, Guangzhou 510530, Guangdong, Peoples R China.	liu_jinsong@gibh.ac.cn		Liu, Jinsong/0000-0003-2317-0558	National Key Research and Development Program [2017YFA0504104]; National Natural Science Foundation of China [31770817]; Guangdong Science and Technology Department [2015A030312017]; Guangdong Provincial Key Laboratory of Biocomputing [2016B030301007]; National R&D Infrastructure and Facility Development Program of China "Fundamental Science Data Sharing Platform" [DKA2017-12-02-22]	National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department; Guangdong Provincial Key Laboratory of Biocomputing; National R&D Infrastructure and Facility Development Program of China "Fundamental Science Data Sharing Platform"	This work was supported by National Key Research and Development Program Grant 2017YFA0504104, National Natural Science Foundation of China Grant 31770817, Guangdong Science and Technology Department Grant 2015A030312017, Guangdong Provincial Key Laboratory of Biocomputing Grant 2016B030301007, and National R&D Infrastructure and Facility Development Program of China, "Fundamental Science Data Sharing Platform" Grant DKA2017-12-02-22. The authors declare that they have no conflicts of interest with the contents of this article.	Akwabi-Ameyaw A, 2008, BIOORG MED CHEM LETT, V18, P4339, DOI 10.1016/j.bmcl.2008.06.073; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Bruning JB, 2010, NAT CHEM BIOL, V6, P837, DOI 10.1038/NCHEMBIO.451; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Downes M, 2003, MOL CELL, V11, P1079, DOI 10.1016/S1097-2765(03)00104-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fernandez EJ, 2018, PHARMACOL THERAPEUT, V183, P152, DOI 10.1016/j.pharmthera.2017.10.014; Fiorucci S, 2011, MINI-REV MED CHEM, V11, P753, DOI 10.2174/138955711796355258; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Gabler M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25158-5; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kim KH, 2017, DIGEST DIS, V35, P203, DOI 10.1159/000450912; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Kojetin DJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9013; LEBLANC BP, 1995, GENE DEV, V9, P1811, DOI 10.1101/gad.9.15.1811; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Li GD, 2015, ACTA PHARM SIN B, V5, P93, DOI 10.1016/j.apsb.2015.01.005; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Peng L., 2017, NUCL RECEPTOR RES, V4; Pogenberg V, 2005, J BIOL CHEM, V280, P1625, DOI 10.1074/jbc.M409302200; Schuetz EG, 2001, J BIOL CHEM, V276, P39411, DOI 10.1074/jbc.M106340200; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Svensson S, 2003, EMBO J, V22, P4625, DOI 10.1093/emboj/cdg456; Wallace BD, 2013, J MOL BIOL, V425, P2561, DOI 10.1016/j.jmb.2013.04.012; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang YD, 2008, CELL RES, V18, P1087, DOI 10.1038/cr.2008.289; Wright E, 2007, BIOCHEMISTRY-US, V46, P862, DOI 10.1021/bi061627i; Zheng W., 2018, J BIOL CHEM	38	23	24	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18180	18191		10.1074/jbc.RA118.004652	http://dx.doi.org/10.1074/jbc.RA118.004652			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30275017	Green Published, hybrid			2022-12-28	WOS:000451375200013
J	Lahham, M; Pavkov-Keller, T; Fuchs, M; Niederhauser, J; Chalhoub, G; Daniel, B; Kroutil, W; Gruber, K; Macheroux, P				Lahham, Majd; Pavkov-Keller, Tea; Fuchs, Michael; Niederhauser, Johannes; Chalhoub, Gabriel; Daniel, Bastian; Kroutil, Wolfgang; Gruber, Karl; Macheroux, Peter			Oxidative cyclization of N-methyl-dopa by a fungal flavoenzyme of the amine oxidase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oxidation-reduction (redox); flavoprotein; flavin adenine dinucleotide (FAD); X-ray crystallography; biosynthesis; amine oxidase; fructose amine oxidase; fumisoquin biosynthesis; isoquinolines; oxidative cyclization	MONOMERIC SARCOSINE OXIDASE; OXYGEN ACTIVATION; FLAVOPROTEIN OXIDASES; SITE; MECHANISM; BIOSYNTHESIS	Flavin-dependent enzymes catalyze many oxidations, including formation of ring structures in natural products. The gene cluster for biosynthesis of fumisoquins, secondary metabolites structurally related to isoquinolines, in the filamentous fungus Aspergillus fumigatus harbors a gene that encodes a flavoprotein of the amine oxidase family, termed fsqB (fumisoquin biosynthesis gene B). This enzyme catalyzes an oxidative ring closure reaction that leads to the formation of isoquinoline products. This reaction is reminiscent of the oxidative cyclization reported for berberine bridge enzyme and tetrahydrocannabinol synthase. Despite these similarities, amine oxidases and berberine bridge enzyme-like enzymes possess distinct structural properties, prompting us to investigate the structure-function relationships of FsqB. Here, we report the recombinant production and purification of FsqB, elucidation of its crystal structure, and kinetic analysis employing five putative substrates. The crystal structure at 2.6 angstrom resolution revealed that FsqB is a member of the amine oxidase family with a covalently bound FAD cofactor. N-methyl-dopa was the best substrate for FsqB and was completely converted to the cyclic isoquinoline product. The absence of the meta-hydroxyl group, as e.g. in l-N-methyl-tyrosine, resulted in a 25-fold lower rate of reduction and the formation of the demethylated product l-tyrosine, instead of a cyclic product. Surprisingly, FsqB did not accept the d-stereoisomer of N-methyltyrosine, in contrast to N-methyl-dopa, for which both stereoisomers were oxidized with similar rates. On the basis of the crystal structure and docking calculations, we postulate a substrate-dependent population of distinct binding modes that rationalizes stereospecific oxidation in the FsqB active site.	[Lahham, Majd; Niederhauser, Johannes; Chalhoub, Gabriel; Daniel, Bastian; Macheroux, Peter] Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria; [Pavkov-Keller, Tea; Gruber, Karl] Karl Franzens Univ Graz, Inst Mol Biosci, Humboldtstr 50, A-8010 Graz, Austria; [Fuchs, Michael; Kroutil, Wolfgang] Karl Franzens Univ Graz, Inst Chem, Heinrichstr 28-2, A-8010 Graz, Austria	Graz University of Technology; University of Graz; University of Graz	Macheroux, P (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	peter.macheroux@tugraz.at	Kroutil, Wolfgang/V-1155-2019; Gruber, Karl/GPP-6706-2022; Macheroux, Peter/AAB-5157-2019; Pavkov-Keller, Tea/K-9234-2015	Kroutil, Wolfgang/0000-0002-2151-6394; Gruber, Karl/0000-0002-3485-9740; Macheroux, Peter/0000-0002-0242-454X; Pavkov-Keller, Tea/0000-0001-7871-6680; Fuchs, Michael/0000-0001-6757-7638	Austrian Science Fund doctoral program "Molecular Enzymology" [W901, P28678]; Erasmus Mundus Action 2 Project Avempace + Fellowship Grant [2014-0659/001-001-EMA2]	Austrian Science Fund doctoral program "Molecular Enzymology"; Erasmus Mundus Action 2 Project Avempace + Fellowship Grant	This work was supported by Austrian Science Fund doctoral program "Molecular Enzymology" Grants W901 (to W.K., K.G., and P.M.) and P28678 (to K.G. and P.M.) and by Erasmus Mundus Action 2 Project Avempace + Fellowship Grant 2014-0659/001-001-EMA2 (to M.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2017, PHYS CHEM CHEM PHYS, V19, P9811, DOI 10.1039/c6cp08172j; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2018, SMALL MOL DRUG DISC; Augustin P, 2016, FEBS J, V283, P3587, DOI 10.1111/febs.13828; Baccile JA, 2016, NAT CHEM BIOL, V12, P419, DOI [10.1038/NCHEMBIO.2061, 10.1038/nchembio.2061]; Carrell CJ, 2007, STRUCTURE, V15, P928, DOI 10.1016/j.str.2007.06.010; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Daniel B, 2017, ARCH BIOCHEM BIOPHYS, V632, P88, DOI 10.1016/j.abb.2017.06.023; DeLano W. L., 2018, THE PYMOL MOLECULAR; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzpatrick PF, 2010, ARCH BIOCHEM BIOPHYS, V493, P13, DOI 10.1016/j.abb.2009.07.019; Forneris F, 2009, FEBS J, V276, P4304, DOI 10.1111/j.1742-4658.2009.07142.x; Gadda G, 2012, BIOCHEMISTRY-US, V51, P2662, DOI 10.1021/bi300227d; Gan W., 2015, ACTA CRYSTALLOGR F, V71; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ilari A, 2008, PROTEINS, V71, P2065, DOI 10.1002/prot.21898; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karasulu B, 2015, ACS CATAL, V5, P1227, DOI 10.1021/cs501694q; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Kommoju PR, 2011, BIOCHEMISTRY-US, V50, P5521, DOI 10.1021/bi200388g; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Macheroux P, 1999, METH MOL B, V131, P1; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ravindranath PA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004586; Rigoldi F, 2016, PROTEINS, V84, P744, DOI 10.1002/prot.25015; Shoyama Y, 2012, J MOL BIOL, V423, P96, DOI 10.1016/j.jmb.2012.06.030; Trickey P, 1999, STRUCTURE, V7, P331, DOI 10.1016/S0969-2126(99)80043-4; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wagner MA, 2000, BIOCHEMISTRY-US, V39, P8813, DOI 10.1021/bi000349z; Wagner MA, 2000, BIOCHEMISTRY-US, V39, P8825, DOI 10.1021/bi000350y; Wagner MA, 1999, BIOCHEMISTRY-US, V38, P5588, DOI 10.1021/bi982955o; Winkler A, 2008, NAT CHEM BIOL, V4, P739, DOI 10.1038/nchembio.123; Wolfbeis OS, 2015, BIOESSAYS, V37, P921, DOI 10.1002/bies.201500002; Zhao GH, 2008, BIOCHEMISTRY-US, V47, P9124, DOI 10.1021/bi8008642	36	3	3	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17021	17032		10.1074/jbc.RA118.004227	http://dx.doi.org/10.1074/jbc.RA118.004227			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30194285	Green Published, hybrid			2022-12-28	WOS:000449466500006
J	Vogeli, B; Rosenthal, RG; Stoffel, GMM; Wagner, T; Kiefer, P; Cortina, NS; Shima, S; Erb, TJ				Voegeli, Bastian; Rosenthal, Raoul G.; Stoffel, Gabriele M. M.; Wagner, Tristan; Kiefer, Patrick; Cortina, Nina Socorro; Shima, Seigo; Erb, Tobias J.			InhA, the enoyl-thioester reductase from Mycobacterium tuberculosis forms a covalent adduct during catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; enzyme mechanism; reductase; enzyme structure; enzyme kinetics; enoyl-CoA reductase; InhA; Mycobacterium tuberculosis; pericyclic reaction; short-chain dehydrogenase; reductase	ACP REDUCTASE; CRYSTAL-STRUCTURE; NADH; INHIBITION; EXPRESSION; MECHANISM; COMPLEX; MODEL	The enoyl-thioester reductase InhA catalyzes an essential step in fatty acid biosynthesis of Mycobacterium tuberculosis and is a key target of antituberculosis drugs to combat multidrug-resistant M. tuberculosis strains. This has prompted intense interest in the mechanism and intermediates of the InhA reaction. Here, using enzyme mutagenesis, NMR, stopped-flow spectroscopy, and LC-MS, we found that the NADH cofactor and the CoA thioester substrate form a covalent adduct during the InhA catalytic cycle. We used the isolated adduct as a molecular probe to directly access the second half-reaction of the catalytic cycle of InhA (i.e. the proton transfer), independently of the first half-reaction (i.e. the initial hydride transfer) and to assign functions to two conserved active-site residues, Tyr-158 and Thr-196. We found that Tyr-158 is required for the stereospecificity of protonation and that Thr-196 is partially involved in hydride transfer and protonation. The natural tendency of InhA to form a covalent C2-ene adduct calls for a careful reconsideration of the enzyme's reaction mechanism. It also provides the basis for the development of effective tools to study, manipulate, and inhibit the catalytic cycle of InhA and related enzymes of the short-chain dehydrogenase/reductase (SDR) superfamily. In summary, our work has uncovered the formation of a covalent adduct during the InhA catalytic cycle and identified critical residues required for catalysis, providing further insights into the InhA reaction mechanism important for the development of antituberculosis drugs.	[Voegeli, Bastian; Rosenthal, Raoul G.; Stoffel, Gabriele M. M.; Cortina, Nina Socorro; Erb, Tobias J.] Max Planck Inst Terr Microbiol, Dept Biochem & Synthet Metab, D-35043 Marburg, Germany; [Wagner, Tristan; Shima, Seigo] Max Planck Inst Terr Microbiol, Dept Microbial Prot Struct, D-35043 Marburg, Germany; [Kiefer, Patrick] Swiss Fed Inst Technol, Inst Microbiol, CH-8093 Zurich, Switzerland	Max Planck Society; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich	Erb, TJ (corresponding author), Max Planck Inst Terr Microbiol, Karl von Frisch Str 10, D-35043 Marburg, Germany.	toerb@mpi-marburg.mpg.de		Vogeli, Bastian/0000-0001-7870-7311; Cortina, Nina/0000-0002-0930-660X; Stoffel, Gabriele/0000-0002-4470-1031	European Research Council [637675]; Max Planck Society	European Research Council(European Research Council (ERC)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by European Research Council Grant ERC 637675 "SYBORG" and by the Max Planck Society. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2010, J APPL CRYSTALLOGR, V43, P669, DOI 10.1107/S0021889810015608; Bell AF, 2007, J AM CHEM SOC, V129, P6425, DOI 10.1021/ja068219m; Bull HG, 1996, J AM CHEM SOC, V118, P2359, DOI 10.1021/ja953069t; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chollet A, 2015, J STRUCT BIOL, V190, P328, DOI 10.1016/j.jsb.2015.04.008; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fillgrove KL, 2000, BIOCHEMISTRY-US, V39, P7001, DOI 10.1021/bi0000566; Hartkoorn RC, 2014, NAT CHEM BIOL, V10, P96, DOI 10.1038/nchembio.1405; Jornvall H, 2010, BIOCHEM BIOPH RES CO, V396, P125, DOI 10.1016/j.bbrc.2010.03.094; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khare D, 2015, STRUCTURE, V23, P2213, DOI 10.1016/j.str.2015.09.013; Libby RD, 2012, BIOORG CHEM, V40, P57, DOI 10.1016/j.bioorg.2011.10.002; Lillelund VH, 2002, CHEM REV, V102, P515, DOI 10.1021/cr000433k; MIWA GT, 1985, ARCH BIOCHEM BIOPHYS, V239, P155, DOI 10.1016/0003-9861(85)90822-7; NORTHROP DB, 1981, ANNU REV BIOCHEM, V50, P103, DOI 10.1146/annurev.bi.50.070181.000535; NORTHROP DB, 1975, BIOCHEMISTRY-US, V14, P2644, DOI 10.1021/bi00683a013; Parikh S, 1999, BIOCHEMISTRY-US, V38, P13623, DOI 10.1021/bi990529c; Peter DM, 2016, MOLECULES, V21, DOI 10.3390/molecules21040517; Peter DM, 2015, ANGEW CHEM INT EDIT, V54, P13457, DOI 10.1002/anie.201505282; QUEMARD A, 1995, BBA-LIPID LIPID MET, V1254, P98, DOI 10.1016/0005-2760(94)00174-W; QUEMARD A, 1995, BIOCHEMISTRY-US, V34, P8235, DOI 10.1021/bi00026a004; Rosenthal RG, 2017, NAT CHEM BIOL, V13, P745, DOI 10.1038/nchembio.2375; Rosenthal RG, 2015, NAT CHEM BIOL, V11, P398, DOI 10.1038/nchembio.1794; Rosenthal RG, 2014, NAT CHEM BIOL, V10, P50, DOI [10.1038/NCHEMBIO.1385, 10.1038/nchembio.1385]; Rozwarski DA, 1999, J BIOL CHEM, V274, P15582, DOI 10.1074/jbc.274.22.15582; Sandor R, 2018, PHYTOCHEMISTRY, V145, P77, DOI 10.1016/j.phytochem.2017.10.010; Shirude PS, 2013, FUTURE MED CHEM, V5, P499, DOI [10.4155/fmc.13.26, 10.4155/FMC.13.26]; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	29	8	8	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17200	17207		10.1074/jbc.RA118.005405	http://dx.doi.org/10.1074/jbc.RA118.005405			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30217823	Green Published, hybrid			2022-12-28	WOS:000449466500019
J	Chrudinova, M; Zakova, L; Marek, A; Socha, O; Budesinsky, M; Hubalek, M; Picha, J; Machackova, K; Jiracek, J; Selicharova, I				Chrudinova, Martina; Zakova, Lenka; Marek, Ales; Socha, Ondrej; Budesinsky, Milos; Hubalek, Martin; Picha, Jan; Machackova, Katerina; Jiracek, Jiri; Selicharova, Irena			A versatile insulin analog with high potency for both insulin and insulin-like growth factor 1 receptors: Structural implications for receptor binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin; insulin-like growth factor (IGF); structure-function; insulin receptor; protein design; kinetics; binding; Site 1	FACTOR-I; HIGH-AFFINITY; LIGAND-BINDING; B-CHAIN; SITE; ISOFORMS; REGIONS; CONFORMATION; SPECIFICITY; ACTIVATION	Insulin and insulin-like growth factor 1 (IGF-1) are closely related hormones involved in the regulation of metabolism and growth. They elicit their functions through activation of tyrosine kinase-type receptors: insulin receptors (IR-A and IR-B) and IGF-1 receptor (IGF-1R). Despite similarity in primary and three-dimensional structures, insulin and IGF-1 bind the noncognate receptor with substantially reduced affinity. We prepared [d-His(B24), Gly(B31), Tyr(B32)]-insulin, which binds all three receptors with high affinity (251 or 338% binding affinity to IR-A respectively to IR-B relative to insulin and 12.4% binding affinity to IGF-1R relative to IGF-1). We prepared other modified insulins with the aim of explaining the versatility of [d-His(B24), Gly(B31), Tyr(B32)]-insulin. Through structural, activity, and kinetic studies of these insulin analogs, we concluded that the ability of [d-His(B24), Gly(B31), Tyr(B32)]-insulin to stimulate all three receptors is provided by structural changes caused by a reversed chirality at the B24 combined with the extension of the C terminus of the B chain by two extra residues. We assume that the structural changes allow the directing of the B chain C terminus to some extra interactions with the receptors. These unusual interactions lead to a decrease of dissociation rate from the IR and conversely enable easier association with IGF-1R. All of the structural changes were made at the hormones' Site 1, which is thought to interact with the Site 1 of the receptors. The results of the study suggest that merely modifications of Site 1 of the hormone are sufficient to change the receptor specificity of insulin.	[Chrudinova, Martina; Zakova, Lenka; Marek, Ales; Socha, Ondrej; Budesinsky, Milos; Hubalek, Martin; Picha, Jan; Machackova, Katerina; Jiracek, Jiri; Selicharova, Irena] Czech Acad Sci, Inst Organ Chem & Biochem, Flemingovo 2, Prague 16610 6, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Selicharova, I (corresponding author), Czech Acad Sci, Inst Organ Chem & Biochem, Flemingovo 2, Prague 16610 6, Czech Republic.	selicharova@uochb.cas.cz	Jiracek, Jiri/Y-6703-2019; Zakova, Lenka/Y-6234-2019; Marek, Ales/G-5635-2014; Chrudinova, Martina/G-5597-2014; Zakova, Lenka/A-7119-2008; Jiracek, Jiri/A-7124-2008; Hubalek, Martin/H-1400-2014; Socha, Ondřej/AEV-7090-2022; Selicharova, Irena/G-5546-2014	Jiracek, Jiri/0000-0003-3848-2773; Zakova, Lenka/0000-0001-6439-2574; Marek, Ales/0000-0001-9031-8263; Chrudinova, Martina/0000-0003-2998-9476; Jiracek, Jiri/0000-0003-3848-2773; Hubalek, Martin/0000-0003-0247-7956; Socha, Ondřej/0000-0002-7218-9119; Selicharova, Irena/0000-0002-0180-6781	Medical Research Council [MR/K000179/1, MR/R009066/1]; Czech Academy of Sciences [RVO 61388963]; European Regional Development Fund; OP RDE; Project: "Chemical biology for drugging undruggable targets (ChemBioDrug)" [CZ. 02.1.01/0.0/0.0/16_019/0000729]; MRC [MR/R009066/1, MR/K000179/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Czech Academy of Sciences(Czech Academy of Sciences); European Regional Development Fund(European Commission); OP RDE; Project: "Chemical biology for drugging undruggable targets (ChemBioDrug)"; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant MR/K000179/1 and partly also by Medical Research Council Grant MR/R009066/1. Institutional support was provided by Czech Academy of Sciences Project RVO 61388963 (for the Institute of Organic Chemistry and Biochemistry). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the European Regional Development Fund; OP RDE; Project: "Chemical biology for drugging undruggable targets (ChemBioDrug)" (CZ. 02.1.01/0.0/0.0/16_019/0000729).	Antolikova E, 2011, J BIOL CHEM, V286, P36968, DOI 10.1074/jbc.M111.265249; BAYNE ML, 1990, J BIOL CHEM, V265, P15648; Belfiore A, 2017, ENDOCR REV, V38, P379, DOI 10.1210/er.2017-00073; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; De Meyts P, 2015, BIOESSAYS, V37, P389, DOI 10.1002/bies.201400190; DEMEYTS P, 1978, NATURE, V273, P504; Gauguin L, 2008, J BIOL CHEM, V283, P20821, DOI 10.1074/jbc.M802620200; Gutmann T, 2018, J CELL BIOL, V217, P1643, DOI 10.1083/jcb.201711047; Jensen M, 2007, J BIOL CHEM, V282, P35179, DOI 10.1074/jbc.M704599200; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; Jorgensen AMM, 1996, J MOL BIOL, V257, P684, DOI 10.1006/jmbi.1996.0194; Kavran JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03772; Keyhanfar M, 2007, BIOCHEM J, V401, P269, DOI 10.1042/BJ20060890; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Knudsen L, 2011, BIOCHEM J, V440, P397, DOI 10.1042/BJ20110550; KRISTENSEN C, 1995, BIOCHEM J, V305, P981, DOI 10.1042/bj3050981; Krizkova K, 2016, BIOCHEMISTRY-US, V55, P2903, DOI 10.1021/acs.biochem.6b00140; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Lawrence MC, 2007, CURR OPIN STRUC BIOL, V17, P699, DOI 10.1016/j.sbi.2007.07.007; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Machackova K, 2018, BIOCHEMISTRY-US, V57, P2373, DOI 10.1021/acs.biochem.7b01260; Machackova K, 2017, J MED CHEM, V60, P10105, DOI 10.1021/acs.jmedchem.7b01331; Menting JG, 2015, STRUCTURE, V23, P1271, DOI 10.1016/j.str.2015.04.016; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Mizoguchi A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00217; Morcavallo A, 2012, J BIOL CHEM, V287, P11422, DOI 10.1074/jbc.M111.252478; NAKAGAWA SH, 1987, J BIOL CHEM, V262, P12054; Pandyarajan V, 2016, J BIOL CHEM, V291, P12978, DOI 10.1074/jbc.M115.708347; Perillo M, 2014, GEN COMP ENDOCR, V205, P68, DOI 10.1016/j.ygcen.2014.06.014; Sajid W, 2009, BIOCHEMISTRY-US, V48, P11283, DOI 10.1021/bi901269j; Scapin G, 2018, NATURE, V556, P122, DOI 10.1038/nature26153; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SCHUMACHER R, 1993, J BIOL CHEM, V268, P1087; Siddle Kenneth, 2012, Front Endocrinol (Lausanne), V3, P34, DOI 10.3389/fendo.2012.00034; Slieker LJ, 1997, DIABETOLOGIA, V40, pS54, DOI 10.1007/s001250051402; Versteyhe Soetkin, 2013, Front Endocrinol (Lausanne), V4, P98, DOI 10.3389/fendo.2013.00098; Ward CW, 2013, BIOESSAYS, V35, P945, DOI 10.1002/bies.201300065; Xu YB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03219-7; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w; Zakova L, 2007, J PEPT SCI, V13, P334, DOI 10.1002/psc.847; Zakova L, 2014, ACTA CRYSTALLOGR D, V70, P2765, DOI 10.1107/S1399004714017775; Zakova L, 2013, J BIOL CHEM, V288, P10230, DOI 10.1074/jbc.M112.448050; ZHANG WG, 1994, J BIOL CHEM, V269, P10609	44	4	4	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16818	16829		10.1074/jbc.RA118.004852	http://dx.doi.org/10.1074/jbc.RA118.004852			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30213860	hybrid, Green Published			2022-12-28	WOS:000448515100022
J	Holliday, MJ; Ferrao, R; Boenig, GD; Estevez, A; Helgason, E; Rohou, A; Dueber, EC; Fairbrother, WJ				Holliday, Michael J.; Ferrao, Ryan; Boenig, Gladys de Leon; Estevez, Alberto; Helgason, Elizabeth; Rohou, Alexis; Dueber, Erin C.; Fairbrother, Wayne J.			Picomolar zinc binding modulates formation of Bcl10-nucleating assemblies of the caspase recruitment domain (CARD) of CARD9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); metal ion-protein interaction; oligomerization; protein dynamic; cell signaling; innate immunity; crystallography; electron microscopy (EM); structural biology; Bcl10; CARD9; cell signaling	TORSION ANGLE DYNAMICS; C-TYPE LECTIN; CROHNS-DISEASE; PROTEIN; CELL; CRYSTALLOGRAPHY; SUSCEPTIBILITY; RECOGNITION; HOMEOSTASIS; ASSIGNMENT	The caspase recruitment domain-containing protein 9 (CARD9)-B-cell lymphoma/leukemia 10 (Bcl10) signaling axis is activated in myeloid cells during the innate immune response to a variety of diverse pathogens. This signaling pathway requires a critical caspase recruitment domain (CARD)-CARD interaction between CARD9 and Bcl10 that promotes downstream activation of factors, including NF-B and the mitogen-activated protein kinase (MAPK) p38. Despite these insights, CARD9 remains structurally uncharacterized, and little mechanistic understanding of its regulation exists. We unexpectedly found here that the CARD in CARD9 binds to Zn2+ with picomolar affinitya concentration comparable with the levels of readily accessible Zn2+ in the cytosol. NMR solution structures of the CARD9-CARD in the apo and Zn2+-bound states revealed that Zn2+ has little effect on the ground-state structure of the CARD; yet the stability of the domain increased considerably upon Zn2+ binding, with a concomitant reduction in conformational flexibility. Moreover, Zn2+ binding inhibited polymerization of the CARD9-CARD into helical assemblies. Here, we also present a 20- resolution negative-stain EM (NS-EM) structure of these filamentous assemblies and show that they adopt a similar helical symmetry as reported previously for filaments of the Bcl10 CARD. Using both bulk assays and direct NS-EM visualization, we further show that the CARD9-CARD assemblies can directly template and thereby nucleate Bcl10 polymerization, a capacity considered critical to propagation of the CARD9-Bcl10 signaling cascade. Our findings indicate that CARD9 is a potential target of Zn2+-mediated signaling that affects Bcl10 polymerization in innate immune responses.	[Holliday, Michael J.; Helgason, Elizabeth; Dueber, Erin C.; Fairbrother, Wayne J.] Genentech Inc, Early Discovery Biochem Dept, 1 DNA Way, San Francisco, CA 94080 USA; [Ferrao, Ryan; Boenig, Gladys de Leon; Estevez, Alberto; Rohou, Alexis] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Ferrao, Ryan] Gilead Sci, Dept Struct Chem, Foster City, CA 94404 USA	Roche Holding; Genentech; Roche Holding; Genentech; Gilead Sciences	Dueber, EC; Fairbrother, WJ (corresponding author), Genentech Inc, Early Discovery Biochem Dept, 1 DNA Way, San Francisco, CA 94080 USA.	dueber.erin@gene.com; fairbrother.wayne@gene.com		Holliday, Michael/0000-0002-1112-9892; Estevez, Alberto/0000-0002-9141-5003; Rohou, Alexis/0000-0002-3343-9621				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ADEBODUN F, 1995, J CELL PHYSIOL, V163, P80, DOI 10.1002/jcp.1041630109; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Bafaro E, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.29; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Bozym RA, 2006, ACS CHEM BIOL, V1, P103, DOI 10.1021/cb500043a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; David L, 2018, P NATL ACAD SCI USA, V115, P1499, DOI 10.1073/pnas.1721967115; Desfosses A, 2014, J STRUCT BIOL, V185, P15, DOI 10.1016/j.jsb.2013.11.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haase H, 2008, J IMMUNOL, V181, P6491, DOI 10.4049/jimmunol.181.9.6491; Haase H, 2009, ANNU REV NUTR, V29, P133, DOI 10.1146/annurev-nutr-080508-141119; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hessels AM, 2015, ACS CHEM BIOL, V10, P2126, DOI 10.1021/acschembio.5b00211; Hojyo S, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/6762343; Hong SN, 2016, GUT, V65, P788, DOI 10.1136/gutjnl-2014-308617; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; IRVING H, 1953, J CHEM SOC, P3192, DOI 10.1039/jr9530003192; JEFFERSON JR, 1990, ANAL BIOCHEM, V187, P328, DOI 10.1016/0003-2697(90)90465-L; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Lanternier F, 2015, J ALLERGY CLIN IMMUN, V135, P1558, DOI 10.1016/j.jaci.2014.12.1930; Lanternier F, 2013, NEW ENGL J MED, V369, P1704, DOI 10.1056/NEJMoa1208487; Lee EJ, 2016, J IMMUNOL, V196, P3148, DOI 10.4049/jimmunol.1502355; Li Y, 2009, EXP CELL RES, V315, P2463, DOI 10.1016/j.yexcr.2009.05.016; Maret W, 2013, ADV NUTR, V4, P82, DOI 10.3945/an.112.003038; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McCranor BJ, 2014, METALLOMICS, V6, P1034, DOI 10.1039/c3mt00305a; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; PECK EJ, 1971, J BIOL CHEM, V246, P1160; Peterson MR, 2016, DRUG DES DEV THER, V10, P3799, DOI 10.2147/DDDT.S122508; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Qiao Q, 2013, MOL CELL, V51, P766, DOI 10.1016/j.molcel.2013.08.032; Qin Y, 2013, ACS CHEM BIOL, V8, P2366, DOI 10.1021/cb4003859; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rieber N, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89890; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Roth S, 2014, NAT IMMUNOL, V15, P538, DOI 10.1038/ni.2888; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; SENN H, 1989, FEBS LETT, V249, P113, DOI 10.1016/0014-5793(89)80027-4; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIMONS TJB, 1993, J BIOCHEM BIOPH METH, V27, P25, DOI 10.1016/0165-022X(93)90065-V; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/nmeth.1368, 10.1038/NMETH.1368]; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang SD, 2017, J CELL MOL MED, V21, P1182, DOI 10.1111/jcmm.13050; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016	60	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16803	16817		10.1074/jbc.RA118.004821	http://dx.doi.org/10.1074/jbc.RA118.004821			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30206119	hybrid, Green Published			2022-12-28	WOS:000448515100021
J	Sjogren, L; Floris, M; Barghetti, A; Vollmy, F; Linding, R; Brodersen, P				Sjoegren, Lars; Floris, Maina; Barghetti, Andrea; Voellmy, Franziska; Linding, Rune; Brodersen, Peter			Farnesylated heat shock protein 40 is a component of membrane-bound RISC in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; Argonaute; chaperone DnaJ (DnaJ); microRNA mechanism; membrane; ARGONAUTE; Chaperones; Protein farnesylation; Rough Endoplasmic Reticulum; Small RNA	REGULATES MICRORNA ACTIVITY; DISEASE RESISTANCE PROTEIN; ABSCISIC-ACID; ENDOPLASMIC-RETICULUM; MEVALONATE PATHWAY; RNA INTERFERENCE; MIRNA ACTIVITY; HSP90; ARGONAUTE; DROSOPHILA	ARGONAUTE1 (AGO1) binds directly to small regulatory RNA and is a key effector protein of post-transcriptional gene silencing mediated by microRNA (miRNA) and small interfering RNA (siRNA) in Arabidopsis. The formation of an RNA-induced silencing complex (RISC) of AGO1 and small RNA requires the function of the heat shock protein 70/90 chaperone system. Some functions of AGO1 occur in association with endomembranes, in particular the rough endoplasmic reticulum (RER), but proteins interacting with AGO1 in membrane fractions remain unidentified. In this study, we show that the farnesylated heat shock protein 40 homologs, J2 and J3, associate with AGO1 in membrane fractions in a manner that involves protein farnesylation. We also show that three changes in AGO1 function are detectable in mutants in protein farnesylation and J2/J3. First, perturbations of the HSP40/70/90 pathway by mutation of J3, HSP90, and farnesyl transferase affect the amounts of AGO1 associated with membranes. Second, miRNA association with membrane-bound polysomes is increased in farnesyl transferase and farnesylation-deficient J2/J3 mutants. Third, silencing by noncell autonomously acting short interfering RNAs is impaired. These observations highlight the involvement of farnesylated J2/J3 in small RNA-mediated gene regulation, and suggest that the importance of chaperone-AGO1 interaction is not limited to the RISC assembly process.	[Sjoegren, Lars; Floris, Maina; Barghetti, Andrea; Brodersen, Peter] Univ Copenhagen, Dept Biol, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark; [Voellmy, Franziska; Linding, Rune] Biotech Res & Innovat Ctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark; [Sjoegren, Lars] Lund Univ, Box 117, S-22100 Lund, Sweden	University of Copenhagen; Lund University	Brodersen, P (corresponding author), Univ Copenhagen, Dept Biol, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	pbrodersen@bio.ku.dk	Voellmy, Franziska/H-4939-2017; Brodersen, Peter/T-8818-2017	Voellmy, Franziska/0000-0002-0345-1910; Linding, Rune/0000-0003-0420-4839; Barghetti, Andrea/0000-0002-5805-9289; Brodersen, Peter/0000-0003-1083-1150				Alvira S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6484; Barghetti A, 2017, GENE DEV, V31, P2282, DOI 10.1101/gad.301242.117; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brodersen P, 2012, P NATL ACAD SCI USA, V109, P1778, DOI 10.1073/pnas.1112500109; CHOJNACKI T, 1988, BIOCHEM J, V251, P1; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crowell DN, 2009, TRENDS PLANT SCI, V14, P163, DOI 10.1016/j.tplants.2008.12.001; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; Derrien B, 2012, P NATL ACAD SCI USA, V109, P15942, DOI 10.1073/pnas.1209487109; Dufourc Erick J, 2008, J Chem Biol, V1, P63, DOI 10.1007/s12154-008-0010-6; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Dunoyer P, 2007, NAT GENET, V39, P848, DOI 10.1038/ng2081; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Flom GA, 2008, MOL BIOL CELL, V19, P5249, DOI 10.1091/mbc.E08-04-0435; Flores-Jasso CF, 2013, RNA, V19, P271, DOI 10.1261/rna.036921.112; Fu HW, 1999, RECENT PROG HORM RES, V54, P315; Ghosh S, 2015, MOL BIOL CELL, V26, P1072, DOI 10.1091/mbc.E14-11-1521; Gibbings D, 2012, NAT CELL BIOL, V14, P1314, DOI 10.1038/ncb2611; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Graaf MR, 2004, CANCER TREAT REV, V30, P609, DOI 10.1016/j.ctrv.2004.06.010; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Holt BF, 2005, SCIENCE, V309, P929, DOI 10.1126/science.1109977; Huang S, 2014, PLANT J, V79, P427, DOI 10.1111/tpj.12573; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Iki T, 2012, EMBO J, V31, P267, DOI 10.1038/emboj.2011.395; Iki T, 2010, MOL CELL, V39, P282, DOI 10.1016/j.molcel.2010.05.014; Iwasaki S, 2015, NATURE, V521, P533, DOI 10.1038/nature14254; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Johnson CD, 2005, PLANT PHYSIOL, V139, P722, DOI 10.1104/pp.105.065045; Kanazawa M, 1997, J BIOCHEM-TOKYO, V121, P890; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lecampion C, 2016, JOVE-J VIS EXP, DOI 10.3791/54231; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Li SB, 2016, ELIFE, V5, DOI 10.7554/eLife.22750; Li SB, 2013, CELL, V153, P562, DOI 10.1016/j.cell.2013.04.005; Li ST, 2014, P NATL ACAD SCI USA, V111, P6970, DOI 10.1073/pnas.1322545111; LORD JM, 1987, METHOD ENZYMOL, V148, P576; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martinez NJ, 2013, RNA, V19, P1583, DOI 10.1261/rna.040790.113; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Miyoshi T, 2010, NAT STRUCT MOL BIOL, V17, P1024, DOI 10.1038/nsmb.1875; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Pontier D, 2012, MOL CELL, V48, P121, DOI 10.1016/j.molcel.2012.07.027; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Sahoo MR, 2017, EMBO REP, V18, P241, DOI 10.15252/embr.201642386; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Shi Z, 2012, P NATL ACAD SCI USA, V109, P4568, DOI 10.1073/pnas.1202421109; Sjogren LLE, 2004, PLANT PHYSIOL, V136, P4114, DOI 10.1104/pp.104.053835; Smibert P, 2013, NAT STRUCT MOL BIOL, V20, P789, DOI 10.1038/nsmb.2606; Smith MR, 2009, P NATL ACAD SCI USA, V106, P5424, DOI 10.1073/pnas.0812729106; Stalder L, 2013, EMBO J, V32, P1115, DOI 10.1038/emboj.2013.52; Stempfle D, 2010, MOL CELL BIOL, V30, P3165, DOI 10.1128/MCB.00030-10; Tabach Y, 2013, NATURE, V493, P694, DOI 10.1038/nature11779; Tahbaz N, 2001, J BIOL CHEM, V276, P43294, DOI 10.1074/jbc.M107808200; TRUERNIT E, 1995, PLANTA, V196, P564, DOI 10.1007/BF00203657; Tsuboyama K, 2018, MOL CELL, V70, P722, DOI 10.1016/j.molcel.2018.04.010; Vasquez-Rifo A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003961; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vranova E, 2013, ANNU REV PLANT BIOL, V64, P665, DOI 10.1146/annurev-arplant-050312-120116; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Yang L, 2012, P NATL ACAD SCI USA, V109, P315, DOI 10.1073/pnas.1114673109; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhang JF, 2008, PLANT CELL ENVIRON, V31, P562, DOI 10.1111/j.1365-3040.2008.01786.x	77	9	10	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16608	16622		10.1074/jbc.RA118.003887	http://dx.doi.org/10.1074/jbc.RA118.003887			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30194279	Green Published, hybrid			2022-12-28	WOS:000448515100006
J	Yao, QY; Liu, J; Zhang, ZH; Li, F; Zhang, C; Lai, BC; Xiao, L; Wang, NP				Yao, Qinyu; Liu, Jia; Zhang, Zihui; Li, Fan; Zhang, Chao; Lai, Baochang; Xiao, Lei; Wang, Nanping			Peroxisome proliferator-activated receptor (PPAR gamma) induces the gene expression of integrin (V5) to promote macrophage M2 polarization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						integrin; peroxisome proliferator-activated receptor (PPAR); gene regulation; protein-protein interaction; inflammation; integrin alpha V; integrin beta 5; macrophage polarization	CELLS; ACID	Peroxisome proliferator-activated receptor (PPAR) is a member of the nuclear receptor superfamily and polarizes the macrophages into an anti-inflammatory M2 state. Integrins are transmembrane receptors that drive various cellular functions, including monocyte adhesion and foam cell formation. In this study, we first reported that the expression of integrins (V) and (5) was up-regulated by PPAR activation in RAW264.7 cells and human peripheral blood monocytes. Luciferase reporter and ChIP assay revealed that PPAR directly bound to the potential PPAR-responsive elements sites in the 5-flanking regions of both murine and human integrin (V) and (5) genes, respectively. In addition, we showed that PPAR augmented the ligation of integrins (V) and (5). Knockdown of integrin (V5) by siRNA strategy or treatment with cilengitide, a potent inhibitor of integrin (V5), attenuated PPAR-induced expression of Ym1 (chitinase-like protein 3), Arg1 (Arginase1), Fizz1 (resistin-like molecule RELM), and other M2 marker genes, suggesting that the heterodimers of integrin (V5) were involved in PPAR-induced M2 polarization. In conclusion, these results provided novel evidence that PPAR-mediated gene expression and the ensuing ligation of integrins (V) and (5) are implicated in macrophage M2 polarization.	[Yao, Qinyu; Liu, Jia; Zhang, Zihui; Li, Fan; Zhang, Chao; Lai, Baochang; Xiao, Lei] Xi An Jiao Tong Univ, Sch Basic Med Sci, Cardiovasc Res Ctr, Xian 710061, Shaanxi, Peoples R China; [Wang, Nanping] Dalian Med Univ, Adv Inst Med Sci, Dalian 116044, Peoples R China	Xi'an Jiaotong University; Dalian Medical University	Wang, NP (corresponding author), Dalian Med Univ, Adv Inst Med Sci, Dalian 116044, Peoples R China.	nanpingwang2003@yahoo.com						Antonov AS, 2004, AM J PATHOL, V165, P247, DOI 10.1016/S0002-9440(10)63293-2; Aziz MH, 2017, J IMMUNOL, V198, P4855, DOI 10.4049/jimmunol.1602175; Bermudez B, 2017, ARTERIOSCL THROM VAS, V37, P1157, DOI 10.1161/ATVBAHA.116.308187; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Chen Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep30322; Chung KJ, 2017, NAT IMMUNOL, V18, P654, DOI 10.1038/ni.3728; Cory TJ, 2014, J CYST FIBROS, V13, P164, DOI 10.1016/j.jcf.2013.08.007; Covarrubias AJ, 2015, SEMIN IMMUNOL, V27, P286, DOI 10.1016/j.smim.2015.08.001; Delerive P, 1999, CIRC RES, V85, P394, DOI 10.1161/01.RES.85.5.394; Fang L, 2016, PPAR RES, V2016, DOI 10.1155/2016/6042162; Ge Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep40253; Gliem M, 2015, STROKE, V46, P2935, DOI 10.1161/STROKEAHA.115.010557; Guo XH, 2017, J BIOL CHEM, V292, P14003, DOI 10.1074/jbc.M117.802066; Guri AJ, 2008, J NUTR BIOCHEM, V19, P216, DOI 10.1016/j.jnutbio.2007.02.010; Halabi CM, 2008, CELL METAB, V7, P215, DOI 10.1016/j.cmet.2007.12.008; HOSHIGA M, 1995, CIRC RES, V77, P1129, DOI 10.1161/01.RES.77.6.1129; Kahn CR, 2000, J CLIN INVEST, V106, P1305, DOI 10.1172/JCI11705; Ketsawatsomkron P, 2010, J BIOL CHEM, V285, P9311, DOI 10.1074/jbc.R109.025031; Kim KH, 2015, J CLIN INVEST, V125, P1886, DOI 10.1172/JCI79327; Kobori T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00334; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee J, 2016, NAT MATER, V15, P856, DOI [10.1038/nmat4610, 10.1038/NMAT4610]; Mccall-Culbreath KD, 2008, BLOOD, V111, P3562, DOI 10.1182/blood-2007-08-107664; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Park YK, 2016, NAT REV NEUROSCI, V17, P745, DOI 10.1038/nrn.2016.138; Pello OM, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1151991; Ploeger DTA, 2012, IMMUNOBIOLOGY, V217, P299, DOI 10.1016/j.imbio.2011.10.007; Rahal OM, 2018, INT J RADIAT ONCOL, V100, P1034, DOI 10.1016/j.ijrobp.2017.11.043; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rotty JD, 2017, DEV CELL, V42, P498, DOI 10.1016/j.devcel.2017.08.003; Schittenhelm L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01866; St-Pierre J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006592; Steiger S, 2017, J IMMUNOL, V199, P1440, DOI 10.4049/jimmunol.1601982; Su XM, 2016, CANCER RES, V76, P3484, DOI 10.1158/0008-5472.CAN-15-2663; Tian JW, 2010, HYPERTENSION, V56, P129, DOI 10.1161/HYPERTENSIONAHA.110.150375; Vergadi E, 2017, J IMMUNOL, V198, P1006, DOI 10.4049/jimmunol.1601515; Vitillo L, 2017, CURR STEM CELL REP, V3, P358, DOI 10.1007/s40778-017-0100-x; Wang DK, 2018, KIDNEY INT, V94, P91, DOI 10.1016/j.kint.2017.12.025; Xiao L, 2016, MOL IMMUNOL, V80, P17, DOI 10.1016/j.molimm.2016.10.006; Zandi S, 2015, CELL REP, V10, P1173, DOI 10.1016/j.celrep.2015.01.050; Zhang LP, 2012, J BIOL CHEM, V287, P6177, DOI 10.1074/jbc.M111.292649	43	38	44	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16572	16582		10.1074/jbc.RA118.003161	http://dx.doi.org/10.1074/jbc.RA118.003161			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30181212	hybrid, Green Published			2022-12-28	WOS:000448515100003
J	Vashist, A; Malhotra, V; Sharma, G; Tyagi, JS; Clark-Curtiss, JE				Vashist, Atul; Malhotra, Vandana; Sharma, Gunjan; Tyagi, Jaya Sivaswami; Clark-Curtiss, Josephine E.			Interplay of PhoP and DevR response regulators defines expression of the dormancy regulon in virulent Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; bacterial signal transduction; gene expression; protein-protein interaction; protein-DNA interaction; DevR; DosR; dormancy regulon; negative regulation; PhoP; two-component system	DNA-BINDING DOMAIN; 2-COMPONENT SYSTEM; ESCHERICHIA-COLI; HYPOXIC RESPONSE; CARBON-MONOXIDE; DOSR; TRANSCRIPTION; OPERON; SENSOR; GENE	The DevR response regulator of Mycobacterium tuberculosis is an established regulator of the dormancy response in mycobacteria and can also be activated during aerobic growth conditions in avirulent strains, suggesting a complex regulatory system. Previously, we reported culture medium-specific aerobic induction of the DevR regulon genes in avirulent M. tuberculosis H37Ra that was absent in the virulent H37Rv strain. To understand the underlying basis of this differential response, we have investigated aerobic expression of the Rv3134c-devR-devS operon using M. tuberculosis H37Ra and H37Rv devR overexpression strains, designated as LIX48 and LIX50, respectively. Overexpression of DevR led to the up-regulation of a large number of DevR regulon genes in aerobic cultures of LIX48, but not in LIX50. To ascertain the involvement of PhoP response regulator, also known to co-regulate a subset of DevR regulon genes, we complemented the naturally occurring mutant phoP(Ra) gene of LIX48 with the WT phoP(Rv) gene. PhoP(Rv) dampened the induced expression of the DevR regulon by >70-80%, implicating PhoP in the negative regulation of devR expression. Electrophoretic mobility shift assays confirmed phosphorylation-independent binding of PhoP(Rv) to the Rv3134c promoter and further revealed that DevR and PhoP(Rv) proteins exhibit differential DNA binding properties to the target DNA. Through co-incubations with DNA, ELISA, and protein complementation assays, we demonstrate that DevR forms a heterodimer with PhoP(Rv) but not with the mutant PhoP(Ra) protein. The study puts forward a new possible mechanism for coordinated expression of the dormancy regulon, having implications in growth adaptations critical for development of latency.	[Malhotra, Vandana] Univ Delhi, Sri Venkateswara Coll, Dept Biochem, New Delhi 110021, India; [Malhotra, Vandana; Clark-Curtiss, Josephine E.] Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA; [Clark-Curtiss, Josephine E.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Vashist, Atul; Sharma, Gunjan; Tyagi, Jaya Sivaswami] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Clark-Curtiss, Josephine E.] Univ Florida, Coll Med, Dept Med, Div Infect Dis & Global Med, Gainesville, FL 32610 USA	University of Delhi; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; All India Institute of Medical Sciences (AIIMS) New Delhi; State University System of Florida; University of Florida	Malhotra, V (corresponding author), Univ Delhi, Sri Venkateswara Coll, Dept Biochem, New Delhi 110021, India.	vmal71@gmail.com	Vashist, Atul/AAX-6219-2021	Vashist, Atul/0000-0002-2843-1166; Sharma, Gunjan/0000-0003-3110-9239	Department of Science and Technology, Government of India, Start-Up Research Grant [YSS/2015/000562/LS]; Department of Biotechnology, Government of India [BT/Bio-CARe/07/9843]; Department of Science and Technology, Government of India, J. C. Bose National Fellowship; National Institutes of Health Public Health Service Grant [AI46428]; Arizona State University start-up funding	Department of Science and Technology, Government of India, Start-Up Research Grant; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India, J. C. Bose National Fellowship; National Institutes of Health Public Health Service Grant; Arizona State University start-up funding	Supported by Department of Science and Technology, Government of India, Start-Up Research Grant YSS/2015/000562/LS.; Supported by Department of Biotechnology, Government of India, Grant BT/Bio-CARe/07/9843.; Supported by the Department of Science and Technology, Government of India, J. C. Bose National Fellowship.; Supported by National Institutes of Health Public Health Service Grant AI46428 and Arizona State University start-up funding.	Al-Bassam MM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004554; Flores-Valdez MA, 2015, ANN MICROBIOL, V65, P713, DOI 10.1007/s13213-014-0910-3; Bae HJ, 2017, MOL CELLS, V40, P632, DOI 10.14348/molcells.2017.0076; Bagchi G, 2005, MICROBIOL-SGM, V151, P4045, DOI 10.1099/mic.0.28333-0; Bansal R, 2017, MOL MICROBIOL, V104, P400, DOI 10.1111/mmi.13635; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Boon C, 2012, FUTURE MICROBIOL, V7, P513, DOI [10.2217/fmb.12.14, 10.2217/FMB.12.14]; Bretl DJ, 2012, INFECT IMMUN, V80, P3018, DOI 10.1128/IAI.00520-12; Chao JD, 2010, J BIOL CHEM, V285, P29239, DOI 10.1074/jbc.M110.132894; Chauhan S, 2008, J BACTERIOL, V190, P4301, DOI 10.1128/JB.01308-07; Chauhan S, 2011, NUCLEIC ACIDS RES, V39, P7400, DOI 10.1093/nar/gkr375; Chen YH, 2003, J BACTERIOL, V185, P262, DOI 10.1128/JB.185.1.262-273.2003; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Das AK, 2010, J MOL BIOL, V398, P647, DOI 10.1016/j.jmb.2010.03.056; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; De Majumdar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009448; Domenech P, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00696-16; Fallow A, 2010, J BACTERIOL, V192, P2228, DOI 10.1128/JB.01597-09; Fol M, 2006, MOL MICROBIOL, V60, P643, DOI 10.1111/j.1365-2958.2006.05137.x; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Gao R, 2008, MOL MICROBIOL, V69, P1358, DOI 10.1111/j.1365-2958.2008.06355.x; Gautam US, 2015, AM J RESP CELL MOL, V52, P708, DOI 10.1165/rcmb.2014-0230OC; Gautam US, 2014, J BACTERIOL, V196, P790, DOI 10.1128/JB.01270-13; Gonzalo-Asensio J, 2014, P NATL ACAD SCI USA, V111, P11491, DOI 10.1073/pnas.1406693111; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; He HJ, 2011, J BACTERIOL, V193, P5105, DOI 10.1128/JB.05562-11; Kaur K., 2011, THESIS; KINGER AK, 1993, GENE, V131, P113, DOI 10.1016/0378-1119(93)90678-V; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Majumdar SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035847; Malhotra V, 2004, FEMS MICROBIOL LETT, V231, P237, DOI 10.1016/S0378-1097(04)00002-3; Malhotra V, 2015, J BIOL CHEM, V290, P8294, DOI 10.1074/jbc.M114.591800; Malhotra V, 2009, TUBERCULOSIS, V89, P169, DOI 10.1016/j.tube.2008.12.003; Mehra S, 2015, AM J RESP CRIT CARE, V191, P1185, DOI 10.1164/rccm.201408-1502OC; Minch K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035935; Pannen D, 2016, J BIOL CHEM, V291, P2357, DOI 10.1074/jbc.M115.696815; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Saini DK, 2004, FEBS LETT, V565, P75, DOI 10.1016/j.febslet.2004.02.092; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Salscheider SL, 2014, NUCLEIC ACIDS RES, V42, P2999, DOI 10.1093/nar/gkt1298; Sharma S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160723; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Sikri K, 2015, MICROBIOL-SGM, V161, P739, DOI 10.1099/mic.0.000049; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; Sinha A, 2008, J BACTERIOL, V190, P1317, DOI 10.1128/JB.01074-07; Sun RG, 2004, MOL MICROBIOL, V52, P25, DOI 10.1111/j.1365-2958.2003.03958.x; Taneja NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010860; Vashist A, 2016, FEBS J, V283, P1286, DOI 10.1111/febs.13664; Voskuil Martin I., 2009, P119; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wang S, 2007, BIOCHEMISTRY-US, V46, P14751, DOI 10.1021/bi700970a; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	57	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16413	16425		10.1074/jbc.RA118.004331	http://dx.doi.org/10.1074/jbc.RA118.004331			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30181216	Green Published, hybrid			2022-12-28	WOS:000447833600024
J	Wu, WX; Hatterschide, J; Syu, YC; Cantara, WA; Blower, RJ; Hanson, HM; Mansky, LM; Musier-Forsyth, K				Wu, Weixin; Hatterschide, Joshua; Syu, Yu-Ci; Cantara, William A.; Blower, Ruth J.; Hanson, Heather M.; Mansky, Louis M.; Musier-Forsyth, Karin			Human T-cell leukemia virus type 1 Gag domains have distinct RNA-binding specificities with implications for RNA packaging and dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA structure; retrovirus; RNA folding; viral replication; RNA binding protein; Gag; HTLV-1; matrix domain; nucleocapsid; RNA dimerization	ACID-CHAPERONE ACTIVITY; HIV-1 NUCLEOCAPSID PROTEIN; PRIMER ACTIVATION SIGNAL; GENOMIC RNA; MATRIX PROTEIN; STEM-LOOP; REVERSE TRANSCRIPTION; VIRAL-RNA; NUCLEOTIDE COMPOSITION; ENCAPSIDATION SIGNAL	Human T-cell leukemia virus type 1 (HTLV-1) is the first retrovirus that has conclusively been shown to cause human diseases. In HIV-1, specific interactions between the nucleocapsid (NC) domain of the Gag protein and genomic RNA (gRNA) mediate gRNA dimerization and selective packaging; however, the mechanism for gRNA packaging in HTLV-1, a deltaretrovirus, is unclear. In other deltaretroviruses, the matrix (MA) and NC domains of Gag are both involved in gRNA packaging, but MA binds nucleic acids with higher affinity and has more robust chaperone activity, suggesting that this domain may play a primary role. Here, we show that the MA domain of HTLV-1, but not the NC domain, binds short hairpin RNAs derived from the putative gRNA packaging signal. RNA probing of the HTLV-1 5 leader and cross-linking studies revealed that the primer-binding site and a region within the putative packaging signal form stable hairpins that interact with MA. In addition to a previously identified palindromic dimerization initiation site (DIS), we identified a new DIS in HTLV-1 gRNA and found that both palindromic sequences bind specifically the NC domain. Surprisingly, a mutant partially defective in dimer formation in vitro exhibited a significant increase in RNA packaging into HTLV-1-like particles, suggesting that efficient RNA dimerization may not be strictly required for RNA packaging in HTLV-1. Moreover, the lifecycle of HTLV-1 and other deltaretroviruses may be characterized by NC and MA functions that are distinct from those of the corresponding HIV-1 proteins, but together provide the functions required for viral replication.	[Wu, Weixin; Hatterschide, Joshua; Syu, Yu-Ci; Cantara, William A.; Musier-Forsyth, Karin] Ohio State Univ, Dept Chem & Biochem, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Wu, Weixin; Hatterschide, Joshua; Syu, Yu-Ci; Cantara, William A.; Musier-Forsyth, Karin] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Blower, Ruth J.; Hanson, Heather M.; Mansky, Louis M.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Hanson, Heather M.; Mansky, Louis M.] Univ Minnesota, Mol Cellular Dev Biol & Genet Grad Program, Minneapolis, MN 55455 USA; [Mansky, Louis M.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Musier-Forsyth, K (corresponding author), Ohio State Univ, Dept Chem & Biochem, 140 W 18th Ave,3033B McPherson Lab, Columbus, OH 43210 USA.	musier@chemistry.ohio-state.edu	Cantara, William/GRF-5853-2022	Blower, Ruth/0000-0001-7557-2677; Grace, Mara/0000-0001-7049-5852; Hatterschide, Joshua/0000-0003-3562-4166	National Institutes of Health [R01 GM065056, P50 GM103368, R01 GM098550]; Pelotonia postdoctoral fellowship from Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI083196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098550, P50GM103368, R01GM065056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pelotonia postdoctoral fellowship from Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM065056 and P50 GM103368 (HIV Interactions and Viral Evolution Center, which supported development of the software used for XL-SHAPE data analysis) (to K. M.-F.) and R01 GM098550 (to L. M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Pelotonia postdoctoral fellowship from Ohio State University.	Abbink TEM, 2003, J BIOL CHEM, V278, P11601, DOI 10.1074/jbc.M210291200; Alfadhli A, 2011, J MOL BIOL, V410, P653, DOI 10.1016/j.jmb.2011.04.063; Araujo THA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042123; Amarasinghe GK, 2000, J MOL BIOL, V301, P491, DOI 10.1006/jmbi.2000.3979; Anderson MD, 2004, J VIROL METHODS, V116, P195, DOI 10.1016/j.jviromet.2003.11.016; Askjaer P, 1998, J BIOL CHEM, V273, P11463, DOI 10.1074/jbc.273.19.11463; Banks JD, 2000, J VIROL, V74, P456, DOI 10.1128/JVI.74.1.456-464.2000; Beerens N, 2001, J BIOL CHEM, V276, P31247, DOI 10.1074/jbc.M102441200; Bell NM, 2013, TRENDS MICROBIOL, V21, P136, DOI 10.1016/j.tim.2012.11.006; Berkhout B, 1997, NUCLEIC ACIDS RES, V25, P4013, DOI 10.1093/nar/25.20.4013; Berkhout B, 1996, J VIROL, V70, P6723, DOI 10.1128/JVI.70.10.6723-6732.1996; Bieniasz P, 2018, ANNU REV VIROL, V5, P165, DOI 10.1146/annurev-virology-092917-043448; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cantara WA, 2017, RNA, V23, P240, DOI 10.1261/rna.058404.116; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Cruceanu M, 2006, J MOL BIOL, V363, P867, DOI 10.1016/j.jmb.2006.08.070; D'Souza V, 2005, NAT REV MICROBIOL, V3, P643, DOI 10.1038/nrmicro1210; D'Souza V, 2004, NATURE, V431, P586, DOI 10.1038/nature02944; Damgaard CK, 2004, J MOL BIOL, V336, P369, DOI 10.1016/j.jmb.2003.12.010; Damgaard CK, 1998, NUCLEIC ACIDS RES, V26, P3667, DOI 10.1093/nar/26.16.3667; DARLIX JL, 1995, J MOL BIOL, V254, P523, DOI 10.1006/jmbi.1995.0635; Darugar Q, 2008, J VIROL, V82, P12164, DOI 10.1128/JVI.01158-08; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Dubois N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00527; Fisher RJ, 2006, NUCLEIC ACIDS RES, V34, P472, DOI 10.1093/nar/gkj442; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Gherghe C, 2010, P NATL ACAD SCI USA, V107, P19248, DOI 10.1073/pnas.1006897107; GIRARD PM, 1995, BIOCHEMISTRY-US, V34, P9785, DOI 10.1021/bi00030a016; Greatorex JS, 1996, NUCLEIC ACIDS RES, V24, P2919, DOI 10.1093/nar/24.15.2919; Heng X, 2012, J MOL BIOL, V417, P224, DOI 10.1016/j.jmb.2012.01.033; Hill MK, 2003, J VIROL, V77, P8329, DOI 10.1128/JVI.77.15.8329-8335.2003; Jewell NA, 2005, ARCH VIROL, V150, P1161, DOI 10.1007/s00705-004-0476-7; Jewell NA, 2000, J GEN VIROL, V81, P1889, DOI 10.1099/0022-1317-81-8-1889; Jones CP, 2013, RNA, V19, P219, DOI 10.1261/rna.036681.112; Jones CP, 2011, J VIROL, V85, P1594, DOI 10.1128/JVI.01809-10; KATOH I, 1993, J VIROL, V67, P1830, DOI 10.1128/JVI.67.4.1830-1839.1993; KATOH I, 1991, J VIROL, V65, P6845, DOI 10.1128/JVI.65.12.6845-6855.1991; Keane SC, 2015, SCIENCE, V348, P917, DOI 10.1126/science.aaa9266; Kenyon JC, 2015, SCI REP-UK, V5, DOI 10.1038/srep14369; KURG A, 1995, VIROLOGY, V211, P434, DOI 10.1006/viro.1995.1425; Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057; Kuzembayeva M, 2014, VIROLOGY, V454, P362, DOI 10.1016/j.virol.2014.01.019; Laughrea M, 1997, J VIROL, V71, P3397, DOI 10.1128/JVI.71.5.3397-3406.1997; Le Blanc I, 2000, J GEN VIROL, V81, P105, DOI 10.1099/0022-1317-81-1-105; Le Blanc I, 1999, J VIROL, V73, P1860, DOI 10.1128/JVI.73.3.1860-1867.1999; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Liu Y, 2017, J MOL BIOL, V429, P2542, DOI 10.1016/j.jmb.2017.06.018; Lu K, 2011, SCIENCE, V334, P242, DOI 10.1126/science.1210460; Lu K, 2011, J MOL BIOL, V410, P609, DOI 10.1016/j.jmb.2011.04.029; Ly H, 2002, J VIROL, V76, P3135, DOI 10.1128/JVI.76.7.3135-3144.2002; MALDONADO JO, 2016, VIRUSES-BASEL, V8, DOI DOI 10.3390/v8050132; MANSKY LM, 1995, J VIROL, V69, P3282, DOI 10.1128/JVI.69.6.3282-3289.1995; Mansky LM, 1998, J VIROL, V72, P3196, DOI 10.1128/JVI.72.4.3196-3204.1998; Mansky LM, 2002, VIROLOGY, V301, P272, DOI 10.1006/viro.2002.1578; Martin JL, 2017, J VIROL, V91, DOI 10.1128/JVI.00298-17; Martin JL, 2016, J VIROL, V90, P8074, DOI 10.1128/JVI.00666-16; Martin JL, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020031; MATHEWS DH, 2014, CURR PROTOC BIOINFOR, V46, DOI [DOI 10.1002/0471250953.BI1206S46, 10.1002/0471250953.bi1206s46]; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Monie T, 2001, VIRUS RES, V78, P45, DOI 10.1016/S0168-1702(01)00283-0; Monie TP, 2004, BIOCHEMISTRY-US, V43, P6085, DOI 10.1021/bi030237i; Moore MD, 2009, AIDS REV, V11, P91; Narayanan N, 2006, BIOCHEMISTRY-US, V45, P12617, DOI 10.1021/bi060925c; Ooms M, 2007, NUCLEIC ACIDS RES, V35, P1649, DOI 10.1093/nar/gkm046; Ott DE, 2005, J VIROL, V79, P13839, DOI 10.1128/JVI.79.22.13839-13847.2005; Pachulska-Wieczorek K, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0245-1; Paillart JC, 1996, P NATL ACAD SCI USA, V93, P5572, DOI 10.1073/pnas.93.11.5572; Parent LJ, 2011, J MOL BIOL, V410, P553, DOI 10.1016/j.jmb.2011.04.072; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Purohit P, 2001, RNA, V7, P576, DOI 10.1017/S1355838201002023; Qualley DF, 2013, PROTEINS, V81, P1377, DOI 10.1002/prot.24281; Qualley DF, 2010, J BIOL CHEM, V285, P295, DOI 10.1074/jbc.M109.051334; Rein A, 1998, TRENDS BIOCHEM SCI, V23, P297, DOI 10.1016/S0968-0004(98)01256-0; Rein A, 2010, RNA BIOL, V7, P700, DOI 10.4161/rna.7.6.13685; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Ruggero K, 2014, J VIROL, V88, P3612, DOI 10.1128/JVI.02823-13; Ryder Sean P., 2008, V488, P99, DOI 10.1007/978-1-60327-475-3_7; Rye-McCurdy T, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090256; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; Song R, 2008, BIOCHEMISTRY-US, V47, P3283, DOI 10.1021/bi7023173; Song R, 2007, J MOL BIOL, V371, P1084, DOI 10.1016/j.jmb.2007.06.010; Steen KA, 2012, J AM CHEM SOC, V134, P13160, DOI 10.1021/ja304027m; Stewart-Maynard KM, 2008, J VIROL, V82, P10129, DOI 10.1128/JVI.01169-08; Sun M, 2014, J VIROL, V88, P1271, DOI 10.1128/JVI.02151-13; Todd GC, 2017, RNA, V23, P395, DOI 10.1261/rna.058453.116; TORRENT C, 1994, J VIROL, V68, P661, DOI 10.1128/JVI.68.2.661-667.1994; Tran T, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0209-x; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; van Hemert F, 2016, J GEN VIROL, V97, P2608, DOI 10.1099/jgv.0.000579; van Hemert F, 2014, VIRUS RES, V193, P16, DOI 10.1016/j.virusres.2014.03.019; Wang HT, 2003, J VIROL, V77, P9431, DOI 10.1128/JVI.77.17.9431-9438.2003; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Webb JA, 2013, RNA, V19, P1078, DOI 10.1261/rna.038869.113; Weiss RA, 1996, J ANTIMICROB CHEMOTH, V37, P1, DOI 10.1093/jac/37.suppl_B.1; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Xing L, 2011, J VIROL, V85, P1847, DOI 10.1128/JVI.02010-10; Yildiz FZ, 2013, VIRUS RES, V171, P278, DOI 10.1016/j.virusres.2012.07.020; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	101	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16261	16276		10.1074/jbc.RA118.005531	http://dx.doi.org/10.1074/jbc.RA118.005531			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30217825	Green Published, hybrid			2022-12-28	WOS:000447833600013
J	Ran, YC; Zheng, AP; Thibodeau, PH				Ran, Yanchao; Zheng, Aiping; Thibodeau, Patrick H.			Structural analysis reveals pathomechanisms associated with pseudoxanthoma elasticum-causing mutations in the ABCC6 transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein folding; X-ray crystallography; membrane protein; ABC transporter; protein misfolding; protein structure; protein stability; connective tissue; glycoprotein biosynthesis; ABCC6; connective tissue disorder; elastic fiber; pseudoxanthoma elasticum	TRANSMEMBRANE CONDUCTANCE REGULATOR; ATP-BINDING CASSETTE; CRYSTAL-STRUCTURE; ECTOPIC MINERALIZATION; IN-VIVO; DOMAIN; MUTANTS; GENE; CFTR; PROTEIN	Mutations in ABC subfamily C member 6 (ABCC6) transporter are associated with pseudoxanthoma elasticum (PXE), a disease resulting in ectopic mineralization and affecting multiple tissues. A growing number of mutations have been identified in individuals with PXE. For most of these variants, no mechanistic information is available regarding their role in normal and pathophysiologies. To assess how PXE-associated mutations alter ABCC6 biosynthesis and structure, we biophysically and biochemically evaluated the N-terminal nucleotide-binding domain. A high-resolution X-ray structure of nucleotide-binding domain 1 (NBD1) of human ABCC6 was obtained at 2.3 angstrom that provided a template on which to evaluate PXE-causing mutations. Biochemical analysis of mutations in this domain indicated that multiple PXE-causing mutations altered its structural properties. Analyses of the full-length protein revealed a strong correlation between the alterations in NBD properties and the processing and expression of ABCC6. These results suggest that a significant fraction of PXE-associated mutations located in NBD1 causes changes in its structural properties and that these mutation-induced alterations directly affect the maturation of the full-length ABCC6 protein.	[Ran, Yanchao; Zheng, Aiping; Thibodeau, Patrick H.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thibodeau, PH (corresponding author), 450 Technol Dr, Pittsburgh, PA 15219 USA.	thibodea@pitt.edu	Zheng, Aiping/U-5313-2019	Thibodeau, Patrick/0000-0002-6790-144X	National Institutes of Health [GM122091, DK083284]; Cystic Fibrosis Foundation [THIBOD15XX0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083284, R56DK083284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM122091 and DK083284 and Cystic Fibrosis Foundation Grant THIBOD15XX0 (to P. H. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Apschner A, 2014, DIS MODEL MECH, V7, P811, DOI 10.1242/dmm.015693; Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109; Bukowska MA, 2015, BIOCHEMISTRY-US, V54, P3086, DOI 10.1021/acs.biochem.5b00188; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Gaudet R, 2001, EMBO J, V20, P4964, DOI 10.1093/emboj/20.17.4964; GOODMAN RM, 1963, MEDICINE, V42, P297, DOI 10.1097/00005792-196309000-00001; Grossmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6419; Hanrahan JW, 2017, CURR OPIN PHARMACOL, V34, P105, DOI 10.1016/j.coph.2017.09.016; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Ilias A, 2002, J BIOL CHEM, V277, P16860, DOI 10.1074/jbc.M110918200; Jansen RS, 2014, ARTERIOSCL THROM VAS, V34, P1985, DOI 10.1161/ATVBAHA.114.304017; Jansen RS, 2013, P NATL ACAD SCI USA, V110, P20206, DOI 10.1073/pnas.1319582110; Johnson ZL, 2017, CELL, V168, P1075, DOI 10.1016/j.cell.2017.01.041; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Lee KPK, 2017, ELIFE, V6, DOI 10.7554/eLife.32481; Legrand A, 2017, GENET MED, V19, P909, DOI 10.1038/gim.2016.213; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.31054; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Miglionico R, 2016, J BIOENERG BIOMEMBR, V48, P259, DOI 10.1007/s10863-016-9654-z; Miksch S, 2005, HUM MUTAT, V26, P235, DOI 10.1002/humu.20206; Moitra K, 2011, BIOL CHEM, V392, P29, DOI 10.1515/BC.2011.006; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Pfendner EG, 2007, J MED GENET, V44, P621, DOI 10.1136/jmg.2007.051094; Pomozi V, 2017, J INVEST DERMATOL, V137, P595, DOI 10.1016/j.jid.2016.10.035; Pomozi V, 2014, J INVEST DERMATOL, V134, P946, DOI 10.1038/jid.2013.482; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Ramaen O, 2006, J MOL BIOL, V359, P940, DOI 10.1016/j.jmb.2006.04.005; Ran YC, 2017, J BIOL CHEM, V292, P1559, DOI 10.1074/jbc.M116.759811; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Vernon RM, 2017, J BIOL CHEM, V292, P14147, DOI 10.1074/jbc.M116.772335; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389; Xue P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097360; Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200; Zhao JY, 2017, J INVEST DERMATOL, V137, P2336, DOI 10.1016/j.jid.2017.06.006; Ziegler SG, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal1669	45	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15855	15866		10.1074/jbc.RA118.004806	http://dx.doi.org/10.1074/jbc.RA118.004806			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30154241	Green Published, hybrid			2022-12-28	WOS:000447256000009
J	Duan, YW; Liu, T; Zhou, Y; Dou, TY; Yang, Q				Duan, Yanwei; Liu, Tian; Zhou, Yong; Dou, Tongyi; Yang, Qing			Glycoside hydrolase family 18 and 20 enzymes are novel targets of the traditional medicine berberine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; chitinase; inhibitor; protein crystallization; human; insect; -N-acetyl-D-hexosaminidase; berberine	BETA-N-ACETYLHEXOSAMINIDASE; ACIDIC MAMMALIAN CHITINASE; CELL-CYCLE ARREST; ACETYLGLUCOSAMINIDASE GENE; COMPLEXES REVEAL; RNA INTERFERENCE; NATURAL-PRODUCT; HEXOSAMINIDASE; DERIVATIVES; INHIBITORS	Berberine is a traditional medicine that has multiple medicinal and agricultural applications. However, little is known about whether berberine can be a bioactive molecule toward carbohydrate-active enzymes, which play numerous vital roles in the life process. In this study, berberine and its analogs were discovered to be competitive inhibitors of glycoside hydrolase family 20 -N-acetyl-d-hexosaminidase (GH20 Hex) and GH18 chitinase from both humans and the insect pest Ostrinia furnacalis. Berberine and its analog SYSU-1 inhibit insect GH20 Hex from O. furnacalis (OfHex1), with K-i values of 12 and 8.5 m, respectively. Co-crystallization of berberine and its analog SYSU-1 in complex with OfHex1 revealed that the positively charged conjugate plane of berberine forms - stacking interactions with Trp(490), which are vital to its inhibitory activity. Moreover, the 1,3-dioxole group of berberine binds an unexplored pocket formed by Trp(322), Trp(483), and Val(484), which also contributes to its inhibitory activity. Berberine was also found to be an inhibitor of human GH20 Hex (HsHexB), human GH18 chitinase (HsCht and acidic mammalian chitinase), and insect GH18 chitinase (OfChtI). Besides GH18 and GH20 enzymes, berberine was shown to weakly inhibit human GH84 O-GlcNAcase (HsOGA) and Saccharomyces cerevisiae GH63 -glucosidase I (ScGluI). By analyzing the published crystal structures, berberine was revealed to bind with its targets in an identical mechanism, namely via - stacking and electrostatic interactions with the aromatic and acidic residues in the binding pockets. This paper reports new molecular targets of berberine and may provide a berberine-based scaffold for developing multitarget drugs.	[Duan, Yanwei; Liu, Tian; Zhou, Yong; Yang, Qing] Dalian Univ Technol, Sch Life Sci & Biotechnol, State Key Lab Fine Chem Engn, Dalian 116024, Peoples R China; [Duan, Yanwei; Liu, Tian; Zhou, Yong; Yang, Qing] Dalian Univ Technol, Sch Software, Dalian 116024, Peoples R China; [Dou, Tongyi] Dalian Univ Technol, Sch Life Sci & Med, Panjin 124221, Peoples R China; [Yang, Qing] Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China	Dalian University of Technology; Dalian University of Technology; Dalian University of Technology; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Liu, T; Yang, Q (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, State Key Lab Fine Chem Engn, Dalian 116024, Peoples R China.; Liu, T; Yang, Q (corresponding author), Dalian Univ Technol, Sch Software, Dalian 116024, Peoples R China.; Yang, Q (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China.	tianliu@dlut.edu.cn; qingyang@dlut.edu.cn	Yang, Qing/GZK-2526-2022; Liu, Tian/E-2481-2012	Yang, Qing/0000-0001-8623-7532; Liu, Tian/0000-0001-9768-5496	Program for National Natural Science Funds for Distinguished Young Scholar [31425021]; National Natural Science Foundation of China [31830076, 31871959]	Program for National Natural Science Funds for Distinguished Young Scholar; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Program for National Natural Science Funds for Distinguished Young Scholar (Grant 31425021) and the National Natural Science Foundation of China (Grants 31830076 and 31871959). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adrangi S, 2013, BIOTECHNOL ADV, V31, P1786, DOI 10.1016/j.biotechadv.2013.09.012; Andersen OA, 2005, NAT PROD REP, V22, P563, DOI 10.1039/b416660b; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barker MK, 2013, J BIOL CHEM, V288, P13563, DOI 10.1074/jbc.M113.460436; Chai YS, 2013, EUR J PHARMACOL, V708, P44, DOI 10.1016/j.ejphar.2013.02.041; Chen L, 2014, J BIOL CHEM, V289, P17932, DOI 10.1074/jbc.M114.564534; Chen XYL, 2018, J STORED PROD RES, V77, P156, DOI 10.1016/j.jspr.2018.04.012; da Silva AR, 2016, ANTIMICROB AGENTS CH, V60, P3551, DOI 10.1128/AAC.01846-15; Derosa G, 2012, EXPERT OPIN BIOL TH, V12, P1113, DOI 10.1517/14712598.2012.704014; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fatehi-Hassanabad Z, 2005, PHYTOTHER RES, V19, P222, DOI 10.1002/ptr.1661; Hogenkamp DG, 2008, INSECT BIOCHEM MOLEC, V38, P478, DOI 10.1016/j.ibmb.2007.08.002; Horsch M, 1997, PHARMACOL THERAPEUT, V76, P187, DOI 10.1016/S0163-7258(97)00110-1; Iwasa K, 2000, BIOSCI BIOTECH BIOCH, V64, P1998, DOI 10.1271/bbb.64.1998; Jiang X, 2016, J CHEM INF MODEL, V56, P2413, DOI 10.1021/acs.jcim.6b00615; Jung HA, 2009, BIOL PHARM BULL, V32, P1433, DOI 10.1248/bpb.32.1433; Kim LK, 2015, P NATL ACAD SCI USA, V112, pE2891, DOI 10.1073/pnas.1507393112; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kong LD, 2001, PLANTA MED, V67, P74, DOI 10.1055/s-2001-10874; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li BB, 2017, NAT STRUCT MOL BIOL, V24, P362, DOI 10.1038/nsmb.3390; Liu JJ, 2001, CHEM BIOL, V8, P701, DOI 10.1016/S1074-5521(01)00045-X; LIU T, 2014, SCI REP UK, V4; Liu T, 2018, BIOTECHNOL ADV, V36, P1127, DOI 10.1016/j.biotechadv.2018.03.013; Liu T, 2015, FEBS LETT, V589, P110, DOI 10.1016/j.febslet.2014.11.032; Liu T, 2011, BIOCHEM J, V438, P467, DOI 10.1042/BJ20110390; Liu TA, 2011, J BIOL CHEM, V286, P4049, DOI 10.1074/jbc.M110.184796; Liu T, 2009, PROTEIN EXPRES PURIF, V68, P99, DOI 10.1016/j.pep.2009.06.004; Ma C, 2013, CHEM BIOL DRUG DES, V81, P775, DOI 10.1111/cbdd.12124; Ma Y, 2009, BIOORG MED CHEM LETT, V19, P3414, DOI 10.1016/j.bmcl.2009.05.030; Mahuran DJ, 1999, BBA-MOL BASIS DIS, V1455, P105, DOI 10.1016/S0925-4439(99)00074-5; Maier T, 2003, J MOL BIOL, V328, P669, DOI 10.1016/S0022-2836(03)00311-5; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miyazawa M, 2002, J SCI FOOD AGR, V82, P830, DOI 10.1002/jsfa.1112; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Newberry KJ, 2008, J BIOL CHEM, V283, P26795, DOI 10.1074/jbc.M804191200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng PL, 2006, TOXICOL APPL PHARM, V214, P8, DOI 10.1016/j.taap.2005.11.010; Peng WH, 2007, LIFE SCI, V81, P933, DOI 10.1016/j.lfs.2007.08.003; Peters KM, 2008, BIOCHEMISTRY-US, V47, P8122, DOI 10.1021/bi8008246; Qian XH, 2010, J AGR FOOD CHEM, V58, P2613, DOI 10.1021/jf904098w; Qin Y, 2007, CHEM BIODIVERS, V4, P481, DOI 10.1002/cbdv.200790040; Rong S, 2013, INSECT SCI, V20, P109, DOI 10.1111/j.1744-7917.2012.01573.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Singh IP, 2013, EXPERT OPIN THER PAT, V23, P215, DOI 10.1517/13543776.2013.746314; Slamova K, 2010, BIOTECHNOL ADV, V28, P682, DOI 10.1016/j.biotechadv.2010.04.004; Sun YY, 2009, ANTI-CANCER DRUG, V20, P757, DOI 10.1097/CAD.0b013e328330d95b; Sutherland TE, 2011, CHEM BIOL, V18, P569, DOI 10.1016/j.chembiol.2011.02.017; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; Van Dyken SJ, 2017, CELL, V169, P497, DOI 10.1016/j.cell.2017.03.044; Vinetz JM, 1999, P NATL ACAD SCI USA, V96, P14061, DOI 10.1073/pnas.96.24.14061; Vuddanda PR, 2010, EXPERT OPIN INV DRUG, V19, P1297, DOI 10.1517/13543784.2010.517745; Wiesner DL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004701; Williams LK, 2015, NAT CHEM BIOL, V11, P691, DOI [10.1038/NCHEMBIO.1865, 10.1038/nchembio.1865]; Wu Y, 2001, J BIOL CHEM, V276, P42557, DOI 10.1074/jbc.M103479200; Xi Y, 2015, INSECT MOL BIOL, V24, P601, DOI 10.1111/imb.12187; Yamasaki S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3078; Yang Y, 2011, CHEMBIOCHEM, V12, P457, DOI 10.1002/cbic.201000561; Yu G, 2011, J ALZHEIMERS DIS, V24, P525, DOI 10.3233/JAD-2011-101779; Zhang H, 2016, J ASIA-PAC ENTOMOL, V19, P721, DOI 10.1016/j.aspen.2016.06.012; Zhao HL, 2012, DIABETES, V61, P933, DOI 10.2337/db11-1164; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	65	34	38	2	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15429	15438		10.1074/jbc.RA118.004351	http://dx.doi.org/10.1074/jbc.RA118.004351			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30135205	Green Published, hybrid			2022-12-28	WOS:000446549200008
J	Son, YO; Pratheeshkumar, P; Roy, RV; Hitron, JA; Wang, L; Divya, SP; Xu, M; Luo, J; Chen, G; Zhang, Z; Shi, XL				Son, Young-Ok; Pratheeshkumar, Poyil; Roy, Ram Vinod; Hitron, John Andrew; Wang, Lei; Divya, Sasidharan Padmaja; Xu, Mei; Luo, Jia; Chen, Gang; Zhang, Zhuo; Shi, Xianglin			RETRACTION: Antioncogenic and oncogenic properties of Nrf2 in arsenic-induced carcinogenesis. (Retraction of Vol 290, Pg 27090, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Son YO, 2015, J BIOL CHEM, V290, P27090, DOI 10.1074/jbc.M115.675371	1	0	0	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15456	15456		10.1074/jbc.W118.005758	http://dx.doi.org/10.1074/jbc.W118.005758			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30291177	hybrid, Green Published			2022-12-28	WOS:000446549200011
J	De, S; Karim, F; Kiessu, E; Cushing, L; Lin, LL; Ghandil, P; Hoarau, C; Casanova, JL; Puel, A; Rao, VR				De, Saurav; Karim, Fawziya; Kiessu, Ezechielle; Cushing, Leah; Lin, Lih-Ling; Ghandil, Pegah; Hoarau, Cyrille; Casanova, Jean-Laurent; Puel, Anne; Rao, Vikram R.			Mechanism of dysfunction of human variants of the IRAK4 kinase and a role for its kinase activity in interleukin-1 receptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interleukin 1 (IL-1); myeloid differentiation primary response gene 88 (MyD88); Toll; interleukin-1 receptor (TIR); protein kinase; inflammation; cytokine; cell signaling; innate immunity; interleukin-1 receptor-associated kinase 4 (IRAK4)	BACTERIAL-INFECTIONS; MYD88; ACTIVATION; REDUNDANT; AUTOPHOSPHORYLATION; PHOSPHORYLATION; INFLAMMATION	Interleukin-1 receptor (IL1R)-associated kinase 4 (IRAK4) is a central regulator of innate immune signaling, controlling IL1R and Toll-like receptor (TLR)-mediated responses and containing both scaffolding and kinase activities. Humans deficient in IRAK4 activity have autosomal recessive primary immune deficiency (PID). Here, we characterized the molecular mechanism of dysfunction of two IRAK4 PID variants, G298D and the compound variant R12C (R12C/R391H/T458I). Using these variants and the kinase-inactive D329A variant to delineate the contributions of IRAK4's scaffolding and kinase activities to IL1R signaling, we found that the G298D variant is kinase-inactive and expressed at extremely low levels, acting functionally as a null mutation. The R12C compound variant possessed WT kinase activity, but could not interact with myeloid differentiation primary response 88 (MyD88) and IRAK1, causing impairment of IL-1-induced signaling and cytokine production. Quantitation of IL-1 signaling in IRAK4-deficient cells complemented with either WT or the R12C or D329A variant indicated that the loss of MyD88 interaction had a greater impact on IL-1-induced signaling and cytokine expression than the loss of IRAK4 kinase activity. Importantly, kinase-inactive IRAK4 exhibited a greater association with MyD88 and a weaker association with IRAK1 in IRAK4-deficient cells expressing kinase-inactive IRAK4 and in primary cells treated with a selective IRAK4 inhibitor. Loss of IRAK4 kinase activity only partially inhibited IL-1-induced cytokine and NF-B signaling. Therefore, the IRAK4-MyD88 scaffolding function is essential for IL-1 signaling, but IRAK4 kinase activity can control IL-1 signal strength by modulating the association of IRAK4, MyD88, and IRAK1.	[De, Saurav; Karim, Fawziya; Kiessu, Ezechielle; Cushing, Leah; Lin, Lih-Ling; Rao, Vikram R.] Pfizer Inc, Inflammat & Immunol Res Unit, Cambridge, MA 02139 USA; [Casanova, Jean-Laurent; Puel, Anne] Paris Descartes Univ, Imagine Inst, F-75015 Paris, France; [Casanova, Jean-Laurent; Puel, Anne] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10065 USA; [Casanova, Jean-Laurent] Necker Hosp Sick Children, AP HP, Pediat Hematol Immunol Unit, F-75015 Paris, France; [Casanova, Jean-Laurent; Puel, Anne] INSERM, U1163, Necker Branch, Lab Human Genet Infect Dis, F-75015 Paris, France; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY 10065 USA; [Hoarau, Cyrille] Reg Univ Hosp Ctr Tours, Transversal Unit Allergol & Clin Immunol, F-37044 Tours 9, France; [Ghandil, Pegah] Ahvaz Jundishapur Univ Med Sci, Diabet Res Ctr, Ahvaz 6135715794, Iran; [Ghandil, Pegah] Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Med Genet, Ahvaz 6135715794, Iran; [Karim, Fawziya] Pfizer Biotherapeut Pharmaceut Res & Dev, Formulat & Proc Dev, Andover, MA 01810 USA; [Kiessu, Ezechielle] Shenandoah Univ, Sch Pharm, Winchester, VA 22601 USA; [Cushing, Leah] EMD Serono Inc, 45 Middlesex Turnpike, Billerica, MA 01821 USA; [Lin, Lih-Ling] Sanofi Immunol & Inflammat, 270 Albany St, Cambridge, MA 02139 USA	Pfizer; UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute; Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS); Pfizer; Merck KGaA; EMD Serono Inc.	Rao, VR (corresponding author), Inflammat & Immunol Res Unit, 1 Portland St, Cambridge, MA 02139 USA.	vikram.rao@pfizer.com	Puel, Anne/H-7305-2017	Puel, Anne/0000-0003-2603-0323	Pfizer Inc.	Pfizer Inc.(Pfizer)	This work was supported by Pfizer Inc. S. D., F. K,. and V. R. R. are paid employees of Pfizer Inc. E. K., L. C., and L.- L. L. were paid employees of Pfizer Inc. at the time of this work.	Alsina L, 2014, NAT IMMUNOL, V15, P1134, DOI 10.1038/ni.3028; Chaudhary D, 2015, J MED CHEM, V58, P96, DOI 10.1021/jm5016044; Cushing L, 2017, J BIOL CHEM, V292, P18689, DOI 10.1074/jbc.M117.796912; Cushing L, 2014, J BIOL CHEM, V289, P10865, DOI 10.1074/jbc.M113.544809; Dossang ACG, 2016, SCI REP-UK, V6, DOI 10.1038/srep37267; Ferrao R, 2014, MOL CELL, V55, P891, DOI 10.1016/j.molcel.2014.08.006; Hoarau C, 2007, J IMMUNOL, V179, P4754, DOI 10.4049/jimmunol.179.7.4754; Israel L, 2017, CELL, V168, P789, DOI 10.1016/j.cell.2017.01.039; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Lee KL, 2017, J MED CHEM, V60, P5521, DOI 10.1021/acs.jmedchem.7b00231; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Luciano BS, 2004, J BIOL CHEM, V279, P52117, DOI 10.1074/jbc.M403716200; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Qin JZ, 2004, J BIOL CHEM, V279, P26748, DOI 10.1074/jbc.M400785200; Schett G, 2016, NAT REV RHEUMATOL, V12, P14, DOI 10.1038/nrrheum.2016.166; Song KW, 2009, MOL IMMUNOL, V46, P1458, DOI 10.1016/j.molimm.2008.12.012; Vollmer S, 2017, BIOCHEM J, V474, P2027, DOI 10.1042/BCJ20170097; Yamamoto T, 2014, MOL IMMUNOL, V58, P66, DOI 10.1016/j.molimm.2013.11.008	20	11	12	0	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15208	15220		10.1074/jbc.RA118.003831	http://dx.doi.org/10.1074/jbc.RA118.003831			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30115681	Green Published, hybrid			2022-12-28	WOS:000445998400021
J	Li, SH; Sato, K; Gordon, WC; Sendtner, M; Bazan, NG; Jin, MH				Li, Songhua; Sato, Kota; Gordon, William C.; Sendtner, Michael; Bazan, Nicolas G.; Jin, Minghao			Ciliary neurotrophic factor (CNTF) protects retinal cone and rod photoreceptors by suppressing excessive formation of the visual pigments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phototransduction; retinal degeneration; retinoid; photoreceptor; vision; CNTF; electroretinography; opsin; RPE65; visual cycle	LEUKEMIA INHIBITORY FACTOR; CELL INTRAOCULAR IMPLANTS; LIGHT-INDUCED DEGENERATION; RETINITIS-PIGMENTOSA; MOUSE RETINA; IN-VIVO; BINDING PROTEIN; RAT RETINA; MEDIATED DIFFERENTIATION; MACULAR DEGENERATION	The retinal pigment epithelium (RPE)-dependent visual cycle provides 11-cis-retinal to opsins in the photoreceptor outer segments to generate functional visual pigments that initiate phototransduction in response to light stimuli. Both RPE65 isomerase of the visual cycle and the rhodopsin visual pigment have recently been identified as critical players in mediating light-induced retinal degeneration. These findings suggest that the expression and function of RPE65 and rhodopsin need to be coordinately controlled to sustain normal vision and to protect the retina from photodamage. However, the mechanism controlling the development of the retinal visual system remains poorly understood. Here, we show that deficiency in ciliary neurotrophic factor (CNTF) up-regulates the levels of rod and cone opsins accompanied by an increase in the thickness of the outer nuclear layers and the lengths of cone and rod outer segments in the mouse retina. Moreover, retinoid isomerase activity, expression levels of RPE65 and lecithin:retinol acyltransferase (LRAT), which synthesizes the RPE65 substrate, were also significantly increased in the Cntf(-/-) RPE. Rod a-wave and cone b-wave amplitudes of electroretinograms were increased in Cntf(-/-) mice, but rod b-wave amplitudes were unchanged compared with those in WT mice. Up-regulated RPE65 and LRAT levels accelerated both the visual cycle rate and recovery rate of rod light sensitivity in Cntf(-/-) mice. Of note, rods and cones in Cntf(-/-) mice exhibited hypersusceptibility to light-induced degeneration. These results indicate that CNTF is a common extracellular factor that prevents excessive production of opsins, the photoreceptor outer segments, and 11-cis-retinal to protect rods and cones from photodamage.	[Li, Songhua; Sato, Kota; Gordon, William C.; Bazan, Nicolas G.; Jin, Minghao] Louisiana State Univ, Sch Med, Neurosci Ctr Excellence, New Orleans, LA 70112 USA; [Gordon, William C.; Bazan, Nicolas G.; Jin, Minghao] Louisiana State Univ, Sch Med, Dept Ophthalmol, New Orleans, LA 70112 USA; [Sendtner, Michael] Univ Hosp Wurzburg, Inst Clin Neurobiol, D-97078 Wurzburg, Germany	Louisiana State University System; Louisiana State University System; University of Wurzburg	Jin, MH (corresponding author), LSU Sch Med, Neurosci Ctr, 2020 Gravier St, New Orleans, LA 70112 USA.	mjin@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020; Sendtner, Michael/M-8137-2014	Bazan, Nicolas/0000-0002-9243-5444; Sendtner, Michael/0000-0002-4737-2974	National Institutes of Health [EY021208, GM103340, EY005121]; Louisiana State University School of Medicine Research Enhancement Fund; Interdisziplinares Zentrum fur Klinische Forschung Grant [N-304]; NATIONAL EYE INSTITUTE [R01EY028572, R01EY021208, R01EY005121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana State University School of Medicine Research Enhancement Fund; Interdisziplinares Zentrum fur Klinische Forschung Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants EY021208 (to M. J.), GM103340 (to N. G. B.), and EY005121 (to N. G. B), Louisiana State University School of Medicine Research Enhancement Fund (to M. J.), and Interdisziplinares Zentrum fur Klinische Forschung Grant N-304 (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BATTELLE BA, 1978, EXP EYE RES, V26, P487, DOI 10.1016/0014-4835(78)90134-3; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Beltran WA, 2005, MOL VIS, V11, P232; Beltran WA, 2003, INVEST OPHTH VIS SCI, V44, P3642, DOI 10.1167/iovs.02-0763; Beltran WA, 2007, EXP EYE RES, V84, P753, DOI 10.1016/j.exer.2006.12.019; Bhattacharya S, 2004, MOL CELL NEUROSCI, V27, P32, DOI 10.1016/j.mcn.2004.05.004; Birch DG, 2016, AM J OPHTHALMOL, V170, P10, DOI 10.1016/j.ajo.2016.07.013; Birch DG, 2013, AM J OPHTHALMOL, V156, P283, DOI 10.1016/j.ajo.2013.03.021; Bok D, 2002, EXP EYE RES, V74, P719, DOI 10.1006/exer.2002.1176; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Bush RA, 2004, INVEST OPHTH VIS SCI, V45, P2420, DOI 10.1167/iovs.03-1342; Campochiaro PA, 2018, PROG RETIN EYE RES, V62, P24, DOI 10.1016/j.preteyeres.2017.08.004; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Chucair-Elliott AJ, 2012, J BIOL CHEM, V287, P24092, DOI 10.1074/jbc.M112.378240; Danciger M, 2000, MAMM GENOME, V11, P422, DOI 10.1007/s003350010081; Do Rhee K, 2007, INVEST OPHTH VIS SCI, V48, P1389, DOI 10.1167/iovs.06-0677; Elliott J, 2006, DEV BIOL, V300, P583, DOI 10.1016/j.ydbio.2006.09.002; Ezzeddine ZD, 1997, DEVELOPMENT, V124, P1055; Fischer D, 2017, EYE, V31, P173, DOI 10.1038/eye.2016.234; FUHRMANN S, 1995, DEVELOPMENT, V121, P2695; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Graham DR, 2005, INVEST OPHTH VIS SCI, V46, P2601, DOI 10.1167/iovs.05-0129; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Gupta SK, 1997, BIOCHEM CELL BIOL, V75, P119, DOI 10.1139/bcb-75-2-119; Hafezi F, 1997, NAT MED, V3, P346, DOI 10.1038/nm0397-346; Hollyfield JG, 1999, INVEST OPHTH VIS SCI, V40, P2767; Hood DC, 1996, J OPT SOC AM A, V13, P623, DOI 10.1364/JOSAA.13.000623; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jin MH, 2007, J BIOL CHEM, V282, P20915, DOI 10.1074/jbc.M701432200; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; Ju WK, 1999, NEUROREPORT, V10, P419, DOI 10.1097/00001756-199902050-00038; Kaschula CH, 2006, EXP EYE RES, V82, P111, DOI 10.1016/j.exer.2005.05.010; Kassen SC, 2009, EXP EYE RES, V88, P1051, DOI 10.1016/j.exer.2009.01.007; Kaylor JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125921; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Komeima K, 2008, FREE RADICAL BIO MED, V45, P905, DOI 10.1016/j.freeradbiomed.2008.06.020; Kondo M, 2001, INVEST OPHTH VIS SCI, V42, P305; Kunchithapautham K, 2011, INVEST OPHTH VIS SCI, V52, P2967, DOI 10.1167/iovs.10-6278; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; Lee M, 2016, INVEST OPHTH VIS SCI, V57, P1553, DOI 10.1167/iovs.15-18551; Lei B, 2000, INVEST OPHTH VIS SCI, V41, P262; Li RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024417; Li SH, 2016, J NEUROSCI, V36, P5808, DOI 10.1523/JNEUROSCI.3857-15.2016; Li SH, 2014, J BIOL CHEM, V289, P18943, DOI 10.1074/jbc.M114.552117; Li SH, 2013, J BIOL CHEM, V288, P11395, DOI 10.1074/jbc.M112.418251; Li SH, 2013, J NEUROSCI, V33, P3178, DOI 10.1523/JNEUROSCI.2428-12.2013; Li YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009495; Liang FQ, 2001, MOL THER, V3, P241, DOI 10.1006/mthe.2000.0252; Liang FQ, 2001, MOL THER, V4, P461, DOI 10.1006/mthe.2001.0473; Lopes VS, 2011, HUM MOL GENET, V20, P2560, DOI 10.1093/hmg/ddr155; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; McGill TJ, 2007, INVEST OPHTH VIS SCI, V48, P5756, DOI 10.1167/iovs.07-0054; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Okano K, 2012, J NEUROCHEM, V121, P146, DOI 10.1111/j.1471-4159.2012.07647.x; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Rhee KD, 2004, J NEUROSCI, V24, P9779, DOI 10.1523/JNEUROSCI.1785-04.2004; Rhee KD, 2003, MOL VIS, V9, P715; Rhee KD, 2013, P NATL ACAD SCI USA, V110, pE4520, DOI 10.1073/pnas.1303604110; Roger J, 2006, DEV BIOL, V298, P527, DOI 10.1016/j.ydbio.2006.07.003; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Sato K, 2013, J NEUROSCI, V33, P17458, DOI 10.1523/JNEUROSCI.1380-13.2013; Schlichtenbrede FC, 2003, GENE THER, V10, P523, DOI 10.1038/sj.gt.3301929; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; Sherry DM, 2005, J NEUROSCI RES, V82, P316, DOI 10.1002/jnr.20619; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Sieving PA, 2001, P NATL ACAD SCI USA, V98, P1835, DOI 10.1073/pnas.041606498; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; Talcott KE, 2011, INVEST OPHTH VIS SCI, V52, P2219, DOI 10.1167/iovs.10-6479; Tao W, 2002, INVEST OPHTH VIS SCI, V43, P3292; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Usui S, 2009, J NEUROCHEM, V110, P1028, DOI 10.1111/j.1471-4159.2009.06195.x; Walsh N, 2001, EXP EYE RES, V72, P495, DOI 10.1006/exer.2000.0984; WEN R, 1995, J NEUROSCI, V15, P7377; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; Wen R, 2012, PROG RETIN EYE RES, V31, P136, DOI 10.1016/j.preteyeres.2011.11.005; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Xie HQ, 2000, INVEST OPHTH VIS SCI, V41, P4317; Xiong WJ, 2015, J CLIN INVEST, V125, P1433, DOI 10.1172/JCI79735; Xue W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020326; Zhang K, 2011, P NATL ACAD SCI USA, V108, P6241, DOI 10.1073/pnas.1018987108; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	84	13	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15256	15268		10.1074/jbc.RA118.004008	http://dx.doi.org/10.1074/jbc.RA118.004008			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30115683	Green Published, hybrid			2022-12-28	WOS:000445998400025
J	Desbois, M; Crawley, O; Evans, PR; Baker, ST; Masuho, I; Yasuda, R; Grill, B				Desbois, Muriel; Crawley, Oliver; Evans, Paul R.; Baker, Scott T.; Masuho, Ikuo; Yasuda, Ryohei; Grill, Brock			PAM forms an atypical SCF ubiquitin ligase complex that ubiquitinates and degrades NMNAT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; neuron; axon; proteasome; fluorescence resonance energy transfer (FRET); Caenorhabditis elegans (C; elegans); neurodegeneration; FBXO45; MYCBP2; NMNAT; PAM; RPM-1; PHR protein; ubiquitin ligase; FSN-1; F-box; axon degeneration; ubiquitination	REGULATES AXON TERMINATION; C-ELEGANS RPM-1; WALLERIAN DEGENERATION; NEURONAL DEVELOPMENT; PROTEIN-DEGRADATION; CANCER; SYNAPTOGENESIS; DROSOPHILA; REVEALS; GROWTH	PHR (PAM/Highwire/RPM-1) proteins are conserved RING E3 ubiquitin ligases that function in developmental processes, such as axon termination and synapse formation, as well as axon degeneration. At present, our understanding of how PHR proteins form ubiquitin ligase complexes remains incomplete. Although genetic studies indicate NMNAT2 is an important mediator of PHR protein function in axon degeneration, it remains unknown how PHR proteins inhibit NMNAT2. Here, we decipher the biochemical basis for how the human PHR protein PAM, also called MYCBP2, forms a noncanonical Skp/Cullin/F-box (SCF) complex that contains the F-box protein FBXO45 and SKP1 but lacks CUL1. We show FBXO45 does not simply function in substrate recognition but is important for assembly of the PAM/FBXO45/SKP1 complex. Interestingly, we demonstrate a novel role for SKP1 as an auxiliary component of the target recognition module that enhances binding of FBXO45 to NMNAT2. Finally, we provide biochemical evidence that PAM polyubiquitinates NMNAT2 and regulates NMNAT2 protein stability and degradation by the proteasome.	[Desbois, Muriel; Crawley, Oliver; Baker, Scott T.; Masuho, Ikuo; Grill, Brock] Scripps Res Inst, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA; [Evans, Paul R.; Yasuda, Ryohei] Max Planck Florida Inst Neurosci, Jupiter, FL 33458 USA	Scripps Research Institute; Max Planck Society	Grill, B (corresponding author), Scripps Res Inst, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA.	bgrill@scripps.edu	Crawley, Oliver/U-2606-2018; Desbois, Muriel/AAD-3598-2022; Crawley, Oliver/AAE-9865-2019	Crawley, Oliver/0000-0002-5054-0051; Desbois, Muriel/0000-0002-8070-2525; Crawley, Oliver/0000-0002-5054-0051; Grill, Brock/0000-0002-0379-3267; Yasuda, Ryohei/0000-0001-6263-9297	National Institutes of Health [R01 NS072129]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01 NS072129 (to B. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali YO, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002472; Avery MA, 2009, J CELL BIOL, V184, P501, DOI 10.1083/jcb.200808042; Babetto E, 2013, CELL REP, V3, P1422, DOI 10.1016/j.celrep.2013.04.013; Baker ST, 2017, J BIOL CHEM, V292, P2519, DOI 10.1074/jbc.M116.748004; Baker ST, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004297; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Borgen M, 2017, GENETICS, V205, P1229, DOI 10.1534/genetics.116.197343; Borgen MA, 2017, DEVELOPMENT, V144, P4658, DOI 10.1242/dev.154187; Brace EJ, 2014, J NEUROSCI, V34, P8398, DOI 10.1523/JNEUROSCI.4715-13.2014; Brazill JM, 2017, CURR OPIN GENET DEV, V44, P156, DOI 10.1016/j.gde.2017.03.014; Chang JY, 2017, NEURON, V94, P800, DOI 10.1016/j.neuron.2017.04.041; Chang LF, 2014, CURR OPIN STRUC BIOL, V29, P1, DOI 10.1016/j.sbi.2014.08.003; Chen X, 2014, CELL DEATH DIFFER, V21, P1535, DOI 10.1038/cdd.2014.92; Chung FZ, 2014, J BIOL CHEM, V289, P28448, DOI 10.1074/jbc.M114.561241; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Davis MA, 2013, GENE DEV, V27, P151, DOI 10.1101/gad.207720.112; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Gao MX, 2008, CELL DEATH DIFFER, V15, P1054, DOI 10.1038/cdd.2008.30; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Goo MS, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00060; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Grill B, 2016, NEURAL DEV, V11, DOI 10.1186/s13064-016-0063-0; Hebbar N, 2017, CANCER RES, V77, P4039, DOI 10.1158/0008-5472.CAN-16-1970; Hicks AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047869; Huntwork-Rodriguez S, 2013, J CELL BIOL, V202, P747, DOI 10.1083/jcb.201303066; Kirkin V, 2011, CURR OPIN GENET DEV, V21, P21, DOI 10.1016/j.gde.2010.10.004; Kitay BM, 2013, HUM MOL GENET, V22, P1601, DOI 10.1093/hmg/ddt009; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Ljungberg MC, 2012, HUM MOL GENET, V21, P251, DOI 10.1093/hmg/ddr492; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Matarin M, 2015, CELL REP, V10, P633, DOI 10.1016/j.celrep.2014.12.041; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Neukomm LJ, 2017, NEURON, V95, P78, DOI 10.1016/j.neuron.2017.06.031; Opperman KJ, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-10; Pao KC, 2018, NATURE, V556, P381, DOI 10.1038/s41586-018-0026-1; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reitsma JM, 2017, CELL, V171, P1326, DOI 10.1016/j.cell.2017.10.016; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ruan K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10057; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Salat D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130288; Scaravilli M, 2015, PROSTATE, V75, P798, DOI 10.1002/pros.22961; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Sharma J, 2014, J BIOL CHEM, V289, P34654, DOI 10.1074/jbc.M114.614065; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tricoli JV, 2018, CANCER-AM CANCER SOC, V124, P1070, DOI 10.1002/cncr.31136; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wu CL, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-16; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xiong X, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001440; Xu M, 2015, ONCOTARGET, V6, P979, DOI 10.18632/oncotarget.2825; Yamagishi Y, 2016, CELL REP, V17, P774, DOI 10.1016/j.celrep.2016.09.043; Yasuda R, 2006, CURR OPIN NEUROBIOL, V16, P551, DOI 10.1016/j.conb.2006.08.012; Yasuda R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005611; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	66	20	19	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13897	13909		10.1074/jbc.RA118.002176	http://dx.doi.org/10.1074/jbc.RA118.002176			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	29997255	hybrid, Green Published			2022-12-28	WOS:000444070700016
J	Shridas, P; De Beer, MC; Webb, NR				Shridas, Preetha; De Beer, Maria C.; Webb, Nancy R.			High-density lipoprotein inhibits serum amyloid A-mediated reactive oxygen species generation and NLRP3 inflammasome activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABDOMINAL AORTIC-ANEURYSM; ACUTE-PHASE PROTEIN; PEPTIDE RECEPTOR 2; PERITONEAL-MACROPHAGES; CHOLESTEROL CRYSTALS; NALP3 INFLAMMASOME; PHYSIOLOGICAL-ROLE; CCL2 PRODUCTION; ROS PRODUCTION; CUTTING EDGE	Serum amyloid A (SAA) is a high-density apolipoprotein whose plasma levels can increase more than 1000-fold during a severe acute-phase inflammatory response and are more modestly elevated in chronic inflammation. SAA is thought to play important roles in innate immunity, but its biological activities have not been completely delineated. We previously reported that SAA deficiency protects mice from developing abdominal aortic aneurysms (AAAs) induced by chronic angiotensin II (AngII) infusion. Here, we report that SAA is required for AngII-induced increases in interleukin-1 beta (IL-1 beta), a potent proinflammatory cytokine that is tightly controlled by the Nod-like receptor protein 3 (NLRP3) inflammasome and caspase-1 and has been implicated in both human and mouse AAAs. We determined that purified SAA stimulates IL-1 beta secretion in murine J774 and bone marrow-derived macrophages through a mechanism that depends on NLRP3 expression and caspase-1 activity, but is independent of P2X7 nucleotide receptor (P2X7R) activation. Inhibiting reactive oxygen species (ROS) by N-acetyl-L-cysteine or mito-TEMPO and inhibiting activation of cathepsin B by CA-074 blocked SAA-mediated inflammasome activation and IL-1 beta secretion. Moreover, inhibiting cellular potassium efflux with glyburide or increasing extracellular potassium also significantly reduced SAA-mediated IL-1 beta secretion. Of note, incorporating SAA into high-density lipoprotein (HDL) prior to its use in cell treatments completely abolished its ability to stimulate ROS generation and inflammasome activation. These results provide detailed insights into SAA-mediated IL-1 beta production and highlight HDL's role in regulating SAA's proinflammatory effects.	[Shridas, Preetha] Univ Kentucky, Dept Internal Med, 537 CT Wethington Bldg,900 S Limestone St, Lexington, KY 40536 USA; [De Beer, Maria C.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [De Beer, Maria C.; Webb, Nancy R.] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA; [Webb, Nancy R.] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Shridas, Preetha; De Beer, Maria C.; Webb, Nancy R.] Univ Kentucky, Barnstable Brown Diabet Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Shridas, P (corresponding author), Univ Kentucky, Dept Internal Med, 537 CT Wethington Bldg,900 S Limestone St, Lexington, KY 40536 USA.	pshri2@uky.edu	Webb, Nancy/AAL-7030-2021	shridas, Preetha/0000-0002-2532-4007	National Institutes of Health [HL134731]; Institutional Development Award (IDeA), National Institute of Health NIGMS [P20 GM103527]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL134731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527, P30GM127211] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Development Award (IDeA), National Institute of Health NIGMS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant HL134731 (to N. R. W) and Institutional Development Award (IDeA), National Institute of Health NIGMS Grant P20 GM103527. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amstad PA, 2001, BIOTECHNIQUES, V31, P608, DOI 10.2144/01313pf01; Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Anderberg RJ, 2015, LAB INVEST, V95, P250, DOI 10.1038/labinvest.2014.163; Ather JL, 2011, J IMMUNOL, V187, P64, DOI 10.4049/jimmunol.1100500; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bjorkman L, 2008, J LEUKOCYTE BIOL, V83, P245, DOI 10.1189/jlb.0607-408; Bjorkman L, 2010, ARTHRITIS RHEUM-US, V62, P1660, DOI 10.1002/art.27440; Cai L, 2005, J BIOL CHEM, V280, P2954, DOI 10.1074/jbc.M411555200; Calero C, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-95; Chen MJ, 2014, IMMUNOBIOLOGY, V219, P916, DOI 10.1016/j.imbio.2014.08.002; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Claus S, 2017, EMBO REP, V18, P1352, DOI 10.15252/embr.201643411; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; Connolly M, 2010, J IMMUNOL, V184, P6427, DOI 10.4049/jimmunol.0902941; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; de Beer MC, 2010, J LIPID RES, V51, P3117, DOI 10.1194/jlr.M005413; DEBEER MC, 1995, J LIPID RES, V36, P526; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Gombault A, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00414; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Han CY, 2016, J CLIN INVEST, V126, P796, DOI 10.1172/JCI86401; Hatanaka E, 2011, CLIN EXP IMMUNOL, V163, P362, DOI 10.1111/j.1365-2249.2010.04300.x; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Jabaut J, 2013, FREE RADICAL BIO MED, V60, P233, DOI 10.1016/j.freeradbiomed.2013.01.025; Jayaraman S, 2015, J LIPID RES, V56, P1531, DOI 10.1194/jlr.M059162; Jin CC, 2011, P NATL ACAD SCI USA, V108, P14867, DOI 10.1073/pnas.1111101108; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; Johnston WF, 2014, CIRCULATION, V130, pS51, DOI 10.1161/CIRCULATIONAHA.113.006800; Johnston WF, 2013, ARTERIOSCL THROM VAS, V33, P294, DOI 10.1161/ATVBAHA.112.300432; Juvonen J, 1997, ARTERIOSCL THROM VAS, V17, P2843, DOI 10.1161/01.ATV.17.11.2843; Kim MH, 2013, CYTOKINE, V61, P506, DOI 10.1016/j.cyto.2012.10.019; Kluve-Beckerman B, 1999, AM J PATHOL, V155, P123, DOI 10.1016/S0002-9440(10)65107-3; Kluve-Beckerman B, 2001, SCAND J IMMUNOL, V53, P393, DOI 10.1046/j.1365-3083.2001.00879.x; KLUVEBECKERMAN B, 1991, DNA CELL BIOL, V10, P651, DOI 10.1089/dna.1991.10.651; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee HY, 2008, J IMMUNOL, V181, P4332, DOI 10.4049/jimmunol.181.6.4332; Lee HY, 2010, EXP MOL MED, V42, P302, DOI 10.3858/emm.2010.42.4.029; Lindhorst E, 1997, BBA-PROTEIN STRUCT M, V1339, P143, DOI 10.1016/S0167-4838(96)00227-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lopez-Campos JL, 2013, INT J MED SCI, V10, P938, DOI 10.7150/ijms.6152; Man SM, 2015, IMMUNOL REV, V265, P6, DOI 10.1111/imr.12296; MCCUBBIN WD, 1988, BIOCHEM J, V256, P775, DOI 10.1042/bj2560775; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; Migita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096703; Navab Mohamad, 2007, Curr Atheroscler Rep, V9, P244, DOI 10.1007/s11883-007-0026-3; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Pannell M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0735-z; Patel MN, 2017, TRENDS MOL MED, V23, P165, DOI 10.1016/j.molmed.2016.12.007; Patke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064974; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; PRECIADOPATT L, 1994, EUR J BIOCHEM, V223, P35, DOI 10.1111/j.1432-1033.1994.tb18963.x; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ren SW, 2014, INT J OPHTHALMOL-CHI, V7, P187, DOI 10.3980/j.issn.2222-3959.2014.02.01; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Roberts RL, 2011, ATHEROSCLEROSIS, V218, P123, DOI 10.1016/j.atherosclerosis.2011.04.043; Rocken C, 2005, ANN RHEUM DIS, V64, P808, DOI 10.1136/ard.2004.030429; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Simons JP, 2013, P NATL ACAD SCI USA, V110, P16115, DOI 10.1073/pnas.1306621110; Song CJ, 2009, ATHEROSCLEROSIS, V207, P374, DOI 10.1016/j.atherosclerosis.2009.05.007; Srinivasan S, 2013, J BIOL CHEM, V288, P2744, DOI 10.1074/jbc.M112.394155; STRACHAN AF, 1989, BIOCHEM J, V263, P365, DOI 10.1042/bj2630365; Sun WL, 2015, J MOL CELL CARDIOL, V81, P96, DOI 10.1016/j.yjmcc.2015.02.005; Tam SP, 2002, J LIPID RES, V43, P1410, DOI 10.1194/jlr.M100388-JLR200; Tannock LR, 2018, J LIPID RES, V59, P339, DOI 10.1194/jlr.M080887; Thacker SG, 2016, IMMUNOLOGY, V149, P306, DOI 10.1111/imm.12638; Tolle M, 2012, CARDIOVASC RES, V94, P154, DOI 10.1093/cvr/cvs089; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Usui F, 2015, ARTERIOSCL THROM VAS, V35, P127, DOI 10.1161/ATVBAHA.114.303763; van den Brand B, 2013, ARTHRITIS RHEUM-US, V65, P283, DOI 10.1002/art.37737; Webb NR, 2015, ARTERIOSCL THROM VAS, V35, P1156, DOI 10.1161/ATVBAHA.114.304776; Witting PK, 2011, FREE RADICAL BIO MED, V51, P1390, DOI 10.1016/j.freeradbiomed.2011.06.031; Wu D, 2017, ARTERIOSCL THROM VAS, V37, P694, DOI 10.1161/ATVBAHA.116.307648	80	42	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13257	13269		10.1074/jbc.RA118.002428	http://dx.doi.org/10.1074/jbc.RA118.002428			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29976759	Green Published, hybrid			2022-12-28	WOS:000442730200024
J	Gozdziewicz, TK; Lugowski, C; Lukasiewicz, J				Gozdziewicz, Tomasz K.; Lugowski, Czeslaw; Lukasiewicz, Jolanta			First evidence for a covalent linkage between enterobacterial common antigen and lipopolysaccharide in Shigella sonnei phase II ECA(LPS) (vol 289, pg 2745, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Lugowski, Czeslaw/0000-0002-2336-0530; Lukasiewicz, Jolanta/0000-0001-8081-7261				Gozdziewicz TK, 2014, J BIOL CHEM, V289, P2745, DOI 10.1074/jbc.M113.512749; Jansson PE, 2006, CARBOHYD RES, V341, P1003, DOI 10.1016/j.carres.2006.02.034; Lundborg M, 2011, ANAL CHEM, V83, P1514, DOI 10.1021/ac1032534	3	3	4	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11652	11653		10.1074/jbc.AAC118.004605	http://dx.doi.org/10.1074/jbc.AAC118.004605			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	30030387	hybrid, Green Published			2022-12-28	WOS:000439449700036
J	Thompson, JL; Yue, LZ; Stathopulos, PB; Grossfield, A; Shuttleworth, TJ				Thompson, Jill L.; Yue Lai-Zhao; Stathopulos, Peter B.; Grossfield, Alan; Shuttleworth, Trever J.			Phosphorylation-mediated structural changes within the SOAR domain of stromal interaction molecule 1 enable specific activation of distinct Orai channels (vol 293, pg 3145, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Stathopulos, Peter B./0000-0002-0536-6656	NIGMS NIH HHS [R01 GM040457] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040457] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Thompson JL, 2018, J BIOL CHEM, V293, P3145, DOI 10.1074/jbc.M117.819078	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11241	11241		10.1074/jbc.AAC118.004562	http://dx.doi.org/10.1074/jbc.AAC118.004562			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	30006386	hybrid, Green Published			2022-12-28	WOS:000438882800034
J	Todaro, DR; Augustus-Wallace, AC; Klein, JM; Haas, AL				Todaro, Dustin R.; Augustus-Wallace, Allison C.; Klein, Jennifer M.; Haas, Arthur L.			Oligomerization of the HECT ubiquitin ligase NEDD4-2/NEDD4L is essential for polyubiquitin chain assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E2; E3; ubiquitin; ubiquitin ligase; enzyme mechanism; enzyme kinetics; protein complex; protein degradation; protein-protein interactions; HECT ligase; HECT domain; linkage specificity; transthiolation; oligomer	EPITHELIAL NA+ CHANNEL; GATED SODIUM-CHANNELS; PROTEIN; MECHANISMS; DOMAIN; DEGRADATION; SUBSTRATE; REVEALS; NEDD4; THIOL	The NEDD4-2 (neural precursor cell-expressed developmentally down-regulated 4-2) HECT ligase catalyzes polyubiquitin chain assembly by an ordered two-step mechanism requiring two functionally distinct E2 approximate to ubiquitin-binding sites, analogous to the trimeric E6AP/UBE3A HECT ligase. This conserved catalytic mechanism suggests that NEDD4-2, and presumably all HECT ligases, requires oligomerization to catalyze polyubiquitin chain assembly. To explore this hypothesis, we examined the catalytic mechanism of NEDD4-2 through the use of biochemically defined kinetic assays examining rates of I-125-labeled polyubiquitin chain assembly and biophysical techniques. The results from gel filtration chromatography and dynamic light-scattering analyses demonstrate for the first time that active NEDD4-2 is a trimer. Homology modeling to E6AP revealed that the predicted intersubunit interface has an absolutely conserved Phe-823, substitution of which destabilized the trimer and resulted in a 10(4)-fold decrease in k(cat) for polyubiquitin chain assembly. The small-molecule Phe-823 mimic, N-acetylphenylalanyl-amide, acted as a noncompetitive inhibitor (K-i = 8 +/- 1.2 mm) of polyubiquitin chain elongation by destabilizing the active trimer, suggesting a mechanism for therapeutically targeting HECT ligases. Additional kinetic experiments indicated that monomeric NEDD4-2 catalyzes only HECT approximate to ubiquitin thioester formation and monoubiquitination, whereas polyubiquitin chain assembly requires NEDD4-2 oligomerization. These results provide evidence that the previously identified sites 1 and 2 of NEDD4-2 function in trans to support chain elongation, explicating the requirement for oligomerization. Finally, we identified a conserved catalytic ensemble comprising Glu-646 and Arg-604 that supports HECT-ubiquitin thioester exchange and isopeptide bond formation at the active-site Cys-922 of NEDD4-2.	[Todaro, Dustin R.; Augustus-Wallace, Allison C.; Klein, Jennifer M.; Haas, Arthur L.] Louisiana State Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Haas, Arthur L.] Louisiana State Univ, Sch Med, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University System	Haas, AL (corresponding author), LSU Hlth Sci Ctr, Dept Biochem & Mol Biol, 1901 Perdido St, New Orleans, LA 70112 USA.	ahaas@lsuhsc.edu			National Institutes of Health [R01 GM034009, P30 GM106392]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034009, P30GM106392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM034009 (to A.L.H.) and P30 GM106392 (to Daniel R. Kapusta) and an appropriation from the Louisiana State University School of Medicine, New Orleans. The authors declare that they have no conflicts of interest with the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Baboshina OV, 2001, J BIOL CHEM, V276, P39428, DOI 10.1074/jbc.M106967200; Bailey CC, 2013, J BIOL CHEM, V288, P32184, DOI 10.1074/jbc.M113.514356; Bracher PJ, 2011, ORIGINS LIFE EVOL B, V41, P399, DOI 10.1007/s11084-011-9243-4; Brooks WS, 2008, J BIOL CHEM, V283, P22304, DOI 10.1074/jbc.M803238200; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; Castro EA, 1999, CHEM REV, V99, P3505, DOI 10.1021/cr990001d; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; DeLano W.L., 2002, CCP4 NEWSL PROTEIN C, V40, P82; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Edwards DJ, 2014, J BIOL CHEM, V289, P34114, DOI 10.1074/jbc.M114.609164; FEDOR LR, 1965, J AM CHEM SOC, V87, P4138, DOI 10.1021/ja01096a024; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Freed EO, 2002, J VIROL, V76, P4679, DOI 10.1128/JVI.76.10.4679-4687.2002; Goel P, 2015, GENE, V557, P1, DOI 10.1016/j.gene.2014.11.051; Gong TWL, 2003, GENOMICS, V82, P143, DOI 10.1016/S0888-7543(03)00111-3; Gong W, 2015, ACTA CRYSTALLOGR F, V71, P1251, DOI 10.1107/S2053230X1501554X; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Grau-Bove X, 2013, GENOME BIOL EVOL, V5, P833, DOI 10.1093/gbe/evt052; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Haas Arthur L., 2005, V301, P23; Han ZY, 2016, J VIROL, V90, P9163, DOI 10.1128/JVI.01078-16; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kim HT, 2012, METHODS MOL BIOL, V832, P653, DOI 10.1007/978-1-61779-474-2_46; Kimura T, 2011, P NATL ACAD SCI USA, V108, P3216, DOI 10.1073/pnas.1010334108; Laedermann Cedric J, 2014, Handb Exp Pharmacol, V221, P231, DOI 10.1007/978-3-642-41588-3_11; Laedermann CJ, 2013, J CLIN INVEST, V123, P3002, DOI 10.1172/JCI68996; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lorenz S, 2018, BIOL CHEM, V399, P127, DOI 10.1515/hsz-2017-0184; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Mari S, 2014, STRUCTURE, V22, P1639, DOI 10.1016/j.str.2014.09.006; Marin I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-56; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Poole LB, 2015, FREE RADICAL BIO MED, V80, P148, DOI 10.1016/j.freeradbiomed.2014.11.013; Ronchi VP, 2017, J BIOL CHEM, V292, P18006, DOI 10.1074/jbc.M117.813477; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; Ronchi VP, 2013, J BIOL CHEM, V288, P10349, DOI 10.1074/jbc.M113.458059; Ronchi VP, 2012, METHODS MOL BIOL, V832, P197, DOI 10.1007/978-1-61779-474-2_14; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Segel I.H., 1975, ENZYME KINETICS; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Todaro DR, 2017, J BIOL CHEM, V292, P19521, DOI 10.1074/jbc.M117.817882; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Uchiki T, 2009, J BIOL CHEM, V284, P12622, DOI 10.1074/jbc.M900556200; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wu LW, 2015, PHYSIOL BEHAV, V143, P104, DOI 10.1016/j.physbeh.2015.02.026; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	62	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18192	18206		10.1074/jbc.RA118.003716	http://dx.doi.org/10.1074/jbc.RA118.003716			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30287686	Green Published, hybrid			2022-12-28	WOS:000451375200014
J	He, Q; Tang, QY; Sun, YF; Zhou, M; Gartner, W; Zhao, KH				He, Qi; Tang, Qi-Ying; Sun, Ya-Fang; Zhou, Ming; Gaertner, Wolfgang; Zhao, Kai-Hong			Chromophorylation of cyanobacteriochrome Slr1393 from Synechocystis sp PCC 6803 is regulated by protein Slr2111 through allosteric interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyanobacteria; protein-protein interaction; photosynthesis; photosynthetic pigment; photoreceptor; phototransduction; adenosine-binding protein; co-immunoprecipitation; cystathionine beta-synthase domain; phycocyanobilin; regulation	BETA-SYNTHASE DOMAIN; NUCLEOTIDE-BINDING; HISTIDINE KINASE; CBS DOMAINS; INOSINE 5-MONOPHOSPHATE; SIGNAL-TRANSDUCTION; SWISS-MODEL; GAF DOMAIN; FLUORESCENCE; PHYCOCYANOBILIN	Cyanobacteriochromes (CBCRs) are photochromic proteins in cyanobacteria that act as photosensors. CBCRs bind bilins as chromophores and sense nearly the entire visible spectrum of light, but the regulation of the chromophorylation of CBCRs is unknown. Slr1393 from Synechocystis sp. PCC 6803 is a CBCR containing three consecutive GAF (cGMP phosphodiesterase, adenylyl cyclase, and FhlA protein) domains, of which only the third one (Slr1393g3) can be phycocyanobilin-chromophorylated. The protein Slr2111 from Synechocystis sp. PCC 6803 includes a cystathionine -synthase (CBS) domain pair of an as yet unknown function at its N terminus. CBS domains are often characterized as sensors of cellular energy status by binding nucleotides. In this work, we demonstrate that Slr2111 strongly interacts with Slr1393 in vivo and in vitro, which generates a complex in a 1:1 molar ratio. This tight interaction inhibits the chromophorylation of Slr1393g3, even if the chromophore is present. Instead, the complex stability and thereby the chromophorylation of Slr1393 are regulated by the binding of nucleotides (ATP, ADP, AMP) to the CBS domains of Slr2111 with varying affinities. It is demonstrated that residues Asp-53 and Arg-97 of Slr2111 are involved in nucleotide binding. While ATP binds to Slr2111, the association between the two proteins gets weaker and chromophorylation of Slr1393 are enabled. In contrast, AMP binding to Slr2111 leads to a stronger association, thereby inhibiting the chromophorylation. It is concluded that Slr2111 acts as a sensor of the cellular energy status that regulates the chromophorylation of Slr1393 and thereby its function as a light-driven histidine kinase.	[He, Qi; Tang, Qi-Ying; Sun, Ya-Fang; Zhou, Ming; Zhao, Kai-Hong] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China; [Gaertner, Wolfgang] Univ Leipzig, Inst Analyt Chem, D-04103 Leipzig, Germany	Huazhong Agricultural University; Leipzig University	Zhao, KH (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.	khzhao@163.com			National Natural Science Foundation of China [31370777, 21472055, 31770822]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31370777 (to M. Z.) and 21472055 and 31770822 (to K. H. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Baugh L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053851; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; Bilwes AM, 2001, NAT STRUCT BIOL, V8, P353, DOI 10.1038/86243; BIRDSALL B, 1983, ANAL BIOCHEM, V132, P353, DOI 10.1016/0003-2697(83)90020-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bussell AN, 2013, P NATL ACAD SCI USA, V110, P12834, DOI 10.1073/pnas.1303371110; Chen L, 2012, NAT STRUCT MOL BIOL, V19, P716, DOI 10.1038/nsmb.2319; Chen Y, 2012, FEBS J, V279, P40, DOI 10.1111/j.1742-4658.2011.08397.x; COLE WJ, 1968, BIOCHEMISTRY-US, V7, P2929, DOI 10.1021/bi00848a033; De Angeli A, 2009, J BIOL CHEM, V284, P26526, DOI 10.1074/jbc.M109.005132; Ereno-Orbea J, 2013, ARCH BIOCHEM BIOPHYS, V540, P70, DOI 10.1016/j.abb.2013.10.008; Fushimi K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00588; Gomez-Garcia I, 2010, J MOL BIOL, V399, P53, DOI 10.1016/j.jmb.2010.03.045; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Jamsen J, 2007, BIOCHEM J, V408, P327, DOI 10.1042/BJ20071017; Jeong BC, 2013, J STRUCT BIOL, V183, P40, DOI 10.1016/j.jsb.2013.04.013; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; Kushwaha HR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Lucas M, 2010, J MOL BIOL, V396, P800, DOI 10.1016/j.jmb.2009.12.012; Ma Q, 2012, FEBS J, V279, P4095, DOI 10.1111/febs.12003; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Miller J. N., 1979, ANAL P, V16, P203; Narikawa R, 2008, J MOL BIOL, V380, P844, DOI 10.1016/j.jmb.2008.05.035; Nicholas K.B., 1997, EMBNETNEWS, V4, P1; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Paul BK, 2012, PHYS CHEM CHEM PHYS, V14, P15482, DOI 10.1039/c2cp42415k; Pimkin M, 2008, MOL MICROBIOL, V68, P342, DOI 10.1111/j.1365-2958.2008.06153.x; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P9667, DOI 10.1021/bi3013565; Rockwell NC, 2011, P NATL ACAD SCI USA, V108, P11854, DOI 10.1073/pnas.1107844108; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SAMWORTH CM, 1988, EUR J BIOCHEM, V171, P81, DOI 10.1111/j.1432-1033.1988.tb13761.x; Sato S, 2007, DNA RES, V14, P207, DOI 10.1093/dnares/dsm021; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shrivastava R, 2007, FEBS LETT, V581, P1903, DOI 10.1016/j.febslet.2007.03.089; Stewart RC, 1998, BIOCHEMISTRY-US, V37, P12269, DOI 10.1021/bi980970n; Storf M, 2001, BIOCHEMISTRY-US, V40, P12444, DOI 10.1021/bi010776s; Surette MG, 1996, J BIOL CHEM, V271, P939, DOI 10.1074/jbc.271.2.939; TAWA P, 1994, BIOCHEMISTRY-US, V33, P7917, DOI 10.1021/bi00191a019; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Huynh TN, 2016, MOL MICROBIOL, V102, P233, DOI 10.1111/mmi.13456; Ulijasz AT, 2009, J BIOL CHEM, V284, P29757, DOI 10.1074/jbc.M109.038513; Wang W, 1996, BIOCHEMISTRY-US, V35, P95, DOI 10.1021/bi951499q; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xu XL, 2014, CHEMBIOCHEM, V15, P1190, DOI 10.1002/cbic.201400053; Zhang JA, 2010, ANGEW CHEM INT EDIT, V49, P5456, DOI 10.1002/anie.201001094; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200	53	2	2	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17705	17715		10.1074/jbc.RA118.003830	http://dx.doi.org/10.1074/jbc.RA118.003830			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30242127	hybrid, Green Published			2022-12-28	WOS:000450409500004
J	Buchert, F; Hamon, M; Gabelein, P; Scholz, M; Hippler, M; Wollman, FA				Buchert, Felix; Hamon, Marion; Gaebelein, Philipp; Scholz, Martin; Hippler, Michael; Wollman, Francis-Andre			The labile interactions of cyclic electron flow effector proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chlamydomonas; photosynthesis; protein cross-linking; membrane protein; electron transfer complex; cytochrome b6f complex	CYTOCHROME B(6)F COMPLEX; CHLAMYDOMONAS-REINHARDTII; STATE TRANSITIONS; PHOTOSYSTEM-I; MEMBRANE-PROTEINS; PHOTOSYNTHETIC APPARATUS; OXYGENIC PHOTOSYNTHESIS; FLAVODIIRON PROTEINS; THYLAKOID MEMBRANES; AQUEOUS-SOLUTIONS	The supramolecular organization of membrane proteins (MPs) is sensitive to environmental changes in photosynthetic organisms. Isolation of MP supercomplexes from the green algae Chlamydomonas reinhardtii, which are believed to contribute to cyclic electron flow (CEF) between the cytochrome b(6)f complex (Cyt-b(6)f) and photosystem I (PSI), proved difficult. We were unable to isolate a supercomplex containing both Cyt-b(6)f and PSI because in our hands, most of Cyt-b(6)f did not comigrate in sucrose density gradients, even upon using chemical cross-linkers or amphipol substitution of detergents. Assisted by independent affinity purification and MS approaches, we utilized disintegrating MP assemblies and demonstrated that the algae-specific CEF effector proteins PETO and ANR1 are bona fide Cyt-b(6)f interactors, with ANR1 requiring the presence of an additional, presently unknown, protein. We narrowed down the Cyt-b(6)f interface, where PETO is loosely attached to cytochrome f and to a stromal region of subunit IV, which also contains phosphorylation sites for the STT7 kinase.	[Buchert, Felix; Wollman, Francis-Andre] Sorbonne Univ, CNRS, UMR7141, Inst Biol Physicochim, 13 Rue P&M Curie, F-75005 Paris, France; [Buchert, Felix; Gaebelein, Philipp; Scholz, Martin; Hippler, Michael] Univ Munster, Inst Plant Biol & Biotechnol, Schlosspl 8, D-48143 Munster, Germany; [Hamon, Marion] Sorbonne Univ, CNRS, Inst Biol Physicochim, UMR8226,FRC550, 13 Rue P&M Curie, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Munster; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Wollman, FA (corresponding author), Sorbonne Univ, CNRS, UMR7141, Inst Biol Physicochim, 13 Rue P&M Curie, F-75005 Paris, France.	Wollman@ibpc.fr		Michael, Hippler/0000-0001-9670-6101; Buchert, Felix/0000-0001-6704-6634	CNRS; "Initiative d' Excellence" Program from the French state grant "DYNAMO" [ANR-11-LABX-0011-01]; Deutsche Forschungsgemeinschaft (DFG) [HI 739/13-1]	CNRS(Centre National de la Recherche Scientifique (CNRS)); "Initiative d' Excellence" Program from the French state grant "DYNAMO"; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by CNRS and the "Initiative d' Excellence" Program from the French state grant "DYNAMO", ANR-11-LABX-0011-01. This work was also supported by Deutsche Forschungsgemeinschaft (DFG) Grant HI 739/13-1 (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	ALLEN JF, 1981, NATURE, V291, P25, DOI 10.1038/291025a0; ARNON DI, 1959, NATURE, V184, P10; BENNOUN P, 1982, P NATL ACAD SCI-BIOL, V79, P4352, DOI 10.1073/pnas.79.14.4352; Benz JP, 2009, PLANT CELL, V21, P3965, DOI 10.1105/tpc.109.069815; Bergner SV, 2015, PLANT PHYSIOL, V168, P615, DOI 10.1104/pp.15.00072; Breyton C, 2004, FEBS LETT, V564, P312, DOI 10.1016/S0014-5793(04)00227-3; BULTE L, 1990, BIOCHIM BIOPHYS ACTA, V1020, P72, DOI 10.1016/0005-2728(90)90095-L; Catalanotti C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00150; Chaux F, 2017, PLANT PHYSIOL, V174, P1825, DOI 10.1104/pp.17.00421; Choquet Y, 2003, PLANT CELL, V15, P1443, DOI 10.1105/tpc.011692; CHUA NH, 1975, P NATL ACAD SCI USA, V72, P2175, DOI 10.1073/pnas.72.6.2175; DalCorso G, 2008, CELL, V132, P273, DOI 10.1016/j.cell.2007.12.028; DEBUCHY R, 1989, EMBO J, V8, P2803, DOI 10.1002/j.1460-2075.1989.tb08426.x; Dumas L, 2017, P NATL ACAD SCI USA, V114, P12063, DOI 10.1073/pnas.1713343114; Fischer N, 1997, BIOCHEMISTRY-US, V36, P93, DOI 10.1021/bi962244v; Fleischmann MM, 1999, J BIOL CHEM, V274, P30987, DOI 10.1074/jbc.274.43.30987; Foyer CH, 2012, J EXP BOT, V63, P1637, DOI 10.1093/jxb/ers013; Hamel P, 2000, J BIOL CHEM, V275, P17072, DOI 10.1074/jbc.M001468200; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; Hanke GT, 2005, PLANT CELL ENVIRON, V28, P1146, DOI 10.1111/j.1365-3040.2005.01352.x; Hemschemeier A, 2011, BBA-BIOENERGETICS, V1807, P919, DOI 10.1016/j.bbabio.2011.02.010; Hertle AP, 2013, MOL CELL, V49, P511, DOI 10.1016/j.molcel.2012.11.030; Hovers J, 2011, MOL MEMBR BIOL, V28, P170, DOI 10.3109/09687688.2011.552440; Ilik P, 2017, NEW PHYTOL, V214, P967, DOI 10.1111/nph.14536; Iwai M, 2008, PLANT CELL, V20, P2177, DOI 10.1105/tpc.108.059352; Iwai M, 2010, NATURE, V464, P1210, DOI 10.1038/nature08885; Jans F, 2008, P NATL ACAD SCI USA, V105, P20546, DOI 10.1073/pnas.0806896105; Joliot P, 2004, BBA-BIOENERGETICS, V1656, P166, DOI 10.1016/j.bbabio.2004.03.010; Joliot P, 2011, P NATL ACAD SCI USA, V108, P13317, DOI 10.1073/pnas.1110189108; Juric S, 2009, PLANT J, V60, P783, DOI 10.1111/j.1365-313X.2009.03999.x; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kuras R, 2007, P NATL ACAD SCI USA, V104, P9906, DOI 10.1073/pnas.0702340104; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; LEMAIRE C, 1986, BIOCHIM BIOPHYS ACTA, V851, P229, DOI 10.1016/0005-2728(86)90130-1; Mosebach L, 2017, PHOTOSYNTH RES, V134, P291, DOI 10.1007/s11120-017-0408-5; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Nagy JK, 2001, FEBS LETT, V501, P115, DOI 10.1016/S0014-5793(01)02627-8; Nawrocki W., 2017, BIORXIV, DOI [10.1101/153288, DOI 10.1101/153288]; Nawrocki WJ, 2015, ANNU REV PLANT BIOL, V66, P49, DOI 10.1146/annurev-arplant-043014-114744; Okutani S, 2005, PLANT PHYSIOL, V139, P1451, DOI 10.1104/pp.105.070813; Peden EA, 2013, J BIOL CHEM, V288, P35192, DOI 10.1074/jbc.M113.483727; Picard M, 2006, BIOCHEMISTRY-US, V45, P1861, DOI 10.1021/bi051954a; PIERRE Y, 1995, J BIOL CHEM, V270, P29342, DOI 10.1074/jbc.270.49.29342; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rimbault B, 2000, MOL GEN GENET, V264, P486, DOI 10.1007/s004380000332; Rochaix JD, 2012, PHILOS T R SOC B, V367, P3466, DOI 10.1098/rstb.2012.0064; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Singh SK, 2016, J BIOL CHEM, V291, P21740, DOI 10.1074/jbc.M116.732545; Skinner JJ, 2017, P NATL ACAD SCI USA, V114, P13453, DOI 10.1073/pnas.1711543114; Steinbeck J, 2018, P NATL ACAD SCI USA, V115, P10517, DOI 10.1073/pnas.1809973115; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; STURM NR, 1994, MOL CELL BIOL, V14, P6171, DOI 10.1128/MCB.14.9.6171; Szyszka-Mroz B, 2015, PLANT PHYSIOL, V169, P717, DOI 10.1104/pp.15.00625; Takahashi H, 2016, MOL PLANT, V9, P558, DOI 10.1016/j.molp.2015.12.017; Takahashi H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2954; Terashima M, 2012, P NATL ACAD SCI USA, V109, P17717, DOI 10.1073/pnas.1207118109; Terashima M, 2010, MOL CELL PROTEOMICS, V9, P1514, DOI 10.1074/mcp.M900421-MCP200; Tolleter D, 2011, PLANT CELL, V23, P2619, DOI 10.1105/tpc.111.086876; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Trouillard M, 2012, BBA-BIOENERGETICS, V1817, P2140, DOI 10.1016/j.bbabio.2012.08.006; VALLON O, 1991, P NATL ACAD SCI USA, V88, P8262, DOI 10.1073/pnas.88.18.8262; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; WOLLMAN FA, 1988, BIOCHIM BIOPHYS ACTA, V933, P85, DOI 10.1016/0005-2728(88)90058-8; Yadav KNS, 2017, BBA-BIOENERGETICS, V1858, P12, DOI 10.1016/j.bbabio.2016.10.006; Yamamoto H, 2013, J BIOL CHEM, V288, P36328, DOI 10.1074/jbc.M113.511584; Yang C, 2016, PLANT CELL, V28, P712, DOI 10.1105/tpc.15.01027; Yang WQ, 2015, P NATL ACAD SCI USA, V112, P14978, DOI 10.1073/pnas.1515240112; Yu FC, 2017, J PROTEOME RES, V16, P3942, DOI 10.1021/acs.jproteome.7b00338; Zhang HM, 2001, J BIOL CHEM, V276, P38159; Zoonens M, 2014, J MEMBRANE BIOL, V247, P759, DOI 10.1007/s00232-014-9666-8	73	9	9	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17559	17573		10.1074/jbc.RA118.004475	http://dx.doi.org/10.1074/jbc.RA118.004475			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30228184	Green Published, hybrid			2022-12-28	WOS:000449799000020
J	Kakad, PP; Penserga, T; Davis, BP; Henry, B; Boerner, J; Riso, A; Pielage, J; Godenschwege, TA				Kakad, Priyanka P.; Penserga, Tyrone; Davis, Blake P.; Henry, Brittany; Boerner, Jana; Riso, Anna; Pielage, Jan; Godenschwege, Tanja A.			An ankyrin-binding motif regulates nuclear levels of L1-type neuroglian and expression of the oncogene Myc in Drosophila neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription regulation; ankyrin; cancer; Drosophila; Myc (c-Myc); oxidative stress; L1-CAM; neuroglian; nuclear function; ankyrin-binding motif	ADHESION MOLECULE L1; CELL-ADHESION; C-MYC; PRESENILIN/GAMMA-SECRETASE; DNA-DAMAGE; CANCER; L1-CAM; RECEPTOR; TRANSLOCATION; MIGRATION	L1 cell adhesion molecule (L1CAM) is well-known for its importance in nervous system development and cancer progression. In addition to its role as a plasma membrane protein in cytoskeletal organization, recent in vitro studies have revealed that both transmembrane and cytosolic fragments of proteolytically cleaved vertebrate L1CAM translocate to the nucleus. In vitro studies indicate that nuclear L1CAM affects genes with functions in DNA post-replication repair, cell cycle control, and cell migration and differentiation, but its in vivo role and how its nuclear levels are regulated is less well-understood. Here, we report that mutations in the conserved ankyrin-binding domain affect nuclear levels of the sole Drosophila homolog neuroglian (Nrg) and that it also has a noncanonical role in regulating transcript levels of the oncogene Myc in the adult nervous system. We further show that altered nuclear levels of Nrg correlate with altered transcript levels of Myc in neurons, similar to what has been reported for human glioblastoma stem cells. However, whereas previous in vitro studies suggest that increased nuclear levels of L1CAM promote tumor cell survival, we found here that elevated levels of nuclear Nrg in neurons are associated with increased sensitivity to oxidative stress and reduced life span of adult animals. We therefore conclude that these findings are of potential relevance to the management of neurodegenerative diseases associated with oxidative stress and cancer.	[Kakad, Priyanka P.; Penserga, Tyrone; Davis, Blake P.; Henry, Brittany; Boerner, Jana; Godenschwege, Tanja A.] Florida Atlantic Univ, Dept Biol Sci, Jupiter, FL 33458 USA; [Riso, Anna] Florida Atlantic Univ, Harriet L Wilkes Honors Coll, Jupiter, FL 33458 USA; [Pielage, Jan] Univ Kaiserslautern, Div Zool Neurobiol, Dept Biol, D-67653 Kaiserslautern, Germany	State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University; University of Kaiserslautern	Godenschwege, TA (corresponding author), Florida Atlantic Univ, John D MacArthur Campus,5353 Parkside Dr, Jupiter, FL 33458 USA.	godensch@fau.edu	; Godenschwege, Tanja/A-2830-2010	Pielage, Jan/0000-0002-5115-5884; Godenschwege, Tanja/0000-0003-3322-4134	NINDS, National Institutes of Health [R15 NS090043]; Jupiter Life Sciences Initiative at Florida Atlantic University; SURF fellowship; Office of Undergraduate Research and Inquiry at Florida Atlantic University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS090043] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Jupiter Life Sciences Initiative at Florida Atlantic University; SURF fellowship; Office of Undergraduate Research and Inquiry at Florida Atlantic University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NINDS, National Institutes of Health, Grant R15 NS090043 (to T. A. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Jupiter Life Sciences Initiative at Florida Atlantic University.; Supported by a SURF fellowship and an undergraduate research grant from the Office of Undergraduate Research and Inquiry at Florida Atlantic University.	Boerner J, 2011, JOVE-J VIS EXP, DOI 10.3791/3080; Boerner J, 2010, J NEUROGENET, V24, P158, DOI 10.3109/01677063.2010.489624; Bondong S, 2012, ANN ONCOL, V23, P1795, DOI 10.1093/annonc/mdr568; Brand TM, 2013, RADIOTHER ONCOL, V108, P370, DOI 10.1016/j.radonc.2013.06.010; Cai MS, 2011, J GEN VIROL, V92, P621, DOI 10.1099/vir.0.027029-0; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Carpenter G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008979; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Cassari M, 2015, HUM MOL GENET, V24, P197, DOI 10.1093/hmg/ddu430; Chen MM, 2009, BIOCHEM BIOPH RES CO, V389, P257, DOI 10.1016/j.bbrc.2009.08.143; Cheng L, 2005, J NEUROSCI, V25, P395, DOI 10.1523/JNEUROSCI.4097-04.2005; Cheng L, 2011, EMBO J, V30, P800, DOI 10.1038/emboj.2011.10; Costantini LM, 2012, TRAFFIC, V13, P643, DOI 10.1111/j.1600-0854.2012.01336.x; DAVIS JQ, 1993, J CELL BIOL, V121, P121, DOI 10.1083/jcb.121.1.121; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Enneking EM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001537; Fogel M, 2003, LANCET, V362, P869, DOI 10.1016/S0140-6736(03)14342-5; Freitas N, 2009, CURR GENOMICS, V10, P550, DOI 10.2174/138920209789503941; Godenschwege TA, 2006, CURR BIOL, V16, P12, DOI 10.1016/j.cub.2005.11.062; Greer C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074641; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Hofmann JW, 2015, CELL, V160, P477, DOI 10.1016/j.cell.2014.12.016; Hortsch M, 2000, MOL CELL NEUROSCI, V15, P1, DOI 10.1006/mcne.1999.0809; Hosamani R, 2010, NEUROCHEM RES, V35, P1402, DOI 10.1007/s11064-010-0198-z; Jumbo-Lucioni PP, 2013, DIS MODEL MECH, V6, P84, DOI 10.1242/dmm.010207; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Kudumala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076974; Kudumala SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183605; Li S, 2009, CLIN CANCER RES, V15, P7345, DOI 10.1158/1078-0432.CCR-09-0959; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lutz D, 2014, J NEUROCHEM, V128, P713, DOI 10.1111/jnc.12473; Lutz D, 2012, J BIOL CHEM, V287, P17161, DOI 10.1074/jbc.M112.346759; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Minois N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.139; Montero L, 2008, GENESIS, V46, P104, DOI 10.1002/dvg.20373; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Nishimura K, 2003, J CELL BIOL, V163, P1077, DOI 10.1083/jcb.200303060; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Rached J, 2016, INT J ONCOL, V49, P1722, DOI 10.3892/ijo.2016.3625; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; Schlessinger J, 2006, CELL, V127, P45, DOI 10.1016/j.cell.2006.09.013; Schwartz L, 2017, ANTI-CANCER AGENT ME, V17, P164, DOI 10.2174/1871520616666161031143301; Sedivy JM, 2015, MOL CANCER RES, V13, DOI 10.1158/1557-3125.MYC15-IA20; Siegenthaler D, 2015, J CELL BIOL, V208, P1003, DOI 10.1083/jcb.201407131; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Tanaka K, 2002, EXP GERONTOL, V37, P1469, DOI 10.1016/S0531-5565(02)00167-5; Tuvia S, 1997, P NATL ACAD SCI USA, V94, P12957, DOI 10.1073/pnas.94.24.12957; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Wang Qi-En, 2015, World J Biol Chem, V6, P57, DOI 10.4331/wjbc.v6.i3.57; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Whittard JD, 2006, MOL BIOL CELL, V17, P2696, DOI 10.1091/mbc.E06-01-0090; Yu L, 2009, J ONCOL, V2009, DOI 10.1155/2009/780874	55	5	5	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17442	17453		10.1074/jbc.RA118.004240	http://dx.doi.org/10.1074/jbc.RA118.004240			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30257867	Green Published, hybrid			2022-12-28	WOS:000449799000011
J	Nie, M; Wang, YD; Guo, C; Li, XY; Wang, Y; Deng, YX; Yao, B; Gui, T; Ma, C; Liu, M; Wang, PX; Wang, RY; Tan, RX; Fang, M; Chen, B; He, YH; Huang, DCS; Ju, JY; Zhao, Q				Nie, Min; Wang, Yadong; Guo, Chan; Li, Xinyu; Wang, Ying; Deng, Yexuan; Yao, Bing; Gui, Tao; Ma, Chi; Liu, Ming; Wang, Panxue; Wang, Ruoyun; Tan, Renxiang; Fang, Ming; Chen, Bing; He, Yinghong; Huang, David C. S.; Ju, Junyi; Zhao, Quan			CARM1-mediated methylation of protein arginine methyltransferase 5 represses human -globin gene expression in erythroleukemia cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein arginine N-methyltransferase 5 (PRMT5); protein methylation; hemoglobin; histone methylation; gene expression; CARM1	FETAL-HEMOGLOBIN EXPRESSION; TERMINAL DOMAIN; HISTONE H3; CARM1; PRMT5; DISEASE; TRANSCRIPTION; INHIBITION; COMPLEX; DIMETHYLARGININE	Protein arginine methyltransferase 5 (PRMT5) is a member of the arginine methyltransferase protein family that critically mediates the symmetric dimethylation of Arg-3 at histone H4 (H4R3me2s) and is involved in many key cellular processes, including hematopoiesis. However, the post-translational modifications (PTMs) of PRMT5 that may affect its biological functions remain less well-understood. In this study, using MS analyses, we found that PRMT5 itself is methylated in human erythroleukemia Lys-562 cells. Biochemical assays revealed that coactivator-associated arginine methyltransferase 1 (CARM1) interacts directly with and methylates PRMT5 at Arg-505 both in vivo and in vitro. Substitutions at Arg-505 significantly reduced PRMT5's methyltransferase activity, decreased H4R3me2s enrichment at the -globin gene promoter, and increased the expression of the -globin gene in Lys-562 cells. Moreover, CARM1 knockdown consistently reduced PRMT5 activity and activated -globin gene expression. Importantly, we show that CARM1-mediated methylation of PRMT5 is essential for the intracellular homodimerization of PRMT5 to its active form. These results thus reveal a critical PTM of PRMT5 that represses human -globin gene expression. We conclude that CARM1-mediated asymmetric methylation of PRMT5 is critical for its dimerization and methyltransferase activity leading to the repression of -globin expression. Given PRMT5's crucial role in diverse cellular processes, these findings may inform strategies for manipulating its methyltransferase activity for managing hemoglobinopathy or cancer.	[Nie, Min; Wang, Yadong; Guo, Chan; Li, Xinyu; Wang, Ying; Deng, Yexuan; Yao, Bing; Gui, Tao; Ma, Chi; Liu, Ming; Wang, Panxue; Wang, Ruoyun; Tan, Renxiang; Chen, Bing; Ju, Junyi; Zhao, Quan] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Hematol,Sch Life Sci, Affiliated Drum Tower Hosp,Med Sch,China Australi, Nanjing 210023, Jiangsu, Peoples R China; [Tan, Renxiang] Nanjing Univ Chinese Med, State Key Lab Cultivat Base TCM Qual & Efficacy, Nanjing 210046, Jiangsu, Peoples R China; [Fang, Ming] Southeast Univ, Inst Life Sci, Nanjing 210096, Jiangsu, Peoples R China; [He, Yinghong] Dali Univ, Sch Basic Med, Dali 671003, Yunnan, Peoples R China; [Huang, David C. S.] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Dept Med Biol, Melbourne, Vic 3010, Australia	Nanjing University; Nanjing University of Chinese Medicine; Southeast University - China; Dali University; University of Melbourne	Ju, JY; Zhao, Q (corresponding author), 163 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.	jujunyi@nju.edu.cn; qzhao@nju.edu.cn	Zhao, Quan/E-9147-2011; Xinyu, Li/AAG-1655-2021; Huang, David C. S./C-7586-2013	Zhao, Quan/0000-0002-8533-1938; Xinyu, Li/0000-0003-3694-4188; Huang, David C. S./0000-0002-3101-4873; ju, junyi/0000-0002-9141-2363	National Natural Science Foundation of China [NSFC 31770809, 31470750, 81700108, 31701191]; China Postdoctoral Science Foundation [2017M621706, 2016M590442]; State Key Laboratory (SKL) fund [01KF-201703]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); State Key Laboratory (SKL) fund	This work was supported by National Natural Science Foundation of China NSFC 31770809 and 31470750 (to Q. Z.), 81700108 (to J. J.), and 31701191 (to M. L.), China Postdoctoral Science Foundation 2017M621706 (to J. J.) and 2016M590442 (to M. L.), and State Key Laboratory (SKL) fund 01KF-201703 (to M. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Bode-Boger SM, 2006, J AM SOC NEPHROL, V17, P1128, DOI 10.1681/ASN.2005101119; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Breveglieri G, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0450-3; Casadio F, 2013, P NATL ACAD SCI USA, V110, P14894, DOI 10.1073/pnas.1312925110; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen DY, 2017, AM J HUM GENET, V101, P130, DOI 10.1016/j.ajhg.2017.05.012; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Cui SY, 2015, BLOOD, V126, P386, DOI 10.1182/blood-2015-02-626259; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; El-Shafey A, 2006, PROTEIN SCI, V15, P429, DOI 10.1110/ps.051685706; Feng Q, 2006, MOL CELL BIOL, V26, P7846, DOI 10.1128/MCB.00568-06; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Fujiwara T, 2006, MOL CELL BIOL, V26, P2273, DOI 10.1128/MCB.26.6.2273-2285.2006; Geng PY, 2017, FASEB J, V31, P2287, DOI 10.1096/fj.201601196R; Gu ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044033; Ju JY, 2014, NUCLEIC ACIDS RES, V42, P9740, DOI 10.1093/nar/gku718; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; Kawabe YI, 2012, CELL STEM CELL, V11, P333, DOI 10.1016/j.stem.2012.07.001; Kim KY, 2015, MOL CELL BIOL, V35, P238, DOI 10.1128/MCB.00945-14; Krivega I, 2015, BLOOD, V126, P665, DOI 10.1182/blood-2015-02-629972; Kuhn P, 2011, NUCLEIC ACIDS RES, V39, P2717, DOI 10.1093/nar/gkq1246; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Li J, 2013, J IMMUNOL, V190, P597, DOI 10.4049/jimmunol.1102513; Liu F, 2015, J CLIN INVEST, V125, P3532, DOI 10.1172/JCI81749; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Naeem H, 2007, MOL CELL BIOL, V27, P120, DOI 10.1128/MCB.00815-06; Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3; Pimentel H, 2014, NUCLEIC ACIDS RES, V42, P4031, DOI 10.1093/nar/gkt1388; Quan X, 2015, J NEUROCHEM, V134, P969, DOI 10.1111/jnc.13191; Rank G, 2010, BLOOD, V116, P1585, DOI 10.1182/blood-2009-10-251116; Ratovitski T, 2015, CELL CYCLE, V14, P1716, DOI 10.1080/15384101.2015.1033595; Renneville A, 2015, BLOOD, V126, P1930, DOI 10.1182/blood-2015-06-649087; Richters A, 2017, FUTURE MED CHEM, V9, P2081, DOI 10.4155/fmc-2017-0089; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Sims RJ, 2011, SCIENCE, V332, P99, DOI 10.1126/science.1202663; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Wang L, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500463; Wang L, 2014, CANCER CELL, V25, P21, DOI 10.1016/j.ccr.2013.12.007; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110; Yang YZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7428; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Zhang HT, 2016, BBA-MOL CELL RES, V1863, P335, DOI 10.1016/j.bbamcr.2015.12.001; Zhao HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027026; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	50	15	15	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17454	17463		10.1074/jbc.RA118.004028	http://dx.doi.org/10.1074/jbc.RA118.004028			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30257864	hybrid, Green Published			2022-12-28	WOS:000449799000012
J	Maziarz, M; Broselid, S; DiGiacomo, V; Park, JC; Luebbers, A; Garcia-Navarrete, L; Blanco-Canosa, JB; Baillie, GS; Garcia-Marcos, M				Maziarz, Marcin; Broselid, Stefan; DiGiacomo, Vincent; Park, Jong-Chan; Luebbers, Alex; Garcia-Navarrete, Lucia; Blanco-Canosa, Juan B.; Baillie, George S.; Garcia-Marcos, Mikel			A biochemical and genetic discovery pipeline identifies PLC4b as a nonreceptor activator of heterotrimeric G-proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G-protein-coupled receptor (GPCR); guanine nucleotide exchange factor (GEF); GTPase; bioluminescence resonance energy transfer (BRET); heterotrimeric G-protein; phospholipase C	PHOSPHOLIPASE C-DELTA-4; STRUCTURAL INSIGHTS; REGULATORY MOTIF; HIGH-THROUGHPUT; EXCHANGE FACTOR; RGS PROTEINS; ALPHA; MECHANISM; RECEPTORS; GIV/GIRDIN	Recent evidence has revealed that heterotrimeric G-proteins can be activated by cytoplasmic proteins that share an evolutionarily conserved sequence called the G-binding-and-activating (GBA) motif. This mechanism provides an alternative to canonical activation by G-protein-coupled receptors (GPCRs) and plays important roles in cell function, and its dysregulation is linked to diseases such as cancer. Here, we describe a discovery pipeline that uses biochemical and genetic approaches to validate GBA candidates identified by sequence similarity. First, putative GBA motifs discovered in bioinformatics searches were synthesized on peptide arrays and probed in batch for G(i3) binding. Then, cDNAs encoding proteins with G(i3)-binding sequences were expressed in a genetically-modified yeast strain that reports mammalian G-protein activity in the absence of GPCRs. The resulting GBA motif candidates were characterized by comparison of their biochemical, structural, and signaling properties with those of all previously described GBA motifs in mammals (GIV/Girdin, DAPLE, Calnuc, and NUCB2). We found that the phospholipase C4 (PLC4) GBA motif binds G-proteins with high affinity, has guanine nucleotide exchange factor activity in vitro, and activates G-protein signaling in cells, as indicated by bioluminescence resonance energy transfer (BRET)-based biosensors of G-protein activity. Interestingly, the PLC4 isoform b (PLC4b), which lacks the domains required for PLC activity, bound and activated G-proteins more efficiently than the full-length isoform a, suggesting that PLC4b functions as a G-protein regulator rather than as a PLC. In summary, we have identified PLC4 as a nonreceptor activator of G-proteins and established an experimental pipeline to discover and characterize GBA motif-containing proteins.	[Maziarz, Marcin; Broselid, Stefan; DiGiacomo, Vincent; Park, Jong-Chan; Luebbers, Alex; Garcia-Navarrete, Lucia; Garcia-Marcos, Mikel] Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K,Rm K208 Off, Boston, MA 02118 USA; [Blanco-Canosa, Juan B.] CSIC, IQAC, Inst Adv Chem Catalonia, Dept Biol Chem & Mol Modelling, ES-08034 Barcelona, Spain; [Baillie, George S.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [DiGiacomo, Vincent] Hartwell Fdn, Memphis, TN USA	Boston University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); University of Glasgow	Garcia-Marcos, M (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K,Rm K208 Off, Boston, MA 02118 USA.	mgm1@bu.edu	Blanco-Canosa, Juan B./H-4544-2015	Blanco-Canosa, Juan B./0000-0001-5738-6993	National Institutes of Health [R01GM108733, R01GM130120]; American Cancer Society [RSG-13-362-01-TBE]; Medical Research Council [MR/M013944/1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM130120, R01GM108733] Funding Source: NIH RePORTER; MRC [MR/J007412/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by National Institutes of Health Grants R01GM108733 and R01GM130120, American Cancer Society Grant RSG-13-362-01-TBE (to M.G.-M.), and by Medical Research Council Grant MR/M013944/1 (to G.S.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Austin RJ, 2008, J MOL BIOL, V377, P1406, DOI 10.1016/j.jmb.2008.01.032; Aznar N, 2015, ELIFE, V4, DOI 10.7554/eLife.07091; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blumer JB, 2012, ACTA PHYSIOL, V204, P202, DOI 10.1111/j.1748-1716.2011.02327.x; Cabrita LD, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-12; Chan P, 2011, J BIOL CHEM, V286, P19932, DOI 10.1074/jbc.M110.163675; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cismowski MJ, 2002, METHOD ENZYMOL, V344, P153; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Coleman BD, 2016, MOL BIOL EVOL, V33, P820, DOI 10.1093/molbev/msv336; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; de Alba E, 2004, BIOCHEMISTRY-US, V43, P10039, DOI 10.1021/bi049310a; de Mendoza A, 2014, GENOME BIOL EVOL, V6, P606, DOI 10.1093/gbe/evu038; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; DiGiacomo V, 2018, BIOCHEMISTRY-US, V57, P255, DOI 10.1021/acs.biochem.7b00845; DiGiacomo V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08829-7; Druey KM, 1997, P NATL ACAD SCI USA, V94, P12851, DOI 10.1073/pnas.94.24.12851; Ehrenberger T, 2015, METHODS MOL BIOL, V1278, P57, DOI 10.1007/978-1-4939-2425-7_4; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Fukami K, 2003, J CELL BIOL, V161, P79, DOI 10.1083/jcb.200210057; Fukami K, 2001, SCIENCE, V292, P920, DOI 10.1126/science.1059042; Garcia-Marcos M, 2011, MOL BIOL CELL, V22, P673, DOI 10.1091/mbc.E10-08-0738; Garcia-Marcos M, 2015, J BIOL CHEM, V290, P6697, DOI 10.1074/jbc.R114.613414; Garcia-Marcos M, 2012, P NATL ACAD SCI USA, V109, P1961, DOI 10.1073/pnas.1120538109; Garcia-Marcos M, 2011, J BIOL CHEM, V286, P28138, DOI 10.1074/jbc.M110.204099; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2015, AGING-US, V7, P469, DOI 10.18632/aging.100781; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Harden TK, 2011, CHEM REV, V111, P6120, DOI 10.1021/cr200209p; Hepler JR, 1999, TRENDS PHARMACOL SCI, V20, P376, DOI 10.1016/S0165-6147(99)01369-3; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; de Opakua AI, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15163; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Klarenbeek JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019170; KLEUSS C, 1994, P NATL ACAD SCI USA, V91, P9828, DOI 10.1073/pnas.91.21.9828; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; KROLL S, 1989, J BIOL CHEM, V264, P4490; Lee MJ, 2008, CELL, V135, P65, DOI 10.1016/j.cub.2008.01.007; Lee SB, 1996, J BIOL CHEM, V271, P25, DOI 10.1074/jbc.271.1.25; Lee SB, 2004, J BIOL CHEM, V279, P24362, DOI 10.1074/jbc.M312772200; Leung DW, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-15; Leyme A, 2017, P NATL ACAD SCI USA, V114, pE10319, DOI 10.1073/pnas.1707992114; Leyme A, 2015, J CELL BIOL, V210, P1165, DOI 10.1083/jcb.201506041; Lin CS, 2014, MOL BIOL CELL, V25, P3654, DOI 10.1091/mbc.E14-05-0978; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; Lopez-Sanchez I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5451; Lyon AM, 2013, MOL PHARMACOL, V84, P488, DOI 10.1124/mol.113.087403; Ma GS, 2015, P NATL ACAD SCI USA, V112, pE2602, DOI 10.1073/pnas.1505543112; Marivin A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad2429; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Maziarz M, 2017, METHOD CELL BIOL, V142, P145, DOI 10.1016/bs.mcb.2017.08.001; Midde KK, 2015, P NATL ACAD SCI USA, V112, pE937, DOI 10.1073/pnas.1420140112; Mukhopadhyay S, 2002, METHOD ENZYMOL, V344, P350; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; NAKASHIMA S, 1995, BIOCHEM BIOPH RES CO, V211, P364, DOI 10.1006/bbrc.1995.1822; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Parag-Sharma K, 2016, J BIOL CHEM, V291, P27098, DOI 10.1074/jbc.M116.764431; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Peterson YK, 2002, J BIOL CHEM, V277, P6767, DOI 10.1074/jbc.C100699200; Preininger AM, 2003, BIOCHEMISTRY-US, V42, P7931, DOI 10.1021/bi0345438; Ramachandran S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.166538; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Sasaki K, 2015, J CELL SCI, V128, P2244, DOI 10.1242/jcs.160879; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Sjogren B, 2010, PROG MOL BIOL TRANSL, V91, P81, DOI 10.1016/S1877-1173(10)91004-1; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Weiss TS, 2001, P NATL ACAD SCI USA, V98, P14961, DOI 10.1073/pnas.261572098	82	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					16964	16983		10.1074/jbc.RA118.003580	http://dx.doi.org/10.1074/jbc.RA118.003580			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30194280	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000449466500002
J	Sato, K; Otomo, A; Ueda, MT; Hiratsuka, Y; Suzuki-Utsunomiya, K; Sugiyama, J; Murakoshi, S; Mitsui, S; Ono, S; Nakagawa, S; Shang, HF; Hadano, S				Sato, Kai; Otomo, Asako; Ueda, Mahoko Takahashi; Hiratsuka, Yui; Suzuki-Utsunomiya, Kyoko; Sugiyama, Junya; Murakoshi, Shuji; Mitsui, Shun; Ono, Suzuka; Nakagawa, So; Shang, Hui-Fang; Hadano, Shinji			Altered oligomeric states in pathogenic ALS2 variants associated with juvenile motor neuron diseases cause loss of ALS2-mediated endosomal function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); mutant; oligomerization; membrane trafficking; endosome; ALS2; alsin; macropinosome; membrane ruffle; missense mutation; neurological disease; neurodegeneration	AMYOTROPHIC-LATERAL-SCLEROSIS; HEREDITARY SPASTIC PARALYSIS; GUANINE-NUCLEOTIDE EXCHANGE; SMALL GTPASE RAB5; INFANTILE-ONSET; BULBAR INVOLVEMENT; MISSENSE MUTATION; SITE MUTATION; GENE; PROTEIN	Familial amyotrophic lateral sclerosis type 2 (ALS2) is a juvenile autosomal recessive motor neuron disease caused by the mutations in the ALS2 gene. The ALS2 gene product, ALS2/alsin, forms a homophilic oligomer and acts as a guanine nucleotide-exchange factor (GEF) for the small GTPase Rab5. This oligomerization is crucial for both Rab5 activation and ALS2-mediated endosome fusion and maturation in cells. Recently, we have shown that pathogenic missense ALS2 mutants retaining the Rab5 GEF activity fail to properly localize to endosomes via Rac1-stimulated macropinocytosis. However, the molecular mechanisms underlying dysregulated distribution of ALS2 variants remain poorly understood. Therefore, we sought to clarify the relationship between intracellular localization and oligomeric states of pathogenic ALS2 variants. Upon Rac family small GTPase 1 (Rac1) activation, all mutants tested moved from the cytosol to membrane ruffles but not to macropinosomes and/or endosomes. Furthermore, most WT ALS2 complexes were tetramers. Importantly, the sizes of an ALS2 complex carrying missense mutations in the N terminus of the regulator of chromosome condensation 1-like domain (RLD) or in-frame deletion in the pleckstrin homology domain were shifted toward higher molecular weight, whereas the C-terminal vacuolar protein sorting 9 (VPS9) domain missense mutant existed as a smaller dimeric or trimeric smaller form. Furthermore, in silico mutagenesis analyses using the RLD protein structure in conjunction with a cycloheximide chase assay in vitro disclosed that these missense mutations led to a decrease in protein stability. Collectively, disorganized higher structures of ALS2 variants might explain their impaired endosomal localization and the stability, leading to loss of the ALS2 function.	[Sato, Kai; Otomo, Asako; Hiratsuka, Yui; Suzuki-Utsunomiya, Kyoko; Sugiyama, Junya; Murakoshi, Shuji; Mitsui, Shun; Ono, Suzuka; Nakagawa, So; Hadano, Shinji] Tokai Univ, Dept Mol Life Sci, Sch Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Otomo, Asako; Nakagawa, So; Hadano, Shinji] Tokai Univ, Inst Med Sci, Isehara, Kanagawa 2591193, Japan; [Otomo, Asako; Ueda, Mahoko Takahashi; Nakagawa, So] Tokai Univ, Micro Nano Technol Ctr, Hiratsuka, Kanagawa 2591292, Japan; [Shang, Hui-Fang] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610041, Sichuan, Peoples R China; [Hadano, Shinji] Tokai Univ, Res Ctr Brain & Nervous Dis, Grad Sch Med, Isehara, Kanagawa 2591193, Japan	Tokai University; Tokai University; Tokai University; Sichuan University; Tokai University	Hadano, S (corresponding author), Tokai Univ, Dept Mol Life Sci, Sch Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	shinji@is.icc.u-tokai.ac.jp	Nakagawa, So/Q-2712-2015; Hadano, Shinji/ABA-5052-2021; Otomo, Asako/AAA-6374-2019	Nakagawa, So/0000-0003-1760-3839; Hadano, Shinji/0000-0002-4997-3968; Otomo, Asako/0000-0002-7849-4309; Ueda, Mahoko/0000-0002-3960-0922	Japanese Society for Promotion of Science [26290018, 24650189]; National Natural Science Foundation of China; JSPS Bilateral Joint Research Project	Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); JSPS Bilateral Joint Research Project	This work was supported by Japanese Society for Promotion of Science Grants 26290018 and 24650189 (to S.H.) and in part by the National Natural Science Foundation of China (to H.-F.S.) and JSPS Bilateral Joint Research Project (to S.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Anborgh PH, 1999, MOL CELL BIOL, V19, P4611; BENHAMIDA M, 1990, BRAIN, V113, P347; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Daud S, 2016, AMYOTROPH LAT SCL FR, V17, P260, DOI 10.3109/21678421.2015.1125501; Devon RS, 2003, CLIN GENET, V64, P210, DOI 10.1034/j.1399-0004.2003.00138.x; Egami Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00374; Eker HK, 2014, EUR J MED GENET, V57, P275, DOI 10.1016/j.ejmg.2014.03.006; Eymard-Pierre E, 2002, AM J HUM GENET, V71, P518, DOI 10.1086/342359; Eymard-Pierre E, 2006, ANN NEUROL, V59, P976, DOI 10.1002/ana.20879; Farg MA, 2017, HUM MOL GENET, V26, P4093, DOI 10.1093/hmg/ddx309; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Flor-de-Lima F., 2014, CASE REP GENET, V2014, DOI DOI 10.1155/2014/691515; Gros-Louis F, 2003, ANN NEUROL, V53, P144, DOI 10.1002/ana.10422; Hadano S, 2005, METHOD ENZYMOL, V403, P310, DOI 10.1016/S0076-6879(05)03026-0; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hadano S, 2016, HUM MOL GENET, V25, P3321, DOI 10.1093/hmg/ddw180; Hadano S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009805; Herzfeld T, 2009, NEUROGENETICS, V10, P59, DOI 10.1007/s10048-008-0148-y; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hsu FS, 2018, ELIFE, V7, DOI 10.7554/eLife.32282; Kim S, 2001, J BIOL CHEM, V276, P10581, DOI 10.1074/jbc.C000806200; Koh CG, 2001, J CELL SCI, V114, P4239; Kress JA, 2005, ANN NEUROL, V58, P800, DOI 10.1002/ana.20665; Kunita R, 2004, J BIOL CHEM, V279, P38626, DOI 10.1074/jbc.M406120200; Kunita R, 2007, J BIOL CHEM, V282, P16599, DOI 10.1074/jbc.M610682200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lai C, 2006, J NEUROSCI, V26, P11798, DOI 10.1523/JNEUROSCI.2084-06.2006; Luigetti M, 2013, AMYOTROPH LA SCL FR, V14, P470, DOI 10.3109/21678421.2012.756036; Mintchev N, 2009, NEUROLOGY, V72, P28, DOI 10.1212/01.wnl.0000338530.77394.60; Mori Y, 2013, J BIOL CHEM, V288, P9835, DOI 10.1074/jbc.M112.427591; Nishiyama A, 2017, NEUROBIOL AGING, V53, DOI 10.1016/j.neurobiolaging.2017.01.004; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Otomo A, 2008, BIOCHEM BIOPH RES CO, V370, P87, DOI 10.1016/j.bbrc.2008.01.177; Otomo A, 2011, FEBS LETT, V585, P730, DOI 10.1016/j.febslet.2011.01.045; Panzeri C, 2006, BRAIN, V129, P1710, DOI 10.1093/brain/awl104; Racis L, 2014, EUR J PAEDIATR NEURO, V18, P235, DOI 10.1016/j.ejpn.2013.09.009; Rosa JL, 1996, EMBO J, V15, P4262, DOI 10.1002/j.1460-2075.1996.tb00801.x; Saito K, 2005, METHOD ENZYMOL, V403, P276, DOI 10.1016/S0076-6879(05)03023-5; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sheerin UM, 2014, NEUROLOGY, V82, P1065, DOI 10.1212/WNL.0000000000000254; Shi Y., 2012, AMYOTROPHIC LATERAL, V13, P111, DOI [10.3109/17482968.2012.721231G, DOI 10.3109/17482968.2012.721231G]; Shi YX, 2018, NAT MED, V24, P313, DOI 10.1038/nm.4490; Shirakawa K, 2009, NEUROLOGY, V73, P2124, DOI 10.1212/WNL.0b013e3181c67be0; Siddiqi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113258; Soares DC, 2009, J MOL MODEL, V15, P113, DOI 10.1007/s00894-008-0381-1; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Suzuki-Utsunomiya K, 2007, BIOCHEM BIOPH RES CO, V354, P491, DOI 10.1016/j.bbrc.2006.12.229; Sztriha L, 2008, CLIN GENET, V73, P591, DOI 10.1111/j.1399-0004.2008.00993.x; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Tariq H, 2017, J NEUROGENET, V31, P26, DOI 10.1080/01677063.2017.1324441; Taylor RC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000166; Tudor EL, 2005, J BIOL CHEM, V280, P34735, DOI 10.1074/jbc.M506216200; Verschuuren-Bemelmans CC, 2008, EUR J HUM GENET, V16, P1407, DOI 10.1038/ejhg.2008.108; Wakil SM, 2014, GENE, V536, P217, DOI 10.1016/j.gene.2013.11.043; Xie F, 2015, NEUROL SCI, V36, P1279, DOI 10.1007/s10072-014-2018-8; Yamanaka K, 2003, P NATL ACAD SCI USA, V100, P16041, DOI 10.1073/pnas.2635267100; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zhu KJ, 2001, MOL CELL BIOL, V21, P425, DOI 10.1128/MCB.21.2.425-437.2001	62	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17135	17153		10.1074/jbc.RA118.003849	http://dx.doi.org/10.1074/jbc.RA118.003849			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30224357	Green Published, hybrid			2022-12-28	WOS:000449466500015
J	Walker, NM; Mazzoni, SM; Vittal, R; Fingar, DC; Lama, VN				Walker, Natalie M.; Mazzoni, Serina M.; Vittal, Ragini; Fingar, Diane C.; Lama, Vibha N.			c-Jun N-terminal kinase (JNK)-mediated induction of mSin1 expression and mTORC2 activation in mesenchymal cells during fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mammalian target of rapamycin (mTOR); c-Jun N-terminal kinase (JNK); extracellular matrix protein; siRNA; ubiquitylation (ubiquitination); bronchiolitis obliterans; chronic allograft rejection; lysophosphatidic acid; mesenchymal cells; protein stability	GROWTH-FACTOR-BETA; BRONCHIOLITIS-OBLITERANS-SYNDROME; SIGNAL-TRANSDUCTION PATHWAY; LUNG TRANSPLANTATION; MAMMALIAN TARGET; PULMONARY-FIBROSIS; MECHANISTIC TARGET; COMPLEX 2; SIN1; STRESS	Mammalian target of rapamycin complex 2 (mTORC2) has been shown to regulate mTORC1/4E-BP1/eIF4E signaling and collagen I expression in mesenchymal cells (MCs) during fibrotic activation. Here we investigated the regulation of the mTORC2 binding partner mammalian stress-activated protein kinase-interacting protein 1 (mSin1) in MCs derived from human lung allografts and identified a novel role for mSin1 during fibrosis. mSin1 was identified as a common downstream target of key fibrotic pathways, and its expression was increased in MCs in response to pro-fibrotic mediators: lysophosphatidic acid (LPA), transforming growth factor , and interleukin 13. Fibrotic MCs had higher mSin1 protein levels than nonfibrotic MCs, and siRNA-mediated silencing of mSIN1 inhibited collagen I expression and mTORC1/2 activity in these cells. Autocrine LPA signaling contributed to constitutive up-regulation of mSin1 in fibrotic MCs, and mSin1 was decreased because of LPA receptor 1 siRNA treatment. We identified c-Jun N-terminal kinase (JNK) as a key intermediary in mSin1 up-regulation by the pro-fibrotic mediators, as pharmacological and siRNA-mediated inhibition of JNK prevented the LPA-induced mSin1 increase. Proteasomal inhibition rescued mSin1 levels after JNK inhibition in LPA-treated MCs, and the decrease in mSin1 ubiquitination in response to LPA was counteracted by JNK inhibitors. Constitutive JNK1 overexpression induced mSin1 expression and could drive mTORC2 and mTORC1 activation and collagen I expression in nonfibrotic MCs, effects that were reversed by siRNA-mediated mSIN1 silencing. These results indicate that LPA stabilizes mSin1 protein expression via JNK signaling by blocking its proteasomal degradation and identify the LPA/JNK/mSin1/mTORC/collagen I pathway as critical for fibrotic activation of MCs.	[Walker, Natalie M.; Mazzoni, Serina M.; Vittal, Ragini; Lama, Vibha N.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Fingar, Diane C.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lama, VN (corresponding author), Univ Michigan Hlth Syst, Dept Internal Med, Div Pulm & Crit Care Med, 1500 E Med Ctr Dr,3916 Taubman Ctr, Ann Arbor, MI 48109 USA.	vlama@umich.edu	VITTAL, RAGINI/AAE-9052-2020	Walker, Natalie/0000-0002-7445-3534; Mazzoni-Putman, Serina/0000-0001-7433-9478	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094622, R01HL118017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL118017, R01 HL094622] Funding Source: Medline; NIDDK NIH HHS [P30 DK020572] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Badri L, 2012, STEM CELLS, V30, P2010, DOI 10.1002/stem.1171; Bernacchioni C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010139; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; Cameron AJM, 2011, BIOCHEM J, V439, P287, DOI 10.1042/BJ20110678; Cao PX, 2017, J CLIN INVEST, V127, P1517, DOI 10.1172/JCI88896; Chang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106155; Chen CH, 2013, J BIOL CHEM, V288, P27019, DOI 10.1074/jbc.M113.498055; Chen CH, 2011, J BIOL CHEM, V286, P40386, DOI 10.1074/jbc.M111.282590; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Copeland CAF, 2013, CHEST, V143, P744, DOI 10.1378/chest.12-0971; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Ediger TL, 2002, AM J PHYSIOL-LUNG C, V282, pL91, DOI 10.1152/ajplung.2002.282.1.L91; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Ferguson KT, 2017, J CELL BIOCHEM, V118, P2241, DOI 10.1002/jcb.25878; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Ghosh D, 2008, P NATL ACAD SCI USA, V105, P11673, DOI 10.1073/pnas.0803182105; Grande JP, 1997, P SOC EXP BIOL MED, V214, P27; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hancock A, 1998, AM J RESP CELL MOL, V18, P60, DOI 10.1165/ajrcmb.18.1.2627; Houssaini A, 2013, AM J RESP CELL MOL, V48, P568, DOI 10.1165/rcmb.2012-0429OC; Hu ZW, 2017, BIOCHEM BIOPH RES CO, V483, P645, DOI 10.1016/j.bbrc.2016.12.089; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Keane MP, 2007, J IMMUNOL, V178, P511, DOI 10.4049/jimmunol.178.1.511; KHALIL N, 1991, AM J RESP CELL MOL, V5, P155, DOI 10.1165/ajrcmb/5.2.155; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Koo J, 2015, J BIOL CHEM, V290, P14120, DOI 10.1074/jbc.M114.633057; Krymskaya VP, 2011, FASEB J, V25, P1922, DOI 10.1096/fj.10-175018; Lama VN, 2006, AM J PATHOL, V169, P47, DOI 10.2353/ajpath.2006.050975; Liu PD, 2015, CANCER DISCOV, V5, P1194, DOI 10.1158/2159-8290.CD-15-0460; Lund LH, 2013, J HEART LUNG TRANSPL, V32, P951, DOI 10.1016/j.healun.2013.08.006; Maher P, 2018, CYTOKINE, V103, P114, DOI 10.1016/j.cyto.2017.09.018; Mesri M, 1999, J BIOL CHEM, V274, P23111, DOI 10.1074/jbc.274.33.23111; Patel MR, 2012, INT J ONCOL, V40, P577, DOI 10.3892/ijo.2011.1252; Rahimi RA, 2009, CANCER RES, V69, P84, DOI 10.1158/0008-5472.CAN-08-2146; Riaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032081; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schroder W, 2005, CELL SIGNAL, V17, P761, DOI 10.1016/j.cellsig.2004.10.015; Todd JL, 2014, AM J RESP CRIT CARE, V190, P19, DOI 10.1164/rccm.201402-0384UP; Vock DM, 2017, ANN AM THORAC SOC, V14, P172, DOI 10.1513/AnnalsATS.201606-507OC; Walker N, 2011, AM J PATHOL, V178, P2461, DOI 10.1016/j.ajpath.2011.01.058; Walker NM, 2016, J BIOL CHEM, V291, P6262, DOI 10.1074/jbc.M115.672170; Wang Q, 2017, ONCOGENE, V36, P6225, DOI 10.1038/onc.2017.228; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wilkinson MG, 1999, EMBO J, V18, P4210, DOI 10.1093/emboj/18.15.4210; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Xu JF, 2013, CANCER-AM CANCER SOC, V119, P2247, DOI 10.1002/cncr.28023; Yang G, 2015, CELL REP, V12, P937, DOI 10.1016/j.celrep.2015.07.016; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yao CA, 2017, ONCOTARGET, V8, P63392, DOI 10.18632/oncotarget.18818	51	3	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17229	17239		10.1074/jbc.RA118.003926	http://dx.doi.org/10.1074/jbc.RA118.003926			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30217824	hybrid, Green Published			2022-12-28	WOS:000449466500022
J	Burkholder, NT; Mayfield, JE; Yu, XH; Irani, S; Arce, DK; Jiang, FQ; Matthews, WL; Xue, YC; Zhang, YJ				Burkholder, Nathaniel Tate; Mayfield, Joshua E.; Yu, Xiaohua; Irani, Seema; Arce, Daniel K.; Jiang, Faqin; Matthews, Wendy L.; Xue, Yuanchao; Zhang, Yan Jessie			Phosphatase activity of small C-terminal domain phosphatase 1 (SCP1) controls the stability of the key neuronal regulator RE1-silencing transcription factor (REST)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatase; X-ray crystallography; post-transcriptional regulation; gene silencing; brain-derived neurotrophic factor (BDNF); neurodifferentiation; CTD small phosphatase 1 (CTDSP1); nuclear phosphatase	REST/NRSF TARGET GENES; RNA-POLYMERASE-II; NEURAL STEM-CELLS; HUNTINGTONS-DISEASE; IN-VIVO; LUNG-CANCER; REPRESSOR; EXPRESSION; DIFFERENTIATION; NEUROGENESIS	The RE1-silencing transcription factor (REST) is the major scaffold protein for assembly of neuronal gene silencing complexes that suppress gene transcription through regulating the surrounding chromatin structure. REST represses neuronal gene expression in stem cells and non-neuronal cells, but it is minimally expressed in neuronal cells to ensure proper neuronal development. Dysregulation of REST function has been implicated in several cancers and neurological diseases. Modulating REST gene silencing is challenging because cellular and developmental differences can affect its activity. We therefore considered the possibility of modulating REST activity through its regulatory proteins. The human small C-terminal domain phosphatase 1 (SCP1) regulates the phosphorylation state of REST at sites that function as REST degradation checkpoints. Using kinetic analysis and direct visualization with X-ray crystallography, we show that SCP1 dephosphorylates two degron phosphosites of REST with a clear preference for phosphoserine 861 (pSer-861). Furthermore, we show that SCP1 stabilizes REST protein levels, which sustains REST's gene silencing function in HEK293 cells. In summary, our findings strongly suggest that REST is a bona fide substrate for SCP1 in vivo and that SCP1 phosphatase activity protects REST against degradation. These observations indicate that targeting REST via its regulatory protein SCP1 can modulate its activity and alter signaling in this essential developmental pathway.	[Burkholder, Nathaniel Tate; Mayfield, Joshua E.; Arce, Daniel K.; Matthews, Wendy L.; Zhang, Yan Jessie] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Irani, Seema] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Zhang, Yan Jessie] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Yu, Xiaohua; Xue, Yuanchao] Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol, Beijing 100101, Peoples R China; [Jiang, Faqin] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China; [Mayfield, Joshua E.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Chinese Academy of Sciences; Institute of Biophysics, CAS; Shanghai Jiao Tong University; University of California System; University of California San Diego	Zhang, YJ (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.; Zhang, YJ (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	jzhang@cm.utexas.edu	Irani, Seema/R-5077-2019	Zhang, Yan/0000-0002-9360-5388; XUE, YUANCHAO/0000-0002-8113-2333; Burkholder, Nathaniel/0000-0002-1769-3750	National Institutes of Health [R01 GM104896]; Welch Foundation [F-1778]; Natural Science Foundation of China [31601107]; Alzheimer's Drug Discovery Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104896, R01GM125882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Alzheimer's Drug Discovery Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM104896 (to Y. J. Z.), Welch Foundation Grant F-1778 (to Y. J. Z.), Natural Science Foundation of China Grant 31601107 (to X. H. Y.), and the Alzheimer's Drug Discovery Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aoki H, 2012, DEVELOPMENT, V139, P667, DOI 10.1242/dev.072272; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Buckley NJ, 2010, NEUROBIOL DIS, V39, P28, DOI 10.1016/j.nbd.2010.02.003; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Conti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038486; Coulson JM, 2000, CANCER RES, V60, P1840; Dobson THW, 2017, MOL CANCER RES, V15, P1073, DOI 10.1158/1541-7786.MCR-16-0424; Gao S, 2012, TUMOR BIOL, V33, P1759, DOI 10.1007/s13277-012-0435-y; Gao ZL, 2011, J NEUROSCI, V31, P9772, DOI 10.1523/JNEUROSCI.1604-11.2011; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Gopalakrishnan V, 2009, FUTUR NEUROL, V4, P317, DOI 10.2217/FNL.09.1; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kamal MM, 2012, STEM CELLS, V30, P405, DOI 10.1002/stem.1020; Kamenski T, 2004, MOL CELL, V15, P399, DOI 10.1016/j.molcel.2004.06.035; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Lebok P, 2016, ONCOL LETT, V11, P1987, DOI 10.3892/ol.2016.4206; Liang JF, 2014, INT J MOL SCI, V15, P11220, DOI 10.3390/ijms150711220; Liao P, 2017, ELIFE, V6, DOI 10.7554/eLife.22058; Lu M, 2011, J BIOL CHEM, V286, P10755, DOI 10.1074/jbc.M110.174540; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Mayfield JE, 2015, ACS CHEM BIOL, V10, P2405, DOI 10.1021/acschembio.5b00296; Mukherjee S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13360; Nesti E, 2014, P NATL ACAD SCI USA, V111, pE3929, DOI 10.1073/pnas.1414770111; Neumann SB, 2004, MOL BRAIN RES, V120, P173, DOI 10.1016/j.molbrainres.2003.10.021; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Paquette AJ, 2000, P NATL ACAD SCI USA, V97, P12318, DOI 10.1073/pnas.97.22.12318; Rigamonti D, 2009, CURR PHARM DESIGN, V15, P3958, DOI 10.2174/138161209789649303; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Singh SK, 2015, STEM CELL RES, V15, P305, DOI 10.1016/j.scr.2015.05.003; Spencer EM, 2006, NEUROBIOL DIS, V24, P41, DOI 10.1016/j.nbd.2006.04.020; Su XH, 2004, MOL CELL BIOL, V24, P8018, DOI 10.1128/MCB.24.18.8018-8025.2004; Wagoner MP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-686; Wagoner MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000979; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Yeo M, 2005, SCIENCE, V307, P596, DOI 10.1126/science.1100801; Yu M, 2009, NEUROSCI RES, V65, P236, DOI 10.1016/j.neures.2009.07.006; Zhang MM, 2013, FEBS J, V280, P4739, DOI 10.1111/febs.12481; Zhang MM, 2011, ACS CHEM BIOL, V6, P511, DOI 10.1021/cb100357t; Zhang MM, 2010, PROTEIN SCI, V19, P974, DOI 10.1002/pro.375; Zhang Y, 2006, MOL CELL, V24, P759, DOI 10.1016/j.molcel.2006.10.027; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	46	9	10	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16851	16861		10.1074/jbc.RA118.004722	http://dx.doi.org/10.1074/jbc.RA118.004722			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30217818	hybrid, Green Published			2022-12-28	WOS:000448515100025
J	Yang, DX; Xiao, P; Li, Q; Fu, XL; Pan, C; Lu, D; Wen, SS; Xia, WY; He, DF; Li, H; Fang, H; Shen, YM; Xu, ZG; Lin, A; Wang, C; Yu, X; Wu, JW; Sun, JP				Yang, Duxiao; Xiao, Peng; Li, Qing; Fu, Xiaolei; Pan, Chang; Lu, Di; Wen, Shishuai; Xia, Wanying; He, Dongfang; Li, Hui; Fang, Hao; Shen, Yuemao; Xu, Zhigang; Lin, Amy; Wang, Chuan; Yu, Xiao; Wu, Jiawei; Sun, Jinpeng			Allosteric modulation of the catalytic VYD loop in Slingshot by its N-terminal domain underlies both Slingshot auto-inhibition and activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; allosteric regulation; amino acid; biosensor; phosphatase; phosphorylation; serine; threonine protein kinase; cytoskeleton; assay development; auto-inhibition; bioluminescence resonance energy transfer; fluorescein arsenical hairpin binder; Slingshot; actin activation; fluorescein arsenical hairpin binder	DEPENDENT CONFORMATIONAL-CHANGES; TYROSINE-PHOSPHATASE SHP-2; PROTEIN-KINASE D1; PRE-STEADY-STATE; CRYSTAL-STRUCTURE; LIM KINASE; CELL-MIGRATION; COFILIN; RECEPTOR; GROWTH	Slingshots are phosphatases that modulate cytoskeleton dynamics, and their activities are tightly regulated in different physiological contexts. Recently, abnormally elevated Slingshot activity has been implicated in many human diseases, such as cancer, Alzheimer's disease, and vascular diseases. Therefore, Slingshot-specific inhibitors have therapeutic potential. However, an enzymological understanding of the catalytic mechanism of Slingshots and of their activation by actin is lacking. Here, we report that the N-terminal region of human Slingshot2 auto-inhibits its phosphatase activity in a noncompetitive manner. pH-dependent phosphatase assays and leaving-group dependence studies suggested that the N-terminal domain of Slingshot2 regulates the stability of the leaving group of the product during catalysis by modulating the general acid Asp(361) in the catalytic VYD loop. F-actin binding relieved this auto-inhibition and restored the function of the general acid. Limited tryptic digestion and biophysical studies identified large conformational changes in Slingshot2 after the F-actin binding. The dissociation of N-terminal structural elements, including Leu(63), and the exposure of the loop between -helix-2 and -sheet-3 of the phosphatase domain served as the structural basis for Slingshot activation via F-actin binding in vitro and via neuregulin stimulation in cells. Moreover, we designed a FlAsH-BRET-based Slingshot2 biosensor whose readout was highly correlated with the in vivo phosphatase activities of Slingshot2. Our results reveal the auto-inhibitory mechanism and allosteric activation mechanisms of a human Slingshot phosphatase. They also contribute to the design of new strategies to study Slingshot regulation in various cellular contexts and to screen for new activators/inhibitors of Slingshot activity.	[Yang, Duxiao; Xiao, Peng; Fu, Xiaolei; Pan, Chang; Lu, Di; Xia, Wanying; He, Dongfang; Sun, Jinpeng] Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Key Lab Expt Teratol,Minist Educ, Jinan 250012, Shandong, Peoples R China; [Li, Qing; Li, Hui; Yu, Xiao] Shandong Univ, Sch Med, Dept Physiol, Jinan 250012, Shandong, Peoples R China; [Xiao, Peng; Wen, Shishuai; Fang, Hao; Shen, Yuemao] Shandong Univ, Sch Pharmaceut Sci, Jinan 250012, Shandong, Peoples R China; [Xu, Zhigang] Shandong Univ, Sch Life Sci, Jinan 250003, Shandong, Peoples R China; [Lin, Amy] Duke Univ, Sch Med, Durham, NC 27705 USA; [Wu, Jiawei] Tsinghua Univ, Sch Life Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Wang, Chuan] Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China; [Sun, Jinpeng] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China; [Sun, Jinpeng] Peking Univ, Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Duke University; Tsinghua University; Hebei Medical University; Peking University; Peking University	Wu, JW (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China.; Sun, JP (corresponding author), Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China.; Sun, JP (corresponding author), Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan 250012, Shandong, Peoples R China.	jiaweiwu@mail.tsinghua.edu.cn; sunjinpeng@sdu.edu.cn	sun, Jinpeng/AAR-9196-2020		National Natural Science Foundation of China [31470789, 31611540337, 81773704, 31471102, 31671197, 31700692]; Shandong Natural Science Fund for Distinguished Young Scholars Grant [JQ201517]; Shandong Natural Science Fund Grant [ZR2016CQ07]; Key Research and Development Program of Shandong Province Grant [2018GSF118147]; Fundamental Research Fund of Shandong University [2016JC017]; China Postdoctoral Science Foundation [2015M582082]; Program for Changjiang Scholars and Innovative Research Team in University Grant [IRT_17R68]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Natural Science Fund for Distinguished Young Scholars Grant; Shandong Natural Science Fund Grant; Key Research and Development Program of Shandong Province Grant; Fundamental Research Fund of Shandong University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Program for Changjiang Scholars and Innovative Research Team in University Grant(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work is supported by National Natural Science Foundation of China Grants 31470789, 31611540337, and 81773704 (to J.-P. S.), 31471102 and 31671197 (to X. Y.), and 31700692 (to P. X.); Shandong Natural Science Fund for Distinguished Young Scholars Grant JQ201517 (to J.-P. S.), Shandong Natural Science Fund Grant ZR2016CQ07 (to P. X.); Key Research and Development Program of Shandong Province Grant 2018GSF118147 (to P. X.); Fundamental Research Fund of Shandong University Grant 2016JC017 (to J.-P. S.); China Postdoctoral Science Foundation Grant 2015M582082 (to P. X.); and the Program for Changjiang Scholars and Innovative Research Team in University Grant IRT_17R68 (to X. Y. and J.-P. S). The authors declare that they have no conflicts of interest with the contents of this article.	Almer H, 1996, J AM CHEM SOC, V118, P7921, DOI 10.1021/ja953399d; Anyatonwu G, 2010, J BIOL CHEM, V285, P25085, DOI 10.1074/jbc.M110.123208; Bielig H, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004351; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Dai SP, 2004, CELL MICROBIOL, V6, P459, DOI 10.1111/j.1462-5822.2004.00375.x; Dawaliby R, 2016, NAT CHEM BIOL, V12, P35, DOI [10.1038/NCHEMBIO.1960, 10.1038/nchembio.1960]; Doppler H, 2013, J BIOL CHEM, V288, P455, DOI 10.1074/jbc.M112.397448; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Endo M, 2003, J NEUROSCI, V23, P2527; Endres NF, 2011, CURR OPIN STRUC BIOL, V21, P777, DOI 10.1016/j.sbi.2011.07.007; Gilmartin AG, 2014, NAT CHEM BIOL, V10, P181, DOI [10.1038/nchembio.1427, 10.1038/NCHEMBIO.1427]; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Horita Y, 2008, J BIOL CHEM, V283, P6013, DOI 10.1074/jbc.M706538200; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Jung SK, 2007, PROTEINS, V68, P408, DOI 10.1002/prot.21399; Kaji N, 2003, J BIOL CHEM, V278, P33450, DOI 10.1074/jbc.M305802200; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Kurita S, 2008, J BIOL CHEM, V283, P32542, DOI 10.1074/jbc.M804627200; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Lee SY, 2017, PHARMACOL RES, V119, P422, DOI 10.1016/j.phrs.2017.03.003; Li H, 2016, CELL REP, V15, P1345, DOI 10.1016/j.celrep.2016.04.016; Li R, 2013, FEBS J, V280, P2700, DOI 10.1111/febs.12275; Li SJ, 2016, CELL RES, V26, P336, DOI 10.1038/cr.2016.14; Li TY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02401-7; Liu CH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14335; Liu X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10879; Lu X, 2014, ONCOGENE, V33, P956, DOI 10.1038/onc.2013.27; Maheswaranathan M, 2011, J BIOL CHEM, V286, P35430, DOI 10.1074/jbc.M111.268284; Matozaki T, 2009, CANCER SCI, V100, P1786, DOI 10.1111/j.1349-7006.2009.01257.x; Mayer C, 2008, EMBO REP, V9, P774, DOI 10.1038/embor.2008.109; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; Nobles KN, 2007, J BIOL CHEM, V282, P21370, DOI 10.1074/jbc.M611483200; Nuber S, 2016, NATURE, V531, P661, DOI 10.1038/nature17198; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pan C, 2013, SCI REP-UK, V3, DOI 10.1038/srep02333; Park H, 2013, J MOL GRAPH MODEL, V39, P65, DOI 10.1016/j.jmgm.2012.10.008; Pedersen AK, 2004, BIOCHEM J, V378, P421, DOI 10.1042/BJ20030565; Selden LA, 2000, BIOCHEMISTRY-US, V39, P64, DOI 10.1021/bi9914964; Sommer ME, 2005, J BIOL CHEM, V280, P6861, DOI 10.1074/jbc.M411341200; Sparrow N, 2012, J NEUROSCI, V32, P5284, DOI 10.1523/JNEUROSCI.6207-11.2012; Takahashi K, 2017, BIOCHEM BIOPH RES CO, V482, P686, DOI 10.1016/j.bbrc.2016.11.095; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Torres RA, 2011, ARTERIOSCL THROM VAS, V31, P2424, DOI 10.1161/ATVBAHA.111.232769; Wang HM, 2014, CELL RES, V24, P1067, DOI 10.1038/cr.2014.99; Wang Q, 2015, ELIFE, V4, DOI 10.7554/eLife.06074; Wang WQ, 2004, J BIOL CHEM, V279, P30459, DOI 10.1074/jbc.M402217200; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Woo JA, 2015, CELL DEATH DIFFER, V22, P1069, DOI 10.1038/cdd.2015.41; Wu L, 1996, BIOCHEMISTRY-US, V35, P5426, DOI 10.1021/bi952885a; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Xiao P, 2014, INT J BIOCHEM CELL B, V57, P84, DOI 10.1016/j.biocel.2014.10.004; Xu XH, 2015, MOL BIOL CELL, V26, P874, DOI 10.1091/mbc.E14-05-0982; Yamashiro Y, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3141; Yang F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9202; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zhang K, 2016, ONCOGENE, V35, P1271, DOI 10.1038/onc.2015.184; ZHANG ZY, 1991, J BIOL CHEM, V266, P1516	59	3	3	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16226	16241		10.1074/jbc.RA118.004175	http://dx.doi.org/10.1074/jbc.RA118.004175			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30154244	Green Published, hybrid			2022-12-28	WOS:000447833600011
J	Li, WJ; Xiong, XH; Abdalla, A; Alejo, S; Zhu, LY; Lu, F; Sun, H				Li, Wenjing; Xiong, Xiahui; Abdalla, Amro; Alejo, Salvador; Zhu, Linyu; Lu, Fei; Sun, Hong			HGF-induced formation of the MET-AXL-ELMO2-DOCK180 complex promotes RAC1 activation, receptor clustering, and cancer cell migration and invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; receptor tyrosine kinase; Ras-related C3 botulinum toxin substrate 1 (Rac1); guanine nucleotide exchange factor (GEF); cell migration; cell invasion; glioblastoma; cancer	SMALL-MOLECULE INHIBITOR; TYROSINE KINASE; PROLONGS SURVIVAL; BREAST-CANCER; HUMAN GLIOMAS; AXL KINASE; MET; RESISTANCE; GROWTH; PATHWAY	The MET proto-oncogene-encoded receptor tyrosine kinase (MET) and AXL receptor tyrosine kinase (AXL) are independently operating receptor tyrosine kinases (RTKs) that are functionally associated with aggressive and invasive cancer cell growth. However, how MET and AXL regulate the migratory properties of cancer cells remains largely unclear. We report here that the addition of hepatocyte growth factor (HGF), the natural ligand of MET, to serum-starved human glioblastoma cells induces the rapid activation of both MET and AXL and formation of highly polarized MET-AXL clusters on the plasma membrane. HGF also promoted the formation of the MET and AXL protein complexes and phosphorylation of AXL, independent of AXL's ligand, growth arrest-specific 6 (GAS6). The HGF-induced MET-AXL complex stimulated rapid and dynamic cytoskeleton reorganization by activating the small GTPase RAC1, a process requiring both MET and AXL kinase activities. We further found that HGF also promotes the recruitment of ELMO2 and DOCK180, a bipartite guanine nucleotide exchange factor for RAC1, to the MET-AXL complex and thereby stimulates the RAC1-dependent cytoskeleton reorganization. We also demonstrated that the MET-AXL-ELMO2-DOCK180 complex is critical for HGF-induced cell migration and invasion in glioblastoma or other cancer cells. Our findings uncover a critical HGF-dependent signaling pathway that involves the assembly of a large protein complex consisting of MET, AXL, ELMO2, and DOCK180 on the plasma membrane, leading to RAC1-dependent cell migration and invasion in various cancer cells.	[Li, Wenjing; Xiong, Xiahui; Abdalla, Amro; Alejo, Salvador; Zhu, Linyu; Sun, Hong] Univ Nevada, Dept Chem & Biochem, Las Vegas, NV 89154 USA; [Li, Wenjing; Lu, Fei] Peking Univ, Sch Chem Biol & Biotechnol, Shenzhen Grad Sch, Shenzhen 518055, Guangdong, Peoples R China	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Peking University; University Town of Shenzhen	Sun, H (corresponding author), Univ Nevada, Dept Chem & Biochem, Las Vegas, NV 89154 USA.	hong.sun@unlv.edu		Alejo, Salvador/0000-0002-1390-9892; Sun, Hong/0000-0003-2100-1451; Li, Wenjing/0000-0001-9151-9219	National Institutes of Health [R15NS096694]; Cancer Research Gift Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS096694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Gift Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R15NS096694 and a grant from the Cancer Research Gift Fund to the College of Sciences at University of Nevada, Las Vegas (to H. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Thuraia A, 2015, MOL CELL BIOL, V35, P76, DOI 10.1128/MCB.00764-14; Baumann C, 2017, MOL ONCOL, V11, P1430, DOI 10.1002/1878-0261.12109; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Brand TM, 2014, CANCER RES, V74, P5152, DOI 10.1158/0008-5472.CAN-14-0294; Braunger J, 1997, ONCOGENE, V14, P2619, DOI 10.1038/sj.onc.1201123; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cao HH, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0367-4; Cavet ME, 2008, ARTERIOSCL THROM VAS, V28, P886, DOI 10.1161/ATVBAHA.108.162693; Cheng P, 2015, STEM CELL REP, V4, P899, DOI 10.1016/j.stemcr.2015.03.005; Clague MJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002422; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fay David S, 2013, WormBook, P1, DOI 10.1895/wormbook.1.159.1; Fridell YWC, 1996, MOL CELL BIOL, V16, P135; Gajiwala KS, 2017, J BIOL CHEM, V292, P15705, DOI 10.1074/jbc.M116.771485; Harder T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00050; Heideman MR, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3564; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Jarzynka NJ, 2007, CANCER RES, V67, P7203, DOI 10.1158/0008-5472.CAN-07-0473; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Koochekpour S, 1997, CANCER RES, V57, P5391; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lin L., 2012, CHEMOTHER RES PRACT, V2012, DOI DOI 10.1155/2012/817297; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Menard L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4907; Meyer AS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004155; Onken J, 2017, ONCOTARGET, V8, P50403, DOI 10.18632/oncotarget.18468; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Postel-Vinay S, 2012, NAT GENET, V44, P835, DOI 10.1038/ng.2362; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Ruan GX, 2012, EMBO J, V31, P1692, DOI 10.1038/emboj.2012.21; Salian-Mehta S, 2013, MOL CELL ENDOCRINOL, V374, P92, DOI 10.1016/j.mce.2013.04.018; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Segarra J, 2006, J BIOL CHEM, V281, P4771, DOI 10.1074/jbc.M508298200; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; Vouri M, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.66; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6; Zhu LY, 2016, J CELL SCI, V129, P4238, DOI 10.1242/jcs.191684	45	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15397	15418		10.1074/jbc.RA118.003063	http://dx.doi.org/10.1074/jbc.RA118.003063			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30108175	hybrid, Green Published			2022-12-28	WOS:000446549200006
J	Schwerter, D; Grimm, I; Girzalsky, W; Erdmann, R				Schwerter, Daniel; Grimm, Immanuel; Girzalsky, Wolfgang; Erdmann, Ralf			Receptor recognition by the peroxisomal AAA complex depends on the presence of the ubiquitin moiety and is mediated by Pex1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peroxisome; protein targeting; protein translocation; protein sorting; ATPases associated with diverse cellular activities (AAA); ubiquitin	MATRIX PROTEIN IMPORT; SIGNAL TYPE-1 RECEPTOR; N-TERMINAL HALF; SACCHAROMYCES-CEREVISIAE; PTS1 RECEPTOR; CONSERVED CYSTEINE; MEMBRANE-RECEPTOR; ESCHERICHIA-COLI; PEROXINS PEX1P; GENETIC-CODE	The receptor cycle of type I peroxisomal matrix protein import is completed by ubiquitination of the membrane-bound peroxisome biogenesis factor 5 (Pex5p) and its subsequent export back to the cytosol. The receptor export is the only ATP-dependent step of the whole process and is facilitated by two members of the AAA family of proteins (ATPases associated with various cellular activities), namely Pex1p and Pex6p. To gain further insight into substrate recognition by the AAA complex, we generated an N-terminally linked ubiquitin-Pex5p fusion protein. This fusion protein displayed biological activity because it is able to functionally complement a PEX5-deletion in Saccharomyces cerevisiae. In vitro assays revealed its interaction at WT level with the native cargo protein Pcs60p and Pex14p, a constituent of the receptor docking complex. We also demonstrate in vitro deubiquitination by the deubiquitinating enzyme Ubp15p. In vitro pulldown assays and cross-linking studies demonstrate that Pex5p recognition by the AAA complex depends on the presence of the ubiquitin moiety and is mediated by Pex1p.	[Schwerter, Daniel; Grimm, Immanuel; Girzalsky, Wolfgang; Erdmann, Ralf] Ruhr Univ Bochum, Fac Med, Inst Biochem & Pathobiochem, Syst Biochem, D-44780 Bochum, Germany	Ruhr University Bochum	Erdmann, R (corresponding author), Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Univ Str 150, D-44780 Bochum, Germany.	Ralf.Erdmann@rub.de			Deutsche Forschungsgemeinschaft [FOR1905]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant FOR1905 (to R. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Alencastre IS, 2009, J BIOL CHEM, V284, P27243, DOI 10.1074/jbc.M109.032565; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Beyer A, 1997, PROTEIN SCI, V6, P2043; Birschmann I, 2005, FEBS J, V272, P47, DOI 10.1111/j.1432-1033.2004.04393.x; Birschmann I, 2003, MOL BIOL CELL, V14, P2226, DOI 10.1091/mbc.E02-11-0752; Blobel F, 1996, EUR J BIOCHEM, V240, P468, DOI 10.1111/j.1432-1033.1996.0468h.x; Blok NB, 2015, P NATL ACAD SCI USA, V112, pE4017, DOI 10.1073/pnas.1500257112; Braverman NE, 2016, MOL GENET METAB, V117, P313, DOI 10.1016/j.ymgme.2015.12.009; Brown LA, 2003, J CELL MOL MED, V7, P388, DOI 10.1111/j.1582-4934.2003.tb00241.x; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Ciniawsky S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8331; Collins CS, 2000, MOL CELL BIOL, V20, P7516, DOI 10.1128/MCB.20.20.7516-7526.2000; Debelyy MO, 2011, J BIOL CHEM, V286, P28223, DOI 10.1074/jbc.M111.238600; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; FIELDS S, 1994, TRENDS GENET, V10, P286, DOI 10.1016/0168-9525(90)90012-U; Foster J, 2014, FEBS LETT, V588, P160, DOI 10.1016/j.febslet.2013.11.026; Francisco T, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700047; Francisco T, 2013, J BIOL CHEM, V288, P29151, DOI 10.1074/jbc.M113.487140; Gardner BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02474-4; Gardner BM, 2015, J MOL BIOL, V427, P1375, DOI 10.1016/j.jmb.2015.01.019; Gietz R.D., 1994, MOL GENETICS YEAST P, P121; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; Girzalsky W, 2010, BBA-MOL CELL RES, V1803, P724, DOI 10.1016/j.bbamcr.2010.01.002; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; Gouveia AM, 2003, ADV EXP MED BIOL, V544, P219; Grimm I, 2016, BBA-MOL CELL RES, V1863, P828, DOI 10.1016/j.bbamcr.2015.10.001; Grimm I, 2016, SCI REP-UK, V6, DOI 10.1038/srep19838; Grou CP, 2012, J BIOL CHEM, V287, P12815, DOI 10.1074/jbc.M112.340158; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Hagen S, 2015, J BIOL CHEM, V290, P26610, DOI 10.1074/jbc.M115.657973; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Harlow E., 1988, ANTIBODIES LAB MANUA; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 1996, CELL, V84, P813, DOI 10.1016/S0092-8674(00)81058-2; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Huseinovic A, 2018, TOXICOL IN VITRO, V47, P259, DOI 10.1016/j.tiv.2017.12.007; JAMES GL, 1994, J BIOL CHEM, V269, P14182; James P, 1996, GENETICS, V144, P1425; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Kouranti I, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000471; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Leon S, 2007, J BIOL CHEM, V282, P7424, DOI 10.1074/jbc.M611627200; Ma CL, 2013, J BIOL CHEM, V288, P27220, DOI 10.1074/jbc.M113.492694; MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Montilla-Martinez M, 2015, CELL REP, V13, P2126, DOI 10.1016/j.celrep.2015.11.016; Nordgren M, 2015, AUTOPHAGY, V11, P1326, DOI 10.1080/15548627.2015.1061846; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; Park S, 2005, STRUCTURE, V13, P995, DOI 10.1016/j.str.2005.04.013; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta H. W., 2014, MOL MACHINES INVOLVE, P347; Platta HW, 2008, BIOCHEM SOC T, V36, P99, DOI 10.1042/BST0360099; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2016, BBA-MOL CELL RES, V1863, P838, DOI 10.1016/j.bbamcr.2015.09.010; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; Rodrigues TA, 2014, MOL CELL BIOL, V34, P2917, DOI 10.1128/MCB.01727-13; Rosenkranz K, 2006, FEBS J, V273, P3804, DOI 10.1111/j.1742-4658.2006.05388.x; Saffian D, 2012, J STRUCT BIOL, V179, P126, DOI 10.1016/j.jsb.2012.06.002; Schafer A, 2004, MOL CELL BIOL, V24, P8895, DOI 10.1128/MCB.24.20.8895-8906.2004; Schliebs W, 2010, NAT REV MOL CELL BIO, V11, P885, DOI 10.1038/nrm3008; Schwartzkopff B, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150103; Schwerter DP, 2017, BIOL CHEM, V398, P607, DOI 10.1515/hsz-2016-0293; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Stanley WA, 2006, BBA-MOL CELL RES, V1763, P1592, DOI 10.1016/j.bbamcr.2006.10.015; Tamura S, 2006, J BIOL CHEM, V281, P27693, DOI 10.1074/jbc.M605159200; Tamura S, 2014, J BIOL CHEM, V289, P24336, DOI 10.1074/jbc.M114.588038; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; Varland S, 2015, PROTEOMICS, V15, P2385, DOI 10.1002/pmic.201400619; VOORNBROUWER T, 1993, BIOCHIM BIOPHYS ACTA, V1216, P325, DOI 10.1016/0167-4781(93)90166-B; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Waterham HR, 2016, BBA-MOL CELL RES, V1863, P922, DOI 10.1016/j.bbamcr.2015.11.015; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200	84	9	9	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15458	15470		10.1074/jbc.RA118.003936	http://dx.doi.org/10.1074/jbc.RA118.003936			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30097517	Green Published, hybrid			2022-12-28	WOS:000446549200013
J	Billings, PC; Yang, E; Mundy, C; Pacifici, M				Billings, Paul C.; Yang, Evan; Mundy, Christina; Pacifici, Maurizio			Domains with highest heparan sulfate-binding affinity reside at opposite ends in BMP2/4 versus BMP5/6/7: Implications for function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); heparan sulfate; cartilage biology; cell signaling; heparin-binding protein; chondrogenesis; Cardein-Weintraub motif; heparin-binding domain; hyaluronic acid	HEREDITARY-MULTIPLE-EXOSTOSES; BONE MORPHOGENETIC PROTEIN-2; BIOLOGICAL-ACTIVITY; CELL-MEMBRANE; LIMB BUD; CHONDROGENESIS; SITES; IDENTIFICATION; PROTEOGLYCANS; SUPERFAMILY	Signaling proteins, including bone morphogenetic proteins (BMPs), specifically interact with heparan sulfate (HS). These interactions regulate protein distribution and function and are largely mediated by domains rich in basic amino acids. The N-terminal region of BMP2 and BMP4 contains one such domain with a typical Cardin-Weintraub (CW) motif, but it is unclear whether the same occurs in BMP5, BMP6, and BMP7 that constitute a separate evolutionary subgroup. Peptides spanning the N-terminal domain of BMP2/4 interacted with substrate-bound HS with nanomolar affinity, but peptides spanning BMP5/6/7 N-terminal domain did not. We re-examined the entire BMP5/6/7 sequences and identified a novel CW-like motif at their C terminus. Peptides spanning this domain displayed high-affinity HS binding, but corresponding BMP2/4 C-terminal peptides did not, likely because of acidic or noncharged residue substitutions. Peptides pre-assembled into NeutrAvidin tetramers displayed the same exact binding selectivity of respective monomers but bound HS with greater affinity. Tests of possible peptide biological activities showed that the HS-binding N-terminal BMP2/4 and C-terminal BMP5/6/7 peptides stimulated chondrogenesis in vitro, potentially by freeing endogenous BMPs. Thus, HS interactions appear largely ascribable to domains at opposite ends of BMP2/4 versus BMP5/6/7, reiterating the evolutionary distance of these BMP subgroups and possible functional diversification.	[Billings, Paul C.; Yang, Evan; Mundy, Christina; Pacifici, Maurizio] Childrens Hosp Philadelphia, Div Orthopaed Surg, Translat Res Program Pediat Orthopaed, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Billings, PC (corresponding author), Div Orthopaed Surg, Translat Res Program Pediat Orthopaed, ARC 904,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	BillingsP@email.chop.edu			National Institutes of Health [RO1AR061758]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061758] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant RO1AR061758. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Billings PC, 2015, CONNECT TISSUE RES, V56, P272, DOI 10.3109/03008207.2015.1045066; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brazil DP, 2015, TRENDS CELL BIOL, V25, P249, DOI 10.1016/j.tcb.2014.12.004; Brkljacic J, 2013, INT ORTHOP, V37, P529, DOI 10.1007/s00264-012-1714-3; Buckland RA, 1998, MECH DEVELOP, V71, P143, DOI 10.1016/S0925-4773(98)00008-2; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chang SC, 2011, J BIOL CHEM, V286, P44391, DOI 10.1074/jbc.M111.285361; Cheung PK, 2001, AM J HUM GENET, V69, P55, DOI 10.1086/321278; Choi YJ, 2010, BIOMATERIALS, V31, P7226, DOI 10.1016/j.biomaterials.2010.05.022; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Dundas CM, 2013, APPL MICROBIOL BIOT, V97, P9343, DOI 10.1007/s00253-013-5232-z; Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147; Gandhi NS, 2012, BBA-PROTEINS PROTEOM, V1824, P1374, DOI 10.1016/j.bbapap.2012.07.002; Gutiérrez María Lucía, 2012, Univ. Sci., V17, P167; Hecht JT, 2005, DIFFERENTIATION, V73, P212, DOI 10.1111/j.1432-0436.2005.00025.x; HECHT JT, 1995, AM J HUM GENET, V56, P1125; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hinck AP, 2012, FEBS LETT, V586, P1860, DOI 10.1016/j.febslet.2012.05.028; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Huegel J, 2015, AM J PATHOL, V185, P1676, DOI 10.1016/j.ajpath.2015.02.014; Huegel J, 2013, DEV BIOL, V377, P100, DOI 10.1016/j.ydbio.2013.02.008; Huminiecki L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-28; Iozzo RV, 2001, J CLIN INVEST, V108, P165, DOI 10.1172/JCI13560; Irie A, 2003, BIOCHEM BIOPH RES CO, V308, P858, DOI 10.1016/S0006-291X(03)01500-6; Iyer S, 2011, FEBS J, V278, P4304, DOI 10.1111/j.1742-4658.2011.08350.x; James AW, 2016, TISSUE ENG PART B-RE, V22, P284, DOI [10.1089/ten.teb.2015.0357, 10.1089/ten.TEB.2015.0357]; Janda CY, 2017, NATURE, V545, P234, DOI 10.1038/nature22306; Jones KB, 2011, J PEDIATR ORTHOPED, V31, P577, DOI 10.1097/BPO.0b013e31821c7738; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Lefebvre V, 2010, CURR TOP DEV BIOL, V90, P291, DOI 10.1016/S0070-2153(10)90008-2; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lindahl U, 2013, J INTERN MED, V273, P555, DOI 10.1111/joim.12061; Lissenberg-Thunnissen SN, 2011, INT ORTHOP, V35, P1271, DOI 10.1007/s00264-011-1301-z; LORTAT-JACOB H, 1995, BIOCHEM J, V310, P497, DOI 10.1042/bj3100497; LOZZIO BB, 1979, LEUKEMIA RES, V3, P363, DOI 10.1016/0145-2126(79)90033-X; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; MARGALIT H, 1993, J BIOL CHEM, V268, P19228; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsuo I, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0545; McClarence D., 2011, THESIS; MIKIC B, 1995, BONE, V16, P445; Mundy C, 2018, J BIOL CHEM, V293, P7703, DOI 10.1074/jbc.RA117.000264; Mundy C, 2016, J CELL PHYSIOL, V231, P1033, DOI 10.1002/jcp.25192; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Ohlig S, 2012, J BIOL CHEM, V287, P43708, DOI 10.1074/jbc.M112.356667; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Perry MJ, 2008, BONE, V42, P216, DOI 10.1016/j.bone.2007.09.053; Richard B, 2009, J BIOL CHEM, V284, P27054, DOI 10.1074/jbc.M109.029892; Rider CC, 2006, BIOCHEM SOC T, V34, P458, DOI 10.1042/BST0340458; Rider CC, 2017, MOLECULES, V22, DOI 10.3390/molecules22050713; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590; Schultz V, 2017, J BIOL CHEM, V292, P2495, DOI 10.1074/jbc.M116.761585; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shimokawa K, 2011, DEV CELL, V21, P257, DOI 10.1016/j.devcel.2011.06.027; Sinha S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006742; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; SUN PD, 1995, ANNU REV BIOPH BIOM, V24, P269, DOI 10.1146/annurev.bb.24.060195.001413; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; Whalen DM, 2013, P NATL ACAD SCI USA, V110, P16420, DOI 10.1073/pnas.1310097110; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680	75	23	23	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14371	14383		10.1074/jbc.RA118.003191	http://dx.doi.org/10.1074/jbc.RA118.003191			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30082319	Green Published, hybrid			2022-12-28	WOS:000444671500017
J	Garza-Lopez, E; Lopez, JA; Hagen, J; Sheffer, R; Meiner, V; Lee, A				Garza-Lopez, Edgar; Lopez, Josue A.; Hagen, Jussara; Sheffer, Ruth; Meiner, Vardiella; Lee, Amy			Role of a conserved glutamine in the function of voltage-gated Ca2+ channels revealed by a mutation in human CACNA1D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; gating; ion channel; autism; epilepsy; CACNA1D; calcium voltage-gated channel subunit alpha1 D; Ca2+ channel; modulation; inactivation; intellectual disability; hearing impairment	AUTISM SPECTRUM DISORDERS; INNER HAIR-CELLS; CALCIUM-CHANNELS; DEPENDENT INACTIVATION; CA(V)1.3 CHANNELS; TIMOTHY-SYNDROME; MOLECULAR DETERMINANTS; CONGENITAL DEAFNESS; ALPHA(1A) SUBUNIT; MODULATION	Voltage-gated Ca-v Ca2+ channels play crucial roles in regulating gene transcription, neuronal excitability, and synaptic transmission. Natural or pathological variations in Ca-v channels have yielded rich insights into the molecular determinants controlling channel function. Here, we report the consequences of a natural, putatively disease-associated mutation in the CACNA1D gene encoding the pore-forming Ca(v)1.3 (1) subunit. The mutation causes a substitution of a glutamine residue that is highly conserved in the extracellular S1-S2 loop of domain II in all Ca-v channels with a histidine and was identified by whole-exome sequencing of an individual with moderate hearing impairment, developmental delay, and epilepsy. When introduced into the rat Ca(v)1.3 cDNA, Q558H significantly decreased the density of Ca2+ currents in transfected HEK293T cells. Gating current analyses and cell-surface biotinylation experiments suggested that the smaller current amplitudes caused by Q558H were because of decreased numbers of functional Ca(v)1.3 channels at the cell surface. The substitution also produced more sustained Ca2+ currents by weakening voltage-dependent inactivation. When inserted into the corresponding locus of Ca(v)2.1, the substitution had similar effects as in Ca(v)1.3. However, the substitution introduced in Ca(v)3.1 reduced current density, but had no effects on voltage-dependent inactivation. Our results reveal a critical extracellular determinant of current density for all Ca-v family members and of voltage-dependent inactivation of Ca(v)1.3 and Ca(v)2.1 channels.	[Garza-Lopez, Edgar; Lopez, Josue A.; Hagen, Jussara; Lee, Amy] Univ Iowa, Dept Mol Physiol, Iowa City, IA 52242 USA; [Garza-Lopez, Edgar; Lopez, Josue A.; Hagen, Jussara; Lee, Amy] Univ Iowa, Dept Biophys, Iowa City, IA 52242 USA; [Garza-Lopez, Edgar; Lopez, Josue A.; Hagen, Jussara; Lee, Amy] Univ Iowa, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA; [Garza-Lopez, Edgar; Lopez, Josue A.; Hagen, Jussara; Lee, Amy] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Garza-Lopez, Edgar; Lopez, Josue A.; Hagen, Jussara; Lee, Amy] Univ Iowa, Iowa Neurosci Inst, Iowa City, IA 52242 USA; [Sheffer, Ruth; Meiner, Vardiella] Hadassah Hebrew Univ, Med Ctr, Dept Genet & Metab Dis, IL-91120 Jerusalem, Israel	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Hebrew University of Jerusalem; Hadassah University Medical Center	Lee, A (corresponding author), PBDB 5318,169 Newton RD, Iowa City, IA 52242 USA.	amy-lee@uiowa.edu		Lopez, Josue A./0000-0003-0232-4407; Garza Lopez-Hinton, Edgar/0000-0003-0243-0816; Sheffer, Ruth/0000-0002-3623-8016	Karl Kahane Foundation; Conacyt (Mexico) postdoctoral fellowship; National Institutes of Health [NS084190, DC009433]; Carver Research Program of Excellence Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC009433, R01DC009433] Funding Source: NIH RePORTER	Karl Kahane Foundation; Conacyt (Mexico) postdoctoral fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Research Program of Excellence Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Karl Kahane Foundation (to V. M. and R. S.), Conacyt (Mexico) postdoctoral fellowship (to E. G. L.), and National Institutes of Health Grants NS084190 and DC009433 and Carver Research Program of Excellence Award (to A. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Baig SM, 2011, NAT NEUROSCI, V14, P77, DOI 10.1038/nn.2694; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Berrou L, 2001, BIOPHYS J, V80, P215, DOI 10.1016/S0006-3495(01)76008-0; Bett Glenna Cl, 2012, N Am J Med Sci (Boston), V5, P135; Bourinet E, 1999, NAT NEUROSCI, V2, P407, DOI 10.1038/8070; Brandt A, 2003, J NEUROSCI, V23, P10832; Buraei Z, 2013, BBA-BIOMEMBRANES, V1828, P1530, DOI 10.1016/j.bbamem.2012.08.028; Christel C, 2012, BBA-GEN SUBJECTS, V1820, P1243, DOI 10.1016/j.bbagen.2011.12.012; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; Dou HV, 2004, JARO-J ASSOC RES OTO, V5, P215, DOI 10.1007/s10162-003-4020-3; Ehlinger DG, 2017, EUR J NEUROSCI, V46, P2416, DOI 10.1111/ejn.13707; Full Y, 2013, PFLUG ARCH EUR J PHY, V465, P797, DOI 10.1007/s00424-012-1184-x; Grant AO, 2002, J CLIN INVEST, V110, P1201, DOI 10.1172/JCI200215570; Graybiel AM, 2016, RES PER NEUROSCI, P81, DOI 10.1007/978-3-319-28802-4_6; Gregory FD, 2013, J PHYSIOL-LONDON, V591, P3253, DOI 10.1113/jphysiol.2013.254367; Hamid J, 2006, NEUROSCIENCE, V143, P717, DOI 10.1016/j.neuroscience.2006.08.023; Harel T, 2017, AM J MED GENET A, V173, P2539, DOI 10.1002/ajmg.a.38347; Hennessey JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106982; Herlitze S, 1997, P NATL ACAD SCI USA, V94, P1512, DOI 10.1073/pnas.94.4.1512; Hubner CA, 2002, HUM MOL GENET, V11, P2435, DOI 10.1093/hmg/11.20.2435; Joensuu M, 2018, PROG NEURO-PSYCHOPH, V84, P362, DOI 10.1016/j.pnpbp.2017.08.023; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Mckeown L, 2008, J BIOL CHEM, V283, P30421, DOI 10.1074/jbc.M708921200; McKinney BC, 2006, LEARN MEMORY, V13, P584, DOI 10.1101/lm.279006; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Palovcak E, 2014, J GEN PHYSIOL, V143, P145, DOI 10.1085/jgp.201311103; Pantazis A, 2014, P NATL ACAD SCI USA, V111, P18381, DOI 10.1073/pnas.1411127112; Pietrobon D, 2010, PFLUG ARCH EUR J PHY, V460, P375, DOI 10.1007/s00424-010-0802-8; Pinggera A, 2017, HUM MOL GENET, V26, P2923, DOI 10.1093/hmg/ddx175; Pinggera A, 2015, BIOL PSYCHIAT, V77, P816, DOI 10.1016/j.biopsych.2014.11.020; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Scholl UI, 2013, NAT GENET, V45, P1050, DOI 10.1038/ng.2695; Schraders M, 2012, AM J HUM GENET, V91, P883, DOI 10.1016/j.ajhg.2012.09.012; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Sinnegger-Brauns MJ, 2009, MOL PHARMACOL, V75, P407, DOI 10.1124/mol.108.049981; Spaetgens RL, 1999, J BIOL CHEM, V274, P22428, DOI 10.1074/jbc.274.32.22428; Stanika R, 2016, SCI REP-UK, V6, DOI 10.1038/srep34528; Stawarski M, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00068; Stotz SC, 2001, J BIOL CHEM, V276, P33001, DOI 10.1074/jbc.M104387200; Striessnig J, 2010, PFLUG ARCH EUR J PHY, V460, P361, DOI 10.1007/s00424-010-0800-x; Tadross MR, 2010, J GEN PHYSIOL, V135, P197, DOI 10.1085/jgp.200910308; Takahashi SX, 2004, P NATL ACAD SCI USA, V101, P7193, DOI 10.1073/pnas.0306665101; Wang SY, 2017, J NEUROSCI, V37, P4679, DOI 10.1523/JNEUROSCI.2583-16.2017; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Wehrens XHT, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9136; WEI XY, 1994, J BIOL CHEM, V269, P1635; Wu JP, 2016, NATURE, V537, P191, DOI 10.1038/nature19321; Zhang H, 2006, EUR J NEUROSCI, V23, P2297, DOI 10.1111/j.1460-9568.2006.04734.x	53	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14444	14454		10.1074/jbc.RA118.003681	http://dx.doi.org/10.1074/jbc.RA118.003681			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30054272	Green Published, hybrid			2022-12-28	WOS:000444671500023
J	Matsubara, T; Yasumori, H; Ito, K; Shimoaka, T; Hasegawa, T; Sato, T				Matsubara, Teruhiko; Yasumori, Hanaki; Ito, Koichiro; Shimoaka, Takafumi; Hasegawa, Takeshi; Sato, Toshinori			Amyloid- fibrils assembled on ganglioside-enriched membranes contain both parallel -sheets and turns	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid (A); fibril; ganglioside; Fourier transform IR (FTIR); atomic force microscopy (AFM); Alzheimer's disease; parallel -structure; lipid bilayer; neuronal membrane; neurodegeneration	TRANSFORM INFRARED-SPECTROSCOPY; PROTEIN SECONDARY STRUCTURES; SOLID-STATE NMR; ALZHEIMERS-DISEASE; GM1 GANGLIOSIDE; BETA-PROTEIN; FTIR SPECTROSCOPY; STRUCTURAL MODEL; PEPTIDE; OLIGOMERS	Some protein and peptide aggregates, such as those of amyloid- protein (A), are neurotoxic and have been implicated in several neurodegenerative diseases. A accumulates at nanoclusters enriched in neuronal lipids called gangliosides in the presynaptic neuronal membrane, and the resulting oligomeric and/or fibrous forms accelerate the development of Alzheimer's disease. Although the presence of A deposits at such nanoclusters is known, the mechanism of their assembly and the relationship between A secondary structure and topography are still unclear. Here, we first confirmed by atomic force microscopy that A(40) fibrils can be obtained by incubating seed-free A(40) monomers with a membrane composed of sphingomyelin, cholesterol, and the ganglioside GM1. Using Fourier transform infrared (FTIR) reflection-absorption spectroscopy, we then found that these lipid-associated fibrils contained parallel -sheets, whereas self-assembled A(40) molecules formed antiparallel -sheets. We also found that the fibrils obtained at GM1-rich nanoclusters were generated from turn A(40). Our findings indicate that A generally self-assembles into antiparallel -structures but can also form protofibrils with parallel -sheets by interacting with ganglioside-bound A. We concluded that by promoting the formation of parallel -sheets, highly ganglioside-enriched nanoclusters help accelerate the elongation of A fibrils. These results advance our understanding of ganglioside-induced A fibril formation in neuronal membranes and may help inform the development of additional therapies for Alzheimer's disease.	[Matsubara, Teruhiko; Yasumori, Hanaki; Ito, Koichiro; Sato, Toshinori] Keio Univ, Dept Biosci & Informat, Kouhoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan; [Shimoaka, Takafumi; Hasegawa, Takeshi] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan	Keio University; Kyoto University	Sato, T (corresponding author), Keio Univ, Dept Biosci & Informat, Kouhoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	sato@bio.keio.ac.jp	; Hasegawa, Takeshi/G-6659-2018	Sato, Toshinori/0000-0002-4429-6101; Hasegawa, Takeshi/0000-0001-5574-9869	Kakenhi from the Japan Society for the Promotion of Science [22300118]; Suzuken Memorial Foundation [11-093]; Keio Gijuku Academic Development Funds; National Center for Geriatrics and Gerontology, Japan [25-19]	Kakenhi from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Suzuken Memorial Foundation; Keio Gijuku Academic Development Funds; National Center for Geriatrics and Gerontology, Japan	This work was supported by Kakenhi Grant 22300118 from the Japan Society for the Promotion of Science (to T. M.), by Grant 11-093 from the Suzuken Memorial Foundation (to T. M.), by the Keio Gijuku Academic Development Funds (to T. M.), and by Research Funding for Longevity Sciences, Grant 25-19, from the National Center for Geriatrics and Gerontology, Japan (to T. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; BANDEKAR J, 1992, BIOCHIM BIOPHYS ACTA, V1120, P123, DOI 10.1016/0167-4838(92)90261-B; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; BURDICK D, 1992, J BIOL CHEM, V267, P546; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022; Dreissig I, 2009, SPECTROCHIM ACTA A, V71, P2069, DOI 10.1016/j.saa.2008.08.008; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Evangelisti E, 2016, SCI REP-UK, V6, DOI 10.1038/srep32721; Fu Z, 2015, BIOCHEMISTRY-US, V54, P4197, DOI 10.1021/acs.biochem.5b00467; Fukunaga S, 2012, BIOCHEMISTRY-US, V51, P8125, DOI 10.1021/bi300839u; GUN J, 1984, J COLLOID INTERF SCI, V101, P201, DOI 10.1016/0021-9797(84)90020-1; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Hoshino T, 2013, J PHYS CHEM B, V117, P8085, DOI 10.1021/jp4029062; Hu ZP, 2015, PHYS CHEM CHEM PHYS, V17, P22711, DOI 10.1039/c5cp02366a; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; LANSBURY PT, 1995, NAT STRUCT BIOL, V2, P990, DOI 10.1038/nsb1195-990; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Matsubara T, 2017, LANGMUIR, V33, P13874, DOI 10.1021/acs.langmuir.7b02091; Matsubara T, 2013, LANGMUIR, V29, P2258, DOI 10.1021/la3038999; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; McLaurin J, 1996, J BIOL CHEM, V271, P26482, DOI 10.1074/jbc.271.43.26482; MERRITT EA, 1994, PROTEIN SCI, V3, P166; Moore DJ, 1997, J PHYS CHEM B, V101, P8933, DOI 10.1021/jp9718109; Oikawa N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121356; Pelton JT, 2000, ANAL BIOCHEM, V277, P167, DOI 10.1006/abio.1999.4320; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Qiang W, 2017, NATURE, V541, P217, DOI 10.1038/nature20814; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Shimoaka T, 2013, ANAL BIOANAL CHEM, V405, P9411, DOI 10.1007/s00216-013-7400-5; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Sonnino S, 2006, CHEM REV, V106, P2111, DOI 10.1021/cr0100446; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; SUSI H, 1983, BIOCHEM BIOPH RES CO, V115, P391, DOI 10.1016/0006-291X(83)91016-1; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Utsumi M, 2009, GLYCOCONJUGATE J, V26, P999, DOI 10.1007/s10719-008-9216-7; WISNIEWSKI T, 1991, BIOCHEM BIOPH RES CO, V179, P1247, DOI 10.1016/0006-291X(91)91706-I; Yagi-Utsumi M, 2015, GLYCOCONJUGATE J, V32, P105, DOI 10.1007/s10719-015-9587-5; Yagi-Utsumi M, 2010, FEBS LETT, V584, P831, DOI 10.1016/j.febslet.2010.01.005; Yamada N, 1998, J AM CHEM SOC, V120, P12192, DOI 10.1021/ja981363q; Yamamoto N, 2007, J BIOL CHEM, V282, P2646, DOI 10.1074/jbc.M606202200; Yamamoto N, 2008, BBA-BIOMEMBRANES, V1778, P2717, DOI 10.1016/j.bbamem.2008.07.028; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yanagisawa K, 2007, BBA-BIOMEMBRANES, V1768, P1943, DOI 10.1016/j.bbamem.2007.01.018; Yanagisawa K, 2015, GLYCOCONJUGATE J, V32, P87, DOI 10.1007/s10719-015-9579-5; Yanagisawa K, 2011, J NEUROCHEM, V116, P806, DOI 10.1111/j.1471-4159.2010.07006.x; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n	55	21	21	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14146	14154		10.1074/jbc.RA118.002787	http://dx.doi.org/10.1074/jbc.RA118.002787			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30018137	hybrid, Green Published			2022-12-28	WOS:000444070700035
J	Sharma, A; Dubey, V; Sharma, R; Devnath, K; Gupta, VK; Akhter, J; Bhando, T; Verma, A; Ambatipudi, K; Sarkar, M; Pathania, R				Sharma, Atin; Dubey, Vineet; Sharma, Rajnikant; Devnath, Kuldip; Gupta, Vivek Kumar; Akhter, Jawed; Bhando, Timsy; Verma, Aparna; Ambatipudi, Kiran; Sarkar, Mihir; Pathania, Ranjana			The unusual glycine-rich C terminus of the Acinetobacter baumannii RNA chaperone Hfq plays an important role in bacterial physiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						virulence factor; gene regulation; biofilm; bacterial adhesion; RNA binding protein; AbsR25; chaperone; Gram negative pathogen; resistance; small RNA; intrinsically disordered protein; pathogen	ESCHERICHIA-COLI HFQ; MULTIDRUG-RESISTANT; VIRULENCE; PROTEINS; DOMAIN; BIOREMEDIATION; INSIGHTS	Acinetobacter baumannii is a Gram-negative nosocomial pathogen that causes soft tissue infections in patients who spend a long time in intensive care units. This recalcitrant bacterium is very well known for developing rapid drug resistance, which is a combined outcome of its natural competence and mobile genetic elements. Successful efforts to treat these infections would be aided by additional information on the physiology of A. baumannii. Toward that end, we recently reported on a small RNA (sRNA), AbsR25, in this bacterium that regulates the genes of several efflux pumps. Because sRNAs often require the RNA chaperone Hfq for assistance in binding to their cognate mRNA targets, we identified and characterized this protein in A. baumannii. The homolog in A. baumannii is a large protein with an extended C terminus unlike Hfqs in other Gram-negative pathogens. The extension has a compositional bias toward glycine and, to a lower extent, phenylalanine and glutamine, suggestive of an intrinsically disordered region. We studied the importance of this glycine-rich tail using truncated versions of Hfq in biophysical assays and complementation of an hfq deletion mutant, finding that the tail was necessary for high-affinity RNA binding. Further tests implicate Hfq in important cellular processes of A. baumannii like metabolism, drug resistance, stress tolerance, and virulence. Our findings underline the importance of the glycine-rich C terminus in RNA binding, ribo-regulation, and auto-regulation of Hfq, demonstrating this hitherto overlooked protein motif to be an indispensable part of the A. baumannii Hfq.	[Sharma, Atin; Dubey, Vineet; Sharma, Rajnikant; Devnath, Kuldip; Gupta, Vivek Kumar; Akhter, Jawed; Bhando, Timsy; Verma, Aparna; Ambatipudi, Kiran; Pathania, Ranjana] Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee 247667, Uttar Pradesh, India; [Sarkar, Mihir] Indian Vet Res Inst, ICAR, Div Physiol & Climatol, Izatnagar 243122, UP, India; [Sharma, Rajnikant] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; University of North Carolina; University of North Carolina Chapel Hill	Pathania, R (corresponding author), Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee 247667, Uttar Pradesh, India.	rpathfbs@iitr.ac.in	Sharma, Atin/HII-8073-2022; Sharma, Rajnikant/AGO-9487-2022; Sharma, Atin/N-5204-2015	Pathania, Ranjana/0000-0002-7965-8176; Sharma, Atin/0000-0002-9422-1853; Devnath, Kuldip/0000-0001-9466-4577	Department of Biotechnology, Government of India [BT/PR11943/MED/29/874/2014]; Ministry of Human Resource Development, Government of India; Department of Biotechnology, Government of India; Indian Council of Medical Research	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Ministry of Human Resource Development, Government of India(Ministry of Human Resource Development (MHRD), Government of India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by Department of Biotechnology, Government of India, Grant BT/PR11943/MED/29/874/2014; Ministry of Human Resource Development, Government of India, Ph.D. support fellowships (to A.S., R.S., T.B., and A.V.); a grant from the Department of Biotechnology, Government of India (to V.D.); and a grant from the Indian Council of Medical Research (to J.A.). The authors declare that they have no conflicts of interest with the contents of this article. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Abbott A, 2005, NATURE, V436, P758, DOI 10.1038/436758a; Abdel-el-haleem D., 2003, AFR J BIOTECHNOL, V2, P71, DOI 10.5897/AJB2003.000-1014; Amin SV, 2016, RNA BIOL, V13, P331, DOI 10.1080/15476286.2016.1144010; Arluison V, 2004, EUR J BIOCHEM, V271, P1258, DOI 10.1111/j.1432-1033.2004.04026.x; Beich-Frandsen M, 2011, NUCLEIC ACIDS RES, V39, P4900, DOI 10.1093/nar/gkq1346; Bigot S, 2017, VIRULENCE, V8, P653, DOI 10.1080/21505594.2017.1283465; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Chiang MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022248; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fortas E, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140128; Garcia-Quintanilla M, 2016, ANTIMICROB AGENTS CH, V60, P5076, DOI 10.1128/AAC.00407-16; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; Hanson KG, 1997, CURR MICROBIOL, V35, P191, DOI 10.1007/s002849900237; Kawamura-Sato K, 2010, J ANTIMICROB CHEMOTH, V65, P1975, DOI 10.1093/jac/dkq227; Kim JS, 2007, NUCLEIC ACIDS RES, V35, P506, DOI 10.1093/nar/gkl1076; Kuo HY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02068; Lee CR, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00055; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10; Nadler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037984; Olsen AS, 2010, J MOL BIOL, V404, P173, DOI 10.1016/j.jmb.2010.09.038; Paisio CE, 2016, ENVIRON TECHNOL, V37, P2379, DOI 10.1080/09593330.2016.1150352; Papenfort K, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00091; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Poulikakos P, 2014, EUR J CLIN MICROBIOL, V33, P1675, DOI 10.1007/s10096-014-2124-9; Rogelj B., 2011, RNA BINDING PROTEINS, P1; Sachetto-Martins G, 2000, BBA-GENE STRUCT EXPR, V1492, P1, DOI 10.1016/S0167-4781(00)00064-6; Santiago-Frangos A, 2017, ELIFE, V6, DOI 10.7554/eLife.27049; Schilling D, 2009, J BACTERIOL, V191, P5553, DOI 10.1128/JB.00490-09; Sharma A, 2017, J ANTIMICROB CHEMOTH, V72, P68, DOI 10.1093/jac/dkw382; Sharma R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093833; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sobrero P, 2012, CRIT REV MICROBIOL, V38, P276, DOI 10.3109/1040841X.2012.664540; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Svensson SL, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0028-2015; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Tucker AT, 2014, MBIO, V5, DOI 10.1128/mBio.01313-14; Updegrove TB, 2016, CURR OPIN MICROBIOL, V30, P133, DOI 10.1016/j.mib.2016.02.003; Valentine SC, 2008, J CLIN MICROBIOL, V46, P2499, DOI 10.1128/JCM.00367-08; Vecerek B, 2008, NUCLEIC ACIDS RES, V36, P133, DOI 10.1093/nar/gkm985; Vincent HA, 2012, J MOL BIOL, V420, P56, DOI 10.1016/j.jmb.2012.03.028; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Zhang AX, 2013, J MOL BIOL, V425, P3678, DOI 10.1016/j.jmb.2013.01.006	44	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13377	13388		10.1074/jbc.RA118.002921	http://dx.doi.org/10.1074/jbc.RA118.002921			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30002121	hybrid, Green Published			2022-12-28	WOS:000443375500003
J	Reid, HM; Mulvaney, EP; Turner, EC; Kinsella, BT				Reid, Helen M.; Mulvaney, Eamon P.; Turner, Elizebeth C.; Kinsella, B. Therese			RETRACTION: Interaction of the human prostacyclin receptor with Rab11. Characterization of a novel Rab11 binding domain within alpha-helix 8 that is regulated by palmitoylation (Retraction of Vol 285, Pg 18709, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Reid HM, 2010, J BIOL CHEM, V285, P18709, DOI 10.1074/jbc.M110.106476	1	0	0	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12287	12287		10.1074/jbc.W118.004807	http://dx.doi.org/10.1074/jbc.W118.004807			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	30076259	hybrid, Green Published			2022-12-28	WOS:000440803200029
J	Lawler, OA; Miggin, SM; Kinsella, BT				Lawler, Orlaith A.; Miggin, Sinead M.; Kinsella, B. Therese			Protein kinase A-mediated phosphorylation of serine 357 of the mouse prostacyclin receptor regulates its coupling to G(s)-, to G(i)-, and to G(q)-coupled effector signaling (vol 276, pg 33596, 2001)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Lawler OA, 2001, J BIOL CHEM, V276, P33596, DOI 10.1074/jbc.M104434200	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11046	11046		10.1074/jbc.AAC118.004491	http://dx.doi.org/10.1074/jbc.AAC118.004491			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	30006385	Green Published, hybrid			2022-12-28	WOS:000438882800017
J	Liou, G; Chiang, YC; Wang, Y; Weng, JK				Liou, Geoffrey; Chiang, Ying-Chih; Wang, Yi; Weng, Jing-Ke			Mechanistic basis for the evolution of chalcone synthase catalytic cysteine reactivity in land plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINEAR CONSTRAINT SOLVER; MOLECULAR-DYNAMICS; MODEL; PROTEINS; GENETICS; PK(A); LINCS	Flavonoids are important polyphenolic natural products, ubiquitous in land plants, that play diverse functions in plants' survival in their ecological niches, including UV protection, pigmentation for attracting pollinators, symbiotic nitrogen fixation, and defense against herbivores. Chalcone synthase (CHS) catalyzes the first committed step in plant flavonoid biosynthesis and is highly conserved in all land plants. In several previously reported crystal structures of CHSs from flowering plants, the catalytic cysteine is oxidized to sulfinic acid, indicating enhanced nucleophilicity in this residue associated with its increased susceptibility to oxidation. In this study, we report a set of new crystal structures of CHSs representing all five major lineages of land plants (bryophytes, lycophytes, monilophytes, gymnosperms, and angiosperms), spanning 500 million years of evolution. We reveal that the structures of CHS from a lycophyte and a moss species preserve the catalytic cysteine in a reduced state, in contrast to the cysteine sulfinic acid seen in all euphyl-lophyte CHS structures. In vivo complementation, in vitro biochemical and mutagenesis analyses, and molecular dynamics simulations identified a set of residues that differ between basal-plant and euphyllophyte CHSs and modulate catalytic cysteine reactivity. We propose that the CHS active-site environment has evolved in euphyllophytes to further enhance the nucleophilicity of the catalytic cysteine since the divergence of euphyllophytes from other vascular plant lineages 400 million years ago. These changes in CHS could have contributed to the diversification of flavonoid biosynthesis in euphyllophytes, which in turn contributed to their dominance in terrestrial ecosystems.	[Liou, Geoffrey; Weng, Jing-Ke] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Liou, Geoffrey; Weng, Jing-Ke] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Chiang, Ying-Chih; Wang, Yi] Chinese Univ Hong Kong, Dept Phys, Shatin, Hong Kong, Peoples R China	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Chinese University of Hong Kong	Weng, JK (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	wengj@wi.mit.edu	Weng, Jing-Ke/V-5934-2019	Weng, Jing-Ke/0000-0003-3059-0075; Liou, Geoffrey/0000-0003-4712-9023; Chiang, Ying-Chih/0000-0002-1585-7213	Howard Hughes Medical Institute, National Science Foundation [CHE-1709616]; Pew Scholars Program in the Biomedical Sciences Grant [27345]; Searle Scholars Program of the Kinship Foundation Grant [15-SSP-162]; Chinese University of Hong Kong; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	Howard Hughes Medical Institute, National Science Foundation; Pew Scholars Program in the Biomedical Sciences Grant; Searle Scholars Program of the Kinship Foundation Grant; Chinese University of Hong Kong(Chinese University of Hong Kong); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute, National Science Foundation Grant CHE-1709616 (to J. K. W.), Pew Scholars Program in the Biomedical Sciences Grant 27345 (to J. K. W.), Searle Scholars Program of the Kinship Foundation Grant 15-SSP-162 (to J. K. W.), and direct grants from the Chinese University of Hong Kong (to Y. W.). J. K. W. is a co-founder, a member of the Scientific Advisory Board, and a shareholder of DoubleRainbow Biosciences, which develops biotechnologies related to natural products. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Ashkenazy H, 2012, NUCLEIC ACIDS RES, V40, pW580, DOI 10.1093/nar/gks498; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W. L, 2016, PYMOL MOL GRAPHICS S; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Jez JM, 2000, J BIOL CHEM, V275, P39640, DOI 10.1074/jbc.M008569200; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Matasci N, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-17; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Oliveira SHP, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-197; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peralta D, 2015, NAT CHEM BIOL, V11, P156, DOI [10.1038/NCHEMBIO.1720, 10.1038/nchembio.1720]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rausher MD., 2006, SCI FLAVONOIDS, P175, DOI [10.1007/978-0-387-28822-2_7, DOI 10.1007/978-0-387-28822-2_7]; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Schlegel BP, 1998, BIOCHEMISTRY-US, V37, P3538, DOI 10.1021/bi9723055; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; STORER AC, 1994, METHOD ENZYMOL, V244, P486; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Weigel D., 2002, ARABIDOPSIS LAB MANU; Weng JK, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00119; Weng JK, 2012, METHOD ENZYMOL, V515, P317, DOI [10.1016/B978-0-12-394290-6.00015-X, 10.1016/B978-0-12-394290-6.00014-8]; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7	44	20	22	3	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18601	18612		10.1074/jbc.RA118.005695	http://dx.doi.org/10.1074/jbc.RA118.005695			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30291143	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000458467300015
J	Macdonald, R; Cascio, D; Collazo, MJ; Phillips, M; Clubb, RT				Macdonald, Ramsay; Cascio, Duilio; Collazo, Michael J.; Phillips, Martin; Clubb, Robert T.			The Streptococcus pyogenes Shr protein captures human hemoglobin using two structurally unique binding domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Streptococcus pyogenes (S; pyogenes); hemoglobin; X-ray crystallography; nuclear magnetic resonance (NMR); isothermal titration calorimetry (ITC); receptor; bacterial pathogen; DUF1533; Shr	CELL-SURFACE PROTEIN; STAPHYLOCOCCUS-AUREUS USES; HEME-BINDING; IRON ACQUISITION; NEAT DOMAIN; TRANSPORTER DOMAINS; CRYSTAL-STRUCTURE; RECEPTOR; ISDB; HTSA	In order to proliferate and mount an infection, many bacterial pathogens need to acquire iron from their host. The most abundant iron source in the body is the oxygen transporter hemoglobin (Hb). Streptococcus pyogenes, a potentially lethal human pathogen, uses the Shr protein to capture Hb on the cell surface. Shr is an important virulence factor, yet the mechanism by which it captures Hb and acquires its heme is not well-understood. Here, we show using NMR and biochemical methods that Shr binds Hb using two related modules that were previously defined as domains of unknown function (DUF1533). These hemoglobin-interacting domains (HIDs), called HID1 and HID2, are autonomously folded and independently bind Hb. The 1.5 resolution crystal structure of HID2 revealed that it is a structurally unique Hb-binding domain. Mutagenesis studies revealed a conserved tyrosine in both HIDs that is essential for Hb binding. Our biochemical studies indicate that HID2 binds Hb with higher affinity than HID1 and that the Hb tetramer is engaged by two Shr receptors. NMR studies reveal the presence of a third autonomously folded domain between HID2 and a heme-binding NEAT1 domain, suggesting that this linker domain may position NEAT1 near Hb for heme capture.	[Macdonald, Ramsay; Phillips, Martin; Clubb, Robert T.] UCLA, Dept Chem & Biochem, 602 Boyer Hall,611 Charles Young Dr East, Los Angeles, CA 90025 USA; [Macdonald, Ramsay; Cascio, Duilio; Collazo, Michael J.; Clubb, Robert T.] UCLA, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Clubb, Robert T.] UCLA, Mol Biol Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clubb, RT (corresponding author), UCLA, Dept Chem & Biochem, 602 Boyer Hall,611 Charles Young Dr East, Los Angeles, CA 90025 USA.	rclubb@mbi.ucla.edu			National Institutes of Health Equipment Grant [S10OD016336]; National Institutes of Health from NIGMS [P41 GM103403]; National Institutes of Health-ORIP HEI Grant [S10 RR029205]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016336] Funding Source: NIH RePORTER	National Institutes of Health Equipment Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health-ORIP HEI Grant; DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Robert Peterson for assistance with NMR experiments. We also thank Dr. Brendan R. Amer and Orlando Martinez for assistance with the SEC-MALS experiments and Dr. William Silkworth for assistance with ITC experiments. We are grateful for useful discussions with Dr. Megan Sjodt, as well as members of the Clubb laboratory. We thank Professors Zehava Eichenbaum and John Olson for providing useful reagents. NMR equipment used in this research was purchased using funds from shared National Institutes of Health Equipment Grant S10OD016336. This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines that are funded by National Institutes of Health Grant P41 GM103403 from NIGMS. The Pilatus 6M detector on 24-ID-C beam line is funded by National Institutes of Health-ORIP HEI Grant S10 RR029205. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andrade MA, 2002, GENOME BIOL, V3; Aranda R, 2007, J MOL BIOL, V374, P374, DOI 10.1016/j.jmb.2007.08.058; Balderas MA, 2012, J BACTERIOL, V194, P5513, DOI 10.1128/JB.00685-12; Bates CS, 2003, INFECT IMMUN, V71, P1042, DOI 10.1128/IAI.71.3.1042-1055.2003; Bowden CFM, 2018, J BIOL CHEM, V293, P177, DOI 10.1074/jbc.M117.806562; Bowden CFM, 2014, BIOCHEMISTRY-US, V53, P2286, DOI 10.1021/bi500230f; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cobessi D, 2010, PROTEINS, V78, P286, DOI 10.1002/prot.22539; Dahesh S, 2012, VIRULENCE, V3, P566, DOI 10.4161/viru.21933; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2004, PYMOL USERS GUIDE VE; Dickson CF, 2015, ACTA CRYSTALLOGR D, V71, P1295, DOI 10.1107/S1399004715005817; Dickson CF, 2014, J BIOL CHEM, V289, P6728, DOI 10.1074/jbc.M113.545566; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Fisher M, 2008, INFECT IMMUN, V76, P5006, DOI 10.1128/IAI.00300-08; Fonner BA, 2014, BIOCHEMISTRY-US, V53, P3922, DOI 10.1021/bi5005188; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Ge RG, 2014, METALLOMICS, V6, P996, DOI 10.1039/c4mt00011k; GODDARD TD, 2006, SPARKY3; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Hare SA, 2017, BBA-PROTEINS PROTEOM, V1865, P422, DOI 10.1016/j.bbapap.2017.01.006; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Honsa ES, 2011, J BIOL CHEM, V286, P33652, DOI 10.1074/jbc.M111.241687; Hoshino M, 2017, BIOCHEM BIOPH RES CO, V493, P1109, DOI 10.1016/j.bbrc.2017.09.055; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Keller R., 2004, COMPUTER AIDED RESON, V1; Kumar KK, 2011, J BIOL CHEM, V286, P38439, DOI 10.1074/jbc.M111.287300; Lei Benfang, 2010, World J Biol Chem, V1, P286, DOI 10.4331/wjbc.v1.i9.286; Lei BF, 2002, INFECT IMMUN, V70, P4494, DOI 10.1128/IAI.70.8.4494-4500.2002; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Liu MY, 2005, INFECT IMMUN, V73, P5086, DOI 10.1128/IAI.73.8.5086-5092.2005; LOOKER D, 1994, METHOD ENZYMOL, V231, P364; LOOKER D, 1992, NATURE, V356, P258, DOI 10.1038/356258a0; Lu CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037556; Malmirchegini GR, 2014, J BIOL CHEM, V289, P34886, DOI 10.1074/jbc.M114.583013; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Moriwaki Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145125; Moriwaki Y, 2013, BIOCHEMISTRY-US, V52, P8866, DOI 10.1021/bi4008325; NMR Software Department, 2016, TOPSPIN NMRDATA PUBL; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; Ouattara M, 2013, ARCH BIOCHEM BIOPHYS, V538, P71, DOI 10.1016/j.abb.2013.08.009; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pishchany G, 2014, J INFECT DIS, V209, P1764, DOI 10.1093/infdis/jit817; Pishchany G, 2009, INFECT IMMUN, V77, P2624, DOI 10.1128/IAI.01531-08; Pluym M, 2008, J INORG BIOCHEM, V102, P480, DOI 10.1016/j.jinorgbio.2007.11.011; Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280; Ran YC, 2007, J BIOL CHEM, V282, P31380, DOI 10.1074/jbc.M705967200; Ran YC, 2013, BIOCHEMISTRY-US, V52, P6537, DOI 10.1021/bi400965u; Ran YC, 2010, BIOCHEMISTRY-US, V49, P2834, DOI 10.1021/bi901987h; Saederup KL, 2016, J BIOL CHEM, V291, P23989, DOI 10.1074/jbc.M116.755934; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Sheldon JR, 2015, FEMS MICROBIOL REV, V39, P592, DOI 10.1093/femsre/fuv009; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Sjodt M, 2018, J BIOL CHEM, V293, P6942, DOI 10.1074/jbc.RA117.000803; Sjodt M, 2016, J MOL BIOL, V428, P1107, DOI 10.1016/j.jmb.2015.02.008; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Spirig T, 2013, J BIOL CHEM, V288, P1065, DOI 10.1074/jbc.M112.419119; STEVENS DL, 1995, EMERG INFECT DIS, V1, P69, DOI 10.3201/eid0103.950301; Stodkilde K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6487; Tsatsaronis JA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004266; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Vicente JJ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-1; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Vu NT, 2013, PROTEIN SCI, V22, P942, DOI 10.1002/pro.2276; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Wong CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10172; Zhu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100744; Zhu LC, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00460-17	83	4	4	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18365	18377		10.1074/jbc.RA118.005261	http://dx.doi.org/10.1074/jbc.RA118.005261			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30301765	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000451375200027
J	Kapuria, V; Rohrig, UF; Waridel, P; Lammers, F; Borodkin, VS; van Aalten, DMF; Zoete, V; Herr, W				Kapuria, Vaibhav; Rohrig, Ute F.; Waridel, Patrice; Lammers, Fabienne; Borodkin, Vladimir S.; van Aalten, Daan M. F.; Zoete, Vincent; Herr, Winship			The conserved threonine-rich region of the HCF-1(PRO) repeat activates promiscuous OGT:UDP-GlcNAc glycosylation and proteolysis activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); post-translational modification (PTM); enzyme mechanism; glycobiology; host-cell factor-1	TRANSFERASE; PROTEIN; CLEAVAGE; DYNAMICS; COMPLEX; WATER; SITE	O-Linked GlcNAc transferase (OGT) possesses dual glycosyltransferase-protease activities. OGT thereby stably glycosylates serines and threonines of numerous proteins and, via a transient glutamate glycosylation, cleaves a single known substratethe so-called HCF-1(PRO) repeat of the transcriptional co-regulator host-cell factor 1 (HCF-1). Here, we probed the relationship between these distinct glycosylation and proteolytic activities. For proteolysis, the HCF-1(PRO) repeat possesses an important extended threonine-rich region that is tightly bound by the OGT tetratricopeptide-repeat (TPR) region. We report that linkage of this HCF-1(PRO)-repeat, threonine-rich region to heterologous substrate sequences also potentiates robust serine glycosylation with the otherwise poor R-p-S-UDP-GlcNAc diastereomer phosphorothioate and UDP-5S-GlcNAc OGT co-substrates. Furthermore, it potentiated proteolysis of a non-HCF-1(PRO)-repeat cleavage sequence, provided it contained an appropriately positioned glutamate residue. Using serine- or glutamate-containing HCF-1(PRO)-repeat sequences, we show that proposed OGT-based or UDP-GlcNAc-based serine-acceptor residue activation mechanisms can be circumvented independently, but not when disrupted together. In contrast, disruption of both proposed activation mechanisms even in combination did not inhibit OGT-mediated proteolysis. These results reveal a multiplicity of OGT glycosylation strategies, some leading to proteolysis, which could be targets of alternative molecular regulatory strategies.	[Kapuria, Vaibhav; Lammers, Fabienne; Herr, Winship] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Rohrig, Ute F.; Zoete, Vincent] Swiss Inst Bioinformat, Mol Modelling Grp, CH-1015 Lausanne, Switzerland; [Waridel, Patrice] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, Prot Anal Facil, CH-1015 Lausanne, Switzerland; [Borodkin, Vladimir S.; van Aalten, Daan M. F.] Univ Dundee, Sch Life Sci, Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Zoete, Vincent] Univ Lausanne, Fac Biol & Med, Ludwig Lausanne Branch, Dept Fundamental Oncol, CH-1066 Epalinges, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; University of Dundee; University of Lausanne	Herr, W (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	winship.herr@unil.ch	; Herr, Winship/E-6491-2012	Roehrig, Ute/0000-0002-4676-4087; Herr, Winship/0000-0002-3606-4546; van Aalten, Daan/0000-0002-1499-6908; Kapuria, Vaibhav/0000-0003-1514-419X	Swiss National Science Foundation [31003A_170150]; University of Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Lausanne	This work was supported by Swiss National Science Foundation Grant 31003A_170150 and the University of Lausanne (to W. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Bhuiyan T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136636; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Janetzko J, 2016, NAT CHEM BIOL, V12, P899, DOI [10.1038/NCHEMBIO.2173, 10.1038/nchembio.2173]; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kapuria V, 2016, GENE DEV, V30, P960, DOI 10.1101/gad.275925.115; Kotzler MP, 2016, J BIOL CHEM, V291, P429, DOI 10.1074/jbc.C115.698696; KRISTIE TM, 1995, J BIOL CHEM, V270, P4387, DOI 10.1074/jbc.270.9.4387; Kumari M, 2015, J PHYS CHEM B, V119, P4371, DOI 10.1021/jp511235f; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Rafie K, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170078; Rose PW, 2017, NUCLEIC ACIDS RES, V45, pD271, DOI 10.1093/nar/gkw1000; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445	24	2	2	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17754	17768		10.1074/jbc.RA118.004185	http://dx.doi.org/10.1074/jbc.RA118.004185			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30224358	Green Published, hybrid			2022-12-28	WOS:000450409500008
J	Pan, GP; Cao, XY; Liu, B; Li, CW; Li, D; Zheng, J; Lai, CF; Olkkonen, VM; Zhong, WB; Yan, DG				Pan, Guoping; Cao, Xiuye; Liu, Bo; Li, Chaowen; Li, Dan; Zheng, Jie; Lai, Chaofeng; Olkkonen, Vesa M.; Zhong, Wenbin; Yan, Daoguang			OSBP-related protein 4L promotes phospholipase C3 translocation from the nucleus to the plasma membrane in Jurkat T-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vesicles; protein complex; calcium; inositol 1; 4; 5-trisphosphate (IP3); G protein-coupled receptor (GPCR); OSBP-related protein 4L; PLC3 translocation; RAN activation; signal transduction; VAPA	OXYSTEROL-BINDING-PROTEINS; CONTACT SITES; SUBCELLULAR-DISTRIBUTION; EXPORT SIGNALS; FRIEND-CELLS; TRANSPORT; DIFFERENTIATION; FAMILY; RAN; ISOFORMS	Phosphoinositide phospholipases C (PLCs) are a family of eukaryotic intracellular enzymes with important roles in signal transduction. In addition to their location at the plasma membrane, PLCs also exist within the cell nucleus where they are stored. We previously demonstrated that OSBP-related protein 4L (ORP4L) anchors cluster of differentiation 3E (CD3E) to the heterotrimeric G protein subunit (G(q/11)) to control PLC3 relocation and activation. However, the underlying mechanism by which ORP4L facilitates PLC3 translocation remains unknown. Here, using confocal immunofluorescence microscopy and coimmunoprecipitation assays, we report that ORP4L stimulates PLC3 translocation from the nucleus to the plasma membrane in Jurkat T-cells in two steps. First, we found that ORP4L is required for the activation of Ras-related nuclear protein (RAN), a GTP-binding nuclear protein that binds to exportin 1 and eventually promotes the nuclear export of PLC3. Second, we also observed that ORP4L interacts with vesicle-associated membrane protein-associated protein A (VAPA) through its two phenylalanines in an acidic tract (FFAT) motif. This complex enabled PLC3 movement to the plasma membrane, indicating that PLC3 translocation occurs in a VAPA-dependent manner. This study reveals detailed mechanistic insight into the role of ORP4L in PLC3 redistribution from storage within the nucleus to the plasma membrane via RAN activation and interaction with VAPA in Jurkat T-cells.	[Pan, Guoping; Cao, Xiuye; Liu, Bo; Li, Chaowen; Li, Dan; Zheng, Jie; Lai, Chaofeng; Zhong, Wenbin; Yan, Daoguang] Jinan Univ, Dept Biol, Guangzhou 510632, Guangdong, Peoples R China; [Olkkonen, Vesa M.] Minerva Fdn, Inst Med Res, Biomedicum 2U, FI-00290 Helsinki, Finland	Jinan University	Zhong, WB; Yan, DG (corresponding author), Jinan Univ, Dept Biol, Guangzhou 510632, Guangdong, Peoples R China.	twbzhong@jnu.edu.cn; tydg@jnu.edu.cn			Basic Research Program of Guangdong province, China [2017A030308002]; National Natural Science Foundation of China (NSFC) [81770438, 91439122, 30971104]; Academy of Finland [285223]; Sigrid Juselius Foundation; Magnus Ehrnrooth Foundation; Finnish Foundation for Cardiovascular Research	Basic Research Program of Guangdong province, China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Magnus Ehrnrooth Foundation; Finnish Foundation for Cardiovascular Research	This work was supported by grants from the Basic Research Program of Guangdong province, China (Grant 2017A030308002 to D. Y.) and National Natural Science Foundation of China (NSFC) (Grants 81770438, 91439122, and 30971104 to D. Y.); Academy of Finland Grant 285223 (to V. M. O.); and the Sigrid Juselius Foundation, the Magnus Ehrnrooth Foundation, and the Finnish Foundation for Cardiovascular Research (to V. M. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Avis JM, 1996, J CELL SCI, V109, P2423; Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Berberian G, 2009, CELL CALCIUM, V45, P546, DOI 10.1016/j.ceca.2009.03.010; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; Cocco L, 2001, BBA-MOL CELL BIOL L, V1530, P1, DOI 10.1016/S1388-1981(00)00169-4; Di Ventura B, 2016, CURR OPIN CHEM BIOL, V34, P62, DOI 10.1016/j.cbpa.2016.06.009; DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3; Faenza I, 2004, J CELL PHYSIOL, V200, P291, DOI 10.1002/jcp.20001; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fournier MV, 1999, CANCER RES, V59, P3748; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; Ghai R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00861-5; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kentala H, 2015, STEROIDS, V99, P248, DOI 10.1016/j.steroids.2015.01.027; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lehto M, 2001, J LIPID RES, V42, P1203; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Levine TP, 2013, STRUCTURE, V21, P1070, DOI 10.1016/j.str.2013.06.010; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; MANZOLI L, 1995, CANCER RES, V55, P2978; MARTELLI AM, 1994, CANCER RES, V54, P2536; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; MOORE MS, 1994, TRENDS BIOCHEM SCI, V19, P211, DOI 10.1016/0968-0004(94)90024-8; Moore MS, 1998, J BIOL CHEM, V273, P22857, DOI 10.1074/jbc.273.36.22857; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; Ramazzotti G, 2008, CELL SIGNAL, V20, P2013, DOI 10.1016/j.cellsig.2008.07.009; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; Silva NH, 2003, INT J MOL MED, V12, P663; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; TAYLOR FR, 1984, J BIOL CHEM, V259, P2382; THOMAS GMH, 1993, CELL, V74, P919, DOI 10.1016/0092-8674(93)90471-2; Tong J, 2013, STRUCTURE, V21, P1203, DOI 10.1016/j.str.2013.05.007; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Wang S, 2000, ENDOCRINOLOGY, V141, P2589, DOI 10.1210/en.141.7.2589; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Wyles JP, 2004, EXP CELL RES, V297, P533, DOI 10.1016/j.yexcr.2004.03.052; Yan DG, 2008, INT REV CYTOL, V265, P253, DOI 10.1016/S0074-7696(07)65007-4; Yue CP, 2001, MOL CELL ENDOCRINOL, V175, P149, DOI 10.1016/S0303-7207(01)00383-5; Zhong WB, 2016, CIRC RES, V119, P1296, DOI 10.1161/CIRCRESAHA.116.309603; Zhong WB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12702; ZINI N, 1993, EXP CELL RES, V208, P257, DOI 10.1006/excr.1993.1245	49	12	12	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17430	17441		10.1074/jbc.RA118.005437	http://dx.doi.org/10.1074/jbc.RA118.005437			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30237164	hybrid, Green Published			2022-12-28	WOS:000449799000010
J	Sheng, SH; Chen, JX; Mukherjee, A; Yates, ME; Buck, TM; Brodsky, JL; Tolino, MA; Hughey, RP; Kleyman, TR				Sheng, Shaohu; Chen, Jingxin; Mukherjee, Anindit; Yates, Megan E.; Buck, Teresa M.; Brodsky, Jeffrey L.; Tolino, Michael A.; Hughey, Rebecca P.; Kleyman, Thomas R.			Thumb domains of the three epithelial Na+ channel subunits have distinct functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial sodium channel (ENaC); acid sensing ion channel (ASIC); protein domain; protein denaturation; ion channel; amiloride; channel gating; self-inhibition	SODIUM-CHANNEL; SELF-INHIBITION; ALPHA-SUBUNIT; GAMMA-SUBUNIT; SURFACE EXPRESSION; EXTRACELLULAR DOMAINS; HISTIDINE-RESIDUES; XENOPUS-OOCYTES; ENAC; BINDING	The epithelial Na+ channel (ENaC) possesses a large extracellular domain formed by a -strand core enclosed by three peripheral -helical subdomains, which have been dubbed thumb, finger, and knuckle. Here we asked whether the ENaC thumb domains play specific roles in channel function. To this end, we examined the characteristics of channels lacking a thumb domain in an individual ENaC subunit (, , or ). Removing the subunit thumb domain had no effect on Na+ currents when expressed in Xenopus oocytes, but moderately reduced channel surface expression. In contrast, ENaCs lacking the or subunit thumb domain exhibited significantly reduced Na+ currents along with a large reduction in channel surface expression. Moreover, channels lacking an or thumb domain exhibited a diminished Na+ self-inhibition response, whereas this response was retained in channels lacking a thumb domain. In turn, deletion of the thumb domain had no effect on the degradation rate of the immature subunit as assessed by cycloheximide chase analysis. However, accelerated degradation of the immature subunit and mature subunit was observed when the or thumb domain was deleted, respectively. Our results suggest that the thumb domains in each ENaC subunit are required for optimal surface expression in oocytes and that the and thumb domains both have important roles in the channel's inhibitory response to external Na+. Our findings support the notion that the extracellular helical domains serve as functional modules that regulate ENaC biogenesis and activity.	[Sheng, Shaohu; Chen, Jingxin; Mukherjee, Anindit; Tolino, Michael A.; Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Yates, Megan E.; Buck, Teresa M.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Mukherjee, Anindit] Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, Dept Med, Portland, OR 97239 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Oregon Health & Science University	Kleyman, TR (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, 3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu	Sheng, Shaohu/G-7052-2016	Sheng, Shaohu/0000-0002-7198-1702; Yates, Megan/0000-0002-5932-1592; , Thomas/0000-0002-2413-5415	National Institutes of Health [P30 DK079307, K01 DK90195, R03 DK109024, R37 DK051391, R01 GM075061]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK051391, R03DK109024, P30DK079307, K01DK090195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P30 DK079307, K01 DK90195, R03 DK109024, R37 DK051391, and R01 GM075061. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams A, 1997, METHODS YEAST GENETI; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Buck TM, 2017, BIOCHEM J, V474, P357, DOI 10.1042/BCJ20160760; Buck TM, 2015, PHYSIOL GENOMICS, V47, P198, DOI 10.1152/physiolgenomics.00101.2014; Buck TM, 2013, J BIOL CHEM, V288, P18366, DOI 10.1074/jbc.M113.469882; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Chen JX, 2015, J BIOL CHEM, V290, P25140, DOI 10.1074/jbc.M115.665398; Chen JX, 2014, AM J PHYSIOL-RENAL, V306, pF561, DOI 10.1152/ajprenal.00587.2013; Chen JX, 2012, J BIOL CHEM, V287, P35589, DOI 10.1074/jbc.M112.394734; Chen JX, 2011, J BIOL CHEM, V286, P27436, DOI 10.1074/jbc.M111.232058; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2014, J GEN PHYSIOL, V144, P337, DOI 10.1085/jgp.201411208; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Frindt G, 2018, J PHYSIOL-LONDON, V596, P3585, DOI 10.1113/JP275988; FUCHS W, 1977, J PHYSIOL-LONDON, V267, P137, DOI 10.1113/jphysiol.1977.sp011805; Fyfe GK, 1998, J GEN PHYSIOL, V112, P423, DOI 10.1085/jgp.112.4.423; Harris M, 2008, J BIOL CHEM, V283, P7455, DOI 10.1074/jbc.M707399200; Horisberger JD., 2004, NEPHRON PHYSIOL, V96, P37, DOI [10.1159/000076406, DOI 10.1159/000076406]; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2018, AM J PHYSIOL-RENAL, V314, pF483, DOI 10.1152/ajprenal.00195.2017; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kashlan OB, 2012, J BIOL CHEM, V287, P20720, DOI 10.1074/jbc.M112.358218; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; Kellenberger S, 2003, MOL PHARMACOL, V64, P848, DOI 10.1124/mol.64.4.848; Kellenberger S, 2002, J PHYSIOL-LONDON, V543, P413, DOI 10.1113/jphysiol.2002.022020; Kleyman TR, 2018, ANNU REV PHYSIOL, V80, P263, DOI 10.1146/annurev-physiol-021317-121143; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Krauson AJ, 2016, J BIOL CHEM, V291, P11407, DOI 10.1074/jbc.M115.702316; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Salih M, 2017, J AM SOC NEPHROL, V28, P3290, DOI 10.1681/ASN.2016111163; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Shi S, 2012, J BIOL CHEM, V287, P44027, DOI 10.1074/jbc.M112.421743; Shi SJ, 2012, J BIOL CHEM, V287, P15439, DOI 10.1074/jbc.M112.346551; Shi SJ, 2011, J BIOL CHEM, V286, P14753, DOI 10.1074/jbc.M110.191734; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Vullo S, 2017, P NATL ACAD SCI USA, V114, P3768, DOI 10.1073/pnas.1620560114; Warnock DG, 2014, NAT REV NEPHROL, V10, P146, DOI 10.1038/nrneph.2013.275; Winarski KL, 2010, J BIOL CHEM, V285, P26088, DOI 10.1074/jbc.M110.149963; Yang L, 2018, AM J PHYSIOL-RENAL, V315, pF1032, DOI 10.1152/ajprenal.00117.2018; Yoder N, 2018, NATURE, V555, P397, DOI 10.1038/nature25782; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	58	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17582	17592		10.1074/jbc.RA118.003618	http://dx.doi.org/10.1074/jbc.RA118.003618			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30228189	hybrid, Green Published			2022-12-28	WOS:000449799000022
J	Weber, B; Brandl, MJ; Cendales, MDP; Berner, C; Pradhan, T; Feind, GM; Zacharias, M; Reif, B; Buchner, J				Weber, Benedikt; Brandl, Matthias J.; Cendales, Maria Daniela Pulido; Berner, Carolin; Pradhan, Tejaswini; Feind, Gina Maria; Zacharias, Martin; Reif, Bernd; Buchner, Johannes			A single residue switch reveals principles of antibody domain integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein folding; protein aggregation; molecular dynamics; nuclear magnetic resonance (NMR); biophysics; immunoglobulin fold; antibody engineering; antibody; protein stability; antibody constant domain; CH2 domain	IMMUNOGLOBULIN HEAVY-CHAIN; INTRACHAIN DISULFIDE BOND; HUMAN IGG1; CHEMICAL-MODIFICATIONS; CONSTANT FRAGMENT; HYDROPHOBIC CORE; FOLDING PATHWAY; C(H)2 DOMAIN; FAB FRAGMENT; STABILITY	Despite their importance for antibody architecture and design, the principles governing antibody domain stability are still not understood in sufficient detail. Here, to address this question, we chose a domain from the invariant part of IgG, the C(H)2 domain. We found that compared with other Ig domains, the isolated C(H)2 domain is a surprisingly unstable monomer, exhibiting a melting temperature of approximate to 44 degrees C. We further show that the presence of an additional C-terminal lysine in a C(H)2 variant substantially increases the melting temperature by approximate to 14 degrees C relative to C(H)2 WT. To explore the molecular mechanism of this effect, we employed biophysical approaches to probe structural features of C(H)2. The results revealed that Lys(101) is key for the formation of three secondary structure elements: the very C-terminal -strand and two adjacent -helices. We also noted that a dipole interaction between Lys(101) and the nearby -helix, is important for stabilizing the C(H)2 architecture by protecting the hydrophobic core. Interestingly, this interaction between the -helix and C-terminal charged residues is highly conserved in antibody domains, suggesting that it represents a general mechanism for maintaining their integrity. We conclude that the observed interactions involving terminal residues have practical applications for defining domain boundaries in the development of antibody therapeutics and diagnostics.	[Weber, Benedikt; Brandl, Matthias J.; Berner, Carolin; Pradhan, Tejaswini; Feind, Gina Maria; Reif, Bernd; Buchner, Johannes] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem, D-85748 Garching, Germany; [Cendales, Maria Daniela Pulido; Zacharias, Martin] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Phys, D-85748 Garching, Germany	Technical University of Munich; Technical University of Munich	Buchner, J (corresponding author), Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem, D-85748 Garching, Germany.	johannes.buchner@tum.de	Brandl, Matthias J/M-1650-2017; Buchner, Johannes/A-2651-2010	Brandl, Matthias J/0000-0002-1052-4233; Weber, Benedikt/0000-0003-4888-5103; Buchner, Johannes/0000-0003-1282-7737	DFG [SFB-1035]; Helmholtz-Gemeinschaft; Center for Integrated Protein Science Munich (CIPS-M)	DFG(German Research Foundation (DFG)); Helmholtz-Gemeinschaft(Helmholtz Association); Center for Integrated Protein Science Munich (CIPS-M)	This work was supported by an individual grant from the DFG (to J.B.); the DFG Grant SFB-1035, projects B07 (to B.R.) and B02 (to M.Z.); Helmholtz-Gemeinschaft (to B.R.); and Center for Integrated Protein Science Munich (CIPS-M). The authors declare that they have no conflicts of interest with the contents of this article.	Alt M, 1999, FEBS LETT, V454, P90, DOI 10.1016/S0014-5793(99)00782-6; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Boxer DH, 2004, ORG BIOMOL CHEM, V2, P2829, DOI 10.1039/b404185b; BUCKEL P, 1987, GENE, V51, P13, DOI 10.1016/0378-1119(87)90469-0; Case D. A., 2016, AMBER 2016; Chothia C, 1998, J MOL BIOL, V278, P457, DOI 10.1006/jmbi.1998.1653; Dayhoff M., 1978, ATLAS PROTEIN SEQUEN; Di Nardo AA, 2003, J MOL BIOL, V333, P641, DOI 10.1016/j.jmb.2003.08.035; Dimitrov DS, 2009, MABS, V1, P26, DOI 10.4161/mabs.1.1.7480; Feige MJ, 2008, P NATL ACAD SCI USA, V105, P13373, DOI 10.1073/pnas.0802809105; Feige MJ, 2007, J MOL BIOL, V365, P1232, DOI 10.1016/j.jmb.2006.10.049; Feige MJ, 2010, TRENDS BIOCHEM SCI, V35, P189, DOI 10.1016/j.tibs.2009.11.005; Feige MJ, 2009, J MOL BIOL, V391, P599, DOI 10.1016/j.jmb.2009.06.048; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Feige MJ, 2010, J MOL BIOL, V399, P719, DOI 10.1016/j.jmb.2010.04.032; Feige MJ, 2004, J MOL BIOL, V344, P107, DOI 10.1016/j.jmb.2004.09.033; Gehlsen KR, 2012, MABS-AUSTIN, V4, P466, DOI 10.4161/mabs.20652; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Gong R, 2013, MOL PHARMACEUT, V10, P2642, DOI 10.1021/mp400075f; GOTO Y, 1981, J MOL BIOL, V146, P321, DOI 10.1016/0022-2836(81)90391-0; GOTO Y, 1979, J BIOCHEM-TOKYO, V86, P1433, DOI 10.1093/oxfordjournals.jbchem.a132661; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabat E. A., 1992, SEQUENCES PROTEINS I, P103; Kastner J, 2011, WIRES COMPUT MOL SCI, V1, P932, DOI 10.1002/wcms.66; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KEHRY M, 1979, P NATL ACAD SCI USA, V76, P2932, DOI 10.1073/pnas.76.6.2932; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Lilie H, 1997, FEBS LETT, V417, P239, DOI 10.1016/S0014-5793(97)01293-3; Liu HC, 2012, MABS-AUSTIN, V4, P17, DOI 10.4161/mabs.4.1.18347; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; MORGAN A, 1995, IMMUNOLOGY, V86, P319; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Munson M, 1996, PROTEIN SCI, V5, P1584, DOI 10.1002/pro.5560050813; Nokwe CN, 2016, J MOL BIOL, V428, P1315, DOI 10.1016/j.jmb.2016.01.015; Nokwe CN, 2015, J MOL BIOL, V427, P3572, DOI 10.1016/j.jmb.2015.09.012; Nokwe CN, 2014, J BIOL CHEM, V289, P26829, DOI 10.1074/jbc.M114.582247; PACE CN, 1992, J MOL BIOL, V226, P29, DOI 10.1016/0022-2836(92)90121-Y; PHILLIPS SR, 1986, CURR EYE RES, V5, P611, DOI 10.3109/02713688609015126; POLJAK RJ, 1973, P NATL ACAD SCI USA, V70, P3305, DOI 10.1073/pnas.70.12.3305; RABBITTS TH, 1981, NUCLEIC ACIDS RES, V9, P4509, DOI 10.1093/nar/9.18.4509; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; SAKANO H, 1979, NATURE, V277, P627, DOI 10.1038/277627a0; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHLEUCHER J, 1993, ANGEW CHEM INT EDIT, V32, P1489, DOI 10.1002/anie.199314891; SHIMIZU A, 1981, NATURE, V289, P149, DOI 10.1038/289149a0; Simpson ER, 2009, J MOL BIOL, V392, P1326, DOI 10.1016/j.jmb.2009.07.075; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; TALLMADGE DH, 1989, PHOTOCHEM PHOTOBIOL, V49, P381, DOI 10.1111/j.1751-1097.1989.tb09183.x; TAO MH, 1991, J EXP MED, V173, P1025, DOI 10.1084/jem.173.4.1025; Thies MJW, 1999, J MOL BIOL, V293, P67, DOI 10.1006/jmbi.1999.3128; Thies MJW, 2000, J CHROMATOGR B, V737, P63, DOI 10.1016/S0378-4347(99)00377-1; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wagschal K, 1999, PROTEIN SCI, V8, P2312; Wang JH, 2013, PROTEIN CELL, V4, P569, DOI 10.1007/s13238-013-3903-2; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wolny M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44341; Zhang AM, 2014, ANAL CHEM, V86, P3468, DOI 10.1021/ac404130a	67	5	5	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17107	17118		10.1074/jbc.RA118.005475	http://dx.doi.org/10.1074/jbc.RA118.005475			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30228183	Green Published, hybrid			2022-12-28	WOS:000449466500013
J	Dey, T; Rao, KK; Khatun, J; Rangarajan, PN				Dey, Trishna; Rao, Kamisetty Krishna; Khatun, Jesminara; Rangarajan, Pundi N.			The nuclear transcription factor Rtg1p functions as a cytosolic, post-transcriptional regulator in the methylotrophic yeast Pichia pastoris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Saccharomyces cerevisiae; signaling; basic helix-loop-helix transcription factor (bHLH); post-transcriptional regulation; metabolism; alcohol oxidase; metabolic pathway; methanol metabolism; Pichia pastoris; retrograde transcription factor	METHANOL UTILIZATION PATHWAY; RETROGRADE RESPONSE; AMINO-ACIDS; 1 MXR1P; EXPRESSION; GENES; MITOCHONDRIA; COMPLEX; TARGET	Rtg1p and Rtg3p are two basic helix-loop-helix, retrograde transcription factors in the budding yeast Saccharomyces cerevisiae. Both factors heterodimerize to activate the transcription of nuclear genes in response to mitochondrial dysfunction and glutamate auxotrophy, but are not well characterized in other yeasts. Here, we demonstrate that the Rtg1p/Rtg3p-mediated retrograde signaling pathway is absent in the methylotrophic yeast Pichia pastoris. We observed that P. pastoris Rtg1p (PpRtg1p) heterodimerizes with S. cerevisiae Rtg3p and functions as a nuclear, retrograde transcription factor in S. cerevisiae, but not in P. pastoris. We noted that P. pastoris Rtg3p lacks a functional leucine zipper and interacts with neither S. cerevisiae Rtg1p (ScRtg1p) nor PpRtg1p. In the absence of an interaction with Rtg3p, PpRtg1p has apparently acquired a novel function as a cytosolic regulator of multiple P. pastoris metabolic pathways, including biosynthesis of glutamate dehydrogenase 2 and phosphoenolpyruvate carboxykinase required for the utilization of glutamate as the sole carbon source. PpRtg1p also had an essential role in methanol metabolism and regulated alcohol oxidase synthesis and was required for the metabolism of ethanol, acetate, and oleic acid, but not of glucose and glycerol. Although PpRtg1p could functionally complement ScRtg1p, ScRtg1p could not complement PpRtg1p, indicating that ScRtg1p is not a functional PpRtg1p homolog. Thus, PpRtg1p functions as a nuclear, retrograde transcription factor in S. cerevisiae and as a cytosolic, post-transcriptional regulator in P. pastoris. We conclude that PpRtg1p is a key component of a signaling pathway that regulates multiple metabolic processes in P. pastoris.	[Dey, Trishna; Rao, Kamisetty Krishna; Khatun, Jesminara; Rangarajan, Pundi N.] Indian Inst Sci, Dept Biochem, Bangalore 60012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Rangarajan, PN (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 60012, Karnataka, India.	pnr@iisc.ac.in	Rangarajan, Pundi/A-7365-2009	Rangarajan, Pundi/0000-0002-6536-9891	Science and Engineering Research Board, Department of Science and Technology, New Delhi, India [EMR/2015/000567, SB/S2/JCB-025/2015]; Department of Science and Technology Fund for Improvement of Science and Technology (S&T) Infrastructure in Higher Educational Institutions (DST-FIST); University Grants Commission	Science and Engineering Research Board, Department of Science and Technology, New Delhi, India; Department of Science and Technology Fund for Improvement of Science and Technology (S&T) Infrastructure in Higher Educational Institutions (DST-FIST); University Grants Commission(University Grants Commission, India)	This work was supported by the Research Grant EMR/2015/000567 and J. C. Bose Fellowship Grant SB/S2/JCB-025/2015 awarded by the Science and Engineering Research Board, Department of Science and Technology, New Delhi, India (to P. N. R.) and by the Department of Science and Technology Fund for Improvement of Science and Technology (S&T) Infrastructure in Higher Educational Institutions (DST-FIST) and University Grants Commission. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad M, 2014, APPL MICROBIOL BIOT, V98, P5301, DOI 10.1007/s00253-014-5732-5; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; CREGG JM, 1989, MOL CELL BIOL, V9, P1316, DOI 10.1128/MCB.9.3.1316; Dilova I, 2002, CURR BIOL, V12, P389, DOI 10.1016/S0960-9822(02)00677-2; Dilova I, 2004, J BIOL CHEM, V279, P46527, DOI 10.1074/jbc.M409012200; Freese S, 2011, YEAST, V28, P375, DOI 10.1002/yea.1845; Higgins DR, 1998, METH MOL B, V103, P1; Jazwinski SM, 2014, PROG MOL BIOL TRANSL, V127, P133, DOI 10.1016/B978-0-12-394625-6.00005-2; Jia YK, 1997, MOL CELL BIOL, V17, P1110, DOI 10.1128/MCB.17.3.1110; Kang Z, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-016-2185-2; Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863; Kranthi BV, 2009, BBA-GENE REGUL MECH, V1789, P460, DOI 10.1016/j.bbagrm.2009.05.004; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; Lin-Cereghino GP, 2006, MOL CELL BIOL, V26, P883, DOI 10.1128/MCB.26.3.883-897.2006; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ruiz-Roig C, 2012, MOL BIOL CELL, V23, P4286, DOI 10.1091/mbc.E12-04-0289; Sahu U, 2016, J BIOL CHEM, V291, P20588, DOI 10.1074/jbc.M116.740191; Sahu U, 2016, J BIOL CHEM, V291, P3648, DOI 10.1074/jbc.M115.673640; Sahu U, 2014, BIOCHEM BIOPH RES CO, V451, P158, DOI 10.1016/j.bbrc.2014.07.094; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Shen W, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0578-4; Unlu ES, 2013, FEMS YEAST RES, V13, P495, DOI 10.1111/1567-1364.12055; Vogl T, 2018, BIOTECHNOL BIOENG, V115, P1037, DOI 10.1002/bit.26529; Vogl T, 2014, ACS SYNTH BIOL, V3, P188, DOI 10.1021/sb400091p; Vogl T, 2013, CURR OPIN BIOTECH, V24, P1094, DOI 10.1016/j.copbio.2013.02.024; Wang JJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41850; Yan HB, 2014, FEMS YEAST RES, V14, P614, DOI 10.1111/1567-1364.12148; Zhang F, 2013, GENES-BASEL, V4, P86, DOI 10.3390/genes4010086	30	4	4	2	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16647	16660		10.1074/jbc.RA118.004486	http://dx.doi.org/10.1074/jbc.RA118.004486			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30185617	Green Published, hybrid			2022-12-28	WOS:000448515100009
J	Fleet, AJ; Hamel, PA				Fleet, Andrew J.; Hamel, Paul A.			The protein-specific activities of the transmembrane modules of Ptch1 and Ptch2 are determined by their adjacent protein domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hedgehog signaling pathway; sonic hedgehog (SHH); transmembrane domain; membrane protein; protein chimera; transporter; NPC1; Patched-1; Patched-2; sterol-sensing domain	BASAL-CELL CARCINOMA; STEROL-SENSING DOMAIN; PATCHED GENE; HEDGEHOG; SHH; MUTATION; MEDULLOBLASTOMA; ACTIVATION; INHIBITION; REVEALS	Signaling through the Hedgehog (Hh) pathway is mediated by the Patched (Ptch) family of proteins. Although the vertebrate Ptch proteins Ptch1 and Ptch2 harbor two closely related transmembrane modules related to sterol-sensing domains (SSDs), the role of these closely related receptors in the Hh pathway are not equivalent. Ptch1 is essential for development and appears to be the principal receptor mediating responses to Hh ligands, whereas Ptch2 is nonessential, and its role in Hh-signaling remains ambiguous. We hypothesized that the SSDs of the Ptch proteins function as generic modules whose protein-specific activities are determined by the adjacent cytoplasmic and luminal domains. We first showed that individual N-terminal and C-terminal halves of Ptch1 associated noncovalently to mediate ligand-dependent regulation of Hh signaling. The analogous regions of Ptch2 also interacted noncovalently but did not repress the Hh pathway. However, the SSD of Ptch2 were capable of repressing Hh signaling, as determined using chimeric proteins where the SSDs of Ptch1 were replaced by those from Ptch2. Replacement of the SSDs of Ptch1 with the analogous regions from the cholesterol transporter NPC1 failed to produce a chimeric protein capable of Hh repression. Further refinement of the specific regions in Ptch1 and Ptch2 revealed that specific cytoplasmic domains of Ptch1 were necessary but not sufficient for repression of Hh signaling and that the two principal luminal domains of Ptch1 and Ptch2 were interchangeable. These data support a model where the SSDs of the Ptch family proteins exhibit generic activities and that the adjacent cytoplasmic and luminal domains determine their protein-specific activities.	[Fleet, Andrew J.; Hamel, Paul A.] Univ Toronto, Dept Lab Med & Pathobiol, Fac Med, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada	University of Toronto	Hamel, PA (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Fac Med, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	paul.hamel@utoronto.ca			Canadian Institutes of Health Research Grant [MOP-142490]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was funded by Canadian Institutes of Health Research Grant MOP-142490 (to P. A. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alfaro AC, 2014, DEVELOPMENT, V141, P3331, DOI 10.1242/dev.110056; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; Bosanac I, 2009, NAT STRUCT MOL BIOL, V16, P691, DOI 10.1038/nsmb.1632; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Canterini S, 2017, HUM MOL GENET, V26, P2277, DOI 10.1093/hmg/ddx118; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Chang H, 2010, INT J BIOCHEM CELL B, V42, P1462, DOI 10.1016/j.biocel.2010.04.016; Chen XLL, 2014, MOL CELL BIOL, V34, P3855, DOI 10.1128/MCB.00960-14; Chen Y, 1998, DEVELOPMENT, V125, P4943; Chidambaram A, 1996, CANCER RES, V56, P4599; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Fleet A, 2016, J BIOL CHEM, V291, P17557, DOI 10.1074/jbc.M116.731745; Formichi P, 2018, J CELL PHYSIOL, V233, P663, DOI 10.1002/jcp.25926; Gong X, 2018, SCIENCE, V361, DOI 10.1126/science.aas8935; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Harvey MC, 2014, J BIOL CHEM, V289, P10939, DOI 10.1074/jbc.M113.514844; Hausmann G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000146; Holtz AM, 2013, DEVELOPMENT, V140, P3423, DOI 10.1242/dev.095083; Huang SJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001721; Incardona JP, 2000, DEV BIOL, V224, P440, DOI 10.1006/dbio.2000.9775; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Johnson RL, 2000, MOL CELL, V6, P467, DOI 10.1016/S1097-2765(00)00045-9; Kim J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa5622; Klein C, 2016, J EXP MED, V213, P273, DOI 10.1084/jem.20150556; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee Y, 2006, CANCER RES, V66, P6964, DOI 10.1158/0008-5472.CAN-06-0505; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lu Y, 2008, CHINESE MED J-PEKING, V121, P118, DOI 10.1097/00029330-200801020-00005; Martin V, 2001, CURR BIOL, V11, P601, DOI 10.1016/S0960-9822(01)00178-6; Motoyama J, 1998, NAT GENET, V18, P104, DOI 10.1038/ng0298-104; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Nieuwenhuis E, 2006, MOL CELL BIOL, V26, P6609, DOI 10.1128/MCB.00295-06; Okolowsky N, 2014, DEV BIOL, V391, P219, DOI 10.1016/j.ydbio.2014.04.007; Polizio AH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002396; Qi XF, 2018, NATURE, V560, P128, DOI 10.1038/s41586-018-0308-7; Rahnama F, 2004, BIOCHEM J, V378, P325, DOI 10.1042/BJ20031200; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; SAIER MH, 1994, MICROBIOL REV, V58, P71, DOI 10.1128/MMBR.58.1.71-93.1994; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Smyth I, 1999, HUM MOL GENET, V8, P291, DOI 10.1093/hmg/8.2.291; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Tukachinsky H, 2016, P NATL ACAD SCI USA, V113, pE5866, DOI 10.1073/pnas.1606719113; Wakabayashi Y, 2007, NATURE, V445, P761, DOI 10.1038/nature05489; Yue S, 2014, ELIFE, V3, DOI 10.7554/eLife.02555; Zaphiropoulos PG, 1999, CANCER RES, V59, P787; Zhang Y., 2018, BIORXIV, DOI [10.1101/352443, DOI 10.1101/352443]; Zhong Y, 2014, GENET MOL RES, V13, P7318, DOI 10.4238/2014.February.13.11; Zhulyn O, 2015, DEV BIOL, V397, P191, DOI 10.1016/j.ydbio.2014.10.023; Zhulyn O, 2014, DEV CELL, V29, P241, DOI 10.1016/j.devcel.2014.03.002	55	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16583	16595		10.1074/jbc.RA118.004478	http://dx.doi.org/10.1074/jbc.RA118.004478			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30166346	Green Published, hybrid			2022-12-28	WOS:000448515100004
J	Chambers, DM; Moretti, L; Zhang, JJ; Cooper, SW; Chambers, DM; Santangelo, PJ; Barker, TH				Chambers, Dwight M.; Moretti, Leandro; Zhang, Jennifer J.; Cooper, Spencer W.; Chambers, Davis M.; Santangelo, Philip J.; Barker, Thomas H.			LEM domain-containing protein 3 antagonizes TGF beta-SMAD2/3 signaling in a stiffness-dependent manner in both the nucleus and cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						SMAD transcription factor; transforming growth factor (TGF-); mechanotransduction; pulmonary fibrosis; nuclear membrane; actin; Buschke-Ollendorff syndrome; LEM; LEMD3; MAN1; nuclear lamina	BUSCHKE-OLLENDORFF-SYNDROME; IDIOPATHIC PULMONARY-FIBROSIS; TGF-BETA; MEMBRANE PROTEIN; IN-VITRO; EXTRACELLULAR-MATRIX; NONSENSE MUTATION; LATENT TGF-BETA-1; INTEGRAL PROTEIN; SMAD PROTEINS	Transforming growth factor-beta (TGF beta) signaling through SMAD2/3 is an important driver of pathological fibrosis in multiple organ systems. TGF signaling and extracellular matrix (ECM) stiffness form an unvirtuous pathological circuit in which matrix stiffness drives activation of latent TGF beta, and TGF beta signaling then drives cellular stress and ECM synthesis. Moreover, ECM stiffness also appears to sensitize cells to exogenously activated TGF beta through unknown mechanisms. Here, using human fibroblasts, we explored the effect of ECM stiffness on a putative inner nuclear membrane protein, LEM domain-containing protein 3 (LEMD3), which is physically connected to the cell's actin cytoskeleton and inhibits TGF beta signaling. We showed that LEMD3-SMAD2/3 interactions are inversely correlated with ECM stiffness and TGF beta-driven luciferase activity and that LEMD3 expression is correlated with the mechanical response of the TGF beta-driven luciferase reporter. We found that actin polymerization but not cellular stress or LEMD3-nuclear-cytoplasmic couplings were necessary for LEMD3-SMAD2/3 interactions. Intriguingly, LEMD3 and SMAD2/3 frequently interacted in the cytosol, and we discovered LEMD3 was proteolytically cleaved into protein fragments. We confirmed that a consensus C-terminal LEMD3 fragment binds SMAD2/3 in a stiffness-dependent manner throughout the cell and is sufficient for antagonizing SMAD2/3 signaling. Using human lung biopsies, we observed that these nuclear and cytosolic interactions are also present in tissue and found that fibrotic tissues exhibit locally diminished and cytoplasmically shifted LEMD3-SMAD2/3 interactions, as noted in vitro. Our work reveals novel LEMD3 biology and stiffness-dependent regulation of TGF beta by LEMD3, providing a novel target to antagonize pathological TGF beta signaling.	[Chambers, Dwight M.; Zhang, Jennifer J.; Cooper, Spencer W.; Santangelo, Philip J.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Chambers, Dwight M.; Zhang, Jennifer J.; Cooper, Spencer W.; Santangelo, Philip J.] Emory Univ, Sch Med, Atlanta, GA 30332 USA; [Moretti, Leandro; Barker, Thomas H.] Univ Virginia, Biomed Engn, Charlottesville, VA 22908 USA; [Chambers, Davis M.] Georgia State Univ, Coll Arts & Sci, Atlanta, GA 30303 USA	University System of Georgia; Georgia Institute of Technology; Emory University; University of Virginia; University System of Georgia; Georgia State University	Barker, TH (corresponding author), Univ Virginia, Biomed Engn, Charlottesville, VA 22908 USA.	thomas.barker@virginia.edu	Barker, Thomas/I-1608-2016	Barker, Thomas/0000-0002-3218-8111; Chambers, Dwight/0000-0003-0814-9136; Cooper, Spencer/0000-0002-8466-9531	National Institutes of Health [R01 HL127283, R01 HL132585, F30 HL122065]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL122065, R01HL132585, R01HL127283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL127283 and R01 HL132585 (to T. H. B.) and F30 HL122065 (to Dwight M. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abascal F, 2015, BIOINFORMATICS, V31, P2257, DOI 10.1093/bioinformatics/btv132; Bermeo S, 2017, J CELL BIOCHEM, V118, P4425, DOI 10.1002/jcb.26096; Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC; Bourgeois B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003411; Buhling F, 2004, AM J PATHOL, V164, P2203, DOI 10.1016/S0002-9440(10)63777-7; Burger B, 2010, EUR J DERMATOL, V20, P693, DOI 10.1684/ejd.2010.1051; Caputo S, 2006, J BIOL CHEM, V281, P18208, DOI 10.1074/jbc.M601980200; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; Condorelli A, 2017, PEDIATR DERMATOL, V34, pE345, DOI 10.1111/pde.13287; Couto AR, 2007, CALCIFIED TISSUE INT, V81, P81, DOI 10.1007/s00223-007-9043-z; DePianto DJ, 2015, THORAX, V70, P48, DOI 10.1136/thoraxjnl-2013-204596; Du J, 2017, BLOOD, V129, P2570, DOI 10.1182/blood-2017-01-758854; Fukuda Y, 1998, LAB INVEST, V78, P687; Garcia-Prieto E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013242; Gardinassi LG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005123; Gass JK, 2008, J AM ACAD DERMATOL, V58, pS103, DOI 10.1016/j.jaad.2007.03.031; Grannas K, 2015, J MOL BIOL, V427, P3407, DOI 10.1016/j.jmb.2015.04.015; Gutierrez D, 2015, PEDIATR DERMATOL, V32, pE219, DOI 10.1111/pde.12634; HARPER JW, 1985, BIOCHEMISTRY-US, V24, P1831, DOI 10.1021/bi00329a005; Hellemans J, 2004, NAT GENET, V36, P1213, DOI 10.1038/ng1453; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Holt I, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0105-9; Jones MG, 2013, RESPIRATION, V86, P353, DOI 10.1159/000356958; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Klingberg F, 2014, J CELL BIOL, V207, P283, DOI 10.1083/jcb.201402006; Kobayashi Y, 2006, EXP CELL RES, V312, P3152, DOI 10.1016/j.yexcr.2006.06.026; Konde E, 2010, BIOCHEMISTRY-US, V49, P8020, DOI 10.1021/bi101153w; Korekawa A, 2012, BRIT J DERMATOL, V166, P900, DOI 10.1111/j.1365-2133.2011.10691.x; Kratzsch J, 2016, JAMA DERMATOL, V152, P844, DOI 10.1001/jamadermatol.2016.0350; Kristensen JH, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0048-5; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lin F, 2005, HUM MOL GENET, V14, P437, DOI 10.1093/hmg/ddi040; Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Liu J, 2003, P NATL ACAD SCI USA, V100, P4598, DOI 10.1073/pnas.0730821100; Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700; Mansharamani M, 2005, J BIOL CHEM, V280, P13863, DOI 10.1074/jbc.M413020200; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Nance T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092111; Olsen AL, 2011, AM J PHYSIOL-GASTR L, V301, pG110, DOI 10.1152/ajpgi.00412.2010; Osada SI, 2003, DEVELOPMENT, V130, P1783, DOI 10.1242/dev.00401; Ostlund C, 2006, BIOCHEMISTRY-US, V45, P1374, DOI 10.1021/bi052156n; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Pan D, 2005, J BIOL CHEM, V280, P15992, DOI 10.1074/jbc.M411234200; Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Pope V, 2016, BRIT J DERMATOL, V174, P723, DOI 10.1111/bjd.14366; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Rajgor D, 2016, MOL BIOL CELL, V27, P3894, DOI 10.1091/mbc.E16-06-0346; Rajgor D, 2014, J CELL BIOL, V205, P457, DOI 10.1083/jcb.201306076; Rajgor D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040098; Raju GP, 2003, J BIOL CHEM, V278, P428, DOI 10.1074/jbc.M210505200; Rho HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-240; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Rinker TE, 2018, ACTA BIOMATER, V68, P125, DOI 10.1016/j.actbio.2017.12.038; Ruijter JM, 2014, MICROCHIM ACTA, V181, P1689, DOI 10.1007/s00604-013-1155-8; Samarakoon R, 2008, J MOL CELL CARDIOL, V44, P527, DOI 10.1016/j.yjmcc.2007.12.006; Santos M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113732; Shi YL, 2013, MOL MED REP, V7, P419, DOI 10.3892/mmr.2012.1213; Song JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033747; Srivastava M, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-54; Stahnke T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172592; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Vancheri C, 2018, AM J RESP CRIT CARE, V197, P356, DOI 10.1164/rccm.201706-1301OC; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Wagner N, 2006, EUR J CELL BIOL, V85, P91, DOI 10.1016/j.ejcb.2005.10.002; Walton KL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00461; Wang YG, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0472-9; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wu W, 2002, J CELL SCI, V115, P1361; Yadegari M, 2010, ARCH DERMATOL, V146, P63, DOI 10.1001/archdermatol.2009.320; Yamashita CM, 2011, AM J PATHOL, V179, P1733, DOI 10.1016/j.ajpath.2011.06.041; Yuste-Chaves M, 2011, PEDIATR DERMATOL, V28, P447, DOI 10.1111/j.1525-1470.2010.01206.x; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhang W, 2017, GENE, V627, P123, DOI 10.1016/j.gene.2017.06.009; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099; Zurla C, 2017, METHODS MOL BIOL, V1468, P155, DOI 10.1007/978-1-4939-4035-6_12	84	15	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15867	15886		10.1074/jbc.RA118.003658	http://dx.doi.org/10.1074/jbc.RA118.003658			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30108174	Green Published, hybrid			2022-12-28	WOS:000447256000010
J	Weckel, A; Ahamada, D; Bellais, S; Mehats, C; Plainvert, C; Longo, M; Poyart, C; Fouet, A				Weckel, Antonin; Ahamada, Dorian; Bellais, Samuel; Mehats, Celine; Plainvert, Celine; Longo, Magalie; Poyart, Claire; Fouet, Agnes			The N-terminal domain of the R28 protein promotes emm28 group A Streptococcus adhesion to host cells via direct binding to three integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Streptococcus pyogenes (S pyogenes); host-pathogen interaction; infection; adhesion; integrin; protein-protein interaction	GROUP-B STREPTOCOCCUS; ALPHA-C-PROTEIN; SURFACE-PROTEINS; GENOME SEQUENCE; COLONIZATION; EXPRESSION; IDENTIFICATION; RECEPTOR; GLYCOSAMINOGLYCAN; INTERNALIZATION	Group A Streptococcus (GAS) is a human-specific pathogen responsible for a wide range of diseases, ranging from superficial to life-threatening invasive infections, including endometritis, and autoimmune sequelae. GAS strains express a vast repertoire of virulence factors that varies depending on the strain genotype, and many adhesin proteins that enable GAS to adhere to host cells are restricted to some genotypes. GAS emm28 is the third most prevalent genotype in invasive infections in France and is associated with gyneco-obstetrical infections. emm28 strains harbor R28, a cell wall-anchored surface protein that has previously been reported to promote adhesion to cervical epithelial cells. Here, using cellular and biochemical approaches, we sought to determine whether R28 supports adhesion also to other cells and to characterize its cognate receptor. We show that through its N-terminal domain, R28(Nt), R28 promotes bacterial adhesion to both endometrial-epithelial and endometrial-stromal cells. R28(Nt) was further subdivided into two domains, and we found that both are involved in cell binding. R28(Nt) and both subdomains interacted directly with the laminin-binding alpha 3 beta 1, alpha 6 beta 1, and alpha 6 beta 4 integrins; interestingly, these bindings events did not require divalent cations. R28 is the first GAS adhesin reported to bind directly to integrins that are expressed in most epithelial cells. Finally, R28(Nt) also promoted binding to keratinocytes and pulmonary epithelial cells, suggesting that it may be involved in supporting the prevalence in invasive infections of the emm28 genotype.	[Weckel, Antonin; Ahamada, Dorian; Bellais, Samuel; Mehats, Celine; Plainvert, Celine; Longo, Magalie; Poyart, Claire; Fouet, Agnes] Inst Cochin, INSERM, U1016, Paris, France; [Weckel, Antonin; Ahamada, Dorian; Bellais, Samuel; Mehats, Celine; Plainvert, Celine; Longo, Magalie; Poyart, Claire; Fouet, Agnes] CNRS, UMR 8104, Paris, France; [Weckel, Antonin; Ahamada, Dorian; Bellais, Samuel; Mehats, Celine; Plainvert, Celine; Longo, Magalie; Poyart, Claire; Fouet, Agnes] Univ Paris 05, UMR S1016, Paris, France; [Plainvert, Celine; Poyart, Claire; Fouet, Agnes] Ctr Natl Reference Streptocoques, F-75014 Paris, France; [Plainvert, Celine; Poyart, Claire] Hop Univ Paris Ctr, AP HP, Inst Cochin, F-75014 Paris, France; [Bellais, Samuel] Bioaster, 28 Rue Dr Roux, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Fouet, A (corresponding author), Inst Cochin, 22 Rue Mech, F-75014 Paris, France.	agnes.fouet@inserm.fr	Mehats, Celine/D-8650-2017	Fouet, Agnes/0000-0001-7715-9157; Mehats, Celine/0000-0002-3677-2024; Weckel, Antonin/0000-0002-5085-0551	European Regional Development Fund (ERDF) through the Operational Programme for Competitiveness Factors and Employment 2007-2013; Canceropole Ile de France	European Regional Development Fund (ERDF) through the Operational Programme for Competitiveness Factors and Employment 2007-2013; Canceropole Ile de France(Region Ile-de-France)	We thank Wassim El Nemer, Julie Guignot, and Cecile Arrieumerlou for helpful discussions and Philippe Glaser for sequencing and providing the relevant contigs of the Delta R28 strain. We thank Cedric Broussard (LC-MS supervision and in-gel protein digestion); Evangeline Bennana (proteomics data collection, analysis, and reporting), Marjorie Leduc (LIMS management); and Francois Guillonneau, Philippe Chafey, and Patrick Mayeux (proteomics expertise and experimental design) from the 3P5 proteomics facility of the Universite Paris Descartes, Sorbonne Paris Cite and the Imag'IC facility, both at the Cochin Institute. We thank the Margottin-Pique team for access to the TECAN plate reader. The Orbitrap Fusion mass spectrometer was acquired with funds from the European Regional Development Fund (ERDF) through the Operational Programme for Competitiveness Factors and Employment 2007-2013 and from the Canceropole Ile de France.	Abban CY, 2010, VIROLOGY, V403, P1, DOI 10.1016/j.virol.2010.04.007; Areschoug T, 2004, VACCINE, V22, pS9, DOI 10.1016/j.vaccine.2004.08.010; Auperin TC, 2005, J BIOL CHEM, V280, P18245, DOI 10.1074/jbc.M412391200; BAKER CJ, 1977, J INFECT DIS, V135, P392, DOI 10.1093/infdis/135.3.392; Baron MJ, 2007, J BIOL CHEM, V282, P10526, DOI 10.1074/jbc.M608279200; Baron MJ, 2004, J BIOL CHEM, V279, P24714, DOI 10.1074/jbc.M402164200; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Bessen DE, 2016, CURR OPIN INFECT DIS, V29, P295, DOI 10.1097/QCO.0000000000000262; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Bolduc GR, 2007, MICROBIOL-SGM, V153, P4039, DOI 10.1099/mic.0.2007/009134-0; Bolduc GR, 2002, CELL MICROBIOL, V4, P751, DOI 10.1046/j.1462-5822.2002.00227.x; Brouwer S, 2016, FEBS LETT, V590, P3739, DOI 10.1002/1873-3468.12254; Callebaut I, 2000, PROTEIN SCI, V9, P1382, DOI 10.1110/ps.9.7.1382; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Castelbaum AJ, 1997, J CLIN ENDOCR METAB, V82, P136, DOI 10.1210/jc.82.1.136; Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200; Chapot-Chartier MP, 2010, J BIOL CHEM, V285, P10464, DOI 10.1074/jbc.M109.082958; COLMAN G, 1993, J MED MICROBIOL, V39, P165, DOI 10.1099/00222615-39-3-165; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Cywes C, 2000, J CLIN INVEST, V106, P995, DOI 10.1172/JCI10195; FALCIONI R, 1994, EXP CELL RES, V210, P113, DOI 10.1006/excr.1994.1017; Gallotta M, 2014, INFECT IMMUN, V82, P2890, DOI 10.1128/IAI.00064-14; Gherardi G, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00059; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Green NM, 2005, J CLIN MICROBIOL, V43, P4083, DOI 10.1128/JCM.43.8.4083-4091.2005; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Hamzaoui N, 2004, CELL MICROBIOL, V6, P817, DOI 10.1111/j.1462-5822.2004.00391.x; HASTY DL, 1992, INFECT IMMUN, V60, P2147, DOI 10.1128/IAI.60.6.2147-2152.1992; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; Jin H, 2005, J MOL BIOL, V350, P27, DOI 10.1016/j.jmb.2005.04.063; Koller T, 2010, J MED MICROBIOL, V59, P442, DOI 10.1099/jmm.0.013581-0; Kong FR, 2002, J CLIN MICROBIOL, V40, P620, DOI 10.1128/JCM.40.2.620-626.2002; Lachenauer CS, 2000, P NATL ACAD SCI USA, V97, P9630, DOI 10.1073/pnas.97.17.9630; LESSEY BA, 1994, FERTIL STERIL, V62, P497; Li ZY, 2003, J INFECT DIS, V188, P1587, DOI 10.1086/379050; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Linke C, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.376434; Longo M, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00750-15; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; Lynskey NN, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006493; Nobbs AH, 2015, INFECT GENET EVOL, V33, P361, DOI 10.1016/j.meegid.2014.09.018; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; OKADA N, 1995, P NATL ACAD SCI USA, V92, P2489, DOI 10.1073/pnas.92.7.2489; Plainvert C, 2012, CLIN MICROBIOL INFEC, V18, P702, DOI 10.1111/j.1469-0691.2011.03624.x; Rezcallah MS, 2005, CELL MICROBIOL, V7, P645, DOI 10.1111/j.1462-5822.2004.00497.x; Rohde M, 2016, STREPTOCOCCUS PYOGEN, P1; Sitkiewicz I, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-65; Six A, 2015, MOL MICROBIOL, V97, P1209, DOI 10.1111/mmi.13097; Stalhammar-Carlemalm M, 1999, MOL MICROBIOL, V33, P208, DOI 10.1046/j.1365-2958.1999.01470.x; Stalhammar-Carlemalm M, 2000, J INFECT DIS, V182, P142, DOI 10.1086/315693; Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; VOGEL BE, 1993, J CELL BIOL, V121, P461, DOI 10.1083/jcb.121.2.461; Wadehra M, 2005, DEV BIOL, V287, P336, DOI 10.1016/j.ydbio.2005.09.003; Wastfelt M, 1996, J BIOL CHEM, V271, P18892, DOI 10.1074/jbc.271.31.18892; Werner J, 2012, INNATE IMMUN-LONDON, V18, P55, DOI 10.1177/1753425910392934	60	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16006	16018		10.1074/jbc.RA118.004134	http://dx.doi.org/10.1074/jbc.RA118.004134			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30150299	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000447256000021
J	Abeywardana, T; Oh, M; Jiang, L; Yang, Y; Kong, M; Song, JK; Yang, YZ				Abeywardana, Tharindumala; Oh, Myungeun; Jiang, Lei; Yang, Ying; Kong, Mei; Song, Jikui; Yang, Yanzhong			CARM1 suppresses de novo serine synthesis by promoting PKM2 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein methylation; pyruvate kinase; serine; metabolic regulation; proliferation; CARM1	PYRUVATE-KINASE M2; METHYLTRANSFERASE 1 CARM1; ONE-CARBON METABOLISM; CELL-PROLIFERATION; ARGININE METHYLATION; CANCER-CELLS; LACTATE METABOLISM; AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; TUMOR PROGRESSION	Glucose is a critical nutrient for cell proliferation. However, the molecular pathways that regulate glucose metabolism are still elusive. We discovered that co-activator-associated arginine methyltransferase 1 (CARM1) suppresses glucose metabolism toward serine biosynthesis. By tracing the C-13-labeled glucose, we found that Carm1 knockout mouse embryonic fibroblasts exhibit significantly increased de novo serine synthesis than WT cells. This is caused, at least in part, by the reduced pyruvate kinase (PK) activity in these cells. The M2 isoform of PK (PKM2) is arginine-methylated by CARM1, and methylation enhances its activity. Mechanistically, CARM1 methylates PKM2 at arginines 445 and 447, which enhances PKM2 tetramer formation. Consequently, Carm1 knockout cells exhibit significant survival advantages over WT cells when extracellular serine is limited, likely due to their enhanced de novo serine synthesis capacity. Altogether, we identified CARM1 as an important regulator of glucose metabolism and serine synthesis.	[Abeywardana, Tharindumala; Yang, Yanzhong] City Hope Canc Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA; [Oh, Myungeun; Jiang, Lei] City Hope Canc Ctr, Beckman Res Inst, Dept Mol & Cellular Endocrinol, Duarte, CA 91010 USA; [Yang, Ying; Kong, Mei] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Song, Jikui] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California Irvine; University of California System; University of California Riverside	Yang, YZ (corresponding author), City Hope Canc Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA.	yyang@coh.org	yang, yanzhong/AAH-6132-2019; Yang, Ying/I-8380-2019	Abeywardana, Tharindumala/0000-0002-1743-0491	NCI, National Institutes of Health [P30CA33572]; NATIONAL CANCER INSTITUTE [R01CA183989, P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119721] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Lei Zhang and Yunan Miao from TBDC for their assistance with LC-MS/MS. We thank Kerin Higa for providing helpful comments on scientific writing. Research reported in this publication includes work performed in the Translational Biomarker Discovery Core supported by NCI, National Institutes of Health, under Award P30CA33572.	Al-Dhaheri M, 2011, CANCER RES, V71, P2118, DOI 10.1158/0008-5472.CAN-10-2426; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cheng HX, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-129; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Dayton TL, 2016, EMBO REP, V17, P1721, DOI 10.15252/embr.201643300; de Freitas RF, 2016, J MED CHEM, V59, P6838, DOI 10.1021/acs.jmedchem.6b00668; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Drew AE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18446-z; El Messaoudi S, 2006, P NATL ACAD SCI USA, V103, P13351, DOI 10.1073/pnas.0605692103; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Gao X, 2016, CELL METAB, V24, P777, DOI 10.1016/j.cmet.2016.11.012; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; GOSALVEZ M, 1974, EUR J BIOCHEM, V46, P133, DOI 10.1111/j.1432-1033.1974.tb03605.x; GOSALVEZ M, 1975, EUR J BIOCHEM, V55, P315, DOI 10.1111/j.1432-1033.1975.tb02165.x; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang LF, 2018, NUCLEIC ACIDS RES, V46, P3061, DOI 10.1093/nar/gky103; Israelsen WJ, 2015, SEMIN CELL DEV BIOL, V43, P43, DOI 10.1016/j.semcdb.2015.08.004; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Jiang L, 2017, METAB ENG, V43, P198, DOI 10.1016/j.ymben.2016.11.004; Kaniskan HUU, 2016, MEDCHEMCOMM, V7, P1793, DOI [10.1039/c6md00342g, 10.1039/C6MD00342G]; Kim YR, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-197; Kornberg MD, 2018, SCIENCE, V360, P449, DOI 10.1126/science.aan4665; Kung C, 2012, CHEM BIOL, V19, P1187, DOI 10.1016/j.chembiol.2012.07.021; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Li SH, 2018, CELL REP, V23, P389, DOI 10.1016/j.celrep.2018.03.051; Liberti MV, 2017, CELL METAB, V26, P648, DOI 10.1016/j.cmet.2017.08.017; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Liu FB, 2017, NAT CELL BIOL, V19, P1358, DOI 10.1038/ncb3630; Lunt SY, 2015, MOL CELL, V57, P95, DOI 10.1016/j.molcel.2014.10.027; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Luo WB, 2012, TRENDS ENDOCRIN MET, V23, P560, DOI 10.1016/j.tem.2012.06.010; Mattaini KR, 2016, J CELL BIOL, V214, P248, DOI 10.1083/jcb.201604085; Mehrmohamadi M, 2014, CELL REP, V9, P1507, DOI 10.1016/j.celrep.2014.10.026; Morita M, 2018, CANCER CELL, V33, P355, DOI 10.1016/j.ccell.2018.02.004; Mulukutla BC, 2016, TRENDS BIOTECHNOL, V34, P638, DOI 10.1016/j.tibtech.2016.04.012; Narayanan N, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2016.48; O'Brien KB, 2010, DEVELOPMENT, V137, P2147, DOI 10.1242/dev.037150; Ohkura N, 2005, J BIOL CHEM, V280, P28927, DOI 10.1074/jbc.M502173200; Pacold ME, 2016, NAT CHEM BIOL, V12, P452, DOI [10.1038/NCHEMBIO.2070, 10.1038/nchembio.2070]; Parnell KM, 2013, MOL CANCER THER, V12, P1453, DOI 10.1158/1535-7163.MCT-13-0026; Romero-Garcia S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00052; San-Millan I, 2017, CARCINOGENESIS, V38, P119, DOI 10.1093/carcin/bgw127; Sanchez G, 2016, NUCLEIC ACIDS RES, V44, P2661, DOI 10.1093/nar/gkv1334; Shen YD, 2016, J MED CHEM, V59, P9124, DOI 10.1021/acs.jmedchem.6b01033; Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342; Shin HJR, 2016, NATURE, V534, P553, DOI 10.1038/nature18014; Walport LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11974; Walsh M. J., 2010, PROBE REPORTS NIH MO; Wang HJ, 2014, P NATL ACAD SCI USA, V111, P279, DOI 10.1073/pnas.1311249111; Wang L, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500463; Wang L, 2014, CANCER CELL, V25, P21, DOI 10.1016/j.ccr.2013.12.007; Wang YP, 2016, MOL CELL, V64, P673, DOI 10.1016/j.molcel.2016.09.028; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Xie JS, 2016, J BIOL CHEM, V291, P8987, DOI 10.1074/jbc.M115.704825; Yadav N, 2008, EMBO REP, V9, P193, DOI 10.1038/sj.embor.7401151; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Yang WW, 2015, J CELL SCI, V128, P1655, DOI 10.1242/jcs.166629; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109	68	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15290	15303		10.1074/jbc.RA118.004512	http://dx.doi.org/10.1074/jbc.RA118.004512			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30131339	Green Published, hybrid			2022-12-28	WOS:000445998400028
J	Dempsey, A; Keating, SE; Carty, M; Bowie, AG				Dempsey, Alan; Keating, Sinead E.; Carty, Michael; Bowie, Andrew G.			Poxviral protein E3-altered cytokine production reveals that DExD/H-box helicase 9 controls Toll-like receptor-stimulated immune responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						toll-like receptor (TLR); signal transduction; pattern recognition receptor (PRR); poxvirus; NF-B (NF-KB); interleukin 6 (IL-6); innate immunity; host-pathogen interaction; DExD; H-box helicase (DHX9); Immune evasion	DOUBLE-STRANDED-RNA; VIRUS E3 PROTEIN; NF-KAPPA-B; DENDRITIC CELLS; INNATE IMMUNITY; MESSENGER-RNAS; A INTERACTS; HELA-CELLS; GENE; DNA	Host pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) detect viruses and other pathogens, inducing production of cytokines that cause inflammation and mobilize cells to control infection. Vaccinia virus (VACV) encodes proteins that antagonize these host innate immune responses, and elucidating the mechanisms of action of these viral proteins helped shed light on PRR signaling mechanisms. The VACV virulence factor E3 is one of the most intensely studied VACV proteins and has multiple effects on host cells, many of which cannot be explained by the currently known cellular targets of E3. Here, we report that E3 expression in human monocytes alters TLR2- and TLR8-dependent cytokine induction, and particularly inhibits interleukin (IL)-6. Using MS, we identified DExD/H-box helicase 9 (DHX9) as an E3 target. Although DHX9 has previously been implicated as a PRR for sensing nucleic acid in dendritic cells, we found no role for DHX9 as a nucleic acid-sensing PRR in monocytes. Rather, DHX9 suppression in these cells phenocopied the effects of E3 expression on TLR2- and TLR8-dependent cytokine induction, in that DHX9 was required for all TLR8-dependent cytokines measured, and for TLR2-dependent IL-6. Furthermore, DHX9 also had a cell- and stimulus-independent role in IL-6 promoter induction. DHX9 enhanced NF-B-dependent IL-6 promoter activation, which was directly antagonized by E3. These results indicate new roles for DHX9 in regulating cytokines in innate immunity and reveal that VACV E3 disrupts innate immune responses by targeting of DHX9.	[Dempsey, Alan; Keating, Sinead E.; Carty, Michael; Bowie, Andrew G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Keating, Sinead E.] Pfizer Biotherapeut R&D, BioMed Design, Grange Castle Business Pk, Dublin 22, Ireland	Trinity College Dublin; Pfizer	Bowie, AG (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	agbowie@tcd.ie	Carty, Michael/AFK-2889-2022; Carty, Michael/AAG-1249-2022	Bowie, Andrew/0000-0001-5316-4373; Carty, Michael/0000-0003-1588-7479	Irish Health Research Board [PHD/2007/09]; Science Foundation Ireland [11/PI/1056, 16/IA/4376]	Irish Health Research Board; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Irish Health Research Board Grant PHD/2007/09 and Science Foundation Ireland Grants 11/PI/1056 and 16/IA/4376. The authors declare that they have no conflicts of interest with the contents of this article.	Almine JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14392; Aratani S, 2001, MOL CELL BIOL, V21, P4460, DOI 10.1128/MCB.21.14.4460-4469.2001; Bolinger C, 2007, NUCLEIC ACIDS RES, V35, P2629, DOI 10.1093/nar/gkm124; Bolinger C, 2010, NUCLEIC ACIDS RES, V38, P1686, DOI 10.1093/nar/gkp1075; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Brady G, 2017, J VIROL, V91, DOI 10.1128/JVI.00545-17; Brady G, 2014, CYTOKINE GROWTH F R, V25, P611, DOI 10.1016/j.cytogfr.2014.07.004; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; Dueck KJ, 2015, J VIROL, V89, P5382, DOI 10.1128/JVI.03288-14; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Guerra S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000096; Gurtler C, 2014, J IMMUNOL, V192, P4821, DOI 10.4049/jimmunol.1302980; Gurtler C, 2013, TRENDS MICROBIOL, V21, P413, DOI 10.1016/j.tim.2013.04.004; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; Huang M, 2008, NUCLEOS NUCLEOT NUCL, V27, P704, DOI 10.1080/15257770802145132; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Jimenez-Dalmaroni MJ, 2016, AUTOIMMUN REV, V15, P1, DOI 10.1016/j.autrev.2015.08.009; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kwon JA, 2005, P NATL ACAD SCI USA, V102, P12759, DOI 10.1073/pnas.0506011102; Langland JO, 2006, J VIROL, V80, P10083, DOI 10.1128/JVI.00607-06; Lawrence P, 2009, J VIROL, V83, P11356, DOI 10.1128/JVI.02677-08; Lee CG, 1998, P NATL ACAD SCI USA, V95, P13709, DOI 10.1073/pnas.95.23.13709; LEE CG, 1992, J BIOL CHEM, V267, P4398; Lin L, 2012, J VIROL, V86, P1942, DOI 10.1128/JVI.06362-11; Myskiw C, 2011, J VIROL, V85, P12280, DOI 10.1128/JVI.05505-11; Myskiw C, 2009, J VIROL, V83, P6757, DOI 10.1128/JVI.02570-08; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Rahman MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003465; Ranji A, 2010, RNA BIOL, V7, P775, DOI 10.4161/rna.7.6.14249; Reddy TR, 2000, ONCOGENE, V19, P3570, DOI 10.1038/sj.onc.1203676; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Sharp TV, 1998, VIROLOGY, V250, P302, DOI 10.1006/viro.1998.9365; Tang HL, 1997, SCIENCE, V276, P1412, DOI 10.1126/science.276.5317.1412; Tetsuka T, 2004, EUR J BIOCHEM, V271, P3741, DOI 10.1111/j.1432-1033.2004.04314.x; Tettweiler G, 2006, TRENDS BIOCHEM SCI, V31, P607, DOI 10.1016/j.tibs.2006.09.008; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Valentine R, 2010, J GEN VIROL, V91, P2221, DOI 10.1099/vir.0.021998-0; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Zhang ZQ, 2011, J IMMUNOL, V187, P4501, DOI 10.4049/jimmunol.1101307	46	15	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					14989	15001		10.1074/jbc.RA118.005089	http://dx.doi.org/10.1074/jbc.RA118.005089			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30111593	Green Published, hybrid			2022-12-28	WOS:000445998400005
J	Jennings, E; Esposito, D; Rittinger, K; Thurston, TLM				Jennings, Elliott; Esposito, Diego; Rittinger, Katrin; Thurston, Teresa L. M.			Structure-function analyses of the bacterial zinc metalloprotease effector protein GtgA uncover key residues required for deactivating NF-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Salmonella enterica; bacterial pathogenesis; metalloprotease; type III secretion system (T3SS); NF-B; substrate specificity; bacterial effectors; GtgA; virulence factor	KAPPA-B; SECRETION SYSTEM; SUBSTRATE RECOGNITION; HOMODIMER; NLEC; SPECIFICITY; REFINEMENT; MECHANISM; ASTACIN; PHENIX	The closely related type III secretion system zinc metalloprotease effector proteins GtgA, GogA, and PipA are translocated into host cells during Salmonella infection. They then cleave nuclear factor -light-chain-enhancer of activated B cells (NF-B) transcription factor subunits, dampening activation of the NF-B signaling pathway and thereby suppressing host immune responses. We demonstrate here that GtgA, GogA, and PipA cleave a subset of NF-B subunits, including p65, RelB, and cRel but not NF-B1 and NF-B2, whereas the functionally similar type III secretion system effector NleC of enteropathogenic and enterohemorrhagic Escherichia coli cleaved all five NF-B subunits. Mutational analysis of NF-B subunits revealed that a single nonconserved residue in NF-B1 and NF-B2 that corresponds to the P1 residue Arg-41 in p65 prevents cleavage of these subunits by GtgA, GogA, and PipA, explaining the observed substrate specificity of these enzymes. Crystal structures of GtgA in its apo-form and in complex with the p65 N-terminal domain explained the importance of the P1 residue. Furthermore, the pattern of interactions suggested that GtgA recognizes NF-B subunits by mimicking the shape and negative charge of the DNA phosphate backbone. Moreover, structure-based mutational analysis of GtgA uncovered amino acids that are required for the interaction of GtgA with p65, as well as those that are required for full activity of GtgA in suppressing NF-B activation. This study therefore provides detailed and critical insight into the mechanism of substrate recognition by this family of proteins important for bacterial virulence.	[Jennings, Elliott; Thurston, Teresa L. M.] Imperial Coll London, MRC Ctr Mol Bacteriol & Infect, Sect Microbiol, London SW7 2AZ, England; [Esposito, Diego; Rittinger, Katrin] Francis Crick Inst, Mol Struct Cell Signalling Lab, 1 Midland Rd, London NW1 1AT, England	Imperial College London; Francis Crick Institute	Thurston, TLM (corresponding author), Imperial Coll London, Ctr Mol Bacteriol & Infect, Med Res Council, Microbiol Sect, London SW7 2AZ, England.	t.thurston@imperial.ac.uk	Thurston, Teresa/AAZ-9938-2020; Rittinger, Katrin/N-3344-2019	Thurston, Teresa/0000-0001-6139-3723; Rittinger, Katrin/0000-0002-7698-4435; Jennings, Elliott/0000-0002-3118-2375	Francis Crick Institute Grant from Cancer Research UK [FC001142]; UK Medical Research Council; Wellcome Trust; Wellcome Trust [102410/Z/13/ZR]; Imperial College London [RSRO_P50016]; Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship [BB/R011834/1]; BBSRC [BB/R011834/1] Funding Source: UKRI; MRC [MR/P028225/1] Funding Source: UKRI	Francis Crick Institute Grant from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Wellcome Trust(Wellcome Trust); Imperial College London(General Electric); Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Francis Crick Institute Grant FC001142, which receives its core funding from Cancer Research UK, the UK Medical Research Council, and the Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Wellcome Trust Ph.D. Studentship 102410/Z/13/ZR.; Supported by Imperial College London Junior Research Fellowship RSRO_P50016 and Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship BB/R011834/1.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baruch K, 2011, EMBO J, V30, P221, DOI 10.1038/emboj.2010.297; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; Cerda-Costa N, 2014, PROTEIN SCI, V23, P123, DOI 10.1002/pro.2400; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YQ, 1998, NAT STRUCT BIOL, V5, P67, DOI 10.1038/nsb0198-67; Cheng CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001501; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Dummler A, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-34; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esposito D, 2018, J BIOL CHEM, V293, P5064, DOI 10.1074/jbc.RA118.001796; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Ghosh G, 2012, IMMUNOL REV, V246, P36, DOI 10.1111/j.1600-065X.2012.01097.x; Giogha C, 2015, CELL MICROBIOL, V17, P1766, DOI 10.1111/cmi.12469; Grams F, 1996, NAT STRUCT BIOL, V3, P671, DOI 10.1038/nsb0896-671; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hodgson A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004705; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Jennings E, 2017, CELL HOST MICROBE, V22, P217, DOI 10.1016/j.chom.2017.07.009; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Li WQ, 2014, ACTA CRYSTALLOGR D, V70, P40, DOI 10.1107/S1399004713024619; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muhlen S, 2011, J BIOL CHEM, V286, P5100, DOI 10.1074/jbc.M110.172254; Mulero MC, 2017, J BIOL CHEM, V292, P18821, DOI 10.1074/jbc.M117.813980; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nahar K, 2014, MOL PLANT PATHOL, V15, P297, DOI 10.1111/mpp.12079; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Pearson JS, 2011, MOL MICROBIOL, V80, P219, DOI 10.1111/j.1365-2958.2011.07568.x; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Potnis N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-146; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Silva DS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003128; Sun H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005484; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Turco MM, 2014, BIOCHEMISTRY-US, V53, P5131, DOI 10.1021/bi500593e; Wang VYF, 2012, CELL REP, V2, P824, DOI 10.1016/j.celrep.2012.08.042; Yao Q, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004522; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231	44	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15316	15329		10.1074/jbc.RA118.004255	http://dx.doi.org/10.1074/jbc.RA118.004255			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30049795	Green Published, hybrid			2022-12-28	WOS:000445998400030
J	Rathore, U; Purwar, M; Vignesh, VS; Das, R; Kumar, AA; Bhattacharyya, S; Arendt, H; DeStefano, J; Wilson, A; Parks, C; La Branche, CC; Montefiori, DC; Varadarajan, R				Rathore, Ujjwal; Purwar, Mansi; Vignesh, Venkada Subramanian; Das, Raksha; Kumar, Aditya Arun; Bhattacharyya, Sanchari; Arendt, Heather; DeStefano, Joanne; Wilson, Aaron; Parks, Christopher; La Branche, Celia C.; Montefiori, David C.; Varadarajan, Raghavan			Bacterially expressed HIV-1 gp120 outer-domain fragment immunogens with improved stability and affinity for CD4-binding site neutralizing antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein design; mutagenesis; glycosylation; hydrogen-deuterium exchange; vaccine development; protein refolding; yeast surface display	IMMUNODEFICIENCY-VIRUS TYPE-1; YEAST SURFACE DISPLAY; RECOMBINANT GLYCOPROTEIN-120 VACCINE; CROSS-STRAND DISULFIDES; ENVELOPE GLYCOPROTEIN; PROTEIN STABILITY; STRUCTURAL BASIS; CD4-INDUCED ACTIVATION; SEQUENCE STATISTICS; VIRAL INFECTIVITY	Protein minimization is an attractive approach for designing vaccines against rapidly evolving pathogens such as human immunodeficiency virus, type 1 (HIV-1), because it can help in focusing the immune response toward conserved conformational epitopes present on complex targets. The outer domain (OD) of HIV-1 gp120 contains epitopes for a large number of neutralizing antibodies and therefore is a primary target for structure-based vaccine design. We have previously designed a bacterially expressed outer-domain immunogen (ODEC) that bound CD4-binding site (CD4bs) ligands with 3-12 m affinity and elicited a modest neutralizing antibody response in rabbits. In this study, we have optimized ODEC using consensus sequence design, cyclic permutation, and structure-guided mutations to generate a number of variants with improved yields, biophysical properties, stabilities, and affinities (K-D of 10-50 nm) for various CD4bs targeting broadly neutralizing antibodies, including the germline-reverted version of the broadly neutralizing antibody VRC01. In contrast to ODEC, the optimized immunogens elicited high anti-gp120 titers in rabbits as early as 6 weeks post-immunization, before any gp120 boost was given. Following two gp120 boosts, sera collected at week 22 showed cross-clade neutralization of tier 1 HIV-1 viruses. Using a number of different prime/boost combinations, we have identified a cyclically permuted OD fragment as the best priming immunogen, and a trimeric, cyclically permuted gp120 as the most suitable boosting molecule among the tested immunogens. This study also provides insights into some of the biophysical correlates of improved immunogenicity.	[Rathore, Ujjwal; Purwar, Mansi; Vignesh, Venkada Subramanian; Das, Raksha; Kumar, Aditya Arun; Bhattacharyya, Sanchari; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Arendt, Heather; DeStefano, Joanne; Wilson, Aaron; Parks, Christopher] Int AIDS Vaccine Initiat, Brooklyn, NY 11226 USA; [La Branche, Celia C.; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27707 USA; [Varadarajan, Raghavan] Dept Sci & Technol, Durham, NC USA	Indian Institute of Science (IISC) - Bangalore; International AIDS Vaccine Initiative; Duke University	Varadarajan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	varadar@mbu.iisc.ernet.in	Bhattacharyya, Sanchari/L-4344-2019; Rathore, Ujjwal/AAD-9974-2021	Bhattacharyya, Sanchari/0000-0003-3421-4755; Rathore, Ujjwal/0000-0002-0329-7431; Venkadasubramanian, Vignesh/0000-0003-1700-7439	Bill and Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); Government of India: Department of Science and Technology-Fund for Improvement of Science and Technology Infrastructure; University Grants Commission Center for Advanced Study; Department of Biotechnology-IISc Partnership Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118366] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Government of India: Department of Science and Technology-Fund for Improvement of Science and Technology Infrastructure; University Grants Commission Center for Advanced Study; Department of Biotechnology-IISc Partnership Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Monoclonal antibodies b12, VRC01, and sCD4 protein were obtained from the Neutralizing Antibody Consortium of International AIDS Vaccine Initiative. GL-VRC01 was kindly provided by Dr. John R. Mascola. The yeast display vector pPNLS was kindly provided by Dr. Dennis Burton. We thank the Proteomics Facility at the Molecular Biophysics Unit, Indian Institute of Science, especially Sunita Prakash and Raghu Tadala, for assistance with mass spectrometric data generation. The assistance of N. S. Srilatha is duly acknowledged for the SPR experiments. We thank Prof. Jayant Udgaonkar, Pooja Malhotra, Joginder Singh, and Prashant Jethva for help with the use of MS machine for carrying out HDX-MS experiments. We also acknowledge Wayne Koff, Rick King, and Michael Caulfield from International AIDS Vaccine Initiative for their help with the iVSV work. The work of the International AIDS Vaccine Initiative is made possible by the generous support from many donors, including the following: Bill and Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of International AIDS Vaccine Initiative AIDS Vaccine Initiative donors is available at www.iavi.org. We also acknowledge funding for infrastructural support from the following programs of the Government of India: Department of Science and Technology-Fund for Improvement of Science and Technology Infrastructure, University Grants Commission Center for Advanced Study, and the Department of Biotechnology-IISc Partnership Program.	Bhattacharyya S, 2013, J BIOL CHEM, V288, P9815, DOI 10.1074/jbc.M112.425959; Bhattacharyya S, 2010, J BIOL CHEM, V285, P27100, DOI 10.1074/jbc.M110.152272; Bowley DR, 2007, PROTEIN ENG DES SEL, V20, P81, DOI 10.1093/protein/gzl057; BRINKMANN U, 1992, P NATL ACAD SCI USA, V89, P3075, DOI 10.1073/pnas.89.7.3075; Chakraborty K, 2005, BIOCHEMISTRY-US, V44, P14638, DOI 10.1021/bi050921s; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen H, 2008, J GEN VIROL, V89, P2597, DOI 10.1099/vir.0.2008/003491-0; Chen HY, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-33; Connor RI, 1998, J VIROL, V72, P1552, DOI 10.1128/JVI.72.2.1552-1576.1998; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Dacheux L, 2004, J VIROL, V78, P12625, DOI 10.1128/JVI.78.22.12625-12637.2004; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; FENOUILLET E, 1994, TRENDS BIOCHEM SCI, V19, P65, DOI 10.1016/0968-0004(94)90034-5; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Graham BS, 1998, J INFECT DIS, V177, P310, DOI 10.1086/514209; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Guttman M, 2014, STRUCTURE, V22, P974, DOI 10.1016/j.str.2014.05.001; Guttman M, 2012, J VIROL, V86, P8750, DOI 10.1128/JVI.07224-11; Hu DY, 2017, VACCINE, V35, P3067, DOI 10.1016/j.vaccine.2017.04.054; Ibarra-Molero B, 1999, BIOCHEMISTRY-US, V38, P8138, DOI 10.1021/bi9905819; Indu S, 2011, PROTEINS, V79, P244, DOI 10.1002/prot.22878; Indu S, 2010, PROTEINS, V78, P1228, DOI 10.1002/prot.22641; Jackel C, 2010, J MOL BIOL, V399, P541, DOI 10.1016/j.jmb.2010.04.039; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Jones AT, 2018, J VIROL, V92, DOI 10.1128/JVI.01796-17; KELLEY RF, 1987, BIOCHEMISTRY-US, V26, P1406, DOI 10.1021/bi00379a029; Kesavardhana S, 2017, J BIOL CHEM, V292, P278, DOI 10.1074/jbc.M116.725614; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lehmann M, 2001, CURR OPIN BIOTECH, V12, P371, DOI 10.1016/S0958-1669(00)00229-9; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Magliery TJ, 2015, CURR OPIN STRUC BIOL, V33, P161, DOI 10.1016/j.sbi.2015.09.002; MATTHEW JB, 1986, METHOD ENZYMOL, V130, P413; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Morgan Christopher R, 2009, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1706s58; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Najar TA, 2017, STRUCTURE, V25, P395, DOI 10.1016/j.str.2016.12.016; Nakane S, 2015, J BIOL CHEM, V290, P15279, DOI 10.1074/jbc.M114.628610; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Qin YL, 2014, VIROLOGY, V462, P363, DOI 10.1016/j.virol.2014.06.006; Rabinovich S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106597; Rathore U, 2017, J BIOL CHEM, V292, P10197, DOI 10.1074/jbc.M117.788919; Rathore U, 2014, BBA-PROTEINS PROTEOM, V1844, P1891, DOI 10.1016/j.bbapap.2014.05.010; Saha P, 2012, BIOCHEMISTRY-US, V51, P1836, DOI 10.1021/bi300003v; Sahoo A, 2015, ELIFE, V4, DOI 10.7554/eLife.09532; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scharf L, 2013, P NATL ACAD SCI USA, V110, P6049, DOI 10.1073/pnas.1303682110; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Sharma D, 2005, BIOCHEMISTRY-US, V44, P16192, DOI 10.1021/bi051120s; Sheshadri S, 1999, PROTEIN SCI, V8, P1689, DOI 10.1110/ps.8.8.1689; Shingai M, 2012, P NATL ACAD SCI USA, V109, P19769, DOI 10.1073/pnas.1217443109; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; STEIPE B, 1994, J MOL BIOL, V240, P188, DOI 10.1006/jmbi.1994.1434; Street TO, 2006, P NATL ACAD SCI USA, V103, P17064, DOI 10.1073/pnas.0606236103; Strickler SS, 2006, BIOCHEMISTRY-US, V45, P2761, DOI 10.1021/bi0600143; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; Varadarajan R, 2005, J VIROL, V79, P1713, DOI 10.1128/JVI.79.3.1713-1723.2005; Wallace A, 2009, J VIROL, V83, P7883, DOI 10.1128/JVI.00582-09; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Whitehead TA, 2009, PROTEIN ENG DES SEL, V22, P607, DOI 10.1093/protein/gzp034; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiang SH, 2002, J VIROL, V76, P9888, DOI 10.1128/JVI.76.19.9888-9899.2002; Yang XZ, 2006, J VIROL, V80, P11404, DOI 10.1128/JVI.01102-06; Yang XZ, 2004, J VIROL, V78, P12975, DOI 10.1128/JVI.78.23.12975-12986.2004; Yu Y, 2011, TRENDS BIOTECHNOL, V29, P18, DOI 10.1016/j.tibtech.2010.10.004; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	71	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15002	15020		10.1074/jbc.RA118.005006	http://dx.doi.org/10.1074/jbc.RA118.005006			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30093409	Green Published, hybrid			2022-12-28	WOS:000445998400006
J	Yogavel, M; Nettleship, JE; Sharma, A; Harlos, K; Jamwal, A; Chaturvedi, R; Sharma, M; Jain, V; Chhibber-Goel, J; Sharma, A				Yogavel, Manickam; Nettleship, Joanne E.; Sharma, Akansha; Harlos, Karl; Jamwal, Abhishek; Chaturvedi, Rini; Sharma, Manmohan; Jain, Vitul; Chhibber-Goel, Jyoti; Sharma, Amit			Structure of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase-dihydropteroate synthase from Plasmodium vivax sheds light on drug resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug resistance; malaria; plasmodium; crystal structure; infectious disease; dihydropteroate synthase; HPPK-DHPS; p-aminobenzoic acid; Plasmodium vivax; sulfadoxine	HIV-1 PROTEASE INHIBITORS; AMINO-ACID MUTATIONS; CRYSTAL-STRUCTURE; FOLATE METABOLISM; MALARIA; PYRIMETHAMINE; FALCIPARUM; SUBSTRATE; DHPS; REFINEMENT	The genomes of the malaria-causing Plasmodium parasites encode a protein fused of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase (HPPK) and dihydropteroate synthase (DHPS) domains that catalyze sequential reactions in the folate biosynthetic pathway. Whereas higher organisms derive folate from their diet and lack the enzymes for its synthesis, most eubacteria and a number of lower eukaryotes including malaria parasites synthesize tetrahydrofolate via DHPS. Plasmodium falciparum (Pf) and Plasmodium vivax (Pv) HPPK-DHPSs are currently targets of drugs like sulfadoxine (SDX). The SDX effectiveness as an antimalarial drug is increasingly diminished by the rise and spread of drug-resistant mutations. Here, we present the crystal structure of PvHPPK-DHPS in complex with four substrates/analogs, revealing the bifunctional PvHPPK-DHPS architecture in an unprecedented state of enzymatic activation. SDX's effect on HPPK-DHPS is due to 4-amino benzoic acid (pABA) mimicry, and the PvHPPK-DHPS structure sheds light on the SDX-binding cavity, as well as on mutations that effect SDX potency. We mapped five dominant drug resistance mutations in PvHPPK-DHPS: S382A, A383G, K512E/D, A553G, and V585A, most of which occur individually or in clusters proximal to the pABA-binding site. We found that these resistance mutations subtly alter the intricate enzyme/pABA/SDX interactions such that DHPS affinity for pABA is diminished only moderately, but its affinity for SDX is changed substantially. In conclusion, the PvHPPK-DHPS structure rationalizes and unravels the structural bases for SDX resistance mutations and highlights architectural features in HPPK-DHPSs from malaria parasites that can form the basis for developing next-generation anti-folate agents to combat malaria parasites.	[Yogavel, Manickam; Sharma, Akansha; Jamwal, Abhishek; Chaturvedi, Rini; Sharma, Manmohan; Chhibber-Goel, Jyoti; Sharma, Amit] Int Ctr Genet Engn & Biotechnol, Mol Med Struct Parasitol Grp, New Delhi 110067, India; [Nettleship, Joanne E.; Harlos, Karl; Jain, Vitul] Univ Oxford, Wellcome Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; [Nettleship, Joanne E.] Rutherford Appleton Lab, Oxford Prot Prod Facil, United Kingdom Res Complex Harwell, Oxford OX11 0FA, England	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Oxford; Wellcome Centre for Human Genetics; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Oxford	Yogavel, M (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct Parasitol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	myogavel@gmail.com	Chaturvedi, Rini/GLU-2991-2022; Chhibber-Goel, Jyoti/AAC-5735-2020; Jain, Vitul/AAP-9467-2020; Sharma, Akansha/HGA-9893-2022; Goel, Jyoti/L-4510-2019; Manickam, Yogavel/O-4570-2015	Chhibber-Goel, Jyoti/0000-0003-4654-5463; Jain, Vitul/0000-0002-8396-8329; Chaturvedi, Rini/0000-0003-1437-5121; Manickam, Yogavel/0000-0002-2119-062X; sharma, Manmohan/0000-0002-0215-6223	Department of Science and Technology (DST), Ministry of Science and Technology, Government of India [EMR/2016/004898]; Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA); Wellcome Centre for Human Genetics [090532/Z/09/Z]; DST, Ministry of Science and Technology, Government of India; MRC [MR/K018779/1] Funding Source: UKRI	Department of Science and Technology (DST), Ministry of Science and Technology, Government of India; Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA)(Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA)); Wellcome Centre for Human Genetics; DST, Ministry of Science and Technology, Government of India; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grant (EMR/2016/004898) from Department of Science and Technology (DST), Ministry of Science and Technology, Government of India. This work was also supported in part by a travel grant from the Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA) (to M. Y. and M. S.), Core Grant Award 090532/Z/09/Z from the Wellcome Centre for Human Genetics (to K. H.), and a J.C. Bose fellowship from DST, Ministry of Science and Technology, Government of India (to Am. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Achari A, 1997, NAT STRUCT BIOL, V4, P490, DOI 10.1038/nsb0697-490; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altman MD, 2008, J AM CHEM SOC, V130, P6099, DOI 10.1021/ja076558p; Auliff A, 2006, AM J TROP MED HYG, V75, P617, DOI 10.4269/ajtmh.2006.75.617; Baca AM, 2000, J MOL BIOL, V302, P1193, DOI 10.1006/jmbi.2000.4094; Dias MVB, 2018, FUTURE MED CHEM, V10, P935, DOI 10.4155/fmc-2017-0168; Blaszczyk J, 2004, STRUCTURE, V12, P467, DOI 10.1016/j.str.2004.02.003; Blaszczyk J, 2007, ACTA CRYSTALLOGR D, V63, P1169, DOI 10.1107/S0907444907047452; Chhabra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029444; Chotpatiwetchkul W, 2017, ORG BIOMOL CHEM, V15, P5593, DOI 10.1039/c7ob01272a; CHULAY JD, 1984, AM J TROP MED HYG, V33, P325, DOI 10.4269/ajtmh.1984.33.325; Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010313; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Duffy S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-408; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FERONE R, 1970, J BIOL CHEM, V245, P850; Fidock DA, 2010, NATURE, V465, P297, DOI 10.1038/465297a; Fidock DA, 2008, TRENDS PARASITOL, V24, P537, DOI 10.1016/j.pt.2008.09.005; Garcon A, 2006, J MOL BIOL, V360, P644, DOI 10.1016/j.jmb.2006.05.038; Gaudilliere JP, 2009, B HIST MED, V83, P218; Hammoudeh DI, 2013, FUTURE MED CHEM, V5, P1331, DOI 10.4155/fmc.13.97; Hawkins VN, 2009, AM J TROP MED HYG, V81, P348, DOI 10.4269/ajtmh.2009.81.348; HURLEY M. G. D., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P412, DOI 10.1016/0035-9203(59)90044-6; Lawrence MC, 2005, J MOL BIOL, V348, P655, DOI 10.1016/j.jmb.2005.03.021; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller IB, 2013, MOL BIOCHEM PARASIT, V188, P63, DOI 10.1016/j.molbiopara.2013.02.008; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nalam MNL, 2010, J VIROL, V84, P5368, DOI 10.1128/JVI.02531-09; Nzila A, 2005, TRENDS PARASITOL, V21, P292, DOI 10.1016/j.pt.2005.04.002; Pemble CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014165; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PINICHPONGSE S, 1982, B WORLD HEALTH ORGAN, V60, P907; Pornthanakasem W, 2016, ANTIMICROB AGENTS CH, V60, P4453, DOI 10.1128/AAC.01835-15; Ragsdale SW, 2008, VITAM HORM, V79, P293, DOI 10.1016/S0083-6729(08)00410-X; ROLAND S, 1979, J BIOL CHEM, V254, P337; Rungsihirunrat K, 2008, AM J TROP MED HYG, V78, P462, DOI 10.4269/ajtmh.2008.78.462; SHIOTA T, 1984, CHEM BIOCH FOLATES, P121; Snounou G, 2004, TRENDS PARASITOL, V20, P333, DOI 10.1016/j.pt.2004.05.004; THAITHONG S, 1992, MOL BIOCHEM PARASIT, V52, P149, DOI 10.1016/0166-6851(92)90047-N; Triglia T, 1997, P NATL ACAD SCI USA, V94, P13944, DOI 10.1073/pnas.94.25.13944; Waterman DG, 2016, ACTA CRYSTALLOGR D, V72, P558, DOI 10.1107/S2059798316002187; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; World Health Organization, 2017, GLOB HEP REP, DOI DOI 10.1071/EC12504; World Health Organization (WHO), 2010, WHO MOD LIST ESS MED, P4; Wright DL, 2011, EXPERT OPIN THER PAT, V21, P1293, DOI 10.1517/13543776.2011.587804; Yun MK, 2014, BIOORGAN MED CHEM, V22, P2157, DOI 10.1016/j.bmc.2014.02.022; Yun MK, 2012, SCIENCE, V335, P1110, DOI 10.1126/science.1214641	47	9	9	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					14962	14972		10.1074/jbc.RA118.004558	http://dx.doi.org/10.1074/jbc.RA118.004558			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30104413	Green Published, hybrid			2022-12-28	WOS:000445998400002
J	Choi, S; Park, M; Kim, J; Park, W; Kim, S; Lee, DK; Hwang, JY; Choe, J; Won, MH; Ryoo, S; Ha, KS; Kwon, YG; Kim, YM				Choi, Seunghwan; Park, Minsik; Kim, Joohwan; Park, Wonjin; Kim, Suji; Lee, Dong-Keon; Hwang, Jong Yun; Choe, Jongseon; Won, Moo-Ho; Ryoo, Sungwoo; Ha, Kwon-Soo; Kwon, Young-Guen; Kim, Young-Myeong			TNF-alpha elicits phenotypic and functional alterations of vascular smooth muscle cells by miR-155-5p-dependent down-regulation of cGMP-dependent kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor necrosis factor (TNF); protein kinase G (PKG); microRNA (miRNA); NF-kappa B (NF-B); vascular smooth muscle cells; cGMP-dependent protein kinase 1	NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; NEOINTIMAL LESION FORMATION; NITRIC-OXIDE; INFLAMMATORY CYTOKINES; IN-VIVO; EXPRESSION; ATHEROSCLEROSIS; PROLIFERATION; HYPERTENSION	cGMP-dependent protein kinase 1 (PKG1) plays an important role in nitric oxide (NO)/cGMP-mediated maintenance of vascular smooth muscle cell (VSMC) phenotype and vasorelaxation. Inflammatory cytokines, including tumor necrosis factor-alpha(TNF alpha), have long been understood to mediate several inflammatory vascular diseases. However, the underlying mechanism of TNF alpha-dependent inflammatory vascular disease is unclear. Here, we found that TNF alpha treatment decreased PKG1 expression in cultured VSMCs, which correlated with NF-kappa B-dependent biogenesis of miR-155-5p that targeted the 3'-UTR of PKG1 mRNA. TNF alpha induced VSMC phenotypic switching from a contractile to a synthetic state through the down-regulation of VSMC marker genes, suppression of actin polymerization, alteration of cell morphology, and elevation of cell proliferation and migration. All of these events were blocked by treatment with an inhibitor of miR-155-5p or PKG1, whereas transfection with miR-155-5p mimic or PKG1 siRNA promoted phenotypic modulation, similar to the response to TNF alpha. In addition, TNF alpha-induced miR-155-5p inhibited the vasorelaxant response of de-endothelialized mouse aortic vessels to 8-Br-cGMP by suppressing phosphorylation of myosin phosphatase and myosin light chain, both of which are downstream signal modulators of PKG1. Moreover, TNF alpha-induced VSMC phenotypic alteration and vasodilatory dysfunction were blocked by NF-kappa B inhibition. These results suggest that TNF alpha impairs NO/cGMP-mediated maintenance of the VSMC contractile phenotype and vascular relaxation by down-regulating PKG1 through NF-kappa B-dependent biogenesis of miR-155-5p. Thus, the NF-kappa B/miR-155-5p/PKG1 axis may be crucial in the pathogenesis of inflammatory vascular diseases, such as atherosclerotic intimal hyperplasia and preeclamptic hypertension.	[Choi, Seunghwan; Park, Minsik; Kim, Joohwan; Park, Wonjin; Kim, Suji; Lee, Dong-Keon; Ha, Kwon-Soo; Kim, Young-Myeong] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon 24341, Gangwon Do, South Korea; [Hwang, Jong Yun] Kangwon Natl Univ, Sch Med, Dept Obstet & Gynecol, Chunchon 24341, Gangwon Do, South Korea; [Choe, Jongseon] Kangwon Natl Univ, Sch Med, Dept Immunol, Chunchon 24341, Gangwon Do, South Korea; [Won, Moo-Ho] Kangwon Natl Univ, Sch Med, Dept Neurobiol, Chunchon 24341, Gangwon Do, South Korea; [Ryoo, Sungwoo] Kangwon Natl Univ, Dept Biol, Coll Nat Sci, Chunchon 24341, Gangwon Do, South Korea; [Kwon, Young-Guen] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University; Yonsei University	Kim, YM (corresponding author), Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon 24341, Gangwon Do, South Korea.	ymkim@kangwon.ac.kr	Ha, Kwon-Soo/AAU-4417-2020	Ha, Kwon-Soo/0000-0002-4219-1787	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2016M3A9B6903103]; Kangwon National University [520170431]	National Research Foundation of Korea (NRF) - Korea government (MSIP); Kangwon National University	This work was supported by the National Research Foundation of Korea (NRF) Grant 2016M3A9B6903103 funded by the Korea government (MSIP) and also a 2017 Research Grant from Kangwon National University (Grant 520170431). The authors declare that they have no conflicts of interest with the contents of this article.	Afzal TA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004629; Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Anderson PG, 2000, ARTERIOSCL THROM VAS, V20, P2192, DOI 10.1161/01.ATV.20.10.2192; Baek YY, 2012, EUR J PHARMACOL, V674, P188, DOI 10.1016/j.ejphar.2011.11.022; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Browner NC, 2004, AM J PHYSIOL-CELL PH, V287, pC88, DOI 10.1152/ajpcell.00039.2004; Chen J, 2011, ARTERIOSCL THROM VAS, V31, P368, DOI 10.1161/ATVBAHA.110.218149; Chen LH, 2004, ARTERIOSCL THROM VAS, V24, P1403, DOI 10.1161/01.ATV.0000134705.39654.53; Chen QS, 2015, J MOL CELL CARDIOL, V89, P75, DOI 10.1016/j.yjmcc.2015.10.017; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cherepanova OA, 2016, NAT MED, V22, P657, DOI 10.1038/nm.4109; Choi S, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.193; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Elks CM, 2009, AM J PHYSIOL-RENAL, V296, pF298, DOI 10.1152/ajprenal.90628.2008; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; Gao YS, 2008, AM J PHYSIOL-LUNG C, V295, pL889, DOI 10.1152/ajplung.00463.2007; Ishida A, 1999, MOL PHARMACOL, V56, P938, DOI 10.1124/mol.56.5.938; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Jovinge S, 1997, ARTERIOSCL THROM VAS, V17, P490, DOI 10.1161/01.ATV.17.3.490; Kim J, 2017, FREE RADICAL BIO MED, V104, P185, DOI 10.1016/j.freeradbiomed.2017.01.010; Kim JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36979; Kitazawa T, 2009, J PHYSIOL-LONDON, V587, P3587, DOI 10.1113/jphysiol.2009.172189; Lee KS, 2014, BIOCHEM BIOPH RES CO, V448, P101, DOI 10.1016/j.bbrc.2014.04.079; Li P, 2013, CIRC RES, V113, P1117, DOI 10.1161/CIRCRESAHA.113.301306; Ma XC, 2013, HEART LUNG CIRC, V22, P811, DOI 10.1016/j.hlc.2013.05.651; Martin-Sanchez P, 2018, FASEB J, V32, P920, DOI 10.1096/fj.201700134RRRR; MORISAKI N, 1993, SCAND J CLIN LAB INV, V53, P347, DOI 10.3109/00365519309086626; Naya M, 2007, HYPERTENS RES, V30, P541, DOI 10.1291/hypres.30.541; Nguyen T, 2015, MOL CELL BIOCHEM, V405, P81, DOI 10.1007/s11010-015-2398-y; Peeters ACTM, 2001, EUR J CLIN INVEST, V31, P31, DOI 10.1046/j.1365-2362.2001.00743.x; Peppel K, 2005, CARDIOVASC RES, V65, P674, DOI 10.1016/j.cardiores.2004.10.031; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; Ren J, 2016, J PHARMACOL EXP THER, V356, P137, DOI 10.1124/jpet.115.227934; Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001; Shaw J, 2016, PLACENTA, V43, P1, DOI 10.1016/j.placenta.2016.04.015; Sinnaeve P, 2002, CIRCULATION, V105, P2911, DOI 10.1161/01.CIR.0000018169.59205.CA; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Sun Y, 2016, ARTERIOSCL THROM VAS, V36, P1230, DOI 10.1161/ATVBAHA.115.306691; Torella D, 2011, CIRC RES, V109, P880, DOI 10.1161/CIRCRESAHA.111.240150; Vanhoutte PM, 2016, CIRC RES, V119, P375, DOI 10.1161/CIRCRESAHA.116.306531; Virtue A, 2017, J BIOL CHEM, V292, P1267, DOI 10.1074/jbc.M116.739839; Wang J, 2013, EXP CELL RES, V319, P1165, DOI 10.1016/j.yexcr.2013.03.010; Wang SX, 2009, AM J PHYSIOL-HEART C, V297, pH2075, DOI 10.1152/ajpheart.00521.2009; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Yang F, 2018, CIRCULATION, V137, P1824, DOI 10.1161/CIRCULATIONAHA.117.027799; Yang LB, 2017, CIRC RES, V121, P1251, DOI 10.1161/CIRCRESAHA.117.311819; Yoshida T, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000230	50	21	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14812	14822		10.1074/jbc.RA118.004220	http://dx.doi.org/10.1074/jbc.RA118.004220			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30104414	Green Published, hybrid			2022-12-28	WOS:000446155000018
J	Sweeny, EA; Singh, AB; Chakravarti, R; Martinez-Guzman, O; Saini, A; Haque, MM; Garee, G; Dans, PD; Hannibal, L; Reddi, AR; Stuehr, DJ				Sweeny, Elizabeth A.; Singh, Anuradha Bharara; Chakravarti, Ritu; Martinez-Guzman, Osiris; Saini, Arushi; Haque, Mohammad Mahfuzul; Garee, Greer; Dans, Pablo D.; Hannibal, Luciana; Reddi, Amit R.; Stuehr, Dennis J.			Glyceraldehyde-3-phosphate dehydrogenase is a chaperone that allocates labile heme in cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme; hemostasis; kinetics; iron; intracellular trafficking; GAPDH; heme chaperone; heme trafficking; porphyrin; tetrapyrroles; heme toxicity	PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; NITRIC-OXIDE; ERYTHROLEUKEMIA-CELLS; PROTEIN; BINDING; BIOSYNTHESIS; SIMULATIONS; TRANSPORT; DIFFERENTIATION	Cellular heme is thought to be distributed between a pool of sequestered heme that is tightly bound within hemeproteins and a labile heme pool required for signaling and transfer into proteins. A heme chaperone that can hold and allocate labile heme within cells has long been proposed but never been identified. Here, we show that the glycolytic protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH) fulfills this role by acting as an essential repository and allocator of bioavailable heme to downstream protein targets. We identified a conserved histidine in GAPDH that is needed for its robust heme binding both in vitro and in mammalian cells. Substitution of this histidine, and the consequent decreases in GAPDH heme binding, antagonized heme delivery to both cytosolic and nuclear hemeprotein targets, including inducible nitric-oxide synthase (iNOS) in murine macrophages and the nuclear transcription factor Hap1 in yeast, even though this GAPDH variant caused cellular levels of labile heme to rise dramatically. We conclude that by virtue of its heme-binding property, GAPDH binds and chaperones labile heme to create a heme pool that is bioavailable to downstream proteins. Our finding solves a fundamental question in cell biology and provides a new foundation for exploring heme homeostasis in health and disease.	[Sweeny, Elizabeth A.; Singh, Anuradha Bharara; Chakravarti, Ritu; Haque, Mohammad Mahfuzul; Garee, Greer; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44195 USA; [Martinez-Guzman, Osiris; Saini, Arushi; Reddi, Amit R.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Martinez-Guzman, Osiris; Saini, Arushi; Reddi, Amit R.] Georgia Inst Technol, Parker Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Dans, Pablo D.] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Balidiri Reixac 10-12, Barcelona 08028, Spain; [Hannibal, Luciana] Univ Freiburg, Med Ctr, Ctr Pediat, Lab Clin Biochem & Metab, D-79106 Freiburg, Germany; [Chakravarti, Ritu] Univ Toledo, Dept Physiol & Pharmacol, Toledo, OH 43614 USA	Cleveland Clinic Foundation; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Freiburg; University System of Ohio; University of Toledo	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Chakravarti, Ritu/K-8928-2019; Dans, Pablo D./K-6330-2019; Hannibal, Luciana/AAY-7689-2021	Chakravarti, Ritu/0000-0003-4680-8374; Dans, Pablo D./0000-0002-5927-372X; Hannibal, Luciana/0000-0002-0911-5758; HAQUE, MOHAMMAD/0000-0003-0852-6368; Saini, Arushi/0000-0003-1917-4468; Sweeny, Elizabeth/0000-0001-7818-9112	National Institutes of Health [RO1 GM097041, PO1 HL081064, PO1 HL103453, R21 ES025661]; National Science Foundation Grant [MCB-1552791]; American Heart Association Postdoctoral Fellowship; Blanchard Professorship; Georgia Institute of Technology start-up funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064, U10HL109250, P01HL103453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES025661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Grant(National Science Foundation (NSF)); American Heart Association Postdoctoral Fellowship(American Heart Association); Blanchard Professorship; Georgia Institute of Technology start-up funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants RO1 GM097041 (to D. J. S.), PO1 HL081064 Project 3 and PO1 HL103453 Project 3 (to D. J. S.), and R21 ES025661 (to A. R. R.), National Science Foundation Grant MCB-1552791 (to A. R. R.), an American Heart Association Postdoctoral Fellowship (to E. A. S.), the Blanchard Professorship (to A. R. R.), and Georgia Institute of Technology start-up funds (to A. R. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi Y, 2017, ARCH BIOCHEM BIOPHYS, V631, P19, DOI 10.1016/j.abb.2017.08.006; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Capece L, 2009, PROTEINS, V75, P885, DOI 10.1002/prot.22297; Chakravarti R, 2015, FREE RADICAL BIO MED, V82, P105, DOI 10.1016/j.freeradbiomed.2015.01.030; Chakravarti R, 2010, P NATL ACAD SCI USA, V107, P18004, DOI 10.1073/pnas.1008133107; Cheatham TE., 2017, AMBER 16; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Dans PD, 2016, NUCLEIC ACIDS RES, V44, P4052, DOI 10.1093/nar/gkw264; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; EBERT PS, 1979, BIOCHEM BIOPH RES CO, V88, P1382, DOI 10.1016/0006-291X(79)91133-1; Ghosh A, 2018, P NATL ACAD SCI USA, V115, pE1117, DOI 10.1073/pnas.1717993115; Ghosh A, 2014, J BIOL CHEM, V289, P15259, DOI 10.1074/jbc.M114.559393; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Hanna DA, 2016, P NATL ACAD SCI USA, V113, P7539, DOI 10.1073/pnas.1523802113; Hannibal L, 2014, HANDB PORPHYR SCI, V30, P55; Hannibal L, 2012, BIOCHEMISTRY-US, V51, P8514, DOI 10.1021/bi300863a; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; HARVEY JW, 1982, BLOOD, V60, P1227; Huang Y, 2017, ARCH BIOCHEM BIOPHYS, V619, P54, DOI 10.1016/j.abb.2017.03.005; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IWAHARA S, 1995, BIOCHEMISTRY-US, V34, P13398, DOI 10.1021/bi00041a017; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nadra AD, 2008, PROTEINS, V71, P695, DOI 10.1002/prot.21814; Narkewicz MR, 1996, BIOCHEM J, V313, P991, DOI 10.1042/bj3130991; Ness F, 1998, J BACTERIOL, V180, P1913, DOI 10.1128/JB.180.7.1913-1919.1998; Perez A, 2007, J AM CHEM SOC, V129, P14739, DOI 10.1021/ja0753546; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Rish KR, 2007, BBA-BIOENERGETICS, V1767, P1107, DOI 10.1016/j.bbabio.2007.06.003; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; SHEDLOFSKY SI, 1987, BIOCHEM J, V248, P229, DOI 10.1042/bj2480229; SMITH DE, 1994, J CHEM PHYS, V100, P3757, DOI 10.1063/1.466363; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; Sun FX, 2015, SCI CHINA LIFE SCI, V58, P757, DOI 10.1007/s11427-015-4885-5; Taketani S, 1998, J BIOL CHEM, V273, P31388, DOI 10.1074/jbc.273.47.31388; VINCENT SH, 1985, J BIOL CHEM, V260, P4521; Waheed SM, 2010, FREE RADICAL BIO MED, V48, P1548, DOI 10.1016/j.freeradbiomed.2010.02.038; Walker RC, 2002, J PHYS CHEM B, V106, P11658, DOI 10.1021/jp0261814; Yuan XJ, 2013, CURR OPIN CHEM BIOL, V17, P204, DOI 10.1016/j.cbpa.2013.01.010; ZHANG J, 1992, P NATL ACAD SCI USA, V89, P9382, DOI 10.1073/pnas.89.20.9382	49	61	61	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14557	14568		10.1074/jbc.RA118.004169	http://dx.doi.org/10.1074/jbc.RA118.004169			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30012884	Green Published, hybrid			2022-12-28	WOS:000444671500032
J	Wu, QY; Fung, AHY; Xu, ML; Poon, K; Liu, EYL; Kong, XP; Yao, P; Xiong, QP; Dong, TTX; Tsim, KWK				Wu, Qiyun; Fung, Aster H. Y.; Xu, Miranda L.; Poon, Kaman; Liu, Etta Y. L.; Kong, Xiang P.; Yao, Ping; Xiong, Qing P.; Dong, Tina T. X.; Tsim, Karl W. K.			Microphthalmia-associated transcription factor up-regulates acetylcholinesterase expression during melanogenesis of murine melanoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylcholinesterase (AChE); melanogenesis; cyclic AMP (cAMP); melanoma; epidermis; melanin; melanocyte; MITF; skin pigment	MOUSE ACETYLCHOLINESTERASE; HUMAN SKIN; MELANOCYTES; RECEPTOR; DIFFERENTIATION; PROMOTER; PATHWAY; ENZYMES; BIOLOGY; MITF	Acetylcholinesterase (AChE) hydrolyzes the neurotransmitter acetylcholine in neurons. However, AChE has been proposed to also have nonneuronal functions in different cell types. Here, we report that AChE is expressed in melanocytes and melanoma cells, and that the tetrameric (G4) form is the major AChE isoform in these cells. During melanogenesis of B16F10 murine melanoma cells, AChE levels decreased markedly. The differentiation of melanoma cells led to (i) an increase in melanin and tyrosinase, (ii) a change in intracellular cAMP levels, and (iii) a decrease in microphthalmia-associated transcription factor (MITF). We hypothesized that the regulation of AChE during melanogenesis is mediated by two transcription factors: cAMP-response element-binding protein (CREB) and MITF. In melanoma cells, exogenous cAMP suppressed AChE expression and the promoter activity of the ACHE gene. This suppression was mediated by a cAMP-response element (CRE) located on the ACHE promoter, as mutation of CRE relieved the suppression. In melanoma, MITF overexpression induced ACHE transcription, and mutation of an E-box site in human ACHE promoter blocked this induction. An AChE inhibitor greatly enhanced acetylcholine-mediated responses of melanogenic gene expression levels in vitro; however, this enhancement was not observed in the presence of agonists of the muscarinic acetylcholine receptor. These results indicate that ACHE transcription is regulated by cAMP-dependent signaling during melanogenesis of B16F10 cells, and the effect of this enzyme on melanin production suggests that it has a potential role in skin pigmentation.	[Wu, Qiyun; Xu, Miranda L.; Liu, Etta Y. L.; Kong, Xiang P.; Dong, Tina T. X.; Tsim, Karl W. K.] Shenzhen Res Inst, Shenzhen Key Lab Edible & Med Bioresources, Shenzhen 518000, Peoples R China; [Wu, Qiyun; Fung, Aster H. Y.; Xu, Miranda L.; Poon, Kaman; Liu, Etta Y. L.; Yao, Ping; Xiong, Qing P.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Peoples R China; [Wu, Qiyun; Fung, Aster H. Y.; Xu, Miranda L.; Poon, Kaman; Liu, Etta Y. L.; Yao, Ping; Xiong, Qing P.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Tsim, KWK (corresponding author), Shenzhen Res Inst, Shenzhen Key Lab Edible & Med Bioresources, Shenzhen 518000, Peoples R China.; Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Peoples R China.; Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Peoples R China.	botsim@ust.hk		Fung, Aster Hei Yiu/0000-0003-0918-9121	Hong Kong Research Grants Council Theme-based Research Scheme [T13-607/12R]; Innovation Technology Fund [UIM/288, UIM/302, UIM/340, UIT/137, ITS/022/16FP, TUYF15SC01]; Shenzhen Science and Technology Committee Research Grant [JCYJ 20,160,229,205,726,699, JCYJ 20,160,229,205, 812,004, JCYJ 20,160,229,210,027,564, CKFW 2,016,082,916,015,476, JCYJ 20,170,413,173,747,440, ZDSYS 201, 707,281,432,317, 20,170, 326]	Hong Kong Research Grants Council Theme-based Research Scheme(Hong Kong Research Grants Council); Innovation Technology Fund; Shenzhen Science and Technology Committee Research Grant	This work was supported by the Hong Kong Research Grants Council Theme-based Research Scheme (T13-607/12R), Innovation Technology Fund (UIM/288, UIM/302, UIM/340, UIT/137, and ITS/022/16FP), TUYF15SC01, and Shenzhen Science and Technology Committee Research Grant (JCYJ 20,160,229,205,726,699, JCYJ 20,160,229,205, 812,004, JCYJ 20,160,229,210,027,564, CKFW 2,016,082,916,015,476, JCYJ 20,170,413,173,747,440, and ZDSYS 201, 707,281,432,317 and 20,170, 326). The authors declare that they have no conflicts of interest with the contents of this article.	ASHKENAZI A, 1987, SCIENCE, V238, P672, DOI 10.1126/science.2823384; Baig AM, 2018, ACS CHEM NEUROSCI, V9, P494, DOI 10.1021/acschemneuro.7b00254; Borovansky J, 2011, MELANINS AND MELANOSOMES: BIOSYNTHESIS, BIOGENESIS, PHYSIOLOGICAL, AND PATHOLOGICAL FUNCTIONS, P343; Boukari F, 2015, J AM ACAD DERMATOL, V72, P189, DOI 10.1016/j.jaad.2014.08.023; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Buchli R, 2001, MOL CELL BIOCHEM, V228, P57, DOI 10.1023/A:1013368509855; Chen VP, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00036; Cheng Q, 2015, NEUROPHARMACOLOGY, V95, P405, DOI 10.1016/j.neuropharm.2015.04.016; Choi RCY, 2000, NEUROREPORT, V11, P801, DOI 10.1097/00001756-200003200-00029; Choi RCY, 1997, NEUROSCI LETT, V236, P167, DOI 10.1016/S0304-3940(97)00789-1; Cichorek M, 2013, POSTEP DERM ALERGOL, V30, P30, DOI 10.5114/pdia.2013.33376; D'Mello SAN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071144; de la Serna IL, 2006, J BIOL CHEM, V281, P20233, DOI 10.1074/jbc.M512052200; delMarmol V, 1996, FEBS LETT, V381, P165, DOI 10.1016/0014-5793(96)00109-3; GOLDGEIER MH, 1984, J INVEST DERMATOL, V82, P235, DOI 10.1111/1523-1747.ep12260111; GRANDO SA, 1993, J INVEST DERMATOL, V101, P32, DOI 10.1111/1523-1747.ep12358588; Grando SA, 1997, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, P41, DOI 10.1038/jidsymp.1997.10; Hartman ML, 2015, CELL MOL LIFE SCI, V72, P1249, DOI 10.1007/s00018-014-1791-0; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hirobe T, 2014, DERMATOL SIN, V32, P200, DOI 10.1016/j.dsi.2014.05.002; IYENGAR B, 1989, ACTA ANAT, V136, P139; Kim B, 2015, EUR J PHARMACOL, V764, P1, DOI 10.1016/j.ejphar.2015.05.006; Liu EYL, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00059; Luk WKW, 2012, FEBS J, V279, P3229, DOI 10.1111/j.1742-4658.2012.08708.x; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Meshorer E, 2002, SCIENCE, V295, P508, DOI 10.1126/science.1066752; MOELLMANN G, 1974, GEN COMP ENDOCR, V23, P45, DOI 10.1016/0016-6480(74)90051-3; MUTERO A, 1995, J BIOL CHEM, V270, P1866, DOI 10.1074/jbc.270.40.23511; Olivera-Bravo S, 2005, BRIT J PHARMACOL, V144, P88, DOI 10.1038/sj.bjp.0705965; Plonka PM, 2009, EXP DERMATOL, V18, P799, DOI 10.1111/j.1600-0625.2009.00912.x; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; SCHALLREUTER KU, 1988, ARCH DERMATOL RES, V280, P137, DOI 10.1007/BF00456842; Schallreuter KU, 2005, EXP DERMATOL, V14, P155, DOI 10.1111/j.0906-6705.2005.0266j.x; Schallreuter KU, 2004, BIOCHEM BIOPH RES CO, V315, P502, DOI 10.1016/j.bbrc.2004.01.082; Schlereth T, 2006, BRIT J PHARMACOL, V147, P183, DOI 10.1038/sj.bjp.0706451; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2033; Siow NL, 2002, J BIOL CHEM, V277, P36129, DOI 10.1074/jbc.M206498200; Sommer L, 2011, PIGM CELL MELANOMA R, V24, P411, DOI 10.1111/j.1755-148X.2011.00834.x; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Tachibana M, 1999, PIGM CELL RES, V12, P344, DOI 10.1111/j.1600-0749.1999.tb00518.x; TIWARI P, 2013, ASIAN PAC J TROP DIS, V3, P413, DOI DOI 10.1016/S2222-1808(13)60094-8; TSIM KWK, 1988, P NATL ACAD SCI USA, V85, P1262, DOI 10.1073/pnas.85.4.1262; Wan DCC, 2000, NEUROSCI LETT, V288, P81, DOI 10.1016/S0304-3940(00)01200-3; Xie HQ, 2009, BRAIN RES, V1265, P13, DOI 10.1016/j.brainres.2009.01.065; Xu ML, 2018, J NEUROCHEM, V146, P390, DOI 10.1111/jnc.14448; Xu ML, 2017, J BIOL CHEM, V292, P12667, DOI 10.1074/jbc.M117.777581; Yajima I, 2008, PIGM CELL MELANOMA R, V21, P471, DOI 10.1111/j.1755-148X.2008.00483.x	48	12	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14417	14428		10.1074/jbc.RA118.003729	http://dx.doi.org/10.1074/jbc.RA118.003729			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30076217	hybrid, Green Published			2022-12-28	WOS:000444671500021
J	You, XH; Guo, ZF; Cheng, F; Yi, B; Yang, F; Liu, XZ; Zhu, N; Zhao, XX; Yan, GJ; Ma, XL; Sun, JX				You, Xiaohua; Guo, Zhi-Fu; Cheng, Fang; Yi, Bing; Yang, Fan; Liu, Xinzhu; Zhu, Ni; Zhao, Xianxian; Yan, Guijun; Ma, Xin-Liang; Sun, Jianxin			Transcriptional up-regulation of relaxin-3 by Nur77 attenuates -adrenergic agonist-induced apoptosis in cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription factor; nuclear receptor; cardiomyocyte; apoptosis; relaxin; isoprenoid; Nur77; relaxin-3; beta-adrenergic receptor; transcriptional regulator; promoter	NUCLEAR RECEPTOR NUR77; ACUTE HEART-FAILURE; H3 RELAXIN; EXPRESSION; SERELAXIN; ACTIVATION; INJURY; NR4A1; GENE; HYPERTROPHY	The relaxin family peptides have been shown to exert several beneficial effects on the heart, including anti-apoptosis, anti-fibrosis, and anti-hypertrophy activity. Understanding their regulation might provide new opportunities for therapeutic interventions, but the molecular mechanism(s) coordinating relaxin expression in the heart remain largely obscured. Previous work demonstrated a role for the orphan nuclear receptor Nur77 in regulating cardiomyocyte apoptosis. We therefore investigated Nur77 in the hopes of identifying novel relaxin regulators. Quantitative real-time PCR (qRT-PCR) and enzyme-linked immunosorbent assay (ELISA) data indicated that ectopic expression of orphan nuclear receptor Nur77 markedly increased the expression of latexin-3 (RLN3), but not relaxin-1 (RLN1), in neonatal rat ventricular cardiomyocytes (NRVMs). Furthermore, we found that the -adrenergic agonist isoproterenol (ISO) markedly stimulated RLN3 expression, and this stimulation was significantly attenuated in Nur77 knockdown cardiomyocytes and Nur77 knockout hearts. We showed that Nur77 significantly increased RLN3 promoter activity via specific binding to the RLN3 promoter, as demonstrated by electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) assays. Furthermore, we found that Nur77 overexpression potently inhibited ISO-induced cardiomyocyte apoptosis, whereas this protective effect was significantly attenuated in RLN3 knockdown cardiomyocytes, suggesting that Nur77-induced RLN3 expression is an important mediator for the suppression of cardiomyocyte apoptosis. These findings show that Nur77 regulates RLN3 expression, therefore suppressing apoptosis in the heart, and suggest that activation of Nur77 may represent a useful therapeutic strategy for inhibition of cardiac fibrosis and heart failure.	[You, Xiaohua; Guo, Zhi-Fu; Zhu, Ni; Zhao, Xianxian; Sun, Jianxin] Second Mil Med Univ, Changhai Hosp, Dept Cardiol, Shanghai 200433, Peoples R China; [You, Xiaohua; Guo, Zhi-Fu; Cheng, Fang; Yi, Bing; Yang, Fan; Liu, Xinzhu; Ma, Xin-Liang; Sun, Jianxin] Thomas Jefferson Univ, Ctr Translat Med, 1020 Locust St, Philadelphia, PA 19107 USA; [Yan, Guijun] Nanjing Univ, Med Sch, Reprod Med Ctr, Affiliated Drum Tower Hosp, Nanjing 211166, Jiangsu, Peoples R China	Naval Medical University; Jefferson University; Nanjing University	Sun, JX (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, 1020 Locust St, Philadelphia, PA 19107 USA.	jianxin.sun@jefferson.edu	Zhu, Ni/AAU-7427-2021		National Institutes of Health [R01 HL103869, R01GM123047]; American Heart Association Established Investigator Award [16EIA27710023]; Chinese Natural Science Foundation [81370418]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator Award(American Heart Association); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 HL103869 and R01GM123047, American Heart Association Established Investigator Award 16EIA27710023, and Chinese Natural Science Foundation Grant 81370418 (to J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bathgate RAD, 2003, TRENDS ENDOCRIN MET, V14, P207, DOI 10.1016/S1043-2760(03)00081-X; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Bathgate RAD, 2006, BIOCHEMISTRY-US, V45, P1043, DOI 10.1021/bi052233e; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; Cheng ZK, 2011, EUR HEART J, V32, P2179, DOI 10.1093/eurheartj/ehq496; De Paoli F, 2015, ATHEROSCLEROSIS, V241, P18, DOI 10.1016/j.atherosclerosis.2015.04.798; Dschietzig T, 2001, FASEB J, V15, P2187, DOI 10.1096/fj.01-0070com; Fang Y, 2013, P NATL ACAD SCI USA, V110, P13416, DOI 10.1073/pnas.1309810110; Felker GM, 2014, J AM COLL CARDIOL, V64, P1591, DOI 10.1016/j.jacc.2014.05.071; Feng XJ, 2015, BRIT J PHARMACOL, V172, P2852, DOI 10.1111/bph.13091; Ghosh RK, 2017, CARDIOVASC THER, V35, P55, DOI 10.1111/1755-5922.12231; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hossain MA, 2011, BIOCHEMISTRY-US, V50, P1368, DOI 10.1021/bi1013968; Kamat AA, 2004, ENDOCRINOLOGY, V145, P4712, DOI 10.1210/en.2004-0515; McGowan BM, 2008, AM J PHYSIOL-ENDOC M, V295, pE278, DOI 10.1152/ajpendo.00028.2008; McGowan BM, 2006, REGUL PEPTIDES, V136, P72, DOI 10.1016/j.regpep.2006.04.009; McGowan BM, 2014, J ENDOCRINOL, V221, P337, DOI 10.1530/JOE-13-0603; McGowan BMC, 2005, ENDOCRINOLOGY, V146, P3295, DOI 10.1210/en.2004-1532; Medzikovic L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15404; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Myers SA, 2009, MOL CELL ENDOCRINOL, V309, P101, DOI 10.1016/j.mce.2009.05.006; Nistri Silvia, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P101, DOI 10.2174/187152507780363179; Nonhoff J, 2017, CARDIOVASC RES, V113, P598, DOI 10.1093/cvr/cvw245; Patil NA, 2017, BRIT J PHARMACOL, V174, P950, DOI 10.1111/bph.13684; Qin Q, 2014, J MOL CELL CARDIOL, V77, P20, DOI 10.1016/j.yjmcc.2014.09.027; Ranhotra HS, 2015, J RECEPT SIG TRANSD, V35, P184, DOI 10.3109/10799893.2014.948555; Samuel CS, 2006, PHARMACOL THERAPEUT, V112, P529, DOI 10.1016/j.pharmthera.2005.05.012; Samuel CS, 2014, HYPERTENSION, V64, P315, DOI 10.1161/HYPERTENSIONAHA.114.03594; Samuel CS, 2005, ANN NY ACAD SCI, V1041, P173, DOI 10.1196/annals.1282.025; Soloff MS, 2003, GENE, V323, P149, DOI 10.1016/j.gene.2003.09.015; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Teichman SL, 2009, HEART FAIL REV, V14, P321, DOI 10.1007/s10741-008-9129-3; van der Westhuizen ET, 2008, DRUG DISCOV TODAY, V13, P640, DOI 10.1016/j.drudis.2008.04.002; Wansa KDSA, 2002, J BIOL CHEM, V277, P33001, DOI 10.1074/jbc.M203572200; Wenzl K, 2015, CURR DRUG TARGETS, V16, P38, DOI 10.2174/1389450115666141120112818; Xie J, 2015, INT J CLIN EXP MED, V8, P4420; Yan GJ, 2015, MOL CELL BIOL, V35, P3312, DOI 10.1128/MCB.00229-15; You B, 2009, CIRC RES, V104, P742, DOI 10.1161/CIRCRESAHA.108.192286; Zhang J, 2005, PEPTIDES, V26, P1632, DOI 10.1016/j.peptides.2005.02.008; Zhang XH, 2018, J CELL MOL MED, V22, P1816, DOI 10.1111/jcmm.13464; Zhang XH, 2017, CELL PHYSIOL BIOCHEM, V43, P1311, DOI 10.1159/000481843; Zhang XH, 2015, BIOCHIMIE, V108, P59, DOI 10.1016/j.biochi.2014.11.004; Zhao Yue, 2009, Drug Discov Today Dis Mech, V6, pe43	44	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14001	14011		10.1074/jbc.RA118.003099	http://dx.doi.org/10.1074/jbc.RA118.003099			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30006349	Green Published, hybrid			2022-12-28	WOS:000444070700024
J	Bava, SV; Puliyappadamba, VT; Deepti, A; Nair, A; Karunagaran, D; Anto, RJ				Bava, Smitha V.; Puliyappadamba, Vineshkumar T.; Deepti, Ayswaria; Nair, Asha; Karunagaran, Devarajan; Anto, Ruby John			Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor- B and the serine/threonine kinase Akt and is independent of tubulin polymerization (vol 280, pg 6301, 2005)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Bava SV, 2005, J BIOL CHEM, V280, P6301, DOI 10.1074/jbc.M410647200	1	5	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12283	12283		10.1074/jbc.AAC118.004745	http://dx.doi.org/10.1074/jbc.AAC118.004745			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	30076255	Green Published, hybrid			2022-12-28	WOS:000440803200025
J	Umate, P; Schwenkert, S; Karbat, I; Bosco, CD; Mlcochova, L; Volz, S; Zer, H; Herrmann, RG; Ohad, I; Meurer, J				Umate, Pavan; Schwenkert, Serena; Karbat, Izhar; Bosco, Cristina Dal; Mlcochova, Lada; Volz, Stefanie; Zer, Hagit; Herrmann, Reinhold G.; Ohad, Itzhak; Meurer, Joerg			Deletion of PsbM in tobacco alters the Q(B) site properties and the electron flow within photosystem II (vol 282, pg 9758, 2007)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Umate P, 2007, J BIOL CHEM, V282, P9758, DOI 10.1074/jbc.M608117200	1	1	1	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11649	11649		10.1074/jbc.AAC118.004608	http://dx.doi.org/10.1074/jbc.AAC118.004608			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	30030384	hybrid, Green Published			2022-12-28	WOS:000439449700033
J	Hohlweg, W; Wagner, GE; Hofbauer, HF; Sarkleti, F; Setz, M; Gubensak, N; Lichtenegger, S; Falsone, SF; Wolinski, H; Kosol, S; Oostenbrink, C; Kohlwein, SD; Zangger, K				Hohlweg, Walter; Wagner, Gabriel E.; Hofbauer, Harald F.; Sarkleti, Florian; Setz, Martina; Guebensak, Nina; Lichtenegger, Sabine; Falsone, Salvatore Fabio; Wolinski, Heimo; Kosol, Simone; Oostenbrink, Chris; Kohlwein, Sepp D.; Zangger, Klaus			A cation-pi interaction in a transmembrane helix of vacuolar ATPase retains the proton-transporting arginine in a hydrophobic environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST V-ATPASE; MEMBRANE-BOUND PEPTIDES; MOLECULAR-DYNAMICS; RELAXATION ENHANCEMENTS; PROTEIN; SUBUNIT; IDENTIFICATION; RESIDUES; SYSTEM; ACIDIFICATION	Vacuolar ATPases are multisubunit protein complexes that are indispensable for acidification and pH homeostasis in a variety of physiological processes in all eukaryotic cells. An arginine residue (Arg(735)) in transmembrane helix 7 (TM7) of subunit a of the yeast ATPase is known to be essential for proton translocation. However, the specific mechanism of its involvement in proton transport remains to be determined. Arginine residues are usually assumed to "snorkel" toward the protein surface when exposed to a hydrophobic environment. Here, using solution NMR spectroscopy, molecular dynamics simulations, and in vivo yeast assays, we obtained evidence for the formation of a transient, membrane-embedded cation-pi interaction in TM7 between Arg(735) and two highly conserved nearby aromatic residues, Tyr(733) and Trp(737). We propose a mechanism by which the transient, membrane-embedded cation-pi complex provides the necessary energy to keep the charged side chain of Arg(735) within the hydrophobic membrane. Such cation-pi interactions may define a general mechanism to retain charged amino acids in a hydrophobic membrane environment.	[Hohlweg, Walter; Guebensak, Nina; Zangger, Klaus] Karl Franzens Univ Graz, Inst Chem, Heinrichstr 28, A-8010 Graz, Austria; [Falsone, Salvatore Fabio] Karl Franzens Univ Graz, Inst Pharmaceut Sci, A-8010 Graz, Austria; [Wagner, Gabriel E.; Lichtenegger, Sabine] Med Univ Graz, Inst Hyg Microbiol & Environm Med, A-8010 Graz, Austria; [Hofbauer, Harald F.; Sarkleti, Florian; Wolinski, Heimo; Kohlwein, Sepp D.] Karl Franzens Univ Graz, BioTechMed Graz, Inst Mol Biosci, A-8010 Graz, Austria; [Setz, Martina; Oostenbrink, Chris] Univ Nat Resources & Life Sci, Inst Mol Modeling & Simulat, A-1190 Vienna, Austria; [Kosol, Simone] Univ Warwick, Dept Chem, Gibbet Hill, Coventry CV4 7AL, W Midlands, England	University of Graz; University of Graz; Medical University of Graz; University of Graz; University of Natural Resources & Life Sciences, Vienna; University of Warwick	Zangger, K (corresponding author), Karl Franzens Univ Graz, Inst Chem, Heinrichstr 28, A-8010 Graz, Austria.	klaus.zangger@uni-graz.at	Oostenbrink, Chris/S-8002-2019; Wagner, Gabriel E./AAB-9433-2022	Oostenbrink, Chris/0000-0002-4232-2556; Wagner, Gabriel E./0000-0002-5704-3955; Falsone, Salvatore Fabio/0000-0002-3724-5824; Hofbauer, Harald F./0000-0003-2617-5901; Wolinski, Heimo/0000-0002-1583-6092; Kosol, Simone/0000-0001-7913-4818	Austrian Science Funds (FWF) DK Molecular Enzymology [W901]; Erwin Schrodinger Fellowship [J3987B21, P25880]; SFB LIPOTOX [F3005]; NAWI Graz	Austrian Science Funds (FWF) DK Molecular Enzymology(Austrian Science Fund (FWF)); Erwin Schrodinger Fellowship; SFB LIPOTOX(German Research Foundation (DFG)); NAWI Graz	This work was supported by Austrian Science Funds (FWF) DK Molecular Enzymology W901 (to Z. K. and S. D. K.), Erwin Schrodinger Fellowship J3987B21 (to H. F. H.), project P25880 (to Z. K.), and SFB LIPOTOX (F3005) (to S. D. K.) and by NAWI Graz. The authors declare that they have no conflicts of interest with the contents of this article.	Aliste MP, 2003, BIOCHEMISTRY-US, V42, P8976, DOI 10.1021/bi027001j; Baerends RJS, 2000, J BIOL CHEM, V275, P9986, DOI 10.1074/jbc.275.14.9986; Bagh MB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14612; Benlekbir S, 2012, NAT STRUCT MOL BIOL, V19, P1356, DOI 10.1038/nsmb.2422; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capecci J, 2013, J BIOL CHEM, V288, P32731, DOI 10.1074/jbc.M113.503771; Carra JH, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-72; Chen YC, 2017, J AM CHEM SOC, V139, P639, DOI 10.1021/jacs.6b12511; Chene P, 2002, NAT REV DRUG DISCOV, V1, P665, DOI 10.1038/nrd894; Chipot C, 1996, J AM CHEM SOC, V118, P11217, DOI 10.1021/ja961379l; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Craven TW, 2016, J AM CHEM SOC, V138, P1543, DOI 10.1021/jacs.5b10285; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dorairaj S, 2007, P NATL ACAD SCI USA, V104, P4943, DOI 10.1073/pnas.0610470104; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dougherty DA, 2013, ACCOUNTS CHEM RES, V46, P885, DOI 10.1021/ar300265y; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Franzmann M, 2009, CHEMBIOCHEM, V10, P2339, DOI 10.1002/cbic.200900347; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gong Z, 2017, ANGEW CHEM INT EDIT, V56, P1002, DOI 10.1002/anie.201609830; Gromiha MM, 2005, INT J BIOL MACROMOL, V35, P55, DOI 10.1016/j.ijbiomac.2004.12.001; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Hamm HE, 2009, PROTEIN SCI, V18, P2326, DOI 10.1002/pro.243; Hartlmuller C, 2016, ANGEW CHEM INT EDIT, V55, P11970, DOI 10.1002/anie.201604788; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hesselink RW, 2005, BBA-BIOMEMBRANES, V1716, P137, DOI 10.1016/j.bbamem.2005.08.010; Hiasa M, 2017, CANCER RES, V77, P1283, DOI 10.1158/0008-5472.CAN-15-3545; Hocking HG, 2013, CHEMPHYSCHEM, V14, P3082, DOI 10.1002/cphc.201300219; Imamura H, 2005, P NATL ACAD SCI USA, V102, P17929, DOI 10.1073/pnas.0507764102; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson M., 2008, NUCLEIC ACIDS RES, V36, P9, DOI DOI 10.1093/NAR/GICN201; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Liu Q, 1997, J BIOL CHEM, V272, P11750, DOI 10.1074/jbc.272.18.11750; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Madl T, 2009, ANGEW CHEM INT EDIT, V48, P8259, DOI 10.1002/anie.200902561; Mahadevi AS, 2013, CHEM REV, V113, P2100, DOI 10.1021/cr300222d; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Mazhab-Jafari MT, 2016, NATURE, V539, P118, DOI 10.1038/nature19828; Miles AL, 2017, ELIFE, V6, DOI 10.7554/eLife.22693; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Murail S, 2017, METHODS MOL BIOL, V1635, P359, DOI 10.1007/978-1-4939-7151-0_20; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Nagy G, 2014, J CHEM INF MODEL, V54, P266, DOI 10.1021/ci400541d; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Peter B, 2014, BIOCHEMISTRY-US, V53, P57, DOI 10.1021/bi401433f; Pinheiro S, 2017, PHYS CHEM CHEM PHYS, V19, P9849, DOI 10.1039/c6cp08448f; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; Rawson S, 2015, STRUCTURE, V23, P461, DOI 10.1016/j.str.2014.12.016; Reif MM, 2012, J CHEM THEORY COMPUT, V8, P3705, DOI 10.1021/ct300156h; Respondek M, 2007, J AM CHEM SOC, V129, P5228, DOI 10.1021/ja069004f; Roh SH, 2018, MOL CELL, V69, P993, DOI 10.1016/j.molcel.2018.02.006; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sambade M, 2005, GENETICS, V170, P1539, DOI 10.1534/genetics.105.042812; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmid N, 2012, COMPUT PHYS COMMUN, V183, P890, DOI 10.1016/j.cpc.2011.12.014; Schrank E, 2013, MOLECULES, V18, P7407, DOI 10.3390/molecules18077407; Schulze S, 2010, NATURE, V467, P233, DOI 10.1038/nature09310; Strandberg E, 2002, BIOCHEMISTRY-US, V41, P7190, DOI 10.1021/bi012047i; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; Toei M, 2011, J BIOL CHEM, V286, P35176, DOI 10.1074/jbc.M111.273409; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; TORDA AE, 1989, CHEM PHYS LETT, V157, P289, DOI 10.1016/0009-2614(89)87249-5; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wang YR, 2004, J BIOL CHEM, V279, P44628, DOI 10.1074/jbc.M407345200; Wolinski Heimo, 2008, V457, P151, DOI 10.1007/978-1-59745-261-8_11; Zangger K, 2009, J PHYS CHEM B, V113, P4400, DOI 10.1021/jp808501x	77	4	4	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18977	18988		10.1074/jbc.RA118.005276	http://dx.doi.org/10.1074/jbc.RA118.005276			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30209131	hybrid, Green Published			2022-12-28	WOS:000458467400013
J	Park, MH; Wolff, EC				Park, Myung Hee; Wolff, Edith C.			Hypusine, a polyamine-derived amino acid critical for eukaryotic translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							INITIATION-FACTOR 5A; ELONGATION-FACTOR-P; HUMAN DEOXYHYPUSINE SYNTHASE; CRYSTAL-STRUCTURE; PROTEIN-SYNTHESIS; EF-P; POSTTRANSLATIONAL MODIFICATION; CELL VIABILITY; FACTOR EIF5A; SACCHAROMYCES-CEREVISIAE	The natural amino acid hypusine (N-is an element of-4-amino-2-hydroxybutyl( lysine)) is derived from the polyamine spermidine, and occurs only in a single family of cellular proteins, eukaryotic translation factor 5A (eIF5A) isoforms. Hypusine is formed by conjugation of the aminobutyl moiety of spermidine to a specific lysine residue of this protein. The posttranslational synthesis of hypusine involves two enzymatic steps, catalyzed by deoxyhypusine synthase (DHPS) and deoxyhypusine hydroxylase (DOHH). Hypusine is essential for eIF5A activity. Inactivation of either the eIF5A or the DHPS gene is lethal in yeast and mouse, underscoring the vital role of eIF5A hypusination in eukaryotic cell growth and animal development. The long and basic side chain of the hypusine residue promotes eIF5A-mediated translation elongation by facilitating peptide bond formation at polyproline stretches and at many other ribosome-pausing sites. It also enhances translation termination by stimulating peptide release. By promoting translation, the hypusine modification of eIF5A provides a key link between polyamines and cell growth regulation. eIF5A has been implicated in several human pathological conditions. Recent genetic data suggest that eIF5A haploinsufficiency or impaired deoxyhypusine synthase activity is associated with neurodevelopmental disorders in humans.	[Park, Myung Hee; Wolff, Edith C.] NIDCR, NIH, Bldg 30,Rm 3A300,30 Convent Dr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Park, MH (corresponding author), NIDCR, NIH, Bldg 30,Rm 3A300,30 Convent Dr, Bethesda, MD 20892 USA.	mhpark@nih.gov			intramural program of NIDCR, National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000608] Funding Source: NIH RePORTER	intramural program of NIDCR, National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the intramural program of NIDCR, National Institutes of Health. This article is part of a series on "Polyamines," written in honor of Dr. Herbert Tabor's 100th birthday. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABBRUZZESE A, 1986, J BIOL CHEM, V261, P3085; Aksu M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11952; BARTIG D, 1990, SYST APPL MICROBIOL, V13, P112, DOI 10.1016/S0723-2020(11)80156-6; BENNE R, 1978, J BIOL CHEM, V253, P3070; Bullwinkle TJ, 2013, J BIOL CHEM, V288, P4416, DOI 10.1074/jbc.M112.438879; BYERS TL, 1992, BIOCHEM J, V287, P717, DOI 10.1042/bj2870717; BYERS TL, 1994, BIOCHEM J, V303, P363, DOI 10.1042/bj3030363; Cano VSP, 2008, FEBS J, V275, P44, DOI 10.1111/j.1742-4658.2007.06172.x; Chattopadhyay MK, 2008, P NATL ACAD SCI USA, V105, P6554, DOI 10.1073/pnas.0710970105; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P13869, DOI 10.1073/pnas.1835918100; Chattopadhyay MK, 2002, P NATL ACAD SCI USA, V99, P10330, DOI 10.1073/pnas.162362899; Chen ZP, 1997, CANCER LETT, V115, P235, DOI 10.1016/S0304-3835(97)04741-1; Clement PMJ, 2003, EUR J BIOCHEM, V270, P4254, DOI 10.1046/j.1432-1033.2003.03806.x; COOPER HL, 1983, P NATL ACAD SCI-BIOL, V80, P1854, DOI 10.1073/pnas.80.7.1854; COOPER HL, 1982, CELL, V29, P791, DOI 10.1016/0092-8674(82)90441-X; Dever TE, 2014, CRIT REV BIOCHEM MOL, V49, P413, DOI 10.3109/10409238.2014.939608; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; GERNER EW, 1986, BIOCHEM J, V239, P379, DOI 10.1042/bj2390379; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Gregio APB, 2009, BIOCHEM BIOPH RES CO, V380, P785, DOI 10.1016/j.bbrc.2009.01.148; Guan XY, 2001, CANCER RES, V61, P3806; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Han ZG, 2015, STRUCTURE, V23, P882, DOI 10.1016/j.str.2015.03.002; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; Hoque M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-90; Hyvonen MT, 2007, J BIOL CHEM, V282, P34700, DOI 10.1074/jbc.M704282200; Igarashi K, 2015, IUBMB LIFE, V67, P160, DOI 10.1002/iub.1363; IMAOKA N, 1973, BIOCHIM BIOPHYS ACTA, V320, P97, DOI 10.1016/0304-4165(73)90170-0; JAKUS J, 1993, J BIOL CHEM, V268, P13151; Jasiulionis MG, 2007, CELL BIOCHEM FUNCT, V25, P109, DOI 10.1002/cbf.1351; Jasniewski AJ, 2016, J BIOL INORG CHEM, V21, P605, DOI 10.1007/s00775-016-1373-8; Jenkins ZA, 2001, GENOMICS, V71, P101, DOI 10.1006/geno.2000.6418; JOE YA, 1994, J BIOL CHEM, V269, P25916; JOE YA, 1995, J BIOL CHEM, V270, P22386, DOI 10.1074/jbc.270.38.22386; Kang KR, 2007, J BIOL CHEM, V282, P8300, DOI 10.1074/jbc.M607495200; Kapur M, 2018, TRENDS GENET, V34, P218, DOI 10.1016/j.tig.2017.12.007; KEMPER WM, 1976, J BIOL CHEM, V251, P5551; Kim KK, 1998, P NATL ACAD SCI USA, V95, P10419, DOI 10.1073/pnas.95.18.10419; Kim YS, 2006, J BIOL CHEM, V281, P13217, DOI 10.1074/jbc.M601081200; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P224, DOI 10.1073/pnas.95.1.224; Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419; Lassak J, 2016, MOL MICROBIOL, V99, P219, DOI 10.1111/mmi.13233; Lee GH, 2001, BIOCHEM J, V355, P841, DOI 10.1042/bj3550841; Lee SB, 2009, BIOCHEM BIOPH RES CO, V383, P497, DOI 10.1016/j.bbrc.2009.04.049; Lee YB, 1999, BIOCHEM J, V340, P273, DOI 10.1042/0264-6021:3400273; Liao DI, 1998, STRUCTURE, V6, P23, DOI 10.1016/S0969-2126(98)00004-5; Maier B, 2010, DISCOV MED, V10, P18; Mandal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111800; Mandal S, 2013, P NATL ACAD SCI USA, V110, P2169, DOI 10.1073/pnas.1219002110; Mathews MB, 2015, BBA-GENE REGUL MECH, V1849, P836, DOI 10.1016/j.bbagrm.2015.05.002; Melnikov S, 2016, J MOL BIOL, V428, P3570, DOI 10.1016/j.jmb.2016.05.011; Memin E, 2014, CANCER RES, V74, P552, DOI 10.1158/0008-5472.CAN-13-0474; NAKAJIMA T, 1971, BIOCHIM BIOPHYS ACTA, V252, P92, DOI 10.1016/0304-4165(71)90095-X; Nakanishi S, 2016, AMINO ACIDS, V48, P2353, DOI 10.1007/s00726-016-2275-3; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477; Nishimura K, 2012, AMINO ACIDS, V42, P703, DOI 10.1007/s00726-011-0986-z; Ober D, 1999, J BIOL CHEM, V274, P32040, DOI 10.1074/jbc.274.45.32040; Olsen ME, 2017, DNA CELL BIOL, V36, P198, DOI 10.1089/dna.2016.3611; Park JH, 2006, P NATL ACAD SCI USA, V103, P51, DOI 10.1073/pnas.0509348102; Park JH, 2003, J BIOL CHEM, V278, P32683, DOI 10.1074/jbc.M304247200; Park JH, 2012, J BIOL CHEM, V287, P2579, DOI 10.1074/jbc.M111.309633; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; Park MH, 1998, J BIOL CHEM, V273, P1677, DOI 10.1074/jbc.273.3.1677; PARK MH, 1982, J BIOL CHEM, V257, P7217; PARK MH, 1994, J BIOL CHEM, V269, P27827; PARK MH, 1989, J BIOL CHEM, V264, P18531; PARK MH, 1991, J BIOL CHEM, V266, P7988; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Park MH, 2017, AMINO ACIDS, V49, P1793, DOI 10.1007/s00726-017-2477-3; Patel PH, 2009, J CELL BIOL, V185, P1181, DOI 10.1083/jcb.200904161; Pegg AE, 2016, J BIOL CHEM, V291, P14904, DOI 10.1074/jbc.R116.731661; Pegg AE, 2011, METHODS MOL BIOL, V720, P3, DOI 10.1007/978-1-61779-034-8_1; Pelechano V, 2017, NUCLEIC ACIDS RES, V45, P7326, DOI 10.1093/nar/gkx479; Rossi D, 2014, WIRES RNA, V5, P209, DOI 10.1002/wrna.1211; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sasaki K, 1996, FEBS LETT, V384, P151, DOI 10.1016/0014-5793(96)00310-9; Schmidt C, 2016, NUCLEIC ACIDS RES, V44, P1944, DOI 10.1093/nar/gkv1517; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; Schuller AP, 2017, MOL CELL, V66, P194, DOI 10.1016/j.molcel.2017.03.003; Schultz CR, 2018, BIOCHEM J, V475, P531, DOI 10.1042/BCJ20170597; SHIBA T, 1971, BIOCHIM BIOPHYS ACTA, V244, P523, DOI 10.1016/0304-4165(71)90069-9; Sievert H, 2014, DIS MODEL MECH, V7, P963, DOI 10.1242/dmm.014449; SMITMCBRIDE Z, 1989, J BIOL CHEM, V264, P18527; Sugimoto A, 2004, DIFFERENTIATION, V72, P81, DOI 10.1111/j.1432-0436.2004.07202004.x; Nguyen S, 2015, J BIOL CHEM, V290, P19987, DOI 10.1074/jbc.M115.656785; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Thompson GM, 2003, FEBS LETT, V555, P464, DOI 10.1016/S0014-5793(03)01305-X; Tong YF, 2009, PROTEINS, V75, P1040, DOI 10.1002/prot.22378; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Umland TC, 2004, J BIOL CHEM, V279, P28697, DOI 10.1074/jbc.M404095200; Vu VV, 2009, P NATL ACAD SCI USA, V106, P14814, DOI 10.1073/pnas.0904553106; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0; WOLFF EC, 1995, J BIOL CHEM, V270, P8660, DOI 10.1074/jbc.270.15.8660; Wolff EC, 1997, J BIOL CHEM, V272, P15865, DOI 10.1074/jbc.272.25.15865; Wolff EC, 2000, J BIOL CHEM, V275, P9170, DOI 10.1074/jbc.275.13.9170; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Zeesman S, 2012, AM J MED GENET A, V158A, P1832, DOI 10.1002/ajmg.a.35508	99	70	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18710	18718		10.1074/jbc.TM118.003341	http://dx.doi.org/10.1074/jbc.TM118.003341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30257869	Green Published, hybrid			2022-12-28	WOS:000458467300026
J	Boetefuer, EL; Lake, RJ; Dreval, K; Fan, HY				Boetefuer, Erica L.; Lake, Robert J.; Dreval, Kostiantyn; Fan, Hua-Ying			Poly(ADP-ribose) polymerase 1 (PARP1) promotes oxidative stress-induced association of Cockayne syndrome group B protein with chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						base-excision repair (BER); oxidative stress; DNA repair; reactive oxygen species (ROS); transcription regulation; chromatin; ATP-dependent chromatin remodeling; Cockayne syndrome protein; CSB; PARP1; single-strand DNA repair	BASE EXCISION-REPAIR; STRAND BREAK REPAIR; DNA-REPAIR; XERODERMA-PIGMENTOSUM; PRIMARY FIBROBLASTS; CELLULAR REPAIR; COUPLING FACTOR; GENE-PRODUCT; DHFR GENE; TRANSCRIPTION	Cockayne syndrome protein B (CSB) is an ATP-dependent chromatin remodeler that relieves oxidative stress by regulating DNA repair and transcription. CSB is proposed to participate in base-excision repair (BER), the primary pathway for repairing oxidative DNA damage, but exactly how CSB participates in this process is unknown. It is also unclear whether CSB contributes to other repair pathways during oxidative stress. Here, using a patient-derived CS1AN-sv cell line, we examined how CSB is targeted to chromatin in response to menadione-induced oxidative stress, both globally and locus-specifically. We found that menadione-induced, global CSB-chromatin association does not require CSB's ATPase activity and is, therefore, mechanistically distinct from UV-induced CSB-chromatin association. Importantly, poly(ADP-ribose) polymerase 1 (PARP1) enhanced the kinetics of global menadione-induced CSB-chromatin association. We found that the major BER enzymes, 8-oxoguanine DNA glycosylase (OGG1) and apurinic/apyrimidinic endodeoxyribonuclease 1 (APE1), do not influence this association. Additionally, the level of -H2A histone family member X (-H2AX), a marker for dsDNA breaks, was not increased in menadione-treated cells. Therefore, our results support a model whereby PARP1 localizes to ssDNA breaks and recruits CSB to participate in DNA repair. Furthermore, this global CSB-chromatin association occurred independently of RNA polymerase II-mediated transcription elongation. However, unlike global CSB-chromatin association, both PARP1 knockdown and inhibition of transcription elongation interfered with menadione-induced CSB recruitment to specific genomic regions. This observation supports the hypothesis that CSB is also targeted to specific genomic loci to participate in transcriptional regulation in response to oxidative stress.	[Boetefuer, Erica L.; Lake, Robert J.; Dreval, Kostiantyn; Fan, Hua-Ying] Univ New Mexico, Dept Internal Med, Div Mol Med, Program Canc Genet Epigenet & Genom,Comprehens Ca, Albuquerque, NM 87131 USA; [Boetefuer, Erica L.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of New Mexico; University of Pennsylvania	Fan, HY (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Albuquerque, NM 87131 USA.	hufan@salud.unm.edu		Fan, Hua-Ying/0000-0003-1790-4041; Dreval, Kostiantyn/0000-0002-6214-2843	National Institutes of Health [GM115888, T32 GM-07229]; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115888, T32GM007229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM115888 (to H. Y. F.) and T32 GM-07229 (to E. L. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbotts R, 2017, FREE RADICAL BIO MED, V107, P228, DOI 10.1016/j.freeradbiomed.2016.11.039; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Aherne SA, 2000, FREE RADICAL BIO MED, V29, P507, DOI 10.1016/S0891-5849(00)00360-9; Balajee AS, 1997, P NATL ACAD SCI USA, V94, P4306, DOI 10.1073/pnas.94.9.4306; Boetefuer EL, 2018, NUCLEIC ACIDS RES, V46, P7471, DOI 10.1093/nar/gky660; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; BRYANT PE, 1984, MUTAT RES, V131, P19, DOI 10.1016/0167-8817(84)90043-9; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; Cho I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003407; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Dianov G, 1999, NUCLEIC ACIDS RES, V27, P1365, DOI 10.1093/nar/27.5.1365; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Gibson BA, 2016, SCIENCE, V353, P45, DOI 10.1126/science.aaf7865; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hanzlikova H, 2017, NUCLEIC ACIDS RES, V45, P2546, DOI 10.1093/nar/gkw1246; Khobta A, 2013, MECH AGEING DEV, V134, P253, DOI 10.1016/j.mad.2013.03.001; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kyng KJ, 2003, ONCOGENE, V22, P1135, DOI 10.1038/sj.onc.1206187; Lake RJ, 2016, NUCLEIC ACIDS RES, V44, P2125, DOI 10.1093/nar/gkv1219; Lake RJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004284; Lake RJ, 2010, MOL CELL, V37, P235, DOI 10.1016/j.molcel.2009.10.027; LAUTIER D, 1993, MOL CELL BIOCHEM, V122, P171, DOI 10.1007/BF01076101; LEHMANN AR, 1982, MUTAT RES, V106, P347, DOI 10.1016/0027-5107(82)90115-4; Luijsterburg MS, 2016, MOL CELL, V61, P547, DOI 10.1016/j.molcel.2016.01.019; Ma WJ, 2012, P NATL ACAD SCI USA, V109, P6590, DOI 10.1073/pnas.1118078109; MAYNE LV, 1982, CANCER RES, V42, P1473; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Menoni H, 2012, J CELL BIOL, V199, P1037, DOI 10.1083/jcb.201205149; Muftuoglu M, 2009, J BIOL CHEM, V284, P9270, DOI 10.1074/jbc.M807006200; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Newman JC, 2006, P NATL ACAD SCI USA, V103, P9613, DOI 10.1073/pnas.0510909103; Parsons JL, 2005, FEBS J, V272, P2012, DOI 10.1111/j.1742-4658.2005.04628.x; Pascucci B, 2012, AGING CELL, V11, P520, DOI 10.1111/j.1474-9726.2012.00815.x; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Scheibye-Knudsen M, 2014, CELL METAB, V20, P840, DOI 10.1016/j.cmet.2014.10.005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Smeenk G, 2013, J CELL SCI, V126, P889, DOI 10.1242/jcs.109413; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; Thorslund T, 2005, MOL CELL BIOL, V25, P7625, DOI 10.1128/MCB.25.17.7625-7636.2005; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; TROELSTRA C, 1990, MOL CELL BIOL, V10, P5806, DOI 10.1128/MCB.10.11.5806; Tuo J, 2001, J BIOL CHEM, V276, P45772, DOI 10.1074/jbc.M107888200; Tuo JS, 2003, FASEB J, V17, P668, DOI 10.1096/fj.02-0851com; Tuo JS, 2002, J BIOL CHEM, V277, P30832, DOI 10.1074/jbc.M204814200; Tuo JS, 2002, DNA REPAIR, V1, P913, DOI 10.1016/S1568-7864(02)00116-7; vanGool AJ, 1997, EMBO J, V16, P4155, DOI 10.1093/emboj/16.14.4155; VENEMA J, 1990, NUCLEIC ACIDS RES, V18, P443, DOI 10.1093/nar/18.3.443; Wong HK, 2007, NUCLEIC ACIDS RES, V35, P4103, DOI 10.1093/nar/gkm404; Wu PK, 2017, STEM CELL TRANSL MED, V6, P1504, DOI 10.1002/sctm.15-0394; Zhao HL, 2015, MOL CELL, V59, P984, DOI 10.1016/j.molcel.2015.07.019	56	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17863	17874		10.1074/jbc.RA118.004548	http://dx.doi.org/10.1074/jbc.RA118.004548			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30266807	Green Published, hybrid			2022-12-28	WOS:000450409500017
J	Fu, JJ; Dang, YK; Counter, C; Liu, Y				Fu, Jingjing; Dang, Yunkun; Counter, Christopher; Liu, Yi			Codon usage regulates human KRAS expression at both transcriptional and translational levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase Kras (KRAS); transcription; translation; oncogene; chromatin regulation; C content; codon optimization; codon usage bias; oncogenesis; protein folding	MESSENGER-RNA STABILITY; GENE AMPLIFICATION; PROTEIN EXPRESSION; SYNONYMOUS CODONS; ADAPTATION INDEX; POLYMERASE-II; RAS; DROSOPHILA; ELONGATION; SELECTION	KRAS and HRAS are highly homologous oncogenic Ras GTPase family members that are mutated in a wide spectrum of human cancers. Despite having high amino acid identity, KRAS and HRAS have very different codon usage biases: the HRAS gene contains many common codons, and KRAS is enriched for rare codons. Rare codons in KRAS suppress its protein expression, which has been shown to affect both normal and cancer biology in mammals. Here, using HRAS or KRAS expression in different human cell lines and in vitro transcription and translation assays, we show that KRAS rare codons inhibit both translation efficiency and transcription and that the contribution of these two processes varies among different cell lines. We observed that codon usage regulates mRNA translation efficiency such that WT KRAS mRNA is poorly translated. On the other hand, common codons increased transcriptional rates by promoting activating histone modifications and recruitment of transcriptional coactivators. Finally, we found that codon usage also influences KRAS protein conformation, likely because of its effect on co-translational protein folding. Together, our results reveal that codon usage has multidimensional effects on protein expression, ranging from effects on transcription to protein folding in human cells.	[Fu, Jingjing; Liu, Yi] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75235 USA; [Dang, Yunkun] Yunnan Univ, State Key Lab Conservat & Utilizat Bioresources, Sch Life Sci, Kunming 650500, Yunnan, Peoples R China; [Dang, Yunkun] Yunnan Univ, Ctr Life Sci, Sch Life Sci, Kunming 650500, Yunnan, Peoples R China; [Counter, Christopher] Duke Univ, Dept Pharmacol & Canc Biol, Sch Med, Durham, NC 27708 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Yunnan University; Yunnan University; Duke University	Liu, Y (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Yi.Liu@UTsouthwestern.edu		Liu, Yi/0000-0002-8801-9317; Fu, Jingjing/0000-0001-6502-321X; Counter, Christopher M/0000-0003-0748-3079	National Institutes of Health [1R35GM118118, R01CA94184, P01CA203657]; Cancer Prevention and Research Institute of Texas Grant [RP160268]; Welch Foundation [I-1560]; NATIONAL CANCER INSTITUTE [R01CA094184, P01CA203657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas Grant; Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R35GM118118, Cancer Prevention and Research Institute of Texas Grant RP160268, Welch Foundation Grant I-1560 (to Y. L.), and National Institutes of Health Grants R01CA94184 and P01CA203657 (to C. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKASHI H, 1994, GENETICS, V136, P927; Ali M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15617; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bazzini AA, 2016, EMBO J, V35, P2087, DOI 10.15252/embj.201694699; Birkeland E, 2012, BRIT J CANCER, V107, P1997, DOI 10.1038/bjc.2012.477; Boel G, 2016, NATURE, V529, P358, DOI 10.1038/nature16509; Buhr F, 2016, MOL CELL, V61, P341, DOI 10.1016/j.molcel.2016.01.008; Carlini DB, 2003, GENETICS, V163, P239; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cox Adrienne D, 2010, Small GTPases, V1, P2; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; FIORUCCI G, 1988, BIOCHIM BIOPHYS ACTA, V950, P81, DOI 10.1016/0167-4781(88)90076-0; Friberg M, 2004, YEAST, V21, P1083, DOI 10.1002/yea.1150; Fu JJ, 2016, GENE DEV, V30, P1761, DOI 10.1101/gad.281030.116; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Kim SJ, 2015, SCIENCE, V348, P444, DOI 10.1126/science.aaa3974; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kirchner S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000779; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krinner S, 2014, NUCLEIC ACIDS RES, V42, P3551, DOI 10.1093/nar/gkt1358; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Lampson BL, 2013, CURR BIOL, V23, P70, DOI 10.1016/j.cub.2012.11.031; Lazrak A, 2013, FASEB J, V27, P4630, DOI 10.1096/fj.13-227330; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Mallon S, 2012, P NATL ACAD SCI USA, V109, pE3549, DOI 10.1073/pnas.1218783109; McCarthy C, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3609-6; Mishima Y, 2016, MOL CELL, V61, P874, DOI 10.1016/j.molcel.2016.02.027; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Newman ZR, 2016, P NATL ACAD SCI USA, V113, pE1362, DOI 10.1073/pnas.1518976113; Pechmann S, 2014, NAT STRUCT MOL BIOL, V21, P1100, DOI 10.1038/nsmb.2919; Pershing NLK, 2015, J CLIN INVEST, V125, P222, DOI 10.1172/JCI77627; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Radhakrishnan A, 2016, CELL, V167, P122, DOI 10.1016/j.cell.2016.08.053; Sander IM, 2014, J AM CHEM SOC, V136, P858, DOI 10.1021/ja411302m; Sasine J. P., 2018, J CLIN INVEST INSIGH, V3; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Valtorta E, 2013, INT J CANCER, V133, P1259, DOI 10.1002/ijc.28106; Weinberg DE, 2016, CELL REP, V14, P1787, DOI 10.1016/j.celrep.2016.01.043; Wu C, 2007, METHOD ENZYMOL, V429, P203, DOI 10.1016/S0076-6879(07)29010-X; Yu CH, 2015, MOL CELL, V59, P744, DOI 10.1016/j.molcel.2015.07.018; Zhao F, 2017, NUCLEIC ACIDS RES, V45, P8484, DOI 10.1093/nar/gkx501; Zhou M, 2015, MOL MICROBIOL, V97, P974, DOI 10.1111/mmi.13079; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833; Zhou ZP, 2018, ELIFE, V7, DOI [10.7554/eLife.33569.001, 10.7554/eLife.33569]; Zhou ZP, 2016, P NATL ACAD SCI USA, V113, pE6117, DOI 10.1073/pnas.1606724113	65	28	30	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17929	17940		10.1074/jbc.RA118.004908	http://dx.doi.org/10.1074/jbc.RA118.004908			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30275015	Green Published, hybrid			2022-12-28	WOS:000450409500022
J	Sherer, LA; Zweifel, ME; Courtemanche, N				Sherer, Laura A.; Zweifel, Mark E.; Courtemanche, Naomi			Dissection of two parallel pathways for formin-mediated actin filament elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						formin; actin; profilin; fluorescence; cytoskeleton; actin polymerization; Bni1; Cdc12; formin homology domain; TIRF microscopy	FISSION YEAST; HOMOLOGY-2 DOMAIN; CELL-DIVISION; BETA-ACTIN; FH1 DOMAIN; ATP-ACTIN; ADP-ACTIN; PROFILIN; NUCLEATION; MECHANISM	Formins direct the elongation of unbranched actin filaments that are incorporated into a diverse set of cytoskeletal structures. Elongation of formin-bound filaments occurs along two parallel pathways. The formin homology 2 (FH2) pathway allows actin monomers to bind directly to barbed ends bound by dimeric FH2 domains. The formin homology 1 (FH1) pathway involves transfer of profilin-bound actin to the barbed end from polyproline tracts located in the disordered FH1 domains. Here, we used a total internal reflection fluorescence (TIRF) microscopy-based fluorescence approach to determine the fraction of actin subunits incorporated via the FH1 and FH2 pathways during filament elongation mediated by two formins. We found that the fraction of filament elongation that occurs via each pathway directly depends on the efficiency of the other pathway, indicating that these two pathways compete with each other for subunit addition by formins. We conclude that this competition allows formins to compensate for changes in the efficiency of one pathway by adjusting the frequency of subunit addition via the other, thus increasing the overall robustness of formin-mediated actin polymerization.	[Sherer, Laura A.; Zweifel, Mark E.; Courtemanche, Naomi] Univ Minnesota, Dept Genet Cell & Dev Biol, 6-130 MCB,420 Washington Ave SE, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Courtemanche, N (corresponding author), Univ Minnesota, Dept Genet Cell & Dev Biol, 6-130 MCB,420 Washington Ave SE, Minneapolis, MN 55455 USA.	ncourtem@umn.edu			National Institutes of Health [GM 122787]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM 122787. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boyer O, 2011, NEW ENGL J MED, V365, P2377, DOI 10.1056/NEJMoa1109122; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; Courtemanche N, 2012, J BIOL CHEM, V287, P7812, DOI 10.1074/jbc.M111.322958; DeWard AD, 2010, BBA-MOL CELL RES, V1803, P226, DOI 10.1016/j.bbamcr.2009.11.006; Eads JC, 1998, BIOCHEMISTRY-US, V37, P11171, DOI 10.1021/bi9720033; Ercan-Sencicek AG, 2015, EUR J HUM GENET, V23, P165, DOI 10.1038/ejhg.2014.82; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Nakano K, 2002, J CELL SCI, V115, P4629, DOI 10.1242/jcs.00150; Neidt EM, 2009, J BIOL CHEM, V284, P673, DOI 10.1074/jbc.M804201200; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Petersen J, 1998, J CELL BIOL, V141, P1217, DOI 10.1083/jcb.141.5.1217; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7	38	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17917	17928		10.1074/jbc.RA118.004845	http://dx.doi.org/10.1074/jbc.RA118.004845			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30266808	hybrid, Green Published			2022-12-28	WOS:000450409500021
J	Ghovanloo, MR; Shuart, NG; Mezeyova, J; Dean, RA; Ruben, PC; Goodchild, SJ				Ghovanloo, Mohammad-Reza; Shuart, Noah Gregory; Mezeyova, Janette; Dean, Richard A.; Ruben, Peter C.; Goodchild, Samuel J.			Inhibitory effects of cannabidiol on voltage-dependent sodium currents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sodium channel; cannabinoid; neuron; electrophysiology; central nervous system (CNS); cannabidiol; epilepsy; Kv2; 1; phytocannabinoid; voltage-gated sodium channel	NEONATAL-INFANTILE SEIZURES; GATED NA+ CHANNELS; DRAVET SYNDROME; MOLECULAR DETERMINANTS; HIPPOCAMPAL-NEURONS; ANTIEPILEPTIC DRUGS; PLANT CANNABINOIDS; BILAYER ELASTICITY; PROTEIN-BINDING; MODEL	Cannabis sativa contains many related compounds known as phytocannabinoids. The main psychoactive and nonpsychoactive compounds are 9-tetrahydrocannabinol (THC) and cannabidiol (CBD), respectively. Much of the evidence for clinical efficacy of CBD-mediated antiepileptic effects has been from case reports or smaller surveys. The mechanisms for CBD's anticonvulsant effects are unclear and likely involve noncannabinoid receptor pathways. CBD is reported to modulate several ion channels, including sodium channels (Nav). Evaluating the therapeutic mechanisms and safety of CBD demands a richer understanding of its interactions with central nervous system targets. Here, we used voltage-clamp electrophysiology of HEK-293 cells and iPSC neurons to characterize the effects of CBD on Nav channels. Our results show that CBD inhibits hNav1.1-1.7 currents, with an IC50 of 1.9-3.8 m, suggesting that this inhibition could occur at therapeutically relevant concentrations. A steep Hill slope of approximate to 3 suggested multiple interactions of CBD with Nav channels. CBD exhibited resting-state blockade, became more potent at depolarized potentials, and also slowed recovery from inactivation, supporting the idea that CBD binding preferentially stabilizes inactivated Nav channel states. We also found that CBD inhibits other voltage-dependent currents from diverse channels, including bacterial homomeric Nav channel (NaChBac) and voltage-gated potassium channel subunit Kv2.1. Lastly, the CBD block of Nav was temperature-dependent, with potency increasing at lower temperatures. We conclude that CBD's mode of action likely involves 1) compound partitioning in lipid membranes, which alters membrane fluidity affecting gating, and 2) undetermined direct interactions with sodium and potassium channels, whose combined effects are loss of channel excitability.	[Ghovanloo, Mohammad-Reza; Ruben, Peter C.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Ghovanloo, Mohammad-Reza; Shuart, Noah Gregory; Mezeyova, Janette; Dean, Richard A.; Goodchild, Samuel J.] Xenon Pharmaceut, Dept Cellular & Mol Biol, 3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada	Simon Fraser University	Goodchild, SJ (corresponding author), Xenon Pharmaceut, Dept Cellular & Mol Biol, 3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada.	sgoodchild@xenon-pharma.com	Ghovanloo, Mohammad-Reza/AAM-3832-2021; Ghovanloo, Mohammad-Reza/AHC-8430-2022	Ghovanloo, Mohammad-Reza/0000-0002-2171-0744; 	Mitacs fellowship; Agrima Botanicals Inc.; NSERC; Xenon Pharmaceuticals Inc.	Mitacs fellowship; Agrima Botanicals Inc.; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Xenon Pharmaceuticals Inc.	This work was supported by a Mitacs fellowship (to M.-R. G.); funds from Agrima Botanicals Inc. and NSERC (to P. C. R.); and funds from Xenon Pharmaceuticals Inc. (M.-R. G., N. G. S., J. M., R. A. D., and S. J. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01851-9; Beyreuther BK, 2007, CNS DRUG REV, V13, P21, DOI 10.1111/j.1527-3458.2007.00001.x; Bih CI, 2015, NEUROTHERAPEUTICS, V12, P699, DOI 10.1007/s13311-015-0377-3; Blumenfeld H, 2009, EPILEPSIA, V50, P44, DOI 10.1111/j.1528-1167.2008.01710.x; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Brunklaus A, 2012, BRAIN, V135, P2329, DOI 10.1093/brain/aws151; Catterall WA., 2012, JASPERS BASIC MECH E; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; CONSROE P, 1977, J PHARMACOL EXP THER, V201, P26; Deiana S, 2012, PSYCHOPHARMACOLOGY, V219, P859, DOI 10.1007/s00213-011-2415-0; DEMONACO HJ, 1983, ARCH NEUROL-CHICAGO, V40, P481, DOI 10.1001/archneur.1983.04210070021007; Devinsky O, 2017, NEW ENGL J MED, V376, P2011, DOI 10.1056/NEJMoa1611618; Devinsky O, 2014, EPILEPSIA, V55, P791, DOI 10.1111/epi.12631; Dravet C, 2011, EPILEPSIA, V52, P3, DOI 10.1111/j.1528-1167.2011.02994.x; Estacion M, 2010, EXP NEUROL, V224, P362, DOI 10.1016/j.expneurol.2010.04.012; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Ghovanloo MR, 2016, CURR TOP MEMBR, V78, P479, DOI 10.1016/bs.ctm.2016.04.001; Ghovanloo MR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24719-y; Ghovanloo MR, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00039; Grotenhermen F., 2003, Journal of Cannabis Therapeutics, V3, P3, DOI 10.1300/J175v03n01_02; Heron SE, 2002, LANCET, V360, P851, DOI 10.1016/S0140-6736(02)09968-3; Hill AJ, 2014, NEUROSCI LETT, V566, P269, DOI 10.1016/j.neulet.2014.03.013; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; HOOPER WD, 1975, CLIN PHARMACOL THER, V17, P433; Kaplan JS, 2017, P NATL ACAD SCI USA, V114, P11229, DOI 10.1073/pnas.1711351114; Khan AA, 2018, BRIT J PHARMACOL, V175, P2097, DOI 10.1111/bph.14202; Kinney WA, 2016, ACS MED CHEM LETT, V7, P424, DOI 10.1021/acsmedchemlett.6b00009; KUO CC, 1994, MOL PHARMACOL, V46, P716; Kuo CC, 1997, MOL PHARMACOL, V51, P1077, DOI 10.1124/mol.51.6.1077; Ledgerwood CJ, 2011, BRIT J PHARMACOL, V162, P286, DOI 10.1111/j.1476-5381.2010.01015.x; Lee S, 2012, J GEN PHYSIOL, V139, P507, DOI 10.1085/jgp.201210779; LERNER M, 1963, SCIENCE, V140, P175, DOI 10.1126/science.140.3563.175; Longhi R, 2011, DRUG METAB DISPOS, V39, P312, DOI 10.1124/dmd.110.036095; Lundbaek JA, 2005, MOL PHARMACOL, V68, P680, DOI 10.1124/mol.105.013573; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Luszczki JJ, 2006, EPILEPSIA, V47, P10, DOI 10.1111/j.1528-1167.2006.00364.x; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Nabbout R, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-176; O'Brien Janelle E., 2013, Frontiers in Genetics, V4, P213, DOI 10.3389/fgene.2013.00213; OTTO MK, 1984, BIOCHIM BIOPHYS ACTA, V769, P253, DOI 10.1016/0005-2736(84)90030-0; Parihar R, 2013, J HUM GENET, V58, P573, DOI 10.1038/jhg.2013.77; Patel RR, 2016, BRAIN, V139, P2164, DOI 10.1093/brain/aww129; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Pless SA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2761; Porter BE, 2013, EPILEPSY BEHAV, V29, P574, DOI 10.1016/j.yebeh.2013.08.037; Ragsdale DS, 1996, P NATL ACAD SCI USA, V93, P9270, DOI 10.1073/pnas.93.17.9270; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Remy S, 2003, EUR J NEUROSCI, V17, P2648, DOI 10.1046/j.1460-9568.2003.02710.x; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Ross HR, 2008, J BIOL CHEM, V283, P16124, DOI 10.1074/jbc.M707104200; Scalmani P, 2006, J NEUROSCI, V26, P10100, DOI 10.1523/JNEUROSCI.2476-06.2006; Shandra A, 2013, EPILEPSIA, V54, P1167, DOI 10.1111/epi.12237; Sheets PL, 2008, J PHARMACOL EXP THER, V326, P89, DOI 10.1124/jpet.107.133413; Shen HZ, 2017, SCIENCE, V355, DOI 10.1126/science.aal4326; Straiker A, 2018, MOL PHARMACOL, V94, P743, DOI 10.1124/mol.118.111864; Sun MZ, 2002, EPILEPSY RES, V51, P5, DOI 10.1016/S0920-1211(02)00053-0; Veeramah KR, 2012, AM J HUM GENET, V90, P502, DOI 10.1016/j.ajhg.2012.01.006; Yi GS, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00265	58	82	84	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16546	16558		10.1074/jbc.RA118.004929	http://dx.doi.org/10.1074/jbc.RA118.004929			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30219789	Green Published, hybrid			2022-12-28	WOS:000448515100001
J	Singh, SS; Naiyer, S; Bharadwaj, R; Kumar, A; Singh, YP; Ray, AK; Subbarao, N; Bhattacharya, A; Bhattacharya, S				Singh, Shashi Shekhar; Naiyer, Sarah; Bharadwaj, Ravi; Kumar, Amarjeet; Singh, Yatendra Pratap; Ray, Ashwini Kumar; Subbarao, Naidu; Bhattacharya, Alok; Bhattacharya, Sudha			Stress-induced nuclear depletion of Entamoeba histolytica 3'-5' exoribonuclease EhRrp6 and its role in growth and erythrophagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						exosome complex; stress response; ribosomal RNA processing (rRNA processing); precursor ribosomal RNA (pre-rRNA); RNA processing; phagocytosis; confocal microscopy; homology modeling; protein degradation; RNA degradation; 5-ETS; amoebiasis; amoebic dysentery; EhRrp6; Entamoeba histolytica	EUKARYOTIC MESSENGER-RNA; 5.8S RIBOSOMAL-RNA; HUMAN PM-SCL; QUALITY-CONTROL; CRYSTAL-STRUCTURE; EXOSOME COMPLEX; GENE-EXPRESSION; RRP6; DEGRADATION; PROTEIN	The 3-5 exoribonuclease Rrp6 is a key enzyme in RNA homeostasis involved in processing and degradation of many stable RNA precursors, aberrant transcripts, and noncoding RNAs. We previously have shown that in the protozoan parasite Entamoeba histolytica, the 5-external transcribed spacer fragment of pre-rRNA accumulates under serum starvation-induced growth stress. This fragment is a known target of degradation by Rrp6. Here, we computationally and biochemically characterized EhRrp6 and found that it contains the catalytically important EXO and HRDC domains and exhibits exoribonuclease activity with both unstructured and structured RNA substrates, which required the conserved DEDD-Y catalytic-site residues. It lacked the N-terminal PMC2NT domain for binding of the cofactor Rrp47, but could functionally complement the growth defect of a yeast rrp6 mutant. Of note, no Rrp47 homologue was detected in E. histolytica. Immunolocalization studies revealed that EhRrp6 is present both in the nucleus and cytosol of normal E. histolytica cells. However, growth stress induced its complete loss from the nuclei, reversed by proteasome inhibitors. EhRrp6-depleted E. histolytica cells were severely growth restricted, and EhRrp6 overexpression protected the cells against stress, suggesting that EhRrp6 functions as a stress sensor. Importantly EhRrp6 depletion reduced erythrophagocytosis, an important virulence determinant of E. histolytica. This reduction was due to a specific decrease in transcript levels of some phagocytosis-related genes (Ehcabp3 and Ehrho1), whereas expression of other genes (Ehcabp1, Ehcabp6, Ehc2pk, and Eharp2/3) was unaffected. This is the first report of the role of Rrp6 in cell growth and stress responses in a protozoan parasite.	[Singh, Shashi Shekhar; Naiyer, Sarah; Singh, Yatendra Pratap; Ray, Ashwini Kumar; Bhattacharya, Sudha] Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India; [Kumar, Amarjeet; Subbarao, Naidu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Bharadwaj, Ravi; Bhattacharya, Alok] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Bhattacharya, S (corresponding author), Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India.	sbjnu110@gmail.com	Bharadwaj, Ravi/ABE-6055-2021; Subbarao, Prof Naidu/AAZ-1832-2020; Singh, Shashi Shekhar/AAD-7584-2021; Naiyer, Sarah/AAB-4939-2019	Subbarao, Prof Naidu/0000-0002-1720-2165; Singh, Shashi Shekhar/0000-0002-9294-4855; Naiyer, Sarah/0000-0002-3961-5489; Kumar, Amarjeet/0000-0001-7740-9881	J.C. Bose National fellowship; Board of Research in Nuclear Sciences (BRNS); Council of Scientific and Industrial Research fellowship; University Grants Commission UPE-II	J.C. Bose National fellowship; Board of Research in Nuclear Sciences (BRNS)(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS)); Council of Scientific and Industrial Research fellowship(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission UPE-II(University Grants Commission, India)	This work was supported by a J.C. Bose National fellowship and by the Board of Research in Nuclear Sciences (BRNS) (to S. B.), and by a Council of Scientific and Industrial Research fellowship (to S. S. S., A. K., and S. N.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by University Grants Commission UPE-II.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Aslam S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003055; Assenholt J, 2008, RNA, V14, P2305, DOI 10.1261/rna.1108008; Babuta M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005310; Barbosa RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089138; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bharadwaj R, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12851; Bharadwaj R, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12751; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Costello JL, 2011, J BIOL CHEM, V286, P4535, DOI 10.1074/jbc.M110.162826; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Delan-Forino C, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006699; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Feigenbutz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080752; Feigenbutz M, 2013, J BIOL CHEM, V288, P15959, DOI 10.1074/jbc.M112.445759; Fox MJ, 2016, WIRES RNA, V7, P91, DOI 10.1002/wrna.1317; Gaurav AK, 2017, MOL BIOCHEM PARASIT, V211, P84, DOI 10.1016/j.molbiopara.2016.11.004; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Graham AC, 2009, MOL BIOL CELL, V20, P2242, DOI 10.1091/mbc.E08-08-0825; Gupta AK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00303; Haile S, 2007, MOL BIOCHEM PARASIT, V151, P52, DOI 10.1016/j.molbiopara.2006.10.005; Hamann L, 1997, MOL BIOCHEM PARASIT, V84, P83, DOI 10.1016/S0166-6851(96)02771-5; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jain R, 2008, CELL MICROBIOL, V10, P1373, DOI 10.1111/j.1462-5822.2008.01134.x; Januszyk K, 2011, RNA, V17, P1566, DOI 10.1261/rna.2763111; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Lange H, 2008, MOL CELL BIOL, V28, P3038, DOI 10.1128/MCB.02064-07; Lange H, 2011, PLANT J, V68, P51, DOI 10.1111/j.1365-313X.2011.04675.x; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Lykke-Andersen S, 2011, RNA BIOL, V8, P61, DOI 10.4161/rna.8.1.14237; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Makioka A, 2002, PARASITOL RES, V88, P454, DOI 10.1007/s00436-002-0601-z; Malet H, 2010, EMBO REP, V11, P936, DOI 10.1038/embor.2010.164; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; Midtgaard SF, 2006, P NATL ACAD SCI USA, V103, P11898, DOI 10.1073/pnas.0604731103; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Nozaki T, 2015, AMEBIASIS BIOL PATHO; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips S, 2003, RNA, V9, P1098, DOI 10.1261/rna.5560903; Ramakrishnan G, 1997, MOL BIOCHEM PARASIT, V84, P93, DOI 10.1016/S0166-6851(96)02784-3; Rastew E, 2012, INT J PARASITOL, V42, P1007, DOI 10.1016/j.ijpara.2012.08.006; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schilders G, 2007, NUCLEIC ACIDS RES, V35, P2564, DOI 10.1093/nar/gkm082; Scholze H, 1996, J BIOL CHEM, V271, P6212, DOI 10.1074/jbc.271.11.6212; Schuch B, 2014, EMBO J, V33, P2829, DOI 10.15252/embj.201488757; Shirai A., 2006, NAT PROTOC, DOI [10.1038/nprot.2006.191, DOI 10.1038/NPROT.2006.191]; Sikorski PJ, 2015, PLANT J, V83, P991, DOI 10.1111/tpj.12943; Sloan KE, 2014, RNA, V20, P540, DOI 10.1261/rna.043471.113; Somlata, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1199; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; Thomson E, 2010, MOL CELL BIOL, V30, P976, DOI 10.1128/MCB.01359-09; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Van Hooser AA, 2005, CHROMOSOMA, V114, P377, DOI 10.1007/s00412-005-0021-9; Verma D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006332; Wang MS, 2011, NUCLEIC ACIDS RES, V39, P1811, DOI 10.1093/nar/gkq1050; Wasmuth EV, 2017, NUCLEIC ACIDS RES, V45, P846, DOI 10.1093/nar/gkw1152; Wasmuth EV, 2014, NATURE, V511, P435, DOI 10.1038/nature13406; Wasmuth EV, 2012, ENZYMES, V31, P53, DOI 10.1016/B978-0-12-404740-2.00003-3; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Williams CW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-586; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Yadava N, 1997, MOL BIOCHEM PARASIT, V84, P69, DOI 10.1016/S0166-6851(96)02782-X; Zakrzewska-Placzek M, 2010, NUCLEIC ACIDS RES, V38, P4487, DOI 10.1093/nar/gkq172; Zinder JC, 2017, GENE DEV, V31, P88, DOI 10.1101/gad.294769.116; Zuo YH, 2005, STRUCTURE, V13, P973, DOI 10.1016/j.str.2005.04.015	81	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16242	16260		10.1074/jbc.RA118.004632	http://dx.doi.org/10.1074/jbc.RA118.004632			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30171071	Green Published, hybrid			2022-12-28	WOS:000447833600012
J	Haugaard-Kedstrom, LM; Lee, HS; Jones, MV; Song, A; Rathod, V; Hossain, MA; Bathgate, RAD; Rosengren, KJ				Haugaard-Kedstrom, Linda M.; Lee, Han Siean; Jones, Maryon V.; Song, Angela; Rathod, Vishaal; Hossain, Mohammed Akhter; Bathgate, Ross A. D.; Rosengren, K. Johan			Binding conformation and determinants of a single-chain peptide antagonist at the relaxin-3 receptor RXFP3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						relaxin-3; G protein-coupled receptor (GPCR); neuropeptide; peptide conformation; peptide interaction; antagonist; R3 B1-22R; RXFP3; alanine scan; peptide stapling	B-CHAIN; BIOLOGICAL-ACTIVITY; NUCLEUS INCERTUS; CHIMERIC PEPTIDE; FAMILY PEPTIDES; AMINO-ACIDS; H3 RELAXIN; GPCR142; AGONIST; LIGAND	The neuropeptide relaxin-3 and its receptor relaxin family peptide receptor-3 (RXFP3) play key roles in modulating behavior such as memory and learning, food intake, and reward seeking. A linear relaxin-3 antagonist (R3 B1-22R) based on a modified and truncated relaxin-3 B-chain was recently developed. R3 B1-22R is unstructured in solution; thus, the binding conformation and determinants of receptor binding are unclear. Here, we have designed, chemically synthesized, and pharmacologically characterized more than 60 analogues of R3 B1-22R to develop an extensive understanding of its structure-activity relationships. We show that the key driver for affinity is the nonnative C-terminal Arg(23). Additional contributors to binding include amino acid residues that are important also for relaxin-3 binding, including Arg(12), Ile(15), and Ile(19). Intriguingly, amino acid residues that are not exposed in native relaxin-3, including Phe(14) and Ala(17), also interact with RXFP3. We show that R3 B1-22R has a propensity to form a helical structure, and modifications that support a helical conformation are functionally well-tolerated, whereas helix breakers such as proline residues disrupt binding. These data suggest that the peptide adopts a helical conformation, like relaxin-3, upon binding to RXFP3, but that its smaller size allows it to penetrate deeper into the orthosteric binding site, creating more extensive contacts with the receptor.	[Haugaard-Kedstrom, Linda M.; Lee, Han Siean; Jones, Maryon V.; Song, Angela; Rathod, Vishaal; Rosengren, K. Johan] Univ Queensland, Sch Biomed Sci, Fac Med, Brisbane, Qld 4072, Australia; [Haugaard-Kedstrom, Linda M.] Univ Copenhagen, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark; [Hossain, Mohammed Akhter; Bathgate, Ross A. D.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Hossain, Mohammed Akhter] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Bathgate, Ross A. D.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia	University of Queensland; University of Copenhagen; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne	Bathgate, RAD (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia.; Rosengren, KJ (corresponding author), Univ Queensland, Sch Biomed Sci, Fac Med, St Lucia, Qld 4072, Australia.	bathgate@florey.edu.au; j.rosengren@uq.edu.au	Rosengren, K. Johan/P-4450-2016; Bathgate, Ross/ABE-6471-2020; Song, Angela/AAE-3472-2021; Haugaard-Kedstrom, Linda/F-3705-2011	Rosengren, K. Johan/0000-0002-5007-8434; Bathgate, Ross/0000-0001-6301-861X; Hossain, Mohammed/0000-0002-9961-0006; Haugaard-Kedstrom, Linda/0000-0003-0113-6535	National Health and Medical Research Council (NHMRC), Australia [1063425, 1066369]; Victorian Government Operational Infrastructure Support Program; Australian Research Council Future Fellowship	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government Operational Infrastructure Support Program; Australian Research Council Future Fellowship(Australian Research Council)	This work was supported by the National Health and Medical Research Council (NHMRC), Australia, through Project Grants 1063425 and 1066369 (to R. A. D. B. and K. J. R.). Research at the Florey was supported by the Victorian Government Operational Infrastructure Support Program. L. M. H. K., K. J. R., and R. A. D. B. are inventors on Australian Patent 2010904046 and United States patent application 13/821726, Modified Relaxin B Chain Peptides.; Supported by an Australian Research Council Future Fellowship.	Banerjee A, 2010, NEUROPHARMACOLOGY, V58, P145, DOI 10.1016/j.neuropharm.2009.06.019; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Bathgate Ross A D, 2013, Front Endocrinol (Lausanne), V4, P13, DOI 10.3389/fendo.2013.00013; Burazin TCD, 2002, J NEUROCHEM, V82, P1553, DOI 10.1046/j.1471-4159.2002.01114.x; Calvez J, 2016, NEUROPHARMACOLOGY, V102, P207, DOI 10.1016/j.neuropharm.2015.11.014; Clark RJ, 2005, P NATL ACAD SCI USA, V102, P13767, DOI 10.1073/pnas.0504613102; de Araujo AD, 2014, ANGEW CHEM INT EDIT, V53, P6965, DOI 10.1002/anie.201310245; Fischer PM, 2003, CURR PROTEIN PEPT SC, V4, P339, DOI 10.2174/1389203033487054; Haugaard-Jonsson LM, 2008, J BIOL CHEM, V283, P23811, DOI 10.1074/jbc.M800489200; Haugaard-Kedstrom LM, 2015, AMINO ACIDS, V47, P1267, DOI 10.1007/s00726-015-1961-x; Haugaard-Kedstrom LM, 2011, J AM CHEM SOC, V133, P4965, DOI 10.1021/ja110567j; Hojo K, 2016, J MED CHEM, V59, P7445, DOI 10.1021/acs.jmedchem.6b00265; Hossain MA, 2016, J PEPT SCI, V22, pS126, DOI 10.1039/C5SC04754D; Hossain MA, 2008, J BIOL CHEM, V283, P17287, DOI 10.1074/jbc.M801911200; Hossain MA, 2009, CHEM BIOL DRUG DES, V73, P46, DOI 10.1111/j.1747-0285.2008.00756.x; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Hu MJ, 2016, AMINO ACIDS, V48, P2227, DOI 10.1007/s00726-016-2260-x; Jayakody T, 2016, PEPTIDES, V84, P44, DOI 10.1016/j.peptides.2016.08.001; Keller R., 2004, COMPUTER AIDED RESON, V1; Kuei C, 2007, J BIOL CHEM, V282, P25425, DOI 10.1074/jbc.M701416200; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; Liu CL, 2005, J BIOL CHEM, V280, P292, DOI 10.1074/jbc.M409916200; Liu CL, 2005, MOL PHARMACOL, V67, P231, DOI 10.1124/mol.104.006700; Liu CL, 2003, J BIOL CHEM, V278, P50765, DOI 10.1074/jbc.M308996200; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Ma S, 2009, LEARN MEMORY, V16, P730, DOI 10.1101/lm.1438109; Mahalakshmi Radhakrishnan, 2006, V340, P71; McGowan BMC, 2005, ENDOCRINOLOGY, V146, P3295, DOI 10.1210/en.2004-1532; Patil NA, 2017, BRIT J PHARMACOL, V174, P950, DOI 10.1111/bph.13684; Rosengren KJ, 2006, J BIOL CHEM, V281, P5845, DOI 10.1074/jbc.M511210200; Ryan PJ, 2013, P NATL ACAD SCI USA, V110, P20789, DOI 10.1073/pnas.1317807110; Shabanpoor F, 2012, J MED CHEM, V55, P1671, DOI 10.1021/jm201505p; Shabanpoor F, 2010, AMINO ACIDS, V38, P121, DOI 10.1007/s00726-008-0219-2; Shabanpoor F, 2009, VITAM HORM, V80, P1, DOI 10.1016/S0083-6729(08)00601-8; Smith CM, 2014, BEHAV BRAIN RES, V268, P117, DOI 10.1016/j.bbr.2014.03.037; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Tanaka M, 2005, EUR J NEUROSCI, V21, P1659, DOI 10.1111/j.1460-9568.2005.03980.x; Van Der Westhuizen ET, 2005, ANN NY ACAD SCI, V1041, P332, DOI 10.1196/annals.1282.053; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wong LLL, 2018, J BIOL CHEM, V293, P15777, DOI 10.1074/jbc.RA118.002645; Zhang WJ, 2014, AMINO ACIDS, V46, P1393, DOI 10.1007/s00726-014-1705-3	41	7	7	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15765	15776		10.1074/jbc.RA118.002611	http://dx.doi.org/10.1074/jbc.RA118.002611			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30131342	Green Published, hybrid			2022-12-28	WOS:000447256000002
J	Rosener, NS; Gremer, L; Reinartz, E; Konig, A; Brener, O; Heise, H; Hoyer, W; Neudecker, P; Willbold, D				Roesener, Nadine S.; Gremer, Lothar; Reinartz, Elke; Koenig, Anna; Brener, Oleksandr; Heise, Henrike; Hoyer, Wolfgang; Neudecker, Philipp; Willbold, Dieter			A D-enantiomeric peptide interferes with heteroassociation of amyloid-beta oligomers and prion protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid- (A); atomic force microscopy (AFM); oligomerization; protein aggregation; protein-protein interaction; nuclear magnetic resonance (NMR); D-enantiomeric peptides; density gradient ultracentrifugation (DGC); prion protein	N-TERMINAL FRAGMENT; IMAGE PHAGE DISPLAY; ALZHEIMERS A-BETA; TRANSGENIC MICE; PHARMACOKINETIC PROPERTIES; SYNAPTIC PLASTICITY; SIGNAL-TRANSDUCTION; IN-VIVO; DISEASE; RECEPTOR	Alzheimer's disease (AD) is a progressive neurodegenerative disorder that affects millions of people worldwide. One AD hallmark is the aggregation of beta-amyloid (A beta) into soluble oligomers and insoluble fibrils. Several studies have reported that oligomers rather than fibrils are the most toxic species in AD progression. A beta oligomers bind with high affinity to membrane-associated prion protein (PrP), leading to toxic signaling across the cell membrane, which makes the A beta-PrP interaction an attractive therapeutic target. Here, probing this interaction in more detail, we found that both full-length, soluble human (hu) PrP(23-230) and huPrP(23-144), lacking the globular C-terminal domain, bind to A beta oligomers to form large complexes above the megadalton size range. Following purification by sucrose density-gradient ultracentrifugation, the A beta and huPrP contents in these heteroassemblies were quantified by reversed-phase HPLC. The A beta:PrP molar ratio in these assemblies exhibited some limited variation depending on the molar ratio of the initial mixture. Specifically, a molar ratio of about four A beta to one huPrP in the presence of an excess of huPrP(23-230) or huPrP(23-144) suggested that four A beta units are required to form one huPrP-binding site. Of note, an A beta-binding all-D-enantiomeric peptide, RD2D3, competed with huPrP for A beta oligomers and interfered with A beta-PrP heteroassembly in a concentration-dependent manner. Our results highlight the importance of multivalent epitopes on A beta oligomers for A beta-PrP interactions and have yielded an all-D-peptide-based, therapeutically promising agent that competes with PrP for these interactions.	[Roesener, Nadine S.; Gremer, Lothar; Reinartz, Elke; Koenig, Anna; Brener, Oleksandr; Heise, Henrike; Hoyer, Wolfgang; Neudecker, Philipp; Willbold, Dieter] Heinrich Heine Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Roesener, Nadine S.; Gremer, Lothar; Koenig, Anna; Brener, Oleksandr; Heise, Henrike; Hoyer, Wolfgang; Neudecker, Philipp; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich	Willbold, D (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany.	d.willbold@fz-juelich.de	Neudecker, Philipp/AAP-9005-2020; Neudecker, Philipp/G-5265-2013; Hoyer, Wolfgang/H-6193-2013; Heise, Henrike/A-7703-2010; Gremer, Lothar/H-9128-2013; Willbold, Dieter/A-6280-2013	Neudecker, Philipp/0000-0002-0557-966X; Neudecker, Philipp/0000-0002-0557-966X; Hoyer, Wolfgang/0000-0003-4301-5416; Heise, Henrike/0000-0002-9081-3894; Gremer, Lothar/0000-0001-7065-5027; Rosener, Nadine/0000-0002-9481-6347; Willbold, Dieter/0000-0002-0065-7366; Brener, Oleksandr/0000-0001-9771-7515	Portfolio Technology and Medicine; Helmholtz-Validierungsfonds of the Impuls-und Vernetzungs-Fonds der Helmholtzgemeinschaft; "Portfolio Drug Research" of the Impuls-und Vernetzungs-Fonds der Helmholtzgemeinschaft; Deutsche Forschungsgemeinschaft [SFB 1208]; European Research Council Consolidator Grant [726368]	Portfolio Technology and Medicine; Helmholtz-Validierungsfonds of the Impuls-und Vernetzungs-Fonds der Helmholtzgemeinschaft; "Portfolio Drug Research" of the Impuls-und Vernetzungs-Fonds der Helmholtzgemeinschaft; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council Consolidator Grant(European Research Council (ERC))	This work was supported by "Portfolio Technology and Medicine," the Helmholtz-Validierungsfonds of the Impuls-und Vernetzungs-Fonds der Helmholtzgemeinschaft (to N. S. R. and D. W.), "Portfolio Drug Research" of the Impuls-und Vernetzungs-Fonds der Helmholtzgemeinschaft (to D. W.), Deutsche Forschungsgemeinschaft Grant SFB 1208 (to P. N. and D. W.), and European Research Council Consolidator Grant 726368 (to W. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aimi T, 2015, J NEUROCHEM, V134, P611, DOI 10.1111/jnc.13166; Altmeppen Hermann C, 2012, Am J Neurodegener Dis, V1, P15; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Beland M, 2014, NEUROBIOL AGING, V35, P1537, DOI 10.1016/j.neurobiolaging.2014.02.001; Brener O, 2015, SCI REP-UK, V5, DOI 10.1038/srep13222; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Canet-Ferrer J, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/39/395703; Cavini IA, 2018, CHEM COMMUN, V54, P3294, DOI 10.1039/c8cc01458b; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Choi JK, 2016, P NATL ACAD SCI USA, V113, P13851, DOI 10.1073/pnas.1610716113; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Dawson R. M. C., 1986, DATA BIOCH RES, P545; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DINTZIS HM, 1993, PROTEINS, V16, P306, DOI 10.1002/prot.340160309; Dohler F, 2014, BRAIN, V137, P873, DOI 10.1093/brain/awt375; Elezgarai SR, 2016, BIOL CHEM, V397, P1115, DOI 10.1515/hsz-2016-0190; Elfgen A, 2017, EUR J PHARM SCI, V107, P203, DOI 10.1016/j.ejps.2017.07.015; Findeisen M, 2007, MAGN RESON CHEM, V45, P175, DOI 10.1002/mrc.1941; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Funke SA, 2010, ACS CHEM NEUROSCI, V1, P639, DOI 10.1021/cn100057j; Gremer L, 2017, SCIENCE, V358, P116, DOI 10.1126/science.aao2825; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; Jarosz-Griffiths HH, 2016, J BIOL CHEM, V291, P3174, DOI 10.1074/jbc.R115.702704; Jiang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128553; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kang M, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.63; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Kutzsche J, 2017, MOLECULES, V22, DOI 10.3390/molecules22101693; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leithold LHE, 2016, EUR J PHARM SCI, V89, P31, DOI 10.1016/j.ejps.2016.04.016; Leithold LHE, 2016, PHARM RES-DORDR, V33, P328, DOI 10.1007/s11095-015-1791-2; Luers L, 2010, REJUV RES, V13, P214, DOI 10.1089/rej.2009.0932; Markley JL, 1998, PURE APPL CHEM, V70, P117, DOI 10.1351/pac199870010117; Mehlhorn I, 1996, BIOCHEMISTRY-US, V35, P5528, DOI 10.1021/bi952965e; Mitrea DM, 2016, ELIFE, V5, DOI 10.7554/eLife.13571; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Nieznanski K, 2012, J BIOL CHEM, V287, P33104, DOI 10.1074/jbc.C112.400614; Nygaard HB, 2009, ARCH NEUROL-CHICAGO, V66, P1325, DOI 10.1001/archneurol.2009.223; Olubiyi OO, 2014, CURR MED CHEM, V21, P1448, DOI 10.2174/0929867321666131129122247; Pantera B, 2009, J NEUROCHEM, V110, P194, DOI 10.1111/j.1471-4159.2009.06123.x; Peixoto PDS, 2016, LANGMUIR, V32, P7821, DOI 10.1021/acs.langmuir.6b01015; Peters C, 2015, NEUROBIOL AGING, V36, P1369, DOI 10.1016/j.neurobiolaging.2014.11.019; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Purro SA, 2018, BIOL PSYCHIAT, V83, P358, DOI 10.1016/j.biopsych.2017.11.020; Risse E, 2015, J BIOL CHEM, V290, P17020, DOI 10.1074/jbc.M115.637124; Salazar SV, 2017, BIOCHEM BIOPH RES CO, V483, P1143, DOI 10.1016/j.bbrc.2016.09.062; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHLEUCHER J, 1993, ANGEW CHEM INT EDIT, V32, P1489, DOI 10.1002/anie.199314891; Schumacher TNM, 1996, SCIENCE, V271, P1854, DOI 10.1126/science.271.5257.1854; Scott-McKean JJ, 2016, NEUROBIOL DIS, V91, P124, DOI 10.1016/j.nbd.2016.03.001; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SHAKA AJ, 1983, J MAGN RESON, V52, P335, DOI 10.1016/0022-2364(83)90207-X; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; SUZUKI T, 1995, BIOCHEM BIOPH RES CO, V216, P582, DOI 10.1006/bbrc.1995.2662; Tavares GM, 2015, FOOD HYDROCOLLOID, V48, P238, DOI 10.1016/j.foodhyd.2015.02.027; Theint T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00794-z; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; van Groen T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16565-1; van Groen T, 2013, J ALZHEIMERS DIS, V34, P609, DOI 10.3233/JAD-121792; van Groen T, 2008, CHEMMEDCHEM, V3, P1848, DOI 10.1002/cmdc.200800273; Van Regenmortel MHV, 1998, CURR OPIN BIOTECH, V9, P377, DOI 10.1016/S0958-1669(98)80011-6; Wahlberg E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06377-8; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wiesehan K, 2003, CHEMBIOCHEM, V4, P748, DOI 10.1002/cbic.200300631; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wulf MA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0375-5; Younan ND, 2013, FASEB J, V27, P1847, DOI 10.1096/fj.12-222588; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	80	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15748	15764		10.1074/jbc.RA118.003116	http://dx.doi.org/10.1074/jbc.RA118.003116			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30131337	hybrid, Green Published			2022-12-28	WOS:000447256000001
J	Thapa, S; Abdulrahman, B; Abdelaziz, DH; Lu, L; Ben Aissa, M; Schatzl, HM				Thapa, Simrika; Abdulrahman, Basant; Abdelaziz, Dalia H.; Lu, Li; Ben Aissa, Manel; Schatzl, Hermann M.			Overexpression of quality control proteins reduces prion conversion in prion-infected cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prion; prion disease; ER quality control; endoplasmic reticulum stress (ER stress); infection; lentivirus; bovine spongiform encephalopathy; Creutzfeldt-Jakob disease; neurodegeneration; scrapie	ENDOPLASMIC-RETICULUM STRESS; ER STRESS; SECRETORY PATHWAY; NEURODEGENERATIVE DISEASES; ALZHEIMERS-DISEASE; SCRAPIE; NEUROTOXICITY; TRANSLOCATION; ACCUMULATION; DYSFUNCTION	Prion diseases are fatal infectious neurodegenerative disorders in humans and other animals and are caused by misfolding of the cellular prion protein (PrPC) into the pathological isoform PrPSc. These diseases have the potential to transmit within or between species, including zoonotic transmission to humans. Elucidating the molecular and cellular mechanisms underlying prion propagation and transmission is therefore critical for developing molecular strategies for disease intervention. We have shown previously that impaired quality control mechanisms directly influence prion propagation. In this study, we manipulated cellular quality control pathways in vitro by stably and transiently overexpressing selected quality control folding (ERp57) and cargo (VIP36) proteins and investigated the effects of this overexpression on prion propagation. We found that ERp57 or VIP36 overexpression in persistently prion-infected neuroblastoma cells significantly reduces the amount of PrPSc in immunoblots and prion-seeding activity in the real-time quaking-induced conversion (RT-QuIC) assay. Using different cell lines infected with various prion strains confirmed that this effect is not cell type- or prion strain-specific. Moreover, de novo prion infection revealed that the overexpression significantly reduced newly formed PrPSc in acutely infected cells. ERp57-overexpressing cells significantly overcame endoplasmic reticulum stress, as revealed by expression of lower levels of the stress markers BiP and CHOP, accompanied by a decrease in PrP aggregates. Furthermore, application of ERp57-expressing lentiviruses prolonged the survival of prion-infected mice. Taken together, improved cellular quality control via ERp57 or VIP36 overexpression impairs prion propagation and could be utilized as a potential therapeutic strategy.	[Thapa, Simrika; Abdulrahman, Basant; Abdelaziz, Dalia H.; Lu, Li; Ben Aissa, Manel; Schatzl, Hermann M.] Univ Calgary, Calgary Prion Res Unit, Calgary, AB T2N 4Z6, Canada; [Thapa, Simrika; Abdulrahman, Basant; Abdelaziz, Dalia H.; Lu, Li; Ben Aissa, Manel; Schatzl, Hermann M.] Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, TRW 2D10,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada; [Abdulrahman, Basant; Abdelaziz, Dalia H.] Helwan Univ, Dept Biochem & Mol Biol, Fac Pharm, Cairo 11795, Egypt; [Schatzl, Hermann M.] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Schatzl, Hermann M.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	University of Calgary; University of Calgary; Egyptian Knowledge Bank (EKB); Helwan University; University of Wyoming; University of Wyoming	Schatzl, HM (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, TRW 2D10,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	hschaetz@ucalgary.ca		Abdulrahman, Basant/0000-0002-4970-6835; Schatzl, Hermann/0000-0003-4972-8740	NINDS, National Institutes of Health [R01 NS076853-01A1]; Alberta Innovates - Health Solutions [201300003, 201600010, 201610675, 20160740]; Killam Trusts grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076853] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alberta Innovates - Health Solutions; Killam Trusts grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health Grant R01 NS076853-01A1 (to H. M. S.); Alberta Innovates - Health Solutions Grants 201300003 and 201600010 (to H. M. S.), 201610675 (to S. T.), and 20160740 (to B. A.); and Killam Trusts grant (to S. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelaziz DH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11235-8; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Castillo V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136620; Cheng YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166187; D'Castro L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015679; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Fullekrug J, 1999, J CELL SCI, V112, P2813; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Hamdan N, 2017, J CELL BIOL, V216, P2295, DOI 10.1083/jcb.201612165; Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3; Henderson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074377; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hetz C, 2007, J BIOL CHEM, V282, P12725, DOI 10.1074/jbc.M611909200; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Hetz CA, 2007, ANTIOXID REDOX SIGN, V9, P2345, DOI 10.1089/ars.2007.1793; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Homma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04504; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Hoozemans JJM, 2012, NEURODEGENER DIS, V10, P212, DOI 10.1159/000334536; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; John TR, 2013, PRION, V7, P253, DOI 10.4161/pri.24430; Kim JY, 2014, JOVE-J VIS EXP, DOI 10.3791/51863; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Maattanen P, 2006, BIOCHEM CELL BIOL, V84, P881, DOI 10.1139/O06-186; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Nunziante M, 2011, J BIOL CHEM, V286, P33942, DOI 10.1074/jbc.M111.272617; Nyfeler B, 2003, BIOCHEM BIOPH RES CO, V304, P599, DOI 10.1016/S0006-291X(03)00634-X; Orru CD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050140; Orru CD, 2015, MBIO, V6, DOI 10.1128/mBio.02451-14; Orru CD, 2009, PROTEIN ENG DES SEL, V22, P515, DOI 10.1093/protein/gzp031; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Park KW, 2017, SCI REP-UK, V7, DOI 10.1038/srep44723; Paschen W, 2005, CELL CALCIUM, V38, P409, DOI 10.1016/j.ceca.2005.06.019; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Reiterer V, 2010, TRAFFIC, V11, P1044, DOI 10.1111/j.1600-0854.2010.01078.x; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sajnani G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002547; Schmitz M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28711; Shen JS, 2005, MOL CELL BIOL, V25, P921, DOI 10.1128/MCB.25.3.921-932.2005; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Stutzbach LD, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-31; Tatzelt A, 2004, AMYLOID, V11, P162, DOI 10.1080/1350-612040000723; Torres M, 2015, J BIOL CHEM, V290, P23631, DOI 10.1074/jbc.M114.635565; Torres M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015658; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; VOGEL JP, 1990, J CELL BIOL, V110, P1885, DOI 10.1083/jcb.110.6.1885; Wang HP, 2015, TOXICOL APPL PHARM, V283, P157, DOI 10.1016/j.taap.2014.12.019; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6; 2004, CONTRIB MICROBIOL, V11, P33, DOI DOI 10.1159/000077061	64	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16069	16082		10.1074/jbc.RA118.002754	http://dx.doi.org/10.1074/jbc.RA118.002754			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30154245	hybrid, Green Published			2022-12-28	WOS:000447256000026
J	Gannoun-Zaki, L; Patzold, L; Huc-Brandt, S; Baronian, G; Elhawy, MI; Gaupp, R; Martin, M; Blanc-Potard, AB; Letourneur, F; Bischoff, M; Molle, V				Gannoun-Zaki, Laila; Paetzold, Linda; Huc-Brandt, Sylvaine; Baronian, Gregory; Elhawy, Mohamed Ibrahem; Gaupp, Rosmarie; Martin, Marianne; Blanc-Potard, Anne-Beatrice; Letourneur, Francois; Bischoff, Markus; Molle, Virginie			PtpA, a secreted tyrosine phosphatase from Staphylococcus aureus, contributes to virulence and interacts with coronin-1A during infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Staphylococcus aureus (S; aureus); bacterial protein phosphatase; host-pathogen interaction; bacterial pathogenesis; protein phosphorylation; coronin	PROTEIN-KINASE; PATHOGENIC MYCOBACTERIA; PHOSPHORYLATION; SURVIVAL; YERSINIA; MACROPHAGES; IDENTIFICATION; RECOGNITION; DETERMINANT; ACTIVATION	Secretion of bacterial signaling proteins and adaptation to the host, especially during infection, are processes that are often linked in pathogenic bacteria. The human pathogen Staphylococcus aureus is equipped with a large arsenal of immune-modulating factors, allowing it to either subvert the host immune response or to create permissive niches for its survival. Recently, we showed that one of the low-molecular-weight protein tyrosine phosphatases produced by S. aureus, PtpA, is secreted during growth. Here, we report that deletion of ptpA in S. aureus affects intramacrophage survival and infectivity. We also observed that PtpA is secreted during macrophage infection. Immunoprecipitation assays identified several host proteins as putative intracellular binding partners for PtpA, including coronin-1A, a cytoskeleton-associated protein that is implicated in a variety of cellular processes. Of note, we demonstrated that coronin-1A is phosphorylated on tyrosine residues upon S. aureus infection and that its phosphorylation profile is linked to PtpA expression. Our results confirm that PtpA has a critical role during infection as a bacterial effector protein that counteracts host defenses.	[Gannoun-Zaki, Laila; Huc-Brandt, Sylvaine; Baronian, Gregory; Martin, Marianne; Blanc-Potard, Anne-Beatrice; Letourneur, Francois; Molle, Virginie] Univ Montpellier, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, F-34000 Montpellier, France; [Paetzold, Linda; Elhawy, Mohamed Ibrahem; Gaupp, Rosmarie; Bischoff, Markus] Univ Saarland, Inst Med Microbiol & Hyg, D-66421 Homburg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Saarland University	Gannoun-Zaki, L (corresponding author), Univ Montpellier, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, F-34000 Montpellier, France.	laila.gannoun@umontpellier.fr; virginie.molle@univ-montp2.fr	Elhawy, Mohamed Ibrahem/AAQ-9990-2021; Brandt, Sylvaine/AAJ-1277-2021; Blanc-Potard, Anne/AAI-9542-2021; Bischoff, Markus/D-2130-2014; MOLLE, Virginie/D-4050-2019	Elhawy, Mohamed Ibrahem/0000-0002-8252-1832; Brandt, Sylvaine/0000-0002-5582-4643; Bischoff, Markus/0000-0001-6734-2732; MOLLE, Virginie/0000-0002-6573-3411; Gannoun, Laila/0000-0002-9644-1083; Letourneur, Francois/0000-0003-2232-6127; MARTIN, Marianne/0000-0001-8932-3129; Blanc-Potard, Anne/0000-0001-9963-6786	ATIP/AVENIR Program; German Egyptian Research Long-term Scholarship (GERLS) program	ATIP/AVENIR Program; German Egyptian Research Long-term Scholarship (GERLS) program	This work was supported by grants from the ATIP/AVENIR Program (to V. M. and L. G.-Z.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the German Egyptian Research Long-term Scholarship (GERLS) program.	Alibaud L, 2003, BIOTECHNIQUES, V35, P78, DOI 10.2144/03351st03; Alto NM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006114; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Bischoff M, 2016, STAPHYLOCOCCUS: GENETICS AND PHYSIOLOGY, P301; Black DS, 1998, MOL MICROBIOL, V29, P1263, DOI 10.1046/j.1365-2958.1998.01014.x; BLISKA JB, 1992, J EXP MED, V176, P1625, DOI 10.1084/jem.176.6.1625; Bliska JB, 2000, TRENDS MICROBIOL, V8, P205, DOI 10.1016/S0966-842X(00)01738-8; Bohnenberger H, 2011, EUR J IMMUNOL, V41, P1550, DOI 10.1002/eji.201041326; BoseDasgupta S, 2014, FEBS LETT, V588, P3898, DOI 10.1016/j.febslet.2014.08.036; BoseDasgupta S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003879; Brelle S, 2016, BIOCHEM BIOPH RES CO, V469, P619, DOI 10.1016/j.bbrc.2015.11.123; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Cornejo E, 2017, J CELL BIOL, V216, P3931, DOI 10.1083/jcb.201701095; Cozzone AJ, 2005, J MOL MICROB BIOTECH, V9, P198, DOI 10.1159/000089648; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; DIMENT S, 1989, J BIOL CHEM, V264, P13403; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Flannagan RS, 2015, PATHOGENS, V4, P826, DOI 10.3390/pathogens4040826; Fraunholz M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00043; Gaupp R, 2016, INFECT IMMUN, V84, P2031, DOI 10.1128/IAI.00285-16; Gemayel R, 2007, FEBS J, V274, P4360, DOI 10.1111/j.1742-4658.2007.05948.x; Hamza T, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0207-5; Heneberg P, 2012, CURR MED CHEM, V19, P1530, DOI 10.2174/092986712799828274; Hingley-Wilson SM, 2003, NAT IMMUNOL, V4, P949, DOI 10.1038/ni981; Horn J, 2018, INT J MED MICROBIOL, V308, P607, DOI 10.1016/j.ijmm.2017.11.009; Itoh S, 2002, BIOL PHARM BULL, V25, P837, DOI 10.1248/bpb.25.837; Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Jubrail J, 2016, CELL MICROBIOL, V18, P80, DOI 10.1111/cmi.12485; Kaniga K, 1996, MOL MICROBIOL, V21, P633, DOI 10.1111/j.1365-2958.1996.tb02571.x; Koul A, 2000, J BACTERIOL, V182, P5425, DOI 10.1128/JB.182.19.5425-5432.2000; Koziel J, 2015, J INNATE IMMUN, V7, P187, DOI 10.1159/000368048; Koziel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005210; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee YG, 2009, INT J BIOCHEM CELL B, V41, P811, DOI 10.1016/j.biocel.2008.08.011; Lin SL, 2003, CELL MICROBIOL, V5, P267, DOI 10.1046/j.1462-5822.2003.t01-1-00274.x; Lowy FD, 2000, TRENDS MICROBIOL, V8, P341, DOI 10.1016/S0966-842X(00)01803-5; MANSTEIN DJ, 1995, GENE, V162, P129, DOI 10.1016/0378-1119(95)00351-6; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Monk IR, 2015, MBIO, V6, DOI 10.1128/mBio.00308-15; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Oku T, 2012, J BIOL CHEM, V287, P42910, DOI 10.1074/jbc.M112.349829; Persson C, 1999, MOL MICROBIOL, V33, P828, DOI 10.1046/j.1365-2958.1999.01529.x; Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307; Schlievert PM, 2016, STAPHYLOCOCCUS: GENETICS AND PHYSIOLOGY, P81; Seaman MNJ, 2002, MOL BIOL CELL, V13, P2826, DOI 10.1091/mbc.02-05-0064; Seto S, 2012, CELL MICROBIOL, V14, P710, DOI 10.1111/j.1462-5822.2012.01754.x; Singh B, 2003, CLIN EXP IMMUNOL, V134, P70, DOI 10.1046/j.1365-2249.2003.02258.x; Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002; Soulat D, 2002, J BACTERIOL, V184, P5194, DOI 10.1128/JB.184.18.5194-5199.2002; Surewaard BGJ, 2016, J EXP MED, V213, P1141, DOI 10.1084/jem.20160334; Tranchemontagne ZR, 2016, INFECT IMMUN, V84, P241, DOI 10.1128/IAI.00704-15; Vega C, 2011, J MOL BIOL, V413, P24, DOI 10.1016/j.jmb.2011.08.015; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Wang J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00279-z; Wang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30018; Whitmore SE, 2012, INT J ORAL SCI, V4, P1, DOI 10.1038/ijos.2012.6; Wienke D, 2006, EUR J CELL BIOL, V85, P991, DOI 10.1016/j.ejcb.2006.04.010; Wong D, 2013, TRENDS MICROBIOL, V21, P100, DOI 10.1016/j.tim.2012.09.002; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Yi YS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/270302	65	9	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15569	15580		10.1074/jbc.RA118.003555	http://dx.doi.org/10.1074/jbc.RA118.003555			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30131335	Green Published, hybrid			2022-12-28	WOS:000446549200021
J	Yu, SH; Zhao, P; Prabhakar, PK; Sun, TT; Beedle, A; Boons, GJ; Moremen, KW; Wells, L; Steet, R				Yu, Seok-Ho; Zhao, Peng; Prabhakar, Pradeep K.; Sun, Tiantian; Beedle, Aaron; Boons, Geert-Jan; Moremen, Kelley W.; Wells, Lance; Steet, Richard			Defective mucin-type glycosylation on -dystroglycan in COG-deficient cells increases its susceptibility to bacterial proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; dystroglycan; neuraminidase; click chemistry; protease; conserved oligomeric Golgi complex; mucin-type glycan	LOW-DENSITY-LIPOPROTEIN; LASSA VIRUS ENTRY; OF-THE-LITERATURE; CONGENITAL DISORDERS; VIBRIO-CHOLERAE; PROTEIN GLYCOSYLATION; COMPLEX; EXPRESSION; DROSOPHILA; FEATURES	Deficiency in subunits of the conserved oligomeric Golgi (COG) complex results in pleiotropic defects in glycosylation and causes congenital disorders in humans. Insight regarding the functional consequences of this defective glycosylation and the identity of specific glycoproteins affected is lacking. A chemical glycobiology strategy was adopted to identify the surface glycoproteins most sensitive to altered glycosylation in COG-deficient Chinese hamster ovary (CHO) cells. Following metabolic labeling, an unexpected increase in GalNAz incorporation into several glycoproteins, including -dystroglycan (-DG), was noted in cog1-deficient ldlB cells. Western blotting analysis showed a significantly lower molecular weight for -DG in ldlB cells compared with WT CHO cells. The underglycosylated -DG molecules on ldlB cells are highly vulnerable to bacterial proteases that co-purify with V. cholerae neuraminidase, leading to rapid removal of the protein from the cell surface. The purified bacterial mucinase StcE can cleave both WT and ldlB -DG but did not cause rapid degradation of the fragments, implicating other V. cholerae proteases in the final proteolysis of the fragments. Extending terminal glycosylation on the existing mucin-type glycans of ldlB -DG stabilized the resulting fragments, indicating that fragment stability, but not the initial fragmentation of the protein, is influenced by the glycosylation status of the cell. This discovery highlights a functional importance for mucin-type O-glycans found on -DG and reinforces a growing role for these glycans as regulators of extracellular proteolysis and protein stability.	[Yu, Seok-Ho; Zhao, Peng; Prabhakar, Pradeep K.; Sun, Tiantian; Beedle, Aaron; Boons, Geert-Jan; Moremen, Kelley W.; Wells, Lance; Steet, Richard] Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Steet, R (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	rsteet@ccrc.uga.edu	Prabhakar, Pradeep/AAM-8080-2021; Boons, Geert-Jan P H/J-3211-2016; Moremen, Kelley/AAD-4661-2019; Beedle, Aaron/AAI-7014-2020; Beedle, Aaron/K-1902-2015	Boons, Geert-Jan P H/0000-0003-3111-5954; Wells, Lance/0000-0003-4956-5363; Zhao, Peng/0000-0002-9296-5293; Prabhakar, Pradeep/0000-0003-2450-5890; Beedle, Aaron/0000-0002-1019-3235; Yu, Seok-Ho/0000-0002-8372-1094	National Institutes of Health [P01GM107012, R01GM111939]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM107012, R01GM111939, P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P01GM107012 (to R. S., K. W. M., L. W., and G.-J. B.) and R01GM111939 (to L. W. and A. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilan JT, 2009, GLYCOBIOLOGY, V19, P971, DOI 10.1093/glycob/cwp074; Barone R, 2014, SEMIN NEUROL, V34, P357, DOI 10.1055/s-0034-1387197; Brancaccio A, 1997, EUR J BIOCHEM, V246, P166, DOI 10.1111/j.1432-1033.1997.00166.x; BURNET FM, 1947, AUST J EXP BIOL MED, V25, P219, DOI 10.1038/icb.1947.32; CRENNELL S, 1994, STRUCTURE, V2, P535, DOI 10.1016/S0969-2126(00)00053-8; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; Fortunato MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097567; Foulquier F, 2006, P NATL ACAD SCI USA, V103, P3764, DOI 10.1073/pnas.0507685103; Frappaolo A, 2017, J CELL SCI, V130, P3637, DOI 10.1242/jcs.209049; Freeze HH, 2007, CURR MOL MED, V7, P389, DOI 10.2174/156652407780831548; Friscourt F, 2012, J AM CHEM SOC, V134, P5381, DOI 10.1021/ja3002666; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; Heng S, 2015, FASEB J, V29, P4011, DOI 10.1096/fj.14-269456; Hennet T, 2012, BBA-GEN SUBJECTS, V1820, P1306, DOI 10.1016/j.bbagen.2012.02.001; Jae LT, 2014, SCIENCE, V344, P1506, DOI 10.1126/science.1252480; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Jaeken J, 2010, ANN NY ACAD SCI, V1214, P190, DOI 10.1111/j.1749-6632.2010.05840.x; Kim YM, 2018, J HUM GENET, V63, P383, DOI 10.1038/s10038-017-0386-7; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; KOZARSKY KF, 1986, J CELL BIOL, V102, P1567, DOI 10.1083/jcb.102.5.1567; Kranz C, 2007, HUM MOL GENET, V16, P731, DOI 10.1093/hmg/ddm028; Krasnewich D, 2007, AM J MED GENET C, V145C, P302, DOI 10.1002/ajmg.c.30143; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Lubbehusen J, 2010, HUM MOL GENET, V19, P3623, DOI 10.1093/hmg/ddq278; Marques-da-Silva D, 2017, J INHERIT METAB DIS, V40, P657, DOI 10.1007/s10545-017-0066-y; Marques-da-Silva D, 2017, J INHERIT METAB DIS, V40, P195, DOI 10.1007/s10545-016-0012-4; Mbua NE, 2011, CHEMBIOCHEM, V12, P1911, DOI 10.1002/cbic.201100117; Moremen KW, 2018, NAT CHEM BIOL, V14, P156, DOI [10.1038/NCHEMBIO.2539, 10.1038/nchembio.2539]; Oka T, 2004, MOL BIOL CELL, V15, P2423, DOI 10.1091/mbc.E03-09-0699; Paesold-Burda P, 2009, HUM MOL GENET, V18, P4350, DOI 10.1093/hmg/ddp389; Palmigiano A, 2017, J MASS SPECTROM, V52, P372, DOI 10.1002/jms.3936; Rymen D, 2015, MOL GENET METAB, V116, P163, DOI 10.1016/j.ymgme.2015.07.003; Rymen D, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-94; SCHNEIDER DR, 1982, J INFECT DIS, V145, P474, DOI 10.1093/infdis/145.4.474; Schneider M, 2006, DEVELOPMENT, V133, P3805, DOI 10.1242/dev.02549; Shestakova A, 2006, TRAFFIC, V7, P191, DOI 10.1111/j.1600-0854.2005.00376.x; STEWARTTULL DES, 1986, J MED MICROBIOL, V22, P325, DOI 10.1099/00222615-22-4-325; Szabady RL, 2011, MICROBIOL-SGM, V157, P516, DOI 10.1099/mic.0.044529-0; Ungar D, 2002, J CELL BIOL, V157, P405, DOI 10.1083/jcb.200202016; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041; Xia BY, 2013, ANAL BIOCHEM, V442, P178, DOI 10.1016/j.ab.2013.07.037; Yu SH, 2016, J BIOL CHEM, V291, P3982, DOI 10.1074/jbc.M115.700369; Zolov SN, 2005, J CELL BIOL, V168, P747, DOI 10.1083/jcb.200412003	45	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14534	14544		10.1074/jbc.RA118.003014	http://dx.doi.org/10.1074/jbc.RA118.003014			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30049793	Green Published, hybrid			2022-12-28	WOS:000444671500030
J	Chakravarti, A; Selvadurai, K; Shahoei, R; Lee, H; Fatma, S; Tajkhorshid, E; Huang, RH				Chakravarti, Arpita; Selvadurai, Kiruthika; Shahoei, Rezvan; Lee, Hugo; Fatma, Shirin; Tajkhorshid, Emad; Huang, Raven H.			Reconstitution and substrate specificity for isopentenyl pyrophosphate of the antiviral radical SAM enzyme viperin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; enzyme mechanism; radical; antiviral agent; isoprenoid; adenylation; isopentenyl pyrophosphate; radical addition; radical SAM enzyme; viperin; interferon-stimulated protein; antiviral cellular factor; antiviral protein; hydrogen abstraction	WEST NILE VIRUS; PROTEIN VIPERIN; FUNCTIONAL-CHARACTERIZATION; ENCEPHALITIS-VIRUS; IDENTIFICATION; REPLICATION; INHIBIT; EXPRESSION; INFECTION; BINDING	Viperin is a radical SAM enzyme that has been shown to possess antiviral activity against a broad spectrum of viruses; however, its molecular mechanism is unknown. We report here that recombinant fungal and archaeal viperin enzymes catalyze the addition of the 5-deoxyadenosyl radical (5-dA(center dot)) to the double bond of isopentenyl pyrophosphate (IPP), producing a new compound we named adenylated isopentyl pyrophosphate (AIPP). The reaction is specific for IPP, as other pyrophosphate compounds involved in the mevalonate biosynthetic pathway did not react with 5-dA(center dot). Enzymatic reactions employing IPP derivatives as substrates revealed that any chemical change in IPP diminishes its ability to be an effective substrate of fungal viperin. Mutational studies disclosed that the hydroxyl group on the side chain of Tyr-245 in fungal viperin is the likely source of hydrogen in the last step of the radical addition, providing mechanistic insight into the radical reaction catalyzed by fungal viperin. Structure-based molecular dynamics (MD) simulations of viperin interacting with IPP revealed a good fit of the isopentenyl motif of IPP to the active site cavity of viperin, unraveling the molecular basis of substrate specificity of viperin for IPP. Collectively, our findings indicate that IPP is an effective substrate of fungal and archaeal viperin enzymes and provide critical insights into the reaction mechanism.	[Chakravarti, Arpita; Selvadurai, Kiruthika; Lee, Hugo; Fatma, Shirin; Tajkhorshid, Emad; Huang, Raven H.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Shahoei, Rezvan] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Shahoei, Rezvan; Tajkhorshid, Emad] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Tajkhorshid, Emad; Huang, Raven H.] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Huang, RH (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.; Huang, RH (corresponding author), Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA.	huang@illinois.edu	Tajkhorshid, Emad/AAN-8323-2021; fatma, shirin/AIE-7476-2022; Shahoei, Rezvan/AAS-2088-2021	fatma, shirin/0000-0002-4504-4272; Tajkhorshid, Emad/0000-0001-8434-1010	National Institutes of Health [GM107533, P41 GM104601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107533, P41GM104601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM107533 (to R. H. H.) and P41 GM104601 (to E. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Carlton-Smith C, 2012, J VIROL, V86, P11548, DOI 10.1128/JVI.01773-12; Chan YL, 2008, J VIROL, V82, P10455, DOI 10.1128/JVI.00438-08; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Ebrahimi KH, 2017, FEBS LETT, V591, P2394, DOI 10.1002/1873-3468.12769; Ebrahimi KH, 2012, NAT CHEM BIOL, V8, P941, DOI [10.1038/NCHEMBIO.1071, 10.1038/nchembio.1071]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fenwick MK, 2017, P NATL ACAD SCI USA, V114, P6806, DOI 10.1073/pnas.1705402114; Frey PA, 2001, ANNU REV BIOCHEM, V70, P121, DOI 10.1146/annurev.biochem.70.1.121; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Gizzi AS, 2018, NATURE, V558, P610, DOI 10.1038/s41586-018-0238-4; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; HENNESSY DJ, 1984, CAN J CHEM, V62, P721, DOI 10.1139/v84-121; Hinson ER, 2010, J IMMUNOL, V184, P5723, DOI 10.4049/jimmunol.0903752; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Hover BM, 2015, P NATL ACAD SCI USA, V112, P6347, DOI 10.1073/pnas.1500697112; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim BH, 2016, NAT IMMUNOL, V17, P481, DOI 10.1038/ni.3440; Landgraf BJ, 2016, ANNU REV BIOCHEM, V85, P485, DOI 10.1146/annurev-biochem-060713-035504; Lei MM, 2015, DEV COMP IMMUNOL, V53, P293, DOI 10.1016/j.dci.2015.07.008; Lim ES, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-55; Makins C, 2016, J BIOL CHEM, V291, P26806, DOI 10.1074/jbc.M116.751040; McGillivary G, 2013, J INNATE IMMUN, V5, P60, DOI 10.1159/000342473; Mikulecky P, 2018, FEBS LETT, V592, P199, DOI 10.1002/1873-3468.12941; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; Nelp MT, 2017, BIOCHEMISTRY-US, V56, P3874, DOI 10.1021/acs.biochem.7b00608; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rabbani MAG, 2016, J VIROL, V90, P11145, DOI 10.1128/JVI.01551-16; Rivieccio MA, 2006, J IMMUNOL, V177, P4735, DOI 10.4049/jimmunol.177.7.4735; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Seo JY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003497; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Shaveta G, 2010, BIOCHEM BIOPH RES CO, V391, P1390, DOI 10.1016/j.bbrc.2009.12.070; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Stirnweiss A, 2010, J IMMUNOL, V184, P5179, DOI 10.4049/jimmunol.0902264; Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11; Tang HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep30529; Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120; Upadhyay AS, 2017, J BIOL CHEM, V292, P13879, DOI 10.1074/jbc.M117.780122; Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241; Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07; Zhu H, 1997, P NATL ACAD SCI USA, V94, P13985, DOI 10.1073/pnas.94.25.13985	57	9	10	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14122	14133		10.1074/jbc.RA118.003998	http://dx.doi.org/10.1074/jbc.RA118.003998			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30030381	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000444070700033
J	Frick, IM; Shannon, O; Neumann, A; Karlsson, C; Wikstrom, M; Bjorck, L				Frick, Inga-Maria; Shannon, Oonagh; Neumann, Ariane; Karlsson, Christofer; Wikstrom, Mats; Bjorck, Lars			Streptococcal inhibitor of complement (SIC) modulates fibrinolysis and enhances bacterial survival within fibrin clots	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						thrombin; plasminogen; innate immunity; Streptococcus pyogenes (S; pyogenes); fibrinolysis; antimicrobial agent; bacterial clearance; group A streptococci; streptococcal inhibitor of complement; virulence	GROUP-A STREPTOCOCCI; INNATE IMMUNITY; PLASMINOGEN ACTIVATION; COAGULATION SYSTEM; BINDING-PROTEIN; ANTIBACTERIAL PEPTIDES; CONTACT SYSTEM; PYOGENES; STREPTOKINASE; VIRULENCE	Some strains of the bacterial pathogen Streptococcus pyogenes secrete protein SIC (streptococcal inhibitor of complement), including strains of the clinically relevant M1 serotype. SIC neutralizes the effect of a number of antimicrobial proteins/peptides and interferes with the function of the host complement system. Previous studies have shown that some S. pyogenes proteins bind and modulate coagulation and fibrinolysis factors, raising the possibility that SIC also may interfere with the activity of these factors. Here we show that SIC interacts with both human thrombin and plasminogen, key components of coagulation and fibrinolysis. We found that during clot formation, SIC binds fibrin through its central region and that SIC inhibits fibrinolysis by interacting with plasminogen. Flow cytometry results indicated that SIC and plasminogen bind simultaneously to S. pyogenes bacteria, and fluorescence microscopy revealed co-localization of the two proteins at the bacterial surface. As a consequence, SIC-expressing bacteria entrapped in clots inhibit fibrinolysis, leading to delayed bacterial escape from the clots as compared with mutant bacteria lacking SIC. Moreover, within the clots SIC-expressing bacteria were protected against killing. In an animal model of subcutaneous infection, SIC-expressing bacteria exhibited a delayed systemic spread. These results demonstrate that the bacterial protein SIC interferes with coagulation and fibrinolysis and thereby enhances bacterial survival, a finding that has significant implications for S. pyogenes virulence.	[Frick, Inga-Maria; Shannon, Oonagh; Neumann, Ariane; Karlsson, Christofer; Bjorck, Lars] Lund Univ, Dept Clin Sci, Div Infect Med, SE-22184 Lund, Sweden; [Wikstrom, Mats] Univ Copenhagen, Prot Funct & Interact Grp, Novo Nordisk Fdn, Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Wikstrom, Mats] Amgen Inc, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA	Lund University; Novo Nordisk Foundation; University of Copenhagen; Amgen	Frick, IM (corresponding author), Lund Univ, Dept Clin Sci, Div Infect Med, SE-22184 Lund, Sweden.	Inga-Maria.Frick@med.lu.se		Shannon, Oonagh/0000-0001-8291-8189; Frick, Inga-Maria/0000-0003-3860-3010	Swedish Research Council [7480]; Knut and Alice Wallenberg Foundation; Torsten Soderberg Foundation; Alfred Osterlund Foundation; O. E. and Edla Johansson Foundation; Hansa Medical AB; Swedish Government Funds for Clinical Research (ALF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Torsten Soderberg Foundation; Alfred Osterlund Foundation; O. E. and Edla Johansson Foundation; Hansa Medical AB; Swedish Government Funds for Clinical Research (ALF)	This work was supported by Project 7480 from the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Torsten Soderberg Foundation, the Alfred Osterlund Foundation, the O. E. and Edla Johansson Foundation, Hansa Medical AB, and Swedish Government Funds for Clinical Research (ALF). The authors declare that they have no conflicts of interest with the contents of this article.	Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081; Akesson P, 2010, MICROBIOL-SGM, V156, P3660, DOI 10.1099/mic.0.039578-0; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Binks MJ, 2005, J BIOL CHEM, V280, P20120, DOI 10.1074/jbc.M414194200; BROZE GJ, 1995, ANNU REV MED, V46, P103, DOI 10.1146/annurev.med.46.1.103; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; Egesten A, 2007, J INFECT DIS, V195, P684, DOI 10.1086/510857; Facklam RF, 2002, CLIN INFECT DIS, V34, P28, DOI 10.1086/324621; Fernie-King BA, 2004, IMMUNOLOGY, V111, P444, DOI 10.1111/j.0019-2805.2004.01837.x; Fernie-King BA, 2002, INFECT IMMUN, V70, P4908, DOI 10.1128/IAI.70.9.4908-4916.2002; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Frick IM, 2003, J BIOL CHEM, V278, P16561, DOI 10.1074/jbc.M301995200; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; Frick IM, 2011, J BIOL CHEM, V286, P1331, DOI 10.1074/jbc.M110.178350; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; Glinton K, 2017, J BIOL CHEM, V292, P6775, DOI 10.1074/jbc.M116.768937; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Harder J, 2007, J ENDOTOXIN RES, V13, P317, DOI 10.1177/0968051907088275; HERWALD H, 1995, J BIOL CHEM, V270, P14634; Hoe NP, 2002, P NATL ACAD SCI USA, V99, P7646, DOI 10.1073/pnas.112039899; Iba T, 2014, CRIT CARE, V18, DOI 10.1186/cc13983; Imohl M, 2010, FEMS IMMUNOL MED MIC, V58, P389, DOI 10.1111/j.1574-695X.2010.00652.x; Khil J, 2003, J INFECT DIS, V188, P497, DOI 10.1086/377100; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Levi M, 2003, CARDIOVASC RES, V60, P26, DOI 10.1016/S0008-6363(02)00857-X; Li ZQ, 1999, J INFECT DIS, V179, P907, DOI 10.1086/314654; LIJNEN HR, 1994, EUR J BIOCHEM, V224, P863, DOI 10.1111/j.1432-1033.1994.00863.x; Loof TG, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00128; Loof TG, 2011, BLOOD, V118, P2589, DOI 10.1182/blood-2011-02-337568; Loof TG, 2011, J INNATE IMMUN, V3, P34, DOI 10.1159/000321641; Lukomski S, 2000, INFECT IMMUN, V68, P535, DOI 10.1128/IAI.68.2.535-542.2000; Malmstrom E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10261; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; Olsen RJ, 2009, CELL MICROBIOL, V11, P1, DOI 10.1111/j.1462-5822.2008.01225.x; Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854; Pahlman LI, 2013, THROMB HAEMOSTASIS, V109, P930, DOI 10.1160/TH12-10-0739; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Papareddy P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000857; Parry MAA, 2000, TRENDS BIOCHEM SCI, V25, P53, DOI 10.1016/S0968-0004(99)01521-2; Peetermans M, 2016, CRIT REV MICROBIOL, V42, P866, DOI 10.3109/1040841X.2015.1080214; Pence MA, 2010, J INNATE IMMUN, V2, P587, DOI 10.1159/000317672; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Shannon O, 2013, CURR TOP MICROBIOL, V368, P189, DOI 10.1007/82_2012_283; Shannon O, 2010, BLOOD, V116, P2365, DOI 10.1182/blood-2010-02-271858; Shelburne SA, 2005, INFECT IMMUN, V73, P4723, DOI 10.1128/IAI.73.8.4723-4731.2005; Smith SA, 2015, CRIT REV BIOCHEM MOL, V50, P326, DOI 10.3109/10409238.2015.1050550; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; Sun HM, 2009, BLOOD, V113, P1358, DOI 10.1182/blood-2008-07-170506; Tsakiris DA, 1999, THROMB HAEMOSTASIS, V81, P177, DOI 10.1055/s-0037-1614439; Waldetoft KW, 2016, INFECT IMMUN, V84, P2813, DOI 10.1128/IAI.00307-16; Walker MJ, 2014, CLIN MICROBIOL REV, V27, P264, DOI 10.1128/CMR.00101-13; WANG H, 1995, MICROB PATHOGENESIS, V18, P153, DOI 10.1016/S0882-4010(95)90013-6; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Wattam AR, 2017, NUCLEIC ACIDS RES, V45, pD535, DOI 10.1093/nar/gkw1017; Winram SB, 1996, MICROBIOL-SGM, V142, P2311, DOI 10.1099/13500872-142-8-2311; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Young KC, 1998, J BIOL CHEM, V273, P3110, DOI 10.1074/jbc.273.5.3110; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	65	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13578	13591		10.1074/jbc.RA118.001988	http://dx.doi.org/10.1074/jbc.RA118.001988			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30002122	Green Published, hybrid			2022-12-28	WOS:000443375500018
J	Hauck, AK; Zhou, T; Hahn, W; Petegrosso, R; Kuang, R; Chen, Y; Bernlohr, DA				Hauck, Amy K.; Zhou, Tong; Hahn, Wendy; Petegrosso, Raphael; Kuang, Rui; Chen, Yue; Bernlohr, David A.			Obesity-induced protein carbonylation in murine adipose tissue regulates the DNA-binding domain of nuclear zinc finger proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oxidative stress; zinc finger; adipose tissue; nuclear receptor; obesity; carbonylation; zinc finger proteins; nucleus; estrogen-related receptor; reactive oxygen species; metabolic syndrome; transcription factor	LARGE GENE LISTS; OXIDATIVE STRESS; ERR-GAMMA; INSULIN-RESISTANCE; PROTEOMIC ANALYSIS; METABOLIC SYNDROME; ACID OXIDATION; ALDEHYDES; PRODUCT; IDENTIFICATION	In obesity-linked insulin resistance, oxidative stress in adipocytes leads to lipid peroxidation and subsequent carbonylation of proteins by diffusible lipid electrophiles. Reduction in oxidative stress attenuates protein carbonylation and insulin resistance, suggesting that lipid modification of proteins may play a role in metabolic disease, but the mechanisms remain incompletely understood. Herein, we show that in vivo, diet-induced obesity in mice surprisingly results in preferential carbonylation of nuclear proteins by 4-hydroxy-trans-2,3-nonenal (4-HNE) or 4-hydroxy-trans-2,3-hexenal (4-HHE). Proteomic and structural analyses revealed that residues in or around the sites of zinc coordination of zinc finger proteins, such as those containing the C2H2 or MATRIN, RING, C3H1, or N4-type DNA-binding domains, are particularly susceptible to carbonylation by lipid aldehydes. These observations strongly suggest that carbonylation functionally disrupts protein secondary structure supported by metal coordination. Analysis of one such target, the nuclear protein estrogen-related receptor (ERR-), showed that ERR- is modified by 4-HHE in the obese state. In vitro carbonylation decreased the DNA-binding capacity of ERR- and correlated with the obesity-linked down-regulation of many key genes promoting mitochondrial bioenergetics. Taken together, these findings reveal a novel mechanistic connection between oxidative stress and metabolic dysfunction arising from carbonylation of nuclear zinc finger proteins, such as the transcriptional regulator ERR-.	[Hauck, Amy K.; Zhou, Tong; Hahn, Wendy; Chen, Yue; Bernlohr, David A.] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Petegrosso, Raphael; Kuang, Rui] Univ Minnesota Twin Cities, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bernlohr, DA (corresponding author), Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	bernl001@umn.edu			National Institutes of Health [R01 DK084669, T32 GM008347]; Minnesota Agricultural Experiment Station; CAPES Foundation, Ministry of Education of Brazil [BEX 13250/13-2]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Agricultural Experiment Station; CAPES Foundation, Ministry of Education of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 DK084669 and the Minnesota Agricultural Experiment Station (to D.A.B.), National Institutes of Health Grant T32 GM008347 (to A.K.H.), and the CAPES Foundation, Ministry of Education of Brazil (BEX 13250/13-2) (to R.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andringa KK, 2014, REDOX BIOL, V2, P1038, DOI 10.1016/j.redox.2014.09.006; Atsriku C, 2005, J AM SOC MASS SPECTR, V16, P2017, DOI 10.1016/j.jasms.2005.08.009; Awada M, 2012, J LIPID RES, V53, P2069, DOI 10.1194/jlr.M026179; Ayyadevara S, 2005, AGING CELL, V4, P257, DOI 10.1111/j.1474-9726.2005.00168.x; Boden G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4765; BRUENNER BA, 1995, CHEM RES TOXICOL, V8, P552, DOI 10.1021/tx00046a009; Chavez JD, 2011, J PROTEOMICS, V74, P2417, DOI 10.1016/j.jprot.2011.03.031; Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI [10.1002/0471250953.bi1315s35, 10.1002/0471250953.bi1316s36]; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Curtis JM, 2012, J BIOL CHEM, V287, P32967, DOI 10.1074/jbc.M112.400663; Curtis JM, 2012, TRENDS ENDOCRIN MET, V23, P399, DOI 10.1016/j.tem.2012.05.008; Curtis JM, 2010, DIABETES, V59, P1132, DOI 10.2337/db09-1105; Dixen K, 2013, OBESITY, V21, P516, DOI 10.1002/oby.20067; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Ecco G, 2017, DEVELOPMENT, V144, P2719, DOI 10.1242/dev.132605; Eichner LJ, 2011, MITOCHONDRION, V11, P544, DOI 10.1016/j.mito.2011.03.121; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fedotova AA, 2017, ACTA NATURAE, V9, P47, DOI 10.32607/20758251-2017-9-2-47-58; Frohnert BI, 2014, DIABETES, V63, P89, DOI 10.2337/db13-0777; Frohnert BI, 2011, OBESITY, V19, P1735, DOI 10.1038/oby.2011.115; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Galinier A, 2006, J BIOL CHEM, V281, P12682, DOI 10.1074/jbc.M506949200; Garton M, 2015, NUCLEIC ACIDS RES, V43, P9147, DOI 10.1093/nar/gkv919; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Grimsrud PA, 2007, MOL CELL PROTEOMICS, V6, P624, DOI 10.1074/mcp.M600120-MCP200; Gueraud F, 2010, FREE RADICAL RES, V44, P1098, DOI 10.3109/10715762.2010.498477; Hahn WS, 2014, AM J PHYSIOL-ENDOC M, V306, pE1033, DOI 10.1152/ajpendo.00422.2013; Hamdy O, 2006, CURR DIABETES REV, V2, P367, DOI 10.2174/1573399810602040367; Hauck AK, 2016, J LIPID RES, V57, P1976, DOI 10.1194/jlr.R066597; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ilbert M, 2006, ANTIOXID REDOX SIGN, V8, P835, DOI 10.1089/ars.2006.8.835; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kida YS, 2015, CELL STEM CELL, V16, P547, DOI 10.1016/j.stem.2015.03.001; Kristal BS, 1996, J BIOL CHEM, V271, P6033, DOI 10.1074/jbc.271.11.6033; Kroncke KD, 2009, ANTIOXID REDOX SIGN, V11, P1015, DOI [10.1089/ars.2008.2269, 10.1089/ARS.2008.2269]; Long EK, 2008, J NEUROCHEM, V105, P714, DOI 10.1111/j.1471-4159.2007.05175.x; Long EK, 2013, FREE RADICAL BIO MED, V63, P390, DOI 10.1016/j.freeradbiomed.2013.05.030; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Misra J, 2017, TRENDS ENDOCRIN MET, V28, P261, DOI 10.1016/j.tem.2016.12.005; Moller IM, 2011, J PROTEOMICS, V74, P2228, DOI 10.1016/j.jprot.2011.05.004; NADKARNI DV, 1995, CHEM RES TOXICOL, V8, P284, DOI 10.1021/tx00044a014; Pace NJ, 2014, BIOMOLECULES, V4, P419, DOI 10.3390/biom4020419; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698; Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Shearn CT, 2015, FREE RADICAL BIO MED, V89, P1144, DOI 10.1016/j.freeradbiomed.2015.10.420; Shearn CT, 2016, REDOX BIOL, V7, P68, DOI 10.1016/j.redox.2015.11.013; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; UCHIDA K, 1993, P NATL ACAD SCI USA, V90, P8742, DOI 10.1073/pnas.90.18.8742; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Vigilanza P, 2011, J CELL PHYSIOL, V226, P2016, DOI 10.1002/jcp.22542; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang T, 2015, MOL CELL BIOL, V35, P1281, DOI 10.1128/MCB.01156-14; Wong CM, 2008, CIRC RES, V102, P310, DOI 10.1161/CIRCRESAHA.107.159814; Wong HL, 2008, CHEM RES TOXICOL, V21, P796, DOI 10.1021/tx700433m; Xu QH, 2014, METHOD ENZYMOL, V538, P249, DOI 10.1016/B978-0-12-800280-3.00014-1; Yoshihara E, 2016, CELL METAB, V23, P622, DOI 10.1016/j.cmet.2016.03.005	61	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13464	13476		10.1074/jbc.RA118.003469	http://dx.doi.org/10.1074/jbc.RA118.003469			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30012885	hybrid, Green Published			2022-12-28	WOS:000443375500010
J	Mandon, EC; Butova, C; Lachapelle, A; Gilmore, R				Mandon, Elisabet C.; Butova, Cameron; Lachapelle, Amber; Gilmore, Reid			Conserved motifs on the cytoplasmic face of the protein translocation channel are critical for the transition between resting and active conformations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); membrane protein; protein synthesis; protein translocation; ribosome; Sec61; translocation channel	SIGNAL RECOGNITION PARTICLE; ENDOPLASMIC-RETICULUM MEMBRANE; SACCHAROMYCES-CEREVISIAE; RIBOSOME-BINDING; COTRANSLATIONAL TRANSLOCATION; SEQUENCE RECOGNITION; TARGETING ROUTE; SEC61 COMPLEX; ER MEMBRANE; YEAST	The Sec61 complex is the primary cotranslational protein translocation channel in yeast (Saccharomyces cerevisiae). The structural transition between the closed inactive conformation of the Sec61 complex and its open and active conformation is thought to be promoted by binding of the ribosome nascent-chain complex to the cytoplasmic surface of the Sec61 complex. Here, we have analyzed new yeast Sec61 mutants that selectively interfere with cotranslational translocation across the endoplasmic reticulum. We found that a single substitution at the junction between transmembrane segment TM7 and the L6/7 loop interferes with cotranslational translocation by uncoupling ribosome binding to the L6/7 loop from the separation of the lateral gate transmembrane spans. Substitutions replacing basic residues with acidic residues in the C-terminal tail of Sec61 had an unanticipated impact upon binding of ribosomes to the Sec61 complex. We found that similar charge-reversal mutations in the N-terminal tail and in cytoplasmic loop L2/3 did not alter ribosome binding but interfered with translocation channel gating. These findings indicated that these segments are important for the structural transition between the inactive and active conformations of the Sec61 complex. In summary our results have identified additional cytosolic segments of the Sec61 complex important for promoting the structural transition between the closed and open conformations of the complex. We conclude that positively charged residues in multiple cytosolic segments, as well as bulky hydrophobic residues in the L6/7-TM7 junction, are required for cotranslational translocation or integration of membrane proteins by the Sec61 complex.	[Mandon, Elisabet C.; Butova, Cameron; Lachapelle, Amber; Gilmore, Reid] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Butova, Cameron] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Lachapelle, Amber] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Amherst; Framingham Heart Study	Gilmore, R (corresponding author), 364 Plantat St, Worcester, MA 01605 USA.	reid.gilmore@umassmed.edu			NIGMS, National Institutes of Health [RO1 GM35687]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035687] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIGMS, National Institutes of Health Grant RO1 GM35687. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARNOLD CE, 1994, J BIOL CHEM, V269, P30412; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Aviram N, 2016, NATURE, V540, P134, DOI 10.1038/nature20169; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Chartron JW, 2016, NATURE, V536, P224, DOI 10.1038/nature19309; Cheng ZL, 2006, NAT STRUCT MOL BIOL, V13, P930, DOI 10.1038/nsmb1146; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; Corsi AK, 1996, J BIOL CHEM, V271, P30299, DOI 10.1074/jbc.271.48.30299; Costa EA, 2018, SCIENCE, V359, P689, DOI 10.1126/science.aar3607; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; HANN BC, 1991, CELL, V67, P131, DOI 10.1016/0092-8674(91)90577-L; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Jiang Y, 2008, J CELL BIOL, V180, P1149, DOI 10.1083/jcb.200707196; JOHNSSON N, 1994, EMBO J, V13, P2686, DOI 10.1002/j.1460-2075.1994.tb06559.x; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Mutka SC, 2001, MOL BIOL CELL, V12, P577, DOI 10.1091/mbc.12.3.577; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; OGG SC, 1992, MOL BIOL CELL, V3, P895, DOI 10.1091/mbc.3.8.895; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Prinz A, 2000, BIOL CHEM, V381, P1025, DOI 10.1515/BC.2000.126; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Raden D, 2000, J CELL BIOL, V150, P53, DOI 10.1083/jcb.150.1.53; ROTHBLATT J, 1989, METHOD CELL BIOL, V32, P3; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; SILBERSTEIN S, 1995, J CELL BIOL, V131, P371, DOI 10.1083/jcb.131.2.371; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Tripathi A, 2017, J BIOL CHEM, V292, P8007, DOI 10.1074/jbc.M116.761122; Trueman SF, 2012, J CELL BIOL, V199, P907, DOI 10.1083/jcb.201207163; Trueman SF, 2011, MOL BIOL CELL, V22, P2983, DOI 10.1091/mbc.E11-01-0070; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Wittke S, 2002, MOL BIOL CELL, V13, P2223, DOI 10.1091/mbc.01-10-0518; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	48	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13662	13672		10.1074/jbc.RA118.004123	http://dx.doi.org/10.1074/jbc.RA118.004123			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29986881	Green Published, hybrid			2022-12-28	WOS:000443375500025
J	Xu, XH; Wang, L; Liu, BF; Xie, W; Chen, YG				Xu, Xuanhao; Wang, Lu; Liu, Bofeng; Xie, Wei; Chen, Ye-Guang			Activin/Smad2 and Wnt/beta-catenin up-regulate HAS2 and ALDH3A2 to facilitate mesendoderm differentiation of human embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; PRIMITIVE STREAK; RETINOIC ACID; SELF-RENEWAL; CHROMATIN; HYALURONAN; SMADS; FATE; WNT; TRANSCRIPTION	Activin and Wnt signaling are necessary and sufficient for mesendoderm (ME) differentiation of human embryonic stem cells (ESCs). In this study, we report that during ME differentiation induced by Activin and Wnt, Activin/Smad2 induces a decrease of the repressive histone modification ofH3K27me3by promoting the proteasome-dependent degradation of enhancer of zeste 2 polycomb (EZH2)-repressive complex 2 subunit. As a result, recruitment of the forkhead protein FOXH1 on open chromatin regions integrates the signals of Activin/Smad2 and Wnt/beta-catenin to activate the expression of the ME genes including HAS2 and ALDH3A2. Consistently, H3K27me3 decrease is enriched on open chromatin around regulatory regions. Furthermore, knockdown ofHAS2orALDH3A2greatly attenuates ME differentiation. These findings unveil a pathway from extracellular signals to epigenetic modification-mediated gene activation during ME commitment.	[Xu, Xuanhao; Wang, Lu; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Liu, Bofeng; Xie, Wei] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Chen, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019		National Natural Science Foundation of China [31730056]; National Key Research and Development Program of China [2017YFA0103601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by National Natural Science Foundation of China Grant 31730056 and National Key Research and Development Program of China Grant 2017YFA0103601 (to Y. G. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Attisano L, 2001, MOL CELL ENDOCRINOL, V180, P3, DOI 10.1016/S0303-7207(01)00524-X; Bertero A, 2015, GENE DEV, V29, P702, DOI 10.1101/gad.255984.114; Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; CHEN M, 1994, MOL PHARMACOL, V46, P88; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Choudhary M, 2007, STEM CELLS, V25, P3045, DOI 10.1634/stemcells.2007-0296; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Collinson A, 2016, CELL REP, V17, P2700, DOI 10.1016/j.celrep.2016.11.032; Davenport C, 2016, STEM CELLS, V34, P2635, DOI 10.1002/stem.2428; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Estaras C, 2015, MOL CELL, V58, P780, DOI 10.1016/j.molcel.2015.04.001; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Funa NS, 2015, CELL STEM CELL, V16, P639, DOI 10.1016/j.stem.2015.03.008; Gaarenstroom T, 2014, SEMIN CELL DEV BIOL, V32, P107, DOI 10.1016/j.semcdb.2014.01.009; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hill CS, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022079; Hoodless PA, 2001, GENE DEV, V15, P1257, DOI 10.1101/gad.881501; Huang W, 2014, DEV BIOL, V394, P83, DOI 10.1016/j.ydbio.2014.07.021; Itoh F, 2014, SEMIN CELL DEV BIOL, V32, P98, DOI 10.1016/j.semcdb.2014.05.017; Jiang W, 2013, CELL RES, V23, P122, DOI 10.1038/cr.2012.119; Keller MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5439; Kim SW, 2011, DEV BIOL, V357, P492, DOI 10.1016/j.ydbio.2011.06.009; Kimura H, 2013, J HUM GENET, V58, P439, DOI 10.1038/jhg.2013.66; Kunwar PS, 2003, DEVELOPMENT, V130, P5589, DOI 10.1242/dev.00803; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Li M, 2012, NAT REV MOL CELL BIO, V13, P524, DOI 10.1038/nrm3393; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Liu YT, 2015, INT J CLIN EXP MED, V8, P17601; Loh KM, 2016, CELL, V166, P451, DOI 10.1016/j.cell.2016.06.011; Lolas M, 2014, P NATL ACAD SCI USA, V111, P4478, DOI 10.1073/pnas.1402612111; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Munoz-Descalzo S, 2015, SEMIN CELL DEV BIOL, V47-48, P101, DOI 10.1016/j.semcdb.2015.08.011; Pan MR, 2018, CELL MOL LIFE SCI, V75, P209, DOI 10.1007/s00018-017-2596-8; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Reissmann E, 2001, GENE DEV, V15, P2010, DOI 10.1101/gad.201801; Spicer AP, 1996, J BIOL CHEM, V271, P23400, DOI 10.1074/jbc.271.38.23400; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang L, 2017, J BIOL CHEM, V292, P1339, DOI 10.1074/jbc.M116.766949; Wang L, 2016, J MOL BIOL, V428, P1409, DOI 10.1016/j.jmb.2015.06.013; Wang Q, 2017, CELL STEM CELL, V20, P70, DOI 10.1016/j.stem.2016.10.002; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu YL, 2013, EMBO MOL MED, V5, P531, DOI 10.1002/emmm.201201783; Zhou S, 1998, MOL CELL, V2, P121, DOI 10.1016/S1097-2765(00)80120-3	49	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18444	18453		10.1074/jbc.RA118.003688	http://dx.doi.org/10.1074/jbc.RA118.003688			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30282636	hybrid, Green Published			2022-12-28	WOS:000458467300003
J	Wood, BM; Maria, JPS; Matano, LM; Vickery, CR; Walker, S				Wood, B. McKay; Maria, John P. Santa, Jr.; Matano, Leigh M.; Vickery, Christopher R.; Walker, Suzanne			A partial reconstitution implicates DltD in catalyzing lipoteichoic acid d-alanylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						teichoic acid; acyltransferase; cell wall; Staphylococcus aureus (S; aureus); membrane protein; DLT pathway; MBOAT; pathway reconstitution; DltB	GRAM-POSITIVE BACTERIA; CARRIER PROTEIN LIGASE; WALL TEICHOIC-ACID; ALANINE ESTER SUBSTITUTION; GHRELIN O-ACYLTRANSFERASE; STAPHYLOCOCCUS-AUREUS; BACILLUS-SUBTILIS; ANTIMICROBIAL PEPTIDES; STREPTOCOCCUS-MUTANS; CRYSTAL-STRUCTURE	Modifications to the Gram-positive bacterial cell wall play important roles in antibiotic resistance and pathogenesis, but the pathway for the d-alanylation of teichoic acids (DLT pathway), a ubiquitous modification, is poorly understood. The d-alanylation machinery includes two membrane proteins of unclear function, DltB and DltD, which are somehow involved in transfer of d-alanine from a carrier protein inside the cell to teichoic acids on the cell surface. Here, we probed the role of DltD in the human pathogen Staphylococcus aureus using both cell-based and biochemical assays. We first exploited a known synthetic lethal interaction to establish the essentiality of each gene in the DLT pathway for d-alanylation of lipoteichoic acid (LTA) and confirmed this by directly detecting radiolabeled d-Ala-LTA both in cells and in vesicles prepared from mutant strains of S. aureus. We developed a partial reconstitution of the pathway by using cell-derived vesicles containing DltB, but no other components of the d-alanylation pathway, and showed that d-alanylation of previously formed lipoteichoic acid in the DltB vesicles requires the presence of purified and reconstituted DltA, DltC, and DltD, but not of the LTA synthase LtaS. Finally, based on the activity of DltD mutants in cells and in our reconstituted system, we determined that Ser-70 and His-361 are essential for d-alanylation activity, and we propose that DltD uses a catalytic dyad to transfer d-alanine to LTA. In summary, we have developed a suite of assays for investigating the bacterial DLT pathway and uncovered a role for DltD in LTA d-alanylation.	[Wood, B. McKay; Maria, John P. Santa, Jr.; Matano, Leigh M.; Vickery, Christopher R.; Walker, Suzanne] Harvard Med Sch, Dept Microbiol, HIM Rm 1013,4 Blackfan Circle, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Walker, S (corresponding author), Harvard Med Sch, Dept Microbiol, HIM Rm 1013,4 Blackfan Circle, Boston, MA 02115 USA.	suzanne_walker@hms.harvard.edu			National Institutes of Health [R01AI099144, R21AI119892, P01AI083214]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083214, R01AI099144, R21AI119892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R01AI099144, R21AI119892, and P01AI083214 (to S. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARCHIBALD AR, 1973, BIOCHIM BIOPHYS ACTA, V291, P629; Asler IL, 2017, ACS CHEM BIOL, V12, P1928, DOI 10.1021/acschembio.6b01140; Atila Metin, 2016, F1000Res, V5, P121, DOI 10.12688/f1000research.7842.2; Barnett BP, 2010, SCIENCE, V330, P1689, DOI 10.1126/science.1196154; BEINING PR, 1975, J BACTERIOL, V121, P137, DOI 10.1128/JB.121.1.137-143.1975; Bensaci MF, 2007, FEMS MICROBIOL LETT, V268, P106, DOI 10.1111/j.1574-6968.2006.00591.x; Boyd DA, 2000, J BACTERIOL, V182, P6055, DOI 10.1128/JB.182.21.6055-6065.2000; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Clemans DL, 1999, INFECT IMMUN, V67, P2464, DOI 10.1128/IAI.67.5.2464-2474.1999; Collins LV, 2002, J INFECT DIS, V186, P214, DOI 10.1086/341454; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Debabov DV, 1996, J BACTERIOL, V178, P3869, DOI 10.1128/jb.178.13.3869-3876.1996; Debabov DV, 2000, J BACTERIOL, V182, P2855, DOI 10.1128/JB.182.10.2855-2864.2000; Du LQ, 2008, BIOCHEMISTRY-US, V47, P11473, DOI 10.1021/bi801363b; Du Liqin, 2014, F1000Res, V3, P106, DOI 10.12688/f1000research.4097.1; Fabretti F, 2006, INFECT IMMUN, V74, P4164, DOI 10.1128/IAI.00111-06; FISCHER W, 1980, FEBS LETT, V119, P224, DOI 10.1016/0014-5793(80)80257-2; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; HANCOCK IC, 1976, FEBS LETT, V69, P75, DOI 10.1016/0014-5793(76)80657-6; HEATON MP, 1994, J BACTERIOL, V176, P681, DOI 10.1128/jb.176.3.681-690.1994; HEATON MP, 1992, J BACTERIOL, V174, P4707, DOI 10.1128/JB.174.14.4707-4717.1992; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hunt CL, 2006, J IMMUNOL, V176, P4987, DOI 10.4049/jimmunol.176.8.4987; Hyyrylainen HL, 2000, J BIOL CHEM, V275, P26696; Kamar R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01437; Kang KM, 2017, J MICROBIOL, V55, P153, DOI 10.1007/s12275-017-6509-1; Kato F, 2011, J MICROBIOL METH, V87, P76, DOI 10.1016/j.mimet.2011.07.010; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kiriukhin MY, 2001, J BACTERIOL, V183, P2051, DOI 10.1128/JB.183.6.2051-2058.2001; Knol J, 1998, BIOCHEMISTRY-US, V37, P16410, DOI 10.1021/bi981596u; KOCH HU, 1985, J BACTERIOL, V164, P1211, DOI 10.1128/JB.164.3.1211-1217.1985; Koprivnjak T, 2006, J BACTERIOL, V188, P3622, DOI 10.1128/JB.188.10.3622-3630.2006; Kovacs M, 2006, J BACTERIOL, V188, P5797, DOI 10.1128/JB.00336-06; Kristian SA, 2005, J BACTERIOL, V187, P6719, DOI 10.1128/JB.187.19.6719-6725.2005; LAMBERT PA, 1975, BIOCHEM J, V151, P671, DOI 10.1042/bj1510671; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lee LC, 2006, BIOCHEM J, V397, P69, DOI 10.1042/BJ20051645; MACARTHUR AE, 1984, J BACTERIOL, V160, P792, DOI 10.1128/JB.160.2.792-793.1984; MAJERUS PW, 1965, P NATL ACAD SCI USA, V53, P410, DOI 10.1073/pnas.53.2.410; Maria JPS, 2014, P NATL ACAD SCI USA, V111, P12510, DOI 10.1073/pnas.1404099111; Matano LM, 2016, BIOORGAN MED CHEM, V24, P6307, DOI 10.1016/j.bmc.2016.08.003; May JJ, 2005, FEBS J, V272, P2993, DOI 10.1111/j.1742-4658.2005.04700.x; Mazda Y, 2012, MOL ORAL MICROBIOL, V27, P124, DOI 10.1111/j.2041-1014.2012.00637.x; McBride SM, 2011, MICROBIOL-SGM, V157, P1457, DOI 10.1099/mic.0.045997-0; Mishra NN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107426; Nakao A, 2000, RES MICROBIOL, V151, P823, DOI 10.1016/S0923-2508(00)01148-7; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Nilsson M, 2016, INT J ANTIMICROB AG, V48, P298, DOI 10.1016/j.ijantimicag.2016.06.019; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Osman KT, 2009, J MOL BIOL, V388, P345, DOI 10.1016/j.jmb.2009.03.040; Pasquina L, 2016, NAT CHEM BIOL, V12, P40, DOI [10.1038/NCHEMBIO.1967, 10.1038/nchembio.1967]; Percy MG, 2014, ANNU REV MICROBIOL, V68, P81, DOI 10.1146/annurev-micro-091213-112949; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Reichmann NT, 2013, MICROBIOL-SGM, V159, P1868, DOI 10.1099/mic.0.069898-0; Resh MD, 2016, PROG LIPID RES, V63, P120, DOI 10.1016/j.plipres.2016.05.002; Revilla-Guarinos A, 2014, J APPL MICROBIOL, V116, P1250, DOI 10.1111/jam.12442; Riley LM, 2013, J BIOL CHEM, V288, P22299, DOI 10.1074/jbc.M113.484931; RUHLAND GJ, 1990, ARCH MICROBIOL, V154, P375, DOI 10.1007/BF00276534; Sham LT, 2014, SCIENCE, V345, P220, DOI 10.1126/science.1254522; SPECTOR A A, 1979, Progress in Lipid Research, V18, P31, DOI 10.1016/0163-7827(79)90003-1; Steen A, 2005, J BACTERIOL, V187, P114, DOI 10.1128/JB.187.1.114-124.2005; Taylor MS, 2013, J BIOL CHEM, V288, P32211, DOI 10.1074/jbc.M113.510313; Velez MP, 2007, APPL ENVIRON MICROB, V73, P3595, DOI 10.1128/AEM.02083-06; Volkman BF, 2001, BIOCHEMISTRY-US, V40, P7964, DOI 10.1021/bi010355a; Walter J, 2007, ENVIRON MICROBIOL, V9, P1750, DOI 10.1111/j.1462-2920.2007.01292.x; Wecke J, 1997, MICROBIOL-UK, V143, P2953, DOI 10.1099/00221287-143-9-2953; Wecke J, 1996, MICROB DRUG RESIST, V2, P123, DOI 10.1089/mdr.1996.2.123; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wobser D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107827; Wormann ME, 2011, J BACTERIOL, V193, P5279, DOI 10.1128/JB.00369-11; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200; Zimmermann S, 2015, FEBS LETT, V589, P2283, DOI 10.1016/j.febslet.2015.07.008; Zweytick D, 2000, EUR J BIOCHEM, V267, P1075, DOI 10.1046/j.1432-1327.2000.01103.x	83	24	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17985	17996		10.1074/jbc.RA118.004561	http://dx.doi.org/10.1074/jbc.RA118.004561			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30237166	Green Published, hybrid			2022-12-28	WOS:000450409500026
J	Rao, YL; Wan, QY; Su, H; Xiao, X; Liao, ZW; Ji, JF; Yang, CR; Lin, L; Su, JG				Rao, Youliang; Wan, Quanyuan; Su, Hang; Xiao, Xun; Liao, Zhiwei; Ji, Jianfei; Yang, Chunrong; Lin, Li; Su, Jianguo			ROS-induced HSP70 promotes cytoplasmic translocation of high-mobility group box 1b and stimulates antiviral autophagy in grass carp kidney cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; heat shock protein (HSP); innate immunity; Beclin-1 (BECN1); oxidative stress; viral replication; Ctenopharyngodon idella; GCRV; HMGB1; HSP70; innate immunity	HEAT-SHOCK-RESPONSE; OXIDATIVE STRESS; REGULATES AUTOPHAGY; VIRUS-REPLICATION; TARGETING HMGB1; POTENTIAL ROLES; MECHANISM; RELEASE; HEAT-SHOCK-PROTEIN-72; ACTIVATION	Autophagy plays many physiological and pathophysiological roles. However, the roles and the regulatory mechanisms of autophagy in response to viral infections are poorly defined in teleost fish, such as grass carp (Ctenopharyngodon idella), which is one of the most important aquaculture species in China. In this study, we found that both grass carp reovirus (GCRV) infection and hydrogen peroxide (H2O2) treatment induced the accumulation of reactive oxygen species (ROS) in C. idella kidney cells and stimulate autophagy. Suppressing ROS accumulation with N-acetyl-l-cysteine significantly inhibited GCRV-induced autophagy activation and enhanced GCRV replication. Although ROS-induced autophagy, in turn, restricted GCRV replication, further investigation revealed that the multifunctional cellular protein high-mobility group box 1b (HMGB1b) serves as a heat shock protein 70 (HSP70)-dependent, pro-autophagic protein in grass carp. Upon H2O2 treatment, cytoplasmic HSP70 translocated to the nucleus, where it interacted with HMGB1b and promoted cytoplasmic translocation of HMGB1b. Overexpression and siRNA-mediated knockdown assays indicated that HSP70 and HMGB1b synergistically enhance ROS-induced autophagic activation in the cytoplasm. Moreover, HSP70 reinforced an association of HMGB1b with the C. idella ortholog of Beclin 1 (a mammalian ortholog of the autophagy-associated yeast protein ATG6) by directly interacting with C. idella Beclin 1. In summary, this study highlights the antiviral function of ROS-induced autophagy in response to GCRV infection and reveals the positive role of HSP70 in HMGB1b-mediated autophagy initiation in teleost fish.	[Rao, Youliang; Wan, Quanyuan; Su, Hang; Xiao, Xun; Liao, Zhiwei; Ji, Jianfei; Su, Jianguo] Huazhong Agr Univ, Coll Fisheries, Wuhan 430070, Hubei, Peoples R China; [Rao, Youliang; Su, Jianguo] Pilot Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266237, Peoples R China; [Wan, Quanyuan; Lin, Li] Zhongkai Univ Agr & Engn, Coll Anim Sci & Technol, Guangzhou 510225, Guangdong, Peoples R China; [Yang, Chunrong] Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan 430070, Hubei, Peoples R China	Huazhong Agricultural University; Qingdao National Laboratory for Marine Science & Technology; Zhongkai University of Agriculture & Engineering; Huazhong Agricultural University	Su, JG (corresponding author), Huazhong Agr Univ, Coll Fisheries, Wuhan 430070, Hubei, Peoples R China.; Su, JG (corresponding author), Pilot Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266237, Peoples R China.	sujianguo@mail.hzau.edu.cn	Wan, Quanyuan/AAD-5810-2022; Su, Jianguo/A-7444-2015; Wan, Quanyuan/D-1149-2015; Su, Jianguo/G-9277-2012	Wan, Quanyuan/0000-0003-4227-1530; Su, Jianguo/0000-0002-9083-0715; Wan, Quanyuan/0000-0003-4227-1530; Su, Jianguo/0000-0002-9083-0715	National Natural Science Foundation of China [31572648]; Huazhong Agricultural University Scientific and Technological Self-innovation Foundation [2014RC019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huazhong Agricultural University Scientific and Technological Self-innovation Foundation	This work was supported by the National Natural Science Foundation of China (31572648) and the Huazhong Agricultural University Scientific and Technological Self-innovation Foundation (2014RC019). The authors declare that they have no conflicts of interest with the contents of this article.	Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Delorme-Axford E, 2013, AUTOPHAGY, V9, P2173, DOI 10.4161/auto.26558; Dokladny K, 2015, AUTOPHAGY, V11, P200, DOI 10.1080/15548627.2015.1009776; Dokladny K, 2013, J BIOL CHEM, V288, P14959, DOI 10.1074/jbc.M113.462408; Dong XN, 2013, J INNATE IMMUN, V5, P480, DOI 10.1159/000346388; He RN, 2015, AUTOPHAGY, V11, P740, DOI 10.1080/15548627.2015.1034404; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang R, 2011, AUTOPHAGY, V7, P1256, DOI 10.4161/auto.7.10.16753; Kang R, 2010, AUTOPHAGY, V6, P1209, DOI 10.4161/auto.6.8.13651; Kobayashi S, 2014, VIRUS RES, V191, P83, DOI 10.1016/j.virusres.2014.07.016; Lahaye X, 2012, J VIROL, V86, P4743, DOI 10.1128/JVI.06501-11; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li LL, 2015, CELL MOL NEUROBIOL, V35, P615, DOI 10.1007/s10571-015-0166-x; Li S, 2011, AM J PATHOL, V179, P2822, DOI 10.1016/j.ajpath.2011.08.013; Li YH, 2011, J GENET GENOMICS, V38, P111, DOI 10.1016/j.jgg.2011.02.001; Liu K, 2014, AUTOPHAGY, V10, P442, DOI 10.4161/auto.27418; Liu LY, 2015, CELL MICROBIOL, V17, P595, DOI 10.1111/cmi.12387; Liu XH, 2016, FISH PHYSIOL BIOCHEM, V42, P111, DOI 10.1007/s10695-015-0122-1; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moy RH, 2014, IMMUNITY, V40, P51, DOI 10.1016/j.immuni.2013.10.020; Navarro-Yepes J, 2014, ANTIOXID REDOX SIGN, V21, P66, DOI 10.1089/ars.2014.5837; Rao YL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00352; Rao YL, 2015, CELL MOL IMMUNOL, V12, P342, DOI 10.1038/cmi.2014.55; Rao YL, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/670437; Rao YL, 2013, DEV COMP IMMUNOL, V41, P164, DOI 10.1016/j.dci.2013.06.002; Reshi Mohammad Latif, 2014, Int J Cell Biol, V2014, P467452, DOI 10.1155/2014/467452; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sharma M, 2014, AUTOPHAGY, V10, P1637, DOI 10.4161/auto.29455; Sun XF, 2014, AUTOPHAGY, V10, P1873, DOI 10.4161/auto.32184; Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046; Tang D, 2010, ONCOGENE, V29, P5299, DOI 10.1038/onc.2010.261; Tang DL, 2007, J IMMUNOL, V179, P1236, DOI 10.4049/jimmunol.179.2.1236; Tang DL, 2007, J IMMUNOL, V178, P7376, DOI 10.4049/jimmunol.178.11.7376; Tang DL, 2011, CELL METAB, V13, P701, DOI 10.1016/j.cmet.2011.04.008; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Varga M, 2015, METHODS, V75, P172, DOI 10.1016/j.ymeth.2014.12.004; Vriend J, 2015, MOL CELL ENDOCRINOL, V401, P213, DOI 10.1016/j.mce.2014.12.013; Wan QY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12946; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Yang CR, 2013, FISH SHELLFISH IMMUN, V35, P1501, DOI 10.1016/j.fsi.2013.08.019; Yang CR, 2013, DEV COMP IMMUNOL, V39, P133, DOI 10.1016/j.dci.2012.11.008; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI 10.1016/j.bbagrm.2009.11.019; Yang YH, 2013, P NATL ACAD SCI USA, V110, P6841, DOI 10.1073/pnas.1217692110; Yu Y, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00093; Zhong LM, 2017, J VIROL, V91, DOI 10.1128/JVI.00001-17; Zhu L, 2016, NEUROSCIENCE, V315, P286, DOI 10.1016/j.neuroscience.2015.12.020	48	35	39	4	73	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17387	17401		10.1074/jbc.RA118.003840	http://dx.doi.org/10.1074/jbc.RA118.003840			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30237170	hybrid, Green Published			2022-12-28	WOS:000449799000007
J	Ward, SJ; Gratton, HE; Indrayudha, P; Michavila, C; Mukhopadhyay, R; Maurer, SK; Caulton, SG; Emsley, J; Dreveny, I				Ward, Stephanie J.; Gratton, Hayley E.; Indrayudha, Peni; Michavila, Camille; Mukhopadhyay, Rishov; Maurer, Sigrun K.; Caulton, Simon G.; Emsley, Jonas; Dreveny, Ingrid			The structure of the deubiquitinase USP15 reveals a misaligned catalytic triad and an open ubiquitin-binding channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; deubiquitylation (deubiquitination); cysteine protease; protein conformation; ubiquitin; protease; protein degradation; catalytic triad; ubiquitin-specific protease; USP15	DEUBIQUITYLATING ENZYMES; MITOXANTRONE TARGETS; TGF-BETA; CYLD USP; DOMAIN; ACTIVATION; SPECIFICITY; MECHANISMS; INHIBITOR; POLYUBIQUITIN	Ubiquitin-specific protease 15 (USP15) regulates important cellular processes, including transforming growth factor (TGF-) signaling, mitophagy, mRNA processing, and innate immune responses; however, structural information on USP15's catalytic domain is currently unavailable. Here, we determined crystal structures of the USP15 catalytic core domain, revealing a canonical USP fold, including a finger, palm, and thumb region. Unlike for the structure of paralog USP4, the catalytic triad is in an inactive configuration with the catalytic cysteine approximate to 10 apart from the catalytic histidine. This conformation is atypical, and a similar misaligned catalytic triad has so far been observed only for USP7, although USP15 and USP7 are differently regulated. Moreover, we found that the active-site loops are flexible, resulting in a largely open ubiquitin tail-binding channel. Comparison of the USP15 and USP4 structures points to a possible activation mechanism. Sequence differences between these two USPs mainly map to the S1 region likely to confer specificity, whereas the S1 ubiquitin-binding pocket is highly conserved. Isothermal titration calorimetry monoubiquitin- and linear diubiquitin-binding experiments showed significant differences in their thermodynamic profiles, with USP15 displaying a lower affinity for monoubiquitin than USP4. Moreover, we report that USP15 is weakly inhibited by the antineoplastic agent mitoxantrone in vitro. A USP15-mitoxantrone complex structure disclosed that the anthracenedione interacts with the S1 binding site. Our results reveal first insights into USP15's catalytic domain structure, conformational changes, differences between paralogs, and small-molecule interactions and establish a framework for cellular probe and inhibitor development.	[Ward, Stephanie J.; Gratton, Hayley E.; Indrayudha, Peni; Michavila, Camille; Mukhopadhyay, Rishov; Maurer, Sigrun K.; Caulton, Simon G.; Emsley, Jonas; Dreveny, Ingrid] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England	University of Nottingham	Dreveny, I (corresponding author), Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England.	ingrid.dreveny@nottingham.ac.uk	emsley, jonas/A-8509-2016; Indrayudha, Peni/AAO-8429-2021; Dreveny, Ingrid/E-8939-2017	emsley, jonas/0000-0002-8949-8030; Indrayudha, Peni/0000-0001-8502-8958; Dreveny, Ingrid/0000-0003-2256-642X; Hubberstey, Hayley/0000-0002-3719-916X; caulton, simon/0000-0001-7509-9728	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H012656/1]; BBSRC DTP studentships at the University of Nottingham; Indonesian Ministry of Research, Technology and Higher Education, Direktorat Jenderal Pendidikan Tinggi (DIKTI) scholarship; Erasmus scholarship; University of Nottingham; BBSRC [BB/H012656/1, 1803618] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC DTP studentships at the University of Nottingham(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Indonesian Ministry of Research, Technology and Higher Education, Direktorat Jenderal Pendidikan Tinggi (DIKTI) scholarship; Erasmus scholarship; University of Nottingham; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) [grant number BB/H012656/1] (to I. D.) and BBSRC DTP studentships at the University of Nottingham (to S. J. W., H. E. G., and S. K. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an Indonesian Ministry of Research, Technology and Higher Education, Direktorat Jenderal Pendidikan Tinggi (DIKTI) scholarship. Present address: Faculty of Pharmacy, Universitas Muhammadiyah Surakarta, Jl A. Yani Tromol Pos I, Pabelan, Kartasura, Sukoharjo 57102, Indonesia.; Supported by an Erasmus scholarship.; Supported by the University of Nottingham.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Avvakumov GV, 2012, BIOCHEMISTRY-US, V51, P1188, DOI 10.1021/bi200854q; Basters A, 2017, NAT STRUCT MOL BIOL, V24, P270, DOI 10.1038/nsmb.3371; Boland MP, 2000, J BIOL CHEM, V275, P25231, DOI 10.1074/jbc.275.33.25231; Burkhart RA, 2013, MOL CANCER RES, V11, P901, DOI 10.1158/1541-7786.MCR-12-0699; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiang C, 2018, J VIROL, V92, DOI 10.1128/JVI.01737-17; Chou CK, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030483; Chuang SJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21476-w; Clerici M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6399; Cornelissen T, 2014, HUM MOL GENET, V23, P5227, DOI 10.1093/hmg/ddu244; Das T, 2017, NUCLEIC ACIDS RES, V45, P4866, DOI 10.1093/nar/gkw1365; Dharadhar S, 2016, J STRUCT BIOL, V196, P437, DOI 10.1016/j.jsb.2016.09.011; Eichhorn PJA, 2012, NAT MED, V18, P429, DOI 10.1038/nm.2619; Elliott PR, 2011, FEBS LETT, V585, P3385, DOI 10.1016/j.febslet.2011.09.040; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faesen AC, 2011, MOL CELL, V44, P147, DOI 10.1016/j.molcel.2011.06.034; Faronato M, 2013, CELL CYCLE, V12, P1964, DOI 10.4161/cc.25035; Fukushima T, 2017, BIOCHEM BIOPH RES CO, V484, P522, DOI 10.1016/j.bbrc.2017.01.101; Gersch M, 2017, NAT STRUCT MOL BIOL, V24, P920, DOI 10.1038/nsmb.3475; Golubovskaya VM, 2013, ANTI-CANCER AGENT ME, V13, P546; Harper S, 2014, BIOCHEMISTRY-US, V53, P2966, DOI 10.1021/bi500116x; Harper S, 2011, BIOCHEMISTRY-US, V50, P7995, DOI 10.1021/bi200726e; Harrigan JA, 2018, NAT REV DRUG DISCOV, V17, P57, DOI 10.1038/nrd.2017.152; Herhaus L, 2014, CELL SIGNAL, V26, P2186, DOI 10.1016/j.cellsig.2014.06.012; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Iyengar PV, 2015, SCI REP-UK, V5, DOI 10.1038/srep14733; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kategaya L, 2017, NATURE, V550, P534, DOI 10.1038/nature24006; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Lamberto I, 2017, CELL CHEM BIOL, V24, P1490, DOI 10.1016/j.chembiol.2017.09.003; Li H, 2016, MOL CELL, V63, P249, DOI 10.1016/j.molcel.2016.05.031; Ma JH, 2010, ARCH BIOCHEM BIOPHYS, V503, P207, DOI 10.1016/j.abb.2010.08.020; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Molland K, 2014, ACTA CRYSTALLOGR F, V70, P283, DOI 10.1107/S2053230X14002519; Nishi R, 2014, NAT CELL BIOL, V16, P1016, DOI 10.1038/ncb3028; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Ozen A, 2018, STRUCTURE, V26, P72, DOI 10.1016/j.str.2017.11.010; Pal A, 2014, CANCER RES, V74, P4955, DOI 10.1158/0008-5472.CAN-14-1211; Park JK, 2016, NUCLEIC ACIDS RES, V44, P5424, DOI 10.1093/nar/gkw218; Porter CM, 2012, BIOORG CHEM, V43, P44, DOI 10.1016/j.bioorg.2011.11.001; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Ronau JA, 2016, CELL RES, V26, P441, DOI 10.1038/cr.2016.38; Rouge L, 2016, STRUCTURE, V24, P1335, DOI 10.1016/j.str.2016.05.020; Sato Y, 2015, NAT STRUCT MOL BIOL, V22, P222, DOI 10.1038/nsmb.2970; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Turnbull AP, 2017, NATURE, V550, P481, DOI 10.1038/nature24451; Vlasschaert C, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0511-1; Wan XB, 2013, J MED CHEM, V56, P2619, DOI 10.1021/jm400045y; Wang LJ, 2013, J VIROL, V87, P4507, DOI 10.1128/JVI.00031-13; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu CC, 2013, NUCLEIC ACIDS RES, V41, P10630, DOI 10.1093/nar/gkt828; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17; Yin JP, 2015, STRUCTURE, V23, P2043, DOI 10.1016/j.str.2015.08.010; Zhang Q, 2016, J BIOL CHEM, V291, P17283, DOI 10.1074/jbc.M116.740787; Zou Q, 2014, NAT IMMUNOL, V15, P562, DOI 10.1038/ni.2885	61	24	25	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17362	17374		10.1074/jbc.RA118.003857	http://dx.doi.org/10.1074/jbc.RA118.003857			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30228188	hybrid, Green Published			2022-12-28	WOS:000449799000005
J	Patrick, RM; Lee, JCH; Teetsel, JRJ; Yang, SH; Choy, GS; Browning, KS				Patrick, Ryan M.; Lee, Jessica C. H.; Teetsel, Jade R. J.; Yang, Soo-Hyun; Choy, Grace S.; Browning, Karen S.			Discovery and characterization of conserved binding of eIF4E 1 (CBE1), a eukaryotic translation initiation factor 4E-binding plant protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eukaryotic translation initiation factor 4E (eIF4E); translation initiation factor; translation control; protein synthesis; Arabidopsis thaliana; 4E-binding protein; eIF4E-binding; RNA cap-binding complex; translation; cell cycle; mitosis	MESSENGER-RNA TRANSLATION; DROSOPHILA CUP; LOCI ENCODE; FACTOR 4E; CAP; GENE; COMPLEX; EXPRESSION; SUBUNIT; GROWTH	In many eukaryotes, translation initiation is regulated by proteins that bind to the mRNA cap-binding protein eukaryotic translation initiation factor 4E (eIF4E). These proteins commonly prevent association of eIF4E with eIF4G or form repressive messenger ribonucleoproteins that exclude the translation machinery. Such gene-regulatory mechanisms in plants, and even the presence of eIF4E-interacting proteins other than eIF4G (and the plant-specific isoform eIFiso4G, which binds eIFiso4E), are unknown. Here, we report the discovery of a plant-specific protein, conserved binding of eIF4E 1 (CBE1). We found that CBE1 has an evolutionarily conserved eIF4E-binding motif in its N-terminal domain and binds eIF4E or eIFiso4E in vitro. CBE1 thereby forms cap-binding complexes and is an eIF4E-dependent constituent of these complexes in vivo. Of note, plant mutants lacking CBE1 exhibited dysregulation of cell cycle-related transcripts and accumulated higher levels of mRNAs encoding proteins involved in mitosis than did WT plants. Our findings indicate that CBE1 is a plant protein that can form mRNA cap-binding complexes having the potential for regulating gene expression. Because mammalian translation factors are known regulators of cell cycle progression, we propose that CBE1 may represent such first translation factor-associated plant-specific cell cycle regulator.	[Browning, Karen S.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Browning, KS (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	kbrowning@cm.utexas.edu			National Science Foundation [MCB1052530]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB1052530 (to K.S.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Ambrose JC, 2007, PLANT CELL, V19, P226, DOI 10.1105/tpc.106.047613; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Browning K. S., 2014, MOL BIOL, P129; Browning Karen S, 2015, Arabidopsis Book, V13, pe0176, DOI 10.1199/tab.0176; Bush MS, 2009, PLANT J, V59, P400, DOI 10.1111/j.1365-313X.2009.03882.x; Callot C, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27940; Cao QP, 2002, EMBO J, V21, P3852, DOI 10.1093/emboj/cdf353; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dobrikov MI, 2014, MOL CELL BIOL, V34, P439, DOI 10.1128/MCB.01046-13; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; Duprat A, 2002, PLANT J, V32, P927, DOI 10.1046/j.1365-313X.2002.01481.x; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Freire MA, 2000, PLANT MOL BIOL, V44, P129, DOI 10.1023/A:1006494628892; Freire MA, 2005, GENE, V345, P271, DOI 10.1016/j.gene.2004.11.030; Gallie DR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191474; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Hernandez G, 2013, MOL CELL BIOL, V33, P2854, DOI 10.1128/MCB.01354-12; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jiang D, 2007, PLANT CELL, V19, P2975, DOI 10.1105/tpc.107.052373; Jung MY, 2006, MOL CELL BIOL, V26, P4277, DOI 10.1128/MCB.02470-05; Kevei Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020618; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lellis AD, 2002, CURR BIOL, V12, P1046, DOI 10.1016/S0960-9822(02)00898-9; Lellis AD, 2010, PLANT MOL BIOL, V74, P249, DOI 10.1007/s11103-010-9670-z; MADER S, 1995, MOL CELL BIOL, V15, P4990; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Mayberry LK, 2011, J BIOL CHEM, V286, P42566, DOI 10.1074/jbc.M111.280099; Menges M, 2005, PLANT J, V41, P546, DOI 10.1111/j.1365-313X.2004.02319.x; Miras M, 2017, PLANT PHYSIOL, V174, P1476, DOI 10.1104/pp.17.00193; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Patrick RM, 2014, PLANT PHYSIOL, V164, P1820, DOI 10.1104/pp.113.227785; Patrick RM, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/287814; Reichel M, 2016, PLANT CELL, V28, P2435, DOI 10.1105/tpc.16.00562; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Ruud KA, 1998, J BIOL CHEM, V273, P10325, DOI 10.1074/jbc.273.17.10325; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vos JW, 2008, PLANT CELL, V20, P2783, DOI 10.1105/tpc.107.056796; Yoshii M, 2004, J VIROL, V78, P6102, DOI 10.1128/JVI.78.12.6102-6111.2004	46	13	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17240	17247		10.1074/jbc.RA118.003945	http://dx.doi.org/10.1074/jbc.RA118.003945			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30213859	Green Published, hybrid			2022-12-28	WOS:000449466500023
J	Tokmina-Roszyk, M; Fields, GB				Tokmina-Roszyk, Michal; Fields, Gregg B.			Dissecting MMP P-10 and P-11 subsite sequence preferences, utilizing a positional scanning, combinatorial triple-helical peptide library	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; matrix metalloproteinase (MMP); extracellular matrix; connective tissue; proteolysis; fluorescence resonance energy transfer (FRET); activity-based fingerprinting; peptide library; triple helix	TYPE-1 MATRIX-METALLOPROTEINASE; COLLAGEN-BINDING DOMAIN; SUBSTRATE RECOGNITION; QUENCHED FLUOROPHORES; RAPID IDENTIFICATION; STRUCTURAL INSIGHTS; TRIGGERED RELEASE; MODEL PEPTIDES; IN-VIVO; CLEAVAGE	Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that remodel the extracellular matrix environment and mitigate outside-in signaling. Loss of regulation of MMP activity plays a role in numerous pathological states. In particular, aberrant collagenolysis affects tumor invasion and metastasis, osteoarthritis, and cardiovascular and neurodegenerative diseases. To evaluate the collagen sequence preferences of MMPs, a positional scanning synthetic combinatorial library was synthesized herein and was used to investigate the P-10 and P-11 substrate subsites. The scaffold for the library was a triple-helical peptide mimic of the MMP cleavage site in types I-III collagen. A FRET-based enzyme activity assay was used to evaluate the sequence preferences of eight MMPs. Deconvolution of the library data revealed distinct motifs for several MMPs and discrimination among closely related MMPs. On the basis of the screening results, several individual peptides were designed and evaluated. A triple-helical substrate incorporating Asp-Lys in the P-10-P-11 subsites offered selectivity between MMP-14 and MMP-15, whereas Asp-Lys or Trp-Lys in these subsites discriminated between MMP-2 and MMP-9. Future screening of additional subsite positions will enable the design of selective triple-helical MMP probes that could be used for monitoring in vivo enzyme activity and enzyme-facilitated drug delivery. Furthermore, selective substrates could serve as the basis for the design of specific triple-helical peptide inhibitors targeting only those MMPs that play a detrimental role in a disease of interest.	[Tokmina-Roszyk, Michal; Fields, Gregg B.] Florida Atlantic Univ, Dept Chem & Biochem, Jupiter, FL 33458 USA; [Fields, Gregg B.] Scripps Res Inst Scripps Florida, Dept Chem, Jupiter, FL 33458 USA	State University System of Florida; Florida Atlantic University; Scripps Research Institute; State University System of Florida; University of Florida	Fields, GB (corresponding author), Florida Atlantic Univ, 5353 Parkside Dr, Jupiter, FL 33458 USA.; Fields, GB (corresponding author), Scripps Res Inst Scripps Florida, 130 Scripps Way, Jupiter, FL 33458 USA.	fieldsg@fau.edu			National Institutes of Health Grant [CA098799]; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant CA098799 (to G.B.F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akers WJ, 2012, BIOCONJUGATE CHEM, V23, P656, DOI 10.1021/bc300027y; Amar S, 2017, BBA-MOL CELL RES, V1864, P1940, DOI 10.1016/j.bbamcr.2017.04.015; Arnold LH, 2011, J BIOL CHEM, V286, P45073, DOI 10.1074/jbc.M111.285213; Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097; Bertini I, 2012, J AM CHEM SOC, V134, P2100, DOI 10.1021/ja208338j; Bhowmick M, 2017, J MED CHEM, V60, P3814, DOI 10.1021/acs.jmedchem.7b00018; Bhowmick M, 2015, CHEMBIOCHEM, V16, P1084, DOI 10.1002/cbic.201402716; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Byrne C, 2011, CHEM COMMUN, V47, P2589, DOI 10.1039/c0cc04795c; Cerofolini L, 2016, SCI REP-UK, V6, DOI 10.1038/srep29511; Chen EI, 2002, J BIOL CHEM, V277, P4485, DOI 10.1074/jbc.M109469200; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; DeLano W. L., 2018, THE PYMOL MOLECULAR; Deng SJ, 2000, J BIOL CHEM, V275, P31422, DOI 10.1074/jbc.M004538200; Diaz N, 2015, BIOCHEMISTRY-US, V54, P1243, DOI 10.1021/bi501014w; Eckhard U, 2016, DATA BRIEF, V7, P299, DOI 10.1016/j.dib.2016.02.036; Eckhard U, 2016, MATRIX BIOL, V49, P37, DOI 10.1016/j.matbio.2015.09.003; Elegbede AI, 2008, J AM CHEM SOC, V130, P10633, DOI 10.1021/ja801548g; Fallas JA, 2012, J BIOL CHEM, V287, P8039, DOI 10.1074/jbc.M111.296574; Fan CY, 2008, FASEB J, V22, P3795, DOI 10.1096/fj.08-111484; Fields GB, 1996, BIOPOLYMERS, V40, P345, DOI 10.1002/(SICI)1097-0282(1996)40:4<345::AID-BIP1>3.0.CO;2-W; Fields GB, 2013, J BIOL CHEM, V288, P8785, DOI 10.1074/jbc.R113.451211; Fields Gregg B., 2008, P827, DOI 10.1007/978-0-387-69057-5_39; FURKA A, 1991, INT J PEPT PROT RES, V37, P487, DOI 10.1111/j.1399-3011.1991.tb00765.x; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Giulianotti MA, 2012, ACS COMB SCI, V14, P503, DOI 10.1021/co300060s; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; Han SJ, 2010, J BIOL CHEM, V285, P22276, DOI 10.1074/jbc.M110.102079; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0; HOUGHTEN RA, 1992, BIOTECHNIQUES, V13, P412; Hynes RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a004903; Kim DH, 2012, J PEPT SCI, V18, P394, DOI 10.1002/psc.2409; Koide T, 2016, BIOL PHARM BULL, V39, P135, DOI 10.1248/bpb.b15-00561; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; Kridel SJ, 2001, J BIOL CHEM, V276, P20572, DOI 10.1074/jbc.M100900200; Kukreja M, 2015, CHEM BIOL, V22, P1122, DOI 10.1016/j.chembiol.2015.07.008; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; Lauer JL, 2014, J BIOL CHEM, V289, P1981, DOI 10.1074/jbc.M113.513408; Lauer JL, 2010, CANCER DRUG DISCOV D, P477, DOI 10.1007/978-1-4419-6615-5_23; Lauer-Fields J, 2007, J AM CHEM SOC, V129, P10408, DOI 10.1021/ja0715849; Lauer-Fields JL, 2008, J BIOL CHEM, V283, P20087, DOI 10.1074/jbc.M801438200; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; Lauer-Fields JL, 2002, BIOL CHEM, V383, P1095, DOI 10.1515/BC.2002.118; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Maskos K, 2005, BIOCHIMIE, V87, P249, DOI 10.1016/j.biochi.2004.11.019; Mekkat A, 2018, J STRUCT BIOL, V203, P247, DOI 10.1016/j.jsb.2018.05.002; Mikhailova M, 2012, MATRIX BIOL, V31, P380, DOI 10.1016/j.matbio.2012.10.001; Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i; Minond D, 2007, BIOCHEMISTRY-US, V46, P3724, DOI 10.1021/bi062199j; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Muller JCD, 2000, BIOCHEMISTRY-US, V39, P5111, DOI 10.1021/bi992724x; Ndinguri MW, 2012, J DRUG DELIV, V2012, DOI 10.1155/2012/592602; Newby AC, 2012, VASC PHARMACOL, V56, P232, DOI 10.1016/j.vph.2012.01.007; Ohkubo S, 1999, BIOCHEM BIOPH RES CO, V266, P308, DOI 10.1006/bbrc.1999.1816; OSTRESH JM, 1994, BIOPOLYMERS, V34, P1681, DOI 10.1002/bip.360341212; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pan WJ, 2003, J BIOL CHEM, V278, P27820, DOI 10.1074/jbc.M304436200; Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2005, BIOCHEMISTRY-US, V44, P1414, DOI 10.1021/bi048216r; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Persikov AV, 2000, BIOPOLYMERS, V55, P436, DOI 10.1002/1097-0282(2000)55:6<436::AID-BIP1019>3.0.CO;2-D; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PINILLA C, 1992, BIOTECHNIQUES, V13, P901; Ratnikov BI, 2014, P NATL ACAD SCI USA, V111, pE4148, DOI 10.1073/pnas.1406134111; Robichaud TK, 2011, J BIOL CHEM, V286, P37535, DOI 10.1074/jbc.M111.273391; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruddy JM, 2016, J VASC RES, V53, P1, DOI 10.1159/000446703; Sarkar N, 2008, BIOCONJUGATE CHEM, V19, P57, DOI 10.1021/bc070081p; Sarkar NR, 2005, CHEM COMMUN, P999, DOI 10.1039/b416827e; Schenk S, 2003, TRENDS CELL BIOL, V13, P366, DOI 10.1016/S0962-8924(03)00129-6; Shinde A, 2015, J PEPT SCI, V21, P77, DOI 10.1002/psc.2725; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; Stawikowski MJ, 2017, METHODS MOL BIOL, V1579, P137, DOI 10.1007/978-1-4939-6863-3_8; Subiros-Funosas R, 2013, ALDRICHIM ACTA, V46, P21; Sun HY, 2007, BIOPOLYMERS, V88, P141, DOI 10.1002/bip.20664; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tokmina-Roszyk M, 2013, BIOPOLYMERS, V100, P347, DOI 10.1002/bip.22222; Troeberg L, 2012, BBA-PROTEINS PROTEOM, V1824, P133, DOI 10.1016/j.bbapap.2011.06.020; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Webb Benjamin, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi0506s47; Woessner J.F., 2000, PROTEIN PROFILE SER; Xiao JX, 2010, J BIOL CHEM, V285, P34181, DOI 10.1074/jbc.M110.128355; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Yamazaki CM, 2013, ANGEW CHEM INT EDIT, V52, P5497, DOI 10.1002/anie.201301266; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yao Q, 2018, TRENDS PHARMACOL SCI, V39, P766, DOI 10.1016/j.tips.2018.06.003; Yasui H, 2013, BIOPOLYMERS, V100, P705, DOI 10.1002/bip.22234; Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979; Zhang X, 2014, BIOORG MED CHEM LETT, V24, P3786, DOI 10.1016/j.bmcl.2014.06.072; Zhang X, 2014, MOLECULES, V19, P8571, DOI 10.3390/molecules19068571; Zhao YC, 2015, STRUCTURE, V23, P257, DOI 10.1016/j.str.2014.11.021	96	2	2	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16661	16676		10.1074/jbc.RA118.003266	http://dx.doi.org/10.1074/jbc.RA118.003266			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30185620	Green Published, hybrid			2022-12-28	WOS:000448515100010
J	Backes, CS; Friedmann, KS; Mang, S; Knorck, A; Hoth, M; Kummerow, C				Backes, Christian S.; Friedmann, Kim S.; Mang, Sebastian; Knoerck, Arne; Hoth, Markus; Kummerow, Carsten			Natural killer cells induce distinct modes of cancer cell death: Discrimination, quantification, and modulation of apoptosis, necrosis, and mixed forms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						natural killer cells (NK cells); cancer; apoptosis; necrosis (necrotic death); cell death; calcium; caspase; cellular immune response; imaging; immunology	CYTOTOXIC T-LYMPHOCYTES; CALCIUM INFLUX; PERFORIN; THERAPY; IMMUNOTHERAPY; EXOCYTOSIS; EXPRESSION; GRANULES; SYNAPSE; LIGHT	Immune therapy of cancer is among the most promising recent advances in medicine. Whether the immune system can keep cancer in check depends on, among other factors, the efficiency of immune cells to recognize and eliminate cancer cells. We describe a time-resolved single-cell assay that reports the quality, quantity, and kinetics of target cell death induced by single primary human natural killer (NK) cells. The assay reveals that single NK cells induce cancer cell death by apoptosis and necrosis but also by mixed forms. Inhibition of either one of the two major cytotoxic pathways, perforin/granzyme release or FasL/FasR interaction, unmasked the parallel activity of the other one. Ca2+ influx through Orai channels is important for tuning killer cell function. We found that the apoptosis/necrosis ratio of cancer cell death by NK cells is controlled by the magnitude of Ca2+ entry and furthermore by the relative concentrations of perforin and granzyme B. The possibility to change the apoptosis/necrosis ratio employed by NK cells offers an intriguing possibility to modulate the immunogenicity of the tumor microenvironment.	[Backes, Christian S.; Friedmann, Kim S.; Mang, Sebastian; Knoerck, Arne; Hoth, Markus; Kummerow, Carsten] Univ Saarland, Sch Med, Dept Biophys, Ctr Integrat Physiol & Mol Med, D-66421 Homburg, Germany	Saarland University	Hoth, M; Kummerow, C (corresponding author), Univ Saarland, Sch Med, Dept Biophys, Ctr Integrat Physiol & Mol Med, D-66421 Homburg, Germany.	markus.hoth@uks.eu; carsten.kummerow@uks.eu		Hoth, Markus/0000-0001-7080-4643; Knorck, Arne/0000-0001-8980-6673; Kummerow, Carsten/0000-0001-5667-2293	Deutsche Forschungsgemeinschaft (DFG) [SFB 894, SFB 1027, IRTG 1830]; Bundesministerium fur Bildung und Forschung (BMBF) [031LO133]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This project was supported by Deutsche Forschungsgemeinschaft (DFG) Grants SFB 894 (project A1 MH), SFB 1027 (project A2 MH), and IRTG 1830 (to M. H. and Barbara Niemeyer). This work was also supported by Bundesministerium fur Bildung und Forschung (BMBF) Grant 031LO133. The authors declare that they have no conflicts of interest with the contents of this article.	Benkova B, 2009, ANAL BIOCHEM, V394, P68, DOI 10.1016/j.ab.2009.07.012; Bhat SS, 2016, BBA-MOL CELL RES, V1863, P1653, DOI 10.1016/j.bbamcr.2016.04.014; Boudreau JE, 2018, TRENDS IMMUNOL, V39, P222, DOI 10.1016/j.it.2017.12.001; Caricchio R, 1998, J IMMUNOL, V161, P241; Chia J, 2009, P NATL ACAD SCI USA, V106, P9809, DOI 10.1073/pnas.0903815106; Clausen J, 2003, IMMUNOBIOLOGY, V207, P85, DOI 10.1078/0171-2985-00219; de Saint Basile G, 2010, NAT REV IMMUNOL, V10, P568, DOI 10.1038/nri2803; Frey M, 1998, J IMMUNOL, V161, P400; Griffin MM, 2013, EXPERT OPIN BIOL TH, V13, P803, DOI 10.1517/14712598.2013.786698; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Gwalani LA, 2018, J IMMUNOL, V200, P3231, DOI 10.4049/jimmunol.1701500; Hernandez-Ilizaliturri FJ, 2005, CLIN CANCER RES, V11, P5984, DOI 10.1158/1078-0432.CCR-05-0577; Hoth M, 2016, BBA-MOL CELL RES, V1863, P1408, DOI 10.1016/j.bbamcr.2015.12.009; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Janka GE, 2012, ANNU REV MED, V63, P233, DOI 10.1146/annurev-med-041610-134208; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kataoka T, 1996, J IMMUNOL, V156, P3678; Kershaw MH, 2013, NAT REV CANCER, V13, P525, DOI 10.1038/nrc3565; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kummerow C, 2014, EUR J IMMUNOL, V44, P1870, DOI 10.1002/eji.201444518; Lopez JA, 2013, J IMMUNOL, V191, P2328, DOI 10.4049/jimmunol.1301205; Lyubchenko TA, 2001, IMMUNITY, V15, P847, DOI 10.1016/S1074-7613(01)00233-3; Maul-Pavicic A, 2011, P NATL ACAD SCI USA, V108, P3324, DOI 10.1073/pnas.1013285108; Nisihara T, 2001, J IMMUNOL, V167, P3266, DOI 10.4049/jimmunol.167.6.3266; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Schoppmeyer R, 2018, JOVE-J VIS EXP, DOI 10.3791/57651; Schwarz EC, 2013, BBA-MOL CELL RES, V1833, P1603, DOI 10.1016/j.bbamcr.2012.11.016; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shcherbo D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-24; Smaglo BG, 2014, NAT REV CLIN ONCOL, V11, P637, DOI 10.1038/nrclinonc.2014.159; Smith MB, 2011, BIOPHYS J, V101, P1794, DOI 10.1016/j.bpj.2011.09.007; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Strobl F, 2017, NAT PROTOC, V12, P1103, DOI 10.1038/nprot.2017.028; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thakur A, 2018, BLOOD REV, V32, P339, DOI 10.1016/j.blre.2018.02.004; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Weiner LM, 2007, NAT REV CANCER, V7, P701, DOI 10.1038/nrc2209; Wenning AS, 2011, BBA-MOL CELL RES, V1813, P412, DOI 10.1016/j.bbamcr.2010.12.022; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; Zhou X, 2018, J PHYSIOL-LONDON, V596, P2681, DOI 10.1113/JP274964; Zhu YT, 2016, ONCOTARGET, V7, P47163, DOI 10.18632/oncotarget.9980	47	44	44	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16348	16363		10.1074/jbc.RA118.004549	http://dx.doi.org/10.1074/jbc.RA118.004549			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30190323	Green Published, hybrid			2022-12-28	WOS:000447833600019
J	Roehrkasse, AM; Booe, JM; Lee, SM; Warner, ML; Pioszak, AA				Roehrkasse, Amanda M.; Booe, Jason M.; Lee, Sang-Min; Warner, Margaret L.; Pioszak, Augen A.			Structure-function analyses reveal a triple beta-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); molecular pharmacology; peptide hormone; fluorescence anisotropy; X-ray crystallography; protein engineering; receptor structure-function; signal transduction; cardioprotection; class B GPCR; receptor activity-modifying protein; vasodilation	GENE-RELATED PEPTIDE; ACTIVITY-MODIFYING PROTEINS; CRYO-EM STRUCTURE; CLASS-B GPCR; CALCITONIN-RECEPTOR; EXTRACELLULAR DOMAIN; ECTODOMAIN COMPLEX; COUPLED-RECEPTOR; OXIDATIVE STRESS; N-GLYCOSYLATION	The cardioprotective vasodilator peptide adrenomedullin 2/intermedin (AM2/IMD) and the related adrenomedullin (AM) and calcitonin gene-related peptide (CGRP) signal through three heterodimeric receptors comprising the calcitonin receptor-like class B G protein-coupled receptor (CLR) and a variable receptor activity-modifying protein (RAMP1, -2, or -3) that determines ligand selectivity. The CGRP receptor (RAMP1:CLR) favors CGRP binding, whereas the AM(1) (RAMP2:CLR) and AM(2) (RAMP3:CLR) receptors favor AM binding. How AM2/IMD binds the receptors and how RAMPs modulate its binding is unknown. Here, we show that AM2/IMD binds the three purified RAMP-CLR extracellular domain (ECD) complexes with a selectivity profile that is distinct from those of CGRP and AM. AM2/IMD bound all three ECD complexes but preferred the CGRP and AM(2) receptor complexes. A 2.05 angstrom resolution crystal structure of an AM2/IMD antagonist fragment-bound RAMP1-CLR ECD complex revealed that AM2/IMD binds the complex through a unique triple beta-turn conformation that was confirmed by peptide and receptor mutagenesis. Comparisons of the receptor-bound conformations of AM2/IMD, AM, and a high-affinity CGRP analog revealed differences that may have implications for biased signaling. Guided by the structure, enhanced-affinity AM2/IMD antagonist variants were developed, including one that discriminates the AM(1) and AM(2) receptors with similar to 40-fold difference in affinities and one stabilized by an intramolecular disulfide bond. These results reveal differences in how the three peptides engage the receptors, inform development of AM2/IMD-based pharmacological tools and therapeutics, and provide insights into RAMP modulation of receptor pharmacology.	[Roehrkasse, Amanda M.; Booe, Jason M.; Lee, Sang-Min; Warner, Margaret L.; Pioszak, Augen A.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Pioszak, AA (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA.	augen-pioszak@ouhsc.edu		Lee, Sangmin/0000-0002-7262-159X	National Institutes of Health [P20GM103640, DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103640, R01GM104251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Debbie Hay for helpful discussions and for sharing plasmids expressing the alanine-substituted full-length CLR and RAMP1 variants. We thank Spencer Anderson for assistance with remote data collection at LS-CAT beamline 21-ID-G of the Advanced Photon Source, Argonne National Laboratory. Use of the crystal-imaging microscope was supported by National Institutes of Health Grant P20GM103640. The Advanced Photon Source is a United States Department of Energy facility operated under Contract DE-AC02-06CH11357. Use of LS-CAT sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817).	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Barbash S, 2017, P NATL ACAD SCI USA, V114, P12015, DOI 10.1073/pnas.1713074114; Bell D, 2016, PEPTIDES, V76, P19, DOI 10.1016/j.peptides.2015.12.003; Bell D, 2016, PEPTIDES, V76, P1, DOI 10.1016/j.peptides.2015.12.005; Booe JM, 2018, MOL PHARMACOL, V93, P355, DOI 10.1124/mol.117.110916; Booe JM, 2015, MOL CELL, V58, P1040, DOI 10.1016/j.molcel.2015.04.018; Buhlmann N, 2000, FEBS LETT, V486, P320, DOI 10.1016/S0014-5793(00)02259-6; Chauhan M, 2005, BIOCHEMISTRY-US, V44, P782, DOI 10.1021/bi049153f; CHIBA T, 1989, AM J PHYSIOL, V256, pE331, DOI 10.1152/ajpendo.1989.256.2.E331; Duddy WJ, 2004, PROTEIN SCI, V13, P3051, DOI 10.1110/ps.04920904; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Flahaut M, 2003, BIOCHEMISTRY-US, V42, P10333, DOI 10.1021/bi0347508; Gujer R, 2001, BIOCHEMISTRY-US, V40, P5392, DOI 10.1021/bi002497v; Hagiwara M, 2008, AM J PHYSIOL-RENAL, V295, pF1735, DOI 10.1152/ajprenal.90427.2008; Hay DL, 2018, BRIT J PHARMACOL, V175, P3, DOI 10.1111/bph.14075; Hay DL, 2016, ANNU REV PHARMACOL, V56, P469, DOI 10.1146/annurev-pharmtox-010715-103120; Hill HE, 2013, PROTEIN EXPRES PURIF, V88, P107, DOI 10.1016/j.pep.2012.11.019; Hirose T, 2011, HYPERTENS RES, V34, P1327, DOI 10.1038/hr.2011.131; Holmes D, 2013, CURR PROTEIN PEPT SC, V14, P294, DOI 10.2174/13892037113149990049; Hong YG, 2012, BRIT J PHARMACOL, V166, P110, DOI 10.1111/j.1476-5381.2011.01530.x; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Jia YX, 2006, EUR J PHARMACOL, V549, P117, DOI 10.1016/j.ejphar.2006.07.054; Kamitani S, 2001, BBA-MOL CELL RES, V1539, P131, DOI 10.1016/S0167-4889(01)00100-8; Korner C, 2014, PEPTIDES, V62, P49, DOI 10.1016/j.peptides.2014.09.022; Koth CM, 2010, BIOCHEMISTRY-US, V49, P1862, DOI 10.1021/bi901848m; Kusano S, 2012, PROTEIN SCI, V21, P199, DOI 10.1002/pro.2003; Lee SM, 2017, BIOCHEMISTRY-US, V56, P3380, DOI 10.1021/acs.biochem.7b00256; Lee SM, 2016, J BIOL CHEM, V291, P8686, DOI 10.1074/jbc.M115.713628; Lei SF, 2018, J BIOL CHEM, V293, P9370, DOI 10.1074/jbc.RA118.003278; Liang YL, 2018, NATURE, V555, P121, DOI 10.1038/nature25773; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Lv Y, 2016, J BIOL CHEM, V291, P23390, DOI 10.1074/jbc.M116.735563; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Moad HE, 2013, PROTEIN SCI, V22, P1775, DOI 10.1002/pro.2377; Moore EL, 2010, BIOCHEM BIOPH RES CO, V394, P141, DOI 10.1016/j.bbrc.2010.02.131; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagata S, 2017, DRUG DEVELOP RES, V78, P129, DOI 10.1002/ddr.21383; Nilsson C, 2016, EUR J PHARMACOL, V773, P24, DOI 10.1016/j.ejphar.2016.01.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; Takahashi K, 2011, J MOL NEUROSCI, V43, P182, DOI 10.1007/s12031-010-9413-2; Takei Y, 2004, FEBS LETT, V556, P53, DOI 10.1016/S0014-5793(03)01368-1; Taylor MM, 2005, BRAIN RES, V1045, P199, DOI 10.1016/j.brainres.2005.03.034; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; Walker CS, 2010, TRENDS PHARMACOL SCI, V31, P476, DOI 10.1016/j.tips.2010.06.006; Wang LJ, 2018, ARTERIOSCL THROM VAS, V38, P398, DOI 10.1161/ATVBAHA.117.310317; Watkins HA, 2013, BRIT J PHARMACOL, V169, P143, DOI 10.1111/bph.12118; Watkins HA, 2016, J BIOL CHEM, V291, P11657, DOI 10.1074/jbc.M115.688218; Watkins HA, 2012, DRUG DISCOV TODAY, V17, P1006, DOI 10.1016/j.drudis.2012.05.005; Weston C, 2016, J BIOL CHEM, V291, P21925, DOI 10.1074/jbc.M116.751362; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woolley MJ, 2017, BIOCHEM PHARMACOL, V142, P96, DOI 10.1016/j.bcp.2017.07.005; Wootten D, 2017, CHEM REV, V117, P111, DOI 10.1021/acs.chemrev.6b00049; Wootten D, 2016, CELL, V165, P1632, DOI 10.1016/j.cell.2016.05.023; Yang JH, 2009, REGUL PEPTIDES, V158, P19, DOI 10.1016/j.regpep.2009.05.012; Zhang H, 2016, INT J OBESITY, V40, P852, DOI 10.1038/ijo.2016.2; Zhang SY, 2018, BRIT J PHARMACOL, V175, P1230, DOI 10.1111/bph.13814; Zhao L, 2012, PEPTIDES, V33, P329, DOI 10.1016/j.peptides.2011.12.016	62	11	11	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15840	15854		10.1074/jbc.RA118.005062	http://dx.doi.org/10.1074/jbc.RA118.005062			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30139742	hybrid, Green Published			2022-12-28	WOS:000447256000008
J	Lamothe, SM; Hogan-Cann, AE; Li, WT; Guo, J; Yang, TH; Tschirhart, JN; Zhang, ST				Lamothe, Shawn M.; Hogan-Cann, Aja E.; Li, Wentao; Guo, Jun; Yang, Tonghua; Tschirhart, Jared N.; Zhang, Shetuan			The N terminus and transmembrane segment S1 of Kv1.5 can coassemble with the rest of the channel independently of the S1-S2 linkage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; structure-function relationships; voltage-gated potassium channel; molecular biology; patch clamp; trafficking; channel assembly; ion channel; Kv1; 5; transmembrane domain; Shaker superfamily	GATED K+ CHANNELS; POTASSIUM CHANNEL; T1 DOMAIN; COMPLEMENTARY FRAGMENTS; CHLORIDE CHANNELS; MOLECULAR-BASIS; I-KR; SUBUNIT; INACTIVATION; EXPRESSION	The voltage-gated potassium channel Kv1.5 belongs to the Shaker superfamily. Kv1.5 is composed of four subunits, each comprising 613 amino acids, which make up the N terminus, six transmembrane segments (S1-S6), and the C terminus. We recently demonstrated that, in HEK cells, extracellularly applied proteinase K (PK) cleaves Kv1.5 channels at a single site in the S1-S2 linker. This cleavage separates Kv1.5 into an N-fragment (N terminus to S1) and a C-fragment (S2 to C terminus). Interestingly, the cleavage does not impair channel function. Here, we investigated the role of the N terminus and S1 in Kv1.5 expression and function by creating plasmids encoding various fragments, including those that mimic PK-cleaved products. Our results disclosed that although expression of the pore-containing fragment (Frag(304-613)) alone could not produce current, coexpression with Frag(1-303) generated a functional channel. Immunofluorescence and biotinylation analyses uncovered that Frag(1-303) was required for Frag(304-613) to traffic to the plasma membrane. Biochemical analysis revealed that the two fragments interacted throughout channel trafficking and maturation. In Frag(1-303)+(304-613)-coassembled channels, which lack a covalent linkage between S1 and S2, amino acid residues 1-209 were important for association with Frag(304-613), and residues 210-303 were necessary for mediating trafficking of coassembled channels to the plasma membrane. We conclude that the N terminus and S1 of Kv1.5 can attract and coassemble with the rest of the channel (i.e. Frag(304-613)) to form a functional channel independently of the S1-S2 linkage.	[Lamothe, Shawn M.; Hogan-Cann, Aja E.; Li, Wentao; Guo, Jun; Yang, Tonghua; Tschirhart, Jared N.; Zhang, Shetuan] Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Tschirhart, Jared/0000-0003-1313-350X; Hogan-Cann, Aja/0000-0003-2272-1776; Zhang, Shetuan/0000-0002-2297-0193; Lamothe, Shawn/0000-0001-8722-2631	Natural Sciences and Engineering Research Council of Canada [RGPIN-2018-05037]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2018-05037 (to S. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Archer SL, 1998, J CLIN INVEST, V101, P2319, DOI 10.1172/JCI333; BABILA T, 1994, NEURON, V12, P615, DOI 10.1016/0896-6273(94)90217-8; BIBI E, 1990, P NATL ACAD SCI USA, V87, P4325, DOI 10.1073/pnas.87.11.4325; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eldstrom J, 2003, FEBS LETT, V547, P205, DOI 10.1016/S0014-5793(03)00668-9; FEDIDA D, 1993, CIRC RES, V73, P210, DOI 10.1161/01.RES.73.1.210; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Hogan-Cann A, 2016, BBA-BIOMEMBRANES, V1858, P1082, DOI 10.1016/j.bbamem.2016.02.012; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; Kurata HT, 2002, J BIOL CHEM, V277, P29045, DOI 10.1074/jbc.M111470200; Kurata HT, 2001, J GEN PHYSIOL, V118, P315, DOI 10.1085/jgp.118.3.315; Lamothe SM, 2016, J BIOL CHEM, V291, P20387, DOI 10.1074/jbc.M116.743138; LEE TE, 1994, BIOPHYS J, V66, P667, DOI 10.1016/S0006-3495(94)80840-9; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; London B, 1998, P NATL ACAD SCI USA, V95, P2926, DOI 10.1073/pnas.95.6.2926; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Maduke M, 1998, BIOCHEMISTRY-US, V37, P1315, DOI 10.1021/bi972418o; MAGGIO R, 1993, FEBS LETT, V319, P195, DOI 10.1016/0014-5793(93)80066-4; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Mo L, 2004, AM J PHYSIOL-CELL PH, V286, pC79, DOI 10.1152/ajpcell.00009.2003; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; Patel KA, 2005, INVEST OPHTH VIS SCI, V46, P2282, DOI 10.1167/iovs.05-0179; Ravens U, 2011, CARDIOVASC RES, V89, P776, DOI 10.1093/cvr/cvq398; SchmidtRose T, 1997, J BIOL CHEM, V272, P20515, DOI 10.1074/jbc.272.33.20515; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; SHEN NV, 1993, NEURON, V11, P67; Strang C, 2001, J BIOL CHEM, V276, P28493, DOI 10.1074/jbc.M010540200; Tu LW, 1996, J BIOL CHEM, V271, P18904, DOI 10.1074/jbc.271.31.18904; Wang J, 1997, J CLIN INVEST, V100, P2347, DOI 10.1172/JCI119774; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; ZEN KH, 1994, BIOCHEMISTRY-US, V33, P8198, DOI 10.1021/bi00193a005	41	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15347	15358		10.1074/jbc.RA118.004065	http://dx.doi.org/10.1074/jbc.RA118.004065			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30121572	Green Published, hybrid			2022-12-28	WOS:000446549200002
J	Fedders, R; Muenzner, M; Weber, P; Sommerfeld, M; Knauer, M; Kedziora, S; Kast, N; Heidenreich, S; Raila, J; Weger, S; Henze, A; Schupp, M				Fedders, Ronja; Muenzner, Matthias; Weber, Pamela; Sommerfeld, Manuela; Knauer, Miriam; Kedziora, Sarah; Kast, Naomi; Heidenreich, Steffi; Raila, Jens; Weger, Stefan; Henze, Andrea; Schupp, Michael			Liver-secreted RBP4 does not impair glucose homeostasis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						liver; retinoid-binding protein; glucose metabolism; insulin resistance; mouse; TTR	RETINOL-BINDING-PROTEIN; TRANSTHYRETIN-DEFICIENT MICE; VITAMIN-A-DEFICIENCY; INSULIN-RESISTANCE; INDEPENDENT MECHANISM; MEMBRANE-RECEPTOR; ADIPOSE-TISSUE; RETINOL-BINDING-PROTEIN-4; GENE; EXPRESSION	Retinol-binding protein 4 (RBP4) is the major transport protein for retinol in blood. Recent evidence from genetic mouse models shows that circulating RBP4 derives exclusively from hepatocytes. Because RBP4 is elevated in obesity and associates with the development of glucose intolerance and insulin resistance, we tested whether a liver-specific overexpression of RBP4 in mice impairs glucose homeostasis. We used adeno-associated viruses (AAV) that contain a highly liver-specific promoter to drive expression of murine RBP4 in livers of adult mice. The resulting increase in serum RBP4 levels in these mice was comparable with elevated levels that were reported in obesity. Surprisingly, we found that increasing circulating RBP4 had no effect on glucose homeostasis. Also during a high-fat diet challenge, elevated levels of RBP4 in the circulation failed to aggravate the worsening of systemic parameters of glucose and energy homeostasis. These findings show that liver-secreted RBP4 does not impair glucose homeostasis. We conclude that a modest increase of its circulating levels in mice, as observed in the obese, insulin-resistant state, is unlikely to be a causative factor for impaired glucose homeostasis.	[Fedders, Ronja; Muenzner, Matthias; Weber, Pamela; Sommerfeld, Manuela; Knauer, Miriam; Kedziora, Sarah; Kast, Naomi; Heidenreich, Steffi; Schupp, Michael] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, D-10115 Berlin, Germany; [Fedders, Ronja; Muenzner, Matthias; Weber, Pamela; Sommerfeld, Manuela; Knauer, Miriam; Kedziora, Sarah; Kast, Naomi; Heidenreich, Steffi; Schupp, Michael] Berlin Inst Hlth, Inst Pharmacol, D-10115 Berlin, Germany; [Raila, Jens; Henze, Andrea] Univ Potsdam, Inst Nutr Sci, Dept Physiol & Pathophysiol, D-14558 Nuthetal, Germany; [Weger, Stefan] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Campus Benjamin Franklin, D-12203 Berlin, Germany; [Weger, Stefan] Berlin Inst Hlth, Inst Virol, Campus Benjamin Franklin, D-12203 Berlin, Germany; [Henze, Andrea] Univ Potsdam, Inst Nutr Sci, Jr Res Grp ProAID, D-14558 Nuthetal, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Potsdam	Schupp, M (corresponding author), Charite Univ Med Berlin, Inst Pharmacol, D-10115 Berlin, Germany.	michael.schupp@charite.de	Henze, Andrea/A-9176-2019	Henze, Andrea/0000-0002-5708-2989; Schupp, Michael/0000-0003-3720-1052; Weger, Stefan/0000-0002-0906-5252	German Research Foundation (Deutsche Forschungsgemeinschaft) [SCHU 2546/1-1, SCHU 2546/5-1]; European Union [CIG 291867]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by German Research Foundation (Deutsche Forschungsgemeinschaft) Grant SCHU 2546/1-1 Emmy Noether and SCHU 2546/5-1 and a Career Integration Grant CIG 291867 from the European Union (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alapatt P, 2013, J BIOL CHEM, V288, P1250, DOI 10.1074/jbc.M112.369132; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Buxbaum JN, 2014, NEUROSCIENCE, V275, P352, DOI 10.1016/j.neuroscience.2014.06.019; Du M, 2015, MOL CELL BIOL, V35, P2771, DOI 10.1128/MCB.00181-15; Fedders R, 2015, HORM MOL BIOL CLIN I, V22, P27, DOI 10.1515/hmbci-2015-0013; Gaetani S, 2002, CLIN CHEM LAB MED, V40, P1211, DOI 10.1515/CCLM.2002.211; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Heidenreich S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00430-w; Henze A, 2008, DIABETES, V57, P3323, DOI 10.2337/db08-0866; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Lee SA, 2016, HEPATOLOGY, V64, P1534, DOI 10.1002/hep.28659; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Mody N, 2008, AM J PHYSIOL-ENDOC M, V294, pE785, DOI 10.1152/ajpendo.00521.2007; Monk JA, 2013, AM J PHYSIOL-ENDOC M, V304, pE23, DOI 10.1152/ajpendo.00216.2012; Moraes-Vieira PM, 2016, DIABETES, V65, P1317, DOI 10.2337/db15-1696; Moraes-Vieira PM, 2014, CELL METAB, V19, P512, DOI 10.1016/j.cmet.2014.01.018; Motani A, 2009, J BIOL CHEM, V284, P7673, DOI 10.1074/jbc.M809654200; Muenzner M, 2013, MOL CELL BIOL, V33, P4068, DOI 10.1128/MCB.00221-13; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Perduca M, 2018, BBA-MOL CELL BIOL L, V1863, P458, DOI 10.1016/j.bbalip.2018.01.010; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2002, J BIOL CHEM, V277, P30191, DOI 10.1074/jbc.M205046200; Raila J, 2007, KIDNEY INT, V72, P505, DOI 10.1038/sj.ki.5002372; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Thompson SJ, 2017, DIABETES, V66, P58, DOI 10.2337/db16-0286; Trasino SE, 2015, SCI REP-UK, V5, DOI 10.1038/srep15893; van Bennekum AM, 2001, J BIOL CHEM, V276, P1107, DOI 10.1074/jbc.M008091200; Wang LL, 2010, MOL THER, V18, P118, DOI 10.1038/mt.2009.246; WEI SH, 1995, J BIOL CHEM, V270, P866, DOI 10.1074/jbc.270.2.866; White JA, 1997, J BIOL CHEM, V272, P18538, DOI 10.1074/jbc.272.30.18538; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	33	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15269	15276		10.1074/jbc.RA118.004294	http://dx.doi.org/10.1074/jbc.RA118.004294			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30126844	hybrid, Green Published			2022-12-28	WOS:000445998400026
J	Park, CK; Sanchez, JL; Barahona, C; Basantes, LE; Sanchez, J; Hernandez, C; Horton, NC				Park, Chad K.; Sanchez, Jonathan L.; Barahona, Claudia; Basantes, L. Emilia; Sanchez, Juan; Hernandez, Christian; Horton, N. C.			The run-on oligomer filament enzyme mechanism of SgrAI: Part 2. Kinetic modeling of the full DNA cleavage pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; enzyme mechanism; allosteric regulation; DNA endonuclease; structure-function; alternation of enzyme specificity; control of enzyme activation; fiber forming enzyme; filament forming enzyme; Run-on oligomer mechanism	METABOLIC ENZYMES; SACCHAROMYCES-CEREVISIAE; RESTRICTION ENZYMES; REORGANIZATION; ENDONUCLEASE; EXPLORER; SEQUESTRATION; SPECTROMETRY; CYTOOPHIDIUM; SPECIFICITY	Filament or run-on oligomer formation by enzymes is now recognized as a widespread phenomenon with potentially unique enzyme regulatory properties and biological roles. SgrAI is an allosteric type II restriction endonuclease that forms run-on oligomeric filaments with activated DNA cleavage activity and altered DNA sequence specificity. In this two-part work, we measure individual steps in the run-on oligomer filament mechanism to address specific questions of cooperativity, trapping, filament growth mechanisms, and sequestration of activity using fluorophore-labeled DNA, kinetic FRET measurements, and reaction modeling with global data fitting. The final models and rate constants show that the assembly step involving association of SgrAI-DNA complexes into the run-on oligomer filament is relatively slow (3-4 orders of magnitude slower than diffusion limited) and rate-limiting at low to moderate concentrations of SgrAI-DNA. The disassembly step involving dissociation of complexes of SgrAI-DNA from each other in the run-on oligomer filament is the next slowest step but is fast enough to limit the residence time of any one copy of SgrAI or DNA within the dynamic filament. Further, the rate constant for DNA cleavage is found to be 4 orders of magnitude faster in the run-on oligomer filament than in isolated SgrAI-DNA complexes and faster than dissociation of SgrAI-DNA complexes from the run-on oligomer filament, making the reaction efficient in that each association into the filament likely leads to DNA cleavage before filament dissociation.	[Park, Chad K.; Sanchez, Jonathan L.; Barahona, Claudia; Basantes, L. Emilia; Sanchez, Juan; Hernandez, Christian; Horton, N. C.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona	Horton, NC (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	nhorton@email.arizona.edu	Horton, Nancy C/E-7881-2011	Horton, Nancy C/0000-0003-2710-8284; Sanchez, Jonathan/0000-0003-0097-465X	National Science Foundation [MCB-1410355]; Office of the Director of the National Institutes of Health [S10OD013237]; NIGMS, National Institutes of Health [T32GM008659]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008659] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD013237] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Science Foundation Grant MCB-1410355, by the Office of the Director of the National Institutes of Health under Grant S10OD013237, and by the NIGMS, National Institutes of Health under Grant T32GM008659 (to J. L. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBERTY RA, 1958, J PHYS CHEM-US, V62, P154, DOI 10.1021/j150560a005; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Aughey GN, 2014, BIOL OPEN, V3, P1045, DOI 10.1242/bio.201410165; Barry RM, 2014, ELIFE, V3, DOI 10.7554/eLife.03638; Barry RM, 2011, CURR OPIN MICROBIOL, V14, P704, DOI 10.1016/j.mib.2011.09.015; Bitinaite J, 2002, MOL GENET GENOMICS, V267, P664, DOI 10.1007/s00438-002-0701-6; Dryden DTF, 2013, STRUCTURE, V21, P1720, DOI 10.1016/j.str.2013.09.009; Dunten PW, 2008, NUCLEIC ACIDS RES, V36, P5405, DOI 10.1093/nar/gkn510; EIGEN M, 1963, ADV ENZYMOL REL S BI, V25, P1; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Hingorani-Varma K, 2003, J BIOL CHEM, V278, P40392, DOI 10.1074/jbc.M304603200; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kim CW, 2010, P NATL ACAD SCI USA, V107, P9626, DOI 10.1073/pnas.1001292107; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; LESSER DR, 1990, SCIENCE, V250, P776, DOI 10.1126/science.2237428; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Little EJ, 2011, ACTA CRYSTALLOGR D, V67, P67, DOI 10.1107/S0907444910047785; Liu JL, 2016, ANNU REV CELL DEV BI, V32, P349, DOI 10.1146/annurev-cellbio-111315-124907; Lynch EM, 2017, NAT STRUCT MOL BIOL, V24, P507, DOI 10.1038/nsmb.3407; Lyumkis D, 2013, STRUCTURE, V21, P1848, DOI 10.1016/j.str.2013.08.012; Ma X, 2013, BIOCHEMISTRY-US, V52, P4373, DOI 10.1021/bi3013214; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; O'Connell JD, 2012, ANNU REV CELL DEV BI, V28, P89, DOI 10.1146/annurev-cellbio-101011-155841; Park CK, 2018, J BIOL CHEM, V293, P14585, DOI 10.1074/jbc.RA118.003680; Park CK, 2010, BIOCHEMISTRY-US, V49, P8818, DOI 10.1021/bi100557v; Petrovska I, 2014, ELIFE, V3, DOI 10.7554/eLife.02409; Prouteau M, 2017, NATURE, V550, P265, DOI 10.1038/nature24021; Sam MD, 1999, J AM CHEM SOC, V121, P1444, DOI 10.1021/ja983787q; Schmitt DL, 2016, ACS CHEM BIOL, V11, P1917, DOI 10.1021/acschembio.6b00039; Shah S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124783; Shen QJ, 2016, J GENET GENOMICS, V43, P393, DOI 10.1016/j.jgg.2016.03.008; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Suresh HG, 2015, MOL BIOL CELL, V26, P1601, DOI 10.1091/mbc.E14-11-1559; Vajjhala PR, 2017, MOL IMMUNOL, V86, P23, DOI 10.1016/j.molimm.2017.02.012; Werner JN, 2009, P NATL ACAD SCI USA, V106, P7858, DOI 10.1073/pnas.0901781106; Zaganjor E, 2017, J CELL BIOL, V216, P2239, DOI 10.1083/jcb.201706005	39	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14599	14615		10.1074/jbc.RA118.003682	http://dx.doi.org/10.1074/jbc.RA118.003682			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30054273	Green Published, hybrid			2022-12-28	WOS:000446155000003
J	Ma, XL; Liu, K; Li, J; Li, HH; Li, J; Liu, YF; Yang, CL; Liang, HH				Ma, Xinli; Liu, Kai; Li, Jian; Li, Huanhuan; Li, Jun; Liu, Yingfang; Yang, Chonglin; Liang, Huanhuan			A non-canonical GTPase interaction enables ORP1L-Rab7-RILP complex formation and late endosome positioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; trafficking; crystal structure; protein-protein interaction; GTPase; protein complex; cholesterol; ORP1L; Rab7; RILP; trafficking	RAB7 EFFECTOR; PROTEIN RILP; RECRUITMENT; BINDING; ORP1L; RAB7-RILP-P150(GLUED); TRANSPORT; BIOLOGY	Endosomal transport represents the primary mode for intracellular trafficking and signaling transduction and thus has to be tightly controlled. The molecular processes controlling the endosomal positioning utilize several large protein complexes, one of which contains the small GTPase Rab7, Rab-interacting lysosomal protein (RILP), and oxysterol-binding protein-related protein 1 (ORP1L). Rab7 is known to interact with RILP through a canonical binding site termed the effector-interacting switch region, but it is not clear how Rab7 interacts with ORP1L, limiting our understanding of the overall process. Here, we report structural and biochemical investigation of the Rab7-ORP1L interaction. We found that, contrary to prior studies, the interaction between Rab7 and the N-terminal ankyrin repeat domain (ARD(N)) of ORP1L is independent of Rab7's GTP- or GDP-binding state. Moreover, we show that Rab7 interacts with ORP1L ARD(N) via a unique region consisting of helix3 (3) and 3(10)-helix 2 (2). This architecture leaves the canonical effector-interacting switch regions available for RILP binding and thus allows formation of the ORP1L-Rab7-RILP tripartite complex. Mutational disruption of the interacting interface between ORP1L and Rab7 compromised the ability of ORP1L-Rab7-RILP to regulate the late endosome positioning. Collectively, our results again manifested the versatility in the interaction between GTPase and its effector.	[Ma, Xinli; Li, Jian; Li, Huanhuan; Li, Jun; Liu, Yingfang; Liang, Huanhuan] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Liu, Kai; Yang, Chonglin] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China; [Ma, Xinli; Liu, Kai; Li, Huanhuan] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Liu, Kai; Yang, Chonglin] Yunnan Univ, State Key Lab Utilizat & Conservat Bioresources Y, Kunming 650500, Yunnan, Peoples R China; [Liu, Kai; Yang, Chonglin] Yunnan Univ, Life Sci Ctr, Kunming 650500, Yunnan, Peoples R China; [Liu, Kai; Yang, Chonglin] Yunnan Univ, Sch Life Sci, Kunming 650500, Yunnan, Peoples R China; [Liu, Yingfang] Sun Yat Sen Univ, Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Huanhuan] Sun Yat Sen Univ, Sch Pharmaceut Sci Shenzhen, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Yunnan University; Yunnan University; Yunnan University; Sun Yat Sen University; Sun Yat Sen University	Liang, HH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Yang, CL (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.; Yang, CL (corresponding author), Yunnan Univ, State Key Lab Utilizat & Conservat Bioresources Y, Kunming 650500, Yunnan, Peoples R China.; Yang, CL (corresponding author), Yunnan Univ, Life Sci Ctr, Kunming 650500, Yunnan, Peoples R China.; Yang, CL (corresponding author), Yunnan Univ, Sch Life Sci, Kunming 650500, Yunnan, Peoples R China.; Liang, HH (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci Shenzhen, Guangzhou 510275, Guangdong, Peoples R China.	clyang@ynu.edu.cn; lianghh26@mail.sysu.edu.cn		Liu, Kai/0000-0002-8014-2310	National Natural Science Foundation of China [31530015, 31470744, 31000331]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31530015, 31470744, and 31000331. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burke JE, 2014, SCIENCE, V344, P1035, DOI 10.1126/science.1253397; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Clark BS, 2011, DEV DYNAM, V240, P2452, DOI 10.1002/dvdy.22758; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hesketh GG, 2014, DEV CELL, V29, P591, DOI 10.1016/j.devcel.2014.04.010; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Johansson M, 2005, MOL BIOL CELL, V16, P5480, DOI 10.1091/mbc.E05-03-0189; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khan AR, 2013, STRUCTURE, V21, P1284, DOI 10.1016/j.str.2013.06.016; Kobayashi T, 2000, MOL BIOL CELL, V11, P1829, DOI 10.1091/mbc.11.5.1829; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee MTG, 2009, TRAFFIC, V10, P1377, DOI 10.1111/j.1600-0854.2009.00942.x; Liu K, 2017, J CELL BIOL, V216, P3307, DOI 10.1083/jcb.201705151; Liu K, 2016, J CELL BIOL, V212, P181, DOI 10.1083/jcb.201506081; Mahmood T, 2012, N AM J MED SCI, V4, P429, DOI 10.4103/1947-2714.100998; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Mott HR, 2015, CRIT REV BIOCHEM MOL, V50, P85, DOI 10.3109/10409238.2014.999191; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; Sun QM, 2010, P NATL ACAD SCI USA, V107, P19338, DOI 10.1073/pnas.1010554107; Vetter M, 2015, NAT STRUCT MOL BIOL, V22, P695, DOI 10.1038/nsmb.3065; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu MS, 2005, EMBO J, V24, P1491, DOI 10.1038/sj.emboj.7600643	35	13	13	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14155	14164		10.1074/jbc.RA118.001854	http://dx.doi.org/10.1074/jbc.RA118.001854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30012887	Green Published, hybrid			2022-12-28	WOS:000444070700036
J	Beyrakhova, K; Li, L; Xu, CS; Gagarinova, A; Cygler, M				Beyrakhova, Ksenia; Li, Lei; Xu, Caishuang; Gagarinova, Alla; Cygler, Miroslaw			Legionella pneumophila effector Lem4 is a membrane-associated protein tyrosine phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4-PHOSPHATE; PHOSPHOTYROSINE PHOSPHATASE; LEGIONNAIRES-DISEASE; ACTIVATION; MDP-1; SUPERFAMILY; VALIDATION; REGULATOR; SUBSTRATE; INSIGHTS	Legionella pneumophila is a Gram-negative pathogenic bacterium that causes severe pneumonia in humans. It establishes a replicative niche called Legionella containing vacuole (LCV) that allows bacteria to survive and replicate inside pulmonary macrophages. To hijack host cell defense systems, L pneumophila injects over 300 effector proteins into the host cell cytosol. The Lem4 effector (lpg1101) consists of two domains: an N-terminal haloacid dehalogenase (HAD) domain with unknown function and a C-terminal phosphatidylinositol 4-phosphate-binding domain that anchors Lem4 to the membrane of early LCVs. Herein, we demonstrate that the HAD domain (Lem4-N) is structurally similar to mouse MDP-1 phosphatase and displays phosphotyrosine phosphatase activity. Substrate specificity of Lem4 was probed using a tyrosine phosphatase substrate set, which contained a selection of 360 phosphopeptides derived from human phosphorylation sites. This assay allowed us to identify a consensus pTyr-containing motif. Based on the localization of Lem4 to lysosomes and to some extent to plasma membrane when expressed in human cells, we hypothesize that this protein is involved in protein-protein interactions with an LCV or plasma membrane-associated tyrosine-phosphorylated host target.	[Beyrakhova, Ksenia; Li, Lei; Xu, Caishuang; Gagarinova, Alla; Cygler, Miroslaw] Univ Saskatchewan, Dept Biochem, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada; [Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	University of Saskatchewan; McGill University	Cygler, M (corresponding author), Univ Saskatchewan, Dept Biochem, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	miroslaw.cygler@usask.ca		Cygler, Miroslaw/0000-0003-4579-1881	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research; DOE Office of Science [DE-AC02-06CH11357]	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); DOE Office of Science(United States Department of Energy (DOE))	We acknowledge the Protein Characterization and Crystallization Facility, College of Medicine, University of Saskatchewan, for access to the crystallization robot and the 08ID-1 beamline at the Canadian Light Source for diffraction data collection. The Canadian Light Source is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly, which operates the facility.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Babu M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004120; Baccarini M, 1991, Receptor, V1, P243; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Burstein D, 2016, NAT GENET, V48, P167, DOI 10.1038/ng.3481; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; DAUM G, 1993, ANAL BIOCHEM, V211, P50, DOI 10.1006/abio.1993.1231; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; Declerck P, 2010, ENVIRON MICROBIOL, V12, P557, DOI 10.1111/j.1462-2920.2009.02025.x; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldheim YS, 2016, MOL MICROBIOL, V99, P1059, DOI 10.1111/mmi.13290; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Fields BS, 1996, TRENDS MICROBIOL, V4, P286, DOI 10.1016/0966-842X(96)10041-X; Fontana MF, 2012, INFECT IMMUN, V80, P3570, DOI 10.1128/IAI.00557-12; Gagnaire A, 2017, NAT REV MICROBIOL, V15, P109, DOI 10.1038/nrmicro.2016.171; Gomez-Valero L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00208; Grochulski P, 2011, J SYNCHROTRON RADIAT, V18, P681, DOI 10.1107/S0909049511019431; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Haneburger I, 2014, CURR TOP MICROBIOL, V376, P155, DOI 10.1007/82_2013_341; Hempstead AD, 2014, CURR TOP MICROBIOL, V376, P249, DOI 10.1007/82_2013_342; Hilbi H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00091; Hoffmann C, 2014, CELL MICROBIOL, V16, P1034, DOI 10.1111/cmi.12256; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Hu GC, 2012, CRIT REV IMMUNOL, V32, P127, DOI 10.1615/CritRevImmunol.v32.i2.20; Huang H, 2015, P NATL ACAD SCI USA, V112, pE1974, DOI 10.1073/pnas.1423570112; Hubber A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004222; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Huynh J, 2012, CELL SIGNAL, V24, P1753, DOI 10.1016/j.cellsig.2012.04.022; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lau AW, 2008, J CELL SCI, V121, P4008, DOI 10.1242/jcs.033522; Li J, 2015, BOUND VALUE PROBL, DOI 10.1186/s13661-014-0269-1; Lifshitz Z, 2013, P NATL ACAD SCI USA, V110, pE707, DOI 10.1073/pnas.1215278110; Liu Y, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006186; Losick VP, 2010, CELL MICROBIOL, V12, P1083, DOI 10.1111/j.1462-5822.2010.01452.x; Lu ZB, 2009, J BIOL CHEM, V284, P1224, DOI 10.1074/jbc.M807056200; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; O'Shea JP, 2013, NAT METHODS, V10, P1211, DOI [10.1038/NMETH.2646, 10.1038/nmeth.2646]; Peisach E, 2004, BIOCHEMISTRY-US, V43, P12770, DOI 10.1021/bi0490688; Pinotsis N, 2017, J BIOL CHEM, V292, P9240, DOI 10.1074/jbc.M117.781948; Prevost MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10249-6; Quaile AT, 2018, J BIOL CHEM, V293, P3307, DOI 10.1074/jbc.M117.812727; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schaale K, 2011, EUR J CELL BIOL, V90, P553, DOI 10.1016/j.ejcb.2010.11.004; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schoebel S, 2010, EMBO REP, V11, P598, DOI 10.1038/embor.2010.97; Selengut JD, 2001, BIOCHEMISTRY-US, V40, P12704, DOI 10.1021/bi011405e; Selengut JD, 2000, BIOCHEMISTRY-US, V39, P8315, DOI 10.1021/bi0005052; Shin S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000220; So EC, 2015, CAN J MICROBIOL, V61, P617, DOI 10.1139/cjm-2015-0166; Stanley ER, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a021857; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tanner JR, 2016, MOL MICROBIOL, V100, P1017, DOI 10.1111/mmi.13365; Urbanus ML, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20167381; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Yu WF, 2012, J BIOL CHEM, V287, P13694, DOI 10.1074/jbc.M112.355610; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	66	6	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13044	13058		10.1074/jbc.RA118.003845	http://dx.doi.org/10.1074/jbc.RA118.003845			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29976756	Green Published, hybrid			2022-12-28	WOS:000442730200007
J	Yap, CC; Digilio, L; Kruczek, K; Roszkowska, M; Fu, XQ; Liu, JS; Winckler, B				Yap, Chan Choo; Digilio, Laura; Kruczek, Kamil; Roszkowska, Matylda; Fu, Xiao-qin; Liu, Judy S.; Winckler, Bettina			A dominant dendrite phenotype caused by the disease-associated G253D mutation in doublecortin (DCX) is not due to its endocytosis defect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE; KINASE; NEUROFASCIN; MAINTENANCE; MIGRATION; INTERACTS; ADAPTER; DOMAIN	Doublecortin (DCX) is a protein needed for cortical development, and DCX mutations cause cortical malformations in humans. The microtubule-binding activity of DCX is well-described and is important for its function, such as supporting neuronal migration and dendrite growth during development. Previous work showed that microtubule binding is not sufficient for DCX-mediated promotion of dendrite growth and that domains in DCX's C terminus are also required. The more C-terminal regions of DCX bind several other proteins, including the adhesion receptor neurofascin and clathrin adaptors. We recently identified a role for DCX in endocytosis of neurofascin. The disease-associated DCX-G253D mutant protein is known to be deficient in binding neurofascin, and we now asked if disruption of neurofascin endocytosis underlies the DCX-G253D-associated pathology. We first demonstrated that DCX functions in endocytosis as a complex with both the clathrin adaptor AP-2 and neurofascin: disrupting either clathrin adaptor binding (DCX-ALPA) or neurofascin binding (DCX-G253D) decreased neurofascin endocytosis in primary neurons. We then investigated a known function for DCX, namely, increasing dendrite growth in cultured neurons. Surprisingly, we found that the DCX-ALPA and DCX-G253D mutants yield distinct dendrite phenotypes. Unlike DCX-ALPA, DCX-G253D caused a dominant-negative dendrite growth phenotype. The endocytosis defect of DCX-G253D thus was separable from its detrimental effects on dendrite growth. We recently identified Dcx-R59H as a dominant allele and can now classify Dcx-G253D as a second Dcx allele that acts dominantly to cause pathology, but does so via a different mechanism.	[Yap, Chan Choo; Digilio, Laura; Winckler, Bettina] Univ Virginia, Dept Cell Biol, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA; [Kruczek, Kamil] Jagiellonian Univ, Program Biotechnol, PL-31007 Krakow, Poland; [Roszkowska, Matylda] Jagiellonian Univ, Fac Biol & Earth Sci, PL-31007 Krakow, Poland; [Fu, Xiao-qin; Liu, Judy S.] Brown Univ, Dept Neurol, Providence, RI 02912 USA; [Kruczek, Kamil] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, 6 Ctr Dr, Bethesda, MD 20892 USA; [Roszkowska, Matylda] Polish Acad Sci, Nencki Inst Expt Biol, Lab Mol & Syst Neuromorphol, PL-02093 Warsaw, Poland; [Fu, Xiao-qin] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou 325027, Zhejiang, Peoples R China; [Fu, Xiao-qin] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325027, Zhejiang, Peoples R China	University of Virginia; Jagiellonian University; Jagiellonian University; Brown University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Wenzhou Medical University; Wenzhou Medical University	Winckler, B (corresponding author), Univ Virginia, Dept Cell Biol, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	BWinckler@virginia.edu	Roszkowska, Matylda/HGC-4112-2022	Roszkowska, Matylda/0000-0001-9280-8063; Winckler, Bettina/0000-0002-7924-9313	National Institutes of Health [R01NS081674]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01NS081674 (to B. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bazelot M, 2012, EUR J NEUROSCI, V35, P244, DOI 10.1111/j.1460-9568.2011.07962.x; Bechstedt S, 2012, DEV CELL, V23, P181, DOI 10.1016/j.devcel.2012.05.006; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Cohen D, 2008, DEV NEUROSCI-BASEL, V30, P187, DOI 10.1159/000109862; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Dixon-Salazar TJ, 2010, ANN NY ACAD SCI, V1214, P156, DOI 10.1111/j.1749-6632.2010.05819.x; Ebel Julia, 2014, Adv Neurobiol, V8, P231; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; Friocourt G, 2001, MOL CELL NEUROSCI, V18, P307, DOI 10.1006/mcne.2001.1022; Friocourt G, 2011, ACTA NEUROPATHOL, V121, P149, DOI 10.1007/s00401-010-0768-9; Fu XQ, 2013, J NEUROSCI, V33, P709, DOI 10.1523/JNEUROSCI.4603-12.2013; Gurevich VV, 2014, CURR OPIN CELL BIOL, V27, P1, DOI 10.1016/j.ceb.2013.10.007; Jean DC, 2012, HUM MOL GENET, V21, P5511, DOI 10.1093/hmg/dds395; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kappeler C, 2007, J COMP NEUROL, V500, P239, DOI 10.1002/cne.21170; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Kim SH, 2009, J NEUROSCI, V29, P3865, DOI 10.1523/JNEUROSCI.5639-08.2009; Kizhatil K, 2002, J NEUROSCI, V22, P7948; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Kriebel M, 2011, J BIOL CHEM, V286, P24385, DOI 10.1074/jbc.M110.212191; Liu JS, 2012, MOL CELL, V47, P707, DOI 10.1016/j.molcel.2012.06.025; Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Martineau FS, 2018, CEREB CORTEX, V28, P2976, DOI 10.1093/cercor/bhy113; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Reider A, 2011, J CELL SCI, V124, P1613, DOI 10.1242/jcs.073395; Sapir T, 2000, HUM MOL GENET, V9, P703, DOI 10.1093/hmg/9.5.703; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Tint I, 2009, J NEUROSCI, V29, P10995, DOI 10.1523/JNEUROSCI.3399-09.2009; Toriyama M, 2012, J BIOL CHEM, V287, P12691, DOI 10.1074/jbc.M111.316307; Traub LM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016790; Tsukada M, 2003, MECH DEVELOP, V120, P1033, DOI 10.1016/S0925-4773(03)00177-1; Volkmer H, 1996, J CELL BIOL, V135, P1059, DOI 10.1083/jcb.135.4.1059; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Yap C. C., 2017, SCI REP, V7, P1, DOI 10.1038/s41598-017-07667-x; Yap CC, 2016, J BIOL CHEM, V291, P26613, DOI 10.1074/jbc.M116.760777; Yap CC, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00119; Yap CC, 2012, J NEUROSCI, V32, P7439, DOI 10.1523/JNEUROSCI.5318-11.2012; Zonta B, 2011, NEURON, V69, P945, DOI 10.1016/j.neuron.2011.02.021	43	7	7	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18890	18902		10.1074/jbc.RA118.004462	http://dx.doi.org/10.1074/jbc.RA118.004462			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30291144	Green Published, hybrid			2022-12-28	WOS:000458467400007
J	Richards, E; Bouche, L; Panico, M; Arbeloa, A; Vinogradov, E; Morris, H; Wren, B; Logan, SM; Dell, A; Fairweather, NF				Richards, Emma; Bouche, Laura; Panico, Maria; Arbeloa, Ana; Vinogradov, Evgeny; Morris, Howard; Wren, Brendan; Logan, Susan M.; Dell, Anne; Fairweather, Neil F.			The S-layer protein of a Clostridium difficile SLCT-11 strain displays a complex glycan required for normal cell growth and morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); nuclear magnetic resonance (NMR); microbiology; glycoprotein structure; genetics; Clostridium difficile; surface layer; virulence; glycosylation; glycomics; glycoproteomics; cell wall	SURFACE-LAYER; MASS-SPECTROMETRY; ANTHRACIS; GENE; RECONSTRUCTION; GLYCOSYLATION; TRANSMISSION; FLAGELLIN; DOMAINS	Clostridium difficile is a bacterial pathogen that causes major health challenges worldwide. It has a well-characterized surface (S)-layer, a para-crystalline proteinaceous layer surrounding the cell wall. In many bacterial and archaeal species, the S-layer is glycosylated, but no such modifications have been demonstrated in C. difficile. Here, we show that a C. difficile strain of S-layer cassette type 11, Ox247, has a complex glycan attached via an O-linkage to Thr-38 of the S-layer low-molecular-weight subunit. Using MS and NMR, we fully characterized this glycan. We present evidence that it is composed of three domains: (i) a core peptide-linked tetrasaccharide with the sequence -4--Rha-3--Rha-3--Rha-3--Gal-peptide; (ii) a repeating pentasaccharide with the sequence -4--Rha-4--Glc-3--Rha-4-(-Rib-3-)-Rha-; and (iii) a nonreducing end-terminal 2,3 cyclophosphoryl-rhamnose attached to a ribose-branched sub-terminal rhamnose residue. The Ox247 genome contains a 24-kb locus containing genes for synthesis and protein attachment of this glycan. Mutations in genes within this locus altered or completely abrogated formation of this glycan, and their phenotypes suggested that this S-layer modification may affect sporulation, cell length, and biofilm formation of C. difficile. In summary, our findings indicate that the S-layer protein of SLCT-11 strains displays a complex glycan and suggest that this glycan is required for C. difficile sporulation and control of cell shape, a discovery with implications for the development of antimicrobials targeting the S-layer.	[Richards, Emma; Bouche, Laura; Panico, Maria; Arbeloa, Ana; Morris, Howard; Dell, Anne; Fairweather, Neil F.] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England; [Vinogradov, Evgeny; Logan, Susan M.] CNR, Human Hlth Therapeut Res Ctr, Vaccine Program, Ottawa, ON K1A 0R6, Canada; [Morris, Howard] Lido Med Ctr, Biopharmaspec, Suite 3-1,St Saviours Rd, Jersey JE2 7LA, England; [Wren, Brendan] London Sch Hyg & Trop Med, London WC1E 7HT, England	Imperial College London; National Research Council Canada; University of London; London School of Hygiene & Tropical Medicine	Dell, A (corresponding author), Imperial Coll London, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England.; Fairweather, NF (corresponding author), Imperial Coll London, Dept Life Sci, Flowers Bldg, London SW7 2AZ, England.	a.dell@imperial.ac.uk; n.fairweather@imperial.ac.uk		Dell, Anne/0000-0003-1380-2347; Fairweather, Neil/0000-0002-3224-0207	Medical Research Council [G1001721]; National Research Council of Canada; Wellcome Trust [102978/Z/13/Z]; MRC [MR/K000551/1, G1001721, G1000214] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Council of Canada; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a Medical Research Council Studentship.; Supported by Medical Research Council Grant G1001721 (to N.F.).; Supported by the National Research Council of Canada.; Recipient of funding from Wellcome Trust Award 102978/Z/13/Z.	Abt MC, 2016, NAT REV MICROBIOL, V14, P609, DOI 10.1038/nrmicro.2016.108; Abu-Qarn M, 2008, CURR OPIN STRUC BIOL, V18, P544, DOI 10.1016/j.sbi.2008.06.010; Anderson VJ, 2011, MOL MICROBIOL, V81, P192, DOI 10.1111/j.1365-2958.2011.07688.x; [Anonymous], 2016, Nat Rev Dis Primers, V2, P16021, DOI 10.1038/nrdp.2016.21; Arbing MA, 2012, P NATL ACAD SCI USA, V109, P11812, DOI 10.1073/pnas.1120595109; Baranova E, 2012, NATURE, V487, P119, DOI 10.1038/nature11155; Beveridge TJ, 1997, FEMS MICROBIOL REV, V20, P99, DOI 10.1016/S0168-6445(97)00043-0; Bharat TAM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.59; Bouche L, 2016, J BIOL CHEM, V291, P25439, DOI 10.1074/jbc.M116.749481; Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; Canis K, 2012, BIOCHEM J, V447, P217, DOI 10.1042/BJ20120810; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Clarke BR, 2011, J BIOL CHEM, V286, P41391, DOI 10.1074/jbc.M111.295857; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Dell A, 2001, SCIENCE, V291, P2351, DOI 10.1126/science.1058890; Dingle KE, 2013, J INFECT DIS, V207, P675, DOI 10.1093/infdis/jis734; Emerson JE, 2009, MOL MICROBIOL, V74, P541, DOI 10.1111/j.1365-2958.2009.06812.x; Fagan R, 2010, METHODS MOL BIOL, V646, P117, DOI 10.1007/978-1-60327-365-7_8; Fagan RP, 2014, NAT REV MICROBIOL, V12, P211, DOI 10.1038/nrmicro3213; Fagan RP, 2009, MOL MICROBIOL, V71, P1308, DOI 10.1111/j.1365-2958.2009.06603.x; Faulds-Pain A, 2014, MOL MICROBIOL, V94, P272, DOI 10.1111/mmi.12755; Ganeshapillai J, 2008, CARBOHYD RES, V343, P703, DOI 10.1016/j.carres.2008.01.002; Gebhart D, 2012, J BACTERIOL, V194, P6240, DOI 10.1128/JB.01272-12; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Iavarone AT, 2002, INT J MASS SPECTROM, V219, P63, DOI 10.1016/S1387-3806(02)00587-0; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; Kern J, 2011, J BIOL CHEM, V286, P26042, DOI 10.1074/jbc.M111.248070; Kern J, 2010, MOL MICROBIOL, V75, P324, DOI 10.1111/j.1365-2958.2009.06958.x; Kirk JA, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6813; Kirk JA, 2017, MICROB BIOTECHNOL, V10, P76, DOI 10.1111/1751-7915.12372; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Merrigan MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078404; Mesnage S, 1999, J APPL MICROBIOL, V87, P256, DOI 10.1046/j.1365-2672.1999.00880.x; Moody AM, 2003, J BIOL CHEM, V278, P7240, DOI 10.1074/jbc.M210468200; Morris HR, 2007, INT J MASS SPECTROM, V259, P16, DOI 10.1016/j.ijms.2006.09.002; Morris HR, 1996, RAPID COMMUN MASS SP, V10, P889, DOI 10.1002/(SICI)1097-0231(19960610)10:8<889::AID-RCM615>3.0.CO;2-F; Morris HR, 1997, J PROTEIN CHEM, V16, P469, DOI 10.1023/A:1026309410737; Panico M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32956; Qazi O, 2009, J MASS SPECTROM, V44, P368, DOI 10.1002/jms.1514; Ristl Robin, 2011, Int J Microbiol, V2011, DOI 10.1155/2011/127870; Ryan A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002076; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Schaffer C, 2017, FEMS MICROBIOL REV, V41, P49, DOI 10.1093/femsre/fuw036; Seekatz AM, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0298-8; Sernee MF, 2006, P NATL ACAD SCI USA, V103, P9458, DOI 10.1073/pnas.0603539103; SLEYTR UB, 1988, J BACTERIOL, V170, P2891, DOI 10.1128/jb.170.7.2891-2897.1988; Stewart A, 1998, CARBOHYD RES, V313, P193, DOI 10.1016/S0008-6215(98)00271-7; SWEET DP, 1974, BIOMED MASS SPECTROM, V1, P263, DOI 10.1002/bms.1200010410; Tarlovsky Y, 2010, J BACTERIOL, V192, P3503, DOI 10.1128/JB.00054-10; van der Wel H, 2001, J BIOL CHEM, V276, P33952, DOI 10.1074/jbc.M102555200; Willing SE, 2015, MOL MICROBIOL, V96, P596, DOI 10.1111/mmi.12958	54	10	10	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18123	18137		10.1074/jbc.RA118.004530	http://dx.doi.org/10.1074/jbc.RA118.004530			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30275012	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000451375200009
J	Joseph, SK; Young, MP; Alzayady, K; Yule, DI; Ali, M; Booth, DM; Hajnoczky, G				Joseph, Suresh K.; Young, Michael P.; Alzayady, Kamil; Yule, David I.; Ali, Mehboob; Booth, David M.; Hajnoczky, Gyorgy			Redox regulation of type-I inositol trisphosphate receptors in intact mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						redox regulation; inositol 1; 4; 5-trisphosphate (IP3); calcium intracellular release; calcium transport; endoplasmic reticulum (ER); calcium channel; inositol 1; 4; 5-trisphosphate receptor; oxidative stress; proteomics; redox-sensitive cysteine	PROTEIN S-GLUTATHIONYLATION; 1,4,5-TRISPHOSPHATE RECEPTOR; OXIDIZED GLUTATHIONE; LIGAND-BINDING; IP3 RECEPTOR; HYDROGEN-PEROXIDE; SUPPRESSOR DOMAIN; CA2+; THIMEROSAL; RELEASE	A sensitization of inositol 1,4,5-trisphosphate receptor (IP3R)-mediated Ca2+ release is associated with oxidative stress in multiple cell types. These effects are thought to be mediated by alterations in the redox state of critical thiols in the IP3R, but this has not been directly demonstrated in intact cells. Here, we utilized a combination of gel-shift assays with MPEG-maleimides and LC-MS/MS to monitor the redox state of recombinant IP(3)R1 expressed in HEK293 cells. We found that under basal conditions, approximate to 5 of the 60 cysteines are oxidized in IP(3)R1. Cell treatment with 50 m thimerosal altered gel shifts, indicating oxidation of approximate to 20 cysteines. By contrast, the shifts induced by 0.5 mm H2O2 or other oxidants were much smaller. Monitoring of biotin-maleimide attachment to IP(3)R1 by LC-MS/MS with 71% coverage of the receptor sequence revealed modification of two cytosolic (Cys-292 and Cys-1415) and two intraluminal cysteines (Cys-2496 and Cys-2533) under basal conditions. The thimerosal treatment modified an additional eleven cysteines, but only three (Cys-206, Cys-767, and Cys-1459) were consistently oxidized in multiple experiments. H2O2 also oxidized Cys-206 and additionally oxidized two residues not modified by thimerosal (Cys-214 and Cys-1397). Potentiation of IP3R channel function by oxidants was measured with cysteine variants transfected into a HEK293 IP3R triple-knockout cell line, indicating that the functionally relevant redox-sensitive cysteines are predominantly clustered within the N-terminal suppressor domain of IP3R. To our knowledge, this study is the first that has used proteomic methods to assess the redox state of individual thiols in IP3R in intact cells.	[Joseph, Suresh K.; Young, Michael P.; Booth, David M.; Hajnoczky, Gyorgy] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, MitoCare Ctr, Philadelphia, PA 19107 USA; [Alzayady, Kamil; Yule, David I.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Ali, Mehboob] Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH 43205 USA	Jefferson University; University of Rochester; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Joseph, SK (corresponding author), Dept Pathol & Cell Biol, Rm 527E JAH,1020 Locust St, Philadelphia, PA 19107 USA.	suresh.joseph@jefferson.edu			National Institutes of Health [RO1 DK103558, RO1 DK051526]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051526, R01DK103558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants RO1 DK103558 (to S. K. J. and G. H.) and RO1 DK051526 (to G. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alzayady KJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad6281; Alzayady KJ, 2013, J BIOL CHEM, V288, P29772, DOI 10.1074/jbc.M113.502203; Anelli T, 2012, ANTIOXID REDOX SIGN, V16, P1077, DOI 10.1089/ars.2011.4004; Appenzeller-Herzog C, 2011, J CELL SCI, V124, P847, DOI 10.1242/jcs.080895; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bansaghi S, 2014, J BIOL CHEM, V289, P8170, DOI 10.1074/jbc.M113.504159; BIRD GS, 1993, J BIOL CHEM, V268, P17917; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; Booth DM, 2016, MOL CELL, V63, P240, DOI 10.1016/j.molcel.2016.05.040; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Bultynck G, 2004, BIOCHEM J, V381, P87, DOI 10.1042/BJ20040072; Casey JP, 2017, J NEUROL, V264, P1444, DOI 10.1007/s00415-017-8545-5; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Chan J, 2010, J BIOL CHEM, V285, P36092, DOI 10.1074/jbc.M110.140160; Chandrasekhar R, 2016, J BIOL CHEM, V291, P4846, DOI 10.1074/jbc.M115.705301; Chaube R, 2014, J BIOL CHEM, V289, P8612, DOI 10.1074/jbc.M114.548925; Dutta A, 2010, BIOCHEMISTRY-US, V49, P6317, DOI 10.1021/bi100338e; Elferink JGR, 1999, GEN PHARMACOL, V33, P1, DOI 10.1016/S0306-3623(98)00258-4; Fan GZ, 2015, NATURE, V527, P336, DOI 10.1038/nature15249; Fredericks GJ, 2014, P NATL ACAD SCI USA, V111, P16478, DOI 10.1073/pnas.1417176111; Go Young-Mi, 2011, J Proteomics Bioinform, V4, P196; Heinz C, 2003, J BIOL CHEM, V278, P8678, DOI 10.1074/jbc.M212280200; HENSCHKE PN, 1995, BIOCHEM J, V312, P485, DOI 10.1042/bj3120485; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Hudson DA, 2015, FREE RADICAL BIO MED, V80, P171, DOI 10.1016/j.freeradbiomed.2014.07.037; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Islam MS, 1997, BIOCHEM J, V321, P347, DOI 10.1042/bj3210347; Ivanova H, 2014, BBA-MOL CELL RES, V1843, P2164, DOI 10.1016/j.bbamcr.2014.03.007; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; James SJ, 2005, NEUROTOXICOLOGY, V26, P1, DOI 10.1016/j.neuro.2004.07.012; Ji YH, 2013, ANAL CHEM, V85, P11952, DOI 10.1021/ac402850s; Joseph SK, 2006, BIOCHEM J, V393, P575, DOI 10.1042/BJ20050889; JOSEPH SK, 1993, J BIOL CHEM, V268, P6477; Kang S, 2008, J BIOL CHEM, V283, P25567, DOI 10.1074/jbc.M803321200; KAPLIN AI, 1994, J BIOL CHEM, V269, P28972; Khan SA, 2013, BIOCHEM J, V451, P177, DOI 10.1042/BJ20121600; Kiviluoto S, 2013, BBA-MOL CELL RES, V1833, P1612, DOI 10.1016/j.bbamcr.2013.01.026; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; Leichert LI, 2006, ANTIOXID REDOX SIGN, V8, P763, DOI 10.1089/ars.2006.8.763; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Lock JT, 2012, J PHYSIOL-LONDON, V590, P3431, DOI [10.1113/jphysiol.2012.230656, 10.1113/jphysiol.2012.232645]; Lock JT, 2011, AM J PHYSIOL-HEART C, V300, pH493, DOI 10.1152/ajpheart.01073.2010; Madesh M, 2005, J CELL BIOL, V170, P1079, DOI 10.1083/jcb.200505022; Makmura L, 2001, ANTIOXID REDOX SIGN, V3, P1105, DOI 10.1089/152308601317203611; Mataragka S, 2018, J CELL SCI, V131, DOI 10.1242/jcs.220848; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Muthuramalingam M, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00089, 10.3389/fpls.2013.00054]; Paknejad N, 2018, NAT STRUCT MOL BIOL, V25, P660, DOI 10.1038/s41594-018-0089-6; PRUIJN FB, 1990, BIOCHEM PHARMACOL, V40, P1947, DOI 10.1016/0006-2952(90)90223-8; Redondo PC, 2004, BIOCHEM PHARMACOL, V67, P491, DOI 10.1016/j.bcp.2003.09.031; RENARD DC, 1992, BIOCHEM J, V284, P507, DOI 10.1042/bj2840507; RENARDROONEY DC, 1995, BIOCHEM J, V310, P185, DOI 10.1042/bj3100185; Rong YP, 2009, BBA-MOL CELL RES, V1793, P971, DOI 10.1016/j.bbamcr.2008.10.015; Rossi AM, 2009, NAT CHEM BIOL, V5, P631, DOI 10.1038/nchembio.195; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Schwaller M, 2003, J BIOL CHEM, V278, P7154, DOI 10.1074/jbc.M211036200; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009; SUZUKI YJ, 1992, AM J PHYSIOL, V262, pH114, DOI 10.1152/ajpheart.1992.262.1.H114; Szlufcik K, 2006, CELL CALCIUM, V39, P325, DOI 10.1016/j.ceca.2005.11.007; Thrower EC, 1996, BIOCHEM J, V318, P61, DOI 10.1042/bj3180061; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Vais H, 2010, BIOPHYS J, V99, P407, DOI 10.1016/j.bpj.2010.04.034; Wesson Donald E., 1995, Microcirculation (New York), V2, P195, DOI 10.3109/10739689509146767; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Yamazaki H, 2010, J BIOL CHEM, V285, P36081, DOI 10.1074/jbc.M110.140129; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	71	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17464	17476		10.1074/jbc.RA118.005624	http://dx.doi.org/10.1074/jbc.RA118.005624			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30228182	hybrid, Green Published			2022-12-28	WOS:000449799000013
J	Furniss, RCD; Low, WW; Mavridou, DAI; Dagley, LF; Webb, AI; Tate, EW; Clements, A				Furniss, R. Christopher D.; Low, Wen Wen; Mavridou, Despoina A. I.; Dagley, Laura F.; Webb, Andrew I.; Tate, Edward W.; Clements, Abigail			Plasma membrane profiling during enterohemorrhagic E-coli infection reveals that the metalloprotease StcE cleaves CD55 from host epithelial surfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteomics; cell surface; host-pathogen interaction; infection; neutrophil; metalloprotease; CD55; EHEC; EPHA2; StcE	DECAY-ACCELERATING FACTOR; COMPUTATIONAL PLATFORM; FACTOR DAF; EXPRESSION; COMPLEMENT; INHIBITION; O157-H7; CELLS; PROTEASE; TRANSPORTERS	Enterohemorrhagic Escherichia coli (EHEC) is one of several E. coli pathotypes that infect the intestinal tract and cause disease. Formation of the characteristic attaching and effacing lesion on the surface of infected cells causes significant remodeling of the host cell surface; however, limited information is available about changes at the protein level. Here we employed plasma membrane profiling, a quantitative cell-surface proteomics technique, to identify host proteins whose cell-surface levels are altered during infection. Using this method, we quantified more than 1100 proteins, 280 of which showed altered cell-surface levels after exposure to EHEC. 22 host proteins were significantly reduced on the surface of infected epithelial cells. These included both known and unknown targets of EHEC infection. The complement decay-accelerating factor cluster of differentiation 55 (CD55) exhibited the greatest reduction in cell-surface levels during infection. We showed by flow cytometry and Western blot analysis that CD55 is cleaved from the cell surface by the EHEC-specific protease StcE and found that StcE-mediated CD55 cleavage results in increased neutrophil adhesion to the apical surface of intestinal epithelial cells. This suggests that StcE alters host epithelial surfaces to depress neutrophil transepithelial migration during infection. This work is the first report of the global manipulation of the epithelial cell surface by a bacterial pathogen and illustrates the power of quantitative cell-surface proteomics in uncovering critical aspects of bacterial infection biology.	[Furniss, R. Christopher D.; Low, Wen Wen; Mavridou, Despoina A. I.; Clements, Abigail] Imperial Coll London, Dept Life Sci, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Dagley, Laura F.; Webb, Andrew I.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Dagley, Laura F.; Webb, Andrew I.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3050, Australia; [Tate, Edward W.] Imperial Coll London, Dept Chem, London SW7 2AZ, England	Imperial College London; Walter & Eliza Hall Institute; University of Melbourne; Imperial College London	Clements, A (corresponding author), Imperial Coll London, Dept Life Sci, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England.	a.clements@imperial.ac.uk	Furniss, Chris/AAG-7373-2020; Mavridou, Despoina/ABG-5940-2020	Furniss, Chris/0000-0002-5806-5099; Mavridou, Despoina/0000-0002-7449-1151; Clements, Abigail/0000-0003-2285-777X; Low, Wen Wen/0000-0003-4004-7244; Tate, Edward/0000-0003-2213-5814	Medical Research Council (MRC) Centre for Molecular Bacteriology and Infection (CMBI) PhD scholarship as part of the CMBI Centre Award [MR/J006874/1]; Medical Research Council (MRC) Career Development Award [MR/M009505/1]; MRC [MR/M009505/1, MR/J006874/1] Funding Source: UKRI	Medical Research Council (MRC) Centre for Molecular Bacteriology and Infection (CMBI) PhD scholarship as part of the CMBI Centre Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council (MRC) Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Recipient of a Medical Research Council (MRC) Centre for Molecular Bacteriology and Infection (CMBI) PhD scholarship as part of the CMBI Centre Award MR/J006874/1.; Funded by a Medical Research Council (MRC) Career Development Award MR/M009505/1.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Berger CN, 2017, CELL METAB, V26, P738, DOI 10.1016/j.cmet.2017.09.003; Bingle LEH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080160; Borthakur A, 2006, AM J PHYSIOL-GASTR L, V290, pG30, DOI 10.1152/ajpgi.00302.2005; Brandt-Bohne U, 2007, BIOCHEM J, V401, P447, DOI 10.1042/BJ20060691; Brazil JC, 2016, IMMUNOL REV, V273, P94, DOI 10.1111/imr.12446; Broer A, 2016, J BIOL CHEM, V291, P13194, DOI 10.1074/jbc.M115.700534; Broughton SE, 2012, CURR OPIN STRUC BIOL, V22, P350, DOI 10.1016/j.sbi.2012.03.015; Burland V, 1998, NUCLEIC ACIDS RES, V26, P4196, DOI 10.1093/nar/26.18.4196; CLEARY TG, 1988, PEDIATR CLIN N AM, V35, P485; Clements A, 2014, CELL MICROBIOL, V16, P1693, DOI 10.1111/cmi.12319; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Dziva F, 2007, FEMS MICROBIOL LETT, V271, P258, DOI 10.1111/j.1574-6968.2007.00724.x; Furniss R. C. D., 2017, J BACTERIOL, V200, DOI [10.1128/JB.0033617, DOI 10.1128/JB.0033617]; Furniss RCD, 2016, J MOL BIOL, V428, P3399, DOI 10.1016/j.jmb.2016.05.023; Geiger T, 2011, NAT PROTOC, V6, P147, DOI 10.1038/nprot.2010.192; Giepmans BNG, 2009, BBA-BIOMEMBRANES, V1788, P820, DOI 10.1016/j.bbamem.2008.07.015; Gill RK, 2007, J CLIN INVEST, V117, P428, DOI 10.1172/JCI29625; Grys TE, 2005, INFECT IMMUN, V73, P1295, DOI 10.1128/IAI.73.3.1295-1303.2005; Hews CL, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12717; Hong JY, 2016, CLIN SCI, V130, P1993, DOI 10.1042/CS20160360; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Lathem WW, 2004, J EXP MED, V199, P1077, DOI 10.1084/jem.20030255; Lathem WW, 2002, MOL MICROBIOL, V45, P277, DOI 10.1046/j.1365-2958.2002.02997.x; Lawrence DW, 2003, J EXP MED, V198, P999, DOI 10.1084/jem.20030380; LEBIVIC A, 1990, J CELL BIOL, V111, P1351, DOI 10.1083/jcb.111.4.1351; Lim JY, 2010, J MICROBIOL BIOTECHN, V20, P5, DOI 10.4014/jmb.0908.08007; Long J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01086; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Matheson NJ, 2015, CELL HOST MICROBE, V18, P409, DOI 10.1016/j.chom.2015.09.003; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; MEDOF ME, 1984, J EXP MED, V160, P1558, DOI 10.1084/jem.160.5.1558; MEDOF ME, 1987, J EXP MED, V165, P848, DOI 10.1084/jem.165.3.848; Mitchell EK, 2004, EUR J IMMUNOL, V34, P2559, DOI 10.1002/eji.200425314; MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983; Muller WA, 2016, IMMUNOL REV, V273, P61, DOI 10.1111/imr.12443; Ozen A, 2017, NEW ENGL J MED, V377, P52, DOI 10.1056/NEJMoa1615887; Paul NR, 2015, CURR BIOL, V25, pR1092, DOI 10.1016/j.cub.2015.09.049; Pillai L, 2006, INFECT IMMUN, V74, P3742, DOI 10.1128/IAI.00402-06; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; REDDY P, 1989, J BIOL CHEM, V264, P17329; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Sandow JJ, 2017, PROTEOM CLIN APPL, V11, DOI 10.1002/prca.201700013; Scholz R, 2015, MOL CELL PROTEOMICS, V14, P1927, DOI 10.1074/mcp.M114.046847; Schweigel-Rontgen M, 2014, CURR TOP MEMBR, V73, P321, DOI 10.1016/B978-0-12-800223-0.00009-8; Spehlmann ME, 2009, J IMMUNOL, V183, P3332, DOI 10.4049/jimmunol.0900600; Szabady RL, 2011, MICROBIOL-SGM, V157, P516, DOI 10.1099/mic.0.044529-0; Szabady RL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000320; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Weekes MP, 2014, CELL, V157, P1460, DOI 10.1016/j.cell.2014.04.028; Weekes MP, 2012, J PROTEOME RES, V11, P1475, DOI 10.1021/pr201135e; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Zeng L, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00272; Zeng Y, 2009, NAT METHODS, V6, P207, DOI [10.1038/NMETH.1305, 10.1038/nmeth.1305]; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	59	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17188	17199		10.1074/jbc.RA118.005114	http://dx.doi.org/10.1074/jbc.RA118.005114			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30190327	Green Published, hybrid			2022-12-28	WOS:000449466500018
J	Tetley, GJN; Szeto, A; Fountain, AJ; Mott, HR; Owen, D				Tetley, George J. N.; Szeto, Aydan; Fountain, Adam J.; Mott, Helen R.; Owen, Darerca			Bond swapping from a charge cloud allows flexible coordination of upstream signals through WASP: Multiple regulatory roles for the WASP basic region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CDC42; cell signaling; cytoskeleton; intrinsically disordered protein; protein conformation; protein motif; protein-protein interaction; small GTPase; structure-function; thermodynamics	ALDRICH-SYNDROME PROTEIN; GTPASE-BINDING DOMAIN; CDC42 EFFECTOR PROTEINS; N-WASP; ARP2/3 COMPLEX; ACTIN POLYMERIZATION; COALESCE MECHANISM; ACTIVATION; RHO; MOTIF	Wiskott-Aldrich syndrome protein (WASP) activates the actin-related protein 2/3 homolog (Arp2/3) complex and regulates actin polymerization in a physiological setting. Cell division cycle 42 (Cdc42) is a key activator of WASP, which binds Cdc42 through a Cdc42/Rac-interactive binding (CRIB)-containing region that defines a subset of Cdc42 effectors. Here, using site-directed mutagenesis and binding affinity determination and kinetic assays, we report the results of an investigation into the energetic contributions of individual WASP residues to both the Cdc42-WASP binding interface and the kinetics of complex formation. Our results support the previously proposed dock-and-coalesce binding mechanism, initiated by electrostatic steering driven by WASP's basic region and followed by a coalescence phase likely driven by the conserved CRIB motif. The WASP basic region, however, appears also to play a role in the final complex, as its mutation affected both on- and off-rates, suggesting a more comprehensive physiological role for this region centered on the C-terminal triad of positive residues. These results highlight the expanding roles of the basic region in WASP and other CRIB-containing effector proteins in regulating complex cellular processes and coordinating multiple input signals. The data presented improve our understanding of the Cdc42-WASP interface and also add to the body of information available for Cdc42-effector complex formation, therapeutic targeting of which has promise for Ras-driven cancers. Our findings suggest that combining high-affinity peptide-binding sequences with short electrostatic steering sequences could increase the efficacy of peptidomimetic candidates designed to interfere with Cdc42 signaling in cancer.	[Tetley, George J. N.; Szeto, Aydan; Fountain, Adam J.; Mott, Helen R.; Owen, Darerca] Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England; [Szeto, Aydan] MRC, Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England	University of Cambridge; MRC Laboratory Molecular Biology	Owen, D (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	do202@cam.ac.uk		Tetley, George/0000-0002-7134-7066	Medical Research Council CASE Studentship [MR/K017101/1]; Wellcome Trust Biomedical Vacation Scholarship [2202640/Z/16/Z]; short-term Glover Research Fund Fellowship	Medical Research Council CASE Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Biomedical Vacation Scholarship(Wellcome Trust); short-term Glover Research Fund Fellowship	This work was supported by Medical Research Council CASE Studentship MR/K017101/1 (to D. O. and H. R. M.), a Wellcome Trust Biomedical Vacation Scholarship 2202640/Z/16/Z (to A. J. F.), and a short-term Glover Research Fund Fellowship (to G. J. N. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Arias-Romero LE, 2013, EXPERT OPIN THER TAR, V17, P1263, DOI 10.1517/14728222.2013.828037; Baskaran Y, 2012, EMBO REP, V13, P653, DOI 10.1038/embor.2012.75; Bu WY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012153; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Elliot-Smith AE, 2005, BIOCHEMISTRY-US, V44, P12373, DOI 10.1021/bi0506021; Flock T, 2014, CURR OPIN STRUC BIOL, V26, P62, DOI 10.1016/j.sbi.2014.05.007; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Ha BH, 2018, P NATL ACAD SCI USA, V115, P531, DOI 10.1073/pnas.1717437115; Hamann MJ, 2007, MOL CELL BIOL, V27, P1380, DOI 10.1128/MCB.01608-06; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Hirsch DS, 2001, J BIOL CHEM, V276, P875, DOI 10.1074/jbc.M007039200; Jain N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15031; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Lin Q, 2012, BIOCHEM J, V445, P255, DOI 10.1042/BJ20111575; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Liu Y, 2009, LUNG CANCER, V63, P375, DOI 10.1016/j.lungcan.2008.12.012; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Mott H. R., 2018, SEMIN CANCER BIOL, V2018, DOI [10.1016/S1044-579X(17)30243-2, DOI 10.1016/S1044-579X(17)30243-2]; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Nur-E-Kamal MSA, 1999, ONCOGENE, V18, P7787; Ou L, 2017, FEBS J, V284, P3381, DOI 10.1111/febs.14197; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Pang XD, 2016, PROTEINS, V84, P674, DOI 10.1002/prot.25018; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Pirone DM, 2001, TRENDS GENET, V17, P370, DOI 10.1016/S0168-9525(01)02311-3; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Stengel KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037317; Suetsugu S, 2001, J BIOL CHEM, V276, P33175, DOI 10.1074/jbc.M102866200; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Tetley GJN, 2017, J BIOL CHEM, V292, P11361, DOI 10.1074/jbc.M117.789883; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Thundimadathil Jyothi, 2012, J Amino Acids, V2012, P967347, DOI 10.1155/2012/967347; Tucci MG, 2007, BRIT J DERMATOL, V157, P1212, DOI 10.1111/j.1365-2133.2007.08246.x; Wang J, 2012, BIOL OPEN, V1, P857, DOI 10.1242/bio.20122071; Watson JR, 2016, J BIOL CHEM, V291, P13875, DOI 10.1074/jbc.M116.724294	48	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15136	15151		10.1074/jbc.RA118.003290	http://dx.doi.org/10.1074/jbc.RA118.003290			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30104412	hybrid, Green Published			2022-12-28	WOS:000445998400016
J	Kong, YF; Cheng, LJ; Mao, FY; Zhang, ZZ; Zhang, YQ; Farah, E; Bosler, J; Bai, YF; Ahmad, N; Kuang, SH; Li, L; Liu, XQ				Kong, Yifan; Cheng, Lijun; Mao, Fengyi; Zhang, Zhuangzhuang; Zhang, Yanquan; Farah, Elia; Bosler, Jacob; Bai, Yunfeng; Ahmad, Nihal; Kuang, Shihuan; Li, Lang; Liu, Xiaoqi			Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug resistance; prostate cancer; cholesterol regulation; tumor therapy; hormone receptor	ANDROGEN DEPRIVATION THERAPY; STATIN USE; CELLS; RECEPTOR; SIMVASTATIN; PROGRESSION	Enzalutamide, a nonsteroidal second-generation antiandrogen, has been recently approved for the management of castration-resistant prostate cancer (CRPC). Although patients can benefit from enzalutamide at the beginning of this therapy, acquired enzalutamide resistance usually occurs within a short period. This motivated us to investigate the mechanism involved and possible approaches for overcoming enzalutamide resistance in CRPC. In the present study, we found that 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR), a crucial enzyme in the mevalonate pathway for sterol biosynthesis, is elevated in enzalutamide-resistant prostate cancer cell lines. HMGCR knockdown could resensitize these cells to the drug, and HMGCR overexpression conferred resistance to it, suggesting that aberrant HMGCR expression is an important enzalutamide-resistance mechanism in prostate cancer cells. Furthermore, enzalutamide-resistant prostate cancer cells were more sensitive to statins, which are HMGCR inhibitors. Of note, a combination of simvastatin and enzalutamide significantly inhibited the growth of enzalutamide-resistant prostate cancer cells in vitro and tumors in vivo. Mechanistically, simvastatin decreased protein levels of the androgen receptor (AR), which was further reduced in combination with enzalutamide. We observed that the decrease in AR may occur through simvastatin-mediated inhibition of the mTOR pathway, whose activation was associated with increased HMGCR and AR expression. These results indicate that simvastatin enhances the efficacy of enzalutamide-based therapy, highlighting the therapeutic potential of statins to overcome enzalutamide resistance in CRPC.	[Kong, Yifan; Mao, Fengyi; Zhang, Zhuangzhuang; Zhang, Yanquan; Farah, Elia; Bosler, Jacob; Bai, Yunfeng; Liu, Xiaoqi] Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA; [Kong, Yifan; Mao, Fengyi; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Kuang, Shihuan; Liu, Xiaoqi] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Cheng, Lijun; Li, Lang] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Ahmad, Nihal] Univ Wisconsin, Dept Dermatol, Madison, WI 53715 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University System of Ohio; Ohio State University; University of Wisconsin System; University of Wisconsin Madison	Liu, XQ (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	liu8@purdue.edu	Ahmad, Nihal/AAR-4249-2021; Mao, Feng/B-8280-2019; Zhang, Yanquan/D-5615-2017	Ahmad, Nihal/0000-0002-4239-9887; Zhang, Yanquan/0000-0003-3527-9972; Kuang, Shihuan/0000-0001-9180-3180; Zhang, Zhuangzhuang/0000-0003-2578-7375	National Institutes of Health [R01 CA157429, R01 CA192894, R01 CA196835, R01 CA196634, R01 AR059130, R01 CA176748]; Chinese Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA192894, R01CA176748, R01CA196634, R01CA196835, P30CA023168, R01CA157429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants R01 CA157429 (to X. L.), R01 CA192894 (to X. L.), R01 CA196835 (to X. L.), R01 CA196634 (to X. L.), R01 AR059130 (to N. A.), and R01 CA176748 (to N. A.) and by funds from the Chinese Scholarship Council (to Y. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akduman B, 2010, UROLOGY, V76, P1048, DOI 10.1016/j.urology.2010.03.044; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Balbas MD, 2013, ELIFE, V2, DOI 10.7554/eLife.00499; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Claessens F, 2014, NAT REV UROL, V11, P712, DOI 10.1038/nrurol.2014.243; Cui YY, 2014, ENDOCR-RELAT CANCER, V21, P435, DOI 10.1530/ERC-14-0107; Dai DH, 2005, CANCER RES, V65, P9517, DOI 10.1158/0008-5472.CAN-05-1613; Hager MH, 2006, CURR OPIN CLIN NUTR, V9, P379, DOI 10.1097/01.mco.0000232896.66791.62; Hamilton RJ, 2008, JNCI-J NATL CANCER I, V100, DOI 10.1093/jnci/djn362; Han W, 2018, ONCOGENE, V37, P710, DOI 10.1038/onc.2017.385; Harshman LC, 2015, JAMA ONCOL, V1, P495, DOI 10.1001/jamaoncol.2015.0829; Hong MY, 2008, J MED FOOD, V11, P657, DOI 10.1089/jmf.2007.0702; Jung J, 2015, KOREAN J UROL, V56, P630, DOI 10.4111/kju.2015.56.9.630; Lee BH, 2013, CANCER RES, V73, P1211, DOI 10.1158/0008-5472.CAN-12-3128; Liu CF, 2015, CANCER RES, V75, P1413, DOI 10.1158/0008-5472.CAN-14-3080; Miraglia E, 2012, INT J ONCOL, V40, P867, DOI 10.3892/ijo.2011.1223; Mittal A, 2011, ASIAN PAC J CANCER P, V12, P1905; Murtola TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039445; Nguyen HG, 2014, ONCOGENE, V33, P4521, DOI 10.1038/onc.2014.25; Prekovic S, 2016, MOL CANCER THER, V15, P1702, DOI 10.1158/1535-7163.MCT-15-0892; Rodriguez-Vida A, 2015, DRUG DES DEV THER, V9, P3325, DOI 10.2147/DDDT.S69433; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Sekine Y, 2008, BIOCHEM BIOPH RES CO, V372, P356, DOI 10.1016/j.bbrc.2008.05.043; Shafique K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-25; Shao C, 2017, CELL CYCLE, V16, P957, DOI 10.1080/15384101.2017.1310351; Stopsack KH, 2017, CARCINOGENESIS, V38, P806, DOI 10.1093/carcin/bgx058; Syvala H, 2016, BIOCHEM BIOPH RES CO, V481, P46, DOI 10.1016/j.bbrc.2016.11.021; Yang L, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.12.074; Yokomizo A, 2011, PROSTATE, V71, P298, DOI 10.1002/pros.21243; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019; Zhang Z, 2014, CANCER RES, V74, P6635, DOI 10.1158/0008-5472.CAN-14-1916; Zhong SL, 2015, CANCER TREAT REV, V41, P554, DOI 10.1016/j.ctrv.2015.04.005	32	50	52	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14328	14341		10.1074/jbc.RA118.004442	http://dx.doi.org/10.1074/jbc.RA118.004442			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30089652	Green Published, hybrid			2022-12-28	WOS:000444671500014
J	Sayeed, M; Gautam, S; Verma, DP; Afshan, T; Kumari, T; Srivastava, AK; Ghosh, JK				Sayeed, Mohd; Gautam, Sudeep; Verma, Devesh Pratap; Afshan, Tayyaba; Kumari, Tripti; Srivastava, Arvind Kumar; Ghosh, Jimut Kanti			A collagen domain-derived short adiponectin peptide activates APPL1 and AMPK signaling pathways and improves glucose and fatty acid metabolisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Type 2 diabetes; adiponectin; AMP-activated kinase (AMPK); cell signaling; peptide chemical synthesis; adiponectin collagen domain; APPL-1; fatty acid metabolism; oral glucose tolerance test (OGTT); peptide oligomerization	INDUCED INSULIN-RESISTANCE; PROTEIN-KINASE; SKELETAL-MUSCLE; L6 MYOTUBES; OB/OB MICE; ADIPOSE; CELLS; BONE; ADIPOGENESIS; HYPOADIPONECTINEMIA	Adiponectin is a fat tissue-derived adipokine with beneficial effects against diabetes, cardiovascular diseases, and cancer. Accordingly, adiponectin-mimetic molecules possess significant pharmacological potential. Oligomeric states of adiponectin appear to determine its biological activity. We identified a highly conserved, 13-residue segment (ADP-1) from adiponectin's collagen domain, which comprises GXXG motifs and has one asparagine and two histidine residues that assist in oligomeric protein assembly. We therefore hypothesized that ADP-1 promotes oligomeric assembly and thereby mediates potential metabolic effects. We observed here that ADP-1 is stable in human serum and oligomerizes in aqueous environments. We also found that ADP-1 activates AMP-activated protein kinase (AMPK) in an adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 (APPL1)-dependent pathway and stimulates glucose uptake in rat skeletal muscle cells (L6 myotubes). ADP-1-induced glucose transport coincided with ADP-1-induced biosynthesis of glucose transporter 4 and its translocation to the plasma membrane. ADP-1 induced an interaction between APPL1 and the small GTPase Rab5, resulting in AMPK phosphorylation, in turn leading to phosphorylation of p38 mitogen-activated protein kinase (MAPK), acetyl-CoA carboxylase, and peroxisome proliferator-activated receptor . Similar to adiponectin, ADP-1 increased the expression of the adiponectin receptor 1 (AdipoR1) gene. Of note, ADP-1 decreased blood glucose levels and enhanced insulin production in pancreatic cells in db/db mice. Further, ADP-1 beneficially affected lipid metabolism by enhancing lipid globule formation in mouse 3T3-L1 adipocytes. To our knowledge, this is the first report on identification of a short peptide from adiponectin with positive effects on glucose or fatty acid metabolism.	[Sayeed, Mohd; Verma, Devesh Pratap; Afshan, Tayyaba; Kumari, Tripti; Ghosh, Jimut Kanti] Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Sect 10,Jankipuram Extens,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India; [Gautam, Sudeep; Srivastava, Arvind Kumar] Cent Drug Res Inst, CSIR, Biochem Div, Sect 10,Jankipuram Extens,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Ghosh, JK (corresponding author), Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Sect 10,Jankipuram Extens,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.	jk_ghosh@cdri.res.in			CSIR-network project [BSC 0120]; CSIR-Central Drug Research Institute [9716]	CSIR-network project(Council of Scientific & Industrial Research (CSIR) - India); CSIR-Central Drug Research Institute	This work was supported by CSIR-network project BSC 0120. The CSIR-Central Drug Research Institute communication number of this article is 9716. The authors declare that they have no conflicts of interest with the contents of this article.	Achari AE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061321; Almer G., BIOLOGICS, V5, P95; Anhe GF, 2012, EUR J PHARMACOL, V689, P285, DOI 10.1016/j.ejphar.2012.06.007; Armani A, 2010, J CELL BIOCHEM, V110, P564, DOI 10.1002/jcb.22598; Benvenuti S, 2007, J ENDOCRINOL INVEST, V30, pRC26, DOI 10.1007/BF03350807; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Caprio M, 2007, FASEB J, V21, P2185, DOI 10.1096/fj.06-7970com; Cheng HX, 2011, J PHOTOCH PHOTOBIO B, V105, P126, DOI 10.1016/j.jphotobiol.2011.07.004; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Del Aguila LF, 1999, AM J PHYSIOL-ENDOC M, V276, pE849, DOI 10.1152/ajpendo.1999.276.5.E849; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Gautam S, 2015, EUR J PHARMACOL, V762, P419, DOI 10.1016/j.ejphar.2015.05.021; Gautam S, 2014, APPL BIOCHEM BIOTECH, V174, P2446, DOI 10.1007/s12010-014-1192-8; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hindi L, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2248; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x; Iwaniak Anna, 2008, Polish Journal of Food and Nutrition Sciences, V58, P289; Jakopitsch C, 2003, EUR J BIOCHEM, V270, P1006, DOI 10.1046/j.1432-1033.2003.03476.x; Ruiz-Ojeda FJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071040; Jiao HL, 2015, CURR OSTEOPOROS REP, V13, P327, DOI 10.1007/s11914-015-0286-8; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; KLIP A, 1987, BIOCHEM J, V242, P131, DOI 10.1042/bj2420131; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Lecka-Czernik B, 2017, DIABETOLOGIA, V60, P1163, DOI 10.1007/s00125-017-4269-4; Liu ML, 2014, BEST PRACT RES CL EN, V28, P25, DOI 10.1016/j.beem.2013.06.003; Lorenzo M, 2008, J Anim Sci, V86, pE94; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; McFalls EO, 2004, AM J PHYSIOL-HEART C, V287, pH1328, DOI 10.1152/ajpheart.01188.2003; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Nayak AR, 2016, J STRUCT BIOL, V195, P129, DOI 10.1016/j.jsb.2016.02.020; Otvos L, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-90; Ouchi N, 2003, HYPERTENSION, V42, P231, DOI 10.1161/01.HYP.0000083488.67550.B8; Ruan H, 2016, J MOL CELL BIOL, V8, P101, DOI 10.1093/jmcb/mjw014; Rubin MR, 2015, CURR OSTEOPOROS REP, V13, P186, DOI 10.1007/s11914-015-0265-0; Sawada K, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-36; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Sinha S, 2004, J BIOL CHEM, V279, P41294, DOI 10.1074/jbc.M406514200; Srivastava S, 2013, ANTIMICROB AGENTS CH, V57, P2457, DOI 10.1128/AAC.00169-13; Tanabe J., 2013, J ORAL TISSUE ENG, V11, P9, DOI [10.11223/jarde.11.9, DOI 10.11223/JARDE.11.9]; Varshney S, 2014, J LIPID RES, V55, P1019, DOI 10.1194/jlr.M039925; Vianna AGD, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0274-5; Wang HF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19445; Wu XD, 2003, DIABETES, V52, P1355, DOI 10.2337/diabetes.52.6.1355; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yap A, 2007, CYTOTECHNOLOGY, V55, P103, DOI 10.1007/s10616-007-9107-y; Yonemitsu S, 2001, DIABETES, V50, P1093, DOI 10.2337/diabetes.50.5.1093; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322; Yu JG, 2002, DIABETES, V51, P2968, DOI 10.2337/diabetes.51.10.2968; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357	56	17	19	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13509	13523		10.1074/jbc.RA118.001801	http://dx.doi.org/10.1074/jbc.RA118.001801			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29991592	Green Published, hybrid			2022-12-28	WOS:000443375500013
J	Liu, M; Tso, P; Woods, SC				Liu, Min; Tso, Patrick; Woods, Stephen C.			Receptor CD36 links a risk-associated allele to obesity and metabolic disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							NEUROTROPHIC FACTOR; INSULIN-RESISTANCE; MACROPHAGE	Mice harboring a particular allele of the human brain-derived neurotropic factor (BDNFM/M mice) develop extreme obesity and insulin resistance when fed a high-fat diet. The underlying mechanisms of this genetic risk factor for obesity are unclear. In the current issue of JBC, Yang et al. report that pharmacological inhibition of integral membrane protein CD36 significantly reduces body weight gain and improves glucose tolerance in BDNFM/M mice. Targeting CD36 may therefore be a promising strategy to improve metabolic dysfunctions and normalize risk factors in obese individuals.	[Liu, Min; Tso, Patrick] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA; [Woods, Stephen C.] Univ Cincinnati, Coll Med, Dept Psychiat & Behav Neurosci, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Liu, M (corresponding author), Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA.	lium@uc.edu			NIDDK NIH HHS [R01 DK103557, R01 DK095440, R01 DK092779, R01 DK119135, U2C DK059630] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103557, R01DK092779, R01DK095440, U2CDK059630] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bao Y, 2012, ATHEROSCLEROSIS, V223, P152, DOI 10.1016/j.atherosclerosis.2012.05.006; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Handberg A, 2010, J CLIN ENDOCR METAB, V95, P1939, DOI 10.1210/jc.2009-2002; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; Moulle VS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074021; Moustafa JSES, 2013, NAT REV ENDOCRINOL, V9, P402, DOI 10.1038/nrendo.2013.57; Rosas-Vargas H, 2011, ARCH MED RES, V42, P482, DOI 10.1016/j.arcmed.2011.09.005; Xu BJ, 2016, NAT REV NEUROSCI, V17, P282, DOI 10.1038/nrn.2016.24; Yang J, 2018, J BIOL CHEM, V293, P13338, DOI 10.1074/jbc.RA118.002405	10	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13349	13350		10.1074/jbc.H118.004818	http://dx.doi.org/10.1074/jbc.H118.004818			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	30143599	Green Published, hybrid			2022-12-28	WOS:000442730200031
J	Majumder, S; Varadharaj, S; Ghoshal, K; Monani, U; Burghes, AHM; Jacob, ST				Majumder, Sarmila; Varadharaj, Saradhadevi; Ghoshal, Kalpana; Monani, Umrao; Burghes, Arthur H. M.; Jacob, Samson T.			RETRACTION: Identification of a novel cyclic AMP-response element (CRE-II) and the role of CREB-1 in the cAMP-induced expression of the survival motor neuron (SMN) gene (Retraction of Vol 279, Pg 14803, 2004)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction														Burghes, Arthur/0000-0001-9031-1555				Majumder S, 2004, J BIOL CHEM, V279, P14803, DOI 10.1074/jbc.M308225200	1	0	0	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12946	12946		10.1074/jbc.W118.004968	http://dx.doi.org/10.1074/jbc.W118.004968			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	30120150	Green Published, hybrid			2022-12-28	WOS:000442203500026
J	Michael, AJ				Michael, Anthony J.			Polyamine function in archaea and bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HYPUSINE-CONTAINING PROTEIN; CHOLERAE BIOFILM FORMATION; AMINO-ACID; ARGININE DECARBOXYLASE; ADENOSYLMETHIONINE DECARBOXYLASE; SPERMIDINE BIOSYNTHESIS; DEOXYHYPUSINE SYNTHASE; EXTREME THERMOPHILE; AGMATINE DEIMINASE; CHAIN POLYAMINES	Most of the phylogenetic diversity of life is found in bacteria and archaea, and is reflected in the diverse metabolism and functions of bacterial and archaeal polyamines. The polyamine spermidine was probably present in the last universal common ancestor, and polyamines are known to be necessary for critical physiological functions in bacteria, such as growth, biofilm formation, and other surface behaviors, and production of natural products, such as siderophores. There is also phylogenetic diversity of function, indicated by the role of polyamines in planktonic growth of different species, ranging from absolutely essential to entirely dispensable. However, the cellular molecular mechanisms responsible for polyamine function in bacterial growth are almost entirely unknown. In contrast, the molecular mechanisms of essential polyamine functions in archaea are better understood: covalent modification by polyamines of translation factor aIF5A and the agmatine modification of tRNA(Ile). As with bacterial hyperthermophiles, archaeal thermophiles require long-chain and branched polyamines for growth at high temperatures. For bacterial species in which polyamines are essential for growth, it is still unknown whether the molecular mechanisms underpinning polyamine function involve covalent or noncovalent interactions. Understanding the cellular molecular mechanisms of polyamine function in bacterial growth and physiology remains one of the great challenges for future polyamine research.	[Michael, Anthony J.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Michael, AJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	anthony.michael@utsouthwestern.edu						Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Adam PS, 2017, ISME J, V11, P2407, DOI 10.1038/ismej.2017.122; Baars O, 2018, ENVIRON MICROBIOL, V20, P1667, DOI 10.1111/1462-2920.14078; BARTIG D, 1992, EUR J BIOCHEM, V204, P751, DOI 10.1111/j.1432-1033.1992.tb16690.x; BARTIG D, 1990, SYST APPL MICROBIOL, V13, P112, DOI 10.1016/S0723-2020(11)80156-6; Becerra-Rivera VA, 2018, MICROBIOL-SGM, V164, P600, DOI 10.1099/mic.0.000615; Blaby IK, 2010, ARCHAEA, V2010, DOI 10.1155/2010/426239; Bontemps-Gallo S, 2018, MOL MICROBIOL, V108, P350, DOI 10.1111/mmi.13940; Burnat M, 2018, MOL MICROBIOL, V109, P763, DOI 10.1111/mmi.14006; Burrell M, 2012, MOL MICROBIOL, V86, P485, DOI 10.1111/j.1365-2958.2012.08208.x; Burrell M, 2010, J BIOL CHEM, V285, P39224, DOI 10.1074/jbc.M110.163154; Castelle CJ, 2018, CELL, V172, P1181, DOI 10.1016/j.cell.2018.02.016; Chattopadhyay MK, 2009, J BACTERIOL, V191, P5549, DOI 10.1128/JB.00381-09; Chawla B, 2010, J BIOL CHEM, V285, P453, DOI 10.1074/jbc.M109.048850; CHEN KY, 1984, BIOCHEM BIOPH RES CO, V124, P423, DOI 10.1016/0006-291X(84)91570-5; Chien YT, 2000, J BACTERIOL, V182, P3247, DOI 10.1128/JB.182.11.3247-3253.2000; Codd R, 2018, J BIOL INORG CHEM, V23, P969, DOI 10.1007/s00775-018-1585-1; Codd R, 2018, ACS CHEM BIOL, V13, P11, DOI 10.1021/acschembio.7b00851; COOPER HL, 1983, P NATL ACAD SCI-BIOL, V80, P1854, DOI 10.1073/pnas.80.7.1854; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Ding YZ, 2014, APPL ENVIRON MICROB, V80, P1498, DOI 10.1128/AEM.03461-13; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fukuda W, 2008, FEMS MICROBIOL LETT, V287, P113, DOI 10.1111/j.1574-6968.2008.01303.x; Giles TN, 2008, J BIOL CHEM, V283, P25829, DOI 10.1074/jbc.M802674200; Graham DE, 2002, J BIOL CHEM, V277, P23500, DOI 10.1074/jbc.M203467200; Green R, 2011, MOL MICROBIOL, V81, P1109, DOI 10.1111/j.1365-2958.2011.07757.x; GRIFFITHS GL, 1984, J BIOL CHEM, V259, P383; Griswold AR, 2006, J BACTERIOL, V188, P834, DOI 10.1128/JB.188.3.834-841.2006; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; HAMANA K, 1985, J BIOCHEM-TOKYO, V97, P1653, DOI 10.1093/oxfordjournals.jbchem.a135223; Hamana K, 2003, J GEN APPL MICROBIOL, V49, P287, DOI 10.2323/jgam.49.287; HAMANA K, 1992, CRIT REV MICROBIOL, V18, P261, DOI 10.3109/10408419209113518; Hamana K, 2002, J GEN APPL MICROBIOL, V48, P177, DOI 10.2323/jgam.48.177; HAMANA K, 1995, J GEN APPL MICROBIOL, V41, P153, DOI 10.2323/jgam.41.153; Hanfrey CC, 2011, J BIOL CHEM, V286, P43301, DOI 10.1074/jbc.M111.307835; HERBST EDWARD J., 1955, JOUR BIOL CHEM, V214, P175; HERBST EJ, 1949, J BIOL CHEM, V181, P47; Hirao T, 2000, J BACTERIOL, V182, P1154, DOI 10.1128/JB.182.4.1154-1157.2000; Hobley L, 2017, J BIOL CHEM, V292, P12041, DOI 10.1074/jbc.M117.789644; Hobley L, 2014, CELL, V156, P844, DOI 10.1016/j.cell.2014.01.012; Hosoya R., 2006, MICROBIOL CULT; Ikeuchi Y, 2010, NAT CHEM BIOL, V6, P277, DOI [10.1038/NCHEMBIO.323, 10.1038/nchembio.323]; Jansson BPM, 2000, J BACTERIOL, V182, P1158, DOI 10.1128/JB.182.4.1158-1161.2000; KAMEKURA M, 1986, BIOCHIM BIOPHYS ACTA, V880, P204, DOI 10.1016/0304-4165(86)90081-4; KAMIO Y, 1986, J BIOL CHEM, V261, P6585; KAMIO Y, 1981, J BACTERIOL, V145, P122, DOI 10.1128/JB.145.1.122-128.1981; Kanjee U, 2011, BIOCHEMISTRY-US, V50, P9388, DOI 10.1021/bi201161k; Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005; Kera K, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00664-17; Kim SH, 2016, ACS CHEM BIOL, V11, P491, DOI 10.1021/acschembio.5b00893; Kurihara S, 2009, FEMS MICROBIOL LETT, V294, P97, DOI 10.1111/j.1574-6968.2009.01552.x; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; Li B, 2016, ACS CHEM BIOL, V11, P2782, DOI 10.1021/acschembio.6b00629; LINDEROTH N, 1983, BIOCHEM BIOPH RES CO, V117, P616, DOI 10.1016/0006-291X(83)91245-7; Lowe-Power TM, 2018, ENVIRON MICROBIOL, V20, P1330, DOI 10.1111/1462-2920.14020; Mandal D, 2010, P NATL ACAD SCI USA, V107, P2872, DOI 10.1073/pnas.0914869107; MARTIN WH, 1952, SCIENCE, V116, P483, DOI 10.1126/science.116.3018.483; McGinnis MW, 2009, FEMS MICROBIOL LETT, V299, P166, DOI 10.1111/j.1574-6968.2009.01744.x; Michael AJ, 2016, BIOCHEM J, V473, P2315, DOI 10.1042/BCJ20160185; Michael AJ, 2016, J BIOL CHEM, V291, P14896, DOI 10.1074/jbc.R116.734780; Morimoto N, 2010, J BACTERIOL, V192, P4991, DOI 10.1128/JB.00279-10; MURAMATSU T, 1988, J BIOL CHEM, V263, P9261; Nakada Y, 2003, MICROBIOL-SGM, V149, P707, DOI 10.1099/mic.0.26009-0; Nakashima M, 2017, GENES CELLS, V22, P628, DOI 10.1111/gtc.12502; Nishimura K, 2012, AMINO ACIDS, V42, P703, DOI 10.1007/s00726-011-0986-z; Nishio T, 2018, CHEMPHYSCHEM, V19, P2299, DOI 10.1002/cphc.201800396; Ohnuma M, 2005, J BIOL CHEM, V280, P30073, DOI 10.1074/jbc.M413332200; Okada K, 2014, J BACTERIOL, V196, P1866, DOI 10.1128/JB.01515-14; ONG SA, 1979, J BIOL CHEM, V254, P1860; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; Oshima T, 2010, PLANT PHYSIOL BIOCH, V48, P521, DOI 10.1016/j.plaphy.2010.03.011; Park JH, 2006, P NATL ACAD SCI USA, V103, P51, DOI 10.1073/pnas.0509348102; Park JH, 2003, J BIOL CHEM, V278, P32683, DOI 10.1074/jbc.M304247200; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; Penwell WF, 2015, CHEMBIOCHEM, V16, P1896, DOI 10.1002/cbic.201500147; Potter AJ, 2014, J BACTERIOL, V196, P3556, DOI 10.1128/JB.01981-14; Prunetti L, 2016, ARCHAEA, V2016, DOI 10.1155/2016/7316725; Rajkovic A, 2017, ANNU REV MICROBIOL, V71, P117, DOI 10.1146/annurev-micro-090816-093629; ROSENTHAL SM, 1962, J BACTERIOL, V84, P859, DOI 10.1128/JB.84.4.859-863.1962; Sakanaka M, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny003; Sakanaka M, 2016, AMINO ACIDS, V48, P2443, DOI 10.1007/s00726-016-2233-0; Sasaki K, 1996, FEBS LETT, V384, P151, DOI 10.1016/0014-5793(96)00310-9; SCHERER P, 1983, J BACTERIOL, V154, P1315, DOI 10.1128/JB.154.3.1315-1322.1983; SCHUMANN H, 1989, SYST APPL MICROBIOL, V11, P103, DOI 10.1016/S0723-2020(89)80047-5; Skiebe E, 2012, INT J MED MICROBIOL, V302, P117, DOI 10.1016/j.ijmm.2012.03.003; Sobe RC, 2017, J BIOL CHEM, V292, P17025, DOI [10.1074/jbc.M117.801068, 10.1074/jbc.m117.801068]; Soma A, 2003, MOL CELL, V12, P689, DOI 10.1016/S1097-2765(03)00346-0; Spang A, 2017, SCIENCE, V357, DOI 10.1126/science.aaf3883; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Sturgill G, 2004, MOL MICROBIOL, V51, P437, DOI 10.1046/j.1365-2958.2003.03835.x; Nguyen S, 2013, J BIOL CHEM, V288, P15256, DOI 10.1074/jbc.M113.461137; Suzuki T, 2014, RNA BIOL, V11, P1586, DOI 10.4161/15476286.2014.992281; TABOR CW, 1978, J BIOL CHEM, V253, P3671; Terui Y, 2005, BIOCHEM J, V388, P427, DOI 10.1042/BJ20041778; Wang Y, 2016, J BACTERIOL, V198, P2682, DOI 10.1128/JB.00265-16; Weiss MC, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.116, 10.1038/nmicrobiol.2016.116]; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wortham BW, 2010, ENVIRON MICROBIOL, V12, P2034, DOI 10.1111/j.1462-2920.2010.02219.x; Yoshida T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159494	100	75	78	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18693	18701		10.1074/jbc.TM118.005670	http://dx.doi.org/10.1074/jbc.TM118.005670			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30254075	hybrid, Green Published			2022-12-28	WOS:000458467300024
J	Lv, ZY; Williams, KM; Yuan, LM; Atkison, JH; Olsen, SK				Lv, Zongyang; Williams, Katelyn M.; Yuan, Lingmin; Atkison, James H.; Olsen, Shaun K.			Crystal structure of a human ubiquitin E1-ubiquitin complex reveals conserved functional elements essential for activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; enzyme mechanism; enzyme structure; structure-function; X-ray crystallography; conformational change; protein degradation; adenylation; E1; thioester	ACTIVATING ENZYME; PROTEIN-ACTIVATION; INSIGHTS; MECHANISM; E3; E2; E1; INHIBITORS; BINDING; SYSTEM	Ubiquitin (Ub) signaling plays a key regulatory role in nearly every aspect of eukaryotic biology and is initiated by E1 enzymes that activate and transfer Ub to E2 Ub-conjugating enzymes. Despite Ub E1's fundamental importance to the cell and its attractiveness as a target for therapeutic intervention in cancer and other diseases, its only available structural information is derived from yeast orthologs of human ubiquitin-like modifier-activating enzyme 1 (hUBA1). To illuminate structural differences between yeast and hUBA1 structures that might be exploited for the development of small-molecule therapeutics, we determined the first crystal structure of a hUBA1-Ub complex. Using structural analysis, molecular modeling, and biochemical analysis, we demonstrate that hUBA1 shares a conserved overall structure and mechanism with previously characterized yeast orthologs, but displays subtle structural differences, particularly within the active site. Computational analysis revealed four potential ligand-binding hot spots on the surface of hUBA1 that might serve as targets to inhibit hUBA1 at the level of Ub activation or E2 recruitment or that might potentially be used in approaches such as protein-targeting chimeric molecules. Taken together, our work enhances our understanding of the hUBA1 mechanism, provides an improved framework for the development of small-molecule inhibitors of UBA1, and serves as a stepping stone for structural studies that involve the enzymes of the human Ub system at the level of both E1 and E2.	Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Olsen, SK (corresponding author), Dept Biochem & Mol Biol, 173 Ashley Ave,MSC 509,Rm 501, Charleston, SC 29425 USA.	olsensk@musc.edu		Olsen, Shaun/0000-0002-1265-7101	National Institutes of Health from NIGMS [P41 GM103403]; National Institutes of Health ORIP HEI [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; Office of the Vice President for Research at the Medical University of South Carolina; National Institutes of Health Shared Instrumentation Award [S10 RR027139-01]; NATIONAL CANCER INSTITUTE [T32CA193201, F30CA216921] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027139, S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115568, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health ORIP HEI; DOE Office of Science(United States Department of Energy (DOE)); Office of the Vice President for Research at the Medical University of South Carolina; National Institutes of Health Shared Instrumentation Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by National Institutes of Health Grant P41 GM103403 from NIGMS. X-ray diffraction data were collected at SER-CAT 22-ID and NE-CAT 24-ID-E beamlines at the Advanced Photon Source, Argonne National Laboratory. The Pilatus 6M detector on 24-ID-C beam line is funded by National Institutes of Health ORIP HEI Grant S10 RR029205. This work used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No.DE-AC02-06CH11357. The X-ray crystallography facility used for this work was supported by the Office of the Vice President for Research at the Medical University of South Carolina. The liquid handling robot used was purchased via National Institutes of Health Shared Instrumentation Award S10 RR027139-01.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Buetow L, 2016, NAT REV MOL CELL BIO, V17, P626, DOI 10.1038/nrm.2016.91; Cappadocia L, 2018, CHEM REV, V118, P889, DOI 10.1021/acs.chemrev.6b00737; DeLano W.L, PYMOL MOL GRAPHICS S; Deshaies RJ, 2015, NAT CHEM BIOL, V11, P634, DOI 10.1038/nchembio.1887; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1988, J BIOL CHEM, V263, P13268; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hyer ML, 2018, NAT MED, V24, P186, DOI 10.1038/nm.4474; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Lv ZY, 2017, J BIOL CHEM, V292, P12089, DOI 10.1074/jbc.M117.787622; Lv ZY, 2017, MOL CELL, V65, P699, DOI 10.1016/j.molcel.2017.01.008; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Mattern MR, 2012, BBA-MOL CELL RES, V1823, P2014, DOI 10.1016/j.bbamcr.2012.05.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Misra M, 2017, STRUCTURE, V25, P1120, DOI 10.1016/j.str.2017.05.001; Olsen SK, 2013, MOL CELL, V49, P884, DOI 10.1016/j.molcel.2013.01.013; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; PICKART CM, 1985, J BIOL CHEM, V260, P1573; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Schafer A, 2014, ACTA CRYSTALLOGR D, V70, P1311, DOI 10.1107/S1399004714002910; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Singh RK, 2017, ANAL CHEM, V89, P7852, DOI 10.1021/acs.analchem.6b04194; Spratt DE, 2014, BIOCHEM J, V458, P421, DOI 10.1042/BJ20140006; Streich FC, 2014, ANNU REV BIOPHYS, V43, P357, DOI 10.1146/annurev-biophys-051013-022958; Streich FC, 2010, SUBCELL BIOCHEM, V54, P1, DOI 10.1007/978-1-4419-6676-6_1; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Tokgoz Z, 2006, J BIOL CHEM, V281, P14729, DOI 10.1074/jbc.M513562200; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Yuan LM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00272-6	40	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18337	18352		10.1074/jbc.RA118.003975	http://dx.doi.org/10.1074/jbc.RA118.003975			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30279270	hybrid, Green Published			2022-12-28	WOS:000451375200025
J	Heidarieh, H; Alcami, A				Heidarieh, Haleh; Alcami, Antonio			Mechanism of action of the viral chemokine-binding protein E163 from ectromelia virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemokine; glycosaminoglycan; virus; poxvirus; inflammation; cell migration; immune evasion; viral chemokine binding protein	GLYCOSAMINOGLYCAN BINDING; T1/35KDA FAMILY; CELL-SURFACE; RECEPTOR; INHIBITOR; EVASION; INTERLEUKIN-18; GLYCOPROTEIN; MODULATION; EXPRESSION	Chemokines interact with glycosaminoglycans (GAGs) at the cellular surface and to specific cell-surface receptors to activate signaling pathways. The GAG interaction allows the formation of a chemotactic gradient of chemokine required for cell haptotaxis and chemokine oligomerization. Poxviruses encode secreted chemokine-binding proteins with no sequence similarity to their cellular counterparts to modulate the host immune system. The E163 protein from ectromelia virus, the causative agent of mousepox, binds chemokines through their GAG-binding domain. In addition, E163 interacts with GAGs to be anchored at the cell surface, but its ability to interfere with chemokine-GAG interactions has not been demonstrated. We report the identification of the GAG-binding regions in E163 and the generation of mutant forms deficient of GAG binding. Chemokine binding assays show that some of the E163 GAG-binding sites are also involved in the interaction with chemokines. By using recombinant GAG-binding mutant forms we demonstrate that E163 prevents the interaction of chemokines with cell-surface GAGs, providing mechanisms for the immunomodulatory activity of the viral chemokine-binding protein E163.	CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; Univ Autonoma Madrid, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Alcami, A (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Nicolas Cabrera 1, E-28049 Madrid, Spain.	aalcami@cbm.csic.es	Alcami, Antonio/F-8512-2015	Alcami, Antonio/0000-0002-3333-6016	Spanish Ministry of Economy and Competitiveness; European Union (European Regional Development's Funds) [SAF2012-38957, SAF2015-67485-R]; Formacion de Personal Investigador studentship	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Union (European Regional Development's Funds); Formacion de Personal Investigador studentship	This work was supported Spanish Ministry of Economy and Competitiveness and European Union (European Regional Development's Funds, FEDER) Grants SAF2012-38957 and SAF2015-67485-R. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Formacion de Personal Investigador studentship.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Alcami A, 1998, J IMMUNOL, V160, P624; Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Alejo A, 2006, P NATL ACAD SCI USA, V103, P5995, DOI 10.1073/pnas.0510462103; Alexander JM, 2002, CELL, V111, P343, DOI 10.1016/S0092-8674(02)01007-3; Alexander-Brett JM, 2007, J EXP MED, V204, P3157, DOI 10.1084/jem.20071677; Arnold PL, 2006, J VIROL, V80, P7439, DOI 10.1128/JVI.00576-06; Bahar MW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040005; Born TL, 2000, J IMMUNOL, V164, P3246, DOI 10.4049/jimmunol.164.6.3246; Born TL, 2000, J BIOL CHEM, V275, P29946, DOI 10.1074/jbc.M004077200; Bryant NA, 2003, EMBO J, V22, P833, DOI 10.1093/emboj/cdg092; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Carfi A, 1999, P NATL ACAD SCI USA, V96, P12379, DOI 10.1073/pnas.96.22.12379; Clark RH, 2006, J GEN VIROL, V87, P29, DOI 10.1099/vir.0.81417-0; de Marco MDF, 2010, FASEB J, V24, P1479, DOI 10.1096/fj.09-144733; Dyer DP, 2016, J BIOL CHEM, V291, P12627, DOI 10.1074/jbc.M116.720953; Dyer DP, 2014, J IMMUNOL, V192, P2177, DOI 10.4049/jimmunol.1300194; Epperson ML, 2012, IMMUNOL REV, V250, P199, DOI 10.1111/imr.12009; Esteban DJ, 2004, J GEN VIROL, V85, P1291, DOI 10.1099/vir.0.79902-0; Felix J, 2017, NAT REV IMMUNOL, V17, P112, DOI 10.1038/nri.2016.134; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Gonzalez-Motos V, 2016, CYTOKINE GROWTH F R, V30, P71, DOI 10.1016/j.cytogfr.2016.02.007; Graham KA, 1997, VIROLOGY, V229, P12, DOI 10.1006/viro.1996.8423; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Heidarieh H, 2015, VIRUS RES, V209, P67, DOI 10.1016/j.virusres.2015.02.028; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Laguri C, 2008, CARBOHYD RES, V343, P2018, DOI 10.1016/j.carres.2008.01.047; Lalani AS, 1998, VIROLOGY, V250, P173, DOI 10.1006/viro.1998.9340; Lau EK, 2004, ADV PROTEIN CHEM, V68, P351; Lubman OY, 2014, J VIROL, V88, P538, DOI 10.1128/JVI.02729-13; Martinez-Martin N, 2016, J GEN VIROL, V97, P3007, DOI 10.1099/jgv.0.000616; Martinez-Martin N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7163; Mavian C, 2014, VIROLOGY, V462, P218, DOI 10.1016/j.virol.2014.06.010; Mellado M, 2001, ANNU REV IMMUNOL, V19, P397, DOI 10.1146/annurev.immunol.19.1.397; Montanuy I, 2011, FASEB J, V25, P1960, DOI 10.1096/fj.10-177188; Nelson CA, 2015, VIRUSES-BASEL, V7, P4873, DOI 10.3390/v7092848; Ng A, 2001, J GEN VIROL, V82, P2095, DOI 10.1099/0022-1317-82-9-2095; Parry CM, 2000, J EXP MED, V191, P573, DOI 10.1084/jem.191.3.573; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10030070; Rueda P, 2012, CIRCULATION, V126, P1882, DOI 10.1161/CIRCULATIONAHA.112.113290; Ruiz-Arguello MB, 2008, J VIROL, V82, P917, DOI 10.1128/JVI.02111-07; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Seet BT, 2001, J BIOL CHEM, V276, P30504, DOI 10.1074/jbc.M011401200; Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; Smith VP, 2000, J VIROL, V74, P8460, DOI 10.1128/JVI.74.18.8460-8471.2000; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Tsung KL, 1996, J VIROL, V70, P165, DOI 10.1128/JVI.70.1.165-171.1996; Viejo-Borbolla A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002497; Webb LMC, 2004, FASEB J, V18, P571, DOI 10.1096/fj.03-0485fje; Xiang Y, 2003, J VIROL, V77, P2623, DOI 10.1128/JVI.77.4.2623-2630.2003; Xue XG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002162; Zhang L, 2006, P NATL ACAD SCI USA, V103, P13985, DOI 10.1073/pnas.0602142103; Zhang LJ, 2006, METHOD ENZYMOL, V416, P205, DOI 10.1016/S0076-6879(06)16013-9; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243	57	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17418	17429		10.1074/jbc.RA118.004432	http://dx.doi.org/10.1074/jbc.RA118.004432			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30257868	hybrid, Green Published			2022-12-28	WOS:000449799000009
J	Miyata, N; Fujii, S; Kuge, O				Miyata, Non; Fujii, Satoru; Kuge, Osamu			Porin proteins have critical functions in mitochondrial phospholipid metabolism in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phospholipid; cardiolipin; phosphatidylethanolamine; phosphatidic acid; phosphatidylserine; mitochondria; lipid metabolism; membrane transport; porin	SACCHAROMYCES-CEREVISIAE; INTERMEMBRANE SPACE; PHOSPHATIDYLSERINE DECARBOXYLASE; CARDIOLIPIN SYNTHASE; TRANSPORT; COMPLEX; CLONING; GENE; UPS1P; UPS2-MDM35	Mitochondrial synthesis of cardiolipin (CL) and phosphatidylethanolamine requires the transport of their precursors, phosphatidic acid and phosphatidylserine, respectively, to the mitochondrial inner membrane. In yeast, the Ups1-Mdm35 and Ups2-Mdm35 complexes transfer phosphatidic acid and phosphatidylserine, respectively, between the mitochondrial outer and inner membranes. Moreover, a Ups1-independent CL accumulation pathway requires several mitochondrial proteins with unknown functions including Mdm31. Here, we identified a mitochondrial porin, Por1, as a protein that interacts with both Mdm31 and Mdm35 in budding yeast (Saccharomyces cerevisiae). Depletion of the porins Por1 and Por2 destabilized Ups1 and Ups2, decreased CL levels by approximate to 90%, and caused loss of Ups2-dependent phosphatidylethanolamine synthesis, but did not affect Ups2-independent phosphatidylethanolamine synthesis in mitochondria. Por1 mutations that affected its interactions with Mdm31 and Mdm35, but not respiratory growth, also decreased CL levels. Using HeLa cells, we show that mammalian porins also function in mitochondrial CL metabolism. We conclude that yeast porins have specific and critical functions in mitochondrial phospholipid metabolism and that porin-mediated regulation of CL metabolism appears to be evolutionarily conserved.	[Miyata, Non; Fujii, Satoru; Kuge, Osamu] Kyushu Univ, Dept Chem, Fac Sci, Fukuoka, Fukuoka 8190395, Japan	Kyushu University	Miyata, N; Kuge, O (corresponding author), Motooka 744,Nishi Ku, Fukuoka, Fukuoka 8190395, Japan.	miyata@chem.kyushu-univ.jp; kuge@chem.kyushu-univ.jp		, Non/0000-0001-5766-8771; Kuge, Osamu/0000-0003-4962-3519	Japan Society for the Promotion of Science KAKENHI [16K07354, 17K15120]; Takeda Science Foundation; Naito Foundation; Yamada Science Foundation; Ono Medical Research Foundation; Tokyo Biochemical Research Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Yamada Science Foundation; Ono Medical Research Foundation; Tokyo Biochemical Research Foundation	This work was supported by the Japan Society for the Promotion of Science KAKENHI Grants 16K07354 (to O. K.) and 17K15120 (to N. M.), the Takeda Science Foundation (to N. M.), the Naito Foundation (to N. M.), the Yamada Science Foundation (to N. M.), the Ono Medical Research Foundation (to N. M.), and Grant-in-Aid from the Tokyo Biochemical Research Foundation (to O. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Aaltonen MJ, 2016, J CELL BIOL, V213, P525, DOI 10.1083/jcb.201602007; Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; BlachlyDyson E, 1997, MOL CELL BIOL, V17, P5727, DOI 10.1128/MCB.17.10.5727; BLACHLYDYSON E, 1993, J BIOL CHEM, V268, P1835; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Checchetto V, 2014, CELL PHYSIOL BIOCHEM, V34, P842, DOI 10.1159/000363047; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Dimmer KS, 2005, J CELL BIOL, V168, P103, DOI 10.1083/jcb.200410030; GAWAZ M, 1990, J BIOL CHEM, V265, P14202; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Kmita H, 2000, BBA-BIOMEMBRANES, V1509, P86, DOI 10.1016/S0005-2736(00)00284-4; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kuroda T, 2011, MOL MICROBIOL, V80, P248, DOI 10.1111/j.1365-2958.2011.07569.x; Lahiri S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001969; Lee AC, 1998, J MEMBRANE BIOL, V161, P173, DOI 10.1007/s002329900324; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; Messina A, 2012, BBA-BIOMEMBRANES, V1818, P1466, DOI 10.1016/j.bbamem.2011.10.005; MIHARA K, 1985, EMBO J, V4, P769, DOI 10.1002/j.1460-2075.1985.tb03695.x; Miyata N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16661-2; Miyata N, 2016, J CELL BIOL, V214, P77, DOI 10.1083/jcb.201601082; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Potting C, 2010, EMBO J, V29, P2888, DOI 10.1038/emboj.2010.169; Sesaki H, 2006, J CELL BIOL, V173, P651, DOI 10.1083/jcb.200603092; Tamura Y, 2014, TRAFFIC, V15, P933, DOI 10.1111/tra.12188; Tamura Y, 2013, CELL METAB, V17, P709, DOI 10.1016/j.cmet.2013.03.018; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Tamura Y, 2010, EMBO J, V29, P2875, DOI 10.1038/emboj.2010.149; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tomasello MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081522; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; VANDYCK E, 1995, MOL GEN GENET, V246, P426, DOI 10.1007/BF00290446; Watanabe Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8922	38	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17593	17605		10.1074/jbc.RA118.005410	http://dx.doi.org/10.1074/jbc.RA118.005410			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30237174	Green Published, hybrid			2022-12-28	WOS:000449799000023
J	Dunys, J; Valverde, A; Checler, F				Dunys, Julie; Valverde, Audrey; Checler, Frederic			Are N- and C-terminally truncated A species key pathological triggers in Alzheimer's disease?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Alzheimer disease; aggregation; toxicity; biomarker; amyloid- (A); neurodegeneration; production; therapeutic strategy; truncated A species	AMYLOID PRECURSOR PROTEIN; A-BETA PEPTIDES; GLUTAMINYL CYCLASE; SYNAPTIC PLASTICITY; SECRETASE CLEAVAGE; COGNITIVE DECLINE; GAMMA-SECRETASES; MOUSE MODEL; APP; FRAGMENT	The histopathology of Alzheimer's disease (AD) is characterized by neuronal loss, neurofibrillary tangles, and senile plaque formation. The latter results from an exacerbated production (familial AD cases) or altered degradation (sporadic cases) of 40/42-amino acid-long -amyloid peptides (A peptides) that are produced by sequential cleavages of A precursor protein (APP) by - and -secretases. The amyloid cascade hypothesis proposes a key role for the full-length A42 and the A40/42 ratio in AD etiology, in which soluble A oligomers lead to neurotoxicity, tau hyperphosphorylation, aggregation, and, ultimately, cognitive defects. However, following this postulate, during the last decade, several clinical approaches aimed at decreasing full-length A42 production or neutralizing it by immunotherapy have failed to reduce or even stabilize AD-related decline. Thus, the A peptide (A40/42)-centric hypothesis is probably a simplified view of a much more complex situation involving a multiplicity of APP fragments and A catabolites. Indeed, biochemical analyses of AD brain deposits and fluids have unraveled an A peptidome consisting of additional A-related species. Such A catabolites could be due to either primary enzymatic cleavages of APP or secondary processing of A itself by exopeptidases. Here, we review the diversity of N- and C-terminally truncated A peptides and their biosynthesis and outline their potential function/toxicity. We also highlight their potential as new pharmaceutical targets and biomarkers.	[Dunys, Julie; Valverde, Audrey; Checler, Frederic] Univ Cote Azur, CNRS, INSERM, IPMC,Team Labeled Lab Excellence LABEX Distalz, 660 Route Lucioles, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Checler, F (corresponding author), Univ Cote Azur, CNRS, INSERM, IPMC,Team Labeled Lab Excellence LABEX Distalz, 660 Route Lucioles, F-06560 Valbonne, France.	checler@ipmc.cnrs.fr	Valverde, Audrey/AAZ-4106-2021; Checler, Frederic/C-1241-2009	Checler, Frederic/0000-0003-2098-1750; Valverde, Audrey/0000-0002-6060-3503	LABEX (Excellence Laboratory, Program Investment for the Future); DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease); Hospital University Federation (FHU) OncoAge; Fondation Plan Alzheimer	LABEX (Excellence Laboratory, Program Investment for the Future); DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease); Hospital University Federation (FHU) OncoAge; Fondation Plan Alzheimer	This work was supported by LABEX (Excellence Laboratory, Program Investment for the Future), DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease), the Hospital University Federation (FHU) OncoAge, and the Fondation Plan Alzheimer. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham JD, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.58; Alexandru A, 2011, J NEUROSCI, V31, P12790, DOI 10.1523/JNEUROSCI.1794-11.2011; Ancolio K, 1999, P NATL ACAD SCI USA, V96, P4119, DOI 10.1073/pnas.96.7.4119; Antonios G, 2015, SCI REP-UK, V5, DOI 10.1038/srep17338; Antonios G, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-56; Antonyan A, 2018, NEUROCHEM INT, V113, P112, DOI 10.1016/j.neuint.2017.12.001; Armogida M, 2001, NAT CELL BIOL, V3, P1030, DOI 10.1038/ncb1101-1030; Baranger K, 2017, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00163; Baranger K, 2016, CELL MOL LIFE SCI, V73, P217, DOI 10.1007/s00018-015-1992-1; BAUER K, 1979, EUR J BIOCHEM, V99, P239, DOI 10.1111/j.1432-1033.1979.tb13250.x; Benilova I, 2014, J BIOL CHEM, V289, P30977, DOI 10.1074/jbc.M114.599027; Bertram L, 2012, PROG MOL BIOL TRANSL, V107, P79, DOI 10.1016/B978-0-12-385883-2.00008-4; Bibl M, 2012, J NEURAL TRANSM, V119, P805, DOI 10.1007/s00702-012-0801-3; Bouter Y, 2013, ACTA NEUROPATHOL, V126, P189, DOI 10.1007/s00401-013-1129-2; Buchholz M, 2006, J MED CHEM, V49, P664, DOI 10.1021/jm050756e; Cabrera E, 2018, BBA-MOL BASIS DIS, V1864, P208, DOI 10.1016/j.bbadis.2017.07.005; Caillava C, 2014, NEUROBIOL AGING, V35, P1570, DOI 10.1016/j.neurobiolaging.2014.01.011; Catalano SM, 2006, CURR TOP MED CHEM, V6, P597, DOI 10.2174/156802606776743066; Chami L, 2012, J BIOL CHEM, V287, P24573, DOI 10.1074/jbc.M111.333054; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Checler F., 1994, METHODS NEUROTRANS 2, P375; Cisse M, 2017, MOL PSYCHIATR, V22, P1562, DOI 10.1038/mp.2016.152; Cynis H, 2008, BIOCHEMISTRY-US, V47, P7405, DOI 10.1021/bi800250p; Dammers C, 2017, CHEM SCI, V8, P4996, DOI 10.1039/c6sc04797a; De Kimpe L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044674; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Fluhrer R, 2003, J BIOL CHEM, V278, P5531, DOI 10.1074/jbc.M211485200; Frost JL, 2012, NEURODEGENER DIS, V10, P265, DOI 10.1159/000335913; Galante D, 2016, INT J BIOCHEM CELL B, V79, P261, DOI 10.1016/j.biocel.2016.08.037; Grochowska KM, 2017, EMBO REP, V18, P962, DOI 10.15252/embr.201643519; Gunn AP, 2016, J BIOL CHEM, V291, P6134, DOI 10.1074/jbc.M115.655183; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hernandez-Guillamon M, 2015, J BIOL CHEM, V290, P15078, DOI 10.1074/jbc.M114.610931; Hosoda R, 1998, J NEUROPATH EXP NEUR, V57, P1089, DOI 10.1097/00005072-199811000-00012; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Iwatsubo T, 1996, AM J PATHOL, V149, P1823; Jawhar S, 2011, J BIOL CHEM, V286, P4454, DOI 10.1074/jbc.M110.185819; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kuo YM, 1997, BIOCHEM BIOPH RES CO, V237, P188, DOI 10.1006/bbrc.1997.7083; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lai MT, 2006, J NEUROCHEM, V96, P118, DOI 10.1111/j.1471-4159.2005.03528.x; Lauritzen I, 2016, ACTA NEUROPATHOL, V132, P257, DOI 10.1007/s00401-016-1577-6; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lewis H, 2006, NEUROPATH APPL NEURO, V32, P103, DOI 10.1111/j.1365-2990.2006.00696.x; Maddalena AS, 2004, NEURODEGENER DIS, V1, P231, DOI 10.1159/000080991; Marr RA, 2003, J NEUROSCI, V23, P1992; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Matsumura N, 2014, J BIOL CHEM, V289, P5109, DOI 10.1074/jbc.M113.510131; Mattsson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031084; Mazzitelli S, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0381-9; Meckler X, 2016, J BIOL CHEM, V291, P12821, DOI 10.1074/jbc.M115.708297; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Moore BD, 2018, J EXP MED, V215, P283, DOI 10.1084/jem.20170600; Morawski M, 2014, J ALZHEIMERS DIS, V39, P385, DOI 10.3233/JAD-131535; Nixon RA, 2017, FASEB J, V31, P2729, DOI 10.1096/fj.201700359; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Portelius E, 2006, J PROTEOME RES, V5, P1010, DOI 10.1021/pr050475v; Portelius E, 2006, NEUROSCI LETT, V409, P215, DOI 10.1016/j.neulet.2006.09.044; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; Ranaldi S, 2013, NEUROBIOL AGING, V34, P523, DOI 10.1016/j.neurobiolaging.2012.05.016; Reinert J, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0294-7; Russo C, 2000, NATURE, V405, P531, DOI 10.1038/35014735; Russo C, 2002, J NEUROCHEM, V82, P1480, DOI 10.1046/j.1471-4159.2002.01107.x; Sannerud R, 2016, CELL, V166, P193, DOI 10.1016/j.cell.2016.05.020; Saul A, 2013, NEUROBIOL AGING, V34, P1416, DOI 10.1016/j.neurobiolaging.2012.11.014; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schilling S, 2008, J NEUROCHEM, V106, P1225, DOI 10.1111/j.1471-4159.2008.05471.x; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Sevalle J, 2009, J NEUROCHEM, V110, P275, DOI 10.1111/j.1471-4159.2009.06131.x; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Shi XP, 2003, J BIOL CHEM, V278, P21286, DOI 10.1074/jbc.M209859200; Sofola-Adesakin O, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0380-x; Tomaselli S, 2017, ACS CHEM NEUROSCI, V8, P759, DOI 10.1021/acschemneuro.6b00456; Tomidokoro Y, 2005, J BIOL CHEM, V280, P36883, DOI 10.1074/jbc.M504038200; Vandermeeren M, 2001, NEUROSCI LETT, V315, P145, DOI 10.1016/S0304-3940(01)02369-2; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; Wilson CA, 2003, J NEUROSCI RES, V74, P361, DOI 10.1002/jnr.10776; Wilson CA, 2002, NAT NEUROSCI, V5, P849, DOI 10.1038/nn898; Wiltfang J, 2002, J NEUROCHEM, V81, P481, DOI 10.1046/j.1471-4159.2002.00818.x; Wiltfang J, 2001, J BIOL CHEM, V276, P42645, DOI 10.1074/jbc.M102790200; Wirths O, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0309-z; Wirths O, 2009, ACTA NEUROPATHOL, V118, P487, DOI 10.1007/s00401-009-0557-5; Wittnam JL, 2012, J BIOL CHEM, V287, P8154, DOI 10.1074/jbc.M111.308601	94	54	54	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15419	15428		10.1074/jbc.R118.003999	http://dx.doi.org/10.1074/jbc.R118.003999			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30143530	hybrid, Green Published			2022-12-28	WOS:000446549200007
J	Guo, XT; Zhang, MM; Cao, MH; Zhang, W; Kang, ZQ; Xu, P; Ma, CQ; Gao, C				Guo, Xiaoting; Zhang, Manman; Cao, Menghao; Zhang, Wen; Kang, Zhaoqi; Xu, Ping; Ma, Cuiqing; Gao, Chao			d-2-Hydroxyglutarate dehydrogenase plays a dual role in l-serine biosynthesis and d-malate utilization in the bacterium Pseudomonas stutzeri	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dehydrogenase; serine; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); enzyme kinetics; Pseudomonas; D-2-hydroxyglutarate; D-2-hydroxyglutarate dehydrogenase; D-malate; oxaloacetate; phosphoglycerate dehydrogenase	ESCHERICHIA-COLI; TARTRATE DEHYDROGENASE; D-3-PHOSPHOGLYCERATE DEHYDROGENASE; OXIDATIVE DECARBOXYLATION; MICROBIAL-PRODUCTION; MUTATIONS; METABOLISM; MECHANISM; LACTATE; BINDING	Pseudomonas is a very large bacterial genus in which several species can use d-malate for growth. However, the enzymes that can metabolize d-malate, such as d-malate dehydrogenase, appear to be absent in most Pseudomonas species. d-3-Phosphoglycerate dehydrogenase (SerA) can catalyze the production of d-2-hydroxyglutarate (d-2-HG) from 2-ketoglutarate to support d-3-phosphoglycerate dehydrogenation, which is the initial reaction in bacterial l-serine biosynthesis. In this study, we show that SerA of the Pseudomonas stutzeri strain A1501 reduces oxaloacetate to d-malate and that d-2-HG dehydrogenase (D2HGDH) from P. stutzeri displays d-malate-oxidizing activity. Of note, D2HGDH participates in converting a trace amount of d-malate to oxaloacetate during bacterial l-serine biosynthesis. Moreover, D2HGDH is crucial for the utilization of d-malate as the sole carbon source for growth of P. stutzeri A1501. We also found that the D2HGDH expression is induced by the exogenously added d-2-HG or d-malate and that a flavoprotein functions as a soluble electron carrier between D2HGDH and electron transport chains to support d-malate utilization by P. stutzeri. These results support the idea that D2HGDH evolves as an enzyme for both d-malate and d-2-HG dehydrogenation in P. stutzeri. In summary, D2HGDH from P. stutzeri A1501 participates in both a core metabolic pathway for l-serine biosynthesis and utilization of extracellular d-malate.	[Guo, Xiaoting; Zhang, Manman; Cao, Menghao; Kang, Zhaoqi; Ma, Cuiqing; Gao, Chao] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Zhang, Wen] Shandong Univ, Inst Med Sci, Hosp 2, Jinan 250033, Shandong, Peoples R China; [Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Joint Int Res Lab Metab & Dev Sci, Shanghai 200240, Peoples R China; [Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China	Shandong University; Shandong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, C (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China.	jieerbu@sdu.edu.cn		Zhang, Wen/0000-0003-0821-7143; Gao, Chao/0000-0002-5205-0670; Xu, Ping/0000-0002-4418-9680	National Natural Science Foundation of China [31470164, 31670041]; Shandong Provincial Funds for Distinguished Young Scientists [JQ 201806]; Shandong University [2015WLJH25]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Funds for Distinguished Young Scientists; Shandong University	This work was supported by National Natural Science Foundation of China Grants 31470164 and 31670041, Shandong Provincial Funds for Distinguished Young Scientists Grant JQ 201806, and Young Scholars Program of Shandong University Grant 2015WLJH25 (to C. G.). The authors declare that they have no conflicts of interest with the contents of this article.	AlRabiee R, 1996, J BIOL CHEM, V271, P23235, DOI 10.1074/jbc.271.38.23235; ASANO Y, 1993, APPL ENVIRON MICROB, V59, P1110, DOI 10.1128/AEM.59.4.1110-1113.1993; Becker-Kettern J, 2016, J BIOL CHEM, V291, P6036, DOI 10.1074/jbc.M115.704494; Burton RL, 2007, J BIOL CHEM, V282, P31517, DOI 10.1074/jbc.M704032200; Dang L, 2017, ANNU REV BIOCHEM, V86, P305, DOI 10.1146/annurev-biochem-061516-044732; Engqvist M, 2009, J BIOL CHEM, V284, P25026, DOI 10.1074/jbc.M109.021253; Fan J, 2015, ACS CHEM BIOL, V10, P510, DOI 10.1021/cb500683c; Grant GA, 2018, BIOCHEMISTRY-US, V57, P1798, DOI 10.1021/acs.biochem.8b00074; Gu PF, 2014, J IND MICROBIOL BIOT, V41, P1443, DOI 10.1007/s10295-014-1476-6; Gusyatiner M.M., 2015, REF J CHEM, V5, P21, DOI [10.1134/S2079978015010021, DOI 10.1134/S2079978015010021]; HOPPER DJ, 1970, J BACTERIOL, V104, P1197, DOI 10.1128/JB.104.3.1197-1202.1970; Karlstaedt A, 2016, P NATL ACAD SCI USA, V113, P10436, DOI 10.1073/pnas.1601650113; Karsten WE, 2002, BIOCHEMISTRY-US, V41, P12193, DOI 10.1021/bi026278g; Karsten WE, 2006, BIOCHEMISTRY-US, V45, P9000, DOI 10.1021/bi0607251; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5; Kranendijk M, 2010, SCIENCE, V330, P336, DOI 10.1126/science.1192632; Kranendijk M, 2010, HUM MUTAT, V31, P279, DOI 10.1002/humu.21186; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Liu K, 2015, APPL ENVIRON MICROB, V81, P5753, DOI 10.1128/AEM.00975-15; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Lukas H, 2010, J BACTERIOL, V192, P2503, DOI 10.1128/JB.01665-09; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Martinez-Luque M, 2001, CURR MICROBIOL, V43, P154, DOI 10.1007/s002840010279; Mundhada H, 2016, BIOTECHNOL BIOENG, V113, P807, DOI 10.1002/bit.25844; RABIN R, 1965, SCIENCE, V150, P1548, DOI 10.1126/science.150.3703.1548; REEVES HC, 1963, BIOCHEM BIOPH RES CO, V12, P132, DOI 10.1016/0006-291X(63)90248-1; Rudolph J, 2010, BIOCHEMISTRY-US, V49, P9249, DOI 10.1021/bi101291d; Saha SK, 2014, NATURE, V513, P110, DOI 10.1038/nature13441; Tazoe M, 2006, J BACTERIOL, V188, P4635, DOI 10.1128/JB.01999-05; TIPTON PA, 1993, BIOCHEMISTRY-US, V32, P2822, DOI 10.1021/bi00062a013; Unden Gottfried, 2016, EcoSal Plus, V7, DOI 10.1128/ecosalplus.ESP-0021-2015; Vorobieva AA, 2014, J BIOL CHEM, V289, P29086, DOI 10.1074/jbc.M114.595363; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124925; Zhang W, 2017, P NATL ACAD SCI USA, V114, pE7574, DOI 10.1073/pnas.1619034114; Zhang XM, 2018, TRENDS BIOTECHNOL, V36, P700, DOI 10.1016/j.tibtech.2018.02.001; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	39	7	8	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15513	15523		10.1074/jbc.RA118.003897	http://dx.doi.org/10.1074/jbc.RA118.003897			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30131334	Green Published, hybrid			2022-12-28	WOS:000446549200017
J	Son, YO; Pratheeshkumar, P; Divya, SP; Zhang, Z; Shi, XL				Son, Young-Ok; Pratheeshkumar, Poyil; Divya, Sasidharan Padmaja; Zhang, Zhuo; Shi, Xianglin			RETRACTION: Nuclear factor erythroid 2-related factor 2 enhances carcinogenesis by suppressing apoptosis and promoting autophagy in nickel-transformed cells. (Retraction of Vol 292, Pg 8315, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Son YO, 2017, J BIOL CHEM, V292, P8315, DOI 10.1074/jbc.M116.773986	1	1	1	3	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15457	15457		10.1074/jbc.W118.005759	http://dx.doi.org/10.1074/jbc.W118.005759			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30291178	Green Published, hybrid			2022-12-28	WOS:000446549200012
J	Grinkevich, P; Sinha, D; Iermak, I; Guzanova, A; Weiserova, M; Ludwig, J; Mesters, JR; Ettrich, RH				Grinkevich, Pavel; Sinha, Dhiraj; Iermak, Iuliia; Guzanova, Alena; Weiserova, Marie; Ludwig, Jost; Mesters, Jeroen R.; Ettrich, Ruediger H.			Crystal structure of a novel domain of the motor subunit of the Type I restriction enzyme EcoR124 involved in complex assembly and DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; X-ray crystallography; DNA endonuclease; DNA binding protein; Escherichia coli (E; coli); C-terminal domain; EcoR124; GFP fusion; HsdR; restriction-modification	VIBRIO-VULNIFICUS YJ016; ESCHERICHIA-COLI; MODIFICATION SYSTEM; HSDR SUBUNIT; SEQUENCE; PROTEIN; GENES; CRYSTALLIZATION; TRANSLOCATION; PURIFICATION	Although EcoR124 is one of the better-studied Type I restriction-modification enzymes, it still presents many challenges to detailed analyses because of its structural and functional complexity and missing structural information. In all available structures of its motor subunit HsdR, responsible for DNA translocation and cleavage, a large part of the HsdR C terminus remains unresolved. The crystal structure of the C terminus of HsdR, obtained with a crystallization chaperone in the form of pHluorin fusion and refined to 2.45 , revealed that this part of the protein forms an independent domain with its own hydrophobic core and displays a unique -helical fold. The full-length HsdR model, based on the WT structure and the C-terminal domain determined here, disclosed a proposed DNA-binding groove lined by positively charged residues. In vivo and in vitro assays with a C-terminal deletion mutant of HsdR supported the idea that this domain is involved in complex assembly and DNA binding. Conserved residues identified through sequence analysis of the C-terminal domain may play a key role in protein-protein and protein-DNA interactions. We conclude that the motor subunit of EcoR124 comprises five structural and functional domains, with the fifth, the C-terminal domain, revealing a unique fold characterized by four conserved motifs in the IC subfamily of Type I restriction-modification systems. In summary, the structural and biochemical results reported here support a model in which the C-terminal domain of the motor subunit HsdR of the endonuclease EcoR124 is involved in complex assembly and DNA binding.	[Grinkevich, Pavel; Sinha, Dhiraj; Iermak, Iuliia; Ludwig, Jost; Ettrich, Ruediger H.] Acad Sci Czech Republ, Inst Microbiol, Ctr Nanobiol & Struct Biol, Zamek 136, Nove Hrady 37333, Czech Republic; [Grinkevich, Pavel] Univ South Bohemia Ceske Budejovice, Fac Sci, Branisovska 1760, Ceske Budejovice 37005, Czech Republic; [Iermak, Iuliia] Max Planck Inst Biochem, Dept Struct Cell Biol Mol Mech DNA Repair, Klopferspitz 18, D-82152 Martinsried, Germany; [Guzanova, Alena; Weiserova, Marie] Acad Sci Czech Republ, Inst Microbiol, Videnska 1083, Prague 14220 4, Czech Republic; [Mesters, Jeroen R.] Univ Lubeck, Inst Biochem, Ratzeburger Allee 160, Lubeck, Germany; [Ettrich, Ruediger H.] Larkin Univ, Coll Biomed Sci, Miami, FL 33169 USA	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Max Planck Society; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Lubeck	Ettrich, RH (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Ctr Nanobiol & Struct Biol, Zamek 136, Nove Hrady 37333, Czech Republic.; Ettrich, RH (corresponding author), Larkin Univ, Coll Biomed Sci, Miami, FL 33169 USA.	ettrich@nh.cas.cz	Grinkevich, Pavel/AAV-3387-2020; Ludwig, Jost/K-3446-2017; Ettrich, Rudi H/C-1463-2011	Grinkevich, Pavel/0000-0003-1523-7708; Ettrich, Rudi H/0000-0001-8624-7706; Mesters, Jeroen/0000-0001-8532-6699	Czech Science Foundation [P207/12/2323]; Institute of Microbiology, Czech Academy of Sciences; College of Biomedical Sciences, Larkin University; Czech Research Infrastructure for Systems Biology C4SYS [LM2015055]	Czech Science Foundation(Grant Agency of the Czech Republic); Institute of Microbiology, Czech Academy of Sciences; College of Biomedical Sciences, Larkin University; Czech Research Infrastructure for Systems Biology C4SYS	This work was supported by the Czech Science Foundation (P207/12/2323) and by a Memorandum of Agreement between the Institute of Microbiology, Czech Academy of Sciences, and the College of Biomedical Sciences, Larkin University. Access to instruments and other facilities was supported by the Czech Research Infrastructure for Systems Biology C4SYS (LM2015055). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BERTANI G, 1953, J BACTERIOL, V65, P113, DOI 10.1128/JB.65.2.113-121.1953; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Calisto RM, 2005, J MOL BIOL, V351, P749, DOI 10.1016/j.jmb.2005.06.050; Cianci M, 2017, J SYNCHROTRON RADIAT, V24, P323, DOI 10.1107/S1600577516016465; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Csefalvay E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128700; Davies GP, 1999, J MOL BIOL, V290, P565, DOI 10.1006/jmbi.1999.2908; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Dryden DTF, 2001, NUCLEIC ACIDS RES, V29, P3728, DOI 10.1093/nar/29.18.3728; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erwin AL, 2008, J BACTERIOL, V190, P1473, DOI 10.1128/JB.01207-07; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Furuta Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004272; Gao P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017346; Grinkevich P, 2016, ACTA CRYSTALLOGR F, V72, P672, DOI 10.1107/S2053230X16011626; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; HORIUCHI K, 1972, P NATL ACAD SCI USA, V69, P3220, DOI 10.1073/pnas.69.11.3220; HUBACEK J, 1970, J MOL BIOL, V50, P111, DOI 10.1016/0022-2836(70)90108-7; JACOB F, 1955, ANN I PASTEUR PARIS, V88, P724; Janscak P, 1996, J MOL BIOL, V257, P977, DOI 10.1006/jmbi.1996.0217; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kennaway CK, 2012, GENE DEV, V26, P92, DOI 10.1101/gad.179085.111; Kennaway CK, 2009, NUCLEIC ACIDS RES, V37, P762, DOI 10.1093/nar/gkn988; Kim JS, 2005, P NATL ACAD SCI USA, V102, P3248, DOI 10.1073/pnas.0409851102; Kobe B, 2015, ACTA CRYSTALLOGR F, V71, P861, DOI 10.1107/S2053230X15011061; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Lapkouski M, 2009, NAT STRUCT MOL BIOL, V16, P94, DOI 10.1038/nsmb.1523; Liu YP, 2017, P NATL ACAD SCI USA, V114, P11151, DOI 10.1073/pnas.1711754114; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P3, DOI 10.1093/nar/gkt990; Manso AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6055; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPherson A., 1982, PREPARATION ANAL PRO, P19; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murray NE, 2002, MICROBIOL-SGM, V148, P3, DOI 10.1099/00221287-148-1-3; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Obarska-Kosinska A, 2008, J MOL BIOL, V376, P438, DOI 10.1016/j.jmb.2007.11.024; Oliveira PH, 2014, NUCLEIC ACIDS RES, V42, P10618, DOI 10.1093/nar/gku734; Pages H, 2019, BIOSTRINGS EFFICIENT; Park SY, 2012, ACTA CRYSTALLOGR D, V68, P1570, DOI 10.1107/S0907444912038826; PATEL J, 1992, GENE, V112, P21, DOI 10.1016/0378-1119(92)90298-4; Piekarowicz A, 2001, MOL MICROBIOL, V41, P1199, DOI 10.1046/j.1365-2958.2001.02587.x; Qi D, 2008, J VIROL METHODS, V149, P85, DOI 10.1016/j.jviromet.2008.01.002; R Development Core Team, 2017, R LANG ENV STAT COMP; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sinha D, 2018, J MOL MODEL, V24, DOI 10.1007/s00894-018-3722-8; Sisakova E, 2008, J MOL BIOL, V384, P1273, DOI 10.1016/j.jmb.2008.10.017; SOMMER R, 1979, MOL GEN GENET, V168, P331, DOI 10.1007/BF00271504; SURI B, 1984, EMBO J, V3, P575, DOI 10.1002/j.1460-2075.1984.tb01850.x; TAYLOR I, 1992, NUCLEIC ACIDS RES, V20, P179, DOI 10.1093/nar/20.2.179; Uyen NT, 2009, NUCLEIC ACIDS RES, V37, P6960, DOI 10.1093/nar/gkp603; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Thor JJ, 2005, J BIOL CHEM, V280, P33652, DOI 10.1074/jbc.M505473200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Youell J, 2008, MICROBIOL MOL BIOL R, V72, P365, DOI 10.1128/MMBR.00043-07	61	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15043	15054		10.1074/jbc.RA118.003978	http://dx.doi.org/10.1074/jbc.RA118.003978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30054276	Green Published, hybrid			2022-12-28	WOS:000445998400009
J	Gerber, KJ; Squires, KE; Hepler, JR				Gerber, Kyle J.; Squires, Katherine E.; Hepler, John R.			14-3-3 gamma binds regulator of G protein signaling 14 (RGS14) at distinct sites to inhibit the RGS14:G alpha(i)-AIF(4)(-) signaling complex and RGS14 nuclear localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						regulator of G protein signaling (RGS); 14-3-3 protein; protein-protein interaction; Ras protein; G protein; heterotrimeric G protein; nucleus; Gi; G protein regulatory (GPR) motif; GoLoco motif; H-Ras; RGS14	LONG-TERM POTENTIATION; EXOENZYME-S; PSEUDOMONAS-AERUGINOSA; COUPLED RECEPTORS; STRUCTURAL BASIS; KINASE-ACTIVITY; RAF-1 KINASE; LIVE CELLS; PHOSPHORYLATION; ACTIVATION	Regulator of G protein signaling 14 (RGS14) is a multifunctional brain scaffolding protein that integrates G protein and Ras/ERK signaling pathways. It is also a nucleocytoplasmic shuttling protein. RGS14 binds active G alpha(i/o) via its RGS domain, Raf and active H-Ras-GTP via its R1 Ras-binding domain (RBD), and inactive G alpha(i1/3) via its G protein regulatory (GPR) domain. RGS14 suppresses long-term potentiation (LTP) in the CA2 region of the hippocampus, thereby regulating hippocampally based learning and memory. The 14-3-3 family of proteins is necessary for hippocampal LTP and associative learning and memory. Here, we show direct interaction between RGS14 and 14-3-3 gamma at two distinct sties, one phosphorylation-independent and the other phosphorylation-dependent at Ser-218 that is markedly potentiated by signaling downstream of active H-Ras. Using bioluminescence resonance energy transfer (BRET), we show that the pSer-218-dependent RGS14/14-3-3 gamma interaction inhibits active G alpha(i1)-AlF4- binding to the RGS domain of RGS14 but has no effect on active H-Ras and inactive G alpha(i1)-GDP binding to RGS14. By contrast, the phosphorylation-independent binding of 14-3-3 has no effect on RGS14/G alpha(i) interactions but, instead, inhibits (directly or indirectly) RGS14 nuclear import and nucleocytoplasmic shuttling. Together, our findings describe a novel mechanism of negative regulation of RGS14 functions, specifically interactions with active G alpha(i) and nuclear import, while leaving the function of other RGS14 domains intact. Ongoing studies will further elucidate the physiological function of this interaction between RGS14 and 14-3-3 gamma, providing insight into the functions of both RGS14 and 14-3-3 in their roles in modulating synaptic plasticity in the hippocampus.	[Gerber, Kyle J.; Squires, Katherine E.; Hepler, John R.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Hepler, JR (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Rollins Res Ctr, 1510 Clifton Rd,Suite G205, Atlanta, GA 30322 USA.	jhepler@emory.edu			NINDS, National Institutes of Health Core Facilities Grant [5P30NS055077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077, R01NS037112, F31NS098648, R21NS087488] Funding Source: NIH RePORTER	NINDS, National Institutes of Health Core Facilities Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Haian Fu (Emory University, Atlanta, GA) for the very generous contribution of the 14-3-3 plasmids used for this study. We also thank Suneela Ramineni for outstanding technical assistance. The Emory University Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience was supported by NINDS, National Institutes of Health Core Facilities Grant 5P30NS055077.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P2209, DOI 10.1016/j.cellsig.2006.05.011; AITKEN A, 1995, TRENDS BIOCHEM SCI, V20, P95, DOI 10.1016/S0968-0004(00)88971-9; ALAM R, 1994, J BIOCHEM-TOKYO, V116, P416, DOI 10.1093/oxfordjournals.jbchem.a124541; Astuti P, 2011, CELL CYCLE, V10, P1960, DOI 10.4161/cc.10.12.15819; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Baxter HC, 2002, NEUROSCIENCE, V109, P5, DOI 10.1016/S0306-4522(01)00492-4; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Benzing T, 2000, J BIOL CHEM, V275, P28167; Benzing T, 2002, J BIOL CHEM, V277, P32954, DOI 10.1074/jbc.M200859200; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Branch MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184497; Brown NE, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.249; Brown NE, 2015, J BIOL CHEM, V290, P9037, DOI 10.1074/jbc.M114.634329; Burchett SA, 2003, J NEUROCHEM, V87, P551, DOI 10.1046/j.1471-4159.2003.02047.x; Burgon PG, 2001, J BIOL CHEM, V276, P32828, DOI 10.1074/jbc.M100960200; Campbell JK, 1997, BIOCHEMISTRY-US, V36, P15363, DOI 10.1021/bi9708085; Chatterjee TK, 2000, J BIOL CHEM, V275, P29660, DOI 10.1074/jbc.M000330200; Chatterjee TK, 2003, J BIOL CHEM, V278, P30272, DOI 10.1074/jbc.M212688200; Chatterjee TK, 2002, MOL CELL BIOL, V22, P4334, DOI 10.1128/MCB.22.12.4334-4345.2002; Chen J, 2007, J NEUROSCI RES, V85, P1724, DOI 10.1002/jnr.21304; Cho HS, 2005, J BIOL CHEM, V280, P805, DOI 10.1074/jbc.M408163200; Clark GJ, 1997, J BIOL CHEM, V272, P20990, DOI 10.1074/jbc.272.34.20990; Demirkan G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021729; Dulin NO, 2000, J BIOL CHEM, V275, P21317, DOI 10.1074/jbc.M910079199; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Evans PR, 2014, J COMP NEUROL, V522, P186, DOI 10.1002/cne.23395; Fischer A, 2009, J BIOL CHEM, V284, P3183, DOI 10.1074/jbc.M804795200; FU H, 1993, P NATL ACAD SCI USA, V90, P2320, DOI 10.1073/pnas.90.6.2320; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hollinger S, 2003, BIOCHEMISTRY-US, V42, P811, DOI 10.1021/bi026664y; Hollinger S, 2001, J NEUROCHEM, V79, P941, DOI 10.1046/j.1471-4159.2001.00629.x; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Lee JK, 2015, PROG MOL BIOL TRANSL, V133, P153, DOI 10.1016/bs.pmbts.2015.01.005; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; LI SF, 1995, EMBO J, V14, P685, DOI 10.1002/j.1460-2075.1995.tb07047.x; Light Y, 2002, MOL CELL BIOL, V22, P4984, DOI 10.1128/MCB.22.14.4984-4996.2002; Lundby A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1871; Masters SC, 1999, BIOCHEMISTRY-US, V38, P5216, DOI 10.1021/bi982492m; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Molzan M, 2012, J MOL BIOL, V423, P486, DOI 10.1016/j.jmb.2012.08.009; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Niu JX, 2002, BIOCHEM J, V365, P677, DOI 10.1042/BJ20020390; Nufer O, 2003, CURR BIOL, V13, pR391, DOI 10.1016/S0960-9822(03)00318-X; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Pinto SM, 2015, PROTEOMICS, V15, P532, DOI 10.1002/pmic.201400303; Qiao HF, 2014, J NEUROSCI, V34, P4801, DOI 10.1523/JNEUROSCI.4393-13.2014; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Rezabkova L, 2011, J BIOL CHEM, V286, P43527, DOI 10.1074/jbc.M111.273573; Rezabkova L, 2010, J STRUCT BIOL, V170, P451, DOI 10.1016/j.jsb.2010.03.009; Rose JJ, 2000, J NEUROCHEM, V75, P2103, DOI 10.1046/j.1471-4159.2000.0752103.x; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Roy S, 1998, MOL CELL BIOL, V18, P3947, DOI 10.1128/MCB.18.7.3947; Shu FJ, 2007, CELL SIGNAL, V19, P163, DOI 10.1016/j.cellsig.2006.06.002; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Snow BE, 1997, BIOCHEM BIOPH RES CO, V233, P770, DOI 10.1006/bbrc.1997.6537; Squires KE, 2018, BRAIN STRUCT FUNCT, V223, P233, DOI 10.1007/s00429-017-1487-y; Traver S, 2000, BIOCHEM J, V350, P19, DOI 10.1042/0264-6021:3500019; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Vellano CP, 2013, J BIOL CHEM, V288, P3620, DOI 10.1074/jbc.M112.440057; Vellano CP, 2011, J BIOL CHEM, V286, P38659, DOI 10.1074/jbc.M111.274928; Willard FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004884; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717	76	7	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14616	14631		10.1074/jbc.RA118.002816	http://dx.doi.org/10.1074/jbc.RA118.002816			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30093406	Green Published, hybrid			2022-12-28	WOS:000446155000004
J	Jensch, A; Frey, Y; Bitschar, K; Weber, P; Schmid, S; Hausser, A; Olayioye, MA; Radde, NE				Jensch, Antje; Frey, Yannick; Bitschar, Katharina; Weber, Patrick; Schmid, Simone; Hausser, Angelika; Olayioye, Monilola A.; Radde, Nicole E.			The tumor suppressor protein DLC1 maintains protein kinase D activity and Golgi secretory function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase D (PKD); Rho (Rho GTPase); deleted in liver cancer 1 (DLC1); secretion; kinetics; model selection; profile likelihood; trans-Golgi network; kinetic modeling	D-MEDIATED PHOSPHORYLATION; C-MU; SIGNALING PATHWAY; RHOA ACTIVITY; NETWORK; ACTIVATION; TRANSPORT; DYNAMICS; CANCER; PKD	Many newly synthesized cellular proteins pass through the Golgi complex from where secretory transport carriers sort them to the plasma membrane and the extracellular environment. The formation of these secretory carriers at the trans-Golgi network is promoted by the protein kinase D (PKD) family of serine/threonine kinases. Here, using mathematical modeling and experimental validation of the PKD activation and substrate phosphorylation kinetics, we reveal that the expression level of the PKD substrate deleted in liver cancer 1 (DLC1), a Rho GTPase-activating protein that is inhibited by PKD-mediated phosphorylation, determines PKD activity at the Golgi membranes. RNAi-mediated depletion of DLC1 reduced PKD activity in a Rho-Rho-associated protein kinase (ROCK)-dependent manner, impaired the exocytosis of the cargo protein horseradish peroxidase, and was associated with the accumulation of the small GTPase RAB6 on Golgi membranes, indicating a protein-trafficking defect. In summary, our findings reveal that DLC1 maintains basal activation of PKD at the Golgi and Golgi secretory activity, in part by down-regulating Rho-ROCK signaling. We propose that PKD senses cytoskeletal changes downstream of DLC1 to coordinate Rho signaling with Golgi secretory function.	[Jensch, Antje; Weber, Patrick; Radde, Nicole E.] Univ Stuttgart, Inst Syst Theory & Automat Control, D-70569 Stuttgart, Germany; [Frey, Yannick; Bitschar, Katharina; Schmid, Simone; Hausser, Angelika; Olayioye, Monilola A.] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany; [Hausser, Angelika; Olayioye, Monilola A.; Radde, Nicole E.] SRCSB, D-70569 Stuttgart, Germany; [Bitschar, Katharina] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany	University of Stuttgart; University of Stuttgart; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Radde, NE (corresponding author), Univ Stuttgart, Inst Syst Theory & Automat Control, D-70569 Stuttgart, Germany.; Olayioye, MA (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany.; Olayioye, MA; Radde, NE (corresponding author), SRCSB, D-70569 Stuttgart, Germany.	monilola.olayioye@izi.uni-stuttgart.de; nicole.radde@ist.uni-stuttgart.de	Hausser, Angelika/AAC-4531-2021	Radde, Nicole/0000-0002-5145-0058; Olayioye, Monilola/0000-0003-1093-263X	Heisenberg program of the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) [OL239/8]; DFG within the Cluster of Excellence in Simulation Technology at the University of Stuttgart [EXC 310/2]	Heisenberg program of the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG))(German Research Foundation (DFG)); DFG within the Cluster of Excellence in Simulation Technology at the University of Stuttgart(German Research Foundation (DFG))	This work was supported in part by Grant ID OL239/8 from the Heisenberg program of the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) (to M. A. O.). This work was also supported by the DFG within the Cluster of Excellence in Simulation Technology (Grant EXC 310/2) at the University of Stuttgart (to A. J., N. R., and M. A. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Alpy F, 2014, BIOCHIMIE, V96, P85, DOI 10.1016/j.biochi.2013.09.015; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Braun AC, 2015, CELL SIGNAL, V27, P1643, DOI 10.1016/j.cellsig.2015.04.003; Cowell CF, 2009, J CELL BIOCHEM, V106, P714, DOI 10.1002/jcb.22067; Degasperi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087293; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Durand N, 2016, SCI REP-UK, V6, DOI 10.1038/srep35963; Fritsche-Guenther R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.27; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Fuchs YF, 2009, TRAFFIC, V10, P858, DOI 10.1111/j.1600-0854.2009.00918.x; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Gehart H, 2012, DEV CELL, V23, P756, DOI 10.1016/j.devcel.2012.07.019; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hausser A, 1999, J BIOL CHEM, V274, P9258, DOI 10.1074/jbc.274.14.9258; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Holeiter G, 2008, CANCER RES, V68, P8743, DOI 10.1158/0008-5472.CAN-08-0984; HOMMA Y, 1995, EMBO J, V14, P286, DOI 10.1002/j.1460-2075.1995.tb07002.x; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Malhotra V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005280; Nhek S, 2010, MOL BIOL CELL, V21, P2327, DOI 10.1091/mbc.E10-02-0090; Olayioye MA, 2013, CELL SIGNAL, V25, P1739, DOI 10.1016/j.cellsig.2013.04.010; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Popescu NC, 2014, MOL DIAGN THER, V18, P293, DOI 10.1007/s40291-014-0086-3; Pusapati GV, 2012, J BIOL CHEM, V287, P9473, DOI 10.1074/jbc.M112.339564; Quassollo G, 2015, CURR BIOL, V25, P971, DOI 10.1016/j.cub.2015.01.075; Roy A, 2017, BBA-REV CANCER, V1868, P283, DOI 10.1016/j.bbcan.2017.05.008; Salvarezza SB, 2009, MOL BIOL CELL, V20, P438, DOI 10.1091/mbc.E08-08-0891; Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251; Song J, 2006, AM J PHYSIOL-CELL PH, V290, pC1469, DOI 10.1152/ajpcell.00486.2005; Stehbens SJ, 2014, NAT CELL BIOL, V16, P558, DOI 10.1038/ncb2975; Storz P, 2000, J BIOL CHEM, V275, P24601, DOI 10.1074/jbc.M002964200; von Blume J, 2009, J CELL BIOL, V187, P1055, DOI 10.1083/jcb.200908040; Wakana Y, 2012, EMBO J, V31, P3976, DOI 10.1038/emboj.2012.235; Weber P, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0147-1; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200	40	4	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14407	14416		10.1074/jbc.RA118.003787	http://dx.doi.org/10.1074/jbc.RA118.003787			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30045871	Green Published, hybrid			2022-12-28	WOS:000444671500020
J	Zmora, P; Hoffmann, M; Kollmus, H; Moldenhauer, AS; Danov, O; Braun, A; Winkler, M; Schughart, K; Pohlmann, S				Zmora, Pawel; Hoffmann, Markus; Kollmus, Heike; Moldenhauer, Anna-Sophie; Danov, Olga; Braun, Armin; Winkler, Michael; Schughart, Klaus; Poehlmann, Stefan			TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						influenza virus; protease; protease inhibitor; virus entry; virology; TMPRSS11A	HOST-CELL ENTRY; RESPIRATORY SYNDROME CORONAVIRUS; HUMAN AIRWAY EPITHELIUM; PROTEOLYTIC ACTIVATION; SERINE PROTEASES; MATRIPTASE; INHIBITOR; CLEAVAGE; IDENTIFICATION; TRYPSIN	The influenza virus hemagglutinin (HA) facilitates viral entry into target cells. Cleavage of HA by host cell proteases is essential for viral infectivity, and the responsible enzymes are potential targets for antiviral intervention. The type II transmembrane serine protease (TTSP) TMPRSS2 has been identified as an HA activator in cell culture and in the infected host. However, it is less clear whether TMPRSS2-related enzymes can also activate HA for spread in target cells. Moreover, the activity of cellular serine protease inhibitors against HA-activating TTSPs is poorly understood. Here, we show that TMPRSS11A, another member of the TTSP family, cleaves and activates the influenza A virus (FLUAV) HA and the Middle East respiratory syndrome coronavirus spike protein (MERS-S). Moreover, we demonstrate that TMPRSS11A is expressed in murine tracheal epithelium, which is a target of FLUAV infection, and in human trachea, suggesting that the protease could support FLUAV spread in patients. Finally, we show that HA activation by the TMPRSS11A-related enzymes human airway tryptase and DESC1, but not TMPRSS11A itself, is blocked by the cellular serine protease inhibitor hepatocyte growth factor activator inhibitor type-1 (HAI-1). Our results suggest that TMPRSS11A could promote FLUAV spread in target cells and that HA-activating TTSPs exhibit differential sensitivity to blockade by cellular serine protease inhibitors.	[Zmora, Pawel; Hoffmann, Markus; Moldenhauer, Anna-Sophie; Winkler, Michael; Poehlmann, Stefan] German Primate Ctr, Leibniz Inst Primate Res, Infect Biol Unit, D-37077 Gottingen, Germany; [Kollmus, Heike; Schughart, Klaus] Helmholtz Ctr Infect Res, Dept Infect Genet, D-38124 Braunschweig, Germany; [Schughart, Klaus] Univ Vet Med Hannover, D-30599 Hannover, Germany; [Schughart, Klaus] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Danov, Olga; Braun, Armin] German Ctr Lung Res DZL, Fraunhofer Inst Toxicol & Expt Med ITEM, Biomed Res Endstage & Obstruct Lung Dis Hannover, REBIRTH Cluster Excellence, D-30625 Hannover, Germany; [Poehlmann, Stefan] Univ Gottingen, Fac Biol & Psychol, D-37073 Gottingen, Germany	Deutsches Primatenzentrum (DPZ); Helmholtz Association; Helmholtz-Center for Infection Research; University of Veterinary Medicine Hannover, Foundation; University of Tennessee System; University of Tennessee Health Science Center; Fraunhofer Gesellschaft	Zmora, P (corresponding author), Max Planck Inst Dynam Complex Tech Syst, Dept Bioproc Engn, Sandtorstr 1, D-39106 Magdeburg, Germany.; Pohlmann, S (corresponding author), German Primate Ctr, Infect Biol Unit, Kellnerweg 4, D-37077 Gottingen, Germany.	zmora@mpi-magdeburg.mpg.de; spoehlmann@dpz.eu	Zmora, Pawel/V-3843-2019; Hoffmann, Markus/J-7836-2018; Pöhlmann, Stefan/H-2395-2011; Braun, Armin/B-8750-2009	Zmora, Pawel/0000-0002-2012-7223; Hoffmann, Markus/0000-0003-4603-7696; Pöhlmann, Stefan/0000-0001-6086-9136; Braun, Armin/0000-0002-1142-1463; Winkler, Michael/0000-0002-6198-554X; Kollmus, Heike/0000-0002-9473-8676; Schughart, Klaus/0000-0002-6824-7523	Deutsche Forschungsgemeinschaft [PO 716/6-1]; Helmholtz Association; Leibniz Association	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Association(Helmholtz Association); Leibniz Association	This work was supported by Deutsche Forschungsgemeinschaft Grant PO 716/6-1 (to S. P.). This work was also supported by Intramural grants (Infection and Immunity Program) from the Helmholtz Association and by Intramural support from the Leibniz Association. The authors declare that they have no conflicts of interest with the contents of this article.	Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Baron J, 2013, J VIROL, V87, P1811, DOI 10.1128/JVI.02320-12; Beaulieu A, 2013, J VIROL, V87, P4237, DOI 10.1128/JVI.03005-12; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Bertram S, 2013, J VIROL, V87, P6150, DOI 10.1128/JVI.03372-12; Bertram S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035876; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bertram S, 2010, REV MED VIROL, V20, P298, DOI 10.1002/rmv.657; Bottcher E, 2009, VACCINE, V27, P6324, DOI 10.1016/j.vaccine.2009.03.029; Bottcher-Friebertshauser E, 2013, PATHOG DIS, V69, P87, DOI 10.1111/2049-632X.12053; Bottcher-Friebertshauser E, 2011, J VIROL, V85, P1554, DOI 10.1128/JVI.01294-10; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Brauer R, 2015, JOVE-J VIS EXP, DOI 10.3791/52421; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Cheng ZS, 2015, J INFECT DIS, V212, P1214, DOI 10.1093/infdis/jiv246; Dittmann M, 2015, CELL, V160, P631, DOI 10.1016/j.cell.2015.01.040; Dunning J, 2014, LANCET INFECT DIS, V14, P1259, DOI 10.1016/S1473-3099(14)70821-7; Edinger TO, 2014, J GEN VIROL, V95, P263, DOI 10.1099/vir.0.059477-0; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Garten W, 2015, EUR J CELL BIOL, V94, P375, DOI 10.1016/j.ejcb.2015.05.013; Gierer S, 2015, J INFECT DIS, V211, P889, DOI 10.1093/infdis/jiu407; Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Hamilton BS, 2014, BIOCHEM BIOPH RES CO, V450, P1070, DOI 10.1016/j.bbrc.2014.06.109; Hamilton BS, 2012, J VIROL, V86, P10579, DOI 10.1128/JVI.00306-12; Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kato M, 2012, J BIOCHEM, V151, P179, DOI 10.1093/jb/mvr131; Kido H, 2007, CURR PHARM DESIGN, V13, P405, DOI 10.2174/138161207780162971; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; Kuhn N, 2016, J VIROL, V90, P4298, DOI 10.1128/JVI.02693-15; Leist SR, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2483-y; Matthaei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056659; Millet JK, 2014, P NATL ACAD SCI USA, V111, P15214, DOI 10.1073/pnas.1407087111; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Paules C, 2017, LANCET, V390, P697, DOI 10.1016/S0140-6736(17)30129-0; Richard M, 2016, FEMS MICROBIOL REV, V40, P68, DOI 10.1093/femsre/fuv039; Sakai K, 2015, J VIROL, V89, P5154, DOI 10.1128/JVI.00124-15; Sakai K, 2014, J VIROL, V88, P5608, DOI 10.1128/JVI.03677-13; Sales KU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023261; Shirato K, 2013, J VIROL, V87, P12552, DOI 10.1128/JVI.01890-13; Sun XJ, 2013, ADV EXP MED BIOL, V790, P72, DOI 10.1007/978-1-4614-7651-1_4; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Tarnow C, 2014, J VIROL, V88, P4744, DOI 10.1128/JVI.03799-13; Watanabe T, 2015, CURR OPIN VIROL, V14, P71, DOI 10.1016/j.coviro.2015.08.008; Winkler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043337; Wrensch F, 2014, VIRUSES-BASEL, V6, P3683, DOI 10.3390/v6093683; Zmora P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138380; Zmora P, 2014, J VIROL, V88, P12087, DOI 10.1128/JVI.01427-14	52	25	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13863	13873		10.1074/jbc.RA118.001273	http://dx.doi.org/10.1074/jbc.RA118.001273			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	29976755	Green Published, hybrid			2022-12-28	WOS:000444070700013
J	Tsin, A; Betts-Obregon, B; Grigsby, J				Tsin, Andrew; Betts-Obregon, Brandi; Grigsby, Jeffery			Visual cycle proteins: Structure, function, and roles in human retinal disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BINDING PROTEIN; GENE-THERAPY; PIGMENT EPITHELIUM; IRBP PROMOTES; VITAMIN-A; RPE65; MUTATIONS; ISOMERASE; RELEASE; REGENERATION	Here, we seek to summarize the current understanding of the biochemical and molecular events mediated by visual cycle molecules in the eye. The structures and functions of selected visual cycle proteins and their roles in human retinal diseases are also highlighted. Genetic mutations and malfunctions of these proteins provide etiological evidence that many ocular diseases arise from anomalies of retinoid (vitamin A) metabolism and related visual processes. Genetic retinal disorders such as retinitis pigmentosa, Leber's congenital amaurosis, and Stargardt's disease are linked to structural changes in visual cycle proteins. Moreover, recent reports suggest that visual cycle proteins may also play a role in the development of diabetic retinopathy. Basic science has laid the groundwork for finding a cure for many of these blindness-causing afflictions, but much work remains. Some translational research projects have advanced to the clinical trial stage, while many others are still in progress, and more are at the ideas stage and remain yet to be tested. Some examples of these studies are discussed. Recent and future progress in our understanding of the visual cycle will inform intervention strategies to preserve human vision and prevent blindness.	[Tsin, Andrew; Betts-Obregon, Brandi] Univ Texas Rio Grande Valley Sch Med, Dept Biomed Sci, Edinburg, TX 78541 USA; [Grigsby, Jeffery] Vis Hlth Specialties, Midland, TX 79707 USA; [Grigsby, Jeffery] Univ Houston, Coll Optometry, Houston, TX 77204 USA; [Grigsby, Jeffery] Texas Tech Univ, Hlth Sci Ctr, Sch Hlth Profess, Dept Lab Sci & Primary Care, Midland, TX 79705 USA	University of Texas System; University of Texas Rio Grande Valley; University of Houston System; University of Houston; Texas Tech University System; Texas Tech University	Tsin, A (corresponding author), Univ Texas Rio Grande Valley Sch Med, Dept Biomed Sci, Edinburg, TX 78541 USA.	Andrew.Tsin@utrgv.edu			University of Texas Rio Grande Valley; University of Texas Rio Grande Valley School of Medicine	University of Texas Rio Grande Valley; University of Texas Rio Grande Valley School of Medicine	We thank the University of Texas Rio Grande Valley and University of Texas Rio Grande Valley School of Medicine for support of this work.	Ala-Laurila P, 2006, J GEN PHYSIOL, V128, P153, DOI 10.1085/jgp.200609557; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Assawachananont J, 2014, STEM CELL REP, V2, P662, DOI 10.1016/j.stemcr.2014.03.011; Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022; Betts-Obregon BS, 2014, INVEST OPHTH VIS SCI, V55, P6265, DOI 10.1167/iovs.14-14721; Cai X, 2009, OPHTHALMIC GENET, V30, P57, DOI 10.1080/13816810802626399; CARLSON A, 1992, BIOCHEMISTRY-US, V31, P9056, DOI 10.1021/bi00152a049; Chen Y, 2013, J CLIN INVEST, V123, P5119, DOI 10.1172/JCI69076; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; ELDER MJ, 1994, J PEDIATR OPHTHALMOL, V31, P38; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Garcia-Ramirez M, 2009, DIABETOLOGIA, V52, P2633, DOI 10.1007/s00125-009-1548-8; Garlipp MA, 2013, EXP EYE RES, V113, P192, DOI 10.1016/j.exer.2013.02.003; Gonzalez-Fernandez F, 2003, VISION RES, V43, P3021, DOI 10.1016/j.visres.2003.09.019; Gonzalez-Fernandez F, 2008, EXP EYE RES, V86, P169, DOI 10.1016/j.exer.2006.09.003; Gonzalez-Fernandez F, 2015, PHOTOCHEM PHOTOBIOL, V91, P371, DOI 10.1111/php.12416; Gonzalez-Fernandez F, 2014, EXP EYE RES, V120, P167, DOI 10.1016/j.exer.2014.01.002; Gonzalez-Fernandez Federico, 2012, J Ophthalmic Vis Res, V7, P100; Grigsby J. G., 2018, EARLY EVENTS DIABETI, P3; Grigsby JG, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/705783; Hareendran S, 2013, REV MED VIROL, V23, P399, DOI 10.1002/rmv.1762; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HO MTP, 1989, J BIOL CHEM, V264, P928; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kashani AH, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao4097; Kiser PD, 2016, ANNU REV VIS SCI, V2, P197, DOI 10.1146/annurev-vision-111815-114407; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Kolesnikov AV, 2007, VISION RES, V47, P363, DOI 10.1016/j.visres.2006.08.024; Kumaran N, 2018, INVEST OPHTH VIS SCI, V59, P85, DOI 10.1167/iovs.17-22905; Lopez-Rubio S, 2018, MOL VIS, V24, P105; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Malechka VV, 2017, AM J PATHOL, V187, P2222, DOI 10.1016/j.ajpath.2017.06.007; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Muniz A, 2007, EXP EYE RES, V85, P175, DOI 10.1016/j.exer.2007.05.003; Muniz A, 2014, INVEST OPHTH VIS SCI, V55, P198, DOI 10.1167/iovs.13-11740; Muniz A, 2009, BIOCHEMISTRY-US, V48, P6854, DOI 10.1021/bi9002937; OKAJIMA TIL, 1990, P NATL ACAD SCI USA, V87, P6907, DOI 10.1073/pnas.87.17.6907; Palczewski K, 1999, BIOCHEMISTRY-US, V38, P12012, DOI 10.1021/bi990504d; Parker R, 2011, J NEUROSCI, V31, P4714, DOI 10.1523/JNEUROSCI.3722-10.2011; Parker RO, 2010, ADV EXP MED BIOL, V664, P141, DOI 10.1007/978-1-4419-1399-9_17; Parker RO, 2009, J NEUROSCI, V29, P4616, DOI 10.1523/JNEUROSCI.0063-09.2009; PEPPERBERG DR, 1993, MOL NEUROBIOL, V7, P61, DOI 10.1007/BF02780609; Qtaishat NM, 2005, EXP EYE RES, V81, P455, DOI 10.1016/j.exer.2005.03.005; Rayapudi S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008428.pub2; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Saari John C, 2016, Subcell Biochem, V81, P231; Schnedermann C, 2018, NAT CHEM, V10, P449, DOI 10.1038/s41557-018-0014-y; Sharma M. C., 2012, COLOR ATLAS SYNOPSIS, P228; Spark Therapeutics, 2017, LUXT INJ DRUG RAAV R; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Travis GH, 2010, METHODS MOL BIOL, V652, P329, DOI 10.1007/978-1-60327-325-1_19; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Westerfeld Corey, 2008, Semin Ophthalmol, V23, P59, DOI 10.1080/08820530701745249; Wiggs J. L., 2014, MOL GENETICS SELECTE, P9	58	17	18	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13016	13021		10.1074/jbc.AW118.003228	http://dx.doi.org/10.1074/jbc.AW118.003228			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	30002120	hybrid, Green Published			2022-12-28	WOS:000442730200004
J	Zhong, FL; Robinson, K; Teo, DET; Tan, KY; Lim, C; Harapas, CR; Yu, CH; Xie, WH; Sobota, RM; Au, VB; Hopkins, R; D'Osualdo, A; Reed, JC; Connolly, JE; Masters, SL; Reversade, B				Zhong, Franklin L.; Robinson, Kim; Teo, Daniel Eng Thiam; Tan, Kiat-Yi; Lim, Chrissie; Harapas, Cassandra R.; Yu, Chien-Hsiung; Xie, William H.; Sobota, Radoslaw M.; Au, Veonice Bijin; Hopkins, Richard; D'Osualdo, Andrea; Reed, John C.; Connolly, John E.; Masters, Seth L.; Reversade, Bruno			Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; INHIBITION; PHOSPHORYLATION; CASPASE-1; KERATINOCYTES; PYROPTOSIS; BACTERIAL; PATHWAYS; ASC	The inflammasome is a critical molecular complex that activates interleukin-1 driven inflammation in response to pathogen- and danger-associated signals. Germline mutations in the inflammasome sensor NLRP1 cause Mendelian systemic auto-immunity and skin cancer susceptibility, but its endogenous regulation remains less understood. Here we use a proteomics screen to uncover dipeptidyl dipeptidase DPP9 as a novel interacting partner with human NLRP1 and a related inflammasome regulator, CARD8. DPP9 functions as an endogenous inhibitor of NLRP1 inflammasome in diverse primary cell types from human and mice. DPP8/9 inhibition via small molecule drugs and CRISPR/Cas9-mediated genetic deletion specifically activate the human NLRP1 inflammasome, leading to ASC speck formation, pyroptotic cell death, and secretion of cleaved interleukin-1 beta. Mechanistically, DPP9 interacts with a unique auto-proteolytic domain (Function to Find Domain (FIIND)) found in NLRP1 and CARD8. This scaffolding function of DPP9 and its catalytic activity act synergistically to maintain NLRP1 in its inactive state and repress downstream inflammasome activation. We further identified a single patient-derived germline missense mutation in the NLRP1 FIIND domain that abrogates DPP9 binding, leading to inflammasome hyperactivation seen in the Mendelian autoinflammatory disease Autoinflammation with Arthritis and Dyskeratosis. These results unite recent findings on the regulation of murine Nlrp1b by Dpp8/9 and uncover a new regulatory mechanism for the NLRP1 inflammasome in primary human cells. Our results further suggest that DPP9 could be a multifunctional inflammasome regulator involved in human autoinflammatory diseases.	[Zhong, Franklin L.; Teo, Daniel Eng Thiam; Tan, Kiat-Yi; Lim, Chrissie; Sobota, Radoslaw M.; Au, Veonice Bijin; Hopkins, Richard; Connolly, John E.; Reversade, Bruno] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Zhong, Franklin L.; Robinson, Kim; Teo, Daniel Eng Thiam; Xie, William H.; Reversade, Bruno] ASTAR, Inst Med Biol, Singapore 138648, Singapore; [Zhong, Franklin L.; Robinson, Kim; Teo, Daniel Eng Thiam] Skin Res Inst Singapore, Singapore 138648, Singapore; [Harapas, Cassandra R.; Yu, Chien-Hsiung; Masters, Seth L.] Walter & Eliza Hall Inst Med Res, Inflammat Div, Parkville, Vic 3052, Australia; [Masters, Seth L.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Connolly, John E.] Baylor Univ, Inst Biomed Studies, Waco, TX 76712 USA; [Connolly, John E.] Natl Univ Singapore, Dept Microbiol & Immunol, Singapore 117545, Singapore; [D'Osualdo, Andrea] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, CH-4070 Basel, Switzerland; [Reed, John C.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Reversade, Bruno] Amsterdam UMC, Reprod Biol Lab, Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands; [Reversade, Bruno] Natl Univ Singapore, Dept Paediat, Singapore 119228, Singapore; [Reversade, Bruno] Koc Univ, Sch Med, Med Genet Dept, TR-34010 Istanbul, Turkey; [Zhong, Franklin L.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 636921, Singapore; [Reversade, Bruno] Branco Weiss Fdn, Zurich, Switzerland	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR); Skin Research Institute of Singapore (SRIS); Walter & Eliza Hall Institute; University of Melbourne; Baylor University; National University of Singapore; Roche Holding; Sanford Burnham Prebys Medical Discovery Institute; University of Amsterdam; National University of Singapore; Koc University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zhong, FL; Reversade, B (corresponding author), ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore.; Zhong, FL; Reversade, B (corresponding author), ASTAR, Inst Med Biol, Singapore 138648, Singapore.; Zhong, FL (corresponding author), Skin Res Inst Singapore, Singapore 138648, Singapore.; Reversade, B (corresponding author), Amsterdam UMC, Reprod Biol Lab, Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands.; Reversade, B (corresponding author), Natl Univ Singapore, Dept Paediat, Singapore 119228, Singapore.; Reversade, B (corresponding author), Koc Univ, Sch Med, Med Genet Dept, TR-34010 Istanbul, Turkey.; Zhong, FL (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 636921, Singapore.; Reversade, B (corresponding author), Branco Weiss Fdn, Zurich, Switzerland.	franklin.zhong@reversade.com; bruno@reversade.com	Hopkins, Richard/AAI-5007-2020; Masters, Seth L/N-2886-2013	Masters, Seth L/0000-0003-4763-576X; Sobota, Radoslaw/0000-0002-2455-2526; Yu, Chien-Hsiung Alan/0000-0003-1744-3791; Xie, William Haowei/0000-0002-0376-7165; Zhong, Franklin/0000-0002-0516-6021; REVERSADE, Bruno/0000-0002-4070-7997; Au, Bijin/0000-0002-3670-4670	Institute of Molecular and Cell Biology (IMCB); Institute of Medical Biology (IMB) Strategic Positioning Fund (Biomedical Research Council (BMRC), A*STAR); Young Investigator Grant YIG 2015 (BMRC, A*STAR); National Medical Research Council MS-CETSA platform Grant [MOHIAFCAT2/004/2015]; National Medical Research Council Young Investigator Grant [NMRC/OFYIRG/0046/2017]; National Health and Medical Research Council [1142354, 1099262]; Sylvia and Charles Viertel Foundation; Howard Hughes Medical Institute-Wellcome International Research Scholarship; GlaxoSmithKline; National Research Foundation (NRF)	Institute of Molecular and Cell Biology (IMCB); Institute of Medical Biology (IMB) Strategic Positioning Fund (Biomedical Research Council (BMRC), A*STAR)(Agency for Science Technology & Research (A*STAR)); Young Investigator Grant YIG 2015 (BMRC, A*STAR); National Medical Research Council MS-CETSA platform Grant(National Medical Research Council, Singapore); National Medical Research Council Young Investigator Grant; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation; Howard Hughes Medical Institute-Wellcome International Research Scholarship; GlaxoSmithKline(GlaxoSmithKline); National Research Foundation (NRF)	This work was supported by core funding from the Institute of Molecular and Cell Biology (IMCB) and Institute of Medical Biology (IMB) Strategic Positioning Fund (Biomedical Research Council (BMRC), A*STAR) (to B. R. and R. M. S.), Young Investigator Grant YIG 2015 (BMRC, A*STAR) (to B. R. and R. M. S.), National Medical Research Council MS-CETSA platform Grant MOHIAFCAT2/004/2015 (to B. R. and R. M. S.), National Medical Research Council Young Investigator Grant NMRC/OFYIRG/0046/2017 (to F. L. Z.), National Health and Medical Research Council Grants 1142354 and 1099262 (to S. L. M.), funds from the Sylvia and Charles Viertel Foundation (to S. L. M.), a Howard Hughes Medical Institute-Wellcome International Research Scholarship (to S. L. M.), and funds from GlaxoSmithKline (to S. L. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Fellow of the Branco Weiss Foundation. Recipient of the A*STAR Investigatorship and Senior National Research Foundation (NRF) fellowship. EMBO Young Investigator.	Adams S, 2004, CANCER RES, V64, P5471, DOI 10.1158/0008-5472.CAN-04-0447; Agudelo D, 2017, NAT METHODS, V14, P615, DOI [10.1038/NMETH.4265, 10.1038/nmeth.4265]; Bachovchin D, 2018, BIORXIV, DOI [10.1101/317826, DOI 10.1101/317826]; Chang MX, 2010, DEV COMP IMMUNOL, V34, P1, DOI 10.1016/j.dci.2009.08.002; Chavarria-Smith J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003452; Cirelli KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003927; D'Osualdo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027396; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Ewald SE, 2014, INFECT IMMUN, V82, P460, DOI 10.1128/IAI.01170-13; Finger JN, 2012, J BIOL CHEM, V287, P25030, DOI 10.1074/jbc.M112.378323; Gall MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078378; Grandemange S, 2017, ANN RHEUM DIS, V76, P1191, DOI 10.1136/annrheumdis-2016-210021; Guo CS, 2016, IMMUNITY, V45, P802, DOI 10.1016/j.immuni.2016.09.008; Johnson DC, 2018, NAT MED, V24, P1151, DOI 10.1038/s41591-018-0082-y; Justa-Schuch D, 2016, ELIFE, V5, DOI [10.7554/eLife.16370, 10.7554/elife.16370]; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim ML, 2015, J EXP MED, V212, P927, DOI 10.1084/jem.20142384; Kim M, 2017, DEV BIOL, V431, P297, DOI 10.1016/j.ydbio.2017.09.001; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Lamkanfi M, 2011, J IMMUNOL, V187, P597, DOI 10.4049/jimmunol.1100229; Liston A, 2017, NAT REV IMMUNOL, V17, P208, DOI 10.1038/nri.2016.151; Mao LM, 2018, J CLIN INVEST, V128, P1793, DOI 10.1172/JCI98642; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; Moghaddas F, 2015, CYTOKINE, V74, P237, DOI 10.1016/j.cyto.2015.02.012; Okondo MC, 2018, CELL CHEM BIOL, V25, P262, DOI 10.1016/j.chembiol.2017.12.013; Okondo MC, 2017, NAT CHEM BIOL, V13, P46, DOI [10.1038/NCHEMBIO.2229, 10.1038/nchembio.2229]; Pratley RE, 2007, CURR MED RES OPIN, V23, P919, DOI 10.1185/030079906X162746; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Sand J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0009-4; Schott WH, 2004, DIABETES, V53, P99, DOI 10.2337/diabetes.53.1.99; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; Spalinger MR, 2016, J CLIN INVEST, V126, P1783, DOI 10.1172/JCI83669; Stutz A, 2017, J EXP MED, V214, P1725, DOI 10.1084/jem.20160933; Taabazuing CY, 2017, CELL CHEM BIOL, V24, P507, DOI 10.1016/j.chembiol.2017.03.009; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yazbeck R, 2009, TRENDS PHARMACOL SCI, V30, P600, DOI 10.1016/j.tips.2009.08.003; Zhong FL, 2016, CELL, V167, P187, DOI 10.1016/j.cell.2016.09.001	47	93	94	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18864	18878		10.1074/jbc.RA118.004350	http://dx.doi.org/10.1074/jbc.RA118.004350			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30291141	Green Published, hybrid			2022-12-28	WOS:000458467400005
J	Yu, G; Liu, YA; Qin, J; Wang, ZJ; Hu, YS; Wang, F; Li, YB; Chakrabarti, S; Chen, QY; Wang, QK				Yu, Gang; Liu, Yinan; Qin, Jun; Wang, Zhijie; Hu, Yushuang; Wang, Fan; Li, Yabo; Chakrabarti, Susmita; Chen, Qiuyun; Wang, Qing Kenneth			Mechanistic insights into the interaction of the MOG1 protein with the cardiac sodium channel Na(v)1.5 clarify the molecular basis of Brugada syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiovascular disease; sodium channel; protein-protein interaction; membrane trafficking; molecular modeling; Brugada syndrome (BrS); MOG1; Nav1; 5 sodium channel; SCN5A; trafficking; genetic disorder; cardiac disease; arrhythmia; myocardial ischemia	SCN5A MUTATION; RAN; IDENTIFICATION; GENE; SUSCEPTIBILITY; BINDING; DEATH; N1325S	Na(v)1.5 is the -subunit of the cardiac sodium channel complex. Abnormal expression of Na(v)1.5 on the cell surface because of mutations that disrupt Na(v)1.5 trafficking causes Brugada syndrome (BrS), sick sinus syndrome (SSS), cardiac conduction disease, dilated cardiomyopathy, and sudden infant death syndrome. We and others previously reported that Ran-binding protein MOG1 (MOG1), a small protein that interacts with Na(v)1.5, promotes Na(v)1.5 intracellular trafficking to plasma membranes and that a substitution in MOG1, E83D, causes BrS. However, the molecular basis for the MOG1/Nav1.5 interaction and how the E83D substitution causes BrS remains unknown. Here, we assessed the effects of defined MOG1 deletions and alanine-scanning substitutions on MOG1's interaction with Na(v)1.5. Large deletion analysis mapped the MOG1 domain required for the interaction with Na(v)1.5 to the region spanning amino acids 146-174, and a refined deletion analysis further narrowed this domain to amino acids 146-155. Site-directed mutagenesis further revealed that Asp-148, Arg-150, and Ser-151 cluster in a peptide loop essential for binding to Na(v)1.5. GST pulldown and electrophysiological analyses disclosed that the substitutions E83D, D148Q, R150Q, and S151Q disrupt MOG1's interaction with Na(v)1.5 and significantly reduce its trafficking to the cell surface. Examination of MOG1's 3D structure revealed that Glu-83 and the loop containing Asp-148, Arg-150, and Ser-151 are spatially proximal, suggesting that these residues form a critical binding site for Na(v)1.5. In conclusion, our findings identify the structural elements in MOG1 that are crucial for its interaction with Na(v)1.5 and improve our understanding of how the E83D substitution causes BrS.	[Yu, Gang; Liu, Yinan; Wang, Zhijie; Hu, Yushuang; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, CardioX Ctr, Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Peoples R China; [Yu, Gang; Liu, Yinan; Wang, Zhijie; Hu, Yushuang; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China; [Yu, Gang; Qin, Jun; Wang, Zhijie; Wang, Fan; Li, Yabo; Chakrabarti, Susmita; Chen, Qiuyun; Wang, Qing Kenneth] Case Western Reserve Univ, Cleveland Clin, Dept Mol Cardiol, Ctr Cardiovasc Genet,Lerner Res Inst, Cleveland, OH 44195 USA; [Yu, Gang; Qin, Jun; Wang, Zhijie; Wang, Fan; Li, Yabo; Chakrabarti, Susmita; Chen, Qiuyun; Wang, Qing Kenneth] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA; [Li, Yabo] Lanzhou Univ, Coll Life Sci, Lanzhou, Gansu, Peoples R China; [Wang, Qing Kenneth] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Lanzhou University; Case Western Reserve University	Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, CardioX Ctr, Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Peoples R China.; Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China.; Wang, QK (corresponding author), Case Western Reserve Univ, Cleveland Clin, Dept Mol Cardiol, Ctr Cardiovasc Genet,Lerner Res Inst, Cleveland, OH 44195 USA.; Wang, QK (corresponding author), Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA.; Wang, QK (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.; Chen, QY (corresponding author), 9500 Euclid Ave, Cleveland, OH 44195 USA.	chenq3@ccf.org; qkwang@hust.edu.cn	Chakrabarti, Susmita/CAH-2331-2022	Chakrabarti, Susmita/0000-0003-1197-2780; Wang, Qing Kenneth/0000-0002-2235-6572; Wang, Qing/0000-0002-5639-8519; Qin, Jun/0000-0002-2647-9270; Wang, Zhijie/0000-0003-4619-0543; WANG, FAN/0000-0001-9806-5037	NHLBI, National Institutes of Health [R01 HL121358, R01 HL126729]; National Natural Science Foundation of China [81630002, 31430047, 91439129]; Hubei Province's Innovative Team Grant; 2016 Top-Notch Innovative Talent Development Project from the Bureau of Human Resources and Social Security of Wuhan City; Hubei Province Natural Science Programs [2016CFB224, 2014CFA074]; Chinese National Basic Research Programs (973 Programs) [2013CB531101, 2012CB517801]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121358, R01HL126729] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Province's Innovative Team Grant; 2016 Top-Notch Innovative Talent Development Project from the Bureau of Human Resources and Social Security of Wuhan City; Hubei Province Natural Science Programs; Chinese National Basic Research Programs (973 Programs)(National Basic Research Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NHLBI, National Institutes of Health Grants R01 HL121358 and R01 HL126729; the National Natural Science Foundation of China Grants 81630002, 31430047, and 91439129; Hubei Province's Innovative Team Grant, 2016 Top-Notch Innovative Talent Development Project from the Bureau of Human Resources and Social Security of Wuhan City, Hubei Province Natural Science Programs 2016CFB224 and 2014CFA074; and Chinese National Basic Research Programs (973 Programs) 2013CB531101 and 2012CB517801. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker RP, 2001, J BIOL CHEM, V276, P41255, DOI 10.1074/jbc.M106060200; Baker RP, 2000, ACTA CRYSTALLOGR D, V56, P229, DOI 10.1107/S0907444999016856; Bao XL, 2018, J MOL CELL BIOL, V10, P18, DOI 10.1093/jmcb/mjx045; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Chakrabarti S, 2013, CIRC-ARRHYTHMIA ELEC, V6, P392, DOI 10.1161/CIRCEP.111.000206; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; Gui JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010985; Kattygnarath D, 2011, CIRC-CARDIOVASC GENE, V4, P261, DOI 10.1161/CIRCGENETICS.110.959130; Marfatia KA, 2001, GENE, V266, P45, DOI 10.1016/S0378-1119(01)00364-X; Oki M, 1998, P NATL ACAD SCI USA, V95, P15388, DOI 10.1073/pnas.95.26.15388; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Otagiri T, 2008, PEDIATR RES, V64, P482, DOI 10.1203/PDR.0b013e3181841eca; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; Steggerda SM, 2000, J BIOL CHEM, V275, P23175, DOI 10.1074/jbc.C000252200; Steggerda SM, 2001, TRAFFIC, V2, P804, DOI 10.1034/j.1600-0854.2001.21109.x; Stewart M, 2000, J MOL BIOL, V299, P213, DOI 10.1006/jmbi.2000.3733; Tian XL, 2004, CARDIOVASC RES, V61, P256, DOI 10.1016/j.cardiores.2003.11.007; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; Wang Zhan-shan, 2018, Huanjing Kexue, V39, P1, DOI 10.13227/j.hjkx.201705276; WILLICH SN, 1987, AM J CARDIOL, V60, P801, DOI 10.1016/0002-9149(87)91027-7; Wu L, 2008, J BIOL CHEM, V283, P6968, DOI 10.1074/jbc.M709721200; Yong SRL, 2007, BIOCHEM BIOPH RES CO, V352, P378, DOI 10.1016/j.bbrc.2006.11.019; Zhang T, 2007, BIOCHEM BIOPH RES CO, V355, P444, DOI 10.1016/j.bbrc.2007.01.170	26	14	14	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18207	18217		10.1074/jbc.RA118.003997	http://dx.doi.org/10.1074/jbc.RA118.003997			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30282806	Green Published, hybrid			2022-12-28	WOS:000451375200015
J	Carrington, SJ; Hernandez, CC; Swale, DR; Aluko, OA; Denton, JS; Cone, RD				Carrington, Sheridan J.; Hernandez, Ciria C.; Swale, Daniel R.; Aluko, Oluwatosin A.; Denton, Jerod S.; Cone, Roger D.			G protein-coupled receptors differentially regulate glycosylation and activity of the inwardly rectifying potassium channel Kir7.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; G protein-coupled receptor (GPCR); potassium channel; glycosylation; signal transduction	MULTIPLE-SCLEROSIS; GOLGI EXPORT; KCNJ13; INHIBITION; MUTATION; KIR4.1; EXCITABILITY; TRAFFICKING; ANTIBODIES; SUBUNITS	Kir7.1 is an inwardly rectifying potassium channel with important roles in the regulation of the membrane potential in retinal pigment epithelium, uterine smooth muscle, and hypothalamic neurons. Regulation of G protein-coupled inwardly rectifying potassium (GIRK) channels by G protein-coupled receptors (GPCRs) via the G protein subunits has been well characterized. However, how Kir channels are regulated is incompletely understood. We report here that Kir7.1 is also regulated by GPCRs, but through a different mechanism. Using Western blotting analysis, we observed that multiple GPCRs tested caused a striking reduction in the complex glycosylation of Kir7.1. Further, GPCR-mediated reduction of Kir7.1 glycosylation in HEK293T cells did not alter its expression at the cell surface but decreased channel activity. Of note, mutagenesis of the sole Kir7.1 glycosylation site reduced conductance and open probability, as indicated by single-channel recording. Additionally, we report that the L241P mutation of Kir7.1 associated with Lebers congenital amaurosis (LCA), an inherited retinal degenerative disease, has significantly reduced complex glycosylation. Collectively, these results suggest that Kir7.1 channel glycosylation is essential for function, and this activity within cells is suppressed by most GPCRs. The melanocortin-4 receptor (MC4R), a GPCR previously reported to induce ligand-regulated activity of this channel, is the only GPCR tested that does not have this effect on Kir7.1.	[Carrington, Sheridan J.; Cone, Roger D.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Carrington, Sheridan J.; Hernandez, Ciria C.; Aluko, Oluwatosin A.; Cone, Roger D.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Swale, Daniel R.] Louisiana State Univ, Dept Entomol, AgCtr, Baton Rouge, LA 70803 USA; [Denton, Jerod S.] Vanderbilt Univ, Dept Anesthesiol, Sch Med, Nashville, TN 37232 USA; [Denton, Jerod S.] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; [Cone, Roger D.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Vanderbilt University; University of Michigan System; University of Michigan; Louisiana State University System; Louisiana State University; Vanderbilt University; Vanderbilt University; University of Michigan System; University of Michigan	Cone, RD (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	rcone@umich.edu		Cone, Roger/0000-0003-3333-5651	National Institutes of Health [RO1 DK070332]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070332, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant RO1 DK070332 (to R. D. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Cha SK, 2011, J BIOL CHEM, V286, P1828, DOI 10.1074/jbc.M110.160390; Chandrasekhar KD, 2006, J BIOL CHEM, V281, P40015, DOI 10.1074/jbc.M604398200; Cohen NA, 1996, J BIOL CHEM, V271, P32301, DOI 10.1074/jbc.271.50.32301; Cornejo I, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00428; Doring F, 1998, J NEUROSCI, V18, P8625; Ghamari-Langroudi M, 2015, NATURE, V520, P94, DOI 10.1038/nature14051; Hejtmancik JF, 2008, AM J HUM GENET, V82, P174, DOI 10.1016/j.ajhg.2007.08.002; Hibino H, 2004, J BIOL CHEM, V279, P44065, DOI 10.1074/jbc.M405985200; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Huang CF, 2007, AM J PHYSIOL-RENAL, V292, pF1073, DOI 10.1152/ajprenal.00269.2006; Iwashita M, 2006, PLOS GENET, V2, P1861, DOI 10.1371/journal.pgen.0020197; Khan AO, 2015, OPHTHALMIC GENET, V36, P79, DOI 10.3109/13816810.2014.985846; Kumar M, 2014, CHANNELS, V8, P488, DOI 10.4161/19336950.2014.959809; Lewis LM, 2009, MOL PHARMACOL, V76, P1094, DOI 10.1124/mol.109.059840; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Li XM, 2016, J BIOL CHEM, V291, P14963, DOI 10.1074/jbc.M116.729822; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Marnetto F, 2017, J IMMUNOL METHODS, V445, P53, DOI 10.1016/j.jim.2017.03.008; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.31054; McCloskey C, 2014, EMBO MOL MED, V6, P1161, DOI 10.15252/emmm.201403944; Nakamura N, 1999, BIOCHEM J, V342, P329, DOI 10.1042/0264-6021:3420329; Pabon A, 2000, J BIOL CHEM, V275, P30677, DOI 10.1074/jbc.M005338200; Pattnaik BR, 2015, HUM MUTAT, V36, P720, DOI 10.1002/humu.22807; Pattnaik BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071744; Probstel AK, 2016, NEW ENGL J MED, V374, P1496, DOI 10.1056/NEJMc1507131; Rabouille C, 2011, COLD SPRING HARB PER, V3; Raphemot R, 2014, MOL PHARMACOL, V85, P858, DOI 10.1124/mol.114.091884; Raphemot R, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00075; SCHWALBE RA, 1995, J BIOL CHEM, V270, P15336, DOI 10.1074/jbc.270.25.15336; Sergouniotis PI, 2011, AM J HUM GENET, V89, P183, DOI 10.1016/j.ajhg.2011.06.002; Shealy RT, 2003, BIOPHYS J, V84, P2929, DOI 10.1016/S0006-3495(03)70020-4; Shen W, 2007, NAT NEUROSCI, V10, P1458, DOI 10.1038/nn1972; Stanley Pamela, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a005199; Yang DL, 2003, INVEST OPHTH VIS SCI, V44, P3178, DOI 10.1167/iovs.02-1189; Yin WG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05043-5; York N, 2017, CELL SIGNAL, V37, P93, DOI 10.1016/j.cellsig.2017.06.005; Zhang W, 2013, AM J PHYSIOL-CELL PH, V304, pC440, DOI 10.1152/ajpcell.00363.2012	39	9	9	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17739	17753		10.1074/jbc.RA118.003238	http://dx.doi.org/10.1074/jbc.RA118.003238			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30257863	Green Published, hybrid			2022-12-28	WOS:000450409500007
J	Kaasboll, OJ; Gadicherla, AK; Wang, JH; Monsen, VT; Hagelin, EMV; Dong, MQ; Attramadal, H				Kaasboll, Ole Jorgen; Gadicherla, Ashish K.; Wang, Jian-Hua; Monsen, Vivi Talstad; Hagelin, Else Marie Valbjorn; Dong, Meng-Qiu; Attramadal, Havard			Connective tissue growth factor (CCN2) is a matricellular preproprotein controlled by proteolytic activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						connective tissue growth factor (CTGF); extracellular matrix protein; protein chemistry; protein processing; protein structure; recombinant protein expression; fibrosis; CCN protein; CCN2; Cyr61; matricellular protein; NOV	FACTOR CTGF; PULMONARY-FIBROSIS; LUNG FIBROBLASTS; CELL-ADHESION; FC-RECEPTOR; TGF-BETA; PROTEIN; EXPRESSION; BINDING; FAMILY	Connective tissue growth factor (CTGF; now often referred to as CCN2) is a secreted protein predominantly expressed during development, in various pathological conditions that involve enhanced fibrogenesis and tissue fibrosis, and in several cancers and is currently an emerging target in several early-phase clinical trials. Tissues containing high CCN2 activities often display smaller degradation products of full-length CCN2 (FL-CCN2). Interpretation of these observations is complicated by the fact that a uniform protein structure that defines biologically active CCN2 has not yet been resolved. Here, using DG44 CHO cells engineered to produce and secrete FL-CCN2 and cell signaling and cell physiological activity assays, we demonstrate that FL-CCN2 is itself an inactive precursor and that a proteolytic fragment comprising domains III (thrombospondin type 1 repeat) and IV (cystine knot) appears to convey all biologically relevant activities of CCN2. In congruence with these findings, purified FL-CCN2 could be cleaved and activated following incubation with matrix metalloproteinase activities. Furthermore, the C-terminal fragment of CCN2 (domains III and IV) also formed homodimers that were approximate to 20-fold more potent than the monomeric form in activating intracellular phosphokinase cascades. The homodimer elicited activation of fibroblast migration, stimulated assembly of focal adhesion complexes, enhanced RANKL-induced osteoclast differentiation of RAW264.7 cells, and promoted mammosphere formation of MCF-7 mammary cancer cells. In conclusion, CCN2 is synthesized and secreted as a preproprotein that is autoinhibited by its two N-terminal domains and requires proteolytic processing and homodimerization to become fully biologically active.	[Kaasboll, Ole Jorgen; Gadicherla, Ashish K.; Monsen, Vivi Talstad; Hagelin, Else Marie Valbjorn; Attramadal, Havard] Oslo Univ Hosp, Inst Surg Res, A3-1057,POB 4950 Nydalen, NO-0424 Oslo, Norway; [Kaasboll, Ole Jorgen; Gadicherla, Ashish K.; Monsen, Vivi Talstad; Hagelin, Else Marie Valbjorn; Attramadal, Havard] Univ Oslo, NO-0424 Oslo, Norway; [Kaasboll, Ole Jorgen; Gadicherla, Ashish K.; Monsen, Vivi Talstad; Hagelin, Else Marie Valbjorn; Attramadal, Havard] Univ Oslo, Ctr Heart Failure Res, NO-0316 Oslo, Norway; [Wang, Jian-Hua; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Gadicherla, Ashish K.] Max Planck Inst Biophys, D-60438 Frankfurt, Germany	University of Oslo; University of Oslo; University of Oslo; National Institute of Biological Sciences, Beijing; Max Planck Society	Attramadal, H (corresponding author), Oslo Univ Hosp, Inst Surg Res, A3-1057,POB 4950 Nydalen, NO-0424 Oslo, Norway.; Attramadal, H (corresponding author), Univ Oslo, NO-0424 Oslo, Norway.	havard.attramadal@medisin.uio.no		Monsen, Vivi Talstad/0000-0003-2821-5145; Dong, Meng-Qiu/0000-0002-6094-1182; Attramadal, Havard/0000-0001-9506-0687	Norwegian Council for Cardiovascular Research; Scientia fellowship program, University of Oslo	Norwegian Council for Cardiovascular Research; Scientia fellowship program, University of Oslo	This work was supported by the Norwegian Council for Cardiovascular Research (to O. J. K.) and Scientia fellowship program, University of Oslo (to A. K. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Ahmed MS, 2011, AM J PHYSIOL-HEART C, V300, pH1291, DOI 10.1152/ajpheart.00604.2010; Ahmed MS, 2004, J MOL CELL CARDIOL, V36, P393, DOI 10.1016/j.yjmcc.2003.12.004; ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; Aoyama E, 2009, BIOCHEM J, V420, P413, DOI 10.1042/BJ20081991; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Ball DK, 1998, BIOL REPROD, V59, P828, DOI 10.1095/biolreprod59.4.828; Ball DK, 2003, REPRODUCTION, V125, P271, DOI 10.1530/rep.0.1250271; Ball DK, 2003, J ENDOCRINOL, V176, pR1, DOI 10.1677/joe.0.176R001; Bickelhaupt S, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw339; Bohr W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016000; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Brenner MC, 2016, PHARM RES-DORDR, V33, P1833, DOI 10.1007/s11095-016-1918-0; Brigstock DR, 1997, J BIOL CHEM, V272, P20275, DOI 10.1074/jbc.272.32.20275; Butler GS, 2017, MATRIX BIOL, V59, P23, DOI 10.1016/j.matbio.2016.07.006; Canalis E, 2010, ENDOCRINOLOGY, V151, P221, DOI 10.1210/en.2009-0574; CANFIELD SM, 1991, J EXP MED, V173, P1483, DOI 10.1084/jem.173.6.1483; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; Chen NY, 2004, J BIOL CHEM, V279, P44166, DOI 10.1074/jbc.M406813200; Chien WW, 2011, INT J ONCOL, V38, P1741, DOI 10.3892/ijo.2011.985; Crean JKG, 2002, J BIOL CHEM, V277, P44187, DOI 10.1074/jbc.M203715200; CUNNINGHAM BC, 1991, SCIENCE, V253, P545, DOI 10.1126/science.1907025; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Morales MG, 2013, HUM MOL GENET, V22, P4938, DOI 10.1093/hmg/ddt352; Galban S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066248; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Glaesner W, 2010, DIABETES-METAB RES, V26, P287, DOI 10.1002/dmrr.1080; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; Guillon-Munos A, 2011, J BIOL CHEM, V286, P25505, DOI 10.1074/jbc.M110.213231; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Heath E, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-18; Hecht R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049345; Heng ECK, 2006, J CELL BIOCHEM, V98, P409, DOI 10.1002/jcb.20810; Hishikawa K, 1999, J BIOL CHEM, V274, P37461, DOI 10.1074/jbc.274.52.37461; Holbourn KP, 2011, J BIOL CHEM, V286, P22243, DOI 10.1074/jbc.M111.225755; Johnson BG, 2017, J AM SOC NEPHROL, V28, P1769, DOI 10.1681/ASN.2016080826; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Jun JI, 2017, J CELL COMMUN SIGNAL, V11, P15, DOI 10.1007/s12079-016-0359-1; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kyurkchiev Stanimir, 2004, Cell Commun Signal, V2, P9, DOI 10.1186/1478-811X-2-9; Lau LF, 2016, J CELL COMMUN SIGNAL, V10, P121, DOI 10.1007/s12079-016-0324-z; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lee CH, 2015, J CLIN INVEST, V125, P2690, DOI [10.1172/JCI84508, 10.1172/JCI81589]; Lin CH, 2013, BBA-MOL CELL RES, V1833, P2823, DOI 10.1016/j.bbamcr.2013.07.016; Lu Shan, 2018, Biophys Rep, V4, P68, DOI 10.1007/s41048-018-0050-6; Lu S, 2015, NAT METHODS, V12, P329, DOI [10.1038/nmeth.3283, 10.1038/NMETH.3283]; Matsushita Y, 2013, J BIOL CHEM, V288, P19973, DOI 10.1074/jbc.M113.454652; Miura H, 2014, CELL STRUCT FUNCT, V39, P9, DOI 10.1247/csf.13018; Mochizuki S, 2010, BIOCHEM BIOPH RES CO, V402, P651, DOI 10.1016/j.bbrc.2010.10.077; Moe IT, 2013, J CELL COMMUN SIGNAL, V7, P31, DOI 10.1007/s12079-012-0183-1; Mokalled MH, 2016, SCIENCE, V354, P630, DOI 10.1126/science.aaf2679; Murphy-Ullrich JE, 2014, MATRIX BIOL, V37, P1, DOI 10.1016/j.matbio.2014.07.005; Neesse A, 2013, P NATL ACAD SCI USA, V110, P12325, DOI 10.1073/pnas.1300415110; Nishida T, 2011, J BONE MINER RES, V26, P351, DOI 10.1002/jbmr.222; Nishida Y, 2005, GENE, V344, P133, DOI 10.1016/j.gene.2004.09.007; Pi LY, 2015, AM J PATHOL, V185, P1552, DOI 10.1016/j.ajpath.2015.02.008; Rachfal AW, 2005, VITAM HORM, V70, P69, DOI 10.1016/S0083-6729(05)70003-0; Raghu G, 2016, EUR RESPIR J, V47, P1481, DOI 10.1183/13993003.01030-2015; Robertson IB, 2013, CYTOKINE GROWTH F R, V24, P355, DOI 10.1016/j.cytogfr.2013.06.003; Robinson PM, 2012, INVEST OPHTH VIS SCI, V53, P8093, DOI 10.1167/iovs.12-10419; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sage EH, 2003, J BIOL CHEM, V278, P37849, DOI 10.1074/jbc.M302946200; Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676; Schutze N, 2005, PROTEIN EXPRES PURIF, V42, P219, DOI 10.1016/j.pep.2005.03.031; Schutze N, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-45; Steffen CL, 1998, GROWTH FACTORS, V15, P199, DOI 10.3109/08977199809002117; Su BY, 2001, J CLIN PATHOL-MOL PA, V54, P184, DOI 10.1136/mp.54.3.184; Takafuji V, 2007, ONCOGENE, V26, P6361, DOI 10.1038/sj.onc.1210463; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; Tan TK, 2013, LAB INVEST, V93, P434, DOI 10.1038/labinvest.2013.3; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tong ZY, 2009, HEPATOLOGY, V50, P939, DOI 10.1002/hep.23102; Wang XC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12469; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; Weng Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22456-w; Xu ER, 2017, J BIOL CHEM, V292, P12516, DOI 10.1074/jbc.M117.788992; Yang ZZ, 2015, MOL MED REP, V12, P1091, DOI 10.3892/mmr.2015.3537; Zhu XP, 2015, ONCOTARGET, V6, P25320, DOI 10.18632/oncotarget.4659	80	38	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17953	17970		10.1074/jbc.RA118.004559	http://dx.doi.org/10.1074/jbc.RA118.004559			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30262666	hybrid, Green Published			2022-12-28	WOS:000450409500024
J	Joshi, A; Shaikh, M; Singh, S; Rajendran, A; Mhetre, A; Kamat, SS				Joshi, Alaumy; Shaikh, Minhaj; Singh, Shubham; Rajendran, Abinaya; Mhetre, Amol; Kamat, Siddhesh S.			Biochemical characterization of the PHARC-associated serine hydrolase ABHD12 reveals its preference for very-long-chain lipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurodegenerative disease; enzyme kinetics; Michaelis-Menten; lipase; subcellular fractionation; ABHD12; hydrolase; PHARC; very-long-chain lipids	FATTY-ACIDS; PHOSPHATIDYLSERINE; MUTATIONS; PHYSIOLOGY; PROTEINS; SPECTRUM	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract (PHARC) is a rare genetic human neurological disorder caused by null mutations to the Abhd12 gene, which encodes the integral membrane serine hydrolase enzyme ABHD12. Although the role that ABHD12 plays in PHARC is understood, the thorough biochemical characterization of ABHD12 is lacking. Here, we report the facile synthesis of mono-1-(fatty)acyl-glycerol lipids of varying chain lengths and unsaturation and use this lipid substrate library to biochemically characterize recombinant mammalian ABHD12. The substrate profiling study for ABHD12 suggested that this enzyme requires glycosylation for optimal activity and that it has a strong preference for very-long-chain lipid substrates. We further validated this substrate profile against brain membrane lysates generated from WT and ABHD12 knockout mice. Finally, using cellular organelle fractionation and immunofluorescence assays, we show that mammalian ABHD12 is enriched on the endoplasmic reticulum membrane, where most of the very-long-chain fatty acids are biosynthesized in cells. Taken together, our findings provide a biochemical explanation for why very-long-chain lipids (such as lysophosphatidylserine lipids) accumulate in the brains of ABHD12 knockout mice, which is a murine model of PHARC.	[Joshi, Alaumy; Singh, Shubham; Rajendran, Abinaya; Mhetre, Amol; Kamat, Siddhesh S.] Indian Inst Sci Educ & Res Pune, Dept Biol, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India; [Shaikh, Minhaj] Indian Inst Sci Educ & Res Pune, Dept Chem, Pune 411008, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune; Indian Institute of Science Education & Research (IISER) Pune	Kamat, SS (corresponding author), Indian Inst Sci Educ & Res Pune, Dept Biol, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India.	siddhesh@iiserpune.ac.in		Kamat, Siddhesh/0000-0001-6132-7574; Joshi, Alaumy/0000-0002-4637-5639; Singh, Shubham/0000-0002-2428-7718	Wellcome Trust-Department of Biotechnology (DBT) India Alliance Intermediate Fellowship [IA/I/15/2/502058]; Department of Science and Technology-Funds for Improvement of S&T Infrastructure (DST-FIST) Infrastructure Development Grant	Wellcome Trust-Department of Biotechnology (DBT) India Alliance Intermediate Fellowship; Department of Science and Technology-Funds for Improvement of S&T Infrastructure (DST-FIST) Infrastructure Development Grant	This work was supported by Wellcome Trust-Department of Biotechnology (DBT) India Alliance Intermediate Fellowship IA/I/15/2/502058 (to S.S.K.) and a Department of Science and Technology-Funds for Improvement of S&T Infrastructure (DST-FIST) Infrastructure Development Grant (to the Indian Institute of Science Education and Research Pune Biology Department). The authors declare that they have no conflicts of interest with the contents of this article.	Aoki J, 2002, BBA-MOL CELL BIOL L, V1582, P26, DOI 10.1016/S1388-1981(02)00134-8; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Blankman JL, 2013, P NATL ACAD SCI USA, V110, P1500, DOI 10.1073/pnas.1217121110; Chen DH, 2013, HUM MUTAT, V34, P1672, DOI 10.1002/humu.22437; Christie W.W., 1993, ADV LIPID METHODOLOG, P69, DOI DOI 10.1016/0009-3084(94)02308-5; Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Criscuolo C, 2013, EUR J NEUROL, V20, pe60, DOI 10.1111/ene.12056; Eisenberger T, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-59; Fiskerstrand T, 2009, NEUROLOGY, V72, P20, DOI 10.1212/01.wnl.0000333664.90605.23; Fiskerstrand T, 2010, AM J HUM GENET, V87, P410, DOI 10.1016/j.ajhg.2010.08.002; Hosono H, 2001, J BIOL CHEM, V276, P29664, DOI 10.1074/jbc.M104597200; Hsu KL, 2012, NAT CHEM BIOL, V8, P999, DOI [10.1038/NCHEMBIO.1105, 10.1038/nchembio.1105]; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/nmeth.2368, 10.1038/NMETH.2368]; Iwashita M, 2009, J MED CHEM, V52, P5837, DOI 10.1021/jm900598m; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Kamat SS, 2015, NAT CHEM BIOL, V11, P164, DOI [10.1038/NCHEMBIO.1721, 10.1038/nchembio.1721]; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kolar MJ, 2016, BIOCHEMISTRY-US, V55, P4636, DOI 10.1021/acs.biochem.6b00565; Lamari F, 2013, J INHERIT METAB DIS, V36, P411, DOI 10.1007/s10545-012-9509-7; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Navia-Paldanius D, 2012, J LIPID RES, V53, P2413, DOI 10.1194/jlr.M030411; Niphakis MJ, 2015, CELL, V161, P1668, DOI 10.1016/j.cell.2015.05.045; Nishiguchi KM, 2014, OPHTHALMOLOGY, V121, P1620, DOI 10.1016/j.ophtha.2014.02.008; Parker CG, 2017, CELL, V168, P527, DOI 10.1016/j.cell.2016.12.029; Rai P, 2017, P NATL ACAD SCI USA, V114, P12958, DOI 10.1073/pnas.1713292114; Sassa T, 2014, BIOMOL THER, V22, P83, DOI 10.4062/biomolther.2014.017; Savinainen JR, 2012, ACTA PHYSIOL, V204, P267, DOI 10.1111/j.1748-1716.2011.02280.x; Wu CL, 2016, NUCLEIC ACIDS RES, V44, pD313, DOI 10.1093/nar/gkv1104; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yoshimura H, 2015, ANN OTO RHINOL LARYN, V124, p77S, DOI 10.1177/0003489415574513	34	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					16953	16963		10.1074/jbc.RA118.005640	http://dx.doi.org/10.1074/jbc.RA118.005640			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30237167	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000449466500001
J	Shen, YF; Cohen, JL; Nicoloro, SM; Kelly, M; Yenilmez, B; Henriques, F; Tsagkaraki, E; Edwards, YJK; Hu, XD; Friedline, RH; Kim, JK; Czech, MP				Shen, Yuefei; Cohen, Jessica L.; Nicoloro, Sarah M.; Kelly, Mark; Yenilmez, Batuhan; Henriques, Felipe; Tsagkaraki, Emmanouela; Edwards, Yvonne J. K.; Hu, Xiaodi; Friedline, Randall H.; Kim, Jason K.; Czech, Michael P.			CRISPR-delivery particles targeting nuclear receptor-interacting protein 1 (Nrip1) in adipose cells to enhance energy expenditure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; ribonuclear protein (RNP); drug delivery system; adipocyte; metabolic disease; browning; CRISPR-delivery particle; gene deletion; nanoparticle; therapeutic strategy; guide RNA; therapeutic strategy; fat tissue	CAS9 RIBONUCLEOPROTEIN; GLUCOSE-HOMEOSTASIS; COREPRESSOR RIP140; EFFICIENT DELIVERY; GLUCAN PARTICLES; ENDOCRINE ROLE; WEB TOOL; GENOME; MOUSE; BROWN	RNA-guided, engineered nucleases derived from the prokaryotic adaptive immune system CRISPR-Cas represent a powerful platform for gene deletion and editing. When used as a therapeutic approach, direct delivery of Cas9 protein and single-guide RNA (sgRNA) could circumvent the safety issues associated with plasmid delivery and therefore represents an attractive tool for precision genome engineering. Gene deletion or editing in adipose tissue to enhance its energy expenditure, fatty acid oxidation, and secretion of bioactive factors through a browning process presents a potential therapeutic strategy to alleviate metabolic disease. Here, we developed CRISPR-delivery particles, denoted CriPs, composed of nano-size complexes of Cas9 protein and sgRNA that are coated with an amphipathic peptide called Endo-Porter that mediates entry into cells. Efficient CRISPR-Cas9-mediated gene deletion of ectopically expressed GFP by CriPs was achieved in multiple cell types, including a macrophage cell line, primary macrophages, and primary pre-adipocytes. Significant GFP loss was also observed in peritoneal exudate cells with minimum systemic toxicity in GFP-expressing mice following intraperitoneal injection of CriPs containing Gfp-targeting sgRNA. Furthermore, disruption of a nuclear co-repressor of catabolism, the Nrip1 gene, in white adipocytes by CriPs enhanced adipocyte browning with a marked increase of uncoupling protein 1 (UCP1) expression. Of note, the CriP-mediated Nrip1 deletion did not produce detectable off-target effects. We conclude that CriPs offer an effective Cas9 and sgRNA delivery system for ablating targeted gene products in cultured cells and in vivo, providing a potential therapeutic strategy for metabolic disease.	[Shen, Yuefei; Cohen, Jessica L.; Nicoloro, Sarah M.; Kelly, Mark; Yenilmez, Batuhan; Henriques, Felipe; Tsagkaraki, Emmanouela; Edwards, Yvonne J. K.; Kim, Jason K.; Czech, Michael P.] Univ Massachusetts, Med Sch, Program Mol Med, Worcester, MA 01605 USA; [Hu, Xiaodi; Friedline, Randall H.; Kim, Jason K.] Univ Massachusetts, Med Sch, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA 01605 USA; [Tsagkaraki, Emmanouela] Univ Crete, Fac Med, Sch Sci, Mol Basis Human Dis Grad Program, POB 2208, Iraklion 71003, Crete, Greece	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Crete	Czech, MP (corresponding author), Univ Massachusetts, Med Sch, 373 Plantat St, Worcester, MA 01605 USA.	michael.czech@umassmed.edu	; Henriques, Felipe/I-6312-2015	Edwards, Yvonne/0000-0001-8505-3168; Nicoloro, Sarah/0000-0002-8638-4556; Kim, Jason/0000-0002-7185-042X; kelly, mark/0000-0001-9018-594X; Henriques, Felipe/0000-0002-9245-7141; Tsagkaraki, Emmanouela/0000-0001-7754-8945	National Institutes of Health [5U2C-DK093000, DK103047, DK030898]; International Research Alliance of the Novo Nordisk Foundation Center for Metabolic Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030898, R01DK103047, U2CDK093000, R01DK030898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Research Alliance of the Novo Nordisk Foundation Center for Metabolic Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by National Institutes of Health Grants DK103047 and DK030898 and a grant from the International Research Alliance of the Novo Nordisk Foundation Center for Metabolic Research (to M.P.C.). The National MMPC at the University of Massachusetts is supported by National Institutes of Health Grant 5U2C-DK093000 (to J.K.K. and M.P.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aouadi M, 2013, P NATL ACAD SCI USA, V110, P8278, DOI 10.1073/pnas.1300492110; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Arner P, 2011, NATURE, V478, P110, DOI 10.1038/nature10426; Bartz R, 2011, BIOCHEM J, V435, P475, DOI 10.1042/BJ20101021; Centers for Disease Control and Prevention, 2017, NAT DIAB STAT REP 20; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005; Cohen JL, 2016, MOL PHARMACEUT, V13, P964, DOI 10.1021/acs.molpharmaceut.5b00831; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Finn JD, 2018, CELL REP, V22, P2227, DOI 10.1016/j.celrep.2018.02.014; Gao X, 2018, NATURE, V553, P217, DOI 10.1038/nature25164; Glass Z, 2018, TRENDS BIOTECHNOL, V36, P173, DOI 10.1016/j.tibtech.2017.11.006; Gundry MC, 2016, CELL REP, V17, P1453, DOI 10.1016/j.celrep.2016.09.092; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080; Jiang C, 2017, CELL RES, V27, P440, DOI 10.1038/cr.2017.16; Kang YK, 2017, BIOCONJUGATE CHEM, V28, P957, DOI 10.1021/acs.bioconjchem.6b00676; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kiskinis E, 2014, MOL ENDOCRINOL, V28, P344, DOI 10.1210/me.2013-1254; Komor AC, 2017, CELL, V169, P559, DOI 10.1016/j.cell.2017.04.005; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lee K, 2017, NAT BIOMED ENG, V1, P889, DOI 10.1038/s41551-017-0137-2; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li L, 2018, BIOMATERIALS, V171, P207, DOI 10.1016/j.biomaterials.2018.04.031; Li L, 2015, HUM GENE THER, V26, P452, DOI 10.1089/hum.2015.069; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Miller JB, 2017, ANGEW CHEM INT EDIT, V56, P1059, DOI 10.1002/anie.201610209; Min SY, 2016, NAT MED, V22, P312, DOI 10.1038/nm.4031; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Mout R, 2017, ACS NANO, V11, P2452, DOI 10.1021/acsnano.6b07600; Pedersen BK, 2001, J PHYSIOL-LONDON, V536, P329, DOI 10.1111/j.1469-7793.2001.0329c.xd; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665; Staahl BT, 2017, NAT BIOTECHNOL, V35, P431, DOI 10.1038/nbt.3806; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tesz GJ, 2011, BIOCHEM J, V436, P351, DOI 10.1042/BJ20110352; Villarroya F, 2015, ENDOCRINOLOGY, V156, P2368, DOI 10.1210/en.2015-1423; Villarroya J, 2013, AM J PHYSIOL-ENDOC M, V305, pE567, DOI 10.1152/ajpendo.00250.2013; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang HX, 2018, P NATL ACAD SCI USA, V115, P4903, DOI 10.1073/pnas.1712963115; Wang HX, 2017, CHEM REV, V117, P9874, DOI 10.1021/acs.chemrev.6b00799; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Wang XN, 2017, BIOINFORMATICS, V33, P3811, DOI 10.1093/bioinformatics/btx518; Wu WB, 2017, P NATL ACAD SCI USA, V114, P1660, DOI 10.1073/pnas.1614775114; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	62	25	27	3	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17291	17305		10.1074/jbc.RA118.004554	http://dx.doi.org/10.1074/jbc.RA118.004554			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30190322	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000449466500027
J	Garcia-Cazorla, Y; Getino, M; Sanabria-Rios, DJ; Carballeira, NM; de la Cruz, F; Arechaga, I; Cabezon, E				Garcia-Cazorla, Yolanda; Getino, Maria; Sanabria-Rios, David J.; Carballeira, Nestor M.; de la Cruz, Fernando; Arechaga, Ignacio; Cabezon, Elena			Conjugation inhibitors compete with palmitic acid for binding to the conjugative traffic ATPase TrwD, providing a mechanism to inhibit bacterial conjugation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; ATPase; drug design; bacterial conjugation; secretion; antibiotic resistance; ATPase inhibitors; bacterial conjugation; drug design; type IV secretion system	IV SECRETION APPARATUS; FATTY-ACIDS; MOLECULAR MOTORS; PLASMID R388; VIRB11; 2-BROMOPALMITATE; PALMITOYLATION; PROTEIN; SYSTEMS; VIRD4	Bacterial conjugation is a key mechanism by which bacteria acquire antibiotic resistance. Therefore, conjugation inhibitors (COINs) are promising compounds in the fight against the spread of antibiotic resistance genes among bacteria. Unsaturated fatty acids (uFAs) and alkynoic fatty acid derivatives, such as 2-hexadecanoic acid (2-HDA), have been reported previously as being effective COINs. The traffic ATPase TrwD, a VirB11 homolog in plasmid R388, is the molecular target of these compounds, which likely affect binding of TrwD to bacterial membranes. In this work, we demonstrate that COINs are abundantly incorporated into Escherichia coli membranes, replacing palmitic acid as the major component of the membrane. We also show that TrwD binds palmitic acid, thus facilitating its interaction with the membrane. Our findings also suggest that COINs bind TrwD at a site that is otherwise occupied by palmitic acid. Accordingly, molecular docking predictions with palmitic acid indicated that it shares the same binding site as uFAs and 2-HDA, although it differs in the contacts involved in this interaction. We also identified 2-bromopalmitic acid, a palmitate analog that inhibits many membrane-associated enzymes, as a compound that effectively reduces TrwD ATPase activity and bacterial conjugation. Moreover, we demonstrate that 2-bromopalmitic and palmitic acids both compete for the same binding site in TrwD. Altogether, these detailed findings open up a new avenue in the search for effective synthetic inhibitors of bacterial conjugation, which may be pivotal for combating multidrug-resistant bacteria.	[Garcia-Cazorla, Yolanda; Getino, Maria; de la Cruz, Fernando; Arechaga, Ignacio; Cabezon, Elena] Univ Cantabria, CSIC, Dept Biol Mol, Santander 39011, Spain; [Garcia-Cazorla, Yolanda; Getino, Maria; de la Cruz, Fernando; Arechaga, Ignacio; Cabezon, Elena] Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantabria, Santander 39011, Spain; [Sanabria-Rios, David J.] Interamer Univ Puerto Rico, Fac Sci & Technol, Metropolitan Campus, San Juan, PR 00919 USA; [Carballeira, Nestor M.] Univ Puerto Rico, Dept Chem, Rio Piedras Campus, San Juan, PR 00925 USA; [Getino, Maria] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Inter American University of Puerto Rico-San German; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Surrey	Arechaga, I; Cabezon, E (corresponding author), Univ Cantabria, CSIC, Dept Biol Mol, Santander 39011, Spain.; Arechaga, I; Cabezon, E (corresponding author), Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantabria, Santander 39011, Spain.	arechagai@unican.es; cabezone@unican.es	Cabezon, Elena/K-5874-2014; Getino, Maria/L-8541-2019; de la Cruz, Fernando/L-2812-2014	Getino, Maria/0000-0002-2937-3420; de la Cruz, Fernando/0000-0003-4758-6857; Cabezon, Elena/0000-0002-6177-5016; Carballeira, Nestor/0000-0001-7404-0505	NIGMS NIH HHS [P20 GM103475] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103475] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aguilar J, 2011, MBIO, V2, DOI 10.1128/mBio.00218-11; Arndt Claudia, 2012, Methods Mol Biol, V869, P49, DOI 10.1007/978-1-61779-821-4_5; Atmakuri K, 2004, MOL MICROBIOL, V54, P1199, DOI 10.1111/j.1365-2958.2004.04345.x; Cabezon E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02329; Cabezon E, 2015, FEMS MICROBIOL REV, V39, P81, DOI 10.1111/1574-6976.12085; Carballeira NM, 2006, LIPIDS, V41, P507, DOI 10.1007/s11745-006-5124-4; Christie PJ, 2014, BBA-MOL CELL RES, V1843, P1578, DOI 10.1016/j.bbamcr.2013.12.019; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; COLEMAN RA, 1992, BIOCHIM BIOPHYS ACTA, V1125, P203, DOI 10.1016/0005-2760(92)90046-X; Das A, 2014, MICROBIOLOGYOPEN, V3, P793, DOI 10.1002/mbo3.208; Davda D, 2013, ACS CHEM BIOL, V8, P1912, DOI 10.1021/cb400380s; Fernandez-Lopez R, 2005, MICROBIOL-SGM, V151, P3517, DOI 10.1099/mic.0.28216-0; Getino M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148098; Getino M, 2015, MBIO, V6, DOI 10.1128/mBio.01032-15; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Hare S, 2006, J MOL BIOL, V360, P56, DOI 10.1016/j.jmb.2006.04.060; Hwang DH, 2016, EUR J PHARMACOL, V785, P24, DOI 10.1016/j.ejphar.2016.04.024; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Judd PK, 2005, P NATL ACAD SCI USA, V102, P11498, DOI 10.1073/pnas.0505290102; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Machon C, 2002, J BACTERIOL, V184, P1661, DOI 10.1128/JB.184.6.1661-1668.2002; Mazel D, 1999, CELL MOL LIFE SCI, V56, P742, DOI 10.1007/s000180050021; Moncalian G, 1997, J MOL BIOL, V270, P188, DOI 10.1006/jmbi.1997.1082; Pena A, 2013, J MOL MICROB BIOTECH, V23, P357, DOI 10.1159/000351360; Planet PJ, 2001, P NATL ACAD SCI USA, V98, P2503, DOI 10.1073/pnas.051436598; Quevillon-Cheruel S, 2009, J BIOL CHEM, V284, P3552, DOI 10.1074/jbc.M808334200; Ripoll-Rozada J, 2016, MOL MICROBIOL, V100, P912, DOI 10.1111/mmi.13359; Ripoll-Rozada J, 2013, J BACTERIOL, V195, P4195, DOI 10.1128/JB.00437-13; Ripoll-Rozada J, 2012, J BIOL CHEM, V287, P17408, DOI 10.1074/jbc.M112.357905; Savvides SN, 2003, EMBO J, V22, P1969, DOI 10.1093/emboj/cdg223; Yeo HJ, 2000, MOL CELL, V6, P1461, DOI 10.1016/S1097-2765(00)00142-8	32	15	17	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16923	16930		10.1074/jbc.RA118.004716	http://dx.doi.org/10.1074/jbc.RA118.004716			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30201608	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000448515100031
J	Su, WM; Han, GS; Dey, P; Carman, GM				Su, Wen-Min; Han, Gil-Soo; Dey, Prabuddha; Carman, George M.			Protein kinase A phosphorylates the Nem1-Spo7 protein phosphatase complex that regulates the phosphorylation state of the phosphatidate phosphatase Pah1 in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phospholipid; diacylglycerol; triacylglycerol; protein phosphatase; yeast metabolism; Saccharomyces cerevisiae; protein kinase A (PKA); lipid metabolism; Nem1-Spo7 protein phosphatase; PA phosphatase	NUCLEAR-MEMBRANE GROWTH; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; LIPID-SYNTHESIS; CTP SYNTHETASE; PHOSPHATIDYLSERINE SYNTHASE; MULTISITE PHOSPHORYLATION; ORTHOLOGUE PAH1P; ACID PHOSPHATASE; SHUTTLE VECTORS	The Nem1-Spo7 protein phosphatase plays a role in lipid synthesis by controlling the membrane localization of Pah1, the diacylglycerol-producing phosphatidate (PA) phosphatase that is crucial for the synthesis of triacylglycerol in the yeast Saccharomyces cerevisiae. By dephosphorylating Pah1, Nem1-Spo7 facilitates its translocation to the nuclear/endoplasmic reticulum membrane for catalytic activity. Like its substrate Pah1, Nem1-Spo7 is phosphorylated in the cell, but the specific protein kinases involved remain to be identified. In this study, we demonstrate that the Nem1-Spo7 complex is phosphorylated by protein kinase A (PKA), which is associated with active cell growth, metabolic activity, and membrane phospholipid synthesis. In vitro phosphorylation of purified Nem1-Spo7 and of their synthetic peptides revealed that both subunits of the phosphatase complex are PKA substrates. Using phosphoamino acid and phosphopeptide-mapping analyses coupled with site-directed mutagenesis, we identified Ser-140 and Ser-210 of Nem1 and Ser-28 of Spo7 as PKA-targeted phosphorylation sites. Immunodetection of the phosphatase complex from the cell with anti-PKA substrate antibody confirmed the in vivo phosphorylations of Nem1 and Spo7 on the serine residues. Lipid-labeling analysis of cells bearing phosphorylation-deficient alleles of NEM1 and SPO7 indicated that the PKA phosphorylation of the phosphatase complex stimulates phospholipid synthesis and attenuates the synthesis of triacylglycerol. This work advances the understanding of how PKA-mediated posttranslational modifications of Nem1 and Spo7 regulate lipid synthesis in yeast.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, 61 Dudley Rd, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 61 Dudley Rd, New Brunswick, NJ 08901 USA.	gcarman@rutgers.edu		Carman, George/0000-0003-4951-8233; Su, Wen-Min/0000-0002-1861-6335	National Institutes of Health [NS046593]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The MS data were obtained from an Orbitrap mass spectrometer funded in part by National Institutes of Health Grant NS046593, for the support of the Rutgers Mass Spectrometry Center for Integrative Neuroscience Research.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Barbosa AD, 2015, MOL BIOL CELL, V26, P3641, DOI 10.1091/mbc.E15-03-0173; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boroda S, 2017, J BIOL CHEM, V292, P20481, DOI 10.1074/jbc.M117.786574; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broach J R, 1990, Adv Cancer Res, V54, P79, DOI 10.1016/S0065-230X(08)60809-X; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Chang HJ, 2004, GENETICS, V168, P1899, DOI 10.1534/genetics.104.032961; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Dubots E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104194; Eaton JM, 2013, J BIOL CHEM, V288, P9933, DOI 10.1074/jbc.M112.441493; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2017, J BIOL CHEM, V292, P13230, DOI 10.1074/jbc.M117.801720; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han S, 2012, J BIOL CHEM, V287, P3123, DOI 10.1074/jbc.M111.324350; Harlow E., 1988, ANTIBODIES LAB MANUA; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; Hsieh LS, 2016, J BIOL CHEM, V291, P9974, DOI 10.1074/jbc.M116.726588; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; Ingrell CR, 2007, BIOINFORMATICS, V23, P895, DOI 10.1093/bioinformatics/btm020; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kim KH, 1999, J BIOL CHEM, V274, P9531, DOI 10.1074/jbc.274.14.9531; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN YP, 1989, J BIOL CHEM, V264, P8641; Lussier M, 1997, GENETICS, V147, P435; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Orij R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r80; Park TS, 1999, BIOCHEMISTRY-US, V38, P8839, DOI 10.1021/bi990784x; Park Y, 2015, J BIOL CHEM, V290, P25382, DOI 10.1074/jbc.M115.680314; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterfy M, 2010, J BIOL CHEM, V285, P3857, DOI 10.1074/jbc.M109.072488; Rahman MA, 2018, FEBS J, V285, P1840, DOI 10.1111/febs.14448; Rose MD., 1990, METHODS YEAST GENETI; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Ruiz C, 1999, YEAST, V15, P1001; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Sherr GL, 2017, BIOCHEM BIOPH RES CO, V491, P693, DOI 10.1016/j.bbrc.2017.07.127; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 2000, J BIOL CHEM, V275, P19352, DOI 10.1074/jbc.M001314200; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; SMITH SW, 1957, J BIOL CHEM, V228, P915; Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007; Sreenivas A, 2003, J BIOL CHEM, V278, P20673, DOI 10.1074/jbc.M300132200; Stuart SA, 2015, MOL CELL PROTEOMICS, V14, P1599, DOI 10.1074/mcp.M114.047233; Su WM, 2014, J BIOL CHEM, V289, P34699, DOI 10.1074/jbc.M114.614883; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Wu R, 2011, BIOCHEMISTRY-US, V50, P3045, DOI 10.1021/bi200336b; Xu XY, 2018, BIOCHEM BIOPH RES CO, V496, P51, DOI 10.1016/j.bbrc.2017.12.163; Yang WL, 1996, J BIOL CHEM, V271, P28777, DOI 10.1074/jbc.271.46.28777; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983; Zhang PX, 2017, BBA-BIOMEMBRANES, V1859, P1583, DOI 10.1016/j.bbamem.2017.04.007	89	9	10	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15801	15814		10.1074/jbc.RA118.005348	http://dx.doi.org/10.1074/jbc.RA118.005348			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30201607	hybrid, Green Published			2022-12-28	WOS:000447256000005
J	Koduru, SV; Sun, BH; Walker, JM; Zhu, ML; Simpson, C; Dhodapkar, M; Insogna, KL				Koduru, Srinivas V.; Sun, Ben-hua; Walker, Joanne M.; Zhu, Meiling; Simpson, Christine; Dhodapkar, Madhav; Insogna, Karl L.			The contribution of cross-talk between the cell-surface proteins CD36 and CD47-TSP-1 in osteoclast formation and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						osteoblast; osteoclast; osteocyte; osteoporosis; thrombospondin; bone; parathyroid hormone; bone resorption; CD36; CD47; TSP-1	NITRIC-OXIDE SYNTHASE; IN-VIVO; BONE HOMEOSTASIS; REGULATES BONE; FUSION; DIFFERENTIATION; CD47; RECEPTOR; RANKL; ASSOCIATION	Antibody-mediated blockade of cluster of differentiation 47 (CD47)-thrombospondin-1 (TSP-1) interactions blocks osteoclast formation in vitro and attenuates parathyroid hormone (PTH)-induced hypercalcemia in vivo in mice. Hypercalcemia in this model reflects increased bone resorption. TSP-1 has two cell-associated binding partners, CD47 and CD36. The roles of these two molecules in mediating the effects of TSP1 in osteoclasts are unclear. Osteoclast formation was attenuated but not absent when preosteoclasts isolated from CD47(-/-) mice were cocultured with WT osteoblasts. Suppressing CD36 in osteoclast progenitors also attenuated osteoclast formation. The hypercalcemic response to a PTH infusion was blunted in CD47(-/-)/CD36(-/-) (double knockout (DKO)) female mice but not CD47(-/-) mice or CD36(-/-) animals, supporting a role for both CD47 and CD36 in mediating this effect. Consistent with this, DKO osteoclasts had impaired resorptive activity when analyzed in vitro. Inhibition of nitric oxide (NO) signaling is known to promote osteoclastogenesis, and TSP-1 suppresses NO production and signaling. An anti-TSP-1 antibody increased NO production in osteoclasts, and the inhibitory effect of anti-TSP-1 on osteoclastogenesis was completely rescued by l-nitroarginine methyl ester (l-NAME), a competitive NO synthase inhibitor. Supportive of an important role for CD36 in mediating the pro-osteoclastogenic effects of TSP-1, engaging CD36 with a synthetic agonist, p907, suppressed NO production in anti-TSP-1-treated cultures, allowing osteoclast maturation to occur. These results establish that CD36 and CD47 both participate in mediating the actions of TSP-1 in osteoclasts and establish a physiologically relevant cross-talk in bone tissue between these two molecules.	[Koduru, Srinivas V.; Dhodapkar, Madhav] Yale Sch Med, Dept Med Hematol, New Haven, CT 06520 USA; [Koduru, Srinivas V.; Dhodapkar, Madhav] Yale Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Sun, Ben-hua; Walker, Joanne M.; Zhu, Meiling; Simpson, Christine; Insogna, Karl L.] Yale Sch Med, Dept Med Endocrinol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Insogna, KL (corresponding author), Yale Sch Med, Dept Internal Med, Sect Endocrinol, POB 208020,333 Cedar St, New Haven, CT 06520 USA.	karl.insogna@yale.edu	Koduru, Srinivas V/L-3637-2019	Koduru, Srinivas V/0000-0001-6827-2908; Zhu, Meiling/0000-0002-6227-9858	NIAMS, National Institutes of Health [AR060322]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060322] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIAMS, National Institutes of Health Grant AR060322 (to K. L. I. and M. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKATSU T, 1992, J BONE MINER RES, V7, P1297; Amend SR, 2015, J BONE MINER RES, V30, P106, DOI 10.1002/jbmr.2308; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; BRANDI ML, 1995, P NATL ACAD SCI USA, V92, P2954, DOI 10.1073/pnas.92.7.2954; Collin-Osdoby P, 2000, J BONE MINER RES, V15, P474, DOI 10.1359/jbmr.2000.15.3.474; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; DIXIT VM, 1985, BIOCHEMISTRY-US, V24, P4270, DOI 10.1021/bi00337a003; DuBose KB, 2012, BIOCHEM BIOPH RES CO, V422, P488, DOI 10.1016/j.bbrc.2012.05.020; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Helming L, 2009, J CELL SCI, V122, P453, DOI 10.1242/jcs.037200; Hoosdally SJ, 2009, J BIOL CHEM, V284, P16277, DOI 10.1074/jbc.M109.007849; Insogna KL, 1997, J CLIN INVEST, V100, P2476, DOI 10.1172/JCI119790; INSOGNA KL, 1984, ENDOCRINOLOGY, V114, P888, DOI 10.1210/endo-114-3-888; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; Josien R, 1999, J IMMUNOL, V162, P2562; KASTEN TP, 1994, P NATL ACAD SCI USA, V91, P3569, DOI 10.1073/pnas.91.9.3569; Kawano T, 2013, BONE, V52, P70, DOI 10.1016/j.bone.2012.09.024; Kevorkova O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077701; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Koskinen C, 2013, J BIOL CHEM, V288, P29333, DOI 10.1074/jbc.M113.494591; Kukreja A, 2009, BLOOD, V114, P3413, DOI 10.1182/blood-2009-03-211920; Maile LA, 2011, J BONE MINER RES, V26, P2068, DOI 10.1002/jbmr.441; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Miyamoto Takeshi, 2011, Keio Journal of Medicine, V60, P101; Oursler MJ, 2010, J CELL BIOCHEM, V110, P1058, DOI 10.1002/jcb.22640; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PFEILSCHIFTER J, 1989, J BONE MINER RES, V4, P113, DOI 10.1002/jbmr.5650040116; Uluckan O, 2009, CANCER RES, V69, P3196, DOI 10.1158/0008-5472.CAN-08-3358; Xing LP, 2012, WORLD J ORTHOP, V3, P212, DOI 10.5312/wjo.v3.i12.212; Yao GQ, 2009, AM J PHYSIOL-ENDOC M, V296, pE714, DOI 10.1152/ajpendo.90631.2008; Yeo L, 2011, ANN RHEUM DIS, V70, P2022, DOI 10.1136/ard.2011.153312; Zhu ML, 2016, J BONE MINER RES, V31, P864, DOI 10.1002/jbmr.2733	34	20	22	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15055	15069		10.1074/jbc.RA117.000633	http://dx.doi.org/10.1074/jbc.RA117.000633			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30082316	Green Published, hybrid			2022-12-28	WOS:000445998400010
J	Park, CK; Sanchez, JL; Barahona, C; Basantes, LE; Sanchez, J; Hernandez, C; Horton, NC				Park, Chad K.; Sanchez, Jonathan L.; Barahona, Claudia; Basantes, L. Emilia; Sanchez, Juan; Hernandez, Christian; Horton, N. C.			The run-on oligomer filament enzyme mechanism of SgrAI: Part 1. Assembly kinetics of the run-on oligomer filament	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA endonuclease; enzyme kinetics; enzyme mechanism; fluorescence resonance energy transfer (FRET); molecular modeling; allosteric regulation; Allostery; Approach to Equilibrium; Fiber forming enzyme; Filament forming enzyme; Global Kinetic Modeling	ACETYL-COA CARBOXYLASE; RESTRICTION-MODIFICATION SYSTEMS; METABOLIC ENZYMES; SACCHAROMYCES-CEREVISIAE; CTP SYNTHASE; DNA CLEAVAGE; REORGANIZATION; ACTIVATION; EXPLORER; COMPARTMENTATION	Filament or run-on oligomer formation by metabolic enzymes is now recognized as a widespread phenomenon having potentially unique enzyme regulatory properties and biological roles, and its dysfunction is implicated in human diseases such as cancer, diabetes, and developmental disorders. SgrAI is a bacterial allosteric type II restriction endonuclease that binds to invading phage DNA, may protect the host DNA from off-target cleavage activity, and forms run-on oligomeric filaments with enhanced DNA-cleavage activity and altered DNA sequence specificity. However, the mechanisms of SgrAI filament growth, cooperativity in filament formation, sequestration of enzyme activity, and advantages over other filament mechanisms remain unknown. In this first of a two-part series, we developed methods and models to derive association and dissociation rate constants of DNA-bound SgrAI in run-on oligomers and addressed the specific questions of cooperativity and filament growth mechanisms. We show that the derived rate constants are consistent with the run-on oligomer sizes determined by EM analysis and are most consistent with a noncooperative growth mode of the run-on oligomer. These models and methods are extended in the accompanying article to include the full DNA-cleavage pathway and address specific questions related to the run-on oligomer mechanism including the sequestration of DNA-cleavage activity and trapping of products.	[Park, Chad K.; Sanchez, Jonathan L.; Barahona, Claudia; Basantes, L. Emilia; Sanchez, Juan; Hernandez, Christian; Horton, N. C.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona	Horton, NC (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	nhorton@email.arizona.edu	Horton, Nancy C/E-7881-2011	Horton, Nancy C/0000-0003-2710-8284; Sanchez, Jonathan/0000-0003-0097-465X	National Science Foundation [MCB-1410355]; Office of the Director of National Institutes of Health [S10OD013237]; NIGMS, National Institutes of Health [T32GM008659]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008659] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD013237] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Office of the Director of National Institutes of Health; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Science Foundation Grant MCB-1410355 (to N. C. H.), by the Office of the Director of National Institutes of Health under Grant S10OD013237 (to C. K. P.), and by NIGMS, National Institutes of Health Grant T32GM008659 (to J. L. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Aughey GN, 2014, BIOL OPEN, V3, P1045, DOI 10.1242/bio.201410165; Barry RM, 2014, ELIFE, V3, DOI 10.7554/eLife.03638; Barry RM, 2011, CURR OPIN MICROBIOL, V14, P704, DOI 10.1016/j.mib.2011.09.015; BEATY NB, 1983, J BIOL CHEM, V258, P3043; Bitinaite J, 2002, P NATL ACAD SCI USA, V99, P1164, DOI 10.1073/pnas.022346799; Dunten PW, 2008, NUCLEIC ACIDS RES, V36, P5405, DOI 10.1093/nar/gkn510; Fasman G. D, 1975, CRC HDB BIOCH MOL BI, V3rd; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kasarjian JKA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng022; Kim CW, 2010, P NATL ACAD SCI USA, V107, P9626, DOI 10.1073/pnas.1001292107; KLEINSCH.AK, 1969, SCIENCE, V166, P1276, DOI 10.1126/science.166.3910.1276; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lee S, 2012, APPL ENVIRON MICROB, V78, P2623, DOI 10.1128/AEM.07203-11; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Little EJ, 2011, ACTA CRYSTALLOGR D, V67, P67, DOI 10.1107/S0907444910047785; Liu JL, 2016, ANNU REV CELL DEV BI, V32, P349, DOI 10.1146/annurev-cellbio-111315-124907; Liu JL, 2010, J GENET GENOMICS, V37, P281, DOI 10.1016/S1673-8527(09)60046-1; Lynch EM, 2017, NAT STRUCT MOL BIOL, V24, P507, DOI 10.1038/nsmb.3407; Lyumkis D, 2013, STRUCTURE, V21, P1848, DOI 10.1016/j.str.2013.08.012; Ma X, 2013, BIOCHEMISTRY-US, V52, P4373, DOI 10.1021/bi3013214; MEREDITH MJ, 1978, J BIOL CHEM, V253, P3381; MOINEAU S, 1993, APPL ENVIRON MICROB, V59, P197, DOI 10.1128/AEM.59.1.197-202.1993; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; O'Connell JD, 2014, MOL BIOSYST, V10, P851, DOI 10.1039/c3mb70508k; O'Connell JD, 2012, ANNU REV CELL DEV BI, V28, P89, DOI 10.1146/annurev-cellbio-101011-155841; Park CK, 2018, J BIOL CHEM, V293, P14599, DOI 10.1074/jbc.RA118.003682; Park CK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000554; Park CK, 2010, BIOCHEMISTRY-US, V49, P8818, DOI 10.1021/bi100557v; Petrovska I, 2014, ELIFE, V3, DOI 10.7554/eLife.02409; Prouteau M, 2017, NATURE, V550, P265, DOI 10.1038/nature24021; Schmitt DL, 2016, ACS CHEM BIOL, V11, P1917, DOI 10.1021/acschembio.6b00039; Shah S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124783; Shen QJ, 2016, J GENET GENOMICS, V43, P393, DOI 10.1016/j.jgg.2016.03.008; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Suresh HG, 2015, MOL BIOL CELL, V26, P1601, DOI 10.1091/mbc.E14-11-1559; Vajjhala PR, 2017, MOL IMMUNOL, V86, P23, DOI 10.1016/j.molimm.2017.02.012; Werner JN, 2009, P NATL ACAD SCI USA, V106, P7858, DOI 10.1073/pnas.0901781106; Zaganjor E, 2017, J CELL BIOL, V216, P2239, DOI 10.1083/jcb.201706005	43	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14585	14598		10.1074/jbc.RA118.003680	http://dx.doi.org/10.1074/jbc.RA118.003680			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30068553	Green Published, hybrid			2022-12-28	WOS:000446155000002
J	Gao, Z; Liao, Y; Chen, C; Liao, CY; He, DX; Chen, JM; Ma, JX; Liu, ZG; Wu, YL				Gao, Zhan; Liao, Yi; Chen, Chao; Liao, Chunyan; He, Danxue; Chen, Jingmeng; Ma, Jianxing; Liu, Zuguo; Wu, Yalin			Conversion of all-trans-retinal into all-trans-retinal dimer reflects an alternative metabolic/antidotal pathway of all-trans-retinal in the retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						retinal metabolism; photoreceptor; retina; retinoid; phagocytosis; all-trans-retinal; all-trans-retinal dimer; metabolic; antidotal pathway; primary porcine RPE cells; retina	PIGMENT EPITHELIAL-CELLS; POTENTIAL THERAPEUTIC AGENTS; PHOTORECEPTOR OUTER SEGMENTS; RECESSIVE STARGARDT-DISEASE; VISUAL CYCLE; TRANSPORTER ABCA4; LIPOFUSCIN; RPE; A2E; IDENTIFICATION	Free all-trans-retinal (atRAL) and retinal pigment epithelium (RPE) lipofuscin are both considered to play etiological roles in Stargardt disease and age-related macular degeneration. A2E and all-trans-retinal dimer (atRAL-dimer) are two well characterized bisretinoid constituents of RPE lipofuscin. In this study, we found that, after treatment of primary porcine RPE (pRPE) cells with atRAL, atRAL-dimer readily formed and accumulated in a concentration- and time-dependent manner, but A2E was barely detected. Cell-based assays revealed that atRAL, the precursor of atRAL-dimer, significantly altered the morphology of primary pRPE cells and decreased cell viability at a concentration of 80 m regardless of light exposure. By contrast, atRAL-dimer was not cytotoxic and phototoxic to primary pRPE cells. Compared with atRAL and A2E, atRAL-dimer was more vulnerable to light, followed by the generation of its photocleaved products. Moreover, we observed the presence of atRAL-dimer in reaction mixtures of atRAL with porcine rod outer segments (ROS), RPE/choroid, or neural retina. Taken together, we here proposed an alternative metabolic/antidotal pathway of atRAL in the retina: atRAL that evades participation of the visual (retinoid) cycle undergoes a condensation reaction to yield atRAL-dimer in both ROS and RPE. Translocation of atRAL, all-trans N-retinylidene-phosphatidylethanolamine (NR-PE), atRAL-dimer, and photocleavage products of atRAL-dimer from ROS into RPE is accomplished by phagocytosing shed ROS on a daily basis. Without causing damage to RPE cells, light breaks up total atRAL-dimer within RPE cells to release low-molecular-weight photocleavage fragments. The latter, together with ROS-atRAL-dimer photocleavage products, may easily move across membranes and thereby be metabolically eliminated.	[Gao, Zhan; Liao, Yi; Chen, Chao; Liao, Chunyan; He, Danxue; Liu, Zuguo; Wu, Yalin] Xiamen Univ, Coll Med, Eye Inst, Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiangan South Rd, Xiamen 361102, Peoples R China; [Chen, Jingmeng] Xiamen Univ, Coll Med, Clin Skills Training Ctr, Xiamen 361102, Peoples R China; [Ma, Jianxing] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Dept Physiol, Oklahoma City, OK 73104 USA	Xiamen University; Xiamen University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Wu, YL (corresponding author), Xiamen Univ, Coll Med, Eye Inst, Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiangan South Rd, Xiamen 361102, Peoples R China.	yalinw@xmu.edu.cn		Chao, Chen/0000-0002-3191-0838	China National Natural Science Foundation [81570857, 81700864]; Sanming Project of Medicine in Shenzhen [SZSM201612022]; Fundamental Research Funds for the Central Universities; Natural Science Foundation of Fujian Province [2017J01148, 2016J01412]; research grant for young and mid-aged teachers of Fujian Province [JAT160011]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Sanming Project of Medicine in Shenzhen; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); research grant for young and mid-aged teachers of Fujian Province	This work was supported in part by grants from the China National Natural Science Foundation (81570857 to Y. W. and 81700864 to Y. L.), the Sanming Project of Medicine in Shenzhen (SZSM201612022 to Z. L. and Y. W.), the Fundamental Research Funds for the Central Universities (to Y. W. and Y. L.), and the Natural Science Foundation of Fujian Province (2017J01148 to Y. W. and 2016J01412 to Y. L.) and in part by a research grant for young and mid-aged teachers of Fujian Province (JAT160011 to Y. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Chen CH, 2002, BIOPHYS J, V83, P1403, DOI 10.1016/S0006-3495(02)73911-8; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Fishkin N, 2004, CHEM REC, V4, P120, DOI 10.1002/tcr.20000; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; Li J, 2016, TOXICOLOGY, V371, P41, DOI 10.1016/j.tox.2016.10.005; Li J, 2013, J BIOL CHEM, V288, P35671, DOI 10.1074/jbc.M113.511386; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; Liu X, 2016, INVEST OPHTH VIS SCI, V57, P1017, DOI 10.1167/iovs.15-18429; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Molday RS, 2006, ADV EXP MED BIOL, V572, P465; Okubo A, 1999, INVEST OPHTH VIS SCI, V40, P443; Parinot C, 2014, JOVE-J VIS EXP, DOI 10.3791/52100; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Sakai N, 1996, J AM CHEM SOC, V118, P1559, DOI 10.1021/ja953480g; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Sullivan JM, 2009, EXP EYE RES, V89, P602, DOI 10.1016/j.exer.2009.03.005; Sun H, 2001, J BIOENERG BIOMEMBR, V33, P523, DOI 10.1023/A:1012883306823; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Tsybovsky Y, 2011, BIOCHEMISTRY-US, V50, P6855, DOI 10.1021/bi200774w; vonRuckmann A, 1997, INVEST OPHTH VIS SCI, V38, P478; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wielgus AR, 2010, PHOTOCHEM PHOTOBIOL, V86, P781, DOI 10.1111/j.1751-1097.2010.00750.x; Wu Y, 2009, J BIOL CHEM, V284, P20155, DOI 10.1074/jbc.M109.021345; Zhao JL, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20734	30	5	5	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14507	14519		10.1074/jbc.RA118.002447	http://dx.doi.org/10.1074/jbc.RA118.002447			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30049796	Green Published, hybrid			2022-12-28	WOS:000444671500028
J	Dinkel, BA; Kremer, KN; Rollins, MR; Medlyn, MJ; Hedin, KE				Dinkel, Brittney A.; Kremer, Kimberly N.; Rollins, Meagan R.; Medlyn, Michael J.; Hedin, Karen E.			GRK2 mediates TCR-induced transactivation of CXCR4 and TCR-CXCR4 complex formation that drives PI3K/PREX1 signaling and T cell cytokine secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CXC chemokine receptor type 4 (CXCR-4); G protein-coupled receptor (GPCR); T-cell receptor (TCR); fluorescence resonance energy transfer (FRET); cytokine; phosphorylation; G protein-coupled receptor kinase-2 (GRK2); IL-10; IL-2; PI3 kinase (PI3K); proximity ligation assay (PLA)	COUPLED RECEPTOR KINASE; NUCLEOTIDE EXCHANGE FACTOR; RHEUMATOID-ARTHRITIS; CHEMOKINE RECEPTORS; TYROSINE KINASE; IMMUNOLOGICAL SYNAPSE; PROTEIN-KINASE; BREAST-CANCER; FACTOR-I; PHOSPHORYLATION	The immune system includes abundant examples of biologically-relevant cross-regulation of signaling pathways by the T cell antigen receptor (TCR) and the G protein-coupled chemokine receptor, CXCR4. TCR ligation induces transactivation of CXCR4 and TCR-CXCR4 complex formation, permitting the TCR to signal via CXCR4 to activate a phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein (PREX1)-dependent signaling pathway that drives robust cytokine secretion by T cells. To understand this receptor heterodimer and its regulation, we characterized the molecular mechanisms required for TCR-mediated TCR-CXCR4 complex formation. We found that the cytoplasmic C-terminal domain of CXCR4 and specifically phosphorylation of Ser-339 within this region were required for TCR-CXCR4 complex formation. Interestingly, siRNA-mediated depletion of G protein-coupled receptor kinase-2 (GRK2) or inhibition by the GRK2-specific inhibitor, paroxetine, inhibited TCR-induced phosphorylation of CXCR4-Ser-339 and TCR-CXCR4 complex formation. Either GRK2 siRNA or paroxetine treatment of human T cells significantly reduced T cell cytokine production. Upstream, TCR-activated tyrosine kinases caused inducible tyrosine phosphorylation of GRK2 and were required for the GRK2-dependent events of CXCR4-Ser-339 phosphorylation and TCR-CXCR4 complex formation. Downstream of TCR-CXCR4 complex formation, we found that GRK2 and phosphatidylinositol 3-kinase (PI3K) were required for TCR-stimulated membrane recruitment of PREX1 and for stabilization of cytokine mRNAs and robust cytokine secretion. Together, our results identify a novel role for GRK2 as a target of TCR signaling that is responsible for TCR-induced transactivation of CXCR4 and TCR-CXCR4 complex formation that signals via PI3K/PREX1 to mediate cytokine production. Therapeutic regulation of GRK2 or PI3K may therefore be useful for limiting cytokines produced by T cell malignancies or autoimmune diseases.	[Dinkel, Brittney A.] Mayo Clin, Grad Sch Biomed Sci, Mayo IMM PhD Training Program, Rochester, MN 55905 USA; [Dinkel, Brittney A.; Kremer, Kimberly N.; Rollins, Meagan R.; Medlyn, Michael J.; Hedin, Karen E.] Mayo Clin, Dept Immunol, Coll Med & Sci, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Hedin, KE (corresponding author), Mayo Clin, Dept Immunol, Guggenheim Bldg,3rd Floor,200 First St Southwest, Rochester, MN 55905 USA.	hedin.karen@mayo.edu		Hedin, Karen/0000-0003-1010-923X	Mayo Clinic; National Institutes of Health from NIGMS [RO1 GM59763]; National Institutes of Health [R25 HL092621]; National Institutes of Health Ph.D. Training Grant in Basic Immunology from NIAID [T32 AI07425]; Mayo Clinic Graduate School of Biomedical Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL092621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059763] Funding Source: NIH RePORTER	Mayo Clinic; National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Ph.D. Training Grant in Basic Immunology from NIAID; Mayo Clinic Graduate School of Biomedical Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Mayo Clinic and by National Institutes of Health Grant RO1 GM59763 from NIGMS (to K. E. H.) and Grant R25 HL092621 (to M. J. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Ph.D. Training Grant in Basic Immunology T32 AI07425 from NIAID and the Mayo Clinic Graduate School of Biomedical Sciences.	Akekawatchai C, 2005, J BIOL CHEM, V280, P39701, DOI 10.1074/jbc.M509829200; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Bird H, 2000, J RHEUMATOL, V27, P2791; Borish Larry C., 2003, Journal of Allergy and Clinical Immunology, V111, pS460; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Brault L, 2014, LEUKEMIA, V28, P566, DOI 10.1038/leu.2013.201; Bromley SK, 2002, IMMUNOLOGY, V106, P289, DOI 10.1046/j.1365-2567.2002.01441.x; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Cascio G, 2015, J IMMUNOL, V194, P5509, DOI 10.4049/jimmunol.1402419; Chen SS, 2016, LEUKEMIA, V30, P833, DOI 10.1038/leu.2015.316; Chernock RD, 2001, BLOOD, V97, P608, DOI 10.1182/blood.V97.3.608; Clift IC, 2014, MOL PHARMACOL, V85, P542, DOI 10.1124/mol.113.089714; DEBLASI A, 1995, J CLIN INVEST, V95, P203, DOI 10.1172/JCI117641; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; DeFord-Watts LM, 2007, J BIOL CHEM, V282, P16126, DOI 10.1074/jbc.M609418200; Delcourt N, 2007, TRENDS PHARMACOL SCI, V28, P602, DOI 10.1016/j.tips.2007.09.007; Gonzalez BR, 2016, CURR OPIN ONCOL, V28, P88, DOI 10.1097/CCO.0000000000000243; Gorentla Balachandra K, 2012, J Clin Cell Immunol, V2012, P5; Guccione M, 2016, J MED CHEM, V59, P9277, DOI 10.1021/acs.jmedchem.5b01939; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hawkins PT, 2015, BBA-MOL CELL BIOL L, V1851, P882, DOI 10.1016/j.bbalip.2014.12.006; Huang WS, 2015, J LEUKOCYTE BIOL, V97, P477, DOI 10.1189/jlb.1RI0614-293R; Isik N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003424; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Kohler RE, 2008, BRAIN PATHOL, V18, P504, DOI 10.1111/j.1750-3639.2008.00154.x; Krasel C, 2001, J BIOL CHEM, V276, P1911, DOI 10.1074/jbc.M008773200; Kremer KN, 2007, J IMMUNOL, V178, P1581, DOI 10.4049/jimmunol.178.3.1581; Kremer KN, 2017, BLOOD, V130, P982, DOI 10.1182/blood-2017-03-770982; Kremer KN, 2003, J IMMUNOL, V171, P360, DOI 10.4049/jimmunol.171.1.360; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Kumar A, 2009, METHOD ENZYMOL, V460, P379, DOI 10.1016/S0076-6879(09)05219-7; Launay O, 2013, VACCINE, V31, P3492, DOI 10.1016/j.vaccine.2013.05.095; Li X, 2006, BIOCHEM J, V394, P427, DOI 10.1042/BJ20051560; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Maekawa T, 2000, INTERNAL MED, V39, P90, DOI 10.2169/internalmedicine.39.90; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Mueller W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064975; Murthy KS, 2008, AM J PHYSIOL-CELL PH, V294, pC477, DOI 10.1152/ajpcell.00229.2007; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Pan DX, 2016, J BIOL CHEM, V291, P6359, DOI 10.1074/jbc.M115.686592; Patrussi L, 2007, BLOOD, V110, P1730, DOI 10.1182/blood-2007-01-068411; Patton DT, 2007, BIOCHEM SOC T, V35, P167, DOI 10.1042/BST0350167; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Przybyla JA, 2010, J PHARMACOL EXP THER, V332, P710, DOI 10.1124/jpet.109.162701; Pyne NJ, 2011, TRENDS PHARMACOL SCI, V32, P443, DOI 10.1016/j.tips.2011.04.002; Rocha-Perugini V, 2017, ADV EXP MED BIOL, V1006, P271, DOI 10.1007/978-4-431-56550-5_15; Rodriguez-Frade JM, 1999, J CELL BIOL, V144, P755, DOI 10.1083/jcb.144.4.755; Rodriguez-Frade JM, 1999, P NATL ACAD SCI USA, V96, P3628, DOI 10.1073/pnas.96.7.3628; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Santio NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130340; Sarnago S, 1999, J BIOL CHEM, V274, P34411, DOI 10.1074/jbc.274.48.34411; Siebert S, 2015, PHARMACOL REV, V67, P280, DOI 10.1124/pr.114.009639; Smith X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004018; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Stark AK, 2015, CURR OPIN PHARMACOL, V23, P82, DOI 10.1016/j.coph.2015.05.017; Thal DM, 2012, ACS CHEM BIOL, V7, P1830, DOI 10.1021/cb3003013; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wang QT, 2017, SCI REP-UK, V7, DOI 10.1038/srep45364; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Welch Heidi C E, 2015, Small GTPases, V6, P49, DOI 10.4161/21541248.2014.973770; Yang J, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003519; Zuo K, 2016, SCI REP-UK, V6, DOI 10.1038/srep26812	70	19	19	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14022	14039		10.1074/jbc.RA118.003097	http://dx.doi.org/10.1074/jbc.RA118.003097			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30018141	Green Published, hybrid			2022-12-28	WOS:000444070700026
J	Zhang, XF; Cao, SF; Barila, G; Edreira, MM; Hong, K; Wankhede, M; Naim, N; Buck, M; Altschuler, DL				Zhang, Xuefeng; Cao, Shufen; Barila, Guillermo; Edreira, Martin M.; Hong, Kyoungja; Wankhede, Mamta; Naim, Nyla; Buck, Matthias; Altschuler, Daniel L.			Cyclase-associated protein 1 (CAP1) is a prenyl-binding partner of Rap1 GTPase (vol 293, pg 7659, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Edreira, Martin/AAE-7816-2020	Edreira, Martin/0000-0002-9120-2649	NIGMS NIH HHS [T32 GM008424] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008424] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Zhang XF, 2018, J BIOL CHEM, V293, P7659, DOI 10.1074/jbc.RA118.001779	1	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13849	13849		10.1074/jbc.AAC118.005290	http://dx.doi.org/10.1074/jbc.AAC118.005290			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30194256	Green Published, hybrid			2022-12-28	WOS:000444070700010
J	Hutt, DM; Loguercio, S; Roth, DM; Su, AI; Balch, WE				Hutt, Darren M.; Loguercio, Salvatore; Roth, Daniela Martino; Su, Andrew I.; Balch, William E.			Correcting the F508del-CFTR variant by modulating eukaryotic translation initiation factor 3-mediated translation initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cystic fibrosis transmembrane conductance regulator (CFTR); cystic fibrosis; proteostasis; eukaryotic translation initiation; translation initiation factor; eIF3a; eukaryotic translation initiation factor 3; F508del-CFTR; network hub; protein misfolding; protein translation	TRANSMEMBRANE CONDUCTANCE REGULATOR; RNA RECOGNITION MOTIF; CYSTIC-FIBROSIS; MESSENGER-RNA; IN-VITRO; BIOCHEMICAL-CHARACTERIZATION; PROFILING REVEALS; PROTEIN-SYNTHESIS; EIF3; CFTR	Inherited and somatic rare diseases result from >200,000 genetic variants leading to loss- or gain-of-toxic function, often caused by protein misfolding. Many of these misfolded variants fail to properly interact with other proteins. Understanding the link between factors mediating the transcription, translation, and protein folding of these disease-associated variants remains a major challenge in cell biology. Herein, we utilized the cystic fibrosis transmembrane conductance regulator (CFTR) protein as a model and performed a proteomics-based high-throughput screen (HTS) to identify pathways and components affecting the folding and function of the most common cystic fibrosis-associated mutation, the F508del variant of CFTR. Using a shortest-path algorithm we developed, we mapped HTS hits to the CFTR interactome to provide functional context to the targets and identified the eukaryotic translation initiation factor 3a (eIF3a) as a central hub for the biogenesis of CFTR. Of note, siRNA-mediated silencing of eIF3a reduced the polysome-to-monosome ratio in F508del-expressing cells, which, in turn, decreased the translation of CFTR variants, leading to increased CFTR stability, trafficking, and function at the cell surface. This finding suggested that eIF3a is involved in mediating the impact of genetic variations in CFTR on the folding of this protein. We posit that the number of ribosomes on a CFTR mRNA transcript is inversely correlated with the stability of the translated polypeptide. Polysome-based translation challenges the capacity of the proteostasis environment to balance message fidelity with protein folding, leading to disease. We suggest that this deficit can be corrected through control of translation initiation.	[Hutt, Darren M.; Loguercio, Salvatore; Roth, Daniela Martino; Balch, William E.] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Su, Andrew I.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Roth, Daniela Martino] Locana, 3210 Merryfield Row, San Diego, CA 92122 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Balch, WE (corresponding author), Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA.; Balch, WE (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	webalch@scripps.edu		Loguercio, Salvatore/0000-0002-7544-2992; Su, Andrew I./0000-0002-9859-4104	NHLBI NIH HHS [R01 HL095524] Funding Source: Medline; NIA NIH HHS [P01 AG049665] Funding Source: Medline; NIDDK NIH HHS [R01 DK051870] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG049665] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Ahner A, 2016, AM J PHYSIOL-CELL PH, V310, pC175, DOI 10.1152/ajpcell.00124.2015; Ahner A, 2013, MOL BIOL CELL, V24, P74, DOI 10.1091/mbc.E12-09-0678; Alanis-Lobato G, 2017, NUCLEIC ACIDS RES, V45, pD408, DOI 10.1093/nar/gkw985; Amaral MD, 2015, J CYST FIBROS, V14, P687, DOI 10.1016/j.jcf.2015.09.006; Bauerlein FJB, 2017, CELL, V171, P179, DOI 10.1016/j.cell.2017.08.009; Bagdany M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00444-4; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Balch WE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004499; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Baugh JM, 2004, MOL CELL, V16, P575, DOI 10.1016/j.molcel.2004.10.017; Berger B, 2013, NAT REV GENET, V14, P333, DOI 10.1038/nrg3433; Beznoskova P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003962; Boel G, 2016, NATURE, V529, P358, DOI 10.1038/nature16509; Bouchecareilh M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404707; Brar GA, 2016, CELL, V167, P1681, DOI 10.1016/j.cell.2016.09.022; Brar GA, 2015, NAT REV MOL CELL BIO, V16, P651, DOI 10.1038/nrm4069; Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Callebaut I, 2018, J CYST FIBROS, V17, pS5, DOI 10.1016/j.jcf.2017.08.008; Carter H, 2013, CURR OPIN GENET DEV, V23, P611, DOI 10.1016/j.gde.2013.10.003; Cate JHD, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0176; Chadani Y, 2016, P NATL ACAD SCI USA, V113, pE829, DOI 10.1073/pnas.1520560113; Chaudhuri J, 1997, J BIOL CHEM, V272, P30975, DOI 10.1074/jbc.272.49.30975; Chiu WL, 2010, MOL CELL BIOL, V30, P4415, DOI 10.1128/MCB.00280-10; Churbanov A, 2005, NUCLEIC ACIDS RES, V33, P5512, DOI 10.1093/nar/gki847; Dacheux E, 2017, NUCLEIC ACIDS RES, V45, P6981, DOI 10.1093/nar/gkx430; Dijkstra EW., 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dong ZZ, 2003, MOL BIOL CELL, V14, P3942, DOI 10.1091/mbc.E02-12-0784; Faure G, 2016, NUCLEIC ACIDS RES, V44, P10898, DOI 10.1093/nar/gkw671; Fedyunin I, 2012, FEBS LETT, V586, P3336, DOI 10.1016/j.febslet.2012.07.012; Fernandes LD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17618-1; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; Gobet C, 2017, CURR OPIN GENET DEV, V43, P120, DOI 10.1016/j.gde.2017.03.005; Gong XY, 2016, J BIOL CHEM, V291, P2004, DOI 10.1074/jbc.M115.685628; Gradi A, 1998, MOL CELL BIOL, V18, P334, DOI 10.1128/MCB.18.1.334; Gross AM, 2015, NAT BIOTECHNOL, V33, P720, DOI 10.1038/nbt.3283; Hartl D, 2015, J CYST FIBROS, V14, P415, DOI 10.1016/j.jcf.2015.06.001; Hartl FU, 2017, ANNU REV BIOCHEM, V86, P21, DOI 10.1146/annurev-biochem-061516-044518; Henis-Korenblit S, 2000, MOL CELL BIOL, V20, P496, DOI 10.1128/MCB.20.2.496-506.2000; Heyer EE, 2016, CELL, V164, P757, DOI 10.1016/j.cell.2016.01.003; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hinnebusch AG, 2017, TRENDS BIOCHEM SCI, V42, P589, DOI 10.1016/j.tibs.2017.03.004; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hutt DM, 2012, J BIOL CHEM, V287, P21914, DOI 10.1074/jbc.M112.339788; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Jia MW, 2006, BIOCHEM BIOPH RES CO, V343, P177, DOI 10.1016/j.bbrc.2006.02.135; Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, pD840, DOI 10.1093/nar/gkw971; Kim SJ, 2015, SCIENCE, V348, P444, DOI 10.1126/science.aaa3974; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Kurosaki T, 2016, J CELL SCI, V129, P461, DOI 10.1242/jcs.181008; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lacerda R, 2017, CELL MOL LIFE SCI, V74, P1659, DOI 10.1007/s00018-016-2428-2; Lan A, 2011, NUCLEIC ACIDS RES, V39, pW424, DOI 10.1093/nar/gkr359; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lee ASY, 2015, NATURE, V522, P111, DOI 10.1038/nature14267; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li J, 2017, TRENDS CELL BIOL, V27, P895, DOI 10.1016/j.tcb.2017.08.002; Luck K, 2017, TRENDS BIOCHEM SCI, V42, P342, DOI 10.1016/j.tibs.2017.02.006; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; McClure ML, 2016, AM J PHYSIOL-LUNG C, V311, pL719, DOI 10.1152/ajplung.00431.2015; Meriin AB, 2012, J BIOL CHEM, V287, P34264, DOI 10.1074/jbc.M112.397307; Mohammad MP, 2017, NUCLEIC ACIDS RES, V45, P2658, DOI 10.1093/nar/gkx049; Morgunov AS, 2014, NAT STRUCT MOL BIOL, V21, P1023, DOI 10.1038/nsmb.2926; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Pankow S, 2015, NATURE, V528, P510, DOI 10.1038/nature15729; Pavitt GD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012278; Pechmann S, 2014, NAT STRUCT MOL BIOL, V21, P1100, DOI 10.1038/nsmb.2919; Perlmutter DH, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005801; Pisarev AV, 2007, CELL, V131, P286, DOI 10.1016/j.cell.2007.08.041; Quon BS, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i859; Ratjen F, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.10; Raxwal VK, 2016, BBA-GENE REGUL MECH, V1859, P1538, DOI 10.1016/j.bbagrm.2016.09.001; Rodnina MV, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0182; Rodnina MV, 2016, J MOL BIOL, V428, P2165, DOI 10.1016/j.jmb.2016.03.022; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Roth DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001998; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Sala AJ, 2017, J CELL BIOL, V216, P1231, DOI 10.1083/jcb.201612111; Saletta F, 2010, BBA-REV CANCER, V1806, P275, DOI 10.1016/j.bbcan.2010.07.005; Saxena A, 2012, J BIOL CHEM, V287, P19158, DOI 10.1074/jbc.M111.297580; Schmidt BZ, 2009, J BIOL CHEM, V284, P4168, DOI 10.1074/jbc.M806485200; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; Sesen J, 2017, FRONT BIOSCI-LANDMRK, V22, P1, DOI 10.2741/4469; Sha Z, 2009, MOL CELL, V36, P141, DOI 10.1016/j.molcel.2009.09.026; Shabalina SA, 2013, NUCLEIC ACIDS RES, V41, P2073, DOI 10.1093/nar/gks1205; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; Solomon GM, 2016, ANN AM THORAC SOC, V13, pS169, DOI 10.1513/AnnalsATS.201509-601KV; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Spielberg DR, 2016, ANNU REV GENOM HUM G, V17, P155, DOI 10.1146/annurev-genom-090314-050024; Steffen KK, 2016, CELL METAB, V23, P1004, DOI 10.1016/j.cmet.2016.05.013; Thommen M, 2017, CURR OPIN STRUC BIOL, V42, P83, DOI 10.1016/j.sbi.2016.11.020; Tran JR, 2011, J BIOL CHEM, V286, P5744, DOI 10.1074/jbc.M110.179259; Valasek L, 2001, EMBO J, V20, P891, DOI 10.1093/emboj/20.4.891; Valasek LS, 2017, NUCLEIC ACIDS RES, V45, P10948, DOI 10.1093/nar/gkx805; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Veit G, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002462; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wagner S, 2016, NUCLEIC ACIDS RES, V44, P10772, DOI 10.1093/nar/gkw972; Wagner S, 2014, MOL CELL BIOL, V34, P3041, DOI 10.1128/MCB.00663-14; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Yu MK, 2016, CELL SYST, V2, P77, DOI 10.1016/j.cels.2016.02.003; Zhao F, 2017, NUCLEIC ACIDS RES, V45, P8484, DOI 10.1093/nar/gkx501; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	110	12	13	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13477	13495		10.1074/jbc.RA118.003192	http://dx.doi.org/10.1074/jbc.RA118.003192			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30006345	Green Published, hybrid			2022-12-28	WOS:000443375500011
J	Tykesson, E; Hassinen, A; Zielinska, K; Thelin, MA; Frati, G; Ellervik, U; Westergren-Thorsson, G; Malmstrom, A; Kellokumpu, S; Maccarana, M				Tykesson, Emil; Hassinen, Antti; Zielinska, Katarzyna; Thelin, Martin A.; Frati, Giacomo; Ellervik, Ulf; Westergren-Thorsson, Gunilla; Malmstrom, Anders; Kellokumpu, Sakari; Maccarana, Marco			Dermatan sulfate epimerase 1 and dermatan 4-O-sulfotransferase 1 form complexes that generate long epimerized 4-O-sulfated blocks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chondroitin sulfate; dermatan sulfate; Golgi; glycosaminoglycan; glycobiology; D4ST1; DS-epi1; DS-epi2; epimerization; epimerase	EHLERS-DANLOS-SYNDROME; GROWTH FACTOR/SCATTER FACTOR; HEPARIN-COFACTOR-II; CHONDROITIN SULFATE; IDURONIC ACID; CANCER-CELLS; BIOSYNTHESIS; SUBSTRATE; N-ACETYLGALACTOSAMINYLTRANSFERASE-1; POLYMERIZATION	During the biosynthesis of chondroitin/dermatan sulfate (CS/DS), a variable fraction of glucuronic acid is converted to iduronic acid through the activities of two epimerases, dermatan sulfate epimerases 1 (DS-epi1) and 2 (DS-epi2). Previous in vitro studies indicated that without association with other enzymes, DS-epi1 activity produces structures that have only a few adjacent iduronic acid units. In vivo, concomitant with epimerization, dermatan 4-O-sulfotransferase 1 (D4ST1) sulfates the GalNAc adjacent to iduronic acid. This sulfation facilitates DS-epi1 activity and enables the formation of long blocks of sulfated iduronic acid-containing domains, which can be major components of CS/DS. In this report, we used recombinant enzymes to confirm the concerted action of DS-epi1 and D4ST1. Confocal microscopy revealed that these two enzymes colocalize to the Golgi, and FRET experiments indicated that they physically interact. Furthermore, FRET, immunoprecipitation, and cross-linking experiments also revealed that DS-epi1, DS-epi2, and D4ST1 form homomers and are all part of a hetero-oligomeric complex where D4ST1 directly interacts with DS-epi1, but not with DS-epi2. The cooperation of DS-epi1 with D4ST1 may therefore explain the processive mode of the formation of iduronic acid blocks. In conclusion, the iduronic acid-forming enzymes operate in complexes, similar to other enzymes active in glycosaminoglycan biosynthesis. This knowledge shed light on regulatory mechanisms controlling the biosynthesis of the structurally diverse CS/DS molecule.	[Tykesson, Emil; Zielinska, Katarzyna; Thelin, Martin A.; Frati, Giacomo; Westergren-Thorsson, Gunilla; Malmstrom, Anders; Maccarana, Marco] Lund Univ, Dept Expt Med Sci, SE-22100 Lund, Sweden; [Hassinen, Antti; Kellokumpu, Sakari] Univ Oulu, Fac Biochem & Mol Med, FIN-90570 Oulu, Finland; [Hassinen, Antti] Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00014 Helsinki, Finland; [Ellervik, Ulf] Lund Univ, Dept Chem, SE-22100 Lund, Sweden	Lund University; University of Oulu; University of Helsinki; Lund University	Maccarana, M (corresponding author), BMC C12, S-22184 Lund, Sweden.	marco.maccarana@med.lu.se	maccarana, marco/AAB-4764-2021; Frati, Giacomo/ABE-5974-2021; Tykesson, Emil/F-9879-2014; Frati, Giacomo/ABI-7410-2020	Frati, Giacomo/0000-0001-5584-6060; Tykesson, Emil/0000-0002-0511-9831; Malmstrom, Anders/0000-0002-6691-146X; Maccarana, Marco/0000-0003-3549-8921; Thelin, Martin/0000-0002-2232-5514; Hassinen, Antti/0000-0001-9491-2868	Medical Faculty at Lund University; Lund University; Swedish Research Council; Swedish Cancer Society Grant [140530]; Mizutani Foundation for Glycoscience; Greta and Johan Kock Foundation; FLAK Research School; Albert Osterlund Foundation; Royal Physiographic Society; Lars Hierta Foundation; Academy of Finland Grant; Aaltonen Foundation	Medical Faculty at Lund University; Lund University; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society Grant; Mizutani Foundation for Glycoscience; Greta and Johan Kock Foundation; FLAK Research School; Albert Osterlund Foundation; Royal Physiographic Society; Lars Hierta Foundation; Academy of Finland Grant(Academy of Finland); Aaltonen Foundation	This work was supported by the Medical Faculty at Lund University, Lund University, the Swedish Research Council, the Swedish Cancer Society Grant 140530 (to M.M.), the Mizutani Foundation for Glycoscience, the Greta and Johan Kock Foundation, the FLAK Research School, the Albert Osterlund Foundation, the Royal Physiographic Society, and the Lars Hierta Foundation. The work was also supported by an Academy of Finland Grant and the Aaltonen Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Bartolini B, 2012, GLYCOBIOLOGY, V22, P1007, DOI 10.1093/glycob/cws065; Catlow KR, 2008, J BIOL CHEM, V283, P5235, DOI 10.1074/jbc.M706589200; Deakin JA, 2009, J BIOL CHEM, V284, P6311, DOI 10.1074/jbc.M807671200; Dick G, 2008, GLYCOBIOLOGY, V18, P53, DOI 10.1093/glycob/cwm121; Eklund E, 2000, ARCH BIOCHEM BIOPHYS, V383, P171, DOI 10.1006/abbi.2000.2043; FRANSSON LA, 1982, J BIOL CHEM, V257, P6333; Gouignard N, 2016, DIS MODEL MECH, V9, P607, DOI 10.1242/dmm.024661; Hannesson HH, 1996, BIOCHEM J, V313, P589, DOI 10.1042/bj3130589; Hassinen A, 2014, J BIOL CHEM, V289, P26937, DOI 10.1074/jbc.M114.595058; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; He L, 2008, BLOOD, V111, P4118, DOI 10.1182/blood-2007-12-127928; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Izumikawa T, 2015, J BIOL CHEM, V290, P5438, DOI 10.1074/jbc.M114.603266; Izumikawa T, 2012, BIOCHEM J, V441, P697, DOI 10.1042/BJ20111472; Kellokumpu S, 2016, CELL MOL LIFE SCI, V73, P305, DOI 10.1007/s00018-015-2066-0; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Kokkonen N, 2004, J BIOL CHEM, V279, P39982, DOI 10.1074/jbc.M406698200; Kosho T, 2016, PEDIATR INT, V58, P88, DOI 10.1111/ped.12878; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09; MAIMONE MM, 1990, J BIOL CHEM, V265, P18263; Malmstrom A, 2012, J HISTOCHEM CYTOCHEM, V60, P916, DOI 10.1369/0022155412459857; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Miyake N, 2010, HUM MUTAT, V31, P966, DOI 10.1002/humu.21300; Muller T, 2013, HUM MOL GENET, V22, P3761, DOI 10.1093/hmg/ddt227; Pacheco B, 2009, GLYCOBIOLOGY, V19, P1197, DOI 10.1093/glycob/cwp110; Pacheco B, 2009, J BIOL CHEM, V284, P9788, DOI 10.1074/jbc.M809339200; Pacheco B, 2009, J BIOL CHEM, V284, P1741, DOI 10.1074/jbc.M805479200; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Radek KA, 2009, WOUND REPAIR REGEN, V17, P118, DOI 10.1111/j.1524-475X.2008.00449.x; Stachtea XN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140279; Syx D, 2015, HUM MUTAT, V36, P535, DOI 10.1002/humu.22774; Taylor KR, 2005, J BIOL CHEM, V280, P5300, DOI 10.1074/jbc.m410412200; Thelin MA, 2013, FEBS J, V280, P2431, DOI 10.1111/febs.12214; Thelin MA, 2012, CANCER RES, V72, P1943, DOI 10.1158/0008-5472.CAN-11-1351; Tykesson E, 2016, CHEM SCI, V7, P1447, DOI 10.1039/c5sc03798k; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; Zhou XX, 2011, GLYCOBIOLOGY, V21, P771, DOI 10.1093/glycob/cwr001	41	19	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13725	13735		10.1074/jbc.RA118.003875	http://dx.doi.org/10.1074/jbc.RA118.003875			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29976758	Green Published, hybrid			2022-12-28	WOS:000443375500031
J	Zhou, YQ; Xia, ZC; Cheng, ZK; Xu, G; Yang, XD; Liu, S; Zhu, Y				Zhou, Yaqin; Xia, Zhangchuan; Cheng, Zhikui; Xu, Gang; Yang, Xiaodan; Liu, Shi; Zhu, Ying			Inducible microRNA-590-5p inhibits host antiviral response by targeting the soluble interleukin-6 (IL6) receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); viral replication; cellular immune response; host defense; gene regulation; virus infection	HEPATOCELLULAR-CARCINOMA; VIRUS-INFECTION; PROMOTES; GENE; MIR-590-5P; EXPRESSION; INVASION; PROTEIN; CELLS	MicroRNA (miR)-590-5p has been identified as an important regulator of some signaling pathways such as cell proliferation and tumorigenesis. However, little is known about its role during viral infection. Here, we report that miR-590-5p was significantly induced by various viruses and effectively potentiated virus replication in different viral infection systems. Furthermore, miR-590-5p substantially attenuated the virus-induced expression of type I and type III interferons (IFNs) and inflammatory cytokines, resulting in impaired downstream antiviral signaling. Interleukin-6 receptor (IL6R) was identified as a target of miR-590-5p. Interestingly, the role of miR-590-5p in virus-triggered signaling was abolished in IL6R knockout cells, and this could be rescued by restoring the expression of the soluble IL6R (sIL6R) but not the membrane-bound IL6R (mIL6R), suggesting that sIL6R is indispensable for miR-590-5p in modulating the host antiviral response. Furthermore, miR-590-5p down-regulated endogenous sIL6R and mIL6R expression through a translational repression mechanism. These findings thus uncover a previously uncharacterized role and the underlying mechanism of miR-590-5p in the innate immune response to viral infection.	[Zhou, Yaqin; Xia, Zhangchuan; Cheng, Zhikui; Xu, Gang; Yang, Xiaodan; Liu, Shi; Zhu, Ying] Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China	Wuhan University	Zhu, Y (corresponding author), Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	yingzhu@whu.edu.cn	Xia, Zhangchuan/AAO-3890-2020	Xia, Zhangchuan/0000-0002-1176-0027	National Natural Science Foundation of China [31570870]; Natural Science Foundation of Hubei Province Innovation Group Grant [2017CFA022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province Innovation Group Grant	This work was supported by National Natural Science Foundation of China Grant 31570870 and the Natural Science Foundation of Hubei Province Innovation Group Grant 2017CFA022. The authors declare that they have no conflicts of interest with the contents of this article.	Bakre A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066796; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carroll AP, 2014, WIRES RNA, V5, P361, DOI 10.1002/wrna.1217; Dai Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep22607; Schiavinato JLD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03456-8; Fang JL, 2012, J VIROL, V86, P1010, DOI 10.1128/JVI.06169-11; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He PP, 2014, BIOCHIMIE, V106, P81, DOI 10.1016/j.biochi.2014.08.003; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Jiang XF, 2012, MOL CELLS, V33, P545, DOI 10.1007/s10059-012-2267-4; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kim CW, 2018, CANCER LETT, V416, P31, DOI 10.1016/j.canlet.2017.12.018; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li CJ, 2015, MED SCI MONITOR, V21, P3490, DOI 10.12659/MSM.894987; Li HH, 2015, ONCOTARGET, V6, P14026, DOI 10.18632/oncotarget.4334; Li QS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01954-x; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001985; Li YK, 2013, J BIOL CHEM, V288, P20927, DOI 10.1074/jbc.M112.440115; Li YK, 2013, PROTEIN CELL, V4, P130, DOI 10.1007/s13238-012-2081-y; Lin XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151930; Long X, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.4; Loveday EK, 2015, J GEN VIROL, V96, P30, DOI 10.1099/vir.0.068585-0; Lukashevich IS, 2003, J VIROL, V77, P1727, DOI 10.1128/JVI.77.3.1727-1737.2003; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Mukhtar MM, 2009, INT J BIOCHEM CELL B, V41, P554, DOI 10.1016/j.biocel.2008.07.001; Musto A, 2015, CELL DEATH DIFFER, V22, P1047, DOI 10.1038/cdd.2014.198; Ou CL, 2017, CANCER LETT, V399, P53, DOI 10.1016/j.canlet.2017.04.011; Ouyang XX, 2016, INT J MED SCI, V13, P195, DOI 10.7150/ijms.13996; Preusse M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00246; Pullamsetti SS, 2018, J CLIN INVEST, V128, P1720, DOI 10.1172/JCI120415; Ramakrishnan Muthannan Andavar, 2016, World J Virol, V5, P85, DOI 10.5501/wjv.v5.i2.85; Rokavec M, 2014, J CLIN INVEST, V124, P1853, DOI 10.1172/JCI73531; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Sui JD, 2017, CELL PHYSIOL BIOCHEM, V44, P1188, DOI 10.1159/000485449; Wang J, 2015, CELL MOL IMMUNOL, V12, P633, DOI 10.1038/cmi.2014.80; Wang Q, 2013, J VIROL, V87, P11244, DOI 10.1128/JVI.01248-13; Wang WB, 2018, MICROVASC RES, V120, P21, DOI 10.1016/j.mvr.2018.05.007; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu ZZ, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12483; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yang XD, 2016, J IMMUNOL, V197, P2369, DOI 10.4049/jimmunol.1600627; You S, 2018, GENETICS, V208, P1195, DOI 10.1534/genetics.117.300342; Yue X, 2012, J IMMUNOL, V189, P279, DOI 10.4049/jimmunol.1103405; Zhang XR, 2014, CELL, V158, P607, DOI 10.1016/j.cell.2014.05.047; Zheng QL, 2016, J IMMUNOL, V196, P1317, DOI 10.4049/jimmunol.1502134; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007; Zhu LH, 2010, FEBS J, V277, P3726, DOI 10.1111/j.1742-4658.2010.07773.x	48	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18168	18179		10.1074/jbc.RA118.005057	http://dx.doi.org/10.1074/jbc.RA118.005057			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30291142	Green Published, hybrid			2022-12-28	WOS:000451375200012
J	Byrd, AK; Bell, MR; Raney, KD				Byrd, Alicia K.; Bell, Matthew R.; Raney, Kevin D.			Pif1 helicase unfolding of G-quadruplex DNA is highly dependent on sequence and reaction conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA helicase; G-quadruplex; DNA-protein interaction; enzyme mechanism; enzyme kinetics; pre-steady-state kinetics; DNA unwinding; Pif1; secondary structure	C-MYC PROMOTER; SACCHAROMYCES-CEREVISIAE PIF1; ESCHERICHIA-COLI UVRD; SINGLE-STRANDED-DNA; HUMAN TELOMERIC DNA; TRANSFER-RNA GENES; DUPLEX DNA; STEP-SIZE; GENOME INSTABILITY; CRYSTAL-STRUCTURES	In addition to unwinding double-stranded nucleic acids, helicase activity can also unfold noncanonical structures such as G-quadruplexes. We previously characterized Pif1 helicase catalyzed unfolding of parallel G-quadruplex DNA. Here we characterized unfolding of the telomeric G-quadruplex, which can fold into antiparallel and mixed hybrid structures and found significant differences. Telomeric DNA sequences are unfolded more readily than the parallel quadruplex formed by the c-MYC promoter in K+. Furthermore, we found that under conditions in which the telomeric quadruplex is less stable, such as in Na+, Pif1 traps thermally melted quadruplexes in the absence of ATP, leading to the appearance of increased product formation under conditions in which the enzyme is preincubated with the substrate. Stable telomeric G-quadruplex structures were unfolded in a stepwise manner at a rate slower than that of duplex DNA unwinding; however, the slower dissociation from G-quadruplexes compared with duplexes allowed the helicase to traverse more nucleotides than on duplexes. Consistent with this, the rate of ATP hydrolysis on the telomeric quadruplex DNA was reduced relative to that on single-stranded DNA (ssDNA), but less quadruplex DNA was needed to saturate ATPase activity. Under single-cycle conditions, telomeric quadruplex was unfolded by Pif1, but for the c-MYC quadruplex, unfolding required multiple helicase molecules loaded onto the adjacent ssDNA. Our findings illustrate that Pif1-catalyzed unfolding of G-quadruplex DNA is highly dependent on the specific sequence and the conditions of the reaction, including both the monovalent cation and the order of addition.	[Byrd, Alicia K.; Bell, Matthew R.; Raney, Kevin D.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Raney, KD (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	raneykevind@uams.edu		Bell, Matthew/0000-0003-4313-2989; Byrd, Alicia/0000-0001-5484-0759	National Institutes of Health, NIGMS [R35GM122601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122601] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant R35GM122601 (to K. D. R.) from the National Institutes of Health, NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ail JA, 1999, J MOL BIOL, V293, P815, DOI 10.1006/jmbi.1999.3185; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Barranco-Medina S, 2010, BIOCHEMISTRY-US, V49, P8445, DOI 10.1021/bi100984j; Bharti SK, 2014, J BIOL CHEM, V289, P29975, DOI 10.1074/jbc.M114.567073; Biffi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102711; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Brazda V, 2014, INT J MOL SCI, V15, P17493, DOI 10.3390/ijms151017493; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Byrd AK, 2005, BIOCHEMISTRY-US, V44, P12990, DOI 10.1021/bi050703z; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Byrd AK, 2006, NUCLEIC ACIDS RES, V34, P3020, DOI 10.1093/nar/gkl369; Byrd AK, 2017, BIOCHEM SOC T, V45, P1159, DOI 10.1042/BST20170096; Byrd AK, 2015, J BIOL CHEM, V290, P6482, DOI 10.1074/jbc.M114.630749; Carroll SS, 1996, METHOD ENZYMOL, V275, P365; Chen MC, 2018, NATURE, V558, P465, DOI 10.1038/s41586-018-0209-9; Chen WF, 2016, NUCLEIC ACIDS RES, V44, P2949, DOI 10.1093/nar/gkw033; Chib S, 2016, J BIOL CHEM, V291, P5889, DOI 10.1074/jbc.M115.688648; Dewar JM, 2010, EMBO J, V29, P4020, DOI 10.1038/emboj.2010.267; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dong DW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-677; Duan XL, 2015, J BIOL CHEM, V290, P7722, DOI 10.1074/jbc.M114.628008; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Eoff RL, 2006, NAT STRUCT MOL BIOL, V13, P242, DOI 10.1038/nsmb1055; Eoff RL, 2010, BIOCHEMISTRY-US, V49, P4543, DOI 10.1021/bi100061v; FOURY F, 1985, EMBO J, V4, P3525, DOI 10.1002/j.1460-2075.1985.tb04112.x; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; Geronimo CL, 2016, DNA REPAIR, V44, P151, DOI 10.1016/j.dnarep.2016.05.021; Gray RD, 2014, J MOL BIOL, V426, P1629, DOI 10.1016/j.jmb.2014.01.009; Green JJ, 2003, J AM CHEM SOC, V125, P3763, DOI 10.1021/ja029149w; Guo MH, 2015, J BIOL CHEM, V290, P5174, DOI 10.1074/jbc.M114.634923; Hansel-Hertsch R, 2017, NAT REV MOL CELL BIO, V18, P279, DOI 10.1038/nrm.2017.3; Hatzakis E, 2010, BIOCHEMISTRY-US, V49, P9152, DOI 10.1021/bi100946g; Hou XM, 2015, BIOCHEM J, V466, P189, DOI 10.1042/BJ20140997; Huang WC, 2015, NUCLEIC ACIDS RES, V43, P10102, DOI 10.1093/nar/gkv1061; Jain A, 2010, BIOCHEMISTRY-US, V49, P6992, DOI 10.1021/bi100795m; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kim BG, 2015, BIOCHEMISTRY-US, V54, P3420, DOI 10.1021/acs.biochem.5b00097; LAHAYE A, 1993, J BIOL CHEM, V268, P26155; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Lemmens B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9909; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Li JR, 2016, BIOCHEM BIOPH RES CO, V473, P1235, DOI 10.1016/j.bbrc.2016.04.046; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Long X, 2013, NUCLEIC ACIDS RES, V41, P2746, DOI 10.1093/nar/gks1341; Lu KY, 2018, NUCLEIC ACIDS RES, V46, P1486, DOI 10.1093/nar/gkx1217; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; Maizels N, 2015, EMBO REP, V16, P910, DOI 10.15252/embr.201540607; Manosas M, 2010, NUCLEIC ACIDS RES, V38, P5518, DOI 10.1093/nar/gkq273; Marchand A, 2016, NUCLEIC ACIDS RES, V44, P10999, DOI 10.1093/nar/gkw970; Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079; Mendoza O, 2015, NUCLEIC ACIDS RES, V43, pE71, DOI 10.1093/nar/gkv193; Neidle S, 2016, J MED CHEM, V59, P5987, DOI 10.1021/acs.jmedchem.5b01835; Oliveira PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059907; Osmundson JS, 2017, NAT STRUCT MOL BIOL, V24, P162, DOI 10.1038/nsmb.3342; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Phan AT, 2006, NUCLEIC ACIDS RES, V34, P5715, DOI 10.1093/nar/gkl726; Tran PLT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15025; Qureshi MH, 2012, J PHYS CHEM B, V116, P5588, DOI 10.1021/jp300546u; Rad B, 2015, P NATL ACAD SCI USA, V112, pE6852, DOI 10.1073/pnas.1518028112; Ramanagoudr-Bhojappa R, 2013, J BIOL CHEM, V288, P16185, DOI 10.1074/jbc.M113.470013; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Saini N, 2013, NATURE, V502, P389, DOI 10.1038/nature12584; Sarkies P, 2012, NUCLEIC ACIDS RES, V40, P1485, DOI 10.1093/nar/gkr868; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Sauer M, 2017, BIOCHEM SOC T, V45, P1173, DOI 10.1042/BST20170097; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Seenisamy J, 2004, J AM CHEM SOC, V126, P8702, DOI 10.1021/ja040022b; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Singh SP, 2016, J MOL BIOL, V428, P1053, DOI 10.1016/j.jmb.2016.02.017; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; THIER SO, 1986, AM J MED, V80, P3, DOI 10.1016/0002-9343(86)90334-7; TSANEVA IR, 1993, P NATL ACAD SCI USA, V90, P1315, DOI 10.1073/pnas.90.4.1315; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wanrooij PH, 2012, NUCLEIC ACIDS RES, V40, P10334, DOI 10.1093/nar/gks802; WHITBY MC, 1993, CELL, V75, P341, DOI 10.1016/0092-8674(93)80075-P; Wilson MA, 2013, NATURE, V502, P393, DOI 10.1038/nature12585; Wlodarczyk A, 2005, J PHYS CHEM B, V109, P3594, DOI 10.1021/jp045274d; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Yangyuoru PM, 2018, J BIOL CHEM, V293, P1924, DOI 10.1074/jbc.M117.815076; Zhang B, 2016, NUCLEIC ACIDS RES, V44, P8385, DOI 10.1093/nar/gkw669; Zhou RB, 2014, ELIFE, V3, DOI 10.7554/eLife.02190	88	25	25	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17792	17802		10.1074/jbc.RA118.004499	http://dx.doi.org/10.1074/jbc.RA118.004499			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30257865	Green Published, hybrid			2022-12-28	WOS:000450409500011
J	Choi, BH; Philips, MR; Chen, Y; Lu, L; Dai, W				Choi, Byeong Hyeok; Philips, Mark R.; Chen, Yuan; Lu, Lou; Dai, Wei			K-Ras Lys-42 is crucial for its signaling, cell migration, and invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ras protein; posttranslational modification (PTM); signaling; cell invasion; cell migration; transformation; domain structure; lysine residue; K-Ras; sumoylation	PROTEINS; ASSOCIATION; INHIBITORS	Ras proteins participate in multiple signal cascades, regulating crucial cellular processes, including cell survival, proliferation, and differentiation. We have previously reported that Ras proteins are modified by sumoylation and that Lys-42 plays an important role in mediating the modification. In the current study, we further investigated the role of Lys-42 in regulating cellular activities of K-Ras. Inducible expression of K-Ras(V12) led to the activation of downstream components, including c-RAF, MEK1, and extracellular signal-regulated kinases (ERKs), whereas expression of K-Ras(V12/R42) mutant compromised the activation of the RAF/MEK/ERK signaling axis. Expression of K-Ras(V12/R42) also led to reduced phosphorylation of several other protein kinases, including c-Jun N-terminal kinase (JNK), Chk2, and focal adhesion kinase (FAK). Significantly, K-Ras(V12/R42) expression inhibited cellular migration and invasion in vitro in multiple cell lines, including transformed pancreatic cells. Given that K-Ras plays a crucial role in mediating oncogenesis in the pancreas, we treated transformed pancreatic cells of both BxPC-3 and MiaPaCa-2 with 2-D08, a small ubiquitin-like modifier (SUMO) E2 inhibitor. Treatment with the compound inhibited cell migration in a concentration-dependent manner, which was correlated with a reduced level of K-Ras sumoylation. Moreover, 2-D08 suppressed expression of ZEB1 (a mesenchymal cell marker) with concomitant induction of ZO-1 (an epithelial cell marker). Combined, our studies strongly suggest that posttranslational modification(s), including sumoylation mediated by Lys-42, plays a crucial role in K-Ras activities in vivo.	[Choi, Byeong Hyeok; Dai, Wei] NYU, Langone Med Ctr, Dept Environm Med, Tuxedo Pk, NY 10987 USA; [Lu, Lou] NYU, Langone Med Ctr, Dept Biochem & Mol Pharmacol, Tuxedo Pk, NY 10987 USA; [Philips, Mark R.] NYU, Langone Med Ctr, Dept Med, Tuxedo Pk, NY 10987 USA; [Chen, Yuan] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Dai, Wei] Harbor UCLA Med Ctr, Dept Mol Med, Torrance, CA 90509 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; City of Hope; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Dai, W (corresponding author), NYU, Dept Environm Med, Langone Med Ctr, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	wei.dai@nyumc.org		Choi, Byeong Hyeok/0000-0002-8866-1131; Mark, Philips/0000-0002-1179-8156; Dai, Wei/0000-0003-0169-8327	NIEHS, National Institutes of Health, Center Grant [ES000260]; NATIONAL CANCER INSTITUTE [R01CA216987, R01CA116034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health, Center Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr. Feng Wu and Ziyue Kou in the laboratory for assistance during the study. The New York University Center was supported by NIEHS, National Institutes of Health, Center Grant ES000260.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Athuluri-Divakar SK, 2016, CELL, V165, P643, DOI 10.1016/j.cell.2016.03.045; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Choi BH, 2018, ONCOTARGET, V9, P4440, DOI 10.18632/oncotarget.23269; Cox AD, 2015, CLIN CANCER RES, V21, P1819, DOI 10.1158/1078-0432.CCR-14-3214; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; Henis YI, 2009, MOL MEMBR BIOL, V26, P80, DOI 10.1080/09687680802649582; Herrero A, 2015, CANCER CELL, V28, P170, DOI 10.1016/j.ccell.2015.07.001; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Kim YS, 2014, BIOORG MED CHEM LETT, V24, P1094, DOI 10.1016/j.bmcl.2014.01.010; Landre V, 2014, ONCOTARGET, V5, P7988, DOI 10.18632/oncotarget.2431; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lynch SJ, 2015, J CELL PHYSIOL, V230, P610, DOI 10.1002/jcp.24779; Mezencev R, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2274-5; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Niewerth D, 2013, EXPERT REV ANTICANC, V13, P327, DOI [10.1586/ERA.13.4, 10.1586/era.13.4]; Philips MR, 2007, J CLIN INVEST, V117, P1223, DOI 10.1172/JCI32108; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040435; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Sternberg PW, 1998, CELL, V95, P447, DOI 10.1016/S0092-8674(00)81612-8; Sung PJ, 2013, P NATL ACAD SCI USA, V110, P20593, DOI 10.1073/pnas.1306431110; Tsai FD, 2015, P NATL ACAD SCI USA, V112, P779, DOI 10.1073/pnas.1412811112; Xu LZ, 2010, CURR BIOL, V20, P1372, DOI 10.1016/j.cub.2010.06.051; Yang MH, 2012, P NATL ACAD SCI USA, V109, P10843, DOI 10.1073/pnas.1201487109; Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005; Yu B., P NATL ACAD SCI US, V112, pE1724	30	24	25	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17574	17581		10.1074/jbc.RA118.003723	http://dx.doi.org/10.1074/jbc.RA118.003723			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30228186	Green Published, hybrid			2022-12-28	WOS:000449799000021
J	Grell, TAJ; Kincannon, WM; Bruender, NA; Blaesi, EJ; Krebs, C; Bandarian, V; Drennan, CL				Grell, Tsehai A. J.; Kincannon, William M.; Bruender, Nathan A.; Blaesi, Elizabeth J.; Krebs, Carsten; Bandarian, Vahe; Drennan, Catherine L.			Structural and spectroscopic analyses of the sporulation killing factor biosynthetic enzyme SkfB, a bacterial AdoMet radical sactisynthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; enzyme structure; metalloenzyme; crystal structure; catalysis; AdoMet radical enzymes; iron sulfur clusters; radical SAM; sactionine linkage; sporulation killing factor	THIOETHER BOND FORMATION; X-RAY; CRYSTAL-STRUCTURE; SULFUR INSERTION; THURINCIN H; C-ALPHA; SAM; CLUSTERS; BINDING; COFACTOR	Sactipeptides are a subclass of ribosomally synthesized and post-translationally modified peptides (RiPPs). They contain a unique thioether bond, referred to as a sactionine linkage, between the sulfur atom of a cysteine residue and the -carbon of an acceptor residue. These linkages are formed via radical chemistry and are essential for the spermicidal, antifungal, and antibacterial properties of sactipeptides. Enzymes that form these linkages, called sactisynthases, are AdoMet radical enzymes in the SPASM/Twitch subgroup whose structures are incompletely characterized. Here, we present the X-ray crystal structure to 1.29- resolution and Mossbauer analysis of SkfB, a sactisynthase from Bacillus subtilis involved in making sporulation killing factor (SKF). We found that SkfB is a modular enzyme with an N-terminal peptide-binding domain comprising a RiPP recognition element (RRE), a middle domain that forms a classic AdoMet radical partial (/)(6) barrel structure and displays AdoMet bound to the [4Fe-4S] cluster, and a C-terminal region characteristic of the so-called Twitch domain housing an auxiliary iron-sulfur cluster. Notably, both crystallography and Mossbauer analyses suggest that SkfB can bind a [2Fe-2S] cluster at the auxiliary cluster site, which has been observed only once before in a SPASM/Twitch auxiliary cluster site in the structure of another AdoMet radical enzyme, the pyrroloquinoline quinone biosynthesis enzyme PqqE. Taken together, our findings indicate that SkfB from B. subtilis represents a unique enzyme containing several structural features observed in other AdoMet radical enzymes.	[Grell, Tsehai A. J.; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Kincannon, William M.; Bruender, Nathan A.; Bandarian, Vahe] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; [Blaesi, Elizabeth J.; Krebs, Carsten] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Krebs, Carsten] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Bruender, Nathan A.] St Cloud State Univ, Dept Chem & Biochem, St Cloud, MN 56301 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Minnesota State Colleges & Universities; Saint Cloud State University	Drennan, CL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.; Drennan, CL (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.; Bandarian, V (corresponding author), Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA.; Krebs, C (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.; Krebs, C (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	ckrebs@psu.edu; vahe@chem.utah.edu; cdrennan@mit.edu	Krebs, Carsten/D-4773-2009	Krebs, Carsten/0000-0002-3302-7053; Kincannon, William/0000-0003-2392-2764	DOE Office of Science [DE-AC02-06CH11357]; NIGMS, National Institutes of Health [P41 GM103403]; National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant [S10 RR029205]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, F32GM116353, R35GM126956, R01GM072623, R01GM120638, R35GM126982] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357 and was conducted at the Northeastern Collaborative Access Team beamlines, which are funded by NIGMS, National Institutes of Health Grant P41 GM103403. The Pilatus 6M detector on 24-ID-C beamline is funded by National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant S10 RR029205.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akiva E, 2014, NUCLEIC ACIDS RES, V42, pD521, DOI 10.1093/nar/gkt1130; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; BABASAKI K, 1985, J BIOCHEM, V98, P585, DOI 10.1093/oxfordjournals.jbchem.a135315; Barr I, 2018, BIOCHEMISTRY-US, V57, P1306, DOI 10.1021/acs.biochem.7b01097; Benjdia A, 2016, CHEM COMMUN, V52, P6249, DOI 10.1039/c6cc01317a; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P4131, DOI 10.1021/acs.biochem.6b00598; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P2122, DOI 10.1021/acs.biochem.6b00145; Burkhart BJ, 2015, NAT CHEM BIOL, V11, P564, DOI 10.1038/nchembio.1856; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dailey TA, 2002, J BACTERIOL, V184, P2460, DOI 10.1128/JB.184.9.2460-2464.2002; Datta S, 2001, P NATL ACAD SCI USA, V98, P14268, DOI 10.1073/pnas.241429098; Davis KM, 2017, P NATL ACAD SCI USA, V114, P10420, DOI 10.1073/pnas.1703663114; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dowling DP, 2012, BBA-PROTEINS PROTEOM, V1824, P1178, DOI 10.1016/j.bbapap.2012.04.006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans RL, 2017, BIOCHEMISTRY-US, V56, P2735, DOI 10.1021/acs.biochem.7b00247; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Fluhe L, 2013, CURR OPIN CHEM BIOL, V17, P605, DOI 10.1016/j.cbpa.2013.06.031; Fluhe L, 2013, J AM CHEM SOC, V135, P959, DOI 10.1021/ja310542g; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P15949, DOI 10.1073/pnas.1312228110; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P8519, DOI 10.1073/pnas.1302417110; Grell TAJ, 2015, J BIOL CHEM, V290, P3964, DOI 10.1074/jbc.R114.581249; Grove TL, 2017, J AM CHEM SOC, V139, P11734, DOI 10.1021/jacs.7b01283; Haft DH, 2011, J BACTERIOL, V193, P2745, DOI 10.1128/JB.00040-11; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Harmer JE, 2014, BIOCHEM J, V464, P123, DOI 10.1042/BJ20140895; Kincannon WM, 2018, BIOCHEMISTRY-US, V57, P4816, DOI 10.1021/acs.biochem.8b00537; Koehnke J, 2015, NAT CHEM BIOL, V11, P558, DOI 10.1038/nchembio.1841; Lanz ND, 2014, BIOCHEMISTRY-US, V53, P4557, DOI 10.1021/bi500432r; Lee KH, 2009, BIOCHEMISTRY-US, V48, P10162, DOI 10.1021/bi900939w; Liu WT, 2010, P NATL ACAD SCI USA, V107, P16286, DOI 10.1073/pnas.1008368107; McLaughlin MI, 2016, P NATL ACAD SCI USA, V113, P9446, DOI 10.1073/pnas.1602486113; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nakai T, 2015, J BIOL CHEM, V290, P11144, DOI 10.1074/jbc.M115.638320; Ortega MA, 2015, NATURE, V517, P509, DOI 10.1038/nature13888; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Pandelia ME, 2015, BBA-MOL CELL RES, V1853, P1395, DOI 10.1016/j.bbamcr.2014.12.005; Rea MC, 2010, P NATL ACAD SCI USA, V107, P9352, DOI 10.1073/pnas.0913554107; Saichana N, 2017, FEBS OPEN BIO, V7, P1864, DOI 10.1002/2211-5463.12314; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sit CS, 2011, ANGEW CHEM INT EDIT, V50, P8718, DOI 10.1002/anie.201102527; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Tsai TY, 2009, PROTEINS, V76, P1042, DOI 10.1002/prot.22461; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wecksler SR, 2009, BIOCHEMISTRY-US, V48, P10151, DOI 10.1021/bi900918b; Wieckowski BM, 2015, FEBS LETT, V589, P1802, DOI 10.1016/j.febslet.2015.05.032	53	23	24	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17349	17361		10.1074/jbc.RA118.005369	http://dx.doi.org/10.1074/jbc.RA118.005369			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30217813	Green Published, hybrid			2022-12-28	WOS:000449799000004
J	Xiao, YM; Li, MM; Larocque, R; Zhang, FM; Malhotra, A; Chen, JL; Linhardt, RJ; Konermann, L; Xu, D				Xiao, Yiming; Li, Miaomiao; Larocque, Rinzhi; Zhang, Fuming; Malhotra, Anju; Chen, Jianle; Linhardt, Robert J.; Konermann, Lars; Xu, Ding			Dimerization interface of osteoprotegerin revealed by hydrogen-deuterium exchange mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heparin-binding protein; heparan sulfate; dimerization; hydrogen-deuterium exchange; hydrogen exchange mass spectrometry; bone loss; osteoclastogenesis; osteoporosis; osteoprotegerin; RANKL	HYDROGEN/DEUTERIUM EXCHANGE; HEPARAN-SULFATE; PROTEIN INTERACTIONS; CRYSTAL-STRUCTURE; DECOY RECEPTOR; OSTEOCLASTOGENESIS; DYNAMICS; REDUCTION; BINDING; MS	Previous structural studies of osteoprotegerin (OPG), a crucial negative regulator of bone remodeling and osteoclastogenesis, were mostly limited to the N-terminal ligand-binding domains. It is now known that the three C-terminal domains of OPG also play essential roles in its function by mediating OPG dimerization, OPG-heparan sulfate (HS) interactions, and formation of the OPG-HS-receptor activator of nuclear factor B ligand (RANKL) ternary complex. Employing hydrogen-deuterium exchange MS methods, here we investigated the structure of full-length OPG in complex with HS or RANKL in solution. Our data revealed two noteworthy aspects of the OPG structure. First, we found that the interconnection between the N- and C-terminal domains is much more rigid than previously thought, possibly because of hydrophobic interactions between the fourth cysteine-rich domain and the first death domain. Second, we observed that two hydrophobic clusters located in two separate C-terminal domains directly contribute to OPG dimerization, likely by forming a hydrophobic dimerization interface. Aided by site-directed mutagenesis, we further demonstrated that an intact dimerization interface is essential for the biological activity of OPG. Our study represents an important step toward deciphering the structure-function relationship of the full-length OPG protein.	[Xiao, Yiming; Konermann, Lars] Univ Western Ontario, Dept Chem, London, ON N6A 5B7, Canada; [Li, Miaomiao; Larocque, Rinzhi; Xu, Ding] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14214 USA; [Zhang, Fuming; Malhotra, Anju; Chen, Jianle; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Western University (University of Western Ontario); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Rensselaer Polytechnic Institute	Konermann, L (corresponding author), Univ Western Ontario, Dept Chem, London, ON N6A 5B7, Canada.; Xu, D (corresponding author), SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14214 USA.	konerman@uwo.ca; dingxu@buffalo.edu		Li, Miaomiao/0000-0003-4508-196X	National Institutes of Health NIAMS [AR070179]; National Institutes of Health NIDDK [DK111958]; National Institutes of Health NHLBI [HL125371, HL094463]; Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada (CANRIMT, NSERC) [RGPIN-2018-04243]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125371, R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111958] Funding Source: NIH RePORTER	National Institutes of Health NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada (CANRIMT, NSERC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health NIAMS Grant AR070179, NIDDK Grant DK111958, and NHLBI Grants HL125371 and HL094463 and Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada (CANRIMT, NSERC) Grant RGPIN-2018-04243. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson JS, 2008, BIOCHEMISTRY-US, V47, P6178, DOI 10.1021/bi800284y; Baud'huin M, 2011, EUR J CELL BIOL, V90, P49, DOI 10.1016/j.ejcb.2010.08.001; Bobst CE, 2009, J MOL BIOL, V388, P954, DOI 10.1016/j.jmb.2009.03.044; Burke JE, 2009, J AM CHEM SOC, V131, P8083, DOI 10.1021/ja900098y; Creighton T. E., 1993, PROTEINS STRUCTURES; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Hernaiz M, 2000, BIOCHEM BIOPH RES CO, V276, P292, DOI 10.1006/bbrc.2000.3453; Hui X, 2005, PROTEIN SCI, V14, P543, DOI 10.1110/ps.0411001705; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Li MM, 2016, J BIOL CHEM, V291, P24160, DOI 10.1074/jbc.M116.751974; Luan XD, 2012, J IMMUNOL, V189, P245, DOI 10.4049/jimmunol.1103387; Maaty WS, 2016, J AM CHEM SOC, V138, P1335, DOI 10.1021/jacs.5b11742; Marciano DP, 2014, CURR OPIN STRUC BIOL, V28, P105, DOI 10.1016/j.sbi.2014.08.007; Nelson CA, 2012, STRUCTURE, V20, P1971, DOI 10.1016/j.str.2012.08.030; Nozawa S, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.89624; Pantazatos D, 2004, P NATL ACAD SCI USA, V101, P751, DOI 10.1073/pnas.0307204101; Percy AJ, 2012, ANAL CHIM ACTA, V721, P7, DOI 10.1016/j.aca.2012.01.037; Rand KD, 2014, ACCOUNTS CHEM RES, V47, P3018, DOI 10.1021/ar500194w; Schneeweis LA, 2005, J BIOL CHEM, V280, P41155, DOI 10.1074/jbc.M506366200; Shaw BF, 2010, J AM CHEM SOC, V132, P17411, DOI 10.1021/ja9067035; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Skinner JJ, 2012, PROTEIN SCI, V21, P996, DOI 10.1002/pro.2081; Sowole MA, 2013, J MOL BIOL, V425, P4508, DOI 10.1016/j.jmb.2013.08.005; Taylor Sarah E B, 2014, Bonekey Rep, V3, P585, DOI 10.1038/bonekey.2014.80; Trabjerg E, 2015, ANAL CHEM, V87, P8880, DOI 10.1021/acs.analchem.5b01996; Tsuda E, 1997, BIOCHEM BIOPH RES CO, V234, P137, DOI 10.1006/bbrc.1997.6603; Udagawa N, 2000, ENDOCRINOLOGY, V141, P3478, DOI 10.1210/en.141.9.3478; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wongkongkathep P, 2015, INT J MASS SPECTROM, V390, P137, DOI 10.1016/j.ijms.2015.07.008; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Xu D, 2013, ACS CHEM BIOL, V8, P1611, DOI 10.1021/cb4001553; Xue Y, 2011, P NATL ACAD SCI USA, V108, P16229, DOI 10.1073/pnas.1103407108; Yamaguchi K, 1998, J BIOL CHEM, V273, P5117, DOI 10.1074/jbc.273.9.5117; Zhang HM, 2010, ANAL CHEM, V82, P1450, DOI 10.1021/ac902550n; Zhang J, 2015, INT J MASS SPECTROM, V377, P546, DOI 10.1016/j.ijms.2014.07.047; Zhao DS, 2013, PROTEOMICS, V13, P3256, DOI 10.1002/pmic.201300242	38	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17523	17535		10.1074/jbc.RA118.004489	http://dx.doi.org/10.1074/jbc.RA118.004489			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30254073	Green Published, hybrid			2022-12-28	WOS:000449799000017
J	Gui, Y; Li, JZ; Lu, QM; Feng, Y; Wang, MJ; He, WC; Yang, JW; Dai, CS				Gui, Yuan; Li, Jianzhong; Lu, Qingmiao; Feng, Ye; Wang, Mingjie; He, Weichun; Yang, Junwei; Dai, Chunsun			Yap/Taz mediates mTORC2-stimulated fibroblast activation and kidney fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kidney; Yes-associated protein (YAP); fibroblast; fibrosis; cell signaling; Rictor	EPITHELIAL-MESENCHYMAL TRANSITION; ORGAN SIZE CONTROL; CELL SELF-RENEWAL; HIPPO PATHWAY; MYOFIBROBLAST TRANSITION; RENAL FIBROSIS; PROTEIN YAP; MTOR; GROWTH; DISEASE	Our previously published study demonstrated that mammalian target of rapamycin complex 2 (mTORC2) signaling mediates TGF1-induced fibroblast activation. However, the underlying mechanisms for mTORC2 in stimulating fibroblast activation remain poorly understood. Here, we found that TGF1 could stimulate mTORC2 and Yap/Taz activation in NRK-49F cells. Blocking either mTORC2 or Yap/Taz signaling diminished TGF1-induced fibroblast activation. In addition, blockade of mTORC2 could down-regulate the expression of Yap/Taz, connective tissue growth factor (CTGF), and ankyrin repeat domain 1 (ANKRD1). Overexpression of constitutively active Taz (Taz-S89A) could restore fibroblast activation suppressed by PP242, an mTOR kinase inhibitor in NRK-49F cells. In mouse kidneys with unilateral ureter obstructive (UUO) nephropathy, both mTORC2 and Yap/Taz were activated in the interstitial myofibroblasts. Ablation of Rictor in fibroblasts/pericytes or blockade of mTOR signaling with PP242 attenuated Yap/Taz activation and UUO nephropathy in mice. Together, this study uncovers that targeting mTORC2 retards fibroblast activation and kidney fibrosis through suppressing Yap/Taz activation.	[Gui, Yuan; Li, Jianzhong; Lu, Qingmiao; Feng, Ye; Wang, Mingjie; He, Weichun; Yang, Junwei; Dai, Chunsun] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 North Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China	Nanjing Medical University	Dai, CS (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 North Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China.	daichunsun@njmu.edu.cn			National Science Foundation of China [81570611/H0503, 81770675/H0503, 81700589]; Science Foundation of Jiangsu Province [BK20140048]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Jiangsu Province	This work was supported by National Science Foundation of China Grants 81570611/H0503 and 81770675/H0503 (to D. C.) and 81700589 (to J. L.) and Science Foundation of Jiangsu Province Grant BK20140048 (to D. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Artinian N, 2015, J BIOL CHEM, V290, P19387, DOI 10.1074/jbc.M115.656587; Chen JC, 2016, J AM SOC NEPHROL, V27, P1689, DOI 10.1681/ASN.2015040415; Chen YT, 2011, KIDNEY INT, V80, P1170, DOI 10.1038/ki.2011.208; Csibi A, 2012, NAT CELL BIOL, V14, P1244, DOI 10.1038/ncb2634; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Duffield JS, 2011, KIDNEY INT, V79, P494, DOI 10.1038/ki.2010.338; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Feng Y, 2018, J AM SOC NEPHROL, V29, P182, DOI 10.1681/ASN.2017040391; Goncharova EA, 2011, MOL CELL BIOL, V31, P2484, DOI 10.1128/MCB.01061-10; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hong AW, 2016, NAT REV GASTRO HEPAT, V13, P324, DOI 10.1038/nrgastro.2016.59; Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kocalis HE, 2014, MOL METAB, V3, P394, DOI 10.1016/j.molmet.2014.01.014; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Kramann R, 2017, J AM SOC NEPHROL, V28, P776, DOI 10.1681/ASN.2016030297; Kramann R, 2015, J CLIN INVEST, V125, P2935, DOI 10.1172/JCI74929; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li JZ, 2015, KIDNEY INT, V88, P515, DOI 10.1038/ki.2015.119; Liang M, 2017, J AM SOC NEPHROL, V28, P3277, DOI 10.1681/ASN.2015121354; Liang N, 2014, J EXP MED, V211, P2249, DOI 10.1084/jem.20140341; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Piersma B, 2015, AM J PATHOL, V185, P3326, DOI 10.1016/j.ajpath.2015.08.011; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; Ren JF, 2017, J PATHOL, V242, P488, DOI 10.1002/path.4921; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sciarretta S, 2015, CELL REP, V11, P125, DOI 10.1016/j.celrep.2015.03.010; Serrano I, 2013, ONCOGENE, V32, P50, DOI 10.1038/onc.2012.30; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	47	29	31	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16364	16375		10.1074/jbc.RA118.004073	http://dx.doi.org/10.1074/jbc.RA118.004073			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30154246	hybrid, Green Published			2022-12-28	WOS:000447833600020
J	Hudson, DM; Archer, M; King, KB; Eyre, DR				Hudson, David M.; Archer, Marilyn; King, Karen B.; Eyre, David R.			Glycation of type I collagen selectively targets the same helical domain lysine sites as lysyl oxidase-mediated cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; glycation; diabetes; mass spectrometry (MS); post-translational modification (PTM); tendon; extracellular matrix	RAT TAIL TENDON; MECHANICAL-PROPERTIES; NONENZYMATIC GLYCOSYLATION; ARTICULAR-CARTILAGE; MAILLARD REACTION; ACHILLES-TENDON; AGE; PROTEIN; IDENTIFICATION; ACCUMULATION	Nonenzymatic glycation of collagen has long been associated with the progressive secondary complications of diabetes. How exactly such random glycations result in impaired tissues is still poorly understood. Because of the slow turnover rate of most fibrillar collagens, they are more susceptible to accumulate time-dependent glycations and subsequent advanced glycation end-products. The latter are believed to include cross-links that stiffen host tissues. However, diabetic animal models have also displayed weakened tendons with reduced stiffness. Strikingly, not a single experimentally identified specific molecular site of glycation in a collagen has been reported. Here, using targeted MS, we have identified partial fructosyl-hydroxylysine glycations at each of the helical domain cross-linking sites of type I collagen that are elevated in tissues from a diabetic mouse model. Glycation was not found at any other collagen lysine residues. Type I collagen in mouse tendons is cross-linked intermolecularly by acid-labile aldimine bonds formed by the addition of telopeptide lysine aldehydes to hydroxylysine residues at positions 1(I)Lys(87), 1(I)Lys(930), 2(I)Lys(87), and 2(I)Lys(933) of the triple helix. Our data reveal that site-specific glycations of these specific lysines may significantly impair normal lysyl oxidase-controlled cross-linking in diabetic tendons. We propose that such N-linked glycations can hinder the normal cross-linking process, thus altering the content and/or placement of mature cross-links with the potential to modify tissue material properties.	[Hudson, David M.; Archer, Marilyn; Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [King, Karen B.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO 80045 USA	University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Anschutz Medical Campus	Hudson, DM (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA.	dmhudson@uw.edu			National Institutes of Health Grant (NIAMS) [AR037318]; National Institutes of Health Grant (NICHD) [HD070394]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR037318, R01AR037318] Funding Source: NIH RePORTER	National Institutes of Health Grant (NIAMS); National Institutes of Health Grant (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants (NIAMS) AR037318 (to D. E.) and (NICHD) HD070394 (to D. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANDREASSEN TT, 1981, BIOCHIM BIOPHYS ACTA, V677, P313, DOI 10.1016/0304-4165(81)90101-X; Avery NC, 2006, PATHOL BIOL, V54, P387, DOI 10.1016/j.patbio.2006.07.005; Bank RA, 1998, BIOCHEM J, V330, P345, DOI 10.1042/bj3300345; BRENNAN M, 1989, J BIOL CHEM, V264, P20947; BRENNAN M, 1989, J BIOL CHEM, V264, P20953; BROWNLEE M, 1986, SCIENCE, V232, P1629, DOI 10.1126/science.3487117; Collier TA, 2016, BIOPHYS CHEM, V218, P42, DOI 10.1016/j.bpc.2016.09.003; Collier TA, 2015, MATRIX BIOL, V48, P78, DOI 10.1016/j.matbio.2015.06.001; Connizzo BK, 2014, ANN BIOMED ENG, V42, P1880, DOI 10.1007/s10439-014-1031-7; Dai ZY, 2008, J PROTEOME RES, V7, P2756, DOI 10.1021/pr700874a; de Oliveira RR, 2011, ANN BIOMED ENG, V39, P1528, DOI 10.1007/s10439-011-0247-z; EYRE D, 1987, METHOD ENZYMOL, V144, P115; EYRE DR, 1988, BIOCHEM J, V252, P495, DOI 10.1042/bj2520495; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Fessel G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110948; Fox AJS, 2011, J ORTHOP RES, V29, P880, DOI 10.1002/jor.21327; Frolov A, 2006, J MASS SPECTROM, V41, P1459, DOI 10.1002/jms.1117; Frolov A, 2010, ANAL BIOANAL CHEM, V397, P2349, DOI 10.1007/s00216-010-3810-9; GALESKI A, 1977, J BIOMECH, V10, P775, DOI 10.1016/0021-9290(77)90091-4; Gautieri A, 2014, MATRIX BIOL, V34, P89, DOI 10.1016/j.matbio.2013.09.004; Hamann C, 2012, NAT REV ENDOCRINOL, V8, P297, DOI 10.1038/nrendo.2011.233; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; HAUT RC, 1992, J BIOMECH, V25, P163, DOI 10.1016/0021-9290(92)90273-4; Heard ME, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006002; Heinemeier KM, 2013, FASEB J, V27, P2074, DOI 10.1096/fj.12-225599; Herchenhan A, 2015, J BIOL CHEM, V290, P16440, DOI 10.1074/jbc.M115.641670; Horvat S, 2004, J PEPT SCI, V10, P119, DOI 10.1002/psc.519; Hudson DM, 2017, J PERIODONTAL RES, V52, P1042, DOI 10.1111/jre.12475; Hudson DM, 2017, J BIOL CHEM, V292, P3877, DOI 10.1074/jbc.M116.762245; IBERG N, 1986, J BIOL CHEM, V261, P3542; JAMES VJ, 1991, DIABETES, V40, P391, DOI 10.2337/diabetes.40.3.391; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; Li YF, 2013, MATRIX BIOL, V32, P169, DOI 10.1016/j.matbio.2013.01.003; MCLENNAN S, 1986, DIABETIC MED, V3, P141, DOI 10.1111/j.1464-5491.1986.tb00725.x; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P533, DOI 10.1196/annals.1333.061; REISER KM, 1992, J BIOL CHEM, V267, P24207; Saxena AK, 1999, BIOCHEM BIOPH RES CO, V260, P332, DOI 10.1006/bbrc.1999.0898; Sell DR, 2012, GERONTOLOGY, V58, P227, DOI 10.1159/000334668; Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074; SHAPIRO R, 1980, J BIOL CHEM, V255, P3120; Snedeker Jess G, 2014, Muscles Ligaments Tendons J, V4, P303; Soboleva A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122677; Stolarczyk A, 2018, CLIN EXP PHARMACOL P, V45, P619, DOI 10.1111/1440-1681.12939; Thorpe CT, 2010, J BIOL CHEM, V285, P15674, DOI 10.1074/jbc.M109.077503; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; WATKINS NG, 1985, J BIOL CHEM, V260, P629; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	48	24	25	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15620	15627		10.1074/jbc.RA118.004829	http://dx.doi.org/10.1074/jbc.RA118.004829			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30143533	Green Published, hybrid			2022-12-28	WOS:000446549200025
J	Wang, PC; Wang, YS				Wang, Pengcheng; Wang, Yinsheng			Cytotoxic and mutagenic properties of O-6-alkyl-2-deoxyguanosine lesions in Escherichia coli cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA polymerase; DNA repair; mutagenesis; DNA replication; DNA adduct; DNA alkylation; DNA methylating agent; O6-alkyl-2'-deoxyguanosine; translesion synthesis	3 O-6-SUBSTITUTED GUANINES; IN-VIVO; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; MISMATCH REPAIR; DNA LESIONS; ALKYLATING-AGENTS; SEQUENCE CONTEXT; MAMMALIAN-CELLS; O-6-METHYLGUANINE; REPLICATION	Environmental exposure and cellular metabolism can give rise to DNA alkylation, which can occur on the nitrogen and oxygen atoms of nucleobases, as well as on the phosphate backbone. Although O-6-alkyl-2-deoxyguanosine (O-6-alkyl-dG) lesions are known to be associated with cancer, not much is known about how the alkyl group structures in these lesions affect their repair and replicative bypass in vivo or how translesion synthesis DNA polymerases influence the latter process. To answer these questions, here we synthesized oligodeoxyribonucleotides harboring seven O-6-alkyl-dG lesions, with the alkyl group being Me, Et, nPr, iPr, nBu, iBu, or sBu, and examined the impact of these lesions on DNA replication in Escherichia coli cells. We found that replication past all the O-6-alkyl-dG lesions was highly efficient and that SOS-induced DNA polymerases play redundant roles in bypassing these lesions. Moreover, these lesions directed exclusively the G A mutation, the frequency of which increased with the size of the alkyl group on the DNA. This could be attributed to the varied repair efficiencies of these lesions by O-6-alkylguanine DNA alkyltransferase (MGMT) in cells, which involve the MGMT Ogt and, to a lesser extent, Ada. In conclusion, our study provides important new knowledge about the repair of the O-6-alkyl-dG lesions and their recognition by the E. coli DNA replication machinery. Our results suggest that the lesions' carcinogenic potentials may be attributed, at least in part, to their strong mutagenic potential and their efficient bypass by the DNA replication machinery.	[Wang, Pengcheng; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Wang, Yin/HCI-9352-2022	Wang, Pengcheng/0000-0003-4581-983X	National Institutes of Health [R01 ES025121]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant R01 ES025121. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altshuler KB, 1996, CHEM RES TOXICOL, V9, P980, DOI 10.1021/tx960062w; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Coulter R, 2007, CHEM RES TOXICOL, V20, P1966, DOI 10.1021/tx700271j; Delaney JC, 2006, METHOD ENZYMOL, V408, P1, DOI 10.1016/S0076-6879(06)08001-3; Delaney JC, 2001, BIOCHEMISTRY-US, V40, P14968, DOI 10.1021/bi015578f; ELLISON KS, 1989, P NATL ACAD SCI USA, V86, P8620, DOI 10.1073/pnas.86.22.8620; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; GRAVES RJ, 1989, CARCINOGENESIS, V10, P661, DOI 10.1093/carcin/10.4.661; Guza R, 2010, ACS SYM SER, V1041, P73; Haracska L, 2000, MOL CELL BIOL, V20, P8001, DOI 10.1128/MCB.20.21.8001-8007.2000; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Landini P, 1998, J BIOL CHEM, V273, P13307, DOI 10.1074/jbc.273.21.13307; LI BFL, 1989, BIOCHEMISTRY-US, V28, P5779, DOI 10.1021/bi00440a012; LIEM LK, 1994, NUCLEIC ACIDS RES, V22, P1613, DOI 10.1093/nar/22.9.1613; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Meikrantz W, 1998, CARCINOGENESIS, V19, P369, DOI 10.1093/carcin/19.2.369; Mielecki D, 2014, FEMS MICROBIOL LETT, V355, P1, DOI 10.1111/1574-6968.12462; Mitra S, 2007, DNA REPAIR, V6, P1064, DOI 10.1016/j.dnarep.2007.03.007; Neeley WL, 2007, J BIOL CHEM, V282, P12741, DOI 10.1074/jbc.M700575200; Pages V, 2002, ONCOGENE, V21, P8957, DOI 10.1038/sj.onc.1206006; PAULY GT, 1995, BIOCHEMISTRY-US, V34, P8924, DOI 10.1021/bi00027a045; Pauly GT, 2001, CHEM RES TOXICOL, V14, P894, DOI 10.1021/tx010032f; PAULY GT, 1994, BIOCHEMISTRY-US, V33, P9169, DOI 10.1021/bi00197a020; Rye PT, 2008, DNA REPAIR, V7, P170, DOI 10.1016/j.dnarep.2007.09.003; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262; Singer B., 1983, MOL BIOL MUTAGENS CA; Singh J, 1996, J BIOL CHEM, V271, P28391, DOI 10.1074/jbc.271.45.28391; SMITH CA, 1990, CARCINOGENESIS, V11, P811, DOI 10.1093/carcin/11.5.811; SWANN PF, 1990, MUTAT RES, V233, P81, DOI 10.1016/0027-5107(90)90153-U; VOIGT JM, 1995, CARCINOGENESIS, V16, P1775, DOI 10.1093/carcin/16.8.1775; Wang PC, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv941; WILKINSON MC, 1989, NUCLEIC ACIDS RES, V17, P8475, DOI 10.1093/nar/17.21.8475; WOO JS, 1993, J AM CHEM SOC, V115, P3407, DOI 10.1021/ja00062a002; Yuan BF, 2008, P NATL ACAD SCI USA, V105, P8679, DOI 10.1073/pnas.0711546105; Zhai QQ, 2014, NUCLEIC ACIDS RES, V42, P10529, DOI 10.1093/nar/gku748	37	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15033	15042		10.1074/jbc.RA118.004676	http://dx.doi.org/10.1074/jbc.RA118.004676			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30068548	Green Published, hybrid			2022-12-28	WOS:000445998400008
J	Guo, LS; Carraro, M; Sartori, G; Minervini, G; Eriksson, O; Petronilli, V; Bernardi, P				Guo, Lishu; Carraro, Michela; Sartori, Geppo; Minervini, Giovanni; Eriksson, Ove; Petronilli, Valeria; Bernardi, Paolo			Arginine 107 of yeast ATP synthase subunit g mediates sensitivity of the mitochondrial permeability transition to phenylglyoxal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP synthase; mitochondria; mitochondrial permeability transition (MPT); calcium; bioenergetics	METHYLGLYOXAL METABOLISM; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; CRISTAE MORPHOLOGY; PROTEIN GLYCATION; CHANNEL FORMATION; CA2+ RELEASE; CELL-DEATH; C-SUBUNIT; IN-SITU	Modification with arginine-specific glyoxals modulates the permeability transition (PT) of rat liver mitochondria, with inhibitory or inducing effects that depend on the net charge of the adduct(s). Here, we show that phenylglyoxal (PGO) affects the PT in a species-specific manner (inhibition in mouse and yeast, induction in human and Drosophila mitochondria). Following the hypotheses (i) that the effects are mediated by conserved arginine(s) and (ii) that the PT is mediated by the F-ATP synthase, we have narrowed the search to 60 arginines. Most of these residues are located in subunits alpha, beta, gamma, epsilon, a, and c and were excluded because PGO modification did not significantly affect enzyme catalysis. On the other hand, yeast mitochondria lacking subunit g or bearing a subunit g R107A mutation were totally resistant to PT inhibition by PGO. Thus, the effect of PGO on the PT is specifically mediated by Arg-107, the only subunit g arginine that has been conserved across species. These findings are evidence that the PT is mediated by F-ATP synthase.	[Guo, Lishu; Carraro, Michela; Sartori, Geppo; Minervini, Giovanni; Petronilli, Valeria; Bernardi, Paolo] Univ Padua, CNR, Inst Neurosci, I-35131 Padua, Italy; [Guo, Lishu; Carraro, Michela; Sartori, Geppo; Minervini, Giovanni; Petronilli, Valeria; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Eriksson, Ove] Univ Helsinki, Fac Med, Dept Biochem & Dev Biol, FIN-00290 Helsinki, Finland	Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; University of Helsinki	Bernardi, P (corresponding author), Univ Padua, CNR, Inst Neurosci, I-35131 Padua, Italy.; Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy.	bernardi@bio.unipd.it	Minervini, Giovanni/D-1200-2013; Bernardi, Paolo/C-3656-2008; Eriksson-Rosenberg, Ove/GVU-6692-2022; Petronilli, Valeria/C-3558-2015	Minervini, Giovanni/0000-0001-7013-5785; Bernardi, Paolo/0000-0001-9187-3736; Petronilli, Valeria/0000-0003-4026-6404	AIRC [IG17067]; Fondation Leducq [16CVD04]; China Scholarship Council	AIRC(Fondazione AIRC per la ricerca sul cancro); Fondation Leducq(Leducq Foundation); China Scholarship Council(China Scholarship Council)	This work was supported by AIRC Grant IG17067 (to P. B.) and Fondation Leducq Grant 16CVD04 (to P. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from the China Scholarship Council. This work is in partial fulfillment of the requirements for the Ph.D. for this author at the Department of Biomedical Sciences, University of Padova.	Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185; ALLEN RD, 1995, PROTOPLASMA, V189, P1, DOI 10.1007/BF01280286; Antoniel M, 2018, EMBO REP, V19, P257, DOI 10.15252/embr.201744705; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arselin G, 2004, J BIOL CHEM, V279, P40392, DOI 10.1074/jbc.M404316200; Arselin G, 2003, EUR J BIOCHEM, V270, P1875, DOI 10.1046/j.1432-1033.2003.03557.x; Baker LA, 2012, P NATL ACAD SCI USA, V109, P11675, DOI 10.1073/pnas.1204935109; Bernardi P, 2018, CURR OPIN PHYSIOL, V3, P1, DOI 10.1016/j.cophys.2017.12.006; Bernardi P, 2015, PHYSIOL REV, V95, P1111, DOI 10.1152/physrev.00001.2015; Bernardi P, 2012, CELL CALCIUM, V52, P22, DOI 10.1016/j.ceca.2012.03.004; Bonora M, 2013, CELL CYCLE, V12, P674, DOI 10.4161/cc.23599; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burstein SR, 2018, BBA-BIOENERGETICS, V1859, P423, DOI 10.1016/j.bbabio.2018.03.006; Carraro M, 2016, CELL CALCIUM, V60, P102, DOI 10.1016/j.ceca.2016.03.005; Carraro M, 2014, J BIOL CHEM, V289, P15980, DOI 10.1074/jbc.C114.559633; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Dudkina NV, 2006, FEBS LETT, V580, P3427, DOI 10.1016/j.febslet.2006.04.097; Ellis EM, 2007, PHARMACOL THERAPEUT, V115, P13, DOI 10.1016/j.pharmthera.2007.03.015; Eriksson O, 1998, J BIOL CHEM, V273, P12669, DOI 10.1074/jbc.273.20.12669; Giorgio V, 2018, CELL CALCIUM, V70, P56, DOI 10.1016/j.ceca.2017.05.004; Giorgio V, 2017, EMBO REP, V18, P1065, DOI 10.15252/embr.201643354; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Gomes RA, 2005, FEBS J, V272, P4521, DOI 10.1111/j.1742-4658.2005.04872.x; Gomes RA, 2008, FEMS YEAST RES, V8, P174, DOI 10.1111/j.1567-1364.2007.00337.x; Guo H, 2017, SCIENCE, V358, P936, DOI 10.1126/science.aao4815; Habersetzer J, 2013, INT J BIOCHEM CELL B, V45, P99, DOI 10.1016/j.biocel.2012.05.017; Hahn A, 2016, MOL CELL, V63, P445, DOI 10.1016/j.molcel.2016.05.037; He JY, 2018, P NATL ACAD SCI USA, V115, P2988, DOI 10.1073/pnas.1722086115; He JY, 2017, P NATL ACAD SCI USA, V114, P9086, DOI 10.1073/pnas.1711201114; He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Johans M, 2005, J BIOL CHEM, V280, P12130, DOI 10.1074/jbc.M413454200; KINNALLY KW, 1989, J BIOENERG BIOMEMBR, V21, P497, DOI 10.1007/BF00762521; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laun P, 2012, SUBCELL BIOCHEM, V57, P207, DOI 10.1007/978-94-007-2561-4_10; Lee CF, 2016, CIRCULATION, V134, P883, DOI 10.1161/CIRCULATIONAHA.116.022495; Lindblom Runa, 2015, Rev Diabet Stud, V12, P134, DOI 10.1900/RDS.2015.12.134; Linder MD, 2002, J BIOL CHEM, V277, P937, DOI 10.1074/jbc.M107610200; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Maessen DEM, 2015, CLIN SCI, V128, P839, DOI 10.1042/CS20140683; Martins AMTBS, 2001, FEBS LETT, V499, P41, DOI 10.1016/S0014-5793(01)02519-4; Mitome N, 2010, BIOCHEM J, V430, P171, DOI 10.1042/BJ20100621; NICOLLI A, 1993, BIOCHEMISTRY-US, V32, P4461, DOI 10.1021/bi00067a039; Oya T, 1999, J BIOL CHEM, V274, P18492, DOI 10.1074/jbc.274.26.18492; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; PETRONILLI V, 1989, FEBS LETT, V259, P137, DOI 10.1016/0014-5793(89)81513-3; PETRONILLI V, 1993, J BIOL CHEM, V268, P21939; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piovesan D, 2017, BIOINFORMATICS, V33, P1889, DOI 10.1093/bioinformatics/btx085; PRESCOTT M, 1994, BIOCHEM MOL BIOL INT, V34, P789; Speer O, 2003, J BIOL CHEM, V278, P34757, DOI 10.1074/jbc.M301990200; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Szabo I, 2014, PHYSIOL REV, V94, P519, DOI 10.1152/physrev.00021.2013; UH M, 1990, J BIOL CHEM, V265, P19047; von Stockum S, 2015, J BIOL CHEM, V290, P4537, DOI 10.1074/jbc.C114.629766; von Stockum S, 2011, J BIOL CHEM, V286, P41163, DOI 10.1074/jbc.M111.268375; Wittig I, 2008, MOL CELL PROTEOMICS, V7, P995, DOI 10.1074/mcp.M700465-MCP200; Zeng JM, 2005, CHEM RES TOXICOL, V18, P1232, DOI 10.1021/tx050074u	63	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14632	14645		10.1074/jbc.RA118.004495	http://dx.doi.org/10.1074/jbc.RA118.004495			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30093404	Green Published, hybrid			2022-12-28	WOS:000446155000005
J	Scott, AJ; Walker, SA; Krank, JJ; Wilkinson, AS; Johnson, KM; Lewis, EM; Wilkinson, JC				Scott, Andrew J.; Walker, Sierra A.; Krank, Joshua J.; Wilkinson, Amanda S.; Johnson, Kaitlyn M.; Lewis, Eric M.; Wilkinson, John C.			AIF promotes a JNK1-mediated cadherin switch independently of respiratory chain stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; metabolism; oxidative stress; cancer; cell signaling; epithelial-mesenchymal transition (EMT); MAPK	APOPTOSIS-INDUCING-FACTOR; X-LINKED INHIBITOR; CELL-DEATH; OXIDATIVE-PHOSPHORYLATION; SIGNAL-TRANSDUCTION; TUMOR PROGRESSION; DOWN-REGULATION; CANCER CELLS; MAP KINASES; MUTATION	Apoptosis-inducing factor (AIF) is a mitochondrial flavoprotein occasionally involved in cell death that primarily regulates mitochondrial energy metabolism under normal cellular conditions. AIF catalyzes the oxidation of NADH in vitro, yet the significance of this redox activity in cells remains unclear. Here, we show that through its enzymatic activity AIF is a critical factor for oxidative stress-induced activation of the mitogen-activated protein kinases JNK1 (c-Jun N-terminal kinase), p38, and ERK (extracellular signal-regulated kinase). AIF-dependent JNK1 signaling culminates in the cadherin switch, and genetic reversal of this switch leads to apoptosis when AIF is suppressed. Notably, this widespread ability of AIF to promote JNK signaling can be uncoupled from its more limited role in respiratory chain stabilization. Thus, AIF is a transmitter of extra-mitochondrial signaling cues with important implications for human development and disease.	[Scott, Andrew J.; Walker, Sierra A.; Krank, Joshua J.; Wilkinson, Amanda S.; Johnson, Kaitlyn M.; Wilkinson, John C.] North Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA; [Lewis, Eric M.] Clarion Univ Pennsylvania, Dept Chem Math & Phys, Clarion, PA 16214 USA	North Dakota State University Fargo; Pennsylvania State System of Higher Education (PASSHE); Clarion University of Pennsylvania	Wilkinson, JC (corresponding author), North Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA.	john.wilkinson@ndsu.edu	Walker, Sierra A/AAU-3993-2020	Scott, Andrew/0000-0002-0835-4888; Walker, Sierra/0000-0002-9201-0833	North Dakota State University Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer under National Institutes of Health COBRE Program [1P20GM109024]; State of North Dakota Experimental Program to Stimulate Competitive Research Grant ND-EPSCoR Project [FAR0022246]; Department of Defense Prostate Cancer Research Program [W81XWH-08-1-0045]; American Cancer Society [RSG-09-166-01-CCG]; National Institutes of Health [1R15CA206067-01]; NATIONAL CANCER INSTITUTE [R15CA206067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109024] Funding Source: NIH RePORTER	North Dakota State University Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer under National Institutes of Health COBRE Program; State of North Dakota Experimental Program to Stimulate Competitive Research Grant ND-EPSCoR Project; Department of Defense Prostate Cancer Research Program(United States Department of Defense); American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by North Dakota State University Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer under National Institutes of Health COBRE Program Grant 1P20GM109024, State of North Dakota Experimental Program to Stimulate Competitive Research Grant ND-EPSCoR Project FAR0022246 (to J. C. W.), Grant W81XWH-08-1-0045 (to J. C. W.) from the Department of Defense Prostate Cancer Research Program, Grant RSG-09-166-01-CCG (to J. C. W.) from the American Cancer Society, and Grant 1R15CA206067-01 (to J. C. W.) from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Berger I, 2011, MOL GENET METAB, V104, P517, DOI 10.1016/j.ymgme.2011.09.020; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Brady GF, 2010, MOL CELL BIOL, V30, P1923, DOI 10.1128/MCB.00900-09; Brown D, 2006, P NATL ACAD SCI USA, V103, P9918, DOI 10.1073/pnas.0603950103; Chae S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003266; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dougherty JA, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00022; Fan TL, 2014, TUMOR BIOL, V35, P519, DOI 10.1007/s13277-013-1073-8; Galban S, 2009, BIOCHEM J, V417, P765, DOI 10.1042/BJ20081677; Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002; Goel HL, 2013, J CELL PHYSIOL, V228, P1601, DOI 10.1002/jcp.24323; Hangen E, 2015, MOL CELL, V58, P1001, DOI 10.1016/j.molcel.2015.04.020; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jeong EG, 2006, APMIS, V114, P867, DOI 10.1111/j.1600-0463.2006.apm_502.x; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Krasnik V, 2017, NEOPLASMA, V64, P262, DOI 10.4149/neo_2017_213; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee JW, 2006, PATHOL RES PRACT, V202, P497, DOI 10.1016/j.prp.2006.03.004; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Lenhausen AM, 2016, BIOCHEMISTRY-US, V55, P3285, DOI 10.1021/acs.biochem.6b00306; Lewis EM, 2012, J BIOL CHEM, V287, P43862, DOI 10.1074/jbc.M112.407650; Lewis EM, 2011, BIOCHEMISTRY-US, V50, P11084, DOI 10.1021/bi201483g; Li SY, 2011, ARCH PATHOL LAB MED, V135, P903, DOI 10.1043/2010-0003-OAR1.1; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Milasta S, 2016, IMMUNITY, V44, P88, DOI 10.1016/j.immuni.2015.12.002; Millan A, 2009, J SURG RES, V151, P163, DOI 10.1016/j.jss.2007.05.020; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Panieri E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.105; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Quiros PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23; Reffey SB, 2001, J BIOL CHEM, V276, P26542, DOI 10.1074/jbc.M100331200; Rinaldi C, 2012, AM J HUM GENET, V91, P1095, DOI 10.1016/j.ajhg.2012.10.008; Rodriguez FJ, 2012, BBA-REV CANCER, V1826, P23, DOI 10.1016/j.bbcan.2012.03.002; Rouget R, 2008, J BIOL CHEM, V283, P5533, DOI 10.1074/jbc.M706257200; Sancho P, 2017, NEUROGENETICS, V18, P245, DOI 10.1007/s10048-017-0524-6; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scott AJ, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2320-3; Seo BB, 1999, BBA-BIOENERGETICS, V1412, P56, DOI 10.1016/S0005-2728(99)00051-1; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001; Skyrlas A, 2011, EXP DERMATOL, V20, P674, DOI 10.1111/j.1600-0625.2011.01249.x; Sobel RE, 2005, J UROLOGY, V173, P342, DOI 10.1097/01.ju.0000141580.30910.57; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Su KH, 2016, NAT CELL BIOL, V18, P527, DOI 10.1038/ncb3335; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Takeda K, 2009, P NATL ACAD SCI USA, V106, P12301, DOI 10.1073/pnas.0901823106; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tournier Cathy, 2013, Genes Cancer, V4, P397, DOI 10.1177/1947601913486349; Turner RL, 2014, VIROLOGY, V456, P205, DOI 10.1016/j.virol.2014.03.010; Urbano A, 2005, EMBO J, V24, P2815, DOI 10.1038/sj.emboj.7600746; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Wang HM, 2004, J NEUROSCI, V24, P10963, DOI 10.1523/JNEUROSCI.3461-04.2004; Wang W, 2007, J BIOL CHEM, V282, P24650, DOI 10.1074/jbc.M703167200; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Wilkinson JC, 2004, J BIOL CHEM, V279, P51091, DOI 10.1074/jbc.M409623200; Wilkinson JC, 2004, MOL CELL BIOL, V24, P7003, DOI 10.1128/MCB.24.16.7003-7014.2004; Wilkinson JC, 2008, MOL CELL BIOL, V28, P237, DOI 10.1128/MCB.01065-07; Yu J, 2007, ONCOGENE, V26, P4189, DOI 10.1038/sj.onc.1210196; Zhu C, 2007, CELL DEATH DIFFER, V14, P775, DOI 10.1038/sj.cdd.4402053	73	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14707	14722		10.1074/jbc.RA118.004022	http://dx.doi.org/10.1074/jbc.RA118.004022			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30093403	hybrid, Green Published			2022-12-28	WOS:000446155000011
J	Farrow, SC; Kamileen, MO; Meades, J; Ameyaw, B; Xiao, YL; O'Connor, SE				Farrow, Scott C.; Kamileen, Mohamed O.; Meades, Jessica; Ameyaw, Belinda; Xiao, Youli; O'Connor, Sarah E.			Cytochrome P450 and O-methyltransferase catalyze the final steps in the biosynthesis of the anti-addictive alkaloid ibogaine from Tabernanthe iboga	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						natural product biosynthesis; cytochrome P450; natural product biosynthesis; secondary metabolism; plant biochemistry; ibogaine; monoterpene indole alkaloid; Tabernanthe iboga; O-methyltransferase; Illumina sequencing; transcriptomics	INDOLE ALKALOIDS; EFFICIENT	Monoterpenoid indole alkaloids are a large (approximate to 3000 members) and structurally diverse class of metabolites restricted to a limited number of plant families in the order Gentianales. Tabernanthe iboga or iboga (Apocynaceae) is native to western equatorial Africa and has been used in traditional medicine for centuries. Howard Lotsof is credited with bringing iboga to the attention of Western medicine through his accidental discovery that iboga can alleviate opioid withdrawal symptoms. Since this observation, iboga has been investigated for its use in the general management of addiction. We were interested in elucidating ibogaine biosynthesis to understand the unique reaction steps en route to ibogaine. Furthermore, because ibogaine is currently sourced from plant material, these studies may help improve the ibogaine supply chain through synthetic biology approaches. Here, we used next-generation sequencing to generate the first iboga transcriptome and leveraged homology-guided gene discovery to identify the penultimate hydroxylase and final O-methyltransferase steps in ibogaine biosynthesis, herein named ibogamine 10-hydroxylase (I10H) and noribogaine-10-O-methyltransferase (N10OMT). Heterologous expression in Saccharomyces cerevisiae (I10H) or Escherichia coli (N10OMT) and incubation with putative precursors, along with HPLC-MS analysis, confirmed the predicted activities of both enzymes. Moreover, high expression levels of their transcripts were detected in ibogaine-accumulating plant tissues. These discoveries coupled with our publicly available iboga transcriptome will contribute to additional gene discovery efforts and could lead to the stabilization of the global ibogaine supply chain and to the development of ibogaine as a treatment for addiction.	[Farrow, Scott C.; Kamileen, Mohamed O.; Meades, Jessica; Ameyaw, Belinda; O'Connor, Sarah E.] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Xiao, Youli] Chinese Acad Sci, Ctr Excellence Mol Plant Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai 200000, Peoples R China	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	O'Connor, SE (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England.	sarah.oconnor@jic.ac.uk	O'Connor, Sarah Ellen/X-2893-2019; O'Connor, Sarah/O-5850-2016	O'Connor, Sarah/0000-0003-0356-6213; Farrow, Scott/0000-0001-7106-8924; Kamileen, Mohamed Omar/0000-0002-1346-1055; Ameyaw, Belinda/0000-0001-6391-713X	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J004561/1]; European Molecular Biology Organization (EMBO) Long-term Fellowship [ALTF 846-2016]; CAS-BBSRC alliance	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Organization (EMBO) Long-term Fellowship(European Molecular Biology Organization (EMBO)); CAS-BBSRC alliance	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/J004561/1 (to S. E. O. and Y. X.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by European Molecular Biology Organization (EMBO) Long-term Fellowship ALTF 846-2016.; Supported by the CAS-BBSRC alliance.	Alper K R, 2001, Alkaloids Chem Biol, V56, P1, DOI 10.1016/S0099-9598(01)56005-8; Alper KR, 2008, J ETHNOPHARMACOL, V115, P9, DOI 10.1016/j.jep.2007.08.034; Bisset N. G., 1989, WAGENINGEN AGR U PAP, V89, P1; Caputi L, 2018, SCIENCE, V360, P1235, DOI 10.1126/science.aat4100; Carnicella S, 2010, ADDICT BIOL, V15, P424, DOI 10.1111/j.1369-1600.2010.00251.x; Dang TTT, 2012, PLANT PHYSIOL, V159, P618, DOI 10.1104/pp.112.194886; Delaude C., 1984, B SOC ROY SC LIEGE, V53, P206; Farrow SC, 2015, NAT CHEM BIOL, V11, P728, DOI [10.1038/NCHEMBIO.1879, 10.1038/nchembio.1879]; GUNASEKERA SP, 1980, PHYTOCHEMISTRY, V19, P1213, DOI 10.1016/0031-9422(80)83086-X; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Hagel JM, 2008, TRENDS PLANT SCI, V13, P631, DOI 10.1016/j.tplants.2008.09.005; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KHUONGHUU F, 1976, TETRAHEDRON, V32, P2539, DOI 10.1016/0040-4020(76)88023-4; Meisel L, 2005, BIOL RES, V38, P83, DOI 10.4067/S0716-97602005000100010; MULAMBA T, 1981, J NAT PROD, V44, P184, DOI 10.1021/np50014a007; Nomura T, 2010, PLANT SIGNAL BEHAV, V5, P875, DOI [10.4161/psb.5.7.11901, 10.1074/jbc.M109.086157]; O'Connor SE, 2006, NAT PROD REP, V23, P532, DOI 10.1039/b512615k; OKUYAMA E, 1992, CHEM PHARM BULL, V40, P2075, DOI 10.1248/cpb.40.2075; POPE HG, 1969, ECON BOT, V23, P174, DOI 10.1007/BF02860623; RASTOGI K, 1980, PHYTOCHEMISTRY, V19, P1209, DOI 10.1016/0031-9422(80)83085-8; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Szabo LF, 2008, MOLECULES, V13, P1875, DOI 10.3390/molecules13081875; Tang BQ, 2014, J NAT PROD, V77, P1839, DOI 10.1021/np500240b; YAMASAKI M, 1964, TETRAHEDRON LETT, P1499; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730	25	20	20	1	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13821	13833		10.1074/jbc.RA118.004060	http://dx.doi.org/10.1074/jbc.RA118.004060			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30030374	Green Published, hybrid			2022-12-28	WOS:000444070700008
J	Gonzalez-Serrano, LE; Karim, L; Pierre, F; Schwenzer, H; Rotig, A; Munnich, A; Sissler, M				Gonzalez-Serrano, Ligia Elena; Karim, Loukmane; Pierre, Florian; Schwenzer, Hagen; Rotig, Agnes; Munnich, Arnold; Sissler, Marie			Three human aminoacyl-tRNA synthetases have distinct sub-mitochondrial localizations that are unaffected by disease-associated mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; mitochondria; translation; neurodegenerative disease; human; dual-localization; leukodystrophy; membrane-anchored; mitochondrial disorder; pontocerebellar hypoplasia	SPINAL-CORD INVOLVEMENT; INNER MEMBRANE; LACTATE ELEVATION; BRAIN-STEM; PONTOCEREBELLAR HYPOPLASIA; SUBCELLULAR-LOCALIZATION; PROTEIN-SYNTHESIS; LEUKOENCEPHALOPATHY; TRANSLATION; SEQUENCE	Human mitochondrial aminoacyl-tRNA synthetases (mt-aaRSs) are key enzymes in the mitochondrial protein translation system and catalyze the charging of amino acids on their cognate tRNAs. Mutations in their nuclear genes are associated with pathologies having a broad spectrum of clinical phenotypes, but with no clear molecular mechanism(s). For example, mutations in the nuclear genes encoding mt-AspRS and mt-ArgRS are correlated with the moderate neurodegenerative disorder leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) and with the severe neurodevelopmental disorder pontocerebellar hypoplasia type 6 (PCH6), respectively. Previous studies have shown no or only minor impacts of these mutations on the canonical properties of these enzymes, indicating that the role of the mt-aaRSs in protein synthesis is mostly not affected by these mutations, but their effects on the mitochondrial localizations of aaRSs remain unclear. Here, we demonstrate that three human aaRSs, mt-AspRS, mt-ArgRS, and LysRS, each have a specific sub-mitochondrial distribution, with mt-ArgRS being exclusively localized in the membrane, LysRS exclusively in the soluble fraction, and mt-AspRS being present in both. Chemical treatments revealed that mt-AspRs is anchored in the mitochondrial membrane through electrostatic interactions, whereas mt-ArgRS uses hydrophobic interactions. We also report that novel mutations in mt-AspRS and mt-ArgRS genes from individuals with LBSL and PCH6, respectively, had no significant impact on the mitochondrial localizations of mt-AspRS and mt-ArgRS. The variable sub-mitochondrial locations for these three mt-aaRSs strongly suggest the existence of additional enzyme properties, requiring further investigation to unravel the mechanisms underlying the two neurodegenerative disorders.	[Gonzalez-Serrano, Ligia Elena; Karim, Loukmane; Pierre, Florian; Schwenzer, Hagen; Sissler, Marie] Univ Strasbourg, CNRS, Architecture & React ARN, UPR9002, F-67084 Strasbourg, France; [Rotig, Agnes; Munnich, Arnold] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, INSERM, Lab Genet Mitochondrial Disorders,UMR 1163, F-75015 Paris, France; [Karim, Loukmane] Temple Univ, Lewis Katz Sch Med, Ctr Inflammat Translat & Clin Lung Res CILR, Philadelphia, PA 19140 USA; [Schwenzer, Hagen] Univ Oxford, Dept Oncol, Oxford OX3 7DQ, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Oxford	Sissler, M (corresponding author), IBMC, 15 Rue Rene Descartes, F-67084 Strasbourg, France.	m.sissler@ibmc-cnrs.unistra.fr	; ROTIG, AGNES/G-9592-2017	SISSLER, Marie/0000-0001-8594-5238; ROTIG, AGNES/0000-0003-0589-0703	Centre National de la Recherche Scientifique (CNRS), Universite de Strasbourg (UNISTRA); French National Program "Investissement d'Avenir" (Labex MitoCross) [ANR-11-LABX-0057_MITOCROSS]; Region Alsace; Universite de Strasbourg; AFM; Fondation des Treilles	Centre National de la Recherche Scientifique (CNRS), Universite de Strasbourg (UNISTRA); French National Program "Investissement d'Avenir" (Labex MitoCross)(French National Research Agency (ANR)); Region Alsace(Region Grand-Est); Universite de Strasbourg; AFM(Association Francaise contre les Myopathies); Fondation des Treilles	This work was supported by Centre National de la Recherche Scientifique (CNRS), Universite de Strasbourg (UNISTRA), and the French National Program "Investissement d'Avenir" (Labex MitoCross), administered by the "Agence National de la Recherche", and referenced ANR-11-LABX-0057_MITOCROSS and LabEx MitoCross (to L.E.G.S., L.K. and F.P.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Region Alsace, Universite de Strasbourg, AFM, and Fondation des Treilles. Present address: Dept. of Oncology, University of Oxford, Oxford OX3 7DQ, United Kingdom.	Akaike T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01311-y; Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193; Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; Carapito C, 2017, METHODS, V113, P111, DOI 10.1016/j.ymeth.2016.10.012; Cassandrini D, 2013, J INHERIT METAB DIS, V36, P43, DOI 10.1007/s10545-012-9487-9; Choi H, 2017, BIOCHEM BIOPH RES CO, V493, P1129, DOI 10.1016/j.bbrc.2017.09.008; COCKLE SA, 1980, J BIOL CHEM, V255, P9182; Diodato Daria, 2014, Int J Cell Biol, V2014, P787956, DOI 10.1155/2014/787956; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Engl G, 2012, HUM MOL GENET, V21, P287, DOI 10.1093/hmg/ddr458; Fallaize D, 2015, CELL SIGNAL, V27, P2543, DOI 10.1016/j.cellsig.2015.09.020; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Han JM, 2008, P NATL ACAD SCI USA, V105, P11206, DOI 10.1073/pnas.0800297105; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Jeon YH, 2016, BBA-PROTEINS PROTEOM, V1864, P1707, DOI 10.1016/j.bbapap.2016.09.009; Jester BC, 2011, J BIOTECHNOL, V156, P211, DOI 10.1016/j.jbiotec.2011.09.013; Karnati S, 2013, HISTOCHEM CELL BIOL, V140, P105, DOI 10.1007/s00418-013-1099-4; Kim DG, 2012, FASEB J, V26, P4142, DOI 10.1096/fj.12-207639; Kim HY, 2015, PROTEIN SCI, V24, P2063, DOI 10.1002/pro.2817; Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Liu MQ, 2000, J BIOL CHEM, V275, P29400, DOI 10.1074/jbc.M002173200; Luhl S, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0525-9; Matthews GD, 2010, J CELL SCI, V123, P351, DOI 10.1242/jcs.060749; Messmer M, 2011, BIOCHEM J, V433, P441, DOI 10.1042/BJ20101902; Mirande M, 2017, SUBCELL BIOCHEM, V83, P505, DOI 10.1007/978-3-319-46503-6_18; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Moulinier L, 2017, HUM MUTAT, V38, P1316, DOI 10.1002/humu.23277; Nouws J, 2016, J BIOL CHEM, V291, P989, DOI 10.1074/jbc.M115.689299; OKUBO K, 1991, J BIOL CHEM, V266, P16420; Olmedo-Verd E, 2011, J BIOL CHEM, V286, P41057, DOI 10.1074/jbc.M111.242461; OLSON EN, 1985, J BIOL CHEM, V260, P3784; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; Rajala N, 2014, NUCLEIC ACIDS RES, V42, P952, DOI 10.1093/nar/gkt988; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; Santamaria-Gomez J, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmcb.2016.00857, 10.3389/fmicb.2016.00857]; Sauter C, 2015, SCI REP-UK, V5, DOI 10.1038/srep17332; Scheffler IE, 2001, MITOCHONDRION, V1, P3, DOI 10.1016/S1567-7249(00)00002-7; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; Schlattner U, 2000, J BIOENERG BIOMEMBR, V32, P123, DOI 10.1023/A:1005576831968; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwenzer H, 2014, TOP CURR CHEM, V344, P247, DOI 10.1007/128_2013_457; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002; Suzuki H, 2007, J BIOL CHEM, V282, P4076, DOI 10.1074/jbc.M608187200; TEZUKA T, 1983, PLANT PHYSIOL, V72, P959, DOI 10.1104/pp.72.4.959; van Berge L, 2014, BRAIN, V137, P1019, DOI 10.1093/brain/awu026; van Berge L, 2013, BIOCHEM J, V450, P345, DOI 10.1042/BJ20121564; van Berge L, 2012, BIOCHEM J, V441, P955, DOI 10.1042/BJ20110795; Wang M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12061; Winger AM, 2007, PROTEOMICS, V7, P4158, DOI 10.1002/pmic.200700209; Yano H, 2014, NAT NEUROSCI, V17, P822, DOI 10.1038/nn.3721; YU WH, 1995, J BIOL CHEM, V270, P13998, DOI 10.1074/jbc.270.23.13998	61	7	8	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13604	13615		10.1074/jbc.RA118.003400	http://dx.doi.org/10.1074/jbc.RA118.003400			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30006346	Green Published, hybrid			2022-12-28	WOS:000443375500020
J	Maiuthed, A; Bhummaphan, N; Luanpitpong, S; Mutirangura, A; Aporntewan, C; Meeprasert, A; Rungrotmongkol, T; Rojanasakul, Y; Chanvorachote, P				Maiuthed, Arnatchai; Bhummaphan, Narumol; Luanpitpong, Sudjit; Mutirangura, Apiwat; Aporntewan, Chatchawit; Meeprasert, Arthitaya; Rungrotmongkol, Thanyada; Rojanasakul, Yon; Chanvorachote, Pithi			Nitric oxide promotes cancer cell dedifferentiation by disrupting an Oct4:caveolin-1 complex: A new regulatory mechanism for cancer stem cell formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cancer stem cells; caveolin; cell signaling; lung cancer; proteasome; GSK3; OCT4; nitric oxide; caveolin-1; protein degradation; protein-protein interaction; differentiation; regulation	CAVEOLIN-1 EXPRESSION; MOLECULAR-DYNAMICS; EXTRINSIC CONTROL; OCT4; PROTEIN; GENE; SOX2; RESISTANCE; PATHWAY; WWP2	Cancer stem cells (CSCs) are unique populations of cells that can self-renew and generate different cancer cell lineages. Although CSCs are believed to be a promising target for novel therapies, the specific mechanisms by which these putative therapeutics could intervene are less clear. Nitric oxide (NO) is a biological mediator frequently up-regulated in tumors and has been linked to cancer aggressiveness. Here, we search for targets of NO that could explain its activity. We find that it directly affects the stability and function of octamer-binding transcription factor 4 (Oct4), known to drive the stemness of lung cancer cells. We demonstrated that NO promotes the CSC-regulatory activity of Oct4 through a mechanism that involves complex formation between Oct4 and the scaffolding protein caveolin-1 (Cav-1). In the absence of NO, Oct4 forms a molecular complex with Cav-1, which promotes the ubiquitin-mediated proteasomal degradation of Oct4. NO promotes Akt-dependent phosphorylation of Cav-1 at tyrosine 14, disrupting the Cav-1:Oct4 complex. Site-directed mutagenesis and computational modeling studies revealed that the hydroxyl moiety at tyrosine 14 of Cav-1 is crucial for its interaction with Oct4. Both removal of the hydroxyl via mutation to phenylalanine and phosphorylation lead to an increase in binding free energy (G(bind)) between Oct4 and Cav-1, destabilizing the complex. Together, these results unveiled a novel mechanism of CSC regulation through NO-mediated stabilization of Oct4, a key stem cell transcription factor, and point to new opportunities to design CSC-related therapeutics.	[Maiuthed, Arnatchai; Chanvorachote, Pithi] Chulalongkorn Univ, Dept Pharmacol & Physiol, Bangkok 10330, Thailand; [Maiuthed, Arnatchai; Bhummaphan, Narumol; Chanvorachote, Pithi] Chulalongkorn Univ, Fac Pharmaceut Sci, Cell Based Drug & Hlth Prod Dev Res Unit, Bangkok 10330, Thailand; [Aporntewan, Chatchawit] Chulalongkorn Univ, Dept Math & Comp Sci, Bangkok 10330, Thailand; [Rungrotmongkol, Thanyada] Chulalongkorn Univ, PhD Program Bioinformat & Computat Biol, Bangkok 10330, Thailand; [Meeprasert, Arthitaya; Rungrotmongkol, Thanyada] Chulalongkorn Univ, Struct & Computat Biol Res Grp, Bangkok 10330, Thailand; [Meeprasert, Arthitaya; Rungrotmongkol, Thanyada] Chulalongkorn Univ, Fac Sci, Dept Biochem, Bangkok 10330, Thailand; [Mutirangura, Apiwat] Chulalongkorn Univ, Fac Med, Dept Anat, Ctr Excellence Mol Genet Canc & Human Dis, Bangkok 10330, Thailand; [Bhummaphan, Narumol] Chulalongkorn Univ, Fac Grad Sch, Interdept Program Biomed Sci, Bangkok 10330, Thailand; [Luanpitpong, Sudjit] Mahidol Univ, Siriraj Hosp, Fac Med, Siriraj Ctr Excellence Stem Cell Res, Bangkok 10700, Thailand; [Rojanasakul, Yon] West Virginia Univ, WVU Canc Inst, Morgantown, WV 26506 USA	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Mahidol University; West Virginia University	Chanvorachote, P (corresponding author), Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Pharmacol & Physiol, Bangkok 10330, Thailand.	pithi.ch@gmail.com	Luanpitpong, Sudjit/ABF-1962-2021	Maiuthed, Arnatchai/0000-0001-6528-7346; chanvorachote, pithi/0000-0002-3103-3249; Luanpitpong, Sudjit/0000-0002-1639-4935				Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Aporntewan C, 2011, ASIAN BIOMED, V5, P257, DOI 10.5372/1905-7415.0502.034; Belanger MM, 2004, CHEST, V125, p106S, DOI 10.1378/chest.125.5_suppl.106S; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Byrne DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044879; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Cassinelli G, 2013, CURR MED CHEM, V20, P1923, DOI 10.2174/09298673113209990106; Chang JH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005541; Chanvorachote P, 2006, CANCER RES, V66, P6353, DOI 10.1158/0008-5472.CAN-05-4533; Chanvorachote P, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-52; Chanvorachote P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/941359; Chanvorachote P, 2009, J BIOL CHEM, V284, P28476, DOI 10.1074/jbc.M109.050864; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen SF, 2010, J CELL BIOCHEM, V109, P356, DOI 10.1002/jcb.22407; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Cohen AW, 2005, DIABETES, V54, P679, DOI 10.2337/diabetes.54.3.679; deHaan G, 1997, J EXP MED, V186, P529, DOI 10.1084/jem.186.4.529; Diaz-Valdivia N, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1477-5; Esch D, 2013, NAT CELL BIOL, V15, P295, DOI 10.1038/ncb2680; Felley-Bosco E, 2000, P NATL ACAD SCI USA, V97, P14334, DOI 10.1073/pnas.250406797; Friedmann-Morvinski D, 2014, EMBO REP, V15, P244, DOI 10.1002/embr.201338254; GABBERT H, 1985, CLIN EXP METASTAS, V3, P257, DOI 10.1007/BF01585081; Galbiati F, 2000, J BIOL CHEM, V275, P23368, DOI 10.1074/jbc.M002020200; GLENNEY JR, 1992, FEBS LETT, V314, P45, DOI 10.1016/0014-5793(92)81458-X; Golden BDO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076345; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Hatefi N, 2012, IRAN J BASIC MED SCI, V15, P1154; Hayashi H, 2015, ONCOGENE, V34, P199, DOI 10.1038/onc.2013.547; Hirst DG, 2011, METHODS MOL BIOL, V704, P1, DOI 10.1007/978-1-61737-964-2_1; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; Kaiyawet N, 2013, J CHEM INF MODEL, V53, P1315, DOI 10.1021/ci400131y; Karoubi Golnaz, 2009, Interact Cardiovasc Thorac Surg, V8, P393, DOI 10.1510/icvts.2008.193995; Kato T, 2004, CANCER LETT, V214, P121, DOI 10.1016/j.canlet.2004.04.017; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kempfle JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23293; Kim BW, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-2015-1; Kobayashi I, 2016, BIOCHEM BIOPH RES CO, V473, P125, DOI 10.1016/j.bbrc.2016.03.064; Kogo H, 2004, J BIOL CHEM, V279, P25574, DOI 10.1074/jbc.M310807200; Kongsune P, 2012, MONATSH CHEM, V143, P853, DOI 10.1007/s00706-011-0690-4; Kosaka T, 2016, HUM PATHOL, V51, P1, DOI 10.1016/j.humpath.2015.12.008; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Liao B, 2010, CELL RES, V20, P332, DOI 10.1038/cr.2009.136; Liu AF, 2013, CHIN J CANCER, V32, P483, DOI 10.5732/cjc.012.10282; Liu CG, 2011, ANN SURG, V253, P1165, DOI 10.1097/SLA.0b013e318214c54e; Liu PF, 2018, CLIN RESPIR J, V12, P23, DOI 10.1111/crj.12471; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Masri F, 2010, ANN THORAC MED, V5, P123, DOI 10.4103/1817-1737.65036; Matsumoto A, 2003, SCIENCE, V301, P657, DOI 10.1126/science.1079319; Matsunaga T, 2014, FREE RADICAL RES, V48, P1371, DOI 10.3109/10715762.2014.957694; Meeprasert A, 2014, J CHEM INF MODEL, V54, P1208, DOI 10.1021/ci400605a; Meeprasert A, 2012, J MOL GRAPH MODEL, V38, P148, DOI 10.1016/j.jmgm.2012.06.007; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Powan P, 2014, MOL CELL BIOCHEM, V393, P237, DOI 10.1007/s11010-014-2066-7; Qiao M, 2008, CELL CYCLE, V7, P2991, DOI 10.4161/cc.7.19.6784; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rao CV, 2004, MUTAT RES-FUND MOL M, V555, P107, DOI 10.1016/j.mrfmmm.2004.05.022; Ridnour LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044081; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saisongkorh V, 2016, CELL ONCOL, V39, P449, DOI 10.1007/s13402-016-0287-3; Salcido CD, 2010, BRIT J CANCER, V102, P1636, DOI 10.1038/sj.bjc.6605668; Shackleton M, 2010, SEMIN CANCER BIOL, V20, P85, DOI 10.1016/j.semcancer.2010.04.002; Shi GL, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt39; Shyamsunder P, 2013, GENE, V527, P521, DOI 10.1016/j.gene.2013.06.051; Sun MZ, 2012, BIOMED PHARMACOTHER, V66, P242, DOI 10.1016/j.biopha.2011.11.003; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TAKEDA J, 1992, NUCLEIC ACIDS RES, V20, P4613, DOI 10.1093/nar/20.17.4613; Tang JM, 2006, LUNG CANCER, V51, P181, DOI 10.1016/j.lungcan.2005.10.003; Tantong S, 2016, PEPTIDES, V84, P7, DOI 10.1016/j.peptides.2016.07.005; Tompkins DH, 2011, AM J RESP CELL MOL, V45, P101, DOI 10.1165/rcmb.2010-0149OC; Tompkins DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008248; Trosko JE, 2006, ANN NY ACAD SCI, V1089, P36, DOI 10.1196/annals.1386.018; Villodre ES, 2016, CANCER TREAT REV, V51, P1, DOI 10.1016/j.ctrv.2016.10.003; Wang H, 2011, AM J PHYSIOL-ENDOC M, V300, pE134, DOI 10.1152/ajpendo.00498.2010; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Xu HM, 2009, CELL RES, V19, P561, DOI 10.1038/cr.2009.31; Yokomori H, 2003, J GASTROENTEROL, V38, P854, DOI 10.1007/s00535-003-1161-4; Yongsanguanchai N, 2015, AM J PHYSIOL-CELL PH, V308, pC89, DOI 10.1152/ajpcell.00187.2014; YORK DM, 1993, J CHEM PHYS, V99, P8345, DOI 10.1063/1.465608; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zeineddine D, 2014, AM J STEM CELLS, V3, P74; Zhao QW, 2015, ONCOL REP, V33, P1621, DOI 10.3892/or.2015.3752; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	92	23	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13534	13552		10.1074/jbc.RA117.000287	http://dx.doi.org/10.1074/jbc.RA117.000287			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29986880	hybrid, Green Published			2022-12-28	WOS:000443375500015
J	Praktiknjo, SD; Saad, F; Maier, D; Ip, P; Hipfner, DR				Praktiknjo, Samantha D.; Saad, Farah; Maier, Dominic; Ip, Pamela; Hipfner, David R.			Activation of Smoothened in the Hedgehog pathway unexpectedly increases G(s)-dependent cAMP levels in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hedgehog signaling pathway; heterotrimeric G protein; cyclic AMP (cAMP); G protein-coupled receptor (GPCR); Drosophila; G-protein-coupled receptor kinase; Smoothened	PROTEIN-KINASE-A; HETEROTRIMERIC G-PROTEINS; COUPLED RECEPTOR GPR161; SIGNAL-TRANSDUCTION; SONIC HEDGEHOG; CUBITUS INTERRUPTUS; LIMB DEVELOPMENT; PHOSPHORYLATION; MELANOGASTER; TRAFFICKING	Hedgehog (Hh) signaling plays a key role in the development and maintenance of animal tissues. This signaling is mediated by the atypical G protein-coupled receptor (GPCR) Smoothened (Smo). Smo activation leads to signaling through several well-characterized effectors to activate Hh target gene expression. Recent studies have implicated activation of the heterotrimeric G protein subunit G(i) and the subsequent decrease in cellular cAMP levels in promoting the Hh response in flies and mammals. Although Hh stimulation decreases cAMP levels in some insect cell lines, here using a bioluminescence resonance energy transfer (BRET)-based assay we found that this stimulation had no detectable effect in Drosophila S2-R+ cells. However, we observed an unexpected and significant G(s)-dependent increase in cAMP levels in response to strong Smo activation in Smo-transfected cells. This effect was mediated by Smo's broadly conserved core, and was specifically activated in response to phosphorylation of the Smo C-terminus by GPCR kinase 2 (Gprk2). Genetic analysis of heterotrimeric G protein function in the developing Drosophila wing revealed a positive role for cAMP in the endogenous Hh response. Specifically, we found that mutation or depletion of G(s) diminished low-threshold Hh responses in Drosophila, whereas depletion of G(i) potentiated them (in contrast to previous findings). Our analysis suggested that regulated cAMP production is important for controlling the sensitivity of cellular responses to Hh in Drosophila.	[Praktiknjo, Samantha D.; Saad, Farah; Maier, Dominic; Ip, Pamela; Hipfner, David R.] Inst Rech Clin Montreal, 110 Pine Ave West, Montreal, PQ H2W 1R7, Canada; [Praktiknjo, Samantha D.; Maier, Dominic; Ip, Pamela; Hipfner, David R.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada; [Saad, Farah; Hipfner, David R.] McGill Univ, Dept Biol, Montreal, PQ H3A 0C7, Canada; [Hipfner, David R.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Praktiknjo, Samantha D.] Berlin Inst Med Syst Biol, Max Delbruck Ctr Mol Med Helmholtz Assoc, Syst Biol Gene Regulatory Elements, D-13125 Berlin, Germany	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; McGill University; Universite de Montreal; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Hipfner, DR (corresponding author), Inst Rech Clin Montreal, 110 Pine Ave West, Montreal, PQ H2W 1R7, Canada.	david.hipfner@ircm.qc.ca	Praktiknjo, Samantha/AAI-9126-2020	Praktiknjo, Samantha/0000-0002-0186-5271; Hipfner, David/0000-0002-2265-5871	Canadian Institutes of Health Research (CIHR) [106426]; CIHR New Investigator Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Canadian Institutes of Health Research (CIHR) Grant 106426 (to D.R.H.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a CIHR New Investigator Award.	Apionishev S, 2005, NAT CELL BIOL, V7, P86, DOI 10.1038/ncb1210; Ayers KL, 2010, TRENDS CELL BIOL, V20, P287, DOI 10.1016/j.tcb.2010.02.002; Baker JD, 2002, J EXP BIOL, V205, P2555; Belgacem YH, 2011, P NATL ACAD SCI USA, V108, P4482, DOI 10.1073/pnas.1018217108; Blair SS, 2003, DEVELOPMENT, V130, P5065, DOI 10.1242/dev.00774; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Carbe CJ, 2014, AM J PHYSIOL-HEART C, V307, pH66, DOI 10.1152/ajpheart.00166.2014; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chen YB, 2013, CELL RES, V23, P186, DOI 10.1038/cr.2013.10; Chen YB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001083; Chen YB, 2010, GENE DEV, V24, P2054, DOI 10.1101/gad.1948710; Cheng SF, 2012, DEVELOPMENT, V139, P85, DOI 10.1242/dev.068817; Cheng SF, 2010, DEV BIOL, V337, P99, DOI 10.1016/j.ydbio.2009.10.014; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; DANG DT, 1992, DEV GENET, V13, P367, DOI 10.1002/dvg.1020130507; DasGupta R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r203; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; FRASER SE, 1985, NATURE, V317, P533, DOI 10.1038/317533a0; He XL, 2014, NAT MED, V20, P1035, DOI 10.1038/nm.3666; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Li S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005414; Li S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001239; Li SX, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002481; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Ma GQ, 2016, DEV CELL, V39, P438, DOI 10.1016/j.devcel.2016.09.014; Maier D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004399; Maier D, 2012, FLY, V6, P135, DOI 10.4161/fly.20245; Malpel S, 2007, DEV BIOL, V303, P121, DOI 10.1016/j.ydbio.2006.10.042; Marada S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005473; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Mukhopadhyay S, 2014, SEMIN CELL DEV BIOL, V33, P63, DOI 10.1016/j.semcdb.2014.05.002; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Niewiadomski P, 2013, CELL SIGNAL, V25, P2222, DOI 10.1016/j.cellsig.2013.07.012; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Ogden SK, 2006, J BIOL CHEM, V281, P7237, DOI 10.1074/jbc.M510169200; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Ohlmeyer JT, 1997, GENE DEV, V11, P2250, DOI 10.1101/gad.11.17.2250; Pak E, 2016, DEV CELL, V38, P333, DOI 10.1016/j.devcel.2016.07.026; Pal K, 2016, J CELL BIOL, V212, P861, DOI 10.1083/jcb.201506132; Polizio AH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002396; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; PREAT T, 1993, GENETICS, V135, P1047; Pusapati GV, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao5749; Qi Y, 2016, DEV CELL, V39, P385, DOI 10.1016/j.devcel.2016.11.001; QUAN F, 1991, P NATL ACAD SCI USA, V88, P1898, DOI 10.1073/pnas.88.5.1898; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Sanial M, 2017, DEVELOPMENT, V144, P1841, DOI 10.1242/dev.144782; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Shen F, 2013, MOL PHARMACOL, V83, P691, DOI 10.1124/mol.112.082511; Shi Q, 2011, DEVELOPMENT, V138, P4219, DOI 10.1242/dev.067959; Singh J, 2015, J BIOL CHEM, V290, P29663, DOI 10.1074/jbc.M115.665810; Tiecke E, 2007, DEV BIOL, V305, P312, DOI 10.1016/j.ydbio.2007.02.017; Vilardaga JP, 2014, NAT CHEM BIOL, V10, P700, DOI [10.1038/NCHEMBIO.1611, 10.1038/nchembio.1611]; Villanueva H, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa7355; Wilson CW, 2009, NATURE, V459, P98, DOI 10.1038/nature07883; Xia RH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001238; Zhang C, 2004, P NATL ACAD SCI USA, V101, P17900, DOI 10.1073/pnas.0408093101; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225; Zhao ZH, 2016, EMBO REP, V17, P739, DOI 10.15252/embr.201541532; Zhou QH, 2006, GENETICS, V173, P2049, DOI 10.1534/genetics.106.061036; Zhou QH, 2011, DEV CELL, V20, P802, DOI 10.1016/j.devcel.2011.04.020	69	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13496	13508		10.1074/jbc.RA118.001953	http://dx.doi.org/10.1074/jbc.RA118.001953			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30018136	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000443375500012
J	Lu, WX; Tirumuru, N; St Gelais, C; Koneru, PC; Liu, C; Kvaratskhelia, M; He, C; Wu, L				Lu, Wuxun; Tirumuru, Nagaraja; St Gelais, Corine; Koneru, Pratibha C.; Liu, Chang; Kvaratskhelia, Mamuka; He, Chuan; Wu, Li			N-6-Methyladenosine- binding proteins suppress HIV-1 infectivity and viral production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; M(6)A RNA METHYLOMES; GENE-EXPRESSION; N6-METHYLADENOSINE; REVEALS; CELLS; RESTRICTION; TRANSLATION; METHYLATION; SPECIFICITY	The internal N-6-methyladenosine (m(6)A) modification of cellular mRNA regulates post-transcriptional gene expression. The YTH domain family proteins (YTHDF1-3 or Y1-3) bind to m(6)A-modified cellular mRNAs and modulate their metabolism and processing, thereby affecting cellular protein translation. We previously reported that HIV-1 RNA contains the m(6)A modification and that Y1-3 proteins inhibit HIV-1 infection by decreasing HIV-1 reverse transcription activity. Here, we investigated the mechanisms of Y1-3-mediated inhibition of HIV-1 infection in target cells and the effect of Y1-3 on viral production levels in virus-producing cells. We found that Y1-3 protein overexpression in HIV-1 target cells decreases viral genomic RNA (gRNA) levels and inhibits both early and late reverse transcription. Purified recombinant Y1-3 proteins preferentially bound to the m(6)A-modified 5' leader sequence of gRNA compared with its unmodified RNA counterpart, consistent with the strong binding of Y1-3 proteins to HIV-1 gRNA in infected cells. HIV-1 mutants with two altered m(6)A modification sites in the 5' leader sequence of gRNA exhibited significantly lower infectivity than WT, replication-competent HIV-1, confirming that these sites alter viral infection. HIV-1 produced from cells in which endogenous Y1, Y3, or Y1-3 proteins were (mocked down singly or together had increased viral infectivity compared with HIV-1 produced in control cells. Interestingly, we found that Y1-3 proteins and HIV-1 Gag protein formed a complex with RNA in HIV-1-producing cells. Overall, these results indicate that Y1-3 proteins inhibit HIV-1 infection and provide new insights into the mechanisms by which the m(6)A modification of HIV-1 RNA affects viral replication.	[Lu, Wuxun; Tirumuru, Nagaraja; St Gelais, Corine; Wu, Li] Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, 1900 Coffey Rd, Columbus, OH 43210 USA; [Koneru, Pratibha C.; Kvaratskhelia, Mamuka] Univ Colorado, Div Infect Dis, Sch Med, Aurora, CO 80045 USA; [Liu, Chang; He, Chuan] Univ Chicago, Dept Chem & Biochem, Inst Biophys Dynam, Chicago, IL 60637 USA; [Liu, Chang; He, Chuan] Univ Chicago, Dept Mol Biol, Inst Biophys Dynam, Chicago, IL 60637 USA; [Liu, Chang; He, Chuan] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	University System of Ohio; Ohio State University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Wu, L (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, 1900 Coffey Rd, Columbus, OH 43210 USA.	wu.840@osu.edu	Wu, Li/ABB-2813-2020	Wu, Li/0000-0002-5468-2487; Koneru, Pratibha Chowdary/0000-0003-3955-4548	National Institutes of Health [GM128212, AI062520, AI120209, AI104483]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM128212] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM128212 (to L.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant AI062520.; Supported in part by National Institutes of Health Grants AI120209 and AI104483.	Abd El-Wahab EW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5304; Antonucci JM, 2016, NAT MED, V22, P1072, DOI 10.1038/nm.4163; Arguello AE, 2017, J AM CHEM SOC, V139, P17249, DOI 10.1021/jacs.7b09213; BEEMON K, 1977, J MOL BIOL, V113, P165, DOI 10.1016/0022-2836(77)90047-X; Berkhout B, 2000, Adv Pharmacol, V48, P29; CANAANI D, 1979, NUCLEIC ACIDS RES, V6, P2879, DOI 10.1093/nar/6.8.2879; Cantin R, 2008, J IMMUNOL METHODS, V338, P21, DOI 10.1016/j.jim.2008.07.007; Courtney DG, 2017, CELL HOST MICROBE, V22, P377, DOI 10.1016/j.chom.2017.08.004; CUMMINS LM, 1991, BLOOD, V77, P1111; Das AT, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-59; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dettenhofer M, 1999, J VIROL, V73, P1460, DOI 10.1128/JVI.73.2.1460-1467.1999; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; Dong CS, 2009, J VIROL, V83, P3518, DOI 10.1128/JVI.02665-08; Eckwahl MJ, 2016, MBIO, V7, DOI 10.1128/mBio.02025-15; Edupuganti RR, 2017, NAT STRUCT MOL BIOL, V24, P870, DOI 10.1038/nsmb.3462; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gelais CS, 2015, AIDS RES HUM RETROV, V31, P806, DOI [10.1089/aid.2014.0313, 10.1089/AID.2014.0313]; Gelais CS, 2014, J VIROL, V88, P5834, DOI 10.1128/JVI.00155-14; Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015; Janas AM, 2008, VIROLOGY, V375, P442, DOI 10.1016/j.virol.2008.01.044; Keane SC, 2015, SCIENCE, V348, P917, DOI 10.1126/science.aaa9266; Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002; Kessl JJ, 2016, CELL, V166, P1257, DOI 10.1016/j.cell.2016.07.044; Kharytonchyk S, 2016, P NATL ACAD SCI USA, V113, P13378, DOI 10.1073/pnas.1616627113; KRUG RM, 1976, J VIROL, V20, P45, DOI 10.1128/JVI.20.1.45-53.1976; Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057; Li FD, 2014, CELL RES, V24, P1490, DOI 10.1038/cr.2014.153; Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002; Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Pollom E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003294; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Tan B, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0056-8; Telesnitsky A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080235; Tirumuru N, 2016, ELIFE, V5, DOI [10.7554/eLife.15528, 10.7554/eLife.31482]; Wang JH, 2007, J VIROL, V81, P2497, DOI 10.1128/JVI.01970-06; Wang JH, 2009, J VIROL, V83, P4195, DOI 10.1128/JVI.00006-09; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Ye FC, 2017, J VIROL, V91, DOI 10.1128/JVI.00466-17; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	50	56	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					12992	13005		10.1074/jbc.RA118.004215	http://dx.doi.org/10.1074/jbc.RA118.004215			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29976753	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000442730200002
J	Majumder, S; Ghoshal, K; Datta, J; Bai, SM; Dong, XC; Quan, N; Plass, C; Jacob, ST				Majumder, Sarmila; Ghoshal, Kalpana; Datta, Jharna; Bai, Shoumei; Dong, Xiaocheng; Quan, Ning; Plass, Christoph; Jacob, Samson T.			RETRACTION: Role of de novo DNA methyltransferases and methyl CpG-binding proteins in gene silencing in a rat hepatoma (Retraction of Vol 277, Pg 16048, 2002)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Majumder S, 2002, J BIOL CHEM, V277, P16048, DOI 10.1074/jbc.M111662200	1	0	0	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12948	12948		10.1074/jbc.W118.004970	http://dx.doi.org/10.1074/jbc.W118.004970			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	30120152	Green Published, hybrid			2022-12-28	WOS:000442203500028
J	Chuzel, L; Ganatra, MB; Rapp, E; Henrissat, B; Taron, CH				Chuzel, Lea; Ganatra, Mehul B.; Rapp, Erdmann; Henrissat, Bernard; Taron, Christopher H.			Functional metagenomics identifies an exosialidase with an inverting catalytic mechanism that defines a new glycoside hydrolase family (GH156)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sialidase; glycoside hydrolase; high-throughput screening (HTS); neuraminidase; sialic acid; glycosylation; extremophile; functional metagenomics; inverting mechanism	CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; VIRUS NEURAMINIDASE; TRANS-SIALIDASE; EXPRESSION; MUTAGENESIS; RETENTION; DIVERSITY; RESIDUES; COMPLEX	Exosialidases are glycoside hydrolases that remove a single terminal sialic acid residue from oligosaccharides. They are widely distributed in biology, having been found in prokaryotes, eukaryotes, and certain viruses. Most characterized prokaryotic sialidases are from organisms that are pathogenic or commensal with mammals. However, in this study, we used functional metagenomic screening to seek microbial sialidases encoded by environmental DNA isolated from an extreme ecological niche, a thermal spring. Using recombinant expression of potential exosialidase candidates and a fluorogenic sialidase substrate, we discovered an exosialidase having no homology to known sialidases. Phylogenetic analysis indicated that this protein is a member of a small family of bacterial proteins of previously unknown function. Proton NMR revealed that this enzyme functions via an inverting catalytic mechanism, a biochemical property that is distinct from those of known exosialidases. This unique inverting exosialidase defines a new CAZy glycoside hydrolase family we have designated GH156.	[Chuzel, Lea; Ganatra, Mehul B.; Taron, Christopher H.] New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA; [Chuzel, Lea; Rapp, Erdmann] Max Planck Inst Dynam Complex Tech Syst, D-39106 Magdeburg, Germany; [Rapp, Erdmann] GlyXera GmbH, D-39120 Magdeburg, Germany; [Henrissat, Bernard] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biol, F-13288 Marseille, France; [Henrissat, Bernard] INRA, USC 1408, Architecture & Fonct Macromol Biol, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21589, Saudi Arabia	New England Biolabs; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University	Taron, CH (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	taron@neb.com	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Chuzel, Lea/0000-0001-7185-5872; Rapp, Erdmann/0000-0001-6618-2626; Taron, Christopher/0000-0001-8149-4556	New England Biolabs; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U.S. Department of Energy [DE-SC0015662]	New England Biolabs; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE))	We thank Dr. Donald Comb for basic research funding at New England Biolabs. We thank Rick Morgan for kindly providing hot spring environmental DNA. We also thank Barbara Taron, Saulius Vainauskas, Bill Jack, and Tom Evans for comments and critical review of the manuscript prior to its submission. NMR analysis was performed by the Complex Carbohydrate Research Center supported by the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U.S. Department of Energy Grant DE-SC0015662.	BURMEISTER WP, 1993, STRUCTURE, V1, P19, DOI 10.1016/0969-2126(93)90005-2; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Chan J, 2011, ORG BIOMOL CHEM, V9, P4818, DOI 10.1039/c1ob05079f; Cheng JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172545; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; CHONG AKJ, 1992, EUR J BIOCHEM, V207, P335, DOI 10.1111/j.1432-1033.1992.tb17055.x; Coughlan LM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00672; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; CRENNELL S, 1994, STRUCTURE, V2, P535, DOI 10.1016/S0969-2126(00)00053-8; CRENNELL SJ, 1993, P NATL ACAD SCI USA, V90, P9852, DOI 10.1073/pnas.90.21.9852; Czjzek M., INNOVATING GLYCOSIDE, DOI [10.1073/pnas.1704802114, 10. 1073/pnas. 1704802114, DOI 10.1073/PNAS.1704802114]; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DeCastro ME, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01521; Foley MH, 2016, CELL MOL LIFE SCI, V73, P2603, DOI 10.1007/s00018-016-2242-x; FRIEBOLIN H, 1980, H-S Z PHYSIOL CHEM, V361, P697, DOI 10.1515/bchm2.1980.361.1.697; FRIEBOLIN H, 1981, H-S Z PHYSIOL CHEM, V362, P1455, DOI 10.1515/bchm2.1981.362.2.1455; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Ghate AA, 1998, EUR J BIOCHEM, V258, P320, DOI 10.1046/j.1432-1327.1998.2580320.x; Gladden JM, 2012, BIOTECHNOL BIOENG, V109, P1140, DOI 10.1002/bit.24388; Guo J, 2015, PROCESS BIOCHEM, V50, P752, DOI 10.1016/j.procbio.2015.02.005; Jers C, 2015, PROTEIN ENG DES SEL, V28, P37, DOI 10.1093/protein/gzu054; Kao YH, 1997, GLYCOBIOLOGY, V7, P559, DOI 10.1093/glycob/7.4.559; Leis B, 2013, ADV APPL MICROBIOL, V83, P1, DOI 10.1016/B978-0-12-407678-5.00001-5; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luo Y, 1998, STRUCTURE, V6, P521, DOI 10.1016/S0969-2126(98)00053-7; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Maruthamuthu M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2404-0; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Mewis K, 2013, J BIOTECHNOL, V167, P462, DOI 10.1016/j.jbiotec.2013.07.015; Minami A, 2013, FEBS OPEN BIO, V3, P231, DOI 10.1016/j.fob.2013.05.002; Mirete S, 2016, CURR OPIN BIOTECH, V38, P143, DOI 10.1016/j.copbio.2016.01.017; Morley TJ, 2009, J BIOL CHEM, V284, P17404, DOI 10.1074/jbc.M109.003970; Park KH, 2013, BBA-PROTEINS PROTEOM, V1834, P1510, DOI 10.1016/j.bbapap.2013.04.028; PETTER JG, 1993, J BACTERIOL, V175, P4354, DOI 10.1128/JB.175.14.4354-4363.1993; Rooks DJ, 2012, METHOD ENZYMOL, V510, P375, DOI 10.1016/B978-0-12-415931-0.00020-3; Sathya TA, 2014, J FOOD SCI, V79, pR2149, DOI 10.1111/1750-3841.12677; Sekiguchi Y, 2003, INT J SYST EVOL MICR, V53, P1843, DOI 10.1099/ijs.0.02699-0; Useh NA, 2006, CELL BIOCHEM FUNCT, V24, P347, DOI 10.1002/cbf.1240; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Varki A, 1999, ESSENTIALS GLYCOBIOL, P195; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vester JK, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-72; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Vuong TV, 2010, BIOTECHNOL BIOENG, V107, P195, DOI 10.1002/bit.22838; Wang XD, 2017, BIOTECHNOL APPL BIOC, V64, P195, DOI 10.1002/bab.1475; Watson JN, 2003, BIOCHEMISTRY-US, V42, P12682, DOI 10.1021/bi035396g; WILSON JC, 1995, J AM CHEM SOC, V117, P4214, DOI 10.1021/ja00120a002; Wu DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004207; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	50	17	17	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18138	18150		10.1074/jbc.RA118.003302	http://dx.doi.org/10.1074/jbc.RA118.003302			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30249617	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000451375200010
J	Ejaz, A; Shuman, S				Ejaz, Anam; Shuman, Stewart			Characterization of Lhr-Core DNA helicase and manganese- dependent DNA nuclease components of a bacterial gene cluster encoding nucleic acid repair enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA endonuclease; DNA repair; bacteria; phosphodiesterases; Pseudomonas; DNA ligase; helicase; metallo--lactamase; nuclease	MYCOBACTERIUM-TUBERCULOSIS; RNA; POLYMERASE; PROTEIN; GENOME; FAMILY; DBR1	Lhr is a large superfamily 2 helicase present in mycobacteria and a moderate range of other bacterial taxa. A shorter version of Lhr, here referred to as Lhr-Core, is distributed widely in bacteria, where it is often encoded in a gene cluster along with predicted binuclear metallo-phosphoesterase (MPE), ATP-dependent DNA ligase, and metallo--lactamase exonuclease enzymes. Here we characterized the Lhr-Core and MPE proteins from Pseudomonas putida. We report that P. putida Lhr-Core is an ssDNA-dependent ATPase/dATPase (K-m, 0.37 mm ATP; k(cat), 3.3 s(-1)), an ATP-dependent 3-to-5 single-stranded DNA translocase, and an ATP-dependent 3-to-5 helicase. Lhr-Core unwinds 3-tailed duplexes in which the loading/tracking strand is DNA and the displaced strand is either DNA or RNA. We found that P. putida MPE is a manganese-dependent phosphodiesterase that releases p-nitrophenol from bis-p-nitrophenyl phosphate (k(cat), 212 s(-1)) and p-nitrophenyl-5-thymidylate (k(cat), 34 s(-1)) but displays no detectable phosphomonoesterase activity against p-nitrophenyl phosphate. MPE is also a manganese-dependent DNA endonuclease that sequentially converts a closed-circle plasmid DNA to nicked circle and linear forms prior to degrading the linear DNA to produce progressively smaller fragments. The biochemical activities of MPE and a structure predicted in Phyre2 point to MPE as a new bacterial homolog of Mre11. Genetic linkage of a helicase and DNA nuclease with a ligase and a putative exonuclease (a predicted homolog of the SNM1/Apollo family of nucleases) suggests that these enzymes comprise or participate in a bacterial DNA repair pathway.	[Ejaz, Anam; Shuman, Stewart] Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10065 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [AI64693, P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI64693 and P30CA008748. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allerston CK, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1256; Aniukwu J, 2008, GENE DEV, V22, P512, DOI 10.1101/gad.1631908; Belda E, 2016, ENVIRON MICROBIOL, V18, P3403, DOI 10.1111/1462-2920.13230; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Chang HHY, 2016, NUCLEIC ACIDS RES, V44, P4991, DOI 10.1093/nar/gkw456; Clark NE, 2016, P NATL ACAD SCI USA, V113, P14727, DOI 10.1073/pnas.1612729114; Dominski Z, 2007, CRIT REV BIOCHEM MOL, V42, P67, DOI 10.1080/10409230701279118; Ejaz A, 2018, NUCLEIC ACIDS RES, V46, P442, DOI 10.1093/nar/gkx1163; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Matange N, 2015, BIOCHEM J, V467, P201, DOI 10.1042/BJ20150028; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; Ordonez H, 2013, J BIOL CHEM, V288, P14125, DOI 10.1074/jbc.M113.466854; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Paull TT, 2018, MOL CELL, V71, P419, DOI 10.1016/j.molcel.2018.06.033; Price MN, 2018, NATURE, V557, P503, DOI 10.1038/s41586-018-0124-0; Rand L, 2003, MOL MICROBIOL, V50, P1031, DOI 10.1046/j.1365-2958.2003.03765.x; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Schwer B, 2016, RNA, V22, P1819, DOI 10.1261/rna.058552.116; Wang LK, 2013, NUCLEIC ACIDS RES, V41, P5864, DOI 10.1093/nar/gkt221; Zhu H, 2010, J BIOL CHEM, V285, P4815, DOI 10.1074/jbc.M109.073874	22	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17491	17504		10.1074/jbc.RA118.005296	http://dx.doi.org/10.1074/jbc.RA118.005296			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30224353	hybrid, Green Published			2022-12-28	WOS:000449799000015
J	Ochoa-Lizarralde, B; Gao, YG; Popov, AN; Samygina, VR; Zhai, XH; Mishra, SK; Boldyrev, IA; Molotkovsky, JG; Simanshu, DK; Patel, DJ; Brown, RE; Malinina, L				Ochoa-Lizarralde, Borja; Gao, Yong-Guang; Popov, Alexander N.; Samygina, Valeria R.; Zhai, Xiuhong; Mishra, Shrawan K.; Boldyrev, Ivan A.; Molotkovsky, Julian G.; Simanshu, Dhirendra K.; Patel, Dinshaw J.; Brown, Rhoderick E.; Malinina, Lucy			Structural analyses of 4-phosphate adaptor protein 2 yield mechanistic insights into sphingolipid recognition by the glycolipid transfer protein family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid-protein interaction; sphingolipid; transport; X-ray crystallography; protein complex; protein structure; 4-phosphate-adaptor-protein-2; FAPP2; nonvesicular lipid transport; protein family	MEMBRANE INTERACTION; LIPID-BILAYERS; BOVINE BRAIN; GLTP-FOLD; PIG BRAIN; PURIFICATION; FLUORESCENCE; SPECIFICITY; REFINEMENT; PROBES	The glycolipid transfer protein (GLTP) fold defines a superfamily of eukaryotic proteins that selectively transport sphingolipids (SLs) between membranes. However, the mechanisms determining the protein selectivity for specific glycosphingolipids (GSLs) are unclear. Here, we report the crystal structure of the GLTP homology (GLTPH) domain of human 4-phosphate adaptor protein 2 (FAPP2) bound with N-oleoyl-galactosylceramide. Using this domain, FAPP2 transports glucosylceramide from its cis-Golgi synthesis site to the trans-Golgi for conversion into complex GSLs. The FAPP2-GLTPH structure revealed an element, termed the ID loop, that controls specificity in the GLTP family. We found that, in accordance with FAPP2 preference for simple GSLs, the ID loop protrudes from behind the SL headgroup-recognition center to mitigate binding by complex GSLs. Mutational analyses including GLTP and FAPP2 chimeras with swapped ID loops supported the proposed restrictive role of the FAPP2 ID loop in GSL selectivity. Comparative analysis revealed distinctly designed ID loops in each GLTP family member. This analysis also disclosed a conserved H-bond triplet that clasps both ID-loop ends together to promote structural autonomy and rigidity. The findings indicated that various ID loops work in concert with conserved recognition centers to create different specificities among family members. We also observed four bulky, conserved hydrophobic residues involved in sensor-like interactions with lipid chains in protein hydrophobic pockets and FF motifs in GLTP and FAPP2, well-positioned to provide acyl chain-dependent SL selectivity for the hydrophobic pockets. In summary, our study provides mechanistic insights into sphingolipid recognition by the GLTP fold and uncovers the elements involved in this recognition.	[Ochoa-Lizarralde, Borja; Samygina, Valeria R.; Malinina, Lucy] CIC BioGUNE, Struct Biol Unit, Technol Pk Bizkaia, Derio 48160, Spain; [Gao, Yong-Guang; Zhai, Xiuhong; Mishra, Shrawan K.; Brown, Rhoderick E.; Malinina, Lucy] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Popov, Alexander N.] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Samygina, Valeria R.] RAS, Shubnikov Inst Crystallog, FSRC Crystallog & Photon, Moscow 119333, Russia; [Boldyrev, Ivan A.; Molotkovsky, Julian G.] RAS, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Simanshu, Dhirendra K.; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA	CIC bioGUNE; University of Minnesota System; European Synchrotron Radiation Facility (ESRF); Russian Academy of Sciences; FSRC Crystallography & Photonics RAS; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Memorial Sloan Kettering Cancer Center	Brown, RE; Malinina, L (corresponding author), Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	reb@umn.edu; lucy@hi.umn.edu	Gao, Yongguang/B-8546-2012; Samygina, Valeriya R/A-9069-2014	Gao, Yongguang/0000-0002-9359-4252; Simanshu, Dhirendra/0000-0002-9717-4618; Malinina, Lucy/0000-0001-7973-1831; Samygina, Valeriya/0000-0002-1528-5972; Brown, Rhoderick/0000-0002-7337-3604	NIGMS [GM45928]; NCI [CA121493]; NHLBI [HL125353]; Ministerio de Ciencia e Innovacion Grant [BFU2010-17711]; Russian Foundation for Basic Research Grant [14-04-01671]; CIC bioGUNE funds; Abby Rockefeller Mauze Trust; Maloris Foundation; Hormel Foundation; Federal Agency of Scientific Organizations; NATIONAL CANCER INSTITUTE [R01CA121493] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045928] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ministerio de Ciencia e Innovacion Grant(Spanish Government); Russian Foundation for Basic Research Grant(Russian Foundation for Basic Research (RFBR)); CIC bioGUNE funds; Abby Rockefeller Mauze Trust; Maloris Foundation; Hormel Foundation; Federal Agency of Scientific Organizations; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or part by National Institutes of Health Grants GM45928 from NIGMS, CA121493 from NCI, and HL125353 from NHLBI; Ministerio de Ciencia e Innovacion Grant BFU2010-17711; Russian Foundation for Basic Research Grant 14-04-01671; CIC bioGUNE funds; the Abby Rockefeller Mauze Trust; the Maloris and Hormel Foundations; and the Federal Agency of Scientific Organizations. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABE A, 1982, BIOCHEM BIOPH RES CO, V104, P1386, DOI 10.1016/0006-291X(82)91403-6; ABE A, 1985, J BIOL CHEM, V260, P1231; Boldyrev IA, 2007, J LIPID RES, V48, P1518, DOI 10.1194/jlr.M600459-JLR200; BROWN RE, 1990, BIOCHIM BIOPHYS ACTA, V1044, P77, DOI 10.1016/0005-2760(90)90221-I; BROWN RE, 1985, CHEM PHYS LIPIDS, V38, P79, DOI 10.1016/0009-3084(85)90059-3; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; Carton I, 2010, BIOPHYS J, V99, P2947, DOI 10.1016/j.bpj.2010.09.016; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; D'Angelo G, 2013, NATURE, V501, DOI 10.1038/nature12423; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamlekar RK, 2013, BBA-MOL CELL BIOL L, V1831, P417, DOI 10.1016/j.bbalip.2012.10.010; Kenoth R, 2010, J BIOL CHEM, V285, P13066, DOI 10.1074/jbc.M109.093203; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Malinina L, 2006, PLOS BIOL, V4, P1996, DOI 10.1371/journal.pbio.0040362; Malinina L, 2017, ANNU REV BIOCHEM, V86, P609, DOI 10.1146/annurev-biochem-061516-044445; Malinina L, 2015, Q REV BIOPHYS, V48, P281, DOI 10.1017/S003358351400016X; Mattjus P, 1999, ANAL BIOCHEM, V268, P297, DOI 10.1006/abio.1998.3065; Mattjus P, 2016, CHEM PHYS LIPIDS, V194, P72, DOI 10.1016/j.chemphyslip.2015.07.018; Mattjus P, 2009, BBA-BIOMEMBRANES, V1788, P267, DOI 10.1016/j.bbamem.2008.10.003; METZ RJ, 1982, J BIOL CHEM, V257, P2901; Mikitova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030455; MOLOTKOVSKY JG, 1991, CHEM PHYS LIPIDS, V58, P199, DOI 10.1016/0009-3084(91)90093-Q; MOLOTKOVSKY JG, 1982, BIOORG KHIM+, V8, P1256; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohvo-Rekila H, 2011, BBA-BIOMEMBRANES, V1808, P47, DOI 10.1016/j.bbamem.2010.08.018; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Samygina VR, 2013, ACTA CRYSTALLOGR D, V69, P603, DOI 10.1107/S0907444913000024; Samygina VR, 2011, STRUCTURE, V19, P1644, DOI 10.1016/j.str.2011.09.011; Simanshu DK, 2014, CELL REP, V6, P388, DOI 10.1016/j.celrep.2013.12.023; Simanshu DK, 2013, NATURE, V500, P463, DOI 10.1038/nature12332; Sugiki T, 2010, ANAL BIOCHEM, V399, P162, DOI 10.1016/j.ab.2009.12.031; Tuuf J, 2009, BIOCHEM BIOPH RES CO, V388, P395, DOI 10.1016/j.bbrc.2009.08.023; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Zhai XH, 2017, J BIOL CHEM, V292, P2531, DOI 10.1074/jbc.M116.760256	36	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16709	16723		10.1074/jbc.RA117.000733	http://dx.doi.org/10.1074/jbc.RA117.000733			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30206120	Green Published, hybrid			2022-12-28	WOS:000448515100014
J	Torres, MJ; Ryan, TE; Lin, CT; Zeczycki, TN; Neufer, PD				Torres, Maria J.; Ryan, Terence E.; Lin, Chien-Te; Zeczycki, Tonya N.; Neufer, P. Darrell			Impact of 17 beta-estradiol on complex I kinetics and H2O2 production in liver and skeletal muscle mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						estrogen; complex I; hydrogen peroxide; liver; skeletal muscle; mitochondrial respiratory chain complex; mitochondrial function; ovariectomy	BIOIDENTICAL HORMONE-THERAPY; AMERICAN MENOPAUSE SOCIETY; FATTY-LIVER; INSULIN-RESISTANCE; POSTMENOPAUSAL WOMEN; OXIDATIVE STRESS; REDOX STATE; RAT-LIVER; ESTROGEN; DISEASE	Naturally or surgically induced postmenopausal women are widely prescribed estrogen therapies to alleviate symptoms associated with estrogen loss and to lower the subsequent risk of developing metabolic diseases, including diabetes and nonalcoholic fatty liver disease. However, the molecular mechanisms by which estrogens modulate metabolism across tissues remain ill-defined. We have previously reported that 17-estradiol (E2) exerts antidiabetogenic effects in ovariectomized (OVX) mice by protecting mitochondrial and cellular redox function in skeletal muscle. The liver is another key tissue for glucose homeostasis and a target of E2 therapy. Thus, in the present study we determined the effects of acute loss of ovarian E2 and E2 administration on liver mitochondria. In contrast to skeletal muscle mitochondria, E2 depletion via OVX did not alter liver mitochondrial respiratory function or complex I (CI) specific activities (NADH oxidation, quinone reduction, and H2O2 production). Surprisingly, in vivo E2 replacement therapy and in vitro E2 exposure induced tissue-specific effects on both CI activity and on the rate and topology of CI H2O2 production. Overall, E2 therapy protected and restored the OVX-induced reduction in CI activity in skeletal muscle, whereas in liver mitochondria E2 increased CI H2O2 production and decreased ADP-stimulated respiratory capacity. These results offer novel insights into the tissue-specific effects of E2 on mitochondrial function.	[Torres, Maria J.; Ryan, Terence E.; Lin, Chien-Te; Zeczycki, Tonya N.; Neufer, P. Darrell] East Carolina Univ, East Carolina Diabet & Obes Inst, Brody Sch Med, Greenville, NC 27834 USA; [Torres, Maria J.; Neufer, P. Darrell] East Carolina Univ, Dept Kinesiol, Brody Sch Med, Greenville, NC 27834 USA; [Ryan, Terence E.; Lin, Chien-Te; Neufer, P. Darrell] East Carolina Univ, Dept Physiol, Brody Sch Med, Greenville, NC 27834 USA; [Zeczycki, Tonya N.] East Carolina Univ, Dept Biochem & Mol Biol, Brody Sch Med, Greenville, NC 27834 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Zeczycki, TN; Neufer, PD (corresponding author), East Carolina Univ, East Carolina Diabet & Obes Inst, Brody Sch Med, Greenville, NC 27834 USA.; Neufer, PD (corresponding author), East Carolina Univ, Dept Kinesiol, Brody Sch Med, Greenville, NC 27834 USA.; Neufer, PD (corresponding author), East Carolina Univ, Dept Physiol, Brody Sch Med, Greenville, NC 27834 USA.; Zeczycki, TN (corresponding author), East Carolina Univ, Dept Biochem & Mol Biol, Brody Sch Med, Greenville, NC 27834 USA.	zeczyckit@ecu.edu; neuferp@ecu.edu	Ryan, Terence/W-5576-2019	Zeczycki, Tonya/0000-0002-5216-1960; Lin, Chien-Te/0000-0001-6449-006X; Torres, Maria J./0000-0002-7551-8053	National Institutes of Health from the NIDDK [R01 DK096907, DK110656]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110656, R01DK096907] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by National Institutes of Health Grants R01 DK096907 and DK110656 from the NIDDK (to P. D. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbas AM, 2011, CAN J PHYSIOL PHARM, V89, P497, DOI 10.1139/Y11-053; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Arnold S, 2012, J STEROID BIOCHEM, V131, P2, DOI 10.1016/j.jsbmb.2012.01.012; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Brady CW, 2015, WORLD J GASTROENTERO, V21, P7613, DOI 10.3748/wjg.v21.i25.7613; Brand MD, 2016, FREE RADICAL BIO MED, V100, P14, DOI 10.1016/j.freeradbiomed.2016.04.001; Brinton RD, 2008, TRENDS NEUROSCI, V31, P529, DOI 10.1016/j.tins.2008.07.003; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5; Cox AG, 2010, METHOD ENZYMOL, V474, P51, DOI 10.1016/S0076-6879(10)74004-0; D'Eon TM, 2005, J BIOL CHEM, V280, P35983, DOI 10.1074/jbc.M507339200; ELKIK F, 1982, AM J OBSTET GYNECOL, V143, P888, DOI 10.1016/0002-9378(82)90468-9; Fisher-Wellman KH, 2015, BIOCHEM J, V467, P271, DOI 10.1042/BJ20141447; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Garcia-Ruiz C, 2013, FREE RADICAL RES, V47, P854, DOI 10.3109/10715762.2013.830717; Giustarini D, 2013, NAT PROTOC, V8, P1660, DOI 10.1038/nprot.2013.095; Gustafsson KL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29473; Hensley K, 2000, CARCINOGENESIS, V21, P983, DOI 10.1093/carcin/21.5.983; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; Janssen I, 2008, ARCH INTERN MED, V168, P1568, DOI 10.1001/archinte.168.14.1568; Kand'ar R, 2007, J PHARMACEUT BIOMED, V43, P1382, DOI 10.1016/j.jpba.2006.11.028; Klair JS, 2016, HEPATOLOGY, V64, P85, DOI 10.1002/hep.28514; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Langer RD, 2017, MENOPAUSE, V24, P1101, DOI 10.1097/GME.0000000000000983; Levin ER, 2015, ANNU REV MED, V66, P271, DOI 10.1146/annurev-med-050913-021703; Lobo RA, 2016, ATHEROSCLEROSIS, V254, P282, DOI 10.1016/j.atherosclerosis.2016.10.005; Manson JE, 2015, MENOPAUSE, V22, P247, DOI [10.1097/gme.0000000000000373, 10.1097/GME.0000000000000373]; Mauvais-Jarvis F, 2017, ENDOCR REV, V38, P173, DOI 10.1210/er.2016-1146; Moats RK, 1998, BIOL REPROD, V58, P531, DOI 10.1095/biolreprod58.2.531; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Moreira PI, 2011, J STEROID BIOCHEM, V123, P8, DOI 10.1016/j.jsbmb.2010.09.004; Moreira PI, 2006, J BIOL CHEM, V281, P10143, DOI 10.1074/jbc.M510249200; Moreno AJM, 2013, J BIOENERG BIOMEMBR, V45, P261, DOI 10.1007/s10863-012-9497-1; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; National Center for Health Statistics, 2017, HLTH US 2016 CHARTB; Ohya S, 2005, AM J PHYSIOL-HEART C, V289, pH1635, DOI 10.1152/ajpheart.00016.2005; Orr AL, 2013, FREE RADICAL BIO MED, V65, P1047, DOI 10.1016/j.freeradbiomed.2013.08.170; Paradies G, 2014, WORLD J GASTROENTERO, V20, P14205, DOI 10.3748/wjg.v20.i39.14205; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Petrosillo G, 2007, BBA-BIOENERGETICS, V1767, P1260, DOI 10.1016/j.bbabio.2007.07.011; Phillips D, 2012, AM J PHYSIOL-REG I, V302, pR1034, DOI 10.1152/ajpregu.00596.2011; Pinkerton JV, 2017, MENOPAUSE, V24, P728, DOI 10.1097/GME.0000000000000921; Pinkerton JV, 2016, MENOPAUSE, V23, P215, DOI 10.1097/GME.0000000000000523; Pinkerton JV, 2015, MENOPAUSE, V22, P926, DOI 10.1097/GME.0000000000000420; Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301; Ransac S, 2012, BBA-BIOENERGETICS, V1817, P1958, DOI 10.1016/j.bbabio.2012.03.037; Rattanasopa C, 2015, J STEROID BIOCHEM, V147, P1, DOI 10.1016/j.jsbmb.2014.11.009; Ribas V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3815; Ribeiro RF, 2017, MITOCHONDRION, V35, P87, DOI 10.1016/j.mito.2017.05.011; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Stuenkel CA, 2015, J CLIN ENDOCR METAB, V100, P3975, DOI 10.1210/jc.2015-2236; Suzuki A, 2009, WOMENS HEALTH, V5, P191, DOI 10.2217/17455057.5.2.191; Torres MJ, 2018, CELL METAB, V27, P167, DOI 10.1016/j.cmet.2017.10.003; Verkhovskaya ML, 2008, P NATL ACAD SCI USA, V105, P3763, DOI 10.1073/pnas.0711249105; VONSCHOULTZ B, 1989, PROSTATE, V14, P389, DOI 10.1002/pros.2990140410; Wang J, 2001, J NEUROCHEM, V77, P804, DOI 10.1046/j.1471-4159.2001.00271.x; Wang ZL, 2015, MENOPAUSE, V22, P667, DOI [10.1097/gme.0000000000000352, 10.1097/GME.0000000000000352]; Wend Korinna, 2012, Front Endocrinol (Lausanne), V3, P19, DOI 10.3389/fendo.2012.00019; Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013; Yuksel N, 2017, MENOPAUSE, V24, P1129, DOI 10.1097/GME.0000000000000901; Zhu L, 2013, DIABETES, V62, P424, DOI 10.2337/db11-1718	63	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16889	16898		10.1074/jbc.RA118.005148	http://dx.doi.org/10.1074/jbc.RA118.005148			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30217819	Green Published, hybrid			2022-12-28	WOS:000448515100028
J	Turek, I; Tischer, N; Lassig, R; Trujillo, M				Turek, Ilona; Tischer, Nadine; Lassig, Roman; Trujillo, Marco			Multi-tiered pairing selectivity between E2 ubiquitin-conjugating enzymes and E3 ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; ubiquitin-conjugating enzyme (E2 enzyme); E3 ubiquitin ligase; innate immunity; cell signaling	U-BOX; NEGATIVE REGULATION; ARABIDOPSIS COP10; FLAGELLIN PERCEPTION; POLYUBIQUITIN CHAINS; INNATE IMMUNITY; DOWN-REGULATION; PLANT IMMUNITY; DROUGHT STRESS; PROTEIN-KINASE	Ubiquitination is a prevalent post-translational modification involved in all aspects of cell physiology. It is mediated by an enzymatic cascade and the E2 ubiquitin-conjugating enzymes (UBCs) lie at its heart. Even though E3 ubiquitin ligases determine the specificity of the reaction, E2s catalyze the attachment of ubiquitin and have emerged as key mediators of chain assembly. They are largely responsible for the type of linkage between ubiquitin moieties and thus, the fate endowed onto the modified substrate. However, in vivo E2-E3 pairing remains largely unexplored. We therefore interrogated the interaction selectivity between 37 Arabidopsis E2s and PUB22, a U-box type E3 ubiquitin ligase that is involved in the dampening of immune signaling. We show that whereas the U-box domain, which mediates E2 docking, is able to interact with 18 of 37 tested E2s, the substrate interacting armadillo (ARM) repeats impose a second layer of specificity, allowing the interaction with 11 E2s. In vitro activity assayed by autoubiquitination only partially recapitulated the in vivo selectivity. Moreover, in vivo pairing was modulated during the immune response; pairing with group VI UBC30 was inhibited, whereas interaction with the K63 chain-building UBC35 was increased. Functional analysis of ubc35 ubc36 mutants shows that they partially mimic pub22 pub23 pub24 enhanced activation of immune responses. Together, our work provides a framework to interrogate in vivo E2-E3 pairing and reveals a multi-tiered and dynamic E2-E3 network.	[Turek, Ilona; Tischer, Nadine; Lassig, Roman; Trujillo, Marco] Leibniz Inst Plant Biochem, Independent Jr Res Grp, D-06120 Halle, Saale, Germany; [Trujillo, Marco] Albert Ludwigs Univ Freiburg, Fac Biol, Inst Biol 2, Cell Biol, Schanzlestr 1, D-79104 Freiburg, Germany	Leibniz Institut fur Pflanzenbiochemie; University of Freiburg	Trujillo, M (corresponding author), Albert Ludwigs Univ Freiburg, Cell Biol, Inst Biol 2, Schanzlestr 1, D-79104 Freiburg, Germany.	marco.trujillo@bio.uni-freiburg.de	Trujillo, Marco/M-7900-2017	Trujillo, Marco/0000-0002-5470-7277; Turek, Ilona/0000-0001-6457-7456	Deutsche Forschungsgemeinschaft (DFG); Leibniz Gemeinschaft	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Leibniz Gemeinschaft	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) and the Leibniz Gemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bednarek P, 2010, CURR OPIN PLANT BIOL, V13, P378, DOI 10.1016/j.pbi.2010.05.002; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Chen YC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05584; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Cho SK, 2008, PLANT CELL, V20, P1899, DOI 10.1105/tpc.108.060699; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Couto D, 2016, NAT REV IMMUNOL, V16, P537, DOI 10.1038/nri.2016.77; Cui F, 2012, PLANT CELL, V24, P233, DOI 10.1105/tpc.111.093062; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Ehlert A, 2006, PLANT J, V46, P890, DOI 10.1111/j.1365-313X.2006.02731.x; Eletr ZM, 2007, J MOL BIOL, V369, P419, DOI 10.1016/j.jmb.2007.03.026; Engler C, 2014, METHODS MOL BIOL, V1116, P119, DOI 10.1007/978-1-62703-764-8_9; Fletcher AJ, 2015, EMBO J, V34, P2078, DOI 10.15252/embj.201490361; Furlan G, 2017, PLANT CELL, V29, P726, DOI 10.1105/tpc.16.00654; Gimenez-Ibanez S, 2009, PLANT SIGNAL BEHAV, V4, P539, DOI 10.4161/psb.4.6.8697; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Jacobs S, 2011, PLANT PHYSIOL, V156, P726, DOI 10.1104/pp.111.176446; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Katsiarimpa A, 2014, PLANT CELL PHYSIOL, V55, P727, DOI 10.1093/pcp/pcu019; Katsiarimpa A, 2011, PLANT CELL, V23, P3026, DOI 10.1105/tpc.111.087254; Kim DY, 2013, PLANT CELL, V25, P1523, DOI 10.1105/tpc.112.108613; Kinoshita A, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1028707; Kinoshita A, 2015, DEVELOPMENT, V142, P444, DOI 10.1242/dev.113167; Kong LY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9630; Kowarschik K, 2018, NEW PHYTOL, V217, P1749, DOI 10.1111/nph.14900; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Lau OS, 2009, BIOCHEM J, V418, P683, DOI 10.1042/BJ20081943; Lee HG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12525; Li W, 2012, PLANT PHYSIOL, V159, P239, DOI 10.1104/pp.111.192617; Li WF, 2010, PLANT J, V62, P330, DOI 10.1111/j.1365-313X.2010.04150.x; Liao DH, 2017, NEW PHYTOL, V214, P1646, DOI 10.1111/nph.14472; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; Marino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2479; Ntoukakis V, 2009, SCIENCE, V324, P784, DOI 10.1126/science.1169430; Ohi MD, 2005, MOL CELL BIOL, V25, P451, DOI 10.1128/MCB.25.1.451-460.2005; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Romero-Barrios N, 2018, NEW PHYTOL, V217, P995, DOI 10.1111/nph.14915; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Scaglione KM, 2013, J BIOL CHEM, V288, P18784, DOI 10.1074/jbc.C113.477596; Seo DH, 2016, PLANT CELL, V28, P2952, DOI 10.1105/tpc.16.00347; Seo DH, 2012, PLANT PHYSIOL, V160, P556, DOI 10.1104/pp.112.202143; Soss SE, 2013, BIOCHEMISTRY-US, V52, P2991, DOI 10.1021/bi3015949; Soss SE, 2011, J BIOL CHEM, V286, P21277, DOI 10.1074/jbc.M111.224006; Stefan E, 2007, P NATL ACAD SCI USA, V104, P16916, DOI 10.1073/pnas.0704257104; Stegmann M, 2012, PLANT CELL, V24, P4703, DOI 10.1105/tpc.112.104463; Stewart MD, 2016, CELL RES, V26, P423, DOI 10.1038/cr.2016.35; Suzuki G, 2002, GENE DEV, V16, P554, DOI 10.1101/gad.964602; Tatham MH, 2013, BIOCHEM J, V453, P137, DOI 10.1042/BJ20130244; Teh O.-k., 2018, PHOSPHORYLATION EXOC, DOI [10.1101/266171., DOI 10.1101/266171]; Trujillo M, 2008, CURR BIOL, V18, P1396, DOI 10.1016/j.cub.2008.07.085; Trujillo M, 2018, J EXP BOT, V69, P371, DOI 10.1093/jxb/erx411; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wang JL, 2018, MOL CELL, V69, P493, DOI 10.1016/j.molcel.2017.12.026; Wang YP, 2017, PLANT PHYSIOL, V173, P1235, DOI 10.1104/pp.16.00816; Wiborg J, 2008, BIOCHEM J, V413, P447, DOI 10.1042/BJ20071568; Windheim M, 2008, BIOCHEM J, V409, P723, DOI 10.1042/BJ20071338; Woodson JD, 2015, SCIENCE, V350, P450, DOI 10.1126/science.aac7444; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Yanagawa Y, 2004, GENE DEV, V18, P2172, DOI 10.1101/gad.1229504; Yin XJ, 2007, PLANT CELL, V19, P1898, DOI 10.1105/tpc.107.052035; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhou JG, 2018, P NATL ACAD SCI USA, V115, pE1906, DOI 10.1073/pnas.1712251115; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	70	26	28	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16324	16336		10.1074/jbc.RA118.004226	http://dx.doi.org/10.1074/jbc.RA118.004226			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30185618	Green Published, hybrid			2022-12-28	WOS:000447833600017
J	Cozier, GE; Acharya, KR				Cozier, Gyles E.; Acharya, K. Ravi			How a DNA mimic catches and cleaves NF-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							KAPPA-B; RECOGNITION; MECHANISM; NLEC	Bacterial pathogens use several strategies to infect host cells, one of which involves blocking host defenses. During infection, the bacterial effector proteins GtgA, GogA, PipA, and NleC are injected into host cells by the type III secretion system (T3SS), where they suppress the proinflammatory NF-B signaling pathway to dampen immune responses. The authors demonstrate that these effectors bind NF-B via their DNA-mimicking regions and uncover differences in effector sequences and structures explaining the individual specificities of these effectors for distinct NF-B subunits.	[Cozier, Gyles E.; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Claverton Down, Bath BA2 7AY, Avon, England	University of Bath	Acharya, KR (corresponding author), Univ Bath, Dept Biol & Biochem, Claverton Down, Bath BA2 7AY, Avon, England.	bsskra@bath.ac.uk		Cozier, Gyles/0000-0003-2851-0902				Baruch K, 2011, EMBO J, V30, P221, DOI 10.1038/emboj.2010.297; Chen YQ, 1998, NAT STRUCT BIOL, V5, P67, DOI 10.1038/nsb0198-67; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Jennings E, 2018, J BIOL CHEM, V293, P15316, DOI 10.1074/jbc.RA118.004255; Li WQ, 2014, ACTA CRYSTALLOGR D, V70, P40, DOI 10.1107/S1399004713024619; Pearson JS, 2011, MOL MICROBIOL, V80, P219, DOI 10.1111/j.1365-2958.2011.07568.x; Sun H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005484; Turco MM, 2014, BIOCHEMISTRY-US, V53, P5131, DOI 10.1021/bi500593e	8	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15330	15331		10.1074/jbc.H118.005528	http://dx.doi.org/10.1074/jbc.H118.005528			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30266880	Green Published, hybrid			2022-12-28	WOS:000445998400031
J	Nakazono, A; Adachi, N; Takahashi, H; Seki, T; Hamada, D; Ueyama, T; Sakai, N; Saito, N				Nakazono, Aoi; Adachi, Naoko; Takahashi, Hideyuki; Seki, Takahiro; Hamada, Daizo; Ueyama, Takehiko; Sakai, Norio; Saito, Naoaki			Pharmacological induction of heat shock proteins ameliorates toxicity of mutant PKC gamma in spinocerebellar ataxia type 14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase C (PKC); ataxia; heat shock protein (HSP); neurodegenerative disease; 70-kilodalton heat shock protein (Hsp70); heat shock protein 90 (Hsp90); Hsp40; PKC; SCA14; spinocerebellar ataxia; chaperone protein	KINASE-C-GAMMA; CULTURED PURKINJE-CELLS; CEREBELLAR-ATAXIA; MOLECULAR-MECHANISM; CELASTROL PROTECTS; SCA14 MUTATION; ENERGY CONTENT; AGGREGATION; HSP70; AUTOPHAGY	Amyloid and amyloid-like protein aggregations are hallmarks of multiple, varied neurodegenerative disorders, including Alzheimer's and Parkinson's diseases. We previously reported that spinocerebellar ataxia type 14 (SCA14), a dominant-inherited neurodegenerative disease that affects cerebellar Purkinje cells, is characterized by the intracellular formation of neurotoxic amyloid-like aggregates of genetic variants of protein kinase C (PKC gamma). A number of protein chaperones, including heat shock protein 70 (Hsp70), promote the degradation and/or refolding of misfolded proteins and thereby prevent their aggregation. Here, we report that, in various SCA14-associated, aggregating PKC gamma variants, endogenous Hsp70 is incorporated into aggregates and that expression of these PKC gamma mutants up-regulates Hsp70 expression. We observed that PKC gamma binds Hsp70 and that this interaction is enhanced in the SCA14-associated variants, mediated by the kinase domain that is involved in amyloid-like fibril formation as well as the C2 domain of PKC gamma. Pharmacological up-regulation of Hsp70 by the Hsp90 inhibitors celastrol and herbimycin A attenuated the aggregation of mutant PKC gamma in primary cultured Purkinje cells. Up-regulation of Hsp70 diminished net PKC gamma aggregation by preventing aggregate formation, resulting in decreased levels of apoptotic cell death among primary cultured Purkinje cells expressing the PKC gamma variant. Of note, herbimycin A also ameliorated abnormal dendritic development. Extending our in vitro observations, administration of celastrol to mice up-regulated cerebellar Hsp70. Our findings identify heat shock proteins as important endogenous regulators of pathophysiological PKC gamma aggregation and point to Hsp90 inhibition as a potential therapeutic strategy in the treatment of SCA14.	[Nakazono, Aoi; Adachi, Naoko; Takahashi, Hideyuki; Ueyama, Takehiko; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan; [Seki, Takahiro] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Chemicopharmacol Sci, Kumamoto 8620973, Japan; [Hamada, Daizo] Kobe Univ, Grad Sch Engn, Chuo Ku, 7-1-48 Minatojima Minami Machi, Kobe, Hyogo 6500047, Japan; [Hamada, Daizo] Kobe Univ, CASS, 7-1-48 Minatojima Minami Machi, Kobe, Hyogo 6500047, Japan; [Sakai, Norio] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Pharmacol Neurosci, Hiroshima 7348551, Japan; [Takahashi, Hideyuki] Yale Univ, Sch Med, Dept Neurol, Cellular Neurosci Neurodegenerat & Repair Program, 333 Cedar St, New Haven, CT 06536 USA; [Takahashi, Hideyuki] Yale Univ, Sch Med, Dept Neurobiol, Cellular Neurosci Neurodegenerat & Repair Program, 333 Cedar St, New Haven, CT 06536 USA	Kobe University; Kumamoto University; Kobe University; Kobe University; Hiroshima University; Yale University; Yale University	Adachi, N; Saito, N (corresponding author), Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan.	na@gold.kobe-u.ac.jp; naosaito@kobe-u.ac.jp	Sakai, Norio/AAM-5822-2021; Hamada, Daizo/N-1118-2016	Sakai, Norio/0000-0002-6648-8761; Hamada, Daizo/0000-0002-1799-5476; Adachi, Naoko/0000-0002-8797-0717; Seki, Takahiro/0000-0002-9894-4768	Joint Research Program of the Biosignal Research Center, Kobe University [281007]; JSPS KAKENHI [JP25293060, JP17H04032]	Joint Research Program of the Biosignal Research Center, Kobe University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Joint Research Program of the Biosignal Research Center, Kobe University Grant 281007, and by JSPS KAKENHI Grants JP25293060 and JP17H04032. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi N, 2008, J BIOL CHEM, V283, P19854, DOI 10.1074/jbc.M801492200; Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Asai H, 2009, HUM MOL GENET, V18, P3533, DOI 10.1093/hmg/ddp298; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; Cascao R, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00069; Chen DH, 2003, AM J HUM GENET, V72, P839, DOI 10.1086/373883; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Deane CAS, 2016, CELL STRESS CHAPERON, V21, P837, DOI 10.1007/s12192-016-0708-2; Deng YN, 2013, NEUROCHEM INT, V63, P1, DOI 10.1016/j.neuint.2013.04.005; DeTure M, 2002, AM J PATHOL, V161, P1711, DOI 10.1016/S0002-9440(10)64448-3; Divya T, 2017, PULM PHARMACOL THER, V45, P47, DOI 10.1016/j.pupt.2017.04.003; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Duncan RF, 2005, FEBS J, V272, P5244, DOI 10.1111/j.1742-4658.2005.04921.x; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; Ganos C, 2014, CEREBELLUM, V13, P89, DOI 10.1007/s12311-013-0522-7; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Guo JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140745; GUPTA RS, 1995, MOL MICROBIOL, V15, P1, DOI 10.1111/j.1365-2958.1995.tb02216.x; Hamel L, 2000, CELL STRESS CHAPERON, V5, P121, DOI 10.1379/1466-1268(2000)005<0121:IOHSPB>2.0.CO;2; Hylander BL, 2000, BRAIN RES, V869, P49, DOI 10.1016/S0006-8993(00)02346-5; Isambert N, 2015, ANN ONCOL, V26, P1005, DOI 10.1093/annonc/mdv031; Jezierska J, 2014, J NEUROCHEM, V128, P741, DOI 10.1111/jnc.12491; Kalmar B, 2009, CELL MOL BIOL LETT, V14, P319, DOI 10.2478/s11658-009-0002-8; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Koht J, 2012, ACTA NEUROL SCAND, V125, P116, DOI 10.1111/j.1600-0404.2011.01504.x; KOSE A, 1988, J NEUROSCI, V8, P4262; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Li JX, 2010, NEURON, V68, P45, DOI 10.1016/j.neuron.2010.08.013; Liu JL, 2015, CELL, V161, P999, DOI 10.1016/j.cell.2015.05.011; Luo WJ, 2007, P NATL ACAD SCI USA, V104, P9511, DOI 10.1073/pnas.0701055104; Ma XR, 2015, CELL METAB, V22, P695, DOI 10.1016/j.cmet.2015.08.005; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McFarland NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086048; Neef DW, 2011, NAT REV DRUG DISCOV, V10, P930, DOI 10.1038/nrd3453; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Ogawa K, 2013, BIOCHEM BIOPH RES CO, V440, P25, DOI 10.1016/j.bbrc.2013.09.013; Paris D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-17; Sailer A, 2012, NEUROLOGY, V79, P127, DOI 10.1212/WNL.0b013e31825f048e; SAITO N, 1988, J NEUROSCI, V8, P369; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Seki T, 2005, J BIOL CHEM, V280, P29096, DOI 10.1074/jbc.M501716200; Seki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031232; Seki T, 2011, J PHARMACOL SCI, V116, P239, DOI 10.1254/jphs.11R04CP; Seki T, 2010, J PHARMACOL SCI, V114, P206, DOI 10.1254/jphs.10170FP; Seki T, 2010, J BIOL CHEM, V285, P33252, DOI 10.1074/jbc.M110.146704; Seki T, 2009, NEUROBIOL DIS, V33, P260, DOI 10.1016/j.nbd.2008.10.013; Shen HY, 2005, J BIOL CHEM, V280, P39962, DOI 10.1074/jbc.M505524200; Shuvaev AN, 2011, J NEUROSCI, V31, P14324, DOI 10.1523/JNEUROSCI.5530-10.2011; Silva-Fernandes A, 2014, NEUROTHERAPEUTICS, V11, P433, DOI 10.1007/s13311-013-0255-9; Smeets CJLM, 2016, NEUROBIOL DIS, V88, P96, DOI 10.1016/j.nbd.2016.01.009; Sousa MC, 1998, BIOCHEMISTRY-US, V37, P15392, DOI 10.1021/bi981510x; Takahashi H, 2015, HUM MOL GENET, V24, P525, DOI 10.1093/hmg/ddu472; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Ueda T, 2013, J NEUROL, V260, P1664, DOI 10.1007/s00415-013-6916-0; van Gaalen J, 2013, MOVEMENT DISORD, V28, P1902, DOI 10.1002/mds.25572; Verbeek DS, 2005, BRAIN, V128, P436, DOI 10.1093/brain/awh378; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Wyttenbach A, 2004, J MOL NEUROSCI, V23, P69, DOI 10.1385/JMN:23:1-2:069; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Yamamoto K, 2010, GENES CELLS, V15, P425, DOI 10.1111/j.1365-2443.2010.01395.x; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhang YQ, 2007, J MOL MED-JMM, V85, P1421, DOI 10.1007/s00109-007-0251-9	68	10	11	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14758	14774		10.1074/jbc.RA118.002913	http://dx.doi.org/10.1074/jbc.RA118.002913			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30093405	Green Published, hybrid			2022-12-28	WOS:000446155000014
J	Gottesfeld, JM; Carey, MF				Gottesfeld, Joel M.; Carey, Michael F.			Introduction to the Thematic Minireview Series: Chromatin and transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						RNA polymerase; transcription; chromatin; nucleosome; epigenetics	RNA-POLYMERASE-II; STRUCTURAL INSIGHTS; INITIATION; ACTIVATION; NUCLEOSOME; MEDIATOR; COMPLEX	Regulation of transcription in eukaryotic cells is a dynamic interplay between chromatin structure and recruitment of a plethora of transcription factors to enhancers, upstream activator sequences, and proximal promoter elements. These factors serve to recruit RNA polymerase to the core promoter for productive transcription. In this Thematic Minireview Series on chromatin and transcription, five reviews summarize current knowledge of diverse aspects of transcriptional regulation and the role of chromatin structure in transcription and development.	[Gottesfeld, Joel M.] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Gottesfeld, Joel M.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Carey, Michael F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Gottesfeld, JM (corresponding author), Scripps Res Inst, Dept Mol Med MB 27, La Jolla, CA 92037 USA.	joelg@scripps.edu		Carey, Michael/0000-0003-3899-6280	National Institutes of Health [5R01-NS062856, 5RO1-EY026490, 1RO1-EY029166, 2R01-GM074701]; BioMarin Pharmaceutical; NATIONAL EYE INSTITUTE [R01EY029166, R01EY026490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BioMarin Pharmaceutical(Johnson & Johnson); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (5R01-NS062856, 5RO1-EY026490, and 1RO1-EY029166) and BioMarin Pharmaceutical (to J. M. G.) and by National Institutes of Health Grant 2R01-GM074701 (to M. F. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; Gold HB, 2018, J BIOL CHEM, V293, P13815, DOI 10.1074/jbc.R117.001561; Grunberg S, 2013, TRENDS BIOCHEM SCI, V38, P603, DOI 10.1016/j.tibs.2013.09.002; Hantsche M, 2017, CURR OPIN STRUC BIOL, V47, P17, DOI 10.1016/j.sbi.2017.03.013; Harper TM, 2018, J BIOL CHEM, V293, P13778, DOI 10.1074/jbc.R117.794438; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Jung YH, 2017, CELL REP, V18, P1366, DOI 10.1016/j.celrep.2017.01.034; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Liu X, 2013, BBA-GENE REGUL MECH, V1829, P2, DOI 10.1016/j.bbagrm.2012.09.003; Ngoc LV, 2017, GENE DEV, V31, P1289, DOI 10.1101/gad.303149.117; Mayran A, 2018, J BIOL CHEM, V293, P13795, DOI 10.1074/jbc.R117.001232; Meng H, 2018, J BIOL CHEM, V293, P13786, DOI 10.1074/jbc.R117.813485; Moritz LE, 2018, J BIOL CHEM, V293, P13805, DOI 10.1074/jbc.R117.800367; Muller F, 2007, J BIOL CHEM, V282, P14685, DOI 10.1074/jbc.R700012200; Nogales E, 2017, ANNU REV BIOPHYS, V46, P59, DOI 10.1146/annurev-biophys-070816-033751	19	9	11	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13775	13777		10.1074/jbc.TM118.004544	http://dx.doi.org/10.1074/jbc.TM118.004544			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30068547	Green Published, hybrid			2022-12-28	WOS:000444070700002
J	Qian, KV; Wang, SM; Fu, MN; Zhou, JF; Singh, JP; Li, MD; Yang, YF; Zhang, KS; Wu, J; Nie, YZ; Ruan, HB; Yang, XY				Qian, Kevin; Wang, Simeng; Fu, Minnie; Zhou, Jinfeng; Singh, Jay Prakash; Li, Min-Dian; Yang, Yunfan; Zhang, Kaisi; Wu, Jing; Nie, Yongzhan; Ruan, Hai-Bin; Yang, Xiaoyong			Transcriptional regulation of O-GlcNAc homeostasis is disrupted in pancreatic cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-linked N-acetylglucosamine (O-GlcNAc); O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); E1A binding protein p300 (P300); CCAAT-enhancer-binding protein (C; EBP); extracellular-signal-regulated kinase (ERK); pancreatic cancer; O-GlcNAcase (OGA)	BETA-N-ACETYLGLUCOSAMINE; ACTIVATED PROTEIN-KINASE; GLUCOSE DEPRIVATION; LINKING METABOLISM; UP-REGULATION; C/EBP-BETA; GLCNACYLATION; TRANSFERASE; PHOSPHORYLATION; GLYCOSYLATION	Many intracellular proteins are reversibly modified by O-linked GlcNAc (O-GlcNAc), a post-translational modification that dynamically regulates fundamental cellular processes in response to diverse environmental cues. Accumulating evidence indicates that both excess and deficiency of protein O-GlcNAcylation can have deleterious effects on the cell, suggesting that maintenance of O-GlcNAc homeostasis is essential for proper cellular function. However, the mechanisms through which O-GlcNAc homeostasis is maintained in the physiologic state and altered in the disease state have not yet been investigated. Here, we demonstrate the existence of a homeostatic mechanism involving mutual regulation of the O-GlcNAc-cycling enzymes O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA) at the transcriptional level. Specifically, we found that OGA promotes Ogt transcription through cooperation with the histone acetyltransferase p300 and transcription factor CCAAT/enhancer-binding protein (C/EBP). To examine the role of mutual regulation of OGT and OGA in the disease state, we analyzed gene expression data from human cancer data sets, which revealed that OGT and OGA expression levels are highly correlated in numerous human cancers, particularly in pancreatic adenocarcinoma. Using a Kras(G12D)-driven primary mouse pancreatic ductal adenocarcinoma (PDAC) cell line, we found that inhibition of extracellular signal-regulated kinase (ERK) signaling decreases OGA glycosidase activity and reduces OGT mRNA and protein levels, suggesting that ERK signaling may alter O-GlcNAc homeostasis in PDAC by modulating OGA-mediated Ogt transcription. Our study elucidates a transcriptional mechanism that regulates cellular O-GlcNAc homeostasis, which may lay a foundation for exploring O-GlcNAc signaling as a therapeutic target for human disease.	[Qian, Kevin; Wang, Simeng; Fu, Minnie; Singh, Jay Prakash; Li, Min-Dian; Yang, Yunfan; Zhang, Kaisi; Wu, Jing; Yang, Xiaoyong] Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, 333 Cedar St, New Haven, CT 06510 USA; [Qian, Kevin; Wang, Simeng; Fu, Minnie; Singh, Jay Prakash; Li, Min-Dian; Yang, Yunfan; Zhang, Kaisi; Wu, Jing; Yang, Xiaoyong] Yale Univ, Sch Med, Dept Comparat Med, 333 Cedar St, New Haven, CT 06510 USA; [Qian, Kevin; Li, Min-Dian; Zhang, Kaisi; Yang, Xiaoyong] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Wang, Simeng; Zhou, Jinfeng; Nie, Yongzhan] Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Wu, Jing] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian 710049, Shaanxi, Peoples R China; [Ruan, Hai-Bin] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA	Yale University; Yale University; Yale University; Air Force Military Medical University; Xi'an Jiaotong University; University of Minnesota System; University of Minnesota Twin Cities	Yang, XY (corresponding author), Yale Univ, Sch Med, Dept Comparat Med, 333 Cedar St, New Haven, CT 06510 USA.	xiaoyong.yang@yale.edu	Yang, Yunfan/AAN-9231-2020; Li, Min-Dian/F-1721-2015; Ruan, Hai-Bin/AAN-7777-2021; Wang, Simeng/W-8686-2018	Yang, Yunfan/0000-0002-5266-7208; Li, Min-Dian/0000-0002-3650-1507; Ruan, Hai-Bin/0000-0002-3858-1272; 	National Institutes of Health [R01 DK089098, R01DK102648, P01DK057751]; American Cancer Society [RSG-14-244-01-TBE]; State of Connecticut [DPH2014-0139]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057751, R01DK102648, R01DK089098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); State of Connecticut; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 DK089098, R01DK102648, and P01DK057751; American Cancer Society Grant RSG-14-244-01-TBE; and State of Connecticut Grant DPH2014-0139 (to X. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Burotto M, 2014, CANCER-AM CANCER SOC, V120, P3446, DOI 10.1002/cncr.28864; Carlson SM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002010; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Champattanachai V, 2013, PROTEOMICS, V13, P2088, DOI 10.1002/pmic.201200126; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Ferrari A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00182-7; Ferrer CM, 2016, J MOL BIOL, V428, P3282, DOI 10.1016/j.jmb.2016.05.028; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Groves JA, 2017, J BIOL CHEM, V292, P6493, DOI 10.1074/jbc.M116.760785; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Josefowicz SZ, 2016, MOL CELL, V64, P347, DOI 10.1016/j.molcel.2016.09.026; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Krzeslak A, 2012, CLIN EXP MED, V12, P61, DOI 10.1007/s10238-011-0138-5; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Li X, 2009, J BIOL CHEM, V284, P19248, DOI 10.1074/jbc.M109.005678; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Muthusamy S, 2015, J BIOL CHEM, V290, P31013, DOI 10.1074/jbc.M115.677534; Okamura Y, 2015, NUCLEIC ACIDS RES, V43, pD82, DOI 10.1093/nar/gku1163; Park SK, 2017, CELL REP, V20, P1088, DOI 10.1016/j.celrep.2017.07.017; Rajbhandari P, 2018, CELL, V172, P218, DOI 10.1016/j.cell.2017.11.019; Ruan HB, 2017, GENE DEV, V31, P1655, DOI 10.1101/gad.305441.117; Ruan HB, 2014, CELL, V159, P306, DOI 10.1016/j.cell.2014.09.010; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Shen TJ, 2001, MOL CELL BIOL, V21, P6122, DOI 10.1128/MCB.21.18.6122-6131.2001; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Taylor RP, 2009, J BIOL CHEM, V284, P3425, DOI 10.1074/jbc.M803198200; Wang T, 2017, NAT CELL BIOL, V19, P833, DOI 10.1038/ncb3562; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Yang YR, 2014, ADV BIOCHEM HEALTH D, V10, P3, DOI 10.1007/978-1-4939-0464-8_1; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/nchembio.797, 10.1038/NCHEMBIO.797]; Zhang ER, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aag0486; Zhang XL, 2015, MOL CELL BIOCHEM, V410, P101, DOI 10.1007/s11010-015-2542-8; Zhang Z, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00206	58	43	43	1	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13989	14000		10.1074/jbc.RA118.004709	http://dx.doi.org/10.1074/jbc.RA118.004709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30037904	Green Published, hybrid			2022-12-28	WOS:000444070700023
J	Domingues, MN; Souza, FHM; Vieira, PS; de Morais, MAB; Zanphorlin, LM; dos Santos, CR; Pirolla, RAS; Honorato, RV; de Oliveira, PSL; Gozzo, FC; Murakami, MT				Domingues, Mariane Noronha; Moreira Souza, Flavio Henrique; Vieira, Plinio Salmazo; Bueno de Morais, Mariana Abrahao; Zanphorlin, Leticia Maria; dos Santos, Camila Ramos; Siqueira Pirolla, Renan Augusto; Honorato, Rodrigo Vargas; Lopes de Oliveira, Paulo Sergio; Gozzo, Fabio Cesar; Murakami, Mario Tyago			Structural basis of exo--mannanase activity in the GH2 family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; enzyme; enzyme catalysis; protein structure; protein conformation; site-directed mutagenesis; exo--mannanase; GH2 family; molecular mechanism; Xanthomonas axonopodis pv; citri	BIOLOGICAL MACROMOLECULES; STRUCTURE REFINEMENT; SOLUTION SCATTERING; BETA-GALACTOSIDASE; MOLECULAR GRAPHICS; CRYSTAL-STRUCTURE; GUAR GUM; SPECIFICITY; MANNOSIDASE; RESOLUTION	The classical microbial strategy for depolymerization of -mannan polysaccharides involves the synergistic action of at least two enzymes, endo-1,4--mannanases and -mannosidases. In this work, we describe the first exo--mannanase from the GH2 family, isolated from Xanthomonas axonopodis pv. citri (XacMan2A), which can efficiently hydrolyze both manno-oligosaccharides and -mannan into mannose. It represents a valuable process simplification in the microbial carbon uptake that could be of potential industrial interest. Biochemical assays revealed a progressive increase in the hydrolysis rates from mannobiose to mannohexaose, which distinguishes XacMan2A from the known GH2 -mannosidases. Crystallographic analysis indicates that the active-site topology of XacMan2A underwent profound structural changes at the positive-subsite region, by the removal of the physical barrier canonically observed in GH2 -mannosidases, generating a more open and accessible active site with additional productive positive subsites. Besides that, XacMan2A contains two residue substitutions in relation to typical GH2 -mannosidases, Gly(439) and Gly(556), which alter the active site volume and are essential to its mode of action. Interestingly, the only other mechanistically characterized mannose-releasing exo--mannanase so far is from the GH5 family, and its mode of action was attributed to the emergence of a blocking loop at the negative-subsite region of a cleft-like active site, whereas in XacMan2A, the same activity can be explained by the removal of steric barriers at the positive-subsite region in an originally pocket-like active site. Therefore, the GH2 exo--mannanase represents a distinct molecular route to this rare activity, expanding our knowledge about functional convergence mechanisms in carbohydrate-active enzymes.	[Bueno de Morais, Mariana Abrahao; Zanphorlin, Leticia Maria; dos Santos, Camila Ramos; Murakami, Mario Tyago] Brazilian Bioethanol Sci & Technol Lab, BR-13083970 Campinas, SP, Brazil; [Honorato, Rodrigo Vargas; Lopes de Oliveira, Paulo Sergio] Brazilian Ctr Res Energy & Mat, Brazilian Biosci Natl Lab, BR-13083970 Campinas, SP, Brazil; [Gozzo, Fabio Cesar] Univ Estadual Campinas, Dalton Mass Spectrometry Lab, BR-13083970 Campinas, SP, Brazil	Universidade Estadual de Campinas	Murakami, MT (corresponding author), Brazilian Ctr Res Energy & Mat, Brazilian Bioethanol Sci & Technol Lab, Giuseppe Maximo Scolfaro 10000, BR-13083970 Campinas, SP, Brazil.	mario.murakami@ctbe.cnpem.br	Oliveira, Paulo S/K-5588-2013; Murakami, Mario T/F-5640-2016; Santos, Camila Ramos dos/F-7095-2013; Vargas Honorato, Rodrigo/H-9773-2013	Murakami, Mario T/0000-0002-0405-8010; Santos, Camila Ramos dos/0000-0003-0652-4211; Domingues, Mariane/0000-0003-0229-8261; Morais, Mariana Abrahao Bueno de/0000-0003-1012-1394; Pirolla, Renan/0000-0002-0949-8875; Vargas Honorato, Rodrigo/0000-0001-5267-3002	Sao Paulo Research Foundation (FAPESP) [2015/26982-0]; FAPESP [2013/24622-0, 2016/06509-0, 2016/19995-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation (FAPESP) Grant 2015/26982-0 (to M. T. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ardevol A, 2015, J AM CHEM SOC, V137, P7528, DOI 10.1021/jacs.5b01156; BETTIOL JLP, 2000, Patent No. 1059351; Brett C. T., 1996, TOPICS PLANT FUNCTIO; Capek P, 2000, CARBOHYD RES, V329, P635, DOI 10.1016/S0008-6215(00)00210-X; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Chauhan PS, 2014, BIOPROC BIOSYST ENG, V37, P1459, DOI 10.1007/s00449-013-1118-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Dias FMV, 2004, J BIOL CHEM, V279, P25517, DOI 10.1074/jbc.M401647200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Cairo JPLF, 2013, INSECT BIOCHEM MOLEC, V43, P970, DOI 10.1016/j.ibmb.2013.07.007; Fushinobu S, 2005, J BIOL CHEM, V280, P17180, DOI 10.1074/jbc.M413693200; Ge X, 2001, ANAL CHEM, V73, P5078, DOI 10.1021/ac0105890; Guillotin L, 2017, BIOCHIMIE, V137, P190, DOI 10.1016/j.biochi.2017.03.020; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; Hashimoto H, 2006, CELL MOL LIFE SCI, V63, P2954, DOI 10.1007/s00018-006-6195-3; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Jin Y, 2016, ACS CENTRAL SCI, V2, P896, DOI 10.1021/acscentsci.6b00232; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lavoie J. M., 2011, BIOFUELS ENG PROCESS, V29, P307; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Malgas S, 2015, WORLD J MICROB BIOT, V31, P1167, DOI 10.1007/s11274-015-1878-2; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mussini F. J., 2011, International Journal of Poultry Science, V10, P778; Naran R, 2007, PLANT J, V50, P95, DOI 10.1111/j.1365-313X.2007.03033.x; Nascimento AS, 2014, FEBS J, V281, P4165, DOI 10.1111/febs.12894; Nunes FM, 2006, J AGR FOOD CHEM, V54, P3428, DOI 10.1021/jf052971+; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pangsri P, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1565-7; Parisi GC, 2002, DIGEST DIS SCI, V47, P1697, DOI 10.1023/A:1016419906546; Pee V, 2002, Patent, Patent No. [EP0871596, 0871596]; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; SANDIN RL, 1987, J MED MICROBIOL, V24, P145, DOI 10.1099/00222615-24-2-145; Santos CR, 2014, J BIOL CHEM, V289, P7362, DOI 10.1074/jbc.M113.537167; Santos CR, 2014, J BIOL CHEM, V289, P32186, DOI 10.1074/jbc.M114.605105; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Skalova T, 2005, J MOL BIOL, V353, P282, DOI 10.1016/j.jmb.2005.08.028; Srivastava PK, 2014, PREP BIOCHEM BIOTECH, V44, P392, DOI 10.1080/10826068.2013.833108; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tailford LE, 2008, NAT CHEM BIOL, V4, P306, DOI 10.1038/nchembio.81; Tailford LE, 2007, J BIOL CHEM, V282, P11291, DOI 10.1074/jbc.M610964200; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Zyl WH, 2010, PROCESS BIOCHEM, V45, P1203, DOI 10.1016/j.procbio.2010.05.011; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Yamabhai M, 2016, CRIT REV BIOTECHNOL, V36, P32, DOI 10.3109/07388551.2014.923372	61	11	11	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13636	13649		10.1074/jbc.RA118.002374	http://dx.doi.org/10.1074/jbc.RA118.002374			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29997257	hybrid, Green Published			2022-12-28	WOS:000443375500023
J	King, MT; Huh, I; Shenai, A; Brooks, TM; Brooks, CL				King, Moeko Toride; Huh, Ian; Shenai, Akhilesh; Brooks, Teresa M.; Brooks, Cory L.			Structural basis of VHH-mediated neutralization of the food-borne pathogen Listeria monocytogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; single-domain antibody (sdAb; nanobody); structural biology; protein-protein interaction; virulence factor; Listeria; receptor endocytosis; virulence factor	MULTISTATE OUTBREAK; MAMMALIAN-CELLS; SURFACE PROTEIN; INIB PROTEIN; INVASION; ANTIBODY; ENTRY; INLB; INTERNALIN; RECEPTOR	Listeria monocytogenes causes listeriosis, a potentially fatal food-borne disease. The condition is especially harmful to pregnant women. Listeria outbreaks can originate from diverse foods, highlighting the need for novel strategies to improve food safety. The first step in Listeria invasion is internalization of the bacteria, which is mediated by the interaction of the internalin family of virulence factors with host cell receptors. A crucial interaction for Listeria invasion of the placenta, and thus a target for therapeutic intervention, is between internalin B (InlB) and the receptor c-Met. Single-domain antibodies (VHH, also called nanobodies, or sdAbs) from camel heavy-chain antibodies are a novel solution for preventing Listeria infections. The VHH R303, R330, and R326 all bind InlB with high affinity; however, the molecular mechanism behind their mode of action was unknown. We demonstrate that despite a high degree of sequence and structural diversity, the VHH bind a single epitope on InlB. A combination of gentamicin protection assays and florescent microscopy establish that InlB-specific VHH inhibit Listeria invasion of HeLa cells. A high-resolution X-ray structure of VHH R303 in complex with InlB showed that the VHH binds at the c-Met interaction site on InlB, thereby acting as a competitive inhibitor preventing bacterial invasion. These results point to the potential of VHH as a novel class of therapeutics for the prevention of listeriosis.	[King, Moeko Toride; Huh, Ian; Shenai, Akhilesh; Brooks, Teresa M.; Brooks, Cory L.] Calif State Univ Fresno, Dept Chem, 2555 E San Ramon Ave, Fresno, CA 93740 USA	California State University System; California State University Fresno	Brooks, CL (corresponding author), Calif State Univ Fresno, Dept Chem, 2555 E San Ramon Ave, Fresno, CA 93740 USA.	cbrooks@csufresno.edu			NIGMS, National Institutes of Health [SC3GM112532]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM112532] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grant SC3GM112532. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adolf-Bryfogle J, 2015, NUCLEIC ACIDS RES, V43, pD432, DOI 10.1093/nar/gku1106; Agerer F, 2004, J MICROBIOL METH, V59, P23, DOI 10.1016/j.mimet.2004.05.008; Allerberger F, 2003, FEMS IMMUNOL MED MIC, V35, P183, DOI 10.1016/S0928-8244(02)00447-9; Angelo KM, 2017, EPIDEMIOL INFECT, V145, P848, DOI 10.1017/S0950268816003083; Banerjee M, 2004, MOL MICROBIOL, V52, P257, DOI 10.1111/j.1365-2958.2003.03968.x; Braun L, 1999, MOL MICROBIOL, V34, P10, DOI 10.1046/j.1365-2958.1999.01560.x; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Charlier C, 2017, LANCET INFECT DIS, V17, P510, DOI [10.1016/s1473-3099(16)30521-7, 10.1016/S1473-3099(16)30521-7]; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; Dussurget O, 2004, ANNU REV MICROBIOL, V58, P587, DOI 10.1146/annurev.micro.57.030502.090934; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garner D, 2016, J FOOD PROTECT, V79, P337, DOI 10.4315/0362-028X.JFP-15-387; Gene RW, 2015, J IMMUNOL METHODS, V416, P29, DOI 10.1016/j.jim.2014.10.009; Greiffenberg L, 1998, INFECT IMMUN, V66, P5260, DOI 10.1128/IAI.66.11.5260-5267.1998; Grochulski P, 2011, J SYNCHROTRON RADIAT, V18, P681, DOI 10.1107/S0909049511019431; Hof H, 1997, CLIN MICROBIOL REV, V10, P345, DOI 10.1128/CMR.10.2.345; Huh I, 2014, ACTA CRYSTALLOGR F, V70, P1532, DOI 10.1107/S2053230X1402010X; Janakiraman Vanitha, 2008, Rev Obstet Gynecol, V1, P179; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; Kubala MH, 2010, PROTEIN SCI, V19, P2389, DOI 10.1002/pro.519; Kumaran Jyothi, 2012, Methods Mol Biol, V911, P105, DOI 10.1007/978-1-61779-968-6_7; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; LINGNAU A, 1995, INFECT IMMUN, V63, P3896, DOI 10.1128/IAI.63.10.3896-3903.1995; Lo AWH, 2014, J BIOL CHEM, V289, P25374, DOI 10.1074/jbc.M114.566257; Ma LF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026310; Madjunkov M, 2017, ARCH GYNECOL OBSTET, V296, P143, DOI 10.1007/s00404-017-4401-1; Malik AA, 2016, TOXINS, V8, DOI 10.3390/toxins8040099; Marino M, 1999, MOL CELL, V4, P1063, DOI 10.1016/S1097-2765(00)80234-8; McCollum JT, 2013, NEW ENGL J MED, V369, P944, DOI 10.1056/NEJMoa1215837; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Mylonakis E, 2002, MEDICINE, V81, P260, DOI 10.1097/00005792-200207000-00002; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Puthiyakunnon S, 2017, CURR TOP MED CHEM, V17, P278, DOI 10.2174/1568026616666160829162313; Radoshevich L, 2018, NAT REV MICROBIOL, V16, P32, DOI 10.1038/nrmicro.2017.126; Schubert WD, 2003, CHEMBIOCHEM, V4, P1285, DOI 10.1002/cbic.200300624; Shali A, 2018, INT J BIOL MACROMOL, V114, P1267, DOI 10.1016/j.ijbiomac.2018.03.034; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Sulea T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20599-4; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Yao GR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07457-5; Zhang YZ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0796-y	47	13	15	4	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13626	13635		10.1074/jbc.RA118.003888	http://dx.doi.org/10.1074/jbc.RA118.003888			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29976754	hybrid, Green Published			2022-12-28	WOS:000443375500022
J	Luczkowiak, J; Matamoros, T; Menendez-Arias, L				Luczkowiak, Joanna; Matamoros, Tania; Menendez-Arias, Luis			Template-primer binding affinity and RNase H cleavage specificity contribute to the strand transfer efficiency of HIV-1 reverse transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						reverse transcription; human immunodeficiency virus (HIV); DNA synthesis; retrovirus; ribonuclease; RNase H; strand transfer; template-primer binding	NONTEMPLATED NUCLEOTIDE ADDITION; COPY-CHOICE RECOMBINATION; NUCLEOCAPSID PROTEIN; DNA-SYNTHESIS; LIBRARY CONSTRUCTION; STEADY-STATE; FREQUENCY; FIDELITY; REPLICATION; MUTATIONS	During reverse transcription of the HIV-1 genome, two strand-transfer events occur. Both events rely on the RNase H cleavage activity of reverse transcriptases (RTs) and template homology. Using a panel of mutants of HIV-1(BH10) (group M/subtype B) and HIV-1(ESP49) (group O) RTs and in vitro assays, we demonstrate that there is a strong correlation between RT minus-strand transfer efficiency and template-primer binding affinity. The highest strand transfer efficiencies were obtained with HIV-1(ESP49) RT mutants containing the substitutions K358R/A359G/S360A, alone or in combination with V148I or T355A/Q357M. These HIV-1(ESP49) RT mutants had been previously engineered to increase their DNA polymerase activity at high temperatures. Now, we found that RTs containing RNase H-inactivating mutations (D443N or E478Q) were devoid of strand transfer activity, whereas enzymes containing F61A or L92P had very low strand transfer activity. The strand transfer defect produced by L92P was attributed to a loss of template-primer binding affinity and, more specifically, to the higher dissociation rate constants (k(off)) shown by RTs bearing this substitution. Although L92P also deleteriously affected the RT's nontemplated nucleotide addition activity, neither nontemplated nucleotide addition activity nor the RT's clamp activities contributed to increased template switching when all tested mutant and WT RTs were considered. Interestingly, our results also revealed an association between efficient strand transfer and the generation of secondary cleavages in the donor RNA, consistent with the creation of invasion sites. Exposure of the elongated DNA at these sites facilitate acceptor (RNA or DNA) binding and promote template switching.	CSIC, Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera 1,Campus Cantoblanco, Madrid 28049, Spain; Univ Autonoma Madrid, C Nicolas Cabrera 1,Campus Cantoblanco, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Menendez-Arias, L (corresponding author), Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera 1,Campus Cantoblanco, Madrid 28049, Spain.	lmenendez@cbm.csic.es	Luczkowiak, Joanna/H-3912-2014; Menendez Arias, Luis/N-7447-2016	Luczkowiak, Joanna/0000-0001-6950-9372; Menendez Arias, Luis/0000-0002-1251-6640				Agopian A, 2007, J MOL BIOL, V373, P127, DOI 10.1016/j.jmb.2007.07.044; Alvarez M, 2009, J MOL BIOL, V392, P872, DOI 10.1016/j.jmb.2009.07.081; Basu VP, 2008, VIRUS RES, V134, P19, DOI 10.1016/j.virusres.2007.12.017; Berkhout B, 2001, RNA, V7, P1097, DOI 10.1017/S1355838201002035; Betancor G, 2010, ANTIMICROB AGENTS CH, V54, P4799, DOI 10.1128/AAC.00716-10; Boretto J, 2001, ANAL BIOCHEM, V292, P139, DOI 10.1006/abio.2001.5045; Brincat JL, 2002, J VIROL, V76, P88, DOI 10.1128/JVI.76.1.88-95.2002; Cameron CE, 1997, P NATL ACAD SCI USA, V94, P6700, DOI 10.1073/pnas.94.13.6700; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; COFFIN JM, 1979, J GEN VIROL, V42, P1, DOI 10.1099/0022-1317-42-1-1; Darlix JL, 2011, J MOL BIOL, V410, P565, DOI 10.1016/j.jmb.2011.03.037; Delviks-Frankenberry K, 2011, VIRUSES-BASEL, V3, P1650, DOI 10.3390/v3091650; Derebail SS, 2003, J BIOL CHEM, V278, P15702, DOI 10.1074/jbc.M211701200; DESTEFANO JJ, 1992, J VIROL, V66, P6370, DOI 10.1128/JVI.66.11.6370-6378.1992; Fisher TS, 2003, J MOL BIOL, V325, P443, DOI 10.1016/S0022-2836(02)01225-1; Fisher TS, 2002, J BIOL CHEM, V277, P22345, DOI 10.1074/jbc.M200282200; Golinelli MP, 2002, BIOCHEMISTRY-US, V41, P5894, DOI 10.1021/bi0160415; Golinelli MP, 2002, VIROLOGY, V294, P122, DOI 10.1006/viro.2001.1322; Hanson MN, 2006, J MOL BIOL, V363, P878, DOI 10.1016/j.jmb.2006.08.068; Head SR, 2014, BIOTECHNIQUES, V56, P61, DOI 10.2144/000114133; Herzig E, 2015, J VIROL, V89, P8119, DOI 10.1128/JVI.00809-15; Hu WS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006882; Hwang CK, 2001, P NATL ACAD SCI USA, V98, P12209, DOI 10.1073/pnas.221289898; KATI WM, 1992, J BIOL CHEM, V267, P25988; Langevin SA, 2013, RNA BIOL, V10, P502, DOI 10.4161/rna.24284; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Levin JG, 2010, RNA BIOL, V7, P754, DOI 10.4161/rna.7.6.14115; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; Matamoros T, 2005, J MOL BIOL, V349, P451, DOI 10.1016/j.jmb.2005.04.004; Matamoros T, 2013, BIOCHEMISTRY-US, V52, P9318, DOI 10.1021/bi401390x; Menendez-Arias L, 1998, BIOCHEMISTRY-US, V37, P16636, DOI 10.1021/bi981830g; Menendez-Arias L, 2001, J BIOL CHEM, V276, P27470, DOI 10.1074/jbc.M104342200; Menendez-Arias L, 2017, VIRUS RES, V234, P153, DOI 10.1016/j.virusres.2016.12.019; Moumen A, 2003, J BIOL CHEM, V278, P15973, DOI 10.1074/jbc.M212306200; Moumen A, 2001, NUCLEIC ACIDS RES, V29, P3814, DOI 10.1093/nar/29.18.3814; Muchiri JM, 2011, J MOL BIOL, V412, P354, DOI 10.1016/j.jmb.2011.07.055; Negroni M, 2000, P NATL ACAD SCI USA, V97, P6385, DOI 10.1073/pnas.120520497; Nguyen LA, 2012, J MOL BIOL, V415, P248, DOI 10.1016/j.jmb.2011.11.014; Nikolenko GN, 2004, J VIROL, V78, P8761, DOI 10.1128/JVI.78.16.8761-8770.2004; Ohtsubo Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep41769; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; Operario DJ, 2006, J BIOL CHEM, V281, P32113, DOI 10.1074/jbc.M604665200; Oz-Gleenberg I, 2011, NUCLEIC ACIDS RES, V39, P1042, DOI 10.1093/nar/gkq786; Piekna-Przybylska D, 2011, RNA BIOL, V8, P230, DOI 10.4161/rna.8.2.14802; Purohit V, 2005, J BIOL CHEM, V280, P40534, DOI 10.1074/jbc.M507839200; REARDON JE, 1992, BIOCHEMISTRY-US, V31, P4473, DOI 10.1021/bi00133a013; Schlub TE, 2014, J VIROL, V88, P3837, DOI 10.1128/JVI.03136-13; Simon-Loriere E, 2011, RNA BIOL, V8, P280, DOI 10.4161/rna.8.2.15193; Svarovskaia ES, 2000, J VIROL, V74, P7171, DOI 10.1128/JVI.74.15.7171-7178.2000; TANESE N, 1991, J VIROL, V65, P4387, DOI 10.1128/JVI.65.8.4387-4397.1991; Vo MN, 2006, J MOL BIOL, V363, P244, DOI 10.1016/j.jmb.2006.08.039; Vuilleumier S, 2015, CURR OPIN HIV AIDS, V10, P84, DOI 10.1097/COH.0000000000000137; Warrilow D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013229; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	54	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13351	13363		10.1074/jbc.RA118.004324	http://dx.doi.org/10.1074/jbc.RA118.004324			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29991591	Green Published, hybrid			2022-12-28	WOS:000443375500001
J	Rosling, JEO; Ridgway, MC; Summers, RL; Kirk, K; Lehane, AM				Rosling, James E. O.; Ridgway, Melanie C.; Summers, Robert L.; Kirk, Kiaran; Lehane, Adele M.			Biochemical characterization and chemical inhibition o PfATP4-associated Na+-ATPase activity in Plasmodium falciparum membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; MALARIA-INFECTED ERYTHROCYTES; X-RAY-MICROANALYSIS; SPIROINDOLONE ANTIMALARIALS; PARASITE; PFATP4; TRANSPORT; CHANNEL; TARGET; HOMEOSTASIS	The antimalarial activity of chemically diverse compounds, including the clinical candidate cipargamin, has been linked to the ATPase PfATP4 in the malaria-causing parasite Plasmodium falciparum. The characterization of PfATP4 has been hampered by the inability thus far to achieve its functional expression in a heterologous system. Here, we optimized a membrane ATPase assay to probe the function of PfATP4 and its chemical sensitivity. We found that cipargamin inhibited the Na+-dependent ATPase activity present in P. falciparum membranes from WT parasites and that its potency was reduced in cipargamin-resistant PfATP4-mutant parasites. The cipargamin-sensitive fraction of membrane ATPase activity was inhibited by all 28 of the compounds in the "Malaria Box" shown previously to disrupt ion regulation in P. falciparum in a cipargamin-like manner. This is consistent with PfATP4 being the direct target of these compounds. Characterization of the cipargamin-sensitive ATPase activity yielded data consistent with PfATP4 being a Na+ transporter that is sensitive to physiologically relevant perturbations of pH, but not of [K+] or [Ce2+]. With an apparent K-m for ATP of 0.2 mm and an apparent K-m for Na+ of 16 -17 mm, the protein is predicted to operate at below its half-maximal rate under normal physiological conditions, allowing the rate of Na+ efflux to increase in response to an increase in cytosolic [Na+]. In membranes from a cipargamin-resistant PfATP4-mutant line, the apparent K-m for Na+ is slightly elevated. Our study provides new insights into the biochemical properties and chemical sensitivity of an important new antimalarial drug target.	[Rosling, James E. O.; Ridgway, Melanie C.; Summers, Robert L.; Kirk, Kiaran; Lehane, Adele M.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia	Australian National University	Kirk, K; Lehane, AM (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia.	kiaran.kirk@anu.edu.au; adele.lehane@anu.edu.au	Summers, Robert L/E-8982-2012; Lehane, Adele M/B-4127-2012; Kirk, Kiaran/C-8299-2009	Summers, Robert L/0000-0003-0840-1784; Lehane, Adele M/0000-0002-0050-9101; Kirk, Kiaran/0000-0002-5613-2622; Ridgway, Melanie/0000-0002-6763-2366	Australian Research Council [DE160101035, LP150101226]; National Health and Medical Research Council [1042272]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian Research Council Discovery Early Career Researcher Award (DE160101035 to A. M. L.), an Australian Research Council Linkage Project Grant (LP150101226 to K. K.), and a National Health and Medical Research Council Project Grant (1042272 to K. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adjalley SH, 2010, METHODS MOL BIOL, V634, P87, DOI 10.1007/978-1-60761-652-8_6; Allen RJW, 2010, MOL BIOCHEM PARASIT, V169, P63, DOI 10.1016/j.molbiopara.2009.09.005; Jimenez-Diaz MB, 2014, P NATL ACAD SCI USA, V111, pE5455, DOI 10.1073/pnas.1414221111; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; de Almeida-Amaral EE, 2008, EXP PARASITOL, V118, P165, DOI 10.1016/j.exppara.2007.07.001; Dennis ASM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26819-1; Dennis ASM, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00087-18, 10.1128/aac.00087-18]; Desai SA, 1997, P NATL ACAD SCI USA, V94, P2045, DOI 10.1073/pnas.94.5.2045; DESAI SA, 1993, NATURE, V362, P643, DOI 10.1038/362643a0; Ernst Orna, 2010, J Vis Exp, DOI 10.3791/1918; Flannery EL, 2015, ACS CHEM BIOL, V10, P413, DOI 10.1021/cb500616x; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; Goldgof GM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27806; Hapuarachchi SV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006180; Hewitt SN, 2017, ACS INFECT DIS, V3, P34, DOI 10.1021/acsinfecdis.6b00078; KIRK K, 1994, J BIOL CHEM, V269, P3339; Krishna S, 2001, J BIOL CHEM, V276, P10782, DOI 10.1074/jbc.M010554200; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LEE P, 1988, AM J TROP MED HYG, V39, P157, DOI 10.4269/ajtmh.1988.39.157; Lehane AM, 2014, MOL MICROBIOL, V94, P327, DOI 10.1111/mmi.12765; Mauritz JMA, 2011, BIOPHYS J, V100, P1438, DOI 10.1016/j.bpj.2011.02.007; ROBINSON JD, 1981, J NEUROCHEM, V37, P140, DOI 10.1111/j.1471-4159.1981.tb05301.x; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Saliba KJ, 1999, J BIOL CHEM, V274, P33213, DOI 10.1074/jbc.274.47.33213; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Spillman NJ, 2013, CELL HOST MICROBE, V13, P227, DOI 10.1016/j.chom.2012.12.006; Spillman NJ, 2015, INT J PARASITOL-DRUG, V5, P149, DOI 10.1016/j.ijpddr.2015.07.001; Spry C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054974; Staines HM, 2001, AM J PHYSIOL-CELL PH, V280, pC1576, DOI 10.1152/ajpcell.2001.280.6.C1576; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vaidya AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6521; White NJ, 2014, NEW ENGL J MED, V371, P403, DOI 10.1056/NEJMoa1315860; WINKLER BS, 1980, INVEST OPHTH VIS SCI, V19, P562; Winterberg M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29241; Zahler R, 1997, J GEN PHYSIOL, V110, P201, DOI 10.1085/jgp.110.2.201	37	20	20	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13327	13337		10.1074/jbc.RA118.003640	http://dx.doi.org/10.1074/jbc.RA118.003640			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29986883	Green Published, hybrid			2022-12-28	WOS:000442730200029
J	Hirschberg, CB				Hirschberg, Carlos B.			My journey in the discovery of nucleotide sugar transporters of the Golgi apparatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item						glycobiology; glycoprotein; nucleotide; Golgi; glycoprotein biosynthesis	N-ACETYLGLUCOSAMINE TRANSPORTER; CMP-SIALIC ACID; CAENORHABDITIS-ELEGANS; MOLECULAR-CLONING; RAT-LIVER; ENDOPLASMIC-RETICULUM; MUTANT DEFICIENT; UDP-GALACTOSE; TRANSLOCATION; PURIFICATION	Defects in protein glycosylation can have a dramatic impact on eukaryotic cells and is associated with mental and developmental pathologies in humans. The studies outlined below illustrate how a basic biochemical problem in the mechanisms of protein glycosylation, specifically substrate transporters of nucleotide sugars, including ATP and 3'-phosphoadenyl-5'-phosphosulfate (PAPS), in the membrane of the Golgi apparatus and endoplasmic reticulum, expanded into diverse biological systems from mammals, including humans, to yeast, roundworms, and protozoa. Using these diverse model systems allowed my colleagues and me to answer fundamental biological questions that enabled us to formulate far-reaching hypotheses and expanded our knowledge of human diseases caused by malfunctions in the metabolic processes involved.	[Hirschberg, Carlos B.] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Hirschberg, Carlos B.] Univ Andres Bello, Dept Biol Sci, Santiago, Chile	Boston University; Universidad Andres Bello	Hirschberg, CB (corresponding author), Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA.; Hirschberg, CB (corresponding author), Univ Andres Bello, Dept Biol Sci, Santiago, Chile.	chirschb@bu.edu			NIH [GM 30365, GM 34396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030365, R01GM030365] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I am deeply indebted to my mentors, graduate students, postdocs, and collaborators. Without them, none of the above research could have been done. I was also fortunate to have NIGMS NIH program directors such as Lee van Lenten and Pam Marino, whose support was invaluable. Last, but not least, I am fortunate to have had the ongoing support and love of my wife, Lois Hirschberg. Most of the above research was supported by NIH Grants GM 30365 and GM 34396.	Abeijon C, 1996, P NATL ACAD SCI USA, V93, P5963, DOI 10.1073/pnas.93.12.5963; Berninsone P, 2001, P NATL ACAD SCI USA, V98, P3738, DOI 10.1073/pnas.061593098; BRANDAN E, 1988, J BIOL CHEM, V263, P2417; Bredeston LM, 2005, J BIOL CHEM, V280, P32168, DOI 10.1074/jbc.M507035200; Caffaro CE, 2007, J BIOL CHEM, V282, P27970, DOI 10.1074/jbc.M704485200; Caffaro CE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003331; CAPASSO JM, 1989, J BIOL CHEM, V264, P5233; CAPASSO JM, 1984, P NATL ACAD SCI-BIOL, V81, P7051, DOI 10.1073/pnas.81.22.7051; CAREY DJ, 1980, CELL, V19, P597, DOI 10.1016/S0092-8674(80)80036-5; CARTER HE, 1968, BIOCHEMISTRY-US, V7, P2296, DOI 10.1021/bi00846a036; Cipollo JF, 2005, J BIOL CHEM, V280, P26063, DOI 10.1074/jbc.M503828200; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; Guillen E, 1998, P NATL ACAD SCI USA, V95, P7888, DOI 10.1073/pnas.95.14.7888; Hirschberg C. B., 2016, HIGH LEARN RES COMMU, V6, P4, DOI [10.18870/hlrc.v6i1.318, DOI 10.18870/HLRC.V6I1.318]; HIRSCHBERG CB, 1970, J BIOL CHEM, V245, P3084; HIRSCHBERG CB, 1972, P NATL ACAD SCI USA, V69, P648, DOI 10.1073/pnas.69.3.648; HIRSCHBERG CB, 1974, VIROLOGY, V61, P602, DOI 10.1016/0042-6822(74)90295-5; HIRSCHBERG CB, 1976, BIOCHEMISTRY-US, V15, P3591, DOI 10.1021/bi00661a029; Hirschberg CB, 2001, J CLIN INVEST, V108, P3; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Liu L, 2013, J BIOL CHEM, V288, P10599, DOI 10.1074/jbc.M113.453597; MANDON EC, 1994, P NATL ACAD SCI USA, V91, P10707, DOI 10.1073/pnas.91.22.10707; MILLA ME, 1989, P NATL ACAD SCI USA, V86, P1786, DOI 10.1073/pnas.86.6.1786; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; Parker JL, 2017, NATURE, V551, P521, DOI 10.1038/nature24464; Puglielli L, 1999, J BIOL CHEM, V274, P4474, DOI 10.1074/jbc.274.7.4474; Toma L, 1996, J BIOL CHEM, V271, P3897	29	5	5	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12653	12662		10.1074/jbc.X118.004819	http://dx.doi.org/10.1074/jbc.X118.004819			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	30120148	hybrid, Green Published			2022-12-28	WOS:000442203500001
J	Moncada-Pazos, A; Obaya, AJ; Llamazares, M; Heljasvaara, R; Suarez, MF; Colado, E; Noel, A; Cal, S; Lopez-Otin, C				Moncada-Pazos, Angela; Obaya, Alvaro J.; Llamazares, Maria; Heljasvaara, Ritva; Suarez, Maria F.; Colado, Enrique; Noel, Agnes; Cal, Santiago; Lopez-Otin, Carlos			ADAMTS-12 metalloprotease is necessary for normal inflammatory response (vol 287, pg 39554, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Colado, Enrique/Z-6326-2019; Llamazares-Prada, Maria/ABX-0849-2022; Suárez, María Fernanda Valencia/F-8200-2019; Obaya, Alvaro J./AAQ-6115-2021; Colado, Enrique/GXF-7705-2022	Colado, Enrique/0000-0001-8675-8207; Suárez, María Fernanda Valencia/0000-0001-8987-8431; Obaya, Alvaro J./0000-0002-4163-2173; Noel, Agnes/0000-0002-7670-6179				Moncada-Pazos A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.408625	1	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11648	11648		10.1074/jbc.AAC118.004590	http://dx.doi.org/10.1074/jbc.AAC118.004590			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	30030383	hybrid, Green Published			2022-12-28	WOS:000439449700032
J	Etchegaray, JP; Mostoslavsky, R				Etchegaray, Jean-Pierre; Mostoslavsky, Raul			A sirtuin's role in preventing senescence by protecting ribosomal DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							YEAST; SIR2	Ribosomes are encoded by many copies of ribosomal DNA (rDNA) packed into the nucleolus. High rates of transcription combined with highly repetitive sequences render rDNA loci particularly vulnerable to genomic instability, a proposed underlying cause of cellular senescence. The molecular mechanisms that maintain rDNA stability have remained unclear. A new paper elucidates a sirtuin-dependent mechanism that protects rDNA loci from genomic instability and prevents cellular senescence via heterochromatin silencing mediated by the chromatin remodeler SNF2H. This finding extends our understanding of chromatin dynamics within rDNA regions and offers new mechanistic insights into aging-related pathologies associated with genomic instability.	[Etchegaray, Jean-Pierre; Mostoslavsky, Raul] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Etchegaray, Jean-Pierre; Mostoslavsky, Raul] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Mostoslavsky, Raul] Broad Inst Harvard & Massachusetts Inst Technol, Boston, MA 02113 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Mostoslavsky, R (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.; Mostoslavsky, R (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.; Mostoslavsky, R (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, Boston, MA 02113 USA.	rmostoslavsky@mgh.harvard.edu						Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Paredes S, 2018, J BIOL CHEM, V293, P11242, DOI 10.1074/jbc.AC118.003325; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 1997, SCIENCE, V277, P1313, DOI 10.1126/science.277.5330.1313; Toiber D, 2013, MOL CELL, V51, P454, DOI 10.1016/j.molcel.2013.06.018	10	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11251	11252		10.1074/jbc.H118.004040	http://dx.doi.org/10.1074/jbc.H118.004040			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	30006387	Green Published, hybrid			2022-12-28	WOS:000438882800036
J	Terashima, M; Ishimura, A; Wanna-udom, S; Suzuki, T				Terashima, Minoru; Ishimura, Akihiko; Wanna-udom, Sasithorn; Suzuki, Takeshi			MEG8 long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription regulation; long noncoding RNA (long ncRNA; lncRNA); histone methylation; cancer biology; epithelial-mesenchymal transition (EMT); chromatin; epigenetics; metastasis; transforming growth factor	PRC2; CHROMATIN; SNAIL; RECRUITMENT; EXPRESSION; REPRESSION; PLASTICITY; JARID2; GENES; MARK	Long noncoding RNAs (lncRNAs) are important regulatory molecules in various biological and pathological processes, including cancer development. We have previously shown that the MEG3 lncRNA plays an essential role in transforming growth factor- (TGF-)-induced epithelial-mesenchymal transition (EMT) of human lung cancer cells. In this study, we investigated the function of another lncRNA, MEG8, which shares the DLK1-DIO3 locus with MEG3, in the regulation of EMT. MEG8 lncRNA expression was immediately induced during TGF--mediated EMT of A549 and LC2/ad lung cancer and Panc1 pancreatic cancer cell lines. MEG8 overexpression specifically suppressed the expression of microRNA-34a and microRNA-203 genes, resulting in up-regulation of SNAIL family transcriptional repressor 1 (SNAI1) and SNAI2 transcription factors, which repressed expression of cadherin 1 (CDH1)/E-cadherin. Mechanistic investigations revealed that MEG8 associates with enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2) protein and induces its recruitment to the regulatory regions of the two microRNA genes for histone H3 methylation and transcriptional repression. Interestingly, expression of both MEG8 and MEG3, but not each individually, could induce EMT-related cell morphological changes and increased cell motility in the absence of TGF- by activating the gene expression program required for EMT. MEG8 knockdown indicated that endogenous MEG8 lncRNA is indispensable for TGF--induced EMT in A549 lung cancer and Panc1 pancreatic cancer cells. Our findings indicate that MEG8 lncRNA significantly contributes to epigenetic EMT induction and increase our understanding of the lncRNA-mediated regulatory mechanisms involved in malignant progression of cancer.	[Terashima, Minoru; Ishimura, Akihiko; Wanna-udom, Sasithorn; Suzuki, Takeshi] Kanazawa Univ, Canc Res Inst, Div Funct Genom, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Suzuki, T (corresponding author), Kanazawa Univ, Canc Res Inst, Div Funct Genom, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	suzuki-t@staff.kanazawa-u.ac.jp	Terashima, Minoru/D-8462-2015	Suzuki, Takeshi/0000-0002-1737-0900	Ministry of Education, Culture, Sports, Science and Technology of Japan [15K08263, 16K19030]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research C 15K08263 (to T. S.) and 16K19030 (to M. T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Anastasiadou E, 2018, NAT REV CANCER, V18, P5, DOI 10.1038/nrc.2017.99; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; da Rocha ST, 2014, MOL CELL, V53, P301, DOI 10.1016/j.molcel.2014.01.002; Davidovich C, 2015, RNA, V21, P2007, DOI 10.1261/rna.053918.115; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dong PX, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0415-y; Enkhbaatar Z, 2013, CELL CYCLE, V12, P2100, DOI 10.4161/cc.25142; Fang SS, 2018, NUCLEIC ACIDS RES, V46, pD308, DOI 10.1093/nar/gkx1107; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; He YQ, 2017, ONCOTARGET, V8, P73282, DOI 10.18632/oncotarget.19931; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Liao HZ, 2015, ONCOTARGET, V6, P8914, DOI 10.18632/oncotarget.3563; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mitra R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01781-0; Miyazono K, 2012, UPSALA J MED SCI, V117, P143, DOI 10.3109/03009734.2011.638729; Oktyabri D, 2014, BIOCHEM BIOPH RES CO, V453, P124, DOI 10.1016/j.bbrc.2014.09.082; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Qu Y, 2013, INT J CANCER, V133, P544, DOI 10.1002/ijc.28056; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Sun LD, 2016, CELL MOL LIFE SCI, V73, P4493, DOI 10.1007/s00018-016-2303-1; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; Suzuki T, 2013, CANCER SCI, V104, P795, DOI 10.1111/cas.12169; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tange S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115684; Terashima M, 2017, BIOCHEM BIOPH RES CO, V490, P1407, DOI 10.1016/j.bbrc.2017.07.048; Terashima M, 2017, J BIOL CHEM, V292, P82, DOI 10.1074/jbc.M116.750950; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Yoshida M, 2011, BIOCHEM J, V437, P555, DOI 10.1042/BJ20110343; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	43	72	72	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18016	18030		10.1074/jbc.RA118.004006	http://dx.doi.org/10.1074/jbc.RA118.004006			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30262664	hybrid, Green Published			2022-12-28	WOS:000451375200001
J	Erler, H; Ren, BJ; Gupta, N; Beitz, E				Erler, Holger; Ren, Bingjian; Gupta, Nishith; Beitz, Eric			The intracellular parasite Toxoplasma gondii harbors three druggable FNT-type formate and l-lactate transporters in the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Toxoplasma gondii; plasmodium; transporter; lactic acid; inhibitor; substrate specificity; formate-nitrite transporter; lytic cycle; sugar metabolism; lactate; selectivity; inhibition; Apicomplexa; Plasmodium; proton symporter	PLASMODIUM-FALCIPARUM; NITRITE TRANSPORTERS; ESCHERICHIA-COLI; HEXOSE TRANSPORTER; FOCA; METABOLISM; SEQUENCE; GLUCOSE; PROTEIN; IDENTIFICATION	Toxoplasma gondii is a globally prevalent parasitic protist. It is well-known for its ability to infect almost all nucleated vertebrate cells, which is reflected by its unique metabolic architecture. Its fast-growing tachyzoite stage catabolizes glucose via glycolysis to yield l-lactate as a major by-product that must be exported from the cell to prevent toxicity; the underlying mechanism remains to be elucidated, however. Herein, we report three formate-nitrite transporter (FNT)-type monocarboxylate/proton symporters located in the plasma membrane of the T. gondii tachyzoite stage. We observed that all three proteins transport both l-lactate and formate in a pH-dependent manner and are inhibited by 2-hydroxy-chromanones (a class of small synthetic molecules). We also show that these compounds pharmacologically inhibit T. gondii growth. Using a chemical biology approach, we identified the critical residues in the substrate-selectivity region of the parasite transporters that determine differential specificity and sensitivity toward both substrates and inhibitors. Our findings further indicate that substrate specificity in FNT family proteins from T. gondii has evolved such that a functional repurposing of prokaryotic-type transporters helps fulfill a critical metabolic role in a clinically important parasitic protist. In summary, we have identified and characterized the lactate transporters of T. gondii and have shown that compounds blocking the FNTs in this parasite can inhibit its growth, suggesting that these transporters could have utility as potential drug targets.	[Erler, Holger; Beitz, Eric] Christian Albrechts Univ Kiel, Dept Pharmaceut & Med Chem, D-24118 Kiel, Germany; [Ren, Bingjian; Gupta, Nishith] Humboldt Univ, Dept Mol Parasitol, Fac Life Sci, D-10115 Berlin, Germany	University of Kiel; Humboldt University of Berlin	Gupta, N (corresponding author), Philippstr 13,House 14, D-10115 Berlin, Germany.; Beitz, E (corresponding author), Gutenbergstr 76, D-24118 Kiel, Germany.	Gupta.Nishith@hu-berlin.de; ebeitz@pharmazie.uni-kiel.de		Gupta, Nishith/0000-0003-1452-5126	German Research Foundation (Deutsche Forschungsgemeinschaft) [Be2253/7-1, GRK2046]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by German Research Foundation (Deutsche Forschungsgemeinschaft) Grants Be2253/7-1 (to E. B.) and GRK2046 (to N. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Arroyo-Olarte RD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002288; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Beitz E, 2000, BIOINFORMATICS, V16, P1050, DOI 10.1093/bioinformatics/16.11.1050; Beyer L, 2013, J BACTERIOL, V195, P1428, DOI 10.1128/JB.02166-12; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Blume M, 2015, CELL HOST MICROBE, V18, P210, DOI 10.1016/j.chom.2015.07.008; Blume M, 2011, FASEB J, V25, P1218, DOI 10.1096/fj.10-173278; Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; BZIK DJ, 1993, MOL BIOCHEM PARASIT, V59, P155, DOI 10.1016/0166-6851(93)90016-Q; Czyzewski BK, 2012, NATURE, V483, P494, DOI 10.1038/nature10881; Das P, 2009, MICROBIOL-SGM, V155, P2476, DOI 10.1099/mic.0.029611-0; DONALD RGK, 1995, P NATL ACAD SCI USA, V92, P5749, DOI 10.1073/pnas.92.12.5749; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; GARCIA CK, 1994, CELL, V76, P865, DOI 10.1016/0092-8674(94)90361-1; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Golldack A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006172; Gubbels MJ, 2003, ANTIMICROB AGENTS CH, V47, P309, DOI 10.1128/AAC.47.1.309-316.2003; Gupta N, 2005, J BIOL CHEM, V280, P16345, DOI 10.1074/jbc.M501523200; Hartmann A, 2014, J BIOL CHEM, V289, P6809, DOI 10.1074/jbc.M113.509406; Jia WJ, 2009, BIOCHEM J, V417, P297, DOI 10.1042/BJ20080746; Joet T, 2003, P NATL ACAD SCI USA, V100, P7476, DOI 10.1073/pnas.1330865100; Lu W, 2011, SCIENCE, V332, P352, DOI 10.1126/science.1199098; MacRae JI, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-67; Marchetti RV, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7721; MCKEE RW, 1946, J EXP MED, V84, P569, DOI 10.1084/jem.84.6.569; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nitzsche R, 2017, J BIOL CHEM, V292, P15225, DOI 10.1074/jbc.M117.802702; Nitzsche R, 2016, J BIOL CHEM, V291, P126, DOI 10.1074/jbc.M114.624619; OHSAKA A, 1982, PHYSIOL CHEM PHYS M, V14, P381; SHAKESPEARE PG, 1973, NATURE, V241, P539; Slavic K, 2010, MOL MICROBIOL, V75, P1402, DOI 10.1111/j.1365-2958.2010.07060.x; Soares-Silva I, 2007, MOL MEMBR BIOL, V24, P464, DOI 10.1080/09687680701342669; SUPPMANN B, 1994, MOL MICROBIOL, V11, P965, DOI 10.1111/j.1365-2958.1994.tb00375.x; Wang Y, 2009, NATURE, V462, P467, DOI 10.1038/nature08610; Wiechert M, 2017, CHANNELS, V11, P365, DOI 10.1080/19336950.2017.1329999; Wiechert M, 2017, FEBS J, V284, P2663, DOI 10.1111/febs.14117; Wiechert M, 2017, EMBO J, V36, P949, DOI 10.15252/embj.201695776; Woodrow CJ, 1999, J BIOL CHEM, V274, P7272, DOI 10.1074/jbc.274.11.7272; Wree D, 2011, FEBS J, V278, P740, DOI 10.1111/j.1742-4658.2010.07993.x; Wu BH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7284; Xia NB, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12794	42	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17622	17630		10.1074/jbc.RA118.003801	http://dx.doi.org/10.1074/jbc.RA118.003801			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30237165	Green Published, hybrid			2022-12-28	WOS:000449799000025
J	Bernfeld, E; Menon, D; Vaghela, V; Zerin, I; Faruque, P; Frias, MA; Foster, DA				Bernfeld, Elyssa; Menon, Deepak; Vaghela, Vishaldeep; Zerin, Ismat; Faruque, Promie; Frias, Maria A.; Foster, David A.			Phospholipase D-dependent mTOR complex 1 (mTORC1) activation by glutamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mTOR complex (mTORC); phospholipase D; phosphatidic acid; glutamine; Rag GTPase; RHEB (Ras homolog expressed in brain); -ketoglutarate; Arf1; RalA	CANCER-CELLS; SURVIVAL; ARF; GROWTH; RAPTOR; RALA; RHEB; RAS	Glutamine is a key nutrient required for sustaining cell proliferation, contributing to nucleotide, protein, and lipid synthesis. The mTOR complex 1 (mTORC1) is a highly conserved protein complex that acts as a sensor of nutrients, relaying signals for the shift from catabolic to anabolic metabolism. Although glutamine plays an important role in mTORC1 activation, the mechanism is not clear. Here we describe a leucine- and Rag-independent mechanism of mTORC1 activation by glutamine that depends on phospholipase D and the production of phosphatidic acid, which is required for the stability and activity of mTORC1. The phospholipase D-dependent activation of mTORC1 by glutamine depended on the GTPases ADP ribosylation factor 1 (Arf1), RalA, and Rheb. Glutamine deprivation could be rescued by -ketoglutarate, a downstream metabolite of glutamine. This mechanism represents a distinct nutrient input to mTORC1 that is independent of Rag GTPases and leucine.	[Bernfeld, Elyssa; Menon, Deepak; Vaghela, Vishaldeep; Faruque, Promie; Frias, Maria A.; Foster, David A.] CUNY Hunter Coll, Dept Biol Sci, 413 E 69th St, New York, NY 10065 USA; [Zerin, Ismat] CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA; [Bernfeld, Elyssa; Menon, Deepak; Foster, David A.] CUNY, Grad Ctr, Biochem Program, New York, NY 10016 USA; [Vaghela, Vishaldeep; Foster, David A.] CUNY, Grad Ctr, Biol Program, New York, NY 10016 USA; [Foster, David A.] Weill Cornell Med, Dept Pharmacol, New York, NY 10021 USA; [Bernfeld, Elyssa] Pfizer Worldwide Res & Dev, Oncol R&D Grp, 401 N Middletown Rd, Pearl River, NY 10965 USA; [Menon, Deepak] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Cornell University; Pfizer; University System of Maryland; University of Maryland Baltimore	Foster, DA (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 413 E 69th St, New York, NY 10065 USA.	foster@genectr.hunter.cuny.edu	Menon, Deepak/S-7899-2019	Menon, Deepak/0000-0002-6529-7859; Lehman, Elyssa/0000-0002-9869-1588; Frias, Maria A/0000-0001-7753-6290	National Institutes of Health [R01-CA046677, R01-CA179542]; Research Centers in Minority Institutions from the National Center for Research Resources of the National Institutes of Health [RP-03037]; NATIONAL CANCER INSTITUTE [R01CA179542, R01CA046677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Centers in Minority Institutions from the National Center for Research Resources of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health Grants R01-CA046677 and R01-CA179542 (to D. A. F.) and a pilot project award from the Research Centers in Minority Institutions (RP-03037) from the National Center for Research Resources of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Byun JK, 2017, CELL REP, V20, P586, DOI 10.1016/j.celrep.2017.06.066; Duran RV, 2013, ONCOGENE, V32, P4549, DOI 10.1038/onc.2012.465; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Frohman MA, 2015, TRENDS PHARMACOL SCI, V36, P137, DOI 10.1016/j.tips.2015.01.001; Gentry LR, 2014, BBA-MOL CELL RES, V1843, P2976, DOI 10.1016/j.bbamcr.2014.09.004; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hamanaka RB, 2012, J EXP MED, V209, P211, DOI 10.1084/jem.20120162; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Houghton PJ, 2010, CLIN CANCER RES, V16, P1368, DOI 10.1158/1078-0432.CCR-09-1314; Jackson CL, 2014, J CELL SCI, V127, P4103, DOI 10.1242/jcs.144899; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Kim JH, 1998, FEBS LETT, V430, P231, DOI 10.1016/S0014-5793(98)00661-9; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Luo JQ, 1997, BIOCHEM BIOPH RES CO, V235, P854, DOI 10.1006/bbrc.1997.6793; Luo JQ, 1998, P NATL ACAD SCI USA, V95, P3632, DOI 10.1073/pnas.95.7.3632; Ma WN, 2010, EXP MOL MED, V42, P456, DOI 10.3858/emm.2010.42.6.047; Menon D, 2017, J BIOL CHEM, V292, P6303, DOI 10.1074/jbc.M116.772988; Mukhopadhyay Suman, 2015, Oncoscience, V2, P807; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Patel D, 2016, J BIOL CHEM, V291, P9322, DOI 10.1074/jbc.M115.710145; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Saqcena M, 2015, ONCOGENE, V34, P2672, DOI 10.1038/onc.2014.207; Shi M, 2007, CANCER LETT, V258, P268, DOI 10.1016/j.canlet.2007.09.003; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105; Toda K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081632; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Utter M, 2018, CANCER LETT, V423, P28, DOI 10.1016/j.canlet.2018.03.006; Voss M, 1999, J BIOL CHEM, V274, P34691, DOI 10.1074/jbc.274.49.34691; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Xu LM, 2011, J BIOL CHEM, V286, P25477, DOI 10.1074/jbc.M111.249631; Yoon MS, 2015, MOL CELL, V58, P549, DOI 10.1016/j.molcel.2015.03.028; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	40	23	23	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16390	16401		10.1074/jbc.RA118.004972	http://dx.doi.org/10.1074/jbc.RA118.004972			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30194281	hybrid, Green Published			2022-12-28	WOS:000447833600022
J	Harnos, J; Rynes, J; Viskova, P; Foldynova-Trantirkova, S; Bajard-Esner, L; Trantirek, L; Bryja, V				Harnos, Jakub; Rynes, Jan; Viskova, Pavlina; Foldynova-Trantirkova, Silvie; Bajard-Esner, Lola; Trantirek, Lukas; Bryja, Vitezslav			Analysis of binding interfaces of the human scaffold protein AXIN1 by peptide microarrays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peptide array; scaffold protein; axin; serine; threonine protein kinase; p53; Myc (c-Myc); casein kinase 1E; dishevelled; intrinsically disordered region; Wnt pathway	CASEIN KINASE-I; BETA-CATENIN; STRUCTURAL BASIS; TRANSCRIPTIONAL REGULATION; CRYSTAL-STRUCTURE; COMPLEX; WNT; ACTIVATION; PHOSPHORYLATION; DEGRADATION	Intrinsically disordered regions (IDRs) are protein regions that lack persistent secondary or tertiary structure under native conditions. IDRs represent >40% of the eukaryotic proteome and play a crucial role in protein-protein interactions. The classical approach for identification of these interaction interfaces is based on mutagenesis combined with biochemical techniques such as coimmunoprecipitation or yeast two-hybrid screening. This approach either provides information of low resolution (large deletions) or very laboriously tries to precisely define the binding epitope via single amino acid substitutions. Here, we report the use of a peptide microarray based on the human scaffold protein AXIN1 for high-throughput and -resolution mapping of binding sites for several AXIN1 interaction partners in vitro. For each of the AXIN1-binding partners tested, i.e. casein kinase 1 E (CK1E); c-Myc; peptidyl-prolyl cis/trans isomerase, NIMA-interacting 1 (Pin1); and p53, we found at least three different epitopes, predominantly in the central IDR of AXIN1. We functionally validated the specific AXIN1-CK1E interaction identified here with epitope-mimicking peptides and with AXIN1 variants having deletions of short binding epitopes. On the basis of these results, we propose a model in which AXIN1 competes with dishevelled (DVL) for CK1E and regulates CK1E-induced phosphorylation of DVL and activation of Wnt/-catenin signaling.	[Harnos, Jakub; Bryja, Vitezslav] Masaryk Univ, Fac Sci, Inst Expt Biol, Kamenice 5, Brno 62500, Czech Republic; [Rynes, Jan; Viskova, Pavlina; Foldynova-Trantirkova, Silvie; Bajard-Esner, Lola; Trantirek, Lukas] Masaryk Univ, Cent European Inst Technol, Kamenice 753-5, Brno 62500, Czech Republic; [Bajard-Esner, Lola] Masaryk Univ, Fac Sci, Chem Sect, Res Ctr Tox Cpds Environm RECETOX, Kamenice 5, Brno 62500, Czech Republic; [Rynes, Jan; Foldynova-Trantirkova, Silvie; Bryja, Vitezslav] Acad Sci Czech Republ, Inst Biophys, Vvi, Kralovopolska 135, CS-61265 Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Bryja, V (corresponding author), Masaryk Univ, Fac Sci, Inst Expt Biol, Kamenice 5, Brno 62500, Czech Republic.	bryja@sci.muni.cz	Bryja, Vítězslav/P-4217-2019; Trantirek, Lukas/F-9923-2014; Harnos, Jakub/AAE-7855-2021	Bryja, Vítězslav/0000-0002-9136-5085; Rynes, Jan/0000-0003-2091-390X; Harnos, Jakub/0000-0002-0752-9260; bajard, Lola/0000-0001-9002-7095; Foldynova-Trantirkova, Silvie/0000-0001-8863-083X	Czech Science Foundation [18-17658S, 17-12075S, 15-34405A, 15-22380Y]; Grant Agency of Masaryk University [MUNI/G/1100/2016, MUNI/A/1145/2017]; "Netherlands Organization for Scientific Research" VIDI [700.59.426]; European Regional Development Fund [CZ.02.1.01/0.0/0.0/15_003/0000477]; Neuron-Fund for the Support of Science; Ministry of Education, Youth, and Sports (MEYS) of the Czech Republic [LQ1601]; MEYS CR; National Programme for Sustainability II	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of Masaryk University; "Netherlands Organization for Scientific Research" VIDI(Netherlands Organization for Scientific Research (NWO)); European Regional Development Fund(European Commission); Neuron-Fund for the Support of Science; Ministry of Education, Youth, and Sports (MEYS) of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); MEYS CR; National Programme for Sustainability II	This work was supported by the Czech Science Foundation (Projects 18-17658S, 17-12075S, 15-34405A, and 15-22380Y), Grant Agency of Masaryk University (Grants MUNI/G/1100/2016 and MUNI/A/1145/2017), "Netherlands Organization for Scientific Research" VIDI (Project 700.59.426), European Regional Development Fund (Grant CZ.02.1.01/0.0/0.0/15_003/0000477), and Neuron-Fund for the Support of Science (to V. B.). This work was also supported by the Ministry of Education, Youth, and Sports (MEYS) of the Czech Republic (Grant LQ1601) with financial contribution from the MEYS CR and National Programme for Sustainability II. The authors declare that they have no conflicts of interest with the contents of this article.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Arnold HK, 2009, EMBO J, V28, P500, DOI 10.1038/emboj.2008.279; Bernatik O, 2014, J BIOL CHEM, V289, P23520, DOI 10.1074/jbc.M114.590638; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bryja V, 2004, CELL MOL LIFE SCI, V61, P1384, DOI 10.1007/s00018-004-4081-4; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; de Groot REA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004985; Dunker A Keith, 2013, Intrinsically Disord Proteins, V1, pe24157, DOI 10.4161/idp.24157; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Espejo A, 2002, BIOCHEM J, V367, P697, DOI 10.1042/BJ20020860; Fiedler M, 2011, P NATL ACAD SCI USA, V108, P1937, DOI 10.1073/pnas.1017063108; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Kishida M, 2001, J BIOL CHEM, V276, P33147, DOI 10.1074/jbc.M103555200; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; McKay RM, 2001, DEV BIOL, V235, P388, DOI 10.1006/dbio.2001.0308; Noutsou M, 2011, J MOL BIOL, V405, P773, DOI 10.1016/j.jmb.2010.11.013; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Reinhardt J, 2007, PROTEIN EXPRES PURIF, V54, P101, DOI 10.1016/j.pep.2007.02.020; Rubinfeld B, 2001, J BIOL CHEM, V276, P39037, DOI 10.1074/jbc.M105148200; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zhang Y, 2002, J BIOL CHEM, V277, P17706, DOI 10.1074/jbc.M111982200	33	7	7	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16337	16347		10.1074/jbc.RA118.005127	http://dx.doi.org/10.1074/jbc.RA118.005127			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30166345	hybrid, Green Published			2022-12-28	WOS:000447833600018
J	Moloughney, JG; Vega-Cotto, NM; Liu, SR; Patel, C; Kim, PK; Wu, CC; Albaciete, D; Magaway, C; Chang, A; Rajput, S; Su, XY; Werlen, G; Jacinto, E				Moloughney, Joseph G.; Vega-Cotto, Nicole M.; Liu, Sharon; Patel, Chadni; Kim, Peter K.; Wu, Chang-chih; Albaciete, Danielle; Magaway, Cedric; Chang, Austin; Rajput, Swati; Su, Xiaoyang; Werlen, Guy; Jacinto, Estela			mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mTOR complex (mTORC); glutamine; cell metabolism; protein phosphorylation; Akt PKB; glutaminolysis; hexosamine biosynthesis; metabolism; mTOR; nutrients; hexosamine biosynthetic pathway	HUMAN GLUTAMINE-FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE; PROTEIN-KINASE-C; BIOSYNTHETIC-PATHWAY; MOTIF PHOSPHORYLATION; GLUCOSE-METABOLISM; HIGH EXPRESSION; CANCER-CELLS; COMPLEX; GLUTAMINE; AKT	The mechanistic target of rapamycin (mTOR) controls metabolic pathways in response to nutrients. Recently, we have shown that mTOR complex 2 (mTORC2) modulates the hexosamine biosynthetic pathway (HBP) by promoting the expression of the key enzyme of the HBP, glutamine:fructose-6-phosphate aminotransferase 1 (GFAT1). Here, we found that GFAT1 Ser-243 phosphorylation is also modulated in an mTORC2-dependent manner. In response to glutamine limitation, active mTORC2 prolongs the duration of Ser-243 phosphorylation, albeit at lower amplitude. Blocking glycolysis using 2-deoxyglucose robustly enhances Ser-243 phosphorylation, correlating with heightened mTORC2 activation, increased AMPK activity, and O-GlcNAcylation. However, when 2-deoxyglucose is combined with glutamine deprivation, GFAT1 Ser-243 phosphorylation and mTORC2 activation remain elevated, whereas AMPK activation and O-GlcNAcylation diminish. Phosphorylation at Ser-243 promotes GFAT1 expression and production of GFAT1-generated metabolites including ample production of the HBP end-product, UDP-GlcNAc, despite nutrient starvation. Hence, we propose that the mTORC2-mediated increase in GFAT1 Ser-243 phosphorylation promotes flux through the HBP to maintain production of UDP-GlcNAc when nutrients are limiting. Our findings provide insights on how the HBP is reprogrammed via mTORC2 in nutrient-addicted cancer cells.	[Moloughney, Joseph G.; Vega-Cotto, Nicole M.; Liu, Sharon; Patel, Chadni; Kim, Peter K.; Wu, Chang-chih; Albaciete, Danielle; Magaway, Cedric; Chang, Austin; Rajput, Swati; Werlen, Guy; Jacinto, Estela] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Su, Xiaoyang] Rutgers State Univ, Dept Med, Div Endocrinol, Child Hlth Inst New Jersey, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Jacinto, E (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.	jacintes@rwjms.rutgers.edu		Rajput, Swati/0000-0001-8794-4300; Patel, Chadni/0000-0003-2302-0453; Su, Xiaoyang/0000-0001-8081-1396	National Institutes of Health [GM079176, CA154674]; New Jersey Commission for Cancer Research Grant; Research Supplement to promote diversity in health-related research [CA154674-04S1]; NCI, National Institutes of Health [P30 CA072720]; NATIONAL CANCER INSTITUTE [R01CA154674, P30CA072720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission for Cancer Research Grant; Research Supplement to promote diversity in health-related research; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM079176 and CA154674 (to E. J.), a New Jersey Commission for Cancer Research Grant (to J. G. M.), and a Research Supplement to promote diversity in health-related research CA154674-04S1 (to N. M. V-C.). This work was also supported by Grant P30 CA072720 from the NCI, National Institutes of Health to The Rutgers Cancer Institute of New Jersey (to X. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Chang Q, 2000, J BIOL CHEM, V275, P21981, DOI 10.1074/jbc.M001049200; Chaveroux C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27278; Chen CY, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00338; Dai N, 2013, GENE DEV, V27, P301, DOI 10.1101/gad.209130.112; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Denzel MS, 2014, CELL, V156, P1167, DOI 10.1016/j.cell.2014.01.061; Duan FF, 2016, ONCOTARGET, V7, P38427, DOI 10.18632/oncotarget.9538; Durand P, 2008, ARCH BIOCHEM BIOPHYS, V474, P302, DOI 10.1016/j.abb.2008.01.026; Eguchi S, 2009, GENES CELLS, V14, P179, DOI 10.1111/j.1365-2443.2008.01260.x; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gelinas R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02795-4; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim SJ, 2012, MOL CELL, V48, P875, DOI 10.1016/j.molcel.2012.09.029; Leskoske KL, 2017, GENETICS, V207, P179, DOI 10.1534/genetics.117.1124; Li LL, 2017, ONCOTARGET, V8, P19205, DOI 10.18632/oncotarget.15164; Li X, 2014, EMBO REP, V15, P191, DOI 10.1002/embr.201338119; Li Y, 2007, BIOCHEMISTRY-US, V46, P13163, DOI 10.1021/bi700694c; Liu PD, 2015, CANCER DISCOV, V5, P1194, DOI 10.1158/2159-8290.CD-15-0460; Moloughney JG, 2016, MOL CELL, V63, P811, DOI 10.1016/j.molcel.2016.07.015; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pusapati RV, 2016, CANCER CELL, V29, P548, DOI 10.1016/j.ccell.2016.02.018; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Tobias IS, 2016, BIOCHEM J, V473, P509, DOI 10.1042/BJ20151013; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Vasconcelos-dos-Santos A, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.2; Vasseur S, 2015, SEMIN CANCER BIOL, V33, P34, DOI 10.1016/j.semcancer.2015.04.001; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Xie XJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002207; Yang CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep39044; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zibrova D, 2017, BIOCHEM J, V474, P983, DOI 10.1042/BCJ20160980	45	23	23	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16464	16478		10.1074/jbc.RA118.003991	http://dx.doi.org/10.1074/jbc.RA118.003991			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30201609	hybrid, Green Published			2022-12-28	WOS:000447833600028
J	Xu, CC; Zhang, D; Hann, DR; Xie, ZP; Staehelin, C				Xu, Chang-Chao; Zhang, Di; Hann, Dagmar R.; Xie, Zhi-Ping; Staehelin, Christian			Biochemical properties and in planta effects of NopM, a rhizobial E3 ubiquitin ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; E3 ubiquitin ligase; phosphorylation; type III secretion system (T3SS); symbiosis; effector protein; ubiquitination	ACTIVATED-PROTEIN-KINASE; NODULATION OUTER PROTEINS; SP STRAIN NGR234; TRIGGERED IMMUNITY; TYPE-3 EFFECTOR; SHIGELLA EFFECTOR; SECRETION SYSTEM; LOTUS-JAPONICUS; IPAH FAMILY; DEGRADATION	Nodulation outer protein M (NopM) is an IpaH family type three (T3) effector secreted by the nitrogen-fixing nodule bacterium Sinorhizobium sp. strain NGR234. Previous work indicated that NopM is an E3 ubiquitin ligase required for an optimal symbiosis between NGR234 and the host legume Lablab purpureus. Here, we continued to analyze the function of NopM. Recombinant NopM was biochemically characterized using an in vitro ubiquitination system with Arabidopsis thaliana proteins. In this assay, NopM forms unanchored polyubiquitin chains and possesses auto-ubiquitination activity. In a NopM variant lacking any lysine residues, auto-ubiquitination was not completely abolished, indicating noncanonical auto-ubiquitination of the protein. In addition, we could show intermolecular ubiquitin transfer from NopM to C338A (enzymatically inactive NopM form) in vitro. Bimolecular fluorescence complementation analysis provided clues about NopM-NopM interactions at plasma membranes in planta. NopM, but not C338A, expressed in tobacco cells induced cell death, suggesting that E3 ubiquitin ligase activity of NopM induced effector-triggered immunity responses. Likewise, expression of NopM in Lotus japonicus caused reduced nodule formation, whereas expression of C338A showed no obvious effects on symbiosis. Further experiments indicated that serine residue 26 of NopM is phosphorylated in planta and that NopM can be phosphorylated in vitro by salicylic acid-induced protein kinase (NtSIPK), a mitogen-activated protein kinase (MAPK) of tobacco. Hence, NopM is a phosphorylated T3 effector that can interact with itself, with ubiquitin, and with MAPKs.	[Xu, Chang-Chao; Zhang, Di; Xie, Zhi-Ping; Staehelin, Christian] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, East Campus, Guangzhou 510006, Guangdong, Peoples R China; [Xu, Chang-Chao; Zhang, Di; Xie, Zhi-Ping; Staehelin, Christian] Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Plant Resources, East Campus, Guangzhou 510006, Guangdong, Peoples R China; [Hann, Dagmar R.] Ludwig Maximilians Univ Munchen, Inst Genet, D-82152 Martinsried, Germany; [Xie, Zhi-Ping; Staehelin, Christian] Sun Yat Sen Univ, Sch Life Sci, Shenzhen Res & Dev Ctr, State Key Lab Biocontrol, Shenzhen 518057, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; University of Munich; Sun Yat Sen University	Xie, ZP; Staehelin, C (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, East Campus, Guangzhou 510006, Guangdong, Peoples R China.; Xie, ZP; Staehelin, C (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Shenzhen Res & Dev Ctr, State Key Lab Biocontrol, Shenzhen 518057, Peoples R China.	xiezping@mail.sysu.edu.cn; cst@mail.sysu.edu.cn	Hann, Dagmar/GYA-4366-2022		National Natural Science Foundation of China [31470197]; Department of Science and Technology of Guangdong Province, China [2013B051000043, 2017B030311005]; Science Foundation of the State Key Laboratory of Biocontrol Grants [SKLBC32-2017-A09, SKLBC32-2018-A10]; Guangdong Key Laboratory of Plant Resources Grant [2014B030301026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Guangdong Province, China; Science Foundation of the State Key Laboratory of Biocontrol Grants; Guangdong Key Laboratory of Plant Resources Grant	This work was supported by the National Natural Science Foundation of China Grant 31470197; by the Department of Science and Technology of Guangdong Province, China, Grants 2013B051000043 and 2017B030311005; by the Science Foundation of the State Key Laboratory of Biocontrol Grants SKLBC32-2017-A09 and SKLBC32-2018-A10; and by the Guangdong Key Laboratory of Plant Resources Grant 2014B030301026. The authors declare that they have no conflicts of interest with the contents of this article.	Ashida H, 2016, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00100; Bartsev AV, 2004, PLANT PHYSIOL, V134, P871, DOI 10.1104/pp.103.031740; Bernal-Bayard J, 2009, J BIOL CHEM, V284, P27587, DOI 10.1074/jbc.M109.010363; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Buttner D, 2016, FEMS MICROBIOL REV, V40, P894, DOI 10.1093/femsre/fuw026; Chen M., 2016, Recent trends in PGPR research for sustainable crop productivity. 4th Asian PGPR Conference Proceedings, Hanoi, Vietnam, 3-6 May, 2015, P174; Chen T, 2012, PLANT CELL, V24, P823, DOI 10.1105/tpc.112.095984; Chou YC, 2012, J BIOL CHEM, V287, P268, DOI 10.1074/jbc.M111.316265; Cui HT, 2015, ANNU REV PLANT BIOL, V66, P487, DOI 10.1146/annurev-arplant-050213-040012; Dai WJ, 2008, J BACTERIOL, V190, P5101, DOI 10.1128/JB.00306-08; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; Edwards DJ, 2014, J BIOL CHEM, V289, P34114, DOI 10.1074/jbc.M114.609164; Fotiadis CT, 2012, FEMS MICROBIOL LETT, V327, P66, DOI 10.1111/j.1574-6968.2011.02466.x; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; GAMBORG OL, 1970, PLANT PHYSIOL, V45, P372, DOI 10.1104/pp.45.4.372; Ge YY, 2016, J EXP BOT, V67, P2483, DOI 10.1093/jxb/erw065; Gilkerson J, 2015, PLANT PHYSIOL, V168, P708, DOI 10.1104/pp.15.00402; Haraga A, 2003, INFECT IMMUN, V71, P4052, DOI 10.1128/IAI.71.7.4052-4058.2003; Hicks SW, 2011, CELL HOST MICROBE, V10, P9, DOI 10.1016/j.chom.2011.06.003; Lopez-Baena FJ, 2009, MOL PLANT MICROBE IN, V22, P1445, DOI 10.1094/MPMI-22-11-1445; Kambara K, 2009, MOL MICROBIOL, V71, P92, DOI 10.1111/j.1365-2958.2008.06507.x; Keszei AFA, 2017, P NATL ACAD SCI USA, V114, P1311, DOI 10.1073/pnas.1611595114; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kumagai H, 2003, MOL PLANT MICROBE IN, V16, P663, DOI 10.1094/MPMI.2003.16.8.663; Li P, 2017, NATURE, V551, P378, DOI 10.1038/nature24467; Marin M, 2013, PLANT CELL, V25, P3153, DOI 10.1105/tpc.113.116319; McDowell GS, 2013, INT J BIOCHEM CELL B, V45, P1833, DOI 10.1016/j.biocel.2013.05.026; Nakano M, 2017, MICROBIOL-SGM, V163, P992, DOI 10.1099/mic.0.000495; Nelson MS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00491; Ntoukakis V, 2009, SCIENCE, V324, P784, DOI 10.1126/science.1169430; Okazaki S, 2013, P NATL ACAD SCI USA, V110, P17131, DOI 10.1073/pnas.1302360110; Park Y, 2009, J BIOL CHEM, V284, P1540, DOI 10.1074/jbc.M807554200; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Rodrigues JA, 2007, J PROTEOME RES, V6, P1029, DOI 10.1021/pr060519f; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Seyedarabi A, 2010, FEBS LETT, V584, P4163, DOI 10.1016/j.febslet.2010.09.006; Singer AU, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003121; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Staehelin C, 2015, BIOCHEM J, V470, P263, DOI 10.1042/BJ20150518; Toyotome T, 2001, J BIOL CHEM, V276, P32071, DOI 10.1074/jbc.M101882200; Valkevich EM, 2014, BIOCHEMISTRY-US, V53, P4979, DOI 10.1021/bi5006305; Wandel MP, 2017, CELL HOST MICROBE, V22, P507, DOI 10.1016/j.chom.2017.09.007; Wang XL, 2012, TRAFFIC, V13, P19, DOI 10.1111/j.1600-0854.2011.01269.x; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Xin DW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002707; Yang KY, 2001, P NATL ACAD SCI USA, V98, P741, DOI 10.1073/pnas.98.2.741; Yang SM, 2010, P NATL ACAD SCI USA, V107, P18735, DOI 10.1073/pnas.1011957107; Yasuda M, 2016, PLANT CELL PHYSIOL, V57, P1791, DOI 10.1093/pcp/pcw104; Zhang L, 2011, J BIOL CHEM, V286, P32178, DOI 10.1074/jbc.M111.265942; Zhang SQ, 2001, PLANT CELL, V13, P1877, DOI 10.1105/tpc.13.8.1877; Zhao QZ, 2013, PLANT J, V74, P524, DOI 10.1111/tpj.12127; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517; Zouhir S, 2014, BIOCHEM J, V464, P135, DOI 10.1042/BJ20140587	58	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15304	15315		10.1074/jbc.RA118.004444	http://dx.doi.org/10.1074/jbc.RA118.004444			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30120198	Green Published, hybrid			2022-12-28	WOS:000445998400029
J	White, EJ; Gyulay, G; Lhotak, S; Szewczyk, MM; Chong, T; Fuller, MT; Dadoo, O; Fox-Robichaud, AE; Austin, RC; Trigatti, BL; Igdoura, SA				White, Elizabeth J.; Gyulay, Gabriel; Lhotak, Sarka; Szewczyk, Magdalena M.; Chong, Taryne; Fuller, Mark T.; Dadoo, Omid; Fox-Robichaud, Alison E.; Austin, Richard C.; Trigatti, Bernardo L.; Igdoura, Suleiman A.			Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration, and attenuates atherosclerosis in ApoE knockout mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipoprotein metabolism; monocyte; sialidase; atherosclerosis; glycosylation inhibitor; sialic acid; gene knockout; apolipoprotein E (ApoE); bone marrow; transplantation; Hyaluronic acid; P-selectin	LOW-DENSITY-LIPOPROTEIN; E-DEFICIENT MICE; LYSOSOMAL SIALIDASE; ACID CONTENT; 2-DEOXY-2,3-DEHYDRO-N-ACETYLNEURAMINIC ACID; PLASMA-MEMBRANE; HUMAN MONOCYTES; EXPRESSION; CELLS; MOUSE	Atherosclerosis is a complex disease that involves alterations in lipoprotein metabolism and inflammation. Protein and lipid glycosylation events, such as sialylation, contribute to the development of atherosclerosis and are regulated by specific glycosidases, including sialidases. To evaluate the effect of the sialidase neuraminidase 1 (NEU1) on atherogenesis, here we generated apolipoprotein E (ApoE)-deficient mice that express hypomorphic levels of NEU1 (Neu1(hypo)Apoe(-/-)). We found that the hypomorphic NEU1 expression in male Apoe(-/-) mice reduces serum levels of very-low-density lipoprotein (VLDL) and LDL cholesterol, diminishes infiltration of inflammatory cells into lesions, and decreases aortic sinus atherosclerosis. Transplantation of Apoe(-/-) bone marrow (BM) into Neu1(hypo)Apoe(-/-) mice significantly increased atherosclerotic lesion development and had no effect on serum lipoprotein levels. Moreover, Neu1(hypo)Apoe(-/-) mice exhibited a reduction in circulating monocyte and neutrophil levels and had reduced hyaluronic acid and P-selectin adhesion capability on monocytes/neutrophils and T cells. Consistent with these findings, administration of a sialidase inhibitor, 2-deoxy-2,3-dehydro-N-acetylneuraminic acid, had a significant anti-atherogenic effect in the Apoe(-/-) mice. In summary, the reduction in NEU1 expression or function decreases atherosclerosis in mice via its significant effects on lipid metabolism and inflammatory processes. We conclude that NEU1 may represent a promising target for managing atherosclerosis.	[White, Elizabeth J.; Gyulay, Gabriel; Szewczyk, Magdalena M.; Chong, Taryne; Igdoura, Suleiman A.] McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada; [Fuller, Mark T.; Dadoo, Omid; Trigatti, Bernardo L.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Igdoura, Suleiman A.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4K1, Canada; [Fuller, Mark T.; Dadoo, Omid; Fox-Robichaud, Alison E.; Austin, Richard C.; Trigatti, Bernardo L.] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8S 4K1, Canada; [Lhotak, Sarka; Fox-Robichaud, Alison E.; Austin, Richard C.] McMaster Univ, St Josephs Healthcare, Div Nephrol, Dept Med, Hamilton, ON L8N 4A6, Canada; [Lhotak, Sarka; Fox-Robichaud, Alison E.; Austin, Richard C.] Hamilton Ctr Kidney Res, Hamilton, ON L8N 4A6, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University	Igdoura, SA (corresponding author), McMaster Univ, 1280 Main St W LSB 335, Hamilton, ON L8S 4K1, Canada.	igdoura@mcmaster.ca		Trigatti, Bernardo (Dino) L./0000-0002-4556-119X	Heart & Stroke Foundation of Canada (HSF) grants; Canadian Institutes of Health Research (CIHR) postdoctoral fellowship; CIHR studentship	Heart & Stroke Foundation of Canada (HSF) grants(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR) postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); CIHR studentship(Canadian Institutes of Health Research (CIHR))	This work was supported by Heart & Stroke Foundation of Canada (HSF) grants (to S. A. I.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Canadian Institutes of Health Research (CIHR) postdoctoral fellowship.; Recipient of a CIHR studentship.	Achyuthan KE, 2001, COMP BIOCHEM PHYS B, V129, P29, DOI 10.1016/S1096-4959(01)00372-4; Amith SR, 2009, GLYCOCONJUGATE J, V26, P1197, DOI 10.1007/s10719-009-9239-8; Bonnet P, 2004, PROTEIN SCI, V13, P946, DOI 10.1110/ps.03129704; Carrillo MB, 1997, GLYCOBIOLOGY, V7, P975; Champigny MJ, 2009, MOL GENET METAB, V97, P43, DOI 10.1016/j.ymgme.2009.01.004; Champigny MJ, 2005, EXP CELL RES, V311, P157, DOI 10.1016/j.yexcr.2005.08.023; Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; Covey SD, 2003, ARTERIOSCL THROM VAS, V23, P1589, DOI 10.1161/01.ATV.0000083343.19940.A0; Cross AS, 2012, J BIOL CHEM, V287, P15966, DOI 10.1074/jbc.M112.346817; Cross AS, 2003, J BIOL CHEM, V278, P4112, DOI 10.1074/jbc.M207591200; de Geest N, 2002, HUM MOL GENET, V11, P1455, DOI 10.1093/hmg/11.12.1455; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; FILIPOVIC I, 1979, EUR J BIOCHEM, V93, P51, DOI 10.1111/j.1432-1033.1979.tb12793.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox-Robichaud A, 2000, HEPATOLOGY, V31, P1123, DOI 10.1053/he.2000.6961; Gadhoum SZ, 2008, NAT CHEM BIOL, V4, P751, DOI 10.1038/nchembio.116; Gayral S, 2014, CARDIOVASC RES, V102, P118, DOI 10.1093/cvr/cvt336; Gee K, 2003, J BIOL CHEM, V278, P37275, DOI 10.1074/jbc.M302309200; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Igdoura SA, 1998, HUM MOL GENET, V7, P115, DOI 10.1093/hmg/7.1.115; Katoh S, 1999, J IMMUNOL, V162, P5058; KATOH S, 1995, J EXP MED, V182, P419, DOI 10.1084/jem.182.2.419; Kuipers F, 1997, J CLIN INVEST, V100, P2915, DOI 10.1172/JCI119841; Li XH, 1996, J LIPID RES, V37, P210; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; Lo JC, 2007, SCIENCE, V316, P285, DOI 10.1126/science.1137221; MALMENDIER CL, 1980, ATHEROSCLEROSIS, V37, P277, DOI 10.1016/0021-9150(80)90013-1; MEINDL P, 1974, VIROLOGY, V58, P457, DOI 10.1016/0042-6822(74)90080-4; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Millar JS, 2001, ATHEROSCLEROSIS, V154, P1, DOI 10.1016/S0021-9150(00)00697-3; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Mochizuki S, 2002, J BIOL CHEM, V277, P44854, DOI 10.1074/jbc.M205630200; Monti E, 1999, GENOMICS, V57, P137, DOI 10.1006/geno.1999.5749; NOHLE U, 1982, EUR J BIOCHEM, V126, P543, DOI 10.1111/j.1432-1033.1982.tb06815.x; OREKHOV AN, 1992, J LIPID RES, V33, P805; OREKHOV AN, 1991, ATHEROSCLEROSIS, V86, P153, DOI 10.1016/0021-9150(91)90211-K; Pappu BP, 2004, J IMMUNOL, V173, P275, DOI 10.4049/jimmunol.173.1.275; POTIER M, 1979, FEBS LETT, V108, P345, DOI 10.1016/0014-5793(79)80560-8; Pshezhetsky AV, 1997, NAT GENET, V15, P316, DOI 10.1038/ng0397-316; RUELLAND A, 1993, CLIN CHIM ACTA, V221, P127, DOI 10.1016/0009-8981(93)90027-2; Sakarya S, 2004, GLYCOBIOLOGY, V14, P481, DOI 10.1093/glycob/cwh065; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Sperandio M, 2009, IMMUNOL REV, V230, P97, DOI 10.1111/j.1600-065X.2009.00795.x; SPRAGUE EA, 1988, J CELL PHYSIOL, V137, P251, DOI 10.1002/jcp.1041370207; Stamatos NM, 2010, J LEUKOCYTE BIOL, V88, P1227, DOI 10.1189/jlb.1209776; Stamatos NM, 2005, FEBS J, V272, P2545, DOI 10.1111/j.1742-4658.2005.04679.x; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Yang A, 2012, J LIPID RES, V53, P2573, DOI 10.1194/jlr.M027300; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	51	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14689	14706		10.1074/jbc.RA118.004589	http://dx.doi.org/10.1074/jbc.RA118.004589			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30097518	Green Published, hybrid			2022-12-28	WOS:000446155000010
J	Kratz, K; de Lange, T				Kratz, Katja; de Lange, Titia			Protection of telomeres 1 proteins POT1a and POT1b can repress ATR signaling by RPA exclusion, but binding to CST limits ATR repression by POT1b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						telomere; shelterin; DNA binding protein; DNA damage response; checkpoint control; ATR signaling; CST (Ctc1; Stn1; Ten1); POT1; RPA; single-stranded DNA; POT1a; POT1b; 3 overhang	DNA-DAMAGE RESPONSE; SINGLE-STRANDED-DNA; DYSFUNCTIONAL TELOMERES; MAMMALIAN TELOMERES; HUMAN-CHROMOSOMES; FILL-IN; END; COMPLEX; TPP1; TUMORIGENESIS	Comprised of telomeric TTAGGG repeats and shelterin, telomeres ensure that the natural ends of chromosomes remain impervious to the DNA damage response. Telomeres carry a long constitutive 3 overhang that can bind replication protein A (RPA) and activate the ATR Ser/Thr kinase (ATR), which induces cell cycle arrest. A single-stranded (ss) TTAGGG repeat-binding protein in mouse shelterin, POT1a, has been proposed to repress ATR signaling by preventing RPA binding. Repression of ATR at telomeres requires tethering of POT1a to the other shelterin subunits situated on the double-stranded (ds) telomeric DNA. The simplest model of ATR repression, the tethered exclusion model, suggests that the only critical features of POT1a are its connection to shelterin and its binding to ss telomeric DNA. In agreement with the model, we show here that a shelterin-tethered variant of RPA70 (lacking the ATR recruitment domain) can repress ATR signaling at telomeres that lack POT1a. However, arguing against the tethered exclusion model, the nearly identical POT1b subunit of shelterin has been shown to be much less proficient than POT1a in repression of ATR. We now show that POT1b has the intrinsic ability to fully repress ATR but is prevented from doing so when bound to Ctc1, Stn1, Ten1 (CST), the complex needed for telomere end processing. These results establish that shelterin represses ATR with a tethered ssDNA-binding domain that excludes RPA from the 3 overhang and also reveal an unexpected effect of CST on the ability of POT1b to repress ATR.	[Kratz, Katja; de Lange, Titia] Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10021 USA; [Kratz, Katja] Johannes Gutenberg Univ Mainz, Inst Neurobiol & Dev Biol, IMB Mainz, D-55128 Mainz, Germany	Rockefeller University; Johannes Gutenberg University of Mainz	de Lange, T (corresponding author), Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10021 USA.	delange@rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	EMBO long-term fellowship EMBO [ALTF-1044-2011]; Women & Science Fellowship Program at The Rockefeller University funds; National Institutes of Health [AG016642]; NATIONAL INSTITUTE ON AGING [R01AG016642] Funding Source: NIH RePORTER	EMBO long-term fellowship EMBO; Women & Science Fellowship Program at The Rockefeller University funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by EMBO long-term fellowship EMBO ALTF-1044-2011 and Women & Science Fellowship Program at The Rockefeller University funds (to K. K.). This work was also supported by National Institutes of Health Grant AG016642 (to T. d. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bass TE, 2016, NAT CELL BIOL, V18, P1185, DOI 10.1038/ncb3415; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bhattacharjee A, 2017, NUCLEIC ACIDS RES, V45, P12311, DOI 10.1093/nar/gkx878; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Churikov D, 2008, NAT STRUCT MOL BIOL, V15, P79, DOI 10.1038/nsmb1331; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; de Lange T., 2018, ANN REV GENETICS; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; Diotti R, 2015, MOL CANCER RES, V13, P402, DOI 10.1158/1541-7786.MCR-14-0381; Doksani Y, 2013, CELL, V155, P345, DOI 10.1016/j.cell.2013.09.048; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; Frescas D, 2014, J BIOL CHEM, V289, P24180, DOI 10.1074/jbc.M114.592592; Gong Y, 2010, MOL CELL, V40, P377, DOI 10.1016/j.molcel.2010.10.016; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Haahr P, 2016, NAT CELL BIOL, V18, P1196, DOI 10.1038/ncb3422; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Hockemeyer D, 2008, GENE DEV, V22, P1773, DOI 10.1101/gad.1679208; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Kibe T, 2010, MOL CELL BIOL, V30, P1059, DOI 10.1128/MCB.01498-09; Lazzerini-Denchi E, 2016, NAT REV MOL CELL BIO, V17, P364, DOI 10.1038/nrm.2016.43; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2004, J BIOL CHEM, V279, P13241, DOI 10.1074/jbc.M312309200; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pinzaru AM, 2016, CELL REP, V15, P2170, DOI 10.1016/j.celrep.2016.05.008; Price CM, 2010, CELL CYCLE, V9, P3157, DOI 10.4161/cc.9.16.12547; Ray S, 2014, P NATL ACAD SCI USA, V111, P2990, DOI 10.1073/pnas.1321436111; Rice C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14928; Sfeir AJ, 2005, MOL CELL, V18, P131, DOI 10.1016/j.molcel.2005.02.035; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Takai H, 2016, GENE DEV, V30, P812, DOI 10.1101/gad.276873.115; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Wan M, 2009, J BIOL CHEM, V284, P26725, DOI 10.1074/jbc.M109.021105; Wu P, 2012, CELL, V150, P39, DOI 10.1016/j.cell.2012.05.026; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404	42	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14384	14392		10.1074/jbc.RA118.004598	http://dx.doi.org/10.1074/jbc.RA118.004598			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30082315	Green Published, hybrid			2022-12-28	WOS:000444671500018
J	Nasser, MW; Datta, J; Nuovo, G; Kutay, H; Motiwala, T; Majumder, S; Wang, B; Suster, S; Jacob, ST; Ghoshal, K				Nasser, Mohd W.; Datta, Jharna; Nuovo, Gerard; Kutay, Huban; Motiwala, Tasneem; Majumder, Sarmila; Wang, Bo; Suster, Saul; Jacob, Samson T.; Ghoshal, Kalpana			RETRACTION: Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1 (Retraction of Vol 283, Pg 33394, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Motiwala, Tasneem/AAB-9067-2021		NATIONAL LIBRARY OF MEDICINE [T15LM011270] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200	1	4	5	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12945	12945		10.1074/jbc.W118.004967	http://dx.doi.org/10.1074/jbc.W118.004967			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	30120149	Green Published, hybrid			2022-12-28	WOS:000442203500025
J	Jang, SY; Hwang, J; Kim, BS; Lee, EY; Oh, BH; Kim, MH				Jang, Song Yee; Hwang, Jungwon; Kim, Byoung Sik; Lee, Eun-Young; Oh, Byung-Ha; Kim, Myung Hee			Structural basis of inactivation of Ras and Rap1 small GTPases by Ras/Rap1-specific endopeptidase from the sepsis-causing pathogen Vibrio vulnificus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						toxin; virulence factor; sepsis; host-pathogen interaction; bacterial pathogenesis; effector; MARTX toxin; Ras; Rap1-specific endopeptidase; Vibrio vulnificus	VI SECRETION SYSTEM; BACTERIAL TOXINS; CROSS-LINKING; FAMILY; ACTIVATION; EFFECTOR; DISTINCT; DOMAIN; RESPONSES; DELIVERY	Multifunctional autoprocessing repeats-in-toxin (MARTX) toxins are secreted by Gram-negative bacteria and function as primary virulence-promoting macromolecules that deliver multiple cytopathic and cytotoxic effector domains into the host cytoplasm. Among these effectors, Ras/Rap1-specific endopeptidase (RRSP) catalyzes the sequence-specific cleavage of the Switch I region of the cellular substrates Ras and Rap1 that are crucial for host innate immune defenses during infection. To dissect the molecular basis underpinning RRSP-mediated substrate inactivation, we determined the crystal structure of an RRSP from the sepsis-causing bacterial pathogen Vibrio vulnificus (VvRRSP). Structural and biochemical analyses revealed that VvRRSP is a metal-independent TIKI family endopeptidase composed of an N-terminal membrane-localization and substrate-recruitment domain (N lobe) connected via an inter-lobe linker to the C-terminal active site-coordinating core -sheet-containing domain (C lobe). Structure-based mutagenesis identified the 2His/2Glu catalytic residues in the core catalytic domain that are shared with other TIKI family enzymes and that are essential for Ras processing. In vitro KRas cleavage assays disclosed that deleting the N lobe in VvRRSP causes complete loss of enzymatic activity. Endogenous Ras cleavage assays combined with confocal microscopy analysis of HEK293T cells indicated that the N lobe functions both in membrane localization via the first -helix and in substrate assimilation by altering the functional conformation of the C lobe to facilitate recruitment of cellular substrates. Collectively, these results indicate that RRSP is a critical virulence factor that robustly inactivates Ras and Rap1 and augments the pathogenicity of invading bacteria via the combined effects of its N and C lobes.	[Jang, Song Yee; Oh, Byung-Ha] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea; [Jang, Song Yee; Hwang, Jungwon; Kim, Byoung Sik; Lee, Eun-Young; Kim, Myung Hee] Korea Res Inst Biosci & Biotechnol, Infect & Immun Res Lab, Metab Regulat Res Ctr, Daejeon 34141, South Korea; [Kim, Byoung Sik] Ewha Womans Univ, Dept Food Sci & Engn, Seoul 03760, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Ewha Womans University	Oh, BH (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea.; Hwang, J; Kim, MH (corresponding author), Korea Res Inst Biosci & Biotechnol, Infect & Immun Res Lab, Daejeon 34141, South Korea.	jwhwang@kribb.re.kr; bhoh@kaist.ac.kr; mhk8n@kribb.re.kr	Kim, Byoungsik/AAE-6239-2021	Kim, Byoung Sik/0000-0001-9820-6071	National Research Foundation of Korea; Korea Research Institute of Bioscience and Biotechnology (KRIBB) Initiative Program; Ministry of Science and ICT of Korea [2017R1A2B3007317]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Research Institute of Bioscience and Biotechnology (KRIBB) Initiative Program; Ministry of Science and ICT of Korea	This work was supported by National Research Foundation of Korea, funded by the Ministry of Science and ICT of Korea Grant 2017R1A2B3007317 (to M.H.K.), and the Korea Research Institute of Bioscience and Biotechnology (KRIBB) Initiative Program. The authors declare that they have no conflicts of interest with the contents of this article.	Ackermann JA, 2011, EMBO J, V30, P1621, DOI 10.1038/emboj.2011.74; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; Antic I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8396; Antic I, 2014, PROTEINS, V82, P2643, DOI 10.1002/prot.24628; Bazan JF, 2013, DEV CELL, V25, P225, DOI 10.1016/j.devcel.2013.04.019; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biancucci M, 2017, BIOCHEMISTRY-US, V56, P2747, DOI 10.1021/acs.biochem.7b00246; Boardman BK, 2004, J BACTERIOL, V186, P8137, DOI 10.1128/JB.186.23.8137-8143.2004; Botelho RJ, 2009, J BIOL CHEM, V284, P28522, DOI 10.1074/jbc.M109.009514; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gavin HE, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv092; Geissler B, 2012, CELL MICROBIOL, V14, P286, DOI 10.1111/j.1462-5822.2011.01718.x; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; Gerard A, 2007, J CELL BIOL, V176, P863, DOI 10.1083/jcb.200608161; Hisao GS, 2017, PROTEIN SCI, V26, P497, DOI 10.1002/pro.3097; Johnson DS, 2012, CURR OPIN PHARMACOL, V12, P458, DOI 10.1016/j.coph.2012.02.003; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Kim BS, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00272-17; Kim BS, 2015, MBIO, V6, DOI 10.1128/mBio.00324-15; Kudryashev M, 2015, CELL, V160, P952, DOI 10.1016/j.cell.2015.01.037; Kwak JS, 2011, P NATL ACAD SCI USA, V108, P1645, DOI 10.1073/pnas.1014339108; Lee BC, 2008, INFECT IMMUN, V76, P1509, DOI 10.1128/IAI.01503-07; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Mitchell D, 2010, MOL IMMUNOL, V47, P2065, DOI 10.1016/j.molimm.2010.04.004; Moest TP, 2013, CURR OPIN MICROBIOL, V16, P38, DOI 10.1016/j.mib.2012.11.006; Morar M, 2012, BIOCHEMISTRY-US, V51, P1740, DOI 10.1021/bi201790u; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagahama M, 2011, INFECT IMMUN, V79, P905, DOI 10.1128/IAI.01019-10; Riese MJ, 2011, J BIOL CHEM, V286, P5254, DOI 10.1074/jbc.M110.171884; Sanchez-Pulido L, 2013, BIOINFORMATICS, V29, P2371, DOI 10.1093/bioinformatics/btt412; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Satchell KJF, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.VE-0002-2014; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Shah S, 2018, RILEM BOOKSER, V15, P3, DOI 10.1007/978-94-024-1194-2_1; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Shin J, 2012, J IMMUNOL, V188, P2111, DOI 10.4049/jimmunol.1102265; So EC, 2015, CAN J MICROBIOL, V61, P617, DOI 10.1139/cjm-2015-0166; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Woida PJ, 2018, MOL MICROBIOL, V107, P133, DOI 10.1111/mmi.13875; Woolery AR, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.601310; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zhang XJ, 2016, J BIOL CHEM, V291, P2435, DOI 10.1074/jbc.M115.677807	52	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18110	18122		10.1074/jbc.RA118.004857	http://dx.doi.org/10.1074/jbc.RA118.004857			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30282804	hybrid, Green Published			2022-12-28	WOS:000451375200008
J	Hone, AJ; Talley, TT; Bobango, J; Melo, CH; Hararah, F; Gajewiak, J; Christensen, S; Harvey, PJ; Craik, DJ; McIntosh, JM				Hone, Arik J.; Talley, Todd T.; Bobango, Janet; Melo, Cesar Huidobro; Hararah, Fuaad; Gajewiak, Joanna; Christensen, Sean; Harvey, Peta J.; Craik, David J.; McIntosh, J. Michael			Molecular determinants of alpha-conotoxin potency for inhibition of human and rat alpha 6 beta 4 nicotinic acetylcholine receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nicotinic acetylcholine receptors (nAChR); neuroinflammation; neuroscience; neurotransmitter receptor; neurotoxin; 1; -conotoxin; nicotinic subunit 6; nicotinic subunit 4; nuclear magnetic resonance spectroscopy; X-ray crystallography; small peptide; analgesic; neuropathic pain	DOPAMINE RELEASE; BINDING PROTEIN; CHOLINERGIC-RECEPTORS; SYNAPTIC TRANSMISSION; SUBUNIT COMPOSITION; CRYSTAL-STRUCTURE; DIFFERENT NACHR; MOUSE-BRAIN; SPINAL-CORD; SUBTYPES	Nicotinic acetylcholine receptors (nAChRs) containing 6 and 4 subunits are expressed by dorsal root ganglion neurons and have been implicated in neuropathic pain. Rodent models are often used to evaluate the efficacy of analgesic compounds, but species differences may affect the activity of some nAChR ligands. A previous candidate -conotoxin-based therapeutic yielded promising results in rodent models, but failed in human clinical trials, emphasizing the importance of understanding species differences in ligand activity. Here, we show that human and rat 6/34 nAChRs expressed in Xenopus laevis oocytes exhibit differential sensitivity to -conotoxins. Sequence homology comparisons of human and rat 64 nAChR subunits indicated that 6 residues forming the ligand-binding pocket are highly conserved between the two species, but several residues of 4 differed, including a Leu-Gln difference at position 119. X-ray crystallography of -conotoxin PeIA complexed with the Aplysia californica acetylcholine-binding protein (AChBP) revealed that binding of PeIA orients Pro(13) in close proximity to residue 119 of the AChBP complementary subunit. Site-directed mutagenesis studies revealed that Leu(119) of human 4 contributes to higher sensitivity of human 6/34 nAChRs to -conotoxins, and structure-activity studies indicated that PeIA Pro(13) is critical for high potency. Human and rat 6/34 nAChRs displayed differential sensitivities to perturbations of the interaction between PeIA Pro(13) and residue 119 of the 4 subunit. These results highlight the potential significance of species differences in 64 nAChR pharmacology that should be taken into consideration when evaluating the activity of candidate human therapeutics in rodent models.	[Hone, Arik J.; Melo, Cesar Huidobro; Hararah, Fuaad; Gajewiak, Joanna; Christensen, Sean; McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA; [McIntosh, J. Michael] George E Whalen Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; [Talley, Todd T.] T3 Biosciences, Moses Lake, WA 98837 USA; [Bobango, Janet] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Harvey, Peta J.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; University of Montana System; University of Montana; University of Queensland	Hone, AJ; McIntosh, JM (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.; McIntosh, JM (corresponding author), Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA.	uuneurotox@yahoo.com; mcintosh.mike@gmail.com	Craik, David/B-1695-2010; harvey, peta/D-2048-2017	Craik, David/0000-0003-0007-6796; harvey, peta/0000-0003-4735-6242	NIGMS, NIH; Howard Hughes Medical Institute;  [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103801, P01GM048677] Funding Source: NIH RePORTER	NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Quentin Kaas (University of Queensland, Brisbane, Australia) for critical reading of the manuscript. We acknowledge the contribution to the manuscript by the scientists and support staff of the Berkeley Center for Structural Biology (Berkeley Hills, CA) as well as those at the University of Utah DNA Sequencing and DNA/Peptide Synthesis Core Facilities (Salt Lake City, UT). The Berkeley Center for Structural Biology is supported in part by grants from NIGMS, NIH, and the Howard Hughes Medical Institute. The Advanced Light Source is a Department of Energy Office of Science User Facility under contract DE-AC02-05CH11231.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Bagdas D, 2018, CURR NEUROPHARMACOL, V16, P415, DOI 10.2174/1570159X15666170818102108; Bradaia A, 2002, J PHYSIOL-LONDON, V544, P727, DOI 10.1113/jphysiol.2002.028894; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cierpicki T, 2001, J BIOMOL NMR, V21, P249, DOI 10.1023/A:1012911329730; Clarke PBS, 1996, BRIT J PHARMACOL, V117, P595, DOI 10.1111/j.1476-5381.1996.tb15232.x; Cordero-Erausquin M, 2004, PAIN, V109, P308, DOI 10.1016/j.pain.2004.01.034; Cox BC, 2008, J NEUROCHEM, V105, P1924, DOI 10.1111/j.1471-4159.2008.05282.x; Cuny H, 2018, BRIT J PHARMACOL, V175, P1855, DOI 10.1111/bph.13852; Daly NL, 2011, J BIOL CHEM, V286, P10233, DOI 10.1074/jbc.M110.196170; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Delano W.L., 2017, PYMOL MOL GRAPHICS S; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Exley R, 2012, J NEUROSCI, V32, P2352, DOI 10.1523/JNEUROSCI.4985-11.2012; FAINZILBER M, 1994, BIOCHEMISTRY-US, V33, P9523, DOI 10.1021/bi00198a018; Giribaldi J, 2018, NEUROSCI LETT, V679, P24, DOI 10.1016/j.neulet.2017.11.063; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Grady SR, 2001, J NEUROCHEM, V76, P258, DOI 10.1046/j.1471-4159.2001.00019.x; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2006, J MOL NEUROSCI, V30, P101, DOI 10.1385/JMN:30:1:101; Hone AJ, 2018, FEBS LETT, V592, P1045, DOI 10.1002/1873-3468.12884; Hone AJ, 2015, MOL PHARMACOL, V88, P881, DOI 10.1124/mol.115.100982; Hone AJ, 2013, J BIOL CHEM, V288, P25428, DOI 10.1074/jbc.M113.482059; Hone AJ, 2012, MOL PHARMACOL, V82, P972, DOI 10.1124/mol.112.080853; Hone AJ, 2012, FASEB J, V26, P917, DOI 10.1096/fj.11-195883; Ikeya T, 2006, MAGN RESON CHEM, V44, pS152, DOI 10.1002/mrc.1815; Kaas Q, 2012, NUCLEIC ACIDS RES, V40, pD325, DOI 10.1093/nar/gkr886; Kaiser S, 2000, MOL PHARMACOL, V58, P312, DOI 10.1124/mol.58.2.312; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Lin B, 2016, MAR DRUGS, V14, DOI 10.3390/md14100173; Lu Y, 1998, J PHARMACOL EXP THER, V287, P648; Luo SQ, 1998, J NEUROSCI, V18, P8571; Luo SL, 2013, J BIOL CHEM, V288, P894, DOI 10.1074/jbc.M112.427898; Marritt AM, 2005, MOL PHARMACOL, V68, P1656, DOI 10.1124/mol.105.012380; McIntosh JM, 2005, J BIOL CHEM, V280, P30107, DOI 10.1074/jbc.M504102200; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; McIntosh JM, 1999, ANNU REV BIOCHEM, V68, P59, DOI 10.1146/annurev.biochem.68.1.59; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Salminen O, 2004, MOL PHARMACOL, V65, P1526, DOI 10.1124/mol.65.6.1526; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Talley TT, 2006, J BIOL CHEM, V281, P24678, DOI 10.1074/jbc.M602969200; Talley TT, 2006, BIOCHEMISTRY-US, V45, P8894, DOI 10.1021/bi060534y; Thompson AJ, 2017, NEUROPHARMACOLOGY, V116, P421, DOI 10.1016/j.neuropharm.2017.01.008; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Whiteaker P, 2000, MOL PHARMACOL, V57, P913; Wieskopf JS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3009986; Xu MY, 2017, PROTEIN CELL, V8, P675, DOI 10.1007/s13238-017-0426-2; Yang KC, 2011, J NEUROSCI, V31, P2537, DOI 10.1523/JNEUROSCI.3003-10.2011; Yu RL, 2013, J MED CHEM, V56, P3557, DOI 10.1021/jm400041h; Zhangsun DT, 2015, J BIOL CHEM, V290, P9855, DOI 10.1074/jbc.M114.632646	63	13	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17838	17852		10.1074/jbc.RA118.005649	http://dx.doi.org/10.1074/jbc.RA118.005649			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30249616	Green Published, hybrid			2022-12-28	WOS:000450409500015
J	Lander, N; Chiurillo, MA; Bertolini, MS; Storey, M; Vercesi, AE; Docampo, R				Lander, Noelia; Chiurillo, Miguel A.; Bertolini, Mayara S.; Storey, Melissa; Vercesi, Anibal E.; Docampo, Roberto			Calcium-sensitive pyruvate dehydrogenase phosphatase is required for energy metabolism, growth, differentiation, and infectivity of Trypanosoma cruzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas9; energy metabolism; Trypanosoma cruzi; bioenergetics; calcium; calcium signaling; mitochondrial calcium uniporter; mitochondrial dehydrogenase; pyruvate dehydrogenase phosphatase	AMINO-ACID-SEQUENCES; ESSENTIAL COMPONENT; COMPLEX ACTIVITY; CA-2+ TRANSPORT; BLOOD-STREAM; LIPOIC ACID; IN-SITU; BRUCEI; PHOSPHORYLATION; MITOCHONDRIA	In vertebrate cells, mitochondrial Ca2+ uptake by the mitochondrial calcium uniporter (MCU) leads to Ca2+-mediated stimulation of an intramitochondrial pyruvate dehydrogenase phosphatase (PDP). This enzyme dephosphorylates serine residues in the E1 subunit of pyruvate dehydrogenase (PDH), thereby activating PDH and resulting in increased ATP production. Although a phosphorylation/dephosphorylation cycle for the E1 subunit of PDH from nonvertebrate organisms has been described, the Ca2+-mediated PDP activation has not been studied. In this work, we investigated the Ca2+ sensitivity of two recombinant PDPs from the protozoan human parasites Trypanosoma cruzi (TcPDP) and T. brucei (TbPDP) and generated a TcPDP-KO cell line to establish TcPDP's role in cell bioenergetics and survival. Moreover, the mitochondrial localization of the TcPDP was studied by CRISPR/Cas9-mediated endogenous tagging. Our results indicate that TcPDP and TbPDP both are Ca2+-sensitive phosphatases. Of note, TcPDP-KO epimastigotes exhibited increased levels of phosphorylated TcPDH, slower growth and lower oxygen consumption rates than control cells, an increased AMP/ATP ratio and autophagy under starvation conditions, and reduced differentiation into infective metacyclic forms. Furthermore, TcPDP-KO trypomastigotes were impaired in infecting cultured host cells. We conclude that TcPDP is a Ca2+-stimulated mitochondrial phosphatase that dephosphorylates TcPDH and is required for normal growth, differentiation, infectivity, and energy metabolism in T. cruzi. Our results support the view that one of the main roles of the MCU is linked to the regulation of intramitochondrial dehydrogenases.	[Lander, Noelia; Chiurillo, Miguel A.; Bertolini, Mayara S.; Vercesi, Anibal E.; Docampo, Roberto] Univ Estadual Campinas, Dept Patol Clin, Fac Ciencias Med, BR-13083 Campinas, SP, Brazil; [Storey, Melissa; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Storey, Melissa; Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	Universidade Estadual de Campinas; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Lander, N; Docampo, R (corresponding author), Univ Estadual Campinas, Dept Patol Clin, Fac Ciencias Med, BR-13083 Campinas, SP, Brazil.; Docampo, R (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.; Docampo, R (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	noelia@uga.edu; rdocampo@uga.edu	Docampo, Roberto/X-9424-2019; Vercesi, Aníbal E/C-8767-2012	Docampo, Roberto/0000-0003-4229-8784; Santos Bertolini, Mayara/0000-0002-2489-434X; Lander, Noelia/0000-0003-2178-381X; Chiurillo, Miguel A./0000-0002-5581-9027; Vercesi, Anibal Eugenio/0000-0001-6671-7125	Sao Paulo Research Foundation (FAPESP) [2013/50624-0]; National Institutes of Health [AI107663]; FAPESP [2014/13148-9, 2015/25700-8, 2014/08995-4]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI107663, R01AI107663] Funding Source: NIH RePORTER	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Sao Paulo Research Foundation (FAPESP) Grant 2013/50624-0 (to R. D.) and National Institutes of Health Grant AI107663 (to R. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Postdoctoral fellow of FAPESP, supported by Grant 2014/08995-4. To whom correspondence may be addressed. Tel.: 55-19-35217370; E-mail: noelia@uga.edu.; Postdoctoral fellow of FAPESP, supported by Grant 2014/13148-9.; Master's fellow of FAPESP, supported by Grant 2015/25700-8.	Alonso GD, 2001, FEBS LETT, V498, P22, DOI 10.1016/S0014-5793(01)02473-5; Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; Bourguignon SC, 1998, HISTOCHEM CELL BIOL, V110, P527, DOI 10.1007/s004180050314; Buscaglia CA, 1996, BBA-GENE STRUCT EXPR, V1309, P53, DOI 10.1016/S0167-4781(96)00140-6; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Caruso M, 2001, J BIOL CHEM, V276, P45088, DOI 10.1074/jbc.M105451200; Chiurillo MA, 2017, MBIO, V8, DOI [10.1128/mBio.00574-17, 10.1128/mbio.00574-17]; Chojnacki S, 2017, NUCLEIC ACIDS RES, V45, pW550, DOI 10.1093/nar/gkx273; Crispim M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006170; Cruz-Bustos T, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00377-17, 10.1128/msphere.00377-17]; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315; DENTON RM, 1975, MOL CELL BIOCHEM, V9, P27, DOI 10.1007/BF01731731; DENTON RM, 1972, BIOCHEM J, V128, P161, DOI 10.1042/bj1280161; DOCAMPO R, 1989, J BIOL CHEM, V264, P108; DOCAMPO R, 1989, ARCH BIOCHEM BIOPHYS, V272, P122, DOI 10.1016/0003-9861(89)90202-6; Docampo R, 2014, MOL BIOCHEM PARASIT, V196, P108, DOI 10.1016/j.molbiopara.2014.09.001; Docampo R, 2012, TRENDS PARASITOL, V28, P31, DOI 10.1016/j.pt.2011.10.007; Figueira TR, 2011, MOL GENET METAB, V104, P521, DOI 10.1016/j.ymgme.2011.08.031; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Furuya T, 2000, J BIOL CHEM, V275, P6428, DOI 10.1074/jbc.275.9.6428; Gunasekera K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-556; Guo X, 2017, J BIOL CHEM, V292, P11751, DOI 10.1074/jbc.M117.787341; Huang BL, 2003, DIABETES, V52, P1371, DOI 10.2337/diabetes.52.6.1371; Huang BL, 1998, J BIOL CHEM, V273, P17680, DOI 10.1074/jbc.273.28.17680; Huang GZ, 2018, MBIO, V9, DOI [10.1128/mBio.01700-18, 10.1128/mbio.01700-18]; Huang GZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3865; Korotchkina LG, 2001, J BIOL CHEM, V276, P37223, DOI 10.1074/jbc.M103069200; Lammel EM, 1996, EXP PARASITOL, V83, P240, DOI 10.1006/expr.1996.0070; Lander N, 2018, CELL BIOL INT, V42, P656, DOI 10.1002/cbin.10928; Lander N, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2299; Lander N, 2016, J BIOL CHEM, V291, P25505, DOI 10.1074/jbc.M116.749655; Lander N, 2016, J EUKARYOT MICROBIOL, V63, P679, DOI 10.1111/jeu.12338; Lander N, 2015, MBIO, V6, DOI 10.1128/mBio.01012-15; Lander N, 2013, J BIOL CHEM, V288, P34205, DOI 10.1074/jbc.M113.518993; Lander N, 2010, INFECT IMMUN, V78, P231, DOI 10.1128/IAI.00780-09; Li FJ, 2017, AUTOPHAGY, V13, P715, DOI 10.1080/15548627.2017.1280218; LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234; Love LK, 2011, J APPL PHYSIOL, V111, P427, DOI 10.1152/japplphysiol.00672.2010; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Maugeri DA, 2011, ESSAYS BIOCHEM, V51, P15, DOI [10.1042/BSE0510015, 10.1042/bse0510015]; MCCORMACK JG, 1986, TRENDS BIOCHEM SCI, V11, P258, DOI 10.1016/0968-0004(86)90190-8; MCCORMACK JG, 1981, BIOCHEM J, V196, P619, DOI 10.1042/bj1960619; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MORENO SNJ, 1994, J EXP MED, V180, P1535, DOI 10.1084/jem.180.4.1535; MORENO SNJ, 1992, J BIOL CHEM, V267, P6020; MORENO SNJ, 1992, MOL BIOCHEM PARASIT, V52, P251, DOI 10.1016/0166-6851(92)90057-Q; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Peng D, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000033; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; SCHMATZ DM, 1982, PARASITOLOGY, V85, P115, DOI 10.1017/S0031182000054202; SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597; Silber AM, 2009, MOL BIOCHEM PARASIT, V168, P102, DOI 10.1016/j.molbiopara.2009.07.006; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; SUGDEN PH, 1979, BIOCHEM J, V181, P419, DOI 10.1042/bj1810419; TEAGUE WM, 1982, BIOCHEMISTRY-US, V21, P5585, DOI 10.1021/bi00265a031; Tovar-Mendez A, 2003, EUR J BIOCHEM, V270, P1043, DOI 10.1046/j.1432-1033.2003.03469.x; Turkan A, 2004, BIOCHEMISTRY-US, V43, P15073, DOI 10.1021/bi048901y; UHLINGER DJ, 1986, BIOCHEMISTRY-US, V25, P5673, DOI 10.1021/bi00367a049; Vacchina P, 2018, EXP PARASITOL, V186, P17, DOI 10.1016/j.exppara.2018.01.017; Vassylyev DG, 2007, J MOL BIOL, V370, P417, DOI 10.1016/j.jmb.2007.05.002; VERCESI AE, 1993, J BIOL CHEM, V268, P8564; VERCESI AE, 1992, MOL BIOCHEM PARASIT, V56, P251, DOI 10.1016/0166-6851(92)90174-I; Xiong ZH, 1997, J BIOL CHEM, V272, P31022, DOI 10.1074/jbc.272.49.31022; YEAMAN SJ, 1978, BIOCHEMISTRY-US, V17, P2364, DOI 10.1021/bi00605a017; Zhuo Y, 2017, J BIOL CHEM, V292, P18161, DOI [10.1074/jbc.M117.807495, 10.1074/jbc.m117.807495]	81	32	32	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17402	17417		10.1074/jbc.RA118.004498	http://dx.doi.org/10.1074/jbc.RA118.004498			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30232153	Green Published, hybrid			2022-12-28	WOS:000449799000008
J	Tian, B; Widen, SG; Yang, J; Wood, TG; Kudlicki, A; Zhao, YX; Brasier, AR				Tian, Bing; Widen, Steven G.; Yang, Jun; Wood, Thomas G.; Kudlicki, Andrzej; Zhao, Yingxin; Brasier, Allan R.			The NF kappa B subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NF-B; epithelial-mesenchymal transition (EMT); gene regulation; transforming growth factor (TGF-); transcription regulation; lung disease; mucosal injury; RELA proto-oncogene; Wnt; ZEB	TGF-BETA; PULMONARY-FIBROSIS; SIGNALING PATHWAY; UP-REGULATION; EXPRESSION; INFLAMMATION; MECHANISMS; MODEL; PHOSPHORYLATION; ELONGATION	The epithelial-mesenchymal transition (EMT) is a multistep dedifferentiation program important in tissue repair. Here, we examined the role of the transcriptional regulator NF-B in EMT of primary human small airway epithelial cells (hSAECs). Surprisingly, transforming growth factor (TGF) activated NF-B/RELA proto-oncogene, NF-B subunit (RELA) translocation within 1 day of stimulation, yet induction of its downstream gene regulatory network occurred only after 3 days. A time course of TGF-induced EMT transition was analyzed by RNA-Seq in the absence or presence of inducible shRNA-mediated silencing of RELA. In WT cells, TGF stimulation significantly affected the expression of 2,441 genes. Gene set enrichment analysis identified WNT, cadherin, and NF-B signaling as the most prominent TGF-inducible pathways. By comparison, RELA controlled expression of 3,138 overlapping genes mapping to WNT, cadherin, and chemokine signaling pathways. Conducting upstream regulator analysis, we found that RELA controls six clusters of upstream transcription factors, many of which overlapped with a transcription factor topology map of EMT developed earlier. RELA triggered expression of three key EMT pathways: 1) the WNT/-catenin morphogen pathway, 2) the JUN transcription factor, and 3) the Snail family transcriptional repressor 1 (SNAI1). RELA binding to target genes was confirmed by ChIP. Experiments independently validating WNT dependence on RELA were performed by silencing RELA via genome editing and indicated that TGF-induced WNT5B expression and downstream activation of the WNT target AXIN2 are RELA-dependent. We conclude that RELA is a master transcriptional regulator of EMT upstream of WNT morphogen, JUN, SNAI1-ZEB1, and interleukin-6 autocrine loops.	[Tian, Bing; Yang, Jun; Zhao, Yingxin] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Widen, Steven G.; Wood, Thomas G.; Kudlicki, Andrzej] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Tian, Bing; Widen, Steven G.; Yang, Jun; Wood, Thomas G.; Kudlicki, Andrzej; Zhao, Yingxin] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Kudlicki, Andrzej; Zhao, Yingxin] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Brasier, Allan R.] Univ Wisconsin, Sch Med & Publ Hlth, Inst Clin & Translat Res, Madison, WI 53705 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Wisconsin System; University of Wisconsin Madison	Brasier, AR (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Hlth Sci Learning Ctr 4246, Madison, WI 53705 USA.	abrasier@wisc.edu	Wood, Thomas/GWZ-2481-2022; Kudlicki, Andrzej/AAG-8537-2019	Wood, Thomas/0000-0001-8962-8571; Kudlicki, Andrzej/0000-0001-8158-9600; Brasier, Allan/0000-0002-5012-4090	NIAID, National Institutes of Health Grant [AI062885]; National Center for Advancing Translational Sciences, National Institutes of Health Grant [ULTR00002373]; National Science Foundation [DMS-1361411]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER	NIAID, National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Advancing Translational Sciences, National Institutes of Health Grant; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grant AI062885; National Center for Advancing Translational Sciences, National Institutes of Health Grant ULTR00002373; and National Science Foundation Grant DMS-1361411. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bao J, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003028; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Brasier AR, 2011, J VIROL, V85, P11752, DOI 10.1128/JVI.05360-11; Brasier AR, 2009, CELLULAR SIGNALING AND INNATE IMMUNE RESPONSES TO RNA VIRUS INFECTIONS, P119; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Chang HY, 2016, NUCLEIC ACIDS RES, V44, P2514, DOI 10.1093/nar/gkw126; Cieslik M, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-28; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Forbus J, 2006, PROTEOMICS, V6, P2656, DOI 10.1002/pmic.200500652; Gould J., GENE E MATRIX VISUAL; Harris WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070196; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hoot KE, 2010, J CLIN INVEST, V120, P3606, DOI 10.1172/JCI43304; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Ijaz T, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-13; Jamaluddin M, 2007, CELL SIGNAL, V19, P1419, DOI 10.1016/j.cellsig.2007.01.020; Jamaluddin M, 2009, J VIROL, V83, P10605, DOI 10.1128/JVI.01090-09; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jordan NV, 2011, CELL CYCLE, V10, P2865, DOI 10.4161/cc.10.17.17188; Kalita M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/505864; Kalita MK, 2011, J BIOL CHEM, V286, P37741, DOI 10.1074/jbc.M111.280925; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanazawa A, 2005, BIOCHEM BIOPH RES CO, V330, P505, DOI 10.1016/j.bbrc.2005.03.007; Kanzawa M, 2013, PATHOBIOLOGY, V80, P235, DOI 10.1159/000346843; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim MK, 2013, INT J CLIN EXP PATHO, V6, P1747; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Komiya Yuko, 2008, Organogenesis, V4, P68; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu M, 2013, P NATL ACAD SCI USA, V110, P18144, DOI 10.1073/pnas.1318192110; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tian B, 2018, CELL REP, V23, P1138, DOI 10.1016/j.celrep.2018.03.106; Tian B, 2018, J VIROL, V92, DOI 10.1128/JVI.00441-18; Tian B, 2017, AM J RESP CELL MOL, V56, P506, DOI 10.1165/rcmb.2016-0259OC; Tian B, 2016, AM J PHYSIOL-LUNG C, V311, pL1183, DOI 10.1152/ajplung.00224.2016; Tian B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1707-x; Tian B, 2013, J VIROL, V87, P7075, DOI 10.1128/JVI.03399-12; Tian B, 2012, METHODS MOL BIOL, V809, P105, DOI 10.1007/978-1-61779-376-9_7; Vaughan MB, 2006, DIFFERENTIATION, V74, P141, DOI 10.1111/j.1432-0436.2006.00069.x; Vogelmeier CF, 2017, EUR RESPIR J, V49, DOI [10.1111/resp.13012, 10.1183/13993003.00214-2017, 10.1016/j.arbres.2017.02.001, 10.1164/rccm.201701-0218PP]; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Zhang JY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005304; Zhao YX, 2016, J PROTEOMICS, V148, P126, DOI 10.1016/j.jprot.2016.07.014	70	26	28	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16528	16545		10.1074/jbc.RA118.003662	http://dx.doi.org/10.1074/jbc.RA118.003662			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30166344	Green Published, hybrid			2022-12-28	WOS:000447833600033
J	Zdralevic, M; Brand, A; Di Ianni, L; Dettmer, K; Reinders, J; Singer, K; Peter, K; Schnell, A; Bruss, C; Decking, SM; Koehl, G; Felipe-Abrio, B; Durivault, J; Bayer, P; Evangelista, M; O'Brien, T; Oefner, PJ; Renner, K; Pouyssegur, J; Kreutz, M				Zdralevic, Masa; Brand, Almut; Di Ianni, Lorenza; Dettmer, Katja; Reinders, Joerg; Singer, Katrin; Peter, Katrin; Schnell, Annette; Bruss, Christina; Decking, Sonja-Maria; Koehl, Gudrun; Felipe-Abrio, Blanca; Durivault, Jerome; Bayer, Pascale; Evangelista, Marie; O'Brien, Thomas; Oefner, Peter J.; Renner, Kathrin; Pouyssegur, Jacques; Kreutz, Marina			Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Warburg effect; glycolysis; glucose metabolism; pentose phosphate pathway (PPP); lactic acid; cancer biology; tumor metabolism; CRISPR; Cas; genetic disruption; lactate dehydrogenase; LDHA; LDHB; metabolic plasticity; OXPHOS; tumor growth	HYPOXIA-INDUCIBLE FACTORS; LACTIC-ACID; CELL-PROLIFERATION; AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; CANCER-THERAPY; BREAST-CANCER; INHIBITION; EXPRESSION; SPECIFICITY	Increased glucose consumption distinguishes cancer cells from normal cells and is known as the Warburg effect because of increased glycolysis. Lactate dehydrogenase A (LDHA) is a key glycolytic enzyme, a hallmark of aggressive cancers, and believed to be the major enzyme responsible for pyruvate-to-lactate conversion. To elucidate its role in tumor growth, we disrupted both the LDHA and LDHB genes in two cancer cell lines (human colon adenocarcinoma and murine melanoma cells). Surprisingly, neither LDHA nor LDHB knockout strongly reduced lactate secretion. In contrast, double knockout (LDHA/B-DKO) fully suppressed LDH activity and lactate secretion. Furthermore, under normoxia, LDHA/B-DKO cells survived the genetic block by shifting their metabolism to oxidative phosphorylation (OXPHOS), entailing a 2-fold reduction in proliferation rates in vitro and in vivo compared with their WT counterparts. Under hypoxia (1% oxygen), however, LDHA/B suppression completely abolished in vitro growth, consistent with the reliance on OXPHOS. Interestingly, activation of the respiratory capacity operated by the LDHA/B-DKO genetic block as well as the resilient growth were not consequences of long-term adaptation. They could be reproduced pharmacologically by treating WT cells with an LDHA/B-specific inhibitor (GNE-140). These findings demonstrate that the Warburg effect is not only based on high LDHA expression, as both LDHA and LDHB need to be deleted to suppress fermentative glycolysis. Finally, we demonstrate that the Warburg effect is dispensable even in aggressive tumors and that the metabolic shift to OXPHOS caused by LDHA/B genetic disruptions is responsible for the tumors' escape and growth.	[Zdralevic, Masa; Brand, Almut; Di Ianni, Lorenza; Felipe-Abrio, Blanca; Pouyssegur, Jacques] Univ Cote Azur, IRCAN, Ctr A Lacassagne, CNRS,INSERM, F-06189 Nice, France; [Brand, Almut; Singer, Katrin; Peter, Katrin; Schnell, Annette; Bruss, Christina; Decking, Sonja-Maria; Bayer, Pascale; Renner, Kathrin; Kreutz, Marina] Univ Hosp Regensburg, Dept Internal Med 3, D-93053 Regensburg, Germany; [Koehl, Gudrun] Univ Hosp Regensburg, Dept Surg, D-93053 Regensburg, Germany; [Dettmer, Katja; Reinders, Joerg; Oefner, Peter J.] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Peter, Katrin; Renner, Kathrin; Kreutz, Marina] Univ Regensburg, Ctr Intervent Immunol, D-93053 Regensburg, Germany; [Bayer, Pascale] Univ Cote Azur, Univ Hosp Pasteur, Clin Chem Lab, F-06001 Nice, France; [Evangelista, Marie; O'Brien, Thomas] Genentech Inc, Discovery & Translat Oncol, San Francisco, CA 94080 USA; [Durivault, Jerome; Pouyssegur, Jacques] Ctr Sci Monaco, Dept Med Biol, MC-98000 Monaco, Monaco	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Roche Holding; Genentech	Pouyssegur, J (corresponding author), Univ Cote Azur, IRCAN, Ctr A Lacassagne, CNRS,INSERM, F-06189 Nice, France.; Kreutz, M (corresponding author), Univ Hosp Regensburg, Dept Internal Med 3, D-93053 Regensburg, Germany.; Kreutz, M (corresponding author), Univ Regensburg, Ctr Intervent Immunol, D-93053 Regensburg, Germany.; Pouyssegur, J (corresponding author), Ctr Sci Monaco, Dept Med Biol, MC-98000 Monaco, Monaco.	pouysseg@unice.fr; Marina.Kreutz@klinik.uni-regensburg.de	Ždralević, Maša/P-2823-2019; Renner, Kathrin/H-3211-2013; Zdralevic, Masa/H-7200-2014; Dettmer, Katja/D-6218-2018	Zdralevic, Masa/0000-0003-2236-7957; Dettmer, Katja/0000-0001-7337-2380; Felipe-Abrio, Blanca/0000-0001-7025-3247; Renner, Kathrin/0000-0002-7116-1368; Reinders, Joerg/0000-0003-1025-7849	Conseil General 06; Fonds europeen de developpement regional (FEDER); Ministe re de l'Enseignement Superieur; Region Provence Alpes-Cote d'Azur; INSERM	Conseil General 06(Region Provence-Alpes-Cote d'Azur); Fonds europeen de developpement regional (FEDER)(European Commission); Ministe re de l'Enseignement Superieur; Region Provence Alpes-Cote d'Azur(Region Provence-Alpes-Cote d'Azur); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We thank Ludovic Cervera for cell sorting assistance on the CytoMed platform at the flow cytometry facility at the Institute for Research on Cancer and Aging, Nice (IRCAN). The materials of CytoMed were supported by Conseil General 06, Fonds europeen de developpement regional (FEDER), the Ministe re de l'Enseignement Superieur, the Region Provence Alpes-Cote d'Azur, and INSERM. We also thank Claude Fabre and Claire Tworek, technicians in the clinical chemistry laboratory at the University Hospital of Nice. We thank Milica Vucetic and Valerie Vial for help with mouse experiments at Centre Scientifique de Monaco (CSM), Monaco.	Augoff K, 2015, CANCER LETT, V358, P1, DOI 10.1016/j.canlet.2014.12.035; Balgi AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021549; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boudreau A, 2016, NAT CHEM BIOL, V12, P779, DOI 10.1038/nchembio.2143; Brahimi-Horn MC, 2011, CURR OPIN GENET DEV, V21, P67, DOI 10.1016/j.gde.2010.10.006; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Cascone T, 2018, CELL METAB, V27, P977, DOI 10.1016/j.cmet.2018.02.024; Chae YC, 2016, CANCER CELL, V30, P257, DOI 10.1016/j.ccell.2016.07.004; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Costa ASH, 2017, INT REV CEL MOL BIO, V332, P213, DOI 10.1016/bs.ircmb.2017.01.001; Damgaci S., 2018, IMMUNOLOGY; de Padua MC, 2017, ONCOTARGET, V8, P87623, DOI 10.18632/oncotarget.21007; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Feist M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03803-x; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Gillies R J, 2001, Novartis Found Symp, V240, P1; GOLDBERG E, 1971, P NATL ACAD SCI USA, V68, P349, DOI 10.1073/pnas.68.2.349; Granchi C, 2013, FUTURE MED CHEM, V5, P1967, DOI [10.4155/FMC.13.151, 10.4155/fmc.13.151]; Groussard C, 2000, J APPL PHYSIOL, V89, P169, DOI 10.1152/jappl.2000.89.1.169; Hay N, 2016, NAT REV CANCER, V16, P635, DOI 10.1038/nrc.2016.77; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Hsieh AL, 2015, SEMIN CELL DEV BIOL, V43, P11, DOI 10.1016/j.semcdb.2015.08.003; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hubbi ME, 2015, AM J PHYSIOL-CELL PH, V309, pC775, DOI 10.1152/ajpcell.00279.2015; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; KOEN AL, 1969, BIOCHEM GENET, V3, P457, DOI 10.1007/BF00485606; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Marchiq I, 2016, J MOL MED, V94, P155, DOI 10.1007/s00109-015-1307-x; Marchiq I, 2015, CANCER RES, V75, P171, DOI 10.1158/0008-5472.CAN-14-2260; MARKERT CL, 1959, P NATL ACAD SCI USA, V45, P753, DOI 10.1073/pnas.45.5.753; McCleland ML, 2013, CLIN CANCER RES, V19, P773, DOI 10.1158/1078-0432.CCR-12-2638; McCleland ML, 2012, CANCER RES, V72, P5812, DOI 10.1158/0008-5472.CAN-12-1098; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Parks S. K., 2017, J PHYSL; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Parks SK, 2013, J CELL PHYSIOL, V228, P1854, DOI 10.1002/jcp.24346; Polet F, 2013, J INTERN MED, V273, P156, DOI 10.1111/joim.12016; POUYSSEGUR J, 1982, P NATL ACAD SCI-BIOL, V79, P3935, DOI 10.1073/pnas.79.13.3935; POUYSSEGUR J, 1980, NATURE, V287, P445, DOI 10.1038/287445a0; POUYSSEGUR J, 1980, P NATL ACAD SCI-BIOL, V77, P2698, DOI 10.1073/pnas.77.5.2698; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Semenza GL, 2017, EMBO J, V36, P252, DOI 10.15252/embj.201695204; Sheng SL, 2012, FEBS J, V279, P3898, DOI 10.1111/j.1742-4658.2012.08748.x; Sun WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125976; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; VANDERLINDE RE, 1985, ANN CLIN LAB SCI, V15, P13; VESELL ES, 1965, SCIENCE, V150, P1590, DOI 10.1126/science.150.3703.1590; Vucetic M., 2018, FRONT ONCOL; Wang ZY, 2012, BREAST CANCER RES TR, V131, P791, DOI 10.1007/s10549-011-1466-6; WARBURG O, 1956, SCIENCE, V124, P269; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Zhang Y, 2015, J PROTEOME RES, V14, P4359, DOI 10.1021/acs.jproteome.5b00543	56	110	115	4	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15947	15961		10.1074/jbc.RA118.004180	http://dx.doi.org/10.1074/jbc.RA118.004180			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30158244	Green Published, hybrid			2022-12-28	WOS:000447256000017
J	Singh, R; Stoneham, C; Lim, C; Jia, XF; Guenaga, J; Wyatt, R; Wertheim, JO; Xiong, Y; Guatelli, J				Singh, Rajendra; Stoneham, Charlotte; Lim, Christopher; Jia, Xiaofei; Guenaga, Javier; Wyatt, Richard; Wertheim, Joel O.; Xiong, Yong; Guatelli, John			Phosphoserine acidic cluster motifs bind distinct basic regions on the mu subunits of clathrin adaptor protein complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						host-pathogen interaction; human immunodeficiency virus (HIV); kinetics; membrane trafficking; phosphorylation; protein complex; protein chemistry; clathrin; adaptor protein; medium subunit; acidic cluster; phosphoserine; HIV-1 Vpu; furin; Serinc3	TRANS-GOLGI NETWORK; CYTOPLASMIC DOMAIN; VPU PROTEIN; HIV-1 NEF; STRUCTURAL EXPLANATION; MEDIATED ENDOCYTOSIS; ESCHERICHIA-COLI; DOWN-MODULATION; CELL-SURFACE; VIRUS	Protein trafficking in the endosomal system involves the recognition of specific signals within the cytoplasmic domains (CDs) of transmembrane proteins by clathrin adaptors. One such signal is the phosphoserine acidic cluster (PSAC), the prototype of which is in the endoprotease furin. How PSACs are recognized by clathrin adaptors has been controversial. We reported previously that HIV-1 Vpu, which modulates cellular immunoreceptors, contains a PSAC that binds to the subunits of clathrin adaptor protein (AP) complexes. Here, we show that the CD of furin binds the subunits of AP-1 and AP-2 in a phosphorylation-dependent manner. Moreover, we identify a potential PSAC in a cytoplasmic loop of the cellular transmembrane Serinc3, an inhibitor of the infectivity of retroviruses. The two serines within the PSAC of Serinc3 are phosphorylated by casein kinase II and mediate interaction with the subunits in vitro. The sites of these serines vary among mammals in a manner suggesting host-pathogen conflict, yet the Serinc3 PSAC seems dispensable for anti-HIV activity and for counteraction by HIV-1 Nef. The CDs of Vpu and furin and the PSAC-containing loop of Serinc3 each bind the subunit of AP-2 (2) with similar affinities, but they appear to utilize different basic regions on 2. The Serinc3 loop requires a region previously reported to bind the acidic plasma membrane lipid phosphatidylinositol 4,5-bisphosphate. These data suggest that the PSACs within different proteins recognize different basic regions on the surface, providing the potential to inhibit the activity of viral proteins without necessarily affecting cellular protein trafficking.	[Singh, Rajendra; Stoneham, Charlotte; Wertheim, Joel O.; Guatelli, John] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lim, Christopher; Xiong, Yong] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Jia, Xiaofei] Univ Massachusetts, Dept Chem & Biochem, Dartmouth, MA 02747 USA; [Guenaga, Javier; Wyatt, Richard] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Guatelli, John] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; Yale University; University of Massachusetts System; University Massachusetts Dartmouth; Scripps Research Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Singh, R; Guatelli, J (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Guatelli, J (corresponding author), Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA.	rks003@ucsd.edu; jguatelli@ucsd.edu		Stoneham, Charlotte/0000-0003-3729-6936	National Institutes of Health [P30 AI036214, R37 AI081668, R01 AI129706, R01 AI102778, P01 AI104722, K01 AI110181, R21 AI115701]; International AIDS Vaccine Initiative (IAVI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI110181, R01AI129706, R21AI115701, P30AI036214, R37AI081668, R01AI102778, P01AI104722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative (IAVI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants P30 AI036214 (CFAR supplement) (to R. S.), R37 AI081668 and R01 AI129706 (to J. G.), R01 AI102778 (to Y. X.), P01 AI104722 (to R. W.), and K01 AI110181 and R21 AI115701 (to J. O. W.). This work was also supported by the International AIDS Vaccine Initiative (IAVI). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chande A, 2016, P NATL ACAD SCI USA, V113, P13197, DOI 10.1073/pnas.1612044113; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Crump CM, 2001, EMBO J, V20, P2191, DOI 10.1093/emboj/20.9.2191; Dai WW, 2018, CELL REP, V22, P869, DOI 10.1016/j.celrep.2017.12.082; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; Davies A. K. I., 2017, AP 4 VESICLES UNMASK, DOI [10.1101/235226, DOI 10.1101/235226]; Day JR, 2006, J VIROL METHODS, V137, P125, DOI 10.1016/j.jviromet.2006.06.019; Ghosh P, 2004, ARCH BIOCHEM BIOPHYS, V426, P225, DOI 10.1016/j.abb.2004.02.011; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Jia XF, 2014, ELIFE, V3, DOI 10.7554/eLife.02362; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; JONES BG, 1995, EMBO J, V14, P5869, DOI 10.1002/j.1460-2075.1995.tb00275.x; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kueck T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005141; Kueck T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002609; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Murrell B, 2016, J VIROL, V90, P8085, DOI 10.1128/JVI.00972-16; Negredo PN, 2017, J CELL BIOL, V216, P2927, DOI 10.1083/jcb.201602058; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Noviello CM, 2008, J VIROL, V82, P1249, DOI 10.1128/JVI.00660-07; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Poon AFY, 2008, BIOINFORMATICS, V24, P1949, DOI 10.1093/bioinformatics/btn313; Ramirez PW, 2014, CELL REP, V7, P2019, DOI 10.1016/j.celrep.2014.05.015; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; SCHUBERT U, 1994, J MOL BIOL, V236, P16, DOI 10.1006/jmbi.1994.1114; Shah AH, 2010, CELL HOST MICROBE, V8, P397, DOI 10.1016/j.chom.2010.10.008; Singh RK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008364; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; Stoneham CA, 2017, TRAFFIC, V18, P545, DOI 10.1111/tra.12495; Teuchert M, 1999, J BIOL CHEM, V274, P8199, DOI 10.1074/jbc.274.12.8199; Thomas JG, 1997, APPL BIOCHEM BIOTECH, V66, P197, DOI 10.1007/BF02785589; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Usami Y, 2014, J VIROL, V88, P3443, DOI 10.1128/JVI.01933-13; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; VOORHEES P, 1995, EMBO J, V14, P4961, DOI 10.1002/j.1460-2075.1995.tb00179.x; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Xue XY, 2008, J VIROL, V82, P2515, DOI 10.1128/JVI.02114-07; Xue XY, 2007, J MOL BIOL, V366, P965, DOI 10.1016/j.jmb.2006.11.073	49	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2018	293	40					15678	15690		10.1074/jbc.RA118.003080	http://dx.doi.org/10.1074/jbc.RA118.003080			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW0JH	30135209	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000446549200030
J	Canniffe, DP; Thweatt, JL; Chew, AGM; Hunter, CN; Bryant, DA				Canniffe, Daniel P.; Thweatt, Jennifer L.; Chew, Aline Gomez Maqueo; Hunter, C. Neil; Bryant, Donald A.			A paralog of a bacteriochlorophyll biosynthesis enzyme catalyzes the formation of 1,2-dihydrocarotenoids in green sulfur bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photosynthesis; photosynthetic pigment; carotenoid; bacterial genetics; energy metabolism; Blastochloris viridis; Chlorobaculum tepidum; green sulfur bacterium; Rhodobacter sphaeroides	PHOTOSYNTHETIC REACTION-CENTER; RHODOBACTER-SPHAEROIDES; CHLOROBIUM-TEPIDUM; RHODOPSEUDOMONAS-VIRIDIS; GERANYLGERANYL REDUCTASE; CHLOROPHYLL BIOSYNTHESIS; ENGINEERED BIOSYNTHESIS; NATURAL TRANSFORMATION; FUNCTIONAL ASSIGNMENT; GENE INACTIVATION	Chlorobaculum tepidum, a green sulfur bacterium, utilizes chlorobactene as its major carotenoid, and this organism also accumulates a reduced form of this monocyclic pigment, 1,2-dihydrochlorobactene. The protein catalyzing this reduction is the last unidentified enzyme in the biosynthetic pathways for all of the green sulfur bacterial pigments used for photosynthesis. The genome of C. tepidum contains two paralogous genes encoding members of the FixC family of flavoproteins: bchP, which has been shown to encode an enzyme of bacteriochlorophyll biosynthesis; and bchO, for which a function has not been assigned. Here we demonstrate that a bchO mutant is unable to synthesize 1,2-dihydrochlorobactene, and when bchO is heterologously expressed in a neurosporene-producing mutant of the purple bacterium, Rhodobacter sphaeroides, the encoded protein is able to catalyze the formation of 1,2-dihydroneurosporene, the major carotenoid of the only other organism reported to synthesize 1,2-dihydrocarotenoids, Blastochloris viridis. Identification of this enzyme completes the pathways for the synthesis of photosynthetic pigments in Chlorobiaceae, and accordingly and consistent with its role in carotenoid biosynthesis, we propose to rename the gene cruI. Notably, the absence of cruI in B. viridis indicates that a second 1,2-carotenoid reductase, which is structurally unrelated to CruI (BchO), must exist in nature. The evolution of this carotenoid reductase in green sulfur bacteria is discussed herein.	[Canniffe, Daniel P.; Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Canniffe, Daniel P.; Thweatt, Jennifer L.; Chew, Aline Gomez Maqueo; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Chew, Aline Gomez Maqueo] Univ Valle Mexico, Hermosillo 83165, Sonora, Mexico	University of Sheffield; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman	Canniffe, DP (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.; Canniffe, DP; Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.; Bryant, DA (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	d.canniffe@sheffield.ac.uk; dab14@psu.edu		Canniffe, Daniel/0000-0002-5022-0437	European Commission Marie Sklodowska-Curie Global Fellowship [660652]; Photosynthetic Systems Program, Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-94ER20137]; Biotechnology and Biological Sciences Research Council [BB/M000265/1]; European Research Council [338895]; BBSRC [BB/M000265/1] Funding Source: UKRI	European Commission Marie Sklodowska-Curie Global Fellowship; Photosynthetic Systems Program, Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by European Commission Marie Sklodowska-Curie Global Fellowship 660652 (to D. P. C.), by Grant DE-FG02-94ER20137 from the Photosynthetic Systems Program, Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy (to D. A. B.), by Biotechnology and Biological Sciences Research Council Grant BB/M000265/1 (to C. N. H.), and Advanced Award 338895 from the European Research Council (to C. N. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Addlesee HA, 1999, J BACTERIOL, V181, P7248, DOI 10.1128/JB.181.23.7248-7255.1999; Addlesee HA, 1996, FEBS LETT, V389, P126, DOI 10.1016/0014-5793(96)00549-2; Armstrong G., 1999, COMPREHENSIVE NATURA, P321; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; Bryant DA, 2018, J PHYS B-AT MOL OPT, V51, DOI 10.1088/1361-6455/aa9c3c; Bryant DA, 2012, ADV PHOTOSYNTH RESP, V33, P47, DOI 10.1007/978-94-007-1533-2_3; Canniffe DP, 2014, BBA-BIOENERGETICS, V1837, P1611, DOI 10.1016/j.bbabio.2014.07.011; Canniffe DP, 2014, BIOCHEM J, V462, P433, DOI 10.1042/BJ20140163; Chen GE, 2016, J BACTERIOL, V198, P2056, DOI 10.1128/JB.00121-16; Chew AGM, 2008, J BACTERIOL, V190, P747, DOI 10.1128/JB.01430-07; Chi SC, 2015, BBA-BIOENERGETICS, V1847, P189, DOI 10.1016/j.bbabio.2014.10.004; Claus D., 1977, GERMAN COLLECTION MI, P279; DREWS G, 1966, ARCH MIKROBIOL, V53, P255, DOI 10.1007/BF00446672; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgren T, 2004, J BACTERIOL, V186, P2052, DOI 10.1128/JB.186.7.2052-2060.2004; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; Frigaard NU, 2004, METH MOL B, V274, P325; Frigaard NU, 2004, J BACTERIOL, V186, P5210, DOI 10.1128/JB.186.16.5210-5220.2004; Frigaard NU, 1997, ARCH MICROBIOL, V167, P343, DOI 10.1007/s002030050453; Frigaard NU, 2001, APPL ENVIRON MICROB, V67, P2538, DOI 10.1128/AEM.67.6.2538-2544.2001; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; GIBSON J, 1984, ARCH MICROBIOL, V138, P96, DOI 10.1007/BF00413007; Gisriel C, 2017, SCIENCE, V357, P1021, DOI 10.1126/science.aan5611; Gong LM, 1996, MICROBIOL-UK, V142, P2057, DOI 10.1099/13500872-142-8-2057; Harada J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060026; Hirabayashi H, 2004, PHOTOCHEM PHOTOBIOL, V79, P280, DOI 10.1562/WB-03-11.1; Hitchcock A, 2016, ACS SYNTH BIOL, V5, P948, DOI 10.1021/acssynbio.6b00069; HUNTER CN, 1988, J GEN MICROBIOL, V134, P1471; Klimov VV, 2003, PHOTOSYNTH RES, V76, P247, DOI 10.1023/A:1024990408747; Kumka JE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2162-4; Liu L. N., 2016, GENOME ANNOUNCEMENTS, V4; Liu ZF, 2011, J BACTERIOL, V193, P4996, DOI 10.1128/JB.05520-11; Magdaong NCM, 2016, J PHYS CHEM B, V120, P5159, DOI 10.1021/acs.jpcb.6b04307; MALHOTRA HC, 1970, J CHEM SOC CHEM COMM, P127, DOI 10.1039/c29700000127; Maresca JA, 2008, J BACTERIOL, V190, P6384, DOI 10.1128/JB.00758-08; Maresca JA, 2007, P NATL ACAD SCI USA, V104, P11784, DOI 10.1073/pnas.0702984104; Maresca JA, 2006, J BACTERIOL, V188, P6217, DOI 10.1128/JB.00766-06; MICHEL H, 1986, EMBO J, V5, P2445, DOI 10.1002/j.1460-2075.1986.tb04520.x; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Ortega-Ramos M, 2018, BBA-BIOENERGETICS, V1859, P501, DOI 10.1016/j.bbabio.2018.02.006; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Paulsen H, 1999, ADV PHOTOSYNTH, V8, P123; Permentier HP, 2000, PHOTOSYNTH RES, V64, P27, DOI 10.1023/A:1026515027824; Qian P, 2018, NATURE, V556, P203, DOI 10.1038/s41586-018-0014-5; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHEER H, 1974, J AM CHEM SOC, V96, P3714, DOI 10.1021/ja00818a092; Shpilyov AV, 2005, BBA-BIOENERGETICS, V1706, P195, DOI 10.1016/j.bbabio.2004.11.001; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Takaichi S, 1997, ARCH MICROBIOL, V168, P270, DOI 10.1007/s002030050498; Takaichi S, 1999, PLANT CELL PHYSIOL, V40, P691, DOI 10.1093/oxfordjournals.pcp.a029594; Thweatt JL, 2017, J BIOL CHEM, V292, P1361, DOI 10.1074/jbc.M116.767665; Tikh IB, 2014, APPL MICROBIOL BIOT, V98, P3111, DOI 10.1007/s00253-014-5527-8; Van Gemerden H, 1995, ANOXYGENIC PHOTOSYNT, P49; WAHLUND TM, 1995, J BACTERIOL, V177, P2583, DOI 10.1128/jb.177.9.2583-2588.1995; Yabuzaki J, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax004; Zeng Y., 2017, MODERN TOPICS PHOTOT, P163, DOI [10.1007/978-3-319-46261-5_5, DOI 10.1007/978-3-319-46261-5_5]; Zeng YH, 2015, INT J SYST EVOL MICR, V65, P2410, DOI 10.1099/ijs.0.000272; Zeng YH, 2014, P NATL ACAD SCI USA, V111, P7795, DOI 10.1073/pnas.1400295111	60	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15233	15242		10.1074/jbc.RA118.004672	http://dx.doi.org/10.1074/jbc.RA118.004672			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30126840	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000445998400023
J	Poteet, E; Choudhury, GR; Winters, A; Li, WJ; Ryou, MG; Liu, R; Tang, L; Ghorpade, A; Wen, Y; Yuan, F; Keir, ST; Yan, H; Bigner, DD; Simpkins, JW; Yang, SH				Poteet, Ethan; Choudhury, Gourav Roy; Winters, Ali; Li, Wenjun; Ryou, Myoung-Gwi; Liu, Ran; Tang, Lin; Ghorpade, Anuja; Wen, Yi; Yuan, Fang; Keir, Stephen T.; Yan, Hai; Bigner, Darell D.; Simpkins, James W.; Yang, Shao-Hua			Reversing the Warburg effect as a treatment for glioblastoma (vol 288, pg 9153, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Poteet E, 2013, J BIOL CHEM, V288, P9153, DOI 10.1074/jbc.M112.440354	1	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					14973	14973		10.1074/jbc.AAC118.005625	http://dx.doi.org/10.1074/jbc.AAC118.005625			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30266879	Green Published, hybrid			2022-12-28	WOS:000445998400003
J	Yu, SY; Hsiao, CT; Izawa, M; Yusa, A; Ishida, H; Nakamura, S; Yagi, H; Kannagi, R; Khoo, KH				Yu, Shin-Yi; Hsiao, Cheng-Te; Izawa, Mineko; Yusa, Akiko; Ishida, Hiroji; Nakamura, Shigeo; Yagi, Hirokazu; Kannagi, Reiji; Khoo, Kay-Hooi			Distinct substrate specificities of human GlcNAc-6-sulfotransferases revealed by mass spectrometry-based sulfoglycomic analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); glycobiology; glycomics; analytical chemistry; colorectal cancer; CHST; GlcNAc-6-O-sulfotransferase; MECA-79; sulfoglycomics	HIGH ENDOTHELIAL VENULES; L-SELECTIN LIGAND; SIALYL-LEWIS-X; MUCINOUS ADENOCARCINOMA; PERMETHYLATED GLYCANS; ECTOPIC EXPRESSION; COLORECTAL-CANCER; MOLECULAR-CLONING; SULFATED GLYCANS; O-GLYCANS	Sulfated glycans are known to be involved in several glycan-mediated cell adhesion and recognition pathways. Our mRNA transcript analyses on the genes involved in synthesizing GlcNAc-6-O-sulfated glycans in human colon cancer tissues indicated that GlcNAc6ST-2 (CHST4) is preferentially expressed in cancer cells compared with nonmalignant epithelial cells among the three known major GlcNAc-6-O-sulfotransferases. On the contrary, GlcNAc6ST-3 (CHST5) was only expressed in nonmalignant epithelial cells, whereas GlcNAc6ST-1 (CHST2) was expressed equally in both cancerous and nonmalignant epithelial cells. These results suggest that 6-O-sulfated glycans that are synthesized only by GlcNAc6ST-2 may be highly colon cancer-specific, as supported by immunohistochemical staining of cancer cells using the MECA-79 antibody known to be relatively specific to the enzymatic reaction products of GlcNAc6ST-2. By more precise MS-based sulfoglycomic analyses, we sought to further infer the substrate specificities of GlcNAc6STs via a definitive mapping of various sulfo-glycotopes and O-glycan structures expressed in response to overexpression of transfected GlcNAc6STs in the SW480 colon cancer cell line. By detailed MS/MS sequencing, GlcNAc6ST-3 was shown to preferentially add sulfate onto core 2-based O-glycan structures, but it does not act on extended core 1 structures, whereas GlcNAc6ST-1 prefers core 2-based O-glycans to extended core 1 structures. In contrast, GlcNAc6ST-2 could efficiently add sulfate onto both extended core 1- and core 2-based O-glycans, leading to the production of unique sulfated extended core 1 structures such as R-GlcNAc(6-SO3-)1-3Gal1-4GlcNAc(6-SO3-)1-3Gal1-3GalNAc, which are good candidates to be targeted as cancer-specific glycans.	[Yu, Shin-Yi; Hsiao, Cheng-Te; Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Yu, Shin-Yi; Kannagi, Reiji] Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sec 2, Taipei 115, Taiwan; [Izawa, Mineko; Yusa, Akiko; Kannagi, Reiji] Aichi Canc Ctr, Dept Mol Pathol, Nagoya, Aichi 4648681, Japan; [Ishida, Hiroji; Nakamura, Shigeo; Kannagi, Reiji] Aichi Canc Ctr, Lab Clin Pathol, Nagoya, Aichi 4648681, Japan; [Yagi, Hirokazu; Kannagi, Reiji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4678603, Japan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Aichi Cancer Center; Aichi Cancer Center; Nagoya City University	Kannagi, R (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sec 2, Taipei 115, Taiwan.; Khoo, KH (corresponding author), Acad Sinica, Inst Biol Chem, 128 Acad Rd,Sec 2, Taipei 115, Taiwan.	rkannagi@ibms.sinica.edu.tw; kkhoo@gate.sinica.edu.tw	Yagi, Hirokazu/ABH-6151-2020; Kannagi, Reiji/Q-6459-2018; Khoo, Kay-Hooi/E-1989-2019	Kannagi, Reiji/0000-0003-4202-2921; Khoo, Kay-Hooi/0000-0003-2906-406X; Yagi, Hirokazu/0000-0001-9296-0225; YU, Shin-Yi/0000-0003-0197-9575	Taiwan National Core Facility Program for Biotechnology [NSC 100-2325-B-001-029]	Taiwan National Core Facility Program for Biotechnology	The MALDI- MS and MS/MS data were acquired at the previous Core Facilities for Protein Structural Analysis at Academia Sinica, supported under the Taiwan National Core Facility Program for Biotechnology, NSC 100-2325-B-001-029. We further acknowledge the use of Academia Sinica Common Mass Spectrometry Facilities at Institute of Biological Chemistry and technical assistance of Ming-Chieh Tsai and Dr. Shu-Yu Lin for nanoLC-MS/MS analysis. The synthetic sulfated glycan standards were generously provided by Prof. Chun-Hung Lin (Institute of Biological Chemistry, Academia Sinica) and Prof. James C. Paulson (Scripps Research Institute).	Akama TO, 2000, NAT GENET, V26, P237, DOI 10.1038/79987; Akama TO, 2002, J BIOL CHEM, V277, P42505, DOI 10.1074/jbc.M207412200; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; Bowman KG, 2001, BIOCHEMISTRY-US, V40, P5382, DOI 10.1021/bi001750o; Broad Institute TCGA Genome Data Analysis Center, 2016, AN READ STAND TCGA D, DOI [10.7908/C11G0KM9, DOI 10.7908/C11G0KM9]; Brockhausen I, 2003, BIOCHEM SOC T, V31, P318, DOI 10.1042/BST0310318; Byrd JC, 2004, CANCER METAST REV, V23, P77, DOI 10.1023/A:1025815113599; Campanero-Rhodes MA, 2006, BIOCHEM BIOPH RES CO, V344, P1141, DOI 10.1016/j.bbrc.2006.03.223; Carlsson S, 2007, GLYCOBIOLOGY, V17, P663, DOI 10.1093/glycob/cwm026; Chandrasekaran EV, 2004, J BIOL CHEM, V279, P10032, DOI 10.1074/jbc.M311989200; Chandrasekaran EV, 1997, GLYCOBIOLOGY, V7, P753, DOI 10.1093/glycob/7.6.753; Chandrasekaran EV, 1999, GLYCOCONJUGATE J, V16, P523, DOI 10.1023/A:1007074005371; Cheng CW, 2015, ANAL CHEM, V87, P6380, DOI 10.1021/acs.analchem.5b01409; Cheng PF, 2013, ANAL BIOANAL CHEM, V405, P6683, DOI 10.1007/s00216-013-7128-2; FILIPE MI, 1969, GUT, V10, P577, DOI 10.1136/gut.10.7.577; Fukuda M, 2001, J BIOL CHEM, V276, P47747, DOI 10.1074/jbc.R100049200; FUKUSHIMA K, 1995, GLYCOBIOLOGY, V5, P105, DOI 10.1093/glycob/5.1.105; Grunwell JR, 2002, BIOCHEMISTRY-US, V41, P13117, DOI 10.1021/bi020507h; Hemmerich S, 2001, GLYCOBIOLOGY, V11, P75, DOI 10.1093/glycob/11.1.75; Hiraoka N, 2004, J BIOL CHEM, V279, P3058, DOI 10.1074/jbc.M311150200; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; Hsiao CT, 2017, MOL CELL PROTEOMICS, V16, P2268, DOI 10.1074/mcp.TIR117.000156; Ideo H, 2011, J BIOL CHEM, V286, P11346, DOI 10.1074/jbc.M110.195925; Izawa M, 2000, CANCER RES, V60, P1410; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Kawashima H, 2006, BIOL PHARM BULL, V29, P2343, DOI 10.1248/bpb.29.2343; Khoo KH, 2010, METHOD ENZYMOL, V478, P3, DOI 10.1016/S0076-6879(10)78001-0; Kimura N, 2007, J BIOL CHEM, V282, P32200, DOI 10.1074/jbc.M702341200; Kitagawa H, 2000, J BIOL CHEM, V275, P21075, DOI 10.1074/jbc.M002101200; Kletter D, 2013, MOL CELL PROTEOMICS, V12, P1026, DOI 10.1074/mcp.M112.026641; Kobayashi M, 2011, J PATHOL, V224, P67, DOI 10.1002/path.2851; Kobayashi M, 2009, BIOL PHARM BULL, V32, P774, DOI 10.1248/bpb.32.774; KUHNS W, 1995, GLYCOBIOLOGY, V5, P689, DOI 10.1093/glycob/5.7.689; Lee JK, 2003, GLYCOBIOLOGY, V13, P245, DOI 10.1093/glycob/cwg018; Mitsuoka C, 1998, J BIOL CHEM, V273, P11225, DOI 10.1074/jbc.273.18.11225; Miyazaki K, 2004, CANCER RES, V64, P4498, DOI 10.1158/0008-5472.CAN-03-3614; Okayama H, 2011, CANCER SCI, V102, P1088, DOI 10.1111/j.1349-7006.2011.01895.x; Patnode ML, 2013, J BIOL CHEM, V288, P26533, DOI 10.1074/jbc.M113.485409; Patnode ML, 2013, GLYCOBIOLOGY, V23, P381, DOI 10.1093/glycob/cws166; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Seko A, 2000, GLYCOBIOLOGY, V10, P919, DOI 10.1093/glycob/10.9.919; Seko A, 2005, BIOCHEM J, V391, P77, DOI 10.1042/BJ20050362; Seko A, 2002, JPN J CANCER RES, V93, P507, DOI 10.1111/j.1349-7006.2002.tb01285.x; Seko A, 2002, GLYCOBIOLOGY, V12, P379, DOI 10.1093/glycob/12.6.379; Tateno H, 2010, J BIOL CHEM, V285, P6390, DOI 10.1074/jbc.M109.041863; Tu ZJ, 2013, CHEM-ASIAN J, V8, P1536, DOI 10.1002/asia.201201204; Uchimura K, 2000, BIOCHEM BIOPH RES CO, V274, P291, DOI 10.1006/bbrc.2000.3141; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; Uchimura K, 2002, J BIOL CHEM, V277, P3979, DOI 10.1074/jbc.M106587200; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; VAVASSEUR F, 1994, EUR J BIOCHEM, V222, P415, DOI 10.1111/j.1432-1033.1994.tb18880.x; Yagi H, 2005, GLYCOBIOLOGY, V15, P1051, DOI 10.1093/glycob/cwi092; YAMORI T, 1987, CANCER RES, V47, P2741; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Yu SY, 2006, GLYCOCONJUGATE J, V23, P355, DOI 10.1007/s10719-006-8492-3; Yu SY, 2009, GLYCOBIOLOGY, V19, P1136, DOI 10.1093/glycob/cwp113	57	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2018	293	39					15163	15177		10.1074/jbc.RA118.001937	http://dx.doi.org/10.1074/jbc.RA118.001937			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV3ML	30093410	Green Published, hybrid			2022-12-28	WOS:000445998400018
J	Bautista, SJ; Boras, I; Vissa, A; Mecica, N; Yip, CM; Kim, PK; Antonescu, CN				Bautista, Stephen J.; Boras, Ivan; Vissa, Adriano; Mecica, Noa; Yip, Christopher M.; Kim, Peter K.; Antonescu, Costin N.			mTOR complex 1 controls the nuclear localization and function of glycogen synthase kinase 3 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane trafficking; metabolism; signaling; nuclear translocation; lysosome; Akt; AMPK; PI3K; mTORC1; c-Myc; Snail; Ran; Rab7	C-MYC; MESENCHYMAL TRANSITION; RAG GTPASES; PHOSPHORYLATION; PROTEIN; INACTIVATION; GROWTH; KINASE-3-BETA; AUTOPHAGY; REQUIRES	Glycogen synthase kinase 3 beta (GSK3 beta) phosphorylates and thereby regulates a wide range of protein substrates involved in diverse cellular functions. Some GSK3 beta substrates, such as c-Myc and Snail, are nuclear transcription factors, suggesting the possibility that GSK3 beta function is controlled through its nuclear localization. Here, using ARPE-19 and MDA-MB-231 human cell lines, we found that inhibition of mTOR complex 1 (mTORC1) leads to partial redistribution of GSK3 beta from the cytosol to the nucleus and to a GSK3 beta-dependent reduction of the levels of both c-Myc and Snail. mTORC1 is known to be controlled by metabolic cues, such as by AMP-activated protein kinase (AMPK) or amino acid abundance, and we observed here that AMPK activation or amino acid deprivation promotes GSK3 beta nuclear localization in an mTORC1-dependent manner. GSK3 beta was detected on several distinct endomembrane compartments, including lysosomes. Consistently, disruption of late endosomes/lysosomes through a perturbation of RAS oncogene family member 7 (Rab7) resulted in loss of GSK3 beta from lysosomes and in enhanced GSK3 beta nuclear localization as well as GSK3 beta-dependent reduction of c-Myc levels. These findings indicate that the nuclear localization and function of GSK3 beta is suppressed by mTORC1 and suggest a link between metabolic conditions sensed by mTORC1 and GSK3 beta-dependent regulation of transcriptional networks controlling cellular biomass production.	[Bautista, Stephen J.; Boras, Ivan; Mecica, Noa; Antonescu, Costin N.] Ryerson Univ, Dept Chem & Biol, Toronto, ON M5B 2K3, Canada; [Bautista, Stephen J.; Boras, Ivan; Mecica, Noa; Antonescu, Costin N.] Ryerson Univ, Grad Program Mol Sci, Toronto, ON M5B 2K3, Canada; [Antonescu, Costin N.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada; [Vissa, Adriano; Yip, Christopher M.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3E5, Canada; [Vissa, Adriano; Kim, Peter K.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 0A4, Canada; [Yip, Christopher M.] Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada; [Yip, Christopher M.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada	Toronto Metropolitan University; Toronto Metropolitan University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Antonescu, CN (corresponding author), Ryerson Univ, 350 Victoria St, Toronto, ON M5B 2K3, Canada.	cantonescu@ryerson.ca		Antonescu, Costin/0000-0001-9192-6340	Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Research, Innovation, and Science; New Investigator Award from the Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Research, Innovation, and Science; New Investigator Award from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada; an Early Researcher Award from the Ontario Ministry of Research, Innovation, and Science; and a New Investigator Award from the Canadian Institutes of Health Research (to C. N. A.). The authors declare that they have no conflicts of interest with the contents of this article.	ABRAMS HD, 1982, CELL, V29, P427, DOI 10.1016/0092-8674(82)90159-3; Azoulay-Alfaguter I, 2015, ONCOGENE, V34, P4613, DOI 10.1038/onc.2014.390; Azoulay-Alfaguter I, 2011, J BIOL CHEM, V286, P13470, DOI 10.1074/jbc.M110.127969; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Bin Cho K, 2010, CANCER LETT, V293, P230, DOI 10.1016/j.canlet.2010.01.013; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bone LN, 2017, MOL BIOL CELL, V28, P161, DOI 10.1091/mbc.E16-09-0668; Carey KL, 1996, J CELL BIOL, V133, P985, DOI 10.1083/jcb.133.5.985; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Chu BB, 2015, CELL, V161, P291, DOI 10.1016/j.cell.2015.02.019; Cianfanelli V, 2015, NAT CELL BIOL, V17, P20, DOI 10.1038/ncb3072; Cormier Kevin W, 2017, F1000Res, V6, DOI 10.12688/f1000research.10557.1; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Delos Santos RC, 2017, MOL BIOL CELL, V28, P2802, DOI 10.1091/mbc.E16-12-0871; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Feijs KLH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-5; Fekri F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156754; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Franca-Koh J, 2002, J BIOL CHEM, V277, P43844, DOI 10.1074/jbc.M207265200; Garay C, 2015, MOL BIOL CELL, V26, P3504, DOI 10.1091/mbc.E14-09-1412; Goni-Oliver P, 2007, J BIOL CHEM, V282, P22406, DOI 10.1074/jbc.M702793200; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; HANN SR, 1983, CELL, V34, P789, DOI 10.1016/0092-8674(83)90535-4; Hua R, 2017, J CELL BIOL, V216, P367, DOI 10.1083/jcb.201608128; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Ka MH, 2014, DEVELOPMENT, V141, P4076, DOI 10.1242/dev.108282; Kalkat M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060151; Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9; Li Y, 2016, NAT CELL BIOL, V18, P1065, DOI 10.1038/ncb3407; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; LUSCHER B, 1988, MOL CELL BIOL, V8, P2504; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; NIKOLAKAKI E, 1993, ONCOGENE, V8, P833; Reis CR, 2015, EMBO J, V34, P2132, DOI 10.15252/embj.201591518; Ross E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128013; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Saric A, 2016, MOL BIOL CELL, V27, P321, DOI 10.1091/mbc.E15-05-0272; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Sekiya S, 2011, P NATL ACAD SCI USA, V108, P11175, DOI 10.1073/pnas.1016122108; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Smith KP, 2004, J CELL BIOCHEM, V93, P1282, DOI 10.1002/jcb.20273; Stadler SC, 2013, P NATL ACAD SCI USA, V110, P11851, DOI 10.1073/pnas.1308362110; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Stretton C, 2015, BIOCHEM J, V470, P207, DOI 10.1042/BJ20150404; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Suzuki T, 2013, MOL CELL, V50, P407, DOI 10.1016/j.molcel.2013.03.022; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thomas LR, 2011, ADV CANCER RES, V110, P77, DOI 10.1016/B978-0-12-386469-7.00004-9; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Tsujio I, 2000, FEBS LETT, V469, P111, DOI 10.1016/S0014-5793(00)01234-5; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zmijewski JW, 2004, AGING CELL, V3, P309, DOI 10.1111/j.1474-9728.2004.00117.x; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	84	32	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14723	14739		10.1074/jbc.RA118.002800	http://dx.doi.org/10.1074/jbc.RA118.002800			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30061153	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000446155000012
J	Nakajima, Y; Umena, Y; Nagao, R; Endo, K; Kobayashi, K; Akita, F; Suga, M; Wada, H; Noguchi, T; Shen, JR				Nakajima, Yoshiki; Umena, Yasufumi; Nagao, Ryo; Endo, Kaichiro; Kobayashi, Koichi; Akita, Fusamichi; Suga, Michihiro; Wada, Hajime; Noguchi, Takumi; Shen, Jian-Ren			Thylakoid membrane lipid sulfoquinovosyl-diacylglycerol (SQDG) is required for full functioning of photosystem II in Thermosynechococcus elongatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photosystem II; lipid; crystal structure; mutant; photosynthesis; oxygen evolution; PG; SQDG	S-STATE CYCLE; CHLAMYDOMONAS-REINHARDTII; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURE; CYANOBACTERIA; RESOLUTION; DEFICIENT; MUTANT; PHOSPHATIDYLGLYCEROL; PHOTOSYNTHESIS	Sulfoquinovosyl-diacylglycerol (SQDG) is one of the four lipids present in the thylakoid membranes. Depletion of SQDG causes different degrees of effects on photosynthetic growth and activities in different organisms. Four SQDG molecules bind to each monomer of photosystem II (PSII), but their role in PSII function has not been characterized in detail, and no PSII structure without SQDG has been reported. We analyzed the activities of PSII from an SQDG-deficient mutant of the cyanobacterium Thermosynechococcus elongatus by various spectroscopic methods, which showed that depletion of SQDG partially impaired the PSII activity by impairing secondary quinone (Q(B)) exchange at the acceptor site. We further solved the crystal structure of the PSII dimer from the SQDG deletion mutant at 2.1 angstrom resolution and found that all of the four SQDG-binding sites were occupied by other lipids, most likely PG molecules. Replacement of SQDG at a site near the head of Q(B) provides a possible explanation for the Q(B) impairment. The replacement of two SQDGs located at the monomer-monomer interface by other lipids decreased the stability of the PSII dimer, resulting in an increase in the amount of PSII monomer in the mutant. The present results thus suggest that although SQDG binding in all of the PSII-binding sites is necessary to fully maintain the activity and stability of PSII, replacement of SQDG by other lipids can partially compensate for their functions.	[Nakajima, Yoshiki; Umena, Yasufumi; Nagao, Ryo; Akita, Fusamichi; Suga, Michihiro; Shen, Jian-Ren] Okayama Univ, Grad Sch Nat Sci & Technol, Res Inst Interdisciplinary Sci, Okayama 7008530, Japan; [Endo, Kaichiro; Kobayashi, Koichi; Wada, Hajime] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan; [Akita, Fusamichi] Japan Sci & Technol Agcy, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan; [Noguchi, Takumi] Nagoya Univ, Grad Sch Sci, Div Mat Sci, Nagoya, Aichi 4648602, Japan; [Endo, Kaichiro] Jagiellonian Univ, Malopolska Ctr Biotechnol, PL-30387 Krakow, Poland; [Kobayashi, Koichi] Osaka Prefecture Univ, Fac Liberal Arts & Sci, Sakai, Osaka 5998531, Japan	Okayama University; University of Tokyo; Japan Science & Technology Agency (JST); Nagoya University; Jagiellonian University; Osaka Metropolitan University	Shen, JR (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Res Inst Interdisciplinary Sci, Okayama 7008530, Japan.	shen@cc.okayama-u.ac.jp	Umena, Yasufumi/AAD-5472-2019; Noguchi, Takumi/I-7105-2014; NAGAO, Ryo/D-4117-2012; Shen, Jian-Ren/B-2558-2011; Akita, Fusamichi/C-2034-2015	NAGAO, Ryo/0000-0001-8212-3001; Akita, Fusamichi/0000-0003-0537-6157; Nakajima, Yoshiki/0000-0002-0529-8075; Endo, Kaichiro/0000-0002-4368-6212	Japan Society for the Promotion of Science KAKENHI [JP17H06434, JP16K21181, JP15H05588, JP16KT0058]; PRESTO from Japan Science and Technology Agency of MEXT, Japan [JPMJPR16P1]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); PRESTO from Japan Science and Technology Agency of MEXT, Japan	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants JP17H06434 (to J.-R. S.), JP16K21181 (to F. A.), and JP15H05588 and JP16KT0058 (to Y. U.), and PRESTO from Japan Science and Technology Agency Grant JPMJPR16P1 of MEXT, Japan (to F. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Aoki M, 2004, EUR J BIOCHEM, V271, P685, DOI 10.1111/j.1432-1033.2003.03970.x; Aoki Motohide, 2012, BMC Res Notes, V5, P98, DOI 10.1186/1756-0500-5-98; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Broser M, 2010, J BIOL CHEM, V285, P26255, DOI 10.1074/jbc.M110.127589; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo K, 2016, PLANT CELL PHYSIOL, V57, P2461, DOI 10.1093/pcp/pcw159; Guler S, 1996, J BIOL CHEM, V271, P7501; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hagio M, 2000, PLANT PHYSIOL, V124, P795, DOI 10.1104/pp.124.2.795; Hasan SS, 2014, STRUCTURE, V22, P1008, DOI 10.1016/j.str.2014.05.004; Itoh S, 2012, BBA-BIOENERGETICS, V1817, P287, DOI 10.1016/j.bbabio.2011.10.002; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kobayashi K, 2016, SUBCELL BIOCHEM, V86, P103, DOI 10.1007/978-3-319-25979-6_5; Mazor Y, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.14; Minoda A, 2003, FEBS LETT, V553, P109, DOI 10.1016/S0014-5793(03)00981-5; Minoda A, 2002, EUR J BIOCHEM, V269, P2353, DOI 10.1046/j.1432-1033.2002.02896.x; Mizusawa N, 2012, BBA-BIOENERGETICS, V1817, P194, DOI 10.1016/j.bbabio.2011.04.008; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noguchi T, 2002, SPECTROSC-INT J, V16, P89, DOI 10.1155/2002/960232; Noguchi T, 2001, BIOCHEMISTRY-US, V40, P1497, DOI 10.1021/bi0023807; Qin XC, 2015, SCIENCE, V348, P989, DOI 10.1126/science.aab0214; Sakurai I, 2006, J BIOCHEM, V140, P201, DOI 10.1093/jb/mvj141; SATO N, 1995, EUR J BIOCHEM, V234, P16, DOI 10.1111/j.1432-1033.1995.016_c.x; Sato N, 2003, PLANTA, V217, P245, DOI 10.1007/s00425-003-0992-9; Sato N, 2016, BIOCHEM BIOPH RES CO, V477, P854, DOI 10.1016/j.bbrc.2016.06.148; Sato N, 2009, ADV PHOTOSYNTH RESP, V30, P157; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; Shen JR, 2000, BIOCHEMISTRY-US, V39, P14739, DOI 10.1021/bi001402m; Suga M, 2017, NATURE, V543, P131, DOI 10.1038/nature21400; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Sugimoto K, 2008, BIOCHEM BIOPH RES CO, V369, P660, DOI 10.1016/j.bbrc.2008.02.058; Sugiura M, 2010, BBA-BIOENERGETICS, V1797, P1491, DOI 10.1016/j.bbabio.2010.03.022; Suzuki H, 2006, BIOCHEMISTRY-US, V45, P13454, DOI 10.1021/bi061232z; Suzuki H, 2012, BIOCHEMISTRY-US, V51, P6776, DOI 10.1021/bi300708a; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WADA H, 1989, PLANT CELL PHYSIOL, V30, P971; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu B, 2003, PLANT J, V36, P762, DOI 10.1046/j.1365-313X.2003.01918.x; Yu B, 2002, P NATL ACAD SCI USA, V99, P5732, DOI 10.1073/pnas.082696499	42	18	19	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14786	14797		10.1074/jbc.RA118.004304	http://dx.doi.org/10.1074/jbc.RA118.004304			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30076221	Green Published, hybrid			2022-12-28	WOS:000446155000016
J	Hanne, J; Britton, BM; Park, J; Liu, JQ; Martin-Lopez, J; Jones, N; Schoffner, M; Klajner, P; Bundschuh, R; Lee, JB; Fishel, R				Hanne, Jeungphill; Britton, Brooke M.; Park, Jonghyun; Liu, Jiaquan; Martin-Lopez, Juana; Jones, Nathan; Schoffner, Matthew; Klajner, Piotr; Bundschuh, Ralf; Lee, Jong-Bong; Fishel, Richard			MutS homolog sliding clamps shield the DNA from binding proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; DNA mismatch repair; single-molecule biophysics; fluorescence resonance energy transfer (FRET); DNA binding protein; surface plasmon resonance (SPR); enzyme mechanism; sliding clamp; MutL; MSH2; MSH6	MISMATCH REPAIR; RECOGNITION COMPLEX; MOLECULAR SWITCH; ATPASE ACTIVITY; HMSH2-HMSH6; DIFFUSION; FORMS; IDENTIFICATION; MECHANISMS; SEQUENCE	Sliding clamps on DNA consist of evolutionarily conserved enzymes that coordinate DNA replication, repair, and the cellular DNA damage response. MutS homolog (MSH) proteins initiate mismatch repair (MMR) by recognizing mispaired nucleotides and in the presence of ATP form stable sliding clamps that randomly diffuse along the DNA. The MSH sliding clamps subsequently load MutL homolog (MLH/PMS) proteins that form a second extremely stable sliding clamp, which together coordinate downstream MMR components with the excision-initiation site that may be hundreds to thousands of nucleotides distant from the mismatch. Specific or nonspecific binding of other proteins to the DNA between the mismatch and the distant excision-initiation site could conceivably obstruct the free diffusion of these MMR sliding clamps, inhibiting their ability to initiate repair. Here, we employed bulk biochemical analysis, single-molecule fluorescence imaging, and mathematical modeling to determine how sliding clamps might overcome such hindrances along the DNA. Using both bacterial and human MSH proteins, we found that increasing the number of MSH sliding clamps on a DNA decreased the association of the Escherichia coli transcriptional repressor LacI to its cognate promoter LacO. Our results suggest a simple mechanism whereby thermal diffusion of MSH sliding clamps along the DNA alters the association kinetics of other DNA-binding proteins over extended distances. These observations appear generally applicable to any stable sliding clamp that forms on DNA.	[Hanne, Jeungphill; Britton, Brooke M.; Liu, Jiaquan; Martin-Lopez, Juana; Jones, Nathan; Schoffner, Matthew; Klajner, Piotr; Fishel, Richard] Ohio State Univ, Wexner Med Ctr, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Park, Jonghyun; Lee, Jong-Bong] Pohang Univ Sci & Technol POSTECH, Dept Phys, Pohang 790784, South Korea; [Jones, Nathan; Bundschuh, Ralf; Fishel, Richard] Ohio State Univ, Interdisciplinary Biophys Grad Program, Columbus, OH 43210 USA; [Bundschuh, Ralf] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Bundschuh, Ralf] Ohio State Univ, Ctr RNA Biol, Div Hematol, Dept Chem & Biochem,Dept Internal Med, Columbus, OH 43210 USA; [Lee, Jong-Bong] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, South Korea; [Lee, Jong-Bong] Ohio State Univ, Med Ctr, Dept Canc Biol & Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Pohang University of Science & Technology (POSTECH); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Pohang University of Science & Technology (POSTECH); University System of Ohio; Ohio State University	Fishel, R (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Canc Biol & Genet, Columbus, OH 43210 USA.; Bundschuh, R; Fishel, R (corresponding author), Ohio State Univ, Interdisciplinary Biophys Grad Program, Columbus, OH 43210 USA.; Bundschuh, R (corresponding author), Ohio State Univ, Dept Phys, Columbus, OH 43210 USA.; Bundschuh, R (corresponding author), Ohio State Univ, Ctr RNA Biol, Div Hematol, Dept Chem & Biochem,Dept Internal Med, Columbus, OH 43210 USA.; Lee, JB (corresponding author), Ohio State Univ, Med Ctr, Dept Canc Biol & Genet, Columbus, OH 43210 USA.	bundschuh@mps.ohio-state.edu; jblee@postech.ac.kr; rfishel@osu.edu	Lee, Jong-Bong/AAH-4669-2020; MARTIN-LOPEZ, JUANA VICTORIA/AAB-2367-2021; Bundschuh, Ralf/B-9623-2008	MARTIN-LOPEZ, JUANA VICTORIA/0000-0003-2777-2740; Bundschuh, Ralf/0000-0002-6699-8614; Jones, Nathan/0000-0002-2159-1394; Britton, Brooke/0000-0003-1606-0991	National Science Foundation [DMR-01410172, DMR-01719316]; National Research Foundation of Korea [2017K1A1A2013241]; National Institutes of Health [CA67007]; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA067007] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Research Foundation of Korea(National Research Foundation of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Science Foundation Grants DMR-01410172 and DMR-01719316 (to R. B.), National Research Foundation of Korea Grant No. 2017K1A1A2013241 (J.-B. L.), and National Institutes of Health Grant CA67007 (to R. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Agarwal P, 2013, BIOCONJUGATE CHEM, V24, P846, DOI 10.1021/bc400042a; Biswas I, 1996, J BIOL CHEM, V271, P5040; Chereji RV, 2011, J STAT PHYS, V144, P379, DOI 10.1007/s10955-011-0214-y; Cho WK, 2012, STRUCTURE, V20, P1264, DOI 10.1016/j.str.2012.04.017; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; Fishel R, 2015, J BIOL CHEM, V290, P26395, DOI 10.1074/jbc.R115.660142; Forties RA, 2011, NUCLEIC ACIDS RES, V39, P8306, DOI 10.1093/nar/gkr422; GILBERT W, 1973, P NATL ACAD SCI USA, V70, P3581, DOI 10.1073/pnas.70.12.3581; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; Gorman J, 2012, P NATL ACAD SCI USA, V109, pE3074, DOI 10.1073/pnas.1211364109; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; Hedglin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010165; Heinen CD, 2002, CANCER CELL, V1, P469, DOI 10.1016/S1535-6108(02)00073-9; Heinen CD, 2011, J BIOL CHEM, V286, P40287, DOI 10.1074/jbc.M111.297523; Honda M, 2014, P NATL ACAD SCI USA, V111, pE316, DOI 10.1073/pnas.1312988111; HUGHES MJ, 1992, J BIOL CHEM, V267, P23876; Hwang H, 2011, P NATL ACAD SCI USA, V108, P7414, DOI 10.1073/pnas.1017672108; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Javaid S, 2009, MOL CELL, V36, P1086, DOI 10.1016/j.molcel.2009.12.010; Jeon Y, 2016, P NATL ACAD SCI USA, V113, P3281, DOI 10.1073/pnas.1523748113; Jeong C, 2011, NAT STRUCT MOL BIOL, V18, P379, DOI 10.1038/nsmb.2009; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lee JB, 2014, DNA REPAIR, V20, P82, DOI 10.1016/j.dnarep.2014.02.014; Liu JQ, 2016, NATURE, V539, P583, DOI 10.1038/nature20562; Liu JQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16883; Locke G, 2010, P NATL ACAD SCI USA, V107, P20998, DOI 10.1073/pnas.1003838107; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Mazurek A, 2009, P NATL ACAD SCI USA, V106, P4177, DOI 10.1073/pnas.0808572106; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Tonks L, 1936, PHYS REV, V50, P955, DOI 10.1103/PhysRev.50.955; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659; Yardimci H, 2012, METHODS, V57, P179, DOI 10.1016/j.ymeth.2012.03.033	39	2	2	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14285	14294		10.1074/jbc.RA118.002264	http://dx.doi.org/10.1074/jbc.RA118.002264			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30072380	hybrid, Green Published			2022-12-28	WOS:000444671500010
J	Dijk, W; Ruppert, PMM; Oost, LJ; Kersten, S				Dijk, Wieneke; Ruppert, Philip M. M.; Oost, Lynette J.; Kersten, Sander			Angiopoietin-like 4 promotes the intracellular cleavage of lipoprotein lipase by PCSK3/furin in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipoprotein metabolism; adipocyte; furin; lipase; human; ANGPTL4; lipoprotein lipase; angiopoietin-like 4; PCSK; triglycerides	TRIGLYCERIDE-METABOLISM; PROPROTEIN CONVERTASES; ENDOTHELIAL LIPASE; ADIPOSE-TISSUE; HEPATIC LIPASE; IN-VIVO; ANGPTL3; PROTEIN; FURIN; GPIHBP1	Lipoprotein lipase (LPL) catalyzes the breakdown of circulating triglycerides in muscle and fat. LPL is inhibited by several proteins, including angiopoietin-like 4 (ANGPTL4), and may be cleaved by members of the proprotein convertase subtilisin/kexin (PCSK) family. Here, we aimed to investigate the cleavage of LPL in adipocytes by PCSKs and study the potential involvement of ANGPTL4. A substantial portion of LPL in mouse and human adipose tissue was cleaved into N- and C-terminal fragments. Treatment of different adipocytes with the PCSK inhibitor decanoyl-RVKR-chloromethyl ketone markedly decreased LPL cleavage, indicating that LPL is cleaved by PCSKs. Silencing of Pcsk3/furin significantly decreased LPL cleavage in cell culture medium and lysates of 3T3-L1 adipocytes. Remarkably, PCSK-mediated cleavage of LPL in adipocytes was diminished by Angptl4 silencing and was decreased in adipocytes and adipose tissue of Angptl4(-/-) mice. Differences in LPL cleavage between Angptl4(-/-) and WT mice were abrogated by treatment with decanoyl-RVKR-chloromethyl ketone. Induction of ANGPTL4 in adipose tissue during fasting enhanced PCSK-mediated LPL cleavage, concurrent with decreased LPL activity, in WT but not Angptl4(-/-) mice. In adipocytes, after removal of cell surface LPL by heparin, levels of N-terminal LPL were still markedly higher in WT compared with Angptl4(-/-) adipocytes, suggesting that stimulation of PCSK-mediated LPL cleavage by ANGPTL4 occurs intracellularly. Finally, treating adipocytes with insulin increased full-length LPL and decreased N-terminal LPL in an ANGPTL4-dependent manner. In conclusion, ANGPTL4 promotes PCSK-mediated intracellular cleavage of LPL in adipocytes, likely contributing to regulation of LPL in adipose tissue. Our data provide further support for an intracellular action of ANGPTL4 in adipocytes.	[Dijk, Wieneke; Ruppert, Philip M. M.; Oost, Lynette J.; Kersten, Sander] Wageningen Univ, Div Human Nutr & Hlth, Nutr Metab & Genom Grp, Stippeneng 4, NL-6708 WE Wageningen, Netherlands; [Dijk, Wieneke] INSERM, U1087, Inst Thorax, F-44000 Nantes, France	Wageningen University & Research; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Kersten, S (corresponding author), Wageningen Univ, Div Human Nutr & Hlth, Nutr Metab & Genom Grp, Stippeneng 4, NL-6708 WE Wageningen, Netherlands.	sander.kersten@wur.nl	Dijk, Wieneke/T-1856-2018; Oost, Lynette/AAY-1410-2021; Kersten, Sander/A-1116-2011; Ruppert, Philip/AAO-5002-2021	Dijk, Wieneke/0000-0003-1676-7751; Kersten, Sander/0000-0003-4488-7734; Ruppert, Philip/0000-0002-4028-8200	Fondation Leducq [12CVD04]	Fondation Leducq(Leducq Foundation)	This study was supported by Fondation Leducq Grant 12CVD04. The authors declare that they have no conflicts of interest with the contents of this article.	Alex S, 2013, MOL CELL BIOL, V33, P1303, DOI 10.1128/MCB.00858-12; Allan CM, 2016, J LIPID RES, V57, P1889, DOI 10.1194/jlr.M070813; BENSADOUN A, 1991, ANNU REV NUTR, V11, P217, DOI 10.1146/annurev.nu.11.070191.001245; BENZEEV O, 1994, J LIPID RES, V35, P1511; Catoire M, 2014, P NATL ACAD SCI USA, V111, pE1043, DOI 10.1073/pnas.1400889111; CHAJEKSHAUL T, 1985, BIOCHIM BIOPHYS ACTA, V837, P123, DOI 10.1016/0005-2760(85)90235-8; Chi X, 2017, MOL METAB, V6, P1137, DOI 10.1016/j.molmet.2017.06.014; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; CISAR LA, 1989, J BIOL CHEM, V264, P1767; Cushing EM, 2017, MOL METAB, V6, P809, DOI 10.1016/j.molmet.2017.06.007; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; DAVIS RC, 1992, J BIOL CHEM, V267, P21499; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; Dewey FF, 2016, NEW ENGL J MED, V374, P1123, DOI 10.1056/NEJMoa1510926; Dijk W, 2018, J CLIN LIPIDOL, V12, P773, DOI 10.1016/j.jacl.2018.02.006; Dijk W, 2016, J LIPID RES, V57, P1949, DOI 10.1194/jlr.M067363ERR; Dijk W, 2016, CURR OPIN LIPIDOL, V27, P249, DOI 10.1097/MOL.0000000000000290; Dijk W, 2015, ELIFE, V4, DOI 10.7554/eLife.08428; DOOLITTLE MH, 1990, J BIOL CHEM, V265, P4570; Essalmani R, 2013, J BIOL CHEM, V288, P26410, DOI 10.1074/jbc.M113.501304; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; Gin P, 2012, HUM MOL GENET, V21, P2961, DOI 10.1093/hmg/dds127; Goulbourne CN, 2014, CELL METAB, V19, P849, DOI 10.1016/j.cmet.2014.01.017; Haller JF, 2017, J LIPID RES, V58, P1166, DOI 10.1194/jlr.M075689; Jin WJ, 2005, J BIOL CHEM, V280, P36551, DOI 10.1074/jbc.M502264200; KERN PA, 1990, J LIPID RES, V31, P17; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Kroupa Olessia, 2012, BMC Physiology, V12, P13, DOI 10.1186/1472-6793-12-13; Lagace TA, 2014, CURR OPIN LIPIDOL, V25, P387, DOI 10.1097/MOL.0000000000000114; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Liu J, 2010, J BIOL CHEM, V285, P27561, DOI 10.1074/jbc.M110.144279; Lookene A, 2000, BIOCHEM BIOPH RES CO, V271, P15, DOI 10.1006/bbrc.2000.2530; Lookene A, 1996, BIOCHEMISTRY-US, V35, P12155, DOI 10.1021/bi960008e; Lutz EP, 2001, J CLIN INVEST, V107, P1183, DOI 10.1172/JCI11774; Makoveichuk E, 2013, BIOCHEM BIOPH RES CO, V441, P941, DOI 10.1016/j.bbrc.2013.11.013; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Musunuru K, 2016, CIRC RES, V118, P579, DOI 10.1161/CIRCRESAHA.115.306398; Myocardial IG, 2016, NEW ENGL J MED, V374, P1134, DOI DOI 10.1056/NEJM0A1507652; Mysling S, 2016, ELIFE, V5, DOI 10.7554/eLife.20958; Mysling S, 2016, ELIFE, V5, DOI 10.7554/eLife.12095; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Turpeinen H, 2013, CURR GENOMICS, V14, P453, DOI 10.2174/1389202911314050010; Wang Y, 2015, P NATL ACAD SCI USA, V112, P11630, DOI 10.1073/pnas.1515374112; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Weinstein MM, 2008, J BIOL CHEM, V283, P34511, DOI 10.1074/jbc.M806067200; Xu YX, 2018, ATHEROSCLEROSIS, V268, P196, DOI 10.1016/j.atherosclerosis.2017.08.031	52	39	41	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14134	14145		10.1074/jbc.RA118.002426	http://dx.doi.org/10.1074/jbc.RA118.002426			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30021841	hybrid, Green Published			2022-12-28	WOS:000444070700034
J	Macpherson, A; Liu, XF; Dedi, N; Kennedy, J; Carrington, B; Durrant, O; Heywood, S; van den Elsen, J; Lawson, ADG				Macpherson, Alex; Liu, Xiaofeng; Dedi, Neesha; Kennedy, Jeffery; Carrington, Bruce; Durrant, Oliver; Heywood, Sam; van den Elsen, Jean; Lawson, Alastair D. G.			The rational design of affinity-attenuated OmCI for the purification of complement C5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						complement system; mutagenesis; biophysics; protein purification; complement; complement component C5; immune evasion; OmCI	STRUCTURAL BASIS; 5TH COMPONENT; DOUBLE-BLIND; ECULIZUMAB; INHIBITOR; EFFICACY; RECEPTOR; CONVERTASE; SAFETY; PATHWAY	Complement component C5 is the target of the mAb eculizumab and is the focus of a sustained drug discovery effort to prevent complement-induced inflammation in a range of autoimmune diseases. The immune evasion protein OmCI binds to and potently inactivates C5; this tight-binding interaction can be exploited to affinity-purify C5 protein from serum, offering a vastly simplified protocol compared with existing methods. However, breaking the high-affinity interaction requires conditions that risk denaturing or activating C5. We performed structure-guided in silico mutagenesis to identify prospective OmCI residues that contribute significantly to the binding affinity. We tested our predictions in vitro, using site-directed mutagenesis, and characterized mutants using a range of biophysical techniques, as well as functional assays. Our biophysical analyses suggest that the C5-OmCI interaction is complex with potential for multiple binding modes. We present single mutations that lower the affinity of OmCI for C5 and combinations of mutations that significantly decrease or entirely abrogate formation of the complex. The affinity-attenuated forms of OmCI are suitable for affinity purification and allow elution under mild conditions that are nondenaturing or activating to C5. We present the rational design, biophysical characterization, and experimental validation of affinity-reduced forms of OmCI as tool reagents to enable the affinity purification of C5.	[Macpherson, Alex; Liu, Xiaofeng; Dedi, Neesha; Kennedy, Jeffery; Carrington, Bruce; Durrant, Oliver; Heywood, Sam; Lawson, Alastair D. G.] UCB Celltech, 216 Bath Rd, Slough SL1 3WE, Berks, England; [Macpherson, Alex; van den Elsen, Jean] Univ Bath, Dept Biol & Biochem, Bath BA2 7AX, Avon, England	Celltech Group Ltd; University of Bath	Macpherson, A (corresponding author), UCB Celltech, 216 Bath Rd, Slough SL1 3WE, Berks, England.	Alex.Macpherson@ucb.com		van den Elsen, Jean/0000-0002-0367-1956; Durrant, Oliver/0000-0003-3183-7025; Macpherson, Alex/0000-0002-4508-5322	UCB	UCB(UCB Pharma SA)	This work has been funded by UCB. Except for J.v.d.E., all authors are UCB employees and may hold shares and/or share options in UCB.	Aleshin AE, 2012, J BIOL CHEM, V287, P19642, DOI 10.1074/jbc.M112.361121; DESSAUER A, 1983, IMMUNOBIOLOGY, V164, P370, DOI 10.1016/S0171-2985(83)80033-3; DiScipio RG, 1999, J BIOL CHEM, V274, P31811, DOI 10.1074/jbc.274.45.31811; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Fredslund F, 2008, NAT IMMUNOL, V9, P753, DOI 10.1038/ni.1625; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Hadders MA, 2012, CELL REP, V1, P200, DOI 10.1016/j.celrep.2012.02.003; Hepburn NJ, 2007, J BIOL CHEM, V282, P8292, DOI 10.1074/jbc.M609858200; Hill Anita, 2005, Clin Adv Hematol Oncol, V3, P849; Hillmen P, 2013, BRIT J HAEMATOL, V162, P62, DOI 10.1111/bjh.12347; Howard JF, 2017, LANCET NEUROL, V16, P976, DOI 10.1016/S1474-4422(17)30369-1; Howard JF, 2013, MUSCLE NERVE, V48, P76, DOI 10.1002/mus.23839; Johnson CK, 2015, CURR OPIN ORGAN TRAN, V20, P643, DOI 10.1097/MOT.0000000000000249; Jore MM, 2016, NAT STRUCT MOL BIOL, V23, P378, DOI 10.1038/nsmb.3196; Kaabak M, 2018, PEDIATR TRANSPLANT, V22, DOI 10.1111/petr.13129; Kuhn N, 2016, BIOCONJUGATE CHEM, V27, P2359, DOI 10.1021/acs.bioconjchem.6b00369; KUNKEL SL, 1980, J IMMUNOL METHODS, V35, P337, DOI 10.1016/0022-1759(80)90259-8; Laursen NS, 2011, EMBO J, V30, P606, DOI 10.1038/emboj.2010.341; Licht C, 2015, KIDNEY INT, V87, P1061, DOI 10.1038/ki.2014.423; Lockington D, 2010, CAN J OPHTHALMOL, V45, P649, DOI 10.3129/i10-060; Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657; Nishimura J, 2014, NEW ENGL J MED, V370, P632, DOI 10.1056/NEJMoa1311084; Nunn M. A., 2016, MODIFIED OMCI COMPLE; Onell A, 2005, J MOL RECOGNIT, V18, P307, DOI 10.1002/jmr.745; Pangburn MK, 2002, BIOCHEM SOC T, V30, P1006, DOI 10.1042/bst0301006; Pittock SJ, 2013, LANCET NEUROL, V12, P554, DOI 10.1016/S1474-4422(13)70076-0; Rathbone J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003573; Rawal N, 1998, J BIOL CHEM, V273, P16828, DOI 10.1074/jbc.273.27.16828; Rawal N, 2003, J BIOL CHEM, V278, P38476, DOI 10.1074/jbc.M307017200; Rawal N, 2001, INT IMMUNOPHARMACOL, V1, P415, DOI 10.1016/S1567-5769(00)00039-4; Ricklin D, 2016, SEMIN IMMUNOL, V28, P208, DOI 10.1016/j.smim.2016.06.001; Roversi P, 2007, J MOL BIOL, V369, P784, DOI 10.1016/j.jmb.2007.03.064; Roversi P, 2013, J BIOL CHEM, V288, P18789, DOI 10.1074/jbc.M112.420331; Roy U, 2007, BIOCHEM MOL BIOL EDU, V35, P238, DOI 10.1002/bmb.65; Schatz-Jakobsen JA, 2016, J IMMUNOL, V197, P337, DOI 10.4049/jimmunol.1600280; Serna M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10587; SJOHOLM AG, 1975, SCAND J IMMUNOL, V4, P25, DOI 10.1111/j.1365-3083.1975.tb02596.x; Sottrup-Jensen L, 2014, METHODS MOL BIOL, V1100, P93, DOI 10.1007/978-1-62703-724-2_7; Volk AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31365; WETSEL RA, 1980, J IMMUNOL METHODS, V35, P319, DOI 10.1016/0022-1759(80)90258-6; Woodruff TM, 2011, MOL IMMUNOL, V48, P1631, DOI 10.1016/j.molimm.2011.04.014; Yehoshua Z, 2014, OPHTHALMOLOGY, V121, P693, DOI 10.1016/j.ophtha.2013.09.044	42	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14112	14121		10.1074/jbc.RA118.004043	http://dx.doi.org/10.1074/jbc.RA118.004043			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30030376	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000444070700032
J	Cal, S; Quesada, V; Llamazares, M; Diaz-Perales, A; Garabaya, C; Lopez-Otin, C				Cal, Santiago; Quesada, Victor; Llamazares, Maria; Diaz-Perales, Araceli; Garabaya, Cecilia; Lopez-Otin, Carlos			Human polyserase-2, a novel enzyme with three tandem serine protease domains in a single polypeptide chain (vol 280, pg 1953, 2005)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Díaz-Perales, Araceli/D-8433-2016; Llamazares-Prada, Maria/ABX-0849-2022	Díaz-Perales, Araceli/0000-0002-1093-3627; 				Cal S, 2005, J BIOL CHEM, V280, P1953, DOI 10.1074/jbc.M409139200	1	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11784	11784		10.1074/jbc.AAC118.004649	http://dx.doi.org/10.1074/jbc.AAC118.004649			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	30054290	hybrid, Green Published			2022-12-28	WOS:000440134500011
J	Jorge, R; Zarich, N; Oliva, JL; Azanedo, M; Martinez, N; de la Cruz, X; Rojas, JM				Jorge, Rocio; Zarich, Natasha; Oliva, Jose Luis; Azanedo, Marta; Martinez, Natalia; de la Cruz, Xavier; Rojas, Jose M.			RETRACTION: hSos1 contains a new amino-terminal regulatory motif with specific binding affinity for its pleckstrin homology domain (Retraction of Vol 277, Pg 44171, 2002)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction														Zarich, Natasha/0000-0003-1058-6191				Jorge B, 2002, J BIOL CHEM, V277, P44171, DOI 10.1074/jbc.M204423200	1	1	1	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11650	11650		10.1074/jbc.W118.004643	http://dx.doi.org/10.1074/jbc.W118.004643			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	30030385	Green Published, hybrid			2022-12-28	WOS:000439449700034
